data_2m5g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m5g _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.407 ' CB ' ' HB3' ' A' ' 36' ' ' GLN . 80.4 p . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.927 0.394 . . . . 74.22 110.682 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG23 HG11 ' A' ' 37' ' ' VAL . 27.7 m -86.86 16.65 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.05 0.452 . . . . 75.53 111.083 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 61.93 13.12 5.32 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.566 -0.743 . . . . 71.11 112.211 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.47 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 91.14 101.26 1.25 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.558 -0.829 . . . . 73.21 111.785 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.423 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -92.65 160.19 25.29 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.431 -0.89 . . . . 71.34 111.777 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.511 HG21 ' HA ' ' A' ' 33' ' ' GLN . 66.4 p -143.3 149.17 37.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.883 0.373 . . . . 72.02 110.637 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.489 HG21 HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -123.67 117.86 52.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.997 -0.547 . . . . 74.55 110.503 175.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -95.72 112.51 24.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.399 -0.818 . . . . 61.0 110.118 -177.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 59.4 m-85 -94.39 137.29 33.72 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.812 -0.631 . . . . 65.23 110.562 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.76 ' HZ2' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -114.58 137.62 51.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.973 -0.558 . . . . 75.04 110.301 -179.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.21 -133.41 4.06 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.759 -0.734 . . . . 72.22 112.504 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 49.2 mt-10 60.65 21.27 11.19 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.212 0.53 . . . . 62.1 111.115 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 155' ' ' LYS . 24.8 m -76.32 -23.81 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.748 -0.66 . . . . 75.11 111.132 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.428 HG21 ' CG2' ' A' ' 156' ' ' VAL . 24.1 m -135.71 148.28 28.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.126 -0.488 . . . . 63.14 111.361 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -151.31 26.73 0.68 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.502 -0.925 . . . . 54.42 108.502 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.36 -79.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.115 -0.948 . . . . 54.21 111.408 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -84.73 -37.53 20.77 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.859 0.361 . . . . 72.45 110.858 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -140.7 132.46 27.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.141 -0.481 . . . . 74.04 109.873 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.58 123.21 37.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.254 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 t -66.44 133.33 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.862 -0.422 . . . . 71.24 109.862 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 28' ' ' VAL . 19.2 t70 -62.05 147.96 45.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 72.22 111.043 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.409 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -62.25 -25.39 67.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 74.55 111.783 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 30' ' ' GLN . . . -86.13 -9.76 76.18 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.589 -0.815 . . . . 71.35 111.627 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.0 m -105.23 -23.25 12.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.465 0.174 . . . . 40.34 111.124 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 25.5 m -77.56 -12.18 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.335 0.588 . . . . 74.25 110.215 176.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -153.58 96.01 1.97 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.964 -1.016 . . . . 71.43 109.217 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.457 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 24.9 pt20 -148.34 142.81 26.38 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.01 -0.541 . . . . 74.54 110.421 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.497 HG22 ' HB ' ' A' ' 9' ' ' THR . 6.9 m -124.0 101.3 7.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.628 -0.714 . . . . 72.45 109.649 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.18 129.22 39.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.088 0.47 . . . . 75.45 110.407 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.511 ' HA ' HG21 ' A' ' 9' ' ' THR . 26.2 mp0 -85.63 130.57 34.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.698 -0.683 . . . . 70.22 110.245 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.489 HD21 HG21 ' A' ' 10' ' ' VAL . 2.3 mm? -91.27 -17.08 26.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.152 -0.476 . . . . 73.22 110.109 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.47 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 86.58 174.87 49.47 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.939 -0.648 . . . . 72.14 112.476 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.407 ' HB3' ' CB ' ' A' ' 4' ' ' THR . 81.2 mt-30 -77.36 89.11 3.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.137 -0.32 . . . . 74.25 110.137 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.471 HG11 HG23 ' A' ' 5' ' ' VAL . 9.9 p -68.49 144.67 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.804 -0.443 . . . . 73.44 109.804 176.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 38' ' ' ARG . 44.3 mtp180 -85.31 123.75 31.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.899 -0.408 . . . . 73.02 109.899 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.587 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 35.6 p -68.7 -23.22 64.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.169 -0.469 . . . . 65.54 111.456 -176.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.98 -15.71 61.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 72.15 111.066 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -87.92 -12.7 43.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.398 . . . . 75.21 110.731 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.591 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -129.02 84.75 2.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.225 -0.443 . . . . 74.14 110.089 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.37 19.58 12.71 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.704 -0.399 . . . . 42.41 111.849 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -150.04 140.21 22.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.702 0.287 . . . . 71.22 110.774 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 3.9 tm-20 -56.12 117.96 4.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.714 -0.676 . . . . 72.53 109.478 174.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.35 -1.09 31.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.756 -0.735 . . . . 52.21 112.345 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.15 134.4 42.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 73.54 110.708 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.2 p -119.7 145.83 46.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.21 -0.45 . . . . 74.32 110.934 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 t -110.23 -179.23 3.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.307 -0.406 . . . . 74.24 110.08 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.8 m -70.57 140.74 51.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.346 -0.388 . . . . 71.12 110.255 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -95.58 155.79 16.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.455 0.645 . . . . 73.41 111.936 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.7 m -95.61 152.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.485 -1.234 . . . . 73.42 109.265 170.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.23 79.63 0.26 Allowed Glycine 0 C--N 1.312 -0.793 0 C-N-CA 120.795 -0.717 . . . . 37.35 112.315 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 133' ' ' PHE . 41.8 p90 -87.83 162.48 16.95 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.807 -0.442 . . . . 75.24 109.807 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.487 ' HB2' HG21 ' A' ' 130' ' ' THR . 3.8 p-10 -132.05 142.55 49.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.258 0.551 . . . . 64.12 111.733 -174.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.5 mt -106.62 109.14 27.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.604 -0.725 . . . . 75.23 109.305 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -89.33 136.22 33.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.197 0.523 . . . . 74.35 111.111 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.38 124.66 49.43 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.494 -0.776 . . . . 74.31 109.18 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -100.56 130.64 46.65 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.974 -0.38 . . . . 74.1 109.974 -176.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.8 t70 54.92 74.61 0.35 Allowed 'General case' 0 C--N 1.332 -0.189 0 O-C-N 124.0 0.813 . . . . 73.22 110.619 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 38.3 t -102.28 124.06 47.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.228 -0.896 . . . . 75.02 110.066 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -98.33 137.41 37.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.21 -0.45 . . . . 72.53 111.555 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.423 HG21 ' HB2' ' A' ' 124' ' ' LEU . 64.1 p -110.09 18.97 19.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 61.22 112.071 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -98.96 -26.51 14.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.458 -0.571 . . . . 64.24 109.458 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.0 -2.3 10.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 72.33 110.251 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.589 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -144.21 179.16 7.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 73.3 110.462 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.7 m -141.2 -56.86 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.709 0.29 . . . . 75.43 111.297 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.54 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -136.2 143.09 44.19 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.756 -0.461 . . . . 73.31 109.756 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.446 ' HB1' HD22 ' A' ' 124' ' ' LEU . . . -102.65 123.49 46.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.072 0.463 . . . . 51.32 110.445 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.55 115.15 16.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.633 -0.712 . . . . 74.45 109.606 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 3.3 m -91.53 149.8 3.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.137 0.494 . . . . 75.44 111.282 -173.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.454 ' HB3' ' CD1' ' A' ' 118' ' ' PHE . . . -116.08 118.61 33.36 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.726 -0.67 . . . . 73.11 109.904 174.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.53 ' CE1' HG23 ' A' ' 103' ' ' ILE . 49.2 m-85 -87.96 124.14 33.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.19 0.519 . . . . 74.13 110.993 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 56.4 tp -114.97 125.77 54.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.571 -0.74 . . . . 62.45 109.38 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.66 -179.56 33.6 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.037 -0.825 . . . . 74.43 111.037 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -67.5 120.26 13.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.785 0.293 . . . . 75.23 110.778 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.49 132.55 35.71 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.972 -0.381 . . . . 73.55 109.972 175.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.443 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 7.3 tt -73.78 -25.66 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.017 0.437 . . . . 73.22 110.941 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 19.1 t70 -159.54 174.53 14.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.423 -0.584 . . . . 75.45 109.423 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.06 -33.15 44.88 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.167 0.508 . . . . 75.24 109.974 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.98 -0.58 80.87 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.216 -0.753 . . . . 51.31 111.216 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 53.5 m80 -131.37 43.35 3.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.938 -0.631 . . . . 74.24 109.958 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 p -71.65 -2.06 15.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 74.12 110.984 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 33.6 p-10 -104.02 9.6 36.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.97 -0.559 . . . . 72.43 110.334 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 t -120.36 123.22 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.858 -0.61 . . . . 71.33 110.174 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -68.46 124.58 23.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.158 -0.682 . . . . 73.12 109.158 177.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 78' ' ' ILE . . . -78.0 150.31 33.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.887 -0.597 . . . . 50.51 109.846 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.495 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.5 mm? -78.2 126.23 30.49 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.227 -0.657 . . . . 61.53 109.227 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.555 ' HG2' ' HA ' ' A' ' 150' ' ' ALA . 14.1 mm100 . . . . . 0 CA--C 1.512 -0.497 0 CA-C-O 121.639 0.733 . . . . 64.43 109.752 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.233 0.196 0 N-CA-C 109.862 -0.422 . . . . 72.44 109.862 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.05 152.63 29.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.244 -0.28 . . . . 75.41 110.244 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.57 164.09 30.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.613 -0.435 . . . . 73.42 111.208 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 66.48 16.5 10.43 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.583 -0.735 . . . . 63.23 111.104 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.406 ' O ' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -147.79 -175.07 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 63.21 110.559 175.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -179.68 -167.15 36.49 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.067 -1.213 . . . . 74.24 110.067 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 86' ' ' LEU . 2.3 p -135.8 129.35 48.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.724 0.774 . . . . 74.14 110.847 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -110.54 138.78 46.48 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.132 -0.94 . . . . 64.51 110.322 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.53 HG23 ' CE1' ' A' ' 73' ' ' PHE . 3.9 mp -95.02 114.66 32.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.023 -0.732 . . . . 64.32 109.023 173.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 57.5 mt -85.55 128.0 34.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.724 -0.671 . . . . 64.23 110.331 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.68 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 2.8 t70 -57.42 166.34 1.26 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 64.23 110.406 174.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 106' ' ' ARG . 13.4 ptm180 -58.94 -17.5 25.07 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.386 0.514 . . . . 74.23 112.386 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.1 p -92.08 -7.67 48.01 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.836 0.35 . . . . 64.22 111.512 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.66 48.06 3.29 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.868 -0.682 . . . . 73.14 112.319 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -134.04 134.13 42.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.839 -0.212 . . . . 63.53 110.82 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.01 131.98 48.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.613 0.244 . . . . 73.35 110.911 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.509 HD22 ' HB2' ' A' ' 105' ' ' ASP . 84.9 mt -94.57 134.21 37.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.969 0.414 . . . . 74.14 111.283 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 82.0 m -73.45 134.43 43.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.789 -0.641 . . . . 74.31 110.715 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 43.5 mt -81.08 50.59 1.43 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.478 0.656 . . . . 74.21 110.731 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.413 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 13.9 t70 -90.11 -19.9 23.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.224 -0.898 . . . . 74.11 110.787 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.47 -28.76 6.63 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.776 -0.725 . . . . 43.21 112.349 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.75 4.07 21.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.382 . . . . 74.21 111.006 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 114' ' ' ASP . 26.9 m -90.86 99.83 12.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.382 -0.372 . . . . 72.24 110.1 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.637 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 63.1 m-85 -90.04 157.47 17.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 71.44 111.152 -175.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.68 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . 5.4 m -73.72 -167.24 0.44 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.649 -0.705 . . . . 75.01 111.255 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.9 m -80.98 178.41 8.44 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.875 0.369 . . . . 62.41 111.067 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.54 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 38.1 mt-10 -75.09 105.67 6.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.079 -0.51 . . . . 74.03 111.573 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.514 HG22 HG12 ' A' ' 131' ' ' ILE . 88.4 m -87.32 99.46 12.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.819 -0.808 . . . . 74.21 108.819 168.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.3 m -56.91 114.86 2.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.851 -0.613 . . . . 74.42 110.653 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.498 HD21 ' SG ' ' A' ' 61' ' ' CYS . 97.5 mt -79.89 146.43 32.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.664 -0.698 . . . . 73.5 110.965 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.492 HD21 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -123.06 149.06 44.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.829 -0.804 . . . . 64.0 108.829 174.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 94.6 m-20 -68.52 95.99 0.67 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.964 0.412 . . . . 73.32 110.694 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 146.99 -141.05 9.05 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.998 -0.62 . . . . 73.41 111.8 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.417 ' C ' HD21 ' A' ' 129' ' ' ASN . 29.1 m -81.58 124.71 29.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.001 0.429 . . . . 64.1 110.257 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.468 ' N ' HD21 ' A' ' 129' ' ' ASN . 0.9 OUTLIER -119.8 160.2 23.08 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.321 -0.622 . . . . 72.33 109.321 177.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.487 HG21 ' HB2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -149.06 126.57 11.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.24 -0.281 . . . . 75.34 110.24 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.514 HG12 HG22 ' A' ' 122' ' ' THR . 9.2 mt -104.23 109.41 62.52 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.937 -0.394 . . . . 70.44 109.937 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -88.6 127.31 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.821 2.347 . . . . 72.2 112.904 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . 73.6 m-85 -124.9 167.31 14.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.1 -0.5 . . . . 74.22 110.266 178.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.65 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 99.4 mt-30 -124.27 122.14 36.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.923 0.392 . . . . 74.01 111.1 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.85 123.03 47.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.376 -0.375 . . . . 71.45 110.403 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.495 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 5.7 ptp180 -137.86 161.2 37.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.537 -0.301 . . . . 74.53 110.96 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 63.2 m-85 -80.55 147.15 30.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.987 -0.552 . . . . 74.21 111.204 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -134.38 122.48 22.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.392 -0.822 . . . . 75.34 109.003 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.591 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -86.98 135.36 33.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.91 0.386 . . . . 44.23 111.63 -176.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.561 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 34.8 p -109.45 14.72 23.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.712 0.768 . . . . 71.32 109.228 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.17 -132.05 2.51 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 114.722 -1.126 . . . . 52.01 110.293 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.402 ' O ' HG21 ' A' ' 144' ' ' THR . . . -93.78 100.59 12.77 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.879 -0.786 . . . . 74.41 108.879 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.587 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.47 114.92 0.83 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.013 0.82 . . . . 64.42 110.848 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 142' ' ' ALA . 22.6 p -105.63 143.15 26.25 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 116.281 -0.418 . . . . 63.01 110.198 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.84 158.15 58.6 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.165 2.577 . . . . 71.42 112.821 -174.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.84 -174.38 24.98 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.55 -0.75 . . . . 51.43 111.364 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.93 103.84 2.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.968 0.413 . . . . 72.34 111.144 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.495 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -99.68 66.13 1.39 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.238 0.542 . . . . 74.5 110.535 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -119.88 136.88 54.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.867 -0.606 . . . . 72.55 109.814 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.555 ' HA ' ' HG2' ' A' ' 89' ' ' GLN . . . -136.25 163.63 29.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.083 0.468 . . . . 65.22 111.837 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -123.08 135.24 54.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.541 -0.754 . . . . 74.14 109.559 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' PHE . . . -141.52 129.72 22.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.049 0.452 . . . . 74.44 111.275 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.468 HG23 ' HB3' ' A' ' 13' ' ' LYS . 49.1 p -106.6 125.5 51.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.136 -0.484 . . . . 71.11 109.921 175.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -105.46 136.49 44.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.168 0.508 . . . . 73.21 111.343 -176.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.637 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 10.1 ttmm -113.05 106.45 14.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.645 -0.707 . . . . 72.22 110.213 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.9 OUTLIER -74.56 141.53 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.199 -0.6 . . . . 62.53 109.573 178.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -125.79 115.73 20.48 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.164 -0.471 . . . . 74.04 109.789 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.589 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 1.3 p90 . . . . . 0 C--N 1.32 -0.684 0 CA-C-O 121.465 0.65 . . . . 73.21 110.324 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 120.78 0.324 . . . . 72.11 110.277 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.426 ' CG2' HG11 ' A' ' 37' ' ' VAL . 35.7 m -86.47 14.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.093 0.473 . . . . 71.53 111.053 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 62.81 13.95 6.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.452 -0.794 . . . . 72.51 112.359 175.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.495 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 92.42 89.39 1.51 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.673 -0.775 . . . . 65.34 111.82 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.432 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -76.75 158.13 48.2 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.691 -0.766 . . . . 44.1 112.072 -177.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.545 ' HB ' HG21 ' A' ' 31' ' ' THR . 12.9 p -141.4 139.66 33.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.571 0.224 . . . . 70.23 110.904 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -114.33 120.05 63.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.512 -0.551 . . . . 73.31 109.512 174.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -86.17 102.91 14.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.732 -0.47 . . . . 72.0 109.732 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -92.55 105.43 17.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 75.15 109.776 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 50.3 tttp -106.31 136.43 46.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.012 -0.54 . . . . 75.54 110.149 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.45 -112.81 2.44 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.874 -0.679 . . . . 71.51 112.111 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.555 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 28.0 mt-10 61.09 22.72 12.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.25 0.548 . . . . 71.43 110.685 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.569 HG22 ' HA ' ' A' ' 155' ' ' LYS . 19.1 m -77.72 -27.28 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.311 -0.859 . . . . 71.02 111.798 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.65 145.11 34.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.209 0.528 . . . . 65.24 111.821 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -159.65 84.11 0.75 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.911 -1.04 . . . . 74.23 108.236 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.35 -79.1 0.1 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.571 -0.741 . . . . 73.12 110.947 -172.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.515 ' HB1' ' CE1' ' A' ' 158' ' ' TYR . . . -76.76 -33.12 58.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.293 0.568 . . . . 75.34 109.642 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.6 m -141.73 173.64 11.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.327 -0.851 . . . . 64.31 109.165 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.09 123.81 27.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.683 -0.488 . . . . 74.2 109.683 173.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.7 t -66.14 128.82 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.644 -0.502 . . . . 73.25 109.644 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.458 ' O ' HG13 ' A' ' 28' ' ' VAL . 28.8 t70 -60.7 138.02 58.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.99 -0.55 . . . . 73.1 111.203 -176.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.481 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -59.35 -24.94 63.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.822 -0.627 . . . . 75.41 112.126 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.91 -13.14 83.42 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.581 -0.819 . . . . 71.21 112.229 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.8 p -112.43 -9.83 13.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.714 0.264 . . . . 73.4 111.714 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.3 m -86.35 -1.5 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 122.361 -0.212 . . . . 75.23 111.486 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -156.82 42.27 0.35 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.438 0.637 . . . . 73.53 109.552 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -91.98 123.64 35.49 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.491 -0.777 . . . . 72.12 110.127 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.545 HG21 ' HB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -109.84 95.26 5.48 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.525 -0.761 . . . . 73.52 109.606 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.1 p -81.64 130.06 36.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.984 -0.553 . . . . 63.15 111.28 -174.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -83.94 118.97 24.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.711 -0.677 . . . . 54.13 109.933 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.448 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.6 mm? -79.13 -22.49 45.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.347 0.594 . . . . 71.32 109.468 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.495 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.22 175.92 39.12 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.384 -0.826 . . . . 70.05 111.78 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -78.63 83.95 4.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.441 -0.207 . . . . 72.41 110.441 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.426 HG11 ' CG2' ' A' ' 5' ' ' VAL . 8.8 p -66.52 140.28 19.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.471 -0.566 . . . . 72.02 109.471 176.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -86.19 117.83 25.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.216 0.532 . . . . 74.41 109.838 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 26.7 p -65.75 -21.98 66.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 72.23 111.5 -174.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.56 -17.28 64.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.913 -0.585 . . . . 51.52 111.118 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.7 m -84.02 -14.15 51.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 74.31 111.138 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -123.63 94.49 4.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.925 0.393 . . . . 73.23 109.977 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.39 10.96 10.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.651 0.612 . . . . 54.3 112.651 -170.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -150.04 146.31 26.9 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.873 -0.331 . . . . 64.24 110.851 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -56.35 122.53 12.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.718 -0.674 . . . . 74.53 109.64 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.42 -7.0 32.07 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.646 -0.788 . . . . 72.42 112.272 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.61 119.09 14.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 62.55 110.697 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 p -113.31 130.64 56.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.016 -0.538 . . . . 74.54 110.158 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.5 t -89.98 175.47 7.17 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.977 -0.379 . . . . 74.12 109.977 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.1 m -70.77 136.79 49.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.791 -0.448 . . . . 72.22 109.791 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -89.08 159.69 17.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.526 0.679 . . . . 71.4 112.161 -173.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.1 m -91.31 152.42 3.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.715 -1.13 . . . . 71.34 109.552 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.0 106.13 2.44 Favored Glycine 0 C--N 1.312 -0.759 0 C-N-CA 121.095 -0.574 . . . . 71.52 112.076 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -122.77 170.28 10.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.346 -0.613 . . . . 74.35 109.346 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.457 ' C ' HD21 ' A' ' 55' ' ' ASN . 0.3 OUTLIER -135.89 149.93 49.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.449 0.642 . . . . 70.33 112.454 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.0 mt -103.54 119.79 52.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.369 -0.832 . . . . 64.15 109.129 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -102.85 132.28 49.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.095 0.474 . . . . 73.04 111.187 -172.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.2 mt -115.31 124.7 51.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.902 -0.59 . . . . 75.32 109.757 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -98.95 132.67 44.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.166 -0.47 . . . . 73.43 110.355 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.3 t70 55.65 76.45 0.27 Allowed 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.918 0.762 . . . . 75.31 110.807 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.58 146.96 23.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.286 -0.87 . . . . 74.01 111.282 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -116.92 129.69 56.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.476 -0.784 . . . . 74.55 110.849 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.1 p -105.96 16.71 24.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.283 -0.417 . . . . 74.21 111.791 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -92.24 -32.93 14.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.086 0.469 . . . . 73.44 109.92 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.2 p -105.96 -33.67 2.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.154 -0.476 . . . . 65.12 110.692 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -103.81 178.61 4.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 62.11 110.643 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.456 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 18.5 m -140.19 -56.9 0.54 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.868 0.366 . . . . 73.21 111.049 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.456 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -135.89 154.82 51.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.343 -0.614 . . . . 74.12 109.343 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 157' ' ' GLN . . . -111.26 133.64 53.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.084 0.468 . . . . 72.12 110.104 176.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.01 117.62 9.79 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.623 -0.717 . . . . 63.5 109.622 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.2 m -90.88 147.24 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.085 0.469 . . . . 74.44 111.226 -174.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.2 123.58 41.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.542 -0.754 . . . . 43.22 109.207 172.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 80.1 m-85 -85.59 135.11 33.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.024 0.44 . . . . 75.4 110.577 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.1 tp -133.49 118.69 18.63 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.807 -0.633 . . . . 73.31 110.308 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.42 -168.88 29.28 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.131 -0.788 . . . . 64.0 111.131 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -81.48 118.96 23.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.83 0.315 . . . . 73.33 111.006 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.417 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -77.16 141.77 39.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.251 -0.431 . . . . 74.33 110.366 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.454 HG22 ' HB ' ' A' ' 85' ' ' VAL . 5.1 tt -68.11 -32.47 56.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.282 -0.417 . . . . 73.02 111.18 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.64 175.03 11.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.527 -0.306 . . . . 75.23 110.181 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.59 -33.61 35.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.886 -0.597 . . . . 74.42 110.513 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.58 -14.93 59.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.55 -0.833 . . . . 75.42 111.77 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -114.21 57.71 0.7 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.28 0.562 . . . . 71.3 109.574 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.417 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 1.4 p -77.15 8.5 3.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.382 -0.826 . . . . 73.21 112.474 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.41 ' OD1' HG22 ' A' ' 85' ' ' VAL . 23.4 p30 -108.55 -8.82 15.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.979 0.418 . . . . 75.41 110.802 177.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.454 ' HB ' HG22 ' A' ' 78' ' ' ILE . 48.5 t -98.76 122.56 50.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.459 . . . . 73.5 110.983 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.488 HD13 ' HB2' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -70.39 134.46 47.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 74.42 109.84 177.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.44 152.07 32.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.165 -0.471 . . . . 70.03 110.571 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.419 ' HG ' ' HB2' ' A' ' 96' ' ' ALA . 1.9 mm? -78.02 138.45 38.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.232 -0.44 . . . . 70.33 110.391 -177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 70.31 110.211 177.862 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.919 -0.4 . . . . 73.22 109.919 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.419 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -71.68 153.01 42.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.69 -0.485 . . . . 64.41 109.69 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.44 161.22 38.97 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.612 -0.435 . . . . 72.43 111.025 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 66.45 13.33 9.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.916 -0.584 . . . . 74.04 110.748 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.49 179.76 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.773 -0.649 . . . . 73.11 110.177 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -179.83 -173.43 44.85 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.209 -1.157 . . . . 64.51 110.209 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.9 p -121.9 120.03 60.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.281 0.562 . . . . 73.43 110.935 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.427 ' HG2' ' HB2' ' A' ' 138' ' ' PHE . 1.5 pt20 -108.69 150.19 27.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.819 -0.628 . . . . 72.31 109.823 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.45 HG22 ' CZ ' ' A' ' 73' ' ' PHE . 4.3 mp -111.45 128.1 68.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.181 0.515 . . . . 75.51 110.502 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 13.4 mt -92.93 143.22 26.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.383 -0.826 . . . . 64.34 109.431 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.558 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.0 OUTLIER -70.46 -176.72 1.3 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.287 -0.634 . . . . 62.23 109.287 174.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -64.45 -20.63 66.3 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.197 -0.314 . . . . 74.43 111.708 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.0 p -98.46 6.5 47.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 75.32 111.457 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.76 28.7 28.46 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.972 -0.632 . . . . 73.1 113.464 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.18 128.02 53.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.894 0.347 . . . . 71.14 110.553 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.09 119.05 11.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.859 0.361 . . . . 54.42 110.704 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.6 mt -85.86 129.72 34.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.037 0.446 . . . . 74.34 111.199 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.7 m -73.18 140.65 47.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.623 -0.717 . . . . 74.04 110.557 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 45.4 mt -80.07 40.29 0.47 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.542 . . . . 72.14 111.301 -176.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -81.14 -23.23 38.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.162 0.506 . . . . 73.24 110.278 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.04 -13.54 66.7 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.789 -0.642 . . . . 70.0 111.973 -173.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.9 1.84 11.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.787 0.327 . . . . 74.42 111.728 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 m -86.91 88.06 7.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.086 0.47 . . . . 41.51 110.088 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -83.18 152.63 25.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.864 -0.607 . . . . 73.0 111.199 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.558 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.9 m -67.82 -179.1 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.742 -0.663 . . . . 64.35 111.431 175.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.6 p -68.65 152.9 44.73 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.316 -0.402 . . . . 53.14 110.377 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.34 107.13 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 75.4 111.543 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 m -94.1 103.5 15.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.356 -0.609 . . . . 62.41 109.356 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.8 m -57.16 122.38 12.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.723 -0.671 . . . . 75.14 111.21 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.472 HD22 ' HB2' ' A' ' 69' ' ' ALA . 61.9 mt -78.38 142.32 37.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.128 -0.487 . . . . 74.22 111.077 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.84 148.68 39.66 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.057 -0.72 . . . . 65.54 109.057 170.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -65.37 111.78 3.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.816 0.341 . . . . 75.22 110.256 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 134.56 -126.82 4.26 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.576 -0.61 . . . . 62.52 111.576 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.2 m -108.77 132.44 53.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.848 0.356 . . . . 74.22 110.879 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -127.46 131.46 50.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.35 -0.386 . . . . 74.44 110.592 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.99 115.71 25.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.817 0.341 . . . . 73.25 111.146 176.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mt -93.26 110.71 48.19 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.128 -0.693 . . . . 74.54 109.128 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.31 130.83 7.32 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.467 2.111 . . . . 74.41 112.673 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.458 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 73.0 m-85 -129.39 166.36 19.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.067 0.461 . . . . 75.41 111.267 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.622 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 47.6 mt-30 -130.0 124.45 32.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.654 -0.703 . . . . 73.11 110.766 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.64 126.29 54.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.102 -0.332 . . . . 52.33 110.102 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 6.9 ptp180 -136.72 161.4 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.901 0.381 . . . . 73.45 111.32 -176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.432 ' HH ' ' HA3' ' A' ' 8' ' ' GLY . 60.5 m-85 -82.04 146.09 29.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 75.4 111.074 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.427 ' HB2' ' HG2' ' A' ' 102' ' ' GLN . 61.1 t80 -132.08 126.71 34.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.49 -0.777 . . . . 74.03 109.178 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.587 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -92.73 135.98 33.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.81 0.338 . . . . 60.35 111.443 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 51.0 p -103.88 0.36 30.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.486 0.66 . . . . 75.01 109.552 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.05 -122.56 0.91 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.124 -0.943 . . . . 74.11 111.302 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.63 94.5 9.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.945 -0.391 . . . . 73.41 109.945 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.616 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -47.58 118.99 2.48 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.507 0.504 . . . . 73.34 111.197 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.2 p -112.79 143.89 29.93 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.171 -0.468 . . . . 64.22 110.708 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.12 174.19 8.33 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.714 2.943 . . . . 73.51 113.278 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.73 -168.35 19.76 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.715 -0.755 . . . . 71.5 111.709 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.38 109.44 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 73.22 110.889 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -108.37 52.77 0.7 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.656 0.741 . . . . 62.42 109.766 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -108.65 138.24 45.28 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.968 -1.014 . . . . 74.43 109.669 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.488 ' HB2' HD13 ' A' ' 86' ' ' LEU . . . -144.12 169.38 17.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.42 -0.355 . . . . 73.44 110.101 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.99 144.86 30.37 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.947 -0.39 . . . . 64.05 109.947 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.32 146.12 25.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.081 -0.509 . . . . 74.12 110.705 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 36.0 p -97.5 128.46 44.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.197 -0.456 . . . . 72.23 109.973 176.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -96.42 127.93 42.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.327 0.584 . . . . 73.32 110.042 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.569 ' HA ' HG22 ' A' ' 16' ' ' VAL . 1.8 tmtm? -111.4 100.26 8.89 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.714 -0.676 . . . . 63.21 109.832 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.5 m -77.45 144.3 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.145 0.498 . . . . 70.24 110.471 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 7.3 tt0 -115.02 120.5 40.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.0 -0.546 . . . . 74.42 110.637 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.548 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 9.8 p90 . . . . . 0 C--N 1.326 -0.436 0 O-C-N 123.734 0.646 . . . . 73.51 109.494 170.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.907 0.384 . . . . 74.42 110.427 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.492 ' HB ' ' HB1' ' A' ' 148' ' ' ALA . 35.0 m -87.95 15.05 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.129 0.49 . . . . 72.33 110.399 175.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 62.41 23.51 13.95 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.314 -0.857 . . . . 74.33 112.358 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.471 ' N ' ' HG2' ' A' ' 36' ' ' GLN . . . 77.69 88.13 0.38 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.389 -0.91 . . . . 75.32 111.625 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.57 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -76.17 156.27 46.92 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.566 -0.826 . . . . 71.05 111.998 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.537 ' HB ' HG22 ' A' ' 31' ' ' THR . 5.2 p -142.7 137.18 29.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.559 0.219 . . . . 70.22 110.845 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.476 HG21 HG21 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -111.69 121.36 64.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.602 -0.518 . . . . 72.04 109.602 175.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -88.11 98.42 11.53 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.041 0.448 . . . . 73.2 109.818 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.435 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 61.8 m-85 -88.44 118.35 28.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.927 -0.579 . . . . 73.22 110.044 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 78.3 tttt -112.65 145.28 40.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.384 -0.371 . . . . 75.03 110.486 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -122.66 -116.25 2.32 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.898 -0.667 . . . . 74.15 112.523 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.522 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 93.0 mt-10 64.05 17.7 10.77 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.841 0.457 . . . . 71.3 111.347 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 155' ' ' LYS . 31.0 m -76.85 -28.51 17.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.088 -0.505 . . . . 71.21 111.712 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.504 HG23 ' CG2' ' A' ' 156' ' ' VAL . 17.1 m -137.38 141.41 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.098 0.475 . . . . 74.14 111.973 -176.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -140.39 21.2 2.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.019 -0.992 . . . . 75.5 108.559 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.18 -76.55 0.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.368 -0.833 . . . . 73.52 111.495 -172.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.493 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -88.84 -33.28 17.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.856 0.36 . . . . 73.1 110.751 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -146.09 128.42 15.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.131 -0.486 . . . . 52.41 109.819 -177.14 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.29 128.56 36.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.321 -0.399 . . . . 73.43 110.29 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.415 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 3.6 t -72.5 128.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.019 -0.363 . . . . 74.52 110.019 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 28' ' ' VAL . 16.0 t70 -58.71 142.55 49.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 64.03 111.09 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.489 ' HA ' HG21 ' A' ' 28' ' ' VAL . . . -59.69 -27.09 66.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.989 -0.551 . . . . 73.32 112.073 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.08 -19.11 73.17 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.59 -0.814 . . . . 71.12 112.066 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.9 p -102.94 -16.04 15.97 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.15 -0.22 . . . . 60.43 111.458 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.522 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 27.4 m -81.51 -2.85 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.954 0.407 . . . . 74.3 110.313 175.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -158.34 87.67 0.91 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.402 -0.962 . . . . 71.14 108.402 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.435 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 16.0 pt20 -134.9 98.09 3.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.517 0.675 . . . . 72.33 110.804 -176.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.537 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.5 m -82.07 94.53 7.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.151 -0.931 . . . . 70.15 109.279 174.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.7 p -81.72 130.86 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.9 -0.591 . . . . 74.33 111.187 -174.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -85.9 127.31 34.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.895 -0.593 . . . . 72.42 110.15 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.91 -30.44 17.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.303 0.573 . . . . 73.24 109.737 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.426 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 100.23 167.85 29.09 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.485 -0.779 . . . . 65.43 111.706 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.471 ' HG2' ' N ' ' A' ' 7' ' ' GLY . 60.4 mt-30 -79.27 86.77 5.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.071 0.462 . . . . 73.34 110.841 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.34 145.96 12.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 75.31 109.875 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -83.39 126.78 33.09 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.362 -0.607 . . . . 74.33 109.362 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.618 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 24.4 p -68.55 -25.02 64.7 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.048 -0.523 . . . . 73.34 111.315 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.49 -10.47 58.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.075 -0.511 . . . . 73.43 111.409 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.8 m -86.94 -7.75 57.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.041 0.448 . . . . 75.13 110.607 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 4.7 mp -132.73 90.17 2.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 75.41 110.266 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.44 12.32 11.59 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.311 0.486 . . . . 75.34 112.311 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -144.73 141.55 29.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.767 -0.197 . . . . 75.13 110.695 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 42.9 tt0 -59.5 122.28 13.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.007 0.432 . . . . 72.02 110.141 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.79 -7.06 33.37 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.786 -0.721 . . . . 73.03 111.888 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.489 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . . . -68.23 120.88 15.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.92 0.39 . . . . 60.23 110.302 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 p -112.01 125.43 54.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.953 -0.567 . . . . 72.02 110.454 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 t -84.88 174.91 9.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.486 -0.561 . . . . 70.41 109.486 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.3 m -62.2 136.4 57.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.776 -0.453 . . . . 64.12 109.776 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -95.91 157.25 15.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.309 0.576 . . . . 75.11 111.018 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.1 m -99.18 148.91 5.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.131 -0.94 . . . . 64.42 109.228 172.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.62 86.81 0.54 Allowed Glycine 0 C--N 1.309 -0.947 0 C-N-CA 120.771 -0.728 . . . . 72.4 112.045 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -88.95 170.21 10.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.382 -0.599 . . . . 75.44 109.382 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.515 ' HB2' HG21 ' A' ' 130' ' ' THR . 4.3 p-10 -138.78 150.85 46.54 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.412 0.625 . . . . 74.11 111.904 -175.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.421 HD11 ' CD1' ' A' ' 154' ' ' PHE . 61.4 mt -109.29 110.28 31.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.176 -0.92 . . . . 71.51 108.599 171.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -96.71 122.45 39.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.989 -0.55 . . . . 72.4 110.787 -173.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.5 mt -106.54 119.36 39.09 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.3 -0.409 . . . . 63.21 110.049 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -96.35 133.28 40.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.097 -0.501 . . . . 75.45 110.044 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 54.35 79.31 0.14 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.776 0.798 . . . . 72.15 110.469 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 42.9 t -112.2 138.51 48.79 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.996 -1.002 . . . . 74.21 109.485 -177.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -116.37 141.55 48.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.845 0.355 . . . . 63.01 111.75 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.5 p -105.42 4.25 30.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.137 -0.483 . . . . 74.34 112.157 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -76.14 -41.86 48.61 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.453 -0.573 . . . . 75.15 109.453 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 p -93.33 -35.2 6.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.747 -0.661 . . . . 72.12 111.021 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.558 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -108.19 -174.93 2.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.615 0.245 . . . . 72.22 110.904 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.421 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 34.3 m -148.32 -57.46 0.23 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.834 0.349 . . . . 64.42 110.779 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -138.05 141.65 40.33 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.686 -0.487 . . . . 71.14 109.686 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.417 ' HB2' HD22 ' A' ' 124' ' ' LEU . . . -100.09 130.89 46.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.946 0.403 . . . . 72.15 110.563 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.02 115.21 11.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.875 -0.602 . . . . 64.12 109.587 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 155' ' ' LYS . 1.9 m -92.76 147.18 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.986 0.422 . . . . 72.2 111.136 -173.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.5 ' HB1' ' CD1' ' A' ' 118' ' ' PHE . . . -122.63 131.08 53.65 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.969 -0.559 . . . . 62.21 109.516 173.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.544 ' CE1' HG22 ' A' ' 103' ' ' ILE . 49.5 m-85 -95.46 138.56 32.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.94 0.4 . . . . 72.44 111.047 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.6 tp -133.85 134.94 43.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.838 -0.619 . . . . 74.15 110.021 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.83 -160.8 24.96 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.191 -0.763 . . . . 52.21 111.191 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.0 m -88.4 118.42 28.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.929 0.364 . . . . 75.54 110.209 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -80.45 147.03 31.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.337 -0.392 . . . . 62.31 110.155 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.51 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 7.6 tt -64.41 -26.19 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 74.3 111.139 -177.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 80' ' ' ALA . 20.4 t70 -154.56 -179.8 8.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.4 -0.593 . . . . 74.34 109.4 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.415 ' H ' ' CG ' ' A' ' 79' ' ' ASP . . . -82.44 -32.63 28.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.923 0.392 . . . . 75.12 110.112 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.67 -34.68 24.45 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.699 -0.762 . . . . 61.23 111.561 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -96.64 73.8 2.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.13 0.49 . . . . 70.01 109.972 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.462 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 1.4 p -95.32 15.4 19.5 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.762 -0.654 . . . . 63.35 111.512 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -112.38 -4.32 14.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.144 0.497 . . . . 75.41 110.921 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.8 t -115.24 126.34 72.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.995 -0.548 . . . . 74.33 110.198 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.512 HD13 ' HB2' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -68.68 131.16 44.74 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.525 -0.546 . . . . 72.22 109.525 178.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 78' ' ' ILE . . . -78.54 143.09 36.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.06 -0.518 . . . . 62.33 110.517 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.652 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.6 mm? -75.98 135.78 40.01 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.965 -0.754 . . . . 73.43 108.965 177.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 . . . . . 0 C--N 1.325 -0.471 0 CA-C-O 121.208 0.528 . . . . 74.34 111.06 -175.796 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 109.824 -0.436 . . . . 74.25 109.824 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.01 133.86 48.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.686 -0.487 . . . . 73.21 109.686 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.95 163.87 22.72 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.545 -0.462 . . . . 62.05 110.989 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 66.24 13.7 9.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.604 -0.726 . . . . 73.51 110.496 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.15 -178.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.549 -0.75 . . . . 74.5 109.902 175.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 176.21 -172.24 45.23 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 110.06 -1.216 . . . . 72.4 110.06 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.476 HG21 HG21 ' A' ' 10' ' ' VAL . 2.3 p -118.8 111.43 33.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.549 0.69 . . . . 74.12 110.898 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -96.11 141.13 29.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.511 -0.768 . . . . 74.43 109.502 177.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.544 HG22 ' CE1' ' A' ' 73' ' ' PHE . 3.8 mp -98.71 127.79 50.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.037 0.446 . . . . 71.13 110.13 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 44.4 mt -99.35 138.94 35.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.504 -0.771 . . . . 72.22 110.63 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.583 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 3.8 t70 -60.67 165.95 3.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.642 -0.708 . . . . 74.31 110.188 170.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.415 ' HE ' ' HB3' ' A' ' 120' ' ' SER . 26.5 ptt180 -54.84 -24.67 24.09 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.474 0.546 . . . . 74.35 112.474 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.2 p -87.13 -20.52 26.93 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.758 0.313 . . . . 72.24 111.719 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.38 44.36 1.26 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.663 -0.779 . . . . 71.21 112.661 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.72 130.16 45.11 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.065 -0.346 . . . . 74.51 110.065 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.72 140.3 57.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 73.32 111.183 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.49 155.21 17.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.94 -0.573 . . . . 73.31 110.555 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -94.46 141.15 28.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.363 -0.38 . . . . 72.34 110.176 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 60.5 mt -84.94 51.04 2.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.012 0.434 . . . . 73.13 110.988 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -108.94 -4.54 16.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.43 . . . . 75.55 110.261 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.82 0.11 39.74 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.017 -0.611 . . . . 53.4 112.739 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -116.73 -17.48 10.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.371 . . . . 73.1 111.105 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.3 m -86.06 94.96 9.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.023 0.44 . . . . 73.4 109.836 174.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.678 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 69.3 m-85 -85.59 162.26 18.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.05 -0.523 . . . . 70.43 110.189 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.583 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . 6.9 m -77.95 -172.16 2.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.882 -0.599 . . . . 64.12 110.943 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.415 ' HB3' ' HE ' ' A' ' 106' ' ' ARG . 35.6 t -68.84 148.77 49.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.869 -0.605 . . . . 72.13 110.165 178.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -63.81 98.29 0.19 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.793 0.33 . . . . 72.02 111.293 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.2 m -78.7 102.28 7.97 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.43 -0.581 . . . . 70.45 109.43 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.0 m -57.23 112.17 1.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.44 -0.8 . . . . 65.45 110.997 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.426 HD12 ' SG ' ' A' ' 61' ' ' CYS . 96.0 mt -75.19 143.79 43.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.766 -0.652 . . . . 73.31 111.402 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -125.11 145.24 50.03 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.192 -0.67 . . . . 72.11 109.192 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -53.9 113.02 1.06 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.872 0.368 . . . . 75.43 111.508 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 129.81 -143.09 14.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.15 -0.548 . . . . 62.25 112.462 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.6 m -82.73 122.1 27.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.763 0.316 . . . . 75.11 110.794 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.426 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 21.9 m-80 -114.86 113.08 23.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.976 0.417 . . . . 74.22 110.337 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.515 HG21 ' HB2' ' A' ' 55' ' ' ASN . 1.1 m -102.27 106.37 17.17 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.78 -0.645 . . . . 54.43 110.327 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 6.6 mt -91.66 113.4 58.6 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.847 -0.427 . . . . 65.04 109.847 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 24.7 Cg_endo -88.72 133.07 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.873 2.382 . . . . 74.34 112.706 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -133.1 169.81 16.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.826 -0.624 . . . . 73.3 109.733 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.64 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 97.1 mt-30 -126.1 140.42 52.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.018 0.437 . . . . 72.43 111.122 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.05 125.6 41.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.077 -0.51 . . . . 74.45 109.779 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.508 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 36.7 ptt180 -144.36 166.18 25.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.097 0.475 . . . . 73.22 111.513 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.593 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 82.4 m-85 -81.56 131.91 35.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.323 -0.853 . . . . 73.22 110.456 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -118.13 116.19 26.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.457 -0.792 . . . . 75.34 109.366 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.592 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -80.78 130.92 35.33 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.18 -0.463 . . . . 73.41 110.996 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.446 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 41.7 p -102.05 9.27 40.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.055 -0.721 . . . . 74.05 109.055 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.41 -120.95 0.94 Allowed Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.933 -1.03 . . . . 75.05 111.018 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.89 95.4 7.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.752 -0.462 . . . . 74.34 109.752 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.618 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -47.3 114.63 0.91 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.716 0.635 . . . . 62.24 111.206 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 p -107.02 139.58 20.55 Favored Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-N 116.082 -0.508 . . . . 72.23 110.373 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.56 159.76 51.75 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 123.679 2.919 . . . . 73.32 113.086 -172.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.95 -167.48 28.28 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.667 -0.697 . . . . 45.22 111.404 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.76 112.06 5.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.922 0.392 . . . . 64.4 110.901 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.652 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -109.8 58.62 0.61 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.505 0.669 . . . . 52.25 110.361 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -116.42 133.42 56.04 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.446 -0.797 . . . . 72.14 110.045 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.512 ' HB2' HD13 ' A' ' 86' ' ' LEU . . . -142.16 175.72 9.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.404 -0.362 . . . . 62.32 110.84 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -148.91 150.78 33.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.697 -0.483 . . . . 72.31 109.697 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -154.06 151.26 29.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.86 0.362 . . . . 72.53 110.874 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.6 p -108.77 132.96 53.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.096 -0.502 . . . . 72.5 109.835 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.421 ' CD1' HD11 ' A' ' 56' ' ' ILE . 27.9 p90 -106.53 133.67 50.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.25 0.547 . . . . 63.22 111.082 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.678 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 20.7 ttmt -109.59 103.44 12.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.469 -0.787 . . . . 73.53 110.409 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.504 ' CG2' HG23 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -77.95 130.05 36.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.242 -0.651 . . . . 75.41 109.242 176.141 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -114.67 117.86 32.03 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.862 -0.422 . . . . 74.33 109.862 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.558 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 116.225 -0.443 . . . . 75.41 111.075 175.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 120.986 0.422 . . . . 73.43 110.533 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.412 HG23 HG13 ' A' ' 37' ' ' VAL . 32.0 m -83.9 6.99 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.314 0.578 . . . . 74.13 110.439 175.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 60.77 18.33 8.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.145 -0.934 . . . . 72.32 112.083 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.93 95.67 0.87 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.772 -0.727 . . . . 75.14 111.915 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.48 159.92 31.19 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.43 -0.89 . . . . 74.34 111.366 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.538 ' HB ' HG22 ' A' ' 31' ' ' THR . 60.8 p -139.03 143.55 38.47 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.724 0.262 . . . . 74.32 110.446 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.45 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -111.73 123.68 67.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.855 -0.424 . . . . 74.34 109.855 175.415 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -92.5 113.35 25.6 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.106 -0.497 . . . . 74.21 109.869 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.45 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 95.2 m-85 -104.71 125.96 51.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.167 -0.47 . . . . 70.12 110.389 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -117.67 143.74 45.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.978 -0.379 . . . . 73.11 109.978 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.41 -126.56 2.78 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.74 -0.743 . . . . 63.14 112.849 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.63 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 35.8 mt-10 62.21 27.91 16.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.286 0.565 . . . . 73.04 110.581 -174.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.595 HG22 ' HA ' ' A' ' 155' ' ' LYS . 31.0 m -74.24 -26.48 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.399 -0.818 . . . . 60.44 111.321 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.457 HG23 ' CG2' ' A' ' 156' ' ' VAL . 27.1 m -136.64 147.19 27.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 71.24 111.493 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -143.94 19.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.121 -0.945 . . . . 60.34 109.188 175.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.69 -83.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.538 -0.755 . . . . 71.05 111.489 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.498 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.96 -36.53 30.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.934 -0.307 . . . . 74.23 110.724 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 0.8 OUTLIER -143.01 132.98 24.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.735 0.302 . . . . 51.11 110.19 -176.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.32 126.7 39.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.376 -0.375 . . . . 63.51 110.324 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.417 ' HA ' HD21 ' A' ' 58' ' ' LEU . 8.2 t -65.77 131.97 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.235 -0.283 . . . . 74.43 110.235 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.533 ' O ' HG12 ' A' ' 28' ' ' VAL . 22.9 t70 -58.04 140.83 51.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 65.24 111.717 -176.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.55 -25.3 64.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.835 -0.621 . . . . 61.41 112.15 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.72 -24.84 55.03 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.401 -0.904 . . . . 72.4 112.388 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.2 p -98.11 -12.09 22.17 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.873 0.323 . . . . 42.52 111.873 -175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.63 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 30.8 m -79.85 -4.62 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.672 0.272 . . . . 74.4 111.609 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -166.72 96.01 0.53 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.404 -0.962 . . . . 73.44 108.404 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -145.9 140.78 27.23 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.548 -0.751 . . . . 64.23 109.91 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.538 HG22 ' HB ' ' A' ' 9' ' ' THR . 25.0 m -117.05 103.9 10.71 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.71 -0.677 . . . . 74.01 109.992 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 p -88.26 133.67 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.039 0.447 . . . . 74.42 111.084 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.493 ' HA ' HG21 ' A' ' 9' ' ' THR . 25.3 mp0 -90.67 128.34 36.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 74.01 109.72 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.74 -31.32 21.02 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.156 0.503 . . . . 74.33 110.055 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.64 172.48 24.71 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.668 -0.696 . . . . 73.31 112.025 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -80.79 97.66 7.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.76 0.314 . . . . 72.12 110.358 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.412 HG13 HG23 ' A' ' 5' ' ' VAL . 11.2 p -83.11 143.1 12.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.024 -0.535 . . . . 73.33 110.212 176.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.9 127.7 33.75 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.555 -0.535 . . . . 73.31 109.555 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.4 p -74.49 -10.04 59.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.148 -0.478 . . . . 74.55 111.584 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.47 -21.25 58.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.254 -0.43 . . . . 75.22 111.379 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.5 m -81.14 -23.42 38.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 71.23 110.868 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.561 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 5.2 mp -114.34 99.04 7.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.107 -0.497 . . . . 75.44 109.923 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.83 11.49 6.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.364 0.505 . . . . 71.25 112.364 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -151.43 152.13 32.63 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.693 -0.403 . . . . 65.53 111.432 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.37 120.03 8.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.634 -0.712 . . . . 73.44 109.484 175.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.05 6.8 39.23 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.676 -0.773 . . . . 75.4 112.032 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -81.17 120.27 24.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.837 0.351 . . . . 73.43 110.257 176.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.517 HG23 ' HD1' ' A' ' 138' ' ' PHE . 59.9 p -112.44 128.09 56.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.415 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.9 t -84.73 -177.76 6.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.794 -0.447 . . . . 74.31 109.794 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -67.37 137.2 55.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.272 -0.422 . . . . 64.52 110.074 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -92.01 153.52 19.38 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.664 0.745 . . . . 74.42 111.882 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 27.8 m -93.32 153.74 3.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.363 -1.29 . . . . 72.45 109.536 170.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.22 100.54 1.66 Allowed Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.809 -0.71 . . . . 72.2 111.996 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -116.33 -179.4 3.66 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.416 -0.586 . . . . 73.14 109.416 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.52 ' HB2' HG21 ' A' ' 130' ' ' THR . 4.0 p-10 -146.35 152.72 39.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.502 0.668 . . . . 65.54 111.965 -174.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 74.4 mt -113.84 111.86 37.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.911 -1.04 . . . . 70.12 108.303 167.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -97.75 140.93 31.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.985 0.421 . . . . 73.31 110.801 -172.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.417 HD21 ' HA ' ' A' ' 23' ' ' VAL . 65.7 mt -117.66 124.66 49.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.841 -0.618 . . . . 74.43 109.491 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -102.6 135.85 43.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.79 -0.641 . . . . 73.4 109.386 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 27.3 t70 56.19 87.65 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.821 0.701 . . . . 74.23 110.486 -176.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.533 ' SG ' HD13 ' A' ' 124' ' ' LEU . 42.3 t -124.85 134.85 52.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.704 -0.68 . . . . 61.11 110.373 -174.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.09 138.03 47.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 73.21 111.867 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 p -105.35 10.9 33.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.798 -0.637 . . . . 71.14 112.31 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -88.32 -36.33 16.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.018 0.437 . . . . 64.41 110.027 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 p -102.01 -12.55 8.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.875 -0.602 . . . . 74.24 110.435 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . . . -129.13 -174.11 3.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.866 -0.606 . . . . 73.15 110.423 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -150.59 -56.55 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.78 0.324 . . . . 74.23 111.175 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -137.58 141.3 41.32 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.503 -0.554 . . . . 75.14 109.503 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB2' HD22 ' A' ' 124' ' ' LEU . . . -99.43 130.34 45.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.091 0.472 . . . . 54.25 110.29 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.95 113.66 9.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.559 -0.746 . . . . 72.44 109.792 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 2.0 m -90.37 146.42 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.272 0.558 . . . . 74.2 110.864 -175.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.54 119.24 34.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.356 -0.838 . . . . 61.42 109.166 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 83.7 m-85 -79.55 137.46 37.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.855 -0.424 . . . . 75.22 109.855 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.9 tp -137.33 115.55 11.73 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.671 -0.492 . . . . 74.34 109.671 -175.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.6 -158.12 10.07 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.524 -0.762 . . . . 74.24 111.379 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.494 ' O ' HD11 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -81.09 116.69 21.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.73 0.265 . . . . 62.41 110.869 -178.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -79.69 139.31 37.42 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.936 -0.394 . . . . 73.42 109.936 175.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.499 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 6.6 tt -63.62 -36.12 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.904 0.383 . . . . 72.41 110.781 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -151.92 175.17 12.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.31 -0.626 . . . . 73.33 109.31 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.83 -24.58 28.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.997 0.427 . . . . 73.15 110.503 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.84 -21.54 49.93 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.756 -0.735 . . . . 61.53 111.356 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -118.61 62.46 0.78 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.457 0.646 . . . . 71.55 109.518 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.525 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 2.6 p -80.85 7.64 10.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.421 -0.809 . . . . 72.23 111.407 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -106.25 1.55 26.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.056 0.455 . . . . 73.41 110.947 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.524 HG21 ' HB3' ' A' ' 102' ' ' GLN . 61.9 t -117.34 129.4 73.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.015 -0.539 . . . . 70.32 110.164 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 76' ' ' THR . 0.1 OUTLIER -69.98 133.61 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.715 0.293 . . . . 74.34 110.378 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 78' ' ' ILE . . . -78.14 148.36 34.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.123 -0.49 . . . . 72.12 110.302 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -81.61 149.82 28.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.246 -0.434 . . . . 74.24 110.499 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 . . . . . 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.594 . . . . 73.3 110.334 179.044 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.912 -0.403 . . . . 75.11 109.912 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.08 147.77 29.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.467 -0.333 . . . . 74.12 110.457 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.48 165.55 27.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.557 -0.292 . . . . 64.45 110.335 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 70.11 7.62 6.3 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.327 0.584 . . . . 73.05 110.417 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.35 -177.42 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.272 -0.877 . . . . 71.41 109.644 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 177.22 -170.6 43.25 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.12 -1.192 . . . . 70.32 110.12 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -121.03 115.18 46.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.476 0.655 . . . . 62.32 110.49 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.524 ' HB3' HG21 ' A' ' 85' ' ' VAL . 3.6 pt20 -105.39 145.53 30.66 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.63 -0.713 . . . . 75.41 109.532 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.473 HG22 ' CZ ' ' A' ' 73' ' ' PHE . 4.4 mp -104.96 123.15 58.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.148 0.499 . . . . 72.41 110.385 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 18.8 mt -91.21 139.51 30.68 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.376 -0.829 . . . . 73.43 109.246 177.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.8 OUTLIER -72.57 -169.12 0.51 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.282 -0.417 . . . . 63.32 110.282 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -56.72 -35.07 68.11 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.733 0.272 . . . . 74.12 111.733 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.7 p -87.43 -6.29 58.49 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.883 0.373 . . . . 72.12 111.768 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.89 30.03 10.93 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.606 -0.807 . . . . 73.4 112.804 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.38 134.74 50.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.177 -0.305 . . . . 74.02 110.177 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.37 117.96 10.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.966 0.412 . . . . 72.11 111.175 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.16 132.7 35.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.891 -0.595 . . . . 71.34 110.573 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.3 m -74.33 137.41 42.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.905 -0.589 . . . . 74.31 110.647 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 36.5 mt -82.43 47.89 1.22 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.067 -0.515 . . . . 70.45 110.971 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -104.93 -0.75 26.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.959 0.409 . . . . 75.52 110.332 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.12 10.57 59.6 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.871 -0.604 . . . . 75.24 112.672 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.32 -23.97 4.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 75.11 110.798 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -80.3 99.43 7.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.96 0.41 . . . . 74.11 110.264 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -89.03 157.88 18.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.02 -0.536 . . . . 75.42 110.635 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.537 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.3 m -64.96 171.15 3.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.019 -0.537 . . . . 73.32 111.08 177.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 42.9 m -65.37 156.76 31.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.459 -0.571 . . . . 73.33 109.459 171.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.496 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 45.7 mt-10 -55.6 121.15 8.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.101 0.477 . . . . 72.43 111.913 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.0 m -105.57 98.84 8.48 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.269 -1.011 . . . . 74.34 108.269 168.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.1 m -59.24 122.05 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.556 . . . . 74.11 110.915 -175.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.533 HD13 ' SG ' ' A' ' 61' ' ' CYS . 96.2 mt -82.96 153.23 25.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.464 -0.789 . . . . 72.25 111.662 -174.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.454 HD21 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -123.87 157.32 34.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.356 -0.838 . . . . 72.13 108.911 171.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 3.8 m120 -68.37 99.64 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.913 0.387 . . . . 73.44 110.34 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.06 -136.41 7.95 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.895 -0.669 . . . . 72.31 112.029 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.3 m -84.96 127.58 34.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.022 0.439 . . . . 73.44 110.976 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.42 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 33.5 m-80 -128.61 124.94 37.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.968 -0.56 . . . . 71.24 109.9 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.52 HG21 ' HB2' ' A' ' 55' ' ' ASN . 2.5 m -115.65 114.78 25.34 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.974 -0.291 . . . . 75.11 110.702 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.6 mt -92.25 109.81 40.33 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.282 -0.417 . . . . 71.03 109.95 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.33 138.76 10.06 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.767 2.311 . . . . 72.44 112.806 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 62.3 m-85 -136.55 164.13 28.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 72.51 111.113 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.573 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 97.5 mt-30 -125.59 125.12 42.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.795 -0.639 . . . . 71.22 110.412 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.48 124.08 51.55 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.199 -0.297 . . . . 71.15 110.199 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.493 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 14.9 ptp180 -138.87 160.22 40.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.934 0.397 . . . . 71.12 110.983 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 66.8 m-85 -77.32 139.7 39.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.7 -0.682 . . . . 75.41 110.516 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.517 ' HD1' HG23 ' A' ' 48' ' ' THR . 80.5 t80 -127.59 122.26 32.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.696 -0.684 . . . . 74.15 109.501 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -93.26 137.13 32.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.074 0.464 . . . . 72.11 111.333 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 52.0 p -103.81 5.51 36.02 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.439 -0.801 . . . . 65.14 109.224 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.26 -131.6 2.33 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.901 -1.045 . . . . 54.34 110.697 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.39 94.89 4.96 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.4 -0.222 . . . . 41.24 110.4 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.23 120.9 3.88 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.546 0.529 . . . . 65.31 111.105 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.2 p -111.57 145.1 31.92 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 121.248 0.547 . . . . 73.02 111.2 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.17 163.16 37.16 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.867 3.044 . . . . 74.31 113.089 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.36 -174.76 21.09 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.993 -0.622 . . . . 75.31 111.937 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.73 108.04 0.78 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.971 0.415 . . . . 71.35 111.207 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.43 43.88 1.07 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 73.45 110.228 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -101.74 147.11 26.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.58 -0.736 . . . . 75.15 109.805 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.489 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -153.79 170.61 20.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.46 -0.337 . . . . 72.01 111.07 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.42 146.02 36.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.435 -0.348 . . . . 64.2 110.219 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.49 ' HB3' HD23 ' A' ' 86' ' ' LEU . . . -151.28 149.63 29.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.303 -0.408 . . . . 74.24 110.993 -177.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.7 p -107.21 128.45 54.43 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.019 -0.537 . . . . 73.4 109.621 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -100.01 132.5 45.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.208 0.528 . . . . 75.43 110.831 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.595 ' HA ' HG22 ' A' ' 16' ' ' VAL . 5.8 tmtm? -117.19 105.17 11.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.783 -0.644 . . . . 74.42 110.248 -178.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.2 m -74.87 156.52 6.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.173 0.511 . . . . 74.21 110.614 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 157' ' ' GLN . 1.4 tt0 -140.7 118.48 11.72 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.424 -0.807 . . . . 72.3 108.958 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.535 0 N-CA-C 112.038 0.384 . . . . 74.53 112.038 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.1 p . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 120.973 0.415 . . . . 72.21 110.025 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.547 HG22 HG11 ' A' ' 37' ' ' VAL . 34.2 m -94.26 20.25 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.22 0.533 . . . . 74.41 110.468 175.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 59.75 25.59 14.61 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.934 -1.03 . . . . 75.1 112.542 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.524 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 76.78 89.95 0.27 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.537 -0.839 . . . . 51.01 112.078 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.549 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -78.86 159.95 46.28 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.354 -0.927 . . . . 37.08 112.157 -176.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.564 ' HB ' HG22 ' A' ' 31' ' ' THR . 74.3 p -140.44 145.67 37.28 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.856 -0.424 . . . . 71.13 109.856 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.65 125.25 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 109.803 -0.443 . . . . 74.13 109.803 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -90.04 111.95 23.22 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.73 -0.668 . . . . 75.42 109.6 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -98.86 124.63 43.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.164 -0.471 . . . . 73.12 109.776 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.492 ' HB3' HG22 ' A' ' 153' ' ' THR . 58.6 tttm -118.42 132.88 56.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.444 -0.344 . . . . 74.42 110.644 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.05 -115.11 2.48 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.921 -0.657 . . . . 74.4 112.846 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.434 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 31.6 mt-10 65.18 21.29 12.11 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.939 0.496 . . . . 74.03 111.176 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.55 HG22 ' HA ' ' A' ' 155' ' ' LYS . 13.8 m -79.61 -33.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 113.307 0.855 . . . . 64.21 113.307 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.44 HG23 HG23 ' A' ' 16' ' ' VAL . 21.1 m -140.38 150.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.264 0.554 . . . . 74.0 112.436 -171.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -149.57 34.21 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.627 -1.249 . . . . 74.13 107.627 169.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.45 -74.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.048 -0.978 . . . . 65.41 110.88 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.79 -31.59 13.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.841 0.353 . . . . 73.24 110.629 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -142.36 136.24 29.43 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.923 -0.58 . . . . 61.5 109.976 -176.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.51 130.56 45.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.642 -0.254 . . . . 72.25 110.47 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.61 126.39 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.691 0.282 . . . . 73.41 110.245 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.12 143.99 36.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.935 -0.575 . . . . 73.11 111.516 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.67 -27.64 66.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.784 -0.643 . . . . 74.3 111.99 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 -5.16 87.91 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.51 -0.852 . . . . 63.21 112.216 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.2 p -123.59 12.61 9.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.717 0.265 . . . . 70.42 111.717 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.434 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 26.6 m -98.53 -12.78 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.967 0.413 . . . . 75.51 110.417 174.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -157.9 93.14 1.24 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.43 -0.952 . . . . 75.32 108.43 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pm0 -135.96 142.49 44.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.05 0.452 . . . . 72.23 110.19 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.564 HG22 ' HB ' ' A' ' 9' ' ' THR . 3.6 m -120.29 106.7 12.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.774 -0.648 . . . . 74.01 110.108 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 p -87.0 147.43 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 64.22 111.138 -175.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -99.6 117.46 34.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 73.31 110.466 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.99 -29.25 23.65 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.196 0.522 . . . . 64.22 110.083 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 92.47 171.28 41.01 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.559 -0.746 . . . . 70.14 111.88 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -78.9 91.42 4.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.713 0.292 . . . . 73.05 110.461 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.547 HG11 HG22 ' A' ' 5' ' ' VAL . 9.8 p -72.46 146.78 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.382 -0.599 . . . . 73.44 109.382 175.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -89.07 139.85 30.04 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.944 0.402 . . . . 75.42 110.803 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.9 p -73.13 -7.24 50.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.858 -0.61 . . . . 70.11 111.371 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.67 -26.99 27.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.019 -0.537 . . . . 63.03 110.606 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.506 ' HB2' HD12 ' A' ' 42' ' ' LEU . 9.1 m -74.24 -21.7 59.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 63.21 110.712 -177.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -127.43 107.71 10.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.624 -0.716 . . . . 73.3 109.828 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.78 10.9 3.4 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.708 -0.397 . . . . 73.33 111.781 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -146.66 143.69 28.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.773 0.321 . . . . 72.42 111.351 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.0 tm-20 -57.93 119.51 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.683 -0.69 . . . . 75.34 109.932 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.48 -6.09 29.93 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.793 -0.718 . . . . 54.04 111.999 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.468 ' HB1' ' HB1' ' A' ' 139' ' ' ALA . . . -72.69 131.33 42.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.677 0.275 . . . . 52.01 110.344 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.536 HG21 ' HD1' ' A' ' 138' ' ' PHE . 40.1 p -121.04 145.82 47.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.221 -0.445 . . . . 74.22 110.205 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.6 t -99.3 176.58 5.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.12 -0.696 . . . . 74.43 109.12 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.5 m -71.86 140.34 49.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.956 0.408 . . . . 74.4 110.083 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -92.4 159.36 15.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.573 0.702 . . . . 64.45 111.926 -176.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.3 m -98.33 151.84 4.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.463 -1.244 . . . . 72.2 109.16 170.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.7 73.32 0.27 Allowed Glycine 0 C--N 1.313 -0.733 0 C-N-CA 120.761 -0.733 . . . . 61.25 112.353 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -82.22 153.34 25.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.75 -0.463 . . . . 74.24 109.75 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.576 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.1 p-10 -122.78 145.02 48.79 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.185 0.516 . . . . 71.23 111.808 -174.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.433 HD11 ' CE2' ' A' ' 133' ' ' PHE . 67.3 mt -110.85 118.37 57.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.861 -0.792 . . . . 74.21 108.861 171.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -100.77 130.53 46.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 73.21 110.881 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 128' ' ' THR . 40.9 mt -112.35 118.18 34.5 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.823 -0.436 . . . . 72.21 109.823 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -94.54 140.86 29.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.309 -0.405 . . . . 43.35 110.117 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.4 t70 49.0 76.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.136 0.898 . . . . 73.04 110.721 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 41.7 t -109.68 143.73 39.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.05 -0.977 . . . . 70.02 109.564 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -120.79 153.04 37.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.255 0.465 . . . . 64.14 112.255 -171.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.2 p -115.16 -2.59 12.7 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.934 -0.575 . . . . 72.41 111.835 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -72.15 -38.36 69.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.677 -0.49 . . . . 73.02 109.677 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.86 -32.4 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.864 -0.607 . . . . 65.23 111.383 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.57 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . . . -110.06 171.98 7.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.764 0.316 . . . . 75.24 111.474 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.43 ' CB ' ' HD2' ' A' ' 68' ' ' LYS . 20.1 m -133.73 -58.43 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.349 -0.387 . . . . 74.33 111.439 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -139.21 136.4 34.96 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.087 -0.338 . . . . 64.43 110.087 -177.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HB2' HD22 ' A' ' 124' ' ' LEU . . . -99.4 130.07 45.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.278 0.561 . . . . 71.04 110.676 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.66 125.56 19.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.333 -0.848 . . . . 72.04 109.217 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 2.1 m -95.39 145.13 8.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.927 0.394 . . . . 75.01 110.993 -175.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.82 126.37 54.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.799 -0.637 . . . . 74.32 109.453 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 61.7 m-85 -93.02 137.19 32.6 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.122 0.487 . . . . 73.34 111.16 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.6 tp -134.73 134.1 40.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.7 -0.682 . . . . 75.03 109.709 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.39 -140.31 3.02 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.45 -0.66 . . . . 62.34 111.45 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.493 ' O ' HD12 ' A' ' 86' ' ' LEU . 39.2 m -103.26 118.59 37.12 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.092 -0.336 . . . . 72.13 110.092 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -80.41 138.26 36.61 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.176 -0.305 . . . . 74.14 110.176 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.51 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 10.4 tt -65.69 -27.82 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 75.22 110.694 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -158.83 176.8 11.88 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.323 -0.621 . . . . 71.32 109.323 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.1 -39.5 23.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.965 0.412 . . . . 70.12 110.244 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.02 -17.53 78.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.833 -0.699 . . . . 72.1 111.456 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.404 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 66.2 m80 -119.77 54.34 1.02 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.552 0.691 . . . . 70.12 109.685 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.516 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -78.78 14.62 1.28 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.13 -0.941 . . . . 75.14 111.86 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -112.57 2.38 16.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.201 0.524 . . . . 53.22 110.415 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 102' ' ' GLN . 61.1 t -116.61 125.95 73.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 75.23 110.027 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.532 HD13 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -70.2 132.16 45.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.805 0.336 . . . . 75.21 110.307 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -80.02 152.86 29.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.833 -0.622 . . . . 72.51 110.149 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.649 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.6 mm? -85.61 144.86 27.63 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.378 -0.374 . . . . 71.24 110.635 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 115.904 -0.589 . . . . 64.14 110.926 -178.444 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 120.876 0.37 . . . . 73.22 110.968 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.43 ' O ' HD23 ' A' ' 88' ' ' LEU . . . -69.06 148.76 49.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.082 -0.508 . . . . 70.45 109.672 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.56 160.18 40.57 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.761 -0.375 . . . . 73.52 110.478 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.404 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 44.9 m-80 65.95 8.8 5.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 73.45 110.232 -174.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -151.29 154.46 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 115.356 -0.838 . . . . 74.32 109.8 175.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -159.2 -169.15 22.19 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 110.597 -1.001 . . . . 62.32 110.597 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.41 109.25 27.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.53 0.681 . . . . 52.52 110.376 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.528 ' HB3' HG23 ' A' ' 85' ' ' VAL . 3.3 pt20 -96.88 150.42 20.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.757 -0.656 . . . . 75.41 109.676 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.54 122.18 67.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.151 0.501 . . . . 74.02 110.869 -175.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 14.4 mt -92.84 146.71 23.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 72.34 109.811 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.4 p-10 -78.43 -169.19 1.58 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.104 -0.498 . . . . 71.51 109.811 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -61.22 -30.05 70.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.928 0.344 . . . . 72.32 111.928 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.1 p -84.47 -10.95 57.03 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.692 -0.403 . . . . 71.45 111.218 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.53 23.89 17.56 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.659 -0.781 . . . . 74.03 112.58 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.61 134.05 51.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.327 -0.249 . . . . 74.15 110.327 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.14 132.3 50.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.074 0.464 . . . . 74.24 111.078 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.5 mt -94.38 141.08 28.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.754 -0.657 . . . . 64.21 110.323 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.1 m -78.99 139.56 38.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.353 -0.385 . . . . 73.43 110.436 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.505 HD12 HD21 ' A' ' 86' ' ' LEU . 36.5 mt -86.05 47.77 1.51 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.3 -0.409 . . . . 73.42 110.918 -176.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -104.45 -3.89 23.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.359 -0.382 . . . . 74.5 110.654 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.5 -0.76 63.52 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.149 -0.548 . . . . 54.2 113.345 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.04 -15.79 9.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.03 0.415 . . . . 62.4 111.103 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -84.94 104.17 14.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.252 -0.431 . . . . 74.21 110.545 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.431 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 96.0 m-85 -94.33 162.02 14.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.159 -0.473 . . . . 74.21 110.468 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.526 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.6 m -67.34 179.86 1.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.995 -0.548 . . . . 72.4 111.088 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.0 m -71.91 167.95 18.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.749 -0.463 . . . . 75.22 109.749 172.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.523 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 39.7 mt-10 -68.98 109.03 3.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.984 0.421 . . . . 75.14 111.785 -173.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.0 m -90.92 96.93 10.88 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.798 -0.816 . . . . 62.51 108.798 168.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.0 m -60.55 126.92 29.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.173 0.511 . . . . 73.31 110.484 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.499 HD12 ' SG ' ' A' ' 61' ' ' CYS . 96.5 mt -85.96 153.73 21.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.585 -0.734 . . . . 65.41 112.387 -170.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -128.85 150.53 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.956 -1.02 . . . . 70.05 108.43 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.6 m120 -64.61 107.77 1.5 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.17 0.51 . . . . 64.12 111.016 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.49 -151.21 21.81 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.514 -0.766 . . . . 74.45 111.497 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 50.7 m -89.48 116.92 28.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.267 0.556 . . . . 73.2 111.097 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.412 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 36.6 m-80 -110.06 126.64 54.22 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.744 -0.662 . . . . 72.23 109.974 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.576 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.3 m -106.93 114.95 29.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.247 -0.433 . . . . 52.3 110.148 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.1 mt -91.21 118.74 68.69 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.709 -0.478 . . . . 75.34 109.709 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -84.54 129.57 4.29 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.787 2.325 . . . . 73.41 112.656 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.433 ' CE2' HD11 ' A' ' 56' ' ' ILE . 62.6 m-85 -129.45 168.82 15.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.139 -0.482 . . . . 74.51 110.333 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.648 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 22.8 mt-30 -135.85 120.29 18.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.926 0.394 . . . . 71.41 111.621 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.23 125.97 51.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.373 -0.376 . . . . 72.41 110.039 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 6.2 ptp180 -140.35 165.03 28.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 71.41 110.921 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.549 ' HH ' ' HA3' ' A' ' 8' ' ' GLY . 67.3 m-85 -83.89 145.05 28.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.111 -0.495 . . . . 75.43 110.974 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.536 ' HD1' HG21 ' A' ' 48' ' ' THR . 78.9 t80 -133.58 128.86 36.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.67 -0.695 . . . . 74.31 109.212 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.565 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -94.95 133.92 38.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.269 -0.423 . . . . 75.34 111.496 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.543 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 82.0 p -104.57 6.02 34.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.664 0.745 . . . . 75.44 109.279 175.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.86 -129.57 1.95 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.12 -0.946 . . . . 74.41 111.4 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -85.47 93.03 8.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.244 -0.28 . . . . 72.14 110.244 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -45.75 112.66 0.49 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.755 0.659 . . . . 73.33 111.264 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.2 p -102.48 140.49 21.16 Favored Pre-proline 0 N--CA 1.442 -0.861 0 CA-C-O 121.061 0.457 . . . . 75.44 110.417 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.67 165.76 29.77 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 123.534 2.823 . . . . 74.33 112.666 -175.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.5 -149.76 21.84 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.482 -0.866 . . . . 45.11 111.803 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.86 120.81 35.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.155 -0.313 . . . . 71.42 110.155 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.649 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -111.73 50.35 0.85 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 71.54 111.299 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -101.43 136.21 41.65 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.201 -0.666 . . . . 75.31 109.201 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.532 ' HB1' HD13 ' A' ' 86' ' ' LEU . . . -143.31 165.32 27.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.619 0.247 . . . . 72.21 111.045 -177.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -135.06 143.7 46.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.34 -0.391 . . . . 70.41 110.204 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.21 141.31 24.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.049 0.452 . . . . 74.33 110.959 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 13' ' ' LYS . 35.9 p -103.28 131.29 50.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.938 -0.574 . . . . 75.2 109.616 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.418 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 53.1 p90 -111.78 140.94 46.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.919 0.39 . . . . 73.42 110.557 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.55 ' HA ' HG22 ' A' ' 16' ' ' VAL . 2.0 tmmm? -127.25 111.11 13.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.656 -0.702 . . . . 74.42 110.092 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.3 m -78.44 143.59 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.018 0.437 . . . . 75.32 110.372 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -126.82 126.26 43.06 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.446 -0.575 . . . . 74.43 109.446 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.647 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 120.936 0.398 . . . . 72.44 111.781 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.416 ' CB ' ' HB3' ' A' ' 36' ' ' GLN . 61.8 p . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.962 0.41 . . . . 73.14 110.891 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG23 HG13 ' A' ' 37' ' ' VAL . 33.5 m -90.13 15.48 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.11 0.481 . . . . 72.21 110.601 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 62.19 22.72 13.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.16 -0.927 . . . . 75.31 112.541 172.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.513 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 83.14 90.25 0.7 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.46 -0.876 . . . . 71.42 111.916 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.525 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -85.23 161.03 35.42 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.436 -0.888 . . . . 62.14 112.382 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.508 ' HB ' HG21 ' A' ' 31' ' ' THR . 60.2 p -140.34 146.21 38.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.645 0.259 . . . . 73.43 110.781 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.457 HG23 HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -122.05 122.08 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.586 -0.524 . . . . 73.43 109.586 170.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -93.09 121.82 34.83 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.834 -0.432 . . . . 73.43 109.834 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 85.2 m-85 -107.69 123.32 48.33 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.841 -0.618 . . . . 74.41 110.46 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HB3' HG22 ' A' ' 153' ' ' THR . 41.2 tptt -104.07 137.7 41.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.092 -0.504 . . . . 74.22 110.045 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -125.56 -136.24 4.47 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.709 -0.757 . . . . 72.32 112.836 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.637 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 48.9 mt-10 64.06 20.55 12.24 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.986 0.514 . . . . 64.45 110.89 -176.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.609 HG23 ' HA ' ' A' ' 155' ' ' LYS . 26.8 m -69.62 -24.44 27.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.685 -0.688 . . . . 72.12 111.107 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.45 HG21 ' CG2' ' A' ' 156' ' ' VAL . 16.4 m -138.19 141.17 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.171 0.51 . . . . 75.21 112.004 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -143.75 24.78 1.68 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.961 -1.018 . . . . 73.13 108.483 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.73 -73.5 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.414 -0.812 . . . . 74.01 111.047 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.501 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -90.28 -40.88 11.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.901 0.381 . . . . 74.44 110.502 177.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -139.16 133.14 31.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.098 -0.501 . . . . 71.03 110.038 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.95 124.67 40.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.419 -0.355 . . . . 73.5 110.434 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.449 ' HA ' HD21 ' A' ' 58' ' ' LEU . 7.3 t -63.96 133.4 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.669 -0.493 . . . . 73.21 109.669 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.489 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.7 t70 -59.4 140.42 56.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.239 -0.437 . . . . 71.35 110.671 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.75 -26.49 67.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.488 . . . . 74.01 112.115 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.55 -23.66 72.46 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.496 -0.859 . . . . 45.22 112.062 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.2 p -102.86 -7.72 21.34 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.913 0.338 . . . . 72.44 111.913 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.637 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 34.1 m -84.4 -2.87 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.063 0.458 . . . . 73.52 110.82 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -165.08 85.19 0.39 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.124 -1.065 . . . . 70.53 108.124 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -137.19 133.22 34.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.552 -0.749 . . . . 61.13 110.469 -173.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.508 HG21 ' HB ' ' A' ' 9' ' ' THR . 3.5 m -110.45 100.57 9.38 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.567 -0.742 . . . . 64.24 109.098 176.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.448 HG11 HG22 ' A' ' 10' ' ' VAL . 8.2 p -84.77 128.32 39.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.228 0.537 . . . . 73.14 110.488 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.418 ' HG3' HG22 ' A' ' 9' ' ' THR . 26.4 mp0 -88.43 128.61 35.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.541 -0.754 . . . . 63.22 109.718 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.457 HD21 HG23 ' A' ' 10' ' ' VAL . 2.7 mm? -88.74 -34.56 17.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.336 0.589 . . . . 73.11 109.87 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.513 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 104.37 -179.6 24.72 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.433 -0.803 . . . . 73.44 111.813 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.416 ' HB3' ' CB ' ' A' ' 4' ' ' THR . 44.7 mt-30 -84.44 89.85 7.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.829 0.347 . . . . 72.25 110.576 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.545 HG13 HG23 ' A' ' 5' ' ' VAL . 9.5 p -70.81 141.82 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 74.41 110.267 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.54 137.27 40.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.972 -0.558 . . . . 74.34 109.965 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.3 p -86.88 5.17 38.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.468 0.652 . . . . 74.22 110.346 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.31 -27.87 18.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.433 -0.803 . . . . 73.53 110.737 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.452 ' HB2' HD11 ' A' ' 42' ' ' LEU . 12.3 m -72.23 -41.46 66.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.427 0.632 . . . . 70.24 110.342 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.564 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 5.1 mp -98.88 114.51 27.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.362 -0.835 . . . . 74.33 109.54 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.4 10.78 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.217 0.451 . . . . 65.12 112.217 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -150.57 153.51 35.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.552 0.215 . . . . 74.13 110.854 -177.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.533 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -65.58 121.11 14.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.022 -0.732 . . . . 75.32 109.022 176.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.427 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 106.27 2.57 38.46 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.591 -0.814 . . . . 64.12 111.761 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 139' ' ' ALA . . . -80.91 140.4 35.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.817 0.341 . . . . 74.41 110.74 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.8 p -126.36 151.6 47.4 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.977 -0.556 . . . . 73.42 110.991 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.474 ' O ' ' HD2' ' A' ' 136' ' ' ARG . 27.3 t -104.07 179.47 4.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.044 -0.725 . . . . 65.55 109.044 174.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.3 m -73.54 129.59 38.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.239 -0.282 . . . . 53.45 110.239 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.661 ' HA ' ' HB3' ' A' ' 136' ' ' ARG . . . -82.29 157.6 23.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.595 0.712 . . . . 70.11 112.019 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.2 m -98.12 152.13 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.61 -1.177 . . . . 64.43 109.622 172.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.54 94.78 1.02 Allowed Glycine 0 C--N 1.313 -0.743 0 C-N-CA 120.785 -0.722 . . . . 60.22 112.276 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -107.93 178.34 4.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.031 -0.729 . . . . 72.11 109.031 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.569 ' HB2' HG22 ' A' ' 130' ' ' THR . 0.3 OUTLIER -148.97 151.51 34.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.964 0.727 . . . . 73.41 112.964 -177.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 83.0 mt -109.53 111.8 37.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.905 -1.043 . . . . 74.12 108.837 173.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 52.8 tt0 -94.55 135.01 36.49 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.198 -0.455 . . . . 71.43 111.074 -172.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.449 HD21 ' HA ' ' A' ' 23' ' ' VAL . 75.4 mt -116.12 119.32 35.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.25 -0.432 . . . . 71.31 110.288 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -101.41 146.1 28.06 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.074 -0.512 . . . . 73.12 110.06 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 52.04 65.73 1.41 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.635 0.731 . . . . 73.21 110.224 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.469 ' SG ' HD11 ' A' ' 124' ' ' LEU . 39.1 t -100.24 137.26 38.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.245 -0.889 . . . . 64.12 110.258 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.428 ' OD2' HG11 ' A' ' 65' ' ' VAL . 17.1 t70 -111.64 137.75 49.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.213 -0.448 . . . . 73.12 111.494 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -102.32 0.98 35.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.133 -0.485 . . . . 73.23 112.246 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -79.74 -34.75 39.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.852 0.358 . . . . 64.5 110.371 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.43 HG13 ' HB1' ' A' ' 20' ' ' ALA . 11.7 p -107.5 -12.37 10.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.035 0.445 . . . . 70.13 110.928 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -122.8 179.41 4.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.709 0.29 . . . . 74.24 111.152 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.2 m -143.6 -59.17 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.3 -0.409 . . . . 65.32 110.796 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.559 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -137.94 139.58 39.83 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.576 -0.527 . . . . 73.21 109.576 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.27 118.53 36.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.143 0.497 . . . . 74.21 110.471 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.16 119.11 21.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.545 -0.752 . . . . 74.45 109.476 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 2.4 m -90.31 146.49 6.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.963 0.411 . . . . 74.52 110.838 -175.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' A' ' 118' ' ' PHE . . . -115.07 142.3 46.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.599 -0.728 . . . . 63.23 109.149 172.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.463 ' CZ ' HG22 ' A' ' 103' ' ' ILE . 78.3 m-85 -106.68 140.06 40.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.114 0.483 . . . . 71.14 110.93 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.3 tp -131.54 138.03 48.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.554 -0.748 . . . . 75.14 109.746 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.408 ' HA3' HD23 ' A' ' 86' ' ' LEU . . . -174.39 -160.06 21.86 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.23 -0.748 . . . . 37.67 111.23 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.4 m -91.82 114.37 26.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.671 0.235 . . . . 73.31 110.538 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.83 134.33 43.33 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.07 -0.344 . . . . 73.34 110.07 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.548 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 7.9 tt -63.54 -28.49 45.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.175 -0.466 . . . . 74.22 111.515 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -154.03 -178.94 7.42 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.79 -0.448 . . . . 71.22 109.79 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.81 -29.68 23.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.306 0.574 . . . . 73.43 109.703 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.44 -33.23 53.45 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.785 -0.721 . . . . 61.45 111.572 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -112.97 86.82 2.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.126 0.489 . . . . 73.31 110.155 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.5 p -93.56 8.74 39.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.821 -0.627 . . . . 73.44 111.411 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -115.14 0.47 13.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.146 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 102' ' ' GLN . 85.3 t -114.55 121.89 67.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.292 -0.413 . . . . 72.51 110.12 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.716 HD22 HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -70.56 130.09 40.92 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 110.039 -0.356 . . . . 64.12 110.039 -178.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 78' ' ' ILE . . . -77.1 149.38 35.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.864 -0.607 . . . . 75.41 110.417 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.566 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -86.18 138.45 31.89 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.274 -0.421 . . . . 74.5 110.345 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 121.356 0.598 . . . . 64.42 110.584 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 110.115 -0.328 . . . . 61.41 110.115 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.3 129.49 38.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.341 -0.39 . . . . 74.11 110.41 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.63 163.64 20.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.39 -0.368 . . . . 72.32 110.66 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 69.41 9.38 7.26 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.565 0.54 . . . . 54.23 110.409 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.87 174.12 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.423 -0.808 . . . . 71.13 110.133 174.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.498 ' HA2' HD23 ' A' ' 88' ' ' LEU . . . -172.33 -174.05 39.41 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.255 -1.138 . . . . 65.42 110.255 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.15 114.81 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.469 0.652 . . . . 74.31 110.565 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.429 ' HB3' HG23 ' A' ' 85' ' ' VAL . 3.4 pt20 -104.54 145.03 30.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.753 -0.658 . . . . 74.24 109.396 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.463 HG22 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -104.13 123.63 58.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.142 0.496 . . . . 73.24 110.254 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 16.7 mt -91.46 144.63 25.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.503 -0.771 . . . . 75.43 108.947 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.1 p-10 -71.63 -171.7 0.69 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.7 -0.481 . . . . 74.43 109.7 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.427 ' CG ' ' HB3' ' A' ' 120' ' ' SER . 12.8 ptm180 -63.28 -25.2 68.21 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.098 0.407 . . . . 75.44 112.098 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.1 p -85.88 -34.33 21.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.709 -0.396 . . . . 73.43 110.759 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.74 29.6 1.38 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.655 -0.783 . . . . 63.23 112.446 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.08 131.32 54.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.034 -0.358 . . . . 71.41 110.034 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.35 120.88 15.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.398 -0.365 . . . . 73.22 110.797 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.7 133.31 33.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.168 -0.469 . . . . 63.35 110.539 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.53 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 16.2 m -69.38 139.34 54.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.164 -0.471 . . . . 74.4 110.445 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.716 HD12 HD22 ' A' ' 86' ' ' LEU . 29.6 mt -84.37 47.44 1.35 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.202 -0.454 . . . . 64.54 111.055 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -107.14 -6.04 17.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.964 0.412 . . . . 74.2 110.487 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.69 1.42 77.48 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.972 -0.632 . . . . 70.42 112.621 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -120.7 -0.85 10.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.008 0.432 . . . . 71.51 110.973 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.53 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 10.7 m -98.5 112.4 24.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.059 -0.518 . . . . 71.13 109.659 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.401 ' CD1' ' HB1' ' A' ' 72' ' ' ALA . 96.1 m-85 -103.67 162.38 13.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.189 0.518 . . . . 75.31 111.492 -172.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.7 m -77.63 -175.0 3.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 64.34 111.405 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.427 ' HB3' ' CG ' ' A' ' 106' ' ' ARG . 42.5 t -63.74 153.86 35.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.043 -0.526 . . . . 64.44 110.572 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.559 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 40.4 mt-10 -68.35 97.84 0.78 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.916 -0.584 . . . . 73.34 110.686 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.6 m -79.54 100.5 7.78 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.442 -0.577 . . . . 75.41 109.442 173.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.8 m -57.07 114.95 2.35 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.906 -0.588 . . . . 75.3 110.683 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.469 HD11 ' SG ' ' A' ' 61' ' ' CYS . 91.3 mt -80.47 150.5 29.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.659 -0.7 . . . . 74.43 111.444 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -136.3 157.46 46.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.684 -0.858 . . . . 74.32 108.684 170.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -59.03 115.88 3.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.709 0.29 . . . . 60.34 110.868 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 131.45 -138.44 10.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 64.22 112.383 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 54.9 m -97.43 125.06 41.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.285 0.564 . . . . 75.21 111.378 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -121.97 110.97 16.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.5 -0.773 . . . . 73.45 109.612 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.569 HG22 ' HB2' ' A' ' 55' ' ' ASN . 5.7 m -103.54 116.93 33.29 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.238 -0.437 . . . . 73.14 110.435 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.61 112.9 59.61 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.093 -0.503 . . . . 73.15 110.479 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -80.3 143.37 15.61 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.504 2.136 . . . . 75.53 112.633 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -140.64 165.67 26.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 74.44 110.618 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.623 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 96.4 mt-30 -126.7 121.31 31.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.178 -0.465 . . . . 72.03 111.011 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 52' ' ' VAL . . . -110.34 130.21 55.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.189 -0.3 . . . . 71.55 110.189 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.661 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 39.8 ptt180 -149.78 170.68 18.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 74.04 111.397 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.525 ' HH ' ' HA3' ' A' ' 8' ' ' GLY . 92.0 m-85 -86.37 145.33 26.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.593 -0.73 . . . . 71.33 111.084 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.427 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 75.3 t80 -130.33 133.28 46.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.244 -0.889 . . . . 73.24 108.644 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . . . -100.52 138.7 37.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.039 0.447 . . . . 70.32 111.617 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.533 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 57.0 p -102.98 3.36 36.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.506 -0.77 . . . . 72.23 109.575 176.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.57 -132.92 2.73 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.998 -1.001 . . . . 41.32 110.86 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.54 91.47 2.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.063 -0.347 . . . . 74.32 110.063 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.12 112.49 0.58 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 73.12 111.333 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -104.24 141.44 22.53 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 116.052 -0.522 . . . . 55.24 110.593 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -71.1 171.78 15.24 Favored 'Trans proline' 0 C--N 1.334 -0.222 0 C-N-CA 123.877 3.051 . . . . 73.52 113.035 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.6 -161.35 26.61 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.665 -0.779 . . . . 75.12 111.989 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.31 112.52 16.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.652 0.226 . . . . 73.41 110.397 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.566 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -113.75 71.92 0.76 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.447 . . . . 72.13 111.375 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -120.92 128.09 52.44 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.444 -0.576 . . . . 74.53 109.444 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.501 ' HB2' HD12 ' A' ' 86' ' ' LEU . . . -130.5 171.86 12.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 72.33 111.913 -173.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -129.9 127.22 39.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.667 -0.697 . . . . 73.41 110.428 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 12' ' ' PHE . . . -139.13 125.81 20.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.191 0.519 . . . . 44.22 110.784 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.541 HG22 ' HB3' ' A' ' 13' ' ' LYS . 16.9 p -105.86 130.07 53.9 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.937 -0.574 . . . . 74.44 110.143 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -106.44 141.21 38.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.183 0.516 . . . . 75.44 111.072 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.609 ' HA ' HG23 ' A' ' 16' ' ' VAL . 3.9 tmmm? -126.38 109.39 12.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.602 -0.726 . . . . 73.24 109.808 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -75.2 142.86 14.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.029 0.443 . . . . 75.32 110.321 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -122.31 121.6 37.11 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.5 -0.556 . . . . 74.11 109.5 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.528 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 1.1 p90 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.394 . . . . 75.54 111.075 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 p . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.969 0.414 . . . . 63.44 110.723 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.572 HG22 HG11 ' A' ' 37' ' ' VAL . 33.7 m -89.52 13.69 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.824 0.345 . . . . 64.44 110.871 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 60.61 16.29 6.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.356 -0.838 . . . . 65.44 112.648 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.32 107.02 3.05 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.575 -0.821 . . . . 65.52 112.127 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.577 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -98.23 150.35 19.38 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.383 -0.913 . . . . 44.02 111.772 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.515 HG21 ' HA ' ' A' ' 33' ' ' GLN . 16.9 p -142.55 145.45 33.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.746 0.308 . . . . 64.11 110.766 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.622 HG23 HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -121.39 119.65 59.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.955 -0.566 . . . . 75.21 110.789 175.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -86.65 123.45 31.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.413 -0.812 . . . . 64.32 110.124 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -107.93 126.89 53.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.289 -0.414 . . . . 74.14 110.374 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.507 ' HB3' HG23 ' A' ' 153' ' ' THR . 64.7 tttp -111.88 129.14 56.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.133 -0.485 . . . . 64.14 110.087 177.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.4 -123.99 5.34 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.871 -0.681 . . . . 75.02 111.906 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.48 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 34.7 mt-10 64.33 16.35 10.07 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.135 0.493 . . . . 73.5 111.522 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 155' ' ' LYS . 27.2 m -81.33 -21.63 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.936 -0.575 . . . . 70.35 111.284 -177.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.537 HG13 HG22 ' A' ' 156' ' ' VAL . 18.5 m -137.74 141.88 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.296 0.569 . . . . 73.01 111.352 -176.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -147.0 23.24 1.2 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.289 -1.004 . . . . 71.45 108.289 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.2 -92.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.306 -0.861 . . . . 73.33 111.107 -176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -73.2 -35.53 66.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.898 0.38 . . . . 61.21 110.776 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 1.4 m -141.59 133.12 26.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.938 -0.574 . . . . 73.2 109.825 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.96 126.3 41.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.25 -0.432 . . . . 62.2 110.276 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 t -67.4 131.62 32.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.773 -0.454 . . . . 71.45 109.773 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' HG12 ' A' ' 28' ' ' VAL . 19.4 t70 -62.62 151.53 37.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.436 -0.347 . . . . 75.31 110.949 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.426 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -57.85 -36.02 71.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 73.3 111.472 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.24 -2.01 86.68 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.903 -0.665 . . . . 74.32 111.961 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.414 ' OG ' HG22 ' A' ' 56' ' ' ILE . 46.5 t -119.6 -3.45 10.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.502 0.191 . . . . 72.34 110.901 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.48 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 32.9 m -94.34 -14.34 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.61 -0.515 . . . . 64.34 109.61 172.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -150.38 91.17 1.72 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.194 -0.912 . . . . 75.32 109.577 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -141.17 141.96 34.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.143 0.496 . . . . 72.21 109.978 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.505 HG23 ' HB ' ' A' ' 9' ' ' THR . 9.1 m -123.41 109.6 14.08 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.83 -0.623 . . . . 73.3 109.664 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.419 HG13 HG22 ' A' ' 10' ' ' VAL . 10.9 p -86.29 136.39 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.949 0.404 . . . . 73.43 110.324 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.515 ' HA ' HG21 ' A' ' 9' ' ' THR . 27.0 mp0 -93.31 115.08 27.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.989 -0.551 . . . . 54.24 110.43 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.622 HD21 HG23 ' A' ' 10' ' ' VAL . 2.7 mm? -76.96 -30.03 55.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.65 -0.705 . . . . 74.54 109.61 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.94 -173.48 30.6 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.511 -0.768 . . . . 65.02 111.75 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -83.54 90.45 7.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.564 0.221 . . . . 64.51 110.541 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.572 HG11 HG22 ' A' ' 5' ' ' VAL . 7.5 p -61.6 141.32 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.183 0.516 . . . . 53.43 110.399 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -86.49 116.01 24.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.794 -0.639 . . . . 75.23 110.098 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 p -70.62 -12.65 61.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.362 -0.835 . . . . 73.13 112.197 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.26 -30.47 48.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.887 0.375 . . . . 75.45 111.006 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.2 m -70.28 -40.66 74.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.547 0.689 . . . . 72.13 110.277 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -99.31 87.08 3.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.48 -0.782 . . . . 75.54 110.298 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.13 14.21 9.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.019 0.438 . . . . 73.31 111.257 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -154.64 146.74 23.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.782 -0.645 . . . . 75.51 109.504 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 43.1 tt0 -60.1 136.52 58.05 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.103 -0.332 . . . . 73.45 110.103 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.97 -14.3 60.13 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.606 -0.806 . . . . 63.24 111.813 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.35 125.15 25.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.698 0.285 . . . . 64.33 110.448 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.513 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 20.3 p -117.41 140.5 49.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.323 -0.399 . . . . 72.24 110.515 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.1 t -86.39 174.51 8.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.74 -0.466 . . . . 71.12 109.74 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -68.0 134.53 50.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.504 -0.554 . . . . 61.21 109.504 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -87.06 155.67 20.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.429 0.633 . . . . 73.25 111.757 -175.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.5 m -90.96 152.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.688 -1.142 . . . . 74.3 109.024 169.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.05 87.16 0.46 Allowed Glycine 0 C--N 1.31 -0.888 0 C-N-CA 120.784 -0.722 . . . . 53.04 111.776 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -101.68 173.12 6.56 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.769 -0.456 . . . . 74.23 109.769 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -140.82 146.92 38.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.905 0.383 . . . . 61.22 111.244 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.418 HD13 ' CE1' ' A' ' 154' ' ' PHE . 41.1 mt -102.58 122.45 54.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.605 -0.725 . . . . 72.34 109.251 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -100.72 126.86 47.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.099 -0.5 . . . . 74.25 111.305 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 128' ' ' THR . 70.4 mt -111.44 129.5 56.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.664 -0.698 . . . . 74.34 109.835 175.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -102.27 135.09 44.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.157 -0.474 . . . . 70.41 110.098 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.9 t70 49.09 77.51 0.1 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.069 0.855 . . . . 65.31 111.052 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.457 ' HB3' ' ND2' ' A' ' 129' ' ' ASN . 49.0 t -108.85 129.83 55.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.162 -0.927 . . . . 64.12 110.128 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -99.12 147.55 24.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.029 0.443 . . . . 73.23 111.772 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -115.84 8.99 14.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.647 -0.706 . . . . 74.43 111.546 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -91.24 -31.49 16.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.006 0.431 . . . . 73.32 110.006 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.29 -16.17 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.17 0.509 . . . . 63.01 110.571 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . . . -128.35 -178.33 4.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.269 -0.423 . . . . 74.34 110.792 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.478 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 37.1 m -144.19 -59.2 0.38 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.696 -0.229 . . . . 71.53 111.231 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.6 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -135.65 141.17 44.98 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 110.041 -0.355 . . . . 75.41 110.041 -178.331 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.06 124.74 49.1 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.093 0.473 . . . . 74.42 110.618 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.59 117.71 17.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.734 -0.667 . . . . 74.14 109.369 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.5 m -93.4 150.16 4.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.071 0.462 . . . . 72.45 110.768 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.37 124.15 44.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.49 -0.777 . . . . 65.43 109.474 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CE1' HG22 ' A' ' 103' ' ' ILE . 62.9 m-85 -86.39 134.73 33.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.213 0.53 . . . . 73.12 110.643 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.6 tp -132.38 122.44 25.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.512 -0.767 . . . . 75.31 109.73 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.15 -166.55 27.4 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.127 -0.789 . . . . 71.14 111.127 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.496 ' O ' HD11 ' A' ' 86' ' ' LEU . 4.1 m -76.8 124.95 28.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.476 0.179 . . . . 72.54 110.823 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -80.39 140.62 35.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.264 -0.273 . . . . 73.54 110.264 177.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.439 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 13.3 tt -62.98 -29.03 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.011 0.434 . . . . 75.04 111.118 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -149.68 178.08 9.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.443 -0.577 . . . . 73.12 109.443 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.95 -27.84 30.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.069 0.462 . . . . 74.32 109.981 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.32 -37.91 9.44 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.817 -0.706 . . . . 55.54 111.505 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -95.5 77.57 3.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.709 -0.478 . . . . 72.41 109.709 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 15.6 p -91.61 12.89 19.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.807 -0.633 . . . . 75.11 111.316 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -112.79 -5.01 13.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.125 -0.489 . . . . 73.52 110.993 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -112.12 128.83 68.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.384 -0.371 . . . . 72.44 110.249 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.499 HD12 ' HB2' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -68.64 137.56 54.3 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.014 -0.365 . . . . 72.24 110.014 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.97 157.57 29.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.181 -0.463 . . . . 65.21 110.34 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 99' ' ' VAL . 1.5 mm? -93.71 139.63 30.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.371 -0.377 . . . . 73.44 110.451 -176.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 149' ' ' ASN . 31.4 mt-30 . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 121.256 0.551 . . . . 71.13 109.642 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 54.7 m . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.878 -0.416 . . . . 62.21 109.878 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -92.94 146.26 23.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.68 -0.236 . . . . 62.34 110.38 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.22 164.81 26.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.728 0.299 . . . . 71.35 110.935 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.417 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 23.6 m-80 68.76 7.56 6.21 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.881 0.873 . . . . 72.33 111.285 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.572 ' O ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -147.65 150.21 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-N 115.965 -0.561 . . . . 74.21 109.882 173.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.86 -170.2 15.71 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.712 -0.955 . . . . 54.11 110.712 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 p -121.34 122.44 67.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.155 0.502 . . . . 71.15 110.412 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.16 138.88 51.38 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.136 0.494 . . . . 72.33 109.768 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.456 HG22 ' CE1' ' A' ' 73' ' ' PHE . 4.2 mp -94.14 128.42 45.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.841 -0.618 . . . . 75.43 110.071 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 18.4 mt -96.35 154.86 17.03 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.486 -0.779 . . . . 75.31 109.462 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.536 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 2.4 p-10 -72.92 -167.95 0.43 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.401 -0.592 . . . . 73.41 109.401 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -71.29 -19.06 62.38 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.462 -0.495 . . . . 74.31 111.858 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.409 ' HG1' ' CG ' ' A' ' 105' ' ' ASP . 51.2 p -90.6 -35.22 15.13 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.913 -0.315 . . . . 75.14 110.952 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.83 26.34 1.41 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.516 -0.85 . . . . 62.54 113.349 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . -100.52 140.45 34.76 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.332 -0.247 . . . . 63.33 110.332 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.03 126.33 30.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.317 -0.401 . . . . 71.32 111.465 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.7 mt -87.28 147.28 25.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.017 -0.538 . . . . 72.23 110.326 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.6 m -93.37 141.04 28.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.109 -0.496 . . . . 73.24 110.55 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.434 HD12 HD22 ' A' ' 86' ' ' LEU . 63.7 mt -84.25 60.25 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.074 0.464 . . . . 74.41 110.977 -176.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -119.57 -4.84 10.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.016 -0.538 . . . . 74.41 109.909 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.29 4.97 65.43 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.617 -0.72 . . . . 74.12 112.726 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.48 -16.65 7.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 72.23 110.811 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 m -84.15 97.76 9.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.664 -0.495 . . . . 73.13 109.664 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.473 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 86.6 m-85 -87.49 165.43 15.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.837 -175.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.0 m -74.53 -171.08 1.14 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.948 -0.569 . . . . 74.14 110.888 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.2 p -72.79 164.9 25.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.963 -0.384 . . . . 52.22 109.963 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.421 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 41.7 mt-10 -72.78 103.03 3.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.924 0.392 . . . . 74.05 111.193 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.0 m -84.19 109.65 17.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.317 -0.623 . . . . 75.02 109.317 174.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 m -63.6 113.52 3.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.941 -0.572 . . . . 71.34 111.095 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.456 HD13 ' SG ' ' A' ' 61' ' ' CYS . 94.6 mt -77.66 150.14 34.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.857 -0.61 . . . . 73.22 110.943 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.425 ' C ' HD21 ' A' ' 125' ' ' ASN . 0.4 OUTLIER -135.96 152.47 51.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.949 -0.569 . . . . 71.44 109.642 170.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 2.7 m120 -55.15 113.31 1.32 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.988 0.423 . . . . 72.32 111.587 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.75 -145.93 16.55 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.901 -0.666 . . . . 73.41 112.265 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 28.3 m -82.76 129.27 34.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.782 0.325 . . . . 72.24 110.379 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.457 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 26.1 m-80 -122.25 133.13 54.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.214 -0.448 . . . . 64.52 110.884 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.63 113.33 26.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.245 -0.434 . . . . 64.54 110.922 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 16.1 mt -92.87 106.4 18.82 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.042 -0.725 . . . . 73.5 109.042 175.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 6.2 Cg_exo -79.09 135.13 12.07 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.033 2.489 . . . . 64.23 112.31 -176.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -136.41 166.87 22.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.294 -0.412 . . . . 72.25 110.623 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 27.5 mt-30 -132.89 117.9 18.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.954 -0.566 . . . . 75.11 110.922 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.95 125.26 50.2 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.188 -0.301 . . . . 55.22 110.188 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.513 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 14.8 ptp180 -140.63 164.45 30.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.818 0.342 . . . . 74.23 110.836 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.577 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 58.6 m-85 -81.54 149.02 28.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.931 -0.577 . . . . 72.33 111.206 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -132.03 127.68 36.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.427 -0.806 . . . . 74.45 109.127 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -91.64 135.0 34.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.978 0.418 . . . . 74.22 111.416 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.417 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 55.8 p -101.82 1.03 36.65 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.425 -0.954 . . . . 74.22 108.425 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.82 -123.89 1.1 Allowed Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.34 -1.3 . . . . 60.33 111.189 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.25 98.0 11.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.44 -0.207 . . . . 53.1 110.44 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -47.71 117.3 1.78 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.075 -0.511 . . . . 75.12 111.083 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.6 p -107.29 146.74 33.85 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.169 -0.469 . . . . 75.3 110.79 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.73 167.7 23.65 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.382 2.722 . . . . 61.14 112.726 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.63 -125.04 2.75 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.663 -0.78 . . . . 52.11 111.768 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -129.91 118.47 21.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.738 0.304 . . . . 65.44 110.461 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -114.53 71.85 0.77 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.12 0.486 . . . . 63.4 110.933 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.485 ' N ' HD21 ' A' ' 149' ' ' ASN . 0.8 OUTLIER -111.98 146.16 38.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.392 -0.596 . . . . 73.41 109.392 178.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.499 ' HB2' HD12 ' A' ' 86' ' ' LEU . . . -150.25 163.22 38.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.801 0.334 . . . . 63.01 111.395 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -132.99 144.88 50.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 74.34 109.797 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.96 152.05 33.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.408 0.623 . . . . 74.0 111.68 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 13' ' ' LYS . 7.9 p -108.1 142.6 38.05 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.299 -0.864 . . . . 74.34 109.259 173.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.418 ' CE1' HD13 ' A' ' 56' ' ' ILE . 53.7 p90 -117.94 130.47 56.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.926 0.393 . . . . 75.21 110.572 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.598 ' HA ' HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -110.03 112.45 24.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.098 -0.501 . . . . 75.12 110.36 178.157 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -80.47 146.32 7.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.912 -0.403 . . . . 72.44 109.912 178.31 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -127.29 123.53 36.63 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.281 -0.637 . . . . 62.33 109.281 171.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.6 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--N 1.323 -0.586 0 CA-C-O 120.927 0.394 . . . . 75.22 111.337 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.9 p . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 110.135 -0.32 . . . . 72.54 110.135 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.425 HG23 HG11 ' A' ' 37' ' ' VAL . 27.2 m -87.84 21.49 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.018 0.437 . . . . 72.35 111.27 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 58.83 19.13 6.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.442 -0.799 . . . . 65.53 112.436 173.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.515 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 88.29 99.97 0.94 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.652 -0.785 . . . . 71.45 111.77 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.51 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -92.84 157.74 23.72 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.206 -0.997 . . . . 62.33 112.19 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.553 ' HB ' HG21 ' A' ' 31' ' ' THR . 73.0 p -140.91 148.95 41.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.57 0.224 . . . . 70.54 110.574 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.488 HG22 HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -121.69 119.36 58.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.943 -0.762 . . . . 71.4 108.943 171.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -91.15 109.56 20.82 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.402 -0.519 . . . . 74.13 109.694 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.446 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 97.7 m-85 -96.0 126.49 41.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.703 -0.68 . . . . 75.12 109.901 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -110.38 128.92 55.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.374 -0.376 . . . . 71.45 110.596 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.67 -139.1 10.35 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.056 -0.593 . . . . 62.12 111.85 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 60.83 27.48 17.28 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.356 0.598 . . . . 74.24 111.311 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.595 HG22 ' HA ' ' A' ' 155' ' ' LYS . 31.2 m -83.29 -28.96 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.647 -0.706 . . . . 75.2 111.188 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.641 HG21 HG21 ' A' ' 156' ' ' VAL . 16.4 m -142.36 151.04 18.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.349 -0.387 . . . . 71.42 110.939 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -167.98 84.17 0.2 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.713 -0.847 . . . . 74.12 108.713 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.1 -74.05 0.26 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.349 -0.841 . . . . 74.32 110.025 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.529 ' HB1' ' CD1' ' A' ' 158' ' ' TYR . . . -73.52 -35.27 65.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 75.53 109.997 173.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.411 ' CB ' ' HA ' ' A' ' 61' ' ' CYS . 4.2 m -143.56 -176.63 5.03 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.13 -0.693 . . . . 73.43 109.13 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.64 146.69 41.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.202 -0.666 . . . . 54.13 109.202 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 t -81.32 137.23 21.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.74 -0.467 . . . . 73.54 109.74 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.474 ' O ' HG11 ' A' ' 28' ' ' VAL . 12.3 t70 -65.45 141.35 58.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.61 -0.268 . . . . 73.05 110.328 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.461 ' HA ' HG21 ' A' ' 28' ' ' VAL . . . -57.12 -28.74 62.96 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.405 0.441 . . . . 75.35 111.98 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.28 -11.09 82.19 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.564 -0.827 . . . . 75.44 112.415 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.9 p -124.97 14.96 8.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.833 0.309 . . . . 74.42 111.833 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 24' ' ' ASP . 32.9 m -102.9 -5.74 9.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.087 0.47 . . . . 61.34 110.241 173.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -155.66 90.88 1.26 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.311 -0.859 . . . . 75.11 109.325 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 20.3 pm0 -139.65 124.29 18.33 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.346 0.593 . . . . 70.13 110.672 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.553 HG21 ' HB ' ' A' ' 9' ' ' THR . 2.2 m -100.54 95.09 6.48 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.452 -0.795 . . . . 64.23 109.29 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.99 136.59 24.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.209 0.528 . . . . 75.31 110.718 -174.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -96.58 118.63 33.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.448 -0.796 . . . . 73.41 110.267 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.488 HD21 HG22 ' A' ' 10' ' ' VAL . 2.6 mm? -90.13 -26.2 20.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.116 -0.493 . . . . 71.34 109.855 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.515 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 90.2 179.85 43.98 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.642 -0.708 . . . . 75.02 112.644 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -81.65 90.11 6.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.67 0.271 . . . . 72.33 110.636 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.425 HG11 HG23 ' A' ' 5' ' ' VAL . 7.3 p -79.28 142.36 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 110.249 -0.278 . . . . 74.41 110.249 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 38' ' ' ARG . 48.8 mtt180 -71.89 126.41 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 75.53 110.649 176.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.594 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 32.5 p -74.43 -20.22 60.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.07 0.462 . . . . 72.02 110.903 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.11 -29.95 65.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 73.31 111.442 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -71.06 -35.12 71.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.253 0.549 . . . . 74.41 110.25 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -98.74 74.08 2.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.713 -0.676 . . . . 73.32 110.256 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.94 17.66 18.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.083 0.468 . . . . 73.11 110.993 -172.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -150.37 138.7 20.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.866 -0.606 . . . . 64.42 110.218 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -55.72 126.59 26.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 74.54 110.358 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.37 -9.54 38.71 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.708 -0.758 . . . . 75.23 111.898 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.447 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . . . -62.97 121.04 12.56 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.73 0.3 . . . . 64.11 110.427 177.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.1 p -115.9 119.66 36.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.956 -0.566 . . . . 64.41 110.216 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.5 t -83.04 171.09 14.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.264 -0.425 . . . . 75.31 109.908 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.0 m -64.76 127.94 33.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.985 -0.552 . . . . 60.14 110.368 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 134' ' ' GLN . . . -83.3 147.58 27.87 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.492 0.663 . . . . 72.44 111.638 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.2 m -87.07 151.62 3.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 114.775 -1.102 . . . . 73.25 109.278 171.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.6 97.51 0.99 Allowed Glycine 0 C--N 1.311 -0.84 0 C-N-CA 120.976 -0.631 . . . . 61.32 112.322 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -109.87 172.44 6.85 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.81 -0.441 . . . . 73.24 109.81 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.536 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.3 p-10 -135.25 144.38 46.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.123 0.487 . . . . 74.34 111.648 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 81.7 mt -113.05 124.64 69.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.389 -0.823 . . . . 72.25 108.803 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -109.47 144.1 38.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.847 0.356 . . . . 74.04 111.089 -172.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 128' ' ' THR . 23.7 mt -120.52 133.4 55.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.227 -0.442 . . . . 75.02 109.823 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -112.15 155.29 24.17 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.928 -0.578 . . . . 72.44 109.839 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 51.58 45.77 27.55 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 123.849 0.718 . . . . 72.14 110.638 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.665 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 5.8 t -89.18 143.4 26.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.355 -0.838 . . . . 63.32 110.602 -174.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 64' ' ' ASN . 20.9 t70 -117.87 154.43 31.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 64.42 111.612 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.6 p -124.12 9.64 8.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.354 -0.384 . . . . 72.52 111.263 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.421 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 52.7 m-80 -84.37 -34.12 23.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 73.42 110.159 177.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.5 p -110.7 -17.09 8.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.044 -0.526 . . . . 73.44 110.985 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . . . -122.68 167.38 13.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.631 -0.259 . . . . 71.32 110.983 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.508 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 13.8 m -130.22 -55.4 1.11 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.404 -0.362 . . . . 61.55 111.117 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -138.67 153.23 48.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.177 -0.305 . . . . 73.32 110.177 -178.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.46 ' HB2' HD22 ' A' ' 124' ' ' LEU . . . -105.1 127.11 52.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.061 0.458 . . . . 64.24 110.369 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . . . -135.14 116.0 14.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.746 -0.661 . . . . 75.53 109.56 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.669 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.0 OUTLIER -89.81 144.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.158 0.504 . . . . 75.42 111.199 -174.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.85 118.07 29.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.215 -0.902 . . . . 74.42 109.537 173.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.503 ' CZ ' HG22 ' A' ' 103' ' ' ILE . 89.5 m-85 -82.71 137.83 34.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.188 0.518 . . . . 73.24 110.874 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.2 tp -128.42 135.78 49.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.554 -0.748 . . . . 74.35 109.521 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.08 -177.54 47.68 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.994 -0.622 . . . . 74.21 111.621 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 m -75.16 120.96 21.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.782 0.325 . . . . 75.15 110.818 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -79.18 144.14 34.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.137 -0.483 . . . . 50.14 110.402 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 tt -77.9 -21.26 13.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.013 0.435 . . . . 74.31 110.784 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -155.12 176.32 12.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.552 -0.536 . . . . 74.43 109.552 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.03 -29.02 32.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.98 0.419 . . . . 71.31 110.433 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.78 -24.63 19.97 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.832 -0.699 . . . . 72.43 111.692 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -99.91 50.71 0.91 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.348 0.594 . . . . 71.43 109.652 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.466 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 5.6 p -78.63 4.99 12.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.549 -0.751 . . . . 65.35 112.098 -176.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -107.7 -1.79 20.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.117 0.484 . . . . 72.43 110.525 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.62 123.98 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 73.22 110.285 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.59 HD23 HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -70.04 131.79 44.88 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.982 -0.377 . . . . 75.1 109.982 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.53 149.49 33.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.141 -0.482 . . . . 74.12 110.775 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.406 ' N ' HD21 ' A' ' 88' ' ' LEU . 2.3 mm? -81.02 143.75 32.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.896 -0.593 . . . . 73.31 110.567 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.026 -0.534 . . . . 73.42 111.09 178.102 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.541 -0.541 . . . . 70.13 109.541 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.23 121.73 14.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.094 -0.335 . . . . 74.21 110.094 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.4 160.69 18.15 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.788 -0.365 . . . . 73.14 110.755 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 69.26 14.61 8.59 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.669 -0.696 . . . . 63.44 110.476 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.0 -179.99 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.887 -0.597 . . . . 71.31 110.058 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 179.4 -173.57 45.5 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.172 -1.171 . . . . 73.31 110.172 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 10' ' ' VAL . 3.2 p -119.95 114.59 44.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.628 0.727 . . . . 72.2 110.674 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -103.9 141.7 35.7 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.486 -0.779 . . . . 74.23 109.114 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.503 HG22 ' CZ ' ' A' ' 73' ' ' PHE . 4.3 mp -104.18 127.66 58.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.199 0.523 . . . . 72.31 110.464 -177.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.0 mt -93.44 147.24 23.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.425 -0.807 . . . . 75.34 109.222 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.571 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -70.29 -172.71 0.61 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.494 -0.558 . . . . 73.43 109.494 174.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -67.92 -16.62 64.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.398 0.518 . . . . 74.13 112.398 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.0 p -95.53 -32.49 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.718 -0.393 . . . . 64.54 111.053 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.71 32.49 0.76 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.735 -0.745 . . . . 74.31 112.82 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.4 125.41 50.96 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.724 -0.28 . . . . 72.12 110.36 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.61 116.59 12.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.953 0.406 . . . . 73.34 110.436 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.437 HD12 ' HG ' ' A' ' 119' ' ' SER . 85.6 mt -84.85 132.74 34.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.007 -0.542 . . . . 73.15 111.238 -175.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.408 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 25.0 m -68.72 141.61 55.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.816 -0.629 . . . . 73.35 110.604 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.59 HD11 HD23 ' A' ' 86' ' ' LEU . 49.8 mt -82.7 41.2 0.71 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 75.3 111.207 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.41 -16.36 46.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.86 0.362 . . . . 73.52 110.56 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.67 3.58 89.06 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.735 -0.745 . . . . 71.34 111.603 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -128.1 2.3 5.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.725 0.298 . . . . 60.51 111.316 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.408 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 9.0 m -94.37 102.89 14.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.016 -0.365 . . . . 73.23 110.016 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.484 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 75.6 m-85 -93.99 150.84 19.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.213 -0.449 . . . . 71.55 111.876 -172.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.1 m -68.01 179.82 1.4 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.388 -0.824 . . . . 71.24 111.264 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.2 m -67.36 147.75 52.53 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.019 -0.537 . . . . 74.4 109.766 173.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.468 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 47.0 mt-10 -55.28 110.44 0.69 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 73.21 111.662 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.8 m -96.35 107.25 19.6 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.016 -0.735 . . . . 75.24 109.016 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 m -61.93 132.96 54.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.088 -0.506 . . . . 52.42 111.414 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' A' ' 69' ' ' ALA . 82.2 mt -94.6 149.14 21.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.241 0.543 . . . . 73.14 111.926 -176.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -128.38 151.55 49.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.219 -0.9 . . . . 75.2 108.835 168.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.665 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 17.9 m120 -63.7 121.94 15.18 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.952 0.406 . . . . 74.45 110.68 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.97 -109.94 1.22 Allowed Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.814 -0.63 . . . . 61.01 111.892 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 98.5 m -127.11 133.03 50.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.055 0.455 . . . . 63.41 111.173 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -129.65 145.25 51.52 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.359 -0.608 . . . . 74.34 109.359 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.536 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.6 m -125.82 122.64 36.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.867 0.365 . . . . 74.21 110.73 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.6 mt -102.91 115.74 63.68 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.167 -0.47 . . . . 73.23 110.084 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -80.26 138.27 12.48 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.84 2.36 . . . . 72.31 112.215 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -137.44 163.2 31.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.888 0.375 . . . . 75.12 110.81 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.611 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 19.9 mt-30 -131.82 119.3 21.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.98 -0.555 . . . . 74.5 111.235 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.93 129.9 53.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.442 -0.344 . . . . 71.32 110.259 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.432 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 1.4 ptp180 -140.86 164.97 28.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.892 0.377 . . . . 74.31 111.361 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.51 ' HH ' ' HA3' ' A' ' 8' ' ' GLY . 70.2 m-85 -86.55 141.75 28.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.865 -0.607 . . . . 75.01 110.33 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -127.97 122.53 32.57 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.238 -0.653 . . . . 74.4 109.238 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -85.45 130.55 34.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.89 0.376 . . . . 74.25 110.908 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 63.8 p -102.19 11.43 38.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.716 0.77 . . . . 75.24 108.933 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 163.84 -123.57 1.19 Allowed Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.616 -1.175 . . . . 70.2 111.385 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.9 95.35 8.19 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.242 -0.281 . . . . 61.44 110.242 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.594 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.02 115.55 1.33 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.006 0.432 . . . . 74.13 111.136 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.0 p -103.87 141.39 22.41 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.825 -0.435 . . . . 72.43 109.825 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.49 163.43 38.07 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.449 2.766 . . . . 73.05 112.396 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.35 -153.91 25.63 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.628 -0.796 . . . . 63.34 111.796 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.45 108.07 19.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.737 0.303 . . . . 73.4 110.828 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -107.05 75.78 1.05 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.201 0.524 . . . . 74.04 110.71 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -123.77 134.32 53.67 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.331 -0.618 . . . . 75.01 109.331 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -136.91 167.57 21.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.993 0.425 . . . . 54.14 111.434 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -131.16 142.47 50.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.643 -0.708 . . . . 74.42 109.561 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.81 139.05 27.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.224 0.535 . . . . 71.34 111.255 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.6 p -108.86 117.0 33.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.821 -0.627 . . . . 75.43 110.014 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.429 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 47.4 p90 -95.04 123.6 38.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.511 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.595 ' HA ' HG22 ' A' ' 16' ' ' VAL . 5.5 tmmm? -106.01 100.91 10.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.702 -0.481 . . . . 73.21 109.702 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.669 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.1 m -78.57 133.21 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.314 0.578 . . . . 71.2 110.168 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -111.7 113.38 25.72 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.876 -0.602 . . . . 72.15 110.987 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.529 ' CD1' ' HB1' ' A' ' 20' ' ' ALA . 5.3 p90 . . . . . 0 C--N 1.317 -0.83 0 CA-C-N 115.542 -0.754 . . . . 73.41 109.208 169.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.401 HG21 ' HA ' ' A' ' 38' ' ' ARG . 74.2 p . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 110.156 -0.313 . . . . 72.23 110.156 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.549 HG23 HG11 ' A' ' 37' ' ' VAL . 34.6 m -90.42 17.71 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.901 0.381 . . . . 73.42 111.001 176.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 59.55 31.07 20.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.597 -0.729 . . . . 74.33 112.275 171.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.443 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 79.82 92.53 0.4 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.68 -0.771 . . . . 37.16 112.3 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.454 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -87.31 153.42 25.26 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.208 -0.996 . . . . 65.11 111.678 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.529 ' HB ' HG22 ' A' ' 31' ' ' THR . 45.2 p -138.53 144.97 40.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.71 0.291 . . . . 75.02 110.486 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.498 HG13 ' HB1' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -118.04 120.44 64.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.97 -0.752 . . . . 75.11 108.97 172.294 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -86.86 111.28 20.62 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.405 -0.518 . . . . 73.2 109.611 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -100.92 118.84 37.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.808 -0.633 . . . . 72.1 110.02 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HB3' HG23 ' A' ' 153' ' ' THR . 48.0 tttp -116.21 138.08 51.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.145 -0.479 . . . . 72.1 110.597 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -116.22 -116.43 2.96 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.786 -0.643 . . . . 73.52 111.86 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.907 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 28.3 mt-10 62.45 22.45 13.26 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.158 0.504 . . . . 73.15 110.915 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.737 HG22 HG23 ' A' ' 17' ' ' VAL . 29.7 m -83.13 -26.46 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.574 -0.739 . . . . 73.02 111.659 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.737 HG23 HG22 ' A' ' 16' ' ' VAL . 3.8 m -140.28 134.63 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.099 0.476 . . . . 62.11 112.204 -173.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -139.22 23.4 2.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 75.55 109.33 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.71 -83.1 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 72.31 111.886 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.3 -34.05 70.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.467 0.651 . . . . 73.32 110.637 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 2.8 m -146.44 162.72 37.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.262 -0.881 . . . . 73.32 108.628 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.05 127.22 53.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.482 0.182 . . . . 71.41 110.601 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 t -70.04 130.09 34.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.904 -0.406 . . . . 74.15 109.904 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.9 t70 -57.84 140.87 50.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 64.43 111.067 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.84 -17.08 62.78 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 112.443 0.534 . . . . 72.4 112.443 -174.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.51 -23.12 48.49 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.596 -0.811 . . . . 61.04 111.949 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.0 p -101.63 -8.43 21.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.787 0.292 . . . . 62.41 111.787 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.907 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 30.5 m -82.4 -4.14 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.705 0.288 . . . . 73.11 111.471 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -164.44 85.07 0.43 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.048 -0.723 . . . . 40.25 109.048 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -136.33 130.6 33.11 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.872 -0.604 . . . . 73.31 110.716 -172.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.529 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.1 m -106.43 104.64 14.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.761 -0.654 . . . . 74.51 109.818 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 9' ' ' THR . 12.1 p -88.53 132.55 33.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.13 0.491 . . . . 71.11 110.928 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.412 ' HA ' HG21 ' A' ' 9' ' ' THR . 25.0 mp0 -89.2 123.39 33.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.811 -0.631 . . . . 73.24 110.129 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.475 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.5 mm? -83.6 -23.86 31.73 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.926 -0.768 . . . . 73.23 108.926 175.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 93.19 179.63 39.73 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.077 -0.965 . . . . 75.12 112.058 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -80.82 87.1 5.92 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.219 -0.289 . . . . 63.23 110.219 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.549 HG11 HG23 ' A' ' 5' ' ' VAL . 7.9 p -71.95 136.0 26.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.51 -0.552 . . . . 74.22 109.51 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.401 ' HA ' HG21 ' A' ' 4' ' ' THR . 76.3 mtp180 -78.82 130.29 35.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.245 -0.434 . . . . 73.44 110.411 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.0 p -82.03 13.09 3.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.065 -0.516 . . . . 72.13 111.224 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.4 -22.47 17.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.177 0.513 . . . . 64.14 109.785 174.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -81.88 -15.72 53.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.462 -0.79 . . . . 65.45 110.541 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.0 mp -125.87 117.19 22.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.06 -0.719 . . . . 74.54 109.06 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.96 10.35 2.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.763 0.653 . . . . 61.41 112.763 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -153.98 156.21 37.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.358 -0.238 . . . . 74.24 110.358 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 42.2 tt0 -61.04 131.04 49.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.396 -0.366 . . . . 73.12 110.047 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.45 -1.96 57.36 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.686 -0.769 . . . . 74.52 111.939 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.453 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . . . -78.09 115.57 17.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.008 0.432 . . . . 72.41 110.012 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.534 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 4.7 p -111.46 135.43 52.02 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.766 -0.652 . . . . 73.31 110.431 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 t -88.07 179.47 6.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 62.02 109.649 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 m -71.55 139.57 49.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.725 -0.472 . . . . 75.1 109.725 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -90.96 152.61 20.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.311 0.576 . . . . 75.54 112.03 -175.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 24.7 m -83.53 158.56 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.77 -1.105 . . . . 55.01 109.199 168.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.79 89.92 0.51 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.896 -0.669 . . . . 65.21 112.054 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -103.25 175.56 5.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.575 -0.528 . . . . 73.21 109.575 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.539 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.3 p-10 -143.68 155.06 44.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.367 0.603 . . . . 71.54 111.869 -174.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.413 HD11 ' CE2' ' A' ' 133' ' ' PHE . 80.0 mt -115.05 112.62 40.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.052 -0.976 . . . . 74.22 108.903 171.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -96.52 128.25 43.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.036 0.445 . . . . 74.34 110.703 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.3 mt -110.33 126.01 53.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.88 -0.6 . . . . 75.11 110.046 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -105.36 145.09 31.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.019 -0.537 . . . . 72.24 109.555 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 30.2 t70 49.69 69.14 0.63 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.926 0.869 . . . . 74.12 110.563 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 10.2 t -106.28 114.84 29.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.048 -0.978 . . . . 72.35 109.734 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -96.68 131.59 43.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.08 -0.509 . . . . 75.43 111.515 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.0 p -102.24 12.8 36.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 71.12 111.879 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -87.87 -26.36 22.81 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.539 -0.541 . . . . 65.42 109.539 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.73 -32.97 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.674 -0.694 . . . . 75.0 110.841 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.559 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -113.57 -179.19 3.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.725 0.298 . . . . 74.51 111.326 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 29.4 m -139.32 -55.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.503 -0.317 . . . . 74.4 111.596 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -136.31 144.7 44.84 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 110.408 -0.219 . . . . 72.43 110.408 -177.031 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.487 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -103.23 137.29 41.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.967 0.413 . . . . 65.24 110.72 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.39 113.74 6.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 74.44 109.417 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.5 m -87.01 145.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.98 0.419 . . . . 63.21 110.977 -173.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.558 ' HB1' ' CD1' ' A' ' 118' ' ' PHE . . . -118.18 122.06 42.07 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.738 -0.665 . . . . 53.45 109.919 174.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 103' ' ' ILE . 88.6 m-85 -87.58 130.62 34.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.297 0.57 . . . . 75.34 110.812 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.5 tp -125.41 122.66 37.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.605 -0.725 . . . . 75.04 109.763 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.05 -171.43 29.28 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.768 -0.651 . . . . 63.42 111.586 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.408 ' O ' HD12 ' A' ' 86' ' ' LEU . 8.8 m -84.59 119.9 25.73 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.374 -0.232 . . . . 71.35 110.374 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.5 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -78.65 144.67 35.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.522 -0.308 . . . . 71.33 110.987 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 tt -69.79 -37.29 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.417 . . . . 74.43 110.835 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.33 175.45 10.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.316 -0.624 . . . . 73.42 109.316 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.34 -37.15 38.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.083 0.468 . . . . 70.25 110.323 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.5 -19.01 67.2 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.591 -0.814 . . . . 74.54 111.276 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -111.17 47.57 0.99 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.16 0.505 . . . . 74.42 109.728 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.5 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -74.14 4.1 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.602 -0.727 . . . . 74.51 112.373 -176.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 30.3 p-10 -108.09 -0.6 21.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.158 0.504 . . . . 71.34 110.288 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.2 t -108.01 125.82 64.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.875 -0.602 . . . . 71.51 110.153 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.495 HD22 ' CD1' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -69.0 134.42 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.382 -0.372 . . . . 72.12 110.588 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.36 150.27 35.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.06 -0.518 . . . . 43.32 110.483 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.5 mm? -91.77 134.47 34.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.313 -0.403 . . . . 75.23 110.451 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 . . . . . 0 C--N 1.324 -0.516 0 CA-C-O 121.364 0.602 . . . . 73.42 110.611 -179.5 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 110.18 -0.304 . . . . 73.13 110.18 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.95 149.89 21.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.784 -0.45 . . . . 75.43 109.784 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.45 167.54 21.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.918 -0.401 . . . . 74.41 109.918 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 68.62 10.18 7.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.17 0.51 . . . . 71.04 110.498 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.07 -177.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.634 -0.712 . . . . 75.22 110.444 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.84 -174.78 46.86 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.171 -1.172 . . . . 75.01 110.171 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.65 115.27 46.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.364 0.602 . . . . 71.01 110.62 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -107.28 135.42 48.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.206 -0.664 . . . . 72.44 109.206 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.465 HG22 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -95.83 123.61 48.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.968 0.413 . . . . 73.32 110.813 -175.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.508 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 15.5 mt -88.65 136.19 33.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.485 -0.779 . . . . 75.24 109.336 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.54 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.2 OUTLIER -71.78 -173.64 1.02 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.776 -0.453 . . . . 72.34 109.776 175.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.455 ' HG3' HG21 ' A' ' 107' ' ' THR . 15.4 ptm180 -57.96 -23.77 55.15 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.973 0.36 . . . . 75.03 111.973 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.455 HG21 ' HG3' ' A' ' 106' ' ' ARG . 71.0 p -102.02 11.41 38.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.792 0.33 . . . . 71.33 111.647 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 76.52 35.57 41.13 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.836 -0.697 . . . . 61.54 112.985 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.63 120.71 42.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.352 -0.24 . . . . 75.35 110.352 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 103' ' ' ILE . . . -65.83 111.42 3.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.984 0.421 . . . . 74.13 110.534 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.523 HD12 ' HG ' ' A' ' 119' ' ' SER . 92.5 mt -78.26 132.93 37.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.849 -0.614 . . . . 72.4 111.3 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 15.3 m -67.55 142.06 56.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.492 -0.776 . . . . 74.22 110.598 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.495 ' CD1' HD22 ' A' ' 86' ' ' LEU . 59.5 mt -81.79 44.15 0.81 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.057 0.456 . . . . 74.25 110.808 -177.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -92.97 -18.03 23.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.836 -0.62 . . . . 75.32 110.516 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.58 -16.29 46.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.613 -0.803 . . . . 61.33 112.325 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.82 8.11 20.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.476 . . . . 73.22 110.717 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.1 m -97.03 95.88 8.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.011 -0.541 . . . . 74.04 110.059 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.708 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 65.3 m-85 -93.61 158.0 15.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.178 -0.465 . . . . 73.44 111.405 -173.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.54 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 5.7 m -69.58 -175.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.639 -0.71 . . . . 71.52 111.586 178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.9 t -69.37 163.52 24.98 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.765 -0.457 . . . . 73.22 109.765 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.414 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 48.9 mt-10 -68.03 104.58 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 74.34 111.245 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.499 HG22 HG12 ' A' ' 131' ' ' ILE . 75.1 m -85.14 99.11 10.85 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.649 -0.501 . . . . 64.1 109.649 173.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.4 m -56.16 112.92 1.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.719 -0.673 . . . . 75.33 110.585 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 69' ' ' ALA . 85.1 mt -74.33 144.39 44.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 63.44 111.712 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -117.41 141.93 47.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.188 -0.915 . . . . 75.01 109.215 173.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -55.59 116.69 3.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.36 0.413 . . . . 63.42 110.868 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 119.67 -111.51 2.05 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.592 -0.813 . . . . 73.21 112.57 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.6 m -112.05 134.77 53.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.943 0.401 . . . . 52.53 111.198 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -131.17 124.11 29.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.948 -0.569 . . . . 73.43 110.122 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.539 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.7 m -110.75 107.06 16.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.738 0.304 . . . . 74.34 110.331 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.499 HG12 HG22 ' A' ' 122' ' ' THR . 13.7 mt -88.14 118.04 69.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.365 -0.38 . . . . 74.32 110.119 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.18 137.98 9.83 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.812 2.341 . . . . 74.31 112.956 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 74.2 m-85 -136.43 161.84 34.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 73.1 111.135 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 26.3 mt-30 -130.17 118.1 20.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 72.31 110.934 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -107.05 125.62 51.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.134 -0.321 . . . . 63.14 110.134 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.534 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 10.1 ptp180 -138.64 163.53 31.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.011 0.434 . . . . 72.41 111.092 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 64.4 m-85 -81.52 142.3 32.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 73.14 111.053 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -126.4 116.84 21.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.435 -0.802 . . . . 74.23 109.376 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 45' ' ' GLU . . . -82.19 131.28 35.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.479 -0.328 . . . . 60.24 110.566 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 68.9 p -101.3 2.84 40.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.645 0.736 . . . . 75.15 109.471 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 173.81 -134.75 2.97 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.742 -1.117 . . . . 71.13 110.635 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.407 ' O ' HG22 ' A' ' 144' ' ' THR . . . -78.08 85.91 4.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.712 0.256 . . . . 75.03 110.338 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -46.48 111.67 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.614 0.571 . . . . 52.22 111.781 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 142' ' ' ALA . 20.4 p -102.49 144.49 28.71 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-O 121.075 0.464 . . . . 72.43 111.232 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.41 167.38 26.49 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.413 2.742 . . . . 72.41 112.648 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.39 -128.78 3.14 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.867 -0.682 . . . . 70.52 111.783 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -120.68 117.24 27.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.719 0.295 . . . . 74.43 110.468 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.415 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -118.09 74.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.164 0.507 . . . . 44.53 111.309 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -117.31 138.67 51.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.963 -0.562 . . . . 70.24 109.897 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' A' ' 10' ' ' VAL . . . -135.63 171.58 14.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.586 0.587 . . . . 64.12 112.586 -172.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -134.01 128.67 34.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.247 -0.888 . . . . 73.55 109.739 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.67 144.31 25.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.281 0.562 . . . . 74.13 111.867 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.416 HG23 ' HB3' ' A' ' 13' ' ' LYS . 21.7 p -112.4 150.67 30.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.694 -0.684 . . . . 74.14 109.529 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -121.92 134.25 54.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.257 0.551 . . . . 64.34 111.219 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.708 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 20.2 ttmt -111.22 101.57 10.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.608 -0.724 . . . . 72.22 110.499 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.69 HG22 HG21 ' A' ' 17' ' ' VAL . 1.3 m -75.13 126.82 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 119.983 -0.687 . . . . 74.15 109.539 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -108.48 111.82 23.9 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.874 -0.603 . . . . 72.33 110.434 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 120.882 0.372 . . . . 73.42 110.839 171.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.857 0.36 . . . . 72.33 110.259 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 35.5 m -88.42 13.19 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.189 0.519 . . . . 75.24 110.715 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 63.67 14.31 8.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.233 -0.894 . . . . 71.14 112.502 172.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.422 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 88.59 94.45 1.04 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.674 -0.774 . . . . 71.34 111.677 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.522 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -84.66 152.22 27.29 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.425 -0.893 . . . . 53.55 112.084 -176.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.516 ' HB ' HG22 ' A' ' 31' ' ' THR . 21.0 p -143.06 139.97 30.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.342 -0.244 . . . . 74.41 110.342 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.29 126.28 68.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.835 -0.432 . . . . 72.12 109.835 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -93.91 112.7 24.58 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.574 -0.528 . . . . 65.51 109.574 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -100.08 122.64 43.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.962 -0.563 . . . . 73.35 110.657 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.508 ' HB3' HG22 ' A' ' 153' ' ' THR . 59.3 tttm -112.09 136.09 51.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 74.42 110.092 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.08 -120.72 3.41 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.715 -0.755 . . . . 71.14 112.349 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.548 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 34.8 mt-10 63.28 20.01 12.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.06 0.457 . . . . 75.54 110.943 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' A' ' 155' ' ' LYS . 18.9 m -80.39 -21.95 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.661 . . . . 72.34 112.207 -175.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.401 HG12 HG23 ' A' ' 16' ' ' VAL . 17.3 m -133.49 157.3 42.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.237 0.542 . . . . 74.35 112.032 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -157.54 24.74 0.29 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.696 -1.138 . . . . 72.21 108.49 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.1 -81.07 0.32 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 72.14 111.664 -174.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.77 -38.78 11.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.951 0.405 . . . . 63.54 110.917 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 2.0 m -137.36 128.58 27.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.126 -0.488 . . . . 75.01 110.148 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.08 125.54 35.9 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.645 -0.707 . . . . 71.53 110.361 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.455 ' HA ' HD22 ' A' ' 58' ' ' LEU . 15.8 t -66.23 128.66 29.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.72 -0.474 . . . . 73.4 109.72 177.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.27 145.49 42.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.154 -0.475 . . . . 64.35 111.235 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.505 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -63.11 -22.13 66.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 75.11 111.71 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.66 -10.24 79.72 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.732 -0.747 . . . . 62.24 111.876 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.0 t -104.3 -27.5 11.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.088 . . . . 71.54 110.827 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 27.7 m -74.66 -6.84 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.095 0.474 . . . . 74.41 110.923 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -153.54 95.14 1.87 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.36 -0.836 . . . . 74.1 109.356 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -151.57 137.73 18.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.888 -0.596 . . . . 71.43 110.681 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.516 HG22 ' HB ' ' A' ' 9' ' ' THR . 6.9 m -115.66 111.96 21.4 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.591 -0.731 . . . . 73.34 109.698 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 p -92.87 139.54 17.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.846 0.355 . . . . 74.53 110.691 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -95.86 126.75 41.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.239 -0.437 . . . . 53.52 110.362 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -91.32 -27.59 18.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.39 0.614 . . . . 70.55 109.482 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.422 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.58 171.71 37.76 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.263 -0.881 . . . . 71.21 112.127 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -73.02 88.17 1.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.778 0.323 . . . . 74.43 110.717 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.479 HG11 ' CG2' ' A' ' 5' ' ' VAL . 9.8 p -67.44 151.93 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.478 -0.328 . . . . 73.22 110.171 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -91.31 125.02 35.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.095 -0.502 . . . . 65.55 110.725 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.3 p -74.71 -15.04 60.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.947 -0.569 . . . . 74.53 111.047 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.98 -22.51 60.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.475 . . . . 72.54 111.204 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 m -85.66 -33.93 21.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.136 0.494 . . . . 54.22 110.638 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 5.5 mp -108.61 97.74 7.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.986 -0.552 . . . . 75.22 109.956 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.25 14.87 4.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.025 0.441 . . . . 74.01 111.119 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -152.49 146.98 25.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.858 -0.61 . . . . 72.33 110.086 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 44.2 tt0 -62.65 130.76 46.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 63.34 110.303 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.98 -5.93 42.95 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.678 -0.772 . . . . 73.12 111.617 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . . . -74.88 119.93 19.73 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.99 -0.374 . . . . 72.11 109.99 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.565 ' HB ' HH11 ' A' ' 136' ' ' ARG . 37.9 p -115.15 126.07 54.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.115 -0.493 . . . . 72.2 110.476 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.2 t -80.0 172.4 13.83 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.836 -0.431 . . . . 55.12 109.836 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.7 m -69.58 134.99 49.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.302 -0.408 . . . . 71.42 110.054 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.494 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -86.98 162.12 17.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.625 0.726 . . . . 73.13 111.93 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.5 m -104.66 152.22 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.575 -1.193 . . . . 75.21 109.349 172.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.82 105.23 2.19 Favored Glycine 0 C--N 1.312 -0.779 0 C-N-CA 120.802 -0.714 . . . . 75.11 112.188 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -117.93 171.89 7.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.12 -0.696 . . . . 74.03 109.12 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.82 139.6 32.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.526 0.679 . . . . 75.21 112.507 -175.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.433 HD12 ' CD1' ' A' ' 154' ' ' PHE . 45.9 mt -95.22 116.48 36.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.268 -0.878 . . . . 71.04 109.585 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -93.32 133.39 36.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.771 -0.65 . . . . 75.24 111.249 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 23' ' ' VAL . 69.3 mt -117.76 129.68 55.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.59 -0.732 . . . . 75.22 109.587 176.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -103.89 146.24 28.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.297 -0.41 . . . . 75.43 110.493 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 49.95 41.84 23.56 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.873 0.733 . . . . 54.34 111.235 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 53.6 t -76.76 124.55 27.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.83 -0.623 . . . . 72.52 110.492 -175.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.52 132.48 45.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.054 -0.521 . . . . 71.31 111.292 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.8 p -107.62 18.21 21.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.093 0.473 . . . . 75.43 111.661 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -90.85 -33.66 15.57 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.975 -0.75 . . . . 71.23 108.975 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 p -101.71 -12.88 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.548 -0.751 . . . . 71.53 111.086 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . . . -135.45 169.47 17.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.692 0.282 . . . . 72.41 110.997 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.483 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 44.8 m -129.01 -57.13 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 63.03 111.97 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -135.91 141.73 44.59 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 122.164 -0.335 . . . . 75.22 110.172 -176.26 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.32 134.7 47.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.218 0.533 . . . . 72.24 110.495 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.86 120.43 12.5 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.351 -0.841 . . . . 71.15 109.201 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.6 m -93.78 149.44 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.067 0.461 . . . . 64.01 110.965 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.22 119.32 32.87 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.461 -0.791 . . . . 75.52 109.396 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 62.7 m-85 -83.09 126.28 32.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.955 0.407 . . . . 64.11 110.547 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.8 tp -122.42 127.65 49.92 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.897 -0.592 . . . . 75.34 109.857 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.75 -164.44 26.47 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.343 -0.703 . . . . 71.33 111.343 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.415 ' O ' HD12 ' A' ' 86' ' ' LEU . 8.7 m -82.35 128.33 34.11 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.614 0.207 . . . . 74.23 110.476 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.67 148.48 24.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.176 -0.305 . . . . 63.43 110.176 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.3 tt -74.33 -25.64 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.988 0.423 . . . . 74.32 110.731 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -155.66 -174.2 4.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.522 -0.547 . . . . 73.43 109.522 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.88 -44.11 13.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.078 0.466 . . . . 72.01 110.067 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.3 -18.56 71.23 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.723 -0.751 . . . . 71.34 111.333 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -104.98 46.22 0.93 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.352 0.596 . . . . 73.03 109.89 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.9 12.42 2.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.53 -0.759 . . . . 72.14 111.803 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -107.6 -12.35 15.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.061 -0.518 . . . . 65.21 110.491 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 65.0 t -106.92 125.83 62.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.916 -0.584 . . . . 62.04 110.778 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.502 HD13 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -66.08 133.19 50.24 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.795 -0.446 . . . . 74.42 109.795 178.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.15 147.8 36.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.449 . . . . 51.41 110.114 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.77 145.56 34.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.133 -0.485 . . . . 74.14 110.111 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 8.8 mm-40 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.923 -0.581 . . . . 74.45 110.647 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.736 -0.468 . . . . 75.0 109.736 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.62 142.0 44.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.073 -0.343 . . . . 71.35 110.073 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.0 163.44 30.28 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.02 -0.363 . . . . 65.43 110.02 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 70.32 10.68 7.33 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.512 0.508 . . . . 73.23 110.824 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.63 -177.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.658 -0.701 . . . . 60.32 109.677 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 172.71 -175.89 45.68 Favored Glycine 0 N--CA 1.437 -1.259 0 N-CA-C 110.602 -0.999 . . . . 75.35 110.602 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.52 114.58 46.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.399 0.619 . . . . 72.34 110.83 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -106.37 140.14 39.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.52 -0.764 . . . . 60.35 109.596 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.407 HD11 ' N ' ' A' ' 103' ' ' ILE . 3.9 mp -101.58 123.85 54.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.233 -0.44 . . . . 74.52 110.256 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 16.4 mt -87.74 148.61 24.66 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.537 -0.756 . . . . 75.13 109.411 176.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.553 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 2.1 p-10 -72.39 -170.74 0.68 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.715 -0.476 . . . . 73.32 109.715 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -72.09 -17.09 62.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.135 0.42 . . . . 75.34 112.135 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.6 p -89.23 -36.99 15.32 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.553 -0.459 . . . . 75.45 110.683 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.87 31.04 0.72 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.658 -0.782 . . . . 52.13 113.363 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -117.76 133.04 56.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.783 0.292 . . . . 65.43 110.517 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.03 141.61 57.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.962 0.41 . . . . 65.14 110.973 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.6 mt -91.09 -176.53 4.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.039 -0.528 . . . . 72.12 110.214 178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.3 m -125.29 142.01 51.75 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.003 -0.369 . . . . 62.34 110.003 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 53.9 mt -84.46 39.48 0.73 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.384 -0.371 . . . . 75.41 111.548 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -102.19 -0.59 32.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.99 0.424 . . . . 62.3 110.26 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.3 3.22 45.5 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.747 -0.66 . . . . 53.44 113.141 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -120.88 -11.6 8.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.932 0.366 . . . . 72.45 111.051 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.2 m -91.16 108.6 19.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.015 -0.365 . . . . 71.41 110.015 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.52 ' CE1' ' HE3' ' A' ' 155' ' ' LYS . 93.7 m-85 -98.27 163.96 12.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.107 0.479 . . . . 72.13 111.228 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.553 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 4.0 m -70.23 175.33 4.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 63.25 110.499 175.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.0 t -68.08 146.09 53.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.229 -0.656 . . . . 75.43 109.229 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -53.76 112.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 74.1 111.444 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.6 m -97.19 106.6 18.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.744 -0.662 . . . . 74.5 109.542 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.5 m -58.49 116.34 3.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.228 0.537 . . . . 64.13 111.277 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.463 ' C ' HD21 ' A' ' 125' ' ' ASN . 87.8 mt -77.31 152.44 34.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.362 -0.836 . . . . 72.53 111.544 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.463 HD21 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -122.5 153.34 39.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.514 -0.767 . . . . 72.34 109.583 173.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -68.58 106.63 2.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.838 0.352 . . . . 73.02 110.793 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 131.88 -128.72 5.39 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.747 -0.739 . . . . 70.11 112.497 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.3 m -94.09 127.46 39.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.841 0.353 . . . . 72.52 110.709 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -123.58 150.05 44.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.283 -0.417 . . . . 74.13 110.216 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.59 111.43 10.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.355 -0.384 . . . . 74.44 111.068 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 8.8 mt -90.99 110.17 40.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.233 -0.654 . . . . 74.23 109.233 177.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 2.4 Cg_endo -80.6 133.9 9.61 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.914 2.409 . . . . 72.33 112.127 -177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -131.27 158.85 39.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.426 -0.352 . . . . 75.12 110.501 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.653 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 92.4 mt-30 -123.04 113.53 19.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.864 -0.607 . . . . 75.12 110.804 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.75 126.89 44.5 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 121.008 -0.277 . . . . 61.1 110.329 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.565 HH11 ' HB ' ' A' ' 48' ' ' THR . 13.1 ptp180 -140.8 162.85 34.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.859 0.361 . . . . 71.42 110.809 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 62.3 m-85 -82.28 137.44 34.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.016 -0.538 . . . . 75.04 110.853 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.409 ' HD1' HG23 ' A' ' 48' ' ' THR . 80.2 t80 -121.62 119.52 32.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.771 -0.65 . . . . 73.21 109.4 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.555 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . . . -84.0 130.32 34.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.305 -0.407 . . . . 72.45 110.746 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.496 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 73.6 p -102.01 5.34 40.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.876 0.846 . . . . 74.22 109.258 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.05 -136.89 4.01 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.455 -1.248 . . . . 54.24 110.274 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.15 92.19 6.25 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.663 -0.495 . . . . 72.22 109.663 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.43 114.1 0.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 123.768 0.668 . . . . 75.11 111.334 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 39.9 p -101.89 140.21 20.99 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 121.209 0.528 . . . . 74.51 110.407 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.63 162.52 40.68 Favored 'Trans proline' 0 C--N 1.331 -0.364 0 C-N-CA 123.713 2.942 . . . . 52.35 113.342 -174.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 142.08 -167.05 26.16 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.797 -0.638 . . . . 45.35 111.731 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.88 114.03 4.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 72.43 110.894 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.489 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . . . -112.77 49.85 0.91 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.441 0.639 . . . . 71.44 110.806 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 89' ' ' GLN . 89.1 m-20 -105.79 147.53 28.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.368 -0.833 . . . . 70.01 109.411 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.502 ' HB1' HD13 ' A' ' 86' ' ' LEU . . . -148.82 169.24 20.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.717 0.294 . . . . 71.13 111.083 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -140.16 147.73 40.57 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.528 -0.545 . . . . 50.03 109.528 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.19 144.46 21.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.992 0.425 . . . . 73.12 111.346 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.508 HG22 ' HB3' ' A' ' 13' ' ' LYS . 22.7 p -103.11 123.98 47.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.83 -0.623 . . . . 74.42 109.756 175.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.433 ' CD1' HD12 ' A' ' 56' ' ' ILE . 39.5 p90 -97.21 124.11 41.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.255 0.55 . . . . 75.21 110.654 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.614 ' HA ' HG22 ' A' ' 16' ' ' VAL . 4.1 tmmm? -107.31 104.23 13.79 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.782 -0.645 . . . . 73.31 109.87 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.3 m -75.55 147.95 7.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.026 0.441 . . . . 63.53 110.046 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -133.51 129.39 37.07 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.232 -0.655 . . . . 73.43 109.232 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.594 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 121.042 0.449 . . . . 73.4 110.989 175.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.905 0.383 . . . . 75.11 110.563 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.35 15.64 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.104 0.478 . . . . 75.22 110.526 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.492 ' N ' HD21 ' A' ' 6' ' ' ASN . 0.8 OUTLIER 65.09 11.97 7.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.186 -0.915 . . . . 37.96 112.348 171.63 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.469 ' N ' ' HG2' ' A' ' 36' ' ' GLN . . . 87.8 98.25 0.91 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.441 -0.885 . . . . 53.43 111.537 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.458 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -89.68 153.06 22.91 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.191 -1.004 . . . . 52.42 112.046 -177.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.589 ' HB ' HG21 ' A' ' 31' ' ' THR . 75.0 p -137.05 140.47 42.07 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.857 -0.423 . . . . 74.21 109.857 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -110.85 118.82 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 109.7 -0.481 . . . . 71.4 109.7 176.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 13.1 t-80 -85.88 106.52 17.15 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.987 0.422 . . . . 73.53 110.005 177.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.411 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 77.8 m-85 -94.64 114.43 26.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.968 -0.56 . . . . 72.35 110.313 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 62.9 tttp -109.54 132.73 53.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.678 -0.692 . . . . 74.33 110.179 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.94 -114.64 3.01 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.89 -0.672 . . . . 41.3 112.073 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.65 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 37.4 mt-10 63.94 17.14 10.38 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.006 0.432 . . . . 75.12 111.236 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' A' ' 155' ' ' LYS . 18.4 m -75.19 -30.88 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.905 -0.589 . . . . 72.33 111.92 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.45 HG21 ' CG2' ' A' ' 156' ' ' VAL . 29.6 m -140.16 154.7 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.246 0.546 . . . . 74.11 111.921 -174.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -155.29 28.61 0.4 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.026 -1.101 . . . . 70.12 108.026 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.43 -78.04 0.32 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.252 -0.886 . . . . 64.3 111.523 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -83.9 -37.63 22.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.124 0.487 . . . . 71.34 110.585 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.8 m -142.87 131.53 22.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.759 -0.655 . . . . 74.44 109.567 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.63 124.45 35.07 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.177 -0.465 . . . . 73.1 110.307 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.443 ' HA ' HD21 ' A' ' 58' ' ' LEU . 6.0 t -66.13 124.69 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.244 -0.651 . . . . 70.3 109.244 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' O ' HG13 ' A' ' 28' ' ' VAL . 16.5 t70 -56.89 139.84 50.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 71.35 111.206 -175.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' A' ' 28' ' ' VAL . . . -59.72 -24.44 63.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 74.12 112.146 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.68 -17.55 70.35 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.555 -0.831 . . . . 60.04 111.915 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 p -104.98 -13.28 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.723 0.268 . . . . 65.03 111.723 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.65 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 34.7 m -78.68 -10.59 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.039 0.447 . . . . 75.24 110.623 177.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -152.68 90.43 1.48 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.415 -0.811 . . . . 73.44 108.882 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -142.99 115.96 8.83 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.517 0.675 . . . . 72.14 110.726 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.589 HG21 ' HB ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -97.1 97.02 8.86 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.277 -0.874 . . . . 60.11 108.96 176.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' THR . 8.8 p -75.63 132.3 33.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.938 0.399 . . . . 74.14 110.987 -175.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.524 ' HA ' HG21 ' A' ' 9' ' ' THR . 27.3 mp0 -87.82 125.76 34.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.103 -0.499 . . . . 74.42 110.107 177.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -90.59 -32.63 16.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.963 -0.562 . . . . 73.14 109.886 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.437 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 99.5 168.58 30.08 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.363 -0.835 . . . . 74.24 111.599 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.469 ' HG2' ' N ' ' A' ' 7' ' ' GLY . 77.4 mt-30 -74.35 86.37 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.159 0.479 . . . . 74.41 110.598 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.24 149.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 110.043 -0.355 . . . . 64.32 110.043 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -84.53 128.71 34.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.301 -0.409 . . . . 71.31 110.345 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p -68.32 -23.32 64.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.874 -0.603 . . . . 73.3 111.526 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.48 -18.35 62.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.027 -0.533 . . . . 74.12 111.496 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 m -90.3 -0.68 57.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.381 . . . . 73.53 111.276 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.549 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 3.6 mt -134.09 43.57 2.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.319 0.58 . . . . 73.3 110.285 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.36 8.41 33.63 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.667 0.617 . . . . 75.32 112.667 -168.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -150.51 144.76 25.56 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.347 -0.242 . . . . 74.32 110.347 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 86.0 tt0 -59.4 123.17 15.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.101 0.477 . . . . 62.44 110.018 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.5 -9.77 30.58 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.823 -0.703 . . . . 37.96 111.503 -175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 42' ' ' LEU . . . -71.2 121.86 19.13 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.641 -0.503 . . . . 71.45 109.641 173.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.4 p -117.0 137.0 52.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.159 0.504 . . . . 75.41 111.182 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.547 ' HG ' HD21 ' A' ' 42' ' ' LEU . 64.0 m -85.63 164.45 17.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.775 -0.648 . . . . 75.22 110.689 176.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.7 m -63.99 124.46 21.64 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.66 -0.496 . . . . 51.34 109.66 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -80.59 138.91 36.5 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.217 0.532 . . . . 72.11 111.489 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.2 m -78.49 148.07 6.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.107 -0.951 . . . . 74.12 109.358 170.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.42 90.46 0.69 Allowed Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.976 -0.631 . . . . 60.43 111.579 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -99.63 174.44 6.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.811 -0.44 . . . . 74.21 109.811 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.484 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 3.7 p-10 -138.06 142.78 40.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.325 0.583 . . . . 74.32 112.21 -170.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.482 HD13 ' CE2' ' A' ' 133' ' ' PHE . 73.5 mt -111.77 119.26 59.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.693 -0.855 . . . . 75.52 108.693 169.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -104.48 140.93 37.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.115 0.484 . . . . 74.32 111.238 -171.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.443 HD21 ' HA ' ' A' ' 23' ' ' VAL . 55.1 mt -120.36 122.62 41.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.553 -0.748 . . . . 72.42 109.753 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -100.82 152.02 21.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.761 -0.654 . . . . 73.14 110.378 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 54.38 38.69 30.01 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.968 0.793 . . . . 74.41 110.827 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.28 129.41 34.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.946 -0.57 . . . . 73.34 110.266 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 64' ' ' ASN . 15.7 t70 -111.29 133.95 53.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.565 . . . . 74.15 110.833 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -102.58 16.23 26.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.189 0.44 . . . . 71.13 112.189 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.42 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 93.7 m-20 -90.45 -35.46 15.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.298 0.571 . . . . 74.13 109.478 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.73 -31.5 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.521 -0.763 . . . . 75.3 111.153 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . . . -118.85 173.11 7.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.646 0.26 . . . . 75.23 110.89 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 m -133.84 -58.94 0.86 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.223 -0.444 . . . . 74.42 111.614 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.528 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -134.71 136.62 42.86 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.258 -0.275 . . . . 74.43 110.258 -177.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.71 139.69 36.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.994 0.426 . . . . 75.44 110.594 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.4 122.75 10.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.711 -0.677 . . . . 62.33 109.418 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.0 OUTLIER -96.53 147.07 6.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.068 0.461 . . . . 74.22 110.973 -175.298 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.49 127.09 53.67 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.733 -0.667 . . . . 71.54 109.466 173.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 83.8 m-85 -88.99 131.7 35.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.899 0.38 . . . . 74.31 110.294 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.4 tp -130.52 125.06 33.34 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.976 -0.556 . . . . 71.52 110.355 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.48 -131.95 1.3 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.647 -0.706 . . . . 70.53 111.545 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.1 m -121.34 131.06 53.97 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.177 -0.305 . . . . 74.4 110.177 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -82.46 142.09 32.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.592 -0.276 . . . . 74.51 110.847 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 tt -69.18 -26.53 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.012 0.434 . . . . 73.53 111.09 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -144.6 179.74 7.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.599 -0.519 . . . . 61.52 109.599 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.67 27.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.181 0.515 . . . . 75.43 109.745 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.37 -37.77 7.46 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.812 -0.709 . . . . 73.1 111.594 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -91.17 77.66 5.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.359 0.6 . . . . 70.44 110.163 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.458 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 9.2 p -94.53 6.17 49.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.28 -0.873 . . . . 62.44 111.586 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -111.8 2.34 17.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.207 0.527 . . . . 64.43 110.653 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 102' ' ' GLN . 47.9 t -113.65 125.98 71.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.775 -0.648 . . . . 72.14 109.73 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.505 HD13 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -68.64 135.92 52.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.648 0.261 . . . . 72.14 110.506 -178.338 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.47 149.89 34.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.086 -0.506 . . . . 74.01 110.376 177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.471 HD22 ' O ' ' A' ' 99' ' ' VAL . 1.9 mm? -84.3 139.11 32.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.342 -0.39 . . . . 71.34 110.176 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.403 ' HG3' ' HA ' ' A' ' 150' ' ' ALA . 89.9 mt-30 . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.878 -0.601 . . . . 74.44 110.491 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 109.556 -0.535 . . . . 71.34 109.556 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.45 148.64 51.37 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.091 -0.337 . . . . 65.41 110.091 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.61 159.82 41.43 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.865 -0.334 . . . . 73.4 110.343 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 69.31 4.49 4.64 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.626 0.579 . . . . 73.51 110.586 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.471 ' O ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -146.8 151.62 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 115.279 -0.873 . . . . 74.52 109.035 173.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -153.67 -171.64 21.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.888 -0.885 . . . . 61.03 110.888 177.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.37 112.41 38.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.521 0.676 . . . . 74.11 110.516 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.471 ' HB3' HG23 ' A' ' 85' ' ' VAL . 3.5 pt20 -102.27 139.04 38.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.603 -0.726 . . . . 71.35 109.447 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.479 HG22 ' CZ ' ' A' ' 73' ' ' PHE . 4.8 mp -101.35 117.29 46.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.899 0.38 . . . . 72.12 110.175 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 13.4 mt -86.44 144.81 27.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.622 -0.717 . . . . 60.34 109.37 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.4 p-10 -72.95 -168.24 0.46 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.759 -0.46 . . . . 54.44 109.759 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -64.03 -31.21 72.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.561 -0.29 . . . . 70.34 111.531 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.407 ' HG1' ' CG ' ' A' ' 105' ' ' ASP . 59.1 p -84.85 -29.96 24.88 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.829 -0.349 . . . . 71.32 111.218 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.32 34.68 1.0 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.324 -0.941 . . . . 71.52 113.246 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.39 130.61 56.25 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.96 -0.385 . . . . 71.42 109.96 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.56 119.1 14.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 62.31 110.417 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.1 mt -79.76 132.99 36.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.002 -0.544 . . . . 73.42 111.148 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.443 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 7.9 m -68.36 140.25 55.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.688 -0.687 . . . . 74.14 110.564 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 33.2 mt -85.01 42.95 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.09 -0.504 . . . . 71.24 111.203 -176.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -100.65 -3.03 31.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.006 0.432 . . . . 74.21 110.539 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.03 12.58 68.59 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.879 -0.6 . . . . 54.23 112.795 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.68 -14.45 5.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.749 0.309 . . . . 65.24 111.071 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.443 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 18.3 m -86.25 96.52 9.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.326 -0.397 . . . . 73.43 110.079 175.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -86.51 163.46 17.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.981 -0.554 . . . . 74.5 110.506 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.508 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 1.6 m -72.82 176.26 5.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.079 -0.51 . . . . 64.11 110.805 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.0 t -66.15 139.27 58.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.509 -0.552 . . . . 74.54 109.509 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -51.58 107.42 0.19 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.638 0.586 . . . . 75.43 111.387 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.5 m -93.01 106.24 18.22 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.316 -0.624 . . . . 70.15 109.316 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.528 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 26.5 m -57.36 128.58 37.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 74.31 111.163 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.33 149.86 23.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.723 -0.671 . . . . 73.03 110.918 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -126.61 158.64 35.78 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.871 -0.788 . . . . 74.31 108.871 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -62.33 117.73 6.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.855 0.36 . . . . 72.24 110.564 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 116.7 -134.77 11.53 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.47 -0.872 . . . . 62.13 112.733 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.8 m -86.76 128.61 35.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.94 0.4 . . . . 64.43 110.984 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -124.37 144.4 50.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.568 -0.53 . . . . 74.33 109.568 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.484 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 1.5 m -128.38 118.28 22.89 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.888 0.375 . . . . 75.42 110.582 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 11.2 mt -95.04 114.03 62.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.112 -0.699 . . . . 45.14 109.112 176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 2.1 Cg_endo -81.85 136.14 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.989 2.46 . . . . 71.1 112.554 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.482 ' CE2' HD13 ' A' ' 56' ' ' ILE . 76.3 m-85 -134.19 159.74 39.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.119 -0.492 . . . . 73.34 110.588 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.616 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 19.9 mt-30 -129.15 111.8 13.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.856 -0.611 . . . . 74.34 110.864 -175.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.414 ' O ' HG21 ' A' ' 52' ' ' VAL . . . -101.64 124.54 47.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.473 -0.33 . . . . 75.11 110.358 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 4.7 ptp180 -138.13 160.09 40.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.37 -0.377 . . . . 75.35 110.536 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 69.0 m-85 -79.25 139.58 37.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.93 -0.577 . . . . 73.51 110.23 173.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -127.0 122.63 35.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.652 -0.704 . . . . 74.52 109.328 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -85.35 132.39 34.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.381 -0.372 . . . . 74.23 111.318 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.478 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 74.3 p -105.24 3.61 30.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.635 0.731 . . . . 74.1 109.19 176.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.73 -128.48 1.54 Allowed Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.798 -1.092 . . . . 55.15 110.838 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.24 96.16 10.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.098 -0.334 . . . . 75.41 110.098 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -43.75 109.56 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.721 0.638 . . . . 64.51 111.917 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 26.9 p -102.48 139.35 20.13 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 121.271 0.558 . . . . 64.32 110.407 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.24 -179.84 2.49 Favored 'Trans proline' 0 C--N 1.332 -0.299 0 C-N-CA 124.021 3.147 . . . . 71.33 113.421 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.46 -139.34 10.7 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.408 -0.814 . . . . 55.12 111.83 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.85 117.46 33.88 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.16 -0.311 . . . . 64.41 110.16 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -111.77 60.38 0.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.033 0.444 . . . . 65.15 111.565 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -106.98 145.82 31.82 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.412 -0.588 . . . . 71.34 109.412 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -148.61 168.01 23.94 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.347 -0.242 . . . . 74.35 110.347 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -147.7 146.19 29.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.119 -0.326 . . . . 64.34 110.119 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.481 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -153.2 149.3 27.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.076 -0.511 . . . . 71.42 110.911 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.0 p -101.15 127.24 47.79 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.99 -0.55 . . . . 72.4 109.757 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -99.57 129.29 45.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.311 0.577 . . . . 74.54 110.359 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.539 ' HA ' HG22 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -112.52 107.34 16.04 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.636 -0.711 . . . . 74.54 110.145 -178.06 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.5 m -79.71 147.6 6.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.984 0.421 . . . . 74.12 110.315 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -130.16 124.97 33.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.417 -0.586 . . . . 62.14 109.417 173.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.578 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 121.056 0.455 . . . . 75.13 111.045 176.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.3 p . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 121.019 0.438 . . . . 75.14 110.445 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.434 HG22 HG13 ' A' ' 37' ' ' VAL . 35.6 m -83.83 6.61 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.006 0.431 . . . . 72.4 110.791 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 67.42 -3.46 1.06 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.352 -0.84 . . . . 64.35 112.648 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.17 95.56 1.94 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.938 -0.649 . . . . 74.43 111.738 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.623 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -77.1 154.86 43.52 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.48 -0.867 . . . . 70.03 111.831 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.6 p -146.07 125.89 13.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.714 0.292 . . . . 74.33 110.862 -177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.414 HG21 HG21 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -105.19 122.35 58.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.369 -0.604 . . . . 75.24 109.369 176.035 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -90.23 99.28 12.33 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.379 -0.529 . . . . 73.41 110.049 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -90.86 117.14 29.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.605 -0.725 . . . . 73.32 110.023 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -110.76 136.91 49.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.04 0.448 . . . . 62.14 110.255 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.75 -126.25 5.58 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.768 -0.651 . . . . 44.44 111.82 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 66.52 14.73 9.86 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.462 0.648 . . . . 73.42 110.526 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.595 HG21 ' HA ' ' A' ' 155' ' ' LYS . 29.7 m -76.29 -24.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.366 -0.834 . . . . 75.01 111.856 -175.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.495 HG21 HG21 ' A' ' 156' ' ' VAL . 19.1 m -139.08 142.27 34.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.271 0.558 . . . . 74.15 111.884 -175.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -142.62 18.72 2.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.804 -1.089 . . . . 73.44 108.239 173.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.51 -77.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.171 -0.922 . . . . 62.25 111.426 -172.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.494 ' HB1' ' CE1' ' A' ' 158' ' ' TYR . . . -92.47 -37.07 12.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.941 0.401 . . . . 73.33 110.258 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.34 132.09 25.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.245 -0.434 . . . . 72.24 110.303 -175.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.86 127.41 39.6 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.986 -0.552 . . . . 71.31 109.738 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.425 ' HB ' HG13 ' A' ' 28' ' ' VAL . 13.0 t -64.12 132.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.406 -0.361 . . . . 73.31 110.316 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.448 ' O ' HG12 ' A' ' 28' ' ' VAL . 19.2 t70 -57.27 139.34 53.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.938 -0.574 . . . . 73.11 110.682 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.41 ' HA ' HG21 ' A' ' 28' ' ' VAL . . . -64.02 -19.67 65.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.175 0.435 . . . . 72.32 112.175 -173.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.07 -18.53 74.47 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.394 -0.908 . . . . 74.52 111.937 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 p -110.63 -6.07 14.92 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.235 0.458 . . . . 72.33 112.235 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 24' ' ' ASP . 35.5 m -81.97 -7.29 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.912 0.387 . . . . 73.35 110.893 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -157.94 95.83 1.43 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.909 -0.774 . . . . 74.41 108.909 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -142.24 112.12 6.85 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.862 -0.608 . . . . 73.33 110.567 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.475 HG23 ' HB ' ' A' ' 9' ' ' THR . 7.1 m -92.91 93.7 8.53 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.861 -0.792 . . . . 75.44 108.861 175.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' THR . 8.3 p -80.66 128.93 38.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.968 -0.56 . . . . 73.35 111.07 -172.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -86.62 120.99 28.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.886 -0.597 . . . . 74.12 109.685 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.44 -20.34 40.54 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.453 -0.573 . . . . 73.23 109.453 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.13 -178.72 42.07 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.203 -0.908 . . . . 73.51 111.669 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.92 90.37 6.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.615 -0.513 . . . . 64.24 109.615 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.455 HG21 ' HG ' ' A' ' 49' ' ' SER . 11.8 p -64.64 136.24 26.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 74.04 110.688 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 38' ' ' ARG . 67.2 mtt180 -66.91 108.25 2.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.485 -0.779 . . . . 74.21 109.741 175.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 22.9 p -67.29 -23.63 65.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.197 0.522 . . . . 72.35 110.281 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.01 -5.77 47.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.758 -0.655 . . . . 73.15 111.389 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.9 m -97.79 -4.49 36.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 73.14 110.841 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.578 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 5.4 mp -131.07 101.54 5.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.516 . . . . 65.42 109.755 177.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.18 15.97 5.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.244 0.461 . . . . 73.44 112.244 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.92 147.39 26.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.801 0.334 . . . . 74.43 110.983 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -58.6 123.03 14.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.664 -0.698 . . . . 75.11 109.472 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.464 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 101.97 8.48 44.91 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.512 -0.852 . . . . 73.12 111.965 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.622 ' HB2' ' HB3' ' A' ' 139' ' ' ALA . . . -79.9 128.28 33.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.065 -0.346 . . . . 75.14 110.065 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 p -115.79 118.92 34.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.917 -0.583 . . . . 74.44 110.378 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.455 ' HG ' HG21 ' A' ' 37' ' ' VAL . 12.1 t -83.68 173.59 11.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.86 0.362 . . . . 64.41 110.256 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.2 m -69.21 129.29 39.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.853 -0.612 . . . . 54.13 110.093 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -82.22 165.19 20.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.745 0.783 . . . . 74.43 112.071 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.9 m -101.39 157.62 4.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.458 -1.246 . . . . 75.2 109.22 169.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.5 107.49 2.27 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.829 -0.701 . . . . 65.55 112.059 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -125.07 178.61 5.45 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.749 -0.463 . . . . 64.3 109.749 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.458 ' HB2' HG22 ' A' ' 130' ' ' THR . 30.2 p30 -137.26 156.99 47.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.46 0.648 . . . . 72.31 111.99 -174.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.486 HD13 ' CD1' ' A' ' 154' ' ' PHE . 65.3 mt -123.51 105.37 15.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 107.956 -1.127 . . . . 72.43 107.956 167.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 26.1 tt0 -99.05 143.29 29.49 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.939 -0.573 . . . . 65.04 110.72 -171.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 23' ' ' VAL . 41.5 mt -117.96 125.46 50.46 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.056 -0.52 . . . . 73.34 109.847 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -100.51 143.1 31.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.045 -0.525 . . . . 73.31 110.107 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 52.9 46.96 25.72 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.834 0.708 . . . . 72.13 110.926 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 44.5 t -79.26 139.92 37.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.114 -0.948 . . . . 64.11 110.812 -175.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -108.89 151.47 26.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.045 -0.525 . . . . 61.44 111.592 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 75.6 p -122.92 11.88 9.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.464 -0.334 . . . . 73.44 111.66 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -81.44 -35.32 30.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.449 -0.574 . . . . 73.33 109.449 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.39 -27.9 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.531 -0.759 . . . . 75.35 110.805 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -112.05 166.41 11.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.045 0.45 . . . . 73.1 111.675 -176.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 m -132.7 -56.37 0.94 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.101 -0.5 . . . . 65.25 110.994 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.816 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -136.59 131.06 33.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.458 -0.337 . . . . 73.14 110.194 -177.048 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 158' ' ' TYR . . . -88.38 139.67 30.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.848 0.356 . . . . 52.52 110.707 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . . . -143.88 114.36 7.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.645 -0.707 . . . . 52.32 109.672 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 0.8 OUTLIER -93.48 143.28 11.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.967 0.413 . . . . 74.01 110.563 -175.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.511 ' HB1' ' CD1' ' A' ' 118' ' ' PHE . . . -118.6 125.73 50.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.01 -0.541 . . . . 61.12 110.26 175.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 86.4 m-85 -91.73 122.67 34.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 74.01 110.319 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.3 tp -118.9 133.25 55.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.009 -0.542 . . . . 75.23 110.066 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.91 -174.48 41.6 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.237 -0.745 . . . . 73.4 111.237 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.8 m -75.99 128.0 34.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.803 0.302 . . . . 70.15 111.103 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -82.49 140.67 33.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.773 0.321 . . . . 53.34 110.648 177.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.483 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 11.6 tt -70.58 -27.02 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.382 -0.372 . . . . 75.21 111.458 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 20.1 t70 -141.26 179.29 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.717 -0.475 . . . . 72.55 109.717 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.94 -33.7 26.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.078 0.466 . . . . 71.11 109.774 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.58 -28.26 13.07 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.8 -0.714 . . . . 72.3 111.651 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 77.0 m80 -92.65 69.25 4.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.421 0.629 . . . . 62.42 109.554 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.45 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 4.1 p -91.26 7.99 38.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.277 -0.874 . . . . 74.21 111.201 -178.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -110.0 4.1 21.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.947 -0.569 . . . . 74.14 110.22 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 102' ' ' GLN . 58.7 t -120.04 126.38 75.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 74.22 110.141 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.499 HD11 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -70.72 133.63 46.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.656 0.265 . . . . 73.51 110.361 -178.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.483 ' HB1' ' HA ' ' A' ' 78' ' ' ILE . . . -79.56 155.71 28.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.004 -0.543 . . . . 72.32 110.394 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 99' ' ' VAL . 1.6 mm? -81.84 148.37 28.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.293 -0.412 . . . . 75.3 110.106 -175.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 116.272 -0.422 . . . . 70.55 110.294 178.94 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 120.633 0.254 . . . . 75.43 110.48 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.26 49.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 73.11 110.816 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.14 152.92 47.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.481 -0.327 . . . . 64.02 110.702 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.413 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 42.5 m-80 68.26 7.47 5.94 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.803 -0.635 . . . . 75.14 111.919 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.494 ' O ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -147.6 151.98 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 CA-C-O 120.978 0.418 . . . . 74.15 110.758 176.082 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -151.22 -171.29 19.1 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 110.277 -1.129 . . . . 65.51 110.277 174.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.414 HG21 HG21 ' A' ' 10' ' ' VAL . 2.7 p -117.1 118.81 59.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.378 0.609 . . . . 75.53 110.965 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.436 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.0 pt20 -110.46 147.09 34.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.66 -0.7 . . . . 75.01 109.793 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.427 HD11 ' N ' ' A' ' 103' ' ' ILE . 4.3 mp -107.44 127.87 62.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.987 0.422 . . . . 73.13 110.804 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.2 mt -91.47 142.8 27.26 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.559 -0.746 . . . . 73.45 109.116 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.549 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.9 OUTLIER -75.14 -170.42 1.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.508 -0.314 . . . . 72.32 110.167 178.282 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.5 ptt85 -62.96 -24.8 68.06 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.604 0.224 . . . . 72.04 111.604 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.9 p -93.49 1.06 56.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 75.51 111.391 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.68 29.47 29.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.879 -0.676 . . . . 74.11 112.996 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.8 130.23 55.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.237 -0.283 . . . . 75.23 110.237 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.73 128.55 36.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.897 0.38 . . . . 63.11 111.034 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.45 148.95 23.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.956 -0.565 . . . . 65.24 110.785 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.5 m -85.66 141.9 29.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 74.45 110.251 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 63.4 mt -79.23 42.16 0.48 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.168 0.509 . . . . 73.21 110.683 -178.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.433 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 16.6 t70 -85.37 -18.72 32.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.817 -0.628 . . . . 74.52 110.936 -176.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.74 -24.77 7.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.584 -0.817 . . . . 71.25 112.454 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.2 7.5 19.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.006 0.431 . . . . 73.34 110.563 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 114' ' ' ASP . 15.8 m -93.7 97.29 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 74.42 109.853 175.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.553 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 58.3 m-85 -92.79 162.7 14.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.122 -0.49 . . . . 75.35 111.005 -174.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 5.6 m -72.97 176.35 5.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 64.35 111.314 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.9 m -65.05 131.47 46.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.231 -0.441 . . . . 73.23 110.191 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -44.25 115.48 0.85 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.027 0.829 . . . . 63.41 111.944 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.6 m -102.25 105.27 15.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.137 -0.483 . . . . 71.33 109.965 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.816 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 59.9 m -60.58 115.83 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.48 0.657 . . . . 73.23 111.361 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.538 HD11 ' SG ' ' A' ' 61' ' ' CYS . 96.0 mt -83.22 155.63 23.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.19 -0.913 . . . . 73.02 112.097 -173.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.38 153.3 50.92 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.668 -0.864 . . . . 73.43 108.668 170.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.9 m120 -63.82 112.35 2.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.956 0.408 . . . . 72.33 110.762 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.1 -137.66 9.29 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.934 -0.651 . . . . 62.53 112.046 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.7 m -93.61 126.96 39.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.71 0.291 . . . . 62.12 110.889 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -129.8 120.79 25.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.721 -0.474 . . . . 74.13 109.721 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 57' ' ' GLN . 2.3 m -110.44 117.52 33.79 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.626 0.251 . . . . 74.33 110.468 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.5 mt -95.48 113.9 62.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.597 -0.52 . . . . 73.02 109.597 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.78 138.55 13.39 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.09 2.527 . . . . 72.22 112.667 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.458 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 86.5 m-85 -135.9 161.09 36.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 74.44 110.887 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 52.2 mt-30 -133.04 118.24 18.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.655 . . . . 73.01 110.751 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.37 126.7 50.67 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.318 -0.239 . . . . 73.12 110.44 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -134.44 164.99 26.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.802 0.334 . . . . 72.42 111.048 -178.021 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.623 ' HH ' ' HA3' ' A' ' 8' ' ' GLY . 63.1 m-85 -85.46 142.2 29.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.997 -0.547 . . . . 73.1 110.466 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.464 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 61.1 t80 -126.83 124.11 38.88 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.895 -0.78 . . . . 74.21 108.895 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.622 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . . . -91.19 135.99 33.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.12 0.486 . . . . 71.31 111.572 -176.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.413 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 78.7 p -100.36 1.27 41.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.296 -0.865 . . . . 71.32 108.909 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.11 -128.77 1.7 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.553 -1.203 . . . . 71.15 111.059 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -87.55 95.71 10.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.184 -0.302 . . . . 72.01 110.184 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.451 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -46.52 112.05 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.847 -0.615 . . . . 71.14 111.587 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.2 p -107.61 149.51 38.98 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-O 121.003 0.43 . . . . 73.33 110.736 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.5 163.99 25.08 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.85 3.034 . . . . 72.0 113.239 -176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.91 179.99 18.34 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.672 -0.694 . . . . 64.52 111.975 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.07 119.85 10.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.789 0.328 . . . . 64.14 110.707 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . . . -116.01 42.64 2.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.649 0.738 . . . . 75.14 110.411 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -98.72 145.13 27.22 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.036 -0.984 . . . . 72.32 110.078 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.499 ' HB1' HD11 ' A' ' 86' ' ' LEU . . . -147.45 164.89 31.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.917 0.389 . . . . 63.24 111.322 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -123.05 133.31 54.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.321 -0.622 . . . . 72.41 109.321 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.22 128.94 14.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.932 0.396 . . . . 70.14 111.108 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.0 p -102.53 129.71 49.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.132 -0.485 . . . . 74.03 110.265 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.486 ' CD1' HD13 ' A' ' 56' ' ' ILE . 47.3 p90 -103.45 127.26 50.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.958 0.409 . . . . 73.13 110.706 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.595 ' HA ' HG21 ' A' ' 16' ' ' VAL . 6.9 ttmm -110.14 108.7 18.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.259 -0.428 . . . . 73.54 110.331 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.5 m -80.62 129.7 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.447 -0.575 . . . . 73.33 109.447 174.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -123.02 115.19 21.45 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.143 -0.688 . . . . 71.53 109.143 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.622 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 112.392 0.515 . . . . 75.22 112.392 -177.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 62.4 p . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.891 0.377 . . . . 73.2 110.422 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.51 HG22 HG12 ' A' ' 37' ' ' VAL . 34.8 m -91.31 17.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.013 0.435 . . . . 72.43 110.563 175.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 59.96 20.15 9.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.325 -0.852 . . . . 64.1 111.999 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.12 101.57 1.02 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.718 -0.753 . . . . 71.3 111.712 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.46 151.69 31.39 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.035 -1.078 . . . . 71.44 111.348 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.502 ' HB ' HG23 ' A' ' 31' ' ' THR . 17.4 p -141.47 135.64 30.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.55 0.214 . . . . 71.23 110.913 -176.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.44 ' CG2' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -117.49 115.89 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.566 -0.531 . . . . 73.45 109.566 174.21 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -83.04 108.76 16.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.286 -0.415 . . . . 70.23 109.928 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -100.03 113.78 26.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.302 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -106.12 135.02 48.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.867 -0.42 . . . . 72.33 109.867 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.01 -125.91 5.7 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.962 -0.637 . . . . 36.97 111.888 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 67.6 12.95 9.12 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.886 0.474 . . . . 71.11 110.93 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.543 HG23 HG12 ' A' ' 17' ' ' VAL . 34.2 m -76.38 -30.66 19.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.063 -0.517 . . . . 73.32 111.859 -173.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.543 HG12 HG23 ' A' ' 16' ' ' VAL . 24.9 m -133.75 145.46 33.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.299 0.571 . . . . 73.44 111.468 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -151.68 30.41 0.59 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.933 -1.136 . . . . 61.43 107.933 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.66 -79.26 0.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.227 -0.897 . . . . 75.53 111.214 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.401 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -90.68 -34.87 15.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.969 0.414 . . . . 72.22 110.602 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.2 m -140.78 136.31 32.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.485 . . . . 73.2 109.75 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.31 130.45 47.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.357 -0.383 . . . . 60.11 110.304 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.7 t -67.69 130.93 33.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.964 -0.384 . . . . 74.11 109.964 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.496 ' O ' HG13 ' A' ' 28' ' ' VAL . 15.3 t70 -61.66 141.11 58.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.36 -0.382 . . . . 71.54 110.72 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.81 -26.99 64.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 74.2 111.798 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.84 2.67 79.02 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.792 -0.718 . . . . 75.24 112.302 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.3 p -131.89 3.05 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.593 0.235 . . . . 64.43 111.521 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 24' ' ' ASP . 35.2 m -89.4 -1.32 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.873 0.368 . . . . 73.22 110.687 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -158.72 97.58 1.45 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.085 -0.709 . . . . 73.41 109.085 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -144.6 104.01 4.0 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.483 0.658 . . . . 74.13 111.041 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.502 HG23 ' HB ' ' A' ' 9' ' ' THR . 5.8 m -81.59 94.48 6.92 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.389 -0.823 . . . . 72.24 109.096 173.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.42 140.33 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.122 -0.49 . . . . 75.14 111.043 -172.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -96.58 117.82 31.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 71.44 110.095 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.44 HD21 ' CG2' ' A' ' 10' ' ' VAL . 1.7 mm? -87.98 -23.85 23.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.444 -0.576 . . . . 74.41 109.444 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.29 166.96 32.67 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.317 -0.856 . . . . 55.22 112.618 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -73.21 94.46 1.98 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.907 -0.405 . . . . 75.21 109.907 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.51 HG12 HG22 ' A' ' 5' ' ' VAL . 9.5 p -75.54 145.24 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.19 -0.459 . . . . 65.13 110.858 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -76.47 117.56 18.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.788 -0.642 . . . . 71.34 110.562 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 29.9 p -72.67 -16.28 61.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 72.44 110.99 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.0 -16.52 54.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 71.5 110.909 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.4 m -83.23 -44.34 15.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.167 -0.47 . . . . 72.23 110.263 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.528 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 6.2 mp -93.83 95.85 9.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.18 0.514 . . . . 73.43 110.306 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.47 22.26 5.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.326 0.584 . . . . 73.52 110.379 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.429 ' HG2' ' HB3' ' A' ' 47' ' ' ALA . 3.6 pm0 -151.66 137.96 18.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.311 -0.859 . . . . 74.02 110.233 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 40.8 tt0 -62.26 123.62 18.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.978 0.418 . . . . 60.33 110.117 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.67 -13.35 27.46 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.27 -0.732 . . . . 55.32 111.27 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.429 ' HB3' ' HG2' ' A' ' 44' ' ' GLN . . . -63.95 121.89 15.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.67 0.272 . . . . 73.22 110.281 176.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.51 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 25.4 p -123.75 118.62 27.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.34 -0.391 . . . . 73.42 110.724 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 t -75.8 173.72 10.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.1 -0.5 . . . . 64.43 110.172 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.8 m -64.41 135.79 56.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.107 0.48 . . . . 74.2 110.446 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -85.6 159.37 19.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.733 -0.667 . . . . 64.21 111.771 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.6 m -90.48 158.41 2.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.898 -1.047 . . . . 71.1 108.991 168.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.55 81.13 0.31 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.446 -0.883 . . . . 71.34 112.237 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -95.95 165.33 12.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.989 -0.374 . . . . 75.43 109.989 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.541 ' HB2' HG22 ' A' ' 130' ' ' THR . 2.4 p-10 -138.12 144.66 40.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.38 0.609 . . . . 75.54 111.517 -175.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 79.7 mt -105.53 120.25 55.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.34 -0.846 . . . . 74.32 109.383 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -98.15 136.98 37.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.98 0.419 . . . . 75.41 110.643 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.8 mt -119.04 130.75 55.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 74.54 109.597 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -108.15 144.84 35.02 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.243 -0.435 . . . . 73.45 110.395 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 53.39 46.38 26.41 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.868 0.73 . . . . 52.21 111.225 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.47 ' SG ' HD12 ' A' ' 124' ' ' LEU . 27.5 t -81.34 131.89 35.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.461 -0.791 . . . . 64.54 110.074 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.425 ' OD2' HG11 ' A' ' 65' ' ' VAL . 16.3 t70 -107.68 134.01 51.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.243 -0.435 . . . . 74.32 111.646 -175.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.1 p -104.67 13.77 30.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 73.15 112.064 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -89.07 -35.39 16.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.905 -0.406 . . . . 75.21 109.905 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.425 HG11 ' OD2' ' A' ' 62' ' ' ASP . 14.0 p -97.26 -28.31 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.975 -0.557 . . . . 74.14 111.044 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.533 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -121.1 -177.59 3.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.493 -0.322 . . . . 52.22 110.953 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.2 m -140.75 -54.89 0.5 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.644 0.259 . . . . 73.23 111.454 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.782 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -134.56 140.95 46.5 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.318 -0.239 . . . . 73.33 110.843 -178.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.445 ' HB2' HD23 ' A' ' 124' ' ' LEU . . . -102.59 135.4 44.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.101 0.477 . . . . 71.21 110.557 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.9 114.92 7.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.759 -0.655 . . . . 63.43 109.576 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.5 m -85.32 149.33 4.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.142 0.496 . . . . 75.31 110.895 -174.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.74 118.33 29.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.54 -0.755 . . . . 74.41 109.211 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 75.2 m-85 -83.16 128.98 34.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.027 0.441 . . . . 75.12 110.498 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.7 tp -128.22 127.44 42.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.008 -0.542 . . . . 74.34 109.804 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.47 -167.94 25.79 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.965 -0.854 . . . . 72.22 110.965 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.426 ' O ' HD11 ' A' ' 86' ' ' LEU . 9.5 m -74.29 120.85 20.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.102 0.451 . . . . 64.11 110.622 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.491 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.59 136.17 36.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.592 0.234 . . . . 72.22 110.817 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.466 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 10.9 tt -65.16 -30.6 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.29 -0.414 . . . . 72.23 111.213 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 19.9 t70 -151.3 173.21 14.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.478 -0.564 . . . . 71.2 109.478 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.59 -30.78 52.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.059 -0.519 . . . . 73.4 110.301 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.12 -20.26 28.47 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.842 -0.694 . . . . 54.1 111.711 177.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 65.1 m80 -103.5 47.85 0.87 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.382 -0.599 . . . . 74.43 109.382 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.491 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.4 p -72.81 9.63 1.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.572 -0.74 . . . . 75.11 112.331 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 16.7 p-10 -99.75 -18.6 17.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.784 0.326 . . . . 63.33 110.895 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.7 t -105.03 132.57 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.388 -0.369 . . . . 63.41 110.87 -176.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.481 HD12 ' HB3' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -67.29 135.18 52.94 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.21 -0.45 . . . . 72.41 110.519 179.18 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 78' ' ' ILE . . . -78.83 146.78 33.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.964 -0.562 . . . . 72.03 109.684 175.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.411 HD21 ' N ' ' A' ' 88' ' ' LEU . 2.2 mm? -85.7 129.87 34.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.333 -0.394 . . . . 65.15 110.77 -175.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.646 . . . . 71.04 109.493 176.907 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.608 -0.516 . . . . 71.53 109.608 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.19 144.77 38.08 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.805 -0.443 . . . . 71.43 109.805 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.09 164.7 29.4 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.964 -0.384 . . . . 75.04 109.964 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.503 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 67.0 m-20 69.03 8.11 6.64 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.347 0.594 . . . . 53.12 110.12 -177.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -178.23 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.023 -0.99 . . . . 73.34 109.628 173.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 175.25 -172.07 45.14 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 110.268 -1.133 . . . . 73.45 110.268 177.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 p -126.13 120.06 55.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.096 0.474 . . . . 62.11 110.409 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.459 ' OE1' ' HB1' ' A' ' 110' ' ' ALA . 25.9 pt20 -117.14 149.51 40.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.52 -0.548 . . . . 73.44 109.52 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.42 HD11 ' N ' ' A' ' 103' ' ' ILE . 4.3 mp -101.02 128.2 53.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.089 -0.505 . . . . 72.33 110.598 -174.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 110' ' ' ALA . 16.3 mt -94.1 146.0 24.28 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.367 -0.833 . . . . 75.25 108.917 175.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.4 OUTLIER -72.39 -173.21 1.07 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.825 -0.435 . . . . 63.55 109.825 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -58.31 -32.49 68.52 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.556 0.206 . . . . 74.12 111.556 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.3 p -89.28 0.32 56.88 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.817 0.341 . . . . 72.14 111.793 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.04 29.95 24.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 62.22 113.07 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.78 134.35 46.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.364 -0.236 . . . . 72.34 110.364 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.519 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -67.05 122.76 18.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.998 0.428 . . . . 72.32 111.323 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.6 mt -90.56 148.4 22.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.026 -0.534 . . . . 74.04 110.523 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.483 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 25.8 m -96.91 142.22 29.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.258 -0.428 . . . . 64.43 110.439 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 50.0 mt -83.95 51.55 2.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 74.24 110.857 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -109.72 -5.43 15.61 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.018 0.437 . . . . 73.12 110.046 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.26 2.29 62.46 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.745 -0.661 . . . . 71.42 112.95 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.66 -13.09 9.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 63.33 111.066 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.483 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 12.1 m -85.51 100.29 11.8 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.968 -0.382 . . . . 75.21 109.968 175.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.408 ' HE1' ' HE3' ' A' ' 155' ' ' LYS . 83.3 m-85 -90.17 154.7 19.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.945 -0.571 . . . . 72.11 111.185 -176.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 11.5 m -69.64 179.73 2.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.66 -0.7 . . . . 63.32 110.843 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.8 t -64.14 150.19 46.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.936 -0.394 . . . . 74.44 109.936 174.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -61.83 102.73 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 75.34 111.075 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -84.5 97.81 9.76 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.864 -0.791 . . . . 70.21 108.864 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.782 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 49.8 m -60.69 122.91 15.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.073 -0.512 . . . . 62.31 110.391 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.47 HD12 ' SG ' ' A' ' 61' ' ' CYS . 97.0 mt -80.97 151.98 28.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.383 -0.826 . . . . 61.54 112.066 -170.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -116.78 159.51 22.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.142 -0.936 . . . . 73.2 109.37 170.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.35 108.0 6.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.129 0.49 . . . . 73.11 110.356 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.27 -135.91 9.55 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.739 -0.743 . . . . 72.44 112.339 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.1 m -83.84 126.09 32.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.165 0.507 . . . . 75.21 111.335 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -124.56 160.4 28.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.716 -0.675 . . . . 74.42 109.646 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.541 HG22 ' HB2' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -144.18 122.28 12.16 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.848 -0.341 . . . . 74.23 110.576 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.0 mt -102.98 113.43 65.91 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.984 -0.376 . . . . 63.34 109.984 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.9 137.31 8.62 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 123.131 2.554 . . . . 74.21 112.399 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -134.66 163.17 30.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.028 0.442 . . . . 62.14 111.211 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 99.3 mt-30 -127.89 112.91 15.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.871 -0.604 . . . . 74.51 111.217 -177.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.17 121.59 42.53 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.944 -0.303 . . . . 64.32 110.236 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.51 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 10.6 ptp180 -137.45 164.05 29.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.848 0.356 . . . . 75.12 110.857 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.418 ' CE2' ' HB ' ' A' ' 37' ' ' VAL . 87.4 m-85 -78.95 147.47 32.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.607 . . . . 75.12 111.007 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -131.81 122.14 25.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.673 -0.694 . . . . 74.1 109.529 176.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 42' ' ' LEU . . . -91.32 139.36 30.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.902 0.382 . . . . 63.44 111.528 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 48.0 p -103.89 -0.73 28.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.536 0.684 . . . . 74.32 109.316 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.8 -127.57 1.48 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.05 -0.977 . . . . 72.31 111.111 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.83 93.92 6.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.359 -0.237 . . . . 74.23 110.359 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.32 116.75 1.84 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.384 0.428 . . . . 74.24 111.094 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.0 p -104.12 142.67 25.09 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-O 121.256 0.551 . . . . 75.0 110.898 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.25 165.53 28.35 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.581 2.854 . . . . 73.53 113.018 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 145.99 -140.2 8.72 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.605 -0.725 . . . . 75.22 111.869 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.3 117.01 32.95 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.412 0.149 . . . . 64.4 110.745 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -105.97 58.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.341 0.591 . . . . 71.02 111.141 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.402 HD21 ' N ' ' A' ' 149' ' ' ASN . 0.9 OUTLIER -99.1 140.5 33.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.971 -0.558 . . . . 73.1 109.592 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.481 ' HB3' HD12 ' A' ' 86' ' ' LEU . . . -153.01 165.08 36.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.583 0.23 . . . . 74.31 110.634 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -138.91 148.0 43.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.923 -0.399 . . . . 73.22 109.923 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.476 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -154.72 146.37 23.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.097 0.475 . . . . 75.1 110.951 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.1 p -108.87 127.93 54.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.043 -0.526 . . . . 62.54 110.034 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -96.64 123.5 40.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.006 0.432 . . . . 73.02 110.425 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.54 ' HA ' HG22 ' A' ' 16' ' ' VAL . 5.5 tmmm? -107.49 109.12 20.72 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.201 -0.454 . . . . 73.41 109.802 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.4 m -78.8 136.16 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.28 0.562 . . . . 75.53 110.619 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -114.45 118.14 32.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.871 -0.604 . . . . 73.22 110.067 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 1.5 p90 . . . . . 0 C--N 1.319 -0.752 0 CA-C-O 120.997 0.427 . . . . 75.23 110.15 171.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.3 p . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.846 0.355 . . . . 54.22 110.573 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.529 HG22 HG12 ' A' ' 37' ' ' VAL . 34.4 m -91.25 16.02 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.983 0.421 . . . . 75.32 111.062 177.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 62.57 13.93 6.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.595 -0.73 . . . . 74.43 112.64 173.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.49 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 86.24 95.55 0.82 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.37 -0.919 . . . . 71.31 111.278 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.92 164.06 27.29 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.491 -0.862 . . . . 44.44 112.181 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.528 ' HB ' HG21 ' A' ' 31' ' ' THR . 63.2 p -140.85 147.74 39.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.683 0.278 . . . . 73.12 110.887 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.512 HG23 HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -112.81 123.46 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 N-CA-C 109.044 -0.725 . . . . 72.51 109.044 171.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -90.86 99.41 12.45 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.645 -0.502 . . . . 62.23 109.645 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.415 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 74.6 m-85 -88.89 117.57 27.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.781 -0.645 . . . . 72.21 110.213 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HB3' HG22 ' A' ' 153' ' ' THR . 80.1 tttt -110.12 139.35 45.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 74.03 110.736 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.88 -123.34 3.72 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.882 -0.599 . . . . 61.22 112.176 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HG2' ' HB ' ' A' ' 28' ' ' VAL . 24.9 mm-40 60.44 19.71 9.4 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.695 0.398 . . . . 61.4 111.783 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.689 HG23 HG23 ' A' ' 17' ' ' VAL . 29.1 m -77.78 -28.79 15.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.35 -0.386 . . . . 72.3 111.581 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.689 HG23 HG23 ' A' ' 16' ' ' VAL . 7.7 m -148.04 153.05 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 63.3 110.84 -176.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -162.29 53.99 0.22 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.288 -1.005 . . . . 54.25 108.288 176.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -110.25 -72.88 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.709 -1.132 . . . . 65.13 110.274 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -76.87 -41.56 43.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.959 -0.564 . . . . 70.43 110.147 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -136.36 156.72 48.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.526 -0.546 . . . . 74.34 109.526 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.91 127.67 54.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.862 -0.421 . . . . 72.24 109.862 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.417 ' HA ' HD22 ' A' ' 58' ' ' LEU . 16.4 t -68.23 132.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.974 -0.38 . . . . 71.11 109.974 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.423 ' O ' HG11 ' A' ' 28' ' ' VAL . 24.2 t70 -56.3 143.17 35.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 75.45 111.461 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.49 -25.09 67.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 51.34 112.143 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.73 -15.37 61.63 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.57 -0.824 . . . . 72.22 111.701 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 t -93.89 -24.94 17.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.755 -0.223 . . . . 71.34 110.804 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 24' ' ' ASP . 33.6 m -74.28 -6.92 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.829 0.347 . . . . 74.22 111.083 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -161.13 94.36 1.0 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.944 -0.761 . . . . 63.22 108.944 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.415 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 16.4 pt20 -137.95 114.9 10.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.396 0.617 . . . . 65.15 110.699 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.528 HG21 ' HB ' ' A' ' 9' ' ' THR . 5.2 m -95.91 93.8 7.24 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.205 -0.907 . . . . 73.34 109.752 177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.23 140.08 17.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.748 -0.66 . . . . 72.15 111.164 -173.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -92.59 118.91 31.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 73.53 110.458 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.512 HD21 HG23 ' A' ' 10' ' ' VAL . 2.9 mm? -87.81 -30.26 20.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.223 0.535 . . . . 74.24 109.717 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.49 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.79 174.7 38.2 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.517 -0.765 . . . . 53.24 112.408 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.8 90.67 2.91 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.81 -0.23 . . . . 73.31 110.516 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.529 HG12 HG22 ' A' ' 5' ' ' VAL . 5.0 p -73.87 145.88 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.422 -0.584 . . . . 73.03 109.422 175.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -92.05 128.38 37.87 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.35 -0.386 . . . . 73.44 110.041 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.9 p -66.6 -24.34 66.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.02 -0.536 . . . . 74.44 111.721 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.78 -19.85 65.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.062 -0.517 . . . . 72.54 111.305 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -89.42 -0.58 57.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.126 -0.488 . . . . 72.15 111.21 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.577 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 6.8 mt -137.08 48.61 2.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.224 0.535 . . . . 72.03 110.487 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.84 16.93 16.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.136 -0.484 . . . . 71.24 112.136 -171.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -157.79 142.99 16.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.218 -0.447 . . . . 74.55 110.312 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 33.6 tt0 -59.28 123.56 17.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.942 0.401 . . . . 74.42 110.045 175.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.0 -15.58 21.02 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.206 -0.758 . . . . 64.52 111.206 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 42' ' ' LEU . . . -67.76 123.53 20.77 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.451 -0.574 . . . . 55.34 109.451 174.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.474 HG22 ' HD1' ' A' ' 138' ' ' PHE . 37.3 p -123.27 134.26 54.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.969 0.414 . . . . 74.21 110.94 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.1 t -84.43 176.37 8.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.924 -0.58 . . . . 75.55 109.611 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -68.77 133.43 48.34 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.853 -0.425 . . . . 64.52 109.853 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -88.77 152.69 21.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.599 0.714 . . . . 54.23 111.944 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 23.8 m -94.1 149.92 4.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.354 -1.294 . . . . 75.01 108.922 169.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.76 77.14 0.23 Allowed Glycine 0 C--N 1.311 -0.842 0 C-N-CA 120.988 -0.625 . . . . 61.1 112.255 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -81.77 167.98 18.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.984 -0.376 . . . . 73.21 109.984 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.525 ' HB2' HG23 ' A' ' 130' ' ' THR . 2.2 p-10 -138.05 138.44 38.8 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.998 0.427 . . . . 72.22 111.251 -175.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.5 mt -100.38 114.14 38.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.547 -0.751 . . . . 70.12 109.335 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -98.83 135.67 39.94 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.704 -0.68 . . . . 71.11 110.812 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 23' ' ' VAL . 70.0 mt -114.5 117.8 31.97 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.35 -0.611 . . . . 74.34 109.35 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -96.63 124.18 40.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.775 -0.648 . . . . 63.2 110.649 -175.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.7 t70 61.8 92.37 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.001 0.813 . . . . 50.52 111.122 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 48.4 t -128.6 152.83 47.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.794 -0.639 . . . . 64.21 110.627 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.404 ' HA ' ' ND2' ' A' ' 126' ' ' ASN . 18.3 t70 -116.85 142.13 47.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.873 -0.603 . . . . 74.3 110.978 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.0 p -106.08 14.08 28.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.04 0.385 . . . . 72.22 112.04 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -91.28 -31.17 16.22 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.382 -0.599 . . . . 75.24 109.382 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 p -104.2 -3.79 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.549 -0.75 . . . . 74.33 111.369 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . . . -146.57 178.83 7.99 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.319 -0.238 . . . . 63.42 110.89 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.4 m -143.56 -53.78 0.37 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.053 0.39 . . . . 54.34 112.053 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -137.82 141.81 40.81 Favored 'General case' 0 C--O 1.221 -0.406 0 O-C-N 122.216 -0.302 . . . . 71.35 110.437 -179.014 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.92 127.66 48.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.028 0.442 . . . . 74.55 110.594 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.72 116.18 11.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.821 -0.627 . . . . 74.04 109.729 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.5 m -90.65 146.4 6.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.963 0.411 . . . . 73.11 111.356 -173.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.462 ' HB1' ' CD1' ' A' ' 118' ' ' PHE . . . -119.57 123.06 43.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.736 -0.666 . . . . 74.35 109.513 171.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.559 ' CE1' HG22 ' A' ' 103' ' ' ILE . 55.3 m-85 -86.52 134.59 33.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.107 0.48 . . . . 74.34 110.959 -178.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.0 tp -131.18 129.1 41.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 74.11 110.3 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.23 -160.17 19.13 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.94 -0.864 . . . . 60.02 110.94 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.484 ' O ' HD12 ' A' ' 86' ' ' LEU . 26.3 m -88.05 130.48 34.98 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.258 -0.275 . . . . 74.24 110.258 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.432 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -85.61 144.55 27.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.268 -0.271 . . . . 71.4 110.268 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.478 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 15.3 tt -62.34 -28.18 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 74.42 111.382 -176.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -152.6 177.18 10.93 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.714 -0.476 . . . . 63.42 109.714 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.63 -27.72 34.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.191 -0.459 . . . . 70.24 110.215 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.51 -7.85 61.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.759 -0.734 . . . . 74.2 111.902 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -122.82 75.51 1.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.264 0.554 . . . . 70.43 109.945 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.432 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 1.9 p -90.02 16.24 8.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.691 -0.686 . . . . 73.21 111.795 -176.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -118.94 -0.29 11.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.342 -0.39 . . . . 74.33 111.163 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.414 ' HB ' HG22 ' A' ' 78' ' ' ILE . 47.3 t -117.43 127.32 74.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.35 -0.386 . . . . 72.52 110.096 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.494 HD13 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -66.77 135.22 53.63 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.658 0.266 . . . . 74.13 110.385 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 78' ' ' ILE . . . -78.57 160.49 27.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.124 -0.489 . . . . 64.51 110.583 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.567 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.9 mm? -91.1 137.66 32.19 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.898 -0.408 . . . . 73.45 109.898 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 116.019 -0.537 . . . . 61.32 110.456 178.817 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 110.265 -0.272 . . . . 75.42 110.265 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.48 156.14 21.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.063 -0.347 . . . . 74.43 110.063 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 99' ' ' VAL . 0.2 OUTLIER -145.97 164.65 31.37 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.877 -0.329 . . . . 72.4 110.794 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 68.89 -1.73 1.96 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.619 0.768 . . . . 73.11 111.247 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.567 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -138.76 145.59 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 109.223 -0.658 . . . . 71.43 109.223 170.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -148.81 -167.66 13.97 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 110.753 -0.939 . . . . 75.41 110.753 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.38 110.87 28.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 121.359 0.599 . . . . 70.42 110.326 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.401 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.7 pt20 -100.6 132.03 46.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.748 -0.66 . . . . 74.23 109.416 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.559 HG22 ' CE1' ' A' ' 73' ' ' PHE . 4.0 mp -89.03 123.83 41.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.229 0.538 . . . . 75.45 110.219 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.8 mt -92.73 140.88 29.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.362 -0.835 . . . . 72.25 109.237 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.512 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.6 OUTLIER -71.57 -173.63 0.97 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.74 -0.467 . . . . 73.12 109.74 176.512 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -59.88 -23.36 63.39 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.448 0.536 . . . . 74.43 112.448 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.0 p -91.5 -16.66 26.89 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.502 -0.479 . . . . 62.11 111.236 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.33 29.1 6.13 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.912 -0.661 . . . . 63.24 112.532 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.29 124.7 50.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.515 0.198 . . . . 74.11 110.683 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.04 120.62 11.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 72.15 110.573 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.7 mt -83.78 144.14 29.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.103 -0.499 . . . . 74.33 111.031 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.461 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 3.1 m -73.83 140.29 45.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.2 -0.454 . . . . 73.2 109.951 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.472 HD11 HD22 ' A' ' 86' ' ' LEU . 52.4 mt -85.0 43.24 0.99 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.886 0.374 . . . . 74.03 110.571 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -105.33 -1.55 25.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.524 . . . . 75.43 110.516 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.4 -1.76 41.4 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.073 -0.584 . . . . 42.5 113.353 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.03 -22.12 11.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 117.012 0.406 . . . . 71.11 110.91 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.461 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 8.8 m -81.06 96.17 7.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.273 -0.421 . . . . 60.34 110.26 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.51 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 89.2 m-85 -86.51 162.86 17.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.455 . . . . 75.42 110.327 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 13.4 m -73.55 -178.01 2.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.984 -0.553 . . . . 75.41 110.593 176.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.7 m -69.15 152.98 44.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.387 -0.37 . . . . 74.13 110.288 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.19 111.77 2.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.131 0.491 . . . . 72.1 111.623 -178.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.8 m -95.67 104.52 16.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.876 -0.602 . . . . 64.12 109.426 174.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -57.25 125.55 23.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 72.41 110.888 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.3 mt -91.62 163.4 14.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.203 0.525 . . . . 72.42 111.661 -176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -141.95 157.11 45.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.254 -0.885 . . . . 73.05 108.994 169.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.594 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 16.4 m120 -60.14 111.39 1.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.833 0.349 . . . . 72.42 110.267 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 137.86 -140.15 10.99 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.898 -0.668 . . . . 71.22 111.927 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.1 m -96.55 120.63 37.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.121 0.486 . . . . 65.53 110.939 -177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -114.22 137.14 52.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.974 -0.557 . . . . 71.1 109.79 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.525 HG23 ' HB2' ' A' ' 55' ' ' ASN . 1.4 m -125.45 121.42 33.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.688 0.28 . . . . 73.41 110.449 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 mt -106.31 112.71 63.86 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.801 -0.444 . . . . 74.35 109.801 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.8 139.39 9.81 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.991 2.461 . . . . 74.43 112.611 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.422 ' HD1' ' HA ' ' A' ' 105' ' ' ASP . 71.6 m-85 -138.71 164.02 30.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 71.13 110.309 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 87.0 mt-30 -124.37 134.18 53.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.961 0.41 . . . . 71.24 111.109 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 52' ' ' VAL . . . -121.9 124.73 44.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.07 -0.514 . . . . 64.24 109.952 176.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 18.1 ptp180 -142.85 161.96 36.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.588 -0.278 . . . . 72.53 110.322 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 64.7 m-85 -77.9 135.63 37.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.098 -0.501 . . . . 72.25 110.525 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.474 ' HD1' HG22 ' A' ' 48' ' ' THR . 89.7 t80 -125.88 122.0 34.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.558 -0.746 . . . . 73.44 109.245 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.577 ' HB1' ' HB3' ' A' ' 42' ' ' LEU . . . -83.97 135.68 34.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.276 -0.42 . . . . 74.31 111.311 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.423 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 63.9 p -107.27 2.66 24.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.796 -0.638 . . . . 74.23 109.571 176.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 171.09 -115.99 0.61 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.214 -0.903 . . . . 52.42 111.62 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -98.19 94.21 6.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.702 0.251 . . . . 61.34 110.636 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.11 111.57 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.398 0.436 . . . . 75.12 111.865 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.2 p -104.58 140.84 21.47 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 116.122 -0.49 . . . . 64.3 110.188 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.96 179.96 3.93 Favored 'Trans proline' 0 N--CA 1.472 0.248 0 C-N-CA 123.717 2.945 . . . . 74.24 113.351 -172.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.83 -172.01 16.97 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.631 -0.795 . . . . 74.33 111.811 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.21 102.01 2.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.986 0.422 . . . . 54.22 110.947 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.22 76.85 1.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.179 0.514 . . . . 71.24 110.765 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -121.81 142.92 49.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.964 -0.562 . . . . 74.4 109.492 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.494 ' HB1' HD13 ' A' ' 86' ' ' LEU . . . -141.46 165.66 26.89 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 123.051 0.219 . . . . 72.32 111.027 -176.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -141.85 146.31 35.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.087 -0.338 . . . . 63.3 110.087 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.451 ' HB1' HD23 ' A' ' 86' ' ' LEU . . . -155.39 147.63 23.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.288 -0.415 . . . . 63.55 111.064 -178.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 13' ' ' LYS . 16.6 p -104.29 127.2 51.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.954 -0.566 . . . . 75.55 110.064 175.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -97.09 127.77 43.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.261 0.553 . . . . 74.5 110.947 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.555 ' HA ' HG22 ' A' ' 16' ' ' VAL . 8.5 ttmm -103.18 98.77 8.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.692 -0.686 . . . . 74.24 110.157 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.2 m -74.57 133.4 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.304 0.573 . . . . 74.14 109.631 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -117.17 110.47 18.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.087 -0.506 . . . . 72.33 110.05 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.705 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.619 0.723 . . . . 74.33 110.377 172.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.3 p . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.912 0.387 . . . . 70.42 110.584 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 37' ' ' VAL . 36.0 m -89.18 13.95 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.264 -0.426 . . . . 72.25 110.691 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.429 ' C ' ' HG2' ' A' ' 36' ' ' GLN . 54.8 m-80 64.41 4.87 2.36 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.437 -0.801 . . . . 75.44 112.655 175.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.52 110.78 3.51 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.497 -0.859 . . . . 55.52 111.855 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.671 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -92.46 155.25 22.65 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.368 -0.92 . . . . 61.1 112.383 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.459 ' HB ' ' CG2' ' A' ' 31' ' ' THR . 1.6 p -145.9 125.1 12.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.568 0.223 . . . . 64.04 110.573 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -104.02 126.17 58.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.849 -0.426 . . . . 74.0 109.849 177.023 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -93.21 109.06 20.57 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.11 0.481 . . . . 71.42 110.174 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.464 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 87.6 m-85 -101.86 121.54 42.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.052 -0.522 . . . . 74.0 110.207 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -114.72 138.79 50.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.923 0.392 . . . . 72.34 110.431 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.49 -123.15 5.06 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.535 -0.626 . . . . 73.53 111.535 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.429 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 35.0 mt-10 63.57 25.64 14.44 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.395 0.617 . . . . 55.0 110.31 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.687 HG22 HG23 ' A' ' 17' ' ' VAL . 20.0 m -85.87 -32.33 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.615 -0.721 . . . . 75.4 111.59 -176.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.687 HG23 HG22 ' A' ' 16' ' ' VAL . 6.9 m -141.35 154.96 20.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.375 -0.375 . . . . 75.15 111.164 -174.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -168.74 90.24 0.24 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.434 -0.95 . . . . 74.44 108.434 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.26 -75.1 0.13 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.346 -0.843 . . . . 73.2 109.811 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.77 -37.82 62.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.761 -0.654 . . . . 64.11 109.689 174.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 m -147.17 162.02 39.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.382 -0.826 . . . . 74.34 108.832 -177.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.91 134.92 55.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.188 -0.301 . . . . 72.43 110.188 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.528 ' HA ' HD22 ' A' ' 58' ' ' LEU . 15.6 t -69.01 137.34 24.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.519 -0.31 . . . . 75.21 110.371 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.521 ' O ' HG12 ' A' ' 28' ' ' VAL . 20.5 t70 -57.22 141.55 46.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 74.52 111.69 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.48 -27.0 67.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 75.3 112.093 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.48 -14.06 60.56 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.436 -0.887 . . . . 71.55 111.722 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 t -97.94 -18.83 18.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.413 0.149 . . . . 65.01 110.913 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 24' ' ' ASP . 35.9 m -78.35 -5.74 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.556 0.217 . . . . 74.23 111.177 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -165.07 94.12 0.64 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.417 -0.586 . . . . 73.44 109.417 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -147.52 150.04 33.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.99 -0.55 . . . . 64.22 110.878 -176.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.459 ' CG2' ' HB ' ' A' ' 9' ' ' THR . 5.4 m -121.74 114.15 20.7 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.644 -0.707 . . . . 73.23 109.673 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.75 139.03 18.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.14 -0.482 . . . . 63.54 110.823 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -92.68 121.91 34.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.826 -0.625 . . . . 70.23 110.46 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -97.32 -27.2 14.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.235 0.541 . . . . 74.04 109.842 176.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.38 178.43 44.18 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.582 -0.736 . . . . 65.31 112.225 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.429 ' HG2' ' C ' ' A' ' 6' ' ' ASN . 82.6 mt-30 -80.56 94.2 6.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.154 -0.313 . . . . 73.42 110.154 177.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.451 HG12 HG22 ' A' ' 5' ' ' VAL . 9.0 p -70.25 149.82 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 73.42 110.618 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.01 134.46 35.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.931 -0.577 . . . . 73.33 110.094 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 p -77.5 -19.16 56.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.108 0.48 . . . . 75.45 110.775 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.91 -16.69 60.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 64.53 111.258 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.4 m -90.85 3.68 53.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.103 0.478 . . . . 72.34 110.907 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.1 mt -142.46 54.67 1.43 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.866 -0.606 . . . . 61.25 110.008 -175.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.25 10.53 41.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.114 0.413 . . . . 74.52 112.114 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -145.65 141.44 28.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.699 0.285 . . . . 75.3 111.171 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 8.9 tm-20 -55.43 116.42 2.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.903 -0.59 . . . . 74.13 109.559 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.14 -7.43 27.07 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.665 -0.779 . . . . 72.42 112.375 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.78 132.96 48.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.681 0.277 . . . . 71.33 110.61 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 p -122.78 138.83 54.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.291 -0.413 . . . . 71.14 110.715 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 t -96.36 179.0 5.18 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.356 -0.384 . . . . 74.43 110.519 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 m -68.62 126.05 28.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.936 -0.575 . . . . 65.21 110.265 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -82.49 164.66 20.78 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.668 0.747 . . . . 74.33 112.157 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.0 m -106.33 155.92 7.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.45 -1.25 . . . . 75.31 109.208 171.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.3 93.01 0.67 Allowed Glycine 0 C--N 1.311 -0.847 0 C-N-CA 120.818 -0.706 . . . . 54.43 112.104 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -105.54 171.52 7.28 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.556 -0.535 . . . . 73.41 109.556 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -139.69 142.84 36.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.044 0.449 . . . . 63.31 111.38 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.7 mt -102.27 117.8 48.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.534 -0.757 . . . . 74.43 109.318 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -99.37 137.6 37.65 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.785 -0.643 . . . . 72.24 110.676 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.528 HD22 ' HA ' ' A' ' 23' ' ' VAL . 44.8 mt -117.34 134.72 54.49 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.454 -0.573 . . . . 73.23 109.454 176.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -110.26 143.97 39.65 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.902 -0.407 . . . . 63.43 109.902 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.8 t70 50.39 73.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 124.071 0.857 . . . . 72.11 110.715 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 32.7 t -112.78 119.66 38.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.115 -0.948 . . . . 74.43 110.212 -174.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.73 138.03 36.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.948 0.404 . . . . 72.45 111.734 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.3 p -107.43 5.21 27.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 71.1 112.258 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -78.3 -21.96 48.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.656 -0.498 . . . . 71.41 109.656 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.8 p -112.53 -30.71 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.768 -0.651 . . . . 73.34 111.353 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -116.95 166.57 12.03 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.194 -0.316 . . . . 63.54 111.126 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.486 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 32.7 m -124.64 -56.27 1.6 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.772 0.32 . . . . 73.43 111.569 -177.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.486 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -133.01 157.08 46.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.721 -0.474 . . . . 74.43 109.721 -178.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.415 ' HB2' HD22 ' A' ' 124' ' ' LEU . . . -114.14 132.63 56.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.977 0.418 . . . . 75.25 110.353 175.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.58 120.58 12.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.753 -0.658 . . . . 73.55 109.492 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.0 OUTLIER -92.41 147.3 5.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.097 0.475 . . . . 75.23 111.158 -173.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.51 117.53 28.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.607 -0.724 . . . . 73.15 109.234 174.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 86.8 m-85 -82.81 135.99 34.79 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.951 0.405 . . . . 71.53 111.065 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.1 tp -131.32 115.42 16.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.878 -0.601 . . . . 74.31 109.616 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.31 -174.22 23.39 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.576 -0.738 . . . . 74.53 111.326 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.458 ' O ' HD12 ' A' ' 86' ' ' LEU . 8.1 m -79.3 114.78 18.51 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.242 -0.281 . . . . 72.13 110.242 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.89 149.53 37.75 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.945 -0.391 . . . . 61.22 109.945 178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.511 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 14.5 tt -62.48 -35.79 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.409 . . . . 71.23 110.209 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -162.43 -174.5 4.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.986 -0.552 . . . . 73.44 109.53 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.85 -12.15 59.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.141 0.423 . . . . 73.35 112.141 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.21 -43.71 3.98 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.769 -0.729 . . . . 73.33 111.8 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -103.06 82.2 2.06 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.076 -0.713 . . . . 75.41 109.076 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 p -95.59 7.34 46.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.251 -0.886 . . . . 72.01 112.503 -172.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -107.17 -1.64 21.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.121 0.486 . . . . 75.23 110.541 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.52 121.68 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.739 -0.664 . . . . 75.34 110.292 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.56 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -68.21 132.37 47.03 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.841 -0.429 . . . . 74.13 109.841 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -76.46 149.54 36.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.175 -0.466 . . . . 75.31 110.294 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -77.84 132.93 38.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.157 -0.474 . . . . 74.43 109.839 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.538 ' HG3' ' HA ' ' A' ' 150' ' ' ALA . 90.8 mt-30 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 74.35 110.541 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 120.762 0.315 . . . . 64.14 110.344 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.23 148.22 35.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.579 -0.526 . . . . 73.53 109.579 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.34 163.51 29.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.03 -0.359 . . . . 74.32 110.03 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 69.8 10.99 7.73 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.575 0.547 . . . . 63.13 110.319 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.06 -177.29 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.478 -0.783 . . . . 73.12 110.212 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 175.94 -172.64 45.63 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.574 -1.01 . . . . 74.12 110.574 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.418 HG21 HG21 ' A' ' 10' ' ' VAL . 2.7 p -118.42 115.31 47.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.337 0.589 . . . . 73.23 110.62 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -105.34 140.66 38.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.24 -0.652 . . . . 71.35 109.24 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.425 HG22 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -102.56 122.59 55.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.147 0.499 . . . . 74.52 110.672 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.51 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 15.5 mt -89.58 143.55 26.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.503 -0.771 . . . . 73.34 109.378 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.542 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.9 -170.49 0.91 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.713 -0.477 . . . . 73.34 109.713 175.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -60.0 -29.83 68.73 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.467 0.173 . . . . 54.54 111.467 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.4 p -92.4 3.54 55.24 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.808 0.337 . . . . 71.02 111.573 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 82.08 30.67 33.93 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.858 -0.687 . . . . 72.33 113.1 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.01 126.4 48.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.713 0.256 . . . . 64.25 110.524 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.98 109.02 2.8 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.049 0.452 . . . . 73.15 110.919 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.9 mt -79.07 130.6 35.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 74.4 110.76 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 m -70.56 135.99 48.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 74.23 110.599 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.56 HD13 HD22 ' A' ' 86' ' ' LEU . 34.4 mt -78.05 41.52 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 75.44 110.844 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -98.9 -9.82 23.67 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.021 -0.536 . . . . 74.21 110.472 -175.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.53 1.15 75.56 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.025 -0.607 . . . . 60.32 112.663 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.27 -3.4 11.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.947 0.403 . . . . 74.02 111.228 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.4 m -101.0 109.5 21.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.807 0.337 . . . . 74.42 110.238 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -99.18 156.68 16.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 74.04 111.338 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 1.7 m -68.45 177.02 2.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.561 -0.745 . . . . 73.31 111.291 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.3 t -63.58 148.08 49.79 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.551 -0.537 . . . . 72.44 109.551 170.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.4 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 85.6 mt-10 -63.8 103.63 0.59 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 71.12 111.409 -176.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -87.22 110.86 20.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.962 -0.563 . . . . 74.53 109.743 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 m -59.96 122.4 14.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 75.5 111.28 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.451 ' C ' HD21 ' A' ' 125' ' ' ASN . 85.4 mt -84.38 146.39 27.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.514 . . . . 75.42 111.455 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.451 HD21 ' C ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -122.97 152.83 40.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.412 -0.813 . . . . 70.13 109.244 174.184 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 19.7 m120 -62.82 111.93 2.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.85 0.357 . . . . 61.35 110.569 176.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.17 -128.61 6.68 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.689 -0.767 . . . . 52.41 112.69 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.7 m -96.56 135.71 38.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.744 0.307 . . . . 74.55 110.849 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -132.58 148.56 52.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 70.11 110.482 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.47 120.73 31.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.372 -0.376 . . . . 74.2 111.301 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.2 mt -99.29 113.03 64.47 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.035 -0.728 . . . . 74.03 109.035 174.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.63 140.29 11.7 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.423 2.082 . . . . 73.52 112.704 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 87.4 m-85 -136.65 162.97 31.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 75.44 110.704 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.623 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.0 mt-30 -132.55 110.47 10.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.783 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -97.15 123.6 40.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.424 -0.353 . . . . 74.52 110.28 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 11.2 ptp180 -135.47 160.65 37.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.9 0.381 . . . . 74.54 110.65 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.671 ' HH ' ' HA3' ' A' ' 8' ' ' GLY . 81.3 m-85 -81.28 144.32 31.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.039 -0.528 . . . . 71.23 110.657 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -129.31 126.06 38.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.755 -0.657 . . . . 75.24 109.428 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -89.24 133.47 34.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.294 -0.412 . . . . 73.24 111.356 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.405 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 71.1 p -105.37 7.66 33.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.856 0.836 . . . . 74.05 109.022 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.08 -128.33 1.63 Allowed Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.524 -1.217 . . . . 72.15 110.838 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 96.18 10.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.827 0.314 . . . . 73.3 110.233 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -46.45 113.84 0.71 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.564 0.54 . . . . 64.43 111.539 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 31.9 p -103.14 141.45 22.52 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-O 121.122 0.487 . . . . 74.42 110.669 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.58 170.48 15.0 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 123.642 2.895 . . . . 53.33 113.273 -175.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.58 -122.47 1.77 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.627 -0.715 . . . . 72.23 111.795 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -122.17 133.87 54.73 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.686 -0.487 . . . . 74.13 109.686 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -122.05 51.49 1.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.589 0.709 . . . . 63.13 111.07 -173.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -102.56 144.45 30.96 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.255 -0.884 . . . . 71.41 110.197 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 89' ' ' GLN . . . -152.86 177.26 10.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.113 -0.494 . . . . 71.14 109.979 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -154.1 152.05 30.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.963 -0.295 . . . . 73.43 110.622 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.43 ' HB1' HD23 ' A' ' 86' ' ' LEU . . . -156.29 153.0 28.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.177 -0.465 . . . . 63.1 110.829 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.3 p -105.31 136.71 44.33 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.454 -0.573 . . . . 75.32 109.454 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -109.59 122.82 48.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.088 0.47 . . . . 71.23 110.55 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.579 ' HA ' HG21 ' A' ' 16' ' ' VAL . 2.9 ttmm -102.48 104.85 15.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.081 -0.509 . . . . 74.34 110.224 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.654 HG22 HG21 ' A' ' 17' ' ' VAL . 1.5 m -81.45 139.2 18.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.207 0.527 . . . . 72.21 110.216 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -110.66 110.7 21.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.97 -0.559 . . . . 63.21 111.01 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.563 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 116.088 -0.506 . . . . 73.23 110.401 170.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.407 ' CB ' ' HB3' ' A' ' 36' ' ' GLN . 63.1 p . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.971 0.415 . . . . 63.35 110.363 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.528 HG22 HG13 ' A' ' 37' ' ' VAL . 31.6 m -89.8 14.36 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.756 0.312 . . . . 74.22 111.216 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 66.59 8.87 6.16 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.82 -0.627 . . . . 71.13 112.107 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.41 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 95.78 97.8 1.78 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.112 -0.795 . . . . 64.33 111.112 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.56 154.24 25.81 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.206 -0.997 . . . . 61.04 112.206 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.464 ' HB ' HG22 ' A' ' 31' ' ' THR . 24.4 p -141.85 132.31 25.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.801 0.334 . . . . 71.35 111.128 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.405 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -106.95 120.46 58.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.178 -0.675 . . . . 73.52 109.178 171.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -94.33 106.1 18.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.689 -0.486 . . . . 74.31 109.689 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.405 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 81.8 m-85 -96.91 129.77 44.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.842 -0.617 . . . . 73.54 110.149 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -117.3 133.0 56.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.211 -0.45 . . . . 74.53 110.25 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.97 -123.24 4.24 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.982 -0.627 . . . . 40.53 111.951 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.744 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 31.7 mt-10 63.35 15.94 9.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.135 0.493 . . . . 51.43 110.891 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.578 HG23 ' HA ' ' A' ' 155' ' ' LYS . 24.2 m -76.91 -27.61 16.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.529 -0.76 . . . . 74.23 111.932 -174.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.57 HG21 ' CG2' ' A' ' 156' ' ' VAL . 18.8 m -135.81 144.6 33.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.214 0.531 . . . . 74.34 112.205 -174.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.41 21.38 1.06 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.487 -0.931 . . . . 73.43 108.487 170.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.96 -74.54 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.248 -0.887 . . . . 73.34 110.974 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.457 ' HB2' HG13 ' A' ' 65' ' ' VAL . . . -88.72 -38.71 14.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.067 0.46 . . . . 62.32 110.513 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.8 OUTLIER -144.0 134.99 25.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.555 -0.748 . . . . 73.15 109.847 -176.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.61 151.51 20.09 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.8 -0.445 . . . . 72.11 109.8 177.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.416 ' HB ' HG11 ' A' ' 28' ' ' VAL . 14.9 t -86.52 136.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 110.122 -0.325 . . . . 72.2 110.122 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.462 ' O ' HG13 ' A' ' 28' ' ' VAL . 22.3 t70 -62.86 145.15 55.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.435 -0.348 . . . . 75.02 110.937 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.25 -26.04 66.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.253 0.464 . . . . 74.34 112.253 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.1 -14.79 81.9 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.529 -0.844 . . . . 65.22 112.014 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.9 p -119.94 13.55 12.25 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.83 0.307 . . . . 75.23 111.83 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.744 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 27.2 m -100.56 -11.77 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.161 0.505 . . . . 62.13 110.325 173.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -156.52 81.3 0.96 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.289 -0.869 . . . . 75.01 109.426 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -126.18 133.87 51.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.453 0.644 . . . . 74.43 110.369 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.464 HG22 ' HB ' ' A' ' 9' ' ' THR . 2.9 m -118.24 101.31 8.11 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.764 -0.828 . . . . 74.24 108.764 176.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.48 131.86 32.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.993 -0.549 . . . . 74.4 111.034 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -88.13 110.42 20.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.65 -0.704 . . . . 73.12 109.771 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -81.22 -29.05 34.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.406 0.622 . . . . 55.41 109.495 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.41 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 96.18 172.72 35.58 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.242 -0.89 . . . . 54.21 112.131 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.407 ' HB3' ' CB ' ' A' ' 4' ' ' THR . 69.4 mt-30 -72.83 95.8 1.98 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.448 -0.204 . . . . 73.12 110.448 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.528 HG13 HG22 ' A' ' 5' ' ' VAL . 11.0 p -70.33 142.67 15.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.855 0.36 . . . . 74.2 110.134 177.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -78.22 105.12 9.24 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.201 -0.666 . . . . 65.23 109.201 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 19.5 p -63.05 -25.19 68.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.955 0.407 . . . . 74.02 111.237 -177.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.43 -5.6 37.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.061 -0.518 . . . . 74.43 111.419 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.5 m -95.8 -2.69 47.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.073 0.463 . . . . 65.22 110.411 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.532 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 5.1 mp -131.69 97.3 4.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.888 -0.597 . . . . 75.12 109.504 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.96 17.35 9.32 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.32 -0.552 . . . . 73.15 112.436 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -153.62 150.99 29.21 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.749 -0.381 . . . . 72.23 111.483 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -60.9 119.21 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 73.41 109.827 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.72 -6.19 31.26 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.641 -0.79 . . . . 61.21 111.847 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -72.01 119.39 16.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.014 0.435 . . . . 75.04 110.532 178.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.538 HG21 ' HD1' ' A' ' 138' ' ' PHE . 41.1 p -105.51 148.34 27.33 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.015 -0.539 . . . . 75.13 110.173 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.4 t -100.32 177.54 5.02 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.136 -0.69 . . . . 54.23 109.136 174.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.6 m -70.11 133.51 47.23 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.876 -0.416 . . . . 74.24 109.876 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.52 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -87.34 160.41 18.39 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.644 0.735 . . . . 71.52 111.956 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 31.1 m -103.94 152.9 6.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.433 -1.258 . . . . 72.25 109.083 171.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.45 98.48 1.28 Allowed Glycine 0 C--N 1.312 -0.754 0 C-N-CA 120.729 -0.748 . . . . 70.22 112.147 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -108.96 173.19 6.43 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.6 -0.519 . . . . 63.35 109.6 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.552 ' HB2' HG23 ' A' ' 130' ' ' THR . 4.0 p-10 -139.75 137.19 34.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.476 0.655 . . . . 73.44 111.917 -173.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.4 mt -105.5 115.09 46.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.722 -0.844 . . . . 75.25 108.722 171.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -101.57 144.62 30.09 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.977 0.417 . . . . 75.54 110.823 -173.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.2 mt -117.91 130.01 55.97 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.955 -0.566 . . . . 73.3 109.676 176.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -106.41 131.98 52.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.67 -0.695 . . . . 74.51 109.519 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 27.1 t70 58.15 86.44 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.69 0.757 . . . . 63.42 110.217 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 51.7 t -124.38 124.49 42.46 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.335 -0.848 . . . . 55.04 110.421 -174.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -103.92 140.07 38.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.045 -0.525 . . . . 72.31 111.152 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.8 p -107.96 15.61 24.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.071 0.397 . . . . 74.32 112.071 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -90.34 -39.16 12.87 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.912 -0.773 . . . . 74.33 108.912 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 20' ' ' ALA . 12.7 p -96.12 -3.53 10.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.104 -0.953 . . . . 72.41 110.472 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . . . -144.75 -173.45 4.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 73.14 110.781 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.7 m -151.0 -57.98 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.023 0.379 . . . . 64.14 112.023 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.788 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -138.21 130.4 28.76 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.973 -0.291 . . . . 74.03 110.262 -175.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.43 127.49 41.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.108 0.48 . . . . 53.11 111.0 -175.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.33 119.64 16.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.637 -0.711 . . . . 72.1 109.637 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 2.5 m -90.19 147.62 5.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.977 0.418 . . . . 74.24 110.756 -175.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.428 ' HB1' ' CD2' ' A' ' 118' ' ' PHE . . . -117.48 118.16 31.42 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.741 -0.663 . . . . 73.24 109.752 174.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 82.3 m-85 -85.62 128.49 34.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.979 0.419 . . . . 73.04 110.205 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.1 tp -126.13 126.76 44.68 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.836 -0.62 . . . . 74.05 109.913 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.52 -166.47 21.36 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.446 -0.662 . . . . 62.53 111.446 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.7 m -87.1 119.71 27.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.853 -0.425 . . . . 75.23 109.853 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 83' ' ' THR . . . -76.98 149.52 35.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.446 -0.343 . . . . 73.53 110.436 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.486 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 12.8 tt -61.77 -37.61 78.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.081 0.467 . . . . 75.43 110.7 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -152.02 -171.51 3.95 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.782 -0.821 . . . . 75.54 108.782 174.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.04 -14.89 43.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.056 0.391 . . . . 74.21 112.056 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.31 -49.83 3.6 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.632 -0.794 . . . . 73.52 112.016 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -96.43 76.64 2.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.383 0.611 . . . . 73.34 109.617 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.466 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . 14.6 p -86.97 8.45 23.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.649 -0.705 . . . . 74.25 111.755 -175.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 24.4 p-10 -107.05 7.32 29.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.976 0.417 . . . . 72.54 110.849 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.11 124.91 73.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.542 . . . . 71.54 109.837 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.515 HD22 ' CD1' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -66.94 129.85 41.23 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 110.079 -0.341 . . . . 74.04 110.079 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.46 150.77 34.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.203 -0.453 . . . . 73.23 110.297 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.536 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -88.03 130.3 35.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.561 -0.533 . . . . 72.24 109.561 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 60.2 112.127 -174.184 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 109.899 -0.408 . . . . 54.42 109.899 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.418 ' O ' HD21 ' A' ' 88' ' ' LEU . . . -71.46 136.64 47.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.71 0.291 . . . . 71.51 110.223 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.36 160.71 35.51 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.848 -0.341 . . . . 72.54 110.546 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 68.55 7.36 5.99 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.337 0.589 . . . . 74.23 110.303 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -143.25 -179.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.269 -0.878 . . . . 72.01 109.687 175.124 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.3 -169.82 42.86 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.951 -1.26 . . . . 73.45 109.951 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.85 119.46 58.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.278 0.561 . . . . 75.14 110.465 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -109.42 146.15 34.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.648 -0.705 . . . . 74.13 109.755 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 103' ' ' ILE . 4.1 mp -103.99 124.24 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.425 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.403 HD13 ' NE ' ' A' ' 136' ' ' ARG . 27.5 mt -87.38 140.03 29.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.651 -0.704 . . . . 71.33 109.177 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.538 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.05 -173.13 1.19 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.913 -0.402 . . . . 64.3 109.913 177.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.1 ptt85 -61.04 -20.3 62.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.096 0.406 . . . . 74.33 112.096 -176.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.7 p -101.47 3.56 40.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.935 -0.306 . . . . 72.14 111.548 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.42 31.52 24.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.778 -0.725 . . . . 53.24 112.866 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -112.02 128.51 56.2 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.959 -0.386 . . . . 73.21 109.959 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.85 130.16 42.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.726 0.298 . . . . 72.22 110.884 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.0 mt -92.77 132.83 36.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.225 -0.443 . . . . 74.23 110.979 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 89.9 m -74.31 139.2 44.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.891 -0.595 . . . . 74.13 110.449 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 34.8 mt -81.46 45.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 71.13 110.682 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -90.7 -17.94 25.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.09 0.472 . . . . 71.31 110.369 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.19 -22.97 26.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.996 -0.621 . . . . 70.31 112.329 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.45 3.87 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.164 0.507 . . . . 50.31 110.915 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -95.34 99.36 11.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 75.24 110.064 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.482 ' HE2' ' HD2' ' A' ' 155' ' ' LYS . 96.3 m-85 -95.41 162.31 13.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.969 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.538 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 4.6 m -71.46 -178.83 2.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.666 -0.697 . . . . 72.45 111.003 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.5 t -73.05 165.55 24.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.596 -0.52 . . . . 71.43 109.596 173.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -65.32 106.98 1.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.366 -0.379 . . . . 75.13 111.33 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.8 m -90.66 102.76 15.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.084 -0.71 . . . . 71.13 109.084 172.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.6 m -58.17 119.21 6.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.753 -0.658 . . . . 70.12 111.247 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.42 HD11 ' SG ' ' A' ' 61' ' ' CYS . 95.9 mt -87.27 150.91 23.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.792 -0.64 . . . . 75.12 111.166 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -125.89 158.68 34.51 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.743 -0.836 . . . . 73.4 108.743 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -65.08 114.49 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.868 0.366 . . . . 61.32 111.058 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.43 -133.27 8.07 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.03 -0.605 . . . . 64.13 112.31 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.5 m -92.83 130.88 38.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.795 0.331 . . . . 71.01 110.706 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -128.34 139.25 52.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.73 -0.47 . . . . 70.34 109.73 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.552 HG23 ' HB2' ' A' ' 55' ' ' ASN . 1.2 m -122.51 117.83 26.84 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.755 -0.378 . . . . 73.11 110.78 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.7 mt -95.0 115.26 65.22 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 71.23 109.913 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.19 135.95 7.6 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.469 2.113 . . . . 71.04 112.689 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 68.3 m-85 -134.7 160.76 37.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 72.45 110.258 177.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.598 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 44.9 mt-30 -130.37 114.52 15.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.91 0.386 . . . . 73.32 110.832 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.07 130.63 46.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.547 -0.297 . . . . 74.41 110.407 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.52 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 13.8 ptp180 -141.27 158.12 44.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.582 -0.281 . . . . 74.44 110.825 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 94.4 m-85 -75.93 142.03 42.14 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.148 -0.478 . . . . 74.12 110.257 175.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.538 ' HD1' HG21 ' A' ' 48' ' ' THR . 75.7 t80 -128.81 125.78 38.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.934 -0.575 . . . . 73.52 109.988 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -94.02 131.43 39.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.097 0.475 . . . . 74.03 110.736 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.5 p -101.13 7.31 43.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.502 -0.772 . . . . 72.34 109.572 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.83 -129.66 1.75 Allowed Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.246 -1.141 . . . . 73.21 110.246 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -83.82 95.37 8.44 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.452 -0.573 . . . . 73.11 109.452 175.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.48 111.35 0.48 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.824 -0.625 . . . . 70.23 111.363 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.6 p -103.62 142.98 25.72 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-O 121.328 0.585 . . . . 73.12 110.845 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.75 166.94 22.58 Favored 'Trans proline' 0 C--N 1.331 -0.35 0 C-N-CA 123.816 3.011 . . . . 75.14 112.734 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.02 179.79 19.98 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.799 -0.715 . . . . 64.1 111.513 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.06 112.71 5.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 117.003 0.401 . . . . 72.45 110.915 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.536 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -101.2 74.1 1.55 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.451 0.643 . . . . 71.21 111.031 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.0 123.44 50.34 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.323 -0.621 . . . . 75.22 109.323 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.439 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -129.34 156.45 44.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.95 0.405 . . . . 53.21 111.598 -176.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -125.65 130.18 51.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.69 -0.687 . . . . 71.42 109.826 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.09 137.11 32.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.103 0.478 . . . . 51.42 111.663 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.4 p -112.63 125.0 53.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.679 -0.691 . . . . 72.21 109.902 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -105.52 134.84 47.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.144 0.497 . . . . 74.32 110.682 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.578 ' HA ' HG23 ' A' ' 16' ' ' VAL . 1.9 ttmm -117.9 107.42 14.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.684 -0.689 . . . . 74.14 110.158 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.57 ' CG2' HG21 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -74.45 140.86 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.142 0.496 . . . . 74.12 110.206 179.212 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -128.39 110.12 12.05 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.117 -0.698 . . . . 71.53 109.117 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.788 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.587 0 CA-C-O 120.942 0.401 . . . . 75.42 111.666 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.0 p . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.823 0.344 . . . . 75.13 110.647 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.478 ' CG2' HG11 ' A' ' 37' ' ' VAL . 32.7 m -93.53 15.88 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.975 0.417 . . . . 72.4 110.955 177.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 61.11 20.58 11.06 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.452 -0.795 . . . . 71.3 112.092 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.548 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 84.79 102.85 0.63 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.591 -0.814 . . . . 45.44 111.978 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.467 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -93.64 155.36 22.09 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.242 -0.98 . . . . 43.4 112.048 -177.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 33' ' ' GLN . 53.8 p -140.99 151.5 44.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.899 -0.408 . . . . 74.2 109.899 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.517 HG13 ' HB1' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -121.0 124.1 71.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.042 -0.725 . . . . 60.22 109.042 172.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -92.2 116.99 29.43 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.118 -0.633 . . . . 75.22 109.688 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 93.1 m-85 -104.15 114.5 28.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.626 -0.715 . . . . 73.35 110.157 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -102.32 134.81 45.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 75.4 110.274 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.93 -120.68 3.43 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.944 -0.646 . . . . 53.14 111.899 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.606 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 38.3 mt-10 62.88 19.72 11.73 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.153 0.501 . . . . 61.33 111.085 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.774 HG22 HG21 ' A' ' 17' ' ' VAL . 17.2 m -76.17 -30.49 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.053 -0.521 . . . . 74.13 111.719 -176.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.774 HG21 HG22 ' A' ' 16' ' ' VAL . 4.2 m -149.17 143.87 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.146 0.498 . . . . 64.23 111.145 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -140.7 22.45 2.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.213 -0.903 . . . . 74.01 108.916 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.75 -77.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.089 -0.959 . . . . 72.43 111.131 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.557 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -78.19 -39.15 41.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.024 -0.535 . . . . 65.02 110.492 178.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.8 OUTLIER -143.65 128.39 18.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.055 -0.521 . . . . 74.1 109.778 -176.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.44 119.25 27.53 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.366 -0.379 . . . . 70.53 110.138 -178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.428 ' HA ' HD22 ' A' ' 58' ' ' LEU . 9.6 t -62.45 128.65 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.709 -0.478 . . . . 74.11 109.709 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.441 ' O ' HG13 ' A' ' 28' ' ' VAL . 18.6 t70 -59.57 142.88 51.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.781 -0.645 . . . . 63.44 111.397 -176.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.477 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -62.12 -24.37 67.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.774 -0.648 . . . . 74.32 112.221 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.4 -17.91 70.12 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.618 -0.801 . . . . 37.55 111.932 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 p -105.48 -14.23 15.37 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.821 0.304 . . . . 73.34 111.821 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.606 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 33.8 m -79.73 -8.02 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.09 0.471 . . . . 74.31 110.353 175.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -157.78 90.24 1.06 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.559 -0.904 . . . . 62.52 108.559 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.409 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 17.1 pt20 -137.06 112.86 9.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.726 -0.67 . . . . 74.22 110.52 -176.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.52 HG23 ' HB ' ' A' ' 9' ' ' THR . 7.4 m -97.22 95.37 7.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.532 -0.758 . . . . 74.44 109.094 174.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 p -79.26 134.42 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.541 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.535 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.6 mp0 -91.33 120.96 32.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.121 -0.491 . . . . 75.13 110.281 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.421 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.8 mm? -86.55 -30.04 22.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.777 -0.647 . . . . 75.04 109.356 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.548 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 92.33 177.35 41.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.329 -0.851 . . . . 60.45 111.951 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -72.31 95.34 1.71 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.707 -0.479 . . . . 72.42 109.707 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.478 HG11 ' CG2' ' A' ' 5' ' ' VAL . 9.8 p -66.49 138.49 22.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.209 0.528 . . . . 74.02 110.379 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.6 mtm-85 -75.25 106.55 6.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.623 -0.717 . . . . 74.01 109.967 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 p -62.49 -26.08 68.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 75.21 111.09 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.19 -8.07 52.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 73.54 111.428 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.1 m -97.07 -15.51 20.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.813 0.339 . . . . 74.23 110.749 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 5.8 mp -124.28 95.94 4.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.699 0.285 . . . . 74.42 110.241 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.01 11.34 7.07 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.667 -0.413 . . . . 74.14 112.061 -176.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -152.8 143.42 22.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.417 0.151 . . . . 74.01 110.829 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 41.2 tt0 -58.35 118.46 5.56 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.021 0.438 . . . . 74.34 110.638 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.79 -17.59 8.18 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.22 -0.752 . . . . 64.03 111.22 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.3 124.67 24.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.847 0.356 . . . . 75.25 110.222 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.492 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 4.6 p -121.88 114.23 20.74 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.937 -0.574 . . . . 75.33 110.139 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.468 ' HG ' HG22 ' A' ' 37' ' ' VAL . 15.8 t -72.22 174.46 7.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.069 -0.514 . . . . 55.43 110.838 -175.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -60.54 120.88 10.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 51.3 110.29 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -80.46 142.48 34.23 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.411 0.624 . . . . 52.1 111.276 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.9 m -83.66 147.88 5.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.825 -1.08 . . . . 73.14 109.306 170.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.99 92.02 0.72 Allowed Glycine 0 C--N 1.307 -1.05 0 C-N-CA 120.837 -0.696 . . . . 72.45 112.257 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -102.19 -175.71 2.91 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.407 -0.59 . . . . 75.31 109.407 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.515 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.0 p-10 -147.31 147.48 30.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.39 0.614 . . . . 71.24 111.821 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.45 115.87 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.342 -0.985 . . . . 74.21 108.342 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -103.71 138.45 40.34 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.078 -0.51 . . . . 75.21 111.129 -171.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 23' ' ' VAL . 64.4 mt -119.11 115.23 23.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.711 -0.677 . . . . 75.3 109.744 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -92.63 136.26 33.38 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.977 -0.556 . . . . 74.12 110.239 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 51.02 68.91 0.71 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.944 0.777 . . . . 53.3 110.938 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 53.0 t -98.62 129.39 45.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.954 . . . . 62.05 110.435 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -104.06 138.27 40.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.935 -0.575 . . . . 70.15 111.169 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.5 p -104.95 10.5 34.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.094 0.405 . . . . 73.25 112.094 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -85.13 -37.15 20.57 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.459 -0.571 . . . . 72.23 109.459 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.546 HG13 ' HB1' ' A' ' 20' ' ' ALA . 10.3 p -100.58 -13.7 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.773 -0.649 . . . . 63.11 110.852 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -123.92 179.48 4.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.64 0.257 . . . . 74.44 111.066 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.421 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 20.3 m -143.24 -60.95 0.42 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.486 . . . . 74.21 110.736 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -136.68 140.72 42.9 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.374 -0.602 . . . . 75.32 109.374 -178.254 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.453 ' HB2' HD22 ' A' ' 124' ' ' LEU . . . -98.16 119.8 37.44 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.185 0.517 . . . . 64.32 109.977 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.25 110.84 11.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.538 -0.756 . . . . 75.55 109.754 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.0 OUTLIER -89.03 145.45 7.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.915 0.388 . . . . 72.15 110.298 -175.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.449 ' HB3' ' CD1' ' A' ' 118' ' ' PHE . . . -123.37 123.87 41.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.965 -0.561 . . . . 74.53 109.62 174.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 91.1 m-85 -88.95 130.43 35.45 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.021 0.439 . . . . 74.54 110.696 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.7 tp -130.59 125.56 34.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.771 -0.65 . . . . 75.41 110.154 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.37 -164.2 21.48 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.132 -0.787 . . . . 51.4 111.132 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.445 ' O ' HD11 ' A' ' 86' ' ' LEU . 42.3 m -80.79 122.65 27.44 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.27 -0.271 . . . . 71.14 110.27 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -85.37 140.65 30.6 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.91 -0.404 . . . . 73.43 109.91 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 tt -65.05 -28.98 46.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.886 0.374 . . . . 73.25 110.867 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 22.0 t70 -153.99 174.95 13.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.482 -0.562 . . . . 60.3 109.482 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.36 -37.83 31.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.093 0.473 . . . . 73.14 110.339 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.63 -19.18 62.33 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.161 -0.776 . . . . 65.44 111.161 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 42.4 m80 -107.08 43.5 1.16 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.167 -0.679 . . . . 75.34 109.167 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -72.62 11.45 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.141 -0.936 . . . . 71.23 112.927 -176.028 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.452 ' OD1' HG23 ' A' ' 85' ' ' VAL . 16.4 p30 -110.81 -8.96 14.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.058 0.456 . . . . 73.04 110.554 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.452 HG23 ' OD1' ' A' ' 84' ' ' ASN . 48.3 t -101.84 120.92 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.101 -0.499 . . . . 62.24 110.561 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.566 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -67.03 132.8 48.62 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.16 -0.473 . . . . 75.3 109.746 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.71 148.52 36.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.032 -0.531 . . . . 72.41 110.304 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.437 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 2.0 mm? -82.98 140.77 32.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.14 -0.482 . . . . 61.21 110.557 -177.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.486 -0.779 . . . . 72.24 110.095 177.301 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.63 0.252 . . . . 75.22 110.404 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.92 138.7 50.31 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.061 -0.348 . . . . 74.05 110.061 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.18 159.3 33.32 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.842 -0.343 . . . . 73.1 110.932 -176.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 68.67 10.46 7.9 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.719 -0.673 . . . . 71.0 111.238 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.48 178.28 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.153 -0.476 . . . . 72.44 110.306 174.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 176.28 -175.9 47.59 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 109.831 -1.308 . . . . 53.32 109.831 177.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.4 HG23 HG21 ' A' ' 10' ' ' VAL . 2.6 p -118.9 114.21 44.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.334 0.588 . . . . 75.31 111.162 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -104.15 140.16 38.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.698 -0.683 . . . . 65.45 109.498 173.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.423 HD11 ' N ' ' A' ' 103' ' ' ILE . 4.4 mp -98.11 126.35 51.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.997 -0.547 . . . . 74.21 110.296 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.5 mt -89.92 147.5 23.69 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.262 -0.881 . . . . 72.3 109.141 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.406 ' HA ' ' CD1' ' A' ' 133' ' ' PHE . 1.5 p-10 -70.87 -169.94 0.39 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.773 -0.454 . . . . 73.33 109.773 175.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -61.98 -30.86 71.22 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.108 -0.237 . . . . 73.43 111.527 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.403 ' HG1' ' CG ' ' A' ' 105' ' ' ASP . 51.4 p -81.92 -34.55 29.83 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.748 -0.381 . . . . 71.11 110.76 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.77 31.54 1.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.582 -0.818 . . . . 64.13 112.931 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.48 139.02 42.64 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.128 -0.323 . . . . 73.12 110.128 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.05 130.71 43.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.396 -0.366 . . . . 73.4 111.1 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt -97.37 131.98 43.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.144 -0.48 . . . . 71.03 110.506 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 m -72.23 137.01 46.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.257 -0.428 . . . . 74.44 110.72 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.566 HD13 HD22 ' A' ' 86' ' ' LEU . 49.2 mt -79.64 49.09 0.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 75.24 110.876 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -107.45 -8.43 16.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.441 0.639 . . . . 65.2 110.324 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.23 -12.51 12.78 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.0 -0.619 . . . . 72.4 112.811 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.19 -10.85 23.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.932 0.396 . . . . 73.0 111.153 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.5 m -92.57 95.12 9.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.079 0.466 . . . . 72.22 110.21 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.546 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 72.6 m-85 -91.03 153.01 20.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.784 -0.644 . . . . 73.11 110.241 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.4 m -65.23 171.37 3.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.083 -0.508 . . . . 71.52 111.251 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.3 p -61.3 146.17 48.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.104 -0.498 . . . . 72.35 110.301 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.43 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 41.9 mt-10 -57.57 101.34 0.07 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.96 0.409 . . . . 75.43 111.605 -176.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.6 m -85.85 104.18 15.28 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.947 -0.761 . . . . 70.43 108.947 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 m -63.3 115.08 4.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.262 0.553 . . . . 75.21 110.878 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.511 HD13 ' SG ' ' A' ' 61' ' ' CYS . 92.0 mt -74.59 147.08 42.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.176 -0.92 . . . . 74.12 111.777 -174.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.436 HD21 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -121.14 151.47 39.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.359 -0.837 . . . . 63.52 108.924 171.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 94.6 m-20 -63.12 107.34 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.902 0.382 . . . . 71.32 110.681 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.84 -149.12 20.08 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.967 -0.635 . . . . 65.41 111.789 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 30.1 m -82.12 123.61 29.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.124 0.487 . . . . 73.03 110.994 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 28.0 m-80 -117.48 135.09 54.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.942 -0.572 . . . . 37.55 109.537 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.515 HG22 ' HB2' ' A' ' 55' ' ' ASN . 2.3 m -122.45 118.87 29.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.804 -0.358 . . . . 75.41 110.488 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.0 mt -98.58 112.38 62.34 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.697 -0.482 . . . . 73.11 109.697 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.85 138.96 17.17 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.599 2.2 . . . . 74.42 112.469 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 78.6 m-85 -136.61 163.69 29.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.692 0.282 . . . . 74.0 110.528 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 96.2 mt-30 -130.71 119.09 21.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.102 -0.499 . . . . 72.13 110.896 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.21 123.23 47.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.099 -0.334 . . . . 73.04 110.099 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.516 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 2.8 ptp180 -135.98 159.17 42.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.39 -0.368 . . . . 75.45 111.234 -176.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 59.8 m-85 -80.5 134.41 35.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.746 -0.661 . . . . 64.53 110.418 174.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -117.69 119.21 34.26 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.139 -0.689 . . . . 74.21 109.139 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 45' ' ' GLU . . . -83.6 130.29 34.98 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.023 -0.535 . . . . 72.55 110.661 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 69.3 p -101.32 -0.54 35.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.88 0.848 . . . . 75.33 108.763 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.21 -131.54 1.77 Allowed Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.28 -1.327 . . . . 73.22 110.594 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 144' ' ' THR . . . -88.66 98.72 11.84 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.749 -0.463 . . . . 72.04 109.749 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -47.47 113.01 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.896 0.747 . . . . 72.33 111.395 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.457 HG21 ' O ' ' A' ' 142' ' ' ALA . 41.3 p -104.06 146.34 32.37 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 116.012 -0.54 . . . . 71.33 110.585 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.27 173.36 5.25 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.6 2.866 . . . . 62.55 113.628 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 138.0 -147.47 19.25 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.675 -0.693 . . . . 74.52 111.857 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.84 117.08 32.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.22 -0.289 . . . . 71.1 110.22 175.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.437 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -115.48 59.65 0.71 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.95 0.405 . . . . 75.42 111.625 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -112.69 137.03 51.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.035 -0.728 . . . . 73.34 109.035 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.517 ' HB3' HD12 ' A' ' 86' ' ' LEU . . . -128.81 169.92 13.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.016 0.436 . . . . 62.31 111.756 -175.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -137.8 127.26 24.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.581 -0.736 . . . . 75.12 109.618 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.86 140.59 29.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.075 0.464 . . . . 74.02 111.774 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.1 p -110.28 126.11 53.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.595 . . . . 65.52 109.53 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -106.44 143.39 34.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.059 0.457 . . . . 64.42 110.834 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.571 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.9 ttmm -120.04 111.96 18.55 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.812 -0.631 . . . . 74.5 110.435 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.4 m -81.81 127.17 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.165 -0.68 . . . . 72.5 109.165 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -112.18 121.87 46.14 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.137 -0.483 . . . . 54.04 109.849 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.606 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.585 0 N-CA-C 111.841 0.311 . . . . 72.04 111.841 177.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.906 0.384 . . . . 74.44 110.092 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.547 HG23 HG13 ' A' ' 37' ' ' VAL . 28.1 m -92.64 15.79 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.004 0.43 . . . . 74.15 110.526 176.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 61.95 13.09 5.32 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.355 -0.839 . . . . 74.02 112.563 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.414 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 91.09 94.96 1.27 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.731 -0.747 . . . . 55.25 111.967 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.418 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -86.02 158.64 31.97 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.532 -0.842 . . . . 70.2 112.171 -177.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.505 ' HB ' HG22 ' A' ' 31' ' ' THR . 11.2 p -140.24 135.32 32.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.361 . . . . 64.45 111.102 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.454 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -108.11 125.47 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.423 -0.584 . . . . 74.33 109.423 173.347 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -96.81 111.03 23.39 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.068 0.461 . . . . 72.04 110.19 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.454 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 95.7 m-85 -101.07 122.9 44.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.886 -0.597 . . . . 74.35 110.47 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -108.08 138.43 44.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.449 -0.341 . . . . 70.12 110.535 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -109.3 -133.08 6.65 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.935 -0.65 . . . . 72.04 112.321 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 62.95 34.55 14.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.39 0.614 . . . . 73.13 110.897 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.607 HG22 ' HA ' ' A' ' 155' ' ' LYS . 25.3 m -93.76 -22.88 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.592 -0.731 . . . . 73.42 111.663 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.454 HG23 ' CG2' ' A' ' 156' ' ' VAL . 19.0 m -143.01 149.18 18.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.537 -0.301 . . . . 64.22 111.303 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -156.86 32.04 0.3 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.797 0.808 . . . . 65.22 109.346 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.89 -66.73 0.9 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.313 -0.858 . . . . 75.21 111.469 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.92 -41.03 7.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 61.44 110.804 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 1.8 m -135.63 128.88 31.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.153 -0.476 . . . . 71.55 110.075 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.5 127.84 39.33 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.022 -0.536 . . . . 73.41 110.007 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.58 131.26 31.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.338 -0.392 . . . . 74.15 110.217 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 28' ' ' VAL . 25.1 t70 -57.93 145.45 35.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.736 -0.666 . . . . 71.45 111.254 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.32 -30.72 70.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 65.12 111.775 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.66 -12.03 82.17 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.61 -0.805 . . . . 74.13 111.652 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 t -97.82 -24.38 15.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.453 0.168 . . . . 71.12 110.591 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 24' ' ' ASP . 20.7 m -80.44 -7.14 10.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.822 0.344 . . . . 74.01 110.597 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -154.85 88.95 1.21 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.813 -0.631 . . . . 54.21 109.681 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.86 115.57 10.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.638 0.732 . . . . 65.53 110.98 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.505 HG22 ' HB ' ' A' ' 9' ' ' THR . 3.9 m -98.38 97.63 8.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.027 -0.988 . . . . 72.52 109.067 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.69 127.94 39.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.128 0.49 . . . . 74.44 111.092 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -86.61 125.43 33.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.645 . . . . 65.02 109.976 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.4 HD23 ' CG2' ' A' ' 10' ' ' VAL . 2.7 mm? -87.54 -22.91 24.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.109 0.481 . . . . 72.52 110.032 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.414 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 93.41 173.32 40.1 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.581 -0.736 . . . . 53.42 112.095 -178.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.74 91.49 5.91 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.761 0.315 . . . . 72.11 110.701 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.547 HG13 HG23 ' A' ' 5' ' ' VAL . 7.2 p -78.06 146.07 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.171 -0.468 . . . . 75.2 109.824 176.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -87.07 132.15 33.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.02 -0.363 . . . . 73.51 110.02 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 53.2 p -68.33 -18.64 64.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.228 0.537 . . . . 72.12 111.129 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.44 -12.92 61.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 72.13 111.197 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.0 m -97.04 9.14 42.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.22 0.533 . . . . 65.01 110.426 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.573 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 6.0 mt -145.61 49.35 1.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.584 -0.734 . . . . 72.11 109.612 -174.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.23 6.06 41.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.529 0.937 . . . . 60.32 113.529 -168.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.27 155.34 22.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.488 -0.19 . . . . 70.53 110.488 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 33.1 tt0 -56.95 132.61 53.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 123.347 0.404 . . . . 60.11 110.371 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.84 -17.01 36.15 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.706 -0.759 . . . . 52.31 111.663 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.68 121.61 17.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.333 . . . . 75.2 110.302 176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.493 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 37.7 p -119.15 135.78 54.5 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.045 -0.525 . . . . 74.42 110.432 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.0 t -89.46 178.26 6.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.673 -0.491 . . . . 71.3 109.673 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -67.51 129.27 39.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.375 -0.375 . . . . 74.33 110.069 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -81.36 158.56 24.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.449 0.642 . . . . 73.44 111.316 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 27.7 m -101.22 147.34 8.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.824 -1.08 . . . . 73.22 109.124 171.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.92 86.39 0.58 Allowed Glycine 0 C--N 1.31 -0.911 0 C-N-CA 120.675 -0.774 . . . . 62.3 111.978 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -96.08 166.46 11.75 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.699 -0.482 . . . . 72.14 109.699 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.441 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 20.7 p-10 -125.45 139.37 53.7 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.407 0.622 . . . . 71.1 111.998 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.401 HD12 ' CD1' ' A' ' 154' ' ' PHE . 29.2 mt -109.74 107.05 21.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.562 -0.903 . . . . 74.15 108.562 167.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -100.59 135.51 41.91 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.715 -0.675 . . . . 73.22 111.322 -170.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.4 mt -112.12 132.58 54.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.504 -0.771 . . . . 73.11 109.527 175.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -109.07 145.49 35.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.419 -0.355 . . . . 74.43 110.058 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.11 48.71 20.39 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.616 0.722 . . . . 73.32 110.944 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 48.0 t -85.8 155.97 20.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.066 -0.97 . . . . 74.1 110.323 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' HA ' ' ND2' ' A' ' 126' ' ' ASN . 21.1 t70 -128.3 152.86 47.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.524 -0.307 . . . . 73.34 111.512 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.9 p -119.06 5.81 11.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 72.13 111.677 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -84.34 -34.99 23.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.091 0.472 . . . . 74.4 109.978 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 p -103.68 -21.36 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 74.15 111.196 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . . . -124.27 -175.53 3.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.269 -0.271 . . . . 72.23 110.269 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 20.4 m -146.26 -55.8 0.28 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.731 0.301 . . . . 74.0 111.629 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.468 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -135.97 143.81 45.06 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 109.881 -0.414 . . . . 74.44 109.881 -178.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HB2' HD22 ' A' ' 124' ' ' LEU . . . -106.09 127.48 53.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.135 0.493 . . . . 70.22 110.163 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.2 118.82 15.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.509 -0.769 . . . . 70.0 109.016 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.5 m -90.99 146.76 5.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.999 0.428 . . . . 74.11 110.54 -175.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.425 ' HB1' ' CD2' ' A' ' 118' ' ' PHE . . . -118.79 119.13 33.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.782 -0.645 . . . . 70.21 109.354 174.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 93.8 m-85 -84.67 130.88 34.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.993 0.425 . . . . 63.43 110.527 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.9 tp -125.91 123.59 38.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.664 -0.698 . . . . 74.11 109.935 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.5 -170.99 26.93 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.513 -0.635 . . . . 61.14 111.513 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.7 m -84.06 125.49 32.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.62 0.248 . . . . 74.22 110.631 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -87.72 138.98 30.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.591 -0.277 . . . . 73.1 110.515 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.8 tt -64.06 -31.95 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 74.45 111.224 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 80' ' ' ALA . 22.2 t70 -145.81 -178.19 5.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.268 -0.642 . . . . 72.33 109.268 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.429 ' H ' ' CG ' ' A' ' 79' ' ' ASP . . . -79.57 -42.52 24.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.692 0.282 . . . . 74.22 110.865 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.67 -16.77 74.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.58 -0.819 . . . . 75.34 111.951 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -105.12 51.3 0.76 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.13 0.491 . . . . 74.44 109.979 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.423 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 1.1 p -74.93 3.6 7.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.806 -0.634 . . . . 71.25 112.138 -178.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -104.79 -5.96 20.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.927 0.394 . . . . 75.31 110.671 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.05 120.12 58.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.175 -0.466 . . . . 75.45 110.628 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.502 HD13 ' HB1' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -67.51 129.78 40.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.93 -0.396 . . . . 74.31 109.93 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.49 141.62 39.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.27 -0.423 . . . . 74.32 110.605 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.579 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.8 mm? -82.38 140.32 33.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.074 -0.512 . . . . 71.03 110.027 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.37 0.605 . . . . 74.01 110.748 179.179 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.69 0.281 . . . . 64.02 110.571 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.94 125.45 27.61 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.785 -0.45 . . . . 71.34 109.785 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.07 166.46 16.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.35 -0.386 . . . . 75.35 110.243 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 68.88 9.96 7.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.253 0.549 . . . . 63.1 110.446 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.45 -174.47 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.279 -0.873 . . . . 65.52 109.685 173.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.49 -174.5 46.56 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.637 -0.985 . . . . 64.15 110.637 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 p -119.66 115.65 48.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.446 0.641 . . . . 75.14 110.841 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -107.1 142.22 37.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.489 -0.778 . . . . 74.43 109.642 175.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 103' ' ' ILE . 4.1 mp -103.12 123.78 56.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.032 -0.531 . . . . 73.23 110.3 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.462 HD12 ' NE ' ' A' ' 136' ' ' ARG . 12.7 mt -86.27 147.64 25.99 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.647 -0.706 . . . . 65.22 109.11 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.1 p-10 -74.1 -170.99 1.03 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.59 -0.522 . . . . 73.42 109.59 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -69.04 -25.53 64.52 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.975 -0.29 . . . . 73.01 111.554 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.43 ' HG1' ' CG ' ' A' ' 105' ' ' ASP . 82.1 p -84.69 -26.47 27.71 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 120.647 -0.421 . . . . 72.22 111.015 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.81 34.51 1.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 60.54 112.825 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -114.73 135.56 54.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.424 -0.213 . . . . 71.43 110.424 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.43 122.74 17.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 75.54 110.836 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.1 mt -88.88 135.84 33.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.367 -0.379 . . . . 75.04 110.614 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.2 m -83.7 145.44 28.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.025 -0.534 . . . . 73.1 110.556 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 52.7 mt -81.34 40.14 0.55 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 74.52 111.275 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -77.02 -22.64 52.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.432 -0.349 . . . . 65.3 111.092 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.17 -11.27 37.4 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.764 -0.731 . . . . 74.23 112.005 -172.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.41 2.56 9.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.178 0.513 . . . . 74.33 110.562 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.9 m -99.74 102.65 14.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.829 -0.623 . . . . 71.25 109.491 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.425 ' CD2' ' HB1' ' A' ' 72' ' ' ALA . 83.8 m-85 -93.81 167.24 11.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.746 -0.661 . . . . 70.3 111.771 -171.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.9 m -73.93 179.45 4.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.242 -0.89 . . . . 73.21 110.572 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.7 t -69.08 146.01 52.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.246 -0.649 . . . . 74.23 109.246 173.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -54.14 106.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.475 0.484 . . . . 73.31 111.544 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.5 m -91.16 103.76 16.4 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.076 -0.713 . . . . 73.42 109.076 173.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 m -55.41 124.36 16.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.789 -0.641 . . . . 75.33 111.099 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.497 HD21 ' SG ' ' A' ' 61' ' ' CYS . 83.7 mt -83.38 150.69 25.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.79 -0.641 . . . . 73.55 111.275 -176.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.449 HD21 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -129.34 152.29 49.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.174 -0.921 . . . . 74.25 108.747 171.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.8 m120 -65.53 118.39 9.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.996 0.427 . . . . 71.41 110.43 175.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 124.76 -137.88 10.78 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.817 -0.706 . . . . 72.42 112.167 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 20.5 m -88.61 127.81 35.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.411 . . . . 74.43 111.016 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -124.95 112.72 16.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.219 -0.446 . . . . 74.35 110.078 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.441 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 1.8 m -102.98 106.52 17.07 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.798 0.332 . . . . 74.33 110.527 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.7 mt -87.63 115.39 62.76 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.624 -0.51 . . . . 74.14 109.624 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -84.23 132.94 5.38 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.602 2.201 . . . . 64.33 112.841 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -131.9 159.55 38.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 71.12 110.462 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.67 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 99.2 mt-30 -127.97 112.88 15.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.246 -0.434 . . . . 73.13 111.487 -176.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.54 127.7 45.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.206 -0.452 . . . . 72.44 110.192 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.493 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 15.8 ptp180 -139.06 163.08 33.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.45 -0.341 . . . . 72.02 110.719 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 71.7 m-85 -81.57 142.5 32.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.97 -0.559 . . . . 63.4 110.715 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -130.43 119.79 23.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.639 -0.709 . . . . 74.42 109.421 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.617 ' O ' ' HA ' ' A' ' 45' ' ' GLU . . . -81.27 137.62 35.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.397 -0.365 . . . . 62.11 111.009 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.435 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 68.9 p -110.13 2.79 19.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.676 0.75 . . . . 64.4 109.349 176.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.22 -129.45 1.74 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.915 -1.039 . . . . 75.32 110.864 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.15 90.26 8.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.848 0.324 . . . . 74.31 110.283 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.64 114.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.491 0.495 . . . . 62.33 111.557 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 26.6 p -104.71 139.62 20.28 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-O 121.385 0.612 . . . . 75.24 110.613 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.59 162.77 41.32 Favored 'Trans proline' 0 C--N 1.333 -0.272 0 C-N-CA 123.799 3.0 . . . . 73.01 112.868 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.63 -162.88 26.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.732 -0.747 . . . . 54.25 111.817 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.84 113.65 8.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.866 0.365 . . . . 70.54 111.338 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.579 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -111.47 63.61 0.61 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.5 0.667 . . . . 75.33 110.357 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -117.48 128.46 55.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.818 . . . . 71.33 109.782 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.502 ' HB1' HD13 ' A' ' 86' ' ' LEU . . . -134.21 169.5 17.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.364 -0.38 . . . . 65.43 111.342 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.8 146.36 50.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 63.23 109.62 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.02 138.86 19.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.146 0.498 . . . . 65.14 111.291 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.6 p -107.2 121.81 45.27 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.794 -0.639 . . . . 64.43 109.771 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.401 ' CD1' HD12 ' A' ' 56' ' ' ILE . 52.7 p90 -102.61 137.19 41.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.367 -0.378 . . . . 75.12 110.528 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.607 ' HA ' HG22 ' A' ' 16' ' ' VAL . 3.9 tmmm? -119.78 113.08 20.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.344 -0.389 . . . . 75.44 110.345 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.2 m -77.57 137.28 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.773 -0.454 . . . . 70.52 109.773 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -115.2 123.56 49.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.393 -0.367 . . . . 71.03 110.172 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.601 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 3.1 p90 . . . . . 0 C--N 1.321 -0.672 0 CA-C-N 115.688 -0.687 . . . . 75.14 109.875 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.914 -0.402 . . . . 71.44 109.914 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.98 12.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.898 0.38 . . . . 72.33 110.922 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 61.86 17.89 9.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.58 -0.736 . . . . 75.44 111.872 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.4 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 83.0 95.53 0.56 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.598 -0.81 . . . . 54.25 111.396 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.543 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -77.78 157.39 45.47 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.174 -1.012 . . . . 63.23 111.895 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.466 ' HB ' HG22 ' A' ' 31' ' ' THR . 4.8 p -140.79 138.9 34.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.679 0.276 . . . . 64.22 111.077 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -115.48 120.44 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 116.441 -0.345 . . . . 54.14 110.071 176.025 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -91.09 107.37 19.16 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.165 -0.471 . . . . 65.51 110.08 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.11 125.11 40.42 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.02 -0.536 . . . . 72.52 110.545 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -112.33 133.81 54.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.994 -0.548 . . . . 73.23 111.165 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.07 -130.07 5.62 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.461 -0.79 . . . . 74.4 111.88 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.457 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 44.3 mt-10 62.91 24.13 14.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.123 0.487 . . . . 65.13 110.993 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.582 HG22 ' HA ' ' A' ' 155' ' ' LYS . 22.1 m -77.85 -34.44 19.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.823 -0.626 . . . . 72.43 111.273 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.554 HG21 HG23 ' A' ' 156' ' ' VAL . 17.9 m -142.89 150.28 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.014 0.435 . . . . 64.34 111.189 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -144.34 22.42 1.68 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.417 -0.81 . . . . 74.01 108.961 175.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.92 -82.99 0.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.491 -0.777 . . . . 54.42 111.255 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.459 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -81.34 -35.65 30.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.796 0.332 . . . . 73.34 110.278 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 m -142.54 135.4 28.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.887 0.375 . . . . 64.54 110.023 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.04 123.97 40.92 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.102 -0.499 . . . . 64.3 109.861 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.455 ' HA ' HD22 ' A' ' 58' ' ' LEU . 14.2 t -61.03 131.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 109.722 -0.473 . . . . 73.41 109.722 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 28' ' ' VAL . 27.7 t70 -59.86 140.07 56.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.107 -0.497 . . . . 65.45 111.335 -176.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.13 -27.34 65.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.793 -0.64 . . . . 71.42 111.819 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.86 7.47 79.94 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.717 -0.754 . . . . 74.31 112.282 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.3 p -129.54 -10.96 4.52 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 122.712 -0.287 . . . . 72.55 111.387 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.457 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 29.2 m -78.24 -5.81 8.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 121.109 0.48 . . . . 74.11 110.505 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -157.2 96.14 1.54 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.446 -0.797 . . . . 73.25 109.015 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -143.64 121.8 12.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.212 0.53 . . . . 73.2 110.546 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 16.4 m -106.83 103.19 12.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.406 -0.815 . . . . 73.03 109.542 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 9' ' ' THR . 11.0 p -89.34 137.41 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.919 0.39 . . . . 73.32 110.97 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -91.05 128.7 36.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.767 -0.651 . . . . 74.44 109.574 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.16 -19.92 24.88 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.103 0.478 . . . . 72.42 110.265 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.4 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.6 165.03 35.9 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.868 -0.682 . . . . 71.34 112.082 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -75.18 96.44 3.29 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.055 -0.35 . . . . 62.13 110.055 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 p -80.05 149.34 5.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.152 -0.476 . . . . 74.43 110.274 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.0 mtt85 -83.29 128.68 34.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.996 -0.547 . . . . 74.43 109.864 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 6.6 p -77.78 -13.52 59.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.929 -0.578 . . . . 74.52 111.944 -172.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.14 50.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 75.11 110.915 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.464 ' HB2' HD11 ' A' ' 42' ' ' LEU . 5.5 m -67.42 -29.34 68.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.325 0.583 . . . . 45.04 110.472 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.5 mp -112.77 86.81 2.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.494 -0.775 . . . . 72.31 109.996 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.0 14.58 12.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.127 0.489 . . . . 72.43 111.122 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HG2' ' HB1' ' A' ' 47' ' ' ALA . 3.2 pm0 -141.5 135.91 30.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.052 -0.522 . . . . 75.15 110.324 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.5 tm-20 -59.32 119.97 8.41 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.563 -0.532 . . . . 73.44 109.563 175.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.512 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 109.9 -6.29 30.99 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.738 -0.744 . . . . 71.45 111.752 -175.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.466 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . . . -65.8 135.31 54.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 75.11 111.005 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.1 p -120.97 140.82 51.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.055 -0.521 . . . . 63.55 110.355 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -104.34 -175.79 2.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.216 -0.447 . . . . 75.1 109.814 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.7 m -75.05 133.51 41.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.459 -0.337 . . . . 60.14 110.19 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -89.92 154.81 19.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.496 0.665 . . . . 74.33 112.021 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 31.5 m -92.82 156.65 3.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.646 -1.161 . . . . 65.24 109.22 169.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 101.65 1.22 Allowed Glycine 0 C--N 1.315 -0.587 0 C-N-CA 120.859 -0.686 . . . . 73.05 112.267 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -111.04 176.59 4.96 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.752 -0.462 . . . . 75.54 109.752 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.516 ' HB2' HG21 ' A' ' 130' ' ' THR . 3.5 p-10 -136.24 149.51 48.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.403 0.621 . . . . 75.12 111.904 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.42 HD12 ' CE2' ' A' ' 133' ' ' PHE . 72.6 mt -113.93 113.86 45.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.11 -0.95 . . . . 73.32 108.684 169.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -96.83 140.33 31.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.101 -0.499 . . . . 72.43 110.951 -172.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 23' ' ' VAL . 64.5 mt -120.63 122.35 40.33 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.951 -0.568 . . . . 73.45 109.565 177.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -99.39 143.79 29.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.075 -0.511 . . . . 74.31 110.034 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 56.82 44.02 24.05 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.779 0.674 . . . . 75.35 110.845 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.578 ' SG ' HD22 ' A' ' 124' ' ' LEU . 6.0 t -75.24 142.04 43.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.109 -0.496 . . . . 74.42 110.31 -175.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -117.71 142.36 47.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.944 -0.571 . . . . 63.52 112.044 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.4 p -113.28 4.51 16.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.79 -0.641 . . . . 75.03 111.398 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -76.0 -38.1 57.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.975 0.417 . . . . 74.24 110.085 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 p -107.86 -18.96 7.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.107 -0.497 . . . . 75.02 111.381 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -126.47 161.75 27.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.741 0.305 . . . . 75.32 111.52 -176.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 15.0 m -120.18 -55.74 2.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.203 -0.453 . . . . 72.44 111.462 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -136.53 148.87 47.83 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.81 -0.441 . . . . 71.42 109.81 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.494 ' HB2' HD23 ' A' ' 124' ' ' LEU . . . -103.48 140.6 37.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.039 0.447 . . . . 63.53 110.308 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.57 114.17 6.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.6 -0.727 . . . . 72.31 109.067 176.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.3 m -88.13 145.64 7.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.971 0.415 . . . . 75.1 110.834 -173.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.529 ' HB1' ' CD1' ' A' ' 118' ' ' PHE . . . -119.97 123.28 43.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.807 -0.633 . . . . 71.42 109.74 173.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.441 ' CZ ' HG22 ' A' ' 103' ' ' ILE . 57.4 m-85 -86.34 142.52 28.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.2 0.524 . . . . 74.33 111.096 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.6 tp -134.18 123.15 23.87 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.487 -0.778 . . . . 64.21 109.963 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.64 -177.05 36.95 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.767 -0.933 . . . . 62.23 110.767 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.9 m -77.41 121.73 24.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.954 0.377 . . . . 70.43 110.828 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.28 138.68 39.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 75.41 110.529 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.5 tt -69.14 -30.84 47.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 74.13 111.133 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -146.32 178.67 8.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.995 -0.372 . . . . 71.34 109.995 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.71 -30.77 28.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.074 0.464 . . . . 71.34 110.106 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.5 -25.85 31.91 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.726 -0.749 . . . . 54.32 111.539 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.421 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 67.1 m80 -103.5 72.64 1.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.302 0.572 . . . . 74.54 110.046 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 p -92.1 5.43 50.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.547 -0.751 . . . . 72.42 111.853 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -112.43 2.53 16.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 72.52 110.624 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 102' ' ' GLN . 57.6 t -111.01 122.85 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.861 -0.608 . . . . 74.23 110.095 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -69.88 131.38 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.674 0.274 . . . . 74.15 110.275 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.43 145.72 36.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 74.32 110.441 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.64 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -85.16 135.42 33.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.126 -0.488 . . . . 73.25 109.943 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 72.44 110.099 -179.669 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.684 -0.488 . . . . 64.35 109.684 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.72 106.48 1.51 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.048 0.452 . . . . 62.21 110.319 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.36 159.31 15.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.143 -0.481 . . . . 74.01 110.574 -176.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.473 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 48.1 m-80 67.01 13.05 9.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.333 0.653 . . . . 54.51 111.17 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.48 167.62 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 CA-C-N 116.271 -0.422 . . . . 75.12 110.336 175.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.511 ' HA2' HD22 ' A' ' 88' ' ' LEU . . . -169.08 -173.8 37.07 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.221 -1.152 . . . . 52.03 110.221 176.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.78 115.26 47.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.363 0.601 . . . . 65.41 110.647 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.493 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.2 pt20 -100.49 139.77 35.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.771 -0.65 . . . . 63.35 109.365 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.441 HG22 ' CZ ' ' A' ' 73' ' ' PHE . 4.2 mp -96.36 129.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.955 0.407 . . . . 75.45 110.295 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.526 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 49.0 mt -96.91 141.6 29.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.705 -0.679 . . . . 64.54 109.925 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.58 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.69 -173.05 1.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.131 -0.486 . . . . 75.12 110.033 177.272 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.429 ' HG3' HG21 ' A' ' 107' ' ' THR . 13.7 ptm180 -57.83 -25.28 60.44 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.276 0.473 . . . . 71.23 112.276 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.429 HG21 ' HG3' ' A' ' 106' ' ' ARG . 74.5 p -100.04 1.7 42.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 73.51 111.762 -177.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.526 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 83.32 38.09 11.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.642 -0.79 . . . . 71.14 112.713 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.52 136.13 51.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.228 -0.286 . . . . 74.43 110.228 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.91 120.74 14.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.328 -0.396 . . . . 63.22 111.013 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 105' ' ' ASP . 95.1 mt -88.21 129.94 35.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.064 -0.516 . . . . 74.31 110.617 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.8 m -76.43 137.6 39.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.903 -0.589 . . . . 73.45 110.954 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.459 ' CD1' HD21 ' A' ' 86' ' ' LEU . 37.5 mt -79.56 47.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 74.14 110.98 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -100.11 -14.34 18.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.878 -0.601 . . . . 74.21 110.367 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.4 -13.48 33.86 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.745 -0.74 . . . . 62.23 112.525 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.61 4.83 15.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.943 0.401 . . . . 62.13 111.12 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.2 m -100.5 99.65 10.28 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.555 -0.535 . . . . 65.33 109.555 176.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.529 ' CD1' ' HB1' ' A' ' 72' ' ' ALA . 64.1 m-85 -94.26 164.11 13.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.089 -0.505 . . . . 74.45 111.487 -172.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.58 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 8.3 m -72.94 -178.56 2.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.45 -0.795 . . . . 61.42 111.459 177.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 m -69.05 160.95 30.03 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.915 -0.584 . . . . 74.23 109.521 170.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.66 125.96 25.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 74.44 110.944 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.411 HG22 HG12 ' A' ' 131' ' ' ILE . 20.1 m -109.23 98.72 8.1 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.38 -0.97 . . . . 73.11 108.38 168.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.4 m -57.22 116.58 3.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 73.22 111.078 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.578 HD22 ' SG ' ' A' ' 61' ' ' CYS . 76.3 mt -74.83 150.17 39.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.307 -0.86 . . . . 73.55 111.522 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -128.12 150.42 49.98 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.259 -0.882 . . . . 74.02 108.83 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -65.31 109.96 2.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.802 0.334 . . . . 71.53 110.354 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.4 -139.2 10.86 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.637 -0.792 . . . . 63.24 112.517 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 m -86.31 117.79 25.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.942 0.401 . . . . 71.33 111.061 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.515 ' N ' HD21 ' A' ' 129' ' ' ASN . 0.8 OUTLIER -112.16 148.62 33.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.508 -0.552 . . . . 70.41 109.508 178.198 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.516 HG21 ' HB2' ' A' ' 55' ' ' ASN . 1.2 m -138.01 113.65 9.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.265 -0.272 . . . . 74.32 110.265 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 10.2 mt -94.46 119.71 66.03 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.982 -0.377 . . . . 72.4 109.982 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 4.9 Cg_endo -84.14 133.31 5.59 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.971 2.447 . . . . 74.11 112.514 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 70.7 m-85 -135.63 163.44 30.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.296 -0.411 . . . . 73.32 110.691 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 90.0 mt-30 -126.71 148.87 49.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.016 -0.538 . . . . 75.15 110.66 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.24 122.52 26.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.182 -0.463 . . . . 62.42 110.335 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 2.1 ptp180 -134.1 164.96 26.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.458 -0.337 . . . . 75.01 110.633 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.543 ' HH ' ' HA3' ' A' ' 8' ' ' GLY . 69.6 m-85 -83.98 143.07 30.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.116 -0.493 . . . . 72.22 110.555 175.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.512 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 57.2 t80 -130.17 125.94 36.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.894 -0.78 . . . . 73.23 108.894 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -89.73 135.18 33.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.017 0.437 . . . . 72.31 111.435 -177.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.534 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 72.2 p -102.53 9.91 39.18 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.756 -0.831 . . . . 60.13 108.756 175.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.09 -123.75 1.2 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.833 -1.076 . . . . 37.15 111.111 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.27 96.65 10.41 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.784 -0.45 . . . . 65.43 109.784 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.93 112.19 0.44 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.699 0.624 . . . . 72.4 111.164 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.7 p -105.12 139.57 20.25 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 115.947 -0.57 . . . . 72.52 109.944 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.83 157.41 58.38 Favored 'Trans proline' 0 C--N 1.328 -0.503 0 C-N-CA 123.417 2.745 . . . . 75.01 113.153 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.33 -165.2 29.43 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.598 -0.728 . . . . 62.24 112.11 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.18 114.57 11.51 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.796 0.331 . . . . 74.42 111.086 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.64 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -109.08 69.96 0.72 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.213 0.53 . . . . 72.34 110.361 176.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.45 ' N ' HD21 ' A' ' 149' ' ' ASN . 0.9 OUTLIER -110.34 123.63 50.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.567 -0.531 . . . . 75.14 109.567 179.25 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.496 ' HB2' HD13 ' A' ' 86' ' ' LEU . . . -132.38 158.81 40.99 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.841 0.353 . . . . 75.0 111.036 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.41 143.84 39.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.252 -0.431 . . . . 74.22 110.15 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.443 ' HB3' HD22 ' A' ' 86' ' ' LEU . . . -153.84 157.94 40.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.976 0.417 . . . . 73.12 111.358 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.3 p -109.49 155.12 21.73 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.723 -0.672 . . . . 71.22 109.412 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -127.6 123.22 35.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.092 0.472 . . . . 70.03 110.679 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.582 ' HA ' HG22 ' A' ' 16' ' ' VAL . 9.2 ttmt -102.6 105.63 16.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.095 -0.502 . . . . 72.14 110.359 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.554 HG23 HG21 ' A' ' 17' ' ' VAL . 1.3 m -76.61 128.85 37.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.507 -0.553 . . . . 65.21 109.507 177.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -107.5 129.9 54.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.227 -0.442 . . . . 74.41 110.087 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.595 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.18 -0.464 . . . . 75.0 110.836 174.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.0 p . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 110.203 -0.295 . . . . 74.44 110.203 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.483 HG21 HG11 ' A' ' 37' ' ' VAL . 35.2 m -91.65 17.39 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.137 0.494 . . . . 73.53 110.662 176.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 61.97 11.85 4.49 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.202 -0.908 . . . . 73.43 112.515 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 35' ' ' GLY . . . 82.97 95.53 0.56 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.43 -0.89 . . . . 52.34 111.566 -176.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.19 160.91 33.88 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.198 -1.001 . . . . 74.42 111.305 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.572 ' HB ' HG22 ' A' ' 31' ' ' THR . 65.8 p -138.88 140.6 38.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.684 0.278 . . . . 73.25 110.439 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.96 122.27 63.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.194 -0.669 . . . . 74.33 109.194 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -90.47 109.69 20.82 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.322 -0.621 . . . . 74.44 109.322 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -97.52 124.05 41.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.899 -0.591 . . . . 74.33 110.173 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -106.51 135.13 48.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.951 -0.568 . . . . 74.13 110.816 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.26 -137.72 6.61 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 121.098 -0.573 . . . . 74.41 112.534 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 59.34 27.44 16.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.362 0.601 . . . . 74.24 110.774 -177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.677 HG23 HG21 ' A' ' 17' ' ' VAL . 22.8 m -80.29 -21.93 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.48 -0.782 . . . . 71.34 110.672 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 156' ' ' VAL . 3.5 m -148.46 139.27 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.737 -0.665 . . . . 73.1 110.865 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -139.02 26.3 2.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.02 -0.536 . . . . 75.04 109.637 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.09 -86.97 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.28 0.474 . . . . 74.15 112.28 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.462 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -76.4 -16.79 59.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 72.31 111.08 -178.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 59.7 m -150.87 157.16 42.57 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.425 -0.954 . . . . 62.4 108.425 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.55 116.22 26.19 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.491 -0.559 . . . . 71.34 109.491 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.65 134.04 23.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.378 -0.373 . . . . 64.45 110.113 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 28' ' ' VAL . 16.8 t70 -63.56 142.94 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.503 -0.317 . . . . 64.22 110.923 -177.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.464 ' HA ' HG21 ' A' ' 28' ' ' VAL . . . -59.43 -27.52 66.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 52.43 112.261 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.24 -21.38 78.0 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.508 -0.853 . . . . 73.35 112.095 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 p -104.73 -12.41 16.36 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.062 0.393 . . . . 74.31 112.062 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.464 HG21 ' HA ' ' A' ' 25' ' ' ALA . 31.4 m -80.58 -5.32 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.894 0.378 . . . . 75.35 110.708 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -163.29 89.78 0.63 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.277 -0.638 . . . . 74.15 109.277 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -141.78 132.33 25.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.039 -0.528 . . . . 74.3 110.591 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.572 HG22 ' HB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -107.72 99.29 8.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.757 -0.656 . . . . 62.13 109.286 178.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.6 p -82.32 126.87 40.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.108 0.48 . . . . 74.44 111.252 -175.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.524 ' HA ' HG21 ' A' ' 9' ' ' THR . 25.7 mp0 -84.66 120.7 26.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 74.41 109.706 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.74 -28.83 36.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.058 -0.519 . . . . 73.22 110.183 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.49 ' O ' ' HA2' ' A' ' 7' ' ' GLY . . . 106.38 170.96 22.98 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.765 -0.652 . . . . 62.31 111.911 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -83.93 83.6 7.88 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.893 -0.41 . . . . 64.34 109.893 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 5' ' ' VAL . 9.7 p -67.8 143.04 15.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.018 0.437 . . . . 75.12 110.65 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -77.73 115.51 17.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.818 -0.628 . . . . 63.14 109.795 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.7 p -61.45 -32.04 72.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.274 -0.421 . . . . 75.25 111.318 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.22 -24.34 66.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.515 . . . . 74.24 111.791 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.1 m -76.22 -23.46 54.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.814 0.34 . . . . 74.42 110.939 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.551 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 5.4 mp -114.17 92.03 3.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.094 0.473 . . . . 71.44 110.225 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.36 19.26 8.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.004 0.431 . . . . 73.25 111.245 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -149.73 138.34 20.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.942 -0.572 . . . . 74.23 110.52 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.491 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.6 tm-20 -55.79 124.02 16.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 54.34 109.61 175.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.0 -3.93 38.58 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.961 -0.637 . . . . 61.5 111.962 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -67.42 123.1 19.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.772 0.32 . . . . 74.31 110.554 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.796 ' HB ' HH11 ' A' ' 136' ' ' ARG . 22.9 p -112.72 121.42 44.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.914 -0.585 . . . . 73.14 111.024 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 137' ' ' TYR . 60.7 m -73.81 157.48 36.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.177 -0.465 . . . . 74.25 110.458 175.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.4 m -60.66 127.93 34.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.751 -0.463 . . . . 65.22 109.751 175.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.11 154.95 28.96 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.479 0.656 . . . . 74.42 111.749 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 33.1 m -95.58 147.86 5.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 114.859 -1.064 . . . . 72.1 109.451 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.88 103.06 2.35 Favored Glycine 0 C--N 1.309 -0.964 0 C-N-CA 120.899 -0.667 . . . . 37.68 111.858 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -113.82 179.92 3.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.627 -0.509 . . . . 74.32 109.627 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.485 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 3.9 p-10 -138.34 149.94 46.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.424 0.631 . . . . 54.41 112.308 -173.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.45 HD11 ' CE2' ' A' ' 133' ' ' PHE . 81.1 mt -121.42 113.7 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.932 -1.031 . . . . 75.43 108.484 168.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 29.8 tt0 -99.07 136.9 38.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 65.43 111.181 -172.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.04 129.94 56.04 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.825 -0.625 . . . . 74.14 109.811 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -102.87 136.52 42.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.915 -0.584 . . . . 63.43 110.535 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 54.49 75.88 0.27 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 124.008 0.818 . . . . 74.4 112.055 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.6 m -97.55 138.81 34.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.652 -0.704 . . . . 37.68 111.18 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -112.57 137.63 50.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.727 -0.67 . . . . 63.51 110.638 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 p -102.25 6.2 40.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.099 -0.5 . . . . 75.41 111.94 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -90.27 -31.12 17.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.663 -0.495 . . . . 63.54 109.663 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 p -98.27 -22.18 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.733 -0.667 . . . . 72.55 111.337 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . . . -141.58 168.42 19.82 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.028 -0.42 . . . . 74.31 111.029 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 36.9 m -125.7 -51.7 1.59 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.216 0.451 . . . . 75.14 112.216 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -132.99 150.46 52.16 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.086 -0.383 . . . . 72.32 110.518 -177.028 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.69 130.42 55.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.916 0.389 . . . . 71.34 109.984 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.34 114.84 8.89 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.585 -0.524 . . . . 73.43 109.585 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.5 m -84.2 145.84 7.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 63.01 111.028 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -117.63 116.92 28.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.498 -0.774 . . . . 51.41 109.806 174.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -85.54 130.12 34.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.325 0.583 . . . . 64.53 110.979 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.9 tp -128.9 116.02 18.77 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.33 -0.85 . . . . 74.21 109.951 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.34 -171.54 20.04 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.201 -0.76 . . . . 62.01 111.201 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.7 m -85.58 116.14 23.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.864 0.332 . . . . 74.23 110.177 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.05 147.68 36.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.45 -0.341 . . . . 74.43 110.845 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.417 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 9.3 tt -63.52 -30.22 49.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.998 -0.546 . . . . 74.42 110.643 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.82 -178.56 5.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 73.11 109.584 174.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.74 -10.23 59.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.038 0.385 . . . . 74.23 112.038 -174.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.53 -44.05 3.27 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.978 -0.629 . . . . 63.13 111.607 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.409 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 60.7 m80 -97.1 61.15 1.74 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.576 0.703 . . . . 74.43 109.373 177.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -76.69 5.46 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.106 -0.952 . . . . 74.15 112.266 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -106.07 -4.82 19.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.478 . . . . 61.5 110.349 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.26 127.77 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.613 . . . . 75.11 110.448 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -72.25 134.54 45.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.755 -0.461 . . . . 73.4 109.755 178.382 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.417 ' HB3' ' HA ' ' A' ' 78' ' ' ILE . . . -78.14 149.72 33.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.175 -0.466 . . . . 74.13 110.061 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.438 ' N ' HD23 ' A' ' 88' ' ' LEU . 2.5 mm? -82.04 133.19 35.27 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.222 -0.444 . . . . 75.04 110.374 -176.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.831 -0.622 . . . . 64.15 110.834 -179.288 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 120.749 0.309 . . . . 71.11 110.696 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.33 109.01 2.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 74.13 110.502 -175.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.37 160.68 14.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.154 -0.475 . . . . 71.14 110.974 -174.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 72.02 9.26 6.06 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.8 -0.636 . . . . 62.52 110.743 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.94 -172.37 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.852 -0.613 . . . . 63.41 110.459 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.31 -176.95 46.66 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.552 -1.019 . . . . 71.21 110.552 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.54 113.35 40.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.361 0.6 . . . . 64.34 110.648 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -102.29 137.58 40.36 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.223 -0.658 . . . . 75.13 109.223 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.5 mp -100.42 120.35 49.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.054 0.454 . . . . 71.11 110.349 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.424 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 24.9 mt -86.1 145.86 26.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.686 -0.688 . . . . 74.21 109.225 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.542 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.2 OUTLIER -74.68 -171.93 1.4 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.242 -0.436 . . . . 73.14 109.914 177.569 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 106' ' ' ARG . 19.0 ptt85 -58.49 -27.33 64.35 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.727 0.269 . . . . 71.44 111.727 -177.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.0 p -100.45 7.96 43.87 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.877 0.37 . . . . 64.32 111.838 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 83.71 28.09 36.44 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 37.68 113.099 175.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.23 120.12 39.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.222 -0.288 . . . . 74.23 110.222 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 115.81 4.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.898 0.38 . . . . 74.52 110.518 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.7 mt -83.71 132.56 34.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.328 -0.396 . . . . 73.34 111.129 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.6 m -73.05 140.45 47.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.723 -0.672 . . . . 74.22 110.547 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.404 ' CD1' HD21 ' A' ' 86' ' ' LEU . 74.2 mt -78.74 49.25 0.88 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.329 0.585 . . . . 74.35 110.504 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -85.67 -27.58 25.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.49 -0.777 . . . . 74.21 109.983 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.34 -22.47 32.39 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.627 -0.715 . . . . 41.12 111.539 -172.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.21 14.63 14.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.757 0.313 . . . . 53.53 111.119 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.6 m -95.24 105.25 17.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.47 -0.567 . . . . 74.35 109.47 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 72' ' ' ALA . 86.5 m-85 -97.41 156.29 16.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.225 0.536 . . . . 74.41 111.473 -173.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 7.3 m -68.92 -178.83 1.3 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.392 -0.822 . . . . 72.42 111.143 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.3 t -69.36 156.69 38.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.883 -0.784 . . . . 73.24 108.883 170.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.542 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 51.7 mt-10 -66.06 109.14 2.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.729 0.299 . . . . 72.34 111.476 -175.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.414 ' OG1' ' HD3' ' A' ' 106' ' ' ARG . 22.7 m -89.08 96.82 10.88 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.644 -0.873 . . . . 63.03 108.644 171.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.6 m -60.07 122.05 13.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.911 -0.586 . . . . 74.1 110.903 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.8 mt -81.87 150.45 27.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.423 -0.808 . . . . 74.11 111.16 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -130.68 161.46 31.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.227 -0.657 . . . . 72.15 109.227 169.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -60.35 112.74 2.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 74.02 110.973 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.47 -141.45 13.0 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.766 -0.731 . . . . 71.22 112.595 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.0 m -82.1 131.56 35.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.791 0.329 . . . . 74.2 111.233 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -130.82 114.47 15.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.158 -0.474 . . . . 75.33 109.873 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.485 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 4.7 m -107.04 117.81 35.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.827 0.346 . . . . 61.44 110.267 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.4 mt -94.39 116.8 66.82 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.988 -0.551 . . . . 74.41 110.174 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.59 138.13 10.59 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.033 2.489 . . . . 64.41 111.958 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.45 ' CE2' HD11 ' A' ' 56' ' ' ILE . 74.0 m-85 -135.35 161.77 34.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.365 -0.379 . . . . 72.04 110.53 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.668 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 43.0 mt-30 -127.91 114.65 17.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 74.3 110.802 -175.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.43 132.38 49.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.68 -0.237 . . . . 71.32 110.55 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.796 HH11 ' HB ' ' A' ' 48' ' ' THR . 12.4 ptp180 -143.1 160.07 41.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.967 0.413 . . . . 75.34 111.206 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 73.3 m-85 -80.32 145.83 31.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.776 -0.647 . . . . 74.22 110.553 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.409 ' HE2' ' CD2' ' A' ' 82' ' ' HIS . 64.4 t80 -131.88 118.45 19.84 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.845 -0.616 . . . . 71.34 109.661 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 42' ' ' LEU . . . -86.97 132.66 33.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.299 -0.41 . . . . 75.51 111.235 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.491 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 66.0 p -99.14 5.08 47.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.679 0.752 . . . . 74.41 109.424 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 173.14 -117.78 0.67 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.647 -1.16 . . . . 45.32 110.744 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -94.72 98.47 10.8 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.927 -0.397 . . . . 75.31 109.927 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -50.54 123.71 9.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.018 -0.537 . . . . 60.43 110.807 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 39.9 p -116.02 147.62 39.65 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.125 0.488 . . . . 73.32 110.686 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -64.31 163.18 27.35 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.668 2.912 . . . . 73.25 112.553 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.59 -164.43 27.39 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.645 -0.788 . . . . 61.22 112.065 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -85.35 115.1 22.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.65 0.262 . . . . 70.3 110.459 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -108.48 55.15 0.64 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.138 0.494 . . . . 64.42 111.323 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -105.13 138.98 40.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.062 -0.517 . . . . 73.33 109.895 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.496 ' HB2' HD13 ' A' ' 86' ' ' LEU . . . -140.63 179.69 6.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.932 0.396 . . . . 72.25 111.773 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -143.95 137.1 27.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.621 -0.718 . . . . 75.41 109.71 -178.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.36 139.84 21.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.892 0.377 . . . . 72.22 111.271 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 30.5 p -103.71 132.28 50.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.195 -0.457 . . . . 61.14 109.899 176.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -107.39 124.05 49.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.104 0.478 . . . . 63.2 110.391 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.586 ' HA ' HG22 ' A' ' 16' ' ' VAL . 3.0 tmmm? -105.62 99.39 8.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.921 -0.581 . . . . 75.24 109.492 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.754 HG23 HG22 ' A' ' 17' ' ' VAL . 1.4 m -74.84 127.96 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.64 0.733 . . . . 73.42 110.178 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -103.67 108.61 19.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.525 -0.761 . . . . 73.44 111.009 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 2.5 p90 . . . . . 0 C--N 1.319 -0.735 0 N-CA-C 109.017 -0.734 . . . . 73.02 109.017 166.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 120.51 0.195 . . . . 73.33 110.513 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.73 174.57 3.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.42 . . . . 62.35 110.921 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.7 t -98.68 -4.76 33.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.935 0.398 . . . . 75.53 111.123 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.407 ' CB ' ' HB3' ' A' ' 36' ' ' GLN . 80.4 p -116.97 173.01 6.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.927 0.394 . . . . 74.22 110.682 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG23 HG11 ' A' ' 37' ' ' VAL . 27.7 m -86.86 16.65 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.05 0.452 . . . . 75.53 111.083 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 61.93 13.12 5.32 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.566 -0.743 . . . . 71.11 112.211 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.47 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 91.14 101.26 1.25 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.558 -0.829 . . . . 73.21 111.785 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.423 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -92.65 160.19 25.29 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.431 -0.89 . . . . 71.34 111.777 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.511 HG21 ' HA ' ' A' ' 33' ' ' GLN . 66.4 p -143.3 149.17 37.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.883 0.373 . . . . 72.02 110.637 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.489 HG21 HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -123.67 117.86 52.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.997 -0.547 . . . . 74.55 110.503 175.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -95.72 112.51 24.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.399 -0.818 . . . . 61.0 110.118 -177.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 59.4 m-85 -94.39 137.29 33.72 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.812 -0.631 . . . . 65.23 110.562 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.76 ' HZ2' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -114.58 137.62 51.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.973 -0.558 . . . . 75.04 110.301 -179.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.21 -133.41 4.06 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.759 -0.734 . . . . 72.22 112.504 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 49.2 mt-10 60.65 21.27 11.19 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.212 0.53 . . . . 62.1 111.115 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 155' ' ' LYS . 24.8 m -76.32 -23.81 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.748 -0.66 . . . . 75.11 111.132 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.428 HG21 ' CG2' ' A' ' 156' ' ' VAL . 24.1 m -135.71 148.28 28.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.126 -0.488 . . . . 63.14 111.361 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -151.31 26.73 0.68 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.502 -0.925 . . . . 54.42 108.502 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.36 -79.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.115 -0.948 . . . . 54.21 111.408 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -84.73 -37.53 20.77 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.859 0.361 . . . . 72.45 110.858 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -140.7 132.46 27.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.141 -0.481 . . . . 74.04 109.873 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.58 123.21 37.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.254 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 t -66.44 133.33 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.862 -0.422 . . . . 71.24 109.862 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 28' ' ' VAL . 19.2 t70 -62.05 147.96 45.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 72.22 111.043 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -62.25 -25.39 67.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 74.55 111.783 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 30' ' ' GLN . . . -86.13 -9.76 76.18 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.589 -0.815 . . . . 71.35 111.627 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.0 m -105.23 -23.25 12.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.465 0.174 . . . . 40.34 111.124 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 25.5 m -77.56 -12.18 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.335 0.588 . . . . 74.25 110.215 176.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -153.58 96.01 1.97 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.964 -1.016 . . . . 71.43 109.217 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.457 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 24.9 pt20 -148.34 142.81 26.38 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.01 -0.541 . . . . 74.54 110.421 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.497 HG22 ' HB ' ' A' ' 9' ' ' THR . 6.9 m -124.0 101.3 7.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.628 -0.714 . . . . 72.45 109.649 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.18 129.22 39.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.088 0.47 . . . . 75.45 110.407 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.511 ' HA ' HG21 ' A' ' 9' ' ' THR . 26.2 mp0 -85.63 130.57 34.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.698 -0.683 . . . . 70.22 110.245 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.489 HD21 HG21 ' A' ' 10' ' ' VAL . 2.3 mm? -91.27 -17.08 26.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.152 -0.476 . . . . 73.22 110.109 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.47 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 86.58 174.87 49.47 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.939 -0.648 . . . . 72.14 112.476 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.407 ' HB3' ' CB ' ' A' ' 4' ' ' THR . 81.2 mt-30 -77.36 89.11 3.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.137 -0.32 . . . . 74.25 110.137 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.471 HG11 HG23 ' A' ' 5' ' ' VAL . 9.9 p -68.49 144.67 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.804 -0.443 . . . . 73.44 109.804 176.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 38' ' ' ARG . 44.3 mtp180 -85.31 123.75 31.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.899 -0.408 . . . . 73.02 109.899 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.587 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 35.6 p -68.7 -23.22 64.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.169 -0.469 . . . . 65.54 111.456 -176.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.98 -15.71 61.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 72.15 111.066 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -87.92 -12.7 43.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.398 . . . . 75.21 110.731 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.591 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -129.02 84.75 2.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.225 -0.443 . . . . 74.14 110.089 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.37 19.58 12.71 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.704 -0.399 . . . . 42.41 111.849 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -150.04 140.21 22.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.702 0.287 . . . . 71.22 110.774 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 3.9 tm-20 -56.12 117.96 4.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.714 -0.676 . . . . 72.53 109.478 174.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.35 -1.09 31.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.756 -0.735 . . . . 52.21 112.345 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.15 134.4 42.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 73.54 110.708 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.2 p -119.7 145.83 46.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.21 -0.45 . . . . 74.32 110.934 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 t -110.23 -179.23 3.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.307 -0.406 . . . . 74.24 110.08 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.8 m -70.57 140.74 51.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.346 -0.388 . . . . 71.12 110.255 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -95.58 155.79 16.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.455 0.645 . . . . 73.41 111.936 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.7 m -95.61 152.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.485 -1.234 . . . . 73.42 109.265 170.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.23 79.63 0.26 Allowed Glycine 0 C--N 1.312 -0.793 0 C-N-CA 120.795 -0.717 . . . . 37.35 112.315 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 133' ' ' PHE . 41.8 p90 -87.83 162.48 16.95 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.807 -0.442 . . . . 75.24 109.807 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.487 ' HB2' HG21 ' A' ' 130' ' ' THR . 3.8 p-10 -132.05 142.55 49.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.258 0.551 . . . . 64.12 111.733 -174.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.5 mt -106.62 109.14 27.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.604 -0.725 . . . . 75.23 109.305 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -89.33 136.22 33.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.197 0.523 . . . . 74.35 111.111 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.38 124.66 49.43 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.494 -0.776 . . . . 74.31 109.18 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -100.56 130.64 46.65 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.974 -0.38 . . . . 74.1 109.974 -176.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.8 t70 54.92 74.61 0.35 Allowed 'General case' 0 C--N 1.332 -0.189 0 O-C-N 124.0 0.813 . . . . 73.22 110.619 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 38.3 t -102.28 124.06 47.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.228 -0.896 . . . . 75.02 110.066 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -98.33 137.41 37.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.21 -0.45 . . . . 72.53 111.555 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.423 HG21 ' HB2' ' A' ' 124' ' ' LEU . 64.1 p -110.09 18.97 19.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 61.22 112.071 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -98.96 -26.51 14.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.458 -0.571 . . . . 64.24 109.458 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.0 -2.3 10.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 72.33 110.251 176.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.589 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -144.21 179.16 7.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 73.3 110.462 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.7 m -141.2 -56.86 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.709 0.29 . . . . 75.43 111.297 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.54 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -136.2 143.09 44.19 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.756 -0.461 . . . . 73.31 109.756 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.446 ' HB1' HD22 ' A' ' 124' ' ' LEU . . . -102.65 123.49 46.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.072 0.463 . . . . 51.32 110.445 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.55 115.15 16.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.633 -0.712 . . . . 74.45 109.606 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 3.3 m -91.53 149.8 3.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.137 0.494 . . . . 75.44 111.282 -173.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.454 ' HB3' ' CD1' ' A' ' 118' ' ' PHE . . . -116.08 118.61 33.36 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.726 -0.67 . . . . 73.11 109.904 174.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.53 ' CE1' HG23 ' A' ' 103' ' ' ILE . 49.2 m-85 -87.96 124.14 33.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.19 0.519 . . . . 74.13 110.993 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 56.4 tp -114.97 125.77 54.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.571 -0.74 . . . . 62.45 109.38 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.66 -179.56 33.6 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.037 -0.825 . . . . 74.43 111.037 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -67.5 120.26 13.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.785 0.293 . . . . 75.23 110.778 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.49 132.55 35.71 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.972 -0.381 . . . . 73.55 109.972 175.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.443 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 7.3 tt -73.78 -25.66 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.017 0.437 . . . . 73.22 110.941 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 19.1 t70 -159.54 174.53 14.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.423 -0.584 . . . . 75.45 109.423 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.06 -33.15 44.88 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.167 0.508 . . . . 75.24 109.974 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.98 -0.58 80.87 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.216 -0.753 . . . . 51.31 111.216 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 53.5 m80 -131.37 43.35 3.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.938 -0.631 . . . . 74.24 109.958 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 p -71.65 -2.06 15.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 74.12 110.984 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 33.6 p-10 -104.02 9.6 36.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.97 -0.559 . . . . 72.43 110.334 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 t -120.36 123.22 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.858 -0.61 . . . . 71.33 110.174 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -68.46 124.58 23.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.158 -0.682 . . . . 73.12 109.158 177.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 78' ' ' ILE . . . -78.0 150.31 33.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.887 -0.597 . . . . 50.51 109.846 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.495 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.5 mm? -78.2 126.23 30.49 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.227 -0.657 . . . . 61.53 109.227 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.555 ' HG2' ' HA ' ' A' ' 150' ' ' ALA . 14.1 mm100 -59.73 120.26 9.18 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.639 0.733 . . . . 64.43 109.752 -178.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.449 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 0.7 OUTLIER -85.45 109.08 18.21 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.793 -1.094 . . . . 73.31 110.682 -173.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.5 m -93.96 2.03 56.18 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.68 -0.691 . . . . 71.32 110.315 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 59.54 19.81 8.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.8 -0.636 . . . . 65.11 111.32 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.51 10.38 11.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.067 -0.515 . . . . 74.33 110.322 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 111.58 63.67 0.49 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.693 -0.765 . . . . 72.21 112.255 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 90' ' ' SER . 70.9 m -83.68 160.79 21.26 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.862 -0.422 . . . . 72.44 109.862 175.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.05 152.63 29.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.244 -0.28 . . . . 75.41 110.244 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.57 164.09 30.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.613 -0.435 . . . . 73.42 111.208 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 66.48 16.5 10.43 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.583 -0.735 . . . . 63.23 111.104 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.406 ' O ' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -147.79 -175.07 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 63.21 110.559 175.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -179.68 -167.15 36.49 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.067 -1.213 . . . . 74.24 110.067 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 86' ' ' LEU . 2.3 p -135.8 129.35 48.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.724 0.774 . . . . 74.14 110.847 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -110.54 138.78 46.48 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.132 -0.94 . . . . 64.51 110.322 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.53 HG23 ' CE1' ' A' ' 73' ' ' PHE . 3.9 mp -95.02 114.66 32.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.023 -0.732 . . . . 64.32 109.023 173.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 57.5 mt -85.55 128.0 34.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.724 -0.671 . . . . 64.23 110.331 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.68 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 2.8 t70 -57.42 166.34 1.26 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 64.23 110.406 174.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 106' ' ' ARG . 13.4 ptm180 -58.94 -17.5 25.07 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.386 0.514 . . . . 74.23 112.386 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.1 p -92.08 -7.67 48.01 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.836 0.35 . . . . 64.22 111.512 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.66 48.06 3.29 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.868 -0.682 . . . . 73.14 112.319 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -134.04 134.13 42.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.839 -0.212 . . . . 63.53 110.82 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.01 131.98 48.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.613 0.244 . . . . 73.35 110.911 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.509 HD22 ' HB2' ' A' ' 105' ' ' ASP . 84.9 mt -94.57 134.21 37.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.969 0.414 . . . . 74.14 111.283 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 82.0 m -73.45 134.43 43.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.789 -0.641 . . . . 74.31 110.715 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 43.5 mt -81.08 50.59 1.43 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.478 0.656 . . . . 74.21 110.731 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.413 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 13.9 t70 -90.11 -19.9 23.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.224 -0.898 . . . . 74.11 110.787 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.47 -28.76 6.63 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.776 -0.725 . . . . 43.21 112.349 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.75 4.07 21.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.382 . . . . 74.21 111.006 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 114' ' ' ASP . 26.9 m -90.86 99.83 12.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.382 -0.372 . . . . 72.24 110.1 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.637 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 63.1 m-85 -90.04 157.47 17.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 71.44 111.152 -175.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.68 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . 5.4 m -73.72 -167.24 0.44 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.649 -0.705 . . . . 75.01 111.255 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.9 m -80.98 178.41 8.44 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.875 0.369 . . . . 62.41 111.067 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.54 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 38.1 mt-10 -75.09 105.67 6.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.079 -0.51 . . . . 74.03 111.573 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.514 HG22 HG12 ' A' ' 131' ' ' ILE . 88.4 m -87.32 99.46 12.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.819 -0.808 . . . . 74.21 108.819 168.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.3 m -56.91 114.86 2.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.851 -0.613 . . . . 74.42 110.653 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.498 HD21 ' SG ' ' A' ' 61' ' ' CYS . 97.5 mt -79.89 146.43 32.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.664 -0.698 . . . . 73.5 110.965 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.492 HD21 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -123.06 149.06 44.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.829 -0.804 . . . . 64.0 108.829 174.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 94.6 m-20 -68.52 95.99 0.67 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.964 0.412 . . . . 73.32 110.694 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 146.99 -141.05 9.05 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.998 -0.62 . . . . 73.41 111.8 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.417 ' C ' HD21 ' A' ' 129' ' ' ASN . 29.1 m -81.58 124.71 29.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.001 0.429 . . . . 64.1 110.257 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.468 ' N ' HD21 ' A' ' 129' ' ' ASN . 0.9 OUTLIER -119.8 160.2 23.08 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.321 -0.622 . . . . 72.33 109.321 177.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.487 HG21 ' HB2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -149.06 126.57 11.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.24 -0.281 . . . . 75.34 110.24 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.514 HG12 HG22 ' A' ' 122' ' ' THR . 9.2 mt -104.23 109.41 62.52 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.937 -0.394 . . . . 70.44 109.937 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -88.6 127.31 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.821 2.347 . . . . 72.2 112.904 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . 73.6 m-85 -124.9 167.31 14.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.1 -0.5 . . . . 74.22 110.266 178.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.65 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 99.4 mt-30 -124.27 122.14 36.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.923 0.392 . . . . 74.01 111.1 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.85 123.03 47.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.376 -0.375 . . . . 71.45 110.403 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.495 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 5.7 ptp180 -137.86 161.2 37.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.537 -0.301 . . . . 74.53 110.96 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 63.2 m-85 -80.55 147.15 30.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.987 -0.552 . . . . 74.21 111.204 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -134.38 122.48 22.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.392 -0.822 . . . . 75.34 109.003 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.591 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -86.98 135.36 33.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.91 0.386 . . . . 44.23 111.63 -176.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.561 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 34.8 p -109.45 14.72 23.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.712 0.768 . . . . 71.32 109.228 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.17 -132.05 2.51 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 114.722 -1.126 . . . . 52.01 110.293 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.402 ' O ' HG21 ' A' ' 144' ' ' THR . . . -93.78 100.59 12.77 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.879 -0.786 . . . . 74.41 108.879 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.587 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.47 114.92 0.83 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.013 0.82 . . . . 64.42 110.848 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 142' ' ' ALA . 22.6 p -105.63 143.15 26.25 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 116.281 -0.418 . . . . 63.01 110.198 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.84 158.15 58.6 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.165 2.577 . . . . 71.42 112.821 -174.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.84 -174.38 24.98 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.55 -0.75 . . . . 51.43 111.364 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.93 103.84 2.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.968 0.413 . . . . 72.34 111.144 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.495 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -99.68 66.13 1.39 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.238 0.542 . . . . 74.5 110.535 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -119.88 136.88 54.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.867 -0.606 . . . . 72.55 109.814 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.555 ' HA ' ' HG2' ' A' ' 89' ' ' GLN . . . -136.25 163.63 29.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.083 0.468 . . . . 65.22 111.837 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -123.08 135.24 54.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.541 -0.754 . . . . 74.14 109.559 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' PHE . . . -141.52 129.72 22.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.049 0.452 . . . . 74.44 111.275 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.468 HG23 ' HB3' ' A' ' 13' ' ' LYS . 49.1 p -106.6 125.5 51.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.136 -0.484 . . . . 71.11 109.921 175.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -105.46 136.49 44.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.168 0.508 . . . . 73.21 111.343 -176.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.637 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 10.1 ttmm -113.05 106.45 14.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.645 -0.707 . . . . 72.22 110.213 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.9 OUTLIER -74.56 141.53 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.199 -0.6 . . . . 62.53 109.573 178.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -125.79 115.73 20.48 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.164 -0.471 . . . . 74.04 109.789 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.589 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 1.3 p90 -129.22 -16.77 3.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.465 0.65 . . . . 73.21 110.324 173.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.13 -0.941 . . . . 63.33 109.109 167.646 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 110.09 -0.337 . . . . 73.32 110.09 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.52 148.03 43.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.082 -0.34 . . . . 75.5 110.082 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 t -77.82 -13.11 59.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.984 0.421 . . . . 73.01 111.367 -176.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.8 p -91.2 173.45 7.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.78 0.324 . . . . 72.11 110.277 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.426 ' CG2' HG11 ' A' ' 37' ' ' VAL . 35.7 m -86.47 14.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.093 0.473 . . . . 71.53 111.053 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 62.81 13.95 6.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.452 -0.794 . . . . 72.51 112.359 175.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.495 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 92.42 89.39 1.51 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.673 -0.775 . . . . 65.34 111.82 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.432 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -76.75 158.13 48.2 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.691 -0.766 . . . . 44.1 112.072 -177.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.545 ' HB ' HG21 ' A' ' 31' ' ' THR . 12.9 p -141.4 139.66 33.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.571 0.224 . . . . 70.23 110.904 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -114.33 120.05 63.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.512 -0.551 . . . . 73.31 109.512 174.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -86.17 102.91 14.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.732 -0.47 . . . . 72.0 109.732 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -92.55 105.43 17.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 75.15 109.776 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 50.3 tttp -106.31 136.43 46.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.012 -0.54 . . . . 75.54 110.149 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.45 -112.81 2.44 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.874 -0.679 . . . . 71.51 112.111 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.555 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 28.0 mt-10 61.09 22.72 12.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.25 0.548 . . . . 71.43 110.685 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.569 HG22 ' HA ' ' A' ' 155' ' ' LYS . 19.1 m -77.72 -27.28 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.311 -0.859 . . . . 71.02 111.798 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.65 145.11 34.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.209 0.528 . . . . 65.24 111.821 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -159.65 84.11 0.75 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.911 -1.04 . . . . 74.23 108.236 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.35 -79.1 0.1 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.571 -0.741 . . . . 73.12 110.947 -172.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.515 ' HB1' ' CE1' ' A' ' 158' ' ' TYR . . . -76.76 -33.12 58.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.293 0.568 . . . . 75.34 109.642 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.6 m -141.73 173.64 11.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.327 -0.851 . . . . 64.31 109.165 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.09 123.81 27.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.683 -0.488 . . . . 74.2 109.683 173.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.7 t -66.14 128.82 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.644 -0.502 . . . . 73.25 109.644 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.458 ' O ' HG13 ' A' ' 28' ' ' VAL . 28.8 t70 -60.7 138.02 58.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.99 -0.55 . . . . 73.1 111.203 -176.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.481 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -59.35 -24.94 63.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.822 -0.627 . . . . 75.41 112.126 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.91 -13.14 83.42 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.581 -0.819 . . . . 71.21 112.229 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.8 p -112.43 -9.83 13.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.714 0.264 . . . . 73.4 111.714 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.3 m -86.35 -1.5 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 122.361 -0.212 . . . . 75.23 111.486 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -156.82 42.27 0.35 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.438 0.637 . . . . 73.53 109.552 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -91.98 123.64 35.49 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.491 -0.777 . . . . 72.12 110.127 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.545 HG21 ' HB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -109.84 95.26 5.48 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.525 -0.761 . . . . 73.52 109.606 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.1 p -81.64 130.06 36.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.984 -0.553 . . . . 63.15 111.28 -174.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -83.94 118.97 24.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.711 -0.677 . . . . 54.13 109.933 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.448 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.6 mm? -79.13 -22.49 45.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.347 0.594 . . . . 71.32 109.468 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.495 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.22 175.92 39.12 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.384 -0.826 . . . . 70.05 111.78 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -78.63 83.95 4.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.441 -0.207 . . . . 72.41 110.441 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.426 HG11 ' CG2' ' A' ' 5' ' ' VAL . 8.8 p -66.52 140.28 19.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.471 -0.566 . . . . 72.02 109.471 176.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -86.19 117.83 25.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.216 0.532 . . . . 74.41 109.838 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 26.7 p -65.75 -21.98 66.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 72.23 111.5 -174.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.56 -17.28 64.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.913 -0.585 . . . . 51.52 111.118 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.7 m -84.02 -14.15 51.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 74.31 111.138 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -123.63 94.49 4.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.925 0.393 . . . . 73.23 109.977 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.39 10.96 10.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.651 0.612 . . . . 54.3 112.651 -170.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -150.04 146.31 26.9 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.873 -0.331 . . . . 64.24 110.851 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -56.35 122.53 12.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.718 -0.674 . . . . 74.53 109.64 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.42 -7.0 32.07 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.646 -0.788 . . . . 72.42 112.272 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.61 119.09 14.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 62.55 110.697 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 p -113.31 130.64 56.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.016 -0.538 . . . . 74.54 110.158 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.5 t -89.98 175.47 7.17 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.977 -0.379 . . . . 74.12 109.977 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.1 m -70.77 136.79 49.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.791 -0.448 . . . . 72.22 109.791 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -89.08 159.69 17.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.526 0.679 . . . . 71.4 112.161 -173.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.1 m -91.31 152.42 3.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.715 -1.13 . . . . 71.34 109.552 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.0 106.13 2.44 Favored Glycine 0 C--N 1.312 -0.759 0 C-N-CA 121.095 -0.574 . . . . 71.52 112.076 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -122.77 170.28 10.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.346 -0.613 . . . . 74.35 109.346 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.457 ' C ' HD21 ' A' ' 55' ' ' ASN . 0.3 OUTLIER -135.89 149.93 49.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.449 0.642 . . . . 70.33 112.454 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.0 mt -103.54 119.79 52.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.369 -0.832 . . . . 64.15 109.129 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -102.85 132.28 49.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.095 0.474 . . . . 73.04 111.187 -172.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.2 mt -115.31 124.7 51.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.902 -0.59 . . . . 75.32 109.757 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -98.95 132.67 44.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.166 -0.47 . . . . 73.43 110.355 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.3 t70 55.65 76.45 0.27 Allowed 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.918 0.762 . . . . 75.31 110.807 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.58 146.96 23.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.286 -0.87 . . . . 74.01 111.282 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -116.92 129.69 56.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.476 -0.784 . . . . 74.55 110.849 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.1 p -105.96 16.71 24.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.283 -0.417 . . . . 74.21 111.791 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -92.24 -32.93 14.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.086 0.469 . . . . 73.44 109.92 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.2 p -105.96 -33.67 2.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.154 -0.476 . . . . 65.12 110.692 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -103.81 178.61 4.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 62.11 110.643 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.456 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 18.5 m -140.19 -56.9 0.54 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.868 0.366 . . . . 73.21 111.049 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.456 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -135.89 154.82 51.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.343 -0.614 . . . . 74.12 109.343 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 157' ' ' GLN . . . -111.26 133.64 53.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.084 0.468 . . . . 72.12 110.104 176.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.01 117.62 9.79 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.623 -0.717 . . . . 63.5 109.622 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.2 m -90.88 147.24 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.085 0.469 . . . . 74.44 111.226 -174.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.2 123.58 41.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.542 -0.754 . . . . 43.22 109.207 172.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 80.1 m-85 -85.59 135.11 33.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.024 0.44 . . . . 75.4 110.577 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.1 tp -133.49 118.69 18.63 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.807 -0.633 . . . . 73.31 110.308 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.42 -168.88 29.28 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.131 -0.788 . . . . 64.0 111.131 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -81.48 118.96 23.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.83 0.315 . . . . 73.33 111.006 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.417 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -77.16 141.77 39.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.251 -0.431 . . . . 74.33 110.366 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.454 HG22 ' HB ' ' A' ' 85' ' ' VAL . 5.1 tt -68.11 -32.47 56.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.282 -0.417 . . . . 73.02 111.18 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.64 175.03 11.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.527 -0.306 . . . . 75.23 110.181 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.59 -33.61 35.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.886 -0.597 . . . . 74.42 110.513 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.58 -14.93 59.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.55 -0.833 . . . . 75.42 111.77 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -114.21 57.71 0.7 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.28 0.562 . . . . 71.3 109.574 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.417 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 1.4 p -77.15 8.5 3.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.382 -0.826 . . . . 73.21 112.474 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.41 ' OD1' HG22 ' A' ' 85' ' ' VAL . 23.4 p30 -108.55 -8.82 15.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.979 0.418 . . . . 75.41 110.802 177.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.454 ' HB ' HG22 ' A' ' 78' ' ' ILE . 48.5 t -98.76 122.56 50.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.459 . . . . 73.5 110.983 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.488 HD13 ' HB2' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -70.39 134.46 47.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 74.42 109.84 177.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.44 152.07 32.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.165 -0.471 . . . . 70.03 110.571 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.419 ' HG ' ' HB2' ' A' ' 96' ' ' ALA . 1.9 mm? -78.02 138.45 38.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.232 -0.44 . . . . 70.33 110.391 -177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -61.15 129.43 41.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 70.31 110.211 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -74.85 107.21 6.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.857 -0.611 . . . . 74.11 111.614 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.8 m -87.03 -10.23 53.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.101 -0.499 . . . . 64.43 109.89 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 62.6 22.39 13.28 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.13 -0.941 . . . . 64.12 111.89 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.08 -39.24 0.41 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.758 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.48 74.04 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.393 -0.908 . . . . 53.32 112.777 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.3 m -91.22 154.45 19.29 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.919 -0.4 . . . . 73.22 109.919 175.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.419 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -71.68 153.01 42.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.69 -0.485 . . . . 64.41 109.69 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.44 161.22 38.97 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.612 -0.435 . . . . 72.43 111.025 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 66.45 13.33 9.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.916 -0.584 . . . . 74.04 110.748 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.49 179.76 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.773 -0.649 . . . . 73.11 110.177 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -179.83 -173.43 44.85 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.209 -1.157 . . . . 64.51 110.209 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.9 p -121.9 120.03 60.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.281 0.562 . . . . 73.43 110.935 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.427 ' HG2' ' HB2' ' A' ' 138' ' ' PHE . 1.5 pt20 -108.69 150.19 27.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.819 -0.628 . . . . 72.31 109.823 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.45 HG22 ' CZ ' ' A' ' 73' ' ' PHE . 4.3 mp -111.45 128.1 68.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.181 0.515 . . . . 75.51 110.502 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 13.4 mt -92.93 143.22 26.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.383 -0.826 . . . . 64.34 109.431 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.558 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.0 OUTLIER -70.46 -176.72 1.3 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.287 -0.634 . . . . 62.23 109.287 174.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -64.45 -20.63 66.3 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.197 -0.314 . . . . 74.43 111.708 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.0 p -98.46 6.5 47.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 75.32 111.457 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.76 28.7 28.46 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.972 -0.632 . . . . 73.1 113.464 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.18 128.02 53.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.894 0.347 . . . . 71.14 110.553 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.09 119.05 11.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.859 0.361 . . . . 54.42 110.704 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.6 mt -85.86 129.72 34.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.037 0.446 . . . . 74.34 111.199 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.7 m -73.18 140.65 47.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.623 -0.717 . . . . 74.04 110.557 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 45.4 mt -80.07 40.29 0.47 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.542 . . . . 72.14 111.301 -176.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -81.14 -23.23 38.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.162 0.506 . . . . 73.24 110.278 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.04 -13.54 66.7 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.789 -0.642 . . . . 70.0 111.973 -173.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.9 1.84 11.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.787 0.327 . . . . 74.42 111.728 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 m -86.91 88.06 7.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.086 0.47 . . . . 41.51 110.088 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -83.18 152.63 25.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.864 -0.607 . . . . 73.0 111.199 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.558 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.9 m -67.82 -179.1 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.742 -0.663 . . . . 64.35 111.431 175.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.6 p -68.65 152.9 44.73 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.316 -0.402 . . . . 53.14 110.377 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.34 107.13 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 75.4 111.543 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 m -94.1 103.5 15.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.356 -0.609 . . . . 62.41 109.356 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.8 m -57.16 122.38 12.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.723 -0.671 . . . . 75.14 111.21 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.472 HD22 ' HB2' ' A' ' 69' ' ' ALA . 61.9 mt -78.38 142.32 37.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.128 -0.487 . . . . 74.22 111.077 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.84 148.68 39.66 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.057 -0.72 . . . . 65.54 109.057 170.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -65.37 111.78 3.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.816 0.341 . . . . 75.22 110.256 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 134.56 -126.82 4.26 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.576 -0.61 . . . . 62.52 111.576 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.2 m -108.77 132.44 53.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.848 0.356 . . . . 74.22 110.879 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -127.46 131.46 50.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.35 -0.386 . . . . 74.44 110.592 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.99 115.71 25.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.817 0.341 . . . . 73.25 111.146 176.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mt -93.26 110.71 48.19 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.128 -0.693 . . . . 74.54 109.128 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.31 130.83 7.32 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.467 2.111 . . . . 74.41 112.673 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.458 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 73.0 m-85 -129.39 166.36 19.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.067 0.461 . . . . 75.41 111.267 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.622 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 47.6 mt-30 -130.0 124.45 32.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.654 -0.703 . . . . 73.11 110.766 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.64 126.29 54.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.102 -0.332 . . . . 52.33 110.102 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 6.9 ptp180 -136.72 161.4 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.901 0.381 . . . . 73.45 111.32 -176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.432 ' HH ' ' HA3' ' A' ' 8' ' ' GLY . 60.5 m-85 -82.04 146.09 29.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 75.4 111.074 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.427 ' HB2' ' HG2' ' A' ' 102' ' ' GLN . 61.1 t80 -132.08 126.71 34.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.49 -0.777 . . . . 74.03 109.178 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.587 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -92.73 135.98 33.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.81 0.338 . . . . 60.35 111.443 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 51.0 p -103.88 0.36 30.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.486 0.66 . . . . 75.01 109.552 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.05 -122.56 0.91 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.124 -0.943 . . . . 74.11 111.302 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.63 94.5 9.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.945 -0.391 . . . . 73.41 109.945 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.616 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -47.58 118.99 2.48 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.507 0.504 . . . . 73.34 111.197 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.2 p -112.79 143.89 29.93 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.171 -0.468 . . . . 64.22 110.708 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.12 174.19 8.33 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.714 2.943 . . . . 73.51 113.278 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.73 -168.35 19.76 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.715 -0.755 . . . . 71.5 111.709 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.38 109.44 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 73.22 110.889 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -108.37 52.77 0.7 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.656 0.741 . . . . 62.42 109.766 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -108.65 138.24 45.28 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.968 -1.014 . . . . 74.43 109.669 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.488 ' HB2' HD13 ' A' ' 86' ' ' LEU . . . -144.12 169.38 17.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.42 -0.355 . . . . 73.44 110.101 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.99 144.86 30.37 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.947 -0.39 . . . . 64.05 109.947 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -152.32 146.12 25.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.081 -0.509 . . . . 74.12 110.705 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 36.0 p -97.5 128.46 44.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.197 -0.456 . . . . 72.23 109.973 176.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -96.42 127.93 42.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.327 0.584 . . . . 73.32 110.042 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.569 ' HA ' HG22 ' A' ' 16' ' ' VAL . 1.8 tmtm? -111.4 100.26 8.89 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.714 -0.676 . . . . 63.21 109.832 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.5 m -77.45 144.3 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.145 0.498 . . . . 70.24 110.471 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 7.3 tt0 -115.02 120.5 40.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.0 -0.546 . . . . 74.42 110.637 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.548 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 9.8 p90 -158.09 -30.6 0.08 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.734 0.646 . . . . 73.51 109.494 170.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 . . . . . 0 C--O 1.247 0.972 0 CA-C-N 115.212 -0.904 . . . . 73.43 109.974 177.893 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 120.849 0.357 . . . . 61.01 110.321 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.28 172.31 6.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.499 -0.319 . . . . 73.41 111.197 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.4 t -87.93 -7.36 57.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.541 0.686 . . . . 65.43 110.595 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.7 p -112.71 -176.09 2.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.979 -0.555 . . . . 74.42 110.427 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.492 ' HB ' ' HB1' ' A' ' 148' ' ' ALA . 35.0 m -87.95 15.05 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.129 0.49 . . . . 72.33 110.399 175.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 62.41 23.51 13.95 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.314 -0.857 . . . . 74.33 112.358 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.471 ' N ' ' HG2' ' A' ' 36' ' ' GLN . . . 77.69 88.13 0.38 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.389 -0.91 . . . . 75.32 111.625 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.57 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -76.17 156.27 46.92 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.566 -0.826 . . . . 71.05 111.998 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.537 ' HB ' HG22 ' A' ' 31' ' ' THR . 5.2 p -142.7 137.18 29.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.559 0.219 . . . . 70.22 110.845 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.476 HG21 HG21 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -111.69 121.36 64.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.602 -0.518 . . . . 72.04 109.602 175.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -88.11 98.42 11.53 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.041 0.448 . . . . 73.2 109.818 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.435 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 61.8 m-85 -88.44 118.35 28.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.927 -0.579 . . . . 73.22 110.044 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 78.3 tttt -112.65 145.28 40.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.384 -0.371 . . . . 75.03 110.486 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -122.66 -116.25 2.32 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.898 -0.667 . . . . 74.15 112.523 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.522 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 93.0 mt-10 64.05 17.7 10.77 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.841 0.457 . . . . 71.3 111.347 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 155' ' ' LYS . 31.0 m -76.85 -28.51 17.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.088 -0.505 . . . . 71.21 111.712 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.504 HG23 ' CG2' ' A' ' 156' ' ' VAL . 17.1 m -137.38 141.41 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.098 0.475 . . . . 74.14 111.973 -176.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -140.39 21.2 2.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.019 -0.992 . . . . 75.5 108.559 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.18 -76.55 0.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.368 -0.833 . . . . 73.52 111.495 -172.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.493 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -88.84 -33.28 17.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.856 0.36 . . . . 73.1 110.751 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -146.09 128.42 15.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.131 -0.486 . . . . 52.41 109.819 -177.14 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.29 128.56 36.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.321 -0.399 . . . . 73.43 110.29 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.415 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 3.6 t -72.5 128.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.019 -0.363 . . . . 74.52 110.019 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 28' ' ' VAL . 16.0 t70 -58.71 142.55 49.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 64.03 111.09 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.489 ' HA ' HG21 ' A' ' 28' ' ' VAL . . . -59.69 -27.09 66.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.989 -0.551 . . . . 73.32 112.073 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.08 -19.11 73.17 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.59 -0.814 . . . . 71.12 112.066 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.9 p -102.94 -16.04 15.97 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.15 -0.22 . . . . 60.43 111.458 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.522 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 27.4 m -81.51 -2.85 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.954 0.407 . . . . 74.3 110.313 175.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -158.34 87.67 0.91 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.402 -0.962 . . . . 71.14 108.402 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.435 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 16.0 pt20 -134.9 98.09 3.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.517 0.675 . . . . 72.33 110.804 -176.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.537 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.5 m -82.07 94.53 7.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.151 -0.931 . . . . 70.15 109.279 174.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.7 p -81.72 130.86 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.9 -0.591 . . . . 74.33 111.187 -174.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -85.9 127.31 34.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.895 -0.593 . . . . 72.42 110.15 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.91 -30.44 17.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.303 0.573 . . . . 73.24 109.737 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.426 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 100.23 167.85 29.09 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.485 -0.779 . . . . 65.43 111.706 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.471 ' HG2' ' N ' ' A' ' 7' ' ' GLY . 60.4 mt-30 -79.27 86.77 5.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.071 0.462 . . . . 73.34 110.841 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.34 145.96 12.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 75.31 109.875 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -83.39 126.78 33.09 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.362 -0.607 . . . . 74.33 109.362 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.618 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 24.4 p -68.55 -25.02 64.7 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.048 -0.523 . . . . 73.34 111.315 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.49 -10.47 58.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.075 -0.511 . . . . 73.43 111.409 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.8 m -86.94 -7.75 57.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.041 0.448 . . . . 75.13 110.607 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 4.7 mp -132.73 90.17 2.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 75.41 110.266 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.44 12.32 11.59 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.311 0.486 . . . . 75.34 112.311 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -144.73 141.55 29.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.767 -0.197 . . . . 75.13 110.695 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 42.9 tt0 -59.5 122.28 13.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.007 0.432 . . . . 72.02 110.141 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.79 -7.06 33.37 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.786 -0.721 . . . . 73.03 111.888 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.489 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . . . -68.23 120.88 15.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.92 0.39 . . . . 60.23 110.302 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 p -112.01 125.43 54.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.953 -0.567 . . . . 72.02 110.454 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 t -84.88 174.91 9.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.486 -0.561 . . . . 70.41 109.486 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.3 m -62.2 136.4 57.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.776 -0.453 . . . . 64.12 109.776 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -95.91 157.25 15.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.309 0.576 . . . . 75.11 111.018 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.1 m -99.18 148.91 5.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.131 -0.94 . . . . 64.42 109.228 172.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.62 86.81 0.54 Allowed Glycine 0 C--N 1.309 -0.947 0 C-N-CA 120.771 -0.728 . . . . 72.4 112.045 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -88.95 170.21 10.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.382 -0.599 . . . . 75.44 109.382 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.515 ' HB2' HG21 ' A' ' 130' ' ' THR . 4.3 p-10 -138.78 150.85 46.54 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.412 0.625 . . . . 74.11 111.904 -175.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.421 HD11 ' CD1' ' A' ' 154' ' ' PHE . 61.4 mt -109.29 110.28 31.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.176 -0.92 . . . . 71.51 108.599 171.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -96.71 122.45 39.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.989 -0.55 . . . . 72.4 110.787 -173.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.5 mt -106.54 119.36 39.09 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.3 -0.409 . . . . 63.21 110.049 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -96.35 133.28 40.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.097 -0.501 . . . . 75.45 110.044 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 54.35 79.31 0.14 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.776 0.798 . . . . 72.15 110.469 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 42.9 t -112.2 138.51 48.79 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.996 -1.002 . . . . 74.21 109.485 -177.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -116.37 141.55 48.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.845 0.355 . . . . 63.01 111.75 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.5 p -105.42 4.25 30.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.137 -0.483 . . . . 74.34 112.157 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -76.14 -41.86 48.61 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.453 -0.573 . . . . 75.15 109.453 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 p -93.33 -35.2 6.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.747 -0.661 . . . . 72.12 111.021 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.558 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -108.19 -174.93 2.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.615 0.245 . . . . 72.22 110.904 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.421 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 34.3 m -148.32 -57.46 0.23 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.834 0.349 . . . . 64.42 110.779 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -138.05 141.65 40.33 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.686 -0.487 . . . . 71.14 109.686 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.417 ' HB2' HD22 ' A' ' 124' ' ' LEU . . . -100.09 130.89 46.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.946 0.403 . . . . 72.15 110.563 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.02 115.21 11.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.875 -0.602 . . . . 64.12 109.587 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 155' ' ' LYS . 1.9 m -92.76 147.18 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.986 0.422 . . . . 72.2 111.136 -173.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.5 ' HB1' ' CD1' ' A' ' 118' ' ' PHE . . . -122.63 131.08 53.65 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.969 -0.559 . . . . 62.21 109.516 173.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.544 ' CE1' HG22 ' A' ' 103' ' ' ILE . 49.5 m-85 -95.46 138.56 32.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.94 0.4 . . . . 72.44 111.047 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.6 tp -133.85 134.94 43.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.838 -0.619 . . . . 74.15 110.021 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.83 -160.8 24.96 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.191 -0.763 . . . . 52.21 111.191 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.0 m -88.4 118.42 28.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.929 0.364 . . . . 75.54 110.209 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -80.45 147.03 31.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.337 -0.392 . . . . 62.31 110.155 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.51 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 7.6 tt -64.41 -26.19 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 74.3 111.139 -177.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 80' ' ' ALA . 20.4 t70 -154.56 -179.8 8.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.4 -0.593 . . . . 74.34 109.4 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.415 ' H ' ' CG ' ' A' ' 79' ' ' ASP . . . -82.44 -32.63 28.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.923 0.392 . . . . 75.12 110.112 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.67 -34.68 24.45 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.699 -0.762 . . . . 61.23 111.561 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -96.64 73.8 2.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.13 0.49 . . . . 70.01 109.972 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.462 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 1.4 p -95.32 15.4 19.5 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.762 -0.654 . . . . 63.35 111.512 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -112.38 -4.32 14.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.144 0.497 . . . . 75.41 110.921 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.8 t -115.24 126.34 72.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.995 -0.548 . . . . 74.33 110.198 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.512 HD13 ' HB2' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -68.68 131.16 44.74 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.525 -0.546 . . . . 72.22 109.525 178.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 78' ' ' ILE . . . -78.54 143.09 36.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.06 -0.518 . . . . 62.33 110.517 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.652 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.6 mm? -75.98 135.78 40.01 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.965 -0.754 . . . . 73.43 108.965 177.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -57.84 122.35 12.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.208 0.528 . . . . 74.34 111.06 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.2 p -69.68 110.33 4.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.495 -0.775 . . . . 64.21 110.735 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.1 m -93.46 -7.38 44.61 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.009 -0.542 . . . . 52.5 110.383 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 62.03 28.35 17.17 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.715 -0.675 . . . . 64.22 110.422 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.37 -43.82 0.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.583 -0.735 . . . . 73.5 110.696 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.16 76.78 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.571 -0.823 . . . . 74.31 112.319 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.5 m -92.66 152.44 19.55 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.824 -0.436 . . . . 74.25 109.824 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.01 133.86 48.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.686 -0.487 . . . . 73.21 109.686 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.95 163.87 22.72 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.545 -0.462 . . . . 62.05 110.989 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 66.24 13.7 9.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.604 -0.726 . . . . 73.51 110.496 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.15 -178.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.549 -0.75 . . . . 74.5 109.902 175.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 176.21 -172.24 45.23 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 110.06 -1.216 . . . . 72.4 110.06 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.476 HG21 HG21 ' A' ' 10' ' ' VAL . 2.3 p -118.8 111.43 33.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.549 0.69 . . . . 74.12 110.898 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -96.11 141.13 29.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.511 -0.768 . . . . 74.43 109.502 177.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.544 HG22 ' CE1' ' A' ' 73' ' ' PHE . 3.8 mp -98.71 127.79 50.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.037 0.446 . . . . 71.13 110.13 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 44.4 mt -99.35 138.94 35.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.504 -0.771 . . . . 72.22 110.63 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.583 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 3.8 t70 -60.67 165.95 3.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.642 -0.708 . . . . 74.31 110.188 170.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.415 ' HE ' ' HB3' ' A' ' 120' ' ' SER . 26.5 ptt180 -54.84 -24.67 24.09 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.474 0.546 . . . . 74.35 112.474 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.2 p -87.13 -20.52 26.93 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.758 0.313 . . . . 72.24 111.719 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.38 44.36 1.26 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.663 -0.779 . . . . 71.21 112.661 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.72 130.16 45.11 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.065 -0.346 . . . . 74.51 110.065 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.72 140.3 57.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 73.32 111.183 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.49 155.21 17.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.94 -0.573 . . . . 73.31 110.555 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -94.46 141.15 28.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.363 -0.38 . . . . 72.34 110.176 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 60.5 mt -84.94 51.04 2.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.012 0.434 . . . . 73.13 110.988 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -108.94 -4.54 16.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.43 . . . . 75.55 110.261 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.82 0.11 39.74 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.017 -0.611 . . . . 53.4 112.739 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -116.73 -17.48 10.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.371 . . . . 73.1 111.105 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.3 m -86.06 94.96 9.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.023 0.44 . . . . 73.4 109.836 174.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.678 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 69.3 m-85 -85.59 162.26 18.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.05 -0.523 . . . . 70.43 110.189 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.583 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . 6.9 m -77.95 -172.16 2.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.882 -0.599 . . . . 64.12 110.943 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.415 ' HB3' ' HE ' ' A' ' 106' ' ' ARG . 35.6 t -68.84 148.77 49.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.869 -0.605 . . . . 72.13 110.165 178.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -63.81 98.29 0.19 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.793 0.33 . . . . 72.02 111.293 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.2 m -78.7 102.28 7.97 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.43 -0.581 . . . . 70.45 109.43 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.0 m -57.23 112.17 1.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.44 -0.8 . . . . 65.45 110.997 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.426 HD12 ' SG ' ' A' ' 61' ' ' CYS . 96.0 mt -75.19 143.79 43.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.766 -0.652 . . . . 73.31 111.402 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -125.11 145.24 50.03 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.192 -0.67 . . . . 72.11 109.192 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -53.9 113.02 1.06 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.872 0.368 . . . . 75.43 111.508 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 129.81 -143.09 14.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.15 -0.548 . . . . 62.25 112.462 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.6 m -82.73 122.1 27.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.763 0.316 . . . . 75.11 110.794 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.426 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 21.9 m-80 -114.86 113.08 23.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.976 0.417 . . . . 74.22 110.337 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.515 HG21 ' HB2' ' A' ' 55' ' ' ASN . 1.1 m -102.27 106.37 17.17 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.78 -0.645 . . . . 54.43 110.327 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 6.6 mt -91.66 113.4 58.6 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.847 -0.427 . . . . 65.04 109.847 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 24.7 Cg_endo -88.72 133.07 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.873 2.382 . . . . 74.34 112.706 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -133.1 169.81 16.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.826 -0.624 . . . . 73.3 109.733 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.64 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 97.1 mt-30 -126.1 140.42 52.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.018 0.437 . . . . 72.43 111.122 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.05 125.6 41.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.077 -0.51 . . . . 74.45 109.779 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.508 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 36.7 ptt180 -144.36 166.18 25.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.097 0.475 . . . . 73.22 111.513 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.593 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 82.4 m-85 -81.56 131.91 35.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.323 -0.853 . . . . 73.22 110.456 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -118.13 116.19 26.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.457 -0.792 . . . . 75.34 109.366 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.592 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -80.78 130.92 35.33 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.18 -0.463 . . . . 73.41 110.996 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.446 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 41.7 p -102.05 9.27 40.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.055 -0.721 . . . . 74.05 109.055 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.41 -120.95 0.94 Allowed Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.933 -1.03 . . . . 75.05 111.018 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.89 95.4 7.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.752 -0.462 . . . . 74.34 109.752 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.618 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -47.3 114.63 0.91 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.716 0.635 . . . . 62.24 111.206 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 p -107.02 139.58 20.55 Favored Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-N 116.082 -0.508 . . . . 72.23 110.373 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.56 159.76 51.75 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 123.679 2.919 . . . . 73.32 113.086 -172.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.95 -167.48 28.28 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.667 -0.697 . . . . 45.22 111.404 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.76 112.06 5.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.922 0.392 . . . . 64.4 110.901 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.652 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -109.8 58.62 0.61 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.505 0.669 . . . . 52.25 110.361 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -116.42 133.42 56.04 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.446 -0.797 . . . . 72.14 110.045 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.512 ' HB2' HD13 ' A' ' 86' ' ' LEU . . . -142.16 175.72 9.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.404 -0.362 . . . . 62.32 110.84 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -148.91 150.78 33.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.697 -0.483 . . . . 72.31 109.697 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -154.06 151.26 29.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.86 0.362 . . . . 72.53 110.874 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.6 p -108.77 132.96 53.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.096 -0.502 . . . . 72.5 109.835 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.421 ' CD1' HD11 ' A' ' 56' ' ' ILE . 27.9 p90 -106.53 133.67 50.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.25 0.547 . . . . 63.22 111.082 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.678 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 20.7 ttmt -109.59 103.44 12.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.469 -0.787 . . . . 73.53 110.409 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.504 ' CG2' HG23 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -77.95 130.05 36.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.242 -0.651 . . . . 75.41 109.242 176.141 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -114.67 117.86 32.03 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.862 -0.422 . . . . 74.33 109.862 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.558 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -136.34 -16.73 1.59 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.225 -0.443 . . . . 75.41 111.075 175.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.537 -0.744 . . . . 73.23 109.299 173.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 120.553 0.216 . . . . 74.34 110.726 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.14 -174.61 5.38 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.389 -0.226 . . . . 64.42 110.389 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.4 t -102.61 -15.59 16.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.078 0.466 . . . . 72.11 110.663 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.1 p -110.61 174.26 5.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.986 0.422 . . . . 73.43 110.533 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.412 HG23 HG13 ' A' ' 37' ' ' VAL . 32.0 m -83.9 6.99 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.314 0.578 . . . . 74.13 110.439 175.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 60.77 18.33 8.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.145 -0.934 . . . . 72.32 112.083 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.93 95.67 0.87 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.772 -0.727 . . . . 75.14 111.915 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.48 159.92 31.19 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.43 -0.89 . . . . 74.34 111.366 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.538 ' HB ' HG22 ' A' ' 31' ' ' THR . 60.8 p -139.03 143.55 38.47 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.724 0.262 . . . . 74.32 110.446 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.45 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -111.73 123.68 67.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.855 -0.424 . . . . 74.34 109.855 175.415 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -92.5 113.35 25.6 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.106 -0.497 . . . . 74.21 109.869 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.45 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 95.2 m-85 -104.71 125.96 51.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.167 -0.47 . . . . 70.12 110.389 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -117.67 143.74 45.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.978 -0.379 . . . . 73.11 109.978 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.41 -126.56 2.78 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.74 -0.743 . . . . 63.14 112.849 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.63 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 35.8 mt-10 62.21 27.91 16.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.286 0.565 . . . . 73.04 110.581 -174.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.595 HG22 ' HA ' ' A' ' 155' ' ' LYS . 31.0 m -74.24 -26.48 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.399 -0.818 . . . . 60.44 111.321 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.457 HG23 ' CG2' ' A' ' 156' ' ' VAL . 27.1 m -136.64 147.19 27.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 71.24 111.493 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -143.94 19.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.121 -0.945 . . . . 60.34 109.188 175.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.69 -83.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.538 -0.755 . . . . 71.05 111.489 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.498 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -80.96 -36.53 30.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.934 -0.307 . . . . 74.23 110.724 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 0.8 OUTLIER -143.01 132.98 24.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.735 0.302 . . . . 51.11 110.19 -176.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.32 126.7 39.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.376 -0.375 . . . . 63.51 110.324 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.417 ' HA ' HD21 ' A' ' 58' ' ' LEU . 8.2 t -65.77 131.97 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.235 -0.283 . . . . 74.43 110.235 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.533 ' O ' HG12 ' A' ' 28' ' ' VAL . 22.9 t70 -58.04 140.83 51.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 65.24 111.717 -176.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.55 -25.3 64.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.835 -0.621 . . . . 61.41 112.15 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.72 -24.84 55.03 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.401 -0.904 . . . . 72.4 112.388 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.2 p -98.11 -12.09 22.17 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.873 0.323 . . . . 42.52 111.873 -175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.63 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 30.8 m -79.85 -4.62 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.672 0.272 . . . . 74.4 111.609 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -166.72 96.01 0.53 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.404 -0.962 . . . . 73.44 108.404 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -145.9 140.78 27.23 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.548 -0.751 . . . . 64.23 109.91 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.538 HG22 ' HB ' ' A' ' 9' ' ' THR . 25.0 m -117.05 103.9 10.71 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.71 -0.677 . . . . 74.01 109.992 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 p -88.26 133.67 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.039 0.447 . . . . 74.42 111.084 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.493 ' HA ' HG21 ' A' ' 9' ' ' THR . 25.3 mp0 -90.67 128.34 36.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 74.01 109.72 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.74 -31.32 21.02 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.156 0.503 . . . . 74.33 110.055 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.64 172.48 24.71 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.668 -0.696 . . . . 73.31 112.025 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -80.79 97.66 7.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.76 0.314 . . . . 72.12 110.358 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.412 HG13 HG23 ' A' ' 5' ' ' VAL . 11.2 p -83.11 143.1 12.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.024 -0.535 . . . . 73.33 110.212 176.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.9 127.7 33.75 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.555 -0.535 . . . . 73.31 109.555 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.4 p -74.49 -10.04 59.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.148 -0.478 . . . . 74.55 111.584 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.47 -21.25 58.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.254 -0.43 . . . . 75.22 111.379 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.5 m -81.14 -23.42 38.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 71.23 110.868 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.561 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 5.2 mp -114.34 99.04 7.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.107 -0.497 . . . . 75.44 109.923 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.83 11.49 6.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.364 0.505 . . . . 71.25 112.364 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -151.43 152.13 32.63 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.693 -0.403 . . . . 65.53 111.432 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.37 120.03 8.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.634 -0.712 . . . . 73.44 109.484 175.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.05 6.8 39.23 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.676 -0.773 . . . . 75.4 112.032 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -81.17 120.27 24.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.837 0.351 . . . . 73.43 110.257 176.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.517 HG23 ' HD1' ' A' ' 138' ' ' PHE . 59.9 p -112.44 128.09 56.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.415 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.9 t -84.73 -177.76 6.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.794 -0.447 . . . . 74.31 109.794 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -67.37 137.2 55.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.272 -0.422 . . . . 64.52 110.074 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -92.01 153.52 19.38 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.664 0.745 . . . . 74.42 111.882 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 27.8 m -93.32 153.74 3.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.363 -1.29 . . . . 72.45 109.536 170.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.22 100.54 1.66 Allowed Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.809 -0.71 . . . . 72.2 111.996 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -116.33 -179.4 3.66 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.416 -0.586 . . . . 73.14 109.416 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.52 ' HB2' HG21 ' A' ' 130' ' ' THR . 4.0 p-10 -146.35 152.72 39.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.502 0.668 . . . . 65.54 111.965 -174.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 74.4 mt -113.84 111.86 37.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.911 -1.04 . . . . 70.12 108.303 167.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -97.75 140.93 31.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.985 0.421 . . . . 73.31 110.801 -172.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.417 HD21 ' HA ' ' A' ' 23' ' ' VAL . 65.7 mt -117.66 124.66 49.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.841 -0.618 . . . . 74.43 109.491 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -102.6 135.85 43.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.79 -0.641 . . . . 73.4 109.386 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 27.3 t70 56.19 87.65 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.821 0.701 . . . . 74.23 110.486 -176.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.533 ' SG ' HD13 ' A' ' 124' ' ' LEU . 42.3 t -124.85 134.85 52.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.704 -0.68 . . . . 61.11 110.373 -174.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.09 138.03 47.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 73.21 111.867 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 p -105.35 10.9 33.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.798 -0.637 . . . . 71.14 112.31 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -88.32 -36.33 16.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.018 0.437 . . . . 64.41 110.027 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 p -102.01 -12.55 8.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.875 -0.602 . . . . 74.24 110.435 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . . . -129.13 -174.11 3.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.866 -0.606 . . . . 73.15 110.423 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -150.59 -56.55 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.78 0.324 . . . . 74.23 111.175 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -137.58 141.3 41.32 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.503 -0.554 . . . . 75.14 109.503 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB2' HD22 ' A' ' 124' ' ' LEU . . . -99.43 130.34 45.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.091 0.472 . . . . 54.25 110.29 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.95 113.66 9.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.559 -0.746 . . . . 72.44 109.792 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 2.0 m -90.37 146.42 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.272 0.558 . . . . 74.2 110.864 -175.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.54 119.24 34.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.356 -0.838 . . . . 61.42 109.166 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 83.7 m-85 -79.55 137.46 37.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.855 -0.424 . . . . 75.22 109.855 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.9 tp -137.33 115.55 11.73 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.671 -0.492 . . . . 74.34 109.671 -175.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.6 -158.12 10.07 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.524 -0.762 . . . . 74.24 111.379 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.494 ' O ' HD11 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -81.09 116.69 21.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.73 0.265 . . . . 62.41 110.869 -178.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -79.69 139.31 37.42 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.936 -0.394 . . . . 73.42 109.936 175.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.499 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 6.6 tt -63.62 -36.12 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.904 0.383 . . . . 72.41 110.781 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -151.92 175.17 12.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.31 -0.626 . . . . 73.33 109.31 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.83 -24.58 28.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.997 0.427 . . . . 73.15 110.503 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.84 -21.54 49.93 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.756 -0.735 . . . . 61.53 111.356 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -118.61 62.46 0.78 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.457 0.646 . . . . 71.55 109.518 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.525 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 2.6 p -80.85 7.64 10.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.421 -0.809 . . . . 72.23 111.407 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -106.25 1.55 26.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.056 0.455 . . . . 73.41 110.947 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.524 HG21 ' HB3' ' A' ' 102' ' ' GLN . 61.9 t -117.34 129.4 73.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.015 -0.539 . . . . 70.32 110.164 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 76' ' ' THR . 0.1 OUTLIER -69.98 133.61 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.715 0.293 . . . . 74.34 110.378 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 78' ' ' ILE . . . -78.14 148.36 34.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.123 -0.49 . . . . 72.12 110.302 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -81.61 149.82 28.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.246 -0.434 . . . . 74.24 110.499 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -74.53 128.44 35.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.594 . . . . 73.3 110.334 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 p -84.96 110.79 19.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.025 -0.534 . . . . 73.25 111.376 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.9 m -99.14 -4.35 32.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.163 -0.471 . . . . 71.04 110.391 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 68.56 4.96 4.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.338 -0.846 . . . . 75.55 113.128 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.16 -44.43 3.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.364 0.602 . . . . 74.32 110.033 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.96 85.06 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.621 -0.718 . . . . 45.11 112.046 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.9 m -104.74 149.66 25.42 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.912 -0.403 . . . . 75.11 109.912 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.08 147.77 29.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.467 -0.333 . . . . 74.12 110.457 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.48 165.55 27.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.557 -0.292 . . . . 64.45 110.335 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 70.11 7.62 6.3 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.327 0.584 . . . . 73.05 110.417 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.35 -177.42 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.272 -0.877 . . . . 71.41 109.644 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 177.22 -170.6 43.25 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.12 -1.192 . . . . 70.32 110.12 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -121.03 115.18 46.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.476 0.655 . . . . 62.32 110.49 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.524 ' HB3' HG21 ' A' ' 85' ' ' VAL . 3.6 pt20 -105.39 145.53 30.66 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.63 -0.713 . . . . 75.41 109.532 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.473 HG22 ' CZ ' ' A' ' 73' ' ' PHE . 4.4 mp -104.96 123.15 58.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.148 0.499 . . . . 72.41 110.385 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 18.8 mt -91.21 139.51 30.68 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.376 -0.829 . . . . 73.43 109.246 177.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.8 OUTLIER -72.57 -169.12 0.51 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.282 -0.417 . . . . 63.32 110.282 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -56.72 -35.07 68.11 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.733 0.272 . . . . 74.12 111.733 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.7 p -87.43 -6.29 58.49 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.883 0.373 . . . . 72.12 111.768 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.89 30.03 10.93 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.606 -0.807 . . . . 73.4 112.804 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.38 134.74 50.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.177 -0.305 . . . . 74.02 110.177 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.37 117.96 10.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.966 0.412 . . . . 72.11 111.175 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.16 132.7 35.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.891 -0.595 . . . . 71.34 110.573 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.3 m -74.33 137.41 42.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.905 -0.589 . . . . 74.31 110.647 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 36.5 mt -82.43 47.89 1.22 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.067 -0.515 . . . . 70.45 110.971 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -104.93 -0.75 26.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.959 0.409 . . . . 75.52 110.332 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.12 10.57 59.6 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.871 -0.604 . . . . 75.24 112.672 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.32 -23.97 4.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 75.11 110.798 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -80.3 99.43 7.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.96 0.41 . . . . 74.11 110.264 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -89.03 157.88 18.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.02 -0.536 . . . . 75.42 110.635 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.537 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.3 m -64.96 171.15 3.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.019 -0.537 . . . . 73.32 111.08 177.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 42.9 m -65.37 156.76 31.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.459 -0.571 . . . . 73.33 109.459 171.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.496 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 45.7 mt-10 -55.6 121.15 8.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.101 0.477 . . . . 72.43 111.913 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.0 m -105.57 98.84 8.48 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.269 -1.011 . . . . 74.34 108.269 168.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.1 m -59.24 122.05 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.556 . . . . 74.11 110.915 -175.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.533 HD13 ' SG ' ' A' ' 61' ' ' CYS . 96.2 mt -82.96 153.23 25.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.464 -0.789 . . . . 72.25 111.662 -174.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.454 HD21 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -123.87 157.32 34.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.356 -0.838 . . . . 72.13 108.911 171.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 3.8 m120 -68.37 99.64 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.913 0.387 . . . . 73.44 110.34 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.06 -136.41 7.95 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.895 -0.669 . . . . 72.31 112.029 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.3 m -84.96 127.58 34.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.022 0.439 . . . . 73.44 110.976 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.42 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 33.5 m-80 -128.61 124.94 37.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.968 -0.56 . . . . 71.24 109.9 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.52 HG21 ' HB2' ' A' ' 55' ' ' ASN . 2.5 m -115.65 114.78 25.34 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.974 -0.291 . . . . 75.11 110.702 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.6 mt -92.25 109.81 40.33 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.282 -0.417 . . . . 71.03 109.95 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.33 138.76 10.06 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.767 2.311 . . . . 72.44 112.806 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 62.3 m-85 -136.55 164.13 28.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 72.51 111.113 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.573 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 97.5 mt-30 -125.59 125.12 42.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.795 -0.639 . . . . 71.22 110.412 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.48 124.08 51.55 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.199 -0.297 . . . . 71.15 110.199 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.493 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 14.9 ptp180 -138.87 160.22 40.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.934 0.397 . . . . 71.12 110.983 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 66.8 m-85 -77.32 139.7 39.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.7 -0.682 . . . . 75.41 110.516 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.517 ' HD1' HG23 ' A' ' 48' ' ' THR . 80.5 t80 -127.59 122.26 32.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.696 -0.684 . . . . 74.15 109.501 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -93.26 137.13 32.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.074 0.464 . . . . 72.11 111.333 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 52.0 p -103.81 5.51 36.02 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.439 -0.801 . . . . 65.14 109.224 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.26 -131.6 2.33 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.901 -1.045 . . . . 54.34 110.697 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.39 94.89 4.96 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.4 -0.222 . . . . 41.24 110.4 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.23 120.9 3.88 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.546 0.529 . . . . 65.31 111.105 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.2 p -111.57 145.1 31.92 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 121.248 0.547 . . . . 73.02 111.2 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.17 163.16 37.16 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.867 3.044 . . . . 74.31 113.089 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.36 -174.76 21.09 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.993 -0.622 . . . . 75.31 111.937 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.73 108.04 0.78 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.971 0.415 . . . . 71.35 111.207 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.43 43.88 1.07 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 73.45 110.228 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -101.74 147.11 26.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.58 -0.736 . . . . 75.15 109.805 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.489 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -153.79 170.61 20.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.46 -0.337 . . . . 72.01 111.07 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.42 146.02 36.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.435 -0.348 . . . . 64.2 110.219 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.49 ' HB3' HD23 ' A' ' 86' ' ' LEU . . . -151.28 149.63 29.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.303 -0.408 . . . . 74.24 110.993 -177.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.7 p -107.21 128.45 54.43 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.019 -0.537 . . . . 73.4 109.621 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -100.01 132.5 45.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.208 0.528 . . . . 75.43 110.831 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.595 ' HA ' HG22 ' A' ' 16' ' ' VAL . 5.8 tmtm? -117.19 105.17 11.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.783 -0.644 . . . . 74.42 110.248 -178.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.2 m -74.87 156.52 6.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.173 0.511 . . . . 74.21 110.614 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 157' ' ' GLN . 1.4 tt0 -140.7 118.48 11.72 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.424 -0.807 . . . . 72.3 108.958 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -136.73 -15.02 1.61 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.038 0.384 . . . . 74.53 112.038 177.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.482 -0.77 . . . . 75.25 109.884 177.214 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.728 0.299 . . . . 72.21 110.681 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.85 -174.18 1.76 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 73.33 110.195 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.8 t -107.6 6.52 27.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.415 0.626 . . . . 74.42 110.243 175.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.1 p -124.96 172.86 9.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.275 -0.42 . . . . 72.21 110.025 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.547 HG22 HG11 ' A' ' 37' ' ' VAL . 34.2 m -94.26 20.25 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.22 0.533 . . . . 74.41 110.468 175.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 59.75 25.59 14.61 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.934 -1.03 . . . . 75.1 112.542 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.524 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 76.78 89.95 0.27 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.537 -0.839 . . . . 51.01 112.078 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.549 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -78.86 159.95 46.28 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.354 -0.927 . . . . 37.08 112.157 -176.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.564 ' HB ' HG22 ' A' ' 31' ' ' THR . 74.3 p -140.44 145.67 37.28 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.856 -0.424 . . . . 71.13 109.856 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.65 125.25 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 109.803 -0.443 . . . . 74.13 109.803 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -90.04 111.95 23.22 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.73 -0.668 . . . . 75.42 109.6 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -98.86 124.63 43.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.164 -0.471 . . . . 73.12 109.776 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.492 ' HB3' HG22 ' A' ' 153' ' ' THR . 58.6 tttm -118.42 132.88 56.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.444 -0.344 . . . . 74.42 110.644 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.05 -115.11 2.48 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.921 -0.657 . . . . 74.4 112.846 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.434 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 31.6 mt-10 65.18 21.29 12.11 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.939 0.496 . . . . 74.03 111.176 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.55 HG22 ' HA ' ' A' ' 155' ' ' LYS . 13.8 m -79.61 -33.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 113.307 0.855 . . . . 64.21 113.307 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.44 HG23 HG23 ' A' ' 16' ' ' VAL . 21.1 m -140.38 150.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.264 0.554 . . . . 74.0 112.436 -171.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -149.57 34.21 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.627 -1.249 . . . . 74.13 107.627 169.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.45 -74.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.048 -0.978 . . . . 65.41 110.88 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.79 -31.59 13.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.841 0.353 . . . . 73.24 110.629 176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -142.36 136.24 29.43 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.923 -0.58 . . . . 61.5 109.976 -176.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.51 130.56 45.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.642 -0.254 . . . . 72.25 110.47 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.61 126.39 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.691 0.282 . . . . 73.41 110.245 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.12 143.99 36.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.935 -0.575 . . . . 73.11 111.516 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.67 -27.64 66.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.784 -0.643 . . . . 74.3 111.99 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 -5.16 87.91 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.51 -0.852 . . . . 63.21 112.216 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.2 p -123.59 12.61 9.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.717 0.265 . . . . 70.42 111.717 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.434 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 26.6 m -98.53 -12.78 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.967 0.413 . . . . 75.51 110.417 174.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -157.9 93.14 1.24 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.43 -0.952 . . . . 75.32 108.43 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pm0 -135.96 142.49 44.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.05 0.452 . . . . 72.23 110.19 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.564 HG22 ' HB ' ' A' ' 9' ' ' THR . 3.6 m -120.29 106.7 12.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.774 -0.648 . . . . 74.01 110.108 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 p -87.0 147.43 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 64.22 111.138 -175.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -99.6 117.46 34.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 73.31 110.466 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.99 -29.25 23.65 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.196 0.522 . . . . 64.22 110.083 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 92.47 171.28 41.01 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.559 -0.746 . . . . 70.14 111.88 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -78.9 91.42 4.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.713 0.292 . . . . 73.05 110.461 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.547 HG11 HG22 ' A' ' 5' ' ' VAL . 9.8 p -72.46 146.78 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.382 -0.599 . . . . 73.44 109.382 175.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -89.07 139.85 30.04 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.944 0.402 . . . . 75.42 110.803 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.9 p -73.13 -7.24 50.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.858 -0.61 . . . . 70.11 111.371 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.67 -26.99 27.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.019 -0.537 . . . . 63.03 110.606 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.506 ' HB2' HD12 ' A' ' 42' ' ' LEU . 9.1 m -74.24 -21.7 59.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 63.21 110.712 -177.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -127.43 107.71 10.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.624 -0.716 . . . . 73.3 109.828 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.78 10.9 3.4 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.708 -0.397 . . . . 73.33 111.781 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -146.66 143.69 28.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.773 0.321 . . . . 72.42 111.351 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.0 tm-20 -57.93 119.51 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.683 -0.69 . . . . 75.34 109.932 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.48 -6.09 29.93 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.793 -0.718 . . . . 54.04 111.999 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.468 ' HB1' ' HB1' ' A' ' 139' ' ' ALA . . . -72.69 131.33 42.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.677 0.275 . . . . 52.01 110.344 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.536 HG21 ' HD1' ' A' ' 138' ' ' PHE . 40.1 p -121.04 145.82 47.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.221 -0.445 . . . . 74.22 110.205 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.6 t -99.3 176.58 5.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.12 -0.696 . . . . 74.43 109.12 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.5 m -71.86 140.34 49.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.956 0.408 . . . . 74.4 110.083 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -92.4 159.36 15.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.573 0.702 . . . . 64.45 111.926 -176.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.3 m -98.33 151.84 4.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.463 -1.244 . . . . 72.2 109.16 170.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.7 73.32 0.27 Allowed Glycine 0 C--N 1.313 -0.733 0 C-N-CA 120.761 -0.733 . . . . 61.25 112.353 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -82.22 153.34 25.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.75 -0.463 . . . . 74.24 109.75 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.576 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.1 p-10 -122.78 145.02 48.79 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.185 0.516 . . . . 71.23 111.808 -174.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.433 HD11 ' CE2' ' A' ' 133' ' ' PHE . 67.3 mt -110.85 118.37 57.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.861 -0.792 . . . . 74.21 108.861 171.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -100.77 130.53 46.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 73.21 110.881 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 128' ' ' THR . 40.9 mt -112.35 118.18 34.5 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.823 -0.436 . . . . 72.21 109.823 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -94.54 140.86 29.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.309 -0.405 . . . . 43.35 110.117 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.4 t70 49.0 76.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.136 0.898 . . . . 73.04 110.721 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 41.7 t -109.68 143.73 39.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.05 -0.977 . . . . 70.02 109.564 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -120.79 153.04 37.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.255 0.465 . . . . 64.14 112.255 -171.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.2 p -115.16 -2.59 12.7 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.934 -0.575 . . . . 72.41 111.835 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -72.15 -38.36 69.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.677 -0.49 . . . . 73.02 109.677 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.86 -32.4 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.864 -0.607 . . . . 65.23 111.383 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.57 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . . . -110.06 171.98 7.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.764 0.316 . . . . 75.24 111.474 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.43 ' CB ' ' HD2' ' A' ' 68' ' ' LYS . 20.1 m -133.73 -58.43 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.349 -0.387 . . . . 74.33 111.439 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -139.21 136.4 34.96 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.087 -0.338 . . . . 64.43 110.087 -177.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HB2' HD22 ' A' ' 124' ' ' LEU . . . -99.4 130.07 45.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.278 0.561 . . . . 71.04 110.676 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.66 125.56 19.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.333 -0.848 . . . . 72.04 109.217 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 2.1 m -95.39 145.13 8.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.927 0.394 . . . . 75.01 110.993 -175.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.82 126.37 54.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.799 -0.637 . . . . 74.32 109.453 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 61.7 m-85 -93.02 137.19 32.6 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.122 0.487 . . . . 73.34 111.16 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.6 tp -134.73 134.1 40.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.7 -0.682 . . . . 75.03 109.709 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.39 -140.31 3.02 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.45 -0.66 . . . . 62.34 111.45 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.493 ' O ' HD12 ' A' ' 86' ' ' LEU . 39.2 m -103.26 118.59 37.12 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.092 -0.336 . . . . 72.13 110.092 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -80.41 138.26 36.61 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.176 -0.305 . . . . 74.14 110.176 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.51 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 10.4 tt -65.69 -27.82 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 75.22 110.694 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -158.83 176.8 11.88 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.323 -0.621 . . . . 71.32 109.323 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.1 -39.5 23.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.965 0.412 . . . . 70.12 110.244 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.02 -17.53 78.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.833 -0.699 . . . . 72.1 111.456 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.404 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 66.2 m80 -119.77 54.34 1.02 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.552 0.691 . . . . 70.12 109.685 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.516 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -78.78 14.62 1.28 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.13 -0.941 . . . . 75.14 111.86 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -112.57 2.38 16.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.201 0.524 . . . . 53.22 110.415 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 102' ' ' GLN . 61.1 t -116.61 125.95 73.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 75.23 110.027 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.532 HD13 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -70.2 132.16 45.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.805 0.336 . . . . 75.21 110.307 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -80.02 152.86 29.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.833 -0.622 . . . . 72.51 110.149 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.649 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.6 mm? -85.61 144.86 27.63 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.378 -0.374 . . . . 71.24 110.635 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -71.84 144.52 49.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.904 -0.589 . . . . 64.14 110.926 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.61 102.46 3.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.01 -0.541 . . . . 71.45 109.865 174.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.2 m -101.43 6.09 42.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.067 -0.515 . . . . 61.42 110.573 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.61 13.19 8.77 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.514 -0.766 . . . . 74.31 111.228 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.22 6.17 12.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.773 -0.649 . . . . 71.55 110.483 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.67 95.04 1.03 Allowed Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.778 -0.929 . . . . 73.53 110.778 -176.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.05 154.23 35.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.876 0.37 . . . . 73.22 110.968 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.43 ' O ' HD23 ' A' ' 88' ' ' LEU . . . -69.06 148.76 49.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.082 -0.508 . . . . 70.45 109.672 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.56 160.18 40.57 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.761 -0.375 . . . . 73.52 110.478 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.404 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 44.9 m-80 65.95 8.8 5.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 73.45 110.232 -174.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -151.29 154.46 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 115.356 -0.838 . . . . 74.32 109.8 175.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -159.2 -169.15 22.19 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 110.597 -1.001 . . . . 62.32 110.597 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.41 109.25 27.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.53 0.681 . . . . 52.52 110.376 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.528 ' HB3' HG23 ' A' ' 85' ' ' VAL . 3.3 pt20 -96.88 150.42 20.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.757 -0.656 . . . . 75.41 109.676 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.54 122.18 67.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.151 0.501 . . . . 74.02 110.869 -175.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 14.4 mt -92.84 146.71 23.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 72.34 109.811 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.4 p-10 -78.43 -169.19 1.58 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.104 -0.498 . . . . 71.51 109.811 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -61.22 -30.05 70.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.928 0.344 . . . . 72.32 111.928 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.1 p -84.47 -10.95 57.03 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.692 -0.403 . . . . 71.45 111.218 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.53 23.89 17.56 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.659 -0.781 . . . . 74.03 112.58 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.61 134.05 51.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.327 -0.249 . . . . 74.15 110.327 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.14 132.3 50.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.074 0.464 . . . . 74.24 111.078 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.5 mt -94.38 141.08 28.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.754 -0.657 . . . . 64.21 110.323 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.1 m -78.99 139.56 38.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.353 -0.385 . . . . 73.43 110.436 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.505 HD12 HD21 ' A' ' 86' ' ' LEU . 36.5 mt -86.05 47.77 1.51 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.3 -0.409 . . . . 73.42 110.918 -176.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -104.45 -3.89 23.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.359 -0.382 . . . . 74.5 110.654 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.5 -0.76 63.52 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.149 -0.548 . . . . 54.2 113.345 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.04 -15.79 9.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.03 0.415 . . . . 62.4 111.103 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -84.94 104.17 14.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.252 -0.431 . . . . 74.21 110.545 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.431 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 96.0 m-85 -94.33 162.02 14.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.159 -0.473 . . . . 74.21 110.468 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.526 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.6 m -67.34 179.86 1.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.995 -0.548 . . . . 72.4 111.088 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.0 m -71.91 167.95 18.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.749 -0.463 . . . . 75.22 109.749 172.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.523 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 39.7 mt-10 -68.98 109.03 3.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.984 0.421 . . . . 75.14 111.785 -173.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.0 m -90.92 96.93 10.88 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.798 -0.816 . . . . 62.51 108.798 168.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.0 m -60.55 126.92 29.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.173 0.511 . . . . 73.31 110.484 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.499 HD12 ' SG ' ' A' ' 61' ' ' CYS . 96.5 mt -85.96 153.73 21.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.585 -0.734 . . . . 65.41 112.387 -170.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -128.85 150.53 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.956 -1.02 . . . . 70.05 108.43 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.6 m120 -64.61 107.77 1.5 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.17 0.51 . . . . 64.12 111.016 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.49 -151.21 21.81 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.514 -0.766 . . . . 74.45 111.497 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 50.7 m -89.48 116.92 28.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.267 0.556 . . . . 73.2 111.097 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.412 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 36.6 m-80 -110.06 126.64 54.22 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.744 -0.662 . . . . 72.23 109.974 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.576 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.3 m -106.93 114.95 29.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.247 -0.433 . . . . 52.3 110.148 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.1 mt -91.21 118.74 68.69 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.709 -0.478 . . . . 75.34 109.709 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -84.54 129.57 4.29 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.787 2.325 . . . . 73.41 112.656 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.433 ' CE2' HD11 ' A' ' 56' ' ' ILE . 62.6 m-85 -129.45 168.82 15.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.139 -0.482 . . . . 74.51 110.333 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.648 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 22.8 mt-30 -135.85 120.29 18.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.926 0.394 . . . . 71.41 111.621 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.23 125.97 51.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.373 -0.376 . . . . 72.41 110.039 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 6.2 ptp180 -140.35 165.03 28.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 71.41 110.921 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.549 ' HH ' ' HA3' ' A' ' 8' ' ' GLY . 67.3 m-85 -83.89 145.05 28.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.111 -0.495 . . . . 75.43 110.974 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.536 ' HD1' HG21 ' A' ' 48' ' ' THR . 78.9 t80 -133.58 128.86 36.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.67 -0.695 . . . . 74.31 109.212 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.565 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -94.95 133.92 38.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.269 -0.423 . . . . 75.34 111.496 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.543 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 82.0 p -104.57 6.02 34.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.664 0.745 . . . . 75.44 109.279 175.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.86 -129.57 1.95 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.12 -0.946 . . . . 74.41 111.4 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -85.47 93.03 8.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.244 -0.28 . . . . 72.14 110.244 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -45.75 112.66 0.49 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.755 0.659 . . . . 73.33 111.264 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.2 p -102.48 140.49 21.16 Favored Pre-proline 0 N--CA 1.442 -0.861 0 CA-C-O 121.061 0.457 . . . . 75.44 110.417 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.67 165.76 29.77 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 123.534 2.823 . . . . 74.33 112.666 -175.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.5 -149.76 21.84 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.482 -0.866 . . . . 45.11 111.803 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.86 120.81 35.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.155 -0.313 . . . . 71.42 110.155 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.649 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -111.73 50.35 0.85 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 71.54 111.299 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -101.43 136.21 41.65 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.201 -0.666 . . . . 75.31 109.201 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.532 ' HB1' HD13 ' A' ' 86' ' ' LEU . . . -143.31 165.32 27.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.619 0.247 . . . . 72.21 111.045 -177.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -135.06 143.7 46.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.34 -0.391 . . . . 70.41 110.204 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.21 141.31 24.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.049 0.452 . . . . 74.33 110.959 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 13' ' ' LYS . 35.9 p -103.28 131.29 50.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.938 -0.574 . . . . 75.2 109.616 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.418 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 53.1 p90 -111.78 140.94 46.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.919 0.39 . . . . 73.42 110.557 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.55 ' HA ' HG22 ' A' ' 16' ' ' VAL . 2.0 tmmm? -127.25 111.11 13.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.656 -0.702 . . . . 74.42 110.092 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.3 m -78.44 143.59 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.018 0.437 . . . . 75.32 110.372 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -126.82 126.26 43.06 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.446 -0.575 . . . . 74.43 109.446 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.647 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -136.21 -11.78 1.92 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.936 0.398 . . . . 72.44 111.781 178.042 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.36 -0.829 . . . . 72.51 109.172 172.255 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.976 -0.379 . . . . 61.45 109.976 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.72 -172.67 1.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.445 -0.343 . . . . 53.43 110.199 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.459 HG23 HG23 ' A' ' 4' ' ' THR . 15.0 t -85.92 -8.75 57.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.053 0.454 . . . . 65.42 111.037 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.459 HG23 HG23 ' A' ' 3' ' ' THR . 61.8 p -121.13 -178.37 3.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.962 0.41 . . . . 73.14 110.891 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG23 HG13 ' A' ' 37' ' ' VAL . 33.5 m -90.13 15.48 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.11 0.481 . . . . 72.21 110.601 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 62.19 22.72 13.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.16 -0.927 . . . . 75.31 112.541 172.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.513 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 83.14 90.25 0.7 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.46 -0.876 . . . . 71.42 111.916 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.525 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -85.23 161.03 35.42 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.436 -0.888 . . . . 62.14 112.382 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.508 ' HB ' HG21 ' A' ' 31' ' ' THR . 60.2 p -140.34 146.21 38.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.645 0.259 . . . . 73.43 110.781 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.457 HG23 HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -122.05 122.08 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.586 -0.524 . . . . 73.43 109.586 170.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -93.09 121.82 34.83 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.834 -0.432 . . . . 73.43 109.834 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 85.2 m-85 -107.69 123.32 48.33 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.841 -0.618 . . . . 74.41 110.46 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HB3' HG22 ' A' ' 153' ' ' THR . 41.2 tptt -104.07 137.7 41.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.092 -0.504 . . . . 74.22 110.045 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -125.56 -136.24 4.47 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.709 -0.757 . . . . 72.32 112.836 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.637 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 48.9 mt-10 64.06 20.55 12.24 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.986 0.514 . . . . 64.45 110.89 -176.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.609 HG23 ' HA ' ' A' ' 155' ' ' LYS . 26.8 m -69.62 -24.44 27.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.685 -0.688 . . . . 72.12 111.107 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.45 HG21 ' CG2' ' A' ' 156' ' ' VAL . 16.4 m -138.19 141.17 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.171 0.51 . . . . 75.21 112.004 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -143.75 24.78 1.68 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.961 -1.018 . . . . 73.13 108.483 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.73 -73.5 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.414 -0.812 . . . . 74.01 111.047 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.501 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -90.28 -40.88 11.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.901 0.381 . . . . 74.44 110.502 177.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -139.16 133.14 31.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.098 -0.501 . . . . 71.03 110.038 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.95 124.67 40.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.419 -0.355 . . . . 73.5 110.434 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.449 ' HA ' HD21 ' A' ' 58' ' ' LEU . 7.3 t -63.96 133.4 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.669 -0.493 . . . . 73.21 109.669 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.489 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.7 t70 -59.4 140.42 56.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.239 -0.437 . . . . 71.35 110.671 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.75 -26.49 67.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.488 . . . . 74.01 112.115 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.55 -23.66 72.46 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.496 -0.859 . . . . 45.22 112.062 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.2 p -102.86 -7.72 21.34 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.913 0.338 . . . . 72.44 111.913 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.637 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 34.1 m -84.4 -2.87 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.063 0.458 . . . . 73.52 110.82 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -165.08 85.19 0.39 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.124 -1.065 . . . . 70.53 108.124 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -137.19 133.22 34.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.552 -0.749 . . . . 61.13 110.469 -173.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.508 HG21 ' HB ' ' A' ' 9' ' ' THR . 3.5 m -110.45 100.57 9.38 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.567 -0.742 . . . . 64.24 109.098 176.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.448 HG11 HG22 ' A' ' 10' ' ' VAL . 8.2 p -84.77 128.32 39.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.228 0.537 . . . . 73.14 110.488 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.418 ' HG3' HG22 ' A' ' 9' ' ' THR . 26.4 mp0 -88.43 128.61 35.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.541 -0.754 . . . . 63.22 109.718 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.457 HD21 HG23 ' A' ' 10' ' ' VAL . 2.7 mm? -88.74 -34.56 17.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.336 0.589 . . . . 73.11 109.87 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 104.37 -179.6 24.72 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.433 -0.803 . . . . 73.44 111.813 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.416 ' HB3' ' CB ' ' A' ' 4' ' ' THR . 44.7 mt-30 -84.44 89.85 7.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.829 0.347 . . . . 72.25 110.576 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.545 HG13 HG23 ' A' ' 5' ' ' VAL . 9.5 p -70.81 141.82 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 74.41 110.267 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.54 137.27 40.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.972 -0.558 . . . . 74.34 109.965 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.3 p -86.88 5.17 38.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.468 0.652 . . . . 74.22 110.346 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.31 -27.87 18.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.433 -0.803 . . . . 73.53 110.737 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.452 ' HB2' HD11 ' A' ' 42' ' ' LEU . 12.3 m -72.23 -41.46 66.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.427 0.632 . . . . 70.24 110.342 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.564 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 5.1 mp -98.88 114.51 27.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.362 -0.835 . . . . 74.33 109.54 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.4 10.78 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.217 0.451 . . . . 65.12 112.217 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -150.57 153.51 35.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.552 0.215 . . . . 74.13 110.854 -177.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.533 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -65.58 121.11 14.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.022 -0.732 . . . . 75.32 109.022 176.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.427 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 106.27 2.57 38.46 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.591 -0.814 . . . . 64.12 111.761 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 139' ' ' ALA . . . -80.91 140.4 35.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.817 0.341 . . . . 74.41 110.74 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.8 p -126.36 151.6 47.4 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.977 -0.556 . . . . 73.42 110.991 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.474 ' O ' ' HD2' ' A' ' 136' ' ' ARG . 27.3 t -104.07 179.47 4.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.044 -0.725 . . . . 65.55 109.044 174.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.3 m -73.54 129.59 38.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.239 -0.282 . . . . 53.45 110.239 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.661 ' HA ' ' HB3' ' A' ' 136' ' ' ARG . . . -82.29 157.6 23.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.595 0.712 . . . . 70.11 112.019 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.2 m -98.12 152.13 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.61 -1.177 . . . . 64.43 109.622 172.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.54 94.78 1.02 Allowed Glycine 0 C--N 1.313 -0.743 0 C-N-CA 120.785 -0.722 . . . . 60.22 112.276 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -107.93 178.34 4.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.031 -0.729 . . . . 72.11 109.031 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.569 ' HB2' HG22 ' A' ' 130' ' ' THR . 0.3 OUTLIER -148.97 151.51 34.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.964 0.727 . . . . 73.41 112.964 -177.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 83.0 mt -109.53 111.8 37.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.905 -1.043 . . . . 74.12 108.837 173.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 52.8 tt0 -94.55 135.01 36.49 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.198 -0.455 . . . . 71.43 111.074 -172.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.449 HD21 ' HA ' ' A' ' 23' ' ' VAL . 75.4 mt -116.12 119.32 35.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.25 -0.432 . . . . 71.31 110.288 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -101.41 146.1 28.06 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.074 -0.512 . . . . 73.12 110.06 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 52.04 65.73 1.41 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.635 0.731 . . . . 73.21 110.224 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.469 ' SG ' HD11 ' A' ' 124' ' ' LEU . 39.1 t -100.24 137.26 38.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.245 -0.889 . . . . 64.12 110.258 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.428 ' OD2' HG11 ' A' ' 65' ' ' VAL . 17.1 t70 -111.64 137.75 49.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.213 -0.448 . . . . 73.12 111.494 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -102.32 0.98 35.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.133 -0.485 . . . . 73.23 112.246 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -79.74 -34.75 39.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.852 0.358 . . . . 64.5 110.371 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.43 HG13 ' HB1' ' A' ' 20' ' ' ALA . 11.7 p -107.5 -12.37 10.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.035 0.445 . . . . 70.13 110.928 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -122.8 179.41 4.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.709 0.29 . . . . 74.24 111.152 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.2 m -143.6 -59.17 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.3 -0.409 . . . . 65.32 110.796 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.559 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -137.94 139.58 39.83 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.576 -0.527 . . . . 73.21 109.576 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.27 118.53 36.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.143 0.497 . . . . 74.21 110.471 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.16 119.11 21.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.545 -0.752 . . . . 74.45 109.476 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 2.4 m -90.31 146.49 6.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.963 0.411 . . . . 74.52 110.838 -175.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' A' ' 118' ' ' PHE . . . -115.07 142.3 46.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.599 -0.728 . . . . 63.23 109.149 172.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.463 ' CZ ' HG22 ' A' ' 103' ' ' ILE . 78.3 m-85 -106.68 140.06 40.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.114 0.483 . . . . 71.14 110.93 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.3 tp -131.54 138.03 48.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.554 -0.748 . . . . 75.14 109.746 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.408 ' HA3' HD23 ' A' ' 86' ' ' LEU . . . -174.39 -160.06 21.86 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.23 -0.748 . . . . 37.67 111.23 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.4 m -91.82 114.37 26.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.671 0.235 . . . . 73.31 110.538 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.83 134.33 43.33 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.07 -0.344 . . . . 73.34 110.07 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.548 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 7.9 tt -63.54 -28.49 45.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.175 -0.466 . . . . 74.22 111.515 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -154.03 -178.94 7.42 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.79 -0.448 . . . . 71.22 109.79 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.81 -29.68 23.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.306 0.574 . . . . 73.43 109.703 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.44 -33.23 53.45 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.785 -0.721 . . . . 61.45 111.572 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -112.97 86.82 2.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.126 0.489 . . . . 73.31 110.155 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.5 p -93.56 8.74 39.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.821 -0.627 . . . . 73.44 111.411 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -115.14 0.47 13.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.146 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 102' ' ' GLN . 85.3 t -114.55 121.89 67.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.292 -0.413 . . . . 72.51 110.12 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.716 HD22 HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -70.56 130.09 40.92 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 110.039 -0.356 . . . . 64.12 110.039 -178.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 78' ' ' ILE . . . -77.1 149.38 35.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.864 -0.607 . . . . 75.41 110.417 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.566 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -86.18 138.45 31.89 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.274 -0.421 . . . . 74.5 110.345 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -68.02 141.15 56.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.356 0.598 . . . . 64.42 110.584 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.442 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 0.9 OUTLIER -85.28 116.21 23.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.335 -0.848 . . . . 72.32 111.214 -174.063 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.5 m -92.77 -1.67 56.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.797 -0.638 . . . . 65.04 110.464 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 66.47 5.82 4.01 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.777 -0.647 . . . . 74.54 111.955 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.77 11.24 12.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.149 0.499 . . . . 65.45 110.596 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.78 77.52 0.96 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.641 -0.79 . . . . 71.45 112.135 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 90' ' ' SER . 67.4 m -81.46 156.62 25.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.115 -0.328 . . . . 61.41 110.115 173.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.3 129.49 38.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.341 -0.39 . . . . 74.11 110.41 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.63 163.64 20.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.39 -0.368 . . . . 72.32 110.66 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 69.41 9.38 7.26 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.565 0.54 . . . . 54.23 110.409 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.87 174.12 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.423 -0.808 . . . . 71.13 110.133 174.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.498 ' HA2' HD23 ' A' ' 88' ' ' LEU . . . -172.33 -174.05 39.41 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.255 -1.138 . . . . 65.42 110.255 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.15 114.81 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.469 0.652 . . . . 74.31 110.565 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.429 ' HB3' HG23 ' A' ' 85' ' ' VAL . 3.4 pt20 -104.54 145.03 30.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.753 -0.658 . . . . 74.24 109.396 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.463 HG22 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -104.13 123.63 58.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.142 0.496 . . . . 73.24 110.254 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 16.7 mt -91.46 144.63 25.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.503 -0.771 . . . . 75.43 108.947 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.1 p-10 -71.63 -171.7 0.69 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.7 -0.481 . . . . 74.43 109.7 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.427 ' CG ' ' HB3' ' A' ' 120' ' ' SER . 12.8 ptm180 -63.28 -25.2 68.21 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.098 0.407 . . . . 75.44 112.098 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.1 p -85.88 -34.33 21.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.709 -0.396 . . . . 73.43 110.759 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.74 29.6 1.38 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.655 -0.783 . . . . 63.23 112.446 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.08 131.32 54.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.034 -0.358 . . . . 71.41 110.034 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.35 120.88 15.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.398 -0.365 . . . . 73.22 110.797 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.7 133.31 33.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.168 -0.469 . . . . 63.35 110.539 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.53 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 16.2 m -69.38 139.34 54.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.164 -0.471 . . . . 74.4 110.445 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.716 HD12 HD22 ' A' ' 86' ' ' LEU . 29.6 mt -84.37 47.44 1.35 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.202 -0.454 . . . . 64.54 111.055 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -107.14 -6.04 17.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.964 0.412 . . . . 74.2 110.487 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.69 1.42 77.48 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.972 -0.632 . . . . 70.42 112.621 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -120.7 -0.85 10.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.008 0.432 . . . . 71.51 110.973 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.53 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 10.7 m -98.5 112.4 24.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.059 -0.518 . . . . 71.13 109.659 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.401 ' CD1' ' HB1' ' A' ' 72' ' ' ALA . 96.1 m-85 -103.67 162.38 13.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.189 0.518 . . . . 75.31 111.492 -172.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.7 m -77.63 -175.0 3.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 64.34 111.405 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.427 ' HB3' ' CG ' ' A' ' 106' ' ' ARG . 42.5 t -63.74 153.86 35.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.043 -0.526 . . . . 64.44 110.572 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.559 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 40.4 mt-10 -68.35 97.84 0.78 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.916 -0.584 . . . . 73.34 110.686 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.6 m -79.54 100.5 7.78 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.442 -0.577 . . . . 75.41 109.442 173.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.8 m -57.07 114.95 2.35 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.906 -0.588 . . . . 75.3 110.683 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.469 HD11 ' SG ' ' A' ' 61' ' ' CYS . 91.3 mt -80.47 150.5 29.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.659 -0.7 . . . . 74.43 111.444 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -136.3 157.46 46.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.684 -0.858 . . . . 74.32 108.684 170.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -59.03 115.88 3.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.709 0.29 . . . . 60.34 110.868 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 131.45 -138.44 10.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 64.22 112.383 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 54.9 m -97.43 125.06 41.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.285 0.564 . . . . 75.21 111.378 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -121.97 110.97 16.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.5 -0.773 . . . . 73.45 109.612 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.569 HG22 ' HB2' ' A' ' 55' ' ' ASN . 5.7 m -103.54 116.93 33.29 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.238 -0.437 . . . . 73.14 110.435 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.61 112.9 59.61 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.093 -0.503 . . . . 73.15 110.479 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -80.3 143.37 15.61 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.504 2.136 . . . . 75.53 112.633 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -140.64 165.67 26.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 74.44 110.618 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.623 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 96.4 mt-30 -126.7 121.31 31.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.178 -0.465 . . . . 72.03 111.011 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 52' ' ' VAL . . . -110.34 130.21 55.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.189 -0.3 . . . . 71.55 110.189 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.661 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 39.8 ptt180 -149.78 170.68 18.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 74.04 111.397 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.525 ' HH ' ' HA3' ' A' ' 8' ' ' GLY . 92.0 m-85 -86.37 145.33 26.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.593 -0.73 . . . . 71.33 111.084 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.427 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 75.3 t80 -130.33 133.28 46.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.244 -0.889 . . . . 73.24 108.644 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . . . -100.52 138.7 37.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.039 0.447 . . . . 70.32 111.617 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.533 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 57.0 p -102.98 3.36 36.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.506 -0.77 . . . . 72.23 109.575 176.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.57 -132.92 2.73 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.998 -1.001 . . . . 41.32 110.86 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.54 91.47 2.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.063 -0.347 . . . . 74.32 110.063 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.12 112.49 0.58 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 73.12 111.333 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -104.24 141.44 22.53 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 116.052 -0.522 . . . . 55.24 110.593 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -71.1 171.78 15.24 Favored 'Trans proline' 0 C--N 1.334 -0.222 0 C-N-CA 123.877 3.051 . . . . 73.52 113.035 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.6 -161.35 26.61 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.665 -0.779 . . . . 75.12 111.989 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.31 112.52 16.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.652 0.226 . . . . 73.41 110.397 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.566 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -113.75 71.92 0.76 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.447 . . . . 72.13 111.375 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -120.92 128.09 52.44 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.444 -0.576 . . . . 74.53 109.444 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.501 ' HB2' HD12 ' A' ' 86' ' ' LEU . . . -130.5 171.86 12.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 72.33 111.913 -173.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -129.9 127.22 39.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.667 -0.697 . . . . 73.41 110.428 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 12' ' ' PHE . . . -139.13 125.81 20.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.191 0.519 . . . . 44.22 110.784 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.541 HG22 ' HB3' ' A' ' 13' ' ' LYS . 16.9 p -105.86 130.07 53.9 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.937 -0.574 . . . . 74.44 110.143 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -106.44 141.21 38.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.183 0.516 . . . . 75.44 111.072 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.609 ' HA ' HG23 ' A' ' 16' ' ' VAL . 3.9 tmmm? -126.38 109.39 12.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.602 -0.726 . . . . 73.24 109.808 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -75.2 142.86 14.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.029 0.443 . . . . 75.32 110.321 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -122.31 121.6 37.11 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.5 -0.556 . . . . 74.11 109.5 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.528 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 1.1 p90 -142.22 -17.59 0.73 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.394 . . . . 75.54 111.075 175.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.358 -0.829 . . . . 72.1 108.925 174.855 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.816 0.341 . . . . 72.24 110.724 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.33 -176.96 5.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.088 -0.506 . . . . 62.35 110.134 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 t -81.96 -16.82 49.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.175 0.512 . . . . 74.3 110.375 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 p -98.97 -176.42 3.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.949 -0.569 . . . . 63.44 110.723 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.572 HG22 HG11 ' A' ' 37' ' ' VAL . 33.7 m -89.52 13.69 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.824 0.345 . . . . 64.44 110.871 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 60.61 16.29 6.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.356 -0.838 . . . . 65.44 112.648 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.32 107.02 3.05 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.575 -0.821 . . . . 65.52 112.127 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.577 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -98.23 150.35 19.38 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.383 -0.913 . . . . 44.02 111.772 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.515 HG21 ' HA ' ' A' ' 33' ' ' GLN . 16.9 p -142.55 145.45 33.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.746 0.308 . . . . 64.11 110.766 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.622 HG23 HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -121.39 119.65 59.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.955 -0.566 . . . . 75.21 110.789 175.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -86.65 123.45 31.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.413 -0.812 . . . . 64.32 110.124 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -107.93 126.89 53.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.289 -0.414 . . . . 74.14 110.374 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.507 ' HB3' HG23 ' A' ' 153' ' ' THR . 64.7 tttp -111.88 129.14 56.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.133 -0.485 . . . . 64.14 110.087 177.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.4 -123.99 5.34 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.871 -0.681 . . . . 75.02 111.906 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.48 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 34.7 mt-10 64.33 16.35 10.07 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.135 0.493 . . . . 73.5 111.522 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 155' ' ' LYS . 27.2 m -81.33 -21.63 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.936 -0.575 . . . . 70.35 111.284 -177.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.537 HG13 HG22 ' A' ' 156' ' ' VAL . 18.5 m -137.74 141.88 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.296 0.569 . . . . 73.01 111.352 -176.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -147.0 23.24 1.2 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.289 -1.004 . . . . 71.45 108.289 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.2 -92.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.306 -0.861 . . . . 73.33 111.107 -176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -73.2 -35.53 66.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.898 0.38 . . . . 61.21 110.776 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 1.4 m -141.59 133.12 26.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.938 -0.574 . . . . 73.2 109.825 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.96 126.3 41.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.25 -0.432 . . . . 62.2 110.276 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 t -67.4 131.62 32.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.773 -0.454 . . . . 71.45 109.773 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' HG12 ' A' ' 28' ' ' VAL . 19.4 t70 -62.62 151.53 37.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.436 -0.347 . . . . 75.31 110.949 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.426 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -57.85 -36.02 71.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 73.3 111.472 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.24 -2.01 86.68 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.903 -0.665 . . . . 74.32 111.961 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.414 ' OG ' HG22 ' A' ' 56' ' ' ILE . 46.5 t -119.6 -3.45 10.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.502 0.191 . . . . 72.34 110.901 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.48 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 32.9 m -94.34 -14.34 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.61 -0.515 . . . . 64.34 109.61 172.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -150.38 91.17 1.72 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.194 -0.912 . . . . 75.32 109.577 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -141.17 141.96 34.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.143 0.496 . . . . 72.21 109.978 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.505 HG23 ' HB ' ' A' ' 9' ' ' THR . 9.1 m -123.41 109.6 14.08 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.83 -0.623 . . . . 73.3 109.664 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.419 HG13 HG22 ' A' ' 10' ' ' VAL . 10.9 p -86.29 136.39 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.949 0.404 . . . . 73.43 110.324 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.515 ' HA ' HG21 ' A' ' 9' ' ' THR . 27.0 mp0 -93.31 115.08 27.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.989 -0.551 . . . . 54.24 110.43 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.622 HD21 HG23 ' A' ' 10' ' ' VAL . 2.7 mm? -76.96 -30.03 55.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.65 -0.705 . . . . 74.54 109.61 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.94 -173.48 30.6 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.511 -0.768 . . . . 65.02 111.75 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -83.54 90.45 7.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.564 0.221 . . . . 64.51 110.541 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.572 HG11 HG22 ' A' ' 5' ' ' VAL . 7.5 p -61.6 141.32 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.183 0.516 . . . . 53.43 110.399 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -86.49 116.01 24.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.794 -0.639 . . . . 75.23 110.098 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 p -70.62 -12.65 61.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.362 -0.835 . . . . 73.13 112.197 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.26 -30.47 48.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.887 0.375 . . . . 75.45 111.006 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.2 m -70.28 -40.66 74.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.547 0.689 . . . . 72.13 110.277 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -99.31 87.08 3.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.48 -0.782 . . . . 75.54 110.298 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.13 14.21 9.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.019 0.438 . . . . 73.31 111.257 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -154.64 146.74 23.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.782 -0.645 . . . . 75.51 109.504 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 43.1 tt0 -60.1 136.52 58.05 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.103 -0.332 . . . . 73.45 110.103 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.97 -14.3 60.13 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.606 -0.806 . . . . 63.24 111.813 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.35 125.15 25.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.698 0.285 . . . . 64.33 110.448 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.513 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 20.3 p -117.41 140.5 49.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.323 -0.399 . . . . 72.24 110.515 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.1 t -86.39 174.51 8.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.74 -0.466 . . . . 71.12 109.74 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -68.0 134.53 50.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.504 -0.554 . . . . 61.21 109.504 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -87.06 155.67 20.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.429 0.633 . . . . 73.25 111.757 -175.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.5 m -90.96 152.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.688 -1.142 . . . . 74.3 109.024 169.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.05 87.16 0.46 Allowed Glycine 0 C--N 1.31 -0.888 0 C-N-CA 120.784 -0.722 . . . . 53.04 111.776 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -101.68 173.12 6.56 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.769 -0.456 . . . . 74.23 109.769 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -140.82 146.92 38.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.905 0.383 . . . . 61.22 111.244 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.418 HD13 ' CE1' ' A' ' 154' ' ' PHE . 41.1 mt -102.58 122.45 54.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.605 -0.725 . . . . 72.34 109.251 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -100.72 126.86 47.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.099 -0.5 . . . . 74.25 111.305 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 128' ' ' THR . 70.4 mt -111.44 129.5 56.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.664 -0.698 . . . . 74.34 109.835 175.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -102.27 135.09 44.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.157 -0.474 . . . . 70.41 110.098 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.9 t70 49.09 77.51 0.1 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.069 0.855 . . . . 65.31 111.052 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.457 ' HB3' ' ND2' ' A' ' 129' ' ' ASN . 49.0 t -108.85 129.83 55.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.162 -0.927 . . . . 64.12 110.128 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -99.12 147.55 24.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.029 0.443 . . . . 73.23 111.772 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -115.84 8.99 14.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.647 -0.706 . . . . 74.43 111.546 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -91.24 -31.49 16.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.006 0.431 . . . . 73.32 110.006 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.29 -16.17 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.17 0.509 . . . . 63.01 110.571 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . . . -128.35 -178.33 4.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.269 -0.423 . . . . 74.34 110.792 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.478 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 37.1 m -144.19 -59.2 0.38 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.696 -0.229 . . . . 71.53 111.231 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.6 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -135.65 141.17 44.98 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 110.041 -0.355 . . . . 75.41 110.041 -178.331 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.06 124.74 49.1 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.093 0.473 . . . . 74.42 110.618 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.59 117.71 17.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.734 -0.667 . . . . 74.14 109.369 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.5 m -93.4 150.16 4.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.071 0.462 . . . . 72.45 110.768 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.37 124.15 44.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.49 -0.777 . . . . 65.43 109.474 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CE1' HG22 ' A' ' 103' ' ' ILE . 62.9 m-85 -86.39 134.73 33.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.213 0.53 . . . . 73.12 110.643 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.6 tp -132.38 122.44 25.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.512 -0.767 . . . . 75.31 109.73 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.15 -166.55 27.4 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.127 -0.789 . . . . 71.14 111.127 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.496 ' O ' HD11 ' A' ' 86' ' ' LEU . 4.1 m -76.8 124.95 28.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.476 0.179 . . . . 72.54 110.823 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -80.39 140.62 35.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.264 -0.273 . . . . 73.54 110.264 177.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.439 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 13.3 tt -62.98 -29.03 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.011 0.434 . . . . 75.04 111.118 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -149.68 178.08 9.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.443 -0.577 . . . . 73.12 109.443 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.95 -27.84 30.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.069 0.462 . . . . 74.32 109.981 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.32 -37.91 9.44 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.817 -0.706 . . . . 55.54 111.505 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -95.5 77.57 3.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.709 -0.478 . . . . 72.41 109.709 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 15.6 p -91.61 12.89 19.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.807 -0.633 . . . . 75.11 111.316 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -112.79 -5.01 13.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.125 -0.489 . . . . 73.52 110.993 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -112.12 128.83 68.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.384 -0.371 . . . . 72.44 110.249 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.499 HD12 ' HB2' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -68.64 137.56 54.3 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.014 -0.365 . . . . 72.24 110.014 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.97 157.57 29.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.181 -0.463 . . . . 65.21 110.34 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 99' ' ' VAL . 1.5 mm? -93.71 139.63 30.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.371 -0.377 . . . . 73.44 110.451 -176.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 149' ' ' ASN . 31.4 mt-30 -65.38 135.62 55.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.256 0.551 . . . . 71.13 109.642 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.423 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 1.2 m -96.93 123.52 40.66 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.708 -0.678 . . . . 73.44 110.263 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.4 m -97.78 -3.03 39.78 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.33 -0.396 . . . . 62.34 110.391 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 60.54 26.39 16.05 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.603 -0.726 . . . . 62.54 110.521 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.41 -12.97 1.35 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.701 -0.681 . . . . 75.24 112.134 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.65 74.58 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.137 -1.03 . . . . 51.5 112.679 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.423 ' OG ' ' HA ' ' A' ' 90' ' ' SER . 54.7 m -90.66 168.71 11.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.878 -0.416 . . . . 62.21 109.878 174.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -92.94 146.26 23.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.68 -0.236 . . . . 62.34 110.38 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.22 164.81 26.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.728 0.299 . . . . 71.35 110.935 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.417 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 23.6 m-80 68.76 7.56 6.21 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.881 0.873 . . . . 72.33 111.285 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.572 ' O ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -147.65 150.21 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-N 115.965 -0.561 . . . . 74.21 109.882 173.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.86 -170.2 15.71 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.712 -0.955 . . . . 54.11 110.712 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 p -121.34 122.44 67.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.155 0.502 . . . . 71.15 110.412 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.16 138.88 51.38 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.136 0.494 . . . . 72.33 109.768 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.456 HG22 ' CE1' ' A' ' 73' ' ' PHE . 4.2 mp -94.14 128.42 45.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.841 -0.618 . . . . 75.43 110.071 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 18.4 mt -96.35 154.86 17.03 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.486 -0.779 . . . . 75.31 109.462 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.536 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 2.4 p-10 -72.92 -167.95 0.43 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.401 -0.592 . . . . 73.41 109.401 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -71.29 -19.06 62.38 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.462 -0.495 . . . . 74.31 111.858 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.409 ' HG1' ' CG ' ' A' ' 105' ' ' ASP . 51.2 p -90.6 -35.22 15.13 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.913 -0.315 . . . . 75.14 110.952 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.83 26.34 1.41 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.516 -0.85 . . . . 62.54 113.349 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . -100.52 140.45 34.76 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.332 -0.247 . . . . 63.33 110.332 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.03 126.33 30.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.317 -0.401 . . . . 71.32 111.465 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.7 mt -87.28 147.28 25.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.017 -0.538 . . . . 72.23 110.326 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.6 m -93.37 141.04 28.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.109 -0.496 . . . . 73.24 110.55 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.434 HD12 HD22 ' A' ' 86' ' ' LEU . 63.7 mt -84.25 60.25 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.074 0.464 . . . . 74.41 110.977 -176.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -119.57 -4.84 10.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.016 -0.538 . . . . 74.41 109.909 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.29 4.97 65.43 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.617 -0.72 . . . . 74.12 112.726 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.48 -16.65 7.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 72.23 110.811 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 m -84.15 97.76 9.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.664 -0.495 . . . . 73.13 109.664 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.473 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 86.6 m-85 -87.49 165.43 15.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.837 -175.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.0 m -74.53 -171.08 1.14 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.948 -0.569 . . . . 74.14 110.888 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.2 p -72.79 164.9 25.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.963 -0.384 . . . . 52.22 109.963 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.421 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 41.7 mt-10 -72.78 103.03 3.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.924 0.392 . . . . 74.05 111.193 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.0 m -84.19 109.65 17.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.317 -0.623 . . . . 75.02 109.317 174.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 m -63.6 113.52 3.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.941 -0.572 . . . . 71.34 111.095 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.456 HD13 ' SG ' ' A' ' 61' ' ' CYS . 94.6 mt -77.66 150.14 34.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.857 -0.61 . . . . 73.22 110.943 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.425 ' C ' HD21 ' A' ' 125' ' ' ASN . 0.4 OUTLIER -135.96 152.47 51.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.949 -0.569 . . . . 71.44 109.642 170.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 2.7 m120 -55.15 113.31 1.32 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.988 0.423 . . . . 72.32 111.587 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.75 -145.93 16.55 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.901 -0.666 . . . . 73.41 112.265 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 28.3 m -82.76 129.27 34.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.782 0.325 . . . . 72.24 110.379 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.457 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 26.1 m-80 -122.25 133.13 54.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.214 -0.448 . . . . 64.52 110.884 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.63 113.33 26.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.245 -0.434 . . . . 64.54 110.922 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 16.1 mt -92.87 106.4 18.82 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.042 -0.725 . . . . 73.5 109.042 175.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 6.2 Cg_exo -79.09 135.13 12.07 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.033 2.489 . . . . 64.23 112.31 -176.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -136.41 166.87 22.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.294 -0.412 . . . . 72.25 110.623 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 27.5 mt-30 -132.89 117.9 18.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.954 -0.566 . . . . 75.11 110.922 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.95 125.26 50.2 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.188 -0.301 . . . . 55.22 110.188 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.513 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 14.8 ptp180 -140.63 164.45 30.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.818 0.342 . . . . 74.23 110.836 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.577 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 58.6 m-85 -81.54 149.02 28.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.931 -0.577 . . . . 72.33 111.206 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -132.03 127.68 36.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.427 -0.806 . . . . 74.45 109.127 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -91.64 135.0 34.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.978 0.418 . . . . 74.22 111.416 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.417 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 55.8 p -101.82 1.03 36.65 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.425 -0.954 . . . . 74.22 108.425 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.82 -123.89 1.1 Allowed Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.34 -1.3 . . . . 60.33 111.189 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.25 98.0 11.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.44 -0.207 . . . . 53.1 110.44 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -47.71 117.3 1.78 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.075 -0.511 . . . . 75.12 111.083 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.6 p -107.29 146.74 33.85 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.169 -0.469 . . . . 75.3 110.79 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.73 167.7 23.65 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.382 2.722 . . . . 61.14 112.726 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.63 -125.04 2.75 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.663 -0.78 . . . . 52.11 111.768 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -129.91 118.47 21.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.738 0.304 . . . . 65.44 110.461 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -114.53 71.85 0.77 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.12 0.486 . . . . 63.4 110.933 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.485 ' N ' HD21 ' A' ' 149' ' ' ASN . 0.8 OUTLIER -111.98 146.16 38.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.392 -0.596 . . . . 73.41 109.392 178.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.499 ' HB2' HD12 ' A' ' 86' ' ' LEU . . . -150.25 163.22 38.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.801 0.334 . . . . 63.01 111.395 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -132.99 144.88 50.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 74.34 109.797 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.96 152.05 33.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.408 0.623 . . . . 74.0 111.68 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 13' ' ' LYS . 7.9 p -108.1 142.6 38.05 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.299 -0.864 . . . . 74.34 109.259 173.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.418 ' CE1' HD13 ' A' ' 56' ' ' ILE . 53.7 p90 -117.94 130.47 56.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.926 0.393 . . . . 75.21 110.572 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.598 ' HA ' HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -110.03 112.45 24.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.098 -0.501 . . . . 75.12 110.36 178.157 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -80.47 146.32 7.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.912 -0.403 . . . . 72.44 109.912 178.31 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -127.29 123.53 36.63 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.281 -0.637 . . . . 62.33 109.281 171.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.6 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -135.27 -12.89 2.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.927 0.394 . . . . 75.22 111.337 175.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.23 -0.89 . . . . 62.21 109.559 170.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.882 0.373 . . . . 74.24 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.63 165.0 35.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.141 -0.481 . . . . 74.3 110.137 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.4 t -95.45 12.58 28.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.386 0.612 . . . . 74.44 110.566 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.9 p -118.64 171.49 8.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.042 -0.527 . . . . 72.54 110.135 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.425 HG23 HG11 ' A' ' 37' ' ' VAL . 27.2 m -87.84 21.49 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.018 0.437 . . . . 72.35 111.27 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 58.83 19.13 6.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.442 -0.799 . . . . 65.53 112.436 173.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.515 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 88.29 99.97 0.94 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.652 -0.785 . . . . 71.45 111.77 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.51 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -92.84 157.74 23.72 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.206 -0.997 . . . . 62.33 112.19 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.553 ' HB ' HG21 ' A' ' 31' ' ' THR . 73.0 p -140.91 148.95 41.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.57 0.224 . . . . 70.54 110.574 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.488 HG22 HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -121.69 119.36 58.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.943 -0.762 . . . . 71.4 108.943 171.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -91.15 109.56 20.82 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.402 -0.519 . . . . 74.13 109.694 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.446 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 97.7 m-85 -96.0 126.49 41.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.703 -0.68 . . . . 75.12 109.901 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -110.38 128.92 55.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.374 -0.376 . . . . 71.45 110.596 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.67 -139.1 10.35 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.056 -0.593 . . . . 62.12 111.85 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 60.83 27.48 17.28 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.356 0.598 . . . . 74.24 111.311 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.595 HG22 ' HA ' ' A' ' 155' ' ' LYS . 31.2 m -83.29 -28.96 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.647 -0.706 . . . . 75.2 111.188 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.641 HG21 HG21 ' A' ' 156' ' ' VAL . 16.4 m -142.36 151.04 18.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.349 -0.387 . . . . 71.42 110.939 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -167.98 84.17 0.2 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.713 -0.847 . . . . 74.12 108.713 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.1 -74.05 0.26 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.349 -0.841 . . . . 74.32 110.025 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.529 ' HB1' ' CD1' ' A' ' 158' ' ' TYR . . . -73.52 -35.27 65.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 75.53 109.997 173.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.411 ' CB ' ' HA ' ' A' ' 61' ' ' CYS . 4.2 m -143.56 -176.63 5.03 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.13 -0.693 . . . . 73.43 109.13 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.64 146.69 41.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.202 -0.666 . . . . 54.13 109.202 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 t -81.32 137.23 21.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.74 -0.467 . . . . 73.54 109.74 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.474 ' O ' HG11 ' A' ' 28' ' ' VAL . 12.3 t70 -65.45 141.35 58.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.61 -0.268 . . . . 73.05 110.328 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.461 ' HA ' HG21 ' A' ' 28' ' ' VAL . . . -57.12 -28.74 62.96 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.405 0.441 . . . . 75.35 111.98 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.28 -11.09 82.19 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.564 -0.827 . . . . 75.44 112.415 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.9 p -124.97 14.96 8.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.833 0.309 . . . . 74.42 111.833 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 24' ' ' ASP . 32.9 m -102.9 -5.74 9.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.087 0.47 . . . . 61.34 110.241 173.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -155.66 90.88 1.26 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.311 -0.859 . . . . 75.11 109.325 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 20.3 pm0 -139.65 124.29 18.33 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.346 0.593 . . . . 70.13 110.672 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.553 HG21 ' HB ' ' A' ' 9' ' ' THR . 2.2 m -100.54 95.09 6.48 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.452 -0.795 . . . . 64.23 109.29 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.99 136.59 24.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.209 0.528 . . . . 75.31 110.718 -174.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -96.58 118.63 33.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.448 -0.796 . . . . 73.41 110.267 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.488 HD21 HG22 ' A' ' 10' ' ' VAL . 2.6 mm? -90.13 -26.2 20.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.116 -0.493 . . . . 71.34 109.855 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.515 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 90.2 179.85 43.98 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.642 -0.708 . . . . 75.02 112.644 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -81.65 90.11 6.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.67 0.271 . . . . 72.33 110.636 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.425 HG11 HG23 ' A' ' 5' ' ' VAL . 7.3 p -79.28 142.36 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 110.249 -0.278 . . . . 74.41 110.249 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 38' ' ' ARG . 48.8 mtt180 -71.89 126.41 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 75.53 110.649 176.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.594 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 32.5 p -74.43 -20.22 60.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.07 0.462 . . . . 72.02 110.903 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.11 -29.95 65.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 73.31 111.442 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -71.06 -35.12 71.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.253 0.549 . . . . 74.41 110.25 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -98.74 74.08 2.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.713 -0.676 . . . . 73.32 110.256 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.94 17.66 18.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.083 0.468 . . . . 73.11 110.993 -172.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -150.37 138.7 20.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.866 -0.606 . . . . 64.42 110.218 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -55.72 126.59 26.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 74.54 110.358 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.37 -9.54 38.71 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.708 -0.758 . . . . 75.23 111.898 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.447 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . . . -62.97 121.04 12.56 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.73 0.3 . . . . 64.11 110.427 177.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.1 p -115.9 119.66 36.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.956 -0.566 . . . . 64.41 110.216 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.5 t -83.04 171.09 14.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.264 -0.425 . . . . 75.31 109.908 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.0 m -64.76 127.94 33.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.985 -0.552 . . . . 60.14 110.368 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 134' ' ' GLN . . . -83.3 147.58 27.87 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.492 0.663 . . . . 72.44 111.638 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.2 m -87.07 151.62 3.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 114.775 -1.102 . . . . 73.25 109.278 171.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.6 97.51 0.99 Allowed Glycine 0 C--N 1.311 -0.84 0 C-N-CA 120.976 -0.631 . . . . 61.32 112.322 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -109.87 172.44 6.85 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.81 -0.441 . . . . 73.24 109.81 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.536 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.3 p-10 -135.25 144.38 46.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.123 0.487 . . . . 74.34 111.648 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 81.7 mt -113.05 124.64 69.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.389 -0.823 . . . . 72.25 108.803 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -109.47 144.1 38.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.847 0.356 . . . . 74.04 111.089 -172.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 128' ' ' THR . 23.7 mt -120.52 133.4 55.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.227 -0.442 . . . . 75.02 109.823 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -112.15 155.29 24.17 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.928 -0.578 . . . . 72.44 109.839 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 51.58 45.77 27.55 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 123.849 0.718 . . . . 72.14 110.638 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.665 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 5.8 t -89.18 143.4 26.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.355 -0.838 . . . . 63.32 110.602 -174.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 64' ' ' ASN . 20.9 t70 -117.87 154.43 31.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 64.42 111.612 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.6 p -124.12 9.64 8.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.354 -0.384 . . . . 72.52 111.263 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.421 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 52.7 m-80 -84.37 -34.12 23.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 73.42 110.159 177.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.817 HG23 ' HG3' ' A' ' 159' ' ' GLN . 8.5 p -110.7 -17.09 8.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.044 -0.526 . . . . 73.44 110.985 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . . . -122.68 167.38 13.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.631 -0.259 . . . . 71.32 110.983 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.508 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 13.8 m -130.22 -55.4 1.11 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.404 -0.362 . . . . 61.55 111.117 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -138.67 153.23 48.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.177 -0.305 . . . . 73.32 110.177 -178.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.46 ' HB2' HD22 ' A' ' 124' ' ' LEU . . . -105.1 127.11 52.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.061 0.458 . . . . 64.24 110.369 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . . . -135.14 116.0 14.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.746 -0.661 . . . . 75.53 109.56 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.669 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.0 OUTLIER -89.81 144.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.158 0.504 . . . . 75.42 111.199 -174.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.85 118.07 29.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.215 -0.902 . . . . 74.42 109.537 173.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.503 ' CZ ' HG22 ' A' ' 103' ' ' ILE . 89.5 m-85 -82.71 137.83 34.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.188 0.518 . . . . 73.24 110.874 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.2 tp -128.42 135.78 49.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.554 -0.748 . . . . 74.35 109.521 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.08 -177.54 47.68 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.994 -0.622 . . . . 74.21 111.621 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 m -75.16 120.96 21.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.782 0.325 . . . . 75.15 110.818 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -79.18 144.14 34.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.137 -0.483 . . . . 50.14 110.402 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 tt -77.9 -21.26 13.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.013 0.435 . . . . 74.31 110.784 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -155.12 176.32 12.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.552 -0.536 . . . . 74.43 109.552 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.03 -29.02 32.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.98 0.419 . . . . 71.31 110.433 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.78 -24.63 19.97 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.832 -0.699 . . . . 72.43 111.692 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -99.91 50.71 0.91 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.348 0.594 . . . . 71.43 109.652 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.466 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 5.6 p -78.63 4.99 12.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.549 -0.751 . . . . 65.35 112.098 -176.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -107.7 -1.79 20.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.117 0.484 . . . . 72.43 110.525 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.62 123.98 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 73.22 110.285 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.59 HD23 HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -70.04 131.79 44.88 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.982 -0.377 . . . . 75.1 109.982 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.53 149.49 33.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.141 -0.482 . . . . 74.12 110.775 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.406 ' N ' HD21 ' A' ' 88' ' ' LEU . 2.3 mm? -81.02 143.75 32.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.896 -0.593 . . . . 73.31 110.567 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -63.19 141.68 58.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.026 -0.534 . . . . 73.42 111.09 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.8 p -77.14 112.33 13.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.765 -0.652 . . . . 75.54 110.678 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.5 m -105.17 -8.14 18.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.23 -0.441 . . . . 73.14 110.814 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 64.94 3.88 2.26 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.451 0.7 . . . . 63.22 112.174 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.13 11.03 20.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.219 0.533 . . . . 72.44 110.254 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.54 85.06 1.84 Allowed Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.429 -0.805 . . . . 74.41 111.673 -175.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.1 m -82.11 146.86 29.39 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.541 -0.541 . . . . 70.13 109.541 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.23 121.73 14.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.094 -0.335 . . . . 74.21 110.094 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.4 160.69 18.15 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.788 -0.365 . . . . 73.14 110.755 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 69.26 14.61 8.59 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.669 -0.696 . . . . 63.44 110.476 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.0 -179.99 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.887 -0.597 . . . . 71.31 110.058 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 179.4 -173.57 45.5 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.172 -1.171 . . . . 73.31 110.172 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 10' ' ' VAL . 3.2 p -119.95 114.59 44.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.628 0.727 . . . . 72.2 110.674 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -103.9 141.7 35.7 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.486 -0.779 . . . . 74.23 109.114 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.503 HG22 ' CZ ' ' A' ' 73' ' ' PHE . 4.3 mp -104.18 127.66 58.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.199 0.523 . . . . 72.31 110.464 -177.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.0 mt -93.44 147.24 23.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.425 -0.807 . . . . 75.34 109.222 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.571 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -70.29 -172.71 0.61 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.494 -0.558 . . . . 73.43 109.494 174.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -67.92 -16.62 64.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.398 0.518 . . . . 74.13 112.398 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.0 p -95.53 -32.49 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.718 -0.393 . . . . 64.54 111.053 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.71 32.49 0.76 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.735 -0.745 . . . . 74.31 112.82 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.4 125.41 50.96 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.724 -0.28 . . . . 72.12 110.36 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.61 116.59 12.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.953 0.406 . . . . 73.34 110.436 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.437 HD12 ' HG ' ' A' ' 119' ' ' SER . 85.6 mt -84.85 132.74 34.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.007 -0.542 . . . . 73.15 111.238 -175.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.408 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 25.0 m -68.72 141.61 55.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.816 -0.629 . . . . 73.35 110.604 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.59 HD11 HD23 ' A' ' 86' ' ' LEU . 49.8 mt -82.7 41.2 0.71 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 75.3 111.207 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.41 -16.36 46.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.86 0.362 . . . . 73.52 110.56 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.67 3.58 89.06 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.735 -0.745 . . . . 71.34 111.603 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -128.1 2.3 5.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.725 0.298 . . . . 60.51 111.316 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.408 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 9.0 m -94.37 102.89 14.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.016 -0.365 . . . . 73.23 110.016 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.484 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 75.6 m-85 -93.99 150.84 19.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.213 -0.449 . . . . 71.55 111.876 -172.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.1 m -68.01 179.82 1.4 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.388 -0.824 . . . . 71.24 111.264 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.2 m -67.36 147.75 52.53 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.019 -0.537 . . . . 74.4 109.766 173.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.468 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 47.0 mt-10 -55.28 110.44 0.69 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 73.21 111.662 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.8 m -96.35 107.25 19.6 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.016 -0.735 . . . . 75.24 109.016 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 m -61.93 132.96 54.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.088 -0.506 . . . . 52.42 111.414 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' A' ' 69' ' ' ALA . 82.2 mt -94.6 149.14 21.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.241 0.543 . . . . 73.14 111.926 -176.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -128.38 151.55 49.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.219 -0.9 . . . . 75.2 108.835 168.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.665 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 17.9 m120 -63.7 121.94 15.18 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.952 0.406 . . . . 74.45 110.68 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.97 -109.94 1.22 Allowed Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.814 -0.63 . . . . 61.01 111.892 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 98.5 m -127.11 133.03 50.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.055 0.455 . . . . 63.41 111.173 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -129.65 145.25 51.52 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.359 -0.608 . . . . 74.34 109.359 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.536 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.6 m -125.82 122.64 36.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.867 0.365 . . . . 74.21 110.73 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.6 mt -102.91 115.74 63.68 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.167 -0.47 . . . . 73.23 110.084 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -80.26 138.27 12.48 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.84 2.36 . . . . 72.31 112.215 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -137.44 163.2 31.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.888 0.375 . . . . 75.12 110.81 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.611 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 19.9 mt-30 -131.82 119.3 21.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.98 -0.555 . . . . 74.5 111.235 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.93 129.9 53.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.442 -0.344 . . . . 71.32 110.259 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.432 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 1.4 ptp180 -140.86 164.97 28.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.892 0.377 . . . . 74.31 111.361 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.51 ' HH ' ' HA3' ' A' ' 8' ' ' GLY . 70.2 m-85 -86.55 141.75 28.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.865 -0.607 . . . . 75.01 110.33 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -127.97 122.53 32.57 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.238 -0.653 . . . . 74.4 109.238 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.583 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -85.45 130.55 34.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.89 0.376 . . . . 74.25 110.908 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 63.8 p -102.19 11.43 38.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.716 0.77 . . . . 75.24 108.933 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 163.84 -123.57 1.19 Allowed Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.616 -1.175 . . . . 70.2 111.385 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.9 95.35 8.19 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.242 -0.281 . . . . 61.44 110.242 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.594 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.02 115.55 1.33 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.006 0.432 . . . . 74.13 111.136 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.0 p -103.87 141.39 22.41 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.825 -0.435 . . . . 72.43 109.825 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.49 163.43 38.07 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.449 2.766 . . . . 73.05 112.396 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.35 -153.91 25.63 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.628 -0.796 . . . . 63.34 111.796 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.45 108.07 19.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.737 0.303 . . . . 73.4 110.828 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -107.05 75.78 1.05 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.201 0.524 . . . . 74.04 110.71 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -123.77 134.32 53.67 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.331 -0.618 . . . . 75.01 109.331 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -136.91 167.57 21.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.993 0.425 . . . . 54.14 111.434 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -131.16 142.47 50.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.643 -0.708 . . . . 74.42 109.561 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.81 139.05 27.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.224 0.535 . . . . 71.34 111.255 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.6 p -108.86 117.0 33.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.821 -0.627 . . . . 75.43 110.014 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.429 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 47.4 p90 -95.04 123.6 38.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.511 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.595 ' HA ' HG22 ' A' ' 16' ' ' VAL . 5.5 tmmm? -106.01 100.91 10.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.702 -0.481 . . . . 73.21 109.702 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.669 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.1 m -78.57 133.21 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.314 0.578 . . . . 71.2 110.168 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -111.7 113.38 25.72 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.876 -0.602 . . . . 72.15 110.987 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.529 ' CD1' ' HB1' ' A' ' 20' ' ' ALA . 5.3 p90 -135.39 -40.37 0.73 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.542 -0.754 . . . . 73.41 109.208 169.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.817 ' HG3' HG23 ' A' ' 65' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.073 0 N-CA-C 108.082 -1.081 . . . . 75.31 108.082 176.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 120.9 0.381 . . . . 75.41 110.826 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.9 -179.08 6.26 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.52 -0.548 . . . . 70.23 109.52 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.0 t -97.22 -10.04 26.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.591 0.71 . . . . 74.43 109.881 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.401 HG21 ' HA ' ' A' ' 38' ' ' ARG . 74.2 p -118.01 -178.03 3.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.528 -0.76 . . . . 72.23 110.156 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.549 HG23 HG11 ' A' ' 37' ' ' VAL . 34.6 m -90.42 17.71 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.901 0.381 . . . . 73.42 111.001 176.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 59.55 31.07 20.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.597 -0.729 . . . . 74.33 112.275 171.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.443 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 79.82 92.53 0.4 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.68 -0.771 . . . . 37.16 112.3 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.454 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -87.31 153.42 25.26 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.208 -0.996 . . . . 65.11 111.678 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.529 ' HB ' HG22 ' A' ' 31' ' ' THR . 45.2 p -138.53 144.97 40.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.71 0.291 . . . . 75.02 110.486 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.498 HG13 ' HB1' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -118.04 120.44 64.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.97 -0.752 . . . . 75.11 108.97 172.294 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -86.86 111.28 20.62 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.405 -0.518 . . . . 73.2 109.611 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -100.92 118.84 37.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.808 -0.633 . . . . 72.1 110.02 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HB3' HG23 ' A' ' 153' ' ' THR . 48.0 tttp -116.21 138.08 51.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.145 -0.479 . . . . 72.1 110.597 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -116.22 -116.43 2.96 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.786 -0.643 . . . . 73.52 111.86 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.907 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 28.3 mt-10 62.45 22.45 13.26 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.158 0.504 . . . . 73.15 110.915 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.737 HG22 HG23 ' A' ' 17' ' ' VAL . 29.7 m -83.13 -26.46 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.574 -0.739 . . . . 73.02 111.659 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.737 HG23 HG22 ' A' ' 16' ' ' VAL . 3.8 m -140.28 134.63 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.099 0.476 . . . . 62.11 112.204 -173.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -139.22 23.4 2.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 75.55 109.33 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.71 -83.1 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 72.31 111.886 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.3 -34.05 70.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.467 0.651 . . . . 73.32 110.637 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 2.8 m -146.44 162.72 37.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.262 -0.881 . . . . 73.32 108.628 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.05 127.22 53.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.482 0.182 . . . . 71.41 110.601 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 t -70.04 130.09 34.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.904 -0.406 . . . . 74.15 109.904 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.9 t70 -57.84 140.87 50.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 64.43 111.067 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.84 -17.08 62.78 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 112.443 0.534 . . . . 72.4 112.443 -174.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.51 -23.12 48.49 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.596 -0.811 . . . . 61.04 111.949 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.0 p -101.63 -8.43 21.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.787 0.292 . . . . 62.41 111.787 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.907 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 30.5 m -82.4 -4.14 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.705 0.288 . . . . 73.11 111.471 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -164.44 85.07 0.43 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.048 -0.723 . . . . 40.25 109.048 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -136.33 130.6 33.11 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.872 -0.604 . . . . 73.31 110.716 -172.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.529 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.1 m -106.43 104.64 14.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.761 -0.654 . . . . 74.51 109.818 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 9' ' ' THR . 12.1 p -88.53 132.55 33.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.13 0.491 . . . . 71.11 110.928 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.412 ' HA ' HG21 ' A' ' 9' ' ' THR . 25.0 mp0 -89.2 123.39 33.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.811 -0.631 . . . . 73.24 110.129 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.475 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.5 mm? -83.6 -23.86 31.73 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.926 -0.768 . . . . 73.23 108.926 175.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 93.19 179.63 39.73 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.077 -0.965 . . . . 75.12 112.058 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -80.82 87.1 5.92 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.219 -0.289 . . . . 63.23 110.219 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.549 HG11 HG23 ' A' ' 5' ' ' VAL . 7.9 p -71.95 136.0 26.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.51 -0.552 . . . . 74.22 109.51 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.401 ' HA ' HG21 ' A' ' 4' ' ' THR . 76.3 mtp180 -78.82 130.29 35.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.245 -0.434 . . . . 73.44 110.411 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.0 p -82.03 13.09 3.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.065 -0.516 . . . . 72.13 111.224 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.4 -22.47 17.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.177 0.513 . . . . 64.14 109.785 174.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -81.88 -15.72 53.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.462 -0.79 . . . . 65.45 110.541 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.0 mp -125.87 117.19 22.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.06 -0.719 . . . . 74.54 109.06 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.96 10.35 2.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.763 0.653 . . . . 61.41 112.763 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -153.98 156.21 37.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.358 -0.238 . . . . 74.24 110.358 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 42.2 tt0 -61.04 131.04 49.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.396 -0.366 . . . . 73.12 110.047 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.45 -1.96 57.36 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.686 -0.769 . . . . 74.52 111.939 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.453 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . . . -78.09 115.57 17.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.008 0.432 . . . . 72.41 110.012 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.534 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 4.7 p -111.46 135.43 52.02 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.766 -0.652 . . . . 73.31 110.431 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 t -88.07 179.47 6.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 62.02 109.649 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 m -71.55 139.57 49.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.725 -0.472 . . . . 75.1 109.725 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -90.96 152.61 20.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.311 0.576 . . . . 75.54 112.03 -175.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 24.7 m -83.53 158.56 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.77 -1.105 . . . . 55.01 109.199 168.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.79 89.92 0.51 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.896 -0.669 . . . . 65.21 112.054 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -103.25 175.56 5.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.575 -0.528 . . . . 73.21 109.575 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.539 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.3 p-10 -143.68 155.06 44.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.367 0.603 . . . . 71.54 111.869 -174.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.413 HD11 ' CE2' ' A' ' 133' ' ' PHE . 80.0 mt -115.05 112.62 40.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.052 -0.976 . . . . 74.22 108.903 171.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -96.52 128.25 43.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.036 0.445 . . . . 74.34 110.703 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.3 mt -110.33 126.01 53.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.88 -0.6 . . . . 75.11 110.046 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -105.36 145.09 31.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.019 -0.537 . . . . 72.24 109.555 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 30.2 t70 49.69 69.14 0.63 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.926 0.869 . . . . 74.12 110.563 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 10.2 t -106.28 114.84 29.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.048 -0.978 . . . . 72.35 109.734 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -96.68 131.59 43.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.08 -0.509 . . . . 75.43 111.515 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.0 p -102.24 12.8 36.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 71.12 111.879 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -87.87 -26.36 22.81 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.539 -0.541 . . . . 65.42 109.539 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.73 -32.97 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.674 -0.694 . . . . 75.0 110.841 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.559 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -113.57 -179.19 3.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.725 0.298 . . . . 74.51 111.326 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 29.4 m -139.32 -55.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.503 -0.317 . . . . 74.4 111.596 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -136.31 144.7 44.84 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 110.408 -0.219 . . . . 72.43 110.408 -177.031 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.487 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -103.23 137.29 41.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.967 0.413 . . . . 65.24 110.72 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.39 113.74 6.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 74.44 109.417 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.5 m -87.01 145.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.98 0.419 . . . . 63.21 110.977 -173.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.558 ' HB1' ' CD1' ' A' ' 118' ' ' PHE . . . -118.18 122.06 42.07 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.738 -0.665 . . . . 53.45 109.919 174.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 103' ' ' ILE . 88.6 m-85 -87.58 130.62 34.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.297 0.57 . . . . 75.34 110.812 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.5 tp -125.41 122.66 37.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.605 -0.725 . . . . 75.04 109.763 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.05 -171.43 29.28 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.768 -0.651 . . . . 63.42 111.586 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.408 ' O ' HD12 ' A' ' 86' ' ' LEU . 8.8 m -84.59 119.9 25.73 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.374 -0.232 . . . . 71.35 110.374 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.5 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -78.65 144.67 35.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.522 -0.308 . . . . 71.33 110.987 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 tt -69.79 -37.29 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.417 . . . . 74.43 110.835 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.33 175.45 10.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.316 -0.624 . . . . 73.42 109.316 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.34 -37.15 38.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.083 0.468 . . . . 70.25 110.323 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.5 -19.01 67.2 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.591 -0.814 . . . . 74.54 111.276 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -111.17 47.57 0.99 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.16 0.505 . . . . 74.42 109.728 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.5 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -74.14 4.1 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.602 -0.727 . . . . 74.51 112.373 -176.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 30.3 p-10 -108.09 -0.6 21.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.158 0.504 . . . . 71.34 110.288 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.2 t -108.01 125.82 64.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.875 -0.602 . . . . 71.51 110.153 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.495 HD22 ' CD1' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -69.0 134.42 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.382 -0.372 . . . . 72.12 110.588 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.36 150.27 35.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.06 -0.518 . . . . 43.32 110.483 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.5 mm? -91.77 134.47 34.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.313 -0.403 . . . . 75.23 110.451 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -82.14 130.88 35.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.364 0.602 . . . . 73.42 110.611 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 m -68.33 134.85 50.95 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.9 -1.045 . . . . 53.05 111.707 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.8 m -109.14 3.24 21.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.925 -0.58 . . . . 74.34 110.098 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 59.79 13.37 3.49 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.438 -0.801 . . . . 71.34 112.068 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.58 11.92 14.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.022 0.439 . . . . 54.01 110.405 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.95 77.89 1.06 Allowed Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.463 -0.875 . . . . 72.2 111.153 -176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.2 m -74.35 160.49 30.98 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.18 -0.304 . . . . 73.13 110.18 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.95 149.89 21.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.784 -0.45 . . . . 75.43 109.784 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.45 167.54 21.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.918 -0.401 . . . . 74.41 109.918 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 68.62 10.18 7.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.17 0.51 . . . . 71.04 110.498 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.07 -177.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.634 -0.712 . . . . 75.22 110.444 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.84 -174.78 46.86 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.171 -1.172 . . . . 75.01 110.171 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.65 115.27 46.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.364 0.602 . . . . 71.01 110.62 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -107.28 135.42 48.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.206 -0.664 . . . . 72.44 109.206 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.465 HG22 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -95.83 123.61 48.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.968 0.413 . . . . 73.32 110.813 -175.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.508 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 15.5 mt -88.65 136.19 33.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.485 -0.779 . . . . 75.24 109.336 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.54 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.2 OUTLIER -71.78 -173.64 1.02 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.776 -0.453 . . . . 72.34 109.776 175.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.455 ' HG3' HG21 ' A' ' 107' ' ' THR . 15.4 ptm180 -57.96 -23.77 55.15 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.973 0.36 . . . . 75.03 111.973 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.455 HG21 ' HG3' ' A' ' 106' ' ' ARG . 71.0 p -102.02 11.41 38.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.792 0.33 . . . . 71.33 111.647 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 76.52 35.57 41.13 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.836 -0.697 . . . . 61.54 112.985 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.63 120.71 42.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.352 -0.24 . . . . 75.35 110.352 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 103' ' ' ILE . . . -65.83 111.42 3.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.984 0.421 . . . . 74.13 110.534 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.523 HD12 ' HG ' ' A' ' 119' ' ' SER . 92.5 mt -78.26 132.93 37.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.849 -0.614 . . . . 72.4 111.3 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 15.3 m -67.55 142.06 56.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.492 -0.776 . . . . 74.22 110.598 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.495 ' CD1' HD22 ' A' ' 86' ' ' LEU . 59.5 mt -81.79 44.15 0.81 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.057 0.456 . . . . 74.25 110.808 -177.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -92.97 -18.03 23.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.836 -0.62 . . . . 75.32 110.516 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.58 -16.29 46.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.613 -0.803 . . . . 61.33 112.325 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.82 8.11 20.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.476 . . . . 73.22 110.717 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.1 m -97.03 95.88 8.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.011 -0.541 . . . . 74.04 110.059 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.708 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 65.3 m-85 -93.61 158.0 15.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.178 -0.465 . . . . 73.44 111.405 -173.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.54 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 5.7 m -69.58 -175.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.639 -0.71 . . . . 71.52 111.586 178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.9 t -69.37 163.52 24.98 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.765 -0.457 . . . . 73.22 109.765 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.414 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 48.9 mt-10 -68.03 104.58 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 74.34 111.245 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.499 HG22 HG12 ' A' ' 131' ' ' ILE . 75.1 m -85.14 99.11 10.85 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.649 -0.501 . . . . 64.1 109.649 173.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.4 m -56.16 112.92 1.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.719 -0.673 . . . . 75.33 110.585 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 69' ' ' ALA . 85.1 mt -74.33 144.39 44.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 63.44 111.712 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -117.41 141.93 47.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.188 -0.915 . . . . 75.01 109.215 173.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -55.59 116.69 3.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.36 0.413 . . . . 63.42 110.868 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 119.67 -111.51 2.05 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.592 -0.813 . . . . 73.21 112.57 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.6 m -112.05 134.77 53.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.943 0.401 . . . . 52.53 111.198 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -131.17 124.11 29.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.948 -0.569 . . . . 73.43 110.122 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.539 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.7 m -110.75 107.06 16.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.738 0.304 . . . . 74.34 110.331 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.499 HG12 HG22 ' A' ' 122' ' ' THR . 13.7 mt -88.14 118.04 69.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.365 -0.38 . . . . 74.32 110.119 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.18 137.98 9.83 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.812 2.341 . . . . 74.31 112.956 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 74.2 m-85 -136.43 161.84 34.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 73.1 111.135 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 26.3 mt-30 -130.17 118.1 20.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 72.31 110.934 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -107.05 125.62 51.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.134 -0.321 . . . . 63.14 110.134 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.534 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 10.1 ptp180 -138.64 163.53 31.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.011 0.434 . . . . 72.41 111.092 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 64.4 m-85 -81.52 142.3 32.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 73.14 111.053 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -126.4 116.84 21.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.435 -0.802 . . . . 74.23 109.376 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 45' ' ' GLU . . . -82.19 131.28 35.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.479 -0.328 . . . . 60.24 110.566 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 68.9 p -101.3 2.84 40.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.645 0.736 . . . . 75.15 109.471 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 173.81 -134.75 2.97 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.742 -1.117 . . . . 71.13 110.635 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.407 ' O ' HG22 ' A' ' 144' ' ' THR . . . -78.08 85.91 4.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.712 0.256 . . . . 75.03 110.338 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -46.48 111.67 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.614 0.571 . . . . 52.22 111.781 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 142' ' ' ALA . 20.4 p -102.49 144.49 28.71 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-O 121.075 0.464 . . . . 72.43 111.232 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.41 167.38 26.49 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.413 2.742 . . . . 72.41 112.648 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.39 -128.78 3.14 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.867 -0.682 . . . . 70.52 111.783 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -120.68 117.24 27.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.719 0.295 . . . . 74.43 110.468 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.415 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -118.09 74.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.164 0.507 . . . . 44.53 111.309 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -117.31 138.67 51.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.963 -0.562 . . . . 70.24 109.897 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' A' ' 10' ' ' VAL . . . -135.63 171.58 14.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.586 0.587 . . . . 64.12 112.586 -172.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -134.01 128.67 34.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.247 -0.888 . . . . 73.55 109.739 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.67 144.31 25.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.281 0.562 . . . . 74.13 111.867 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.416 HG23 ' HB3' ' A' ' 13' ' ' LYS . 21.7 p -112.4 150.67 30.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.694 -0.684 . . . . 74.14 109.529 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -121.92 134.25 54.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.257 0.551 . . . . 64.34 111.219 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.708 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 20.2 ttmt -111.22 101.57 10.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.608 -0.724 . . . . 72.22 110.499 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.69 HG22 HG21 ' A' ' 17' ' ' VAL . 1.3 m -75.13 126.82 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 119.983 -0.687 . . . . 74.15 109.539 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -108.48 111.82 23.9 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.874 -0.603 . . . . 72.33 110.434 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -129.92 -21.02 3.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.882 0.372 . . . . 73.42 110.839 171.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 . . . . . 0 C--O 1.249 1.071 0 N-CA-C 109.051 -0.722 . . . . 74.34 109.051 175.401 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.569 -0.53 . . . . 73.23 109.569 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 145' ' ' PRO . . . -65.16 127.87 33.47 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.019 -0.734 . . . . 72.4 109.019 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.6 t -77.65 -14.24 59.68 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.461 0.541 . . . . 64.14 112.461 -169.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.6 p -97.85 176.96 5.61 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.087 -0.383 . . . . 72.33 110.259 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 35.5 m -88.42 13.19 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.189 0.519 . . . . 75.24 110.715 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 63.67 14.31 8.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.233 -0.894 . . . . 71.14 112.502 172.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.422 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 88.59 94.45 1.04 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.674 -0.774 . . . . 71.34 111.677 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.522 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -84.66 152.22 27.29 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.425 -0.893 . . . . 53.55 112.084 -176.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.516 ' HB ' HG22 ' A' ' 31' ' ' THR . 21.0 p -143.06 139.97 30.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.342 -0.244 . . . . 74.41 110.342 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.29 126.28 68.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.835 -0.432 . . . . 72.12 109.835 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -93.91 112.7 24.58 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.574 -0.528 . . . . 65.51 109.574 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -100.08 122.64 43.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.962 -0.563 . . . . 73.35 110.657 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.508 ' HB3' HG22 ' A' ' 153' ' ' THR . 59.3 tttm -112.09 136.09 51.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 74.42 110.092 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.08 -120.72 3.41 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.715 -0.755 . . . . 71.14 112.349 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.548 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 34.8 mt-10 63.28 20.01 12.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.06 0.457 . . . . 75.54 110.943 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' A' ' 155' ' ' LYS . 18.9 m -80.39 -21.95 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.661 . . . . 72.34 112.207 -175.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.401 HG12 HG23 ' A' ' 16' ' ' VAL . 17.3 m -133.49 157.3 42.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.237 0.542 . . . . 74.35 112.032 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -157.54 24.74 0.29 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.696 -1.138 . . . . 72.21 108.49 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.1 -81.07 0.32 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 72.14 111.664 -174.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.77 -38.78 11.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.951 0.405 . . . . 63.54 110.917 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 2.0 m -137.36 128.58 27.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.126 -0.488 . . . . 75.01 110.148 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.08 125.54 35.9 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.645 -0.707 . . . . 71.53 110.361 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.455 ' HA ' HD22 ' A' ' 58' ' ' LEU . 15.8 t -66.23 128.66 29.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.72 -0.474 . . . . 73.4 109.72 177.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.27 145.49 42.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.154 -0.475 . . . . 64.35 111.235 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.505 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -63.11 -22.13 66.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 75.11 111.71 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.66 -10.24 79.72 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.732 -0.747 . . . . 62.24 111.876 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.0 t -104.3 -27.5 11.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.088 . . . . 71.54 110.827 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 27.7 m -74.66 -6.84 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.095 0.474 . . . . 74.41 110.923 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -153.54 95.14 1.87 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.36 -0.836 . . . . 74.1 109.356 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -151.57 137.73 18.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.888 -0.596 . . . . 71.43 110.681 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.516 HG22 ' HB ' ' A' ' 9' ' ' THR . 6.9 m -115.66 111.96 21.4 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.591 -0.731 . . . . 73.34 109.698 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 p -92.87 139.54 17.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.846 0.355 . . . . 74.53 110.691 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -95.86 126.75 41.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.239 -0.437 . . . . 53.52 110.362 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -91.32 -27.59 18.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.39 0.614 . . . . 70.55 109.482 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.58 171.71 37.76 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.263 -0.881 . . . . 71.21 112.127 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -73.02 88.17 1.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.778 0.323 . . . . 74.43 110.717 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.479 HG11 ' CG2' ' A' ' 5' ' ' VAL . 9.8 p -67.44 151.93 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.478 -0.328 . . . . 73.22 110.171 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -91.31 125.02 35.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.095 -0.502 . . . . 65.55 110.725 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.3 p -74.71 -15.04 60.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.947 -0.569 . . . . 74.53 111.047 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.98 -22.51 60.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.475 . . . . 72.54 111.204 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 m -85.66 -33.93 21.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.136 0.494 . . . . 54.22 110.638 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 5.5 mp -108.61 97.74 7.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.986 -0.552 . . . . 75.22 109.956 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.25 14.87 4.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.025 0.441 . . . . 74.01 111.119 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -152.49 146.98 25.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.858 -0.61 . . . . 72.33 110.086 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 44.2 tt0 -62.65 130.76 46.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 63.34 110.303 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.98 -5.93 42.95 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.678 -0.772 . . . . 73.12 111.617 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . . . -74.88 119.93 19.73 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.99 -0.374 . . . . 72.11 109.99 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.565 ' HB ' HH11 ' A' ' 136' ' ' ARG . 37.9 p -115.15 126.07 54.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.115 -0.493 . . . . 72.2 110.476 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.2 t -80.0 172.4 13.83 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.836 -0.431 . . . . 55.12 109.836 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.7 m -69.58 134.99 49.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.302 -0.408 . . . . 71.42 110.054 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.494 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -86.98 162.12 17.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.625 0.726 . . . . 73.13 111.93 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.5 m -104.66 152.22 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.575 -1.193 . . . . 75.21 109.349 172.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.82 105.23 2.19 Favored Glycine 0 C--N 1.312 -0.779 0 C-N-CA 120.802 -0.714 . . . . 75.11 112.188 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -117.93 171.89 7.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.12 -0.696 . . . . 74.03 109.12 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.82 139.6 32.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.526 0.679 . . . . 75.21 112.507 -175.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.433 HD12 ' CD1' ' A' ' 154' ' ' PHE . 45.9 mt -95.22 116.48 36.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.268 -0.878 . . . . 71.04 109.585 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -93.32 133.39 36.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.771 -0.65 . . . . 75.24 111.249 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 23' ' ' VAL . 69.3 mt -117.76 129.68 55.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.59 -0.732 . . . . 75.22 109.587 176.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -103.89 146.24 28.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.297 -0.41 . . . . 75.43 110.493 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 49.95 41.84 23.56 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.873 0.733 . . . . 54.34 111.235 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 53.6 t -76.76 124.55 27.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.83 -0.623 . . . . 72.52 110.492 -175.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.52 132.48 45.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.054 -0.521 . . . . 71.31 111.292 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.8 p -107.62 18.21 21.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.093 0.473 . . . . 75.43 111.661 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -90.85 -33.66 15.57 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.975 -0.75 . . . . 71.23 108.975 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 p -101.71 -12.88 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.548 -0.751 . . . . 71.53 111.086 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . . . -135.45 169.47 17.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.692 0.282 . . . . 72.41 110.997 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.483 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 44.8 m -129.01 -57.13 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 63.03 111.97 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -135.91 141.73 44.59 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 122.164 -0.335 . . . . 75.22 110.172 -176.26 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.32 134.7 47.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.218 0.533 . . . . 72.24 110.495 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.86 120.43 12.5 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.351 -0.841 . . . . 71.15 109.201 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.6 m -93.78 149.44 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.067 0.461 . . . . 64.01 110.965 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.22 119.32 32.87 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.461 -0.791 . . . . 75.52 109.396 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 62.7 m-85 -83.09 126.28 32.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.955 0.407 . . . . 64.11 110.547 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.8 tp -122.42 127.65 49.92 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.897 -0.592 . . . . 75.34 109.857 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.75 -164.44 26.47 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.343 -0.703 . . . . 71.33 111.343 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.415 ' O ' HD12 ' A' ' 86' ' ' LEU . 8.7 m -82.35 128.33 34.11 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.614 0.207 . . . . 74.23 110.476 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.67 148.48 24.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.176 -0.305 . . . . 63.43 110.176 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.3 tt -74.33 -25.64 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.988 0.423 . . . . 74.32 110.731 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -155.66 -174.2 4.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.522 -0.547 . . . . 73.43 109.522 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.88 -44.11 13.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.078 0.466 . . . . 72.01 110.067 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.3 -18.56 71.23 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.723 -0.751 . . . . 71.34 111.333 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -104.98 46.22 0.93 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.352 0.596 . . . . 73.03 109.89 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.9 12.42 2.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.53 -0.759 . . . . 72.14 111.803 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -107.6 -12.35 15.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.061 -0.518 . . . . 65.21 110.491 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 65.0 t -106.92 125.83 62.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.916 -0.584 . . . . 62.04 110.778 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.502 HD13 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -66.08 133.19 50.24 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.795 -0.446 . . . . 74.42 109.795 178.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.15 147.8 36.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.449 . . . . 51.41 110.114 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.77 145.56 34.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.133 -0.485 . . . . 74.14 110.111 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 8.8 mm-40 -62.29 123.65 18.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.923 -0.581 . . . . 74.45 110.647 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 p -71.79 99.42 2.16 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.494 -0.775 . . . . 71.41 110.933 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.4 m -93.28 -10.52 35.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.838 -0.619 . . . . 73.42 110.053 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 64.41 6.17 2.96 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.441 -0.8 . . . . 74.31 112.367 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.26 11.65 14.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.439 0.637 . . . . 73.44 110.449 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 124.78 67.93 0.19 Allowed Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.474 -0.785 . . . . 72.34 111.5 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 m -86.06 148.62 25.64 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.736 -0.468 . . . . 75.0 109.736 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.62 142.0 44.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.073 -0.343 . . . . 71.35 110.073 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.0 163.44 30.28 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.02 -0.363 . . . . 65.43 110.02 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 70.32 10.68 7.33 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.512 0.508 . . . . 73.23 110.824 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.63 -177.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.658 -0.701 . . . . 60.32 109.677 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 172.71 -175.89 45.68 Favored Glycine 0 N--CA 1.437 -1.259 0 N-CA-C 110.602 -0.999 . . . . 75.35 110.602 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.52 114.58 46.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.399 0.619 . . . . 72.34 110.83 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -106.37 140.14 39.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.52 -0.764 . . . . 60.35 109.596 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.407 HD11 ' N ' ' A' ' 103' ' ' ILE . 3.9 mp -101.58 123.85 54.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.233 -0.44 . . . . 74.52 110.256 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 16.4 mt -87.74 148.61 24.66 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.537 -0.756 . . . . 75.13 109.411 176.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.553 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 2.1 p-10 -72.39 -170.74 0.68 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.715 -0.476 . . . . 73.32 109.715 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -72.09 -17.09 62.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.135 0.42 . . . . 75.34 112.135 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.6 p -89.23 -36.99 15.32 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.553 -0.459 . . . . 75.45 110.683 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.87 31.04 0.72 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.658 -0.782 . . . . 52.13 113.363 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -117.76 133.04 56.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.783 0.292 . . . . 65.43 110.517 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.03 141.61 57.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.962 0.41 . . . . 65.14 110.973 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.6 mt -91.09 -176.53 4.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.039 -0.528 . . . . 72.12 110.214 178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.3 m -125.29 142.01 51.75 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.003 -0.369 . . . . 62.34 110.003 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 53.9 mt -84.46 39.48 0.73 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.384 -0.371 . . . . 75.41 111.548 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -102.19 -0.59 32.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.99 0.424 . . . . 62.3 110.26 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.3 3.22 45.5 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.747 -0.66 . . . . 53.44 113.141 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -120.88 -11.6 8.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.932 0.366 . . . . 72.45 111.051 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.2 m -91.16 108.6 19.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.015 -0.365 . . . . 71.41 110.015 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.52 ' CE1' ' HE3' ' A' ' 155' ' ' LYS . 93.7 m-85 -98.27 163.96 12.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.107 0.479 . . . . 72.13 111.228 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.553 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 4.0 m -70.23 175.33 4.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 63.25 110.499 175.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.0 t -68.08 146.09 53.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.229 -0.656 . . . . 75.43 109.229 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -53.76 112.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 74.1 111.444 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.6 m -97.19 106.6 18.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.744 -0.662 . . . . 74.5 109.542 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.5 m -58.49 116.34 3.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.228 0.537 . . . . 64.13 111.277 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.463 ' C ' HD21 ' A' ' 125' ' ' ASN . 87.8 mt -77.31 152.44 34.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.362 -0.836 . . . . 72.53 111.544 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.463 HD21 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -122.5 153.34 39.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.514 -0.767 . . . . 72.34 109.583 173.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -68.58 106.63 2.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.838 0.352 . . . . 73.02 110.793 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 131.88 -128.72 5.39 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.747 -0.739 . . . . 70.11 112.497 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.3 m -94.09 127.46 39.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.841 0.353 . . . . 72.52 110.709 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -123.58 150.05 44.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.283 -0.417 . . . . 74.13 110.216 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.59 111.43 10.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.355 -0.384 . . . . 74.44 111.068 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 8.8 mt -90.99 110.17 40.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.233 -0.654 . . . . 74.23 109.233 177.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 2.4 Cg_endo -80.6 133.9 9.61 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.914 2.409 . . . . 72.33 112.127 -177.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -131.27 158.85 39.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.426 -0.352 . . . . 75.12 110.501 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.653 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 92.4 mt-30 -123.04 113.53 19.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.864 -0.607 . . . . 75.12 110.804 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.75 126.89 44.5 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 121.008 -0.277 . . . . 61.1 110.329 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.565 HH11 ' HB ' ' A' ' 48' ' ' THR . 13.1 ptp180 -140.8 162.85 34.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.859 0.361 . . . . 71.42 110.809 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 62.3 m-85 -82.28 137.44 34.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.016 -0.538 . . . . 75.04 110.853 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.409 ' HD1' HG23 ' A' ' 48' ' ' THR . 80.2 t80 -121.62 119.52 32.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.771 -0.65 . . . . 73.21 109.4 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.555 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . . . -84.0 130.32 34.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.305 -0.407 . . . . 72.45 110.746 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.496 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 73.6 p -102.01 5.34 40.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.876 0.846 . . . . 74.22 109.258 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.05 -136.89 4.01 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.455 -1.248 . . . . 54.24 110.274 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.15 92.19 6.25 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.663 -0.495 . . . . 72.22 109.663 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.43 114.1 0.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 123.768 0.668 . . . . 75.11 111.334 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 39.9 p -101.89 140.21 20.99 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 121.209 0.528 . . . . 74.51 110.407 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.423 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 58.1 Cg_endo -68.63 162.52 40.68 Favored 'Trans proline' 0 C--N 1.331 -0.364 0 C-N-CA 123.713 2.942 . . . . 52.35 113.342 -174.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 142.08 -167.05 26.16 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.797 -0.638 . . . . 45.35 111.731 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.88 114.03 4.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 72.43 110.894 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.489 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . . . -112.77 49.85 0.91 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.441 0.639 . . . . 71.44 110.806 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 89' ' ' GLN . 89.1 m-20 -105.79 147.53 28.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.368 -0.833 . . . . 70.01 109.411 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.502 ' HB1' HD13 ' A' ' 86' ' ' LEU . . . -148.82 169.24 20.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.717 0.294 . . . . 71.13 111.083 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -140.16 147.73 40.57 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.528 -0.545 . . . . 50.03 109.528 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.19 144.46 21.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.992 0.425 . . . . 73.12 111.346 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.508 HG22 ' HB3' ' A' ' 13' ' ' LYS . 22.7 p -103.11 123.98 47.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.83 -0.623 . . . . 74.42 109.756 175.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.433 ' CD1' HD12 ' A' ' 56' ' ' ILE . 39.5 p90 -97.21 124.11 41.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.255 0.55 . . . . 75.21 110.654 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.614 ' HA ' HG22 ' A' ' 16' ' ' VAL . 4.1 tmmm? -107.31 104.23 13.79 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.782 -0.645 . . . . 73.31 109.87 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.3 m -75.55 147.95 7.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.026 0.441 . . . . 63.53 110.046 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -133.51 129.39 37.07 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.232 -0.655 . . . . 73.43 109.232 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.594 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -136.47 -18.68 1.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.042 0.449 . . . . 73.4 110.989 175.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--O 1.245 0.847 0 N-CA-C 109.034 -0.728 . . . . 75.33 109.034 169.188 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.64 0.257 . . . . 74.21 110.361 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.547 ' HB3' HD22 ' A' ' 6' ' ' ASN . . . -71.45 -173.69 0.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 51.35 111.023 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.5 HG23 HG22 ' A' ' 4' ' ' THR . 8.9 t -79.87 -32.84 40.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.036 0.446 . . . . 75.32 111.411 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.5 HG22 HG23 ' A' ' 3' ' ' THR . 52.2 p -104.84 -175.62 2.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.905 0.383 . . . . 75.11 110.563 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.35 15.64 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.104 0.478 . . . . 75.22 110.526 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.547 HD22 ' HB3' ' A' ' 2' ' ' ALA . 0.8 OUTLIER 65.09 11.97 7.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.186 -0.915 . . . . 37.96 112.348 171.63 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.469 ' N ' ' HG2' ' A' ' 36' ' ' GLN . . . 87.8 98.25 0.91 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.441 -0.885 . . . . 53.43 111.537 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.458 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -89.68 153.06 22.91 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.191 -1.004 . . . . 52.42 112.046 -177.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.589 ' HB ' HG21 ' A' ' 31' ' ' THR . 75.0 p -137.05 140.47 42.07 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.857 -0.423 . . . . 74.21 109.857 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -110.85 118.82 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 109.7 -0.481 . . . . 71.4 109.7 176.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 13.1 t-80 -85.88 106.52 17.15 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.987 0.422 . . . . 73.53 110.005 177.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.411 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 77.8 m-85 -94.64 114.43 26.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.968 -0.56 . . . . 72.35 110.313 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 62.9 tttp -109.54 132.73 53.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.678 -0.692 . . . . 74.33 110.179 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.94 -114.64 3.01 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.89 -0.672 . . . . 41.3 112.073 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.65 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 37.4 mt-10 63.94 17.14 10.38 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.006 0.432 . . . . 75.12 111.236 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' A' ' 155' ' ' LYS . 18.4 m -75.19 -30.88 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.905 -0.589 . . . . 72.33 111.92 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.45 HG21 ' CG2' ' A' ' 156' ' ' VAL . 29.6 m -140.16 154.7 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.246 0.546 . . . . 74.11 111.921 -174.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -155.29 28.61 0.4 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.026 -1.101 . . . . 70.12 108.026 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.43 -78.04 0.32 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.252 -0.886 . . . . 64.3 111.523 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -83.9 -37.63 22.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.124 0.487 . . . . 71.34 110.585 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.8 m -142.87 131.53 22.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.759 -0.655 . . . . 74.44 109.567 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.63 124.45 35.07 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.177 -0.465 . . . . 73.1 110.307 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.443 ' HA ' HD21 ' A' ' 58' ' ' LEU . 6.0 t -66.13 124.69 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.244 -0.651 . . . . 70.3 109.244 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' O ' HG13 ' A' ' 28' ' ' VAL . 16.5 t70 -56.89 139.84 50.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 71.35 111.206 -175.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' A' ' 28' ' ' VAL . . . -59.72 -24.44 63.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 74.12 112.146 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.68 -17.55 70.35 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.555 -0.831 . . . . 60.04 111.915 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 p -104.98 -13.28 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.723 0.268 . . . . 65.03 111.723 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.65 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 34.7 m -78.68 -10.59 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.039 0.447 . . . . 75.24 110.623 177.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -152.68 90.43 1.48 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.415 -0.811 . . . . 73.44 108.882 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -142.99 115.96 8.83 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.517 0.675 . . . . 72.14 110.726 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.589 HG21 ' HB ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -97.1 97.02 8.86 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.277 -0.874 . . . . 60.11 108.96 176.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' THR . 8.8 p -75.63 132.3 33.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.938 0.399 . . . . 74.14 110.987 -175.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.524 ' HA ' HG21 ' A' ' 9' ' ' THR . 27.3 mp0 -87.82 125.76 34.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.103 -0.499 . . . . 74.42 110.107 177.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -90.59 -32.63 16.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.963 -0.562 . . . . 73.14 109.886 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.437 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 99.5 168.58 30.08 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.363 -0.835 . . . . 74.24 111.599 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.469 ' HG2' ' N ' ' A' ' 7' ' ' GLY . 77.4 mt-30 -74.35 86.37 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.159 0.479 . . . . 74.41 110.598 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.24 149.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 110.043 -0.355 . . . . 64.32 110.043 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -84.53 128.71 34.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.301 -0.409 . . . . 71.31 110.345 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p -68.32 -23.32 64.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.874 -0.603 . . . . 73.3 111.526 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.48 -18.35 62.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.027 -0.533 . . . . 74.12 111.496 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 m -90.3 -0.68 57.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.381 . . . . 73.53 111.276 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.549 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 3.6 mt -134.09 43.57 2.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.319 0.58 . . . . 73.3 110.285 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.36 8.41 33.63 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.667 0.617 . . . . 75.32 112.667 -168.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -150.51 144.76 25.56 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.347 -0.242 . . . . 74.32 110.347 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 86.0 tt0 -59.4 123.17 15.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.101 0.477 . . . . 62.44 110.018 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.5 -9.77 30.58 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.823 -0.703 . . . . 37.96 111.503 -175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 42' ' ' LEU . . . -71.2 121.86 19.13 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.641 -0.503 . . . . 71.45 109.641 173.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.4 p -117.0 137.0 52.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.159 0.504 . . . . 75.41 111.182 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.547 ' HG ' HD21 ' A' ' 42' ' ' LEU . 64.0 m -85.63 164.45 17.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.775 -0.648 . . . . 75.22 110.689 176.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.7 m -63.99 124.46 21.64 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.66 -0.496 . . . . 51.34 109.66 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -80.59 138.91 36.5 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.217 0.532 . . . . 72.11 111.489 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.2 m -78.49 148.07 6.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.107 -0.951 . . . . 74.12 109.358 170.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.42 90.46 0.69 Allowed Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.976 -0.631 . . . . 60.43 111.579 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -99.63 174.44 6.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.811 -0.44 . . . . 74.21 109.811 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.484 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 3.7 p-10 -138.06 142.78 40.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.325 0.583 . . . . 74.32 112.21 -170.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.482 HD13 ' CE2' ' A' ' 133' ' ' PHE . 73.5 mt -111.77 119.26 59.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.693 -0.855 . . . . 75.52 108.693 169.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -104.48 140.93 37.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.115 0.484 . . . . 74.32 111.238 -171.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.443 HD21 ' HA ' ' A' ' 23' ' ' VAL . 55.1 mt -120.36 122.62 41.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.553 -0.748 . . . . 72.42 109.753 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -100.82 152.02 21.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.761 -0.654 . . . . 73.14 110.378 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 54.38 38.69 30.01 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.968 0.793 . . . . 74.41 110.827 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.28 129.41 34.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.946 -0.57 . . . . 73.34 110.266 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 64' ' ' ASN . 15.7 t70 -111.29 133.95 53.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.565 . . . . 74.15 110.833 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -102.58 16.23 26.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.189 0.44 . . . . 71.13 112.189 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.42 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 93.7 m-20 -90.45 -35.46 15.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.298 0.571 . . . . 74.13 109.478 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.73 -31.5 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.521 -0.763 . . . . 75.3 111.153 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . . . -118.85 173.11 7.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.646 0.26 . . . . 75.23 110.89 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 m -133.84 -58.94 0.86 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.223 -0.444 . . . . 74.42 111.614 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.528 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -134.71 136.62 42.86 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.258 -0.275 . . . . 74.43 110.258 -177.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.71 139.69 36.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.994 0.426 . . . . 75.44 110.594 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.4 122.75 10.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.711 -0.677 . . . . 62.33 109.418 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.0 OUTLIER -96.53 147.07 6.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.068 0.461 . . . . 74.22 110.973 -175.298 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.49 127.09 53.67 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.733 -0.667 . . . . 71.54 109.466 173.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 83.8 m-85 -88.99 131.7 35.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.899 0.38 . . . . 74.31 110.294 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.4 tp -130.52 125.06 33.34 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.976 -0.556 . . . . 71.52 110.355 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.48 -131.95 1.3 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.647 -0.706 . . . . 70.53 111.545 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.1 m -121.34 131.06 53.97 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.177 -0.305 . . . . 74.4 110.177 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -82.46 142.09 32.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.592 -0.276 . . . . 74.51 110.847 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 tt -69.18 -26.53 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.012 0.434 . . . . 73.53 111.09 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -144.6 179.74 7.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.599 -0.519 . . . . 61.52 109.599 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.67 27.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.181 0.515 . . . . 75.43 109.745 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.37 -37.77 7.46 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.812 -0.709 . . . . 73.1 111.594 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -91.17 77.66 5.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.359 0.6 . . . . 70.44 110.163 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.458 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 9.2 p -94.53 6.17 49.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.28 -0.873 . . . . 62.44 111.586 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -111.8 2.34 17.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.207 0.527 . . . . 64.43 110.653 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 102' ' ' GLN . 47.9 t -113.65 125.98 71.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.775 -0.648 . . . . 72.14 109.73 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.505 HD13 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -68.64 135.92 52.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.648 0.261 . . . . 72.14 110.506 -178.338 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.47 149.89 34.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.086 -0.506 . . . . 74.01 110.376 177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.471 HD22 ' O ' ' A' ' 99' ' ' VAL . 1.9 mm? -84.3 139.11 32.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.342 -0.39 . . . . 71.34 110.176 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.403 ' HG3' ' HA ' ' A' ' 150' ' ' ALA . 89.9 mt-30 -61.92 131.89 51.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.878 -0.601 . . . . 74.44 110.491 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.05 113.46 5.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.013 -0.54 . . . . 74.33 110.95 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.1 m -94.57 -4.27 48.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.957 -0.565 . . . . 53.42 110.994 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 61.33 25.76 15.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.844 -0.616 . . . . 73.41 111.335 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.19 -40.18 0.22 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.711 -0.677 . . . . 73.15 110.246 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.03 86.24 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.628 -0.796 . . . . 53.05 112.116 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.3 m -85.63 149.59 25.22 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.556 -0.535 . . . . 71.34 109.556 174.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.45 148.64 51.37 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.091 -0.337 . . . . 65.41 110.091 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.61 159.82 41.43 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.865 -0.334 . . . . 73.4 110.343 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 69.31 4.49 4.64 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.626 0.579 . . . . 73.51 110.586 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.471 ' O ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -146.8 151.62 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 115.279 -0.873 . . . . 74.52 109.035 173.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -153.67 -171.64 21.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.888 -0.885 . . . . 61.03 110.888 177.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.37 112.41 38.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.521 0.676 . . . . 74.11 110.516 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.471 ' HB3' HG23 ' A' ' 85' ' ' VAL . 3.5 pt20 -102.27 139.04 38.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.603 -0.726 . . . . 71.35 109.447 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.479 HG22 ' CZ ' ' A' ' 73' ' ' PHE . 4.8 mp -101.35 117.29 46.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.899 0.38 . . . . 72.12 110.175 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 13.4 mt -86.44 144.81 27.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.622 -0.717 . . . . 60.34 109.37 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.4 p-10 -72.95 -168.24 0.46 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.759 -0.46 . . . . 54.44 109.759 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -64.03 -31.21 72.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.561 -0.29 . . . . 70.34 111.531 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.407 ' HG1' ' CG ' ' A' ' 105' ' ' ASP . 59.1 p -84.85 -29.96 24.88 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.829 -0.349 . . . . 71.32 111.218 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.32 34.68 1.0 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.324 -0.941 . . . . 71.52 113.246 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.39 130.61 56.25 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.96 -0.385 . . . . 71.42 109.96 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.56 119.1 14.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 62.31 110.417 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.1 mt -79.76 132.99 36.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.002 -0.544 . . . . 73.42 111.148 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.443 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 7.9 m -68.36 140.25 55.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.688 -0.687 . . . . 74.14 110.564 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 33.2 mt -85.01 42.95 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.09 -0.504 . . . . 71.24 111.203 -176.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -100.65 -3.03 31.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.006 0.432 . . . . 74.21 110.539 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.03 12.58 68.59 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.879 -0.6 . . . . 54.23 112.795 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.68 -14.45 5.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.749 0.309 . . . . 65.24 111.071 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.443 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 18.3 m -86.25 96.52 9.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.326 -0.397 . . . . 73.43 110.079 175.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -86.51 163.46 17.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.981 -0.554 . . . . 74.5 110.506 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.508 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 1.6 m -72.82 176.26 5.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.079 -0.51 . . . . 64.11 110.805 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.0 t -66.15 139.27 58.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.509 -0.552 . . . . 74.54 109.509 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -51.58 107.42 0.19 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.638 0.586 . . . . 75.43 111.387 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.5 m -93.01 106.24 18.22 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.316 -0.624 . . . . 70.15 109.316 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.528 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 26.5 m -57.36 128.58 37.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 74.31 111.163 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.33 149.86 23.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.723 -0.671 . . . . 73.03 110.918 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -126.61 158.64 35.78 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.871 -0.788 . . . . 74.31 108.871 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -62.33 117.73 6.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.855 0.36 . . . . 72.24 110.564 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 116.7 -134.77 11.53 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.47 -0.872 . . . . 62.13 112.733 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.8 m -86.76 128.61 35.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.94 0.4 . . . . 64.43 110.984 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -124.37 144.4 50.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.568 -0.53 . . . . 74.33 109.568 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.484 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 1.5 m -128.38 118.28 22.89 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.888 0.375 . . . . 75.42 110.582 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 11.2 mt -95.04 114.03 62.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.112 -0.699 . . . . 45.14 109.112 176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 2.1 Cg_endo -81.85 136.14 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.989 2.46 . . . . 71.1 112.554 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.482 ' CE2' HD13 ' A' ' 56' ' ' ILE . 76.3 m-85 -134.19 159.74 39.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.119 -0.492 . . . . 73.34 110.588 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.616 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 19.9 mt-30 -129.15 111.8 13.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.856 -0.611 . . . . 74.34 110.864 -175.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.414 ' O ' HG21 ' A' ' 52' ' ' VAL . . . -101.64 124.54 47.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.473 -0.33 . . . . 75.11 110.358 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 4.7 ptp180 -138.13 160.09 40.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.37 -0.377 . . . . 75.35 110.536 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 69.0 m-85 -79.25 139.58 37.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.93 -0.577 . . . . 73.51 110.23 173.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -127.0 122.63 35.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.652 -0.704 . . . . 74.52 109.328 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -85.35 132.39 34.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.381 -0.372 . . . . 74.23 111.318 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.478 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 74.3 p -105.24 3.61 30.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.635 0.731 . . . . 74.1 109.19 176.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.73 -128.48 1.54 Allowed Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.798 -1.092 . . . . 55.15 110.838 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.24 96.16 10.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.098 -0.334 . . . . 75.41 110.098 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -43.75 109.56 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.721 0.638 . . . . 64.51 111.917 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 26.9 p -102.48 139.35 20.13 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 121.271 0.558 . . . . 64.32 110.407 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.24 -179.84 2.49 Favored 'Trans proline' 0 C--N 1.332 -0.299 0 C-N-CA 124.021 3.147 . . . . 71.33 113.421 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.46 -139.34 10.7 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.408 -0.814 . . . . 55.12 111.83 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.85 117.46 33.88 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.16 -0.311 . . . . 64.41 110.16 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -111.77 60.38 0.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.033 0.444 . . . . 65.15 111.565 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -106.98 145.82 31.82 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.412 -0.588 . . . . 71.34 109.412 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -148.61 168.01 23.94 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.347 -0.242 . . . . 74.35 110.347 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -147.7 146.19 29.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.119 -0.326 . . . . 64.34 110.119 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.481 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -153.2 149.3 27.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.076 -0.511 . . . . 71.42 110.911 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.0 p -101.15 127.24 47.79 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.99 -0.55 . . . . 72.4 109.757 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -99.57 129.29 45.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.311 0.577 . . . . 74.54 110.359 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.539 ' HA ' HG22 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -112.52 107.34 16.04 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.636 -0.711 . . . . 74.54 110.145 -178.06 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.5 m -79.71 147.6 6.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.984 0.421 . . . . 74.12 110.315 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -130.16 124.97 33.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.417 -0.586 . . . . 62.14 109.417 173.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.578 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -139.5 -11.84 1.19 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.056 0.455 . . . . 75.13 111.045 176.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 . . . . . 0 C--O 1.247 0.968 0 CA-C-N 115.337 -0.847 . . . . 74.43 108.829 171.091 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 110.201 -0.296 . . . . 62.41 110.201 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.8 164.2 26.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.355 -0.384 . . . . 63.14 110.709 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.6 t -99.93 -19.92 16.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.135 0.493 . . . . 75.13 110.609 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.3 p -100.06 -179.94 4.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.019 0.438 . . . . 75.14 110.445 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.434 HG22 HG13 ' A' ' 37' ' ' VAL . 35.6 m -83.83 6.61 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.006 0.431 . . . . 72.4 110.791 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 67.42 -3.46 1.06 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.352 -0.84 . . . . 64.35 112.648 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.17 95.56 1.94 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.938 -0.649 . . . . 74.43 111.738 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.623 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -77.1 154.86 43.52 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.48 -0.867 . . . . 70.03 111.831 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.6 p -146.07 125.89 13.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.714 0.292 . . . . 74.33 110.862 -177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.414 HG21 HG21 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -105.19 122.35 58.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.369 -0.604 . . . . 75.24 109.369 176.035 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -90.23 99.28 12.33 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.379 -0.529 . . . . 73.41 110.049 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -90.86 117.14 29.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.605 -0.725 . . . . 73.32 110.023 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -110.76 136.91 49.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.04 0.448 . . . . 62.14 110.255 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.75 -126.25 5.58 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.768 -0.651 . . . . 44.44 111.82 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 66.52 14.73 9.86 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.462 0.648 . . . . 73.42 110.526 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.595 HG21 ' HA ' ' A' ' 155' ' ' LYS . 29.7 m -76.29 -24.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.366 -0.834 . . . . 75.01 111.856 -175.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.495 HG21 HG21 ' A' ' 156' ' ' VAL . 19.1 m -139.08 142.27 34.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.271 0.558 . . . . 74.15 111.884 -175.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -142.62 18.72 2.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.804 -1.089 . . . . 73.44 108.239 173.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.51 -77.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.171 -0.922 . . . . 62.25 111.426 -172.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.494 ' HB1' ' CE1' ' A' ' 158' ' ' TYR . . . -92.47 -37.07 12.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.941 0.401 . . . . 73.33 110.258 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.34 132.09 25.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.245 -0.434 . . . . 72.24 110.303 -175.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.86 127.41 39.6 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.986 -0.552 . . . . 71.31 109.738 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.425 ' HB ' HG13 ' A' ' 28' ' ' VAL . 13.0 t -64.12 132.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.406 -0.361 . . . . 73.31 110.316 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.448 ' O ' HG12 ' A' ' 28' ' ' VAL . 19.2 t70 -57.27 139.34 53.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.938 -0.574 . . . . 73.11 110.682 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.41 ' HA ' HG21 ' A' ' 28' ' ' VAL . . . -64.02 -19.67 65.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.175 0.435 . . . . 72.32 112.175 -173.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.07 -18.53 74.47 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.394 -0.908 . . . . 74.52 111.937 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 p -110.63 -6.07 14.92 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.235 0.458 . . . . 72.33 112.235 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 24' ' ' ASP . 35.5 m -81.97 -7.29 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.912 0.387 . . . . 73.35 110.893 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -157.94 95.83 1.43 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.909 -0.774 . . . . 74.41 108.909 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -142.24 112.12 6.85 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.862 -0.608 . . . . 73.33 110.567 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.475 HG23 ' HB ' ' A' ' 9' ' ' THR . 7.1 m -92.91 93.7 8.53 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.861 -0.792 . . . . 75.44 108.861 175.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 9' ' ' THR . 8.3 p -80.66 128.93 38.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.968 -0.56 . . . . 73.35 111.07 -172.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -86.62 120.99 28.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.886 -0.597 . . . . 74.12 109.685 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.44 -20.34 40.54 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.453 -0.573 . . . . 73.23 109.453 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.13 -178.72 42.07 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.203 -0.908 . . . . 73.51 111.669 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.92 90.37 6.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.615 -0.513 . . . . 64.24 109.615 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.455 HG21 ' HG ' ' A' ' 49' ' ' SER . 11.8 p -64.64 136.24 26.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 74.04 110.688 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 38' ' ' ARG . 67.2 mtt180 -66.91 108.25 2.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.485 -0.779 . . . . 74.21 109.741 175.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 22.9 p -67.29 -23.63 65.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.197 0.522 . . . . 72.35 110.281 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.01 -5.77 47.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.758 -0.655 . . . . 73.15 111.389 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.9 m -97.79 -4.49 36.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 73.14 110.841 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.578 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 5.4 mp -131.07 101.54 5.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.516 . . . . 65.42 109.755 177.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.18 15.97 5.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.244 0.461 . . . . 73.44 112.244 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.92 147.39 26.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.801 0.334 . . . . 74.43 110.983 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -58.6 123.03 14.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.664 -0.698 . . . . 75.11 109.472 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.464 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 101.97 8.48 44.91 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.512 -0.852 . . . . 73.12 111.965 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.622 ' HB2' ' HB3' ' A' ' 139' ' ' ALA . . . -79.9 128.28 33.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.065 -0.346 . . . . 75.14 110.065 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 p -115.79 118.92 34.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.917 -0.583 . . . . 74.44 110.378 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.455 ' HG ' HG21 ' A' ' 37' ' ' VAL . 12.1 t -83.68 173.59 11.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.86 0.362 . . . . 64.41 110.256 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.2 m -69.21 129.29 39.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.853 -0.612 . . . . 54.13 110.093 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -82.22 165.19 20.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.745 0.783 . . . . 74.43 112.071 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.9 m -101.39 157.62 4.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.458 -1.246 . . . . 75.2 109.22 169.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.5 107.49 2.27 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.829 -0.701 . . . . 65.55 112.059 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -125.07 178.61 5.45 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.749 -0.463 . . . . 64.3 109.749 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.458 ' HB2' HG22 ' A' ' 130' ' ' THR . 30.2 p30 -137.26 156.99 47.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.46 0.648 . . . . 72.31 111.99 -174.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.486 HD13 ' CD1' ' A' ' 154' ' ' PHE . 65.3 mt -123.51 105.37 15.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 107.956 -1.127 . . . . 72.43 107.956 167.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 26.1 tt0 -99.05 143.29 29.49 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.939 -0.573 . . . . 65.04 110.72 -171.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 23' ' ' VAL . 41.5 mt -117.96 125.46 50.46 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.056 -0.52 . . . . 73.34 109.847 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -100.51 143.1 31.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.045 -0.525 . . . . 73.31 110.107 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 52.9 46.96 25.72 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.834 0.708 . . . . 72.13 110.926 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 44.5 t -79.26 139.92 37.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.114 -0.948 . . . . 64.11 110.812 -175.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -108.89 151.47 26.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.045 -0.525 . . . . 61.44 111.592 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 75.6 p -122.92 11.88 9.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.464 -0.334 . . . . 73.44 111.66 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -81.44 -35.32 30.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.449 -0.574 . . . . 73.33 109.449 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.39 -27.9 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.531 -0.759 . . . . 75.35 110.805 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -112.05 166.41 11.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.045 0.45 . . . . 73.1 111.675 -176.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 m -132.7 -56.37 0.94 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.101 -0.5 . . . . 65.25 110.994 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.816 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -136.59 131.06 33.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.458 -0.337 . . . . 73.14 110.194 -177.048 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 158' ' ' TYR . . . -88.38 139.67 30.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.848 0.356 . . . . 52.52 110.707 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . . . -143.88 114.36 7.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.645 -0.707 . . . . 52.32 109.672 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 0.8 OUTLIER -93.48 143.28 11.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.967 0.413 . . . . 74.01 110.563 -175.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.511 ' HB1' ' CD1' ' A' ' 118' ' ' PHE . . . -118.6 125.73 50.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.01 -0.541 . . . . 61.12 110.26 175.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 86.4 m-85 -91.73 122.67 34.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 74.01 110.319 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.3 tp -118.9 133.25 55.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.009 -0.542 . . . . 75.23 110.066 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.91 -174.48 41.6 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.237 -0.745 . . . . 73.4 111.237 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.8 m -75.99 128.0 34.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.803 0.302 . . . . 70.15 111.103 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -82.49 140.67 33.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.773 0.321 . . . . 53.34 110.648 177.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.483 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 11.6 tt -70.58 -27.02 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.382 -0.372 . . . . 75.21 111.458 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 20.1 t70 -141.26 179.29 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.717 -0.475 . . . . 72.55 109.717 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.94 -33.7 26.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.078 0.466 . . . . 71.11 109.774 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.58 -28.26 13.07 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.8 -0.714 . . . . 72.3 111.651 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 77.0 m80 -92.65 69.25 4.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.421 0.629 . . . . 62.42 109.554 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.45 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 4.1 p -91.26 7.99 38.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.277 -0.874 . . . . 74.21 111.201 -178.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -110.0 4.1 21.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.947 -0.569 . . . . 74.14 110.22 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 102' ' ' GLN . 58.7 t -120.04 126.38 75.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 74.22 110.141 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.499 HD11 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -70.72 133.63 46.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.656 0.265 . . . . 73.51 110.361 -178.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.483 ' HB1' ' HA ' ' A' ' 78' ' ' ILE . . . -79.56 155.71 28.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.004 -0.543 . . . . 72.32 110.394 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 99' ' ' VAL . 1.6 mm? -81.84 148.37 28.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.293 -0.412 . . . . 75.3 110.106 -175.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -74.78 147.38 41.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.272 -0.422 . . . . 70.55 110.294 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.6 p -90.49 105.29 17.72 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.057 0.456 . . . . 65.12 111.027 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.3 m -101.42 2.3 39.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.07 -0.514 . . . . 55.23 110.621 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 63.22 21.74 12.99 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.763 -0.653 . . . . 74.12 110.952 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.76 1.94 11.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.842 -0.617 . . . . 72.15 110.414 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.39 89.32 1.99 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.779 -0.724 . . . . 73.41 111.675 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.0 m -79.96 157.53 26.83 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.633 0.254 . . . . 75.43 110.48 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.26 49.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 73.11 110.816 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.14 152.92 47.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.481 -0.327 . . . . 64.02 110.702 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.413 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 42.5 m-80 68.26 7.47 5.94 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.803 -0.635 . . . . 75.14 111.919 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.494 ' O ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -147.6 151.98 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 CA-C-O 120.978 0.418 . . . . 74.15 110.758 176.082 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -151.22 -171.29 19.1 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 110.277 -1.129 . . . . 65.51 110.277 174.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.414 HG21 HG21 ' A' ' 10' ' ' VAL . 2.7 p -117.1 118.81 59.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.378 0.609 . . . . 75.53 110.965 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.436 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.0 pt20 -110.46 147.09 34.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.66 -0.7 . . . . 75.01 109.793 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.427 HD11 ' N ' ' A' ' 103' ' ' ILE . 4.3 mp -107.44 127.87 62.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.987 0.422 . . . . 73.13 110.804 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.2 mt -91.47 142.8 27.26 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.559 -0.746 . . . . 73.45 109.116 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.549 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.9 OUTLIER -75.14 -170.42 1.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.508 -0.314 . . . . 72.32 110.167 178.282 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.5 ptt85 -62.96 -24.8 68.06 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.604 0.224 . . . . 72.04 111.604 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.9 p -93.49 1.06 56.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 75.51 111.391 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.68 29.47 29.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.879 -0.676 . . . . 74.11 112.996 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.8 130.23 55.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.237 -0.283 . . . . 75.23 110.237 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.73 128.55 36.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.897 0.38 . . . . 63.11 111.034 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.45 148.95 23.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.956 -0.565 . . . . 65.24 110.785 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.5 m -85.66 141.9 29.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 74.45 110.251 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 63.4 mt -79.23 42.16 0.48 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.168 0.509 . . . . 73.21 110.683 -178.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.433 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 16.6 t70 -85.37 -18.72 32.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.817 -0.628 . . . . 74.52 110.936 -176.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.74 -24.77 7.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.584 -0.817 . . . . 71.25 112.454 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.2 7.5 19.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.006 0.431 . . . . 73.34 110.563 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 114' ' ' ASP . 15.8 m -93.7 97.29 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 74.42 109.853 175.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.553 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 58.3 m-85 -92.79 162.7 14.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.122 -0.49 . . . . 75.35 111.005 -174.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 5.6 m -72.97 176.35 5.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 64.35 111.314 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.9 m -65.05 131.47 46.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.231 -0.441 . . . . 73.23 110.191 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -44.25 115.48 0.85 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.027 0.829 . . . . 63.41 111.944 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.6 m -102.25 105.27 15.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.137 -0.483 . . . . 71.33 109.965 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.816 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 59.9 m -60.58 115.83 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.48 0.657 . . . . 73.23 111.361 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.538 HD11 ' SG ' ' A' ' 61' ' ' CYS . 96.0 mt -83.22 155.63 23.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.19 -0.913 . . . . 73.02 112.097 -173.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.38 153.3 50.92 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.668 -0.864 . . . . 73.43 108.668 170.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.9 m120 -63.82 112.35 2.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.956 0.408 . . . . 72.33 110.762 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.1 -137.66 9.29 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.934 -0.651 . . . . 62.53 112.046 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.7 m -93.61 126.96 39.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.71 0.291 . . . . 62.12 110.889 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -129.8 120.79 25.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.721 -0.474 . . . . 74.13 109.721 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 57' ' ' GLN . 2.3 m -110.44 117.52 33.79 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.626 0.251 . . . . 74.33 110.468 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.5 mt -95.48 113.9 62.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.597 -0.52 . . . . 73.02 109.597 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.78 138.55 13.39 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.09 2.527 . . . . 72.22 112.667 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.458 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 86.5 m-85 -135.9 161.09 36.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 74.44 110.887 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 52.2 mt-30 -133.04 118.24 18.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.655 . . . . 73.01 110.751 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.37 126.7 50.67 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.318 -0.239 . . . . 73.12 110.44 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -134.44 164.99 26.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.802 0.334 . . . . 72.42 111.048 -178.021 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.623 ' HH ' ' HA3' ' A' ' 8' ' ' GLY . 63.1 m-85 -85.46 142.2 29.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.997 -0.547 . . . . 73.1 110.466 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.464 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 61.1 t80 -126.83 124.11 38.88 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.895 -0.78 . . . . 74.21 108.895 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.622 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . . . -91.19 135.99 33.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.12 0.486 . . . . 71.31 111.572 -176.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.413 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 78.7 p -100.36 1.27 41.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.296 -0.865 . . . . 71.32 108.909 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.11 -128.77 1.7 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.553 -1.203 . . . . 71.15 111.059 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -87.55 95.71 10.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.184 -0.302 . . . . 72.01 110.184 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.451 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -46.52 112.05 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.847 -0.615 . . . . 71.14 111.587 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.2 p -107.61 149.51 38.98 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-O 121.003 0.43 . . . . 73.33 110.736 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.5 163.99 25.08 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.85 3.034 . . . . 72.0 113.239 -176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.91 179.99 18.34 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.672 -0.694 . . . . 64.52 111.975 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.07 119.85 10.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.789 0.328 . . . . 64.14 110.707 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . . . -116.01 42.64 2.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.649 0.738 . . . . 75.14 110.411 -176.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -98.72 145.13 27.22 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.036 -0.984 . . . . 72.32 110.078 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.499 ' HB1' HD11 ' A' ' 86' ' ' LEU . . . -147.45 164.89 31.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.917 0.389 . . . . 63.24 111.322 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -123.05 133.31 54.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.321 -0.622 . . . . 72.41 109.321 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.22 128.94 14.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.932 0.396 . . . . 70.14 111.108 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.0 p -102.53 129.71 49.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.132 -0.485 . . . . 74.03 110.265 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.486 ' CD1' HD13 ' A' ' 56' ' ' ILE . 47.3 p90 -103.45 127.26 50.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.958 0.409 . . . . 73.13 110.706 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.595 ' HA ' HG21 ' A' ' 16' ' ' VAL . 6.9 ttmm -110.14 108.7 18.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.259 -0.428 . . . . 73.54 110.331 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.5 m -80.62 129.7 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.447 -0.575 . . . . 73.33 109.447 174.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -123.02 115.19 21.45 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.143 -0.688 . . . . 71.53 109.143 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.622 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -115.08 -11.16 12.11 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.392 0.515 . . . . 75.22 112.392 -177.534 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.534 -0.746 . . . . 71.12 109.232 170.569 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 120.95 0.405 . . . . 71.52 110.748 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.04 143.13 48.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.096 -0.502 . . . . 74.11 109.953 175.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.517 HG23 HG23 ' A' ' 4' ' ' THR . 10.0 t -96.12 -23.12 16.91 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.289 -0.414 . . . . 64.53 110.963 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.517 HG23 HG23 ' A' ' 3' ' ' THR . 62.4 p -111.68 -174.01 2.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 73.2 110.422 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.51 HG22 HG12 ' A' ' 37' ' ' VAL . 34.8 m -91.31 17.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.013 0.435 . . . . 72.43 110.563 175.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 59.96 20.15 9.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.325 -0.852 . . . . 64.1 111.999 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.12 101.57 1.02 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.718 -0.753 . . . . 71.3 111.712 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.46 151.69 31.39 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.035 -1.078 . . . . 71.44 111.348 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.502 ' HB ' HG23 ' A' ' 31' ' ' THR . 17.4 p -141.47 135.64 30.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.55 0.214 . . . . 71.23 110.913 -176.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.44 ' CG2' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -117.49 115.89 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.566 -0.531 . . . . 73.45 109.566 174.21 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -83.04 108.76 16.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.286 -0.415 . . . . 70.23 109.928 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -100.03 113.78 26.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.302 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -106.12 135.02 48.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.867 -0.42 . . . . 72.33 109.867 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.01 -125.91 5.7 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.962 -0.637 . . . . 36.97 111.888 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 67.6 12.95 9.12 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.886 0.474 . . . . 71.11 110.93 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.543 HG23 HG12 ' A' ' 17' ' ' VAL . 34.2 m -76.38 -30.66 19.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.063 -0.517 . . . . 73.32 111.859 -173.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.543 HG12 HG23 ' A' ' 16' ' ' VAL . 24.9 m -133.75 145.46 33.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.299 0.571 . . . . 73.44 111.468 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -151.68 30.41 0.59 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.933 -1.136 . . . . 61.43 107.933 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.66 -79.26 0.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.227 -0.897 . . . . 75.53 111.214 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.401 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -90.68 -34.87 15.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.969 0.414 . . . . 72.22 110.602 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.2 m -140.78 136.31 32.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.485 . . . . 73.2 109.75 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.31 130.45 47.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.357 -0.383 . . . . 60.11 110.304 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.7 t -67.69 130.93 33.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.964 -0.384 . . . . 74.11 109.964 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.496 ' O ' HG13 ' A' ' 28' ' ' VAL . 15.3 t70 -61.66 141.11 58.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.36 -0.382 . . . . 71.54 110.72 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.81 -26.99 64.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 74.2 111.798 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.84 2.67 79.02 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.792 -0.718 . . . . 75.24 112.302 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.3 p -131.89 3.05 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.593 0.235 . . . . 64.43 111.521 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 24' ' ' ASP . 35.2 m -89.4 -1.32 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.873 0.368 . . . . 73.22 110.687 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -158.72 97.58 1.45 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.085 -0.709 . . . . 73.41 109.085 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -144.6 104.01 4.0 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.483 0.658 . . . . 74.13 111.041 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.502 HG23 ' HB ' ' A' ' 9' ' ' THR . 5.8 m -81.59 94.48 6.92 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.389 -0.823 . . . . 72.24 109.096 173.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.42 140.33 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.122 -0.49 . . . . 75.14 111.043 -172.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -96.58 117.82 31.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 71.44 110.095 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.44 HD21 ' CG2' ' A' ' 10' ' ' VAL . 1.7 mm? -87.98 -23.85 23.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.444 -0.576 . . . . 74.41 109.444 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.29 166.96 32.67 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.317 -0.856 . . . . 55.22 112.618 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -73.21 94.46 1.98 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.907 -0.405 . . . . 75.21 109.907 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.51 HG12 HG22 ' A' ' 5' ' ' VAL . 9.5 p -75.54 145.24 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.19 -0.459 . . . . 65.13 110.858 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -76.47 117.56 18.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.788 -0.642 . . . . 71.34 110.562 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 29.9 p -72.67 -16.28 61.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 72.44 110.99 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.0 -16.52 54.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 71.5 110.909 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.4 m -83.23 -44.34 15.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.167 -0.47 . . . . 72.23 110.263 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.528 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 6.2 mp -93.83 95.85 9.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.18 0.514 . . . . 73.43 110.306 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.47 22.26 5.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.326 0.584 . . . . 73.52 110.379 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.429 ' HG2' ' HB3' ' A' ' 47' ' ' ALA . 3.6 pm0 -151.66 137.96 18.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.311 -0.859 . . . . 74.02 110.233 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 40.8 tt0 -62.26 123.62 18.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.978 0.418 . . . . 60.33 110.117 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.67 -13.35 27.46 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.27 -0.732 . . . . 55.32 111.27 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.429 ' HB3' ' HG2' ' A' ' 44' ' ' GLN . . . -63.95 121.89 15.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.67 0.272 . . . . 73.22 110.281 176.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.51 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 25.4 p -123.75 118.62 27.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.34 -0.391 . . . . 73.42 110.724 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 t -75.8 173.72 10.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.1 -0.5 . . . . 64.43 110.172 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.8 m -64.41 135.79 56.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.107 0.48 . . . . 74.2 110.446 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -85.6 159.37 19.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.733 -0.667 . . . . 64.21 111.771 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.6 m -90.48 158.41 2.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.898 -1.047 . . . . 71.1 108.991 168.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.55 81.13 0.31 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.446 -0.883 . . . . 71.34 112.237 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -95.95 165.33 12.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.989 -0.374 . . . . 75.43 109.989 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.541 ' HB2' HG22 ' A' ' 130' ' ' THR . 2.4 p-10 -138.12 144.66 40.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.38 0.609 . . . . 75.54 111.517 -175.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 79.7 mt -105.53 120.25 55.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.34 -0.846 . . . . 74.32 109.383 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -98.15 136.98 37.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.98 0.419 . . . . 75.41 110.643 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.8 mt -119.04 130.75 55.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 74.54 109.597 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -108.15 144.84 35.02 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.243 -0.435 . . . . 73.45 110.395 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 53.39 46.38 26.41 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.868 0.73 . . . . 52.21 111.225 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.47 ' SG ' HD12 ' A' ' 124' ' ' LEU . 27.5 t -81.34 131.89 35.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.461 -0.791 . . . . 64.54 110.074 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.425 ' OD2' HG11 ' A' ' 65' ' ' VAL . 16.3 t70 -107.68 134.01 51.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.243 -0.435 . . . . 74.32 111.646 -175.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.1 p -104.67 13.77 30.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 73.15 112.064 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -89.07 -35.39 16.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.905 -0.406 . . . . 75.21 109.905 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.425 HG11 ' OD2' ' A' ' 62' ' ' ASP . 14.0 p -97.26 -28.31 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.975 -0.557 . . . . 74.14 111.044 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.533 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -121.1 -177.59 3.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.493 -0.322 . . . . 52.22 110.953 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.2 m -140.75 -54.89 0.5 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.644 0.259 . . . . 73.23 111.454 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.782 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -134.56 140.95 46.5 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.318 -0.239 . . . . 73.33 110.843 -178.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.445 ' HB2' HD23 ' A' ' 124' ' ' LEU . . . -102.59 135.4 44.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.101 0.477 . . . . 71.21 110.557 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.9 114.92 7.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.759 -0.655 . . . . 63.43 109.576 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.5 m -85.32 149.33 4.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.142 0.496 . . . . 75.31 110.895 -174.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.74 118.33 29.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.54 -0.755 . . . . 74.41 109.211 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 75.2 m-85 -83.16 128.98 34.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.027 0.441 . . . . 75.12 110.498 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.7 tp -128.22 127.44 42.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.008 -0.542 . . . . 74.34 109.804 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.47 -167.94 25.79 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.965 -0.854 . . . . 72.22 110.965 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.426 ' O ' HD11 ' A' ' 86' ' ' LEU . 9.5 m -74.29 120.85 20.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.102 0.451 . . . . 64.11 110.622 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.491 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.59 136.17 36.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.592 0.234 . . . . 72.22 110.817 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.466 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 10.9 tt -65.16 -30.6 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.29 -0.414 . . . . 72.23 111.213 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 19.9 t70 -151.3 173.21 14.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.478 -0.564 . . . . 71.2 109.478 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.59 -30.78 52.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.059 -0.519 . . . . 73.4 110.301 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.12 -20.26 28.47 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.842 -0.694 . . . . 54.1 111.711 177.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 65.1 m80 -103.5 47.85 0.87 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.382 -0.599 . . . . 74.43 109.382 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.491 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.4 p -72.81 9.63 1.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.572 -0.74 . . . . 75.11 112.331 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 16.7 p-10 -99.75 -18.6 17.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.784 0.326 . . . . 63.33 110.895 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.7 t -105.03 132.57 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.388 -0.369 . . . . 63.41 110.87 -176.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.481 HD12 ' HB3' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -67.29 135.18 52.94 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.21 -0.45 . . . . 72.41 110.519 179.18 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 78' ' ' ILE . . . -78.83 146.78 33.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.964 -0.562 . . . . 72.03 109.684 175.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.411 HD21 ' N ' ' A' ' 88' ' ' LEU . 2.2 mm? -85.7 129.87 34.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.333 -0.394 . . . . 65.15 110.77 -175.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -57.99 131.53 50.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.646 . . . . 71.04 109.493 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 m -85.69 125.0 32.85 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.623 -0.717 . . . . 71.31 111.654 -168.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.2 m -92.01 -10.14 40.3 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.665 -0.698 . . . . 72.51 109.779 175.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.75 -0.0 1.4 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.271 -0.877 . . . . 74.01 111.837 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.67 4.33 10.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.954 0.407 . . . . 63.14 111.169 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 133.61 67.45 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.477 -0.868 . . . . 75.44 112.787 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.3 p -78.17 160.61 27.89 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.608 -0.516 . . . . 71.53 109.608 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.19 144.77 38.08 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.805 -0.443 . . . . 71.43 109.805 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.09 164.7 29.4 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.964 -0.384 . . . . 75.04 109.964 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.503 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 67.0 m-20 69.03 8.11 6.64 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.347 0.594 . . . . 53.12 110.12 -177.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -178.23 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.023 -0.99 . . . . 73.34 109.628 173.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 175.25 -172.07 45.14 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 110.268 -1.133 . . . . 73.45 110.268 177.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 p -126.13 120.06 55.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.096 0.474 . . . . 62.11 110.409 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.459 ' OE1' ' HB1' ' A' ' 110' ' ' ALA . 25.9 pt20 -117.14 149.51 40.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.52 -0.548 . . . . 73.44 109.52 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.42 HD11 ' N ' ' A' ' 103' ' ' ILE . 4.3 mp -101.02 128.2 53.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.089 -0.505 . . . . 72.33 110.598 -174.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 110' ' ' ALA . 16.3 mt -94.1 146.0 24.28 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.367 -0.833 . . . . 75.25 108.917 175.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.4 OUTLIER -72.39 -173.21 1.07 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.825 -0.435 . . . . 63.55 109.825 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -58.31 -32.49 68.52 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.556 0.206 . . . . 74.12 111.556 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.3 p -89.28 0.32 56.88 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.817 0.341 . . . . 72.14 111.793 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.04 29.95 24.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 62.22 113.07 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.78 134.35 46.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.364 -0.236 . . . . 72.34 110.364 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.519 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -67.05 122.76 18.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.998 0.428 . . . . 72.32 111.323 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.6 mt -90.56 148.4 22.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.026 -0.534 . . . . 74.04 110.523 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.483 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 25.8 m -96.91 142.22 29.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.258 -0.428 . . . . 64.43 110.439 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 50.0 mt -83.95 51.55 2.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 74.24 110.857 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -109.72 -5.43 15.61 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.018 0.437 . . . . 73.12 110.046 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.26 2.29 62.46 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.745 -0.661 . . . . 71.42 112.95 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.66 -13.09 9.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 63.33 111.066 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.483 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 12.1 m -85.51 100.29 11.8 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.968 -0.382 . . . . 75.21 109.968 175.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.408 ' HE1' ' HE3' ' A' ' 155' ' ' LYS . 83.3 m-85 -90.17 154.7 19.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.945 -0.571 . . . . 72.11 111.185 -176.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 11.5 m -69.64 179.73 2.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.66 -0.7 . . . . 63.32 110.843 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.8 t -64.14 150.19 46.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.936 -0.394 . . . . 74.44 109.936 174.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -61.83 102.73 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 75.34 111.075 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -84.5 97.81 9.76 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.864 -0.791 . . . . 70.21 108.864 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.782 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 49.8 m -60.69 122.91 15.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.073 -0.512 . . . . 62.31 110.391 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.47 HD12 ' SG ' ' A' ' 61' ' ' CYS . 97.0 mt -80.97 151.98 28.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.383 -0.826 . . . . 61.54 112.066 -170.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -116.78 159.51 22.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.142 -0.936 . . . . 73.2 109.37 170.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.35 108.0 6.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.129 0.49 . . . . 73.11 110.356 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.27 -135.91 9.55 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.739 -0.743 . . . . 72.44 112.339 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.1 m -83.84 126.09 32.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.165 0.507 . . . . 75.21 111.335 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -124.56 160.4 28.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.716 -0.675 . . . . 74.42 109.646 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.541 HG22 ' HB2' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -144.18 122.28 12.16 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.848 -0.341 . . . . 74.23 110.576 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.0 mt -102.98 113.43 65.91 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.984 -0.376 . . . . 63.34 109.984 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.9 137.31 8.62 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 123.131 2.554 . . . . 74.21 112.399 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -134.66 163.17 30.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.028 0.442 . . . . 62.14 111.211 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 99.3 mt-30 -127.89 112.91 15.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.871 -0.604 . . . . 74.51 111.217 -177.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.17 121.59 42.53 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.944 -0.303 . . . . 64.32 110.236 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.51 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 10.6 ptp180 -137.45 164.05 29.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.848 0.356 . . . . 75.12 110.857 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.418 ' CE2' ' HB ' ' A' ' 37' ' ' VAL . 87.4 m-85 -78.95 147.47 32.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.607 . . . . 75.12 111.007 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -131.81 122.14 25.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.673 -0.694 . . . . 74.1 109.529 176.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 42' ' ' LEU . . . -91.32 139.36 30.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.902 0.382 . . . . 63.44 111.528 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 48.0 p -103.89 -0.73 28.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.536 0.684 . . . . 74.32 109.316 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.8 -127.57 1.48 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.05 -0.977 . . . . 72.31 111.111 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.83 93.92 6.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.359 -0.237 . . . . 74.23 110.359 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.32 116.75 1.84 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.384 0.428 . . . . 74.24 111.094 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.0 p -104.12 142.67 25.09 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-O 121.256 0.551 . . . . 75.0 110.898 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.25 165.53 28.35 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.581 2.854 . . . . 73.53 113.018 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 145.99 -140.2 8.72 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.605 -0.725 . . . . 75.22 111.869 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.3 117.01 32.95 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.412 0.149 . . . . 64.4 110.745 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -105.97 58.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.341 0.591 . . . . 71.02 111.141 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.402 HD21 ' N ' ' A' ' 149' ' ' ASN . 0.9 OUTLIER -99.1 140.5 33.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.971 -0.558 . . . . 73.1 109.592 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.481 ' HB3' HD12 ' A' ' 86' ' ' LEU . . . -153.01 165.08 36.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.583 0.23 . . . . 74.31 110.634 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -138.91 148.0 43.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.923 -0.399 . . . . 73.22 109.923 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.476 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -154.72 146.37 23.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.097 0.475 . . . . 75.1 110.951 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.1 p -108.87 127.93 54.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.043 -0.526 . . . . 62.54 110.034 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -96.64 123.5 40.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.006 0.432 . . . . 73.02 110.425 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.54 ' HA ' HG22 ' A' ' 16' ' ' VAL . 5.5 tmmm? -107.49 109.12 20.72 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.201 -0.454 . . . . 73.41 109.802 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.4 m -78.8 136.16 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.28 0.562 . . . . 75.53 110.619 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -114.45 118.14 32.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.871 -0.604 . . . . 73.22 110.067 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 1.5 p90 -134.21 -20.41 1.9 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.997 0.427 . . . . 75.23 110.15 171.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 . . . . . 0 C--O 1.25 1.101 0 CA-C-N 115.411 -0.813 . . . . 64.35 109.12 173.805 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.684 0.278 . . . . 71.4 110.319 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.24 -177.04 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.257 -0.428 . . . . 72.23 110.162 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.52 HG23 HG23 ' A' ' 4' ' ' THR . 8.7 t -102.61 -18.23 15.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.182 0.515 . . . . 75.1 110.476 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.52 HG23 HG23 ' A' ' 3' ' ' THR . 71.3 p -118.43 -179.91 3.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.057 -0.52 . . . . 54.22 110.573 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.529 HG22 HG12 ' A' ' 37' ' ' VAL . 34.4 m -91.25 16.02 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.983 0.421 . . . . 75.32 111.062 177.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 62.57 13.93 6.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.595 -0.73 . . . . 74.43 112.64 173.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.49 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 86.24 95.55 0.82 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.37 -0.919 . . . . 71.31 111.278 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.92 164.06 27.29 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.491 -0.862 . . . . 44.44 112.181 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.528 ' HB ' HG21 ' A' ' 31' ' ' THR . 63.2 p -140.85 147.74 39.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.683 0.278 . . . . 73.12 110.887 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.512 HG23 HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -112.81 123.46 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 N-CA-C 109.044 -0.725 . . . . 72.51 109.044 171.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -90.86 99.41 12.45 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.645 -0.502 . . . . 62.23 109.645 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.415 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 74.6 m-85 -88.89 117.57 27.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.781 -0.645 . . . . 72.21 110.213 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HB3' HG22 ' A' ' 153' ' ' THR . 80.1 tttt -110.12 139.35 45.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 74.03 110.736 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.88 -123.34 3.72 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.882 -0.599 . . . . 61.22 112.176 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HG2' ' HB ' ' A' ' 28' ' ' VAL . 24.9 mm-40 60.44 19.71 9.4 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.695 0.398 . . . . 61.4 111.783 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.689 HG23 HG23 ' A' ' 17' ' ' VAL . 29.1 m -77.78 -28.79 15.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.35 -0.386 . . . . 72.3 111.581 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.689 HG23 HG23 ' A' ' 16' ' ' VAL . 7.7 m -148.04 153.05 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 63.3 110.84 -176.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -162.29 53.99 0.22 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.288 -1.005 . . . . 54.25 108.288 176.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -110.25 -72.88 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.709 -1.132 . . . . 65.13 110.274 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -76.87 -41.56 43.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.959 -0.564 . . . . 70.43 110.147 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -136.36 156.72 48.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.526 -0.546 . . . . 74.34 109.526 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.91 127.67 54.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.862 -0.421 . . . . 72.24 109.862 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.417 ' HA ' HD22 ' A' ' 58' ' ' LEU . 16.4 t -68.23 132.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.974 -0.38 . . . . 71.11 109.974 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.423 ' O ' HG11 ' A' ' 28' ' ' VAL . 24.2 t70 -56.3 143.17 35.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 75.45 111.461 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.49 -25.09 67.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 51.34 112.143 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.73 -15.37 61.63 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.57 -0.824 . . . . 72.22 111.701 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 t -93.89 -24.94 17.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.755 -0.223 . . . . 71.34 110.804 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 24' ' ' ASP . 33.6 m -74.28 -6.92 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.829 0.347 . . . . 74.22 111.083 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -161.13 94.36 1.0 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.944 -0.761 . . . . 63.22 108.944 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.415 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 16.4 pt20 -137.95 114.9 10.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.396 0.617 . . . . 65.15 110.699 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.528 HG21 ' HB ' ' A' ' 9' ' ' THR . 5.2 m -95.91 93.8 7.24 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.205 -0.907 . . . . 73.34 109.752 177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.23 140.08 17.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.748 -0.66 . . . . 72.15 111.164 -173.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -92.59 118.91 31.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 73.53 110.458 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.512 HD21 HG23 ' A' ' 10' ' ' VAL . 2.9 mm? -87.81 -30.26 20.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.223 0.535 . . . . 74.24 109.717 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.49 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.79 174.7 38.2 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.517 -0.765 . . . . 53.24 112.408 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.8 90.67 2.91 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.81 -0.23 . . . . 73.31 110.516 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.529 HG12 HG22 ' A' ' 5' ' ' VAL . 5.0 p -73.87 145.88 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.422 -0.584 . . . . 73.03 109.422 175.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -92.05 128.38 37.87 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.35 -0.386 . . . . 73.44 110.041 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.9 p -66.6 -24.34 66.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.02 -0.536 . . . . 74.44 111.721 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.78 -19.85 65.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.062 -0.517 . . . . 72.54 111.305 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -89.42 -0.58 57.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.126 -0.488 . . . . 72.15 111.21 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.577 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 6.8 mt -137.08 48.61 2.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.224 0.535 . . . . 72.03 110.487 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.84 16.93 16.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.136 -0.484 . . . . 71.24 112.136 -171.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -157.79 142.99 16.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.218 -0.447 . . . . 74.55 110.312 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 33.6 tt0 -59.28 123.56 17.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.942 0.401 . . . . 74.42 110.045 175.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.0 -15.58 21.02 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.206 -0.758 . . . . 64.52 111.206 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 42' ' ' LEU . . . -67.76 123.53 20.77 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.451 -0.574 . . . . 55.34 109.451 174.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.474 HG22 ' HD1' ' A' ' 138' ' ' PHE . 37.3 p -123.27 134.26 54.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.969 0.414 . . . . 74.21 110.94 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.1 t -84.43 176.37 8.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.924 -0.58 . . . . 75.55 109.611 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -68.77 133.43 48.34 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.853 -0.425 . . . . 64.52 109.853 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -88.77 152.69 21.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.599 0.714 . . . . 54.23 111.944 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 23.8 m -94.1 149.92 4.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.354 -1.294 . . . . 75.01 108.922 169.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.76 77.14 0.23 Allowed Glycine 0 C--N 1.311 -0.842 0 C-N-CA 120.988 -0.625 . . . . 61.1 112.255 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -81.77 167.98 18.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.984 -0.376 . . . . 73.21 109.984 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.525 ' HB2' HG23 ' A' ' 130' ' ' THR . 2.2 p-10 -138.05 138.44 38.8 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.998 0.427 . . . . 72.22 111.251 -175.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.5 mt -100.38 114.14 38.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.547 -0.751 . . . . 70.12 109.335 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -98.83 135.67 39.94 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.704 -0.68 . . . . 71.11 110.812 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 23' ' ' VAL . 70.0 mt -114.5 117.8 31.97 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.35 -0.611 . . . . 74.34 109.35 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -96.63 124.18 40.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.775 -0.648 . . . . 63.2 110.649 -175.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.7 t70 61.8 92.37 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.001 0.813 . . . . 50.52 111.122 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 48.4 t -128.6 152.83 47.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.794 -0.639 . . . . 64.21 110.627 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.404 ' HA ' ' ND2' ' A' ' 126' ' ' ASN . 18.3 t70 -116.85 142.13 47.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.873 -0.603 . . . . 74.3 110.978 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.0 p -106.08 14.08 28.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.04 0.385 . . . . 72.22 112.04 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -91.28 -31.17 16.22 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.382 -0.599 . . . . 75.24 109.382 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 p -104.2 -3.79 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.549 -0.75 . . . . 74.33 111.369 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . . . -146.57 178.83 7.99 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.319 -0.238 . . . . 63.42 110.89 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.4 m -143.56 -53.78 0.37 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.053 0.39 . . . . 54.34 112.053 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -137.82 141.81 40.81 Favored 'General case' 0 C--O 1.221 -0.406 0 O-C-N 122.216 -0.302 . . . . 71.35 110.437 -179.014 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.92 127.66 48.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.028 0.442 . . . . 74.55 110.594 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.72 116.18 11.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.821 -0.627 . . . . 74.04 109.729 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.5 m -90.65 146.4 6.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.963 0.411 . . . . 73.11 111.356 -173.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.462 ' HB1' ' CD1' ' A' ' 118' ' ' PHE . . . -119.57 123.06 43.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.736 -0.666 . . . . 74.35 109.513 171.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.559 ' CE1' HG22 ' A' ' 103' ' ' ILE . 55.3 m-85 -86.52 134.59 33.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.107 0.48 . . . . 74.34 110.959 -178.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.0 tp -131.18 129.1 41.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 74.11 110.3 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.23 -160.17 19.13 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.94 -0.864 . . . . 60.02 110.94 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.484 ' O ' HD12 ' A' ' 86' ' ' LEU . 26.3 m -88.05 130.48 34.98 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.258 -0.275 . . . . 74.24 110.258 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.432 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -85.61 144.55 27.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.268 -0.271 . . . . 71.4 110.268 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.478 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 15.3 tt -62.34 -28.18 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 74.42 111.382 -176.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -152.6 177.18 10.93 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.714 -0.476 . . . . 63.42 109.714 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.63 -27.72 34.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.191 -0.459 . . . . 70.24 110.215 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.51 -7.85 61.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.759 -0.734 . . . . 74.2 111.902 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -122.82 75.51 1.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.264 0.554 . . . . 70.43 109.945 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.432 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 1.9 p -90.02 16.24 8.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.691 -0.686 . . . . 73.21 111.795 -176.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -118.94 -0.29 11.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.342 -0.39 . . . . 74.33 111.163 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.414 ' HB ' HG22 ' A' ' 78' ' ' ILE . 47.3 t -117.43 127.32 74.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.35 -0.386 . . . . 72.52 110.096 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.494 HD13 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -66.77 135.22 53.63 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.658 0.266 . . . . 74.13 110.385 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 78' ' ' ILE . . . -78.57 160.49 27.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.124 -0.489 . . . . 64.51 110.583 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.567 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.9 mm? -91.1 137.66 32.19 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.898 -0.408 . . . . 73.45 109.898 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -65.26 130.29 42.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.019 -0.537 . . . . 61.32 110.456 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.66 109.37 6.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.528 -0.76 . . . . 72.43 109.911 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.8 m -92.83 -1.82 56.44 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.893 -0.594 . . . . 43.45 110.607 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 56.91 25.38 10.44 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.93 -0.577 . . . . 72.22 111.107 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.53 -0.9 2.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.929 -0.578 . . . . 75.03 110.864 -178.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 117.22 71.84 0.44 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.683 -0.77 . . . . 62.21 112.334 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.1 m -76.21 163.23 27.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.265 -0.272 . . . . 75.42 110.265 175.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.48 156.14 21.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.063 -0.347 . . . . 74.43 110.063 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 99' ' ' VAL . 0.2 OUTLIER -145.97 164.65 31.37 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.877 -0.329 . . . . 72.4 110.794 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 68.89 -1.73 1.96 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.619 0.768 . . . . 73.11 111.247 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.567 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -138.76 145.59 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 109.223 -0.658 . . . . 71.43 109.223 170.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -148.81 -167.66 13.97 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 110.753 -0.939 . . . . 75.41 110.753 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.38 110.87 28.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 121.359 0.599 . . . . 70.42 110.326 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.401 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.7 pt20 -100.6 132.03 46.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.748 -0.66 . . . . 74.23 109.416 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.559 HG22 ' CE1' ' A' ' 73' ' ' PHE . 4.0 mp -89.03 123.83 41.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.229 0.538 . . . . 75.45 110.219 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.8 mt -92.73 140.88 29.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.362 -0.835 . . . . 72.25 109.237 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.512 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.6 OUTLIER -71.57 -173.63 0.97 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.74 -0.467 . . . . 73.12 109.74 176.512 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -59.88 -23.36 63.39 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.448 0.536 . . . . 74.43 112.448 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.0 p -91.5 -16.66 26.89 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.502 -0.479 . . . . 62.11 111.236 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.33 29.1 6.13 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.912 -0.661 . . . . 63.24 112.532 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.29 124.7 50.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.515 0.198 . . . . 74.11 110.683 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.04 120.62 11.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 72.15 110.573 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.7 mt -83.78 144.14 29.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.103 -0.499 . . . . 74.33 111.031 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.461 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 3.1 m -73.83 140.29 45.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.2 -0.454 . . . . 73.2 109.951 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.472 HD11 HD22 ' A' ' 86' ' ' LEU . 52.4 mt -85.0 43.24 0.99 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.886 0.374 . . . . 74.03 110.571 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -105.33 -1.55 25.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.524 . . . . 75.43 110.516 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.4 -1.76 41.4 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.073 -0.584 . . . . 42.5 113.353 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.03 -22.12 11.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 117.012 0.406 . . . . 71.11 110.91 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.461 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 8.8 m -81.06 96.17 7.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.273 -0.421 . . . . 60.34 110.26 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.51 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 89.2 m-85 -86.51 162.86 17.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.455 . . . . 75.42 110.327 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 13.4 m -73.55 -178.01 2.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.984 -0.553 . . . . 75.41 110.593 176.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.7 m -69.15 152.98 44.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.387 -0.37 . . . . 74.13 110.288 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.19 111.77 2.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.131 0.491 . . . . 72.1 111.623 -178.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.8 m -95.67 104.52 16.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.876 -0.602 . . . . 64.12 109.426 174.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -57.25 125.55 23.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 72.41 110.888 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.3 mt -91.62 163.4 14.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.203 0.525 . . . . 72.42 111.661 -176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -141.95 157.11 45.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.254 -0.885 . . . . 73.05 108.994 169.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.594 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 16.4 m120 -60.14 111.39 1.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.833 0.349 . . . . 72.42 110.267 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 137.86 -140.15 10.99 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.898 -0.668 . . . . 71.22 111.927 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.1 m -96.55 120.63 37.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.121 0.486 . . . . 65.53 110.939 -177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -114.22 137.14 52.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.974 -0.557 . . . . 71.1 109.79 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.525 HG23 ' HB2' ' A' ' 55' ' ' ASN . 1.4 m -125.45 121.42 33.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.688 0.28 . . . . 73.41 110.449 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 mt -106.31 112.71 63.86 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.801 -0.444 . . . . 74.35 109.801 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.8 139.39 9.81 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.991 2.461 . . . . 74.43 112.611 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.422 ' HD1' ' HA ' ' A' ' 105' ' ' ASP . 71.6 m-85 -138.71 164.02 30.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 71.13 110.309 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 87.0 mt-30 -124.37 134.18 53.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.961 0.41 . . . . 71.24 111.109 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 52' ' ' VAL . . . -121.9 124.73 44.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.07 -0.514 . . . . 64.24 109.952 176.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 18.1 ptp180 -142.85 161.96 36.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.588 -0.278 . . . . 72.53 110.322 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 64.7 m-85 -77.9 135.63 37.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.098 -0.501 . . . . 72.25 110.525 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.474 ' HD1' HG22 ' A' ' 48' ' ' THR . 89.7 t80 -125.88 122.0 34.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.558 -0.746 . . . . 73.44 109.245 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.577 ' HB1' ' HB3' ' A' ' 42' ' ' LEU . . . -83.97 135.68 34.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.276 -0.42 . . . . 74.31 111.311 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.423 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 63.9 p -107.27 2.66 24.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.796 -0.638 . . . . 74.23 109.571 176.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 171.09 -115.99 0.61 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.214 -0.903 . . . . 52.42 111.62 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -98.19 94.21 6.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.702 0.251 . . . . 61.34 110.636 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.11 111.57 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.398 0.436 . . . . 75.12 111.865 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.2 p -104.58 140.84 21.47 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 116.122 -0.49 . . . . 64.3 110.188 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.96 179.96 3.93 Favored 'Trans proline' 0 N--CA 1.472 0.248 0 C-N-CA 123.717 2.945 . . . . 74.24 113.351 -172.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.83 -172.01 16.97 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.631 -0.795 . . . . 74.33 111.811 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.21 102.01 2.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.986 0.422 . . . . 54.22 110.947 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.22 76.85 1.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.179 0.514 . . . . 71.24 110.765 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -121.81 142.92 49.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.964 -0.562 . . . . 74.4 109.492 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.494 ' HB1' HD13 ' A' ' 86' ' ' LEU . . . -141.46 165.66 26.89 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 123.051 0.219 . . . . 72.32 111.027 -176.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -141.85 146.31 35.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.087 -0.338 . . . . 63.3 110.087 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.451 ' HB1' HD23 ' A' ' 86' ' ' LEU . . . -155.39 147.63 23.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.288 -0.415 . . . . 63.55 111.064 -178.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 13' ' ' LYS . 16.6 p -104.29 127.2 51.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.954 -0.566 . . . . 75.55 110.064 175.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -97.09 127.77 43.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.261 0.553 . . . . 74.5 110.947 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.555 ' HA ' HG22 ' A' ' 16' ' ' VAL . 8.5 ttmm -103.18 98.77 8.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.692 -0.686 . . . . 74.24 110.157 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.2 m -74.57 133.4 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.304 0.573 . . . . 74.14 109.631 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -117.17 110.47 18.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.087 -0.506 . . . . 72.33 110.05 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.705 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -123.02 -12.63 7.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.619 0.723 . . . . 74.33 110.377 172.058 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.631 ' HG3' ' HD1' ' A' ' 158' ' ' TYR . 51.3 mt-30 . . . . . 0 C--O 1.249 1.072 0 CA-C-N 114.966 -1.015 . . . . 74.04 109.437 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.687 0.279 . . . . 72.05 110.285 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.86 161.46 30.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.297 -0.411 . . . . 75.3 110.319 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 t -87.83 -6.86 57.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.178 0.513 . . . . 61.35 110.719 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.3 p -113.85 176.33 5.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.3 -0.409 . . . . 70.42 110.584 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 37' ' ' VAL . 36.0 m -89.18 13.95 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.264 -0.426 . . . . 72.25 110.691 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.429 ' C ' ' HG2' ' A' ' 36' ' ' GLN . 54.8 m-80 64.41 4.87 2.36 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.437 -0.801 . . . . 75.44 112.655 175.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.52 110.78 3.51 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.497 -0.859 . . . . 55.52 111.855 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.671 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -92.46 155.25 22.65 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.368 -0.92 . . . . 61.1 112.383 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.459 ' HB ' ' CG2' ' A' ' 31' ' ' THR . 1.6 p -145.9 125.1 12.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.568 0.223 . . . . 64.04 110.573 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -104.02 126.17 58.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.849 -0.426 . . . . 74.0 109.849 177.023 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -93.21 109.06 20.57 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.11 0.481 . . . . 71.42 110.174 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.464 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 87.6 m-85 -101.86 121.54 42.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.052 -0.522 . . . . 74.0 110.207 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -114.72 138.79 50.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.923 0.392 . . . . 72.34 110.431 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.49 -123.15 5.06 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.535 -0.626 . . . . 73.53 111.535 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.429 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 35.0 mt-10 63.57 25.64 14.44 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.395 0.617 . . . . 55.0 110.31 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.687 HG22 HG23 ' A' ' 17' ' ' VAL . 20.0 m -85.87 -32.33 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.615 -0.721 . . . . 75.4 111.59 -176.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.687 HG23 HG22 ' A' ' 16' ' ' VAL . 6.9 m -141.35 154.96 20.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.375 -0.375 . . . . 75.15 111.164 -174.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -168.74 90.24 0.24 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.434 -0.95 . . . . 74.44 108.434 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.26 -75.1 0.13 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.346 -0.843 . . . . 73.2 109.811 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.77 -37.82 62.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.761 -0.654 . . . . 64.11 109.689 174.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 m -147.17 162.02 39.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.382 -0.826 . . . . 74.34 108.832 -177.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.91 134.92 55.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.188 -0.301 . . . . 72.43 110.188 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.528 ' HA ' HD22 ' A' ' 58' ' ' LEU . 15.6 t -69.01 137.34 24.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.519 -0.31 . . . . 75.21 110.371 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.521 ' O ' HG12 ' A' ' 28' ' ' VAL . 20.5 t70 -57.22 141.55 46.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 74.52 111.69 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.48 -27.0 67.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 75.3 112.093 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.48 -14.06 60.56 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.436 -0.887 . . . . 71.55 111.722 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 t -97.94 -18.83 18.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.413 0.149 . . . . 65.01 110.913 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 24' ' ' ASP . 35.9 m -78.35 -5.74 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.556 0.217 . . . . 74.23 111.177 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -165.07 94.12 0.64 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.417 -0.586 . . . . 73.44 109.417 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -147.52 150.04 33.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.99 -0.55 . . . . 64.22 110.878 -176.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.459 ' CG2' ' HB ' ' A' ' 9' ' ' THR . 5.4 m -121.74 114.15 20.7 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.644 -0.707 . . . . 73.23 109.673 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.75 139.03 18.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.14 -0.482 . . . . 63.54 110.823 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -92.68 121.91 34.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.826 -0.625 . . . . 70.23 110.46 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -97.32 -27.2 14.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.235 0.541 . . . . 74.04 109.842 176.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.38 178.43 44.18 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.582 -0.736 . . . . 65.31 112.225 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.429 ' HG2' ' C ' ' A' ' 6' ' ' ASN . 82.6 mt-30 -80.56 94.2 6.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.154 -0.313 . . . . 73.42 110.154 177.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.451 HG12 HG22 ' A' ' 5' ' ' VAL . 9.0 p -70.25 149.82 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 73.42 110.618 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.01 134.46 35.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.931 -0.577 . . . . 73.33 110.094 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 p -77.5 -19.16 56.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.108 0.48 . . . . 75.45 110.775 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.91 -16.69 60.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 64.53 111.258 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.4 m -90.85 3.68 53.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.103 0.478 . . . . 72.34 110.907 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.1 mt -142.46 54.67 1.43 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.866 -0.606 . . . . 61.25 110.008 -175.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.25 10.53 41.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.114 0.413 . . . . 74.52 112.114 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -145.65 141.44 28.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.699 0.285 . . . . 75.3 111.171 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 8.9 tm-20 -55.43 116.42 2.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.903 -0.59 . . . . 74.13 109.559 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.14 -7.43 27.07 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.665 -0.779 . . . . 72.42 112.375 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.78 132.96 48.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.681 0.277 . . . . 71.33 110.61 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 p -122.78 138.83 54.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.291 -0.413 . . . . 71.14 110.715 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 t -96.36 179.0 5.18 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.356 -0.384 . . . . 74.43 110.519 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 m -68.62 126.05 28.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.936 -0.575 . . . . 65.21 110.265 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -82.49 164.66 20.78 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.668 0.747 . . . . 74.33 112.157 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.0 m -106.33 155.92 7.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.45 -1.25 . . . . 75.31 109.208 171.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.3 93.01 0.67 Allowed Glycine 0 C--N 1.311 -0.847 0 C-N-CA 120.818 -0.706 . . . . 54.43 112.104 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -105.54 171.52 7.28 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.556 -0.535 . . . . 73.41 109.556 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -139.69 142.84 36.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.044 0.449 . . . . 63.31 111.38 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.7 mt -102.27 117.8 48.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.534 -0.757 . . . . 74.43 109.318 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -99.37 137.6 37.65 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.785 -0.643 . . . . 72.24 110.676 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.528 HD22 ' HA ' ' A' ' 23' ' ' VAL . 44.8 mt -117.34 134.72 54.49 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.454 -0.573 . . . . 73.23 109.454 176.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -110.26 143.97 39.65 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.902 -0.407 . . . . 63.43 109.902 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.8 t70 50.39 73.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 124.071 0.857 . . . . 72.11 110.715 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 32.7 t -112.78 119.66 38.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.115 -0.948 . . . . 74.43 110.212 -174.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.73 138.03 36.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.948 0.404 . . . . 72.45 111.734 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.3 p -107.43 5.21 27.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 71.1 112.258 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -78.3 -21.96 48.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.656 -0.498 . . . . 71.41 109.656 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.8 p -112.53 -30.71 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.768 -0.651 . . . . 73.34 111.353 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -116.95 166.57 12.03 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.194 -0.316 . . . . 63.54 111.126 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.486 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 32.7 m -124.64 -56.27 1.6 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.772 0.32 . . . . 73.43 111.569 -177.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.486 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -133.01 157.08 46.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.721 -0.474 . . . . 74.43 109.721 -178.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.415 ' HB2' HD22 ' A' ' 124' ' ' LEU . . . -114.14 132.63 56.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.977 0.418 . . . . 75.25 110.353 175.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.58 120.58 12.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.753 -0.658 . . . . 73.55 109.492 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.0 OUTLIER -92.41 147.3 5.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.097 0.475 . . . . 75.23 111.158 -173.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.51 117.53 28.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.607 -0.724 . . . . 73.15 109.234 174.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 86.8 m-85 -82.81 135.99 34.79 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.951 0.405 . . . . 71.53 111.065 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.1 tp -131.32 115.42 16.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.878 -0.601 . . . . 74.31 109.616 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.31 -174.22 23.39 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.576 -0.738 . . . . 74.53 111.326 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.458 ' O ' HD12 ' A' ' 86' ' ' LEU . 8.1 m -79.3 114.78 18.51 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.242 -0.281 . . . . 72.13 110.242 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.89 149.53 37.75 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.945 -0.391 . . . . 61.22 109.945 178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.511 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 14.5 tt -62.48 -35.79 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.409 . . . . 71.23 110.209 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -162.43 -174.5 4.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.986 -0.552 . . . . 73.44 109.53 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.85 -12.15 59.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.141 0.423 . . . . 73.35 112.141 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.21 -43.71 3.98 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.769 -0.729 . . . . 73.33 111.8 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -103.06 82.2 2.06 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.076 -0.713 . . . . 75.41 109.076 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 p -95.59 7.34 46.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.251 -0.886 . . . . 72.01 112.503 -172.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -107.17 -1.64 21.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.121 0.486 . . . . 75.23 110.541 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.52 121.68 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.739 -0.664 . . . . 75.34 110.292 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.56 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -68.21 132.37 47.03 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.841 -0.429 . . . . 74.13 109.841 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -76.46 149.54 36.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.175 -0.466 . . . . 75.31 110.294 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -77.84 132.93 38.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.157 -0.474 . . . . 74.43 109.839 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.538 ' HG3' ' HA ' ' A' ' 150' ' ' ALA . 90.8 mt-30 -64.21 128.04 34.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 74.35 110.541 -177.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.76 101.6 0.83 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.919 -0.582 . . . . 74.4 110.977 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.4 m -85.88 -10.77 54.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.072 -0.513 . . . . 75.3 110.296 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.09 5.42 5.28 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.368 -0.833 . . . . 65.45 111.633 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -109.6 -21.29 12.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.035 -0.529 . . . . 72.02 110.701 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 138.74 84.51 0.11 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.863 -0.684 . . . . 61.1 111.986 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.7 p -88.47 164.15 15.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.762 0.315 . . . . 64.14 110.344 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.23 148.22 35.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.579 -0.526 . . . . 73.53 109.579 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.34 163.51 29.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.03 -0.359 . . . . 74.32 110.03 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 69.8 10.99 7.73 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.575 0.547 . . . . 63.13 110.319 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.06 -177.29 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.478 -0.783 . . . . 73.12 110.212 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 175.94 -172.64 45.63 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.574 -1.01 . . . . 74.12 110.574 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.418 HG21 HG21 ' A' ' 10' ' ' VAL . 2.7 p -118.42 115.31 47.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.337 0.589 . . . . 73.23 110.62 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -105.34 140.66 38.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.24 -0.652 . . . . 71.35 109.24 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.425 HG22 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -102.56 122.59 55.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.147 0.499 . . . . 74.52 110.672 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.51 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 15.5 mt -89.58 143.55 26.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.503 -0.771 . . . . 73.34 109.378 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.542 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.9 -170.49 0.91 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.713 -0.477 . . . . 73.34 109.713 175.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -60.0 -29.83 68.73 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.467 0.173 . . . . 54.54 111.467 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.4 p -92.4 3.54 55.24 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.808 0.337 . . . . 71.02 111.573 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 82.08 30.67 33.93 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.858 -0.687 . . . . 72.33 113.1 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.01 126.4 48.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.713 0.256 . . . . 64.25 110.524 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.98 109.02 2.8 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.049 0.452 . . . . 73.15 110.919 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.9 mt -79.07 130.6 35.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 74.4 110.76 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 m -70.56 135.99 48.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 74.23 110.599 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.56 HD13 HD22 ' A' ' 86' ' ' LEU . 34.4 mt -78.05 41.52 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 75.44 110.844 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -98.9 -9.82 23.67 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.021 -0.536 . . . . 74.21 110.472 -175.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.53 1.15 75.56 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.025 -0.607 . . . . 60.32 112.663 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.27 -3.4 11.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.947 0.403 . . . . 74.02 111.228 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.4 m -101.0 109.5 21.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.807 0.337 . . . . 74.42 110.238 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -99.18 156.68 16.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 74.04 111.338 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 1.7 m -68.45 177.02 2.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.561 -0.745 . . . . 73.31 111.291 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.3 t -63.58 148.08 49.79 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.551 -0.537 . . . . 72.44 109.551 170.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.4 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 85.6 mt-10 -63.8 103.63 0.59 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 71.12 111.409 -176.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -87.22 110.86 20.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.962 -0.563 . . . . 74.53 109.743 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 m -59.96 122.4 14.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 75.5 111.28 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.451 ' C ' HD21 ' A' ' 125' ' ' ASN . 85.4 mt -84.38 146.39 27.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.514 . . . . 75.42 111.455 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.451 HD21 ' C ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -122.97 152.83 40.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.412 -0.813 . . . . 70.13 109.244 174.184 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 19.7 m120 -62.82 111.93 2.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.85 0.357 . . . . 61.35 110.569 176.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.17 -128.61 6.68 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.689 -0.767 . . . . 52.41 112.69 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.7 m -96.56 135.71 38.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.744 0.307 . . . . 74.55 110.849 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -132.58 148.56 52.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 70.11 110.482 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.47 120.73 31.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.372 -0.376 . . . . 74.2 111.301 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.2 mt -99.29 113.03 64.47 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.035 -0.728 . . . . 74.03 109.035 174.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.63 140.29 11.7 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.423 2.082 . . . . 73.52 112.704 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 87.4 m-85 -136.65 162.97 31.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 75.44 110.704 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.623 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.0 mt-30 -132.55 110.47 10.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.783 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -97.15 123.6 40.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.424 -0.353 . . . . 74.52 110.28 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 11.2 ptp180 -135.47 160.65 37.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.9 0.381 . . . . 74.54 110.65 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.671 ' HH ' ' HA3' ' A' ' 8' ' ' GLY . 81.3 m-85 -81.28 144.32 31.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.039 -0.528 . . . . 71.23 110.657 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -129.31 126.06 38.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.755 -0.657 . . . . 75.24 109.428 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -89.24 133.47 34.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.294 -0.412 . . . . 73.24 111.356 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.405 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 71.1 p -105.37 7.66 33.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.856 0.836 . . . . 74.05 109.022 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.08 -128.33 1.63 Allowed Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.524 -1.217 . . . . 72.15 110.838 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 96.18 10.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.827 0.314 . . . . 73.3 110.233 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -46.45 113.84 0.71 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.564 0.54 . . . . 64.43 111.539 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 31.9 p -103.14 141.45 22.52 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-O 121.122 0.487 . . . . 74.42 110.669 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.58 170.48 15.0 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 123.642 2.895 . . . . 53.33 113.273 -175.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.58 -122.47 1.77 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.627 -0.715 . . . . 72.23 111.795 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -122.17 133.87 54.73 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.686 -0.487 . . . . 74.13 109.686 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -122.05 51.49 1.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.589 0.709 . . . . 63.13 111.07 -173.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -102.56 144.45 30.96 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.255 -0.884 . . . . 71.41 110.197 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 89' ' ' GLN . . . -152.86 177.26 10.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.113 -0.494 . . . . 71.14 109.979 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -154.1 152.05 30.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.963 -0.295 . . . . 73.43 110.622 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.43 ' HB1' HD23 ' A' ' 86' ' ' LEU . . . -156.29 153.0 28.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.177 -0.465 . . . . 63.1 110.829 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.3 p -105.31 136.71 44.33 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.454 -0.573 . . . . 75.32 109.454 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -109.59 122.82 48.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.088 0.47 . . . . 71.23 110.55 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.579 ' HA ' HG21 ' A' ' 16' ' ' VAL . 2.9 ttmm -102.48 104.85 15.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.081 -0.509 . . . . 74.34 110.224 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.654 HG22 HG21 ' A' ' 17' ' ' VAL . 1.5 m -81.45 139.2 18.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.207 0.527 . . . . 72.21 110.216 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -110.66 110.7 21.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.97 -0.559 . . . . 63.21 111.01 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.563 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -145.46 -32.49 0.37 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.088 -0.506 . . . . 73.23 110.401 170.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.482 ' N ' ' HD1' ' A' ' 158' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.02 0 N-CA-C 108.346 -0.983 . . . . 64.52 108.346 174.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.651 0.262 . . . . 54.32 110.326 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.08 162.44 13.37 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.48 -0.563 . . . . 73.34 109.48 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.48 HG22 HG23 ' A' ' 4' ' ' THR . 11.5 t -94.27 -2.03 53.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.856 0.36 . . . . 74.31 110.942 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.48 HG23 HG22 ' A' ' 3' ' ' THR . 63.1 p -130.98 -173.23 3.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.971 0.415 . . . . 63.35 110.363 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.528 HG22 HG13 ' A' ' 37' ' ' VAL . 31.6 m -89.8 14.36 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.756 0.312 . . . . 74.22 111.216 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 66.59 8.87 6.16 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.82 -0.627 . . . . 71.13 112.107 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.41 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 95.78 97.8 1.78 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.112 -0.795 . . . . 64.33 111.112 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.56 154.24 25.81 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.206 -0.997 . . . . 61.04 112.206 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.464 ' HB ' HG22 ' A' ' 31' ' ' THR . 24.4 p -141.85 132.31 25.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.801 0.334 . . . . 71.35 111.128 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.405 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -106.95 120.46 58.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.178 -0.675 . . . . 73.52 109.178 171.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -94.33 106.1 18.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.689 -0.486 . . . . 74.31 109.689 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.405 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 81.8 m-85 -96.91 129.77 44.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.842 -0.617 . . . . 73.54 110.149 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -117.3 133.0 56.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.211 -0.45 . . . . 74.53 110.25 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.97 -123.24 4.24 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.982 -0.627 . . . . 40.53 111.951 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.744 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 31.7 mt-10 63.35 15.94 9.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.135 0.493 . . . . 51.43 110.891 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.578 HG23 ' HA ' ' A' ' 155' ' ' LYS . 24.2 m -76.91 -27.61 16.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.529 -0.76 . . . . 74.23 111.932 -174.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.57 HG21 ' CG2' ' A' ' 156' ' ' VAL . 18.8 m -135.81 144.6 33.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.214 0.531 . . . . 74.34 112.205 -174.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.41 21.38 1.06 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.487 -0.931 . . . . 73.43 108.487 170.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.96 -74.54 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.248 -0.887 . . . . 73.34 110.974 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.457 ' HB2' HG13 ' A' ' 65' ' ' VAL . . . -88.72 -38.71 14.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.067 0.46 . . . . 62.32 110.513 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.8 OUTLIER -144.0 134.99 25.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.555 -0.748 . . . . 73.15 109.847 -176.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.61 151.51 20.09 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.8 -0.445 . . . . 72.11 109.8 177.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.416 ' HB ' HG11 ' A' ' 28' ' ' VAL . 14.9 t -86.52 136.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 110.122 -0.325 . . . . 72.2 110.122 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.462 ' O ' HG13 ' A' ' 28' ' ' VAL . 22.3 t70 -62.86 145.15 55.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.435 -0.348 . . . . 75.02 110.937 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.25 -26.04 66.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.253 0.464 . . . . 74.34 112.253 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.1 -14.79 81.9 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.529 -0.844 . . . . 65.22 112.014 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.9 p -119.94 13.55 12.25 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.83 0.307 . . . . 75.23 111.83 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.744 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 27.2 m -100.56 -11.77 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.161 0.505 . . . . 62.13 110.325 173.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -156.52 81.3 0.96 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.289 -0.869 . . . . 75.01 109.426 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -126.18 133.87 51.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.453 0.644 . . . . 74.43 110.369 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.464 HG22 ' HB ' ' A' ' 9' ' ' THR . 2.9 m -118.24 101.31 8.11 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.764 -0.828 . . . . 74.24 108.764 176.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.48 131.86 32.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.993 -0.549 . . . . 74.4 111.034 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -88.13 110.42 20.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.65 -0.704 . . . . 73.12 109.771 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -81.22 -29.05 34.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.406 0.622 . . . . 55.41 109.495 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.41 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 96.18 172.72 35.58 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.242 -0.89 . . . . 54.21 112.131 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.407 ' HB3' ' CB ' ' A' ' 4' ' ' THR . 69.4 mt-30 -72.83 95.8 1.98 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.448 -0.204 . . . . 73.12 110.448 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.528 HG13 HG22 ' A' ' 5' ' ' VAL . 11.0 p -70.33 142.67 15.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.855 0.36 . . . . 74.2 110.134 177.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -78.22 105.12 9.24 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.201 -0.666 . . . . 65.23 109.201 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 19.5 p -63.05 -25.19 68.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.955 0.407 . . . . 74.02 111.237 -177.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.43 -5.6 37.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.061 -0.518 . . . . 74.43 111.419 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.5 m -95.8 -2.69 47.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.073 0.463 . . . . 65.22 110.411 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.532 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 5.1 mp -131.69 97.3 4.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.888 -0.597 . . . . 75.12 109.504 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.96 17.35 9.32 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.32 -0.552 . . . . 73.15 112.436 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -153.62 150.99 29.21 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.749 -0.381 . . . . 72.23 111.483 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -60.9 119.21 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 73.41 109.827 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.72 -6.19 31.26 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.641 -0.79 . . . . 61.21 111.847 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -72.01 119.39 16.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.014 0.435 . . . . 75.04 110.532 178.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.538 HG21 ' HD1' ' A' ' 138' ' ' PHE . 41.1 p -105.51 148.34 27.33 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.015 -0.539 . . . . 75.13 110.173 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.4 t -100.32 177.54 5.02 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.136 -0.69 . . . . 54.23 109.136 174.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.6 m -70.11 133.51 47.23 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.876 -0.416 . . . . 74.24 109.876 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.52 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -87.34 160.41 18.39 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.644 0.735 . . . . 71.52 111.956 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 31.1 m -103.94 152.9 6.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.433 -1.258 . . . . 72.25 109.083 171.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.45 98.48 1.28 Allowed Glycine 0 C--N 1.312 -0.754 0 C-N-CA 120.729 -0.748 . . . . 70.22 112.147 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -108.96 173.19 6.43 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.6 -0.519 . . . . 63.35 109.6 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.552 ' HB2' HG23 ' A' ' 130' ' ' THR . 4.0 p-10 -139.75 137.19 34.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.476 0.655 . . . . 73.44 111.917 -173.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.4 mt -105.5 115.09 46.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.722 -0.844 . . . . 75.25 108.722 171.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -101.57 144.62 30.09 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.977 0.417 . . . . 75.54 110.823 -173.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.2 mt -117.91 130.01 55.97 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.955 -0.566 . . . . 73.3 109.676 176.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -106.41 131.98 52.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.67 -0.695 . . . . 74.51 109.519 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 27.1 t70 58.15 86.44 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.69 0.757 . . . . 63.42 110.217 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 51.7 t -124.38 124.49 42.46 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.335 -0.848 . . . . 55.04 110.421 -174.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -103.92 140.07 38.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.045 -0.525 . . . . 72.31 111.152 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.8 p -107.96 15.61 24.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.071 0.397 . . . . 74.32 112.071 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -90.34 -39.16 12.87 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.912 -0.773 . . . . 74.33 108.912 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 20' ' ' ALA . 12.7 p -96.12 -3.53 10.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.104 -0.953 . . . . 72.41 110.472 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . . . -144.75 -173.45 4.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 73.14 110.781 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.7 m -151.0 -57.98 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.023 0.379 . . . . 64.14 112.023 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.788 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -138.21 130.4 28.76 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.973 -0.291 . . . . 74.03 110.262 -175.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.43 127.49 41.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.108 0.48 . . . . 53.11 111.0 -175.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.33 119.64 16.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.637 -0.711 . . . . 72.1 109.637 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 2.5 m -90.19 147.62 5.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.977 0.418 . . . . 74.24 110.756 -175.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.428 ' HB1' ' CD2' ' A' ' 118' ' ' PHE . . . -117.48 118.16 31.42 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.741 -0.663 . . . . 73.24 109.752 174.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 82.3 m-85 -85.62 128.49 34.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.979 0.419 . . . . 73.04 110.205 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.1 tp -126.13 126.76 44.68 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.836 -0.62 . . . . 74.05 109.913 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.52 -166.47 21.36 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.446 -0.662 . . . . 62.53 111.446 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.7 m -87.1 119.71 27.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.853 -0.425 . . . . 75.23 109.853 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 83' ' ' THR . . . -76.98 149.52 35.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.446 -0.343 . . . . 73.53 110.436 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.486 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 12.8 tt -61.77 -37.61 78.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.081 0.467 . . . . 75.43 110.7 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -152.02 -171.51 3.95 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.782 -0.821 . . . . 75.54 108.782 174.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.04 -14.89 43.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.056 0.391 . . . . 74.21 112.056 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.31 -49.83 3.6 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.632 -0.794 . . . . 73.52 112.016 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -96.43 76.64 2.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.383 0.611 . . . . 73.34 109.617 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.466 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . 14.6 p -86.97 8.45 23.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.649 -0.705 . . . . 74.25 111.755 -175.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 24.4 p-10 -107.05 7.32 29.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.976 0.417 . . . . 72.54 110.849 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.11 124.91 73.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.542 . . . . 71.54 109.837 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.515 HD22 ' CD1' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -66.94 129.85 41.23 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 110.079 -0.341 . . . . 74.04 110.079 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.46 150.77 34.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.203 -0.453 . . . . 73.23 110.297 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.536 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -88.03 130.3 35.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.561 -0.533 . . . . 72.24 109.561 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -58.24 142.09 48.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 60.2 112.127 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 p -66.91 106.59 1.95 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.311 -0.859 . . . . 72.33 110.785 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.2 m -101.29 -12.25 18.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.913 -0.585 . . . . 64.23 110.773 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.37 4.5 2.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.065 0.546 . . . . 74.31 112.178 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.9 15.16 14.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.101 0.476 . . . . 75.33 110.628 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.27 76.83 1.22 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.565 -0.826 . . . . 62.31 111.829 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.2 m -82.28 154.83 25.14 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.899 -0.408 . . . . 54.42 109.899 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.418 ' O ' HD21 ' A' ' 88' ' ' LEU . . . -71.46 136.64 47.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.71 0.291 . . . . 71.51 110.223 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.36 160.71 35.51 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.848 -0.341 . . . . 72.54 110.546 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 68.55 7.36 5.99 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.337 0.589 . . . . 74.23 110.303 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -143.25 -179.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.269 -0.878 . . . . 72.01 109.687 175.124 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.3 -169.82 42.86 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.951 -1.26 . . . . 73.45 109.951 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.85 119.46 58.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.278 0.561 . . . . 75.14 110.465 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -109.42 146.15 34.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.648 -0.705 . . . . 74.13 109.755 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 103' ' ' ILE . 4.1 mp -103.99 124.24 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.425 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.403 HD13 ' NE ' ' A' ' 136' ' ' ARG . 27.5 mt -87.38 140.03 29.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.651 -0.704 . . . . 71.33 109.177 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.538 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.05 -173.13 1.19 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.913 -0.402 . . . . 64.3 109.913 177.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.1 ptt85 -61.04 -20.3 62.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.096 0.406 . . . . 74.33 112.096 -176.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.7 p -101.47 3.56 40.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.935 -0.306 . . . . 72.14 111.548 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.42 31.52 24.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.778 -0.725 . . . . 53.24 112.866 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -112.02 128.51 56.2 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.959 -0.386 . . . . 73.21 109.959 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.85 130.16 42.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.726 0.298 . . . . 72.22 110.884 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.0 mt -92.77 132.83 36.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.225 -0.443 . . . . 74.23 110.979 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 89.9 m -74.31 139.2 44.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.891 -0.595 . . . . 74.13 110.449 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 34.8 mt -81.46 45.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 71.13 110.682 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -90.7 -17.94 25.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.09 0.472 . . . . 71.31 110.369 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.19 -22.97 26.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.996 -0.621 . . . . 70.31 112.329 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.45 3.87 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.164 0.507 . . . . 50.31 110.915 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -95.34 99.36 11.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 75.24 110.064 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.482 ' HE2' ' HD2' ' A' ' 155' ' ' LYS . 96.3 m-85 -95.41 162.31 13.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.969 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.538 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 4.6 m -71.46 -178.83 2.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.666 -0.697 . . . . 72.45 111.003 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.5 t -73.05 165.55 24.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.596 -0.52 . . . . 71.43 109.596 173.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -65.32 106.98 1.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.366 -0.379 . . . . 75.13 111.33 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.8 m -90.66 102.76 15.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.084 -0.71 . . . . 71.13 109.084 172.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.6 m -58.17 119.21 6.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.753 -0.658 . . . . 70.12 111.247 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.42 HD11 ' SG ' ' A' ' 61' ' ' CYS . 95.9 mt -87.27 150.91 23.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.792 -0.64 . . . . 75.12 111.166 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -125.89 158.68 34.51 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.743 -0.836 . . . . 73.4 108.743 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -65.08 114.49 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.868 0.366 . . . . 61.32 111.058 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.43 -133.27 8.07 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.03 -0.605 . . . . 64.13 112.31 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.5 m -92.83 130.88 38.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.795 0.331 . . . . 71.01 110.706 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -128.34 139.25 52.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.73 -0.47 . . . . 70.34 109.73 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.552 HG23 ' HB2' ' A' ' 55' ' ' ASN . 1.2 m -122.51 117.83 26.84 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.755 -0.378 . . . . 73.11 110.78 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.7 mt -95.0 115.26 65.22 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 71.23 109.913 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.19 135.95 7.6 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.469 2.113 . . . . 71.04 112.689 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 68.3 m-85 -134.7 160.76 37.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 72.45 110.258 177.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.598 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 44.9 mt-30 -130.37 114.52 15.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.91 0.386 . . . . 73.32 110.832 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.07 130.63 46.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.547 -0.297 . . . . 74.41 110.407 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.52 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 13.8 ptp180 -141.27 158.12 44.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.582 -0.281 . . . . 74.44 110.825 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 94.4 m-85 -75.93 142.03 42.14 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.148 -0.478 . . . . 74.12 110.257 175.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.538 ' HD1' HG21 ' A' ' 48' ' ' THR . 75.7 t80 -128.81 125.78 38.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.934 -0.575 . . . . 73.52 109.988 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -94.02 131.43 39.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.097 0.475 . . . . 74.03 110.736 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.5 p -101.13 7.31 43.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.502 -0.772 . . . . 72.34 109.572 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.83 -129.66 1.75 Allowed Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.246 -1.141 . . . . 73.21 110.246 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -83.82 95.37 8.44 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.452 -0.573 . . . . 73.11 109.452 175.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.48 111.35 0.48 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.824 -0.625 . . . . 70.23 111.363 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.6 p -103.62 142.98 25.72 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-O 121.328 0.585 . . . . 73.12 110.845 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.75 166.94 22.58 Favored 'Trans proline' 0 C--N 1.331 -0.35 0 C-N-CA 123.816 3.011 . . . . 75.14 112.734 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.02 179.79 19.98 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.799 -0.715 . . . . 64.1 111.513 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.06 112.71 5.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 117.003 0.401 . . . . 72.45 110.915 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.536 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -101.2 74.1 1.55 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.451 0.643 . . . . 71.21 111.031 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.0 123.44 50.34 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.323 -0.621 . . . . 75.22 109.323 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.439 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -129.34 156.45 44.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.95 0.405 . . . . 53.21 111.598 -176.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -125.65 130.18 51.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.69 -0.687 . . . . 71.42 109.826 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.09 137.11 32.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.103 0.478 . . . . 51.42 111.663 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.4 p -112.63 125.0 53.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.679 -0.691 . . . . 72.21 109.902 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -105.52 134.84 47.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.144 0.497 . . . . 74.32 110.682 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.578 ' HA ' HG23 ' A' ' 16' ' ' VAL . 1.9 ttmm -117.9 107.42 14.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.684 -0.689 . . . . 74.14 110.158 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.57 ' CG2' HG21 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -74.45 140.86 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.142 0.496 . . . . 74.12 110.206 179.212 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -128.39 110.12 12.05 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.117 -0.698 . . . . 71.53 109.117 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.788 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -113.49 -7.16 13.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.942 0.401 . . . . 75.42 111.666 177.2 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.425 ' NE2' HG21 ' A' ' 65' ' ' VAL . 92.7 mt-30 . . . . . 0 C--O 1.243 0.75 0 CA-C-O 118.5 -0.762 . . . . 64.44 109.513 168.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.883 0.373 . . . . 75.34 110.712 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.09 160.64 37.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 74.13 110.11 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.4 t -89.87 -13.35 36.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.707 0.289 . . . . 72.43 110.934 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.0 p -98.58 -179.56 4.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.823 0.344 . . . . 75.13 110.647 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.478 ' CG2' HG11 ' A' ' 37' ' ' VAL . 32.7 m -93.53 15.88 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.975 0.417 . . . . 72.4 110.955 177.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 61.11 20.58 11.06 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.452 -0.795 . . . . 71.3 112.092 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.548 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 84.79 102.85 0.63 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.591 -0.814 . . . . 45.44 111.978 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.467 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -93.64 155.36 22.09 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.242 -0.98 . . . . 43.4 112.048 -177.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 33' ' ' GLN . 53.8 p -140.99 151.5 44.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.899 -0.408 . . . . 74.2 109.899 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.517 HG13 ' HB1' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -121.0 124.1 71.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.042 -0.725 . . . . 60.22 109.042 172.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -92.2 116.99 29.43 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.118 -0.633 . . . . 75.22 109.688 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 93.1 m-85 -104.15 114.5 28.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.626 -0.715 . . . . 73.35 110.157 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -102.32 134.81 45.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 75.4 110.274 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.93 -120.68 3.43 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.944 -0.646 . . . . 53.14 111.899 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.606 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 38.3 mt-10 62.88 19.72 11.73 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.153 0.501 . . . . 61.33 111.085 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.774 HG22 HG21 ' A' ' 17' ' ' VAL . 17.2 m -76.17 -30.49 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.053 -0.521 . . . . 74.13 111.719 -176.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.774 HG21 HG22 ' A' ' 16' ' ' VAL . 4.2 m -149.17 143.87 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.146 0.498 . . . . 64.23 111.145 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -140.7 22.45 2.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.213 -0.903 . . . . 74.01 108.916 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.75 -77.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.089 -0.959 . . . . 72.43 111.131 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.557 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -78.19 -39.15 41.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.024 -0.535 . . . . 65.02 110.492 178.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.8 OUTLIER -143.65 128.39 18.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.055 -0.521 . . . . 74.1 109.778 -176.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.44 119.25 27.53 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.366 -0.379 . . . . 70.53 110.138 -178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.428 ' HA ' HD22 ' A' ' 58' ' ' LEU . 9.6 t -62.45 128.65 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.709 -0.478 . . . . 74.11 109.709 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.441 ' O ' HG13 ' A' ' 28' ' ' VAL . 18.6 t70 -59.57 142.88 51.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.781 -0.645 . . . . 63.44 111.397 -176.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.477 ' HA ' HG23 ' A' ' 28' ' ' VAL . . . -62.12 -24.37 67.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.774 -0.648 . . . . 74.32 112.221 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.4 -17.91 70.12 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.618 -0.801 . . . . 37.55 111.932 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 p -105.48 -14.23 15.37 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.821 0.304 . . . . 73.34 111.821 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.606 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 33.8 m -79.73 -8.02 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.09 0.471 . . . . 74.31 110.353 175.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -157.78 90.24 1.06 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.559 -0.904 . . . . 62.52 108.559 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.409 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 17.1 pt20 -137.06 112.86 9.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.726 -0.67 . . . . 74.22 110.52 -176.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.52 HG23 ' HB ' ' A' ' 9' ' ' THR . 7.4 m -97.22 95.37 7.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.532 -0.758 . . . . 74.44 109.094 174.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 p -79.26 134.42 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.541 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.535 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.6 mp0 -91.33 120.96 32.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.121 -0.491 . . . . 75.13 110.281 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.421 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.8 mm? -86.55 -30.04 22.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.777 -0.647 . . . . 75.04 109.356 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.548 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 92.33 177.35 41.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.329 -0.851 . . . . 60.45 111.951 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -72.31 95.34 1.71 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.707 -0.479 . . . . 72.42 109.707 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.478 HG11 ' CG2' ' A' ' 5' ' ' VAL . 9.8 p -66.49 138.49 22.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.209 0.528 . . . . 74.02 110.379 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.6 mtm-85 -75.25 106.55 6.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.623 -0.717 . . . . 74.01 109.967 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 p -62.49 -26.08 68.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 75.21 111.09 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.19 -8.07 52.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 73.54 111.428 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.1 m -97.07 -15.51 20.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.813 0.339 . . . . 74.23 110.749 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 5.8 mp -124.28 95.94 4.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.699 0.285 . . . . 74.42 110.241 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.01 11.34 7.07 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.667 -0.413 . . . . 74.14 112.061 -176.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -152.8 143.42 22.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.417 0.151 . . . . 74.01 110.829 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 41.2 tt0 -58.35 118.46 5.56 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.021 0.438 . . . . 74.34 110.638 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.79 -17.59 8.18 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.22 -0.752 . . . . 64.03 111.22 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.3 124.67 24.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.847 0.356 . . . . 75.25 110.222 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.492 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 4.6 p -121.88 114.23 20.74 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.937 -0.574 . . . . 75.33 110.139 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.468 ' HG ' HG22 ' A' ' 37' ' ' VAL . 15.8 t -72.22 174.46 7.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.069 -0.514 . . . . 55.43 110.838 -175.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -60.54 120.88 10.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 51.3 110.29 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -80.46 142.48 34.23 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.411 0.624 . . . . 52.1 111.276 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.9 m -83.66 147.88 5.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.825 -1.08 . . . . 73.14 109.306 170.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.99 92.02 0.72 Allowed Glycine 0 C--N 1.307 -1.05 0 C-N-CA 120.837 -0.696 . . . . 72.45 112.257 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -102.19 -175.71 2.91 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.407 -0.59 . . . . 75.31 109.407 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.515 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.0 p-10 -147.31 147.48 30.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.39 0.614 . . . . 71.24 111.821 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.45 115.87 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.342 -0.985 . . . . 74.21 108.342 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -103.71 138.45 40.34 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.078 -0.51 . . . . 75.21 111.129 -171.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 23' ' ' VAL . 64.4 mt -119.11 115.23 23.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.711 -0.677 . . . . 75.3 109.744 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -92.63 136.26 33.38 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.977 -0.556 . . . . 74.12 110.239 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 51.02 68.91 0.71 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.944 0.777 . . . . 53.3 110.938 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 53.0 t -98.62 129.39 45.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.954 . . . . 62.05 110.435 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -104.06 138.27 40.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.935 -0.575 . . . . 70.15 111.169 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.5 p -104.95 10.5 34.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.094 0.405 . . . . 73.25 112.094 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -85.13 -37.15 20.57 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.459 -0.571 . . . . 72.23 109.459 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.546 HG13 ' HB1' ' A' ' 20' ' ' ALA . 10.3 p -100.58 -13.7 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.773 -0.649 . . . . 63.11 110.852 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -123.92 179.48 4.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.64 0.257 . . . . 74.44 111.066 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.421 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 20.3 m -143.24 -60.95 0.42 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.486 . . . . 74.21 110.736 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -136.68 140.72 42.9 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.374 -0.602 . . . . 75.32 109.374 -178.254 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.453 ' HB2' HD22 ' A' ' 124' ' ' LEU . . . -98.16 119.8 37.44 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.185 0.517 . . . . 64.32 109.977 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.25 110.84 11.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.538 -0.756 . . . . 75.55 109.754 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.0 OUTLIER -89.03 145.45 7.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.915 0.388 . . . . 72.15 110.298 -175.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.449 ' HB3' ' CD1' ' A' ' 118' ' ' PHE . . . -123.37 123.87 41.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.965 -0.561 . . . . 74.53 109.62 174.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 91.1 m-85 -88.95 130.43 35.45 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.021 0.439 . . . . 74.54 110.696 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.7 tp -130.59 125.56 34.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.771 -0.65 . . . . 75.41 110.154 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.37 -164.2 21.48 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.132 -0.787 . . . . 51.4 111.132 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.445 ' O ' HD11 ' A' ' 86' ' ' LEU . 42.3 m -80.79 122.65 27.44 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.27 -0.271 . . . . 71.14 110.27 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -85.37 140.65 30.6 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.91 -0.404 . . . . 73.43 109.91 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 tt -65.05 -28.98 46.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.886 0.374 . . . . 73.25 110.867 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 22.0 t70 -153.99 174.95 13.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.482 -0.562 . . . . 60.3 109.482 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.36 -37.83 31.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.093 0.473 . . . . 73.14 110.339 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.63 -19.18 62.33 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.161 -0.776 . . . . 65.44 111.161 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 42.4 m80 -107.08 43.5 1.16 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.167 -0.679 . . . . 75.34 109.167 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -72.62 11.45 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.141 -0.936 . . . . 71.23 112.927 -176.028 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.452 ' OD1' HG23 ' A' ' 85' ' ' VAL . 16.4 p30 -110.81 -8.96 14.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.058 0.456 . . . . 73.04 110.554 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.452 HG23 ' OD1' ' A' ' 84' ' ' ASN . 48.3 t -101.84 120.92 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.101 -0.499 . . . . 62.24 110.561 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.566 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -67.03 132.8 48.62 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.16 -0.473 . . . . 75.3 109.746 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.71 148.52 36.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.032 -0.531 . . . . 72.41 110.304 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.437 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 2.0 mm? -82.98 140.77 32.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.14 -0.482 . . . . 61.21 110.557 -177.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -62.26 143.0 57.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.486 -0.779 . . . . 72.24 110.095 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 m -111.54 114.63 27.84 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.672 -0.694 . . . . 65.12 110.984 -172.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -90.83 9.72 29.1 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.667 -0.697 . . . . 73.5 110.234 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 66.49 7.28 4.92 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.258 -0.883 . . . . 75.11 111.98 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.04 -45.96 4.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.104 0.478 . . . . 75.22 110.381 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.94 91.2 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.809 -0.71 . . . . 74.33 112.301 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.5 p -84.14 156.36 22.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.63 0.252 . . . . 75.22 110.404 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.92 138.7 50.31 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.061 -0.348 . . . . 74.05 110.061 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.18 159.3 33.32 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.842 -0.343 . . . . 73.1 110.932 -176.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 68.67 10.46 7.9 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.719 -0.673 . . . . 71.0 111.238 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.48 178.28 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.153 -0.476 . . . . 72.44 110.306 174.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 176.28 -175.9 47.59 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 109.831 -1.308 . . . . 53.32 109.831 177.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.4 HG23 HG21 ' A' ' 10' ' ' VAL . 2.6 p -118.9 114.21 44.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.334 0.588 . . . . 75.31 111.162 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -104.15 140.16 38.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.698 -0.683 . . . . 65.45 109.498 173.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.423 HD11 ' N ' ' A' ' 103' ' ' ILE . 4.4 mp -98.11 126.35 51.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.997 -0.547 . . . . 74.21 110.296 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.5 mt -89.92 147.5 23.69 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.262 -0.881 . . . . 72.3 109.141 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.406 ' HA ' ' CD1' ' A' ' 133' ' ' PHE . 1.5 p-10 -70.87 -169.94 0.39 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.773 -0.454 . . . . 73.33 109.773 175.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -61.98 -30.86 71.22 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.108 -0.237 . . . . 73.43 111.527 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.403 ' HG1' ' CG ' ' A' ' 105' ' ' ASP . 51.4 p -81.92 -34.55 29.83 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.748 -0.381 . . . . 71.11 110.76 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.77 31.54 1.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.582 -0.818 . . . . 64.13 112.931 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.48 139.02 42.64 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.128 -0.323 . . . . 73.12 110.128 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.05 130.71 43.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.396 -0.366 . . . . 73.4 111.1 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt -97.37 131.98 43.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.144 -0.48 . . . . 71.03 110.506 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 m -72.23 137.01 46.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.257 -0.428 . . . . 74.44 110.72 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.566 HD13 HD22 ' A' ' 86' ' ' LEU . 49.2 mt -79.64 49.09 0.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 75.24 110.876 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -107.45 -8.43 16.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.441 0.639 . . . . 65.2 110.324 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.23 -12.51 12.78 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.0 -0.619 . . . . 72.4 112.811 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.19 -10.85 23.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.932 0.396 . . . . 73.0 111.153 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.5 m -92.57 95.12 9.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.079 0.466 . . . . 72.22 110.21 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.546 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 72.6 m-85 -91.03 153.01 20.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.784 -0.644 . . . . 73.11 110.241 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.4 m -65.23 171.37 3.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.083 -0.508 . . . . 71.52 111.251 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.3 p -61.3 146.17 48.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.104 -0.498 . . . . 72.35 110.301 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.43 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 41.9 mt-10 -57.57 101.34 0.07 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.96 0.409 . . . . 75.43 111.605 -176.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.6 m -85.85 104.18 15.28 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.947 -0.761 . . . . 70.43 108.947 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 m -63.3 115.08 4.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.262 0.553 . . . . 75.21 110.878 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.511 HD13 ' SG ' ' A' ' 61' ' ' CYS . 92.0 mt -74.59 147.08 42.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.176 -0.92 . . . . 74.12 111.777 -174.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.436 HD21 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -121.14 151.47 39.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.359 -0.837 . . . . 63.52 108.924 171.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 94.6 m-20 -63.12 107.34 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.902 0.382 . . . . 71.32 110.681 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.84 -149.12 20.08 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.967 -0.635 . . . . 65.41 111.789 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 30.1 m -82.12 123.61 29.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.124 0.487 . . . . 73.03 110.994 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 28.0 m-80 -117.48 135.09 54.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.942 -0.572 . . . . 37.55 109.537 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.515 HG22 ' HB2' ' A' ' 55' ' ' ASN . 2.3 m -122.45 118.87 29.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.804 -0.358 . . . . 75.41 110.488 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.0 mt -98.58 112.38 62.34 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.697 -0.482 . . . . 73.11 109.697 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.85 138.96 17.17 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.599 2.2 . . . . 74.42 112.469 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 78.6 m-85 -136.61 163.69 29.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.692 0.282 . . . . 74.0 110.528 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 96.2 mt-30 -130.71 119.09 21.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.102 -0.499 . . . . 72.13 110.896 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.21 123.23 47.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.099 -0.334 . . . . 73.04 110.099 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.516 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 2.8 ptp180 -135.98 159.17 42.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.39 -0.368 . . . . 75.45 111.234 -176.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 59.8 m-85 -80.5 134.41 35.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.746 -0.661 . . . . 64.53 110.418 174.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -117.69 119.21 34.26 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.139 -0.689 . . . . 74.21 109.139 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 45' ' ' GLU . . . -83.6 130.29 34.98 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.023 -0.535 . . . . 72.55 110.661 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 69.3 p -101.32 -0.54 35.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.88 0.848 . . . . 75.33 108.763 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.21 -131.54 1.77 Allowed Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.28 -1.327 . . . . 73.22 110.594 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 144' ' ' THR . . . -88.66 98.72 11.84 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.749 -0.463 . . . . 72.04 109.749 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -47.47 113.01 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.896 0.747 . . . . 72.33 111.395 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.457 HG21 ' O ' ' A' ' 142' ' ' ALA . 41.3 p -104.06 146.34 32.37 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 116.012 -0.54 . . . . 71.33 110.585 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.27 173.36 5.25 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.6 2.866 . . . . 62.55 113.628 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 138.0 -147.47 19.25 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.675 -0.693 . . . . 74.52 111.857 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.84 117.08 32.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.22 -0.289 . . . . 71.1 110.22 175.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.437 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -115.48 59.65 0.71 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.95 0.405 . . . . 75.42 111.625 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -112.69 137.03 51.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.035 -0.728 . . . . 73.34 109.035 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.517 ' HB3' HD12 ' A' ' 86' ' ' LEU . . . -128.81 169.92 13.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.016 0.436 . . . . 62.31 111.756 -175.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -137.8 127.26 24.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.581 -0.736 . . . . 75.12 109.618 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.86 140.59 29.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.075 0.464 . . . . 74.02 111.774 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.1 p -110.28 126.11 53.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.595 . . . . 65.52 109.53 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -106.44 143.39 34.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.059 0.457 . . . . 64.42 110.834 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.571 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.9 ttmm -120.04 111.96 18.55 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.812 -0.631 . . . . 74.5 110.435 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.4 m -81.81 127.17 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.165 -0.68 . . . . 72.5 109.165 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -112.18 121.87 46.14 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.137 -0.483 . . . . 54.04 109.849 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.606 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -137.39 -18.32 1.28 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.841 0.311 . . . . 72.04 111.841 177.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.486 ' HG2' ' OXT' ' A' ' 159' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.926 0 N-CA-C 109.163 -0.68 . . . . 74.13 109.163 170.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.713 0.292 . . . . 62.24 110.293 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.53 179.42 8.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.361 -0.381 . . . . 65.45 110.279 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.406 HG23 HG23 ' A' ' 4' ' ' THR . 9.0 t -113.23 -7.57 13.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.131 0.491 . . . . 71.55 110.099 176.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.406 HG23 HG23 ' A' ' 3' ' ' THR . 73.1 p -121.02 -179.27 3.97 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.911 -0.586 . . . . 74.44 110.092 177.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.547 HG23 HG13 ' A' ' 37' ' ' VAL . 28.1 m -92.64 15.79 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.004 0.43 . . . . 74.15 110.526 176.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 61.95 13.09 5.32 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.355 -0.839 . . . . 74.02 112.563 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.414 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 91.09 94.96 1.27 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.731 -0.747 . . . . 55.25 111.967 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.418 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -86.02 158.64 31.97 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.532 -0.842 . . . . 70.2 112.171 -177.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.505 ' HB ' HG22 ' A' ' 31' ' ' THR . 11.2 p -140.24 135.32 32.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.361 . . . . 64.45 111.102 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.454 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -108.11 125.47 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.423 -0.584 . . . . 74.33 109.423 173.347 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -96.81 111.03 23.39 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.068 0.461 . . . . 72.04 110.19 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.454 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 95.7 m-85 -101.07 122.9 44.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.886 -0.597 . . . . 74.35 110.47 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -108.08 138.43 44.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.449 -0.341 . . . . 70.12 110.535 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -109.3 -133.08 6.65 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.935 -0.65 . . . . 72.04 112.321 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 62.95 34.55 14.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.39 0.614 . . . . 73.13 110.897 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.607 HG22 ' HA ' ' A' ' 155' ' ' LYS . 25.3 m -93.76 -22.88 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.592 -0.731 . . . . 73.42 111.663 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.454 HG23 ' CG2' ' A' ' 156' ' ' VAL . 19.0 m -143.01 149.18 18.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.537 -0.301 . . . . 64.22 111.303 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -156.86 32.04 0.3 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.797 0.808 . . . . 65.22 109.346 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.89 -66.73 0.9 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.313 -0.858 . . . . 75.21 111.469 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.92 -41.03 7.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 61.44 110.804 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 1.8 m -135.63 128.88 31.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.153 -0.476 . . . . 71.55 110.075 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.5 127.84 39.33 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.022 -0.536 . . . . 73.41 110.007 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.58 131.26 31.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.338 -0.392 . . . . 74.15 110.217 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 28' ' ' VAL . 25.1 t70 -57.93 145.45 35.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.736 -0.666 . . . . 71.45 111.254 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.32 -30.72 70.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 65.12 111.775 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.66 -12.03 82.17 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.61 -0.805 . . . . 74.13 111.652 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 t -97.82 -24.38 15.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.453 0.168 . . . . 71.12 110.591 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 24' ' ' ASP . 20.7 m -80.44 -7.14 10.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.822 0.344 . . . . 74.01 110.597 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -154.85 88.95 1.21 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.813 -0.631 . . . . 54.21 109.681 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.86 115.57 10.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.638 0.732 . . . . 65.53 110.98 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.505 HG22 ' HB ' ' A' ' 9' ' ' THR . 3.9 m -98.38 97.63 8.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.027 -0.988 . . . . 72.52 109.067 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.69 127.94 39.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.128 0.49 . . . . 74.44 111.092 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -86.61 125.43 33.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.645 . . . . 65.02 109.976 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.4 HD23 ' CG2' ' A' ' 10' ' ' VAL . 2.7 mm? -87.54 -22.91 24.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.109 0.481 . . . . 72.52 110.032 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.414 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 93.41 173.32 40.1 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.581 -0.736 . . . . 53.42 112.095 -178.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.74 91.49 5.91 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.761 0.315 . . . . 72.11 110.701 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.547 HG13 HG23 ' A' ' 5' ' ' VAL . 7.2 p -78.06 146.07 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.171 -0.468 . . . . 75.2 109.824 176.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -87.07 132.15 33.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.02 -0.363 . . . . 73.51 110.02 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 53.2 p -68.33 -18.64 64.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.228 0.537 . . . . 72.12 111.129 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.44 -12.92 61.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 72.13 111.197 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.0 m -97.04 9.14 42.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.22 0.533 . . . . 65.01 110.426 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.573 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 6.0 mt -145.61 49.35 1.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.584 -0.734 . . . . 72.11 109.612 -174.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.23 6.06 41.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.529 0.937 . . . . 60.32 113.529 -168.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.27 155.34 22.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.488 -0.19 . . . . 70.53 110.488 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 33.1 tt0 -56.95 132.61 53.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 123.347 0.404 . . . . 60.11 110.371 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.84 -17.01 36.15 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.706 -0.759 . . . . 52.31 111.663 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.68 121.61 17.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.333 . . . . 75.2 110.302 176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.493 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 37.7 p -119.15 135.78 54.5 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.045 -0.525 . . . . 74.42 110.432 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.0 t -89.46 178.26 6.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.673 -0.491 . . . . 71.3 109.673 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -67.51 129.27 39.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.375 -0.375 . . . . 74.33 110.069 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -81.36 158.56 24.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.449 0.642 . . . . 73.44 111.316 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 27.7 m -101.22 147.34 8.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.824 -1.08 . . . . 73.22 109.124 171.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.92 86.39 0.58 Allowed Glycine 0 C--N 1.31 -0.911 0 C-N-CA 120.675 -0.774 . . . . 62.3 111.978 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -96.08 166.46 11.75 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.699 -0.482 . . . . 72.14 109.699 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.441 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 20.7 p-10 -125.45 139.37 53.7 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.407 0.622 . . . . 71.1 111.998 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.401 HD12 ' CD1' ' A' ' 154' ' ' PHE . 29.2 mt -109.74 107.05 21.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.562 -0.903 . . . . 74.15 108.562 167.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -100.59 135.51 41.91 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.715 -0.675 . . . . 73.22 111.322 -170.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.4 mt -112.12 132.58 54.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.504 -0.771 . . . . 73.11 109.527 175.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -109.07 145.49 35.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.419 -0.355 . . . . 74.43 110.058 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.11 48.71 20.39 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.616 0.722 . . . . 73.32 110.944 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 48.0 t -85.8 155.97 20.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.066 -0.97 . . . . 74.1 110.323 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' HA ' ' ND2' ' A' ' 126' ' ' ASN . 21.1 t70 -128.3 152.86 47.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.524 -0.307 . . . . 73.34 111.512 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.9 p -119.06 5.81 11.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 72.13 111.677 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -84.34 -34.99 23.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.091 0.472 . . . . 74.4 109.978 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 p -103.68 -21.36 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 74.15 111.196 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . . . -124.27 -175.53 3.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.269 -0.271 . . . . 72.23 110.269 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 20.4 m -146.26 -55.8 0.28 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.731 0.301 . . . . 74.0 111.629 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.468 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -135.97 143.81 45.06 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 109.881 -0.414 . . . . 74.44 109.881 -178.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HB2' HD22 ' A' ' 124' ' ' LEU . . . -106.09 127.48 53.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.135 0.493 . . . . 70.22 110.163 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.2 118.82 15.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.509 -0.769 . . . . 70.0 109.016 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.5 m -90.99 146.76 5.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.999 0.428 . . . . 74.11 110.54 -175.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.425 ' HB1' ' CD2' ' A' ' 118' ' ' PHE . . . -118.79 119.13 33.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.782 -0.645 . . . . 70.21 109.354 174.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 93.8 m-85 -84.67 130.88 34.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.993 0.425 . . . . 63.43 110.527 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.9 tp -125.91 123.59 38.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.664 -0.698 . . . . 74.11 109.935 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.5 -170.99 26.93 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.513 -0.635 . . . . 61.14 111.513 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.7 m -84.06 125.49 32.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.62 0.248 . . . . 74.22 110.631 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 83' ' ' THR . . . -87.72 138.98 30.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.591 -0.277 . . . . 73.1 110.515 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.8 tt -64.06 -31.95 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 74.45 111.224 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 80' ' ' ALA . 22.2 t70 -145.81 -178.19 5.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.268 -0.642 . . . . 72.33 109.268 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.429 ' H ' ' CG ' ' A' ' 79' ' ' ASP . . . -79.57 -42.52 24.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.692 0.282 . . . . 74.22 110.865 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.67 -16.77 74.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.58 -0.819 . . . . 75.34 111.951 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -105.12 51.3 0.76 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.13 0.491 . . . . 74.44 109.979 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.423 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . 1.1 p -74.93 3.6 7.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.806 -0.634 . . . . 71.25 112.138 -178.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -104.79 -5.96 20.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.927 0.394 . . . . 75.31 110.671 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.05 120.12 58.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.175 -0.466 . . . . 75.45 110.628 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.502 HD13 ' HB1' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -67.51 129.78 40.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.93 -0.396 . . . . 74.31 109.93 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.49 141.62 39.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.27 -0.423 . . . . 74.32 110.605 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.579 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.8 mm? -82.38 140.32 33.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.074 -0.512 . . . . 71.03 110.027 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -62.01 127.61 32.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.37 0.605 . . . . 74.01 110.748 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.432 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 0.7 OUTLIER -83.54 115.08 21.94 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.168 -0.924 . . . . 62.3 110.909 -177.312 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.1 m -87.99 -6.89 57.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.062 -0.517 . . . . 73.24 109.776 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.71 16.34 10.45 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.502 -0.772 . . . . 70.54 111.517 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.25 4.28 2.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 60.05 111.452 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.37 64.62 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.289 -0.958 . . . . 51.41 112.749 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 90' ' ' SER . 71.1 m -95.73 149.97 20.91 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.709 -0.289 . . . . 64.02 110.571 173.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.94 125.45 27.61 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.785 -0.45 . . . . 71.34 109.785 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.07 166.46 16.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.35 -0.386 . . . . 75.35 110.243 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 68.88 9.96 7.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.253 0.549 . . . . 63.1 110.446 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.45 -174.47 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.279 -0.873 . . . . 65.52 109.685 173.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.49 -174.5 46.56 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.637 -0.985 . . . . 64.15 110.637 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 p -119.66 115.65 48.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.446 0.641 . . . . 75.14 110.841 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -107.1 142.22 37.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.489 -0.778 . . . . 74.43 109.642 175.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 103' ' ' ILE . 4.1 mp -103.12 123.78 56.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.032 -0.531 . . . . 73.23 110.3 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.462 HD12 ' NE ' ' A' ' 136' ' ' ARG . 12.7 mt -86.27 147.64 25.99 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.647 -0.706 . . . . 65.22 109.11 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.1 p-10 -74.1 -170.99 1.03 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.59 -0.522 . . . . 73.42 109.59 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -69.04 -25.53 64.52 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.975 -0.29 . . . . 73.01 111.554 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.43 ' HG1' ' CG ' ' A' ' 105' ' ' ASP . 82.1 p -84.69 -26.47 27.71 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 120.647 -0.421 . . . . 72.22 111.015 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.81 34.51 1.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 60.54 112.825 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -114.73 135.56 54.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.424 -0.213 . . . . 71.43 110.424 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.43 122.74 17.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 75.54 110.836 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.1 mt -88.88 135.84 33.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.367 -0.379 . . . . 75.04 110.614 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.2 m -83.7 145.44 28.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.025 -0.534 . . . . 73.1 110.556 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 52.7 mt -81.34 40.14 0.55 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 74.52 111.275 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -77.02 -22.64 52.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.432 -0.349 . . . . 65.3 111.092 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.17 -11.27 37.4 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.764 -0.731 . . . . 74.23 112.005 -172.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.41 2.56 9.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.178 0.513 . . . . 74.33 110.562 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.9 m -99.74 102.65 14.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.829 -0.623 . . . . 71.25 109.491 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.425 ' CD2' ' HB1' ' A' ' 72' ' ' ALA . 83.8 m-85 -93.81 167.24 11.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.746 -0.661 . . . . 70.3 111.771 -171.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.9 m -73.93 179.45 4.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.242 -0.89 . . . . 73.21 110.572 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.7 t -69.08 146.01 52.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.246 -0.649 . . . . 74.23 109.246 173.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -54.14 106.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.475 0.484 . . . . 73.31 111.544 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.5 m -91.16 103.76 16.4 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.076 -0.713 . . . . 73.42 109.076 173.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 m -55.41 124.36 16.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.789 -0.641 . . . . 75.33 111.099 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.497 HD21 ' SG ' ' A' ' 61' ' ' CYS . 83.7 mt -83.38 150.69 25.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.79 -0.641 . . . . 73.55 111.275 -176.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.449 HD21 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -129.34 152.29 49.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.174 -0.921 . . . . 74.25 108.747 171.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.8 m120 -65.53 118.39 9.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.996 0.427 . . . . 71.41 110.43 175.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 124.76 -137.88 10.78 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.817 -0.706 . . . . 72.42 112.167 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 20.5 m -88.61 127.81 35.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.411 . . . . 74.43 111.016 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -124.95 112.72 16.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.219 -0.446 . . . . 74.35 110.078 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.441 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 1.8 m -102.98 106.52 17.07 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.798 0.332 . . . . 74.33 110.527 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.7 mt -87.63 115.39 62.76 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.624 -0.51 . . . . 74.14 109.624 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -84.23 132.94 5.38 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.602 2.201 . . . . 64.33 112.841 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -131.9 159.55 38.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 71.12 110.462 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.67 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 99.2 mt-30 -127.97 112.88 15.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.246 -0.434 . . . . 73.13 111.487 -176.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.54 127.7 45.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.206 -0.452 . . . . 72.44 110.192 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.493 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 15.8 ptp180 -139.06 163.08 33.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.45 -0.341 . . . . 72.02 110.719 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 71.7 m-85 -81.57 142.5 32.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.97 -0.559 . . . . 63.4 110.715 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -130.43 119.79 23.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.639 -0.709 . . . . 74.42 109.421 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.617 ' O ' ' HA ' ' A' ' 45' ' ' GLU . . . -81.27 137.62 35.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.397 -0.365 . . . . 62.11 111.009 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.435 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 68.9 p -110.13 2.79 19.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.676 0.75 . . . . 64.4 109.349 176.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.22 -129.45 1.74 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.915 -1.039 . . . . 75.32 110.864 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.15 90.26 8.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.848 0.324 . . . . 74.31 110.283 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.64 114.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.491 0.495 . . . . 62.33 111.557 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 26.6 p -104.71 139.62 20.28 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-O 121.385 0.612 . . . . 75.24 110.613 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.59 162.77 41.32 Favored 'Trans proline' 0 C--N 1.333 -0.272 0 C-N-CA 123.799 3.0 . . . . 73.01 112.868 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.63 -162.88 26.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.732 -0.747 . . . . 54.25 111.817 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.84 113.65 8.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.866 0.365 . . . . 70.54 111.338 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.579 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -111.47 63.61 0.61 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.5 0.667 . . . . 75.33 110.357 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -117.48 128.46 55.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.818 . . . . 71.33 109.782 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.502 ' HB1' HD13 ' A' ' 86' ' ' LEU . . . -134.21 169.5 17.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.364 -0.38 . . . . 65.43 111.342 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.8 146.36 50.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 63.23 109.62 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.02 138.86 19.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.146 0.498 . . . . 65.14 111.291 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.6 p -107.2 121.81 45.27 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.794 -0.639 . . . . 64.43 109.771 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.401 ' CD1' HD12 ' A' ' 56' ' ' ILE . 52.7 p90 -102.61 137.19 41.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.367 -0.378 . . . . 75.12 110.528 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.607 ' HA ' HG22 ' A' ' 16' ' ' VAL . 3.9 tmmm? -119.78 113.08 20.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.344 -0.389 . . . . 75.44 110.345 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.2 m -77.57 137.28 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.773 -0.454 . . . . 70.52 109.773 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -115.2 123.56 49.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.393 -0.367 . . . . 71.03 110.172 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.601 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 3.1 p90 -142.88 -19.07 0.66 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.688 -0.687 . . . . 75.14 109.875 171.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.891 HE21 ' HA ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-N 115.184 -0.916 . . . . 71.32 109.363 168.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.62 0.248 . . . . 54.14 111.015 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.83 -174.91 3.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.7 -0.227 . . . . 64.15 110.853 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 t -94.56 -10.87 30.75 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.883 0.373 . . . . 72.12 110.849 177.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.0 p -113.84 -179.87 3.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.16 -0.473 . . . . 71.44 109.914 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.98 12.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.898 0.38 . . . . 72.33 110.922 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 61.86 17.89 9.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.58 -0.736 . . . . 75.44 111.872 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.4 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 83.0 95.53 0.56 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.598 -0.81 . . . . 54.25 111.396 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.543 ' HA3' ' HH ' ' A' ' 137' ' ' TYR . . . -77.78 157.39 45.47 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.174 -1.012 . . . . 63.23 111.895 -178.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.466 ' HB ' HG22 ' A' ' 31' ' ' THR . 4.8 p -140.79 138.9 34.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.679 0.276 . . . . 64.22 111.077 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -115.48 120.44 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 116.441 -0.345 . . . . 54.14 110.071 176.025 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -91.09 107.37 19.16 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.165 -0.471 . . . . 65.51 110.08 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.11 125.11 40.42 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.02 -0.536 . . . . 72.52 110.545 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -112.33 133.81 54.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.994 -0.548 . . . . 73.23 111.165 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.07 -130.07 5.62 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.461 -0.79 . . . . 74.4 111.88 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.457 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 44.3 mt-10 62.91 24.13 14.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.123 0.487 . . . . 65.13 110.993 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.582 HG22 ' HA ' ' A' ' 155' ' ' LYS . 22.1 m -77.85 -34.44 19.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.823 -0.626 . . . . 72.43 111.273 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.554 HG21 HG23 ' A' ' 156' ' ' VAL . 17.9 m -142.89 150.28 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.014 0.435 . . . . 64.34 111.189 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -144.34 22.42 1.68 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.417 -0.81 . . . . 74.01 108.961 175.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.92 -82.99 0.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.491 -0.777 . . . . 54.42 111.255 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.459 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -81.34 -35.65 30.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.796 0.332 . . . . 73.34 110.278 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 m -142.54 135.4 28.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.887 0.375 . . . . 64.54 110.023 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.04 123.97 40.92 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.102 -0.499 . . . . 64.3 109.861 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.455 ' HA ' HD22 ' A' ' 58' ' ' LEU . 14.2 t -61.03 131.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 109.722 -0.473 . . . . 73.41 109.722 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 28' ' ' VAL . 27.7 t70 -59.86 140.07 56.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.107 -0.497 . . . . 65.45 111.335 -176.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.13 -27.34 65.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.793 -0.64 . . . . 71.42 111.819 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.86 7.47 79.94 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.717 -0.754 . . . . 74.31 112.282 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.3 p -129.54 -10.96 4.52 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 122.712 -0.287 . . . . 72.55 111.387 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.457 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 29.2 m -78.24 -5.81 8.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 121.109 0.48 . . . . 74.11 110.505 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -157.2 96.14 1.54 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.446 -0.797 . . . . 73.25 109.015 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -143.64 121.8 12.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.212 0.53 . . . . 73.2 110.546 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 16.4 m -106.83 103.19 12.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.406 -0.815 . . . . 73.03 109.542 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 9' ' ' THR . 11.0 p -89.34 137.41 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.919 0.39 . . . . 73.32 110.97 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -91.05 128.7 36.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.767 -0.651 . . . . 74.44 109.574 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.16 -19.92 24.88 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.103 0.478 . . . . 72.42 110.265 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.6 165.03 35.9 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.868 -0.682 . . . . 71.34 112.082 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -75.18 96.44 3.29 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.055 -0.35 . . . . 62.13 110.055 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 p -80.05 149.34 5.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.152 -0.476 . . . . 74.43 110.274 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.0 mtt85 -83.29 128.68 34.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.996 -0.547 . . . . 74.43 109.864 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 6.6 p -77.78 -13.52 59.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.929 -0.578 . . . . 74.52 111.944 -172.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.14 50.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 75.11 110.915 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.464 ' HB2' HD11 ' A' ' 42' ' ' LEU . 5.5 m -67.42 -29.34 68.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.325 0.583 . . . . 45.04 110.472 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.5 mp -112.77 86.81 2.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.494 -0.775 . . . . 72.31 109.996 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.0 14.58 12.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.127 0.489 . . . . 72.43 111.122 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HG2' ' HB1' ' A' ' 47' ' ' ALA . 3.2 pm0 -141.5 135.91 30.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.052 -0.522 . . . . 75.15 110.324 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.5 tm-20 -59.32 119.97 8.41 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.563 -0.532 . . . . 73.44 109.563 175.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.512 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 109.9 -6.29 30.99 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.738 -0.744 . . . . 71.45 111.752 -175.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.466 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . . . -65.8 135.31 54.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 75.11 111.005 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.1 p -120.97 140.82 51.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.055 -0.521 . . . . 63.55 110.355 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -104.34 -175.79 2.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.216 -0.447 . . . . 75.1 109.814 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.7 m -75.05 133.51 41.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.459 -0.337 . . . . 60.14 110.19 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 136' ' ' ARG . . . -89.92 154.81 19.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.496 0.665 . . . . 74.33 112.021 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 31.5 m -92.82 156.65 3.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.646 -1.161 . . . . 65.24 109.22 169.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 101.65 1.22 Allowed Glycine 0 C--N 1.315 -0.587 0 C-N-CA 120.859 -0.686 . . . . 73.05 112.267 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -111.04 176.59 4.96 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.752 -0.462 . . . . 75.54 109.752 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.516 ' HB2' HG21 ' A' ' 130' ' ' THR . 3.5 p-10 -136.24 149.51 48.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.403 0.621 . . . . 75.12 111.904 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.42 HD12 ' CE2' ' A' ' 133' ' ' PHE . 72.6 mt -113.93 113.86 45.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.11 -0.95 . . . . 73.32 108.684 169.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -96.83 140.33 31.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.101 -0.499 . . . . 72.43 110.951 -172.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 23' ' ' VAL . 64.5 mt -120.63 122.35 40.33 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.951 -0.568 . . . . 73.45 109.565 177.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -99.39 143.79 29.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.075 -0.511 . . . . 74.31 110.034 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 56.82 44.02 24.05 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.779 0.674 . . . . 75.35 110.845 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.578 ' SG ' HD22 ' A' ' 124' ' ' LEU . 6.0 t -75.24 142.04 43.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.109 -0.496 . . . . 74.42 110.31 -175.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -117.71 142.36 47.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.944 -0.571 . . . . 63.52 112.044 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.4 p -113.28 4.51 16.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.79 -0.641 . . . . 75.03 111.398 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -76.0 -38.1 57.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.975 0.417 . . . . 74.24 110.085 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.402 HG23 ' HG3' ' A' ' 159' ' ' GLN . 12.6 p -107.86 -18.96 7.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.107 -0.497 . . . . 75.02 111.381 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -126.47 161.75 27.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.741 0.305 . . . . 75.32 111.52 -176.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 15.0 m -120.18 -55.74 2.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.203 -0.453 . . . . 72.44 111.462 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -136.53 148.87 47.83 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.81 -0.441 . . . . 71.42 109.81 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.494 ' HB2' HD23 ' A' ' 124' ' ' LEU . . . -103.48 140.6 37.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.039 0.447 . . . . 63.53 110.308 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.57 114.17 6.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.6 -0.727 . . . . 72.31 109.067 176.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.3 m -88.13 145.64 7.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.971 0.415 . . . . 75.1 110.834 -173.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.529 ' HB1' ' CD1' ' A' ' 118' ' ' PHE . . . -119.97 123.28 43.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.807 -0.633 . . . . 71.42 109.74 173.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.441 ' CZ ' HG22 ' A' ' 103' ' ' ILE . 57.4 m-85 -86.34 142.52 28.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.2 0.524 . . . . 74.33 111.096 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.6 tp -134.18 123.15 23.87 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.487 -0.778 . . . . 64.21 109.963 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.64 -177.05 36.95 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.767 -0.933 . . . . 62.23 110.767 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.9 m -77.41 121.73 24.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.954 0.377 . . . . 70.43 110.828 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.28 138.68 39.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 75.41 110.529 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.5 tt -69.14 -30.84 47.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 74.13 111.133 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -146.32 178.67 8.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.995 -0.372 . . . . 71.34 109.995 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.71 -30.77 28.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.074 0.464 . . . . 71.34 110.106 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.5 -25.85 31.91 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.726 -0.749 . . . . 54.32 111.539 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.421 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 67.1 m80 -103.5 72.64 1.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.302 0.572 . . . . 74.54 110.046 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 p -92.1 5.43 50.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.547 -0.751 . . . . 72.42 111.853 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -112.43 2.53 16.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 72.52 110.624 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 102' ' ' GLN . 57.6 t -111.01 122.85 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.861 -0.608 . . . . 74.23 110.095 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -69.88 131.38 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.674 0.274 . . . . 74.15 110.275 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.43 145.72 36.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 74.32 110.441 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.64 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -85.16 135.42 33.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.126 -0.488 . . . . 73.25 109.943 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -59.33 116.17 3.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 72.44 110.099 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 p -67.56 115.4 7.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.818 -0.628 . . . . 70.13 111.978 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.7 m -90.14 -9.82 46.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.778 -0.646 . . . . 52.42 110.146 177.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 67.6 -3.62 1.08 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.384 -0.826 . . . . 74.41 112.282 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -105.08 -22.92 13.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.056 0.455 . . . . 71.42 110.847 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 159.76 76.39 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.456 -0.658 . . . . 73.32 111.456 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 m -92.42 147.8 22.62 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.684 -0.488 . . . . 64.35 109.684 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.72 106.48 1.51 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.048 0.452 . . . . 62.21 110.319 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.36 159.31 15.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.143 -0.481 . . . . 74.01 110.574 -176.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.473 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 48.1 m-80 67.01 13.05 9.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.333 0.653 . . . . 54.51 111.17 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.48 167.62 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 CA-C-N 116.271 -0.422 . . . . 75.12 110.336 175.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.511 ' HA2' HD22 ' A' ' 88' ' ' LEU . . . -169.08 -173.8 37.07 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.221 -1.152 . . . . 52.03 110.221 176.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.78 115.26 47.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.363 0.601 . . . . 65.41 110.647 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.493 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.2 pt20 -100.49 139.77 35.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.771 -0.65 . . . . 63.35 109.365 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.441 HG22 ' CZ ' ' A' ' 73' ' ' PHE . 4.2 mp -96.36 129.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.955 0.407 . . . . 75.45 110.295 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.526 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 49.0 mt -96.91 141.6 29.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.705 -0.679 . . . . 64.54 109.925 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.58 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.69 -173.05 1.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.131 -0.486 . . . . 75.12 110.033 177.272 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.429 ' HG3' HG21 ' A' ' 107' ' ' THR . 13.7 ptm180 -57.83 -25.28 60.44 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.276 0.473 . . . . 71.23 112.276 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.429 HG21 ' HG3' ' A' ' 106' ' ' ARG . 74.5 p -100.04 1.7 42.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 73.51 111.762 -177.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.526 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 83.32 38.09 11.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.642 -0.79 . . . . 71.14 112.713 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.52 136.13 51.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.228 -0.286 . . . . 74.43 110.228 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.91 120.74 14.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.328 -0.396 . . . . 63.22 111.013 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 105' ' ' ASP . 95.1 mt -88.21 129.94 35.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.064 -0.516 . . . . 74.31 110.617 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.8 m -76.43 137.6 39.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.903 -0.589 . . . . 73.45 110.954 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.459 ' CD1' HD21 ' A' ' 86' ' ' LEU . 37.5 mt -79.56 47.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 74.14 110.98 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -100.11 -14.34 18.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.878 -0.601 . . . . 74.21 110.367 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.4 -13.48 33.86 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.745 -0.74 . . . . 62.23 112.525 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.61 4.83 15.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.943 0.401 . . . . 62.13 111.12 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.2 m -100.5 99.65 10.28 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.555 -0.535 . . . . 65.33 109.555 176.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.529 ' CD1' ' HB1' ' A' ' 72' ' ' ALA . 64.1 m-85 -94.26 164.11 13.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.089 -0.505 . . . . 74.45 111.487 -172.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.58 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 8.3 m -72.94 -178.56 2.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.45 -0.795 . . . . 61.42 111.459 177.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 m -69.05 160.95 30.03 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.915 -0.584 . . . . 74.23 109.521 170.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.66 125.96 25.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 74.44 110.944 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.411 HG22 HG12 ' A' ' 131' ' ' ILE . 20.1 m -109.23 98.72 8.1 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.38 -0.97 . . . . 73.11 108.38 168.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.4 m -57.22 116.58 3.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 73.22 111.078 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.578 HD22 ' SG ' ' A' ' 61' ' ' CYS . 76.3 mt -74.83 150.17 39.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.307 -0.86 . . . . 73.55 111.522 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -128.12 150.42 49.98 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.259 -0.882 . . . . 74.02 108.83 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -65.31 109.96 2.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.802 0.334 . . . . 71.53 110.354 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.4 -139.2 10.86 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.637 -0.792 . . . . 63.24 112.517 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 m -86.31 117.79 25.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.942 0.401 . . . . 71.33 111.061 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.515 ' N ' HD21 ' A' ' 129' ' ' ASN . 0.8 OUTLIER -112.16 148.62 33.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.508 -0.552 . . . . 70.41 109.508 178.198 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.516 HG21 ' HB2' ' A' ' 55' ' ' ASN . 1.2 m -138.01 113.65 9.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.265 -0.272 . . . . 74.32 110.265 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 10.2 mt -94.46 119.71 66.03 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.982 -0.377 . . . . 72.4 109.982 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 4.9 Cg_endo -84.14 133.31 5.59 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.971 2.447 . . . . 74.11 112.514 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 70.7 m-85 -135.63 163.44 30.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.296 -0.411 . . . . 73.32 110.691 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 90.0 mt-30 -126.71 148.87 49.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.016 -0.538 . . . . 75.15 110.66 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.24 122.52 26.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.182 -0.463 . . . . 62.42 110.335 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 2.1 ptp180 -134.1 164.96 26.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.458 -0.337 . . . . 75.01 110.633 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.543 ' HH ' ' HA3' ' A' ' 8' ' ' GLY . 69.6 m-85 -83.98 143.07 30.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.116 -0.493 . . . . 72.22 110.555 175.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.512 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 57.2 t80 -130.17 125.94 36.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.894 -0.78 . . . . 73.23 108.894 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -89.73 135.18 33.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.017 0.437 . . . . 72.31 111.435 -177.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.534 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 72.2 p -102.53 9.91 39.18 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.756 -0.831 . . . . 60.13 108.756 175.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.09 -123.75 1.2 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.833 -1.076 . . . . 37.15 111.111 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.27 96.65 10.41 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.784 -0.45 . . . . 65.43 109.784 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.93 112.19 0.44 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.699 0.624 . . . . 72.4 111.164 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.7 p -105.12 139.57 20.25 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 115.947 -0.57 . . . . 72.52 109.944 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.83 157.41 58.38 Favored 'Trans proline' 0 C--N 1.328 -0.503 0 C-N-CA 123.417 2.745 . . . . 75.01 113.153 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.33 -165.2 29.43 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.598 -0.728 . . . . 62.24 112.11 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.18 114.57 11.51 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.796 0.331 . . . . 74.42 111.086 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.64 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -109.08 69.96 0.72 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.213 0.53 . . . . 72.34 110.361 176.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.45 ' N ' HD21 ' A' ' 149' ' ' ASN . 0.9 OUTLIER -110.34 123.63 50.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.567 -0.531 . . . . 75.14 109.567 179.25 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.496 ' HB2' HD13 ' A' ' 86' ' ' LEU . . . -132.38 158.81 40.99 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.841 0.353 . . . . 75.0 111.036 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.41 143.84 39.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.252 -0.431 . . . . 74.22 110.15 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.443 ' HB3' HD22 ' A' ' 86' ' ' LEU . . . -153.84 157.94 40.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.976 0.417 . . . . 73.12 111.358 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.3 p -109.49 155.12 21.73 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.723 -0.672 . . . . 71.22 109.412 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -127.6 123.22 35.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.092 0.472 . . . . 70.03 110.679 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.582 ' HA ' HG22 ' A' ' 16' ' ' VAL . 9.2 ttmt -102.6 105.63 16.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.095 -0.502 . . . . 72.14 110.359 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.554 HG23 HG21 ' A' ' 17' ' ' VAL . 1.3 m -76.61 128.85 37.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.507 -0.553 . . . . 65.21 109.507 177.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -107.5 129.9 54.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.227 -0.442 . . . . 74.41 110.087 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.595 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -153.35 -23.66 0.15 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.18 -0.464 . . . . 75.0 110.836 174.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.402 ' HG3' HG23 ' A' ' 65' ' ' VAL . 19.9 tm0? . . . . . 0 C--O 1.242 0.679 0 N-CA-C 108.415 -0.958 . . . . 73.43 108.415 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.72 0.295 . . . . 64.24 110.53 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 145' ' ' PRO . . . -99.1 -171.54 2.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.093 -0.503 . . . . 74.32 109.675 174.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.446 HG21 HG22 ' A' ' 4' ' ' THR . 14.6 t -115.99 -14.53 11.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.441 0.639 . . . . 73.52 110.359 176.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.446 HG22 HG21 ' A' ' 3' ' ' THR . 49.0 p -120.95 175.72 5.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.84 -0.618 . . . . 74.44 110.203 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.483 HG21 HG11 ' A' ' 37' ' ' VAL . 35.2 m -91.65 17.39 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.137 0.494 . . . . 73.53 110.662 176.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 61.97 11.85 4.49 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.202 -0.908 . . . . 73.43 112.515 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 35' ' ' GLY . . . 82.97 95.53 0.56 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.43 -0.89 . . . . 52.34 111.566 -176.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.19 160.91 33.88 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.198 -1.001 . . . . 74.42 111.305 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.572 ' HB ' HG22 ' A' ' 31' ' ' THR . 65.8 p -138.88 140.6 38.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.684 0.278 . . . . 73.25 110.439 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.96 122.27 63.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.194 -0.669 . . . . 74.33 109.194 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -90.47 109.69 20.82 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.322 -0.621 . . . . 74.44 109.322 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -97.52 124.05 41.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.899 -0.591 . . . . 74.33 110.173 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -106.51 135.13 48.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.951 -0.568 . . . . 74.13 110.816 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.26 -137.72 6.61 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 121.098 -0.573 . . . . 74.41 112.534 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 59.34 27.44 16.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.362 0.601 . . . . 74.24 110.774 -177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.677 HG23 HG21 ' A' ' 17' ' ' VAL . 22.8 m -80.29 -21.93 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.48 -0.782 . . . . 71.34 110.672 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 156' ' ' VAL . 3.5 m -148.46 139.27 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.737 -0.665 . . . . 73.1 110.865 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -139.02 26.3 2.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.02 -0.536 . . . . 75.04 109.637 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.09 -86.97 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.28 0.474 . . . . 74.15 112.28 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.462 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -76.4 -16.79 59.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 72.31 111.08 -178.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 59.7 m -150.87 157.16 42.57 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.425 -0.954 . . . . 62.4 108.425 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.55 116.22 26.19 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.491 -0.559 . . . . 71.34 109.491 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.65 134.04 23.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.378 -0.373 . . . . 64.45 110.113 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 28' ' ' VAL . 16.8 t70 -63.56 142.94 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.503 -0.317 . . . . 64.22 110.923 -177.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.464 ' HA ' HG21 ' A' ' 28' ' ' VAL . . . -59.43 -27.52 66.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 52.43 112.261 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.24 -21.38 78.0 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.508 -0.853 . . . . 73.35 112.095 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 p -104.73 -12.41 16.36 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.062 0.393 . . . . 74.31 112.062 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.464 HG21 ' HA ' ' A' ' 25' ' ' ALA . 31.4 m -80.58 -5.32 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.894 0.378 . . . . 75.35 110.708 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -163.29 89.78 0.63 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.277 -0.638 . . . . 74.15 109.277 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -141.78 132.33 25.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.039 -0.528 . . . . 74.3 110.591 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.572 HG22 ' HB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -107.72 99.29 8.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.757 -0.656 . . . . 62.13 109.286 178.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.6 p -82.32 126.87 40.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.108 0.48 . . . . 74.44 111.252 -175.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.524 ' HA ' HG21 ' A' ' 9' ' ' THR . 25.7 mp0 -84.66 120.7 26.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 74.41 109.706 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.74 -28.83 36.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.058 -0.519 . . . . 73.22 110.183 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.49 ' O ' ' HA2' ' A' ' 7' ' ' GLY . . . 106.38 170.96 22.98 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.765 -0.652 . . . . 62.31 111.911 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -83.93 83.6 7.88 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.893 -0.41 . . . . 64.34 109.893 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 5' ' ' VAL . 9.7 p -67.8 143.04 15.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.018 0.437 . . . . 75.12 110.65 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -77.73 115.51 17.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.818 -0.628 . . . . 63.14 109.795 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.7 p -61.45 -32.04 72.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.274 -0.421 . . . . 75.25 111.318 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.22 -24.34 66.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.515 . . . . 74.24 111.791 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.1 m -76.22 -23.46 54.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.814 0.34 . . . . 74.42 110.939 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.551 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 5.4 mp -114.17 92.03 3.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.094 0.473 . . . . 71.44 110.225 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.36 19.26 8.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.004 0.431 . . . . 73.25 111.245 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -149.73 138.34 20.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.942 -0.572 . . . . 74.23 110.52 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.491 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.6 tm-20 -55.79 124.02 16.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 54.34 109.61 175.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.0 -3.93 38.58 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.961 -0.637 . . . . 61.5 111.962 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -67.42 123.1 19.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.772 0.32 . . . . 74.31 110.554 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.796 ' HB ' HH11 ' A' ' 136' ' ' ARG . 22.9 p -112.72 121.42 44.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.914 -0.585 . . . . 73.14 111.024 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 137' ' ' TYR . 60.7 m -73.81 157.48 36.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.177 -0.465 . . . . 74.25 110.458 175.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.4 m -60.66 127.93 34.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.751 -0.463 . . . . 65.22 109.751 175.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.11 154.95 28.96 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.479 0.656 . . . . 74.42 111.749 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 33.1 m -95.58 147.86 5.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 114.859 -1.064 . . . . 72.1 109.451 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.88 103.06 2.35 Favored Glycine 0 C--N 1.309 -0.964 0 C-N-CA 120.899 -0.667 . . . . 37.68 111.858 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -113.82 179.92 3.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.627 -0.509 . . . . 74.32 109.627 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.485 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 3.9 p-10 -138.34 149.94 46.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.424 0.631 . . . . 54.41 112.308 -173.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.45 HD11 ' CE2' ' A' ' 133' ' ' PHE . 81.1 mt -121.42 113.7 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.932 -1.031 . . . . 75.43 108.484 168.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 29.8 tt0 -99.07 136.9 38.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 65.43 111.181 -172.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.04 129.94 56.04 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.825 -0.625 . . . . 74.14 109.811 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -102.87 136.52 42.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.915 -0.584 . . . . 63.43 110.535 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 54.49 75.88 0.27 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 124.008 0.818 . . . . 74.4 112.055 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.6 m -97.55 138.81 34.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.652 -0.704 . . . . 37.68 111.18 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -112.57 137.63 50.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.727 -0.67 . . . . 63.51 110.638 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 p -102.25 6.2 40.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.099 -0.5 . . . . 75.41 111.94 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -90.27 -31.12 17.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.663 -0.495 . . . . 63.54 109.663 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 p -98.27 -22.18 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.733 -0.667 . . . . 72.55 111.337 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . . . -141.58 168.42 19.82 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.028 -0.42 . . . . 74.31 111.029 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 36.9 m -125.7 -51.7 1.59 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.216 0.451 . . . . 75.14 112.216 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -132.99 150.46 52.16 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.086 -0.383 . . . . 72.32 110.518 -177.028 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.69 130.42 55.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.916 0.389 . . . . 71.34 109.984 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.34 114.84 8.89 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.585 -0.524 . . . . 73.43 109.585 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.5 m -84.2 145.84 7.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 63.01 111.028 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -117.63 116.92 28.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.498 -0.774 . . . . 51.41 109.806 174.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -85.54 130.12 34.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.325 0.583 . . . . 64.53 110.979 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.9 tp -128.9 116.02 18.77 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.33 -0.85 . . . . 74.21 109.951 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.34 -171.54 20.04 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.201 -0.76 . . . . 62.01 111.201 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.7 m -85.58 116.14 23.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.864 0.332 . . . . 74.23 110.177 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.05 147.68 36.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.45 -0.341 . . . . 74.43 110.845 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.417 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 9.3 tt -63.52 -30.22 49.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.998 -0.546 . . . . 74.42 110.643 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.82 -178.56 5.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 73.11 109.584 174.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.74 -10.23 59.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.038 0.385 . . . . 74.23 112.038 -174.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.53 -44.05 3.27 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.978 -0.629 . . . . 63.13 111.607 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.409 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 60.7 m80 -97.1 61.15 1.74 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.576 0.703 . . . . 74.43 109.373 177.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -76.69 5.46 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.106 -0.952 . . . . 74.15 112.266 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -106.07 -4.82 19.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.478 . . . . 61.5 110.349 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.26 127.77 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.613 . . . . 75.11 110.448 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -72.25 134.54 45.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.755 -0.461 . . . . 73.4 109.755 178.382 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.417 ' HB3' ' HA ' ' A' ' 78' ' ' ILE . . . -78.14 149.72 33.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.175 -0.466 . . . . 74.13 110.061 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.438 ' N ' HD23 ' A' ' 88' ' ' LEU . 2.5 mm? -82.04 133.19 35.27 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.222 -0.444 . . . . 75.04 110.374 -176.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -68.25 146.41 53.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.831 -0.622 . . . . 64.15 110.834 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.19 97.38 4.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.897 -0.592 . . . . 74.45 110.831 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.0 m -88.11 3.3 49.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.801 -0.636 . . . . 75.22 110.432 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.82 6.2 3.83 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.496 -0.774 . . . . 63.14 111.985 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -108.18 4.01 24.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.061 0.458 . . . . 73.53 110.738 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.14 89.07 1.86 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.721 -0.952 . . . . 74.21 110.721 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.2 m -73.06 145.36 46.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.749 0.309 . . . . 71.11 110.696 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.33 109.01 2.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 74.13 110.502 -175.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.37 160.68 14.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.154 -0.475 . . . . 71.14 110.974 -174.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 72.02 9.26 6.06 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.8 -0.636 . . . . 62.52 110.743 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.94 -172.37 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.852 -0.613 . . . . 63.41 110.459 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.31 -176.95 46.66 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.552 -1.019 . . . . 71.21 110.552 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.54 113.35 40.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.361 0.6 . . . . 64.34 110.648 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -102.29 137.58 40.36 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.223 -0.658 . . . . 75.13 109.223 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.5 mp -100.42 120.35 49.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.054 0.454 . . . . 71.11 110.349 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.424 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 24.9 mt -86.1 145.86 26.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.686 -0.688 . . . . 74.21 109.225 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.542 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.2 OUTLIER -74.68 -171.93 1.4 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.242 -0.436 . . . . 73.14 109.914 177.569 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 106' ' ' ARG . 19.0 ptt85 -58.49 -27.33 64.35 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.727 0.269 . . . . 71.44 111.727 -177.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.0 p -100.45 7.96 43.87 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.877 0.37 . . . . 64.32 111.838 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 83.71 28.09 36.44 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 37.68 113.099 175.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.23 120.12 39.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.222 -0.288 . . . . 74.23 110.222 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 115.81 4.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.898 0.38 . . . . 74.52 110.518 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.7 mt -83.71 132.56 34.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.328 -0.396 . . . . 73.34 111.129 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.6 m -73.05 140.45 47.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.723 -0.672 . . . . 74.22 110.547 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.404 ' CD1' HD21 ' A' ' 86' ' ' LEU . 74.2 mt -78.74 49.25 0.88 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.329 0.585 . . . . 74.35 110.504 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -85.67 -27.58 25.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.49 -0.777 . . . . 74.21 109.983 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.34 -22.47 32.39 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.627 -0.715 . . . . 41.12 111.539 -172.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.21 14.63 14.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.757 0.313 . . . . 53.53 111.119 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.6 m -95.24 105.25 17.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.47 -0.567 . . . . 74.35 109.47 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 72' ' ' ALA . 86.5 m-85 -97.41 156.29 16.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.225 0.536 . . . . 74.41 111.473 -173.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 7.3 m -68.92 -178.83 1.3 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.392 -0.822 . . . . 72.42 111.143 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.3 t -69.36 156.69 38.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.883 -0.784 . . . . 73.24 108.883 170.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.542 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 51.7 mt-10 -66.06 109.14 2.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.729 0.299 . . . . 72.34 111.476 -175.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.414 ' OG1' ' HD3' ' A' ' 106' ' ' ARG . 22.7 m -89.08 96.82 10.88 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.644 -0.873 . . . . 63.03 108.644 171.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.6 m -60.07 122.05 13.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.911 -0.586 . . . . 74.1 110.903 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.8 mt -81.87 150.45 27.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.423 -0.808 . . . . 74.11 111.16 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -130.68 161.46 31.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.227 -0.657 . . . . 72.15 109.227 169.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -60.35 112.74 2.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 74.02 110.973 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.47 -141.45 13.0 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.766 -0.731 . . . . 71.22 112.595 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.0 m -82.1 131.56 35.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.791 0.329 . . . . 74.2 111.233 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -130.82 114.47 15.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.158 -0.474 . . . . 75.33 109.873 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.485 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 4.7 m -107.04 117.81 35.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.827 0.346 . . . . 61.44 110.267 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.4 mt -94.39 116.8 66.82 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.988 -0.551 . . . . 74.41 110.174 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.59 138.13 10.59 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.033 2.489 . . . . 64.41 111.958 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.45 ' CE2' HD11 ' A' ' 56' ' ' ILE . 74.0 m-85 -135.35 161.77 34.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.365 -0.379 . . . . 72.04 110.53 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.668 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 43.0 mt-30 -127.91 114.65 17.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 74.3 110.802 -175.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.43 132.38 49.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.68 -0.237 . . . . 71.32 110.55 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.796 HH11 ' HB ' ' A' ' 48' ' ' THR . 12.4 ptp180 -143.1 160.07 41.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.967 0.413 . . . . 75.34 111.206 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 73.3 m-85 -80.32 145.83 31.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.776 -0.647 . . . . 74.22 110.553 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.409 ' HE2' ' CD2' ' A' ' 82' ' ' HIS . 64.4 t80 -131.88 118.45 19.84 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.845 -0.616 . . . . 71.34 109.661 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 42' ' ' LEU . . . -86.97 132.66 33.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.299 -0.41 . . . . 75.51 111.235 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.491 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 66.0 p -99.14 5.08 47.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.679 0.752 . . . . 74.41 109.424 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 173.14 -117.78 0.67 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.647 -1.16 . . . . 45.32 110.744 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -94.72 98.47 10.8 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.927 -0.397 . . . . 75.31 109.927 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -50.54 123.71 9.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.018 -0.537 . . . . 60.43 110.807 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 39.9 p -116.02 147.62 39.65 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.125 0.488 . . . . 73.32 110.686 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.422 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 43.4 Cg_endo -64.31 163.18 27.35 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.668 2.912 . . . . 73.25 112.553 -178.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.59 -164.43 27.39 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.645 -0.788 . . . . 61.22 112.065 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -85.35 115.1 22.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.65 0.262 . . . . 70.3 110.459 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -108.48 55.15 0.64 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.138 0.494 . . . . 64.42 111.323 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -105.13 138.98 40.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.062 -0.517 . . . . 73.33 109.895 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.496 ' HB2' HD13 ' A' ' 86' ' ' LEU . . . -140.63 179.69 6.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.932 0.396 . . . . 72.25 111.773 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -143.95 137.1 27.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.621 -0.718 . . . . 75.41 109.71 -178.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.36 139.84 21.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.892 0.377 . . . . 72.22 111.271 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 30.5 p -103.71 132.28 50.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.195 -0.457 . . . . 61.14 109.899 176.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -107.39 124.05 49.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.104 0.478 . . . . 63.2 110.391 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.586 ' HA ' HG22 ' A' ' 16' ' ' VAL . 3.0 tmmm? -105.62 99.39 8.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.921 -0.581 . . . . 75.24 109.492 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.754 HG23 HG22 ' A' ' 17' ' ' VAL . 1.4 m -74.84 127.96 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.64 0.733 . . . . 73.42 110.178 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -103.67 108.61 19.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.525 -0.761 . . . . 73.44 111.009 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 2.5 p90 -126.15 -33.95 2.59 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.017 -0.734 . . . . 73.02 109.017 166.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 C--O 1.245 0.834 0 CA-C-N 115.263 -0.88 . . . . 61.43 109.336 168.617 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.417 ' CB ' ' HB3' ' A' ' 36' ' ' GLN . 80.4 p . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.927 0.394 . . . . 74.22 110.682 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 37' ' ' VAL . 27.7 m -86.86 16.65 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.05 0.452 . . . . 75.53 111.083 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 61.93 13.12 5.32 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.566 -0.743 . . . . 71.11 112.211 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.483 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 91.14 101.26 1.25 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.558 -0.829 . . . . 63.42 111.785 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.65 160.19 25.29 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.431 -0.89 . . . . 71.34 111.777 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 33' ' ' GLN . 66.4 p -143.3 149.17 37.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.883 0.373 . . . . 41.32 110.637 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.518 HG22 HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -123.67 117.86 52.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.997 -0.547 . . . . 72.23 110.503 175.314 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -95.72 112.51 24.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.399 -0.818 . . . . 61.0 110.118 -177.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 59.4 m-85 -94.39 137.29 33.72 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.812 -0.631 . . . . 65.23 110.562 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.598 ' HZ3' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -114.58 137.62 51.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.973 -0.558 . . . . 62.33 110.301 -179.081 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.21 -133.41 4.06 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.759 -0.734 . . . . 60.23 112.504 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 49.2 mt-10 60.65 21.27 11.19 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.212 0.53 . . . . 62.1 111.115 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.56 HG21 ' HA ' ' A' ' 155' ' ' LYS . 24.8 m -76.32 -23.81 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.748 -0.66 . . . . 75.11 111.132 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.428 HG21 ' CG2' ' A' ' 156' ' ' VAL . 24.1 m -135.71 148.28 28.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.126 -0.488 . . . . 35.31 111.361 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -151.31 26.73 0.68 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.502 -0.925 . . . . 54.42 108.502 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.36 -79.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.115 -0.948 . . . . 54.21 111.408 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.468 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -84.73 -37.53 20.77 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.859 0.361 . . . . 71.32 110.858 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -140.7 132.46 27.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.141 -0.481 . . . . 74.04 109.873 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.58 123.21 37.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.254 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 t -66.44 133.33 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.862 -0.422 . . . . 71.24 109.862 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 28' ' ' VAL . 19.2 t70 -62.05 147.96 45.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 72.22 111.043 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -62.25 -25.39 67.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 74.55 111.783 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 30' ' ' GLN . . . -86.13 -9.76 76.18 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.589 -0.815 . . . . 71.35 111.627 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.0 m -105.23 -23.25 12.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.465 0.174 . . . . 40.34 111.124 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 25.5 m -77.56 -12.18 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.335 0.588 . . . . 74.25 110.215 176.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -153.58 96.01 1.97 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.964 -1.016 . . . . 71.43 109.217 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 24.9 pt20 -148.34 142.81 26.38 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.01 -0.541 . . . . 74.54 110.421 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.506 HG22 ' HB ' ' A' ' 9' ' ' THR . 6.9 m -124.0 101.3 7.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.628 -0.714 . . . . 72.45 109.649 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.18 129.22 39.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.088 0.47 . . . . 75.45 110.407 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.515 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.2 mp0 -85.63 130.57 34.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.698 -0.683 . . . . 63.41 110.245 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.518 HD21 HG22 ' A' ' 10' ' ' VAL . 2.3 mm? -91.27 -17.08 26.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.152 -0.476 . . . . 64.35 110.109 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.483 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 86.58 174.87 49.47 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.939 -0.648 . . . . 72.14 112.476 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.417 ' HB3' ' CB ' ' A' ' 4' ' ' THR . 81.2 mt-30 -77.36 89.11 3.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.137 -0.32 . . . . 74.25 110.137 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.459 HG12 HG22 ' A' ' 5' ' ' VAL . 9.9 p -68.49 144.67 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.804 -0.443 . . . . 53.4 109.804 176.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 38' ' ' ARG . 44.3 mtp180 -85.31 123.75 31.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.899 -0.408 . . . . 73.02 109.899 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 35.6 p -68.7 -23.22 64.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.169 -0.469 . . . . 65.54 111.456 -176.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.98 -15.71 61.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 63.23 111.066 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -87.92 -12.7 43.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.398 . . . . 70.34 110.731 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -129.02 84.75 2.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.225 -0.443 . . . . 65.43 110.089 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.37 19.58 12.71 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.704 -0.399 . . . . 42.41 111.849 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -150.04 140.21 22.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.702 0.287 . . . . 65.32 110.774 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 3.9 tm-20 -56.12 117.96 4.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.714 -0.676 . . . . 65.02 109.478 174.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.35 -1.09 31.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.756 -0.735 . . . . 52.21 112.345 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -74.15 134.4 42.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 73.02 110.708 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.2 p -119.7 145.83 46.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.21 -0.45 . . . . 74.32 110.934 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 t -110.23 -179.23 3.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.307 -0.406 . . . . 61.54 110.08 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.8 m -70.57 140.74 51.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.346 -0.388 . . . . 60.02 110.255 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -95.58 155.79 16.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.455 0.645 . . . . 73.41 111.936 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.7 m -95.61 152.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.485 -1.234 . . . . 73.33 109.265 170.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.23 79.63 0.26 Allowed Glycine 0 C--N 1.312 -0.793 0 C-N-CA 120.795 -0.717 . . . . 32.34 112.315 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 133' ' ' PHE . 41.8 p90 -87.83 162.48 16.95 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.807 -0.442 . . . . 75.24 109.807 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.522 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.8 p-10 -132.05 142.55 49.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.258 0.551 . . . . 51.51 111.733 -174.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.5 mt -106.62 109.14 27.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.604 -0.725 . . . . 75.23 109.305 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -89.33 136.22 33.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.197 0.523 . . . . 74.24 111.111 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.38 124.66 49.43 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.494 -0.776 . . . . 52.2 109.18 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -100.56 130.64 46.65 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.974 -0.38 . . . . 74.1 109.974 -176.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.8 t70 54.92 74.61 0.35 Allowed 'General case' 0 C--N 1.332 -0.189 0 O-C-N 124.0 0.813 . . . . 73.22 110.619 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 38.3 t -102.28 124.06 47.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.228 -0.896 . . . . 75.02 110.066 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -98.33 137.41 37.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.21 -0.45 . . . . 72.53 111.555 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.442 HG22 ' HB2' ' A' ' 124' ' ' LEU . 64.1 p -110.09 18.97 19.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 44.32 112.071 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -98.96 -26.51 14.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.458 -0.571 . . . . 34.04 109.458 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 20' ' ' ALA . 8.8 p -109.0 -2.3 10.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 72.33 110.251 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.754 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -144.21 179.16 7.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 73.3 110.462 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.7 m -141.2 -56.86 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.709 0.29 . . . . 75.43 111.297 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -136.2 143.09 44.19 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.756 -0.461 . . . . 64.24 109.756 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.495 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -102.65 123.49 46.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.072 0.463 . . . . 51.32 110.445 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.55 115.15 16.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.633 -0.712 . . . . 74.45 109.606 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 156' ' ' VAL . 3.3 m -91.53 149.8 3.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.137 0.494 . . . . 63.34 111.282 -173.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -116.08 118.61 33.36 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.726 -0.67 . . . . 73.11 109.904 174.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.522 ' CE1' HG21 ' A' ' 103' ' ' ILE . 49.2 m-85 -87.96 124.14 33.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.19 0.519 . . . . 74.13 110.993 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 56.4 tp -114.97 125.77 54.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.571 -0.74 . . . . 60.22 109.38 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.433 ' H ' ' HB3' ' A' ' 113' ' ' LEU . . . -158.66 -179.56 33.6 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.037 -0.825 . . . . 74.43 111.037 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -67.5 120.26 13.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.785 0.293 . . . . 75.23 110.778 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.49 132.55 35.71 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.972 -0.381 . . . . 73.55 109.972 175.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.484 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 7.3 tt -73.78 -25.66 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.017 0.437 . . . . 73.22 110.941 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 19.1 t70 -159.54 174.53 14.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.423 -0.584 . . . . 75.45 109.423 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.06 -33.15 44.88 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.167 0.508 . . . . 62.32 109.974 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.98 -0.58 80.87 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.216 -0.753 . . . . 51.31 111.216 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 53.5 m80 -131.37 43.35 3.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.938 -0.631 . . . . 74.24 109.958 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 p -71.65 -2.06 15.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 72.14 110.984 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 33.6 p-10 -104.02 9.6 36.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.97 -0.559 . . . . 61.34 110.334 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 t -120.36 123.22 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.858 -0.61 . . . . 71.32 110.174 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.494 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -68.46 124.58 23.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.158 -0.682 . . . . 73.12 109.158 177.31 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.0 150.31 33.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.887 -0.597 . . . . 50.51 109.846 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.515 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.5 mm? -78.2 126.23 30.49 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.227 -0.657 . . . . 61.43 109.227 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.592 ' HG2' ' HA ' ' A' ' 150' ' ' ALA . 14.1 mm100 . . . . . 0 CA--C 1.512 -0.497 0 CA-C-O 121.639 0.733 . . . . 64.43 109.752 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.233 0.196 0 N-CA-C 109.862 -0.422 . . . . 72.44 109.862 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.05 152.63 29.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.244 -0.28 . . . . 75.41 110.244 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.57 164.09 30.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.613 -0.435 . . . . 65.4 111.208 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 66.48 16.5 10.43 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.583 -0.735 . . . . 63.23 111.104 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.408 ' O ' HD12 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -147.79 -175.07 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 63.21 110.559 175.26 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -179.68 -167.15 36.49 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.067 -1.213 . . . . 74.24 110.067 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' A' ' 86' ' ' LEU . 2.3 p -135.8 129.35 48.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.724 0.774 . . . . 74.14 110.847 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -110.54 138.78 46.48 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.132 -0.94 . . . . 64.51 110.322 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.522 HG21 ' CE1' ' A' ' 73' ' ' PHE . 3.9 mp -95.02 114.66 32.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.023 -0.732 . . . . 64.32 109.023 173.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 57.5 mt -85.55 128.0 34.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.724 -0.671 . . . . 63.1 110.331 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.685 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 2.8 t70 -57.42 166.34 1.26 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 64.23 110.406 174.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 106' ' ' ARG . 13.4 ptm180 -58.94 -17.5 25.07 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.386 0.514 . . . . 74.23 112.386 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.1 p -92.08 -7.67 48.01 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.836 0.35 . . . . 64.21 111.512 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.66 48.06 3.29 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.868 -0.682 . . . . 70.43 112.319 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -134.04 134.13 42.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.839 -0.212 . . . . 63.53 110.82 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.01 131.98 48.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.613 0.244 . . . . 73.35 110.911 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.549 HD21 ' HB2' ' A' ' 105' ' ' ASP . 84.9 mt -94.57 134.21 37.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.969 0.414 . . . . 74.14 111.283 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 82.0 m -73.45 134.43 43.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.789 -0.641 . . . . 73.14 110.715 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 43.5 mt -81.08 50.59 1.43 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.478 0.656 . . . . 74.21 110.731 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.428 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 13.9 t70 -90.11 -19.9 23.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.224 -0.898 . . . . 74.11 110.787 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.47 -28.76 6.63 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.776 -0.725 . . . . 43.21 112.349 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.75 4.07 21.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.382 . . . . 74.21 111.006 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 114' ' ' ASP . 26.9 m -90.86 99.83 12.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.382 -0.372 . . . . 70.13 110.1 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.656 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 63.1 m-85 -90.04 157.47 17.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 70.54 111.152 -175.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.685 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . 5.4 m -73.72 -167.24 0.44 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.649 -0.705 . . . . 51.23 111.255 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.9 m -80.98 178.41 8.44 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.875 0.369 . . . . 62.41 111.067 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.542 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 38.1 mt-10 -75.09 105.67 6.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.079 -0.51 . . . . 64.31 111.573 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.537 HG21 HG12 ' A' ' 131' ' ' ILE . 88.4 m -87.32 99.46 12.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.819 -0.808 . . . . 74.21 108.819 168.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.3 m -56.91 114.86 2.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.851 -0.613 . . . . 73.21 110.653 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.504 HD22 ' SG ' ' A' ' 61' ' ' CYS . 97.5 mt -79.89 146.43 32.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.664 -0.698 . . . . 63.34 110.965 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -123.06 149.06 44.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.829 -0.804 . . . . 44.34 108.829 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 94.6 m-20 -68.52 95.99 0.67 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.964 0.412 . . . . 73.32 110.694 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 146.99 -141.05 9.05 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.998 -0.62 . . . . 73.41 111.8 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.452 ' C ' HD22 ' A' ' 129' ' ' ASN . 29.1 m -81.58 124.71 29.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.001 0.429 . . . . 62.22 110.257 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.481 HD22 ' N ' ' A' ' 129' ' ' ASN . 0.9 OUTLIER -119.8 160.2 23.08 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.321 -0.622 . . . . 54.14 109.321 177.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -149.06 126.57 11.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.24 -0.281 . . . . 75.34 110.24 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.537 HG12 HG21 ' A' ' 122' ' ' THR . 9.2 mt -104.23 109.41 62.52 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.937 -0.394 . . . . 61.14 109.937 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -88.6 127.31 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.821 2.347 . . . . 72.04 112.904 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . 73.6 m-85 -124.9 167.31 14.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.1 -0.5 . . . . 74.22 110.266 178.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.66 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 99.4 mt-30 -124.27 122.14 36.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.923 0.392 . . . . 74.01 111.1 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.85 123.03 47.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.376 -0.375 . . . . 71.45 110.403 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.514 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 5.7 ptp180 -137.86 161.2 37.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.537 -0.301 . . . . 74.53 110.96 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 63.2 m-85 -80.55 147.15 30.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.987 -0.552 . . . . 74.21 111.204 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -134.38 122.48 22.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.392 -0.822 . . . . 73.51 109.003 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.639 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -86.98 135.36 33.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.91 0.386 . . . . 44.23 111.63 -176.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.573 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 34.8 p -109.45 14.72 23.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.712 0.768 . . . . 62.5 109.228 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.17 -132.05 2.51 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 114.722 -1.126 . . . . 52.01 110.293 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.78 100.59 12.77 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.879 -0.786 . . . . 72.13 108.879 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.593 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.47 114.92 0.83 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.013 0.82 . . . . 64.42 110.848 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.6 p -105.63 143.15 26.25 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 116.281 -0.418 . . . . 63.01 110.198 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.84 158.15 58.6 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.165 2.577 . . . . 71.02 112.821 -174.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.84 -174.38 24.98 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.55 -0.75 . . . . 51.43 111.364 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.93 103.84 2.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.968 0.413 . . . . 61.34 111.144 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.515 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -99.68 66.13 1.39 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.238 0.542 . . . . 74.5 110.535 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -119.88 136.88 54.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.867 -0.606 . . . . 61.43 109.814 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.592 ' HA ' ' HG2' ' A' ' 89' ' ' GLN . . . -136.25 163.63 29.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.083 0.468 . . . . 31.42 111.837 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -123.08 135.24 54.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.541 -0.754 . . . . 74.14 109.559 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 12' ' ' PHE . . . -141.52 129.72 22.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.049 0.452 . . . . 71.33 111.275 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 13' ' ' LYS . 49.1 p -106.6 125.5 51.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.136 -0.484 . . . . 71.11 109.921 175.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -105.46 136.49 44.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.168 0.508 . . . . 72.3 111.343 -176.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.656 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 10.1 ttmm -113.05 106.45 14.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.645 -0.707 . . . . 54.22 110.213 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -74.56 141.53 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.199 -0.6 . . . . 62.53 109.573 178.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -125.79 115.73 20.48 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.164 -0.471 . . . . 64.23 109.789 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.754 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 1.3 p90 . . . . . 0 C--N 1.32 -0.684 0 CA-C-O 121.465 0.65 . . . . 73.21 110.324 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 120.78 0.324 . . . . 72.11 110.277 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.441 HG22 HG12 ' A' ' 37' ' ' VAL . 35.7 m -86.47 14.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.093 0.473 . . . . 64.12 111.053 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 62.81 13.95 6.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.452 -0.794 . . . . 72.51 112.359 175.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.505 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 92.42 89.39 1.51 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.673 -0.775 . . . . 65.34 111.82 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.75 158.13 48.2 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.691 -0.766 . . . . 44.1 112.072 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.577 ' HB ' HG22 ' A' ' 31' ' ' THR . 12.9 p -141.4 139.66 33.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.571 0.224 . . . . 64.33 110.904 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -114.33 120.05 63.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.512 -0.551 . . . . 71.32 109.512 174.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -86.17 102.91 14.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.732 -0.47 . . . . 72.0 109.732 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -92.55 105.43 17.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 75.15 109.776 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 50.3 tttp -106.31 136.43 46.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.012 -0.54 . . . . 75.54 110.149 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.45 -112.81 2.44 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.874 -0.679 . . . . 71.51 112.111 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.585 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 28.0 mt-10 61.09 22.72 12.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.25 0.548 . . . . 71.43 110.685 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.645 HG21 ' HA ' ' A' ' 155' ' ' LYS . 19.1 m -77.72 -27.28 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.311 -0.859 . . . . 71.02 111.798 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.65 145.11 34.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.209 0.528 . . . . 65.24 111.821 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -159.65 84.11 0.75 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.911 -1.04 . . . . 74.23 108.236 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.35 -79.1 0.1 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.571 -0.741 . . . . 73.12 110.947 -172.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.524 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -76.76 -33.12 58.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.293 0.568 . . . . 75.34 109.642 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.6 m -141.73 173.64 11.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.327 -0.851 . . . . 54.34 109.165 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.09 123.81 27.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.683 -0.488 . . . . 71.22 109.683 173.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.7 t -66.14 128.82 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.644 -0.502 . . . . 73.25 109.644 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.468 ' O ' HG13 ' A' ' 28' ' ' VAL . 28.8 t70 -60.7 138.02 58.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.99 -0.55 . . . . 73.1 111.203 -176.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.554 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -59.35 -24.94 63.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.822 -0.627 . . . . 75.41 112.126 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.91 -13.14 83.42 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.581 -0.819 . . . . 71.21 112.229 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.8 p -112.43 -9.83 13.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.714 0.264 . . . . 73.4 111.714 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.3 m -86.35 -1.5 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 122.361 -0.212 . . . . 75.23 111.486 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -156.82 42.27 0.35 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.438 0.637 . . . . 73.53 109.552 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -91.98 123.64 35.49 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.491 -0.777 . . . . 72.12 110.127 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.577 HG22 ' HB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -109.84 95.26 5.48 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.525 -0.761 . . . . 42.54 109.606 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.1 p -81.64 130.06 36.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.984 -0.553 . . . . 63.15 111.28 -174.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -83.94 118.97 24.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.711 -0.677 . . . . 54.13 109.933 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.457 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.6 mm? -79.13 -22.49 45.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.347 0.594 . . . . 71.32 109.468 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.22 175.92 39.12 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.384 -0.826 . . . . 70.05 111.78 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -78.63 83.95 4.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.441 -0.207 . . . . 72.41 110.441 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.441 HG12 HG22 ' A' ' 5' ' ' VAL . 8.8 p -66.52 140.28 19.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.471 -0.566 . . . . 60.44 109.471 176.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -86.19 117.83 25.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.216 0.532 . . . . 74.34 109.838 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.623 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 26.7 p -65.75 -21.98 66.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 70.14 111.5 -174.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.56 -17.28 64.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.913 -0.585 . . . . 50.41 111.118 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.7 m -84.02 -14.15 51.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 74.31 111.138 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -123.63 94.49 4.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.925 0.393 . . . . 73.23 109.977 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.39 10.96 10.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.651 0.612 . . . . 44.04 112.651 -170.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -150.04 146.31 26.9 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.873 -0.331 . . . . 64.1 110.851 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -56.35 122.53 12.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.718 -0.674 . . . . 74.02 109.64 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.42 -7.0 32.07 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.646 -0.788 . . . . 72.42 112.272 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -70.61 119.09 14.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 54.45 110.697 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 p -113.31 130.64 56.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.016 -0.538 . . . . 74.54 110.158 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.5 t -89.98 175.47 7.17 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.977 -0.379 . . . . 74.12 109.977 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.1 m -70.77 136.79 49.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.791 -0.448 . . . . 72.22 109.791 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -89.08 159.69 17.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.526 0.679 . . . . 71.4 112.161 -173.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.1 m -91.31 152.42 3.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.715 -1.13 . . . . 71.34 109.552 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.0 106.13 2.44 Favored Glycine 0 C--N 1.312 -0.759 0 C-N-CA 121.095 -0.574 . . . . 71.52 112.076 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -122.77 170.28 10.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.346 -0.613 . . . . 74.31 109.346 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -135.89 149.93 49.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.449 0.642 . . . . 70.33 112.454 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.0 mt -103.54 119.79 52.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.369 -0.832 . . . . 64.03 109.129 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -102.85 132.28 49.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.095 0.474 . . . . 71.53 111.187 -172.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.2 mt -115.31 124.7 51.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.902 -0.59 . . . . 75.32 109.757 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -98.95 132.67 44.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.166 -0.47 . . . . 62.0 110.355 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.3 t70 55.65 76.45 0.27 Allowed 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.918 0.762 . . . . 75.31 110.807 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.58 146.96 23.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.286 -0.87 . . . . 74.01 111.282 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -116.92 129.69 56.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.476 -0.784 . . . . 74.55 110.849 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.1 p -105.96 16.71 24.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.283 -0.417 . . . . 65.0 111.791 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -92.24 -32.93 14.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.086 0.469 . . . . 73.44 109.92 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.2 p -105.96 -33.67 2.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.154 -0.476 . . . . 65.12 110.692 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -103.81 178.61 4.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 55.33 110.643 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 18.5 m -140.19 -56.9 0.54 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.868 0.366 . . . . 73.21 111.049 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.487 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -135.89 154.82 51.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.343 -0.614 . . . . 73.22 109.343 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.496 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -111.26 133.64 53.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.084 0.468 . . . . 72.12 110.104 176.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.01 117.62 9.79 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.623 -0.717 . . . . 63.5 109.622 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.681 HG12 HG12 ' A' ' 156' ' ' VAL . 1.2 m -90.88 147.24 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.085 0.469 . . . . 54.34 111.226 -174.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.2 123.58 41.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.542 -0.754 . . . . 43.22 109.207 172.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 80.1 m-85 -85.59 135.11 33.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.024 0.44 . . . . 75.4 110.577 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.1 tp -133.49 118.69 18.63 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.807 -0.633 . . . . 64.12 110.308 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.42 -168.88 29.28 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.131 -0.788 . . . . 64.0 111.131 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -81.48 118.96 23.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.83 0.315 . . . . 73.33 111.006 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -77.16 141.77 39.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.251 -0.431 . . . . 74.33 110.366 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 85' ' ' VAL . 5.1 tt -68.11 -32.47 56.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.282 -0.417 . . . . 73.02 111.18 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.64 175.03 11.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.527 -0.306 . . . . 75.23 110.181 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.59 -33.61 35.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.886 -0.597 . . . . 74.42 110.513 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.58 -14.93 59.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.55 -0.833 . . . . 74.04 111.77 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -114.21 57.71 0.7 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.28 0.562 . . . . 53.13 109.574 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.428 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.4 p -77.15 8.5 3.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.382 -0.826 . . . . 70.3 112.474 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.416 ' OD1' HG23 ' A' ' 85' ' ' VAL . 23.4 p30 -108.55 -8.82 15.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.979 0.418 . . . . 75.41 110.802 177.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.489 ' HB ' HG22 ' A' ' 78' ' ' ILE . 48.5 t -98.76 122.56 50.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.459 . . . . 41.12 110.983 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.472 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -70.39 134.46 47.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 74.42 109.84 177.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.44 152.07 32.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.165 -0.471 . . . . 70.03 110.571 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.466 HD22 ' H ' ' A' ' 88' ' ' LEU . 1.9 mm? -78.02 138.45 38.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.232 -0.44 . . . . 70.33 110.391 -177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 70.31 110.211 177.862 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.919 -0.4 . . . . 71.41 109.919 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.432 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -71.68 153.01 42.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.69 -0.485 . . . . 64.41 109.69 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.44 161.22 38.97 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.612 -0.435 . . . . 72.43 111.025 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 66.45 13.33 9.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.916 -0.584 . . . . 74.04 110.748 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.49 179.76 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.773 -0.649 . . . . 73.11 110.177 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -179.83 -173.43 44.85 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.209 -1.157 . . . . 64.51 110.209 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.9 p -121.9 120.03 60.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.281 0.562 . . . . 73.43 110.935 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.456 ' HG2' ' HB2' ' A' ' 138' ' ' PHE . 1.5 pt20 -108.69 150.19 27.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.819 -0.628 . . . . 72.31 109.823 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.446 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.3 mp -111.45 128.1 68.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.181 0.515 . . . . 64.34 110.502 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 13.4 mt -92.93 143.22 26.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.383 -0.826 . . . . 64.34 109.431 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.545 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.0 OUTLIER -70.46 -176.72 1.3 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.287 -0.634 . . . . 53.22 109.287 174.31 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -64.45 -20.63 66.3 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.197 -0.314 . . . . 73.41 111.708 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.414 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 40.0 p -98.46 6.5 47.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 72.3 111.457 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.76 28.7 28.46 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.972 -0.632 . . . . 73.1 113.464 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.18 128.02 53.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.894 0.347 . . . . 65.33 110.553 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.09 119.05 11.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.859 0.361 . . . . 54.42 110.704 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.6 mt -85.86 129.72 34.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.037 0.446 . . . . 72.43 111.199 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.457 ' H ' HG21 ' A' ' 117' ' ' THR . 78.7 m -73.18 140.65 47.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.623 -0.717 . . . . 74.04 110.557 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 45.4 mt -80.07 40.29 0.47 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.542 . . . . 61.01 111.301 -176.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -81.14 -23.23 38.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.162 0.506 . . . . 73.24 110.278 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.04 -13.54 66.7 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.789 -0.642 . . . . 33.14 111.973 -173.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.9 1.84 11.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.787 0.327 . . . . 74.42 111.728 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.457 HG21 ' H ' ' A' ' 112' ' ' THR . 4.3 m -86.91 88.06 7.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.086 0.47 . . . . 41.22 110.088 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -83.18 152.63 25.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.864 -0.607 . . . . 73.0 111.199 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.9 m -67.82 -179.1 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.742 -0.663 . . . . 64.35 111.431 175.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.6 p -68.65 152.9 44.73 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.316 -0.402 . . . . 30.21 110.377 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.34 107.13 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 75.4 111.543 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 m -94.1 103.5 15.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.356 -0.609 . . . . 62.41 109.356 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.8 m -57.16 122.38 12.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.723 -0.671 . . . . 73.35 111.21 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 69' ' ' ALA . 61.9 mt -78.38 142.32 37.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.128 -0.487 . . . . 70.04 111.077 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -115.84 148.68 39.66 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.057 -0.72 . . . . 65.54 109.057 170.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -65.37 111.78 3.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.816 0.341 . . . . 75.22 110.256 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 134.56 -126.82 4.26 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.576 -0.61 . . . . 62.52 111.576 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.2 m -108.77 132.44 53.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.848 0.356 . . . . 74.22 110.879 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -127.46 131.46 50.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.35 -0.386 . . . . 61.35 110.592 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.99 115.71 25.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.817 0.341 . . . . 72.1 111.146 176.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mt -93.26 110.71 48.19 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.128 -0.693 . . . . 73.01 109.128 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.31 130.83 7.32 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.467 2.111 . . . . 74.41 112.673 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 73.0 m-85 -129.39 166.36 19.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.067 0.461 . . . . 75.41 111.267 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.627 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 47.6 mt-30 -130.0 124.45 32.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.654 -0.703 . . . . 73.11 110.766 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.64 126.29 54.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.102 -0.332 . . . . 42.53 110.102 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.545 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 6.9 ptp180 -136.72 161.4 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.901 0.381 . . . . 71.13 111.32 -176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 60.5 m-85 -82.04 146.09 29.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 75.4 111.074 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.456 ' HB2' ' HG2' ' A' ' 102' ' ' GLN . 61.1 t80 -132.08 126.71 34.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.49 -0.777 . . . . 74.03 109.178 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.648 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -92.73 135.98 33.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.81 0.338 . . . . 54.41 111.443 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 51.0 p -103.88 0.36 30.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.486 0.66 . . . . 64.32 109.552 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.05 -122.56 0.91 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.124 -0.943 . . . . 74.11 111.302 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.63 94.5 9.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.945 -0.391 . . . . 72.42 109.945 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.623 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -47.58 118.99 2.48 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.507 0.504 . . . . 73.34 111.197 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.2 p -112.79 143.89 29.93 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.171 -0.468 . . . . 64.22 110.708 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.12 174.19 8.33 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.714 2.943 . . . . 53.01 113.278 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.73 -168.35 19.76 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.715 -0.755 . . . . 71.5 111.709 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.38 109.44 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 63.45 110.889 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.402 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . . . -108.37 52.77 0.7 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.656 0.741 . . . . 62.42 109.766 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -108.65 138.24 45.28 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.968 -1.014 . . . . 73.01 109.669 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -144.12 169.38 17.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.42 -0.355 . . . . 62.41 110.101 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.99 144.86 30.37 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.947 -0.39 . . . . 52.31 109.947 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.416 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -152.32 146.12 25.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.081 -0.509 . . . . 70.41 110.705 -177.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 36.0 p -97.5 128.46 44.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.197 -0.456 . . . . 72.23 109.973 176.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -96.42 127.93 42.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.327 0.584 . . . . 73.32 110.042 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.645 ' HA ' HG21 ' A' ' 16' ' ' VAL . 1.8 tmtm? -111.4 100.26 8.89 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.714 -0.676 . . . . 63.21 109.832 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.681 HG12 HG12 ' A' ' 71' ' ' VAL . 1.5 m -77.45 144.3 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.145 0.498 . . . . 70.24 110.471 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 54.6 tt0 -115.02 120.5 40.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.0 -0.546 . . . . 74.42 110.637 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.579 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 9.8 p90 . . . . . 0 C--N 1.326 -0.436 0 O-C-N 123.734 0.646 . . . . 73.51 109.494 170.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.907 0.384 . . . . 74.42 110.427 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.405 ' HB ' ' CB ' ' A' ' 148' ' ' ALA . 35.0 m -87.95 15.05 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.129 0.49 . . . . 72.33 110.399 175.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 62.41 23.51 13.95 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.314 -0.857 . . . . 74.33 112.358 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.486 ' N ' ' HG2' ' A' ' 36' ' ' GLN . . . 77.69 88.13 0.38 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.389 -0.91 . . . . 75.32 111.625 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.17 156.27 46.92 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.566 -0.826 . . . . 71.05 111.998 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.578 ' HB ' HG22 ' A' ' 31' ' ' THR . 5.2 p -142.7 137.18 29.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.559 0.219 . . . . 70.22 110.845 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -111.69 121.36 64.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.602 -0.518 . . . . 52.23 109.602 175.306 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -88.11 98.42 11.53 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.041 0.448 . . . . 51.52 109.818 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.463 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 61.8 m-85 -88.44 118.35 28.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.927 -0.579 . . . . 72.12 110.044 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 78.3 tttt -112.65 145.28 40.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.384 -0.371 . . . . 63.13 110.486 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -122.66 -116.25 2.32 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.898 -0.667 . . . . 74.15 112.523 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.546 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 93.0 mt-10 64.05 17.7 10.77 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.841 0.457 . . . . 71.3 111.347 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 155' ' ' LYS . 31.0 m -76.85 -28.51 17.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.088 -0.505 . . . . 71.21 111.712 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.515 HG21 ' CG2' ' A' ' 156' ' ' VAL . 17.1 m -137.38 141.41 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.098 0.475 . . . . 63.12 111.973 -176.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -140.39 21.2 2.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.019 -0.992 . . . . 64.33 108.559 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.18 -76.55 0.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.368 -0.833 . . . . 50.21 111.495 -172.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.531 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -88.84 -33.28 17.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.856 0.36 . . . . 73.1 110.751 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -146.09 128.42 15.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.131 -0.486 . . . . 52.41 109.819 -177.14 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.29 128.56 36.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.321 -0.399 . . . . 73.43 110.29 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 3.6 t -72.5 128.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.019 -0.363 . . . . 74.52 110.019 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.444 ' O ' HG13 ' A' ' 28' ' ' VAL . 16.0 t70 -58.71 142.55 49.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 64.03 111.09 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -59.69 -27.09 66.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.989 -0.551 . . . . 73.13 112.073 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.08 -19.11 73.17 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.59 -0.814 . . . . 41.42 112.066 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.9 p -102.94 -16.04 15.97 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.15 -0.22 . . . . 54.14 111.458 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 25' ' ' ALA . 27.4 m -81.51 -2.85 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.954 0.407 . . . . 74.3 110.313 175.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -158.34 87.67 0.91 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.402 -0.962 . . . . 71.14 108.402 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.463 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 16.0 pt20 -134.9 98.09 3.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.517 0.675 . . . . 63.25 110.804 -176.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.578 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.5 m -82.07 94.53 7.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.151 -0.931 . . . . 70.15 109.279 174.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.7 p -81.72 130.86 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.9 -0.591 . . . . 64.15 111.187 -174.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.432 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.7 mp0 -85.9 127.31 34.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.895 -0.593 . . . . 72.42 110.15 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.91 -30.44 17.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.303 0.573 . . . . 65.43 109.737 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.437 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 100.23 167.85 29.09 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.485 -0.779 . . . . 65.43 111.706 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.486 ' HG2' ' N ' ' A' ' 7' ' ' GLY . 60.4 mt-30 -79.27 86.77 5.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.071 0.462 . . . . 73.34 110.841 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.34 145.96 12.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 71.4 109.875 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -83.39 126.78 33.09 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.362 -0.607 . . . . 74.33 109.362 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.629 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 24.4 p -68.55 -25.02 64.7 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.048 -0.523 . . . . 73.34 111.315 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.49 -10.47 58.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.075 -0.511 . . . . 55.35 111.409 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.8 m -86.94 -7.75 57.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.041 0.448 . . . . 75.13 110.607 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.621 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 4.7 mp -132.73 90.17 2.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 75.41 110.266 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.44 12.32 11.59 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.311 0.486 . . . . 75.34 112.311 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -144.73 141.55 29.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.767 -0.197 . . . . 75.13 110.695 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.451 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 42.9 tt0 -59.5 122.28 13.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.007 0.432 . . . . 64.11 110.141 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.79 -7.06 33.37 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.786 -0.721 . . . . 73.03 111.888 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -68.23 120.88 15.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.92 0.39 . . . . 44.15 110.302 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 p -112.01 125.43 54.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.953 -0.567 . . . . 72.02 110.454 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.409 ' HB2' HD21 ' A' ' 42' ' ' LEU . 8.0 t -84.88 174.91 9.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.486 -0.561 . . . . 70.41 109.486 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.3 m -62.2 136.4 57.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.776 -0.453 . . . . 63.21 109.776 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' A' ' 136' ' ' ARG . . . -95.91 157.25 15.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.309 0.576 . . . . 72.1 111.018 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.1 m -99.18 148.91 5.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.131 -0.94 . . . . 63.41 109.228 172.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.62 86.81 0.54 Allowed Glycine 0 C--N 1.309 -0.947 0 C-N-CA 120.771 -0.728 . . . . 72.4 112.045 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -88.95 170.21 10.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.382 -0.599 . . . . 65.14 109.382 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.546 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.3 p-10 -138.78 150.85 46.54 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.412 0.625 . . . . 51.23 111.904 -175.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.425 HD12 HG11 ' A' ' 71' ' ' VAL . 61.4 mt -109.29 110.28 31.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.176 -0.92 . . . . 62.2 108.599 171.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -96.71 122.45 39.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.989 -0.55 . . . . 72.4 110.787 -173.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.5 mt -106.54 119.36 39.09 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.3 -0.409 . . . . 63.21 110.049 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -96.35 133.28 40.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.097 -0.501 . . . . 74.22 110.044 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 54.35 79.31 0.14 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.776 0.798 . . . . 72.15 110.469 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 42.9 t -112.2 138.51 48.79 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.996 -1.002 . . . . 74.21 109.485 -177.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -116.37 141.55 48.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.845 0.355 . . . . 63.01 111.75 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.5 p -105.42 4.25 30.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.137 -0.483 . . . . 74.32 112.157 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -76.14 -41.86 48.61 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.453 -0.573 . . . . 73.41 109.453 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 p -93.33 -35.2 6.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.747 -0.661 . . . . 60.01 111.021 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -108.19 -174.93 2.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.615 0.245 . . . . 64.44 110.904 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 34.3 m -148.32 -57.46 0.23 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.834 0.349 . . . . 64.42 110.779 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -138.05 141.65 40.33 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.686 -0.487 . . . . 71.14 109.686 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -100.09 130.89 46.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.946 0.403 . . . . 44.11 110.563 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.02 115.21 11.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.875 -0.602 . . . . 53.21 109.587 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.617 HG12 HG12 ' A' ' 156' ' ' VAL . 1.9 m -92.76 147.18 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.986 0.422 . . . . 64.13 111.136 -173.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.491 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -122.63 131.08 53.65 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.969 -0.559 . . . . 62.21 109.516 173.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.557 ' CE1' HG21 ' A' ' 103' ' ' ILE . 49.5 m-85 -95.46 138.56 32.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.94 0.4 . . . . 72.14 111.047 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.6 tp -133.85 134.94 43.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.838 -0.619 . . . . 71.23 110.021 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.83 -160.8 24.96 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.191 -0.763 . . . . 44.31 111.191 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.0 m -88.4 118.42 28.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.929 0.364 . . . . 75.54 110.209 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.45 147.03 31.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.337 -0.392 . . . . 61.23 110.155 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.589 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 7.6 tt -64.41 -26.19 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 63.4 111.139 -177.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -154.56 -179.8 8.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.4 -0.593 . . . . 74.34 109.4 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.44 -32.63 28.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.923 0.392 . . . . 74.52 110.112 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.67 -34.68 24.45 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.699 -0.762 . . . . 61.23 111.561 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -96.64 73.8 2.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.13 0.49 . . . . 70.01 109.972 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.452 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.4 p -95.32 15.4 19.5 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.762 -0.654 . . . . 63.35 111.512 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -112.38 -4.32 14.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.144 0.497 . . . . 73.34 110.921 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 102' ' ' GLN . 48.8 t -115.24 126.34 72.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.995 -0.548 . . . . 71.54 110.198 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.585 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -68.68 131.16 44.74 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.525 -0.546 . . . . 54.41 109.525 178.171 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.54 143.09 36.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.06 -0.518 . . . . 62.33 110.517 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.67 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.6 mm? -75.98 135.78 40.01 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.965 -0.754 . . . . 73.21 108.965 177.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 . . . . . 0 C--N 1.325 -0.471 0 CA-C-O 121.208 0.528 . . . . 74.34 111.06 -175.796 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 109.824 -0.436 . . . . 74.25 109.824 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.01 133.86 48.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.686 -0.487 . . . . 73.21 109.686 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.95 163.87 22.72 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.545 -0.462 . . . . 52.13 110.989 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 66.24 13.7 9.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.604 -0.726 . . . . 65.21 110.496 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.15 -178.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.549 -0.75 . . . . 70.02 109.902 175.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 176.21 -172.24 45.23 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 110.06 -1.216 . . . . 72.4 110.06 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 10' ' ' VAL . 2.3 p -118.8 111.43 33.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.549 0.69 . . . . 74.12 110.898 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.41 ' HB3' HG22 ' A' ' 85' ' ' VAL . 2.4 pt20 -96.11 141.13 29.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.511 -0.768 . . . . 70.02 109.502 177.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.557 HG21 ' CE1' ' A' ' 73' ' ' PHE . 3.8 mp -98.71 127.79 50.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.037 0.446 . . . . 71.13 110.13 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 44.4 mt -99.35 138.94 35.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.504 -0.771 . . . . 61.51 110.63 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.592 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 3.8 t70 -60.67 165.95 3.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.642 -0.708 . . . . 74.31 110.188 170.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.44 ' HE ' ' HB3' ' A' ' 120' ' ' SER . 26.5 ptt180 -54.84 -24.67 24.09 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.474 0.546 . . . . 73.1 112.474 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.2 p -87.13 -20.52 26.93 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.758 0.313 . . . . 72.24 111.719 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.38 44.36 1.26 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.663 -0.779 . . . . 71.21 112.661 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.72 130.16 45.11 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.065 -0.346 . . . . 74.43 110.065 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.72 140.3 57.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 73.32 111.183 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.49 155.21 17.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.94 -0.573 . . . . 72.24 110.555 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -94.46 141.15 28.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.363 -0.38 . . . . 72.34 110.176 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 60.5 mt -84.94 51.04 2.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.012 0.434 . . . . 73.13 110.988 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -108.94 -4.54 16.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.43 . . . . 75.55 110.261 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.82 0.11 39.74 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.017 -0.611 . . . . 35.14 112.739 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -116.73 -17.48 10.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.371 . . . . 63.32 111.105 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.3 m -86.06 94.96 9.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.023 0.44 . . . . 64.24 109.836 174.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.689 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 69.3 m-85 -85.59 162.26 18.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.05 -0.523 . . . . 70.43 110.189 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.592 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . 6.9 m -77.95 -172.16 2.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.882 -0.599 . . . . 64.12 110.943 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.44 ' HB3' ' HE ' ' A' ' 106' ' ' ARG . 35.6 t -68.84 148.77 49.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.869 -0.605 . . . . 72.13 110.165 178.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -63.81 98.29 0.19 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.793 0.33 . . . . 71.14 111.293 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.2 m -78.7 102.28 7.97 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.43 -0.581 . . . . 65.14 109.43 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.0 m -57.23 112.17 1.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.44 -0.8 . . . . 64.13 110.997 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 69' ' ' ALA . 96.0 mt -75.19 143.79 43.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.766 -0.652 . . . . 73.31 111.402 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -125.11 145.24 50.03 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.192 -0.67 . . . . 72.11 109.192 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -53.9 113.02 1.06 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.872 0.368 . . . . 64.32 111.508 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 129.81 -143.09 14.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.15 -0.548 . . . . 62.25 112.462 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.6 m -82.73 122.1 27.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.763 0.316 . . . . 75.11 110.794 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.431 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 21.9 m-80 -114.86 113.08 23.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.976 0.417 . . . . 74.22 110.337 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.546 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.1 m -102.27 106.37 17.17 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.78 -0.645 . . . . 54.43 110.327 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 6.6 mt -91.66 113.4 58.6 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.847 -0.427 . . . . 64.14 109.847 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 24.7 Cg_endo -88.72 133.07 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.873 2.382 . . . . 74.34 112.706 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -133.1 169.81 16.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.826 -0.624 . . . . 73.3 109.733 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.651 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 97.1 mt-30 -126.1 140.42 52.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.018 0.437 . . . . 51.04 111.122 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.05 125.6 41.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.077 -0.51 . . . . 74.45 109.779 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.519 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 36.7 ptt180 -144.36 166.18 25.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.097 0.475 . . . . 73.22 111.513 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.602 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 82.4 m-85 -81.56 131.91 35.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.323 -0.853 . . . . 73.22 110.456 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -118.13 116.19 26.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.457 -0.792 . . . . 72.13 109.366 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -80.78 130.92 35.33 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.18 -0.463 . . . . 73.41 110.996 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.451 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 41.7 p -102.05 9.27 40.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.055 -0.721 . . . . 74.05 109.055 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.41 -120.95 0.94 Allowed Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.933 -1.03 . . . . 75.05 111.018 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.89 95.4 7.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.752 -0.462 . . . . 74.34 109.752 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.629 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -47.3 114.63 0.91 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.716 0.635 . . . . 25.31 111.206 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 p -107.02 139.58 20.55 Favored Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-N 116.082 -0.508 . . . . 72.23 110.373 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.56 159.76 51.75 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 123.679 2.919 . . . . 63.33 113.086 -172.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.95 -167.48 28.28 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.667 -0.697 . . . . 45.22 111.404 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.76 112.06 5.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.922 0.392 . . . . 64.4 110.901 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.67 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -109.8 58.62 0.61 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.505 0.669 . . . . 33.14 110.361 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -116.42 133.42 56.04 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.446 -0.797 . . . . 72.14 110.045 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.585 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -142.16 175.72 9.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.404 -0.362 . . . . 62.25 110.84 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -148.91 150.78 33.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.697 -0.483 . . . . 72.31 109.697 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -154.06 151.26 29.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.86 0.362 . . . . 52.15 110.874 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.405 HG22 ' HB3' ' A' ' 13' ' ' LYS . 10.6 p -108.77 132.96 53.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.096 -0.502 . . . . 60.35 109.835 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.406 ' CD1' HD13 ' A' ' 56' ' ' ILE . 27.9 p90 -106.53 133.67 50.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.25 0.547 . . . . 63.22 111.082 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.689 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 20.7 ttmt -109.59 103.44 12.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.469 -0.787 . . . . 71.41 110.409 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.617 HG12 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -77.95 130.05 36.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.242 -0.651 . . . . 75.41 109.242 176.141 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -114.67 117.86 32.03 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.862 -0.422 . . . . 74.33 109.862 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.595 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 116.225 -0.443 . . . . 75.41 111.075 175.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 120.986 0.422 . . . . 73.43 110.533 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.0 m -83.9 6.99 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.314 0.578 . . . . 63.11 110.439 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 60.77 18.33 8.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.145 -0.934 . . . . 62.21 112.083 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.93 95.67 0.87 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.772 -0.727 . . . . 75.14 111.915 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.48 159.92 31.19 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.43 -0.89 . . . . 74.34 111.366 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.561 ' HB ' HG22 ' A' ' 31' ' ' THR . 60.8 p -139.03 143.55 38.47 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.724 0.262 . . . . 41.42 110.446 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -111.73 123.68 67.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.855 -0.424 . . . . 64.11 109.855 175.415 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -92.5 113.35 25.6 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.106 -0.497 . . . . 74.21 109.869 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.459 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 95.2 m-85 -104.71 125.96 51.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.167 -0.47 . . . . 64.34 110.389 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -117.67 143.74 45.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.978 -0.379 . . . . 71.32 109.978 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.41 -126.56 2.78 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.74 -0.743 . . . . 63.14 112.849 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.651 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 35.8 mt-10 62.21 27.91 16.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.286 0.565 . . . . 71.31 110.581 -174.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' A' ' 155' ' ' LYS . 31.0 m -74.24 -26.48 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.399 -0.818 . . . . 51.41 111.321 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.463 HG21 ' CG2' ' A' ' 156' ' ' VAL . 27.1 m -136.64 147.19 27.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 63.54 111.493 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -143.94 19.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.121 -0.945 . . . . 54.44 109.188 175.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.69 -83.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.538 -0.755 . . . . 70.32 111.489 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.559 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -80.96 -36.53 30.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.934 -0.307 . . . . 64.31 110.724 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 0.8 OUTLIER -143.01 132.98 24.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.735 0.302 . . . . 51.11 110.19 -176.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.32 126.7 39.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.376 -0.375 . . . . 63.51 110.324 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.455 ' HA ' HD23 ' A' ' 58' ' ' LEU . 8.2 t -65.77 131.97 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.235 -0.283 . . . . 74.43 110.235 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.54 ' O ' HG13 ' A' ' 28' ' ' VAL . 22.9 t70 -58.04 140.83 51.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 65.24 111.717 -176.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.55 -25.3 64.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.835 -0.621 . . . . 53.22 112.15 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.72 -24.84 55.03 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.401 -0.904 . . . . 55.11 112.388 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.2 p -98.11 -12.09 22.17 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.873 0.323 . . . . 41.42 111.873 -175.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.651 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 30.8 m -79.85 -4.62 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.672 0.272 . . . . 74.4 111.609 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -166.72 96.01 0.53 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.404 -0.962 . . . . 73.44 108.404 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -145.9 140.78 27.23 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.548 -0.751 . . . . 64.23 109.91 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.561 HG22 ' HB ' ' A' ' 9' ' ' THR . 25.0 m -117.05 103.9 10.71 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.71 -0.677 . . . . 53.15 109.992 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 p -88.26 133.67 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.039 0.447 . . . . 74.42 111.084 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.518 ' HA ' HG22 ' A' ' 9' ' ' THR . 25.3 mp0 -90.67 128.34 36.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 74.01 109.72 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.74 -31.32 21.02 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.156 0.503 . . . . 74.33 110.055 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.64 172.48 24.71 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.668 -0.696 . . . . 73.31 112.025 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -80.79 97.66 7.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.76 0.314 . . . . 72.12 110.358 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.11 143.1 12.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.024 -0.535 . . . . 73.33 110.212 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.436 ' CD ' ' H ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -82.9 127.7 33.75 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.555 -0.535 . . . . 73.31 109.555 177.04 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.4 p -74.49 -10.04 59.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.148 -0.478 . . . . 74.55 111.584 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.47 -21.25 58.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.254 -0.43 . . . . 74.04 111.379 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.5 m -81.14 -23.42 38.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 71.23 110.868 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.2 mp -114.34 99.04 7.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.107 -0.497 . . . . 75.44 109.923 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.83 11.49 6.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.364 0.505 . . . . 71.25 112.364 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -151.43 152.13 32.63 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.693 -0.403 . . . . 65.53 111.432 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.37 120.03 8.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.634 -0.712 . . . . 73.44 109.484 175.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.05 6.8 39.23 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.676 -0.773 . . . . 75.4 112.032 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.689 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -81.17 120.27 24.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.837 0.351 . . . . 73.43 110.257 176.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.542 HG22 ' HD1' ' A' ' 138' ' ' PHE . 59.9 p -112.44 128.09 56.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.161 -0.472 . . . . 51.13 110.415 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.9 t -84.73 -177.76 6.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.794 -0.447 . . . . 74.31 109.794 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -67.37 137.2 55.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.272 -0.422 . . . . 64.52 110.074 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -92.01 153.52 19.38 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.664 0.745 . . . . 64.01 111.882 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 27.8 m -93.32 153.74 3.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.363 -1.29 . . . . 63.13 109.536 170.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.22 100.54 1.66 Allowed Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.809 -0.71 . . . . 72.2 111.996 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -116.33 -179.4 3.66 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.416 -0.586 . . . . 71.25 109.416 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.547 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.0 p-10 -146.35 152.72 39.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.502 0.668 . . . . 25.35 111.965 -174.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 74.4 mt -113.84 111.86 37.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.911 -1.04 . . . . 70.12 108.303 167.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -97.75 140.93 31.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.985 0.421 . . . . 73.31 110.801 -172.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 23' ' ' VAL . 65.7 mt -117.66 124.66 49.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.841 -0.618 . . . . 74.43 109.491 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -102.6 135.85 43.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.79 -0.641 . . . . 73.4 109.386 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 27.3 t70 56.19 87.65 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.821 0.701 . . . . 63.22 110.486 -176.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' A' ' 124' ' ' LEU . 42.3 t -124.85 134.85 52.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.704 -0.68 . . . . 61.11 110.373 -174.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.09 138.03 47.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 73.21 111.867 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 p -105.35 10.9 33.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.798 -0.637 . . . . 71.14 112.31 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -88.32 -36.33 16.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.018 0.437 . . . . 64.41 110.027 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 p -102.01 -12.55 8.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.875 -0.602 . . . . 74.24 110.435 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -129.13 -174.11 3.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.866 -0.606 . . . . 73.15 110.423 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -150.59 -56.55 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.78 0.324 . . . . 74.23 111.175 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -137.58 141.3 41.32 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.503 -0.554 . . . . 75.14 109.503 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -99.43 130.34 45.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.091 0.472 . . . . 54.25 110.29 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.95 113.66 9.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.559 -0.746 . . . . 72.21 109.792 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.695 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 2.0 m -90.37 146.42 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.272 0.558 . . . . 65.02 110.864 -175.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.54 119.24 34.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.356 -0.838 . . . . 61.42 109.166 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 83.7 m-85 -79.55 137.46 37.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.855 -0.424 . . . . 61.23 109.855 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.9 tp -137.33 115.55 11.73 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.671 -0.492 . . . . 74.34 109.671 -175.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.6 -158.12 10.07 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.524 -0.762 . . . . 74.24 111.379 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.505 ' O ' HD13 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -81.09 116.69 21.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.73 0.265 . . . . 62.41 110.869 -178.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.564 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -79.69 139.31 37.42 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.936 -0.394 . . . . 71.13 109.936 175.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.558 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 6.6 tt -63.62 -36.12 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.904 0.383 . . . . 70.25 110.781 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -151.92 175.17 12.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.31 -0.626 . . . . 73.33 109.31 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.83 -24.58 28.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.997 0.427 . . . . 65.05 110.503 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.84 -21.54 49.93 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.756 -0.735 . . . . 61.53 111.356 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -118.61 62.46 0.78 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.457 0.646 . . . . 71.55 109.518 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.564 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 2.6 p -80.85 7.64 10.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.421 -0.809 . . . . 72.23 111.407 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -106.25 1.55 26.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.056 0.455 . . . . 73.41 110.947 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.544 HG22 ' HB3' ' A' ' 102' ' ' GLN . 61.9 t -117.34 129.4 73.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.015 -0.539 . . . . 70.32 110.164 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.596 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -69.98 133.61 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.715 0.293 . . . . 65.32 110.378 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.14 148.36 34.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.123 -0.49 . . . . 72.12 110.302 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.443 HD22 ' H ' ' A' ' 88' ' ' LEU . 1.7 mm? -81.61 149.82 28.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.246 -0.434 . . . . 73.05 110.499 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 . . . . . 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.594 . . . . 73.3 110.334 179.044 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.912 -0.403 . . . . 75.11 109.912 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.08 147.77 29.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.467 -0.333 . . . . 74.12 110.457 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.48 165.55 27.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.557 -0.292 . . . . 64.45 110.335 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.422 HD22 HG23 ' A' ' 144' ' ' THR . 26.0 m-20 70.11 7.62 6.3 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.327 0.584 . . . . 73.05 110.417 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.35 -177.42 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.272 -0.877 . . . . 70.32 109.644 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 177.22 -170.6 43.25 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.12 -1.192 . . . . 70.32 110.12 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -121.03 115.18 46.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.476 0.655 . . . . 62.32 110.49 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.544 ' HB3' HG22 ' A' ' 85' ' ' VAL . 8.8 pt20 -105.39 145.53 30.66 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.63 -0.713 . . . . 75.41 109.532 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.476 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.4 mp -104.96 123.15 58.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.148 0.499 . . . . 72.41 110.385 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 18.8 mt -91.21 139.51 30.68 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.376 -0.829 . . . . 72.5 109.246 177.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.8 OUTLIER -72.57 -169.12 0.51 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.282 -0.417 . . . . 54.32 110.282 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -56.72 -35.07 68.11 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.733 0.272 . . . . 74.12 111.733 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.7 p -87.43 -6.29 58.49 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.883 0.373 . . . . 53.15 111.768 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.89 30.03 10.93 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.606 -0.807 . . . . 73.4 112.804 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.38 134.74 50.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.177 -0.305 . . . . 74.02 110.177 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.37 117.96 10.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.966 0.412 . . . . 72.11 111.175 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.16 132.7 35.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.891 -0.595 . . . . 64.5 110.573 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.3 m -74.33 137.41 42.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.905 -0.589 . . . . 74.31 110.647 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.571 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 36.5 mt -82.43 47.89 1.22 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.067 -0.515 . . . . 70.45 110.971 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -104.93 -0.75 26.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.959 0.409 . . . . 65.11 110.332 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.12 10.57 59.6 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.871 -0.604 . . . . 75.24 112.672 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.32 -23.97 4.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 60.3 110.798 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -80.3 99.43 7.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.96 0.41 . . . . 74.11 110.264 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -89.03 157.88 18.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.02 -0.536 . . . . 62.51 110.635 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.537 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.3 m -64.96 171.15 3.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.019 -0.537 . . . . 62.55 111.08 177.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 42.9 m -65.37 156.76 31.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.459 -0.571 . . . . 73.33 109.459 171.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.495 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 45.7 mt-10 -55.6 121.15 8.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.101 0.477 . . . . 72.43 111.913 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.0 m -105.57 98.84 8.48 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.269 -1.011 . . . . 74.34 108.269 168.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.1 m -59.24 122.05 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.556 . . . . 74.11 110.915 -175.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.539 HD13 ' SG ' ' A' ' 61' ' ' CYS . 96.2 mt -82.96 153.23 25.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.464 -0.789 . . . . 72.25 111.662 -174.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -123.87 157.32 34.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.356 -0.838 . . . . 72.13 108.911 171.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 59.6 m-20 -68.37 99.64 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.913 0.387 . . . . 73.44 110.34 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.06 -136.41 7.95 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.895 -0.669 . . . . 72.31 112.029 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.3 m -84.96 127.58 34.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.022 0.439 . . . . 54.5 110.976 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 33.5 m-80 -128.61 124.94 37.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.968 -0.56 . . . . 54.0 109.9 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.547 HG22 ' HB2' ' A' ' 55' ' ' ASN . 2.5 m -115.65 114.78 25.34 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.974 -0.291 . . . . 75.11 110.702 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.6 mt -92.25 109.81 40.33 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.282 -0.417 . . . . 63.13 109.95 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.33 138.76 10.06 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.767 2.311 . . . . 72.44 112.806 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 62.3 m-85 -136.55 164.13 28.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 72.51 111.113 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 97.5 mt-30 -125.59 125.12 42.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.795 -0.639 . . . . 71.22 110.412 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.48 124.08 51.55 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.199 -0.297 . . . . 53.32 110.199 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 14.9 ptp180 -138.87 160.22 40.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.934 0.397 . . . . 63.21 110.983 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 66.8 m-85 -77.32 139.7 39.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.7 -0.682 . . . . 74.12 110.516 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.542 ' HD1' HG22 ' A' ' 48' ' ' THR . 80.5 t80 -127.59 122.26 32.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.696 -0.684 . . . . 74.15 109.501 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.689 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -93.26 137.13 32.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.074 0.464 . . . . 72.11 111.333 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 52.0 p -103.81 5.51 36.02 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.439 -0.801 . . . . 65.14 109.224 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.26 -131.6 2.33 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.901 -1.045 . . . . 54.34 110.697 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.39 94.89 4.96 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.4 -0.222 . . . . 34.13 110.4 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.23 120.9 3.88 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.546 0.529 . . . . 63.54 111.105 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.422 HG23 HD22 ' A' ' 98' ' ' ASN . 33.2 p -111.57 145.1 31.92 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 121.248 0.547 . . . . 73.02 111.2 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.17 163.16 37.16 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.867 3.044 . . . . 74.31 113.089 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.36 -174.76 21.09 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.993 -0.622 . . . . 54.34 111.937 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.73 108.04 0.78 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.971 0.415 . . . . 42.04 111.207 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.43 43.88 1.07 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 65.25 110.228 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -101.74 147.11 26.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.58 -0.736 . . . . 75.15 109.805 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.523 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -153.79 170.61 20.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.46 -0.337 . . . . 72.01 111.07 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.42 146.02 36.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.435 -0.348 . . . . 64.2 110.219 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.596 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -151.28 149.63 29.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.303 -0.408 . . . . 74.24 110.993 -177.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.7 p -107.21 128.45 54.43 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.019 -0.537 . . . . 73.4 109.621 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -100.01 132.5 45.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.208 0.528 . . . . 75.43 110.831 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.648 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.8 tmtm? -117.19 105.17 11.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.783 -0.644 . . . . 71.4 110.248 -178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.695 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.2 m -74.87 156.52 6.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.173 0.511 . . . . 74.21 110.614 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -140.7 118.48 11.72 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.424 -0.807 . . . . 72.3 108.958 175.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.563 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.535 0 N-CA-C 112.038 0.384 . . . . 65.51 112.038 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.1 p . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 120.973 0.415 . . . . 72.21 110.025 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.554 HG22 HG12 ' A' ' 37' ' ' VAL . 34.2 m -94.26 20.25 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.22 0.533 . . . . 54.15 110.468 175.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 59.75 25.59 14.61 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.934 -1.03 . . . . 75.1 112.542 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.537 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 76.78 89.95 0.27 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.537 -0.839 . . . . 51.01 112.078 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.86 159.95 46.28 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.354 -0.927 . . . . 34.13 112.157 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.582 ' HB ' HG22 ' A' ' 31' ' ' THR . 74.3 p -140.44 145.67 37.28 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.856 -0.424 . . . . 71.12 109.856 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.65 125.25 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 109.803 -0.443 . . . . 74.13 109.803 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -90.04 111.95 23.22 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.73 -0.668 . . . . 54.31 109.6 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -98.86 124.63 43.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.164 -0.471 . . . . 73.12 109.776 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.511 ' HB3' HG22 ' A' ' 153' ' ' THR . 58.6 tttm -118.42 132.88 56.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.444 -0.344 . . . . 74.42 110.644 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.05 -115.11 2.48 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.921 -0.657 . . . . 74.4 112.846 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.467 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 31.6 mt-10 65.18 21.29 12.11 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.939 0.496 . . . . 70.51 111.176 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 155' ' ' LYS . 13.8 m -79.61 -33.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 113.307 0.855 . . . . 61.33 113.307 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.456 HG22 HG23 ' A' ' 16' ' ' VAL . 21.1 m -140.38 150.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.264 0.554 . . . . 72.0 112.436 -171.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -149.57 34.21 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.627 -1.249 . . . . 74.13 107.627 169.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.45 -74.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.048 -0.978 . . . . 65.41 110.88 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.417 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -94.79 -31.59 13.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.841 0.353 . . . . 63.11 110.629 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -142.36 136.24 29.43 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.923 -0.58 . . . . 61.5 109.976 -176.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.51 130.56 45.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.642 -0.254 . . . . 72.25 110.47 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.61 126.39 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.691 0.282 . . . . 73.41 110.245 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.12 143.99 36.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.935 -0.575 . . . . 73.11 111.516 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.67 -27.64 66.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.784 -0.643 . . . . 74.3 111.99 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 -5.16 87.91 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.51 -0.852 . . . . 63.21 112.216 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.2 p -123.59 12.61 9.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.717 0.265 . . . . 70.42 111.717 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.467 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 26.6 m -98.53 -12.78 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.967 0.413 . . . . 75.51 110.417 174.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -157.9 93.14 1.24 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.43 -0.952 . . . . 75.32 108.43 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pm0 -135.96 142.49 44.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.05 0.452 . . . . 72.11 110.19 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.582 HG22 ' HB ' ' A' ' 9' ' ' THR . 3.6 m -120.29 106.7 12.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.774 -0.648 . . . . 65.53 110.108 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 p -87.0 147.43 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 64.22 111.138 -175.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -99.6 117.46 34.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 73.31 110.466 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.402 ' HB3' ' HE2' ' A' ' 137' ' ' TYR . 2.7 mm? -85.99 -29.25 23.65 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.196 0.522 . . . . 63.15 110.083 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.537 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 92.47 171.28 41.01 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.559 -0.746 . . . . 70.14 111.88 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -78.9 91.42 4.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.713 0.292 . . . . 73.05 110.461 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.554 HG12 HG22 ' A' ' 5' ' ' VAL . 9.8 p -72.46 146.78 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.382 -0.599 . . . . 71.23 109.382 175.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -89.07 139.85 30.04 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.944 0.402 . . . . 75.42 110.803 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.9 p -73.13 -7.24 50.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.858 -0.61 . . . . 70.11 111.371 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.67 -26.99 27.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.019 -0.537 . . . . 52.15 110.606 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.531 ' HB2' HD12 ' A' ' 42' ' ' LEU . 9.1 m -74.24 -21.7 59.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 60.15 110.712 -177.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -127.43 107.71 10.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.624 -0.716 . . . . 52.12 109.828 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.78 10.9 3.4 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.708 -0.397 . . . . 65.41 111.781 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -146.66 143.69 28.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.773 0.321 . . . . 72.42 111.351 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.0 tm-20 -57.93 119.51 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.683 -0.69 . . . . 75.34 109.932 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.48 -6.09 29.93 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.793 -0.718 . . . . 54.04 111.999 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -72.69 131.33 42.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.677 0.275 . . . . 50.44 110.344 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.536 HG22 ' HD1' ' A' ' 138' ' ' PHE . 40.1 p -121.04 145.82 47.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.221 -0.445 . . . . 74.22 110.205 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.6 t -99.3 176.58 5.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.12 -0.696 . . . . 74.43 109.12 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.5 m -71.86 140.34 49.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.956 0.408 . . . . 74.4 110.083 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -92.4 159.36 15.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.573 0.702 . . . . 51.43 111.926 -176.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.3 m -98.33 151.84 4.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.463 -1.244 . . . . 70.25 109.16 170.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.7 73.32 0.27 Allowed Glycine 0 C--N 1.313 -0.733 0 C-N-CA 120.761 -0.733 . . . . 61.25 112.353 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -82.22 153.34 25.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.75 -0.463 . . . . 64.14 109.75 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.603 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.1 p-10 -122.78 145.02 48.79 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.185 0.516 . . . . 64.1 111.808 -174.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.437 HD12 ' CE2' ' A' ' 133' ' ' PHE . 67.3 mt -110.85 118.37 57.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.861 -0.792 . . . . 74.21 108.861 171.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -100.77 130.53 46.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 71.41 110.881 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 128' ' ' THR . 40.9 mt -112.35 118.18 34.5 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.823 -0.436 . . . . 72.21 109.823 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -94.54 140.86 29.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.309 -0.405 . . . . 41.31 110.117 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.4 t70 49.0 76.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.136 0.898 . . . . 73.04 110.721 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 41.7 t -109.68 143.73 39.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.05 -0.977 . . . . 70.02 109.564 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -120.79 153.04 37.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.255 0.465 . . . . 64.13 112.255 -171.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.2 p -115.16 -2.59 12.7 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.934 -0.575 . . . . 63.2 111.835 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -72.15 -38.36 69.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.677 -0.49 . . . . 73.02 109.677 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.86 -32.4 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.864 -0.607 . . . . 65.23 111.383 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -110.06 171.98 7.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.764 0.316 . . . . 75.24 111.474 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.434 ' CB ' ' HD2' ' A' ' 68' ' ' LYS . 20.1 m -133.73 -58.43 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.349 -0.387 . . . . 34.24 111.439 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -139.21 136.4 34.96 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.087 -0.338 . . . . 54.23 110.087 -177.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.466 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -99.4 130.07 45.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.278 0.561 . . . . 71.04 110.676 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.66 125.56 19.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.333 -0.848 . . . . 72.04 109.217 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.782 HG12 HG12 ' A' ' 156' ' ' VAL . 2.1 m -95.39 145.13 8.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.927 0.394 . . . . 74.41 110.993 -175.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.82 126.37 54.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.799 -0.637 . . . . 62.25 109.453 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 61.7 m-85 -93.02 137.19 32.6 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.122 0.487 . . . . 73.34 111.16 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.6 tp -134.73 134.1 40.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.7 -0.682 . . . . 61.33 109.709 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.39 -140.31 3.02 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.45 -0.66 . . . . 62.34 111.45 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.504 ' O ' HD13 ' A' ' 86' ' ' LEU . 39.2 m -103.26 118.59 37.12 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.092 -0.336 . . . . 72.13 110.092 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.41 138.26 36.61 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.176 -0.305 . . . . 73.13 110.176 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.599 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 10.4 tt -65.69 -27.82 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 75.22 110.694 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -158.83 176.8 11.88 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.323 -0.621 . . . . 44.55 109.323 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.1 -39.5 23.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.965 0.412 . . . . 70.12 110.244 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.02 -17.53 78.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.833 -0.699 . . . . 51.32 111.456 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.404 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 66.2 m80 -119.77 54.34 1.02 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.552 0.691 . . . . 64.21 109.685 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.568 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -78.78 14.62 1.28 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.13 -0.941 . . . . 72.33 111.86 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -112.57 2.38 16.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.201 0.524 . . . . 53.22 110.415 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.558 HG22 ' HB3' ' A' ' 102' ' ' GLN . 61.1 t -116.61 125.95 73.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 75.23 110.027 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.546 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -70.2 132.16 45.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.805 0.336 . . . . 75.21 110.307 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -80.02 152.86 29.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.833 -0.622 . . . . 64.41 110.149 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.662 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.6 mm? -85.61 144.86 27.63 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.378 -0.374 . . . . 71.24 110.635 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 115.904 -0.589 . . . . 64.14 110.926 -178.444 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 120.876 0.37 . . . . 73.22 110.968 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.448 ' O ' HD23 ' A' ' 88' ' ' LEU . . . -69.06 148.76 49.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.082 -0.508 . . . . 62.11 109.672 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.56 160.18 40.57 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.761 -0.375 . . . . 73.52 110.478 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 65.95 8.8 5.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 73.45 110.232 -174.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.29 154.46 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 115.356 -0.838 . . . . 62.11 109.8 175.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -159.2 -169.15 22.19 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 110.597 -1.001 . . . . 55.33 110.597 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.41 109.25 27.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.53 0.681 . . . . 52.52 110.376 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.558 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.3 pt20 -96.88 150.42 20.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.757 -0.656 . . . . 73.4 109.676 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.54 122.18 67.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.151 0.501 . . . . 64.22 110.869 -175.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 14.4 mt -92.84 146.71 23.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 64.31 109.811 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.4 p-10 -78.43 -169.19 1.58 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.104 -0.498 . . . . 71.51 109.811 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -61.22 -30.05 70.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.928 0.344 . . . . 70.14 111.928 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.1 p -84.47 -10.95 57.03 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.692 -0.403 . . . . 70.33 111.218 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.53 23.89 17.56 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.659 -0.781 . . . . 74.03 112.58 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.61 134.05 51.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.327 -0.249 . . . . 74.15 110.327 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.14 132.3 50.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.074 0.464 . . . . 73.24 111.078 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.5 mt -94.38 141.08 28.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.754 -0.657 . . . . 53.01 110.323 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.1 m -78.99 139.56 38.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.353 -0.385 . . . . 73.13 110.436 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.546 HD13 HD22 ' A' ' 86' ' ' LEU . 36.5 mt -86.05 47.77 1.51 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.3 -0.409 . . . . 73.42 110.918 -176.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -104.45 -3.89 23.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.359 -0.382 . . . . 74.5 110.654 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.5 -0.76 63.52 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.149 -0.548 . . . . 54.2 113.345 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.04 -15.79 9.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.03 0.415 . . . . 62.4 111.103 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -84.94 104.17 14.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.252 -0.431 . . . . 71.14 110.545 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.444 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 96.0 m-85 -94.33 162.02 14.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.159 -0.473 . . . . 73.41 110.468 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.6 m -67.34 179.86 1.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.995 -0.548 . . . . 72.4 111.088 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.0 m -71.91 167.95 18.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.749 -0.463 . . . . 71.23 109.749 172.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.525 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 39.7 mt-10 -68.98 109.03 3.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.984 0.421 . . . . 75.14 111.785 -173.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.0 m -90.92 96.93 10.88 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.798 -0.816 . . . . 62.51 108.798 168.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.0 m -60.55 126.92 29.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.173 0.511 . . . . 72.52 110.484 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.521 HD13 ' SG ' ' A' ' 61' ' ' CYS . 96.5 mt -85.96 153.73 21.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.585 -0.734 . . . . 61.14 112.387 -170.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -128.85 150.53 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.956 -1.02 . . . . 70.05 108.43 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.6 m120 -64.61 107.77 1.5 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.17 0.51 . . . . 63.23 111.016 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.49 -151.21 21.81 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.514 -0.766 . . . . 74.45 111.497 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 50.7 m -89.48 116.92 28.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.267 0.556 . . . . 64.55 111.097 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.445 HD22 ' HB3' ' A' ' 61' ' ' CYS . 36.6 m-80 -110.06 126.64 54.22 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.744 -0.662 . . . . 64.11 109.974 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.603 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.3 m -106.93 114.95 29.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.247 -0.433 . . . . 44.45 110.148 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.1 mt -91.21 118.74 68.69 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.709 -0.478 . . . . 62.34 109.709 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -84.54 129.57 4.29 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.787 2.325 . . . . 73.41 112.656 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.437 ' CE2' HD12 ' A' ' 56' ' ' ILE . 62.6 m-85 -129.45 168.82 15.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.139 -0.482 . . . . 74.51 110.333 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 95.6 mt-30 -135.85 120.29 18.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.926 0.394 . . . . 71.41 111.621 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.23 125.97 51.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.373 -0.376 . . . . 72.41 110.039 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.528 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 6.2 ptp180 -140.35 165.03 28.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 71.41 110.921 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 67.3 m-85 -83.89 145.05 28.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.111 -0.495 . . . . 75.43 110.974 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.536 ' HD1' HG22 ' A' ' 48' ' ' THR . 78.9 t80 -133.58 128.86 36.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.67 -0.695 . . . . 72.11 109.212 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -94.95 133.92 38.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.269 -0.423 . . . . 75.04 111.496 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.549 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 82.0 p -104.57 6.02 34.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.664 0.745 . . . . 75.44 109.279 175.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.86 -129.57 1.95 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.12 -0.946 . . . . 74.41 111.4 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -85.47 93.03 8.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.244 -0.28 . . . . 72.14 110.244 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -45.75 112.66 0.49 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.755 0.659 . . . . 73.33 111.264 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.2 p -102.48 140.49 21.16 Favored Pre-proline 0 N--CA 1.442 -0.861 0 CA-C-O 121.061 0.457 . . . . 71.43 110.417 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.67 165.76 29.77 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 123.534 2.823 . . . . 63.25 112.666 -175.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.5 -149.76 21.84 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.482 -0.866 . . . . 45.11 111.803 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.86 120.81 35.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.155 -0.313 . . . . 71.24 110.155 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.662 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -111.73 50.35 0.85 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 71.54 111.299 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -101.43 136.21 41.65 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.201 -0.666 . . . . 75.31 109.201 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.508 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -143.31 165.32 27.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.619 0.247 . . . . 72.21 111.045 -177.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -135.06 143.7 46.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.34 -0.391 . . . . 70.41 110.204 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.21 141.31 24.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.049 0.452 . . . . 74.33 110.959 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 13' ' ' LYS . 35.9 p -103.28 131.29 50.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.938 -0.574 . . . . 63.24 109.616 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.432 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 53.1 p90 -111.78 140.94 46.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.919 0.39 . . . . 61.11 110.557 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.577 ' HA ' HG21 ' A' ' 16' ' ' VAL . 2.0 tmmm? -127.25 111.11 13.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.656 -0.702 . . . . 73.14 110.092 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.782 HG12 HG12 ' A' ' 71' ' ' VAL . 1.3 m -78.44 143.59 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.018 0.437 . . . . 75.32 110.372 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -126.82 126.26 43.06 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.446 -0.575 . . . . 74.43 109.446 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.657 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 120.936 0.398 . . . . 72.44 111.781 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.424 ' CB ' ' HB3' ' A' ' 36' ' ' GLN . 61.8 p . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.962 0.41 . . . . 62.13 110.891 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.561 HG22 HG12 ' A' ' 37' ' ' VAL . 33.5 m -90.13 15.48 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.11 0.481 . . . . 72.21 110.601 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 62.19 22.72 13.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.16 -0.927 . . . . 75.31 112.541 172.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.523 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 83.14 90.25 0.7 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.46 -0.876 . . . . 71.42 111.916 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -85.23 161.03 35.42 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.436 -0.888 . . . . 43.34 112.382 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.532 ' HB ' HG22 ' A' ' 31' ' ' THR . 60.2 p -140.34 146.21 38.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.645 0.259 . . . . 73.43 110.781 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.461 HG23 HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -122.05 122.08 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.586 -0.524 . . . . 73.43 109.586 170.671 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -93.09 121.82 34.83 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.834 -0.432 . . . . 71.4 109.834 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 85.2 m-85 -107.69 123.32 48.33 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.841 -0.618 . . . . 74.34 110.46 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.607 ' HB3' HG22 ' A' ' 153' ' ' THR . 41.2 tptt -104.07 137.7 41.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.092 -0.504 . . . . 73.52 110.045 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -125.56 -136.24 4.47 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.709 -0.757 . . . . 34.42 112.836 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.645 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 48.9 mt-10 64.06 20.55 12.24 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.986 0.514 . . . . 64.45 110.89 -176.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 155' ' ' LYS . 26.8 m -69.62 -24.44 27.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.685 -0.688 . . . . 71.4 111.107 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.483 HG21 ' CG2' ' A' ' 156' ' ' VAL . 16.4 m -138.19 141.17 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.171 0.51 . . . . 75.21 112.004 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -143.75 24.78 1.68 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.961 -1.018 . . . . 63.15 108.483 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.73 -73.5 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.414 -0.812 . . . . 74.01 111.047 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.547 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -90.28 -40.88 11.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.901 0.381 . . . . 74.44 110.502 177.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -139.16 133.14 31.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.098 -0.501 . . . . 53.04 110.038 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.95 124.67 40.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.419 -0.355 . . . . 53.43 110.434 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.489 ' HA ' HD23 ' A' ' 58' ' ' LEU . 7.3 t -63.96 133.4 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.669 -0.493 . . . . 64.22 109.669 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.491 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.7 t70 -59.4 140.42 56.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.239 -0.437 . . . . 71.35 110.671 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -60.75 -26.49 67.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.488 . . . . 74.01 112.115 -174.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.55 -23.66 72.46 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.496 -0.859 . . . . 45.22 112.062 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.2 p -102.86 -7.72 21.34 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.913 0.338 . . . . 70.04 111.913 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.645 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 34.1 m -84.4 -2.87 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.063 0.458 . . . . 65.32 110.82 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -165.08 85.19 0.39 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.124 -1.065 . . . . 53.41 108.124 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -137.19 133.22 34.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.552 -0.749 . . . . 53.32 110.469 -173.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.532 HG22 ' HB ' ' A' ' 9' ' ' THR . 3.5 m -110.45 100.57 9.38 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.567 -0.742 . . . . 53.12 109.098 176.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.461 HG13 HG23 ' A' ' 10' ' ' VAL . 8.2 p -84.77 128.32 39.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.228 0.537 . . . . 73.14 110.488 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HG3' HG22 ' A' ' 9' ' ' THR . 26.4 mp0 -88.43 128.61 35.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.541 -0.754 . . . . 63.22 109.718 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.458 HD21 HG22 ' A' ' 10' ' ' VAL . 2.7 mm? -88.74 -34.56 17.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.336 0.589 . . . . 54.42 109.87 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.523 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 104.37 -179.6 24.72 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.433 -0.803 . . . . 55.02 111.813 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.424 ' HB3' ' CB ' ' A' ' 4' ' ' THR . 44.7 mt-30 -84.44 89.85 7.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.829 0.347 . . . . 72.25 110.576 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.561 HG12 HG22 ' A' ' 5' ' ' VAL . 9.5 p -70.81 141.82 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 73.14 110.267 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.54 137.27 40.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.972 -0.558 . . . . 60.13 109.965 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.3 p -86.88 5.17 38.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.468 0.652 . . . . 63.34 110.346 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.31 -27.87 18.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.433 -0.803 . . . . 53.15 110.737 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.476 ' HB2' HD12 ' A' ' 42' ' ' LEU . 12.3 m -72.23 -41.46 66.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.427 0.632 . . . . 70.24 110.342 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.1 mp -98.88 114.51 27.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.362 -0.835 . . . . 74.33 109.54 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.4 10.78 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.217 0.451 . . . . 65.12 112.217 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -150.57 153.51 35.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.552 0.215 . . . . 74.13 110.854 -177.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -65.58 121.11 14.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.022 -0.732 . . . . 75.32 109.022 176.543 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.424 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 106.27 2.57 38.46 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.591 -0.814 . . . . 64.12 111.761 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -80.91 140.4 35.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.817 0.341 . . . . 62.51 110.74 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.8 p -126.36 151.6 47.4 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.977 -0.556 . . . . 73.42 110.991 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.493 ' O ' ' HD2' ' A' ' 136' ' ' ARG . 27.3 t -104.07 179.47 4.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.044 -0.725 . . . . 53.24 109.044 174.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.3 m -73.54 129.59 38.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.239 -0.282 . . . . 53.45 110.239 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.665 ' HA ' ' HB3' ' A' ' 136' ' ' ARG . . . -82.29 157.6 23.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.595 0.712 . . . . 70.11 112.019 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.2 m -98.12 152.13 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.61 -1.177 . . . . 64.43 109.622 172.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.54 94.78 1.02 Allowed Glycine 0 C--N 1.313 -0.743 0 C-N-CA 120.785 -0.722 . . . . 60.22 112.276 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -107.93 178.34 4.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.031 -0.729 . . . . 72.11 109.031 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.599 ' HB2' HG22 ' A' ' 130' ' ' THR . 0.3 OUTLIER -148.97 151.51 34.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.964 0.727 . . . . 63.51 112.964 -177.401 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.4 HD12 ' CE2' ' A' ' 133' ' ' PHE . 83.0 mt -109.53 111.8 37.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.905 -1.043 . . . . 73.41 108.837 173.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 52.8 tt0 -94.55 135.01 36.49 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.198 -0.455 . . . . 71.43 111.074 -172.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 23' ' ' VAL . 75.4 mt -116.12 119.32 35.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.25 -0.432 . . . . 63.45 110.288 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -101.41 146.1 28.06 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.074 -0.512 . . . . 63.44 110.06 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 52.04 65.73 1.41 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.635 0.731 . . . . 73.21 110.224 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.481 ' SG ' HD13 ' A' ' 124' ' ' LEU . 39.1 t -100.24 137.26 38.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.245 -0.889 . . . . 64.12 110.258 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.44 ' OD2' HG12 ' A' ' 65' ' ' VAL . 17.1 t70 -111.64 137.75 49.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.213 -0.448 . . . . 73.12 111.494 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -102.32 0.98 35.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.133 -0.485 . . . . 73.23 112.246 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -79.74 -34.75 39.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.852 0.358 . . . . 64.5 110.371 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.471 HG13 ' HB2' ' A' ' 20' ' ' ALA . 11.7 p -107.5 -12.37 10.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.035 0.445 . . . . 55.13 110.928 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -122.8 179.41 4.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.709 0.29 . . . . 71.21 111.152 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.2 m -143.6 -59.17 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.3 -0.409 . . . . 52.14 110.796 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -137.94 139.58 39.83 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.576 -0.527 . . . . 65.33 109.576 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.403 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -100.27 118.53 36.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.143 0.497 . . . . 62.13 110.471 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.16 119.11 21.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.545 -0.752 . . . . 74.45 109.476 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 156' ' ' VAL . 2.4 m -90.31 146.49 6.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.963 0.411 . . . . 72.01 110.838 -175.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.07 142.3 46.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.599 -0.728 . . . . 43.03 109.149 172.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.471 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 78.3 m-85 -106.68 140.06 40.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.114 0.483 . . . . 71.14 110.93 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.3 tp -131.54 138.03 48.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.554 -0.748 . . . . 75.14 109.746 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.434 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -174.39 -160.06 21.86 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.23 -0.748 . . . . 31.1 111.23 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.4 m -91.82 114.37 26.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.671 0.235 . . . . 64.1 110.538 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.83 134.33 43.33 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.07 -0.344 . . . . 65.33 110.07 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.629 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 7.9 tt -63.54 -28.49 45.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.175 -0.466 . . . . 74.22 111.515 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -154.03 -178.94 7.42 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.79 -0.448 . . . . 71.22 109.79 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.81 -29.68 23.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.306 0.574 . . . . 73.43 109.703 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.44 -33.23 53.45 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.785 -0.721 . . . . 61.45 111.572 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -112.97 86.82 2.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.126 0.489 . . . . 73.31 110.155 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.5 p -93.56 8.74 39.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.821 -0.627 . . . . 70.22 111.411 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -115.14 0.47 13.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.146 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 102' ' ' GLN . 85.3 t -114.55 121.89 67.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.292 -0.413 . . . . 63.34 110.12 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.771 HD22 HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -70.56 130.09 40.92 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 110.039 -0.356 . . . . 64.12 110.039 -178.656 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.629 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.1 149.38 35.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.864 -0.607 . . . . 75.41 110.417 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.571 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -86.18 138.45 31.89 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.274 -0.421 . . . . 74.5 110.345 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 121.356 0.598 . . . . 64.42 110.584 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.421 ' HA ' ' H ' ' A' ' 147' ' ' ALA . 67.4 m . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 110.115 -0.328 . . . . 61.41 110.115 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.3 129.49 38.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.341 -0.39 . . . . 74.11 110.41 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.63 163.64 20.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.39 -0.368 . . . . 63.15 110.66 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 69.41 9.38 7.26 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.565 0.54 . . . . 52.41 110.409 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.87 174.12 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.423 -0.808 . . . . 71.13 110.133 174.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.528 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . -172.33 -174.05 39.41 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.255 -1.138 . . . . 62.1 110.255 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.15 114.81 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.469 0.652 . . . . 61.2 110.565 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.463 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.4 pt20 -104.54 145.03 30.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.753 -0.658 . . . . 74.22 109.396 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.471 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -104.13 123.63 58.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.142 0.496 . . . . 73.24 110.254 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 16.7 mt -91.46 144.63 25.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.503 -0.771 . . . . 75.43 108.947 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.548 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.1 p-10 -71.63 -171.7 0.69 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.7 -0.481 . . . . 74.43 109.7 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.441 ' CG ' ' HB3' ' A' ' 120' ' ' SER . 12.8 ptm180 -63.28 -25.2 68.21 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.098 0.407 . . . . 75.44 112.098 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.1 p -85.88 -34.33 21.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.709 -0.396 . . . . 71.41 110.759 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.74 29.6 1.38 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.655 -0.783 . . . . 61.54 112.446 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.08 131.32 54.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.034 -0.358 . . . . 71.23 110.034 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.35 120.88 15.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.398 -0.365 . . . . 52.21 110.797 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.7 133.31 33.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.168 -0.469 . . . . 60.34 110.539 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.536 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 16.2 m -69.38 139.34 54.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.164 -0.471 . . . . 74.4 110.445 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.771 HD13 HD22 ' A' ' 86' ' ' LEU . 29.6 mt -84.37 47.44 1.35 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.202 -0.454 . . . . 64.54 111.055 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -107.14 -6.04 17.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.964 0.412 . . . . 74.2 110.487 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.69 1.42 77.48 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.972 -0.632 . . . . 70.42 112.621 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -120.7 -0.85 10.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.008 0.432 . . . . 71.51 110.973 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.536 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 10.7 m -98.5 112.4 24.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.059 -0.518 . . . . 70.55 109.659 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -103.67 162.38 13.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.189 0.518 . . . . 75.31 111.492 -172.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.548 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.7 m -77.63 -175.0 3.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 63.51 111.405 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.441 ' HB3' ' CG ' ' A' ' 106' ' ' ARG . 42.5 t -63.74 153.86 35.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.043 -0.526 . . . . 62.44 110.572 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.564 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 40.4 mt-10 -68.35 97.84 0.78 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.916 -0.584 . . . . 73.34 110.686 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.6 m -79.54 100.5 7.78 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.442 -0.577 . . . . 64.33 109.442 173.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.8 m -57.07 114.95 2.35 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.906 -0.588 . . . . 61.32 110.683 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.481 HD13 ' SG ' ' A' ' 61' ' ' CYS . 91.3 mt -80.47 150.5 29.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.659 -0.7 . . . . 65.32 111.444 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -136.3 157.46 46.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.684 -0.858 . . . . 74.32 108.684 170.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -59.03 115.88 3.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.709 0.29 . . . . 51.2 110.868 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 131.45 -138.44 10.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 64.22 112.383 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 54.9 m -97.43 125.06 41.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.285 0.564 . . . . 75.21 111.378 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -121.97 110.97 16.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.5 -0.773 . . . . 61.44 109.612 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.599 HG22 ' HB2' ' A' ' 55' ' ' ASN . 5.7 m -103.54 116.93 33.29 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.435 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.61 112.9 59.61 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.093 -0.503 . . . . 65.12 110.479 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -80.3 143.37 15.61 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.504 2.136 . . . . 75.53 112.633 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 105' ' ' ASP . 68.2 m-85 -140.64 165.67 26.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 74.44 110.618 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.629 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 96.4 mt-30 -126.7 121.31 31.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.178 -0.465 . . . . 72.03 111.011 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -110.34 130.21 55.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.189 -0.3 . . . . 71.55 110.189 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.665 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 39.8 ptt180 -149.78 170.68 18.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 74.04 111.397 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 92.0 m-85 -86.37 145.33 26.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.593 -0.73 . . . . 71.33 111.084 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.424 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 75.3 t80 -130.33 133.28 46.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.244 -0.889 . . . . 72.25 108.644 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -100.52 138.7 37.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.039 0.447 . . . . 70.32 111.617 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.546 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 57.0 p -102.98 3.36 36.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.506 -0.77 . . . . 70.33 109.575 176.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.57 -132.92 2.73 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.998 -1.001 . . . . 41.32 110.86 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.54 91.47 2.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.063 -0.347 . . . . 62.13 110.063 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.12 112.49 0.58 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 53.54 111.333 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -104.24 141.44 22.53 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 116.052 -0.522 . . . . 55.24 110.593 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -71.1 171.78 15.24 Favored 'Trans proline' 0 C--N 1.334 -0.222 0 C-N-CA 123.877 3.051 . . . . 73.52 113.035 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.6 -161.35 26.61 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.665 -0.779 . . . . 75.12 111.989 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.421 ' H ' ' HA ' ' A' ' 95' ' ' SER . . . -79.31 112.52 16.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.652 0.226 . . . . 64.2 110.397 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.571 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -113.75 71.92 0.76 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.447 . . . . 72.13 111.375 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -120.92 128.09 52.44 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.444 -0.576 . . . . 73.34 109.444 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.488 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -130.5 171.86 12.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 72.33 111.913 -173.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -129.9 127.22 39.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.667 -0.697 . . . . 73.41 110.428 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 12' ' ' PHE . . . -139.13 125.81 20.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.191 0.519 . . . . 43.23 110.784 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.607 HG22 ' HB3' ' A' ' 13' ' ' LYS . 16.9 p -105.86 130.07 53.9 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.937 -0.574 . . . . 74.44 110.143 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -106.44 141.21 38.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.183 0.516 . . . . 75.13 111.072 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.675 ' HA ' HG21 ' A' ' 16' ' ' VAL . 3.9 tmmm? -126.38 109.39 12.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.602 -0.726 . . . . 73.24 109.808 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -75.2 142.86 14.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.029 0.443 . . . . 75.32 110.321 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -122.31 121.6 37.11 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.5 -0.556 . . . . 74.11 109.5 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.579 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 1.1 p90 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.394 . . . . 75.54 111.075 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 p . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.969 0.414 . . . . 62.22 110.723 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.549 HG22 HG12 ' A' ' 37' ' ' VAL . 33.7 m -89.52 13.69 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.824 0.345 . . . . 54.51 110.871 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 60.61 16.29 6.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.356 -0.838 . . . . 65.44 112.648 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.32 107.02 3.05 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.575 -0.821 . . . . 65.52 112.127 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.578 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -98.23 150.35 19.38 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.383 -0.913 . . . . 44.02 111.772 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.523 ' HB ' HG22 ' A' ' 31' ' ' THR . 16.9 p -142.55 145.45 33.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.746 0.308 . . . . 60.21 110.766 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.628 HG22 HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -121.39 119.65 59.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.955 -0.566 . . . . 74.31 110.789 175.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -86.65 123.45 31.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.413 -0.812 . . . . 63.22 110.124 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -107.93 126.89 53.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.289 -0.414 . . . . 74.14 110.374 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HB3' HG22 ' A' ' 153' ' ' THR . 64.7 tttp -111.88 129.14 56.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.133 -0.485 . . . . 55.44 110.087 177.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.4 -123.99 5.34 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.871 -0.681 . . . . 75.02 111.906 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 34.7 mt-10 64.33 16.35 10.07 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.135 0.493 . . . . 73.5 111.522 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 155' ' ' LYS . 27.2 m -81.33 -21.63 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.936 -0.575 . . . . 70.35 111.284 -177.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.539 HG11 HG22 ' A' ' 156' ' ' VAL . 18.5 m -137.74 141.88 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.296 0.569 . . . . 53.22 111.352 -176.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -147.0 23.24 1.2 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.289 -1.004 . . . . 71.24 108.289 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.2 -92.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.306 -0.861 . . . . 73.03 111.107 -176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -73.2 -35.53 66.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.898 0.38 . . . . 55.5 110.776 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 1.4 m -141.59 133.12 26.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.938 -0.574 . . . . 73.2 109.825 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.96 126.3 41.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.25 -0.432 . . . . 23.1 110.276 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 t -67.4 131.62 32.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.773 -0.454 . . . . 70.33 109.773 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.438 ' O ' HG13 ' A' ' 28' ' ' VAL . 19.4 t70 -62.62 151.53 37.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.436 -0.347 . . . . 75.31 110.949 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.421 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -57.85 -36.02 71.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 73.3 111.472 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.24 -2.01 86.68 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.903 -0.665 . . . . 74.32 111.961 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.414 ' OG ' HG23 ' A' ' 56' ' ' ILE . 46.5 t -119.6 -3.45 10.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.502 0.191 . . . . 72.34 110.901 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 32.9 m -94.34 -14.34 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.61 -0.515 . . . . 64.34 109.61 172.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -150.38 91.17 1.72 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.194 -0.912 . . . . 75.32 109.577 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -141.17 141.96 34.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.143 0.496 . . . . 71.14 109.978 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.523 HG22 ' HB ' ' A' ' 9' ' ' THR . 9.1 m -123.41 109.6 14.08 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.83 -0.623 . . . . 65.11 109.664 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.411 HG12 HG23 ' A' ' 10' ' ' VAL . 10.9 p -86.29 136.39 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.949 0.404 . . . . 73.43 110.324 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.516 ' HA ' HG22 ' A' ' 9' ' ' THR . 27.0 mp0 -93.31 115.08 27.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.989 -0.551 . . . . 54.24 110.43 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.628 HD21 HG22 ' A' ' 10' ' ' VAL . 2.7 mm? -76.96 -30.03 55.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.65 -0.705 . . . . 73.32 109.61 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.94 -173.48 30.6 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.511 -0.768 . . . . 64.24 111.75 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -83.54 90.45 7.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.564 0.221 . . . . 60.12 110.541 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.549 HG12 HG22 ' A' ' 5' ' ' VAL . 7.5 p -61.6 141.32 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.183 0.516 . . . . 53.43 110.399 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -86.49 116.01 24.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.794 -0.639 . . . . 73.33 110.098 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 p -70.62 -12.65 61.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.362 -0.835 . . . . 73.13 112.197 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.26 -30.47 48.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.887 0.375 . . . . 63.3 111.006 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.438 ' HB2' HD12 ' A' ' 42' ' ' LEU . 15.2 m -70.28 -40.66 74.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.547 0.689 . . . . 72.13 110.277 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -99.31 87.08 3.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.48 -0.782 . . . . 75.54 110.298 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.13 14.21 9.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.019 0.438 . . . . 72.51 111.257 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -154.64 146.74 23.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.782 -0.645 . . . . 71.1 109.504 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 43.1 tt0 -60.1 136.52 58.05 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.103 -0.332 . . . . 73.45 110.103 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.97 -14.3 60.13 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.606 -0.806 . . . . 63.24 111.813 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.35 125.15 25.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.698 0.285 . . . . 52.23 110.448 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 20.3 p -117.41 140.5 49.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.323 -0.399 . . . . 61.51 110.515 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.1 t -86.39 174.51 8.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.74 -0.466 . . . . 55.51 109.74 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -68.0 134.53 50.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.504 -0.554 . . . . 61.21 109.504 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -87.06 155.67 20.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.429 0.633 . . . . 72.04 111.757 -175.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.5 m -90.96 152.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.688 -1.142 . . . . 72.43 109.024 169.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.05 87.16 0.46 Allowed Glycine 0 C--N 1.31 -0.888 0 C-N-CA 120.784 -0.722 . . . . 41.1 111.776 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -101.68 173.12 6.56 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.769 -0.456 . . . . 73.32 109.769 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -140.82 146.92 38.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.905 0.383 . . . . 61.22 111.244 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.417 HD13 ' CE1' ' A' ' 154' ' ' PHE . 41.1 mt -102.58 122.45 54.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.605 -0.725 . . . . 72.34 109.251 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -100.72 126.86 47.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.099 -0.5 . . . . 74.25 111.305 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 128' ' ' THR . 70.4 mt -111.44 129.5 56.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.664 -0.698 . . . . 74.34 109.835 175.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -102.27 135.09 44.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.157 -0.474 . . . . 63.24 110.098 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.9 t70 49.09 77.51 0.1 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.069 0.855 . . . . 65.31 111.052 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.472 ' SG ' HD13 ' A' ' 124' ' ' LEU . 49.0 t -108.85 129.83 55.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.162 -0.927 . . . . 63.32 110.128 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 64' ' ' ASN . 24.9 t70 -99.12 147.55 24.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.029 0.443 . . . . 70.1 111.772 -176.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -115.84 8.99 14.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.647 -0.706 . . . . 74.43 111.546 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.414 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 55.4 m-80 -91.24 -31.49 16.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.006 0.431 . . . . 60.25 110.006 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.29 -16.17 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.17 0.509 . . . . 63.01 110.571 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.623 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -128.35 -178.33 4.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.269 -0.423 . . . . 74.34 110.792 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.513 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 37.1 m -144.19 -59.2 0.38 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.696 -0.229 . . . . 71.15 111.231 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -135.65 141.17 44.98 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 110.041 -0.355 . . . . 75.41 110.041 -178.331 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.06 124.74 49.1 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.093 0.473 . . . . 64.44 110.618 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.59 117.71 17.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.734 -0.667 . . . . 73.13 109.369 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.626 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -93.4 150.16 4.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.071 0.462 . . . . 61.35 110.768 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.37 124.15 44.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.49 -0.777 . . . . 53.12 109.474 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.451 ' CE1' HG21 ' A' ' 103' ' ' ILE . 62.9 m-85 -86.39 134.73 33.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.213 0.53 . . . . 73.12 110.643 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.6 tp -132.38 122.44 25.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.512 -0.767 . . . . 52.33 109.73 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.15 -166.55 27.4 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.127 -0.789 . . . . 54.22 111.127 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.506 ' O ' HD13 ' A' ' 86' ' ' LEU . 4.1 m -76.8 124.95 28.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.476 0.179 . . . . 72.02 110.823 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.39 140.62 35.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.264 -0.273 . . . . 61.31 110.264 177.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 13.3 tt -62.98 -29.03 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.011 0.434 . . . . 75.04 111.118 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -149.68 178.08 9.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.443 -0.577 . . . . 73.12 109.443 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.95 -27.84 30.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.069 0.462 . . . . 73.3 109.981 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.32 -37.91 9.44 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.817 -0.706 . . . . 55.54 111.505 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -95.5 77.57 3.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.709 -0.478 . . . . 72.41 109.709 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.452 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 15.6 p -91.61 12.89 19.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.807 -0.633 . . . . 70.24 111.316 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -112.79 -5.01 13.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.125 -0.489 . . . . 73.52 110.993 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -112.12 128.83 68.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.384 -0.371 . . . . 72.44 110.249 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.526 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -68.64 137.56 54.3 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.014 -0.365 . . . . 63.21 110.014 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.97 157.57 29.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.181 -0.463 . . . . 65.21 110.34 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.593 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.5 mm? -93.71 139.63 30.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.371 -0.377 . . . . 63.33 110.451 -176.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 149' ' ' ASN . 31.4 mt-30 . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 121.256 0.551 . . . . 71.13 109.642 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 54.7 m . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.878 -0.416 . . . . 62.21 109.878 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -92.94 146.26 23.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.68 -0.236 . . . . 44.1 110.38 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.22 164.81 26.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.728 0.299 . . . . 71.35 110.935 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.407 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 23.6 m-80 68.76 7.56 6.21 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.881 0.873 . . . . 64.11 111.285 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.593 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -147.65 150.21 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-N 115.965 -0.561 . . . . 34.34 109.882 173.137 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.86 -170.2 15.71 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.712 -0.955 . . . . 52.43 110.712 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.428 HG11 HG13 ' A' ' 10' ' ' VAL . 2.5 p -121.34 122.44 67.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.155 0.502 . . . . 71.15 110.412 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -117.16 138.88 51.38 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.136 0.494 . . . . 72.33 109.768 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.451 HG21 ' CE1' ' A' ' 73' ' ' PHE . 4.2 mp -94.14 128.42 45.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.841 -0.618 . . . . 62.23 110.071 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 18.4 mt -96.35 154.86 17.03 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.486 -0.779 . . . . 72.43 109.462 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.557 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 2.4 p-10 -72.92 -167.95 0.43 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.401 -0.592 . . . . 72.22 109.401 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -71.29 -19.06 62.38 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.462 -0.495 . . . . 74.31 111.858 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.2 p -90.6 -35.22 15.13 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.913 -0.315 . . . . 73.34 110.952 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.83 26.34 1.41 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.516 -0.85 . . . . 62.54 113.349 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . -100.52 140.45 34.76 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.332 -0.247 . . . . 43.24 110.332 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.03 126.33 30.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.317 -0.401 . . . . 71.32 111.465 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.7 mt -87.28 147.28 25.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.017 -0.538 . . . . 72.23 110.326 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.6 m -93.37 141.04 28.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.109 -0.496 . . . . 73.24 110.55 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.412 ' CD1' HD22 ' A' ' 86' ' ' LEU . 63.7 mt -84.25 60.25 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.074 0.464 . . . . 74.41 110.977 -176.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -119.57 -4.84 10.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.016 -0.538 . . . . 74.41 109.909 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.29 4.97 65.43 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.617 -0.72 . . . . 74.12 112.726 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.48 -16.65 7.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 72.23 110.811 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 m -84.15 97.76 9.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.664 -0.495 . . . . 72.12 109.664 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.496 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 86.6 m-85 -87.49 165.43 15.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.23 -0.441 . . . . 62.3 110.837 -175.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.0 m -74.53 -171.08 1.14 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.948 -0.569 . . . . 74.14 110.888 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.2 p -72.79 164.9 25.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.963 -0.384 . . . . 52.22 109.963 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.418 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 41.7 mt-10 -72.78 103.03 3.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.924 0.392 . . . . 74.05 111.193 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.0 m -84.19 109.65 17.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.317 -0.623 . . . . 75.02 109.317 174.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 m -63.6 113.52 3.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.941 -0.572 . . . . 62.44 111.095 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.472 HD13 ' SG ' ' A' ' 61' ' ' CYS . 94.6 mt -77.66 150.14 34.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.857 -0.61 . . . . 73.22 110.943 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -135.96 152.47 51.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.949 -0.569 . . . . 63.24 109.642 170.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 45.8 m-20 -55.15 113.31 1.32 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.988 0.423 . . . . 72.32 111.587 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.75 -145.93 16.55 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.901 -0.666 . . . . 73.41 112.265 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 28.3 m -82.76 129.27 34.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.782 0.325 . . . . 53.41 110.379 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 26.1 m-80 -122.25 133.13 54.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.214 -0.448 . . . . 63.23 110.884 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.63 113.33 26.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.245 -0.434 . . . . 62.12 110.922 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 16.1 mt -92.87 106.4 18.82 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.042 -0.725 . . . . 63.34 109.042 175.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 6.2 Cg_exo -79.09 135.13 12.07 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.033 2.489 . . . . 55.31 112.31 -176.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -136.41 166.87 22.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.294 -0.412 . . . . 72.25 110.623 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.574 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 97.9 mt-30 -132.89 117.9 18.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.954 -0.566 . . . . 73.42 110.922 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.95 125.26 50.2 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.188 -0.301 . . . . 55.22 110.188 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.55 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 14.8 ptp180 -140.63 164.45 30.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.818 0.342 . . . . 74.23 110.836 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.578 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 58.6 m-85 -81.54 149.02 28.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.931 -0.577 . . . . 72.33 111.206 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -132.03 127.68 36.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.427 -0.806 . . . . 74.45 109.127 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.645 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -91.64 135.0 34.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.978 0.418 . . . . 74.22 111.416 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 55.8 p -101.82 1.03 36.65 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.425 -0.954 . . . . 74.22 108.425 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.82 -123.89 1.1 Allowed Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.34 -1.3 . . . . 60.33 111.189 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.25 98.0 11.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.44 -0.207 . . . . 31.22 110.44 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -47.71 117.3 1.78 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.075 -0.511 . . . . 75.12 111.083 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.6 p -107.29 146.74 33.85 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.169 -0.469 . . . . 73.44 110.79 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.73 167.7 23.65 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.382 2.722 . . . . 54.42 112.726 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.63 -125.04 2.75 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.663 -0.78 . . . . 42.01 111.768 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -129.91 118.47 21.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.738 0.304 . . . . 65.44 110.461 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -114.53 71.85 0.77 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.12 0.486 . . . . 63.4 110.933 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.442 ' O ' ' HG3' ' A' ' 89' ' ' GLN . 4.0 m-20 -111.98 146.16 38.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.392 -0.596 . . . . 71.24 109.392 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.526 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -150.25 163.22 38.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.801 0.334 . . . . 63.01 111.395 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -132.99 144.88 50.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 74.34 109.797 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.96 152.05 33.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.408 0.623 . . . . 74.0 111.68 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.53 HG22 ' HB3' ' A' ' 13' ' ' LYS . 7.9 p -108.1 142.6 38.05 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.299 -0.864 . . . . 74.34 109.259 173.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.417 ' CE1' HD13 ' A' ' 56' ' ' ILE . 53.7 p90 -117.94 130.47 56.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.926 0.393 . . . . 72.41 110.572 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.625 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -110.03 112.45 24.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.098 -0.501 . . . . 75.12 110.36 178.157 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.626 HG12 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -80.47 146.32 7.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.912 -0.403 . . . . 72.44 109.912 178.31 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -127.29 123.53 36.63 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.281 -0.637 . . . . 62.33 109.281 171.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.623 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.323 -0.586 0 CA-C-O 120.927 0.394 . . . . 75.22 111.337 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.9 p . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 110.135 -0.32 . . . . 72.54 110.135 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.453 HG22 HG12 ' A' ' 37' ' ' VAL . 27.2 m -87.84 21.49 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.018 0.437 . . . . 41.34 111.27 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 58.83 19.13 6.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.442 -0.799 . . . . 65.53 112.436 173.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.526 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 88.29 99.97 0.94 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.652 -0.785 . . . . 71.45 111.77 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.424 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -92.84 157.74 23.72 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.206 -0.997 . . . . 62.33 112.19 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.578 ' HB ' HG22 ' A' ' 31' ' ' THR . 73.0 p -140.91 148.95 41.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.57 0.224 . . . . 70.54 110.574 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.516 HG23 HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -121.69 119.36 58.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.943 -0.762 . . . . 62.24 108.943 171.528 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -91.15 109.56 20.82 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.402 -0.519 . . . . 74.13 109.694 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.455 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 97.7 m-85 -96.0 126.49 41.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.703 -0.68 . . . . 75.12 109.901 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -110.38 128.92 55.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.374 -0.376 . . . . 71.45 110.596 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.67 -139.1 10.35 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.056 -0.593 . . . . 62.12 111.85 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 60.83 27.48 17.28 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.356 0.598 . . . . 74.24 111.311 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.626 HG21 ' HA ' ' A' ' 155' ' ' LYS . 31.2 m -83.29 -28.96 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.647 -0.706 . . . . 74.1 111.188 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.648 HG21 HG22 ' A' ' 156' ' ' VAL . 16.4 m -142.36 151.04 18.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.349 -0.387 . . . . 64.04 110.939 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -167.98 84.17 0.2 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.713 -0.847 . . . . 74.12 108.713 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.1 -74.05 0.26 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.349 -0.841 . . . . 34.11 110.025 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.546 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -73.52 -35.27 65.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 75.53 109.997 173.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.41 ' CB ' ' HA ' ' A' ' 61' ' ' CYS . 4.2 m -143.56 -176.63 5.03 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.13 -0.693 . . . . 73.43 109.13 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.64 146.69 41.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.202 -0.666 . . . . 54.13 109.202 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 t -81.32 137.23 21.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.74 -0.467 . . . . 72.22 109.74 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' O ' HG13 ' A' ' 28' ' ' VAL . 12.3 t70 -65.45 141.35 58.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.61 -0.268 . . . . 73.05 110.328 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -57.12 -28.74 62.96 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.405 0.441 . . . . 74.11 111.98 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.28 -11.09 82.19 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.564 -0.827 . . . . 75.44 112.415 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.9 p -124.97 14.96 8.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.833 0.309 . . . . 74.42 111.833 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 24' ' ' ASP . 32.9 m -102.9 -5.74 9.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.087 0.47 . . . . 61.34 110.241 173.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -155.66 90.88 1.26 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.311 -0.859 . . . . 75.11 109.325 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 20.3 pm0 -139.65 124.29 18.33 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.346 0.593 . . . . 70.13 110.672 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.578 HG22 ' HB ' ' A' ' 9' ' ' THR . 2.2 m -100.54 95.09 6.48 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.452 -0.795 . . . . 63.02 109.29 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.99 136.59 24.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.209 0.528 . . . . 75.31 110.718 -174.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -96.58 118.63 33.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.448 -0.796 . . . . 54.31 110.267 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.516 HD21 HG23 ' A' ' 10' ' ' VAL . 2.6 mm? -90.13 -26.2 20.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.116 -0.493 . . . . 61.02 109.855 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.526 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 90.2 179.85 43.98 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.642 -0.708 . . . . 75.02 112.644 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -81.65 90.11 6.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.67 0.271 . . . . 65.51 110.636 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.453 HG12 HG22 ' A' ' 5' ' ' VAL . 7.3 p -79.28 142.36 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 110.249 -0.278 . . . . 53.21 110.249 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -71.89 126.41 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 74.21 110.649 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.601 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 32.5 p -74.43 -20.22 60.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.07 0.462 . . . . 72.02 110.903 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.11 -29.95 65.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 51.11 111.442 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -71.06 -35.12 71.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.253 0.549 . . . . 74.41 110.25 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -98.74 74.08 2.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.713 -0.676 . . . . 73.32 110.256 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.94 17.66 18.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.083 0.468 . . . . 65.22 110.993 -172.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -150.37 138.7 20.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.866 -0.606 . . . . 64.42 110.218 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -55.72 126.59 26.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 74.54 110.358 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.37 -9.54 38.71 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.708 -0.758 . . . . 75.23 111.898 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -62.97 121.04 12.56 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.73 0.3 . . . . 63.23 110.427 177.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.1 p -115.9 119.66 36.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.956 -0.566 . . . . 53.01 110.216 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.5 t -83.04 171.09 14.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.264 -0.425 . . . . 71.13 109.908 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.0 m -64.76 127.94 33.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.985 -0.552 . . . . 45.32 110.368 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 134' ' ' GLN . . . -83.3 147.58 27.87 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.492 0.663 . . . . 51.03 111.638 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.2 m -87.07 151.62 3.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 114.775 -1.102 . . . . 71.12 109.278 171.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.6 97.51 0.99 Allowed Glycine 0 C--N 1.311 -0.84 0 C-N-CA 120.976 -0.631 . . . . 61.32 112.322 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -109.87 172.44 6.85 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.81 -0.441 . . . . 73.24 109.81 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.579 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.3 p-10 -135.25 144.38 46.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.123 0.487 . . . . 74.34 111.648 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 81.7 mt -113.05 124.64 69.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.389 -0.823 . . . . 72.25 108.803 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -109.47 144.1 38.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.847 0.356 . . . . 74.04 111.089 -172.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 128' ' ' THR . 23.7 mt -120.52 133.4 55.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.227 -0.442 . . . . 75.02 109.823 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -112.15 155.29 24.17 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.928 -0.578 . . . . 61.14 109.839 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 51.58 45.77 27.55 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 123.849 0.718 . . . . 71.22 110.638 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 5.8 t -89.18 143.4 26.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.355 -0.838 . . . . 63.32 110.602 -174.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 64' ' ' ASN . 20.9 t70 -117.87 154.43 31.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 64.42 111.612 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.6 p -124.12 9.64 8.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.354 -0.384 . . . . 72.52 111.263 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.453 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 52.7 m-80 -84.37 -34.12 23.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 73.21 110.159 177.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.5 p -110.7 -17.09 8.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.044 -0.526 . . . . 52.22 110.985 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -122.68 167.38 13.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.631 -0.259 . . . . 71.32 110.983 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.546 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 13.8 m -130.22 -55.4 1.11 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.404 -0.362 . . . . 44.24 111.117 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.546 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -138.67 153.23 48.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.177 -0.305 . . . . 73.3 110.177 -178.225 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.479 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -105.1 127.11 52.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.061 0.458 . . . . 64.24 110.369 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -135.14 116.0 14.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.746 -0.661 . . . . 53.25 109.56 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.0 OUTLIER -89.81 144.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.158 0.504 . . . . 71.13 111.199 -174.178 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.85 118.07 29.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.215 -0.902 . . . . 74.42 109.537 173.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 89.5 m-85 -82.71 137.83 34.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.188 0.518 . . . . 73.24 110.874 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.2 tp -128.42 135.78 49.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.554 -0.748 . . . . 72.44 109.521 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.08 -177.54 47.68 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.994 -0.622 . . . . 74.21 111.621 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 m -75.16 120.96 21.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.782 0.325 . . . . 73.45 110.818 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -79.18 144.14 34.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.137 -0.483 . . . . 45.45 110.402 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 tt -77.9 -21.26 13.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.013 0.435 . . . . 74.31 110.784 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -155.12 176.32 12.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.552 -0.536 . . . . 74.43 109.552 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.03 -29.02 32.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.98 0.419 . . . . 61.25 110.433 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.78 -24.63 19.97 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.832 -0.699 . . . . 72.43 111.692 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -99.91 50.71 0.91 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.348 0.594 . . . . 65.23 109.652 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.459 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 5.6 p -78.63 4.99 12.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.549 -0.751 . . . . 65.35 112.098 -176.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -107.7 -1.79 20.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.117 0.484 . . . . 72.43 110.525 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.422 HG22 ' HB3' ' A' ' 102' ' ' GLN . 60.0 t -108.62 123.98 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 72.25 110.285 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.568 HD22 HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -70.04 131.79 44.88 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.982 -0.377 . . . . 74.44 109.982 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.53 149.49 33.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.141 -0.482 . . . . 52.43 110.775 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.3 mm? -81.02 143.75 32.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.896 -0.593 . . . . 72.42 110.567 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.026 -0.534 . . . . 73.42 111.09 178.102 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.541 -0.541 . . . . 70.13 109.541 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.23 121.73 14.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.094 -0.335 . . . . 74.21 110.094 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.4 160.69 18.15 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.788 -0.365 . . . . 63.41 110.755 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 69.26 14.61 8.59 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.669 -0.696 . . . . 63.44 110.476 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.0 -179.99 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.887 -0.597 . . . . 71.31 110.058 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 179.4 -173.57 45.5 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.172 -1.171 . . . . 73.31 110.172 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.431 HG21 HG21 ' A' ' 10' ' ' VAL . 3.2 p -119.95 114.59 44.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.628 0.727 . . . . 72.13 110.674 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.6 pt20 -103.9 141.7 35.7 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.486 -0.779 . . . . 73.24 109.114 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.498 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.3 mp -104.18 127.66 58.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.199 0.523 . . . . 72.23 110.464 -177.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.0 mt -93.44 147.24 23.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.425 -0.807 . . . . 64.11 109.222 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -70.29 -172.71 0.61 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.494 -0.558 . . . . 71.53 109.494 174.646 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -67.92 -16.62 64.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.398 0.518 . . . . 74.11 112.398 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.403 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 69.0 p -95.53 -32.49 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.718 -0.393 . . . . 64.54 111.053 177.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.71 32.49 0.76 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.735 -0.745 . . . . 73.53 112.82 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.4 125.41 50.96 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.724 -0.28 . . . . 71.34 110.36 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.61 116.59 12.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.953 0.406 . . . . 65.41 110.436 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.6 mt -84.85 132.74 34.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.007 -0.542 . . . . 72.13 111.238 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.449 ' H ' HG21 ' A' ' 117' ' ' THR . 25.0 m -68.72 141.61 55.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.816 -0.629 . . . . 73.35 110.604 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.568 HD13 HD22 ' A' ' 86' ' ' LEU . 49.8 mt -82.7 41.2 0.71 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 74.02 111.207 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.41 -16.36 46.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.86 0.362 . . . . 73.52 110.56 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.67 3.58 89.06 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.735 -0.745 . . . . 71.34 111.603 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -128.1 2.3 5.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.725 0.298 . . . . 51.21 111.316 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 112' ' ' THR . 9.0 m -94.37 102.89 14.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.016 -0.365 . . . . 53.01 110.016 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.515 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 75.6 m-85 -93.99 150.84 19.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.213 -0.449 . . . . 71.55 111.876 -172.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.1 m -68.01 179.82 1.4 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.388 -0.824 . . . . 71.24 111.264 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.2 m -67.36 147.75 52.53 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.019 -0.537 . . . . 74.4 109.766 173.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.469 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 47.0 mt-10 -55.28 110.44 0.69 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 73.14 111.662 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.8 m -96.35 107.25 19.6 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.016 -0.735 . . . . 75.24 109.016 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 m -61.93 132.96 54.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.088 -0.506 . . . . 52.42 111.414 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 69' ' ' ALA . 82.2 mt -94.6 149.14 21.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.241 0.543 . . . . 73.01 111.926 -176.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -128.38 151.55 49.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.219 -0.9 . . . . 73.24 108.835 168.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 17.9 m120 -63.7 121.94 15.18 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.952 0.406 . . . . 74.45 110.68 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.97 -109.94 1.22 Allowed Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.814 -0.63 . . . . 50.3 111.892 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 98.5 m -127.11 133.03 50.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.055 0.455 . . . . 53.12 111.173 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -129.65 145.25 51.52 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.359 -0.608 . . . . 72.32 109.359 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.579 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.6 m -125.82 122.64 36.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.867 0.365 . . . . 74.21 110.73 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.6 mt -102.91 115.74 63.68 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.167 -0.47 . . . . 50.22 110.084 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -80.26 138.27 12.48 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.84 2.36 . . . . 64.24 112.215 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -137.44 163.2 31.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.888 0.375 . . . . 75.12 110.81 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.625 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 94.8 mt-30 -131.82 119.3 21.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.98 -0.555 . . . . 74.5 111.235 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.93 129.9 53.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.442 -0.344 . . . . 63.24 110.259 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.431 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 1.4 ptp180 -140.86 164.97 28.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.892 0.377 . . . . 74.31 111.361 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 70.2 m-85 -86.55 141.75 28.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.865 -0.607 . . . . 75.01 110.33 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -127.97 122.53 32.57 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.238 -0.653 . . . . 70.33 109.238 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.636 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -85.45 130.55 34.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.89 0.376 . . . . 72.32 110.908 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 63.8 p -102.19 11.43 38.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.716 0.77 . . . . 75.24 108.933 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 163.84 -123.57 1.19 Allowed Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.616 -1.175 . . . . 70.2 111.385 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.9 95.35 8.19 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.242 -0.281 . . . . 61.44 110.242 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.601 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.02 115.55 1.33 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.006 0.432 . . . . 74.13 111.136 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.0 p -103.87 141.39 22.41 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.825 -0.435 . . . . 64.43 109.825 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.49 163.43 38.07 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.449 2.766 . . . . 73.05 112.396 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.35 -153.91 25.63 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.628 -0.796 . . . . 63.34 111.796 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.45 108.07 19.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.737 0.303 . . . . 73.4 110.828 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -107.05 75.78 1.05 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.201 0.524 . . . . 74.04 110.71 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -123.77 134.32 53.67 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.331 -0.618 . . . . 75.01 109.331 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -136.91 167.57 21.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.993 0.425 . . . . 41.32 111.434 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -131.16 142.47 50.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.643 -0.708 . . . . 74.42 109.561 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.81 139.05 27.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.224 0.535 . . . . 71.34 111.255 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.6 p -108.86 117.0 33.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.821 -0.627 . . . . 73.22 110.014 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.443 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 47.4 p90 -95.04 123.6 38.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.511 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.626 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.5 tmmm? -106.01 100.91 10.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.702 -0.481 . . . . 73.21 109.702 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.1 m -78.57 133.21 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.314 0.578 . . . . 51.0 110.168 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -111.7 113.38 25.72 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.876 -0.602 . . . . 72.15 110.987 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.546 ' CD1' ' HB3' ' A' ' 20' ' ' ALA . 5.3 p90 . . . . . 0 C--N 1.317 -0.83 0 CA-C-N 115.542 -0.754 . . . . 73.41 109.208 169.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.423 HG22 ' HA ' ' A' ' 38' ' ' ARG . 74.2 p . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 110.156 -0.313 . . . . 61.52 110.156 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.552 HG22 HG12 ' A' ' 37' ' ' VAL . 34.6 m -90.42 17.71 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.901 0.381 . . . . 73.42 111.001 176.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 59.55 31.07 20.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.597 -0.729 . . . . 74.33 112.275 171.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.451 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 79.82 92.53 0.4 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.68 -0.771 . . . . 31.32 112.3 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.31 153.42 25.26 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.208 -0.996 . . . . 65.11 111.678 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.556 ' HB ' HG22 ' A' ' 31' ' ' THR . 45.2 p -138.53 144.97 40.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.71 0.291 . . . . 72.13 110.486 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.485 ' CG2' HD21 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -118.04 120.44 64.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.97 -0.752 . . . . 71.02 108.97 172.294 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -86.86 111.28 20.62 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.405 -0.518 . . . . 73.2 109.611 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -100.92 118.84 37.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.808 -0.633 . . . . 62.2 110.02 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HB3' HG22 ' A' ' 153' ' ' THR . 48.0 tttp -116.21 138.08 51.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.145 -0.479 . . . . 72.1 110.597 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -116.22 -116.43 2.96 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.786 -0.643 . . . . 73.52 111.86 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.934 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 28.3 mt-10 62.45 22.45 13.26 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.158 0.504 . . . . 73.15 110.915 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.683 HG21 ' HA ' ' A' ' 155' ' ' LYS . 29.7 m -83.13 -26.46 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.574 -0.739 . . . . 73.02 111.659 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.705 HG21 HG22 ' A' ' 156' ' ' VAL . 3.8 m -140.28 134.63 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.099 0.476 . . . . 54.03 112.204 -173.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -139.22 23.4 2.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 75.55 109.33 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.71 -83.1 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 50.23 111.886 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.3 -34.05 70.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.467 0.651 . . . . 53.41 110.637 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 2.8 m -146.44 162.72 37.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.262 -0.881 . . . . 73.32 108.628 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.05 127.22 53.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.482 0.182 . . . . 62.42 110.601 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 t -70.04 130.09 34.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.904 -0.406 . . . . 71.21 109.904 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.9 t70 -57.84 140.87 50.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 64.43 111.067 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.431 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -63.84 -17.08 62.78 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 112.443 0.534 . . . . 53.23 112.443 -174.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.51 -23.12 48.49 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.596 -0.811 . . . . 61.04 111.949 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.0 p -101.63 -8.43 21.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.787 0.292 . . . . 61.41 111.787 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.934 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 30.5 m -82.4 -4.14 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.705 0.288 . . . . 64.24 111.471 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -164.44 85.07 0.43 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.048 -0.723 . . . . 40.25 109.048 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -136.33 130.6 33.11 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.872 -0.604 . . . . 64.04 110.716 -172.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.556 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.1 m -106.43 104.64 14.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.761 -0.654 . . . . 74.51 109.818 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' THR . 12.1 p -88.53 132.55 33.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.13 0.491 . . . . 54.55 110.928 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.435 ' HA ' HG22 ' A' ' 9' ' ' THR . 25.0 mp0 -89.2 123.39 33.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.811 -0.631 . . . . 73.24 110.129 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.485 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.5 mm? -83.6 -23.86 31.73 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.926 -0.768 . . . . 71.5 108.926 175.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.451 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 93.19 179.63 39.73 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.077 -0.965 . . . . 75.12 112.058 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -80.82 87.1 5.92 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.219 -0.289 . . . . 63.23 110.219 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.552 HG12 HG22 ' A' ' 5' ' ' VAL . 7.9 p -71.95 136.0 26.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.51 -0.552 . . . . 74.22 109.51 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.423 ' HA ' HG22 ' A' ' 4' ' ' THR . 76.3 mtp180 -78.82 130.29 35.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.245 -0.434 . . . . 73.44 110.411 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.0 p -82.03 13.09 3.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.065 -0.516 . . . . 72.13 111.224 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.4 -22.47 17.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.177 0.513 . . . . 63.02 109.785 174.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -81.88 -15.72 53.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.462 -0.79 . . . . 32.01 110.541 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 5.0 mp -125.87 117.19 22.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.06 -0.719 . . . . 74.54 109.06 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.96 10.35 2.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.763 0.653 . . . . 50.3 112.763 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -153.98 156.21 37.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.358 -0.238 . . . . 74.24 110.358 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 42.2 tt0 -61.04 131.04 49.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.396 -0.366 . . . . 73.12 110.047 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.45 -1.96 57.36 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.686 -0.769 . . . . 54.15 111.939 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -78.09 115.57 17.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.008 0.432 . . . . 63.42 110.012 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.568 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 4.7 p -111.46 135.43 52.02 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.766 -0.652 . . . . 64.32 110.431 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 t -88.07 179.47 6.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 62.02 109.649 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 m -71.55 139.57 49.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.725 -0.472 . . . . 63.3 109.725 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.514 ' HB2' ' HE ' ' A' ' 136' ' ' ARG . . . -90.96 152.61 20.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.311 0.576 . . . . 75.54 112.03 -175.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 24.7 m -83.53 158.56 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.77 -1.105 . . . . 54.33 109.199 168.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.79 89.92 0.51 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.896 -0.669 . . . . 65.21 112.054 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -103.25 175.56 5.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.575 -0.528 . . . . 73.21 109.575 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.58 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.3 p-10 -143.68 155.06 44.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.367 0.603 . . . . 54.25 111.869 -174.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.422 HD12 ' CE2' ' A' ' 133' ' ' PHE . 80.0 mt -115.05 112.62 40.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.052 -0.976 . . . . 74.22 108.903 171.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -96.52 128.25 43.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.036 0.445 . . . . 74.34 110.703 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.3 mt -110.33 126.01 53.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.88 -0.6 . . . . 60.54 110.046 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -105.36 145.09 31.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.019 -0.537 . . . . 72.24 109.555 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 30.2 t70 49.69 69.14 0.63 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.926 0.869 . . . . 71.34 110.563 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.415 ' SG ' HD22 ' A' ' 124' ' ' LEU . 10.2 t -106.28 114.84 29.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.048 -0.978 . . . . 63.05 109.734 -176.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -96.68 131.59 43.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.08 -0.509 . . . . 75.43 111.515 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.0 p -102.24 12.8 36.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 71.12 111.879 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -87.87 -26.36 22.81 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.539 -0.541 . . . . 65.42 109.539 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.73 -32.97 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.674 -0.694 . . . . 63.44 110.841 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -113.57 -179.19 3.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.725 0.298 . . . . 71.34 111.326 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 29.4 m -139.32 -55.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.503 -0.317 . . . . 74.4 111.596 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -136.31 144.7 44.84 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 110.408 -0.219 . . . . 72.43 110.408 -177.031 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.512 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -103.23 137.29 41.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.967 0.413 . . . . 65.24 110.72 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.39 113.74 6.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 74.31 109.417 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.709 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -87.01 145.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.98 0.419 . . . . 54.24 110.977 -173.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.563 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -118.18 122.06 42.07 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.738 -0.665 . . . . 53.45 109.919 174.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.466 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 88.6 m-85 -87.58 130.62 34.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.297 0.57 . . . . 75.34 110.812 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.5 tp -125.41 122.66 37.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.605 -0.725 . . . . 75.04 109.763 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.05 -171.43 29.28 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.768 -0.651 . . . . 63.42 111.586 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.419 ' O ' HD13 ' A' ' 86' ' ' LEU . 8.8 m -84.59 119.9 25.73 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.374 -0.232 . . . . 71.23 110.374 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -78.65 144.67 35.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.522 -0.308 . . . . 65.43 110.987 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.409 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 6.7 tt -69.79 -37.29 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.417 . . . . 73.11 110.835 178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.33 175.45 10.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.316 -0.624 . . . . 73.42 109.316 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.34 -37.15 38.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.083 0.468 . . . . 70.25 110.323 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.5 -19.01 67.2 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.591 -0.814 . . . . 74.54 111.276 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -111.17 47.57 0.99 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.16 0.505 . . . . 74.42 109.728 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.511 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -74.14 4.1 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.602 -0.727 . . . . 53.01 112.373 -176.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 30.3 p-10 -108.09 -0.6 21.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.158 0.504 . . . . 71.34 110.288 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 102' ' ' GLN . 46.2 t -108.01 125.82 64.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.875 -0.602 . . . . 62.42 110.153 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.504 HD22 ' CD1' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -69.0 134.42 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.382 -0.372 . . . . 72.12 110.588 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.409 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.36 150.27 35.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.06 -0.518 . . . . 43.32 110.483 177.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.428 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.5 mm? -91.77 134.47 34.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.313 -0.403 . . . . 74.0 110.451 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 . . . . . 0 C--N 1.324 -0.516 0 CA-C-O 121.364 0.602 . . . . 52.11 110.611 -179.5 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 110.18 -0.304 . . . . 72.44 110.18 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.95 149.89 21.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.784 -0.45 . . . . 75.43 109.784 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.45 167.54 21.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.918 -0.401 . . . . 64.25 109.918 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 68.62 10.18 7.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.17 0.51 . . . . 71.04 110.498 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.07 -177.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.634 -0.712 . . . . 73.04 110.444 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.84 -174.78 46.86 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.171 -1.172 . . . . 75.01 110.171 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.65 115.27 46.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.364 0.602 . . . . 71.01 110.62 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.412 ' HB3' HG22 ' A' ' 85' ' ' VAL . 10.2 pt20 -107.28 135.42 48.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.206 -0.664 . . . . 72.44 109.206 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.466 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -95.83 123.61 48.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.968 0.413 . . . . 73.32 110.813 -175.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.52 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 15.5 mt -88.65 136.19 33.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.485 -0.779 . . . . 72.12 109.336 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.2 OUTLIER -71.78 -173.64 1.02 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.776 -0.453 . . . . 72.34 109.776 175.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.47 ' HG3' HG23 ' A' ' 107' ' ' THR . 15.4 ptm180 -57.96 -23.77 55.15 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.973 0.36 . . . . 73.3 111.973 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.47 HG23 ' HG3' ' A' ' 106' ' ' ARG . 71.0 p -102.02 11.41 38.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.792 0.33 . . . . 52.31 111.647 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.52 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 76.52 35.57 41.13 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.836 -0.697 . . . . 61.54 112.985 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.63 120.71 42.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.352 -0.24 . . . . 75.35 110.352 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 103' ' ' ILE . . . -65.83 111.42 3.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.984 0.421 . . . . 74.13 110.534 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.5 mt -78.26 132.93 37.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.849 -0.614 . . . . 72.4 111.3 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.515 ' H ' HG21 ' A' ' 117' ' ' THR . 15.3 m -67.55 142.06 56.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.492 -0.776 . . . . 54.44 110.598 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.504 ' CD1' HD22 ' A' ' 86' ' ' LEU . 59.5 mt -81.79 44.15 0.81 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.057 0.456 . . . . 74.25 110.808 -177.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -92.97 -18.03 23.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.836 -0.62 . . . . 75.32 110.516 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.58 -16.29 46.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.613 -0.803 . . . . 53.24 112.325 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.82 8.11 20.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.476 . . . . 54.15 110.717 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.515 HG21 ' H ' ' A' ' 112' ' ' THR . 2.1 m -97.03 95.88 8.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.011 -0.541 . . . . 71.23 110.059 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.715 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 65.3 m-85 -93.61 158.0 15.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.178 -0.465 . . . . 73.44 111.405 -173.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 5.7 m -69.58 -175.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.639 -0.71 . . . . 71.52 111.586 178.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.9 t -69.37 163.52 24.98 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.765 -0.457 . . . . 62.42 109.765 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.418 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 48.9 mt-10 -68.03 104.58 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 54.24 111.245 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.513 HG21 HG12 ' A' ' 131' ' ' ILE . 75.1 m -85.14 99.11 10.85 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.649 -0.501 . . . . 64.1 109.649 173.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.4 m -56.16 112.92 1.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.719 -0.673 . . . . 75.33 110.585 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 69' ' ' ALA . 85.1 mt -74.33 144.39 44.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 52.42 111.712 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -117.41 141.93 47.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.188 -0.915 . . . . 75.01 109.215 173.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -55.59 116.69 3.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.36 0.413 . . . . 63.42 110.868 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 119.67 -111.51 2.05 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.592 -0.813 . . . . 73.21 112.57 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.6 m -112.05 134.77 53.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.943 0.401 . . . . 50.04 111.198 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -131.17 124.11 29.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.948 -0.569 . . . . 73.43 110.122 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.58 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.7 m -110.75 107.06 16.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.738 0.304 . . . . 72.22 110.331 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 122' ' ' THR . 13.7 mt -88.14 118.04 69.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.365 -0.38 . . . . 72.4 110.119 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.18 137.98 9.83 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.812 2.341 . . . . 74.31 112.956 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 74.2 m-85 -136.43 161.84 34.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 73.1 111.135 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 74.2 mt-30 -130.17 118.1 20.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 72.31 110.934 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -107.05 125.62 51.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.134 -0.321 . . . . 63.14 110.134 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.568 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 10.1 ptp180 -138.64 163.53 31.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.011 0.434 . . . . 54.3 111.092 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 64.4 m-85 -81.52 142.3 32.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 73.14 111.053 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -126.4 116.84 21.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.435 -0.802 . . . . 74.1 109.376 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -82.19 131.28 35.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.479 -0.328 . . . . 53.14 110.566 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 68.9 p -101.3 2.84 40.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.645 0.736 . . . . 75.15 109.471 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 173.81 -134.75 2.97 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.742 -1.117 . . . . 71.13 110.635 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 144' ' ' THR . . . -78.08 85.91 4.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.712 0.256 . . . . 75.03 110.338 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -46.48 111.67 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.614 0.571 . . . . 42.32 111.781 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 142' ' ' ALA . 20.4 p -102.49 144.49 28.71 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-O 121.075 0.464 . . . . 72.43 111.232 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.41 167.38 26.49 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.413 2.742 . . . . 72.41 112.648 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.39 -128.78 3.14 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.867 -0.682 . . . . 70.52 111.783 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -120.68 117.24 27.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.719 0.295 . . . . 51.15 110.468 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.428 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -118.09 74.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.164 0.507 . . . . 42.03 111.309 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -117.31 138.67 51.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.963 -0.562 . . . . 70.24 109.897 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.473 ' HB3' HG13 ' A' ' 10' ' ' VAL . . . -135.63 171.58 14.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.586 0.587 . . . . 64.12 112.586 -172.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -134.01 128.67 34.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.247 -0.888 . . . . 73.55 109.739 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.415 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -150.67 144.31 25.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.281 0.562 . . . . 74.13 111.867 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.438 HG22 ' HB3' ' A' ' 13' ' ' LYS . 21.7 p -112.4 150.67 30.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.694 -0.684 . . . . 51.24 109.529 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -121.92 134.25 54.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.257 0.551 . . . . 64.34 111.219 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.715 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 20.2 ttmt -111.22 101.57 10.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.608 -0.724 . . . . 70.23 110.499 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.709 HG12 HG12 ' A' ' 71' ' ' VAL . 1.3 m -75.13 126.82 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 119.983 -0.687 . . . . 74.15 109.539 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -108.48 111.82 23.9 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.874 -0.603 . . . . 70.13 110.434 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 120.882 0.372 . . . . 73.13 110.839 171.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.857 0.36 . . . . 72.33 110.259 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.489 ' CG2' HG12 ' A' ' 37' ' ' VAL . 35.5 m -88.42 13.19 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.189 0.519 . . . . 75.24 110.715 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 63.67 14.31 8.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.233 -0.894 . . . . 71.14 112.502 172.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.43 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 88.59 94.45 1.04 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.674 -0.774 . . . . 71.34 111.677 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.412 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -84.66 152.22 27.29 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.425 -0.893 . . . . 53.55 112.084 -176.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.531 ' HB ' HG22 ' A' ' 31' ' ' THR . 21.0 p -143.06 139.97 30.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.342 -0.244 . . . . 74.41 110.342 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.29 126.28 68.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.835 -0.432 . . . . 72.12 109.835 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -93.91 112.7 24.58 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.574 -0.528 . . . . 64.13 109.574 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -100.08 122.64 43.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.962 -0.563 . . . . 53.11 110.657 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HB3' HG22 ' A' ' 153' ' ' THR . 59.3 tttm -112.09 136.09 51.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 61.5 110.092 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.08 -120.72 3.41 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.715 -0.755 . . . . 64.0 112.349 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.573 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 34.8 mt-10 63.28 20.01 12.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.06 0.457 . . . . 75.54 110.943 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.634 HG21 ' HA ' ' A' ' 155' ' ' LYS . 18.9 m -80.39 -21.95 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.661 . . . . 72.34 112.207 -175.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.411 HG13 HG23 ' A' ' 16' ' ' VAL . 17.3 m -133.49 157.3 42.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.237 0.542 . . . . 61.03 112.032 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -157.54 24.74 0.29 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.696 -1.138 . . . . 63.41 108.49 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.1 -81.07 0.32 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 64.43 111.664 -174.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.407 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -93.77 -38.78 11.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.951 0.405 . . . . 63.54 110.917 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 2.0 m -137.36 128.58 27.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.126 -0.488 . . . . 75.01 110.148 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.08 125.54 35.9 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.645 -0.707 . . . . 71.14 110.361 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.473 ' HA ' HD23 ' A' ' 58' ' ' LEU . 15.8 t -66.23 128.66 29.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.72 -0.474 . . . . 70.41 109.72 177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.27 145.49 42.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.154 -0.475 . . . . 64.35 111.235 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.553 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -63.11 -22.13 66.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 75.11 111.71 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.66 -10.24 79.72 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.732 -0.747 . . . . 60.41 111.876 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.0 t -104.3 -27.5 11.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.088 . . . . 54.22 110.827 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.573 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 27.7 m -74.66 -6.84 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.095 0.474 . . . . 74.41 110.923 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -153.54 95.14 1.87 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.36 -0.836 . . . . 73.41 109.356 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -151.57 137.73 18.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.888 -0.596 . . . . 63.25 110.681 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.531 HG22 ' HB ' ' A' ' 9' ' ' THR . 6.9 m -115.66 111.96 21.4 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.591 -0.731 . . . . 73.34 109.698 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 p -92.87 139.54 17.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.846 0.355 . . . . 74.53 110.691 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.439 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.4 mp0 -95.86 126.75 41.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.239 -0.437 . . . . 53.52 110.362 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -91.32 -27.59 18.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.39 0.614 . . . . 70.55 109.482 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.43 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.58 171.71 37.76 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.263 -0.881 . . . . 71.21 112.127 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -73.02 88.17 1.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.778 0.323 . . . . 72.34 110.717 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.489 HG12 ' CG2' ' A' ' 5' ' ' VAL . 9.8 p -67.44 151.93 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.478 -0.328 . . . . 71.01 110.171 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -91.31 125.02 35.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.095 -0.502 . . . . 60.53 110.725 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.3 p -74.71 -15.04 60.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.947 -0.569 . . . . 71.03 111.047 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.98 -22.51 60.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.475 . . . . 53.35 111.204 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 m -85.66 -33.93 21.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.136 0.494 . . . . 51.04 110.638 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.5 mp -108.61 97.74 7.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.986 -0.552 . . . . 71.02 109.956 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.25 14.87 4.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.025 0.441 . . . . 74.01 111.119 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -152.49 146.98 25.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.858 -0.61 . . . . 64.15 110.086 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 44.2 tt0 -62.65 130.76 46.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 63.34 110.303 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.98 -5.93 42.95 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.678 -0.772 . . . . 73.12 111.617 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -74.88 119.93 19.73 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.99 -0.374 . . . . 70.41 109.99 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.582 ' HB ' HH11 ' A' ' 136' ' ' ARG . 37.9 p -115.15 126.07 54.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.115 -0.493 . . . . 72.2 110.476 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.2 t -80.0 172.4 13.83 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.836 -0.431 . . . . 55.12 109.836 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.7 m -69.58 134.99 49.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.302 -0.408 . . . . 71.42 110.054 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -86.98 162.12 17.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.625 0.726 . . . . 62.34 111.93 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.5 m -104.66 152.22 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.575 -1.193 . . . . 61.41 109.349 172.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.82 105.23 2.19 Favored Glycine 0 C--N 1.312 -0.779 0 C-N-CA 120.802 -0.714 . . . . 75.11 112.188 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -117.93 171.89 7.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.12 -0.696 . . . . 65.43 109.12 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.82 139.6 32.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.526 0.679 . . . . 74.24 112.507 -175.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.443 HD13 ' CD1' ' A' ' 154' ' ' PHE . 45.9 mt -95.22 116.48 36.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.268 -0.878 . . . . 71.04 109.585 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -93.32 133.39 36.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.771 -0.65 . . . . 75.24 111.249 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 23' ' ' VAL . 69.3 mt -117.76 129.68 55.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.59 -0.732 . . . . 63.24 109.587 176.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -103.89 146.24 28.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.297 -0.41 . . . . 75.43 110.493 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 49.95 41.84 23.56 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.873 0.733 . . . . 50.53 111.235 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.423 ' SG ' HD22 ' A' ' 124' ' ' LEU . 53.6 t -76.76 124.55 27.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.83 -0.623 . . . . 72.52 110.492 -175.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.52 132.48 45.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.054 -0.521 . . . . 71.31 111.292 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.8 p -107.62 18.21 21.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.093 0.473 . . . . 72.31 111.661 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -90.85 -33.66 15.57 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.975 -0.75 . . . . 62.42 108.975 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 p -101.71 -12.88 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.548 -0.751 . . . . 52.11 111.086 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -135.45 169.47 17.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.692 0.282 . . . . 72.41 110.997 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.506 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 44.8 m -129.01 -57.13 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 35.33 111.97 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -135.91 141.73 44.59 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 122.164 -0.335 . . . . 75.22 110.172 -176.26 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.461 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -104.32 134.7 47.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.218 0.533 . . . . 72.24 110.495 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.86 120.43 12.5 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.351 -0.841 . . . . 71.15 109.201 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 156' ' ' VAL . 1.6 m -93.78 149.44 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.067 0.461 . . . . 64.01 110.965 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.22 119.32 32.87 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.461 -0.791 . . . . 75.52 109.396 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 62.7 m-85 -83.09 126.28 32.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.955 0.407 . . . . 62.2 110.547 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.8 tp -122.42 127.65 49.92 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.897 -0.592 . . . . 65.13 109.857 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.75 -164.44 26.47 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.343 -0.703 . . . . 71.33 111.343 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.418 ' O ' HD13 ' A' ' 86' ' ' LEU . 8.7 m -82.35 128.33 34.11 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.614 0.207 . . . . 74.23 110.476 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -87.67 148.48 24.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.176 -0.305 . . . . 63.43 110.176 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.3 tt -74.33 -25.64 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.988 0.423 . . . . 64.2 110.731 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -155.66 -174.2 4.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.522 -0.547 . . . . 73.43 109.522 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.88 -44.11 13.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.078 0.466 . . . . 72.01 110.067 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.3 -18.56 71.23 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.723 -0.751 . . . . 65.21 111.333 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -104.98 46.22 0.93 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.352 0.596 . . . . 73.03 109.89 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.409 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -78.9 12.42 2.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.53 -0.759 . . . . 72.14 111.803 -178.685 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -107.6 -12.35 15.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.061 -0.518 . . . . 65.21 110.491 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 65.0 t -106.92 125.83 62.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.916 -0.584 . . . . 62.04 110.778 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.55 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -66.08 133.19 50.24 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.795 -0.446 . . . . 72.33 109.795 178.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.15 147.8 36.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.449 . . . . 51.35 110.114 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 2.0 mm? -78.77 145.56 34.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.133 -0.485 . . . . 73.32 110.111 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 8.8 mm-40 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.923 -0.581 . . . . 70.24 110.647 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.736 -0.468 . . . . 75.0 109.736 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.4 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -74.62 142.0 44.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.073 -0.343 . . . . 71.35 110.073 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.0 163.44 30.28 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.02 -0.363 . . . . 60.51 110.02 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.2 m120 70.32 10.68 7.33 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.512 0.508 . . . . 71.54 110.824 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 143' ' ' ALA . 0.0 OUTLIER -146.63 -177.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.658 -0.701 . . . . 60.32 109.677 174.364 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 172.71 -175.89 45.68 Favored Glycine 0 N--CA 1.437 -1.259 0 N-CA-C 110.602 -0.999 . . . . 75.35 110.602 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.52 114.58 46.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.399 0.619 . . . . 72.14 110.83 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.408 ' HG2' ' HB2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -106.37 140.14 39.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.52 -0.764 . . . . 53.31 109.596 176.39 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 103' ' ' ILE . 3.9 mp -101.58 123.85 54.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.233 -0.44 . . . . 74.52 110.256 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 16.4 mt -87.74 148.61 24.66 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.537 -0.756 . . . . 62.34 109.411 176.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.567 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 2.1 p-10 -72.39 -170.74 0.68 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.715 -0.476 . . . . 64.22 109.715 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -72.09 -17.09 62.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.135 0.42 . . . . 75.34 112.135 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.6 p -89.23 -36.99 15.32 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.553 -0.459 . . . . 74.51 110.683 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.87 31.04 0.72 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.658 -0.782 . . . . 52.13 113.363 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -117.76 133.04 56.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.783 0.292 . . . . 62.04 110.517 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.03 141.61 57.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.962 0.41 . . . . 65.14 110.973 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.433 HD12 ' HD1' ' A' ' 73' ' ' PHE . 80.6 mt -91.09 -176.53 4.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.039 -0.528 . . . . 61.1 110.214 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.3 m -125.29 142.01 51.75 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.003 -0.369 . . . . 53.21 110.003 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 53.9 mt -84.46 39.48 0.73 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.384 -0.371 . . . . 75.41 111.548 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -102.19 -0.59 32.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.99 0.424 . . . . 62.3 110.26 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.3 3.22 45.5 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.747 -0.66 . . . . 53.44 113.141 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -120.88 -11.6 8.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.932 0.366 . . . . 72.45 111.051 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.2 m -91.16 108.6 19.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.015 -0.365 . . . . 71.41 110.015 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.53 ' CE1' ' HE3' ' A' ' 155' ' ' LYS . 93.7 m-85 -98.27 163.96 12.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.107 0.479 . . . . 72.13 111.228 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 4.0 m -70.23 175.33 4.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 62.12 110.499 175.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.0 t -68.08 146.09 53.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.229 -0.656 . . . . 75.43 109.229 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -53.76 112.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 62.01 111.444 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.6 m -97.19 106.6 18.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.744 -0.662 . . . . 74.2 109.542 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.5 m -58.49 116.34 3.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.228 0.537 . . . . 64.13 111.277 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 69' ' ' ALA . 87.8 mt -77.31 152.44 34.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.362 -0.836 . . . . 72.42 111.544 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -122.5 153.34 39.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.514 -0.767 . . . . 72.34 109.583 173.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 82.8 m-20 -68.58 106.63 2.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.838 0.352 . . . . 61.41 110.793 176.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 131.88 -128.72 5.39 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.747 -0.739 . . . . 64.11 112.497 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.3 m -94.09 127.46 39.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.841 0.353 . . . . 64.51 110.709 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -123.58 150.05 44.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.283 -0.417 . . . . 74.13 110.216 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.59 111.43 10.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.355 -0.384 . . . . 70.21 111.068 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 mt -90.99 110.17 40.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.233 -0.654 . . . . 74.23 109.233 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.6 133.9 9.61 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.914 2.409 . . . . 72.33 112.127 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.482 ' HE1' ' HG ' ' A' ' 119' ' ' SER . 74.3 m-85 -131.27 158.85 39.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.426 -0.352 . . . . 74.13 110.501 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 92.4 mt-30 -123.04 113.53 19.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.864 -0.607 . . . . 75.12 110.804 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.75 126.89 44.5 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 121.008 -0.277 . . . . 61.1 110.329 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.582 HH11 ' HB ' ' A' ' 48' ' ' THR . 13.1 ptp180 -140.8 162.85 34.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.859 0.361 . . . . 71.42 110.809 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 62.3 m-85 -82.28 137.44 34.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.016 -0.538 . . . . 74.21 110.853 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.421 ' HD1' HG22 ' A' ' 48' ' ' THR . 80.2 t80 -121.62 119.52 32.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.771 -0.65 . . . . 63.23 109.4 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -84.0 130.32 34.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.305 -0.407 . . . . 72.45 110.746 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.502 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 73.6 p -102.01 5.34 40.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.876 0.846 . . . . 71.52 109.258 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.05 -136.89 4.01 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.455 -1.248 . . . . 42.21 110.274 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.15 92.19 6.25 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.663 -0.495 . . . . 72.22 109.663 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.403 ' HB2' HG13 ' A' ' 99' ' ' VAL . . . -48.43 114.1 0.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 123.768 0.668 . . . . 34.14 111.334 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 39.9 p -101.89 140.21 20.99 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 121.209 0.528 . . . . 74.51 110.407 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.63 162.52 40.68 Favored 'Trans proline' 0 C--N 1.331 -0.364 0 C-N-CA 123.713 2.942 . . . . 52.35 113.342 -174.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 142.08 -167.05 26.16 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.797 -0.638 . . . . 45.35 111.731 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.88 114.03 4.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 72.43 110.894 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.484 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . . . -112.77 49.85 0.91 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.441 0.639 . . . . 71.44 110.806 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.52 ' O ' ' HG2' ' A' ' 89' ' ' GLN . 89.1 m-20 -105.79 147.53 28.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.368 -0.833 . . . . 54.3 109.411 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.55 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -148.82 169.24 20.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.717 0.294 . . . . 71.13 111.083 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -140.16 147.73 40.57 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.528 -0.545 . . . . 42.54 109.528 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.19 144.46 21.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.992 0.425 . . . . 73.12 111.346 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 13' ' ' LYS . 22.7 p -103.11 123.98 47.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.83 -0.623 . . . . 64.32 109.756 175.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.443 ' CD1' HD13 ' A' ' 56' ' ' ILE . 39.5 p90 -97.21 124.11 41.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.255 0.55 . . . . 62.24 110.654 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.634 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.1 tmmm? -107.31 104.23 13.79 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.782 -0.645 . . . . 65.44 109.87 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 71' ' ' VAL . 1.3 m -75.55 147.95 7.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.026 0.441 . . . . 63.31 110.046 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -133.51 129.39 37.07 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.232 -0.655 . . . . 73.43 109.232 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.617 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 121.042 0.449 . . . . 73.4 110.989 175.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.905 0.383 . . . . 64.42 110.563 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.35 15.64 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.104 0.478 . . . . 75.22 110.526 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m120 65.09 11.97 7.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.186 -0.915 . . . . 34.35 112.348 171.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.484 ' N ' ' HG2' ' A' ' 36' ' ' GLN . . . 87.8 98.25 0.91 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.441 -0.885 . . . . 53.43 111.537 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.68 153.06 22.91 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.191 -1.004 . . . . 52.42 112.046 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.658 ' HB ' HG22 ' A' ' 31' ' ' THR . 75.0 p -137.05 140.47 42.07 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.857 -0.423 . . . . 74.21 109.857 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -110.85 118.82 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 109.7 -0.481 . . . . 71.4 109.7 176.651 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 13.1 t-80 -85.88 106.52 17.15 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.987 0.422 . . . . 52.01 110.005 177.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 77.8 m-85 -94.64 114.43 26.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.968 -0.56 . . . . 72.35 110.313 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 62.9 tttp -109.54 132.73 53.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.678 -0.692 . . . . 54.13 110.179 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.94 -114.64 3.01 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.89 -0.672 . . . . 41.3 112.073 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.672 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 37.4 mt-10 63.94 17.14 10.38 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.006 0.432 . . . . 75.12 111.236 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 155' ' ' LYS . 18.4 m -75.19 -30.88 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.905 -0.589 . . . . 72.33 111.92 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.453 HG21 ' CG2' ' A' ' 156' ' ' VAL . 29.6 m -140.16 154.7 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.246 0.546 . . . . 71.24 111.921 -174.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -155.29 28.61 0.4 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.026 -1.101 . . . . 70.12 108.026 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.43 -78.04 0.32 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.252 -0.886 . . . . 64.3 111.523 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.508 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -83.9 -37.63 22.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.124 0.487 . . . . 71.34 110.585 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.8 m -142.87 131.53 22.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.759 -0.655 . . . . 74.44 109.567 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.63 124.45 35.07 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.177 -0.465 . . . . 73.1 110.307 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.471 ' HA ' HD23 ' A' ' 58' ' ' LEU . 6.0 t -66.13 124.69 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.244 -0.651 . . . . 63.33 109.244 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' HG13 ' A' ' 28' ' ' VAL . 16.5 t70 -56.89 139.84 50.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 71.35 111.206 -175.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -59.72 -24.44 63.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 74.12 112.146 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.68 -17.55 70.35 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.555 -0.831 . . . . 60.04 111.915 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 p -104.98 -13.28 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.723 0.268 . . . . 65.03 111.723 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.672 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 34.7 m -78.68 -10.59 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.039 0.447 . . . . 63.03 110.623 177.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -152.68 90.43 1.48 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.415 -0.811 . . . . 73.02 108.882 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -142.99 115.96 8.83 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.517 0.675 . . . . 62.53 110.726 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.658 HG22 ' HB ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -97.1 97.02 8.86 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.277 -0.874 . . . . 54.22 108.96 176.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 9' ' ' THR . 8.8 p -75.63 132.3 33.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.938 0.399 . . . . 74.14 110.987 -175.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.56 ' HA ' HG22 ' A' ' 9' ' ' THR . 27.3 mp0 -87.82 125.76 34.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.103 -0.499 . . . . 73.34 110.107 177.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.409 HD21 HG23 ' A' ' 10' ' ' VAL . 2.9 mm? -90.59 -32.63 16.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.963 -0.562 . . . . 65.21 109.886 177.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.447 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 99.5 168.58 30.08 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.363 -0.835 . . . . 74.24 111.599 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.484 ' HG2' ' N ' ' A' ' 7' ' ' GLY . 77.4 mt-30 -74.35 86.37 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.159 0.479 . . . . 74.25 110.598 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.24 149.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 110.043 -0.355 . . . . 61.23 110.043 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -84.53 128.71 34.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.301 -0.409 . . . . 64.01 110.345 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p -68.32 -23.32 64.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.874 -0.603 . . . . 65.34 111.526 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.48 -18.35 62.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.027 -0.533 . . . . 74.12 111.496 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 m -90.3 -0.68 57.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.381 . . . . 73.53 111.276 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 3.6 mt -134.09 43.57 2.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.319 0.58 . . . . 73.3 110.285 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.36 8.41 33.63 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.667 0.617 . . . . 54.51 112.667 -168.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -150.51 144.76 25.56 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.347 -0.242 . . . . 74.32 110.347 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 86.0 tt0 -59.4 123.17 15.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.101 0.477 . . . . 62.44 110.018 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.5 -9.77 30.58 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.823 -0.703 . . . . 30.43 111.503 -175.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 42' ' ' LEU . . . -71.2 121.86 19.13 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.641 -0.503 . . . . 71.45 109.641 173.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.424 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 25.4 p -117.0 137.0 52.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.159 0.504 . . . . 72.51 111.182 -178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.462 ' HB2' ' H ' ' A' ' 137' ' ' TYR . 64.0 m -85.63 164.45 17.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.775 -0.648 . . . . 75.22 110.689 176.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.7 m -63.99 124.46 21.64 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.66 -0.496 . . . . 51.34 109.66 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.509 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -80.59 138.91 36.5 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.217 0.532 . . . . 72.11 111.489 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.2 m -78.49 148.07 6.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.107 -0.951 . . . . 62.33 109.358 170.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.42 90.46 0.69 Allowed Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.976 -0.631 . . . . 54.31 111.579 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -99.63 174.44 6.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.811 -0.44 . . . . 74.21 109.811 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.504 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 3.7 p-10 -138.06 142.78 40.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.325 0.583 . . . . 74.32 112.21 -170.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.495 HD12 ' CE2' ' A' ' 133' ' ' PHE . 73.5 mt -111.77 119.26 59.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.693 -0.855 . . . . 74.3 108.693 169.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -104.48 140.93 37.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.115 0.484 . . . . 74.32 111.238 -171.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 23' ' ' VAL . 55.1 mt -120.36 122.62 41.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.553 -0.748 . . . . 63.24 109.753 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -100.82 152.02 21.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.761 -0.654 . . . . 73.14 110.378 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 54.38 38.69 30.01 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.968 0.793 . . . . 74.41 110.827 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.28 129.41 34.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.946 -0.57 . . . . 73.34 110.266 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.413 ' OD1' ' HB2' ' A' ' 64' ' ' ASN . 15.7 t70 -111.29 133.95 53.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.565 . . . . 74.15 110.833 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -102.58 16.23 26.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.189 0.44 . . . . 62.4 112.189 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.413 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 93.7 m-20 -90.45 -35.46 15.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.298 0.571 . . . . 73.22 109.478 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.73 -31.5 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.521 -0.763 . . . . 72.41 111.153 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.6 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -118.85 173.11 7.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.646 0.26 . . . . 75.23 110.89 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 m -133.84 -58.94 0.86 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.223 -0.444 . . . . 74.42 111.614 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -134.71 136.62 42.86 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.258 -0.275 . . . . 74.43 110.258 -177.678 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.71 139.69 36.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.994 0.426 . . . . 75.44 110.594 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.4 122.75 10.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.711 -0.677 . . . . 62.24 109.418 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.661 HG12 HG12 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -96.53 147.07 6.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.068 0.461 . . . . 70.35 110.973 -175.298 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.49 127.09 53.67 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.733 -0.667 . . . . 71.54 109.466 173.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 83.8 m-85 -88.99 131.7 35.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.899 0.38 . . . . 74.3 110.294 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.4 tp -130.52 125.06 33.34 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.976 -0.556 . . . . 71.52 110.355 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.48 -131.95 1.3 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.647 -0.706 . . . . 70.53 111.545 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.1 m -121.34 131.06 53.97 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.177 -0.305 . . . . 74.4 110.177 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -82.46 142.09 32.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.592 -0.276 . . . . 74.51 110.847 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 tt -69.18 -26.53 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.012 0.434 . . . . 73.53 111.09 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -144.6 179.74 7.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.599 -0.519 . . . . 52.33 109.599 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.67 27.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.181 0.515 . . . . 75.43 109.745 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.37 -37.77 7.46 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.812 -0.709 . . . . 73.1 111.594 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -91.17 77.66 5.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.359 0.6 . . . . 70.44 110.163 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.446 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 9.2 p -94.53 6.17 49.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.28 -0.873 . . . . 52.44 111.586 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -111.8 2.34 17.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.207 0.527 . . . . 64.43 110.653 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 102' ' ' GLN . 47.9 t -113.65 125.98 71.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.775 -0.648 . . . . 53.11 109.73 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -68.64 135.92 52.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.648 0.261 . . . . 72.12 110.506 -178.338 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.47 149.89 34.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.086 -0.506 . . . . 74.01 110.376 177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.474 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.9 mm? -84.3 139.11 32.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.342 -0.39 . . . . 52.33 110.176 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.425 ' HG3' ' HA ' ' A' ' 150' ' ' ALA . 89.9 mt-30 . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.878 -0.601 . . . . 72.4 110.491 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 109.556 -0.535 . . . . 71.34 109.556 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.45 148.64 51.37 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.091 -0.337 . . . . 53.33 110.091 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.61 159.82 41.43 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.865 -0.334 . . . . 73.4 110.343 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 69.31 4.49 4.64 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.626 0.579 . . . . 73.51 110.586 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.474 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -146.8 151.62 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 115.279 -0.873 . . . . 74.52 109.035 173.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -153.67 -171.64 21.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.888 -0.885 . . . . 52.21 110.888 177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 10' ' ' VAL . 3.0 p -117.37 112.41 38.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.521 0.676 . . . . 74.11 110.516 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.507 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.5 pt20 -102.27 139.04 38.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.603 -0.726 . . . . 71.35 109.447 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.487 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.8 mp -101.35 117.29 46.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.899 0.38 . . . . 63.54 110.175 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 13.4 mt -86.44 144.81 27.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.622 -0.717 . . . . 54.23 109.37 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.4 p-10 -72.95 -168.24 0.46 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.759 -0.46 . . . . 54.44 109.759 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -64.03 -31.21 72.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.561 -0.29 . . . . 70.34 111.531 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.1 p -84.85 -29.96 24.88 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.829 -0.349 . . . . 70.43 111.218 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.32 34.68 1.0 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.324 -0.941 . . . . 71.52 113.246 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.39 130.61 56.25 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.96 -0.385 . . . . 51.25 109.96 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.56 119.1 14.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 62.31 110.417 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.1 mt -79.76 132.99 36.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.002 -0.544 . . . . 61.41 111.148 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.443 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 7.9 m -68.36 140.25 55.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.688 -0.687 . . . . 74.14 110.564 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 33.2 mt -85.01 42.95 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.09 -0.504 . . . . 40.34 111.203 -176.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -100.65 -3.03 31.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.006 0.432 . . . . 74.21 110.539 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.03 12.58 68.59 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.879 -0.6 . . . . 54.23 112.795 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.68 -14.45 5.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.749 0.309 . . . . 43.12 111.071 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.443 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 18.3 m -86.25 96.52 9.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.326 -0.397 . . . . 73.43 110.079 175.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -86.51 163.46 17.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.981 -0.554 . . . . 74.5 110.506 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.518 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 1.6 m -72.82 176.26 5.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.079 -0.51 . . . . 55.23 110.805 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.0 t -66.15 139.27 58.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.509 -0.552 . . . . 74.54 109.509 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -51.58 107.42 0.19 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.638 0.586 . . . . 75.43 111.387 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.5 m -93.01 106.24 18.22 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.316 -0.624 . . . . 51.05 109.316 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.55 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 26.5 m -57.36 128.58 37.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 53.33 111.163 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.33 149.86 23.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.723 -0.671 . . . . 72.21 110.918 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -126.61 158.64 35.78 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.871 -0.788 . . . . 62.4 108.871 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -62.33 117.73 6.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.855 0.36 . . . . 72.24 110.564 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 116.7 -134.77 11.53 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.47 -0.872 . . . . 62.13 112.733 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.8 m -86.76 128.61 35.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.94 0.4 . . . . 64.43 110.984 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -124.37 144.4 50.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.568 -0.53 . . . . 72.14 109.568 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 1.5 m -128.38 118.28 22.89 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.888 0.375 . . . . 74.51 110.582 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 11.2 mt -95.04 114.03 62.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.112 -0.699 . . . . 45.14 109.112 176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 2.1 Cg_endo -81.85 136.14 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.989 2.46 . . . . 71.1 112.554 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.495 ' CE2' HD12 ' A' ' 56' ' ' ILE . 76.3 m-85 -134.19 159.74 39.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.119 -0.492 . . . . 73.34 110.588 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.628 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 92.7 mt-30 -129.15 111.8 13.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.856 -0.611 . . . . 72.21 110.864 -175.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -101.64 124.54 47.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.473 -0.33 . . . . 75.11 110.358 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 4.7 ptp180 -138.13 160.09 40.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.37 -0.377 . . . . 75.35 110.536 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 69.0 m-85 -79.25 139.58 37.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.93 -0.577 . . . . 73.51 110.23 173.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -127.0 122.63 35.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.652 -0.704 . . . . 73.42 109.328 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -85.35 132.39 34.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.381 -0.372 . . . . 43.32 111.318 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.474 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 74.3 p -105.24 3.61 30.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.635 0.731 . . . . 64.32 109.19 176.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.73 -128.48 1.54 Allowed Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.798 -1.092 . . . . 54.2 110.838 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.24 96.16 10.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.098 -0.334 . . . . 75.41 110.098 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -43.75 109.56 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.721 0.638 . . . . 64.51 111.917 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 26.9 p -102.48 139.35 20.13 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 121.271 0.558 . . . . 64.32 110.407 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.24 -179.84 2.49 Favored 'Trans proline' 0 C--N 1.332 -0.299 0 C-N-CA 124.021 3.147 . . . . 71.33 113.421 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.46 -139.34 10.7 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.408 -0.814 . . . . 55.12 111.83 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.85 117.46 33.88 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.16 -0.311 . . . . 64.41 110.16 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -111.77 60.38 0.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.033 0.444 . . . . 51.5 111.565 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -106.98 145.82 31.82 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.412 -0.588 . . . . 63.14 109.412 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -148.61 168.01 23.94 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.347 -0.242 . . . . 74.35 110.347 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -147.7 146.19 29.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.119 -0.326 . . . . 64.34 110.119 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -153.2 149.3 27.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.076 -0.511 . . . . 71.42 110.911 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.0 p -101.15 127.24 47.79 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.99 -0.55 . . . . 72.4 109.757 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -99.57 129.29 45.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.311 0.577 . . . . 74.54 110.359 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.581 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -112.52 107.34 16.04 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.636 -0.711 . . . . 74.54 110.145 -178.06 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.661 HG12 HG12 ' A' ' 71' ' ' VAL . 1.5 m -79.71 147.6 6.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.984 0.421 . . . . 70.2 110.315 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -130.16 124.97 33.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.417 -0.586 . . . . 62.14 109.417 173.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.6 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 121.056 0.455 . . . . 75.13 111.045 176.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.3 p . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 121.019 0.438 . . . . 73.11 110.445 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.459 HG23 ' H ' ' A' ' 7' ' ' GLY . 35.6 m -83.83 6.61 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.006 0.431 . . . . 71.41 110.791 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 67.42 -3.46 1.06 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.352 -0.84 . . . . 64.35 112.648 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.459 ' H ' HG23 ' A' ' 5' ' ' VAL . . . 116.17 95.56 1.94 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.938 -0.649 . . . . 74.43 111.738 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.477 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -77.1 154.86 43.52 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.48 -0.867 . . . . 50.25 111.831 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.6 p -146.07 125.89 13.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.714 0.292 . . . . 73.44 110.862 -177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -105.19 122.35 58.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.369 -0.604 . . . . 60.11 109.369 176.035 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -90.23 99.28 12.33 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.379 -0.529 . . . . 73.41 110.049 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -90.86 117.14 29.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.605 -0.725 . . . . 71.2 110.023 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -110.76 136.91 49.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.04 0.448 . . . . 62.14 110.255 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.75 -126.25 5.58 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.768 -0.651 . . . . 44.44 111.82 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 29.3 mt-10 66.52 14.73 9.86 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.462 0.648 . . . . 73.42 110.526 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' A' ' 155' ' ' LYS . 29.7 m -76.29 -24.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.366 -0.834 . . . . 75.01 111.856 -175.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.517 HG21 HG22 ' A' ' 156' ' ' VAL . 19.1 m -139.08 142.27 34.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.271 0.558 . . . . 74.15 111.884 -175.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -142.62 18.72 2.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.804 -1.089 . . . . 73.44 108.239 173.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.51 -77.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.171 -0.922 . . . . 60.43 111.426 -172.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.522 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -92.47 -37.07 12.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.941 0.401 . . . . 64.12 110.258 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.34 132.09 25.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.245 -0.434 . . . . 72.24 110.303 -175.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.86 127.41 39.6 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.986 -0.552 . . . . 71.31 109.738 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.433 ' HB ' HG12 ' A' ' 28' ' ' VAL . 13.0 t -64.12 132.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.406 -0.361 . . . . 73.31 110.316 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.457 ' O ' HG13 ' A' ' 28' ' ' VAL . 19.2 t70 -57.27 139.34 53.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.938 -0.574 . . . . 73.11 110.682 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -64.02 -19.67 65.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.175 0.435 . . . . 72.32 112.175 -173.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.07 -18.53 74.47 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.394 -0.908 . . . . 74.52 111.937 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 p -110.63 -6.07 14.92 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.235 0.458 . . . . 65.54 112.235 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 25' ' ' ALA . 35.5 m -81.97 -7.29 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.912 0.387 . . . . 73.35 110.893 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -157.94 95.83 1.43 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.909 -0.774 . . . . 74.41 108.909 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -142.24 112.12 6.85 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.862 -0.608 . . . . 73.33 110.567 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.49 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.1 m -92.91 93.7 8.53 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.861 -0.792 . . . . 75.44 108.861 175.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' THR . 8.3 p -80.66 128.93 38.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.968 -0.56 . . . . 64.45 111.07 -172.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -86.62 120.99 28.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.886 -0.597 . . . . 74.12 109.685 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.44 -20.34 40.54 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.453 -0.573 . . . . 72.42 109.453 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.13 -178.72 42.07 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.203 -0.908 . . . . 73.51 111.669 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.92 90.37 6.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.615 -0.513 . . . . 61.23 109.615 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.446 HG12 HG22 ' A' ' 5' ' ' VAL . 11.8 p -64.64 136.24 26.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 61.13 110.688 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 38' ' ' ARG . 67.2 mtt180 -66.91 108.25 2.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.485 -0.779 . . . . 73.31 109.741 175.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 22.9 p -67.29 -23.63 65.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.197 0.522 . . . . 64.51 110.281 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.01 -5.77 47.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.758 -0.655 . . . . 73.15 111.389 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.9 m -97.79 -4.49 36.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 73.14 110.841 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -131.07 101.54 5.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.516 . . . . 63.23 109.755 177.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.18 15.97 5.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.244 0.461 . . . . 73.24 112.244 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.92 147.39 26.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.801 0.334 . . . . 62.43 110.983 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -58.6 123.03 14.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.664 -0.698 . . . . 75.11 109.472 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.464 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 101.97 8.48 44.91 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.512 -0.852 . . . . 73.12 111.965 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.697 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -79.9 128.28 33.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.065 -0.346 . . . . 75.14 110.065 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 p -115.79 118.92 34.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.917 -0.583 . . . . 63.22 110.378 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.1 t -83.68 173.59 11.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.86 0.362 . . . . 41.13 110.256 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.2 m -69.21 129.29 39.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.853 -0.612 . . . . 53.43 110.093 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -82.22 165.19 20.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.745 0.783 . . . . 74.43 112.071 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.9 m -101.39 157.62 4.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.458 -1.246 . . . . 64.24 109.22 169.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.5 107.49 2.27 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.829 -0.701 . . . . 65.55 112.059 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -125.07 178.61 5.45 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.749 -0.463 . . . . 64.3 109.749 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.494 ' HB2' HG22 ' A' ' 130' ' ' THR . 30.2 p30 -137.26 156.99 47.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.46 0.648 . . . . 72.21 111.99 -174.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.487 HD13 ' CD1' ' A' ' 154' ' ' PHE . 65.3 mt -123.51 105.37 15.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 107.956 -1.127 . . . . 72.43 107.956 167.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 26.1 tt0 -99.05 143.29 29.49 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.939 -0.573 . . . . 64.13 110.72 -171.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 23' ' ' VAL . 41.5 mt -117.96 125.46 50.46 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.056 -0.52 . . . . 73.34 109.847 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -100.51 143.1 31.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.045 -0.525 . . . . 73.31 110.107 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 52.9 46.96 25.72 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.834 0.708 . . . . 63.1 110.926 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 44.5 t -79.26 139.92 37.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.114 -0.948 . . . . 64.11 110.812 -175.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 64' ' ' ASN . 26.6 t70 -108.89 151.47 26.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.045 -0.525 . . . . 61.44 111.592 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 75.6 p -122.92 11.88 9.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.464 -0.334 . . . . 73.44 111.66 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.408 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 56.3 m-80 -81.44 -35.32 30.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.449 -0.574 . . . . 71.0 109.449 177.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.39 -27.9 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.531 -0.759 . . . . 75.35 110.805 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -112.05 166.41 11.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.045 0.45 . . . . 73.1 111.675 -176.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 m -132.7 -56.37 0.94 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.101 -0.5 . . . . 65.25 110.994 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.835 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -136.59 131.06 33.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.458 -0.337 . . . . 73.14 110.194 -177.048 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 158' ' ' TYR . . . -88.38 139.67 30.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.848 0.356 . . . . 32.23 110.707 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -143.88 114.36 7.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.645 -0.707 . . . . 52.32 109.672 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.612 HG12 HG12 ' A' ' 156' ' ' VAL . 0.8 OUTLIER -93.48 143.28 11.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.967 0.413 . . . . 63.22 110.563 -175.473 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.511 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -118.6 125.73 50.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.01 -0.541 . . . . 61.12 110.26 175.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 86.4 m-85 -91.73 122.67 34.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 72.13 110.319 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.3 tp -118.9 133.25 55.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.009 -0.542 . . . . 75.23 110.066 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.91 -174.48 41.6 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.237 -0.745 . . . . 53.23 111.237 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.8 m -75.99 128.0 34.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.803 0.302 . . . . 70.15 111.103 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -82.49 140.67 33.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.773 0.321 . . . . 53.34 110.648 177.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.503 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 11.6 tt -70.58 -27.02 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.382 -0.372 . . . . 75.11 111.458 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.56 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 20.1 t70 -141.26 179.29 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.717 -0.475 . . . . 72.55 109.717 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.94 -33.7 26.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.078 0.466 . . . . 71.11 109.774 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.58 -28.26 13.07 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.8 -0.714 . . . . 72.3 111.651 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 77.0 m80 -92.65 69.25 4.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.421 0.629 . . . . 62.42 109.554 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.471 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 4.1 p -91.26 7.99 38.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.277 -0.874 . . . . 74.21 111.201 -178.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -110.0 4.1 21.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.947 -0.569 . . . . 74.14 110.22 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 102' ' ' GLN . 58.7 t -120.04 126.38 75.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 72.4 110.141 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.539 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -70.72 133.63 46.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.656 0.265 . . . . 73.51 110.361 -178.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -79.56 155.71 28.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.004 -0.543 . . . . 72.32 110.394 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.514 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.6 mm? -81.84 148.37 28.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.293 -0.412 . . . . 75.3 110.106 -175.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 116.272 -0.422 . . . . 70.55 110.294 178.94 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 120.633 0.254 . . . . 75.43 110.48 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.26 49.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 60.22 110.816 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.14 152.92 47.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.481 -0.327 . . . . 42.22 110.702 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.413 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 42.5 m-80 68.26 7.47 5.94 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.803 -0.635 . . . . 75.14 111.919 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.514 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -147.6 151.98 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 CA-C-O 120.978 0.418 . . . . 73.3 110.758 176.082 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -151.22 -171.29 19.1 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 110.277 -1.129 . . . . 65.51 110.277 174.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 10' ' ' VAL . 2.7 p -117.1 118.81 59.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.378 0.609 . . . . 75.53 110.965 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.456 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.0 pt20 -110.46 147.09 34.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.66 -0.7 . . . . 75.01 109.793 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.3 mp -107.44 127.87 62.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.987 0.422 . . . . 73.13 110.804 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.2 mt -91.47 142.8 27.26 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.559 -0.746 . . . . 73.45 109.116 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.557 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.9 OUTLIER -75.14 -170.42 1.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.508 -0.314 . . . . 72.32 110.167 178.282 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.5 ptt85 -62.96 -24.8 68.06 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.604 0.224 . . . . 72.04 111.604 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.423 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 69.9 p -93.49 1.06 56.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 74.1 111.391 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.68 29.47 29.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.879 -0.676 . . . . 74.11 112.996 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.8 130.23 55.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.237 -0.283 . . . . 74.33 110.237 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.73 128.55 36.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.897 0.38 . . . . 63.02 111.034 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.45 148.95 23.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.956 -0.565 . . . . 65.24 110.785 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.5 m -85.66 141.9 29.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 74.45 110.251 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 63.4 mt -79.23 42.16 0.48 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.168 0.509 . . . . 73.21 110.683 -178.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.449 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 16.6 t70 -85.37 -18.72 32.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.817 -0.628 . . . . 74.52 110.936 -176.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.74 -24.77 7.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.584 -0.817 . . . . 71.25 112.454 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.2 7.5 19.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.006 0.431 . . . . 73.13 110.563 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 114' ' ' ASP . 15.8 m -93.7 97.29 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 72.42 109.853 175.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.57 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 58.3 m-85 -92.79 162.7 14.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.122 -0.49 . . . . 75.35 111.005 -174.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 5.6 m -72.97 176.35 5.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 64.35 111.314 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.9 m -65.05 131.47 46.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.231 -0.441 . . . . 62.44 110.191 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -44.25 115.48 0.85 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.027 0.829 . . . . 52.41 111.944 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.6 m -102.25 105.27 15.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.137 -0.483 . . . . 71.33 109.965 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.835 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 59.9 m -60.58 115.83 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.48 0.657 . . . . 72.4 111.361 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.539 HD13 ' SG ' ' A' ' 61' ' ' CYS . 96.0 mt -83.22 155.63 23.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.19 -0.913 . . . . 64.22 112.097 -173.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.38 153.3 50.92 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.668 -0.864 . . . . 73.43 108.668 170.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.9 m120 -63.82 112.35 2.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.956 0.408 . . . . 72.33 110.762 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.1 -137.66 9.29 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.934 -0.651 . . . . 62.53 112.046 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.7 m -93.61 126.96 39.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.71 0.291 . . . . 62.12 110.889 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -129.8 120.79 25.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.721 -0.474 . . . . 74.13 109.721 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.494 HG22 ' HB2' ' A' ' 55' ' ' ASN . 2.3 m -110.44 117.52 33.79 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.626 0.251 . . . . 74.33 110.468 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.5 mt -95.48 113.9 62.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.597 -0.52 . . . . 72.04 109.597 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.78 138.55 13.39 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.09 2.527 . . . . 72.22 112.667 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 86.5 m-85 -135.9 161.09 36.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 74.44 110.887 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.572 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 52.2 mt-30 -133.04 118.24 18.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.655 . . . . 73.01 110.751 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.37 126.7 50.67 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.318 -0.239 . . . . 55.02 110.44 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.525 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -134.44 164.99 26.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.802 0.334 . . . . 45.4 111.048 -178.021 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.477 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 63.1 m-85 -85.46 142.2 29.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.997 -0.547 . . . . 73.1 110.466 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.464 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 61.1 t80 -126.83 124.11 38.88 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.895 -0.78 . . . . 74.21 108.895 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.697 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -91.19 135.99 33.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.12 0.486 . . . . 71.31 111.572 -176.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.413 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 78.7 p -100.36 1.27 41.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.296 -0.865 . . . . 71.32 108.909 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.11 -128.77 1.7 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.553 -1.203 . . . . 71.15 111.059 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -87.55 95.71 10.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.184 -0.302 . . . . 72.01 110.184 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -46.52 112.05 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.847 -0.615 . . . . 71.14 111.587 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.2 p -107.61 149.51 38.98 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-O 121.003 0.43 . . . . 73.33 110.736 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.5 163.99 25.08 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.85 3.034 . . . . 72.0 113.239 -176.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.91 179.99 18.34 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.672 -0.694 . . . . 64.52 111.975 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.07 119.85 10.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.789 0.328 . . . . 64.14 110.707 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.01 42.64 2.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.649 0.738 . . . . 75.14 110.411 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -98.72 145.13 27.22 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.036 -0.984 . . . . 72.32 110.078 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.539 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -147.45 164.89 31.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.917 0.389 . . . . 63.24 111.322 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -123.05 133.31 54.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.321 -0.622 . . . . 72.41 109.321 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.22 128.94 14.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.932 0.396 . . . . 70.14 111.108 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.0 p -102.53 129.71 49.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.132 -0.485 . . . . 74.03 110.265 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.487 ' CD1' HD13 ' A' ' 56' ' ' ILE . 47.3 p90 -103.45 127.26 50.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.958 0.409 . . . . 73.13 110.706 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.62 ' HA ' HG21 ' A' ' 16' ' ' VAL . 6.9 ttmm -110.14 108.7 18.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.259 -0.428 . . . . 71.41 110.331 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.612 HG12 HG12 ' A' ' 71' ' ' VAL . 1.5 m -80.62 129.7 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.447 -0.575 . . . . 73.33 109.447 174.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -123.02 115.19 21.45 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.143 -0.688 . . . . 60.45 109.143 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.644 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 112.392 0.515 . . . . 75.22 112.392 -177.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 62.4 p . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.891 0.377 . . . . 65.22 110.422 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.523 HG22 HG12 ' A' ' 37' ' ' VAL . 34.8 m -91.31 17.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.013 0.435 . . . . 64.55 110.563 175.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 59.96 20.15 9.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.325 -0.852 . . . . 64.1 111.999 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.12 101.57 1.02 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.718 -0.753 . . . . 34.11 111.712 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.46 151.69 31.39 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.035 -1.078 . . . . 71.44 111.348 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.525 ' HB ' HG22 ' A' ' 31' ' ' THR . 17.4 p -141.47 135.64 30.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.55 0.214 . . . . 54.01 110.913 -176.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.45 ' CG2' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -117.49 115.89 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.566 -0.531 . . . . 65.14 109.566 174.21 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 18.1 t-80 -83.04 108.76 16.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.286 -0.415 . . . . 70.23 109.928 177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -100.03 113.78 26.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.125 -0.489 . . . . 73.14 110.302 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -106.12 135.02 48.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.867 -0.42 . . . . 42.35 109.867 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.01 -125.91 5.7 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.962 -0.637 . . . . 31.33 111.888 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 67.6 12.95 9.12 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.886 0.474 . . . . 71.11 110.93 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.569 HG23 HG13 ' A' ' 17' ' ' VAL . 34.2 m -76.38 -30.66 19.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.063 -0.517 . . . . 65.13 111.859 -173.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.569 HG13 HG23 ' A' ' 16' ' ' VAL . 24.9 m -133.75 145.46 33.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.299 0.571 . . . . 70.02 111.468 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -151.68 30.41 0.59 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.933 -1.136 . . . . 61.43 107.933 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.66 -79.26 0.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.227 -0.897 . . . . 75.53 111.214 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -90.68 -34.87 15.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.969 0.414 . . . . 53.31 110.602 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.2 m -140.78 136.31 32.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.485 . . . . 51.45 109.75 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.31 130.45 47.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.357 -0.383 . . . . 60.11 110.304 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 58' ' ' LEU . 20.7 t -67.69 130.93 33.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.964 -0.384 . . . . 60.4 109.964 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 28' ' ' VAL . 15.3 t70 -61.66 141.11 58.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.36 -0.382 . . . . 71.54 110.72 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.81 -26.99 64.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 34.12 111.798 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.84 2.67 79.02 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.792 -0.718 . . . . 75.24 112.302 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.3 p -131.89 3.05 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.593 0.235 . . . . 64.43 111.521 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 24' ' ' ASP . 35.2 m -89.4 -1.32 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.873 0.368 . . . . 62.21 110.687 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -158.72 97.58 1.45 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.085 -0.709 . . . . 73.41 109.085 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -144.6 104.01 4.0 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.483 0.658 . . . . 74.13 111.041 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.525 HG22 ' HB ' ' A' ' 9' ' ' THR . 5.8 m -81.59 94.48 6.92 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.389 -0.823 . . . . 72.24 109.096 173.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.42 140.33 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.122 -0.49 . . . . 75.14 111.043 -172.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -96.58 117.82 31.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 71.44 110.095 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.45 HD21 ' CG2' ' A' ' 10' ' ' VAL . 1.7 mm? -87.98 -23.85 23.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.444 -0.576 . . . . 74.41 109.444 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.29 166.96 32.67 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.317 -0.856 . . . . 55.22 112.618 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -73.21 94.46 1.98 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.907 -0.405 . . . . 75.21 109.907 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.523 HG12 HG22 ' A' ' 5' ' ' VAL . 9.5 p -75.54 145.24 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.19 -0.459 . . . . 54.4 110.858 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -76.47 117.56 18.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.788 -0.642 . . . . 71.34 110.562 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 29.9 p -72.67 -16.28 61.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 65.41 110.99 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.0 -16.52 54.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 71.5 110.909 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.4 m -83.23 -44.34 15.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.167 -0.47 . . . . 72.23 110.263 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 6.2 mp -93.83 95.85 9.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.18 0.514 . . . . 62.21 110.306 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.47 22.26 5.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.326 0.584 . . . . 71.3 110.379 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.431 ' HG2' ' HB2' ' A' ' 47' ' ' ALA . 3.6 pm0 -151.66 137.96 18.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.311 -0.859 . . . . 54.12 110.233 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 40.8 tt0 -62.26 123.62 18.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.978 0.418 . . . . 60.33 110.117 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.67 -13.35 27.46 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.27 -0.732 . . . . 55.32 111.27 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -63.95 121.89 15.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.67 0.272 . . . . 72.35 110.281 176.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 25.4 p -123.75 118.62 27.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.34 -0.391 . . . . 73.42 110.724 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 t -75.8 173.72 10.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.1 -0.5 . . . . 64.43 110.172 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.8 m -64.41 135.79 56.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.107 0.48 . . . . 74.2 110.446 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -85.6 159.37 19.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.733 -0.667 . . . . 44.32 111.771 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.6 m -90.48 158.41 2.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.898 -1.047 . . . . 71.1 108.991 168.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.55 81.13 0.31 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.446 -0.883 . . . . 71.34 112.237 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -95.95 165.33 12.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.989 -0.374 . . . . 75.43 109.989 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.587 ' HB2' HG22 ' A' ' 130' ' ' THR . 2.4 p-10 -138.12 144.66 40.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.38 0.609 . . . . 75.54 111.517 -175.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.409 HD13 ' CD2' ' A' ' 154' ' ' PHE . 79.7 mt -105.53 120.25 55.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.34 -0.846 . . . . 72.32 109.383 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -98.15 136.98 37.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.98 0.419 . . . . 75.41 110.643 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 23' ' ' VAL . 50.8 mt -119.04 130.75 55.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 74.54 109.597 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -108.15 144.84 35.02 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.243 -0.435 . . . . 72.34 110.395 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 53.39 46.38 26.41 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.868 0.73 . . . . 52.21 111.225 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.487 ' SG ' HD13 ' A' ' 124' ' ' LEU . 27.5 t -81.34 131.89 35.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.461 -0.791 . . . . 64.54 110.074 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.431 ' OD2' HG12 ' A' ' 65' ' ' VAL . 16.3 t70 -107.68 134.01 51.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.243 -0.435 . . . . 74.32 111.646 -175.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.1 p -104.67 13.77 30.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 73.15 112.064 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -89.07 -35.39 16.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.905 -0.406 . . . . 71.33 109.905 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.431 HG12 ' OD2' ' A' ' 62' ' ' ASP . 14.0 p -97.26 -28.31 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.975 -0.557 . . . . 74.14 111.044 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -121.1 -177.59 3.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.493 -0.322 . . . . 52.22 110.953 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.2 m -140.75 -54.89 0.5 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.644 0.259 . . . . 73.23 111.454 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.81 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -134.56 140.95 46.5 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.318 -0.239 . . . . 72.15 110.843 -178.648 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.52 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -102.59 135.4 44.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.101 0.477 . . . . 62.03 110.557 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.9 114.92 7.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.759 -0.655 . . . . 31.52 109.576 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.666 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -85.32 149.33 4.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.142 0.496 . . . . 75.31 110.895 -174.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.74 118.33 29.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.54 -0.755 . . . . 74.41 109.211 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 75.2 m-85 -83.16 128.98 34.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.027 0.441 . . . . 55.04 110.498 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.7 tp -128.22 127.44 42.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.008 -0.542 . . . . 55.23 109.804 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.47 -167.94 25.79 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.965 -0.854 . . . . 70.35 110.965 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.437 ' O ' HD13 ' A' ' 86' ' ' LEU . 9.5 m -74.29 120.85 20.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.102 0.451 . . . . 64.11 110.622 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.59 136.17 36.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.592 0.234 . . . . 72.22 110.817 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.496 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 10.9 tt -65.16 -30.6 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.29 -0.414 . . . . 72.23 111.213 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 19.9 t70 -151.3 173.21 14.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.478 -0.564 . . . . 71.2 109.478 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.59 -30.78 52.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.059 -0.519 . . . . 73.4 110.301 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.12 -20.26 28.47 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.842 -0.694 . . . . 54.1 111.711 177.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 65.1 m80 -103.5 47.85 0.87 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.382 -0.599 . . . . 55.54 109.382 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.495 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.4 p -72.81 9.63 1.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.572 -0.74 . . . . 51.32 112.331 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 16.7 p-10 -99.75 -18.6 17.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.784 0.326 . . . . 62.3 110.895 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.7 t -105.03 132.57 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.388 -0.369 . . . . 61.03 110.87 -176.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -67.29 135.18 52.94 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.21 -0.45 . . . . 72.41 110.519 179.18 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.83 146.78 33.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.964 -0.562 . . . . 60.32 109.684 175.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.2 mm? -85.7 129.87 34.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.333 -0.394 . . . . 65.15 110.77 -175.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.646 . . . . 71.04 109.493 176.907 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.412 ' HA ' ' H ' ' A' ' 147' ' ' ALA . 4.3 p . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.608 -0.516 . . . . 63.32 109.608 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.19 144.77 38.08 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.805 -0.443 . . . . 55.43 109.805 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.09 164.7 29.4 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.964 -0.384 . . . . 75.04 109.964 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.503 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 14.3 m120 69.03 8.11 6.64 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.347 0.594 . . . . 53.12 110.12 -177.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -178.23 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.023 -0.99 . . . . 73.34 109.628 173.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 175.25 -172.07 45.14 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 110.268 -1.133 . . . . 73.45 110.268 177.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 2.5 p -126.13 120.06 55.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.096 0.474 . . . . 54.32 110.409 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.441 ' OE1' ' HB1' ' A' ' 110' ' ' ALA . 25.9 pt20 -117.14 149.51 40.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.52 -0.548 . . . . 71.35 109.52 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.3 mp -101.02 128.2 53.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.089 -0.505 . . . . 71.41 110.598 -174.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 16.3 mt -94.1 146.0 24.28 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.367 -0.833 . . . . 74.21 108.917 175.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.572 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.4 OUTLIER -72.39 -173.21 1.07 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.825 -0.435 . . . . 63.1 109.825 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.427 ' HE ' ' CB ' ' A' ' 120' ' ' SER . 24.1 ptt180 -58.31 -32.49 68.52 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.556 0.206 . . . . 71.52 111.556 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.408 HG23 ' HG3' ' A' ' 106' ' ' ARG . 40.3 p -89.28 0.32 56.88 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.817 0.341 . . . . 72.14 111.793 -177.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.04 29.95 24.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 62.22 113.07 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . -102.78 134.35 46.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.364 -0.236 . . . . 72.34 110.364 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.51 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -67.05 122.76 18.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.998 0.428 . . . . 72.32 111.323 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.6 mt -90.56 148.4 22.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.026 -0.534 . . . . 74.04 110.523 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.485 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 25.8 m -96.91 142.22 29.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.258 -0.428 . . . . 51.3 110.439 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 50.0 mt -83.95 51.55 2.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 74.24 110.857 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -109.72 -5.43 15.61 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.018 0.437 . . . . 73.12 110.046 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.26 2.29 62.46 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.745 -0.661 . . . . 71.14 112.95 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.66 -13.09 9.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 63.33 111.066 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.485 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 12.1 m -85.51 100.29 11.8 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.968 -0.382 . . . . 75.21 109.968 175.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.418 ' HE1' ' HE3' ' A' ' 155' ' ' LYS . 83.3 m-85 -90.17 154.7 19.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.945 -0.571 . . . . 65.23 111.185 -176.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.572 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 11.5 m -69.64 179.73 2.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.66 -0.7 . . . . 63.32 110.843 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.427 ' CB ' ' HE ' ' A' ' 106' ' ' ARG . 40.8 t -64.14 150.19 46.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.936 -0.394 . . . . 72.22 109.936 174.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -61.83 102.73 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 73.34 111.075 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -84.5 97.81 9.76 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.864 -0.791 . . . . 70.21 108.864 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.81 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 49.8 m -60.69 122.91 15.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.073 -0.512 . . . . 61.31 110.391 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 69' ' ' ALA . 97.0 mt -80.97 151.98 28.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.383 -0.826 . . . . 61.24 112.066 -170.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -116.78 159.51 22.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.142 -0.936 . . . . 73.2 109.37 170.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.35 108.0 6.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.129 0.49 . . . . 73.11 110.356 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.27 -135.91 9.55 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.739 -0.743 . . . . 72.44 112.339 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.1 m -83.84 126.09 32.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.165 0.507 . . . . 75.21 111.335 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -124.56 160.4 28.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.716 -0.675 . . . . 74.42 109.646 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.587 HG22 ' HB2' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -144.18 122.28 12.16 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.848 -0.341 . . . . 64.04 110.576 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 7.0 mt -102.98 113.43 65.91 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.984 -0.376 . . . . 63.34 109.984 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 1.8 Cg_endo -82.9 137.31 8.62 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 123.131 2.554 . . . . 62.1 112.399 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -134.66 163.17 30.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.028 0.442 . . . . 54.22 111.211 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 104' ' ' LEU . 99.3 mt-30 -127.89 112.91 15.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.871 -0.604 . . . . 74.51 111.217 -177.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.17 121.59 42.53 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.944 -0.303 . . . . 64.32 110.236 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.55 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 10.6 ptp180 -137.45 164.05 29.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.848 0.356 . . . . 75.12 110.857 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.425 ' CE2' ' HB ' ' A' ' 37' ' ' VAL . 87.4 m-85 -78.95 147.47 32.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.607 . . . . 72.53 111.007 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -131.81 122.14 25.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.673 -0.694 . . . . 74.1 109.529 176.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -91.32 139.36 30.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.902 0.382 . . . . 61.35 111.528 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 48.0 p -103.89 -0.73 28.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.536 0.684 . . . . 74.32 109.316 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.8 -127.57 1.48 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.05 -0.977 . . . . 72.31 111.111 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.83 93.92 6.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.359 -0.237 . . . . 74.23 110.359 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.412 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.32 116.75 1.84 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.384 0.428 . . . . 74.24 111.094 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.0 p -104.12 142.67 25.09 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-O 121.256 0.551 . . . . 75.0 110.898 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.25 165.53 28.35 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.581 2.854 . . . . 72.35 113.018 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 145.99 -140.2 8.72 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.605 -0.725 . . . . 65.32 111.869 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.412 ' H ' ' HA ' ' A' ' 95' ' ' SER . . . -107.3 117.01 32.95 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.412 0.149 . . . . 64.4 110.745 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -105.97 58.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.341 0.591 . . . . 70.41 111.141 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -99.1 140.5 33.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.971 -0.558 . . . . 63.24 109.592 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.484 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -153.01 165.08 36.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.583 0.23 . . . . 74.31 110.634 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -138.91 148.0 43.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.923 -0.399 . . . . 73.22 109.923 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.518 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -154.72 146.37 23.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.097 0.475 . . . . 73.35 110.951 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.1 p -108.87 127.93 54.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.043 -0.526 . . . . 62.54 110.034 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.409 ' CD2' HD13 ' A' ' 56' ' ' ILE . 46.6 p90 -96.64 123.5 40.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.006 0.432 . . . . 72.34 110.425 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.549 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.5 tmmm? -107.49 109.12 20.72 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.201 -0.454 . . . . 71.43 109.802 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.666 HG12 HG12 ' A' ' 71' ' ' VAL . 1.4 m -78.8 136.16 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.28 0.562 . . . . 75.53 110.619 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -114.45 118.14 32.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.871 -0.604 . . . . 61.34 110.067 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.571 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 1.5 p90 . . . . . 0 C--N 1.319 -0.752 0 CA-C-O 120.997 0.427 . . . . 75.23 110.15 171.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.3 p . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.846 0.355 . . . . 54.22 110.573 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.529 HG22 HG12 ' A' ' 37' ' ' VAL . 34.4 m -91.25 16.02 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.983 0.421 . . . . 75.32 111.062 177.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 62.57 13.93 6.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.595 -0.73 . . . . 72.25 112.64 173.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.504 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 86.24 95.55 0.82 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.37 -0.919 . . . . 71.31 111.278 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.92 164.06 27.29 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.491 -0.862 . . . . 44.44 112.181 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.563 ' HB ' HG22 ' A' ' 31' ' ' THR . 63.2 p -140.85 147.74 39.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.683 0.278 . . . . 73.12 110.887 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.526 HG23 HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -112.81 123.46 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 N-CA-C 109.044 -0.725 . . . . 72.51 109.044 171.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -90.86 99.41 12.45 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.645 -0.502 . . . . 62.23 109.645 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 74.6 m-85 -88.89 117.57 27.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.781 -0.645 . . . . 65.42 110.213 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HB3' HG22 ' A' ' 153' ' ' THR . 80.1 tttt -110.12 139.35 45.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 74.03 110.736 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.88 -123.34 3.72 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.882 -0.599 . . . . 61.22 112.176 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.429 ' HG2' ' HB ' ' A' ' 28' ' ' VAL . 24.9 mm-40 60.44 19.71 9.4 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.695 0.398 . . . . 61.4 111.783 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.689 HG23 HG22 ' A' ' 17' ' ' VAL . 29.1 m -77.78 -28.79 15.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.35 -0.386 . . . . 52.33 111.581 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.689 HG22 HG23 ' A' ' 16' ' ' VAL . 7.7 m -148.04 153.05 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 53.15 110.84 -176.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -162.29 53.99 0.22 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.288 -1.005 . . . . 54.25 108.288 176.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -110.25 -72.88 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.709 -1.132 . . . . 65.13 110.274 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -76.87 -41.56 43.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.959 -0.564 . . . . 62.31 110.147 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -136.36 156.72 48.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.526 -0.546 . . . . 74.34 109.526 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.91 127.67 54.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.862 -0.421 . . . . 72.24 109.862 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.426 ' HA ' HD23 ' A' ' 58' ' ' LEU . 16.4 t -68.23 132.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.974 -0.38 . . . . 71.11 109.974 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' HG13 ' A' ' 28' ' ' VAL . 24.2 t70 -56.3 143.17 35.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 63.13 111.461 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.49 -25.09 67.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 51.34 112.143 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.73 -15.37 61.63 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.57 -0.824 . . . . 72.22 111.701 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 t -93.89 -24.94 17.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.755 -0.223 . . . . 71.34 110.804 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 24' ' ' ASP . 33.6 m -74.28 -6.92 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.829 0.347 . . . . 51.33 111.083 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -161.13 94.36 1.0 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.944 -0.761 . . . . 63.22 108.944 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.439 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 16.4 pt20 -137.95 114.9 10.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.396 0.617 . . . . 65.15 110.699 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.563 HG22 ' HB ' ' A' ' 9' ' ' THR . 5.2 m -95.91 93.8 7.24 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.205 -0.907 . . . . 63.41 109.752 177.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.23 140.08 17.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.748 -0.66 . . . . 63.1 111.164 -173.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -92.59 118.91 31.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 73.35 110.458 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.526 HD21 HG23 ' A' ' 10' ' ' VAL . 2.9 mm? -87.81 -30.26 20.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.223 0.535 . . . . 70.41 109.717 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.504 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.79 174.7 38.2 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.517 -0.765 . . . . 51.41 112.408 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.8 90.67 2.91 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.81 -0.23 . . . . 73.31 110.516 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.529 HG12 HG22 ' A' ' 5' ' ' VAL . 5.0 p -73.87 145.88 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.422 -0.584 . . . . 70.04 109.422 175.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -92.05 128.38 37.87 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.35 -0.386 . . . . 73.44 110.041 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.9 p -66.6 -24.34 66.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.02 -0.536 . . . . 74.44 111.721 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.78 -19.85 65.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.062 -0.517 . . . . 72.54 111.305 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -89.42 -0.58 57.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.126 -0.488 . . . . 72.15 111.21 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.637 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 6.8 mt -137.08 48.61 2.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.224 0.535 . . . . 64.43 110.487 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.84 16.93 16.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.136 -0.484 . . . . 63.4 112.136 -171.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 47' ' ' ALA . 4.0 pm0 -157.79 142.99 16.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.218 -0.447 . . . . 74.55 110.312 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 33.6 tt0 -59.28 123.56 17.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.942 0.401 . . . . 74.42 110.045 175.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.0 -15.58 21.02 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.206 -0.758 . . . . 64.52 111.206 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 42' ' ' LEU . . . -67.76 123.53 20.77 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.451 -0.574 . . . . 53.21 109.451 174.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.469 HG22 ' HD1' ' A' ' 138' ' ' PHE . 37.3 p -123.27 134.26 54.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.969 0.414 . . . . 73.43 110.94 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.1 t -84.43 176.37 8.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.924 -0.58 . . . . 75.55 109.611 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -68.77 133.43 48.34 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.853 -0.425 . . . . 64.52 109.853 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -88.77 152.69 21.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.599 0.714 . . . . 54.23 111.944 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 23.8 m -94.1 149.92 4.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.354 -1.294 . . . . 61.22 108.922 169.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.76 77.14 0.23 Allowed Glycine 0 C--N 1.311 -0.842 0 C-N-CA 120.988 -0.625 . . . . 61.1 112.255 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -81.77 167.98 18.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.984 -0.376 . . . . 61.05 109.984 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.558 ' HB2' HG22 ' A' ' 130' ' ' THR . 2.2 p-10 -138.05 138.44 38.8 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.998 0.427 . . . . 72.22 111.251 -175.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.405 HD13 ' CD1' ' A' ' 154' ' ' PHE . 59.5 mt -100.38 114.14 38.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.547 -0.751 . . . . 62.34 109.335 174.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -98.83 135.67 39.94 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.704 -0.68 . . . . 71.11 110.812 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 23' ' ' VAL . 70.0 mt -114.5 117.8 31.97 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.35 -0.611 . . . . 74.34 109.35 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -96.63 124.18 40.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.775 -0.648 . . . . 51.35 110.649 -175.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.7 t70 61.8 92.37 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.001 0.813 . . . . 50.52 111.122 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 48.4 t -128.6 152.83 47.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.794 -0.639 . . . . 64.21 110.627 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.414 ' HA ' ' ND2' ' A' ' 126' ' ' ASN . 18.3 t70 -116.85 142.13 47.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.873 -0.603 . . . . 74.3 110.978 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.0 p -106.08 14.08 28.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.04 0.385 . . . . 64.4 112.04 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -91.28 -31.17 16.22 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.382 -0.599 . . . . 75.24 109.382 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 20' ' ' ALA . 8.0 p -104.2 -3.79 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.549 -0.75 . . . . 65.51 111.369 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.578 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -146.57 178.83 7.99 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.319 -0.238 . . . . 63.42 110.89 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.42 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 49.4 m -143.56 -53.78 0.37 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.053 0.39 . . . . 54.34 112.053 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.726 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -137.82 141.81 40.81 Favored 'General case' 0 C--O 1.221 -0.406 0 O-C-N 122.216 -0.302 . . . . 71.35 110.437 -179.014 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.92 127.66 48.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.028 0.442 . . . . 74.55 110.594 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.72 116.18 11.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.821 -0.627 . . . . 74.04 109.729 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -90.65 146.4 6.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.963 0.411 . . . . 73.11 111.356 -173.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -119.57 123.06 43.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.736 -0.666 . . . . 62.31 109.513 171.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.56 ' CE1' HG21 ' A' ' 103' ' ' ILE . 55.3 m-85 -86.52 134.59 33.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.107 0.48 . . . . 74.34 110.959 -178.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.0 tp -131.18 129.1 41.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 74.11 110.3 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.23 -160.17 19.13 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.94 -0.864 . . . . 60.02 110.94 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.484 ' O ' HD13 ' A' ' 86' ' ' LEU . 26.3 m -88.05 130.48 34.98 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.258 -0.275 . . . . 62.01 110.258 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.421 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -85.61 144.55 27.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.268 -0.271 . . . . 62.44 110.268 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.512 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 15.3 tt -62.34 -28.18 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 74.42 111.382 -176.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -152.6 177.18 10.93 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.714 -0.476 . . . . 63.42 109.714 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.63 -27.72 34.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.191 -0.459 . . . . 65.03 110.215 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.51 -7.85 61.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.759 -0.734 . . . . 74.2 111.902 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -122.82 75.51 1.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.264 0.554 . . . . 70.43 109.945 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.421 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.9 p -90.02 16.24 8.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.691 -0.686 . . . . 63.43 111.795 -176.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -118.94 -0.29 11.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.342 -0.39 . . . . 74.33 111.163 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.422 HG22 ' HB3' ' A' ' 102' ' ' GLN . 47.3 t -117.43 127.32 74.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.35 -0.386 . . . . 54.24 110.096 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.573 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -66.77 135.22 53.63 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.658 0.266 . . . . 74.13 110.385 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.57 160.49 27.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.124 -0.489 . . . . 64.51 110.583 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.58 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.9 mm? -91.1 137.66 32.19 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.898 -0.408 . . . . 73.45 109.898 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 116.019 -0.537 . . . . 61.32 110.456 178.817 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 110.265 -0.272 . . . . 60.24 110.265 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.48 156.14 21.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.063 -0.347 . . . . 74.43 110.063 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.97 164.65 31.37 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.877 -0.329 . . . . 72.4 110.794 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 68.89 -1.73 1.96 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.619 0.768 . . . . 73.11 111.247 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.58 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -138.76 145.59 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 109.223 -0.658 . . . . 62.13 109.223 170.517 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -148.81 -167.66 13.97 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 110.753 -0.939 . . . . 75.41 110.753 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.38 110.87 28.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 121.359 0.599 . . . . 54.41 110.326 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 85' ' ' VAL . 9.6 pt20 -100.6 132.03 46.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.748 -0.66 . . . . 64.14 109.416 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.56 HG21 ' CE1' ' A' ' 73' ' ' PHE . 4.0 mp -89.03 123.83 41.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.229 0.538 . . . . 75.44 110.219 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 134' ' ' GLN . 14.8 mt -92.73 140.88 29.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.362 -0.835 . . . . 72.25 109.237 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.514 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.6 OUTLIER -71.57 -173.63 0.97 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.74 -0.467 . . . . 64.22 109.74 176.512 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -59.88 -23.36 63.39 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.448 0.536 . . . . 74.43 112.448 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.0 p -91.5 -16.66 26.89 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.502 -0.479 . . . . 62.11 111.236 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.33 29.1 6.13 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.912 -0.661 . . . . 63.24 112.532 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.29 124.7 50.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.515 0.198 . . . . 63.43 110.683 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.04 120.62 11.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 72.15 110.573 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.7 mt -83.78 144.14 29.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.103 -0.499 . . . . 74.12 111.031 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.459 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 3.1 m -73.83 140.29 45.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.2 -0.454 . . . . 73.2 109.951 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.496 HD13 HD22 ' A' ' 86' ' ' LEU . 52.4 mt -85.0 43.24 0.99 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.886 0.374 . . . . 74.03 110.571 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -105.33 -1.55 25.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.524 . . . . 75.43 110.516 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.4 -1.76 41.4 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.073 -0.584 . . . . 35.23 113.353 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.03 -22.12 11.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 117.012 0.406 . . . . 71.11 110.91 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.459 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 8.8 m -81.06 96.17 7.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.273 -0.421 . . . . 55.2 110.26 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.524 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 89.2 m-85 -86.51 162.86 17.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.455 . . . . 75.42 110.327 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.514 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 13.4 m -73.55 -178.01 2.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.984 -0.553 . . . . 75.41 110.593 176.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.7 m -69.15 152.98 44.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.387 -0.37 . . . . 74.13 110.288 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.19 111.77 2.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.131 0.491 . . . . 72.1 111.623 -178.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.8 m -95.67 104.52 16.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.876 -0.602 . . . . 64.12 109.426 174.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -57.25 125.55 23.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 72.41 110.888 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.3 mt -91.62 163.4 14.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.203 0.525 . . . . 72.42 111.661 -176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -141.95 157.11 45.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.254 -0.885 . . . . 73.05 108.994 169.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 16.4 m120 -60.14 111.39 1.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.833 0.349 . . . . 72.42 110.267 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 137.86 -140.15 10.99 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.898 -0.668 . . . . 64.3 111.927 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.1 m -96.55 120.63 37.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.121 0.486 . . . . 65.53 110.939 -177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -114.22 137.14 52.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.974 -0.557 . . . . 45.12 109.79 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.558 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.4 m -125.45 121.42 33.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.688 0.28 . . . . 64.05 110.449 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 mt -106.31 112.71 63.86 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.801 -0.444 . . . . 54.41 109.801 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.8 139.39 9.81 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.991 2.461 . . . . 74.43 112.611 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.43 ' HD1' ' HA ' ' A' ' 105' ' ' ASP . 71.6 m-85 -138.71 164.02 30.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 71.13 110.309 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 87.0 mt-30 -124.37 134.18 53.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.961 0.41 . . . . 71.24 111.109 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -121.9 124.73 44.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.07 -0.514 . . . . 64.24 109.952 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.536 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 18.1 ptp180 -142.85 161.96 36.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.588 -0.278 . . . . 72.53 110.322 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 64.7 m-85 -77.9 135.63 37.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.098 -0.501 . . . . 72.25 110.525 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.469 ' HD1' HG22 ' A' ' 48' ' ' THR . 89.7 t80 -125.88 122.0 34.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.558 -0.746 . . . . 61.01 109.245 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.637 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -83.97 135.68 34.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.276 -0.42 . . . . 54.34 111.311 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 63.9 p -107.27 2.66 24.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.796 -0.638 . . . . 74.23 109.571 176.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 171.09 -115.99 0.61 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.214 -0.903 . . . . 52.42 111.62 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -98.19 94.21 6.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.702 0.251 . . . . 61.34 110.636 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.11 111.57 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.398 0.436 . . . . 72.12 111.865 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.2 p -104.58 140.84 21.47 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 116.122 -0.49 . . . . 63.14 110.188 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.96 179.96 3.93 Favored 'Trans proline' 0 N--CA 1.472 0.248 0 C-N-CA 123.717 2.945 . . . . 63.44 113.351 -172.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.83 -172.01 16.97 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.631 -0.795 . . . . 74.33 111.811 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.21 102.01 2.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.986 0.422 . . . . 50.34 110.947 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.22 76.85 1.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.179 0.514 . . . . 71.24 110.765 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -121.81 142.92 49.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.964 -0.562 . . . . 73.42 109.492 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.573 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -141.46 165.66 26.89 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 123.051 0.219 . . . . 72.32 111.027 -176.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -141.85 146.31 35.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.087 -0.338 . . . . 63.3 110.087 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.498 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -155.39 147.63 23.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.288 -0.415 . . . . 63.43 111.064 -178.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 13' ' ' LYS . 16.6 p -104.29 127.2 51.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.954 -0.566 . . . . 64.22 110.064 175.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.405 ' CD1' HD13 ' A' ' 56' ' ' ILE . 36.5 p90 -97.09 127.77 43.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.261 0.553 . . . . 74.13 110.947 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.573 ' HA ' HG21 ' A' ' 16' ' ' VAL . 8.5 ttmm -103.18 98.77 8.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.692 -0.686 . . . . 62.45 110.157 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 71' ' ' VAL . 1.2 m -74.57 133.4 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.304 0.573 . . . . 74.14 109.631 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -117.17 110.47 18.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.087 -0.506 . . . . 72.33 110.05 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.726 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.619 0.723 . . . . 74.33 110.377 172.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.3 p . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.912 0.387 . . . . 70.42 110.584 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.453 HG22 HG12 ' A' ' 37' ' ' VAL . 36.0 m -89.18 13.95 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.264 -0.426 . . . . 70.13 110.691 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.441 ' C ' ' HG2' ' A' ' 36' ' ' GLN . 54.8 m-80 64.41 4.87 2.36 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.437 -0.801 . . . . 65.32 112.655 175.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.52 110.78 3.51 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.497 -0.859 . . . . 55.52 111.855 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.437 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -92.46 155.25 22.65 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.368 -0.92 . . . . 61.1 112.383 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.468 ' HB ' ' CG2' ' A' ' 31' ' ' THR . 1.6 p -145.9 125.1 12.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.568 0.223 . . . . 62.34 110.573 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.473 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -104.02 126.17 58.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.849 -0.426 . . . . 63.22 109.849 177.023 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -93.21 109.06 20.57 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.11 0.481 . . . . 71.42 110.174 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.473 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 87.6 m-85 -101.86 121.54 42.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.052 -0.522 . . . . 70.11 110.207 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -114.72 138.79 50.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.923 0.392 . . . . 72.34 110.431 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.49 -123.15 5.06 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.535 -0.626 . . . . 73.53 111.535 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.457 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 35.0 mt-10 63.57 25.64 14.44 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.395 0.617 . . . . 54.51 110.31 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.723 HG23 HG22 ' A' ' 17' ' ' VAL . 20.0 m -85.87 -32.33 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.615 -0.721 . . . . 72.4 111.59 -176.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.723 HG22 HG23 ' A' ' 16' ' ' VAL . 6.9 m -141.35 154.96 20.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.375 -0.375 . . . . 72.0 111.164 -174.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -168.74 90.24 0.24 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.434 -0.95 . . . . 65.33 108.434 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.26 -75.1 0.13 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.346 -0.843 . . . . 73.2 109.811 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.77 -37.82 62.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.761 -0.654 . . . . 64.11 109.689 174.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 1.8 m -147.17 162.02 39.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.382 -0.826 . . . . 74.34 108.832 -177.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.91 134.92 55.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.188 -0.301 . . . . 72.43 110.188 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.546 ' HA ' HD23 ' A' ' 58' ' ' LEU . 15.6 t -69.01 137.34 24.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.519 -0.31 . . . . 71.33 110.371 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.53 ' O ' HG13 ' A' ' 28' ' ' VAL . 20.5 t70 -57.22 141.55 46.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 72.22 111.69 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.48 -27.0 67.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 72.33 112.093 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.48 -14.06 60.56 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.436 -0.887 . . . . 71.55 111.722 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 t -97.94 -18.83 18.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.413 0.149 . . . . 64.34 110.913 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 24' ' ' ASP . 35.9 m -78.35 -5.74 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.556 0.217 . . . . 74.23 111.177 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -165.07 94.12 0.64 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.417 -0.586 . . . . 73.44 109.417 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -147.52 150.04 33.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.99 -0.55 . . . . 63.22 110.878 -176.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.468 ' CG2' ' HB ' ' A' ' 9' ' ' THR . 5.4 m -121.74 114.15 20.7 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.644 -0.707 . . . . 73.23 109.673 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.75 139.03 18.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.14 -0.482 . . . . 63.54 110.823 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -92.68 121.91 34.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.826 -0.625 . . . . 70.23 110.46 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.409 HD21 HG23 ' A' ' 10' ' ' VAL . 2.2 mm? -97.32 -27.2 14.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.235 0.541 . . . . 74.04 109.842 176.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.38 178.43 44.18 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.582 -0.736 . . . . 65.31 112.225 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.441 ' HG2' ' C ' ' A' ' 6' ' ' ASN . 82.6 mt-30 -80.56 94.2 6.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.154 -0.313 . . . . 73.42 110.154 177.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.453 HG12 HG22 ' A' ' 5' ' ' VAL . 9.0 p -70.25 149.82 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 73.42 110.618 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.01 134.46 35.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.931 -0.577 . . . . 71.44 110.094 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 p -77.5 -19.16 56.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.108 0.48 . . . . 75.45 110.775 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.91 -16.69 60.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 55.5 111.258 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.4 m -90.85 3.68 53.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.103 0.478 . . . . 61.04 110.907 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.735 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.1 mt -142.46 54.67 1.43 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.866 -0.606 . . . . 55.11 110.008 -175.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.25 10.53 41.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.114 0.413 . . . . 74.52 112.114 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -145.65 141.44 28.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.699 0.285 . . . . 75.3 111.171 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 8.9 tm-20 -55.43 116.42 2.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.903 -0.59 . . . . 74.13 109.559 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.14 -7.43 27.07 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.665 -0.779 . . . . 72.42 112.375 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.574 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -67.78 132.96 48.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.681 0.277 . . . . 71.33 110.61 177.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 p -122.78 138.83 54.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.291 -0.413 . . . . 70.23 110.715 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 t -96.36 179.0 5.18 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.356 -0.384 . . . . 74.43 110.519 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 m -68.62 126.05 28.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.936 -0.575 . . . . 65.21 110.265 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.598 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -82.49 164.66 20.78 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.668 0.747 . . . . 74.33 112.157 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.0 m -106.33 155.92 7.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.45 -1.25 . . . . 73.21 109.208 171.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.3 93.01 0.67 Allowed Glycine 0 C--N 1.311 -0.847 0 C-N-CA 120.818 -0.706 . . . . 54.43 112.104 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -105.54 171.52 7.28 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.556 -0.535 . . . . 73.41 109.556 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -139.69 142.84 36.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.044 0.449 . . . . 63.31 111.38 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.7 mt -102.27 117.8 48.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.534 -0.757 . . . . 73.14 109.318 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -99.37 137.6 37.65 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.785 -0.643 . . . . 72.24 110.676 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 23' ' ' VAL . 44.8 mt -117.34 134.72 54.49 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.454 -0.573 . . . . 73.23 109.454 176.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -110.26 143.97 39.65 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.902 -0.407 . . . . 63.43 109.902 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 33.8 t70 50.39 73.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 124.071 0.857 . . . . 72.11 110.715 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 32.7 t -112.78 119.66 38.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.115 -0.948 . . . . 73.21 110.212 -174.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.73 138.03 36.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.948 0.404 . . . . 72.45 111.734 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.3 p -107.43 5.21 27.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 70.41 112.258 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -78.3 -21.96 48.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.656 -0.498 . . . . 61.24 109.656 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.8 p -112.53 -30.71 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.768 -0.651 . . . . 73.34 111.353 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -116.95 166.57 12.03 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.194 -0.316 . . . . 63.54 111.126 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.51 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 32.7 m -124.64 -56.27 1.6 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.772 0.32 . . . . 73.43 111.569 -177.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.51 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -133.01 157.08 46.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.721 -0.474 . . . . 74.43 109.721 -178.238 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -114.14 132.63 56.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.977 0.418 . . . . 63.43 110.353 175.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.58 120.58 12.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.753 -0.658 . . . . 60.31 109.492 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.715 HG12 HG12 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -92.41 147.3 5.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.097 0.475 . . . . 75.23 111.158 -173.534 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.51 117.53 28.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.607 -0.724 . . . . 73.15 109.234 174.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 86.8 m-85 -82.81 135.99 34.79 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.951 0.405 . . . . 71.44 111.065 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.1 tp -131.32 115.42 16.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.878 -0.601 . . . . 74.22 109.616 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.439 ' H ' ' HB3' ' A' ' 113' ' ' LEU . . . -153.31 -174.22 23.39 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.576 -0.738 . . . . 74.53 111.326 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.464 ' O ' HD13 ' A' ' 86' ' ' LEU . 8.1 m -79.3 114.78 18.51 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.242 -0.281 . . . . 72.13 110.242 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -75.89 149.53 37.75 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.945 -0.391 . . . . 61.22 109.945 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.578 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 14.5 tt -62.48 -35.79 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.409 . . . . 71.23 110.209 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -162.43 -174.5 4.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.986 -0.552 . . . . 73.44 109.53 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.85 -12.15 59.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.141 0.423 . . . . 72.33 112.141 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.21 -43.71 3.98 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.769 -0.729 . . . . 73.33 111.8 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -103.06 82.2 2.06 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.076 -0.713 . . . . 74.42 109.076 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.416 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.7 p -95.59 7.34 46.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.251 -0.886 . . . . 72.01 112.503 -172.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -107.17 -1.64 21.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.121 0.486 . . . . 75.23 110.541 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.52 121.68 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.739 -0.664 . . . . 75.34 110.292 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.607 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -68.21 132.37 47.03 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.841 -0.429 . . . . 74.13 109.841 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.578 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -76.46 149.54 36.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.175 -0.466 . . . . 75.21 110.294 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.412 HD22 ' H ' ' A' ' 88' ' ' LEU . 2.1 mm? -77.84 132.93 38.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.157 -0.474 . . . . 52.11 109.839 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.556 ' HG3' ' HA ' ' A' ' 150' ' ' ALA . 90.8 mt-30 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 74.35 110.541 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.472 ' HA ' ' H ' ' A' ' 147' ' ' ALA . 2.7 p . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 120.762 0.315 . . . . 60.24 110.344 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.23 148.22 35.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.579 -0.526 . . . . 42.23 109.579 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.34 163.51 29.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.03 -0.359 . . . . 74.32 110.03 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.405 HD22 HG23 ' A' ' 144' ' ' THR . 57.5 m-20 69.8 10.99 7.73 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.575 0.547 . . . . 63.13 110.319 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.06 -177.29 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.478 -0.783 . . . . 70.13 110.212 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 175.94 -172.64 45.63 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.574 -1.01 . . . . 74.12 110.574 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.406 HG21 HG21 ' A' ' 10' ' ' VAL . 2.7 p -118.42 115.31 47.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.337 0.589 . . . . 64.24 110.62 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -105.34 140.66 38.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.24 -0.652 . . . . 63.21 109.24 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.429 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -102.56 122.59 55.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.147 0.499 . . . . 64.54 110.672 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.522 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 15.5 mt -89.58 143.55 26.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.503 -0.771 . . . . 54.42 109.378 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.544 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.9 -170.49 0.91 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.713 -0.477 . . . . 73.34 109.713 175.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -60.0 -29.83 68.73 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.467 0.173 . . . . 45.03 111.467 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.4 p -92.4 3.54 55.24 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.808 0.337 . . . . 60.34 111.573 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 82.08 30.67 33.93 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.858 -0.687 . . . . 72.33 113.1 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.01 126.4 48.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.713 0.256 . . . . 64.25 110.524 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.98 109.02 2.8 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.049 0.452 . . . . 63.14 110.919 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.9 mt -79.07 130.6 35.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 74.01 110.76 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 m -70.56 135.99 48.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 74.23 110.599 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.607 HD13 HD22 ' A' ' 86' ' ' LEU . 34.4 mt -78.05 41.52 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 73.53 110.844 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -98.9 -9.82 23.67 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.021 -0.536 . . . . 64.03 110.472 -175.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.53 1.15 75.56 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.025 -0.607 . . . . 60.32 112.663 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.27 -3.4 11.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.947 0.403 . . . . 74.02 111.228 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.4 m -101.0 109.5 21.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.807 0.337 . . . . 70.43 110.238 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -99.18 156.68 16.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 74.04 111.338 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 1.7 m -68.45 177.02 2.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.561 -0.745 . . . . 63.44 111.291 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.3 t -63.58 148.08 49.79 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.551 -0.537 . . . . 61.33 109.551 170.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.402 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 85.6 mt-10 -63.8 103.63 0.59 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 71.12 111.409 -176.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -87.22 110.86 20.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.962 -0.563 . . . . 63.51 109.743 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 m -59.96 122.4 14.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 75.5 111.28 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 69' ' ' ALA . 85.4 mt -84.38 146.39 27.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.514 . . . . 75.42 111.455 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -122.97 152.83 40.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.412 -0.813 . . . . 70.13 109.244 174.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 19.7 m120 -62.82 111.93 2.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.85 0.357 . . . . 61.35 110.569 176.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.17 -128.61 6.68 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.689 -0.767 . . . . 52.41 112.69 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.7 m -96.56 135.71 38.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.744 0.307 . . . . 74.55 110.849 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -132.58 148.56 52.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 64.54 110.482 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.47 120.73 31.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.372 -0.376 . . . . 74.2 111.301 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.2 mt -99.29 113.03 64.47 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.035 -0.728 . . . . 70.13 109.035 174.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.63 140.29 11.7 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.423 2.082 . . . . 73.52 112.704 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 87.4 m-85 -136.65 162.97 31.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 73.53 110.704 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.634 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.0 mt-30 -132.55 110.47 10.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.175 -0.466 . . . . 52.42 110.783 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -97.15 123.6 40.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.424 -0.353 . . . . 74.52 110.28 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.598 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 11.2 ptp180 -135.47 160.65 37.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.9 0.381 . . . . 63.13 110.65 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.437 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 81.3 m-85 -81.28 144.32 31.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.039 -0.528 . . . . 71.23 110.657 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -129.31 126.06 38.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.755 -0.657 . . . . 75.24 109.428 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.735 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -89.24 133.47 34.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.294 -0.412 . . . . 73.24 111.356 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.421 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 71.1 p -105.37 7.66 33.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.856 0.836 . . . . 74.05 109.022 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.08 -128.33 1.63 Allowed Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.524 -1.217 . . . . 72.15 110.838 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 96.18 10.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.827 0.314 . . . . 62.41 110.233 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -46.45 113.84 0.71 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.564 0.54 . . . . 33.22 111.539 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.405 HG23 HD22 ' A' ' 98' ' ' ASN . 31.9 p -103.14 141.45 22.52 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-O 121.122 0.487 . . . . 61.12 110.669 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.58 170.48 15.0 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 123.642 2.895 . . . . 43.54 113.273 -175.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.58 -122.47 1.77 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.627 -0.715 . . . . 72.23 111.795 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.472 ' H ' ' HA ' ' A' ' 95' ' ' SER . . . -122.17 133.87 54.73 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.686 -0.487 . . . . 65.35 109.686 177.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -122.05 51.49 1.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.589 0.709 . . . . 63.13 111.07 -173.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -102.56 144.45 30.96 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.255 -0.884 . . . . 65.02 110.197 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.556 ' HA ' ' HG3' ' A' ' 89' ' ' GLN . . . -152.86 177.26 10.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.113 -0.494 . . . . 71.14 109.979 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -154.1 152.05 30.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.963 -0.295 . . . . 73.43 110.622 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -156.29 153.0 28.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.177 -0.465 . . . . 63.1 110.829 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.3 p -105.31 136.71 44.33 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.454 -0.573 . . . . 75.32 109.454 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -109.59 122.82 48.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.088 0.47 . . . . 71.23 110.55 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.603 ' HA ' HG21 ' A' ' 16' ' ' VAL . 2.9 ttmm -102.48 104.85 15.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.081 -0.509 . . . . 74.34 110.224 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.715 HG12 HG12 ' A' ' 71' ' ' VAL . 1.5 m -81.45 139.2 18.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.207 0.527 . . . . 61.42 110.216 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -110.66 110.7 21.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.97 -0.559 . . . . 63.21 111.01 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.609 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 116.088 -0.506 . . . . 73.23 110.401 170.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.415 ' CB ' ' HB3' ' A' ' 36' ' ' GLN . 63.1 p . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.971 0.415 . . . . 63.35 110.363 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 37' ' ' VAL . 31.6 m -89.8 14.36 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.756 0.312 . . . . 54.22 111.216 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 66.59 8.87 6.16 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.82 -0.627 . . . . 61.11 112.107 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 36' ' ' GLN . . . 95.78 97.8 1.78 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.112 -0.795 . . . . 62.34 111.112 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.56 154.24 25.81 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.206 -0.997 . . . . 43.12 112.206 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.48 ' HB ' HG22 ' A' ' 31' ' ' THR . 24.4 p -141.85 132.31 25.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.801 0.334 . . . . 71.35 111.128 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -106.95 120.46 58.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.178 -0.675 . . . . 73.52 109.178 171.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -94.33 106.1 18.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.689 -0.486 . . . . 73.24 109.689 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.415 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 81.8 m-85 -96.91 129.77 44.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.842 -0.617 . . . . 73.54 110.149 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -117.3 133.0 56.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.211 -0.45 . . . . 74.53 110.25 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.97 -123.24 4.24 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.982 -0.627 . . . . 40.53 111.951 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.772 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 31.7 mt-10 63.35 15.94 9.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.135 0.493 . . . . 51.43 110.891 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' A' ' 155' ' ' LYS . 24.2 m -76.91 -27.61 16.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.529 -0.76 . . . . 74.23 111.932 -174.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.6 HG21 ' CG2' ' A' ' 156' ' ' VAL . 18.8 m -135.81 144.6 33.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.214 0.531 . . . . 73.4 112.205 -174.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -148.41 21.38 1.06 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.487 -0.931 . . . . 65.2 108.487 170.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.96 -74.54 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.248 -0.887 . . . . 73.34 110.974 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HB2' HG13 ' A' ' 65' ' ' VAL . . . -88.72 -38.71 14.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.067 0.46 . . . . 62.32 110.513 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.8 OUTLIER -144.0 134.99 25.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.555 -0.748 . . . . 73.15 109.847 -176.846 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.61 151.51 20.09 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.8 -0.445 . . . . 72.11 109.8 177.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.425 ' HB ' HG12 ' A' ' 28' ' ' VAL . 14.9 t -86.52 136.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 110.122 -0.325 . . . . 54.4 110.122 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.467 ' O ' HG13 ' A' ' 28' ' ' VAL . 22.3 t70 -62.86 145.15 55.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.435 -0.348 . . . . 75.02 110.937 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -60.25 -26.04 66.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.253 0.464 . . . . 74.34 112.253 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.1 -14.79 81.9 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.529 -0.844 . . . . 65.22 112.014 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.9 p -119.94 13.55 12.25 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.83 0.307 . . . . 75.23 111.83 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.772 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 27.2 m -100.56 -11.77 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.161 0.505 . . . . 61.4 110.325 173.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -156.52 81.3 0.96 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.289 -0.869 . . . . 62.01 109.426 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -126.18 133.87 51.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.453 0.644 . . . . 74.43 110.369 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.48 HG22 ' HB ' ' A' ' 9' ' ' THR . 2.9 m -118.24 101.31 8.11 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.764 -0.828 . . . . 74.24 108.764 176.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.48 131.86 32.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.993 -0.549 . . . . 64.03 111.034 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -88.13 110.42 20.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.65 -0.704 . . . . 73.12 109.771 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.4 ' HB2' ' OH ' ' A' ' 137' ' ' TYR . 1.8 mm? -81.22 -29.05 34.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.406 0.622 . . . . 54.54 109.495 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.418 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 96.18 172.72 35.58 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.242 -0.89 . . . . 44.33 112.131 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 7' ' ' GLY . 69.4 mt-30 -72.83 95.8 1.98 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.448 -0.204 . . . . 73.12 110.448 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.515 HG12 HG22 ' A' ' 5' ' ' VAL . 11.0 p -70.33 142.67 15.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.855 0.36 . . . . 74.2 110.134 177.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -78.22 105.12 9.24 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.201 -0.666 . . . . 63.31 109.201 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 19.5 p -63.05 -25.19 68.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.955 0.407 . . . . 72.42 111.237 -177.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.43 -5.6 37.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.061 -0.518 . . . . 74.43 111.419 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.5 m -95.8 -2.69 47.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.073 0.463 . . . . 65.22 110.411 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.1 mp -131.69 97.3 4.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.888 -0.597 . . . . 61.23 109.504 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.96 17.35 9.32 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.32 -0.552 . . . . 73.15 112.436 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -153.62 150.99 29.21 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.749 -0.381 . . . . 72.14 111.483 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -60.9 119.21 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 72.54 109.827 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.72 -6.19 31.26 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.641 -0.79 . . . . 61.21 111.847 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -72.01 119.39 16.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.014 0.435 . . . . 75.04 110.532 178.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.548 HG22 ' HD1' ' A' ' 138' ' ' PHE . 41.1 p -105.51 148.34 27.33 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.015 -0.539 . . . . 61.04 110.173 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.4 t -100.32 177.54 5.02 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.136 -0.69 . . . . 54.23 109.136 174.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.6 m -70.11 133.51 47.23 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.876 -0.416 . . . . 73.15 109.876 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -87.34 160.41 18.39 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.644 0.735 . . . . 70.15 111.956 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 31.1 m -103.94 152.9 6.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.433 -1.258 . . . . 72.25 109.083 171.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.45 98.48 1.28 Allowed Glycine 0 C--N 1.312 -0.754 0 C-N-CA 120.729 -0.748 . . . . 45.03 112.147 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -108.96 173.19 6.43 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.6 -0.519 . . . . 63.35 109.6 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.594 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.0 p-10 -139.75 137.19 34.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.476 0.655 . . . . 73.44 111.917 -173.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.4 mt -105.5 115.09 46.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.722 -0.844 . . . . 75.25 108.722 171.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -101.57 144.62 30.09 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.977 0.417 . . . . 75.54 110.823 -173.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.2 mt -117.91 130.01 55.97 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.955 -0.566 . . . . 73.25 109.676 176.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -106.41 131.98 52.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.67 -0.695 . . . . 52.12 109.519 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 27.1 t70 58.15 86.44 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.69 0.757 . . . . 63.42 110.217 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 51.7 t -124.38 124.49 42.46 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.335 -0.848 . . . . 55.04 110.421 -174.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -103.92 140.07 38.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.045 -0.525 . . . . 72.31 111.152 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.8 p -107.96 15.61 24.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.071 0.397 . . . . 65.32 112.071 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -90.34 -39.16 12.87 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.912 -0.773 . . . . 74.33 108.912 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 20' ' ' ALA . 12.7 p -96.12 -3.53 10.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.104 -0.953 . . . . 72.41 110.472 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.616 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -144.75 -173.45 4.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 64.13 110.781 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.7 m -151.0 -57.98 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.023 0.379 . . . . 62.31 112.023 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.799 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -138.21 130.4 28.76 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.973 -0.291 . . . . 72.53 110.262 -175.888 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.43 127.49 41.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.108 0.48 . . . . 53.11 111.0 -175.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.33 119.64 16.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.637 -0.711 . . . . 72.1 109.637 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 156' ' ' VAL . 2.5 m -90.19 147.62 5.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.977 0.418 . . . . 70.21 110.756 -175.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.437 ' HB2' ' CD2' ' A' ' 118' ' ' PHE . . . -117.48 118.16 31.42 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.741 -0.663 . . . . 73.24 109.752 174.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 82.3 m-85 -85.62 128.49 34.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.979 0.419 . . . . 70.44 110.205 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.1 tp -126.13 126.76 44.68 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.836 -0.62 . . . . 61.15 109.913 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.52 -166.47 21.36 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.446 -0.662 . . . . 62.53 111.446 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.7 m -87.1 119.71 27.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.853 -0.425 . . . . 75.23 109.853 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -76.98 149.52 35.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.446 -0.343 . . . . 72.42 110.436 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.573 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 12.8 tt -61.77 -37.61 78.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.081 0.467 . . . . 52.43 110.7 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -152.02 -171.51 3.95 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.782 -0.821 . . . . 53.25 108.782 174.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.04 -14.89 43.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.056 0.391 . . . . 74.21 112.056 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.31 -49.83 3.6 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.632 -0.794 . . . . 73.52 112.016 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -96.43 76.64 2.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.383 0.611 . . . . 73.34 109.617 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.478 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 14.6 p -86.97 8.45 23.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.649 -0.705 . . . . 54.43 111.755 -175.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 24.4 p-10 -107.05 7.32 29.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.976 0.417 . . . . 63.11 110.849 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 138' ' ' PHE . 57.6 t -120.11 124.91 73.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.542 . . . . 71.54 109.837 177.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.523 HD22 ' CD1' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -66.94 129.85 41.23 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 110.079 -0.341 . . . . 64.14 110.079 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.46 150.77 34.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.297 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.548 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -88.03 130.3 35.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.561 -0.533 . . . . 62.14 109.561 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 60.2 112.127 -174.184 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 109.899 -0.408 . . . . 54.42 109.899 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.428 ' O ' HD23 ' A' ' 88' ' ' LEU . . . -71.46 136.64 47.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.71 0.291 . . . . 71.51 110.223 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.36 160.71 35.51 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.848 -0.341 . . . . 72.54 110.546 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 68.55 7.36 5.99 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.337 0.589 . . . . 74.23 110.303 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.405 ' O ' HD12 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -143.25 -179.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.269 -0.878 . . . . 72.01 109.687 175.124 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.3 -169.82 42.86 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.951 -1.26 . . . . 73.45 109.951 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.85 119.46 58.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.278 0.561 . . . . 75.14 110.465 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -109.42 146.15 34.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.648 -0.705 . . . . 74.13 109.755 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.1 mp -103.99 124.24 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.425 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.426 HD11 ' NE ' ' A' ' 136' ' ' ARG . 27.5 mt -87.38 140.03 29.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.651 -0.704 . . . . 43.44 109.177 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.542 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.05 -173.13 1.19 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.913 -0.402 . . . . 64.3 109.913 177.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.1 ptt85 -61.04 -20.3 62.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.096 0.406 . . . . 74.33 112.096 -176.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.7 p -101.47 3.56 40.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.935 -0.306 . . . . 61.54 111.548 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.42 31.52 24.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.778 -0.725 . . . . 53.24 112.866 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -112.02 128.51 56.2 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.959 -0.386 . . . . 60.12 109.959 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.85 130.16 42.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.726 0.298 . . . . 72.22 110.884 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.0 mt -92.77 132.83 36.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.225 -0.443 . . . . 73.1 110.979 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 89.9 m -74.31 139.2 44.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.891 -0.595 . . . . 74.13 110.449 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 34.8 mt -81.46 45.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 71.13 110.682 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -90.7 -17.94 25.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.09 0.472 . . . . 71.31 110.369 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.19 -22.97 26.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.996 -0.621 . . . . 70.31 112.329 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.45 3.87 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.164 0.507 . . . . 41.42 110.915 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.461 HG21 ' H ' ' A' ' 112' ' ' THR . 3.8 m -95.34 99.36 11.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 75.24 110.064 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.493 ' HE2' ' HD2' ' A' ' 155' ' ' LYS . 96.3 m-85 -95.41 162.31 13.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.969 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 4.6 m -71.46 -178.83 2.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.666 -0.697 . . . . 72.45 111.003 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.5 t -73.05 165.55 24.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.596 -0.52 . . . . 71.43 109.596 173.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -65.32 106.98 1.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.366 -0.379 . . . . 75.13 111.33 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.8 m -90.66 102.76 15.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.084 -0.71 . . . . 71.13 109.084 172.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.6 m -58.17 119.21 6.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.753 -0.658 . . . . 60.05 111.247 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.421 HD13 ' SG ' ' A' ' 61' ' ' CYS . 95.9 mt -87.27 150.91 23.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.792 -0.64 . . . . 75.12 111.166 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -125.89 158.68 34.51 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.743 -0.836 . . . . 73.4 108.743 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.4 m120 -65.08 114.49 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.868 0.366 . . . . 50.34 111.058 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.43 -133.27 8.07 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.03 -0.605 . . . . 64.13 112.31 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.5 m -92.83 130.88 38.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.795 0.331 . . . . 65.45 110.706 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -128.34 139.25 52.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.73 -0.47 . . . . 70.34 109.73 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.594 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.2 m -122.51 117.83 26.84 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.755 -0.378 . . . . 73.11 110.78 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.7 mt -95.0 115.26 65.22 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 63.1 109.913 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.19 135.95 7.6 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.469 2.113 . . . . 71.04 112.689 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 68.3 m-85 -134.7 160.76 37.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 64.42 110.258 177.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.61 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 44.9 mt-30 -130.37 114.52 15.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.91 0.386 . . . . 73.32 110.832 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.07 130.63 46.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.547 -0.297 . . . . 65.42 110.407 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 13.8 ptp180 -141.27 158.12 44.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.582 -0.281 . . . . 74.44 110.825 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 94.4 m-85 -75.93 142.03 42.14 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.148 -0.478 . . . . 74.12 110.257 175.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.548 ' HD1' HG22 ' A' ' 48' ' ' THR . 75.7 t80 -128.81 125.78 38.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.934 -0.575 . . . . 73.52 109.988 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -94.02 131.43 39.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.097 0.475 . . . . 72.13 110.736 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.5 p -101.13 7.31 43.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.502 -0.772 . . . . 72.34 109.572 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.83 -129.66 1.75 Allowed Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.246 -1.141 . . . . 73.21 110.246 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 144' ' ' THR . . . -83.82 95.37 8.44 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.452 -0.573 . . . . 73.11 109.452 175.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.48 111.35 0.48 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.824 -0.625 . . . . 70.23 111.363 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 142' ' ' ALA . 36.6 p -103.62 142.98 25.72 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-O 121.328 0.585 . . . . 73.12 110.845 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.75 166.94 22.58 Favored 'Trans proline' 0 C--N 1.331 -0.35 0 C-N-CA 123.816 3.011 . . . . 75.14 112.734 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.02 179.79 19.98 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.799 -0.715 . . . . 64.1 111.513 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.06 112.71 5.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 117.003 0.401 . . . . 72.45 110.915 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.548 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -101.2 74.1 1.55 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.451 0.643 . . . . 62.22 111.031 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -113.0 123.44 50.34 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.323 -0.621 . . . . 72.42 109.323 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.403 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -129.34 156.45 44.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.95 0.405 . . . . 53.21 111.598 -176.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -125.65 130.18 51.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.69 -0.687 . . . . 71.42 109.826 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.09 137.11 32.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.103 0.478 . . . . 44.44 111.663 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.4 p -112.63 125.0 53.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.679 -0.691 . . . . 72.21 109.902 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -105.52 134.84 47.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.144 0.497 . . . . 74.32 110.682 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.592 ' HA ' HG21 ' A' ' 16' ' ' VAL . 1.9 ttmm -117.9 107.42 14.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.684 -0.689 . . . . 74.14 110.158 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -74.45 140.86 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.142 0.496 . . . . 72.14 110.206 179.212 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -128.39 110.12 12.05 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.117 -0.698 . . . . 71.53 109.117 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.799 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.587 0 CA-C-O 120.942 0.401 . . . . 75.42 111.666 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.0 p . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.823 0.344 . . . . 75.13 110.647 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.488 ' CG2' HG12 ' A' ' 37' ' ' VAL . 32.7 m -93.53 15.88 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.975 0.417 . . . . 72.4 110.955 177.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 61.11 20.58 11.06 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.452 -0.795 . . . . 71.3 112.092 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.558 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 84.79 102.85 0.63 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.591 -0.814 . . . . 45.44 111.978 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.465 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -93.64 155.36 22.09 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.242 -0.98 . . . . 22.35 112.048 -177.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 33' ' ' GLN . 53.8 p -140.99 151.5 44.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.899 -0.408 . . . . 74.2 109.899 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -121.0 124.1 71.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.042 -0.725 . . . . 50.44 109.042 172.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -92.2 116.99 29.43 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.118 -0.633 . . . . 72.15 109.688 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.453 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 93.1 m-85 -104.15 114.5 28.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.626 -0.715 . . . . 73.33 110.157 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -102.32 134.81 45.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 75.4 110.274 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.93 -120.68 3.43 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.944 -0.646 . . . . 53.14 111.899 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.639 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 38.3 mt-10 62.88 19.72 11.73 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.153 0.501 . . . . 54.22 111.085 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.785 HG23 HG22 ' A' ' 17' ' ' VAL . 17.2 m -76.17 -30.49 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.053 -0.521 . . . . 64.01 111.719 -176.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.785 HG22 HG23 ' A' ' 16' ' ' VAL . 4.2 m -149.17 143.87 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.146 0.498 . . . . 64.23 111.145 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -140.7 22.45 2.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.213 -0.903 . . . . 74.01 108.916 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.75 -77.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.089 -0.959 . . . . 72.43 111.131 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.569 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -78.19 -39.15 41.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.024 -0.535 . . . . 65.02 110.492 178.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.8 OUTLIER -143.65 128.39 18.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.055 -0.521 . . . . 74.1 109.778 -176.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.44 119.25 27.53 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.366 -0.379 . . . . 70.53 110.138 -178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.452 ' HA ' HD23 ' A' ' 58' ' ' LEU . 9.6 t -62.45 128.65 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.709 -0.478 . . . . 74.11 109.709 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 28' ' ' VAL . 18.6 t70 -59.57 142.88 51.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.781 -0.645 . . . . 63.44 111.397 -176.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -62.12 -24.37 67.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.774 -0.648 . . . . 74.32 112.221 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.4 -17.91 70.12 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.618 -0.801 . . . . 33.11 111.932 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 p -105.48 -14.23 15.37 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.821 0.304 . . . . 52.4 111.821 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.639 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 33.8 m -79.73 -8.02 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.09 0.471 . . . . 73.42 110.353 175.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -157.78 90.24 1.06 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.559 -0.904 . . . . 62.52 108.559 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.429 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 17.1 pt20 -137.06 112.86 9.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.726 -0.67 . . . . 74.22 110.52 -176.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.55 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.4 m -97.22 95.37 7.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.532 -0.758 . . . . 74.44 109.094 174.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 p -79.26 134.42 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.193 -0.458 . . . . 64.0 110.541 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.567 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.6 mp0 -91.33 120.96 32.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.121 -0.491 . . . . 74.01 110.281 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.429 HD21 HG23 ' A' ' 10' ' ' VAL . 2.8 mm? -86.55 -30.04 22.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.777 -0.647 . . . . 74.41 109.356 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.558 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 92.33 177.35 41.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.329 -0.851 . . . . 51.12 111.951 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -72.31 95.34 1.71 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.707 -0.479 . . . . 72.42 109.707 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.488 HG12 ' CG2' ' A' ' 5' ' ' VAL . 9.8 p -66.49 138.49 22.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.209 0.528 . . . . 74.02 110.379 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.6 mtm-85 -75.25 106.55 6.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.623 -0.717 . . . . 74.01 109.967 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 p -62.49 -26.08 68.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 75.21 111.09 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.19 -8.07 52.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 63.25 111.428 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.1 m -97.07 -15.51 20.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.813 0.339 . . . . 61.15 110.749 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -124.28 95.94 4.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.699 0.285 . . . . 72.31 110.241 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.01 11.34 7.07 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.667 -0.413 . . . . 74.14 112.061 -176.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -152.8 143.42 22.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.417 0.151 . . . . 74.01 110.829 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 41.2 tt0 -58.35 118.46 5.56 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.021 0.438 . . . . 74.34 110.638 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.79 -17.59 8.18 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.22 -0.752 . . . . 64.03 111.22 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.3 124.67 24.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.847 0.356 . . . . 43.31 110.222 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.508 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 4.6 p -121.88 114.23 20.74 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.937 -0.574 . . . . 74.01 110.139 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.8 t -72.22 174.46 7.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.069 -0.514 . . . . 33.21 110.838 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -60.54 120.88 10.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 51.3 110.29 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -80.46 142.48 34.23 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.411 0.624 . . . . 44.03 111.276 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.9 m -83.66 147.88 5.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.825 -1.08 . . . . 72.42 109.306 170.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.99 92.02 0.72 Allowed Glycine 0 C--N 1.307 -1.05 0 C-N-CA 120.837 -0.696 . . . . 72.45 112.257 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -102.19 -175.71 2.91 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.407 -0.59 . . . . 75.31 109.407 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.548 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.0 p-10 -147.31 147.48 30.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.39 0.614 . . . . 71.24 111.821 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.45 115.87 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.342 -0.985 . . . . 73.43 108.342 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . 48.7 tt0 -103.71 138.45 40.34 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.078 -0.51 . . . . 75.21 111.129 -171.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 23' ' ' VAL . 64.4 mt -119.11 115.23 23.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.711 -0.677 . . . . 73.14 109.744 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -92.63 136.26 33.38 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.977 -0.556 . . . . 74.12 110.239 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 51.02 68.91 0.71 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.944 0.777 . . . . 53.3 110.938 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.519 ' SG ' HD13 ' A' ' 124' ' ' LEU . 53.0 t -98.62 129.39 45.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.954 . . . . 62.05 110.435 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -104.06 138.27 40.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.935 -0.575 . . . . 70.15 111.169 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.5 p -104.95 10.5 34.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.094 0.405 . . . . 65.52 112.094 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -85.13 -37.15 20.57 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.459 -0.571 . . . . 72.23 109.459 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 20' ' ' ALA . 10.3 p -100.58 -13.7 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.773 -0.649 . . . . 51.05 110.852 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.679 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -123.92 179.48 4.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.64 0.257 . . . . 74.44 111.066 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 20.3 m -143.24 -60.95 0.42 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.486 . . . . 74.21 110.736 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -136.68 140.72 42.9 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.374 -0.602 . . . . 75.32 109.374 -178.254 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -98.16 119.8 37.44 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.185 0.517 . . . . 54.24 109.977 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -131.25 110.84 11.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.538 -0.756 . . . . 73.43 109.754 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -89.03 145.45 7.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.915 0.388 . . . . 72.15 110.298 -175.715 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -123.37 123.87 41.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.965 -0.561 . . . . 35.04 109.62 174.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 91.1 m-85 -88.95 130.43 35.45 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.021 0.439 . . . . 65.32 110.696 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.7 tp -130.59 125.56 34.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.771 -0.65 . . . . 75.41 110.154 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.37 -164.2 21.48 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.132 -0.787 . . . . 51.4 111.132 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.456 ' O ' HD13 ' A' ' 86' ' ' LEU . 42.3 m -80.79 122.65 27.44 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.27 -0.271 . . . . 70.0 110.27 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.518 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -85.37 140.65 30.6 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.91 -0.404 . . . . 73.43 109.91 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 tt -65.05 -28.98 46.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.886 0.374 . . . . 64.34 110.867 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 22.0 t70 -153.99 174.95 13.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.482 -0.562 . . . . 60.3 109.482 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.36 -37.83 31.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.093 0.473 . . . . 73.14 110.339 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.63 -19.18 62.33 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.161 -0.776 . . . . 65.44 111.161 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 42.4 m80 -107.08 43.5 1.16 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.167 -0.679 . . . . 64.14 109.167 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.518 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -72.62 11.45 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.141 -0.936 . . . . 42.2 112.927 -176.028 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 85' ' ' VAL . 16.4 p30 -110.81 -8.96 14.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.058 0.456 . . . . 73.04 110.554 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.455 HG23 ' OD1' ' A' ' 84' ' ' ASN . 48.3 t -101.84 120.92 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.101 -0.499 . . . . 62.24 110.561 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.555 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -67.03 132.8 48.62 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.16 -0.473 . . . . 70.23 109.746 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.71 148.52 36.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.032 -0.531 . . . . 45.01 110.304 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.447 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 2.0 mm? -82.98 140.77 32.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.14 -0.482 . . . . 61.21 110.557 -177.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.486 -0.779 . . . . 53.01 110.095 177.301 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.459 ' HA ' ' H ' ' A' ' 147' ' ' ALA . 1.5 p . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.63 0.252 . . . . 75.22 110.404 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.92 138.7 50.31 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.061 -0.348 . . . . 74.05 110.061 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.18 159.3 33.32 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.842 -0.343 . . . . 63.52 110.932 -176.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 68.67 10.46 7.9 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.719 -0.673 . . . . 71.0 111.238 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.48 178.28 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.153 -0.476 . . . . 72.44 110.306 174.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 176.28 -175.9 47.59 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 109.831 -1.308 . . . . 53.32 109.831 177.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -118.9 114.21 44.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.334 0.588 . . . . 75.31 111.162 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.41 ' HG2' ' HB2' ' A' ' 138' ' ' PHE . 2.9 pt20 -104.15 140.16 38.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.698 -0.683 . . . . 65.45 109.498 173.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.4 mp -98.11 126.35 51.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.997 -0.547 . . . . 73.34 110.296 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.408 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 15.5 mt -89.92 147.5 23.69 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.262 -0.881 . . . . 72.12 109.141 176.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.406 ' HA ' ' CD1' ' A' ' 133' ' ' PHE . 1.5 p-10 -70.87 -169.94 0.39 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.773 -0.454 . . . . 73.33 109.773 175.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 106' ' ' ARG . 16.9 ptt180 -61.98 -30.86 71.22 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.108 -0.237 . . . . 73.43 111.527 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.4 p -81.92 -34.55 29.83 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.748 -0.381 . . . . 65.55 110.76 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 119.77 31.54 1.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.582 -0.818 . . . . 64.13 112.931 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.48 139.02 42.64 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.128 -0.323 . . . . 63.01 110.128 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.05 130.71 43.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.396 -0.366 . . . . 52.11 111.1 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt -97.37 131.98 43.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.144 -0.48 . . . . 71.03 110.506 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.411 ' H ' HG21 ' A' ' 117' ' ' THR . 14.7 m -72.23 137.01 46.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.257 -0.428 . . . . 74.44 110.72 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.555 HD13 HD22 ' A' ' 86' ' ' LEU . 49.2 mt -79.64 49.09 0.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 75.24 110.876 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -107.45 -8.43 16.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.441 0.639 . . . . 62.34 110.324 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.23 -12.51 12.78 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.0 -0.619 . . . . 63.43 112.811 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.19 -10.85 23.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.932 0.396 . . . . 43.4 111.153 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.411 HG21 ' H ' ' A' ' 112' ' ' THR . 24.5 m -92.57 95.12 9.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.079 0.466 . . . . 61.34 110.21 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.569 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 72.6 m-85 -91.03 153.01 20.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.784 -0.644 . . . . 73.11 110.241 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.4 m -65.23 171.37 3.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.083 -0.508 . . . . 71.52 111.251 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.3 p -61.3 146.17 48.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.104 -0.498 . . . . 72.12 110.301 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.431 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 41.9 mt-10 -57.57 101.34 0.07 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.96 0.409 . . . . 73.24 111.605 -176.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.6 m -85.85 104.18 15.28 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.947 -0.761 . . . . 70.43 108.947 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 m -63.3 115.08 4.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.262 0.553 . . . . 73.51 110.878 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.562 HD21 ' HB2' ' A' ' 69' ' ' ALA . 92.0 mt -74.59 147.08 42.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.176 -0.92 . . . . 74.12 111.777 -174.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -121.14 151.47 39.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.359 -0.837 . . . . 61.02 108.924 171.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 94.6 m-20 -63.12 107.34 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.902 0.382 . . . . 71.32 110.681 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.84 -149.12 20.08 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.967 -0.635 . . . . 65.41 111.789 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 30.1 m -82.12 123.61 29.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.124 0.487 . . . . 73.03 110.994 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 28.0 m-80 -117.48 135.09 54.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.942 -0.572 . . . . 32.52 109.537 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.548 HG22 ' HB2' ' A' ' 55' ' ' ASN . 2.3 m -122.45 118.87 29.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.804 -0.358 . . . . 75.41 110.488 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.0 mt -98.58 112.38 62.34 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.697 -0.482 . . . . 73.11 109.697 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.85 138.96 17.17 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.599 2.2 . . . . 71.25 112.469 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 78.6 m-85 -136.61 163.69 29.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.692 0.282 . . . . 74.0 110.528 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 96.2 mt-30 -130.71 119.09 21.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.102 -0.499 . . . . 72.13 110.896 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.21 123.23 47.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.099 -0.334 . . . . 73.04 110.099 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.539 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 2.8 ptp180 -135.98 159.17 42.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.39 -0.368 . . . . 74.12 111.234 -176.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 59.8 m-85 -80.5 134.41 35.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.746 -0.661 . . . . 64.53 110.418 174.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.41 ' HB2' ' HG2' ' A' ' 102' ' ' GLN . 84.8 t80 -117.69 119.21 34.26 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.139 -0.689 . . . . 71.11 109.139 176.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 45' ' ' GLU . . . -83.6 130.29 34.98 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.023 -0.535 . . . . 72.35 110.661 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 69.3 p -101.32 -0.54 35.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.88 0.848 . . . . 71.33 108.763 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.21 -131.54 1.77 Allowed Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.28 -1.327 . . . . 73.22 110.594 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 144' ' ' THR . . . -88.66 98.72 11.84 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.749 -0.463 . . . . 72.04 109.749 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -47.47 113.01 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.896 0.747 . . . . 71.33 111.395 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 142' ' ' ALA . 41.3 p -104.06 146.34 32.37 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 116.012 -0.54 . . . . 64.43 110.585 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.27 173.36 5.25 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.6 2.866 . . . . 62.55 113.628 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 138.0 -147.47 19.25 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.675 -0.693 . . . . 74.52 111.857 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.459 ' H ' ' HA ' ' A' ' 95' ' ' SER . . . -98.84 117.08 32.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.22 -0.289 . . . . 70.43 110.22 175.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.447 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -115.48 59.65 0.71 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.95 0.405 . . . . 34.31 111.625 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -112.69 137.03 51.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.035 -0.728 . . . . 73.34 109.035 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.486 ' HB3' HG13 ' A' ' 10' ' ' VAL . . . -128.81 169.92 13.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.016 0.436 . . . . 55.13 111.756 -175.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -137.8 127.26 24.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.581 -0.736 . . . . 75.12 109.618 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.86 140.59 29.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.075 0.464 . . . . 74.02 111.774 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.1 p -110.28 126.11 53.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.595 . . . . 65.52 109.53 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -106.44 143.39 34.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.059 0.457 . . . . 64.42 110.834 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.594 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.9 ttmm -120.04 111.96 18.55 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.812 -0.631 . . . . 74.15 110.435 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 71' ' ' VAL . 1.4 m -81.81 127.17 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.165 -0.68 . . . . 72.5 109.165 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -112.18 121.87 46.14 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.137 -0.483 . . . . 50.13 109.849 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.679 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.585 0 N-CA-C 111.841 0.311 . . . . 72.04 111.841 177.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.906 0.384 . . . . 74.44 110.092 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.51 HG22 HG12 ' A' ' 37' ' ' VAL . 28.1 m -92.64 15.79 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.004 0.43 . . . . 74.15 110.526 176.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 61.95 13.09 5.32 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.355 -0.839 . . . . 74.02 112.563 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.426 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 91.09 94.96 1.27 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.731 -0.747 . . . . 55.25 111.967 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.02 158.64 31.97 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.532 -0.842 . . . . 70.2 112.171 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.523 ' HB ' HG22 ' A' ' 31' ' ' THR . 11.2 p -140.24 135.32 32.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.361 . . . . 61.21 111.102 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.463 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -108.11 125.47 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.423 -0.584 . . . . 74.33 109.423 173.347 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -96.81 111.03 23.39 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.068 0.461 . . . . 72.04 110.19 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 95.7 m-85 -101.07 122.9 44.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.886 -0.597 . . . . 74.35 110.47 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -108.08 138.43 44.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.449 -0.341 . . . . 70.12 110.535 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -109.3 -133.08 6.65 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.935 -0.65 . . . . 72.04 112.321 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 62.95 34.55 14.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.39 0.614 . . . . 65.2 110.897 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 155' ' ' LYS . 25.3 m -93.76 -22.88 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.592 -0.731 . . . . 73.42 111.663 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.468 HG21 ' CG2' ' A' ' 156' ' ' VAL . 19.0 m -143.01 149.18 18.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.537 -0.301 . . . . 55.41 111.303 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -156.86 32.04 0.3 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.797 0.808 . . . . 65.22 109.346 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.89 -66.73 0.9 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.313 -0.858 . . . . 73.01 111.469 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.414 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -98.92 -41.03 7.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 61.44 110.804 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 1.8 m -135.63 128.88 31.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.153 -0.476 . . . . 71.55 110.075 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.5 127.84 39.33 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.022 -0.536 . . . . 53.33 110.007 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.58 131.26 31.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.338 -0.392 . . . . 51.24 110.217 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 28' ' ' VAL . 25.1 t70 -57.93 145.45 35.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.736 -0.666 . . . . 71.45 111.254 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.32 -30.72 70.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 64.02 111.775 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.66 -12.03 82.17 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.61 -0.805 . . . . 74.13 111.652 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 t -97.82 -24.38 15.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.453 0.168 . . . . 71.12 110.591 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 24' ' ' ASP . 20.7 m -80.44 -7.14 10.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.822 0.344 . . . . 73.4 110.597 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -154.85 88.95 1.21 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.813 -0.631 . . . . 53.33 109.681 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.86 115.57 10.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.638 0.732 . . . . 65.53 110.98 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.523 HG22 ' HB ' ' A' ' 9' ' ' THR . 3.9 m -98.38 97.63 8.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.027 -0.988 . . . . 72.52 109.067 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.69 127.94 39.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.128 0.49 . . . . 74.44 111.092 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -86.61 125.43 33.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.645 . . . . 65.02 109.976 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.406 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.7 mm? -87.54 -22.91 24.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.109 0.481 . . . . 72.52 110.032 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.426 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 93.41 173.32 40.1 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.581 -0.736 . . . . 53.42 112.095 -178.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.74 91.49 5.91 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.761 0.315 . . . . 44.43 110.701 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.51 HG12 HG22 ' A' ' 5' ' ' VAL . 7.2 p -78.06 146.07 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.171 -0.468 . . . . 53.41 109.824 176.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -87.07 132.15 33.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.02 -0.363 . . . . 73.51 110.02 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 53.2 p -68.33 -18.64 64.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.228 0.537 . . . . 72.12 111.129 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.44 -12.92 61.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 63.31 111.197 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.0 m -97.04 9.14 42.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.22 0.533 . . . . 65.01 110.426 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.617 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 6.0 mt -145.61 49.35 1.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.584 -0.734 . . . . 72.11 109.612 -174.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.23 6.06 41.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.529 0.937 . . . . 52.52 113.529 -168.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -161.27 155.34 22.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.488 -0.19 . . . . 63.03 110.488 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 33.1 tt0 -56.95 132.61 53.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 123.347 0.404 . . . . 55.41 110.371 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.84 -17.01 36.15 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.706 -0.759 . . . . 44.24 111.663 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 42' ' ' LEU . . . -69.68 121.61 17.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.333 . . . . 75.2 110.302 176.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.524 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 37.7 p -119.15 135.78 54.5 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.045 -0.525 . . . . 74.42 110.432 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.0 t -89.46 178.26 6.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.673 -0.491 . . . . 64.35 109.673 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -67.51 129.27 39.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.375 -0.375 . . . . 74.33 110.069 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -81.36 158.56 24.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.449 0.642 . . . . 62.35 111.316 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 27.7 m -101.22 147.34 8.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.824 -1.08 . . . . 71.51 109.124 171.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.92 86.39 0.58 Allowed Glycine 0 C--N 1.31 -0.911 0 C-N-CA 120.675 -0.774 . . . . 53.04 111.978 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -96.08 166.46 11.75 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.699 -0.482 . . . . 64.32 109.699 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.469 ' HB2' HG22 ' A' ' 130' ' ' THR . 20.7 p-10 -125.45 139.37 53.7 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.407 0.622 . . . . 70.54 111.998 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.2 mt -109.74 107.05 21.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.562 -0.903 . . . . 74.15 108.562 167.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -100.59 135.51 41.91 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.715 -0.675 . . . . 73.2 111.322 -170.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.4 mt -112.12 132.58 54.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.504 -0.771 . . . . 73.11 109.527 175.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -109.07 145.49 35.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.419 -0.355 . . . . 74.43 110.058 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.11 48.71 20.39 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.616 0.722 . . . . 73.32 110.944 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.51 ' SG ' HD22 ' A' ' 124' ' ' LEU . 48.0 t -85.8 155.97 20.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.066 -0.97 . . . . 74.1 110.323 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' HA ' ' ND2' ' A' ' 126' ' ' ASN . 21.1 t70 -128.3 152.86 47.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.524 -0.307 . . . . 73.34 111.512 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.9 p -119.06 5.81 11.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 72.13 111.677 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -84.34 -34.99 23.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.091 0.472 . . . . 74.4 109.978 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 p -103.68 -21.36 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 54.23 111.196 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -124.27 -175.53 3.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.269 -0.271 . . . . 72.23 110.269 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.5 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 20.4 m -146.26 -55.8 0.28 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.731 0.301 . . . . 74.0 111.629 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.5 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -135.97 143.81 45.06 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 109.881 -0.414 . . . . 62.41 109.881 -178.603 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.523 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -106.09 127.48 53.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.135 0.493 . . . . 42.14 110.163 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.2 118.82 15.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.509 -0.769 . . . . 70.0 109.016 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.725 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -90.99 146.76 5.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.999 0.428 . . . . 74.11 110.54 -175.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.434 ' HB2' ' CD2' ' A' ' 118' ' ' PHE . . . -118.79 119.13 33.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.782 -0.645 . . . . 62.03 109.354 174.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 93.8 m-85 -84.67 130.88 34.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.993 0.425 . . . . 45.31 110.527 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.9 tp -125.91 123.59 38.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.664 -0.698 . . . . 74.11 109.935 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.5 -170.99 26.93 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.513 -0.635 . . . . 61.14 111.513 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.7 m -84.06 125.49 32.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.62 0.248 . . . . 74.22 110.631 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 83' ' ' THR . . . -87.72 138.98 30.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.591 -0.277 . . . . 73.1 110.515 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.446 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 10.8 tt -64.06 -31.95 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 73.31 111.224 -177.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -145.81 -178.19 5.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.268 -0.642 . . . . 72.33 109.268 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.57 -42.52 24.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.692 0.282 . . . . 63.1 110.865 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.67 -16.77 74.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.58 -0.819 . . . . 75.34 111.951 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -105.12 51.3 0.76 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.13 0.491 . . . . 52.44 109.979 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.405 ' HA ' ' CB ' ' A' ' 77' ' ' ALA . 1.1 p -74.93 3.6 7.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.806 -0.634 . . . . 55.14 112.138 -178.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -104.79 -5.96 20.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.927 0.394 . . . . 75.31 110.671 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.05 120.12 58.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.175 -0.466 . . . . 75.45 110.628 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.494 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -67.51 129.78 40.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.93 -0.396 . . . . 74.31 109.93 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.49 141.62 39.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.27 -0.423 . . . . 51.21 110.605 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.8 mm? -82.38 140.32 33.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.074 -0.512 . . . . 71.03 110.027 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.37 0.605 . . . . 74.01 110.748 179.179 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.69 0.281 . . . . 64.02 110.571 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.94 125.45 27.61 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.785 -0.45 . . . . 71.34 109.785 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.07 166.46 16.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.35 -0.386 . . . . 71.1 110.243 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 68.88 9.96 7.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.253 0.549 . . . . 63.1 110.446 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.45 -174.47 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.279 -0.873 . . . . 63.21 109.685 173.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.49 -174.5 46.56 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.637 -0.985 . . . . 41.11 110.637 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 p -119.66 115.65 48.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.446 0.641 . . . . 75.14 110.841 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -107.1 142.22 37.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.489 -0.778 . . . . 73.45 109.642 175.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.1 mp -103.12 123.78 56.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.032 -0.531 . . . . 72.51 110.3 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.493 HD11 ' NE ' ' A' ' 136' ' ' ARG . 12.7 mt -86.27 147.64 25.99 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.647 -0.706 . . . . 60.21 109.11 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.585 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.1 p-10 -74.1 -170.99 1.03 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.59 -0.522 . . . . 73.42 109.59 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -69.04 -25.53 64.52 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.975 -0.29 . . . . 65.43 111.554 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.1 p -84.69 -26.47 27.71 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 120.647 -0.421 . . . . 62.1 111.015 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.81 34.51 1.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 60.54 112.825 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -114.73 135.56 54.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.424 -0.213 . . . . 62.2 110.424 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.43 122.74 17.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 55.53 110.836 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.1 mt -88.88 135.84 33.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.367 -0.379 . . . . 75.04 110.614 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.2 m -83.7 145.44 28.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.025 -0.534 . . . . 51.41 110.556 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 52.7 mt -81.34 40.14 0.55 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 73.1 111.275 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -77.02 -22.64 52.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.432 -0.349 . . . . 65.3 111.092 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.17 -11.27 37.4 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.764 -0.731 . . . . 74.23 112.005 -172.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.41 2.56 9.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.178 0.513 . . . . 64.3 110.562 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.9 m -99.74 102.65 14.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.829 -0.623 . . . . 71.25 109.491 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.434 ' CD2' ' HB2' ' A' ' 72' ' ' ALA . 83.8 m-85 -93.81 167.24 11.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.746 -0.661 . . . . 70.3 111.771 -171.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.585 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.9 m -73.93 179.45 4.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.242 -0.89 . . . . 71.22 110.572 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.7 t -69.08 146.01 52.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.246 -0.649 . . . . 74.23 109.246 173.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -54.14 106.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.475 0.484 . . . . 64.12 111.544 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.5 m -91.16 103.76 16.4 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.076 -0.713 . . . . 72.21 109.076 173.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 m -55.41 124.36 16.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.789 -0.641 . . . . 75.21 111.099 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 69' ' ' ALA . 83.7 mt -83.38 150.69 25.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.79 -0.641 . . . . 73.55 111.275 -176.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -129.34 152.29 49.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.174 -0.921 . . . . 70.13 108.747 171.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.8 m120 -65.53 118.39 9.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.996 0.427 . . . . 71.41 110.43 175.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 124.76 -137.88 10.78 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.817 -0.706 . . . . 64.3 112.167 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 20.5 m -88.61 127.81 35.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.411 . . . . 54.33 111.016 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -124.95 112.72 16.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.219 -0.446 . . . . 74.35 110.078 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.8 m -102.98 106.52 17.07 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.798 0.332 . . . . 74.33 110.527 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.7 mt -87.63 115.39 62.76 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.624 -0.51 . . . . 74.14 109.624 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -84.23 132.94 5.38 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.602 2.201 . . . . 64.33 112.841 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.429 ' HE1' ' HG ' ' A' ' 119' ' ' SER . 76.2 m-85 -131.9 159.55 38.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 54.31 110.462 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.681 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 99.2 mt-30 -127.97 112.88 15.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.246 -0.434 . . . . 73.13 111.487 -176.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.54 127.7 45.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.206 -0.452 . . . . 71.51 110.192 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.524 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 15.8 ptp180 -139.06 163.08 33.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.45 -0.341 . . . . 55.13 110.719 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 71.7 m-85 -81.57 142.5 32.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.97 -0.559 . . . . 63.4 110.715 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -130.43 119.79 23.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.639 -0.709 . . . . 74.42 109.421 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 45' ' ' GLU . . . -81.27 137.62 35.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.397 -0.365 . . . . 61.13 111.009 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.442 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 68.9 p -110.13 2.79 19.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.676 0.75 . . . . 53.31 109.349 176.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.22 -129.45 1.74 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.915 -1.039 . . . . 53.5 110.864 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.15 90.26 8.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.848 0.324 . . . . 74.31 110.283 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.64 114.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.491 0.495 . . . . 62.33 111.557 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 26.6 p -104.71 139.62 20.28 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-O 121.385 0.612 . . . . 75.24 110.613 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.59 162.77 41.32 Favored 'Trans proline' 0 C--N 1.333 -0.272 0 C-N-CA 123.799 3.0 . . . . 73.01 112.868 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.63 -162.88 26.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.732 -0.747 . . . . 54.25 111.817 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.84 113.65 8.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.866 0.365 . . . . 63.24 111.338 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.598 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -111.47 63.61 0.61 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.5 0.667 . . . . 75.33 110.357 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -117.48 128.46 55.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.818 . . . . 63.54 109.782 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.494 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -134.21 169.5 17.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.364 -0.38 . . . . 65.43 111.342 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.8 146.36 50.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 63.23 109.62 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.02 138.86 19.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.146 0.498 . . . . 65.14 111.291 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.6 p -107.2 121.81 45.27 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.794 -0.639 . . . . 64.43 109.771 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -102.61 137.19 41.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.367 -0.378 . . . . 73.34 110.528 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HA ' HG21 ' A' ' 16' ' ' VAL . 3.9 tmmm? -119.78 113.08 20.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.344 -0.389 . . . . 75.44 110.345 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.725 HG12 HG12 ' A' ' 71' ' ' VAL . 1.2 m -77.57 137.28 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.773 -0.454 . . . . 70.52 109.773 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -115.2 123.56 49.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.393 -0.367 . . . . 71.03 110.172 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.647 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 3.1 p90 . . . . . 0 C--N 1.321 -0.672 0 CA-C-N 115.688 -0.687 . . . . 75.14 109.875 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.914 -0.402 . . . . 63.21 109.914 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.98 12.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.898 0.38 . . . . 72.24 110.922 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 61.86 17.89 9.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.58 -0.736 . . . . 75.44 111.872 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.412 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 83.0 95.53 0.56 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.598 -0.81 . . . . 54.25 111.396 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.78 157.39 45.47 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.174 -1.012 . . . . 34.13 111.895 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.473 ' HB ' HG22 ' A' ' 31' ' ' THR . 4.8 p -140.79 138.9 34.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.679 0.276 . . . . 64.22 111.077 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -115.48 120.44 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 116.441 -0.345 . . . . 54.14 110.071 176.025 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -91.09 107.37 19.16 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.165 -0.471 . . . . 65.51 110.08 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.11 125.11 40.42 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.02 -0.536 . . . . 72.52 110.545 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -112.33 133.81 54.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.994 -0.548 . . . . 54.3 111.165 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.07 -130.07 5.62 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.461 -0.79 . . . . 73.11 111.88 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.47 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 44.3 mt-10 62.91 24.13 14.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.123 0.487 . . . . 65.13 110.993 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' A' ' 155' ' ' LYS . 22.1 m -77.85 -34.44 19.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.823 -0.626 . . . . 51.43 111.273 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.584 HG22 HG23 ' A' ' 16' ' ' VAL . 17.9 m -142.89 150.28 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.014 0.435 . . . . 64.14 111.189 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -144.34 22.42 1.68 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.417 -0.81 . . . . 74.01 108.961 175.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.92 -82.99 0.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.491 -0.777 . . . . 54.15 111.255 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.475 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -81.34 -35.65 30.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.796 0.332 . . . . 73.34 110.278 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 m -142.54 135.4 28.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.887 0.375 . . . . 64.54 110.023 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.04 123.97 40.92 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.102 -0.499 . . . . 64.3 109.861 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.487 ' HA ' HD23 ' A' ' 58' ' ' LEU . 14.2 t -61.03 131.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 109.722 -0.473 . . . . 65.34 109.722 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.431 ' O ' HG13 ' A' ' 28' ' ' VAL . 27.7 t70 -59.86 140.07 56.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.107 -0.497 . . . . 61.0 111.335 -176.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.13 -27.34 65.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.793 -0.64 . . . . 71.42 111.819 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.86 7.47 79.94 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.717 -0.754 . . . . 74.31 112.282 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.3 p -129.54 -10.96 4.52 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 122.712 -0.287 . . . . 72.55 111.387 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.47 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 29.2 m -78.24 -5.81 8.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 121.109 0.48 . . . . 73.1 110.505 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -157.2 96.14 1.54 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.446 -0.797 . . . . 73.25 109.015 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -143.64 121.8 12.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.212 0.53 . . . . 64.05 110.546 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 16.4 m -106.83 103.19 12.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.406 -0.815 . . . . 70.22 109.542 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 9' ' ' THR . 11.0 p -89.34 137.41 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.919 0.39 . . . . 73.32 110.97 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -91.05 128.7 36.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.767 -0.651 . . . . 74.44 109.574 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.16 -19.92 24.88 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.103 0.478 . . . . 72.42 110.265 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.6 165.03 35.9 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.868 -0.682 . . . . 32.5 112.082 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -75.18 96.44 3.29 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.055 -0.35 . . . . 62.13 110.055 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 p -80.05 149.34 5.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.152 -0.476 . . . . 74.43 110.274 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.0 mtt85 -83.29 128.68 34.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.996 -0.547 . . . . 64.42 109.864 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 6.6 p -77.78 -13.52 59.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.929 -0.578 . . . . 62.12 111.944 -172.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.14 50.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 65.11 110.915 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.486 ' HB2' HD12 ' A' ' 42' ' ' LEU . 5.5 m -67.42 -29.34 68.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.325 0.583 . . . . 33.45 110.472 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.5 mp -112.77 86.81 2.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.494 -0.775 . . . . 63.11 109.996 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.0 14.58 12.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.127 0.489 . . . . 72.43 111.122 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HG2' ' HB2' ' A' ' 47' ' ' ALA . 3.2 pm0 -141.5 135.91 30.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.052 -0.522 . . . . 75.15 110.324 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.545 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.5 tm-20 -59.32 119.97 8.41 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.563 -0.532 . . . . 73.44 109.563 175.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 109.9 -6.29 30.99 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.738 -0.744 . . . . 71.45 111.752 -175.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -65.8 135.31 54.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 73.43 111.005 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.1 p -120.97 140.82 51.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.055 -0.521 . . . . 45.0 110.355 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -104.34 -175.79 2.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.216 -0.447 . . . . 71.22 109.814 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.7 m -75.05 133.51 41.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.459 -0.337 . . . . 60.14 110.19 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -89.92 154.81 19.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.496 0.665 . . . . 74.33 112.021 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 31.5 m -92.82 156.65 3.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.646 -1.161 . . . . 62.25 109.22 169.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 101.65 1.22 Allowed Glycine 0 C--N 1.315 -0.587 0 C-N-CA 120.859 -0.686 . . . . 73.05 112.267 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -111.04 176.59 4.96 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.752 -0.462 . . . . 75.54 109.752 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.549 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.5 p-10 -136.24 149.51 48.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.403 0.621 . . . . 75.12 111.904 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.435 HD12 ' CE2' ' A' ' 133' ' ' PHE . 72.6 mt -113.93 113.86 45.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.11 -0.95 . . . . 61.03 108.684 169.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . 49.8 tt0 -96.83 140.33 31.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.101 -0.499 . . . . 72.43 110.951 -172.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 23' ' ' VAL . 64.5 mt -120.63 122.35 40.33 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.951 -0.568 . . . . 71.24 109.565 177.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -99.39 143.79 29.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.075 -0.511 . . . . 74.31 110.034 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 56.82 44.02 24.05 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.779 0.674 . . . . 75.35 110.845 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.597 ' SG ' HD22 ' A' ' 124' ' ' LEU . 6.0 t -75.24 142.04 43.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.109 -0.496 . . . . 74.42 110.31 -175.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -117.71 142.36 47.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.944 -0.571 . . . . 63.52 112.044 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.4 p -113.28 4.51 16.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.79 -0.641 . . . . 62.42 111.398 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -76.0 -38.1 57.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.975 0.417 . . . . 74.24 110.085 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 p -107.86 -18.96 7.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.107 -0.497 . . . . 75.02 111.381 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.704 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -126.47 161.75 27.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.741 0.305 . . . . 75.32 111.52 -176.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.551 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 15.0 m -120.18 -55.74 2.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.203 -0.453 . . . . 72.44 111.462 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.551 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -136.53 148.87 47.83 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.81 -0.441 . . . . 65.24 109.81 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.636 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -103.48 140.6 37.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.039 0.447 . . . . 63.53 110.308 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.57 114.17 6.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.6 -0.727 . . . . 65.32 109.067 176.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.655 HG12 HG12 ' A' ' 156' ' ' VAL . 1.3 m -88.13 145.64 7.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.971 0.415 . . . . 60.52 110.834 -173.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.52 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -119.97 123.28 43.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.807 -0.633 . . . . 71.42 109.74 173.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.454 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 57.4 m-85 -86.34 142.52 28.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.2 0.524 . . . . 74.33 111.096 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.6 tp -134.18 123.15 23.87 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.487 -0.778 . . . . 54.41 109.963 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 113' ' ' LEU . . . -164.64 -177.05 36.95 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.767 -0.933 . . . . 62.23 110.767 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.9 m -77.41 121.73 24.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.954 0.377 . . . . 70.43 110.828 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.28 138.68 39.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 62.44 110.529 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.459 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 9.5 tt -69.14 -30.84 47.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 74.13 111.133 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -146.32 178.67 8.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.995 -0.372 . . . . 71.34 109.995 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.71 -30.77 28.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.074 0.464 . . . . 71.34 110.106 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.5 -25.85 31.91 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.726 -0.749 . . . . 54.32 111.539 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.423 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 67.1 m80 -103.5 72.64 1.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.302 0.572 . . . . 74.21 110.046 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 p -92.1 5.43 50.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.547 -0.751 . . . . 72.42 111.853 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -112.43 2.53 16.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 71.13 110.624 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 102' ' ' GLN . 57.6 t -111.01 122.85 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.861 -0.608 . . . . 70.32 110.095 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -69.88 131.38 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.674 0.274 . . . . 74.15 110.275 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.459 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.43 145.72 36.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 52.55 110.441 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.66 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -85.16 135.42 33.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.126 -0.488 . . . . 61.44 109.943 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 72.44 110.099 -179.669 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.684 -0.488 . . . . 64.35 109.684 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.72 106.48 1.51 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.048 0.452 . . . . 62.21 110.319 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.36 159.31 15.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.143 -0.481 . . . . 74.01 110.574 -176.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.46 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 48.1 m-80 67.01 13.05 9.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.333 0.653 . . . . 54.51 111.17 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.48 167.62 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 CA-C-N 116.271 -0.422 . . . . 61.11 110.336 175.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.527 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . -169.08 -173.8 37.07 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.221 -1.152 . . . . 52.03 110.221 176.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.78 115.26 47.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.363 0.601 . . . . 65.41 110.647 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.501 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.2 pt20 -100.49 139.77 35.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.771 -0.65 . . . . 63.35 109.365 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.454 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.2 mp -96.36 129.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.955 0.407 . . . . 62.12 110.295 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.537 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 49.0 mt -96.91 141.6 29.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.705 -0.679 . . . . 63.12 109.925 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.577 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.69 -173.05 1.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.131 -0.486 . . . . 74.15 110.033 177.272 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.438 ' HG3' HG23 ' A' ' 107' ' ' THR . 13.7 ptm180 -57.83 -25.28 60.44 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.276 0.473 . . . . 71.22 112.276 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.438 HG23 ' HG3' ' A' ' 106' ' ' ARG . 74.5 p -100.04 1.7 42.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 73.51 111.762 -177.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 83.32 38.09 11.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.642 -0.79 . . . . 71.14 112.713 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.52 136.13 51.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.228 -0.286 . . . . 74.43 110.228 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.91 120.74 14.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.328 -0.396 . . . . 63.22 111.013 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 105' ' ' ASP . 95.1 mt -88.21 129.94 35.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.064 -0.516 . . . . 74.31 110.617 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.8 m -76.43 137.6 39.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.903 -0.589 . . . . 73.45 110.954 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.472 HD13 HD22 ' A' ' 86' ' ' LEU . 37.5 mt -79.56 47.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 74.05 110.98 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -100.11 -14.34 18.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.878 -0.601 . . . . 74.21 110.367 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.4 -13.48 33.86 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.745 -0.74 . . . . 62.23 112.525 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.61 4.83 15.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.943 0.401 . . . . 62.13 111.12 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.2 m -100.5 99.65 10.28 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.555 -0.535 . . . . 65.33 109.555 176.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.529 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 64.1 m-85 -94.26 164.11 13.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.089 -0.505 . . . . 74.45 111.487 -172.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.577 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 8.3 m -72.94 -178.56 2.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.45 -0.795 . . . . 61.42 111.459 177.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 m -69.05 160.95 30.03 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.915 -0.584 . . . . 72.31 109.521 170.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.66 125.96 25.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 74.44 110.944 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.428 HG21 HG12 ' A' ' 131' ' ' ILE . 20.1 m -109.23 98.72 8.1 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.38 -0.97 . . . . 70.44 108.38 168.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.4 m -57.22 116.58 3.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 73.22 111.078 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.636 HD21 ' HB2' ' A' ' 69' ' ' ALA . 76.3 mt -74.83 150.17 39.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.307 -0.86 . . . . 62.43 111.522 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -128.12 150.42 49.98 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.259 -0.882 . . . . 54.53 108.83 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -65.31 109.96 2.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.802 0.334 . . . . 71.53 110.354 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.4 -139.2 10.86 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.637 -0.792 . . . . 63.24 112.517 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 m -86.31 117.79 25.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.942 0.401 . . . . 63.42 111.061 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.526 HD22 ' N ' ' A' ' 129' ' ' ASN . 0.8 OUTLIER -112.16 148.62 33.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.508 -0.552 . . . . 70.41 109.508 178.198 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.549 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.2 m -138.01 113.65 9.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.265 -0.272 . . . . 72.32 110.265 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 10.2 mt -94.46 119.71 66.03 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.982 -0.377 . . . . 63.23 109.982 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 4.9 Cg_endo -84.14 133.31 5.59 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.971 2.447 . . . . 74.11 112.514 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 70.7 m-85 -135.63 163.44 30.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.296 -0.411 . . . . 73.32 110.691 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 90.0 mt-30 -126.71 148.87 49.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.016 -0.538 . . . . 73.42 110.66 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.24 122.52 26.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.182 -0.463 . . . . 50.21 110.335 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 2.1 ptp180 -134.1 164.96 26.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.458 -0.337 . . . . 64.01 110.633 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -83.98 143.07 30.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.116 -0.493 . . . . 63.5 110.555 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.51 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 57.2 t80 -130.17 125.94 36.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.894 -0.78 . . . . 61.24 108.894 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.648 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -89.73 135.18 33.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.017 0.437 . . . . 72.31 111.435 -177.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.545 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 72.2 p -102.53 9.91 39.18 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.756 -0.831 . . . . 55.04 108.756 175.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.09 -123.75 1.2 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.833 -1.076 . . . . 33.32 111.111 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.27 96.65 10.41 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.784 -0.45 . . . . 61.05 109.784 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.93 112.19 0.44 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.699 0.624 . . . . 62.43 111.164 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.7 p -105.12 139.57 20.25 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 115.947 -0.57 . . . . 72.02 109.944 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.83 157.41 58.38 Favored 'Trans proline' 0 C--N 1.328 -0.503 0 C-N-CA 123.417 2.745 . . . . 75.01 113.153 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.33 -165.2 29.43 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.598 -0.728 . . . . 62.24 112.11 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.18 114.57 11.51 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.796 0.331 . . . . 74.42 111.086 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.66 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -109.08 69.96 0.72 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.213 0.53 . . . . 61.1 110.361 176.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -110.34 123.63 50.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.567 -0.531 . . . . 75.14 109.567 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.455 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -132.38 158.81 40.99 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.841 0.353 . . . . 70.41 111.036 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.41 143.84 39.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.252 -0.431 . . . . 71.22 110.15 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.513 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -153.84 157.94 40.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.976 0.417 . . . . 73.12 111.358 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.3 p -109.49 155.12 21.73 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.723 -0.672 . . . . 64.33 109.412 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -127.6 123.22 35.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.092 0.472 . . . . 70.03 110.679 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.607 ' HA ' HG21 ' A' ' 16' ' ' VAL . 9.2 ttmt -102.6 105.63 16.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.095 -0.502 . . . . 71.03 110.359 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.655 HG12 HG12 ' A' ' 71' ' ' VAL . 1.3 m -76.61 128.85 37.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.507 -0.553 . . . . 54.32 109.507 177.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 57.9 tt0 -107.5 129.9 54.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.227 -0.442 . . . . 55.21 110.087 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.704 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.18 -0.464 . . . . 75.0 110.836 174.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.0 p . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 110.203 -0.295 . . . . 74.44 110.203 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.488 HG22 HG12 ' A' ' 37' ' ' VAL . 35.2 m -91.65 17.39 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.137 0.494 . . . . 63.34 110.662 176.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 61.97 11.85 4.49 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.202 -0.908 . . . . 73.43 112.515 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 35' ' ' GLY . . . 82.97 95.53 0.56 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.43 -0.89 . . . . 52.34 111.566 -176.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.19 160.91 33.88 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.198 -1.001 . . . . 52.45 111.305 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.601 ' HB ' HG22 ' A' ' 31' ' ' THR . 65.8 p -138.88 140.6 38.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.684 0.278 . . . . 72.1 110.439 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.96 122.27 63.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.194 -0.669 . . . . 72.3 109.194 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -90.47 109.69 20.82 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.322 -0.621 . . . . 74.44 109.322 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -97.52 124.05 41.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.899 -0.591 . . . . 63.32 110.173 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -106.51 135.13 48.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.951 -0.568 . . . . 74.13 110.816 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.26 -137.72 6.61 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 121.098 -0.573 . . . . 74.41 112.534 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.408 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 46.4 mt-10 59.34 27.44 16.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.362 0.601 . . . . 64.41 110.774 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.716 HG23 HG22 ' A' ' 17' ' ' VAL . 22.8 m -80.29 -21.93 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.48 -0.782 . . . . 63.15 110.672 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.765 HG21 HG22 ' A' ' 156' ' ' VAL . 3.5 m -148.46 139.27 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.737 -0.665 . . . . 73.1 110.865 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -139.02 26.3 2.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.02 -0.536 . . . . 75.04 109.637 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.09 -86.97 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.28 0.474 . . . . 72.33 112.28 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.485 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -76.4 -16.79 59.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 72.31 111.08 -178.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 58' ' ' LEU . 59.7 m -150.87 157.16 42.57 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.425 -0.954 . . . . 55.14 108.425 178.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.55 116.22 26.19 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.491 -0.559 . . . . 71.01 109.491 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.65 134.04 23.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.378 -0.373 . . . . 64.34 110.113 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.476 ' O ' HG13 ' A' ' 28' ' ' VAL . 16.8 t70 -63.56 142.94 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.503 -0.317 . . . . 64.22 110.923 -177.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -59.43 -27.52 66.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 52.43 112.261 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.24 -21.38 78.0 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.508 -0.853 . . . . 73.35 112.095 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 p -104.73 -12.41 16.36 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.062 0.393 . . . . 74.31 112.062 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 25' ' ' ALA . 31.4 m -80.58 -5.32 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.894 0.378 . . . . 75.35 110.708 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -163.29 89.78 0.63 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.277 -0.638 . . . . 74.15 109.277 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -141.78 132.33 25.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.039 -0.528 . . . . 74.3 110.591 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.601 HG22 ' HB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -107.72 99.29 8.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.757 -0.656 . . . . 43.34 109.286 178.045 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.6 p -82.32 126.87 40.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.108 0.48 . . . . 62.42 111.252 -175.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.564 ' HA ' HG22 ' A' ' 9' ' ' THR . 25.7 mp0 -84.66 120.7 26.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 74.41 109.706 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.74 -28.83 36.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.058 -0.519 . . . . 73.22 110.183 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.494 ' O ' ' HA2' ' A' ' 7' ' ' GLY . . . 106.38 170.96 22.98 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.765 -0.652 . . . . 62.31 111.911 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -83.93 83.6 7.88 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.893 -0.41 . . . . 62.22 109.893 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.488 HG12 HG22 ' A' ' 5' ' ' VAL . 9.7 p -67.8 143.04 15.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.018 0.437 . . . . 75.12 110.65 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -77.73 115.51 17.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.818 -0.628 . . . . 63.14 109.795 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.7 p -61.45 -32.04 72.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.274 -0.421 . . . . 75.25 111.318 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.22 -24.34 66.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.515 . . . . 74.24 111.791 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.1 m -76.22 -23.46 54.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.814 0.34 . . . . 74.42 110.939 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -114.17 92.03 3.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.094 0.473 . . . . 71.44 110.225 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.36 19.26 8.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.004 0.431 . . . . 73.25 111.245 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -149.73 138.34 20.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.942 -0.572 . . . . 74.23 110.52 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.6 tm-20 -55.79 124.02 16.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 53.41 109.61 175.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.0 -3.93 38.58 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.961 -0.637 . . . . 61.5 111.962 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -67.42 123.1 19.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.772 0.32 . . . . 74.31 110.554 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.82 ' HB ' HH11 ' A' ' 136' ' ' ARG . 22.9 p -112.72 121.42 44.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.914 -0.585 . . . . 71.4 111.024 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.47 ' HB2' ' H ' ' A' ' 137' ' ' TYR . 60.7 m -73.81 157.48 36.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.177 -0.465 . . . . 73.21 110.458 175.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.4 m -60.66 127.93 34.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.751 -0.463 . . . . 65.22 109.751 175.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.11 154.95 28.96 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.479 0.656 . . . . 65.11 111.749 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 33.1 m -95.58 147.86 5.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 114.859 -1.064 . . . . 64.14 109.451 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.88 103.06 2.35 Favored Glycine 0 C--N 1.309 -0.964 0 C-N-CA 120.899 -0.667 . . . . 34.2 111.858 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -113.82 179.92 3.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.627 -0.509 . . . . 74.32 109.627 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.5 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 3.9 p-10 -138.34 149.94 46.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.424 0.631 . . . . 54.41 112.308 -173.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.461 HD12 ' CE2' ' A' ' 133' ' ' PHE . 81.1 mt -121.42 113.7 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.932 -1.031 . . . . 74.11 108.484 168.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 29.8 tt0 -99.07 136.9 38.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 65.43 111.181 -172.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 78.3 mt -112.04 129.94 56.04 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.825 -0.625 . . . . 74.14 109.811 176.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -102.87 136.52 42.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.915 -0.584 . . . . 63.43 110.535 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 54.49 75.88 0.27 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 124.008 0.818 . . . . 74.4 112.055 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.6 m -97.55 138.81 34.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.652 -0.704 . . . . 34.15 111.18 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -112.57 137.63 50.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.727 -0.67 . . . . 61.22 110.638 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 p -102.25 6.2 40.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.099 -0.5 . . . . 75.41 111.94 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -90.27 -31.12 17.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.663 -0.495 . . . . 51.32 109.663 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 p -98.27 -22.18 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.733 -0.667 . . . . 72.55 111.337 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -141.58 168.42 19.82 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.028 -0.42 . . . . 25.51 111.029 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.543 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 36.9 m -125.7 -51.7 1.59 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.216 0.451 . . . . 54.22 112.216 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.549 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -132.99 150.46 52.16 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.086 -0.383 . . . . 53.14 110.518 -177.028 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.69 130.42 55.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.916 0.389 . . . . 65.14 109.984 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.34 114.84 8.89 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.585 -0.524 . . . . 73.43 109.585 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.759 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -84.2 145.84 7.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 42.31 111.028 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -117.63 116.92 28.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.498 -0.774 . . . . 51.41 109.806 174.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.409 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 65.7 m-85 -85.54 130.12 34.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.325 0.583 . . . . 64.53 110.979 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.9 tp -128.9 116.02 18.77 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.33 -0.85 . . . . 74.21 109.951 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.34 -171.54 20.04 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.201 -0.76 . . . . 62.01 111.201 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.7 m -85.58 116.14 23.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.864 0.332 . . . . 72.01 110.177 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.05 147.68 36.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.45 -0.341 . . . . 72.12 110.845 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.436 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 9.3 tt -63.52 -30.22 49.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.998 -0.546 . . . . 74.22 110.643 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.82 -178.56 5.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 71.01 109.584 174.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.74 -10.23 59.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.038 0.385 . . . . 74.23 112.038 -174.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.53 -44.05 3.27 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.978 -0.629 . . . . 63.13 111.607 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.406 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 60.7 m80 -97.1 61.15 1.74 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.576 0.703 . . . . 74.43 109.373 177.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -76.69 5.46 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.106 -0.952 . . . . 73.11 112.266 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -106.07 -4.82 19.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.478 . . . . 61.5 110.349 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.26 127.77 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.613 . . . . 72.23 110.448 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.477 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -72.25 134.54 45.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.755 -0.461 . . . . 73.4 109.755 178.382 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.14 149.72 33.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.175 -0.466 . . . . 74.13 110.061 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.5 mm? -82.04 133.19 35.27 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.222 -0.444 . . . . 64.24 110.374 -176.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.831 -0.622 . . . . 43.5 110.834 -179.288 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 120.749 0.309 . . . . 71.11 110.696 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.33 109.01 2.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 73.01 110.502 -175.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.37 160.68 14.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.154 -0.475 . . . . 71.14 110.974 -174.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 72.02 9.26 6.06 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.8 -0.636 . . . . 35.35 110.743 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.94 -172.37 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.852 -0.613 . . . . 62.34 110.459 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.31 -176.95 46.66 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.552 -1.019 . . . . 71.21 110.552 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.54 113.35 40.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.361 0.6 . . . . 64.34 110.648 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -102.29 137.58 40.36 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.223 -0.658 . . . . 72.15 109.223 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.409 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -100.42 120.35 49.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.054 0.454 . . . . 70.31 110.349 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.458 HD11 ' HE ' ' A' ' 136' ' ' ARG . 24.9 mt -86.1 145.86 26.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.686 -0.688 . . . . 72.41 109.225 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.528 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.2 OUTLIER -74.68 -171.93 1.4 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.242 -0.436 . . . . 72.54 109.914 177.569 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.457 HH11 ' HD2' ' A' ' 106' ' ' ARG . 19.0 ptt85 -58.49 -27.33 64.35 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.727 0.269 . . . . 71.44 111.727 -177.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 106' ' ' ARG . 19.0 p -100.45 7.96 43.87 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.877 0.37 . . . . 64.32 111.838 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 83.71 28.09 36.44 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 33.35 113.099 175.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.23 120.12 39.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.222 -0.288 . . . . 74.23 110.222 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 115.81 4.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.898 0.38 . . . . 74.52 110.518 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.7 mt -83.71 132.56 34.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.328 -0.396 . . . . 73.34 111.129 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.516 ' H ' HG21 ' A' ' 117' ' ' THR . 15.6 m -73.05 140.45 47.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.723 -0.672 . . . . 74.22 110.547 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.414 ' CD1' HD22 ' A' ' 86' ' ' LEU . 74.2 mt -78.74 49.25 0.88 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.329 0.585 . . . . 74.35 110.504 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -85.67 -27.58 25.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.49 -0.777 . . . . 74.21 109.983 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.34 -22.47 32.39 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.627 -0.715 . . . . 12.25 111.539 -172.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.21 14.63 14.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.757 0.313 . . . . 30.04 111.119 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.516 HG21 ' H ' ' A' ' 112' ' ' THR . 21.6 m -95.24 105.25 17.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.47 -0.567 . . . . 64.35 109.47 174.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 72' ' ' ALA . 86.5 m-85 -97.41 156.29 16.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.225 0.536 . . . . 74.41 111.473 -173.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 7.3 m -68.92 -178.83 1.3 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.392 -0.822 . . . . 72.42 111.143 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.3 t -69.36 156.69 38.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.883 -0.784 . . . . 73.24 108.883 170.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.549 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 51.7 mt-10 -66.06 109.14 2.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.729 0.299 . . . . 72.34 111.476 -175.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.429 ' OG1' ' HD3' ' A' ' 106' ' ' ARG . 22.7 m -89.08 96.82 10.88 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.644 -0.873 . . . . 53.33 108.644 171.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.6 m -60.07 122.05 13.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.911 -0.586 . . . . 73.14 110.903 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.8 mt -81.87 150.45 27.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.423 -0.808 . . . . 60.5 111.16 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -130.68 161.46 31.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.227 -0.657 . . . . 72.15 109.227 169.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -60.35 112.74 2.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 72.54 110.973 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.47 -141.45 13.0 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.766 -0.731 . . . . 71.22 112.595 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.0 m -82.1 131.56 35.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.791 0.329 . . . . 74.2 111.233 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -130.82 114.47 15.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.158 -0.474 . . . . 74.43 109.873 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.5 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 4.7 m -107.04 117.81 35.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.827 0.346 . . . . 61.23 110.267 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.4 mt -94.39 116.8 66.82 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.988 -0.551 . . . . 74.41 110.174 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.59 138.13 10.59 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.033 2.489 . . . . 64.41 111.958 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.461 ' CE2' HD12 ' A' ' 56' ' ' ILE . 74.0 m-85 -135.35 161.77 34.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.365 -0.379 . . . . 62.43 110.53 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.678 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 43.0 mt-30 -127.91 114.65 17.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 53.31 110.802 -175.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.43 132.38 49.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.68 -0.237 . . . . 71.32 110.55 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.82 HH11 ' HB ' ' A' ' 48' ' ' THR . 12.4 ptp180 -143.1 160.07 41.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.967 0.413 . . . . 75.34 111.206 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.47 ' H ' ' HB2' ' A' ' 49' ' ' SER . 73.3 m-85 -80.32 145.83 31.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.776 -0.647 . . . . 74.22 110.553 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.406 ' HE2' ' CD2' ' A' ' 82' ' ' HIS . 64.4 t80 -131.88 118.45 19.84 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.845 -0.616 . . . . 71.34 109.661 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -86.97 132.66 33.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.299 -0.41 . . . . 75.51 111.235 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.496 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 66.0 p -99.14 5.08 47.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.679 0.752 . . . . 65.21 109.424 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 173.14 -117.78 0.67 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.647 -1.16 . . . . 45.32 110.744 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -94.72 98.47 10.8 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.927 -0.397 . . . . 74.33 109.927 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -50.54 123.71 9.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.018 -0.537 . . . . 60.43 110.807 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 39.9 p -116.02 147.62 39.65 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.125 0.488 . . . . 73.32 110.686 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -64.31 163.18 27.35 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.668 2.912 . . . . 73.25 112.553 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.59 -164.43 27.39 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.645 -0.788 . . . . 61.22 112.065 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -85.35 115.1 22.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.65 0.262 . . . . 70.3 110.459 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -108.48 55.15 0.64 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.138 0.494 . . . . 64.42 111.323 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -105.13 138.98 40.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.062 -0.517 . . . . 73.33 109.895 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.477 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -140.63 179.69 6.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.932 0.396 . . . . 72.25 111.773 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -143.95 137.1 27.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.621 -0.718 . . . . 75.41 109.71 -178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.36 139.84 21.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.892 0.377 . . . . 72.22 111.271 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 30.5 p -103.71 132.28 50.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.195 -0.457 . . . . 51.41 109.899 176.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -107.39 124.05 49.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.104 0.478 . . . . 63.2 110.391 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.619 ' HA ' HG21 ' A' ' 16' ' ' VAL . 3.0 tmmm? -105.62 99.39 8.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.921 -0.581 . . . . 75.24 109.492 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.765 HG22 HG21 ' A' ' 17' ' ' VAL . 1.4 m -74.84 127.96 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.64 0.733 . . . . 73.42 110.178 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -103.67 108.61 19.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.525 -0.761 . . . . 73.44 111.009 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.571 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 2.5 p90 . . . . . 0 C--N 1.319 -0.735 0 N-CA-C 109.017 -0.734 . . . . 73.02 109.017 166.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 120.51 0.195 . . . . 73.33 110.513 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.73 174.57 3.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.42 . . . . 44.34 110.921 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.7 t -98.68 -4.76 33.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.935 0.398 . . . . 75.53 111.123 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.417 ' CB ' ' HB3' ' A' ' 36' ' ' GLN . 80.4 p -116.97 173.01 6.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.927 0.394 . . . . 74.22 110.682 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 37' ' ' VAL . 27.7 m -86.86 16.65 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.05 0.452 . . . . 75.53 111.083 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 61.93 13.12 5.32 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.566 -0.743 . . . . 71.11 112.211 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.483 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 91.14 101.26 1.25 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.558 -0.829 . . . . 63.42 111.785 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.65 160.19 25.29 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.431 -0.89 . . . . 71.34 111.777 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 33' ' ' GLN . 66.4 p -143.3 149.17 37.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.883 0.373 . . . . 41.32 110.637 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.518 HG22 HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -123.67 117.86 52.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.997 -0.547 . . . . 72.23 110.503 175.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -95.72 112.51 24.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.399 -0.818 . . . . 61.0 110.118 -177.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 59.4 m-85 -94.39 137.29 33.72 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.812 -0.631 . . . . 65.23 110.562 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.598 ' HZ3' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -114.58 137.62 51.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.973 -0.558 . . . . 62.33 110.301 -179.081 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.21 -133.41 4.06 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.759 -0.734 . . . . 60.23 112.504 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 49.2 mt-10 60.65 21.27 11.19 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.212 0.53 . . . . 62.1 111.115 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.56 HG21 ' HA ' ' A' ' 155' ' ' LYS . 24.8 m -76.32 -23.81 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.748 -0.66 . . . . 75.11 111.132 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.428 HG21 ' CG2' ' A' ' 156' ' ' VAL . 24.1 m -135.71 148.28 28.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.126 -0.488 . . . . 35.31 111.361 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -151.31 26.73 0.68 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.502 -0.925 . . . . 54.42 108.502 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.36 -79.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.115 -0.948 . . . . 54.21 111.408 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.468 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -84.73 -37.53 20.77 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.859 0.361 . . . . 71.32 110.858 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -140.7 132.46 27.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.141 -0.481 . . . . 74.04 109.873 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.58 123.21 37.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.254 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 t -66.44 133.33 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.862 -0.422 . . . . 71.24 109.862 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 28' ' ' VAL . 19.2 t70 -62.05 147.96 45.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 72.22 111.043 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -62.25 -25.39 67.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 74.55 111.783 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 30' ' ' GLN . . . -86.13 -9.76 76.18 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.589 -0.815 . . . . 71.35 111.627 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.0 m -105.23 -23.25 12.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.465 0.174 . . . . 40.34 111.124 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 25.5 m -77.56 -12.18 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.335 0.588 . . . . 74.25 110.215 176.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -153.58 96.01 1.97 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.964 -1.016 . . . . 71.43 109.217 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 24.9 pt20 -148.34 142.81 26.38 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.01 -0.541 . . . . 74.54 110.421 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.506 HG22 ' HB ' ' A' ' 9' ' ' THR . 6.9 m -124.0 101.3 7.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.628 -0.714 . . . . 72.45 109.649 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.18 129.22 39.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.088 0.47 . . . . 75.45 110.407 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.515 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.2 mp0 -85.63 130.57 34.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.698 -0.683 . . . . 63.41 110.245 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.518 HD21 HG22 ' A' ' 10' ' ' VAL . 2.3 mm? -91.27 -17.08 26.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.152 -0.476 . . . . 64.35 110.109 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.483 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 86.58 174.87 49.47 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.939 -0.648 . . . . 72.14 112.476 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' HB3' ' CB ' ' A' ' 4' ' ' THR . 81.2 mt-30 -77.36 89.11 3.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.137 -0.32 . . . . 74.25 110.137 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.459 HG12 HG22 ' A' ' 5' ' ' VAL . 9.9 p -68.49 144.67 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.804 -0.443 . . . . 53.4 109.804 176.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 38' ' ' ARG . 44.3 mtp180 -85.31 123.75 31.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.899 -0.408 . . . . 73.02 109.899 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 35.6 p -68.7 -23.22 64.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.169 -0.469 . . . . 65.54 111.456 -176.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.98 -15.71 61.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 63.23 111.066 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -87.92 -12.7 43.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.398 . . . . 70.34 110.731 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -129.02 84.75 2.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.225 -0.443 . . . . 65.43 110.089 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.37 19.58 12.71 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.704 -0.399 . . . . 42.41 111.849 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -150.04 140.21 22.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.702 0.287 . . . . 65.32 110.774 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 3.9 tm-20 -56.12 117.96 4.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.714 -0.676 . . . . 65.02 109.478 174.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.35 -1.09 31.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.756 -0.735 . . . . 52.21 112.345 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -74.15 134.4 42.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 73.02 110.708 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.2 p -119.7 145.83 46.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.21 -0.45 . . . . 74.32 110.934 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 t -110.23 -179.23 3.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.307 -0.406 . . . . 61.54 110.08 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.8 m -70.57 140.74 51.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.346 -0.388 . . . . 60.02 110.255 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -95.58 155.79 16.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.455 0.645 . . . . 73.41 111.936 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.7 m -95.61 152.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.485 -1.234 . . . . 73.33 109.265 170.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.23 79.63 0.26 Allowed Glycine 0 C--N 1.312 -0.793 0 C-N-CA 120.795 -0.717 . . . . 32.34 112.315 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 133' ' ' PHE . 41.8 p90 -87.83 162.48 16.95 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.807 -0.442 . . . . 75.24 109.807 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.522 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.8 p-10 -132.05 142.55 49.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.258 0.551 . . . . 51.51 111.733 -174.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.5 mt -106.62 109.14 27.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.604 -0.725 . . . . 75.23 109.305 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -89.33 136.22 33.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.197 0.523 . . . . 74.24 111.111 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.38 124.66 49.43 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.494 -0.776 . . . . 52.2 109.18 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -100.56 130.64 46.65 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.974 -0.38 . . . . 74.1 109.974 -176.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.8 t70 54.92 74.61 0.35 Allowed 'General case' 0 C--N 1.332 -0.189 0 O-C-N 124.0 0.813 . . . . 73.22 110.619 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 38.3 t -102.28 124.06 47.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.228 -0.896 . . . . 75.02 110.066 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -98.33 137.41 37.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.21 -0.45 . . . . 72.53 111.555 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.442 HG22 ' HB2' ' A' ' 124' ' ' LEU . 64.1 p -110.09 18.97 19.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 44.32 112.071 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -98.96 -26.51 14.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.458 -0.571 . . . . 34.04 109.458 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 20' ' ' ALA . 8.8 p -109.0 -2.3 10.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 72.33 110.251 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.754 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -144.21 179.16 7.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 73.3 110.462 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.7 m -141.2 -56.86 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.709 0.29 . . . . 75.43 111.297 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -136.2 143.09 44.19 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.756 -0.461 . . . . 64.24 109.756 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.495 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -102.65 123.49 46.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.072 0.463 . . . . 51.32 110.445 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.55 115.15 16.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.633 -0.712 . . . . 74.45 109.606 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 156' ' ' VAL . 3.3 m -91.53 149.8 3.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.137 0.494 . . . . 63.34 111.282 -173.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -116.08 118.61 33.36 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.726 -0.67 . . . . 73.11 109.904 174.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.522 ' CE1' HG21 ' A' ' 103' ' ' ILE . 49.2 m-85 -87.96 124.14 33.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.19 0.519 . . . . 74.13 110.993 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 56.4 tp -114.97 125.77 54.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.571 -0.74 . . . . 60.22 109.38 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.433 ' H ' ' HB3' ' A' ' 113' ' ' LEU . . . -158.66 -179.56 33.6 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.037 -0.825 . . . . 74.43 111.037 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -67.5 120.26 13.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.785 0.293 . . . . 75.23 110.778 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.49 132.55 35.71 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.972 -0.381 . . . . 73.55 109.972 175.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.484 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 7.3 tt -73.78 -25.66 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.017 0.437 . . . . 73.22 110.941 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 19.1 t70 -159.54 174.53 14.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.423 -0.584 . . . . 75.45 109.423 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.06 -33.15 44.88 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.167 0.508 . . . . 62.32 109.974 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.98 -0.58 80.87 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.216 -0.753 . . . . 51.31 111.216 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 53.5 m80 -131.37 43.35 3.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.938 -0.631 . . . . 74.24 109.958 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 p -71.65 -2.06 15.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 72.14 110.984 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 33.6 p-10 -104.02 9.6 36.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.97 -0.559 . . . . 61.34 110.334 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 t -120.36 123.22 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.858 -0.61 . . . . 71.32 110.174 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.494 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -68.46 124.58 23.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.158 -0.682 . . . . 73.12 109.158 177.31 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.0 150.31 33.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.887 -0.597 . . . . 50.51 109.846 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.515 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.5 mm? -78.2 126.23 30.49 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.227 -0.657 . . . . 61.43 109.227 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.592 ' HG2' ' HA ' ' A' ' 150' ' ' ALA . 14.1 mm100 -59.73 120.26 9.18 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.639 0.733 . . . . 64.43 109.752 -178.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.466 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 0.7 OUTLIER -85.45 109.08 18.21 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.793 -1.094 . . . . 65.34 110.682 -173.472 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.5 m -93.96 2.03 56.18 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.68 -0.691 . . . . 65.01 110.315 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 59.54 19.81 8.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.8 -0.636 . . . . 65.11 111.32 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.51 10.38 11.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.067 -0.515 . . . . 74.33 110.322 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 111.58 63.67 0.49 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.693 -0.765 . . . . 72.21 112.255 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 90' ' ' SER . 70.9 m -83.68 160.79 21.26 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.862 -0.422 . . . . 72.44 109.862 175.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.05 152.63 29.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.244 -0.28 . . . . 75.41 110.244 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.57 164.09 30.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.613 -0.435 . . . . 65.4 111.208 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 66.48 16.5 10.43 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.583 -0.735 . . . . 63.23 111.104 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.408 ' O ' HD12 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -147.79 -175.07 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 63.21 110.559 175.26 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -179.68 -167.15 36.49 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.067 -1.213 . . . . 74.24 110.067 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' A' ' 86' ' ' LEU . 2.3 p -135.8 129.35 48.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.724 0.774 . . . . 74.14 110.847 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -110.54 138.78 46.48 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.132 -0.94 . . . . 64.51 110.322 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.522 HG21 ' CE1' ' A' ' 73' ' ' PHE . 3.9 mp -95.02 114.66 32.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.023 -0.732 . . . . 64.32 109.023 173.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 57.5 mt -85.55 128.0 34.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.724 -0.671 . . . . 63.1 110.331 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.685 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 2.8 t70 -57.42 166.34 1.26 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 64.23 110.406 174.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 106' ' ' ARG . 13.4 ptm180 -58.94 -17.5 25.07 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.386 0.514 . . . . 74.23 112.386 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.1 p -92.08 -7.67 48.01 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.836 0.35 . . . . 64.21 111.512 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.66 48.06 3.29 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.868 -0.682 . . . . 70.43 112.319 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -134.04 134.13 42.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.839 -0.212 . . . . 63.53 110.82 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.01 131.98 48.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.613 0.244 . . . . 73.35 110.911 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.549 HD21 ' HB2' ' A' ' 105' ' ' ASP . 84.9 mt -94.57 134.21 37.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.969 0.414 . . . . 74.14 111.283 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 82.0 m -73.45 134.43 43.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.789 -0.641 . . . . 73.14 110.715 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 43.5 mt -81.08 50.59 1.43 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.478 0.656 . . . . 74.21 110.731 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.428 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 13.9 t70 -90.11 -19.9 23.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.224 -0.898 . . . . 74.11 110.787 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.47 -28.76 6.63 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.776 -0.725 . . . . 43.21 112.349 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.75 4.07 21.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.382 . . . . 74.21 111.006 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 114' ' ' ASP . 26.9 m -90.86 99.83 12.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.382 -0.372 . . . . 70.13 110.1 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.656 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 63.1 m-85 -90.04 157.47 17.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 70.54 111.152 -175.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.685 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . 5.4 m -73.72 -167.24 0.44 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.649 -0.705 . . . . 51.23 111.255 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.9 m -80.98 178.41 8.44 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.875 0.369 . . . . 62.41 111.067 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.542 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 38.1 mt-10 -75.09 105.67 6.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.079 -0.51 . . . . 64.31 111.573 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.537 HG21 HG12 ' A' ' 131' ' ' ILE . 88.4 m -87.32 99.46 12.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.819 -0.808 . . . . 74.21 108.819 168.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.3 m -56.91 114.86 2.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.851 -0.613 . . . . 73.21 110.653 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.504 HD22 ' SG ' ' A' ' 61' ' ' CYS . 97.5 mt -79.89 146.43 32.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.664 -0.698 . . . . 63.34 110.965 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -123.06 149.06 44.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.829 -0.804 . . . . 44.34 108.829 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 94.6 m-20 -68.52 95.99 0.67 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.964 0.412 . . . . 73.32 110.694 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 146.99 -141.05 9.05 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.998 -0.62 . . . . 73.41 111.8 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.452 ' C ' HD22 ' A' ' 129' ' ' ASN . 29.1 m -81.58 124.71 29.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.001 0.429 . . . . 62.22 110.257 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.481 HD22 ' N ' ' A' ' 129' ' ' ASN . 0.9 OUTLIER -119.8 160.2 23.08 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.321 -0.622 . . . . 54.14 109.321 177.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -149.06 126.57 11.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.24 -0.281 . . . . 75.34 110.24 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.537 HG12 HG21 ' A' ' 122' ' ' THR . 9.2 mt -104.23 109.41 62.52 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.937 -0.394 . . . . 61.14 109.937 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -88.6 127.31 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.821 2.347 . . . . 72.04 112.904 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . 73.6 m-85 -124.9 167.31 14.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.1 -0.5 . . . . 74.22 110.266 178.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.66 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 99.4 mt-30 -124.27 122.14 36.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.923 0.392 . . . . 74.01 111.1 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.85 123.03 47.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.376 -0.375 . . . . 71.45 110.403 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.514 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 5.7 ptp180 -137.86 161.2 37.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.537 -0.301 . . . . 74.53 110.96 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 63.2 m-85 -80.55 147.15 30.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.987 -0.552 . . . . 74.21 111.204 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -134.38 122.48 22.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.392 -0.822 . . . . 73.51 109.003 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.639 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -86.98 135.36 33.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.91 0.386 . . . . 44.23 111.63 -176.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.573 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 34.8 p -109.45 14.72 23.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.712 0.768 . . . . 62.5 109.228 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.17 -132.05 2.51 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 114.722 -1.126 . . . . 52.01 110.293 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.78 100.59 12.77 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.879 -0.786 . . . . 72.13 108.879 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.593 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.47 114.92 0.83 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.013 0.82 . . . . 64.42 110.848 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.6 p -105.63 143.15 26.25 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 116.281 -0.418 . . . . 63.01 110.198 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.84 158.15 58.6 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.165 2.577 . . . . 71.02 112.821 -174.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.84 -174.38 24.98 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.55 -0.75 . . . . 51.43 111.364 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.93 103.84 2.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.968 0.413 . . . . 61.34 111.144 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.515 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -99.68 66.13 1.39 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.238 0.542 . . . . 74.5 110.535 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -119.88 136.88 54.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.867 -0.606 . . . . 61.43 109.814 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.592 ' HA ' ' HG2' ' A' ' 89' ' ' GLN . . . -136.25 163.63 29.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.083 0.468 . . . . 31.42 111.837 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -123.08 135.24 54.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.541 -0.754 . . . . 74.14 109.559 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 12' ' ' PHE . . . -141.52 129.72 22.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.049 0.452 . . . . 71.33 111.275 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 13' ' ' LYS . 49.1 p -106.6 125.5 51.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.136 -0.484 . . . . 71.11 109.921 175.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -105.46 136.49 44.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.168 0.508 . . . . 72.3 111.343 -176.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.656 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 10.1 ttmm -113.05 106.45 14.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.645 -0.707 . . . . 54.22 110.213 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -74.56 141.53 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.199 -0.6 . . . . 62.53 109.573 178.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -125.79 115.73 20.48 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.164 -0.471 . . . . 64.23 109.789 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.754 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 1.3 p90 -129.22 -16.77 3.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.465 0.65 . . . . 73.21 110.324 173.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.13 -0.941 . . . . 63.33 109.109 167.646 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 110.09 -0.337 . . . . 73.32 110.09 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.52 148.03 43.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.082 -0.34 . . . . 75.5 110.082 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 t -77.82 -13.11 59.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.984 0.421 . . . . 71.32 111.367 -176.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.8 p -91.2 173.45 7.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.78 0.324 . . . . 72.11 110.277 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.441 HG22 HG12 ' A' ' 37' ' ' VAL . 35.7 m -86.47 14.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.093 0.473 . . . . 64.12 111.053 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 62.81 13.95 6.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.452 -0.794 . . . . 72.51 112.359 175.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.505 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 92.42 89.39 1.51 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.673 -0.775 . . . . 65.34 111.82 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.75 158.13 48.2 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.691 -0.766 . . . . 44.1 112.072 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.577 ' HB ' HG22 ' A' ' 31' ' ' THR . 12.9 p -141.4 139.66 33.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.571 0.224 . . . . 64.33 110.904 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -114.33 120.05 63.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.512 -0.551 . . . . 71.32 109.512 174.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -86.17 102.91 14.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.732 -0.47 . . . . 72.0 109.732 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -92.55 105.43 17.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 75.15 109.776 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 50.3 tttp -106.31 136.43 46.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.012 -0.54 . . . . 75.54 110.149 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.45 -112.81 2.44 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.874 -0.679 . . . . 71.51 112.111 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.585 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 28.0 mt-10 61.09 22.72 12.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.25 0.548 . . . . 71.43 110.685 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.645 HG21 ' HA ' ' A' ' 155' ' ' LYS . 19.1 m -77.72 -27.28 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.311 -0.859 . . . . 71.02 111.798 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.65 145.11 34.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.209 0.528 . . . . 65.24 111.821 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -159.65 84.11 0.75 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.911 -1.04 . . . . 74.23 108.236 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.35 -79.1 0.1 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.571 -0.741 . . . . 73.12 110.947 -172.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.524 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -76.76 -33.12 58.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.293 0.568 . . . . 75.34 109.642 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.6 m -141.73 173.64 11.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.327 -0.851 . . . . 54.34 109.165 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.09 123.81 27.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.683 -0.488 . . . . 71.22 109.683 173.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.7 t -66.14 128.82 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.644 -0.502 . . . . 73.25 109.644 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.468 ' O ' HG13 ' A' ' 28' ' ' VAL . 28.8 t70 -60.7 138.02 58.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.99 -0.55 . . . . 73.1 111.203 -176.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.554 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -59.35 -24.94 63.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.822 -0.627 . . . . 75.41 112.126 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.91 -13.14 83.42 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.581 -0.819 . . . . 71.21 112.229 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.8 p -112.43 -9.83 13.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.714 0.264 . . . . 73.4 111.714 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.3 m -86.35 -1.5 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 122.361 -0.212 . . . . 75.23 111.486 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -156.82 42.27 0.35 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.438 0.637 . . . . 73.53 109.552 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -91.98 123.64 35.49 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.491 -0.777 . . . . 72.12 110.127 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.577 HG22 ' HB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -109.84 95.26 5.48 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.525 -0.761 . . . . 42.54 109.606 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.1 p -81.64 130.06 36.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.984 -0.553 . . . . 63.15 111.28 -174.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -83.94 118.97 24.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.711 -0.677 . . . . 54.13 109.933 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.457 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.6 mm? -79.13 -22.49 45.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.347 0.594 . . . . 71.32 109.468 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.22 175.92 39.12 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.384 -0.826 . . . . 70.05 111.78 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -78.63 83.95 4.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.441 -0.207 . . . . 72.41 110.441 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.441 HG12 HG22 ' A' ' 5' ' ' VAL . 8.8 p -66.52 140.28 19.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.471 -0.566 . . . . 60.44 109.471 176.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -86.19 117.83 25.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.216 0.532 . . . . 74.34 109.838 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.623 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 26.7 p -65.75 -21.98 66.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 70.14 111.5 -174.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.56 -17.28 64.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.913 -0.585 . . . . 50.41 111.118 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.7 m -84.02 -14.15 51.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 74.31 111.138 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -123.63 94.49 4.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.925 0.393 . . . . 73.23 109.977 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.39 10.96 10.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.651 0.612 . . . . 44.04 112.651 -170.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -150.04 146.31 26.9 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.873 -0.331 . . . . 64.1 110.851 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -56.35 122.53 12.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.718 -0.674 . . . . 74.02 109.64 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.42 -7.0 32.07 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.646 -0.788 . . . . 72.42 112.272 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -70.61 119.09 14.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 54.45 110.697 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 p -113.31 130.64 56.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.016 -0.538 . . . . 74.54 110.158 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.5 t -89.98 175.47 7.17 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.977 -0.379 . . . . 74.12 109.977 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.1 m -70.77 136.79 49.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.791 -0.448 . . . . 72.22 109.791 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -89.08 159.69 17.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.526 0.679 . . . . 71.4 112.161 -173.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.1 m -91.31 152.42 3.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.715 -1.13 . . . . 71.34 109.552 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.0 106.13 2.44 Favored Glycine 0 C--N 1.312 -0.759 0 C-N-CA 121.095 -0.574 . . . . 71.52 112.076 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -122.77 170.28 10.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.346 -0.613 . . . . 74.31 109.346 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -135.89 149.93 49.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.449 0.642 . . . . 70.33 112.454 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.0 mt -103.54 119.79 52.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.369 -0.832 . . . . 64.03 109.129 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -102.85 132.28 49.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.095 0.474 . . . . 71.53 111.187 -172.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.2 mt -115.31 124.7 51.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.902 -0.59 . . . . 75.32 109.757 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -98.95 132.67 44.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.166 -0.47 . . . . 62.0 110.355 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.3 t70 55.65 76.45 0.27 Allowed 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.918 0.762 . . . . 75.31 110.807 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.58 146.96 23.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.286 -0.87 . . . . 74.01 111.282 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -116.92 129.69 56.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.476 -0.784 . . . . 74.55 110.849 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.1 p -105.96 16.71 24.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.283 -0.417 . . . . 65.0 111.791 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -92.24 -32.93 14.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.086 0.469 . . . . 73.44 109.92 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.413 ' CG2' HE22 ' A' ' 159' ' ' GLN . 14.2 p -105.96 -33.67 2.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.154 -0.476 . . . . 65.12 110.692 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -103.81 178.61 4.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 55.33 110.643 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 18.5 m -140.19 -56.9 0.54 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.868 0.366 . . . . 73.21 111.049 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.487 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -135.89 154.82 51.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.343 -0.614 . . . . 73.22 109.343 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.496 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -111.26 133.64 53.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.084 0.468 . . . . 72.12 110.104 176.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.01 117.62 9.79 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.623 -0.717 . . . . 63.5 109.622 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.681 HG12 HG12 ' A' ' 156' ' ' VAL . 1.2 m -90.88 147.24 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.085 0.469 . . . . 54.34 111.226 -174.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.2 123.58 41.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.542 -0.754 . . . . 43.22 109.207 172.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 80.1 m-85 -85.59 135.11 33.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.024 0.44 . . . . 75.4 110.577 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.1 tp -133.49 118.69 18.63 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.807 -0.633 . . . . 64.12 110.308 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.42 -168.88 29.28 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.131 -0.788 . . . . 64.0 111.131 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -81.48 118.96 23.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.83 0.315 . . . . 73.33 111.006 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -77.16 141.77 39.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.251 -0.431 . . . . 74.33 110.366 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 85' ' ' VAL . 5.1 tt -68.11 -32.47 56.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.282 -0.417 . . . . 73.02 111.18 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.64 175.03 11.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.527 -0.306 . . . . 75.23 110.181 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.59 -33.61 35.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.886 -0.597 . . . . 74.42 110.513 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.58 -14.93 59.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.55 -0.833 . . . . 74.04 111.77 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -114.21 57.71 0.7 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.28 0.562 . . . . 53.13 109.574 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.428 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.4 p -77.15 8.5 3.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.382 -0.826 . . . . 70.3 112.474 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.416 ' OD1' HG23 ' A' ' 85' ' ' VAL . 23.4 p30 -108.55 -8.82 15.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.979 0.418 . . . . 75.41 110.802 177.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.489 ' HB ' HG22 ' A' ' 78' ' ' ILE . 48.5 t -98.76 122.56 50.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.459 . . . . 41.12 110.983 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.472 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -70.39 134.46 47.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 74.42 109.84 177.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.44 152.07 32.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.165 -0.471 . . . . 70.03 110.571 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.466 HD22 ' H ' ' A' ' 88' ' ' LEU . 1.9 mm? -78.02 138.45 38.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.232 -0.44 . . . . 70.33 110.391 -177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -61.15 129.43 41.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 70.31 110.211 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -74.85 107.21 6.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.857 -0.611 . . . . 74.05 111.614 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.8 m -87.03 -10.23 53.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.101 -0.499 . . . . 64.43 109.89 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 62.6 22.39 13.28 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.13 -0.941 . . . . 64.12 111.89 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.08 -39.24 0.41 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.758 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.48 74.04 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.393 -0.908 . . . . 53.32 112.777 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.3 m -91.22 154.45 19.29 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.919 -0.4 . . . . 71.41 109.919 175.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.432 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -71.68 153.01 42.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.69 -0.485 . . . . 64.41 109.69 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.44 161.22 38.97 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.612 -0.435 . . . . 72.43 111.025 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 66.45 13.33 9.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.916 -0.584 . . . . 74.04 110.748 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.49 179.76 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.773 -0.649 . . . . 73.11 110.177 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -179.83 -173.43 44.85 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.209 -1.157 . . . . 64.51 110.209 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.9 p -121.9 120.03 60.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.281 0.562 . . . . 73.43 110.935 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.456 ' HG2' ' HB2' ' A' ' 138' ' ' PHE . 1.5 pt20 -108.69 150.19 27.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.819 -0.628 . . . . 72.31 109.823 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.446 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.3 mp -111.45 128.1 68.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.181 0.515 . . . . 64.34 110.502 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 13.4 mt -92.93 143.22 26.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.383 -0.826 . . . . 64.34 109.431 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.545 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.0 OUTLIER -70.46 -176.72 1.3 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.287 -0.634 . . . . 53.22 109.287 174.31 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -64.45 -20.63 66.3 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.197 -0.314 . . . . 73.41 111.708 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.414 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 40.0 p -98.46 6.5 47.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 72.3 111.457 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.76 28.7 28.46 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.972 -0.632 . . . . 73.1 113.464 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.18 128.02 53.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.894 0.347 . . . . 65.33 110.553 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.09 119.05 11.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.859 0.361 . . . . 54.42 110.704 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.6 mt -85.86 129.72 34.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.037 0.446 . . . . 72.43 111.199 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.457 ' H ' HG21 ' A' ' 117' ' ' THR . 78.7 m -73.18 140.65 47.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.623 -0.717 . . . . 74.04 110.557 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 45.4 mt -80.07 40.29 0.47 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.542 . . . . 61.01 111.301 -176.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -81.14 -23.23 38.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.162 0.506 . . . . 73.24 110.278 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.04 -13.54 66.7 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.789 -0.642 . . . . 33.14 111.973 -173.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.9 1.84 11.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.787 0.327 . . . . 74.42 111.728 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.457 HG21 ' H ' ' A' ' 112' ' ' THR . 4.3 m -86.91 88.06 7.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.086 0.47 . . . . 41.22 110.088 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -83.18 152.63 25.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.864 -0.607 . . . . 73.0 111.199 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.9 m -67.82 -179.1 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.742 -0.663 . . . . 64.35 111.431 175.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.6 p -68.65 152.9 44.73 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.316 -0.402 . . . . 30.21 110.377 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.34 107.13 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 75.4 111.543 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 m -94.1 103.5 15.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.356 -0.609 . . . . 62.41 109.356 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.8 m -57.16 122.38 12.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.723 -0.671 . . . . 73.35 111.21 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 69' ' ' ALA . 61.9 mt -78.38 142.32 37.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.128 -0.487 . . . . 70.04 111.077 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -115.84 148.68 39.66 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.057 -0.72 . . . . 65.54 109.057 170.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -65.37 111.78 3.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.816 0.341 . . . . 75.22 110.256 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 134.56 -126.82 4.26 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.576 -0.61 . . . . 62.52 111.576 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.2 m -108.77 132.44 53.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.848 0.356 . . . . 74.22 110.879 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -127.46 131.46 50.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.35 -0.386 . . . . 61.35 110.592 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.99 115.71 25.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.817 0.341 . . . . 72.1 111.146 176.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mt -93.26 110.71 48.19 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.128 -0.693 . . . . 73.01 109.128 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.31 130.83 7.32 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.467 2.111 . . . . 74.41 112.673 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 73.0 m-85 -129.39 166.36 19.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.067 0.461 . . . . 75.41 111.267 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.627 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 47.6 mt-30 -130.0 124.45 32.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.654 -0.703 . . . . 73.11 110.766 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.64 126.29 54.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.102 -0.332 . . . . 42.53 110.102 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.545 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 6.9 ptp180 -136.72 161.4 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.901 0.381 . . . . 71.13 111.32 -176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 60.5 m-85 -82.04 146.09 29.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 75.4 111.074 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.456 ' HB2' ' HG2' ' A' ' 102' ' ' GLN . 61.1 t80 -132.08 126.71 34.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.49 -0.777 . . . . 74.03 109.178 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.648 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -92.73 135.98 33.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.81 0.338 . . . . 54.41 111.443 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 51.0 p -103.88 0.36 30.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.486 0.66 . . . . 64.32 109.552 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.05 -122.56 0.91 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.124 -0.943 . . . . 74.11 111.302 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.63 94.5 9.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.945 -0.391 . . . . 72.42 109.945 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.623 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -47.58 118.99 2.48 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.507 0.504 . . . . 73.34 111.197 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.2 p -112.79 143.89 29.93 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.171 -0.468 . . . . 64.22 110.708 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.12 174.19 8.33 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.714 2.943 . . . . 53.01 113.278 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.73 -168.35 19.76 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.715 -0.755 . . . . 71.5 111.709 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.38 109.44 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 63.45 110.889 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.402 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . . . -108.37 52.77 0.7 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.656 0.741 . . . . 62.42 109.766 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -108.65 138.24 45.28 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.968 -1.014 . . . . 73.01 109.669 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -144.12 169.38 17.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.42 -0.355 . . . . 62.41 110.101 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.99 144.86 30.37 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.947 -0.39 . . . . 52.31 109.947 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.416 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -152.32 146.12 25.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.081 -0.509 . . . . 70.41 110.705 -177.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 36.0 p -97.5 128.46 44.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.197 -0.456 . . . . 72.23 109.973 176.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -96.42 127.93 42.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.327 0.584 . . . . 73.32 110.042 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.645 ' HA ' HG21 ' A' ' 16' ' ' VAL . 1.8 tmtm? -111.4 100.26 8.89 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.714 -0.676 . . . . 63.21 109.832 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.681 HG12 HG12 ' A' ' 71' ' ' VAL . 1.5 m -77.45 144.3 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.145 0.498 . . . . 70.24 110.471 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 54.6 tt0 -115.02 120.5 40.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.0 -0.546 . . . . 74.42 110.637 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.579 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 9.8 p90 -158.09 -30.6 0.08 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.734 0.646 . . . . 73.51 109.494 170.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.413 HE22 ' CG2' ' A' ' 65' ' ' VAL . 24.9 tp60 . . . . . 0 C--O 1.247 0.972 0 CA-C-N 115.212 -0.904 . . . . 71.34 109.974 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 120.849 0.357 . . . . 61.01 110.321 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.28 172.31 6.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.499 -0.319 . . . . 71.54 111.197 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.4 t -87.93 -7.36 57.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.541 0.686 . . . . 65.43 110.595 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.7 p -112.71 -176.09 2.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.979 -0.555 . . . . 74.42 110.427 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.405 ' HB ' ' CB ' ' A' ' 148' ' ' ALA . 35.0 m -87.95 15.05 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.129 0.49 . . . . 72.33 110.399 175.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 62.41 23.51 13.95 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.314 -0.857 . . . . 74.33 112.358 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.486 ' N ' ' HG2' ' A' ' 36' ' ' GLN . . . 77.69 88.13 0.38 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.389 -0.91 . . . . 75.32 111.625 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.17 156.27 46.92 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.566 -0.826 . . . . 71.05 111.998 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.578 ' HB ' HG22 ' A' ' 31' ' ' THR . 5.2 p -142.7 137.18 29.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.559 0.219 . . . . 70.22 110.845 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -111.69 121.36 64.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.602 -0.518 . . . . 52.23 109.602 175.306 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -88.11 98.42 11.53 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.041 0.448 . . . . 51.52 109.818 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.463 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 61.8 m-85 -88.44 118.35 28.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.927 -0.579 . . . . 72.12 110.044 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 78.3 tttt -112.65 145.28 40.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.384 -0.371 . . . . 63.13 110.486 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -122.66 -116.25 2.32 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.898 -0.667 . . . . 74.15 112.523 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.546 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 93.0 mt-10 64.05 17.7 10.77 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.841 0.457 . . . . 71.3 111.347 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 155' ' ' LYS . 31.0 m -76.85 -28.51 17.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.088 -0.505 . . . . 71.21 111.712 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.515 HG21 ' CG2' ' A' ' 156' ' ' VAL . 17.1 m -137.38 141.41 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.098 0.475 . . . . 63.12 111.973 -176.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -140.39 21.2 2.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.019 -0.992 . . . . 64.33 108.559 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.18 -76.55 0.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.368 -0.833 . . . . 50.21 111.495 -172.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.531 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -88.84 -33.28 17.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.856 0.36 . . . . 73.1 110.751 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -146.09 128.42 15.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.131 -0.486 . . . . 52.41 109.819 -177.14 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.29 128.56 36.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.321 -0.399 . . . . 73.43 110.29 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 3.6 t -72.5 128.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.019 -0.363 . . . . 74.52 110.019 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.444 ' O ' HG13 ' A' ' 28' ' ' VAL . 16.0 t70 -58.71 142.55 49.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 64.03 111.09 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -59.69 -27.09 66.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.989 -0.551 . . . . 73.13 112.073 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.08 -19.11 73.17 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.59 -0.814 . . . . 41.42 112.066 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.9 p -102.94 -16.04 15.97 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.15 -0.22 . . . . 54.14 111.458 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 25' ' ' ALA . 27.4 m -81.51 -2.85 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.954 0.407 . . . . 74.3 110.313 175.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -158.34 87.67 0.91 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.402 -0.962 . . . . 71.14 108.402 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.463 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 16.0 pt20 -134.9 98.09 3.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.517 0.675 . . . . 63.25 110.804 -176.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.578 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.5 m -82.07 94.53 7.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.151 -0.931 . . . . 70.15 109.279 174.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.7 p -81.72 130.86 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.9 -0.591 . . . . 64.15 111.187 -174.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.432 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.7 mp0 -85.9 127.31 34.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.895 -0.593 . . . . 72.42 110.15 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.91 -30.44 17.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.303 0.573 . . . . 65.43 109.737 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.437 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 100.23 167.85 29.09 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.485 -0.779 . . . . 65.43 111.706 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.486 ' HG2' ' N ' ' A' ' 7' ' ' GLY . 60.4 mt-30 -79.27 86.77 5.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.071 0.462 . . . . 73.34 110.841 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.34 145.96 12.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 71.4 109.875 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -83.39 126.78 33.09 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.362 -0.607 . . . . 74.33 109.362 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.629 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 24.4 p -68.55 -25.02 64.7 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.048 -0.523 . . . . 73.34 111.315 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.49 -10.47 58.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.075 -0.511 . . . . 55.35 111.409 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.8 m -86.94 -7.75 57.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.041 0.448 . . . . 75.13 110.607 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.621 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 4.7 mp -132.73 90.17 2.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 75.41 110.266 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.44 12.32 11.59 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.311 0.486 . . . . 75.34 112.311 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -144.73 141.55 29.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.767 -0.197 . . . . 75.13 110.695 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.451 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 42.9 tt0 -59.5 122.28 13.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.007 0.432 . . . . 64.11 110.141 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.79 -7.06 33.37 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.786 -0.721 . . . . 73.03 111.888 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -68.23 120.88 15.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.92 0.39 . . . . 44.15 110.302 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 p -112.01 125.43 54.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.953 -0.567 . . . . 72.02 110.454 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.409 ' HB2' HD21 ' A' ' 42' ' ' LEU . 8.0 t -84.88 174.91 9.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.486 -0.561 . . . . 70.41 109.486 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.3 m -62.2 136.4 57.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.776 -0.453 . . . . 63.21 109.776 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' A' ' 136' ' ' ARG . . . -95.91 157.25 15.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.309 0.576 . . . . 72.1 111.018 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.1 m -99.18 148.91 5.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.131 -0.94 . . . . 63.41 109.228 172.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.62 86.81 0.54 Allowed Glycine 0 C--N 1.309 -0.947 0 C-N-CA 120.771 -0.728 . . . . 72.4 112.045 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -88.95 170.21 10.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.382 -0.599 . . . . 65.14 109.382 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.546 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.3 p-10 -138.78 150.85 46.54 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.412 0.625 . . . . 51.23 111.904 -175.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.425 HD12 HG11 ' A' ' 71' ' ' VAL . 61.4 mt -109.29 110.28 31.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.176 -0.92 . . . . 62.2 108.599 171.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -96.71 122.45 39.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.989 -0.55 . . . . 72.4 110.787 -173.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.5 mt -106.54 119.36 39.09 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.3 -0.409 . . . . 63.21 110.049 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -96.35 133.28 40.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.097 -0.501 . . . . 74.22 110.044 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 54.35 79.31 0.14 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.776 0.798 . . . . 72.15 110.469 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 42.9 t -112.2 138.51 48.79 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.996 -1.002 . . . . 74.21 109.485 -177.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -116.37 141.55 48.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.845 0.355 . . . . 63.01 111.75 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.5 p -105.42 4.25 30.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.137 -0.483 . . . . 74.32 112.157 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -76.14 -41.86 48.61 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.453 -0.573 . . . . 73.41 109.453 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 p -93.33 -35.2 6.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.747 -0.661 . . . . 60.01 111.021 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -108.19 -174.93 2.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.615 0.245 . . . . 64.44 110.904 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 34.3 m -148.32 -57.46 0.23 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.834 0.349 . . . . 64.42 110.779 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -138.05 141.65 40.33 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.686 -0.487 . . . . 71.14 109.686 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -100.09 130.89 46.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.946 0.403 . . . . 44.11 110.563 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.02 115.21 11.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.875 -0.602 . . . . 53.21 109.587 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.617 HG12 HG12 ' A' ' 156' ' ' VAL . 1.9 m -92.76 147.18 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.986 0.422 . . . . 64.13 111.136 -173.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.491 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -122.63 131.08 53.65 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.969 -0.559 . . . . 62.21 109.516 173.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.557 ' CE1' HG21 ' A' ' 103' ' ' ILE . 49.5 m-85 -95.46 138.56 32.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.94 0.4 . . . . 72.14 111.047 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.6 tp -133.85 134.94 43.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.838 -0.619 . . . . 71.23 110.021 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.83 -160.8 24.96 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.191 -0.763 . . . . 44.31 111.191 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.0 m -88.4 118.42 28.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.929 0.364 . . . . 75.54 110.209 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.45 147.03 31.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.337 -0.392 . . . . 61.23 110.155 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.589 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 7.6 tt -64.41 -26.19 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 63.4 111.139 -177.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -154.56 -179.8 8.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.4 -0.593 . . . . 74.34 109.4 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.44 -32.63 28.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.923 0.392 . . . . 74.52 110.112 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.67 -34.68 24.45 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.699 -0.762 . . . . 61.23 111.561 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -96.64 73.8 2.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.13 0.49 . . . . 70.01 109.972 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.452 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.4 p -95.32 15.4 19.5 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.762 -0.654 . . . . 63.35 111.512 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -112.38 -4.32 14.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.144 0.497 . . . . 73.34 110.921 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 102' ' ' GLN . 48.8 t -115.24 126.34 72.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.995 -0.548 . . . . 71.54 110.198 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.585 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -68.68 131.16 44.74 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.525 -0.546 . . . . 54.41 109.525 178.171 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.54 143.09 36.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.06 -0.518 . . . . 62.33 110.517 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.67 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.6 mm? -75.98 135.78 40.01 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.965 -0.754 . . . . 73.21 108.965 177.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -57.84 122.35 12.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.208 0.528 . . . . 74.34 111.06 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.2 p -69.68 110.33 4.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.495 -0.775 . . . . 62.21 110.735 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.1 m -93.46 -7.38 44.61 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.009 -0.542 . . . . 52.5 110.383 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 62.03 28.35 17.17 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.715 -0.675 . . . . 60.44 110.422 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.37 -43.82 0.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.583 -0.735 . . . . 73.15 110.696 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.16 76.78 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.571 -0.823 . . . . 74.31 112.319 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.5 m -92.66 152.44 19.55 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.824 -0.436 . . . . 74.25 109.824 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.01 133.86 48.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.686 -0.487 . . . . 73.21 109.686 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.95 163.87 22.72 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.545 -0.462 . . . . 52.13 110.989 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 66.24 13.7 9.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.604 -0.726 . . . . 65.21 110.496 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.15 -178.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.549 -0.75 . . . . 70.02 109.902 175.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 176.21 -172.24 45.23 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 110.06 -1.216 . . . . 72.4 110.06 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 10' ' ' VAL . 2.3 p -118.8 111.43 33.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.549 0.69 . . . . 74.12 110.898 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.41 ' HB3' HG22 ' A' ' 85' ' ' VAL . 2.4 pt20 -96.11 141.13 29.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.511 -0.768 . . . . 70.02 109.502 177.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.557 HG21 ' CE1' ' A' ' 73' ' ' PHE . 3.8 mp -98.71 127.79 50.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.037 0.446 . . . . 71.13 110.13 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 44.4 mt -99.35 138.94 35.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.504 -0.771 . . . . 61.51 110.63 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.592 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 3.8 t70 -60.67 165.95 3.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.642 -0.708 . . . . 74.31 110.188 170.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.44 ' HE ' ' HB3' ' A' ' 120' ' ' SER . 26.5 ptt180 -54.84 -24.67 24.09 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.474 0.546 . . . . 73.1 112.474 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.2 p -87.13 -20.52 26.93 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.758 0.313 . . . . 72.24 111.719 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.38 44.36 1.26 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.663 -0.779 . . . . 71.21 112.661 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.72 130.16 45.11 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.065 -0.346 . . . . 74.43 110.065 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.72 140.3 57.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 73.32 111.183 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.49 155.21 17.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.94 -0.573 . . . . 72.24 110.555 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -94.46 141.15 28.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.363 -0.38 . . . . 72.34 110.176 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 60.5 mt -84.94 51.04 2.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.012 0.434 . . . . 73.13 110.988 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -108.94 -4.54 16.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.43 . . . . 75.55 110.261 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.82 0.11 39.74 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.017 -0.611 . . . . 35.14 112.739 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -116.73 -17.48 10.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.371 . . . . 63.32 111.105 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.3 m -86.06 94.96 9.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.023 0.44 . . . . 64.24 109.836 174.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.689 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 69.3 m-85 -85.59 162.26 18.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.05 -0.523 . . . . 70.43 110.189 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.592 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . 6.9 m -77.95 -172.16 2.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.882 -0.599 . . . . 64.12 110.943 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.44 ' HB3' ' HE ' ' A' ' 106' ' ' ARG . 35.6 t -68.84 148.77 49.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.869 -0.605 . . . . 72.13 110.165 178.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -63.81 98.29 0.19 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.793 0.33 . . . . 71.14 111.293 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.2 m -78.7 102.28 7.97 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.43 -0.581 . . . . 65.14 109.43 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.0 m -57.23 112.17 1.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.44 -0.8 . . . . 64.13 110.997 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 69' ' ' ALA . 96.0 mt -75.19 143.79 43.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.766 -0.652 . . . . 73.31 111.402 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -125.11 145.24 50.03 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.192 -0.67 . . . . 72.11 109.192 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -53.9 113.02 1.06 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.872 0.368 . . . . 64.32 111.508 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 129.81 -143.09 14.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.15 -0.548 . . . . 62.25 112.462 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.6 m -82.73 122.1 27.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.763 0.316 . . . . 75.11 110.794 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.431 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 21.9 m-80 -114.86 113.08 23.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.976 0.417 . . . . 74.22 110.337 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.546 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.1 m -102.27 106.37 17.17 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.78 -0.645 . . . . 54.43 110.327 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 6.6 mt -91.66 113.4 58.6 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.847 -0.427 . . . . 64.14 109.847 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 24.7 Cg_endo -88.72 133.07 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.873 2.382 . . . . 74.34 112.706 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -133.1 169.81 16.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.826 -0.624 . . . . 73.3 109.733 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.651 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 97.1 mt-30 -126.1 140.42 52.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.018 0.437 . . . . 51.04 111.122 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.05 125.6 41.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.077 -0.51 . . . . 74.45 109.779 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.519 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 36.7 ptt180 -144.36 166.18 25.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.097 0.475 . . . . 73.22 111.513 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.602 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 82.4 m-85 -81.56 131.91 35.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.323 -0.853 . . . . 73.22 110.456 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -118.13 116.19 26.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.457 -0.792 . . . . 72.13 109.366 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -80.78 130.92 35.33 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.18 -0.463 . . . . 73.41 110.996 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.451 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 41.7 p -102.05 9.27 40.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.055 -0.721 . . . . 74.05 109.055 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.41 -120.95 0.94 Allowed Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.933 -1.03 . . . . 75.05 111.018 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.89 95.4 7.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.752 -0.462 . . . . 74.34 109.752 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.629 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -47.3 114.63 0.91 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.716 0.635 . . . . 25.31 111.206 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 p -107.02 139.58 20.55 Favored Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-N 116.082 -0.508 . . . . 72.23 110.373 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.56 159.76 51.75 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 123.679 2.919 . . . . 63.33 113.086 -172.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.95 -167.48 28.28 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.667 -0.697 . . . . 45.22 111.404 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.76 112.06 5.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.922 0.392 . . . . 64.4 110.901 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.67 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -109.8 58.62 0.61 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.505 0.669 . . . . 33.14 110.361 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -116.42 133.42 56.04 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.446 -0.797 . . . . 72.14 110.045 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.585 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -142.16 175.72 9.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.404 -0.362 . . . . 62.25 110.84 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -148.91 150.78 33.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.697 -0.483 . . . . 72.31 109.697 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -154.06 151.26 29.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.86 0.362 . . . . 52.15 110.874 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.405 HG22 ' HB3' ' A' ' 13' ' ' LYS . 10.6 p -108.77 132.96 53.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.096 -0.502 . . . . 60.35 109.835 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.406 ' CD1' HD13 ' A' ' 56' ' ' ILE . 27.9 p90 -106.53 133.67 50.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.25 0.547 . . . . 63.22 111.082 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.689 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 20.7 ttmt -109.59 103.44 12.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.469 -0.787 . . . . 71.41 110.409 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.617 HG12 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -77.95 130.05 36.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.242 -0.651 . . . . 75.41 109.242 176.141 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -114.67 117.86 32.03 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.862 -0.422 . . . . 74.33 109.862 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.595 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -136.34 -16.73 1.59 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.225 -0.443 . . . . 75.41 111.075 175.376 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.537 -0.744 . . . . 73.23 109.299 173.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 120.553 0.216 . . . . 74.34 110.726 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.14 -174.61 5.38 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.389 -0.226 . . . . 52.15 110.389 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.402 HG23 HG23 ' A' ' 4' ' ' THR . 13.4 t -102.61 -15.59 16.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.078 0.466 . . . . 72.11 110.663 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.402 HG23 HG23 ' A' ' 3' ' ' THR . 73.1 p -110.61 174.26 5.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.986 0.422 . . . . 73.43 110.533 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.0 m -83.9 6.99 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.314 0.578 . . . . 63.11 110.439 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 60.77 18.33 8.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.145 -0.934 . . . . 62.21 112.083 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.93 95.67 0.87 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.772 -0.727 . . . . 75.14 111.915 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.48 159.92 31.19 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.43 -0.89 . . . . 74.34 111.366 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.561 ' HB ' HG22 ' A' ' 31' ' ' THR . 60.8 p -139.03 143.55 38.47 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.724 0.262 . . . . 41.42 110.446 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -111.73 123.68 67.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.855 -0.424 . . . . 64.11 109.855 175.415 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -92.5 113.35 25.6 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.106 -0.497 . . . . 74.21 109.869 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.459 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 95.2 m-85 -104.71 125.96 51.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.167 -0.47 . . . . 64.34 110.389 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -117.67 143.74 45.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.978 -0.379 . . . . 71.32 109.978 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.41 -126.56 2.78 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.74 -0.743 . . . . 63.14 112.849 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.651 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 35.8 mt-10 62.21 27.91 16.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.286 0.565 . . . . 71.31 110.581 -174.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' A' ' 155' ' ' LYS . 31.0 m -74.24 -26.48 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.399 -0.818 . . . . 51.41 111.321 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.463 HG21 ' CG2' ' A' ' 156' ' ' VAL . 27.1 m -136.64 147.19 27.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 63.54 111.493 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -143.94 19.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.121 -0.945 . . . . 54.44 109.188 175.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.69 -83.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.538 -0.755 . . . . 70.32 111.489 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.559 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -80.96 -36.53 30.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.934 -0.307 . . . . 64.31 110.724 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 0.8 OUTLIER -143.01 132.98 24.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.735 0.302 . . . . 51.11 110.19 -176.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.32 126.7 39.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.376 -0.375 . . . . 63.51 110.324 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.455 ' HA ' HD23 ' A' ' 58' ' ' LEU . 8.2 t -65.77 131.97 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.235 -0.283 . . . . 74.43 110.235 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.54 ' O ' HG13 ' A' ' 28' ' ' VAL . 22.9 t70 -58.04 140.83 51.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 65.24 111.717 -176.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.55 -25.3 64.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.835 -0.621 . . . . 53.22 112.15 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.72 -24.84 55.03 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.401 -0.904 . . . . 55.11 112.388 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.2 p -98.11 -12.09 22.17 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.873 0.323 . . . . 41.42 111.873 -175.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.651 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 30.8 m -79.85 -4.62 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.672 0.272 . . . . 74.4 111.609 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -166.72 96.01 0.53 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.404 -0.962 . . . . 73.44 108.404 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -145.9 140.78 27.23 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.548 -0.751 . . . . 64.23 109.91 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.561 HG22 ' HB ' ' A' ' 9' ' ' THR . 25.0 m -117.05 103.9 10.71 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.71 -0.677 . . . . 53.15 109.992 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 p -88.26 133.67 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.039 0.447 . . . . 74.42 111.084 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.518 ' HA ' HG22 ' A' ' 9' ' ' THR . 25.3 mp0 -90.67 128.34 36.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 74.01 109.72 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.74 -31.32 21.02 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.156 0.503 . . . . 74.33 110.055 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.64 172.48 24.71 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.668 -0.696 . . . . 73.31 112.025 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -80.79 97.66 7.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.76 0.314 . . . . 72.12 110.358 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.11 143.1 12.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.024 -0.535 . . . . 73.33 110.212 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.436 ' CD ' ' H ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -82.9 127.7 33.75 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.555 -0.535 . . . . 73.31 109.555 177.04 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.4 p -74.49 -10.04 59.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.148 -0.478 . . . . 74.55 111.584 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.47 -21.25 58.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.254 -0.43 . . . . 74.04 111.379 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.5 m -81.14 -23.42 38.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 71.23 110.868 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.2 mp -114.34 99.04 7.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.107 -0.497 . . . . 75.44 109.923 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.83 11.49 6.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.364 0.505 . . . . 71.25 112.364 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -151.43 152.13 32.63 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.693 -0.403 . . . . 65.53 111.432 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.37 120.03 8.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.634 -0.712 . . . . 73.44 109.484 175.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.05 6.8 39.23 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.676 -0.773 . . . . 75.4 112.032 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.689 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -81.17 120.27 24.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.837 0.351 . . . . 73.43 110.257 176.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.542 HG22 ' HD1' ' A' ' 138' ' ' PHE . 59.9 p -112.44 128.09 56.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.161 -0.472 . . . . 51.13 110.415 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.9 t -84.73 -177.76 6.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.794 -0.447 . . . . 74.31 109.794 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -67.37 137.2 55.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.272 -0.422 . . . . 64.52 110.074 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -92.01 153.52 19.38 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.664 0.745 . . . . 64.01 111.882 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 27.8 m -93.32 153.74 3.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.363 -1.29 . . . . 63.13 109.536 170.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.22 100.54 1.66 Allowed Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.809 -0.71 . . . . 72.2 111.996 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -116.33 -179.4 3.66 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.416 -0.586 . . . . 71.25 109.416 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.547 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.0 p-10 -146.35 152.72 39.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.502 0.668 . . . . 25.35 111.965 -174.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 74.4 mt -113.84 111.86 37.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.911 -1.04 . . . . 70.12 108.303 167.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -97.75 140.93 31.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.985 0.421 . . . . 73.31 110.801 -172.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 23' ' ' VAL . 65.7 mt -117.66 124.66 49.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.841 -0.618 . . . . 74.43 109.491 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -102.6 135.85 43.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.79 -0.641 . . . . 73.4 109.386 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 27.3 t70 56.19 87.65 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.821 0.701 . . . . 63.22 110.486 -176.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' A' ' 124' ' ' LEU . 42.3 t -124.85 134.85 52.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.704 -0.68 . . . . 61.11 110.373 -174.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.09 138.03 47.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 73.21 111.867 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 p -105.35 10.9 33.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.798 -0.637 . . . . 71.14 112.31 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -88.32 -36.33 16.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.018 0.437 . . . . 64.41 110.027 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 p -102.01 -12.55 8.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.875 -0.602 . . . . 74.24 110.435 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -129.13 -174.11 3.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.866 -0.606 . . . . 73.15 110.423 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -150.59 -56.55 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.78 0.324 . . . . 74.23 111.175 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -137.58 141.3 41.32 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.503 -0.554 . . . . 75.14 109.503 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -99.43 130.34 45.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.091 0.472 . . . . 54.25 110.29 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.95 113.66 9.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.559 -0.746 . . . . 72.21 109.792 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.695 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 2.0 m -90.37 146.42 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.272 0.558 . . . . 65.02 110.864 -175.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.54 119.24 34.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.356 -0.838 . . . . 61.42 109.166 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 83.7 m-85 -79.55 137.46 37.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.855 -0.424 . . . . 61.23 109.855 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.9 tp -137.33 115.55 11.73 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.671 -0.492 . . . . 74.34 109.671 -175.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.6 -158.12 10.07 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.524 -0.762 . . . . 74.24 111.379 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.505 ' O ' HD13 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -81.09 116.69 21.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.73 0.265 . . . . 62.41 110.869 -178.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.564 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -79.69 139.31 37.42 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.936 -0.394 . . . . 71.13 109.936 175.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.558 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 6.6 tt -63.62 -36.12 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.904 0.383 . . . . 70.25 110.781 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -151.92 175.17 12.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.31 -0.626 . . . . 73.33 109.31 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.83 -24.58 28.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.997 0.427 . . . . 65.05 110.503 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.84 -21.54 49.93 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.756 -0.735 . . . . 61.53 111.356 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -118.61 62.46 0.78 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.457 0.646 . . . . 71.55 109.518 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.564 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 2.6 p -80.85 7.64 10.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.421 -0.809 . . . . 72.23 111.407 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -106.25 1.55 26.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.056 0.455 . . . . 73.41 110.947 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.544 HG22 ' HB3' ' A' ' 102' ' ' GLN . 61.9 t -117.34 129.4 73.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.015 -0.539 . . . . 70.32 110.164 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.596 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -69.98 133.61 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.715 0.293 . . . . 65.32 110.378 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.14 148.36 34.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.123 -0.49 . . . . 72.12 110.302 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.443 HD22 ' H ' ' A' ' 88' ' ' LEU . 1.7 mm? -81.61 149.82 28.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.246 -0.434 . . . . 73.05 110.499 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -74.53 128.44 35.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.594 . . . . 73.3 110.334 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 p -84.96 110.79 19.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.025 -0.534 . . . . 73.25 111.376 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.9 m -99.14 -4.35 32.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.163 -0.471 . . . . 71.04 110.391 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 68.56 4.96 4.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.338 -0.846 . . . . 75.55 113.128 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.16 -44.43 3.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.364 0.602 . . . . 64.51 110.033 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.96 85.06 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.621 -0.718 . . . . 45.11 112.046 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.9 m -104.74 149.66 25.42 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.912 -0.403 . . . . 75.11 109.912 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.08 147.77 29.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.467 -0.333 . . . . 74.12 110.457 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.48 165.55 27.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.557 -0.292 . . . . 64.45 110.335 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.422 HD22 HG23 ' A' ' 144' ' ' THR . 26.0 m-20 70.11 7.62 6.3 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.327 0.584 . . . . 73.05 110.417 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.35 -177.42 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.272 -0.877 . . . . 70.32 109.644 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 177.22 -170.6 43.25 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.12 -1.192 . . . . 70.32 110.12 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -121.03 115.18 46.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.476 0.655 . . . . 62.32 110.49 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.544 ' HB3' HG22 ' A' ' 85' ' ' VAL . 8.8 pt20 -105.39 145.53 30.66 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.63 -0.713 . . . . 75.41 109.532 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.476 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.4 mp -104.96 123.15 58.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.148 0.499 . . . . 72.41 110.385 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 18.8 mt -91.21 139.51 30.68 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.376 -0.829 . . . . 72.5 109.246 177.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.8 OUTLIER -72.57 -169.12 0.51 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.282 -0.417 . . . . 54.32 110.282 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -56.72 -35.07 68.11 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.733 0.272 . . . . 74.12 111.733 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.7 p -87.43 -6.29 58.49 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.883 0.373 . . . . 53.15 111.768 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.89 30.03 10.93 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.606 -0.807 . . . . 73.4 112.804 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.38 134.74 50.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.177 -0.305 . . . . 74.02 110.177 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.37 117.96 10.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.966 0.412 . . . . 72.11 111.175 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.16 132.7 35.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.891 -0.595 . . . . 64.5 110.573 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.3 m -74.33 137.41 42.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.905 -0.589 . . . . 74.31 110.647 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.571 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 36.5 mt -82.43 47.89 1.22 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.067 -0.515 . . . . 70.45 110.971 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -104.93 -0.75 26.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.959 0.409 . . . . 65.11 110.332 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.12 10.57 59.6 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.871 -0.604 . . . . 75.24 112.672 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.32 -23.97 4.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 60.3 110.798 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -80.3 99.43 7.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.96 0.41 . . . . 74.11 110.264 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -89.03 157.88 18.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.02 -0.536 . . . . 62.51 110.635 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.537 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.3 m -64.96 171.15 3.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.019 -0.537 . . . . 62.55 111.08 177.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 42.9 m -65.37 156.76 31.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.459 -0.571 . . . . 73.33 109.459 171.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.495 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 45.7 mt-10 -55.6 121.15 8.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.101 0.477 . . . . 72.43 111.913 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.0 m -105.57 98.84 8.48 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.269 -1.011 . . . . 74.34 108.269 168.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.1 m -59.24 122.05 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.556 . . . . 74.11 110.915 -175.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.539 HD13 ' SG ' ' A' ' 61' ' ' CYS . 96.2 mt -82.96 153.23 25.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.464 -0.789 . . . . 72.25 111.662 -174.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -123.87 157.32 34.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.356 -0.838 . . . . 72.13 108.911 171.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 59.6 m-20 -68.37 99.64 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.913 0.387 . . . . 73.44 110.34 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.06 -136.41 7.95 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.895 -0.669 . . . . 72.31 112.029 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.3 m -84.96 127.58 34.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.022 0.439 . . . . 54.5 110.976 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 33.5 m-80 -128.61 124.94 37.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.968 -0.56 . . . . 54.0 109.9 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.547 HG22 ' HB2' ' A' ' 55' ' ' ASN . 2.5 m -115.65 114.78 25.34 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.974 -0.291 . . . . 75.11 110.702 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.6 mt -92.25 109.81 40.33 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.282 -0.417 . . . . 63.13 109.95 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.33 138.76 10.06 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.767 2.311 . . . . 72.44 112.806 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 62.3 m-85 -136.55 164.13 28.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 72.51 111.113 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 97.5 mt-30 -125.59 125.12 42.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.795 -0.639 . . . . 71.22 110.412 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.48 124.08 51.55 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.199 -0.297 . . . . 53.32 110.199 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 14.9 ptp180 -138.87 160.22 40.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.934 0.397 . . . . 63.21 110.983 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 66.8 m-85 -77.32 139.7 39.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.7 -0.682 . . . . 74.12 110.516 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.542 ' HD1' HG22 ' A' ' 48' ' ' THR . 80.5 t80 -127.59 122.26 32.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.696 -0.684 . . . . 74.15 109.501 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.689 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -93.26 137.13 32.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.074 0.464 . . . . 72.11 111.333 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 52.0 p -103.81 5.51 36.02 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.439 -0.801 . . . . 65.14 109.224 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.26 -131.6 2.33 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.901 -1.045 . . . . 54.34 110.697 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.39 94.89 4.96 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.4 -0.222 . . . . 34.13 110.4 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.23 120.9 3.88 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.546 0.529 . . . . 63.54 111.105 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.422 HG23 HD22 ' A' ' 98' ' ' ASN . 33.2 p -111.57 145.1 31.92 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 121.248 0.547 . . . . 73.02 111.2 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.17 163.16 37.16 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.867 3.044 . . . . 74.31 113.089 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.36 -174.76 21.09 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.993 -0.622 . . . . 54.34 111.937 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.73 108.04 0.78 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.971 0.415 . . . . 42.04 111.207 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.43 43.88 1.07 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 65.25 110.228 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -101.74 147.11 26.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.58 -0.736 . . . . 75.15 109.805 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.523 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -153.79 170.61 20.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.46 -0.337 . . . . 72.01 111.07 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.42 146.02 36.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.435 -0.348 . . . . 64.2 110.219 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.596 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -151.28 149.63 29.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.303 -0.408 . . . . 74.24 110.993 -177.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.7 p -107.21 128.45 54.43 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.019 -0.537 . . . . 73.4 109.621 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -100.01 132.5 45.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.208 0.528 . . . . 75.43 110.831 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.648 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.8 tmtm? -117.19 105.17 11.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.783 -0.644 . . . . 71.4 110.248 -178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.695 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.2 m -74.87 156.52 6.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.173 0.511 . . . . 74.21 110.614 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -140.7 118.48 11.72 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.424 -0.807 . . . . 72.3 108.958 175.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.563 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -136.73 -15.02 1.61 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.038 0.384 . . . . 65.51 112.038 177.704 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.482 -0.77 . . . . 75.25 109.884 177.214 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.728 0.299 . . . . 72.21 110.681 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.85 -174.18 1.76 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 73.33 110.195 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.8 t -107.6 6.52 27.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.415 0.626 . . . . 74.42 110.243 175.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.1 p -124.96 172.86 9.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.275 -0.42 . . . . 72.21 110.025 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.554 HG22 HG12 ' A' ' 37' ' ' VAL . 34.2 m -94.26 20.25 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.22 0.533 . . . . 54.15 110.468 175.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 59.75 25.59 14.61 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.934 -1.03 . . . . 75.1 112.542 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.537 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 76.78 89.95 0.27 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.537 -0.839 . . . . 51.01 112.078 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.86 159.95 46.28 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.354 -0.927 . . . . 34.13 112.157 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.582 ' HB ' HG22 ' A' ' 31' ' ' THR . 74.3 p -140.44 145.67 37.28 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.856 -0.424 . . . . 71.12 109.856 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.65 125.25 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 109.803 -0.443 . . . . 74.13 109.803 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -90.04 111.95 23.22 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.73 -0.668 . . . . 54.31 109.6 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -98.86 124.63 43.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.164 -0.471 . . . . 73.12 109.776 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.511 ' HB3' HG22 ' A' ' 153' ' ' THR . 58.6 tttm -118.42 132.88 56.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.444 -0.344 . . . . 74.42 110.644 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.05 -115.11 2.48 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.921 -0.657 . . . . 74.4 112.846 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.467 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 31.6 mt-10 65.18 21.29 12.11 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.939 0.496 . . . . 70.51 111.176 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 155' ' ' LYS . 13.8 m -79.61 -33.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 113.307 0.855 . . . . 61.33 113.307 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.456 HG22 HG23 ' A' ' 16' ' ' VAL . 21.1 m -140.38 150.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.264 0.554 . . . . 72.0 112.436 -171.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -149.57 34.21 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.627 -1.249 . . . . 74.13 107.627 169.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.45 -74.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.048 -0.978 . . . . 65.41 110.88 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.417 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -94.79 -31.59 13.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.841 0.353 . . . . 63.11 110.629 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -142.36 136.24 29.43 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.923 -0.58 . . . . 61.5 109.976 -176.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.51 130.56 45.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.642 -0.254 . . . . 72.25 110.47 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.61 126.39 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.691 0.282 . . . . 73.41 110.245 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.12 143.99 36.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.935 -0.575 . . . . 73.11 111.516 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.67 -27.64 66.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.784 -0.643 . . . . 74.3 111.99 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 -5.16 87.91 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.51 -0.852 . . . . 63.21 112.216 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.2 p -123.59 12.61 9.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.717 0.265 . . . . 70.42 111.717 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 26.6 m -98.53 -12.78 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.967 0.413 . . . . 75.51 110.417 174.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -157.9 93.14 1.24 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.43 -0.952 . . . . 75.32 108.43 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pm0 -135.96 142.49 44.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.05 0.452 . . . . 72.11 110.19 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.582 HG22 ' HB ' ' A' ' 9' ' ' THR . 3.6 m -120.29 106.7 12.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.774 -0.648 . . . . 65.53 110.108 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 p -87.0 147.43 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 64.22 111.138 -175.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -99.6 117.46 34.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 73.31 110.466 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.402 ' HB3' ' HE2' ' A' ' 137' ' ' TYR . 2.7 mm? -85.99 -29.25 23.65 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.196 0.522 . . . . 63.15 110.083 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.537 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 92.47 171.28 41.01 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.559 -0.746 . . . . 70.14 111.88 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -78.9 91.42 4.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.713 0.292 . . . . 73.05 110.461 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.554 HG12 HG22 ' A' ' 5' ' ' VAL . 9.8 p -72.46 146.78 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.382 -0.599 . . . . 71.23 109.382 175.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -89.07 139.85 30.04 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.944 0.402 . . . . 75.42 110.803 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.9 p -73.13 -7.24 50.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.858 -0.61 . . . . 70.11 111.371 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.67 -26.99 27.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.019 -0.537 . . . . 52.15 110.606 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.531 ' HB2' HD12 ' A' ' 42' ' ' LEU . 9.1 m -74.24 -21.7 59.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 60.15 110.712 -177.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -127.43 107.71 10.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.624 -0.716 . . . . 52.12 109.828 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.78 10.9 3.4 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.708 -0.397 . . . . 65.41 111.781 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -146.66 143.69 28.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.773 0.321 . . . . 72.42 111.351 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.0 tm-20 -57.93 119.51 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.683 -0.69 . . . . 75.34 109.932 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.48 -6.09 29.93 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.793 -0.718 . . . . 54.04 111.999 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -72.69 131.33 42.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.677 0.275 . . . . 50.44 110.344 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.536 HG22 ' HD1' ' A' ' 138' ' ' PHE . 40.1 p -121.04 145.82 47.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.221 -0.445 . . . . 74.22 110.205 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.6 t -99.3 176.58 5.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.12 -0.696 . . . . 74.43 109.12 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.5 m -71.86 140.34 49.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.956 0.408 . . . . 74.4 110.083 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -92.4 159.36 15.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.573 0.702 . . . . 51.43 111.926 -176.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.3 m -98.33 151.84 4.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.463 -1.244 . . . . 70.25 109.16 170.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.7 73.32 0.27 Allowed Glycine 0 C--N 1.313 -0.733 0 C-N-CA 120.761 -0.733 . . . . 61.25 112.353 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -82.22 153.34 25.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.75 -0.463 . . . . 64.14 109.75 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.603 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.1 p-10 -122.78 145.02 48.79 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.185 0.516 . . . . 64.1 111.808 -174.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.437 HD12 ' CE2' ' A' ' 133' ' ' PHE . 67.3 mt -110.85 118.37 57.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.861 -0.792 . . . . 74.21 108.861 171.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -100.77 130.53 46.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 71.41 110.881 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 128' ' ' THR . 40.9 mt -112.35 118.18 34.5 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.823 -0.436 . . . . 72.21 109.823 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -94.54 140.86 29.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.309 -0.405 . . . . 41.31 110.117 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.4 t70 49.0 76.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.136 0.898 . . . . 73.04 110.721 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 41.7 t -109.68 143.73 39.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.05 -0.977 . . . . 70.02 109.564 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -120.79 153.04 37.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.255 0.465 . . . . 64.13 112.255 -171.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.2 p -115.16 -2.59 12.7 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.934 -0.575 . . . . 63.2 111.835 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -72.15 -38.36 69.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.677 -0.49 . . . . 73.02 109.677 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.86 -32.4 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.864 -0.607 . . . . 65.23 111.383 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -110.06 171.98 7.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.764 0.316 . . . . 75.24 111.474 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.434 ' CB ' ' HD2' ' A' ' 68' ' ' LYS . 20.1 m -133.73 -58.43 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.349 -0.387 . . . . 34.24 111.439 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -139.21 136.4 34.96 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.087 -0.338 . . . . 54.23 110.087 -177.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.466 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -99.4 130.07 45.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.278 0.561 . . . . 71.04 110.676 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.66 125.56 19.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.333 -0.848 . . . . 72.04 109.217 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.782 HG12 HG12 ' A' ' 156' ' ' VAL . 2.1 m -95.39 145.13 8.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.927 0.394 . . . . 74.41 110.993 -175.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.82 126.37 54.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.799 -0.637 . . . . 62.25 109.453 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 61.7 m-85 -93.02 137.19 32.6 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.122 0.487 . . . . 73.34 111.16 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.6 tp -134.73 134.1 40.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.7 -0.682 . . . . 61.33 109.709 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.39 -140.31 3.02 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.45 -0.66 . . . . 62.34 111.45 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.504 ' O ' HD13 ' A' ' 86' ' ' LEU . 39.2 m -103.26 118.59 37.12 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.092 -0.336 . . . . 72.13 110.092 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.41 138.26 36.61 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.176 -0.305 . . . . 73.13 110.176 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.599 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 10.4 tt -65.69 -27.82 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 75.22 110.694 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -158.83 176.8 11.88 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.323 -0.621 . . . . 44.55 109.323 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.1 -39.5 23.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.965 0.412 . . . . 70.12 110.244 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.02 -17.53 78.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.833 -0.699 . . . . 51.32 111.456 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.404 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 66.2 m80 -119.77 54.34 1.02 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.552 0.691 . . . . 64.21 109.685 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.568 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -78.78 14.62 1.28 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.13 -0.941 . . . . 72.33 111.86 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -112.57 2.38 16.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.201 0.524 . . . . 53.22 110.415 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.558 HG22 ' HB3' ' A' ' 102' ' ' GLN . 61.1 t -116.61 125.95 73.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 75.23 110.027 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.546 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -70.2 132.16 45.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.805 0.336 . . . . 75.21 110.307 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -80.02 152.86 29.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.833 -0.622 . . . . 64.41 110.149 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.662 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.6 mm? -85.61 144.86 27.63 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.378 -0.374 . . . . 71.24 110.635 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -71.84 144.52 49.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.904 -0.589 . . . . 64.14 110.926 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.61 102.46 3.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.01 -0.541 . . . . 63.14 109.865 174.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.2 m -101.43 6.09 42.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.067 -0.515 . . . . 33.11 110.573 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.61 13.19 8.77 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.514 -0.766 . . . . 74.31 111.228 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.22 6.17 12.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.773 -0.649 . . . . 64.53 110.483 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.67 95.04 1.03 Allowed Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.778 -0.929 . . . . 73.53 110.778 -176.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.05 154.23 35.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.876 0.37 . . . . 73.22 110.968 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.448 ' O ' HD23 ' A' ' 88' ' ' LEU . . . -69.06 148.76 49.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.082 -0.508 . . . . 62.11 109.672 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.56 160.18 40.57 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.761 -0.375 . . . . 73.52 110.478 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 65.95 8.8 5.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 73.45 110.232 -174.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.29 154.46 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 115.356 -0.838 . . . . 62.11 109.8 175.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -159.2 -169.15 22.19 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 110.597 -1.001 . . . . 55.33 110.597 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.41 109.25 27.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.53 0.681 . . . . 52.52 110.376 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.558 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.3 pt20 -96.88 150.42 20.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.757 -0.656 . . . . 73.4 109.676 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.54 122.18 67.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.151 0.501 . . . . 64.22 110.869 -175.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 14.4 mt -92.84 146.71 23.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 64.31 109.811 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.4 p-10 -78.43 -169.19 1.58 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.104 -0.498 . . . . 71.51 109.811 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -61.22 -30.05 70.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.928 0.344 . . . . 70.14 111.928 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.1 p -84.47 -10.95 57.03 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.692 -0.403 . . . . 70.33 111.218 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.53 23.89 17.56 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.659 -0.781 . . . . 74.03 112.58 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.61 134.05 51.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.327 -0.249 . . . . 74.15 110.327 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.14 132.3 50.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.074 0.464 . . . . 73.24 111.078 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.5 mt -94.38 141.08 28.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.754 -0.657 . . . . 53.01 110.323 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.1 m -78.99 139.56 38.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.353 -0.385 . . . . 73.13 110.436 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.546 HD13 HD22 ' A' ' 86' ' ' LEU . 36.5 mt -86.05 47.77 1.51 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.3 -0.409 . . . . 73.42 110.918 -176.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -104.45 -3.89 23.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.359 -0.382 . . . . 74.5 110.654 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.5 -0.76 63.52 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.149 -0.548 . . . . 54.2 113.345 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.04 -15.79 9.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.03 0.415 . . . . 62.4 111.103 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -84.94 104.17 14.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.252 -0.431 . . . . 71.14 110.545 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.444 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 96.0 m-85 -94.33 162.02 14.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.159 -0.473 . . . . 73.41 110.468 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.6 m -67.34 179.86 1.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.995 -0.548 . . . . 72.4 111.088 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.0 m -71.91 167.95 18.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.749 -0.463 . . . . 71.23 109.749 172.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.525 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 39.7 mt-10 -68.98 109.03 3.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.984 0.421 . . . . 75.14 111.785 -173.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.0 m -90.92 96.93 10.88 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.798 -0.816 . . . . 62.51 108.798 168.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.0 m -60.55 126.92 29.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.173 0.511 . . . . 72.52 110.484 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.521 HD13 ' SG ' ' A' ' 61' ' ' CYS . 96.5 mt -85.96 153.73 21.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.585 -0.734 . . . . 61.14 112.387 -170.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -128.85 150.53 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.956 -1.02 . . . . 70.05 108.43 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.6 m120 -64.61 107.77 1.5 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.17 0.51 . . . . 63.23 111.016 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.49 -151.21 21.81 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.514 -0.766 . . . . 74.45 111.497 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 50.7 m -89.48 116.92 28.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.267 0.556 . . . . 64.55 111.097 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.445 HD22 ' HB3' ' A' ' 61' ' ' CYS . 36.6 m-80 -110.06 126.64 54.22 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.744 -0.662 . . . . 64.11 109.974 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.603 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.3 m -106.93 114.95 29.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.247 -0.433 . . . . 44.45 110.148 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.1 mt -91.21 118.74 68.69 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.709 -0.478 . . . . 62.34 109.709 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -84.54 129.57 4.29 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.787 2.325 . . . . 73.41 112.656 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.437 ' CE2' HD12 ' A' ' 56' ' ' ILE . 62.6 m-85 -129.45 168.82 15.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.139 -0.482 . . . . 74.51 110.333 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 95.6 mt-30 -135.85 120.29 18.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.926 0.394 . . . . 71.41 111.621 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.23 125.97 51.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.373 -0.376 . . . . 72.41 110.039 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.528 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 6.2 ptp180 -140.35 165.03 28.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 71.41 110.921 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 67.3 m-85 -83.89 145.05 28.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.111 -0.495 . . . . 75.43 110.974 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.536 ' HD1' HG22 ' A' ' 48' ' ' THR . 78.9 t80 -133.58 128.86 36.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.67 -0.695 . . . . 72.11 109.212 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -94.95 133.92 38.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.269 -0.423 . . . . 75.04 111.496 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.549 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 82.0 p -104.57 6.02 34.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.664 0.745 . . . . 75.44 109.279 175.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.86 -129.57 1.95 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.12 -0.946 . . . . 74.41 111.4 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -85.47 93.03 8.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.244 -0.28 . . . . 72.14 110.244 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -45.75 112.66 0.49 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.755 0.659 . . . . 73.33 111.264 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.2 p -102.48 140.49 21.16 Favored Pre-proline 0 N--CA 1.442 -0.861 0 CA-C-O 121.061 0.457 . . . . 71.43 110.417 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.67 165.76 29.77 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 123.534 2.823 . . . . 63.25 112.666 -175.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.5 -149.76 21.84 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.482 -0.866 . . . . 45.11 111.803 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.86 120.81 35.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.155 -0.313 . . . . 71.24 110.155 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.662 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -111.73 50.35 0.85 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 71.54 111.299 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -101.43 136.21 41.65 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.201 -0.666 . . . . 75.31 109.201 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.508 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -143.31 165.32 27.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.619 0.247 . . . . 72.21 111.045 -177.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -135.06 143.7 46.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.34 -0.391 . . . . 70.41 110.204 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.21 141.31 24.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.049 0.452 . . . . 74.33 110.959 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 13' ' ' LYS . 35.9 p -103.28 131.29 50.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.938 -0.574 . . . . 63.24 109.616 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.432 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 53.1 p90 -111.78 140.94 46.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.919 0.39 . . . . 61.11 110.557 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.577 ' HA ' HG21 ' A' ' 16' ' ' VAL . 2.0 tmmm? -127.25 111.11 13.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.656 -0.702 . . . . 73.14 110.092 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.782 HG12 HG12 ' A' ' 71' ' ' VAL . 1.3 m -78.44 143.59 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.018 0.437 . . . . 75.32 110.372 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -126.82 126.26 43.06 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.446 -0.575 . . . . 74.43 109.446 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.657 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -136.21 -11.78 1.92 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.936 0.398 . . . . 72.44 111.781 178.042 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.36 -0.829 . . . . 72.51 109.172 172.255 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.976 -0.379 . . . . 61.45 109.976 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.72 -172.67 1.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.445 -0.343 . . . . 43.44 110.199 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.475 HG23 HG23 ' A' ' 4' ' ' THR . 15.0 t -85.92 -8.75 57.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.053 0.454 . . . . 65.42 111.037 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.475 HG23 HG23 ' A' ' 3' ' ' THR . 61.8 p -121.13 -178.37 3.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.962 0.41 . . . . 62.13 110.891 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.561 HG22 HG12 ' A' ' 37' ' ' VAL . 33.5 m -90.13 15.48 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.11 0.481 . . . . 72.21 110.601 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 62.19 22.72 13.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.16 -0.927 . . . . 75.31 112.541 172.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.523 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 83.14 90.25 0.7 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.46 -0.876 . . . . 71.42 111.916 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -85.23 161.03 35.42 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.436 -0.888 . . . . 43.34 112.382 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.532 ' HB ' HG22 ' A' ' 31' ' ' THR . 60.2 p -140.34 146.21 38.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.645 0.259 . . . . 73.43 110.781 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.461 HG23 HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -122.05 122.08 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.586 -0.524 . . . . 73.43 109.586 170.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -93.09 121.82 34.83 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.834 -0.432 . . . . 71.4 109.834 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 85.2 m-85 -107.69 123.32 48.33 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.841 -0.618 . . . . 74.34 110.46 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.607 ' HB3' HG22 ' A' ' 153' ' ' THR . 41.2 tptt -104.07 137.7 41.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.092 -0.504 . . . . 73.52 110.045 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -125.56 -136.24 4.47 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.709 -0.757 . . . . 34.42 112.836 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.645 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 48.9 mt-10 64.06 20.55 12.24 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.986 0.514 . . . . 64.45 110.89 -176.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 155' ' ' LYS . 26.8 m -69.62 -24.44 27.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.685 -0.688 . . . . 71.4 111.107 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.483 HG21 ' CG2' ' A' ' 156' ' ' VAL . 16.4 m -138.19 141.17 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.171 0.51 . . . . 75.21 112.004 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -143.75 24.78 1.68 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.961 -1.018 . . . . 63.15 108.483 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.73 -73.5 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.414 -0.812 . . . . 74.01 111.047 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.547 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -90.28 -40.88 11.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.901 0.381 . . . . 74.44 110.502 177.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -139.16 133.14 31.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.098 -0.501 . . . . 53.04 110.038 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.95 124.67 40.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.419 -0.355 . . . . 53.43 110.434 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.489 ' HA ' HD23 ' A' ' 58' ' ' LEU . 7.3 t -63.96 133.4 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.669 -0.493 . . . . 64.22 109.669 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.491 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.7 t70 -59.4 140.42 56.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.239 -0.437 . . . . 71.35 110.671 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -60.75 -26.49 67.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.488 . . . . 74.01 112.115 -174.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.55 -23.66 72.46 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.496 -0.859 . . . . 45.22 112.062 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.2 p -102.86 -7.72 21.34 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.913 0.338 . . . . 70.04 111.913 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.645 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 34.1 m -84.4 -2.87 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.063 0.458 . . . . 65.32 110.82 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -165.08 85.19 0.39 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.124 -1.065 . . . . 53.41 108.124 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -137.19 133.22 34.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.552 -0.749 . . . . 53.32 110.469 -173.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.532 HG22 ' HB ' ' A' ' 9' ' ' THR . 3.5 m -110.45 100.57 9.38 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.567 -0.742 . . . . 53.12 109.098 176.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.461 HG13 HG23 ' A' ' 10' ' ' VAL . 8.2 p -84.77 128.32 39.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.228 0.537 . . . . 73.14 110.488 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HG3' HG22 ' A' ' 9' ' ' THR . 26.4 mp0 -88.43 128.61 35.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.541 -0.754 . . . . 63.22 109.718 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.458 HD21 HG22 ' A' ' 10' ' ' VAL . 2.7 mm? -88.74 -34.56 17.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.336 0.589 . . . . 54.42 109.87 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.523 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 104.37 -179.6 24.72 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.433 -0.803 . . . . 55.02 111.813 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.424 ' HB3' ' CB ' ' A' ' 4' ' ' THR . 44.7 mt-30 -84.44 89.85 7.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.829 0.347 . . . . 72.25 110.576 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.561 HG12 HG22 ' A' ' 5' ' ' VAL . 9.5 p -70.81 141.82 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 73.14 110.267 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.54 137.27 40.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.972 -0.558 . . . . 60.13 109.965 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.3 p -86.88 5.17 38.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.468 0.652 . . . . 63.34 110.346 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.31 -27.87 18.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.433 -0.803 . . . . 53.15 110.737 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.476 ' HB2' HD12 ' A' ' 42' ' ' LEU . 12.3 m -72.23 -41.46 66.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.427 0.632 . . . . 70.24 110.342 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.1 mp -98.88 114.51 27.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.362 -0.835 . . . . 74.33 109.54 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.4 10.78 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.217 0.451 . . . . 65.12 112.217 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -150.57 153.51 35.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.552 0.215 . . . . 74.13 110.854 -177.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -65.58 121.11 14.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.022 -0.732 . . . . 75.32 109.022 176.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.424 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 106.27 2.57 38.46 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.591 -0.814 . . . . 64.12 111.761 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -80.91 140.4 35.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.817 0.341 . . . . 62.51 110.74 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.8 p -126.36 151.6 47.4 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.977 -0.556 . . . . 73.42 110.991 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.493 ' O ' ' HD2' ' A' ' 136' ' ' ARG . 27.3 t -104.07 179.47 4.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.044 -0.725 . . . . 53.24 109.044 174.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.3 m -73.54 129.59 38.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.239 -0.282 . . . . 53.45 110.239 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.665 ' HA ' ' HB3' ' A' ' 136' ' ' ARG . . . -82.29 157.6 23.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.595 0.712 . . . . 70.11 112.019 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.2 m -98.12 152.13 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.61 -1.177 . . . . 64.43 109.622 172.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.54 94.78 1.02 Allowed Glycine 0 C--N 1.313 -0.743 0 C-N-CA 120.785 -0.722 . . . . 60.22 112.276 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -107.93 178.34 4.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.031 -0.729 . . . . 72.11 109.031 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.599 ' HB2' HG22 ' A' ' 130' ' ' THR . 0.3 OUTLIER -148.97 151.51 34.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.964 0.727 . . . . 63.51 112.964 -177.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.4 HD12 ' CE2' ' A' ' 133' ' ' PHE . 83.0 mt -109.53 111.8 37.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.905 -1.043 . . . . 73.41 108.837 173.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 52.8 tt0 -94.55 135.01 36.49 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.198 -0.455 . . . . 71.43 111.074 -172.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 23' ' ' VAL . 75.4 mt -116.12 119.32 35.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.25 -0.432 . . . . 63.45 110.288 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -101.41 146.1 28.06 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.074 -0.512 . . . . 63.44 110.06 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 52.04 65.73 1.41 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.635 0.731 . . . . 73.21 110.224 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.481 ' SG ' HD13 ' A' ' 124' ' ' LEU . 39.1 t -100.24 137.26 38.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.245 -0.889 . . . . 64.12 110.258 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.44 ' OD2' HG12 ' A' ' 65' ' ' VAL . 17.1 t70 -111.64 137.75 49.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.213 -0.448 . . . . 73.12 111.494 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -102.32 0.98 35.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.133 -0.485 . . . . 73.23 112.246 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -79.74 -34.75 39.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.852 0.358 . . . . 64.5 110.371 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.471 HG13 ' HB2' ' A' ' 20' ' ' ALA . 11.7 p -107.5 -12.37 10.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.035 0.445 . . . . 55.13 110.928 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -122.8 179.41 4.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.709 0.29 . . . . 71.21 111.152 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.2 m -143.6 -59.17 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.3 -0.409 . . . . 52.14 110.796 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -137.94 139.58 39.83 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.576 -0.527 . . . . 65.33 109.576 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.403 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -100.27 118.53 36.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.143 0.497 . . . . 62.13 110.471 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.16 119.11 21.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.545 -0.752 . . . . 74.45 109.476 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 156' ' ' VAL . 2.4 m -90.31 146.49 6.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.963 0.411 . . . . 72.01 110.838 -175.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.07 142.3 46.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.599 -0.728 . . . . 43.03 109.149 172.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.471 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 78.3 m-85 -106.68 140.06 40.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.114 0.483 . . . . 71.14 110.93 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.3 tp -131.54 138.03 48.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.554 -0.748 . . . . 75.14 109.746 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.434 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -174.39 -160.06 21.86 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.23 -0.748 . . . . 31.1 111.23 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.4 m -91.82 114.37 26.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.671 0.235 . . . . 64.1 110.538 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.83 134.33 43.33 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.07 -0.344 . . . . 65.33 110.07 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.629 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 7.9 tt -63.54 -28.49 45.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.175 -0.466 . . . . 74.22 111.515 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -154.03 -178.94 7.42 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.79 -0.448 . . . . 71.22 109.79 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.81 -29.68 23.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.306 0.574 . . . . 73.43 109.703 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.44 -33.23 53.45 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.785 -0.721 . . . . 61.45 111.572 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -112.97 86.82 2.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.126 0.489 . . . . 73.31 110.155 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.5 p -93.56 8.74 39.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.821 -0.627 . . . . 70.22 111.411 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -115.14 0.47 13.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.146 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 102' ' ' GLN . 85.3 t -114.55 121.89 67.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.292 -0.413 . . . . 63.34 110.12 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.771 HD22 HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -70.56 130.09 40.92 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 110.039 -0.356 . . . . 64.12 110.039 -178.656 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.629 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.1 149.38 35.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.864 -0.607 . . . . 75.41 110.417 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.571 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -86.18 138.45 31.89 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.274 -0.421 . . . . 74.5 110.345 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -68.02 141.15 56.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.356 0.598 . . . . 64.42 110.584 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.461 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 0.9 OUTLIER -85.28 116.21 23.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.335 -0.848 . . . . 72.32 111.214 -174.063 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.5 m -92.77 -1.67 56.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.797 -0.638 . . . . 65.04 110.464 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 66.47 5.82 4.01 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.777 -0.647 . . . . 63.12 111.955 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.77 11.24 12.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.149 0.499 . . . . 51.43 110.596 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.78 77.52 0.96 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.641 -0.79 . . . . 71.45 112.135 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' A' ' 90' ' ' SER . 67.4 m -81.46 156.62 25.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.115 -0.328 . . . . 61.41 110.115 173.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.3 129.49 38.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.341 -0.39 . . . . 74.11 110.41 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.63 163.64 20.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.39 -0.368 . . . . 63.15 110.66 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 69.41 9.38 7.26 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.565 0.54 . . . . 52.41 110.409 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.87 174.12 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.423 -0.808 . . . . 71.13 110.133 174.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.528 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . -172.33 -174.05 39.41 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.255 -1.138 . . . . 62.1 110.255 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.15 114.81 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.469 0.652 . . . . 61.2 110.565 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.463 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.4 pt20 -104.54 145.03 30.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.753 -0.658 . . . . 74.22 109.396 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.471 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -104.13 123.63 58.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.142 0.496 . . . . 73.24 110.254 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 16.7 mt -91.46 144.63 25.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.503 -0.771 . . . . 75.43 108.947 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.548 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.1 p-10 -71.63 -171.7 0.69 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.7 -0.481 . . . . 74.43 109.7 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.441 ' CG ' ' HB3' ' A' ' 120' ' ' SER . 12.8 ptm180 -63.28 -25.2 68.21 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.098 0.407 . . . . 75.44 112.098 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.1 p -85.88 -34.33 21.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.709 -0.396 . . . . 71.41 110.759 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.74 29.6 1.38 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.655 -0.783 . . . . 61.54 112.446 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.08 131.32 54.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.034 -0.358 . . . . 71.23 110.034 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.35 120.88 15.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.398 -0.365 . . . . 52.21 110.797 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.7 133.31 33.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.168 -0.469 . . . . 60.34 110.539 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.536 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 16.2 m -69.38 139.34 54.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.164 -0.471 . . . . 74.4 110.445 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.771 HD13 HD22 ' A' ' 86' ' ' LEU . 29.6 mt -84.37 47.44 1.35 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.202 -0.454 . . . . 64.54 111.055 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -107.14 -6.04 17.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.964 0.412 . . . . 74.2 110.487 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.69 1.42 77.48 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.972 -0.632 . . . . 70.42 112.621 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -120.7 -0.85 10.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.008 0.432 . . . . 71.51 110.973 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.536 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 10.7 m -98.5 112.4 24.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.059 -0.518 . . . . 70.55 109.659 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -103.67 162.38 13.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.189 0.518 . . . . 75.31 111.492 -172.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.548 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.7 m -77.63 -175.0 3.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 63.51 111.405 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.441 ' HB3' ' CG ' ' A' ' 106' ' ' ARG . 42.5 t -63.74 153.86 35.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.043 -0.526 . . . . 62.44 110.572 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.564 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 40.4 mt-10 -68.35 97.84 0.78 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.916 -0.584 . . . . 73.34 110.686 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.6 m -79.54 100.5 7.78 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.442 -0.577 . . . . 64.33 109.442 173.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.8 m -57.07 114.95 2.35 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.906 -0.588 . . . . 61.32 110.683 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.481 HD13 ' SG ' ' A' ' 61' ' ' CYS . 91.3 mt -80.47 150.5 29.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.659 -0.7 . . . . 65.32 111.444 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -136.3 157.46 46.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.684 -0.858 . . . . 74.32 108.684 170.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -59.03 115.88 3.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.709 0.29 . . . . 51.2 110.868 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 131.45 -138.44 10.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 64.22 112.383 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 54.9 m -97.43 125.06 41.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.285 0.564 . . . . 75.21 111.378 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -121.97 110.97 16.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.5 -0.773 . . . . 61.44 109.612 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.599 HG22 ' HB2' ' A' ' 55' ' ' ASN . 5.7 m -103.54 116.93 33.29 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.435 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.61 112.9 59.61 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.093 -0.503 . . . . 65.12 110.479 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -80.3 143.37 15.61 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.504 2.136 . . . . 75.53 112.633 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 105' ' ' ASP . 68.2 m-85 -140.64 165.67 26.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 74.44 110.618 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.629 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 96.4 mt-30 -126.7 121.31 31.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.178 -0.465 . . . . 72.03 111.011 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -110.34 130.21 55.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.189 -0.3 . . . . 71.55 110.189 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.665 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 39.8 ptt180 -149.78 170.68 18.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 74.04 111.397 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 92.0 m-85 -86.37 145.33 26.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.593 -0.73 . . . . 71.33 111.084 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.424 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 75.3 t80 -130.33 133.28 46.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.244 -0.889 . . . . 72.25 108.644 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -100.52 138.7 37.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.039 0.447 . . . . 70.32 111.617 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.546 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 57.0 p -102.98 3.36 36.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.506 -0.77 . . . . 70.33 109.575 176.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.57 -132.92 2.73 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.998 -1.001 . . . . 41.32 110.86 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.54 91.47 2.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.063 -0.347 . . . . 62.13 110.063 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.12 112.49 0.58 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 53.54 111.333 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -104.24 141.44 22.53 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 116.052 -0.522 . . . . 55.24 110.593 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -71.1 171.78 15.24 Favored 'Trans proline' 0 C--N 1.334 -0.222 0 C-N-CA 123.877 3.051 . . . . 73.52 113.035 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.6 -161.35 26.61 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.665 -0.779 . . . . 75.12 111.989 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.421 ' H ' ' HA ' ' A' ' 95' ' ' SER . . . -79.31 112.52 16.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.652 0.226 . . . . 64.2 110.397 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.571 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -113.75 71.92 0.76 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.447 . . . . 72.13 111.375 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -120.92 128.09 52.44 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.444 -0.576 . . . . 73.34 109.444 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.488 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -130.5 171.86 12.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 72.33 111.913 -173.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -129.9 127.22 39.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.667 -0.697 . . . . 73.41 110.428 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 12' ' ' PHE . . . -139.13 125.81 20.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.191 0.519 . . . . 43.23 110.784 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.607 HG22 ' HB3' ' A' ' 13' ' ' LYS . 16.9 p -105.86 130.07 53.9 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.937 -0.574 . . . . 74.44 110.143 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -106.44 141.21 38.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.183 0.516 . . . . 75.13 111.072 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.675 ' HA ' HG21 ' A' ' 16' ' ' VAL . 3.9 tmmm? -126.38 109.39 12.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.602 -0.726 . . . . 73.24 109.808 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -75.2 142.86 14.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.029 0.443 . . . . 75.32 110.321 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -122.31 121.6 37.11 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.5 -0.556 . . . . 74.11 109.5 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.579 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 1.1 p90 -142.22 -17.59 0.73 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.394 . . . . 75.54 111.075 175.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.358 -0.829 . . . . 72.1 108.925 174.855 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.816 0.341 . . . . 65.01 110.724 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.33 -176.96 5.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.088 -0.506 . . . . 62.35 110.134 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 t -81.96 -16.82 49.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.175 0.512 . . . . 61.5 110.375 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 p -98.97 -176.42 3.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.949 -0.569 . . . . 62.22 110.723 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.549 HG22 HG12 ' A' ' 37' ' ' VAL . 33.7 m -89.52 13.69 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.824 0.345 . . . . 54.51 110.871 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 60.61 16.29 6.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.356 -0.838 . . . . 65.44 112.648 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.32 107.02 3.05 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.575 -0.821 . . . . 65.52 112.127 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.578 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -98.23 150.35 19.38 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.383 -0.913 . . . . 44.02 111.772 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.523 ' HB ' HG22 ' A' ' 31' ' ' THR . 16.9 p -142.55 145.45 33.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.746 0.308 . . . . 60.21 110.766 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.628 HG22 HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -121.39 119.65 59.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.955 -0.566 . . . . 74.31 110.789 175.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -86.65 123.45 31.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.413 -0.812 . . . . 63.22 110.124 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -107.93 126.89 53.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.289 -0.414 . . . . 74.14 110.374 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HB3' HG22 ' A' ' 153' ' ' THR . 64.7 tttp -111.88 129.14 56.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.133 -0.485 . . . . 55.44 110.087 177.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.4 -123.99 5.34 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.871 -0.681 . . . . 75.02 111.906 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 34.7 mt-10 64.33 16.35 10.07 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.135 0.493 . . . . 73.5 111.522 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 155' ' ' LYS . 27.2 m -81.33 -21.63 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.936 -0.575 . . . . 70.35 111.284 -177.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.539 HG11 HG22 ' A' ' 156' ' ' VAL . 18.5 m -137.74 141.88 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.296 0.569 . . . . 53.22 111.352 -176.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -147.0 23.24 1.2 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.289 -1.004 . . . . 71.24 108.289 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.2 -92.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.306 -0.861 . . . . 73.03 111.107 -176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -73.2 -35.53 66.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.898 0.38 . . . . 55.5 110.776 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 1.4 m -141.59 133.12 26.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.938 -0.574 . . . . 73.2 109.825 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.96 126.3 41.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.25 -0.432 . . . . 23.1 110.276 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 t -67.4 131.62 32.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.773 -0.454 . . . . 70.33 109.773 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.438 ' O ' HG13 ' A' ' 28' ' ' VAL . 19.4 t70 -62.62 151.53 37.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.436 -0.347 . . . . 75.31 110.949 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.421 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -57.85 -36.02 71.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 73.3 111.472 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.24 -2.01 86.68 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.903 -0.665 . . . . 74.32 111.961 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.414 ' OG ' HG23 ' A' ' 56' ' ' ILE . 46.5 t -119.6 -3.45 10.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.502 0.191 . . . . 72.34 110.901 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 32.9 m -94.34 -14.34 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.61 -0.515 . . . . 64.34 109.61 172.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -150.38 91.17 1.72 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.194 -0.912 . . . . 75.32 109.577 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -141.17 141.96 34.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.143 0.496 . . . . 71.14 109.978 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.523 HG22 ' HB ' ' A' ' 9' ' ' THR . 9.1 m -123.41 109.6 14.08 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.83 -0.623 . . . . 65.11 109.664 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.411 HG12 HG23 ' A' ' 10' ' ' VAL . 10.9 p -86.29 136.39 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.949 0.404 . . . . 73.43 110.324 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.516 ' HA ' HG22 ' A' ' 9' ' ' THR . 27.0 mp0 -93.31 115.08 27.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.989 -0.551 . . . . 54.24 110.43 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.628 HD21 HG22 ' A' ' 10' ' ' VAL . 2.7 mm? -76.96 -30.03 55.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.65 -0.705 . . . . 73.32 109.61 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.94 -173.48 30.6 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.511 -0.768 . . . . 64.24 111.75 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -83.54 90.45 7.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.564 0.221 . . . . 60.12 110.541 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.549 HG12 HG22 ' A' ' 5' ' ' VAL . 7.5 p -61.6 141.32 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.183 0.516 . . . . 53.43 110.399 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -86.49 116.01 24.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.794 -0.639 . . . . 73.33 110.098 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 p -70.62 -12.65 61.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.362 -0.835 . . . . 73.13 112.197 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.26 -30.47 48.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.887 0.375 . . . . 63.3 111.006 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.438 ' HB2' HD12 ' A' ' 42' ' ' LEU . 15.2 m -70.28 -40.66 74.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.547 0.689 . . . . 72.13 110.277 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -99.31 87.08 3.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.48 -0.782 . . . . 75.54 110.298 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.13 14.21 9.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.019 0.438 . . . . 72.51 111.257 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -154.64 146.74 23.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.782 -0.645 . . . . 71.1 109.504 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 43.1 tt0 -60.1 136.52 58.05 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.103 -0.332 . . . . 73.45 110.103 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.97 -14.3 60.13 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.606 -0.806 . . . . 63.24 111.813 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.35 125.15 25.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.698 0.285 . . . . 52.23 110.448 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 20.3 p -117.41 140.5 49.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.323 -0.399 . . . . 61.51 110.515 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.1 t -86.39 174.51 8.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.74 -0.466 . . . . 55.51 109.74 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -68.0 134.53 50.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.504 -0.554 . . . . 61.21 109.504 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -87.06 155.67 20.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.429 0.633 . . . . 72.04 111.757 -175.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.5 m -90.96 152.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.688 -1.142 . . . . 72.43 109.024 169.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.05 87.16 0.46 Allowed Glycine 0 C--N 1.31 -0.888 0 C-N-CA 120.784 -0.722 . . . . 41.1 111.776 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -101.68 173.12 6.56 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.769 -0.456 . . . . 73.32 109.769 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -140.82 146.92 38.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.905 0.383 . . . . 61.22 111.244 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.417 HD13 ' CE1' ' A' ' 154' ' ' PHE . 41.1 mt -102.58 122.45 54.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.605 -0.725 . . . . 72.34 109.251 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -100.72 126.86 47.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.099 -0.5 . . . . 74.25 111.305 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 128' ' ' THR . 70.4 mt -111.44 129.5 56.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.664 -0.698 . . . . 74.34 109.835 175.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -102.27 135.09 44.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.157 -0.474 . . . . 63.24 110.098 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.9 t70 49.09 77.51 0.1 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.069 0.855 . . . . 65.31 111.052 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.472 ' SG ' HD13 ' A' ' 124' ' ' LEU . 49.0 t -108.85 129.83 55.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.162 -0.927 . . . . 63.32 110.128 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 64' ' ' ASN . 24.9 t70 -99.12 147.55 24.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.029 0.443 . . . . 70.1 111.772 -176.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -115.84 8.99 14.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.647 -0.706 . . . . 74.43 111.546 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.414 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 55.4 m-80 -91.24 -31.49 16.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.006 0.431 . . . . 60.25 110.006 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.29 -16.17 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.17 0.509 . . . . 63.01 110.571 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.623 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -128.35 -178.33 4.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.269 -0.423 . . . . 74.34 110.792 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.513 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 37.1 m -144.19 -59.2 0.38 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.696 -0.229 . . . . 71.15 111.231 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -135.65 141.17 44.98 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 110.041 -0.355 . . . . 75.41 110.041 -178.331 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.06 124.74 49.1 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.093 0.473 . . . . 64.44 110.618 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.59 117.71 17.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.734 -0.667 . . . . 73.13 109.369 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.626 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -93.4 150.16 4.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.071 0.462 . . . . 61.35 110.768 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.37 124.15 44.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.49 -0.777 . . . . 53.12 109.474 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.451 ' CE1' HG21 ' A' ' 103' ' ' ILE . 62.9 m-85 -86.39 134.73 33.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.213 0.53 . . . . 73.12 110.643 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.6 tp -132.38 122.44 25.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.512 -0.767 . . . . 52.33 109.73 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.15 -166.55 27.4 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.127 -0.789 . . . . 54.22 111.127 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.506 ' O ' HD13 ' A' ' 86' ' ' LEU . 4.1 m -76.8 124.95 28.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.476 0.179 . . . . 72.02 110.823 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.39 140.62 35.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.264 -0.273 . . . . 61.31 110.264 177.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 13.3 tt -62.98 -29.03 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.011 0.434 . . . . 75.04 111.118 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -149.68 178.08 9.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.443 -0.577 . . . . 73.12 109.443 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.95 -27.84 30.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.069 0.462 . . . . 73.3 109.981 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.32 -37.91 9.44 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.817 -0.706 . . . . 55.54 111.505 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -95.5 77.57 3.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.709 -0.478 . . . . 72.41 109.709 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.452 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 15.6 p -91.61 12.89 19.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.807 -0.633 . . . . 70.24 111.316 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -112.79 -5.01 13.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.125 -0.489 . . . . 73.52 110.993 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -112.12 128.83 68.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.384 -0.371 . . . . 72.44 110.249 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.526 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -68.64 137.56 54.3 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.014 -0.365 . . . . 63.21 110.014 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.97 157.57 29.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.181 -0.463 . . . . 65.21 110.34 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.593 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.5 mm? -93.71 139.63 30.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.371 -0.377 . . . . 63.33 110.451 -176.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 149' ' ' ASN . 31.4 mt-30 -65.38 135.62 55.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.256 0.551 . . . . 71.13 109.642 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.438 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 1.2 m -96.93 123.52 40.66 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.708 -0.678 . . . . 73.44 110.263 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.4 m -97.78 -3.03 39.78 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.33 -0.396 . . . . 62.34 110.391 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 60.54 26.39 16.05 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.603 -0.726 . . . . 62.54 110.521 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.41 -12.97 1.35 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.701 -0.681 . . . . 61.14 112.134 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.65 74.58 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.137 -1.03 . . . . 51.5 112.679 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.438 ' OG ' ' HA ' ' A' ' 90' ' ' SER . 54.7 m -90.66 168.71 11.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.878 -0.416 . . . . 62.21 109.878 174.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -92.94 146.26 23.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.68 -0.236 . . . . 44.1 110.38 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.22 164.81 26.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.728 0.299 . . . . 71.35 110.935 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.407 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 23.6 m-80 68.76 7.56 6.21 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.881 0.873 . . . . 64.11 111.285 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.593 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -147.65 150.21 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-N 115.965 -0.561 . . . . 34.34 109.882 173.137 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.86 -170.2 15.71 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.712 -0.955 . . . . 52.43 110.712 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.428 HG11 HG13 ' A' ' 10' ' ' VAL . 2.5 p -121.34 122.44 67.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.155 0.502 . . . . 71.15 110.412 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -117.16 138.88 51.38 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.136 0.494 . . . . 72.33 109.768 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.451 HG21 ' CE1' ' A' ' 73' ' ' PHE . 4.2 mp -94.14 128.42 45.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.841 -0.618 . . . . 62.23 110.071 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 18.4 mt -96.35 154.86 17.03 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.486 -0.779 . . . . 72.43 109.462 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.557 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 2.4 p-10 -72.92 -167.95 0.43 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.401 -0.592 . . . . 72.22 109.401 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -71.29 -19.06 62.38 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.462 -0.495 . . . . 74.31 111.858 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.2 p -90.6 -35.22 15.13 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.913 -0.315 . . . . 73.34 110.952 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.83 26.34 1.41 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.516 -0.85 . . . . 62.54 113.349 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . -100.52 140.45 34.76 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.332 -0.247 . . . . 43.24 110.332 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.03 126.33 30.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.317 -0.401 . . . . 71.32 111.465 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.7 mt -87.28 147.28 25.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.017 -0.538 . . . . 72.23 110.326 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.6 m -93.37 141.04 28.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.109 -0.496 . . . . 73.24 110.55 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.412 ' CD1' HD22 ' A' ' 86' ' ' LEU . 63.7 mt -84.25 60.25 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.074 0.464 . . . . 74.41 110.977 -176.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -119.57 -4.84 10.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.016 -0.538 . . . . 74.41 109.909 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.29 4.97 65.43 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.617 -0.72 . . . . 74.12 112.726 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.48 -16.65 7.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 72.23 110.811 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 m -84.15 97.76 9.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.664 -0.495 . . . . 72.12 109.664 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.496 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 86.6 m-85 -87.49 165.43 15.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.23 -0.441 . . . . 62.3 110.837 -175.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.0 m -74.53 -171.08 1.14 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.948 -0.569 . . . . 74.14 110.888 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.2 p -72.79 164.9 25.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.963 -0.384 . . . . 52.22 109.963 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.418 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 41.7 mt-10 -72.78 103.03 3.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.924 0.392 . . . . 74.05 111.193 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.0 m -84.19 109.65 17.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.317 -0.623 . . . . 75.02 109.317 174.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 m -63.6 113.52 3.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.941 -0.572 . . . . 62.44 111.095 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.472 HD13 ' SG ' ' A' ' 61' ' ' CYS . 94.6 mt -77.66 150.14 34.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.857 -0.61 . . . . 73.22 110.943 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -135.96 152.47 51.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.949 -0.569 . . . . 63.24 109.642 170.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 45.8 m-20 -55.15 113.31 1.32 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.988 0.423 . . . . 72.32 111.587 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.75 -145.93 16.55 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.901 -0.666 . . . . 73.41 112.265 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 28.3 m -82.76 129.27 34.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.782 0.325 . . . . 53.41 110.379 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 26.1 m-80 -122.25 133.13 54.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.214 -0.448 . . . . 63.23 110.884 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.63 113.33 26.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.245 -0.434 . . . . 62.12 110.922 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 16.1 mt -92.87 106.4 18.82 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.042 -0.725 . . . . 63.34 109.042 175.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 6.2 Cg_exo -79.09 135.13 12.07 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.033 2.489 . . . . 55.31 112.31 -176.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -136.41 166.87 22.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.294 -0.412 . . . . 72.25 110.623 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.574 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 97.9 mt-30 -132.89 117.9 18.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.954 -0.566 . . . . 73.42 110.922 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.95 125.26 50.2 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.188 -0.301 . . . . 55.22 110.188 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.55 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 14.8 ptp180 -140.63 164.45 30.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.818 0.342 . . . . 74.23 110.836 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.578 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 58.6 m-85 -81.54 149.02 28.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.931 -0.577 . . . . 72.33 111.206 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -132.03 127.68 36.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.427 -0.806 . . . . 74.45 109.127 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.645 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -91.64 135.0 34.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.978 0.418 . . . . 74.22 111.416 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 55.8 p -101.82 1.03 36.65 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.425 -0.954 . . . . 74.22 108.425 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.82 -123.89 1.1 Allowed Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.34 -1.3 . . . . 60.33 111.189 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.25 98.0 11.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.44 -0.207 . . . . 31.22 110.44 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -47.71 117.3 1.78 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.075 -0.511 . . . . 75.12 111.083 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.6 p -107.29 146.74 33.85 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.169 -0.469 . . . . 73.44 110.79 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.73 167.7 23.65 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.382 2.722 . . . . 54.42 112.726 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.63 -125.04 2.75 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.663 -0.78 . . . . 42.01 111.768 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -129.91 118.47 21.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.738 0.304 . . . . 65.44 110.461 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -114.53 71.85 0.77 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.12 0.486 . . . . 63.4 110.933 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.442 ' O ' ' HG3' ' A' ' 89' ' ' GLN . 4.0 m-20 -111.98 146.16 38.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.392 -0.596 . . . . 71.24 109.392 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.526 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -150.25 163.22 38.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.801 0.334 . . . . 63.01 111.395 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -132.99 144.88 50.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 74.34 109.797 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.96 152.05 33.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.408 0.623 . . . . 74.0 111.68 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.53 HG22 ' HB3' ' A' ' 13' ' ' LYS . 7.9 p -108.1 142.6 38.05 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.299 -0.864 . . . . 74.34 109.259 173.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.417 ' CE1' HD13 ' A' ' 56' ' ' ILE . 53.7 p90 -117.94 130.47 56.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.926 0.393 . . . . 72.41 110.572 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.625 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -110.03 112.45 24.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.098 -0.501 . . . . 75.12 110.36 178.157 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.626 HG12 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -80.47 146.32 7.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.912 -0.403 . . . . 72.44 109.912 178.31 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -127.29 123.53 36.63 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.281 -0.637 . . . . 62.33 109.281 171.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.623 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -135.27 -12.89 2.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.927 0.394 . . . . 75.22 111.337 175.147 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.23 -0.89 . . . . 54.43 109.559 170.982 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.882 0.373 . . . . 74.24 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.63 165.0 35.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.141 -0.481 . . . . 31.41 110.137 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.4 t -95.45 12.58 28.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.386 0.612 . . . . 73.01 110.566 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.9 p -118.64 171.49 8.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.042 -0.527 . . . . 72.54 110.135 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.453 HG22 HG12 ' A' ' 37' ' ' VAL . 27.2 m -87.84 21.49 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.018 0.437 . . . . 41.34 111.27 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 58.83 19.13 6.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.442 -0.799 . . . . 65.53 112.436 173.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.526 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 88.29 99.97 0.94 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.652 -0.785 . . . . 71.45 111.77 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.424 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -92.84 157.74 23.72 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.206 -0.997 . . . . 62.33 112.19 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.578 ' HB ' HG22 ' A' ' 31' ' ' THR . 73.0 p -140.91 148.95 41.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.57 0.224 . . . . 70.54 110.574 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.516 HG23 HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -121.69 119.36 58.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.943 -0.762 . . . . 62.24 108.943 171.528 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -91.15 109.56 20.82 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.402 -0.519 . . . . 74.13 109.694 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.455 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 97.7 m-85 -96.0 126.49 41.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.703 -0.68 . . . . 75.12 109.901 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -110.38 128.92 55.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.374 -0.376 . . . . 71.45 110.596 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.67 -139.1 10.35 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.056 -0.593 . . . . 62.12 111.85 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 60.83 27.48 17.28 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.356 0.598 . . . . 74.24 111.311 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.626 HG21 ' HA ' ' A' ' 155' ' ' LYS . 31.2 m -83.29 -28.96 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.647 -0.706 . . . . 74.1 111.188 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.648 HG21 HG22 ' A' ' 156' ' ' VAL . 16.4 m -142.36 151.04 18.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.349 -0.387 . . . . 64.04 110.939 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -167.98 84.17 0.2 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.713 -0.847 . . . . 74.12 108.713 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.1 -74.05 0.26 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.349 -0.841 . . . . 34.11 110.025 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.546 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -73.52 -35.27 65.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 75.53 109.997 173.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.41 ' CB ' ' HA ' ' A' ' 61' ' ' CYS . 4.2 m -143.56 -176.63 5.03 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.13 -0.693 . . . . 73.43 109.13 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.64 146.69 41.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.202 -0.666 . . . . 54.13 109.202 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 t -81.32 137.23 21.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.74 -0.467 . . . . 72.22 109.74 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' O ' HG13 ' A' ' 28' ' ' VAL . 12.3 t70 -65.45 141.35 58.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.61 -0.268 . . . . 73.05 110.328 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -57.12 -28.74 62.96 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.405 0.441 . . . . 74.11 111.98 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.28 -11.09 82.19 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.564 -0.827 . . . . 75.44 112.415 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.9 p -124.97 14.96 8.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.833 0.309 . . . . 74.42 111.833 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 24' ' ' ASP . 32.9 m -102.9 -5.74 9.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.087 0.47 . . . . 61.34 110.241 173.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -155.66 90.88 1.26 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.311 -0.859 . . . . 75.11 109.325 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 20.3 pm0 -139.65 124.29 18.33 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.346 0.593 . . . . 70.13 110.672 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.578 HG22 ' HB ' ' A' ' 9' ' ' THR . 2.2 m -100.54 95.09 6.48 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.452 -0.795 . . . . 63.02 109.29 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.99 136.59 24.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.209 0.528 . . . . 75.31 110.718 -174.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -96.58 118.63 33.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.448 -0.796 . . . . 54.31 110.267 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.516 HD21 HG23 ' A' ' 10' ' ' VAL . 2.6 mm? -90.13 -26.2 20.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.116 -0.493 . . . . 61.02 109.855 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.526 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 90.2 179.85 43.98 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.642 -0.708 . . . . 75.02 112.644 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -81.65 90.11 6.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.67 0.271 . . . . 65.51 110.636 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.453 HG12 HG22 ' A' ' 5' ' ' VAL . 7.3 p -79.28 142.36 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 110.249 -0.278 . . . . 53.21 110.249 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -71.89 126.41 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 74.21 110.649 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.601 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 32.5 p -74.43 -20.22 60.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.07 0.462 . . . . 72.02 110.903 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.11 -29.95 65.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 51.11 111.442 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -71.06 -35.12 71.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.253 0.549 . . . . 74.41 110.25 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -98.74 74.08 2.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.713 -0.676 . . . . 73.32 110.256 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.94 17.66 18.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.083 0.468 . . . . 65.22 110.993 -172.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -150.37 138.7 20.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.866 -0.606 . . . . 64.42 110.218 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -55.72 126.59 26.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 74.54 110.358 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.37 -9.54 38.71 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.708 -0.758 . . . . 75.23 111.898 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -62.97 121.04 12.56 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.73 0.3 . . . . 63.23 110.427 177.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.1 p -115.9 119.66 36.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.956 -0.566 . . . . 53.01 110.216 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.5 t -83.04 171.09 14.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.264 -0.425 . . . . 71.13 109.908 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.0 m -64.76 127.94 33.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.985 -0.552 . . . . 45.32 110.368 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 134' ' ' GLN . . . -83.3 147.58 27.87 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.492 0.663 . . . . 51.03 111.638 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.2 m -87.07 151.62 3.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 114.775 -1.102 . . . . 71.12 109.278 171.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.6 97.51 0.99 Allowed Glycine 0 C--N 1.311 -0.84 0 C-N-CA 120.976 -0.631 . . . . 61.32 112.322 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -109.87 172.44 6.85 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.81 -0.441 . . . . 73.24 109.81 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.579 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.3 p-10 -135.25 144.38 46.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.123 0.487 . . . . 74.34 111.648 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 81.7 mt -113.05 124.64 69.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.389 -0.823 . . . . 72.25 108.803 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -109.47 144.1 38.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.847 0.356 . . . . 74.04 111.089 -172.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 128' ' ' THR . 23.7 mt -120.52 133.4 55.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.227 -0.442 . . . . 75.02 109.823 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -112.15 155.29 24.17 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.928 -0.578 . . . . 61.14 109.839 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 51.58 45.77 27.55 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 123.849 0.718 . . . . 71.22 110.638 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 5.8 t -89.18 143.4 26.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.355 -0.838 . . . . 63.32 110.602 -174.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 64' ' ' ASN . 20.9 t70 -117.87 154.43 31.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 64.42 111.612 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.6 p -124.12 9.64 8.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.354 -0.384 . . . . 72.52 111.263 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.453 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 52.7 m-80 -84.37 -34.12 23.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 73.21 110.159 177.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.834 HG22 ' HG3' ' A' ' 159' ' ' GLN . 8.5 p -110.7 -17.09 8.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.044 -0.526 . . . . 52.22 110.985 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -122.68 167.38 13.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.631 -0.259 . . . . 71.32 110.983 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.546 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 13.8 m -130.22 -55.4 1.11 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.404 -0.362 . . . . 44.24 111.117 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.546 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -138.67 153.23 48.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.177 -0.305 . . . . 73.3 110.177 -178.225 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.479 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -105.1 127.11 52.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.061 0.458 . . . . 64.24 110.369 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -135.14 116.0 14.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.746 -0.661 . . . . 53.25 109.56 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.0 OUTLIER -89.81 144.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.158 0.504 . . . . 71.13 111.199 -174.178 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.85 118.07 29.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.215 -0.902 . . . . 74.42 109.537 173.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 89.5 m-85 -82.71 137.83 34.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.188 0.518 . . . . 73.24 110.874 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.2 tp -128.42 135.78 49.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.554 -0.748 . . . . 72.44 109.521 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.08 -177.54 47.68 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.994 -0.622 . . . . 74.21 111.621 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 m -75.16 120.96 21.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.782 0.325 . . . . 73.45 110.818 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -79.18 144.14 34.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.137 -0.483 . . . . 45.45 110.402 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 tt -77.9 -21.26 13.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.013 0.435 . . . . 74.31 110.784 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -155.12 176.32 12.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.552 -0.536 . . . . 74.43 109.552 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.03 -29.02 32.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.98 0.419 . . . . 61.25 110.433 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.78 -24.63 19.97 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.832 -0.699 . . . . 72.43 111.692 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -99.91 50.71 0.91 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.348 0.594 . . . . 65.23 109.652 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.459 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 5.6 p -78.63 4.99 12.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.549 -0.751 . . . . 65.35 112.098 -176.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -107.7 -1.79 20.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.117 0.484 . . . . 72.43 110.525 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.422 HG22 ' HB3' ' A' ' 102' ' ' GLN . 60.0 t -108.62 123.98 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 72.25 110.285 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.568 HD22 HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -70.04 131.79 44.88 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.982 -0.377 . . . . 74.44 109.982 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.53 149.49 33.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.141 -0.482 . . . . 52.43 110.775 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.3 mm? -81.02 143.75 32.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.896 -0.593 . . . . 72.42 110.567 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -63.19 141.68 58.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.026 -0.534 . . . . 73.42 111.09 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.8 p -77.14 112.33 13.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.765 -0.652 . . . . 75.54 110.678 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.5 m -105.17 -8.14 18.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.23 -0.441 . . . . 62.11 110.814 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 64.94 3.88 2.26 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.451 0.7 . . . . 63.22 112.174 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.13 11.03 20.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.219 0.533 . . . . 72.44 110.254 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.54 85.06 1.84 Allowed Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.429 -0.805 . . . . 64.41 111.673 -175.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.1 m -82.11 146.86 29.39 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.541 -0.541 . . . . 70.13 109.541 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.23 121.73 14.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.094 -0.335 . . . . 74.21 110.094 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.4 160.69 18.15 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.788 -0.365 . . . . 63.41 110.755 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 69.26 14.61 8.59 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.669 -0.696 . . . . 63.44 110.476 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.0 -179.99 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.887 -0.597 . . . . 71.31 110.058 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 179.4 -173.57 45.5 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.172 -1.171 . . . . 73.31 110.172 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.431 HG21 HG21 ' A' ' 10' ' ' VAL . 3.2 p -119.95 114.59 44.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.628 0.727 . . . . 72.13 110.674 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.6 pt20 -103.9 141.7 35.7 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.486 -0.779 . . . . 73.24 109.114 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.498 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.3 mp -104.18 127.66 58.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.199 0.523 . . . . 72.23 110.464 -177.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.0 mt -93.44 147.24 23.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.425 -0.807 . . . . 64.11 109.222 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -70.29 -172.71 0.61 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.494 -0.558 . . . . 71.53 109.494 174.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -67.92 -16.62 64.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.398 0.518 . . . . 74.11 112.398 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.403 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 69.0 p -95.53 -32.49 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.718 -0.393 . . . . 64.54 111.053 177.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.71 32.49 0.76 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.735 -0.745 . . . . 73.53 112.82 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.4 125.41 50.96 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.724 -0.28 . . . . 71.34 110.36 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.61 116.59 12.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.953 0.406 . . . . 65.41 110.436 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.6 mt -84.85 132.74 34.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.007 -0.542 . . . . 72.13 111.238 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.449 ' H ' HG21 ' A' ' 117' ' ' THR . 25.0 m -68.72 141.61 55.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.816 -0.629 . . . . 73.35 110.604 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.568 HD13 HD22 ' A' ' 86' ' ' LEU . 49.8 mt -82.7 41.2 0.71 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 74.02 111.207 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.41 -16.36 46.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.86 0.362 . . . . 73.52 110.56 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.67 3.58 89.06 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.735 -0.745 . . . . 71.34 111.603 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -128.1 2.3 5.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.725 0.298 . . . . 51.21 111.316 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 112' ' ' THR . 9.0 m -94.37 102.89 14.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.016 -0.365 . . . . 53.01 110.016 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.515 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 75.6 m-85 -93.99 150.84 19.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.213 -0.449 . . . . 71.55 111.876 -172.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.1 m -68.01 179.82 1.4 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.388 -0.824 . . . . 71.24 111.264 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.2 m -67.36 147.75 52.53 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.019 -0.537 . . . . 74.4 109.766 173.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.469 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 47.0 mt-10 -55.28 110.44 0.69 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 73.14 111.662 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.8 m -96.35 107.25 19.6 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.016 -0.735 . . . . 75.24 109.016 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 m -61.93 132.96 54.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.088 -0.506 . . . . 52.42 111.414 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 69' ' ' ALA . 82.2 mt -94.6 149.14 21.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.241 0.543 . . . . 73.01 111.926 -176.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -128.38 151.55 49.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.219 -0.9 . . . . 73.24 108.835 168.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 17.9 m120 -63.7 121.94 15.18 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.952 0.406 . . . . 74.45 110.68 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.97 -109.94 1.22 Allowed Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.814 -0.63 . . . . 50.3 111.892 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 98.5 m -127.11 133.03 50.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.055 0.455 . . . . 53.12 111.173 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -129.65 145.25 51.52 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.359 -0.608 . . . . 72.32 109.359 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.579 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.6 m -125.82 122.64 36.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.867 0.365 . . . . 74.21 110.73 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.6 mt -102.91 115.74 63.68 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.167 -0.47 . . . . 50.22 110.084 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -80.26 138.27 12.48 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.84 2.36 . . . . 64.24 112.215 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -137.44 163.2 31.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.888 0.375 . . . . 75.12 110.81 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.625 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 94.8 mt-30 -131.82 119.3 21.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.98 -0.555 . . . . 74.5 111.235 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.93 129.9 53.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.442 -0.344 . . . . 63.24 110.259 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.431 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 1.4 ptp180 -140.86 164.97 28.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.892 0.377 . . . . 74.31 111.361 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 70.2 m-85 -86.55 141.75 28.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.865 -0.607 . . . . 75.01 110.33 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -127.97 122.53 32.57 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.238 -0.653 . . . . 70.33 109.238 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.636 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -85.45 130.55 34.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.89 0.376 . . . . 72.32 110.908 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 63.8 p -102.19 11.43 38.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.716 0.77 . . . . 75.24 108.933 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 163.84 -123.57 1.19 Allowed Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.616 -1.175 . . . . 70.2 111.385 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.9 95.35 8.19 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.242 -0.281 . . . . 61.44 110.242 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.601 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.02 115.55 1.33 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.006 0.432 . . . . 74.13 111.136 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.0 p -103.87 141.39 22.41 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.825 -0.435 . . . . 64.43 109.825 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.49 163.43 38.07 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.449 2.766 . . . . 73.05 112.396 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.35 -153.91 25.63 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.628 -0.796 . . . . 63.34 111.796 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.45 108.07 19.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.737 0.303 . . . . 73.4 110.828 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -107.05 75.78 1.05 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.201 0.524 . . . . 74.04 110.71 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -123.77 134.32 53.67 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.331 -0.618 . . . . 75.01 109.331 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -136.91 167.57 21.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.993 0.425 . . . . 41.32 111.434 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -131.16 142.47 50.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.643 -0.708 . . . . 74.42 109.561 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.81 139.05 27.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.224 0.535 . . . . 71.34 111.255 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.6 p -108.86 117.0 33.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.821 -0.627 . . . . 73.22 110.014 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.443 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 47.4 p90 -95.04 123.6 38.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.511 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.626 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.5 tmmm? -106.01 100.91 10.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.702 -0.481 . . . . 73.21 109.702 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.1 m -78.57 133.21 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.314 0.578 . . . . 51.0 110.168 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -111.7 113.38 25.72 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.876 -0.602 . . . . 72.15 110.987 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.546 ' CD1' ' HB3' ' A' ' 20' ' ' ALA . 5.3 p90 -135.39 -40.37 0.73 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.542 -0.754 . . . . 73.41 109.208 169.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.834 ' HG3' HG22 ' A' ' 65' ' ' VAL . 10.9 tm0? . . . . . 0 C--O 1.249 1.073 0 N-CA-C 108.082 -1.081 . . . . 75.31 108.082 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 120.9 0.381 . . . . 75.41 110.826 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.9 -179.08 6.26 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.52 -0.548 . . . . 70.23 109.52 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.0 t -97.22 -10.04 26.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.591 0.71 . . . . 71.32 109.881 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.423 HG22 ' HA ' ' A' ' 38' ' ' ARG . 74.2 p -118.01 -178.03 3.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.528 -0.76 . . . . 61.52 110.156 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.552 HG22 HG12 ' A' ' 37' ' ' VAL . 34.6 m -90.42 17.71 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.901 0.381 . . . . 73.42 111.001 176.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 59.55 31.07 20.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.597 -0.729 . . . . 74.33 112.275 171.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.451 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 79.82 92.53 0.4 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.68 -0.771 . . . . 31.32 112.3 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.31 153.42 25.26 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.208 -0.996 . . . . 65.11 111.678 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.556 ' HB ' HG22 ' A' ' 31' ' ' THR . 45.2 p -138.53 144.97 40.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.71 0.291 . . . . 72.13 110.486 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.485 ' CG2' HD21 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -118.04 120.44 64.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.97 -0.752 . . . . 71.02 108.97 172.294 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -86.86 111.28 20.62 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.405 -0.518 . . . . 73.2 109.611 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -100.92 118.84 37.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.808 -0.633 . . . . 62.2 110.02 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HB3' HG22 ' A' ' 153' ' ' THR . 48.0 tttp -116.21 138.08 51.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.145 -0.479 . . . . 72.1 110.597 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -116.22 -116.43 2.96 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.786 -0.643 . . . . 73.52 111.86 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.934 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 28.3 mt-10 62.45 22.45 13.26 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.158 0.504 . . . . 73.15 110.915 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.683 HG21 ' HA ' ' A' ' 155' ' ' LYS . 29.7 m -83.13 -26.46 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.574 -0.739 . . . . 73.02 111.659 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.705 HG21 HG22 ' A' ' 156' ' ' VAL . 3.8 m -140.28 134.63 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.099 0.476 . . . . 54.03 112.204 -173.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -139.22 23.4 2.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 75.55 109.33 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.71 -83.1 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 50.23 111.886 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.3 -34.05 70.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.467 0.651 . . . . 53.41 110.637 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 2.8 m -146.44 162.72 37.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.262 -0.881 . . . . 73.32 108.628 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.05 127.22 53.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.482 0.182 . . . . 62.42 110.601 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 t -70.04 130.09 34.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.904 -0.406 . . . . 71.21 109.904 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.9 t70 -57.84 140.87 50.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 64.43 111.067 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.431 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -63.84 -17.08 62.78 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 112.443 0.534 . . . . 53.23 112.443 -174.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.51 -23.12 48.49 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.596 -0.811 . . . . 61.04 111.949 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.0 p -101.63 -8.43 21.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.787 0.292 . . . . 61.41 111.787 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.934 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 30.5 m -82.4 -4.14 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.705 0.288 . . . . 64.24 111.471 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -164.44 85.07 0.43 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.048 -0.723 . . . . 40.25 109.048 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -136.33 130.6 33.11 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.872 -0.604 . . . . 64.04 110.716 -172.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.556 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.1 m -106.43 104.64 14.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.761 -0.654 . . . . 74.51 109.818 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' THR . 12.1 p -88.53 132.55 33.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.13 0.491 . . . . 54.55 110.928 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.435 ' HA ' HG22 ' A' ' 9' ' ' THR . 25.0 mp0 -89.2 123.39 33.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.811 -0.631 . . . . 73.24 110.129 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.485 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.5 mm? -83.6 -23.86 31.73 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.926 -0.768 . . . . 71.5 108.926 175.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 93.19 179.63 39.73 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.077 -0.965 . . . . 75.12 112.058 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -80.82 87.1 5.92 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.219 -0.289 . . . . 63.23 110.219 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.552 HG12 HG22 ' A' ' 5' ' ' VAL . 7.9 p -71.95 136.0 26.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.51 -0.552 . . . . 74.22 109.51 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.423 ' HA ' HG22 ' A' ' 4' ' ' THR . 76.3 mtp180 -78.82 130.29 35.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.245 -0.434 . . . . 73.44 110.411 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.0 p -82.03 13.09 3.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.065 -0.516 . . . . 72.13 111.224 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.4 -22.47 17.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.177 0.513 . . . . 63.02 109.785 174.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -81.88 -15.72 53.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.462 -0.79 . . . . 32.01 110.541 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 5.0 mp -125.87 117.19 22.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.06 -0.719 . . . . 74.54 109.06 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.96 10.35 2.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.763 0.653 . . . . 50.3 112.763 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -153.98 156.21 37.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.358 -0.238 . . . . 74.24 110.358 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 42.2 tt0 -61.04 131.04 49.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.396 -0.366 . . . . 73.12 110.047 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.45 -1.96 57.36 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.686 -0.769 . . . . 54.15 111.939 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -78.09 115.57 17.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.008 0.432 . . . . 63.42 110.012 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.568 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 4.7 p -111.46 135.43 52.02 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.766 -0.652 . . . . 64.32 110.431 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 t -88.07 179.47 6.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 62.02 109.649 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 m -71.55 139.57 49.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.725 -0.472 . . . . 63.3 109.725 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.514 ' HB2' ' HE ' ' A' ' 136' ' ' ARG . . . -90.96 152.61 20.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.311 0.576 . . . . 75.54 112.03 -175.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 24.7 m -83.53 158.56 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.77 -1.105 . . . . 54.33 109.199 168.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.79 89.92 0.51 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.896 -0.669 . . . . 65.21 112.054 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -103.25 175.56 5.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.575 -0.528 . . . . 73.21 109.575 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.58 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.3 p-10 -143.68 155.06 44.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.367 0.603 . . . . 54.25 111.869 -174.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.422 HD12 ' CE2' ' A' ' 133' ' ' PHE . 80.0 mt -115.05 112.62 40.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.052 -0.976 . . . . 74.22 108.903 171.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -96.52 128.25 43.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.036 0.445 . . . . 74.34 110.703 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.3 mt -110.33 126.01 53.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.88 -0.6 . . . . 60.54 110.046 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -105.36 145.09 31.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.019 -0.537 . . . . 72.24 109.555 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 30.2 t70 49.69 69.14 0.63 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.926 0.869 . . . . 71.34 110.563 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.415 ' SG ' HD22 ' A' ' 124' ' ' LEU . 10.2 t -106.28 114.84 29.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.048 -0.978 . . . . 63.05 109.734 -176.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -96.68 131.59 43.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.08 -0.509 . . . . 75.43 111.515 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.0 p -102.24 12.8 36.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 71.12 111.879 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -87.87 -26.36 22.81 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.539 -0.541 . . . . 65.42 109.539 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.73 -32.97 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.674 -0.694 . . . . 63.44 110.841 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -113.57 -179.19 3.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.725 0.298 . . . . 71.34 111.326 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 29.4 m -139.32 -55.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.503 -0.317 . . . . 74.4 111.596 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -136.31 144.7 44.84 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 110.408 -0.219 . . . . 72.43 110.408 -177.031 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.512 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -103.23 137.29 41.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.967 0.413 . . . . 65.24 110.72 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.39 113.74 6.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 74.31 109.417 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.709 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -87.01 145.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.98 0.419 . . . . 54.24 110.977 -173.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.563 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -118.18 122.06 42.07 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.738 -0.665 . . . . 53.45 109.919 174.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.466 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 88.6 m-85 -87.58 130.62 34.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.297 0.57 . . . . 75.34 110.812 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.5 tp -125.41 122.66 37.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.605 -0.725 . . . . 75.04 109.763 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.05 -171.43 29.28 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.768 -0.651 . . . . 63.42 111.586 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.419 ' O ' HD13 ' A' ' 86' ' ' LEU . 8.8 m -84.59 119.9 25.73 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.374 -0.232 . . . . 71.23 110.374 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -78.65 144.67 35.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.522 -0.308 . . . . 65.43 110.987 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.409 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 6.7 tt -69.79 -37.29 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.417 . . . . 73.11 110.835 178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.33 175.45 10.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.316 -0.624 . . . . 73.42 109.316 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.34 -37.15 38.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.083 0.468 . . . . 70.25 110.323 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.5 -19.01 67.2 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.591 -0.814 . . . . 74.54 111.276 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -111.17 47.57 0.99 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.16 0.505 . . . . 74.42 109.728 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.511 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -74.14 4.1 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.602 -0.727 . . . . 53.01 112.373 -176.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 30.3 p-10 -108.09 -0.6 21.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.158 0.504 . . . . 71.34 110.288 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 102' ' ' GLN . 46.2 t -108.01 125.82 64.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.875 -0.602 . . . . 62.42 110.153 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.504 HD22 ' CD1' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -69.0 134.42 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.382 -0.372 . . . . 72.12 110.588 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.409 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.36 150.27 35.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.06 -0.518 . . . . 43.32 110.483 177.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.428 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.5 mm? -91.77 134.47 34.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.313 -0.403 . . . . 74.0 110.451 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -82.14 130.88 35.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.364 0.602 . . . . 52.11 110.611 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 m -68.33 134.85 50.95 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.9 -1.045 . . . . 51.1 111.707 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.8 m -109.14 3.24 21.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.925 -0.58 . . . . 74.34 110.098 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 59.79 13.37 3.49 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.438 -0.801 . . . . 71.34 112.068 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.58 11.92 14.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.022 0.439 . . . . 52.42 110.405 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.95 77.89 1.06 Allowed Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.463 -0.875 . . . . 72.2 111.153 -176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.2 m -74.35 160.49 30.98 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.18 -0.304 . . . . 72.44 110.18 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.95 149.89 21.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.784 -0.45 . . . . 75.43 109.784 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.45 167.54 21.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.918 -0.401 . . . . 64.25 109.918 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 68.62 10.18 7.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.17 0.51 . . . . 71.04 110.498 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.07 -177.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.634 -0.712 . . . . 73.04 110.444 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.84 -174.78 46.86 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.171 -1.172 . . . . 75.01 110.171 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.65 115.27 46.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.364 0.602 . . . . 71.01 110.62 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.412 ' HB3' HG22 ' A' ' 85' ' ' VAL . 10.2 pt20 -107.28 135.42 48.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.206 -0.664 . . . . 72.44 109.206 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.466 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -95.83 123.61 48.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.968 0.413 . . . . 73.32 110.813 -175.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.52 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 15.5 mt -88.65 136.19 33.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.485 -0.779 . . . . 72.12 109.336 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.2 OUTLIER -71.78 -173.64 1.02 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.776 -0.453 . . . . 72.34 109.776 175.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.47 ' HG3' HG23 ' A' ' 107' ' ' THR . 15.4 ptm180 -57.96 -23.77 55.15 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.973 0.36 . . . . 73.3 111.973 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.47 HG23 ' HG3' ' A' ' 106' ' ' ARG . 71.0 p -102.02 11.41 38.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.792 0.33 . . . . 52.31 111.647 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.52 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 76.52 35.57 41.13 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.836 -0.697 . . . . 61.54 112.985 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.63 120.71 42.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.352 -0.24 . . . . 75.35 110.352 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 103' ' ' ILE . . . -65.83 111.42 3.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.984 0.421 . . . . 74.13 110.534 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.5 mt -78.26 132.93 37.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.849 -0.614 . . . . 72.4 111.3 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.515 ' H ' HG21 ' A' ' 117' ' ' THR . 15.3 m -67.55 142.06 56.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.492 -0.776 . . . . 54.44 110.598 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.504 ' CD1' HD22 ' A' ' 86' ' ' LEU . 59.5 mt -81.79 44.15 0.81 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.057 0.456 . . . . 74.25 110.808 -177.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -92.97 -18.03 23.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.836 -0.62 . . . . 75.32 110.516 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.58 -16.29 46.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.613 -0.803 . . . . 53.24 112.325 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.82 8.11 20.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.476 . . . . 54.15 110.717 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.515 HG21 ' H ' ' A' ' 112' ' ' THR . 2.1 m -97.03 95.88 8.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.011 -0.541 . . . . 71.23 110.059 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.715 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 65.3 m-85 -93.61 158.0 15.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.178 -0.465 . . . . 73.44 111.405 -173.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 5.7 m -69.58 -175.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.639 -0.71 . . . . 71.52 111.586 178.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.9 t -69.37 163.52 24.98 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.765 -0.457 . . . . 62.42 109.765 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.418 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 48.9 mt-10 -68.03 104.58 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 54.24 111.245 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.513 HG21 HG12 ' A' ' 131' ' ' ILE . 75.1 m -85.14 99.11 10.85 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.649 -0.501 . . . . 64.1 109.649 173.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.4 m -56.16 112.92 1.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.719 -0.673 . . . . 75.33 110.585 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 69' ' ' ALA . 85.1 mt -74.33 144.39 44.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 52.42 111.712 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -117.41 141.93 47.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.188 -0.915 . . . . 75.01 109.215 173.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -55.59 116.69 3.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.36 0.413 . . . . 63.42 110.868 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 119.67 -111.51 2.05 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.592 -0.813 . . . . 73.21 112.57 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.6 m -112.05 134.77 53.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.943 0.401 . . . . 50.04 111.198 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -131.17 124.11 29.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.948 -0.569 . . . . 73.43 110.122 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.58 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.7 m -110.75 107.06 16.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.738 0.304 . . . . 72.22 110.331 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 122' ' ' THR . 13.7 mt -88.14 118.04 69.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.365 -0.38 . . . . 72.4 110.119 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.18 137.98 9.83 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.812 2.341 . . . . 74.31 112.956 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 74.2 m-85 -136.43 161.84 34.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 73.1 111.135 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 74.2 mt-30 -130.17 118.1 20.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 72.31 110.934 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -107.05 125.62 51.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.134 -0.321 . . . . 63.14 110.134 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.568 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 10.1 ptp180 -138.64 163.53 31.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.011 0.434 . . . . 54.3 111.092 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 64.4 m-85 -81.52 142.3 32.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 73.14 111.053 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -126.4 116.84 21.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.435 -0.802 . . . . 74.1 109.376 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -82.19 131.28 35.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.479 -0.328 . . . . 53.14 110.566 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 68.9 p -101.3 2.84 40.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.645 0.736 . . . . 75.15 109.471 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 173.81 -134.75 2.97 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.742 -1.117 . . . . 71.13 110.635 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 144' ' ' THR . . . -78.08 85.91 4.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.712 0.256 . . . . 75.03 110.338 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -46.48 111.67 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.614 0.571 . . . . 42.32 111.781 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 142' ' ' ALA . 20.4 p -102.49 144.49 28.71 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-O 121.075 0.464 . . . . 72.43 111.232 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.41 167.38 26.49 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.413 2.742 . . . . 72.41 112.648 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.39 -128.78 3.14 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.867 -0.682 . . . . 70.52 111.783 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -120.68 117.24 27.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.719 0.295 . . . . 51.15 110.468 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.428 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -118.09 74.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.164 0.507 . . . . 42.03 111.309 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -117.31 138.67 51.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.963 -0.562 . . . . 70.24 109.897 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.473 ' HB3' HG13 ' A' ' 10' ' ' VAL . . . -135.63 171.58 14.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.586 0.587 . . . . 64.12 112.586 -172.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -134.01 128.67 34.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.247 -0.888 . . . . 73.55 109.739 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.415 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -150.67 144.31 25.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.281 0.562 . . . . 74.13 111.867 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.438 HG22 ' HB3' ' A' ' 13' ' ' LYS . 21.7 p -112.4 150.67 30.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.694 -0.684 . . . . 51.24 109.529 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -121.92 134.25 54.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.257 0.551 . . . . 64.34 111.219 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.715 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 20.2 ttmt -111.22 101.57 10.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.608 -0.724 . . . . 70.23 110.499 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.709 HG12 HG12 ' A' ' 71' ' ' VAL . 1.3 m -75.13 126.82 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 119.983 -0.687 . . . . 74.15 109.539 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -108.48 111.82 23.9 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.874 -0.603 . . . . 70.13 110.434 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -129.92 -21.02 3.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.882 0.372 . . . . 73.13 110.839 171.107 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 . . . . . 0 C--O 1.249 1.071 0 N-CA-C 109.051 -0.722 . . . . 71.32 109.051 175.401 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.569 -0.53 . . . . 63.34 109.569 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 145' ' ' PRO . . . -65.16 127.87 33.47 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.019 -0.734 . . . . 70.33 109.019 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.6 t -77.65 -14.24 59.68 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.461 0.541 . . . . 60.35 112.461 -169.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.6 p -97.85 176.96 5.61 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.087 -0.383 . . . . 72.33 110.259 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.489 ' CG2' HG12 ' A' ' 37' ' ' VAL . 35.5 m -88.42 13.19 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.189 0.519 . . . . 75.24 110.715 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 63.67 14.31 8.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.233 -0.894 . . . . 71.14 112.502 172.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.43 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 88.59 94.45 1.04 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.674 -0.774 . . . . 71.34 111.677 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.412 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -84.66 152.22 27.29 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.425 -0.893 . . . . 53.55 112.084 -176.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.531 ' HB ' HG22 ' A' ' 31' ' ' THR . 21.0 p -143.06 139.97 30.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.342 -0.244 . . . . 74.41 110.342 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.29 126.28 68.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.835 -0.432 . . . . 72.12 109.835 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -93.91 112.7 24.58 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.574 -0.528 . . . . 64.13 109.574 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -100.08 122.64 43.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.962 -0.563 . . . . 53.11 110.657 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HB3' HG22 ' A' ' 153' ' ' THR . 59.3 tttm -112.09 136.09 51.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 61.5 110.092 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.08 -120.72 3.41 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.715 -0.755 . . . . 64.0 112.349 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.573 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 34.8 mt-10 63.28 20.01 12.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.06 0.457 . . . . 75.54 110.943 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.634 HG21 ' HA ' ' A' ' 155' ' ' LYS . 18.9 m -80.39 -21.95 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.661 . . . . 72.34 112.207 -175.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.411 HG13 HG23 ' A' ' 16' ' ' VAL . 17.3 m -133.49 157.3 42.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.237 0.542 . . . . 61.03 112.032 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -157.54 24.74 0.29 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.696 -1.138 . . . . 63.41 108.49 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.1 -81.07 0.32 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 64.43 111.664 -174.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.407 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -93.77 -38.78 11.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.951 0.405 . . . . 63.54 110.917 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 2.0 m -137.36 128.58 27.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.126 -0.488 . . . . 75.01 110.148 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.08 125.54 35.9 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.645 -0.707 . . . . 71.14 110.361 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.473 ' HA ' HD23 ' A' ' 58' ' ' LEU . 15.8 t -66.23 128.66 29.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.72 -0.474 . . . . 70.41 109.72 177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.27 145.49 42.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.154 -0.475 . . . . 64.35 111.235 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.553 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -63.11 -22.13 66.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 75.11 111.71 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.66 -10.24 79.72 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.732 -0.747 . . . . 60.41 111.876 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.0 t -104.3 -27.5 11.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.088 . . . . 54.22 110.827 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.573 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 27.7 m -74.66 -6.84 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.095 0.474 . . . . 74.41 110.923 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -153.54 95.14 1.87 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.36 -0.836 . . . . 73.41 109.356 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -151.57 137.73 18.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.888 -0.596 . . . . 63.25 110.681 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.531 HG22 ' HB ' ' A' ' 9' ' ' THR . 6.9 m -115.66 111.96 21.4 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.591 -0.731 . . . . 73.34 109.698 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 p -92.87 139.54 17.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.846 0.355 . . . . 74.53 110.691 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.439 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.4 mp0 -95.86 126.75 41.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.239 -0.437 . . . . 53.52 110.362 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -91.32 -27.59 18.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.39 0.614 . . . . 70.55 109.482 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.43 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.58 171.71 37.76 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.263 -0.881 . . . . 71.21 112.127 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -73.02 88.17 1.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.778 0.323 . . . . 72.34 110.717 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.489 HG12 ' CG2' ' A' ' 5' ' ' VAL . 9.8 p -67.44 151.93 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.478 -0.328 . . . . 71.01 110.171 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -91.31 125.02 35.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.095 -0.502 . . . . 60.53 110.725 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.3 p -74.71 -15.04 60.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.947 -0.569 . . . . 71.03 111.047 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.98 -22.51 60.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.475 . . . . 53.35 111.204 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 m -85.66 -33.93 21.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.136 0.494 . . . . 51.04 110.638 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.5 mp -108.61 97.74 7.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.986 -0.552 . . . . 71.02 109.956 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.25 14.87 4.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.025 0.441 . . . . 74.01 111.119 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -152.49 146.98 25.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.858 -0.61 . . . . 64.15 110.086 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 44.2 tt0 -62.65 130.76 46.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 63.34 110.303 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.98 -5.93 42.95 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.678 -0.772 . . . . 73.12 111.617 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -74.88 119.93 19.73 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.99 -0.374 . . . . 70.41 109.99 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.582 ' HB ' HH11 ' A' ' 136' ' ' ARG . 37.9 p -115.15 126.07 54.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.115 -0.493 . . . . 72.2 110.476 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.2 t -80.0 172.4 13.83 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.836 -0.431 . . . . 55.12 109.836 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.7 m -69.58 134.99 49.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.302 -0.408 . . . . 71.42 110.054 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -86.98 162.12 17.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.625 0.726 . . . . 62.34 111.93 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.5 m -104.66 152.22 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.575 -1.193 . . . . 61.41 109.349 172.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.82 105.23 2.19 Favored Glycine 0 C--N 1.312 -0.779 0 C-N-CA 120.802 -0.714 . . . . 75.11 112.188 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -117.93 171.89 7.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.12 -0.696 . . . . 65.43 109.12 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.82 139.6 32.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.526 0.679 . . . . 74.24 112.507 -175.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.443 HD13 ' CD1' ' A' ' 154' ' ' PHE . 45.9 mt -95.22 116.48 36.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.268 -0.878 . . . . 71.04 109.585 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -93.32 133.39 36.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.771 -0.65 . . . . 75.24 111.249 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 23' ' ' VAL . 69.3 mt -117.76 129.68 55.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.59 -0.732 . . . . 63.24 109.587 176.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -103.89 146.24 28.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.297 -0.41 . . . . 75.43 110.493 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 49.95 41.84 23.56 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.873 0.733 . . . . 50.53 111.235 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.423 ' SG ' HD22 ' A' ' 124' ' ' LEU . 53.6 t -76.76 124.55 27.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.83 -0.623 . . . . 72.52 110.492 -175.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.52 132.48 45.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.054 -0.521 . . . . 71.31 111.292 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.8 p -107.62 18.21 21.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.093 0.473 . . . . 72.31 111.661 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -90.85 -33.66 15.57 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.975 -0.75 . . . . 62.42 108.975 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 p -101.71 -12.88 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.548 -0.751 . . . . 52.11 111.086 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -135.45 169.47 17.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.692 0.282 . . . . 72.41 110.997 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.506 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 44.8 m -129.01 -57.13 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 35.33 111.97 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -135.91 141.73 44.59 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 122.164 -0.335 . . . . 75.22 110.172 -176.26 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.461 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -104.32 134.7 47.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.218 0.533 . . . . 72.24 110.495 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.86 120.43 12.5 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.351 -0.841 . . . . 71.15 109.201 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 156' ' ' VAL . 1.6 m -93.78 149.44 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.067 0.461 . . . . 64.01 110.965 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.22 119.32 32.87 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.461 -0.791 . . . . 75.52 109.396 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 62.7 m-85 -83.09 126.28 32.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.955 0.407 . . . . 62.2 110.547 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.8 tp -122.42 127.65 49.92 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.897 -0.592 . . . . 65.13 109.857 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.75 -164.44 26.47 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.343 -0.703 . . . . 71.33 111.343 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.418 ' O ' HD13 ' A' ' 86' ' ' LEU . 8.7 m -82.35 128.33 34.11 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.614 0.207 . . . . 74.23 110.476 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -87.67 148.48 24.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.176 -0.305 . . . . 63.43 110.176 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.3 tt -74.33 -25.64 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.988 0.423 . . . . 64.2 110.731 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -155.66 -174.2 4.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.522 -0.547 . . . . 73.43 109.522 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.88 -44.11 13.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.078 0.466 . . . . 72.01 110.067 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.3 -18.56 71.23 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.723 -0.751 . . . . 65.21 111.333 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -104.98 46.22 0.93 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.352 0.596 . . . . 73.03 109.89 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.409 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -78.9 12.42 2.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.53 -0.759 . . . . 72.14 111.803 -178.685 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -107.6 -12.35 15.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.061 -0.518 . . . . 65.21 110.491 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 65.0 t -106.92 125.83 62.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.916 -0.584 . . . . 62.04 110.778 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.55 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -66.08 133.19 50.24 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.795 -0.446 . . . . 72.33 109.795 178.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.15 147.8 36.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.449 . . . . 51.35 110.114 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 2.0 mm? -78.77 145.56 34.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.133 -0.485 . . . . 73.32 110.111 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 8.8 mm-40 -62.29 123.65 18.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.923 -0.581 . . . . 70.24 110.647 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 p -71.79 99.42 2.16 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.494 -0.775 . . . . 71.41 110.933 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.4 m -93.28 -10.52 35.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.838 -0.619 . . . . 73.42 110.053 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 64.41 6.17 2.96 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.441 -0.8 . . . . 74.31 112.367 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.26 11.65 14.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.439 0.637 . . . . 73.04 110.449 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 124.78 67.93 0.19 Allowed Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.474 -0.785 . . . . 72.34 111.5 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 m -86.06 148.62 25.64 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.736 -0.468 . . . . 75.0 109.736 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.4 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -74.62 142.0 44.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.073 -0.343 . . . . 71.35 110.073 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.0 163.44 30.28 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.02 -0.363 . . . . 60.51 110.02 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.2 m120 70.32 10.68 7.33 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.512 0.508 . . . . 71.54 110.824 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 143' ' ' ALA . 0.0 OUTLIER -146.63 -177.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.658 -0.701 . . . . 60.32 109.677 174.364 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 172.71 -175.89 45.68 Favored Glycine 0 N--CA 1.437 -1.259 0 N-CA-C 110.602 -0.999 . . . . 75.35 110.602 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.52 114.58 46.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.399 0.619 . . . . 72.14 110.83 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.408 ' HG2' ' HB2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -106.37 140.14 39.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.52 -0.764 . . . . 53.31 109.596 176.39 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 103' ' ' ILE . 3.9 mp -101.58 123.85 54.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.233 -0.44 . . . . 74.52 110.256 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 16.4 mt -87.74 148.61 24.66 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.537 -0.756 . . . . 62.34 109.411 176.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.567 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 2.1 p-10 -72.39 -170.74 0.68 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.715 -0.476 . . . . 64.22 109.715 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -72.09 -17.09 62.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.135 0.42 . . . . 75.34 112.135 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.6 p -89.23 -36.99 15.32 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.553 -0.459 . . . . 74.51 110.683 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.87 31.04 0.72 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.658 -0.782 . . . . 52.13 113.363 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -117.76 133.04 56.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.783 0.292 . . . . 62.04 110.517 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.03 141.61 57.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.962 0.41 . . . . 65.14 110.973 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.433 HD12 ' HD1' ' A' ' 73' ' ' PHE . 80.6 mt -91.09 -176.53 4.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.039 -0.528 . . . . 61.1 110.214 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.3 m -125.29 142.01 51.75 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.003 -0.369 . . . . 53.21 110.003 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 53.9 mt -84.46 39.48 0.73 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.384 -0.371 . . . . 75.41 111.548 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -102.19 -0.59 32.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.99 0.424 . . . . 62.3 110.26 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.3 3.22 45.5 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.747 -0.66 . . . . 53.44 113.141 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -120.88 -11.6 8.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.932 0.366 . . . . 72.45 111.051 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.2 m -91.16 108.6 19.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.015 -0.365 . . . . 71.41 110.015 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.53 ' CE1' ' HE3' ' A' ' 155' ' ' LYS . 93.7 m-85 -98.27 163.96 12.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.107 0.479 . . . . 72.13 111.228 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 4.0 m -70.23 175.33 4.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 62.12 110.499 175.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.0 t -68.08 146.09 53.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.229 -0.656 . . . . 75.43 109.229 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -53.76 112.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 62.01 111.444 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.6 m -97.19 106.6 18.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.744 -0.662 . . . . 74.2 109.542 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.5 m -58.49 116.34 3.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.228 0.537 . . . . 64.13 111.277 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 69' ' ' ALA . 87.8 mt -77.31 152.44 34.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.362 -0.836 . . . . 72.42 111.544 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -122.5 153.34 39.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.514 -0.767 . . . . 72.34 109.583 173.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 82.8 m-20 -68.58 106.63 2.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.838 0.352 . . . . 61.41 110.793 176.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 131.88 -128.72 5.39 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.747 -0.739 . . . . 64.11 112.497 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.3 m -94.09 127.46 39.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.841 0.353 . . . . 64.51 110.709 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -123.58 150.05 44.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.283 -0.417 . . . . 74.13 110.216 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.59 111.43 10.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.355 -0.384 . . . . 70.21 111.068 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 mt -90.99 110.17 40.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.233 -0.654 . . . . 74.23 109.233 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.6 133.9 9.61 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.914 2.409 . . . . 72.33 112.127 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.482 ' HE1' ' HG ' ' A' ' 119' ' ' SER . 74.3 m-85 -131.27 158.85 39.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.426 -0.352 . . . . 74.13 110.501 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 92.4 mt-30 -123.04 113.53 19.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.864 -0.607 . . . . 75.12 110.804 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.75 126.89 44.5 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 121.008 -0.277 . . . . 61.1 110.329 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.582 HH11 ' HB ' ' A' ' 48' ' ' THR . 13.1 ptp180 -140.8 162.85 34.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.859 0.361 . . . . 71.42 110.809 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 62.3 m-85 -82.28 137.44 34.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.016 -0.538 . . . . 74.21 110.853 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.421 ' HD1' HG22 ' A' ' 48' ' ' THR . 80.2 t80 -121.62 119.52 32.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.771 -0.65 . . . . 63.23 109.4 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -84.0 130.32 34.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.305 -0.407 . . . . 72.45 110.746 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.502 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 73.6 p -102.01 5.34 40.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.876 0.846 . . . . 71.52 109.258 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.05 -136.89 4.01 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.455 -1.248 . . . . 42.21 110.274 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.15 92.19 6.25 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.663 -0.495 . . . . 72.22 109.663 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.403 ' HB2' HG13 ' A' ' 99' ' ' VAL . . . -48.43 114.1 0.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 123.768 0.668 . . . . 34.14 111.334 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 39.9 p -101.89 140.21 20.99 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 121.209 0.528 . . . . 74.51 110.407 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.455 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 58.1 Cg_endo -68.63 162.52 40.68 Favored 'Trans proline' 0 C--N 1.331 -0.364 0 C-N-CA 123.713 2.942 . . . . 52.35 113.342 -174.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 142.08 -167.05 26.16 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.797 -0.638 . . . . 45.35 111.731 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.88 114.03 4.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 72.43 110.894 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.484 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . . . -112.77 49.85 0.91 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.441 0.639 . . . . 71.44 110.806 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.52 ' O ' ' HG2' ' A' ' 89' ' ' GLN . 89.1 m-20 -105.79 147.53 28.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.368 -0.833 . . . . 54.3 109.411 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.55 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -148.82 169.24 20.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.717 0.294 . . . . 71.13 111.083 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -140.16 147.73 40.57 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.528 -0.545 . . . . 42.54 109.528 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.19 144.46 21.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.992 0.425 . . . . 73.12 111.346 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 13' ' ' LYS . 22.7 p -103.11 123.98 47.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.83 -0.623 . . . . 64.32 109.756 175.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.443 ' CD1' HD13 ' A' ' 56' ' ' ILE . 39.5 p90 -97.21 124.11 41.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.255 0.55 . . . . 62.24 110.654 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.634 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.1 tmmm? -107.31 104.23 13.79 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.782 -0.645 . . . . 65.44 109.87 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 71' ' ' VAL . 1.3 m -75.55 147.95 7.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.026 0.441 . . . . 63.31 110.046 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -133.51 129.39 37.07 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.232 -0.655 . . . . 73.43 109.232 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.617 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -136.47 -18.68 1.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.042 0.449 . . . . 73.4 110.989 175.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--O 1.245 0.847 0 N-CA-C 109.034 -0.728 . . . . 75.33 109.034 169.188 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.64 0.257 . . . . 44.42 110.361 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.45 -173.69 0.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 35.24 111.023 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.519 HG23 HG23 ' A' ' 4' ' ' THR . 8.9 t -79.87 -32.84 40.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.036 0.446 . . . . 75.32 111.411 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.519 HG23 HG23 ' A' ' 3' ' ' THR . 52.2 p -104.84 -175.62 2.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.905 0.383 . . . . 64.42 110.563 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.35 15.64 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.104 0.478 . . . . 75.22 110.526 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m120 65.09 11.97 7.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.186 -0.915 . . . . 34.35 112.348 171.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.484 ' N ' ' HG2' ' A' ' 36' ' ' GLN . . . 87.8 98.25 0.91 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.441 -0.885 . . . . 53.43 111.537 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.68 153.06 22.91 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.191 -1.004 . . . . 52.42 112.046 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.658 ' HB ' HG22 ' A' ' 31' ' ' THR . 75.0 p -137.05 140.47 42.07 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.857 -0.423 . . . . 74.21 109.857 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -110.85 118.82 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 109.7 -0.481 . . . . 71.4 109.7 176.651 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 13.1 t-80 -85.88 106.52 17.15 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.987 0.422 . . . . 52.01 110.005 177.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 77.8 m-85 -94.64 114.43 26.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.968 -0.56 . . . . 72.35 110.313 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 62.9 tttp -109.54 132.73 53.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.678 -0.692 . . . . 54.13 110.179 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.94 -114.64 3.01 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.89 -0.672 . . . . 41.3 112.073 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.672 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 37.4 mt-10 63.94 17.14 10.38 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.006 0.432 . . . . 75.12 111.236 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 155' ' ' LYS . 18.4 m -75.19 -30.88 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.905 -0.589 . . . . 72.33 111.92 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.453 HG21 ' CG2' ' A' ' 156' ' ' VAL . 29.6 m -140.16 154.7 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.246 0.546 . . . . 71.24 111.921 -174.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -155.29 28.61 0.4 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.026 -1.101 . . . . 70.12 108.026 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.43 -78.04 0.32 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.252 -0.886 . . . . 64.3 111.523 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.508 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -83.9 -37.63 22.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.124 0.487 . . . . 71.34 110.585 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.8 m -142.87 131.53 22.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.759 -0.655 . . . . 74.44 109.567 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.63 124.45 35.07 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.177 -0.465 . . . . 73.1 110.307 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.471 ' HA ' HD23 ' A' ' 58' ' ' LEU . 6.0 t -66.13 124.69 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.244 -0.651 . . . . 63.33 109.244 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' HG13 ' A' ' 28' ' ' VAL . 16.5 t70 -56.89 139.84 50.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 71.35 111.206 -175.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -59.72 -24.44 63.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 74.12 112.146 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.68 -17.55 70.35 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.555 -0.831 . . . . 60.04 111.915 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 p -104.98 -13.28 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.723 0.268 . . . . 65.03 111.723 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.672 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 34.7 m -78.68 -10.59 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.039 0.447 . . . . 63.03 110.623 177.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -152.68 90.43 1.48 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.415 -0.811 . . . . 73.02 108.882 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -142.99 115.96 8.83 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.517 0.675 . . . . 62.53 110.726 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.658 HG22 ' HB ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -97.1 97.02 8.86 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.277 -0.874 . . . . 54.22 108.96 176.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 9' ' ' THR . 8.8 p -75.63 132.3 33.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.938 0.399 . . . . 74.14 110.987 -175.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.56 ' HA ' HG22 ' A' ' 9' ' ' THR . 27.3 mp0 -87.82 125.76 34.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.103 -0.499 . . . . 73.34 110.107 177.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.409 HD21 HG23 ' A' ' 10' ' ' VAL . 2.9 mm? -90.59 -32.63 16.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.963 -0.562 . . . . 65.21 109.886 177.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 99.5 168.58 30.08 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.363 -0.835 . . . . 74.24 111.599 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.484 ' HG2' ' N ' ' A' ' 7' ' ' GLY . 77.4 mt-30 -74.35 86.37 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.159 0.479 . . . . 74.25 110.598 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.24 149.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 110.043 -0.355 . . . . 61.23 110.043 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -84.53 128.71 34.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.301 -0.409 . . . . 64.01 110.345 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p -68.32 -23.32 64.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.874 -0.603 . . . . 65.34 111.526 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.48 -18.35 62.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.027 -0.533 . . . . 74.12 111.496 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 m -90.3 -0.68 57.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.381 . . . . 73.53 111.276 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 3.6 mt -134.09 43.57 2.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.319 0.58 . . . . 73.3 110.285 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.36 8.41 33.63 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.667 0.617 . . . . 54.51 112.667 -168.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -150.51 144.76 25.56 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.347 -0.242 . . . . 74.32 110.347 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 86.0 tt0 -59.4 123.17 15.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.101 0.477 . . . . 62.44 110.018 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.5 -9.77 30.58 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.823 -0.703 . . . . 30.43 111.503 -175.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 42' ' ' LEU . . . -71.2 121.86 19.13 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.641 -0.503 . . . . 71.45 109.641 173.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.424 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 25.4 p -117.0 137.0 52.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.159 0.504 . . . . 72.51 111.182 -178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.462 ' HB2' ' H ' ' A' ' 137' ' ' TYR . 64.0 m -85.63 164.45 17.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.775 -0.648 . . . . 75.22 110.689 176.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.7 m -63.99 124.46 21.64 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.66 -0.496 . . . . 51.34 109.66 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.509 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -80.59 138.91 36.5 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.217 0.532 . . . . 72.11 111.489 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.2 m -78.49 148.07 6.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.107 -0.951 . . . . 62.33 109.358 170.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.42 90.46 0.69 Allowed Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.976 -0.631 . . . . 54.31 111.579 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -99.63 174.44 6.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.811 -0.44 . . . . 74.21 109.811 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.504 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 3.7 p-10 -138.06 142.78 40.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.325 0.583 . . . . 74.32 112.21 -170.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.495 HD12 ' CE2' ' A' ' 133' ' ' PHE . 73.5 mt -111.77 119.26 59.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.693 -0.855 . . . . 74.3 108.693 169.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -104.48 140.93 37.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.115 0.484 . . . . 74.32 111.238 -171.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 23' ' ' VAL . 55.1 mt -120.36 122.62 41.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.553 -0.748 . . . . 63.24 109.753 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -100.82 152.02 21.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.761 -0.654 . . . . 73.14 110.378 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 54.38 38.69 30.01 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.968 0.793 . . . . 74.41 110.827 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.28 129.41 34.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.946 -0.57 . . . . 73.34 110.266 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.413 ' OD1' ' HB2' ' A' ' 64' ' ' ASN . 15.7 t70 -111.29 133.95 53.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.565 . . . . 74.15 110.833 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -102.58 16.23 26.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.189 0.44 . . . . 62.4 112.189 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.413 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 93.7 m-20 -90.45 -35.46 15.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.298 0.571 . . . . 73.22 109.478 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.73 -31.5 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.521 -0.763 . . . . 72.41 111.153 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.6 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -118.85 173.11 7.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.646 0.26 . . . . 75.23 110.89 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 m -133.84 -58.94 0.86 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.223 -0.444 . . . . 74.42 111.614 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -134.71 136.62 42.86 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.258 -0.275 . . . . 74.43 110.258 -177.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.71 139.69 36.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.994 0.426 . . . . 75.44 110.594 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.4 122.75 10.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.711 -0.677 . . . . 62.24 109.418 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.661 HG12 HG12 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -96.53 147.07 6.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.068 0.461 . . . . 70.35 110.973 -175.298 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.49 127.09 53.67 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.733 -0.667 . . . . 71.54 109.466 173.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 83.8 m-85 -88.99 131.7 35.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.899 0.38 . . . . 74.3 110.294 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.4 tp -130.52 125.06 33.34 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.976 -0.556 . . . . 71.52 110.355 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.48 -131.95 1.3 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.647 -0.706 . . . . 70.53 111.545 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.1 m -121.34 131.06 53.97 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.177 -0.305 . . . . 74.4 110.177 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -82.46 142.09 32.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.592 -0.276 . . . . 74.51 110.847 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 tt -69.18 -26.53 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.012 0.434 . . . . 73.53 111.09 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -144.6 179.74 7.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.599 -0.519 . . . . 52.33 109.599 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.67 27.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.181 0.515 . . . . 75.43 109.745 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.37 -37.77 7.46 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.812 -0.709 . . . . 73.1 111.594 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -91.17 77.66 5.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.359 0.6 . . . . 70.44 110.163 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.446 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 9.2 p -94.53 6.17 49.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.28 -0.873 . . . . 52.44 111.586 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -111.8 2.34 17.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.207 0.527 . . . . 64.43 110.653 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 102' ' ' GLN . 47.9 t -113.65 125.98 71.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.775 -0.648 . . . . 53.11 109.73 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -68.64 135.92 52.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.648 0.261 . . . . 72.12 110.506 -178.338 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.47 149.89 34.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.086 -0.506 . . . . 74.01 110.376 177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.474 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.9 mm? -84.3 139.11 32.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.342 -0.39 . . . . 52.33 110.176 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.425 ' HG3' ' HA ' ' A' ' 150' ' ' ALA . 89.9 mt-30 -61.92 131.89 51.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.878 -0.601 . . . . 72.4 110.491 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.05 113.46 5.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.013 -0.54 . . . . 61.44 110.95 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.1 m -94.57 -4.27 48.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.957 -0.565 . . . . 53.42 110.994 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 61.33 25.76 15.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.844 -0.616 . . . . 73.41 111.335 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.19 -40.18 0.22 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.711 -0.677 . . . . 73.15 110.246 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.03 86.24 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.628 -0.796 . . . . 50.24 112.116 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.3 m -85.63 149.59 25.22 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.556 -0.535 . . . . 71.34 109.556 174.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.45 148.64 51.37 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.091 -0.337 . . . . 53.33 110.091 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.61 159.82 41.43 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.865 -0.334 . . . . 73.4 110.343 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 69.31 4.49 4.64 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.626 0.579 . . . . 73.51 110.586 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.474 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -146.8 151.62 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 115.279 -0.873 . . . . 74.52 109.035 173.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -153.67 -171.64 21.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.888 -0.885 . . . . 52.21 110.888 177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 10' ' ' VAL . 3.0 p -117.37 112.41 38.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.521 0.676 . . . . 74.11 110.516 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.507 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.5 pt20 -102.27 139.04 38.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.603 -0.726 . . . . 71.35 109.447 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.487 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.8 mp -101.35 117.29 46.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.899 0.38 . . . . 63.54 110.175 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 13.4 mt -86.44 144.81 27.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.622 -0.717 . . . . 54.23 109.37 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.4 p-10 -72.95 -168.24 0.46 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.759 -0.46 . . . . 54.44 109.759 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -64.03 -31.21 72.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.561 -0.29 . . . . 70.34 111.531 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.1 p -84.85 -29.96 24.88 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.829 -0.349 . . . . 70.43 111.218 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.32 34.68 1.0 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.324 -0.941 . . . . 71.52 113.246 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.39 130.61 56.25 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.96 -0.385 . . . . 51.25 109.96 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.56 119.1 14.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 62.31 110.417 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.1 mt -79.76 132.99 36.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.002 -0.544 . . . . 61.41 111.148 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.443 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 7.9 m -68.36 140.25 55.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.688 -0.687 . . . . 74.14 110.564 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 33.2 mt -85.01 42.95 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.09 -0.504 . . . . 40.34 111.203 -176.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -100.65 -3.03 31.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.006 0.432 . . . . 74.21 110.539 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.03 12.58 68.59 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.879 -0.6 . . . . 54.23 112.795 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.68 -14.45 5.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.749 0.309 . . . . 43.12 111.071 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.443 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 18.3 m -86.25 96.52 9.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.326 -0.397 . . . . 73.43 110.079 175.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -86.51 163.46 17.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.981 -0.554 . . . . 74.5 110.506 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.518 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 1.6 m -72.82 176.26 5.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.079 -0.51 . . . . 55.23 110.805 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.0 t -66.15 139.27 58.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.509 -0.552 . . . . 74.54 109.509 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -51.58 107.42 0.19 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.638 0.586 . . . . 75.43 111.387 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.5 m -93.01 106.24 18.22 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.316 -0.624 . . . . 51.05 109.316 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.55 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 26.5 m -57.36 128.58 37.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 53.33 111.163 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.33 149.86 23.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.723 -0.671 . . . . 72.21 110.918 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -126.61 158.64 35.78 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.871 -0.788 . . . . 62.4 108.871 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -62.33 117.73 6.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.855 0.36 . . . . 72.24 110.564 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 116.7 -134.77 11.53 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.47 -0.872 . . . . 62.13 112.733 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.8 m -86.76 128.61 35.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.94 0.4 . . . . 64.43 110.984 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -124.37 144.4 50.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.568 -0.53 . . . . 72.14 109.568 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 1.5 m -128.38 118.28 22.89 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.888 0.375 . . . . 74.51 110.582 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 11.2 mt -95.04 114.03 62.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.112 -0.699 . . . . 45.14 109.112 176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 2.1 Cg_endo -81.85 136.14 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.989 2.46 . . . . 71.1 112.554 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.495 ' CE2' HD12 ' A' ' 56' ' ' ILE . 76.3 m-85 -134.19 159.74 39.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.119 -0.492 . . . . 73.34 110.588 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.628 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 92.7 mt-30 -129.15 111.8 13.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.856 -0.611 . . . . 72.21 110.864 -175.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -101.64 124.54 47.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.473 -0.33 . . . . 75.11 110.358 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 4.7 ptp180 -138.13 160.09 40.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.37 -0.377 . . . . 75.35 110.536 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 69.0 m-85 -79.25 139.58 37.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.93 -0.577 . . . . 73.51 110.23 173.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -127.0 122.63 35.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.652 -0.704 . . . . 73.42 109.328 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -85.35 132.39 34.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.381 -0.372 . . . . 43.32 111.318 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.474 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 74.3 p -105.24 3.61 30.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.635 0.731 . . . . 64.32 109.19 176.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.73 -128.48 1.54 Allowed Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.798 -1.092 . . . . 54.2 110.838 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.24 96.16 10.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.098 -0.334 . . . . 75.41 110.098 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -43.75 109.56 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.721 0.638 . . . . 64.51 111.917 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 26.9 p -102.48 139.35 20.13 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 121.271 0.558 . . . . 64.32 110.407 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.24 -179.84 2.49 Favored 'Trans proline' 0 C--N 1.332 -0.299 0 C-N-CA 124.021 3.147 . . . . 71.33 113.421 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.46 -139.34 10.7 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.408 -0.814 . . . . 55.12 111.83 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.85 117.46 33.88 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.16 -0.311 . . . . 64.41 110.16 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -111.77 60.38 0.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.033 0.444 . . . . 51.5 111.565 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -106.98 145.82 31.82 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.412 -0.588 . . . . 63.14 109.412 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -148.61 168.01 23.94 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.347 -0.242 . . . . 74.35 110.347 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -147.7 146.19 29.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.119 -0.326 . . . . 64.34 110.119 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -153.2 149.3 27.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.076 -0.511 . . . . 71.42 110.911 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.0 p -101.15 127.24 47.79 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.99 -0.55 . . . . 72.4 109.757 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -99.57 129.29 45.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.311 0.577 . . . . 74.54 110.359 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.581 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -112.52 107.34 16.04 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.636 -0.711 . . . . 74.54 110.145 -178.06 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.661 HG12 HG12 ' A' ' 71' ' ' VAL . 1.5 m -79.71 147.6 6.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.984 0.421 . . . . 70.2 110.315 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -130.16 124.97 33.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.417 -0.586 . . . . 62.14 109.417 173.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.6 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -139.5 -11.84 1.19 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.056 0.455 . . . . 75.13 111.045 176.259 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 . . . . . 0 C--O 1.247 0.968 0 CA-C-N 115.337 -0.847 . . . . 74.43 108.829 171.091 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 110.201 -0.296 . . . . 62.41 110.201 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.8 164.2 26.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.355 -0.384 . . . . 63.14 110.709 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.6 t -99.93 -19.92 16.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.135 0.493 . . . . 74.41 110.609 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.3 p -100.06 -179.94 4.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.019 0.438 . . . . 73.11 110.445 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.459 HG23 ' H ' ' A' ' 7' ' ' GLY . 35.6 m -83.83 6.61 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.006 0.431 . . . . 71.41 110.791 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 67.42 -3.46 1.06 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.352 -0.84 . . . . 64.35 112.648 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.459 ' H ' HG23 ' A' ' 5' ' ' VAL . . . 116.17 95.56 1.94 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.938 -0.649 . . . . 74.43 111.738 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.477 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -77.1 154.86 43.52 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.48 -0.867 . . . . 50.25 111.831 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.6 p -146.07 125.89 13.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.714 0.292 . . . . 73.44 110.862 -177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -105.19 122.35 58.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.369 -0.604 . . . . 60.11 109.369 176.035 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -90.23 99.28 12.33 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.379 -0.529 . . . . 73.41 110.049 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -90.86 117.14 29.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.605 -0.725 . . . . 71.2 110.023 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -110.76 136.91 49.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.04 0.448 . . . . 62.14 110.255 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.75 -126.25 5.58 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.768 -0.651 . . . . 44.44 111.82 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 29.3 mt-10 66.52 14.73 9.86 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.462 0.648 . . . . 73.42 110.526 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' A' ' 155' ' ' LYS . 29.7 m -76.29 -24.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.366 -0.834 . . . . 75.01 111.856 -175.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.517 HG21 HG22 ' A' ' 156' ' ' VAL . 19.1 m -139.08 142.27 34.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.271 0.558 . . . . 74.15 111.884 -175.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -142.62 18.72 2.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.804 -1.089 . . . . 73.44 108.239 173.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.51 -77.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.171 -0.922 . . . . 60.43 111.426 -172.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.522 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -92.47 -37.07 12.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.941 0.401 . . . . 64.12 110.258 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.34 132.09 25.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.245 -0.434 . . . . 72.24 110.303 -175.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.86 127.41 39.6 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.986 -0.552 . . . . 71.31 109.738 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.433 ' HB ' HG12 ' A' ' 28' ' ' VAL . 13.0 t -64.12 132.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.406 -0.361 . . . . 73.31 110.316 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.457 ' O ' HG13 ' A' ' 28' ' ' VAL . 19.2 t70 -57.27 139.34 53.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.938 -0.574 . . . . 73.11 110.682 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -64.02 -19.67 65.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.175 0.435 . . . . 72.32 112.175 -173.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.07 -18.53 74.47 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.394 -0.908 . . . . 74.52 111.937 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 p -110.63 -6.07 14.92 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.235 0.458 . . . . 65.54 112.235 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 25' ' ' ALA . 35.5 m -81.97 -7.29 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.912 0.387 . . . . 73.35 110.893 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -157.94 95.83 1.43 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.909 -0.774 . . . . 74.41 108.909 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -142.24 112.12 6.85 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.862 -0.608 . . . . 73.33 110.567 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.49 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.1 m -92.91 93.7 8.53 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.861 -0.792 . . . . 75.44 108.861 175.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' THR . 8.3 p -80.66 128.93 38.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.968 -0.56 . . . . 64.45 111.07 -172.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -86.62 120.99 28.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.886 -0.597 . . . . 74.12 109.685 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.44 -20.34 40.54 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.453 -0.573 . . . . 72.42 109.453 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.13 -178.72 42.07 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.203 -0.908 . . . . 73.51 111.669 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.92 90.37 6.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.615 -0.513 . . . . 61.23 109.615 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.446 HG12 HG22 ' A' ' 5' ' ' VAL . 11.8 p -64.64 136.24 26.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 61.13 110.688 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 38' ' ' ARG . 67.2 mtt180 -66.91 108.25 2.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.485 -0.779 . . . . 73.31 109.741 175.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 22.9 p -67.29 -23.63 65.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.197 0.522 . . . . 64.51 110.281 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.01 -5.77 47.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.758 -0.655 . . . . 73.15 111.389 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.9 m -97.79 -4.49 36.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 73.14 110.841 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -131.07 101.54 5.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.516 . . . . 63.23 109.755 177.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.18 15.97 5.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.244 0.461 . . . . 73.24 112.244 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.92 147.39 26.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.801 0.334 . . . . 62.43 110.983 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -58.6 123.03 14.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.664 -0.698 . . . . 75.11 109.472 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.464 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 101.97 8.48 44.91 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.512 -0.852 . . . . 73.12 111.965 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.697 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -79.9 128.28 33.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.065 -0.346 . . . . 75.14 110.065 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 p -115.79 118.92 34.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.917 -0.583 . . . . 63.22 110.378 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.1 t -83.68 173.59 11.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.86 0.362 . . . . 41.13 110.256 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.2 m -69.21 129.29 39.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.853 -0.612 . . . . 53.43 110.093 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -82.22 165.19 20.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.745 0.783 . . . . 74.43 112.071 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.9 m -101.39 157.62 4.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.458 -1.246 . . . . 64.24 109.22 169.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.5 107.49 2.27 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.829 -0.701 . . . . 65.55 112.059 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -125.07 178.61 5.45 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.749 -0.463 . . . . 64.3 109.749 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.494 ' HB2' HG22 ' A' ' 130' ' ' THR . 30.2 p30 -137.26 156.99 47.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.46 0.648 . . . . 72.21 111.99 -174.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.487 HD13 ' CD1' ' A' ' 154' ' ' PHE . 65.3 mt -123.51 105.37 15.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 107.956 -1.127 . . . . 72.43 107.956 167.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 26.1 tt0 -99.05 143.29 29.49 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.939 -0.573 . . . . 64.13 110.72 -171.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 23' ' ' VAL . 41.5 mt -117.96 125.46 50.46 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.056 -0.52 . . . . 73.34 109.847 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -100.51 143.1 31.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.045 -0.525 . . . . 73.31 110.107 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 52.9 46.96 25.72 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.834 0.708 . . . . 63.1 110.926 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 44.5 t -79.26 139.92 37.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.114 -0.948 . . . . 64.11 110.812 -175.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 64' ' ' ASN . 26.6 t70 -108.89 151.47 26.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.045 -0.525 . . . . 61.44 111.592 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 75.6 p -122.92 11.88 9.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.464 -0.334 . . . . 73.44 111.66 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.408 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 56.3 m-80 -81.44 -35.32 30.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.449 -0.574 . . . . 71.0 109.449 177.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.39 -27.9 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.531 -0.759 . . . . 75.35 110.805 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -112.05 166.41 11.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.045 0.45 . . . . 73.1 111.675 -176.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 m -132.7 -56.37 0.94 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.101 -0.5 . . . . 65.25 110.994 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.835 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -136.59 131.06 33.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.458 -0.337 . . . . 73.14 110.194 -177.048 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 158' ' ' TYR . . . -88.38 139.67 30.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.848 0.356 . . . . 32.23 110.707 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -143.88 114.36 7.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.645 -0.707 . . . . 52.32 109.672 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.612 HG12 HG12 ' A' ' 156' ' ' VAL . 0.8 OUTLIER -93.48 143.28 11.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.967 0.413 . . . . 63.22 110.563 -175.473 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.511 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -118.6 125.73 50.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.01 -0.541 . . . . 61.12 110.26 175.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 86.4 m-85 -91.73 122.67 34.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 72.13 110.319 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.3 tp -118.9 133.25 55.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.009 -0.542 . . . . 75.23 110.066 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.91 -174.48 41.6 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.237 -0.745 . . . . 53.23 111.237 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.8 m -75.99 128.0 34.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.803 0.302 . . . . 70.15 111.103 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -82.49 140.67 33.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.773 0.321 . . . . 53.34 110.648 177.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.503 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 11.6 tt -70.58 -27.02 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.382 -0.372 . . . . 75.11 111.458 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.56 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 20.1 t70 -141.26 179.29 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.717 -0.475 . . . . 72.55 109.717 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.94 -33.7 26.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.078 0.466 . . . . 71.11 109.774 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.58 -28.26 13.07 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.8 -0.714 . . . . 72.3 111.651 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 77.0 m80 -92.65 69.25 4.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.421 0.629 . . . . 62.42 109.554 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.471 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 4.1 p -91.26 7.99 38.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.277 -0.874 . . . . 74.21 111.201 -178.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -110.0 4.1 21.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.947 -0.569 . . . . 74.14 110.22 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 102' ' ' GLN . 58.7 t -120.04 126.38 75.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 72.4 110.141 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.539 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -70.72 133.63 46.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.656 0.265 . . . . 73.51 110.361 -178.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -79.56 155.71 28.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.004 -0.543 . . . . 72.32 110.394 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.514 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.6 mm? -81.84 148.37 28.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.293 -0.412 . . . . 75.3 110.106 -175.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -74.78 147.38 41.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.272 -0.422 . . . . 70.55 110.294 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.6 p -90.49 105.29 17.72 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.057 0.456 . . . . 65.12 111.027 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.3 m -101.42 2.3 39.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.07 -0.514 . . . . 55.23 110.621 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 63.22 21.74 12.99 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.763 -0.653 . . . . 74.12 110.952 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.76 1.94 11.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.842 -0.617 . . . . 72.15 110.414 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.39 89.32 1.99 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.779 -0.724 . . . . 64.24 111.675 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.0 m -79.96 157.53 26.83 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.633 0.254 . . . . 75.43 110.48 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.26 49.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 60.22 110.816 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.14 152.92 47.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.481 -0.327 . . . . 42.22 110.702 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.413 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 42.5 m-80 68.26 7.47 5.94 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.803 -0.635 . . . . 75.14 111.919 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.514 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -147.6 151.98 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 CA-C-O 120.978 0.418 . . . . 73.3 110.758 176.082 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -151.22 -171.29 19.1 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 110.277 -1.129 . . . . 65.51 110.277 174.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 10' ' ' VAL . 2.7 p -117.1 118.81 59.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.378 0.609 . . . . 75.53 110.965 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.456 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.0 pt20 -110.46 147.09 34.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.66 -0.7 . . . . 75.01 109.793 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.3 mp -107.44 127.87 62.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.987 0.422 . . . . 73.13 110.804 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.2 mt -91.47 142.8 27.26 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.559 -0.746 . . . . 73.45 109.116 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.557 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.9 OUTLIER -75.14 -170.42 1.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.508 -0.314 . . . . 72.32 110.167 178.282 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.5 ptt85 -62.96 -24.8 68.06 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.604 0.224 . . . . 72.04 111.604 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.423 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 69.9 p -93.49 1.06 56.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 74.1 111.391 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.68 29.47 29.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.879 -0.676 . . . . 74.11 112.996 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.8 130.23 55.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.237 -0.283 . . . . 74.33 110.237 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.73 128.55 36.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.897 0.38 . . . . 63.02 111.034 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.45 148.95 23.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.956 -0.565 . . . . 65.24 110.785 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.5 m -85.66 141.9 29.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 74.45 110.251 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 63.4 mt -79.23 42.16 0.48 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.168 0.509 . . . . 73.21 110.683 -178.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.449 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 16.6 t70 -85.37 -18.72 32.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.817 -0.628 . . . . 74.52 110.936 -176.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.74 -24.77 7.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.584 -0.817 . . . . 71.25 112.454 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.2 7.5 19.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.006 0.431 . . . . 73.13 110.563 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 114' ' ' ASP . 15.8 m -93.7 97.29 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 72.42 109.853 175.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.57 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 58.3 m-85 -92.79 162.7 14.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.122 -0.49 . . . . 75.35 111.005 -174.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 5.6 m -72.97 176.35 5.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 64.35 111.314 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.9 m -65.05 131.47 46.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.231 -0.441 . . . . 62.44 110.191 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -44.25 115.48 0.85 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.027 0.829 . . . . 52.41 111.944 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.6 m -102.25 105.27 15.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.137 -0.483 . . . . 71.33 109.965 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.835 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 59.9 m -60.58 115.83 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.48 0.657 . . . . 72.4 111.361 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.539 HD13 ' SG ' ' A' ' 61' ' ' CYS . 96.0 mt -83.22 155.63 23.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.19 -0.913 . . . . 64.22 112.097 -173.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.38 153.3 50.92 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.668 -0.864 . . . . 73.43 108.668 170.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.9 m120 -63.82 112.35 2.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.956 0.408 . . . . 72.33 110.762 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.1 -137.66 9.29 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.934 -0.651 . . . . 62.53 112.046 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.7 m -93.61 126.96 39.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.71 0.291 . . . . 62.12 110.889 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -129.8 120.79 25.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.721 -0.474 . . . . 74.13 109.721 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.494 HG22 ' HB2' ' A' ' 55' ' ' ASN . 2.3 m -110.44 117.52 33.79 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.626 0.251 . . . . 74.33 110.468 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.5 mt -95.48 113.9 62.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.597 -0.52 . . . . 72.04 109.597 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.78 138.55 13.39 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.09 2.527 . . . . 72.22 112.667 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 86.5 m-85 -135.9 161.09 36.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 74.44 110.887 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.572 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 52.2 mt-30 -133.04 118.24 18.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.655 . . . . 73.01 110.751 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.37 126.7 50.67 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.318 -0.239 . . . . 55.02 110.44 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.525 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -134.44 164.99 26.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.802 0.334 . . . . 45.4 111.048 -178.021 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.477 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 63.1 m-85 -85.46 142.2 29.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.997 -0.547 . . . . 73.1 110.466 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.464 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 61.1 t80 -126.83 124.11 38.88 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.895 -0.78 . . . . 74.21 108.895 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.697 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -91.19 135.99 33.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.12 0.486 . . . . 71.31 111.572 -176.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.413 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 78.7 p -100.36 1.27 41.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.296 -0.865 . . . . 71.32 108.909 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.11 -128.77 1.7 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.553 -1.203 . . . . 71.15 111.059 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -87.55 95.71 10.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.184 -0.302 . . . . 72.01 110.184 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -46.52 112.05 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.847 -0.615 . . . . 71.14 111.587 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.2 p -107.61 149.51 38.98 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-O 121.003 0.43 . . . . 73.33 110.736 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.5 163.99 25.08 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.85 3.034 . . . . 72.0 113.239 -176.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.91 179.99 18.34 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.672 -0.694 . . . . 64.52 111.975 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.07 119.85 10.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.789 0.328 . . . . 64.14 110.707 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.01 42.64 2.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.649 0.738 . . . . 75.14 110.411 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -98.72 145.13 27.22 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.036 -0.984 . . . . 72.32 110.078 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.539 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -147.45 164.89 31.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.917 0.389 . . . . 63.24 111.322 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -123.05 133.31 54.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.321 -0.622 . . . . 72.41 109.321 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.22 128.94 14.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.932 0.396 . . . . 70.14 111.108 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.0 p -102.53 129.71 49.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.132 -0.485 . . . . 74.03 110.265 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.487 ' CD1' HD13 ' A' ' 56' ' ' ILE . 47.3 p90 -103.45 127.26 50.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.958 0.409 . . . . 73.13 110.706 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.62 ' HA ' HG21 ' A' ' 16' ' ' VAL . 6.9 ttmm -110.14 108.7 18.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.259 -0.428 . . . . 71.41 110.331 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.612 HG12 HG12 ' A' ' 71' ' ' VAL . 1.5 m -80.62 129.7 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.447 -0.575 . . . . 73.33 109.447 174.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -123.02 115.19 21.45 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.143 -0.688 . . . . 60.45 109.143 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.644 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -115.08 -11.16 12.11 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.392 0.515 . . . . 75.22 112.392 -177.534 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.444 HE21 ' HB2' ' A' ' 159' ' ' GLN . 1.3 mp0 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.534 -0.746 . . . . 71.12 109.232 170.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 120.95 0.405 . . . . 71.52 110.748 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.04 143.13 48.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.096 -0.502 . . . . 74.11 109.953 175.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.575 HG23 HG23 ' A' ' 4' ' ' THR . 10.0 t -96.12 -23.12 16.91 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.289 -0.414 . . . . 64.53 110.963 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.575 HG23 HG23 ' A' ' 3' ' ' THR . 62.4 p -111.68 -174.01 2.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 65.22 110.422 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.523 HG22 HG12 ' A' ' 37' ' ' VAL . 34.8 m -91.31 17.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.013 0.435 . . . . 64.55 110.563 175.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 59.96 20.15 9.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.325 -0.852 . . . . 64.1 111.999 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.12 101.57 1.02 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.718 -0.753 . . . . 34.11 111.712 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.46 151.69 31.39 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.035 -1.078 . . . . 71.44 111.348 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.525 ' HB ' HG22 ' A' ' 31' ' ' THR . 17.4 p -141.47 135.64 30.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.55 0.214 . . . . 54.01 110.913 -176.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.45 ' CG2' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -117.49 115.89 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.566 -0.531 . . . . 65.14 109.566 174.21 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 18.1 t-80 -83.04 108.76 16.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.286 -0.415 . . . . 70.23 109.928 177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -100.03 113.78 26.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.125 -0.489 . . . . 73.14 110.302 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -106.12 135.02 48.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.867 -0.42 . . . . 42.35 109.867 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.01 -125.91 5.7 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.962 -0.637 . . . . 31.33 111.888 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 67.6 12.95 9.12 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.886 0.474 . . . . 71.11 110.93 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.569 HG23 HG13 ' A' ' 17' ' ' VAL . 34.2 m -76.38 -30.66 19.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.063 -0.517 . . . . 65.13 111.859 -173.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.569 HG13 HG23 ' A' ' 16' ' ' VAL . 24.9 m -133.75 145.46 33.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.299 0.571 . . . . 70.02 111.468 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -151.68 30.41 0.59 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.933 -1.136 . . . . 61.43 107.933 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.66 -79.26 0.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.227 -0.897 . . . . 75.53 111.214 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -90.68 -34.87 15.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.969 0.414 . . . . 53.31 110.602 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.2 m -140.78 136.31 32.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.485 . . . . 51.45 109.75 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.31 130.45 47.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.357 -0.383 . . . . 60.11 110.304 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 58' ' ' LEU . 20.7 t -67.69 130.93 33.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.964 -0.384 . . . . 60.4 109.964 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 28' ' ' VAL . 15.3 t70 -61.66 141.11 58.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.36 -0.382 . . . . 71.54 110.72 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.81 -26.99 64.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 34.12 111.798 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.84 2.67 79.02 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.792 -0.718 . . . . 75.24 112.302 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.3 p -131.89 3.05 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.593 0.235 . . . . 64.43 111.521 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 24' ' ' ASP . 35.2 m -89.4 -1.32 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.873 0.368 . . . . 62.21 110.687 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -158.72 97.58 1.45 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.085 -0.709 . . . . 73.41 109.085 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -144.6 104.01 4.0 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.483 0.658 . . . . 74.13 111.041 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.525 HG22 ' HB ' ' A' ' 9' ' ' THR . 5.8 m -81.59 94.48 6.92 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.389 -0.823 . . . . 72.24 109.096 173.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.42 140.33 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.122 -0.49 . . . . 75.14 111.043 -172.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -96.58 117.82 31.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 71.44 110.095 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.45 HD21 ' CG2' ' A' ' 10' ' ' VAL . 1.7 mm? -87.98 -23.85 23.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.444 -0.576 . . . . 74.41 109.444 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.29 166.96 32.67 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.317 -0.856 . . . . 55.22 112.618 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -73.21 94.46 1.98 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.907 -0.405 . . . . 75.21 109.907 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.523 HG12 HG22 ' A' ' 5' ' ' VAL . 9.5 p -75.54 145.24 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.19 -0.459 . . . . 54.4 110.858 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -76.47 117.56 18.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.788 -0.642 . . . . 71.34 110.562 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 29.9 p -72.67 -16.28 61.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 65.41 110.99 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.0 -16.52 54.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 71.5 110.909 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.4 m -83.23 -44.34 15.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.167 -0.47 . . . . 72.23 110.263 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 6.2 mp -93.83 95.85 9.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.18 0.514 . . . . 62.21 110.306 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.47 22.26 5.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.326 0.584 . . . . 71.3 110.379 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.431 ' HG2' ' HB2' ' A' ' 47' ' ' ALA . 3.6 pm0 -151.66 137.96 18.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.311 -0.859 . . . . 54.12 110.233 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 40.8 tt0 -62.26 123.62 18.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.978 0.418 . . . . 60.33 110.117 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.67 -13.35 27.46 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.27 -0.732 . . . . 55.32 111.27 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -63.95 121.89 15.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.67 0.272 . . . . 72.35 110.281 176.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 25.4 p -123.75 118.62 27.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.34 -0.391 . . . . 73.42 110.724 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 t -75.8 173.72 10.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.1 -0.5 . . . . 64.43 110.172 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.8 m -64.41 135.79 56.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.107 0.48 . . . . 74.2 110.446 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -85.6 159.37 19.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.733 -0.667 . . . . 44.32 111.771 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.6 m -90.48 158.41 2.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.898 -1.047 . . . . 71.1 108.991 168.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.55 81.13 0.31 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.446 -0.883 . . . . 71.34 112.237 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -95.95 165.33 12.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.989 -0.374 . . . . 75.43 109.989 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.587 ' HB2' HG22 ' A' ' 130' ' ' THR . 2.4 p-10 -138.12 144.66 40.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.38 0.609 . . . . 75.54 111.517 -175.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.409 HD13 ' CD2' ' A' ' 154' ' ' PHE . 79.7 mt -105.53 120.25 55.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.34 -0.846 . . . . 72.32 109.383 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -98.15 136.98 37.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.98 0.419 . . . . 75.41 110.643 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 23' ' ' VAL . 50.8 mt -119.04 130.75 55.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 74.54 109.597 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -108.15 144.84 35.02 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.243 -0.435 . . . . 72.34 110.395 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 53.39 46.38 26.41 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.868 0.73 . . . . 52.21 111.225 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.487 ' SG ' HD13 ' A' ' 124' ' ' LEU . 27.5 t -81.34 131.89 35.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.461 -0.791 . . . . 64.54 110.074 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.431 ' OD2' HG12 ' A' ' 65' ' ' VAL . 16.3 t70 -107.68 134.01 51.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.243 -0.435 . . . . 74.32 111.646 -175.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.1 p -104.67 13.77 30.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 73.15 112.064 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -89.07 -35.39 16.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.905 -0.406 . . . . 71.33 109.905 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.431 HG12 ' OD2' ' A' ' 62' ' ' ASP . 14.0 p -97.26 -28.31 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.975 -0.557 . . . . 74.14 111.044 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -121.1 -177.59 3.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.493 -0.322 . . . . 52.22 110.953 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.2 m -140.75 -54.89 0.5 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.644 0.259 . . . . 73.23 111.454 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.81 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -134.56 140.95 46.5 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.318 -0.239 . . . . 72.15 110.843 -178.648 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.52 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -102.59 135.4 44.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.101 0.477 . . . . 62.03 110.557 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.9 114.92 7.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.759 -0.655 . . . . 31.52 109.576 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.666 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -85.32 149.33 4.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.142 0.496 . . . . 75.31 110.895 -174.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.74 118.33 29.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.54 -0.755 . . . . 74.41 109.211 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 75.2 m-85 -83.16 128.98 34.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.027 0.441 . . . . 55.04 110.498 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.7 tp -128.22 127.44 42.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.008 -0.542 . . . . 55.23 109.804 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.47 -167.94 25.79 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.965 -0.854 . . . . 70.35 110.965 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.437 ' O ' HD13 ' A' ' 86' ' ' LEU . 9.5 m -74.29 120.85 20.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.102 0.451 . . . . 64.11 110.622 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.59 136.17 36.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.592 0.234 . . . . 72.22 110.817 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.496 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 10.9 tt -65.16 -30.6 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.29 -0.414 . . . . 72.23 111.213 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 19.9 t70 -151.3 173.21 14.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.478 -0.564 . . . . 71.2 109.478 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.59 -30.78 52.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.059 -0.519 . . . . 73.4 110.301 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.12 -20.26 28.47 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.842 -0.694 . . . . 54.1 111.711 177.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 65.1 m80 -103.5 47.85 0.87 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.382 -0.599 . . . . 55.54 109.382 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.495 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.4 p -72.81 9.63 1.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.572 -0.74 . . . . 51.32 112.331 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 16.7 p-10 -99.75 -18.6 17.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.784 0.326 . . . . 62.3 110.895 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.7 t -105.03 132.57 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.388 -0.369 . . . . 61.03 110.87 -176.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -67.29 135.18 52.94 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.21 -0.45 . . . . 72.41 110.519 179.18 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.83 146.78 33.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.964 -0.562 . . . . 60.32 109.684 175.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.2 mm? -85.7 129.87 34.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.333 -0.394 . . . . 65.15 110.77 -175.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -57.99 131.53 50.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.646 . . . . 71.04 109.493 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 m -85.69 125.0 32.85 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.623 -0.717 . . . . 71.31 111.654 -168.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.2 m -92.01 -10.14 40.3 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.665 -0.698 . . . . 72.51 109.779 175.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.75 -0.0 1.4 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.271 -0.877 . . . . 74.01 111.837 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.67 4.33 10.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.954 0.407 . . . . 63.14 111.169 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 133.61 67.45 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.477 -0.868 . . . . 75.25 112.787 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.412 ' HA ' ' H ' ' A' ' 147' ' ' ALA . 4.3 p -78.17 160.61 27.89 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.608 -0.516 . . . . 63.32 109.608 171.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.19 144.77 38.08 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.805 -0.443 . . . . 55.43 109.805 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.09 164.7 29.4 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.964 -0.384 . . . . 75.04 109.964 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.503 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 14.3 m120 69.03 8.11 6.64 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.347 0.594 . . . . 53.12 110.12 -177.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -178.23 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.023 -0.99 . . . . 73.34 109.628 173.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 175.25 -172.07 45.14 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 110.268 -1.133 . . . . 73.45 110.268 177.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 2.5 p -126.13 120.06 55.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.096 0.474 . . . . 54.32 110.409 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.441 ' OE1' ' HB1' ' A' ' 110' ' ' ALA . 25.9 pt20 -117.14 149.51 40.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.52 -0.548 . . . . 71.35 109.52 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.3 mp -101.02 128.2 53.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.089 -0.505 . . . . 71.41 110.598 -174.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 16.3 mt -94.1 146.0 24.28 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.367 -0.833 . . . . 74.21 108.917 175.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.572 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.4 OUTLIER -72.39 -173.21 1.07 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.825 -0.435 . . . . 63.1 109.825 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.427 ' HE ' ' CB ' ' A' ' 120' ' ' SER . 24.1 ptt180 -58.31 -32.49 68.52 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.556 0.206 . . . . 71.52 111.556 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.408 HG23 ' HG3' ' A' ' 106' ' ' ARG . 40.3 p -89.28 0.32 56.88 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.817 0.341 . . . . 72.14 111.793 -177.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.04 29.95 24.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 62.22 113.07 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . -102.78 134.35 46.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.364 -0.236 . . . . 72.34 110.364 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.51 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -67.05 122.76 18.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.998 0.428 . . . . 72.32 111.323 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.6 mt -90.56 148.4 22.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.026 -0.534 . . . . 74.04 110.523 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.485 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 25.8 m -96.91 142.22 29.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.258 -0.428 . . . . 51.3 110.439 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 50.0 mt -83.95 51.55 2.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 74.24 110.857 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -109.72 -5.43 15.61 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.018 0.437 . . . . 73.12 110.046 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.26 2.29 62.46 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.745 -0.661 . . . . 71.14 112.95 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.66 -13.09 9.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 63.33 111.066 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.485 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 12.1 m -85.51 100.29 11.8 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.968 -0.382 . . . . 75.21 109.968 175.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.418 ' HE1' ' HE3' ' A' ' 155' ' ' LYS . 83.3 m-85 -90.17 154.7 19.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.945 -0.571 . . . . 65.23 111.185 -176.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.572 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 11.5 m -69.64 179.73 2.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.66 -0.7 . . . . 63.32 110.843 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.427 ' CB ' ' HE ' ' A' ' 106' ' ' ARG . 40.8 t -64.14 150.19 46.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.936 -0.394 . . . . 72.22 109.936 174.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -61.83 102.73 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 73.34 111.075 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -84.5 97.81 9.76 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.864 -0.791 . . . . 70.21 108.864 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.81 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 49.8 m -60.69 122.91 15.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.073 -0.512 . . . . 61.31 110.391 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 69' ' ' ALA . 97.0 mt -80.97 151.98 28.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.383 -0.826 . . . . 61.24 112.066 -170.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -116.78 159.51 22.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.142 -0.936 . . . . 73.2 109.37 170.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.35 108.0 6.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.129 0.49 . . . . 73.11 110.356 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.27 -135.91 9.55 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.739 -0.743 . . . . 72.44 112.339 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.1 m -83.84 126.09 32.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.165 0.507 . . . . 75.21 111.335 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -124.56 160.4 28.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.716 -0.675 . . . . 74.42 109.646 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.587 HG22 ' HB2' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -144.18 122.28 12.16 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.848 -0.341 . . . . 64.04 110.576 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 7.0 mt -102.98 113.43 65.91 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.984 -0.376 . . . . 63.34 109.984 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 1.8 Cg_endo -82.9 137.31 8.62 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 123.131 2.554 . . . . 62.1 112.399 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -134.66 163.17 30.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.028 0.442 . . . . 54.22 111.211 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 104' ' ' LEU . 99.3 mt-30 -127.89 112.91 15.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.871 -0.604 . . . . 74.51 111.217 -177.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.17 121.59 42.53 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.944 -0.303 . . . . 64.32 110.236 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.55 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 10.6 ptp180 -137.45 164.05 29.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.848 0.356 . . . . 75.12 110.857 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.425 ' CE2' ' HB ' ' A' ' 37' ' ' VAL . 87.4 m-85 -78.95 147.47 32.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.607 . . . . 72.53 111.007 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -131.81 122.14 25.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.673 -0.694 . . . . 74.1 109.529 176.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -91.32 139.36 30.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.902 0.382 . . . . 61.35 111.528 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 48.0 p -103.89 -0.73 28.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.536 0.684 . . . . 74.32 109.316 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.8 -127.57 1.48 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.05 -0.977 . . . . 72.31 111.111 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.83 93.92 6.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.359 -0.237 . . . . 74.23 110.359 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.412 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.32 116.75 1.84 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.384 0.428 . . . . 74.24 111.094 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.0 p -104.12 142.67 25.09 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-O 121.256 0.551 . . . . 75.0 110.898 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.25 165.53 28.35 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.581 2.854 . . . . 72.35 113.018 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 145.99 -140.2 8.72 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.605 -0.725 . . . . 65.32 111.869 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.412 ' H ' ' HA ' ' A' ' 95' ' ' SER . . . -107.3 117.01 32.95 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.412 0.149 . . . . 64.4 110.745 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -105.97 58.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.341 0.591 . . . . 70.41 111.141 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -99.1 140.5 33.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.971 -0.558 . . . . 63.24 109.592 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.484 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -153.01 165.08 36.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.583 0.23 . . . . 74.31 110.634 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -138.91 148.0 43.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.923 -0.399 . . . . 73.22 109.923 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.518 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -154.72 146.37 23.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.097 0.475 . . . . 73.35 110.951 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.1 p -108.87 127.93 54.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.043 -0.526 . . . . 62.54 110.034 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.409 ' CD2' HD13 ' A' ' 56' ' ' ILE . 46.6 p90 -96.64 123.5 40.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.006 0.432 . . . . 72.34 110.425 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.549 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.5 tmmm? -107.49 109.12 20.72 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.201 -0.454 . . . . 71.43 109.802 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.666 HG12 HG12 ' A' ' 71' ' ' VAL . 1.4 m -78.8 136.16 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.28 0.562 . . . . 75.53 110.619 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -114.45 118.14 32.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.871 -0.604 . . . . 61.34 110.067 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.571 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 1.5 p90 -134.21 -20.41 1.9 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.997 0.427 . . . . 75.23 110.15 171.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 . . . . . 0 C--O 1.25 1.101 0 CA-C-N 115.411 -0.813 . . . . 64.35 109.12 173.805 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.684 0.278 . . . . 71.4 110.319 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.24 -177.04 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.257 -0.428 . . . . 41.03 110.162 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.554 HG23 HG23 ' A' ' 4' ' ' THR . 8.7 t -102.61 -18.23 15.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.182 0.515 . . . . 75.1 110.476 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.554 HG23 HG23 ' A' ' 3' ' ' THR . 71.3 p -118.43 -179.91 3.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.057 -0.52 . . . . 54.22 110.573 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.529 HG22 HG12 ' A' ' 37' ' ' VAL . 34.4 m -91.25 16.02 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.983 0.421 . . . . 75.32 111.062 177.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 62.57 13.93 6.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.595 -0.73 . . . . 72.25 112.64 173.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.504 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 86.24 95.55 0.82 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.37 -0.919 . . . . 71.31 111.278 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.92 164.06 27.29 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.491 -0.862 . . . . 44.44 112.181 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.563 ' HB ' HG22 ' A' ' 31' ' ' THR . 63.2 p -140.85 147.74 39.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.683 0.278 . . . . 73.12 110.887 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.526 HG23 HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -112.81 123.46 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 N-CA-C 109.044 -0.725 . . . . 72.51 109.044 171.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -90.86 99.41 12.45 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.645 -0.502 . . . . 62.23 109.645 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 74.6 m-85 -88.89 117.57 27.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.781 -0.645 . . . . 65.42 110.213 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HB3' HG22 ' A' ' 153' ' ' THR . 80.1 tttt -110.12 139.35 45.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 74.03 110.736 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.88 -123.34 3.72 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.882 -0.599 . . . . 61.22 112.176 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.429 ' HG2' ' HB ' ' A' ' 28' ' ' VAL . 24.9 mm-40 60.44 19.71 9.4 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.695 0.398 . . . . 61.4 111.783 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.689 HG23 HG22 ' A' ' 17' ' ' VAL . 29.1 m -77.78 -28.79 15.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.35 -0.386 . . . . 52.33 111.581 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.689 HG22 HG23 ' A' ' 16' ' ' VAL . 7.7 m -148.04 153.05 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 53.15 110.84 -176.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -162.29 53.99 0.22 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.288 -1.005 . . . . 54.25 108.288 176.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -110.25 -72.88 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.709 -1.132 . . . . 65.13 110.274 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -76.87 -41.56 43.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.959 -0.564 . . . . 62.31 110.147 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -136.36 156.72 48.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.526 -0.546 . . . . 74.34 109.526 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.91 127.67 54.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.862 -0.421 . . . . 72.24 109.862 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.426 ' HA ' HD23 ' A' ' 58' ' ' LEU . 16.4 t -68.23 132.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.974 -0.38 . . . . 71.11 109.974 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' HG13 ' A' ' 28' ' ' VAL . 24.2 t70 -56.3 143.17 35.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 63.13 111.461 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.49 -25.09 67.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 51.34 112.143 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.73 -15.37 61.63 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.57 -0.824 . . . . 72.22 111.701 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 t -93.89 -24.94 17.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.755 -0.223 . . . . 71.34 110.804 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 24' ' ' ASP . 33.6 m -74.28 -6.92 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.829 0.347 . . . . 51.33 111.083 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -161.13 94.36 1.0 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.944 -0.761 . . . . 63.22 108.944 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.439 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 16.4 pt20 -137.95 114.9 10.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.396 0.617 . . . . 65.15 110.699 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.563 HG22 ' HB ' ' A' ' 9' ' ' THR . 5.2 m -95.91 93.8 7.24 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.205 -0.907 . . . . 63.41 109.752 177.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.23 140.08 17.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.748 -0.66 . . . . 63.1 111.164 -173.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -92.59 118.91 31.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 73.35 110.458 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.526 HD21 HG23 ' A' ' 10' ' ' VAL . 2.9 mm? -87.81 -30.26 20.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.223 0.535 . . . . 70.41 109.717 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.504 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.79 174.7 38.2 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.517 -0.765 . . . . 51.41 112.408 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.8 90.67 2.91 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.81 -0.23 . . . . 73.31 110.516 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.529 HG12 HG22 ' A' ' 5' ' ' VAL . 5.0 p -73.87 145.88 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.422 -0.584 . . . . 70.04 109.422 175.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -92.05 128.38 37.87 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.35 -0.386 . . . . 73.44 110.041 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.9 p -66.6 -24.34 66.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.02 -0.536 . . . . 74.44 111.721 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.78 -19.85 65.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.062 -0.517 . . . . 72.54 111.305 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -89.42 -0.58 57.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.126 -0.488 . . . . 72.15 111.21 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.637 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 6.8 mt -137.08 48.61 2.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.224 0.535 . . . . 64.43 110.487 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.84 16.93 16.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.136 -0.484 . . . . 63.4 112.136 -171.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 47' ' ' ALA . 4.0 pm0 -157.79 142.99 16.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.218 -0.447 . . . . 74.55 110.312 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 33.6 tt0 -59.28 123.56 17.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.942 0.401 . . . . 74.42 110.045 175.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.0 -15.58 21.02 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.206 -0.758 . . . . 64.52 111.206 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 42' ' ' LEU . . . -67.76 123.53 20.77 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.451 -0.574 . . . . 53.21 109.451 174.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.469 HG22 ' HD1' ' A' ' 138' ' ' PHE . 37.3 p -123.27 134.26 54.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.969 0.414 . . . . 73.43 110.94 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.1 t -84.43 176.37 8.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.924 -0.58 . . . . 75.55 109.611 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -68.77 133.43 48.34 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.853 -0.425 . . . . 64.52 109.853 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -88.77 152.69 21.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.599 0.714 . . . . 54.23 111.944 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 23.8 m -94.1 149.92 4.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.354 -1.294 . . . . 61.22 108.922 169.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.76 77.14 0.23 Allowed Glycine 0 C--N 1.311 -0.842 0 C-N-CA 120.988 -0.625 . . . . 61.1 112.255 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -81.77 167.98 18.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.984 -0.376 . . . . 61.05 109.984 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.558 ' HB2' HG22 ' A' ' 130' ' ' THR . 2.2 p-10 -138.05 138.44 38.8 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.998 0.427 . . . . 72.22 111.251 -175.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.405 HD13 ' CD1' ' A' ' 154' ' ' PHE . 59.5 mt -100.38 114.14 38.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.547 -0.751 . . . . 62.34 109.335 174.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -98.83 135.67 39.94 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.704 -0.68 . . . . 71.11 110.812 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 23' ' ' VAL . 70.0 mt -114.5 117.8 31.97 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.35 -0.611 . . . . 74.34 109.35 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -96.63 124.18 40.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.775 -0.648 . . . . 51.35 110.649 -175.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.7 t70 61.8 92.37 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.001 0.813 . . . . 50.52 111.122 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 48.4 t -128.6 152.83 47.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.794 -0.639 . . . . 64.21 110.627 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.414 ' HA ' ' ND2' ' A' ' 126' ' ' ASN . 18.3 t70 -116.85 142.13 47.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.873 -0.603 . . . . 74.3 110.978 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.0 p -106.08 14.08 28.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.04 0.385 . . . . 64.4 112.04 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -91.28 -31.17 16.22 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.382 -0.599 . . . . 75.24 109.382 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 20' ' ' ALA . 8.0 p -104.2 -3.79 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.549 -0.75 . . . . 65.51 111.369 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.578 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -146.57 178.83 7.99 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.319 -0.238 . . . . 63.42 110.89 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.42 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 49.4 m -143.56 -53.78 0.37 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.053 0.39 . . . . 54.34 112.053 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.726 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -137.82 141.81 40.81 Favored 'General case' 0 C--O 1.221 -0.406 0 O-C-N 122.216 -0.302 . . . . 71.35 110.437 -179.014 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.92 127.66 48.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.028 0.442 . . . . 74.55 110.594 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.72 116.18 11.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.821 -0.627 . . . . 74.04 109.729 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -90.65 146.4 6.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.963 0.411 . . . . 73.11 111.356 -173.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -119.57 123.06 43.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.736 -0.666 . . . . 62.31 109.513 171.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.56 ' CE1' HG21 ' A' ' 103' ' ' ILE . 55.3 m-85 -86.52 134.59 33.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.107 0.48 . . . . 74.34 110.959 -178.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.0 tp -131.18 129.1 41.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 74.11 110.3 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.23 -160.17 19.13 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.94 -0.864 . . . . 60.02 110.94 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.484 ' O ' HD13 ' A' ' 86' ' ' LEU . 26.3 m -88.05 130.48 34.98 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.258 -0.275 . . . . 62.01 110.258 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.421 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -85.61 144.55 27.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.268 -0.271 . . . . 62.44 110.268 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.512 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 15.3 tt -62.34 -28.18 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 74.42 111.382 -176.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -152.6 177.18 10.93 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.714 -0.476 . . . . 63.42 109.714 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.63 -27.72 34.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.191 -0.459 . . . . 65.03 110.215 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.51 -7.85 61.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.759 -0.734 . . . . 74.2 111.902 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -122.82 75.51 1.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.264 0.554 . . . . 70.43 109.945 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.421 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.9 p -90.02 16.24 8.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.691 -0.686 . . . . 63.43 111.795 -176.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -118.94 -0.29 11.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.342 -0.39 . . . . 74.33 111.163 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.422 HG22 ' HB3' ' A' ' 102' ' ' GLN . 47.3 t -117.43 127.32 74.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.35 -0.386 . . . . 54.24 110.096 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.573 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -66.77 135.22 53.63 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.658 0.266 . . . . 74.13 110.385 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.57 160.49 27.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.124 -0.489 . . . . 64.51 110.583 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.58 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.9 mm? -91.1 137.66 32.19 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.898 -0.408 . . . . 73.45 109.898 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -65.26 130.29 42.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.019 -0.537 . . . . 61.32 110.456 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.66 109.37 6.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.528 -0.76 . . . . 72.43 109.911 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.8 m -92.83 -1.82 56.44 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.893 -0.594 . . . . 41.33 110.607 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 56.91 25.38 10.44 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.93 -0.577 . . . . 72.22 111.107 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.53 -0.9 2.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.929 -0.578 . . . . 75.03 110.864 -178.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 117.22 71.84 0.44 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.683 -0.77 . . . . 62.21 112.334 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.1 m -76.21 163.23 27.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.265 -0.272 . . . . 60.24 110.265 175.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.48 156.14 21.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.063 -0.347 . . . . 74.43 110.063 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.97 164.65 31.37 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.877 -0.329 . . . . 72.4 110.794 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 68.89 -1.73 1.96 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.619 0.768 . . . . 73.11 111.247 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.58 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -138.76 145.59 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 109.223 -0.658 . . . . 62.13 109.223 170.517 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -148.81 -167.66 13.97 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 110.753 -0.939 . . . . 75.41 110.753 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.38 110.87 28.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 121.359 0.599 . . . . 54.41 110.326 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 85' ' ' VAL . 9.6 pt20 -100.6 132.03 46.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.748 -0.66 . . . . 64.14 109.416 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.56 HG21 ' CE1' ' A' ' 73' ' ' PHE . 4.0 mp -89.03 123.83 41.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.229 0.538 . . . . 75.44 110.219 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 134' ' ' GLN . 14.8 mt -92.73 140.88 29.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.362 -0.835 . . . . 72.25 109.237 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.514 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.6 OUTLIER -71.57 -173.63 0.97 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.74 -0.467 . . . . 64.22 109.74 176.512 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -59.88 -23.36 63.39 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.448 0.536 . . . . 74.43 112.448 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.0 p -91.5 -16.66 26.89 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.502 -0.479 . . . . 62.11 111.236 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.33 29.1 6.13 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.912 -0.661 . . . . 63.24 112.532 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.29 124.7 50.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.515 0.198 . . . . 63.43 110.683 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.04 120.62 11.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 72.15 110.573 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.7 mt -83.78 144.14 29.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.103 -0.499 . . . . 74.12 111.031 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.459 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 3.1 m -73.83 140.29 45.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.2 -0.454 . . . . 73.2 109.951 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.496 HD13 HD22 ' A' ' 86' ' ' LEU . 52.4 mt -85.0 43.24 0.99 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.886 0.374 . . . . 74.03 110.571 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -105.33 -1.55 25.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.524 . . . . 75.43 110.516 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.4 -1.76 41.4 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.073 -0.584 . . . . 35.23 113.353 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.03 -22.12 11.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 117.012 0.406 . . . . 71.11 110.91 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.459 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 8.8 m -81.06 96.17 7.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.273 -0.421 . . . . 55.2 110.26 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.524 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 89.2 m-85 -86.51 162.86 17.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.455 . . . . 75.42 110.327 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.514 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 13.4 m -73.55 -178.01 2.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.984 -0.553 . . . . 75.41 110.593 176.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.7 m -69.15 152.98 44.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.387 -0.37 . . . . 74.13 110.288 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.19 111.77 2.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.131 0.491 . . . . 72.1 111.623 -178.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.8 m -95.67 104.52 16.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.876 -0.602 . . . . 64.12 109.426 174.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -57.25 125.55 23.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 72.41 110.888 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.3 mt -91.62 163.4 14.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.203 0.525 . . . . 72.42 111.661 -176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -141.95 157.11 45.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.254 -0.885 . . . . 73.05 108.994 169.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 16.4 m120 -60.14 111.39 1.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.833 0.349 . . . . 72.42 110.267 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 137.86 -140.15 10.99 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.898 -0.668 . . . . 64.3 111.927 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.1 m -96.55 120.63 37.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.121 0.486 . . . . 65.53 110.939 -177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -114.22 137.14 52.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.974 -0.557 . . . . 45.12 109.79 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.558 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.4 m -125.45 121.42 33.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.688 0.28 . . . . 64.05 110.449 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 mt -106.31 112.71 63.86 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.801 -0.444 . . . . 54.41 109.801 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.8 139.39 9.81 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.991 2.461 . . . . 74.43 112.611 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.43 ' HD1' ' HA ' ' A' ' 105' ' ' ASP . 71.6 m-85 -138.71 164.02 30.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 71.13 110.309 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 87.0 mt-30 -124.37 134.18 53.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.961 0.41 . . . . 71.24 111.109 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -121.9 124.73 44.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.07 -0.514 . . . . 64.24 109.952 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.536 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 18.1 ptp180 -142.85 161.96 36.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.588 -0.278 . . . . 72.53 110.322 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 64.7 m-85 -77.9 135.63 37.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.098 -0.501 . . . . 72.25 110.525 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.469 ' HD1' HG22 ' A' ' 48' ' ' THR . 89.7 t80 -125.88 122.0 34.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.558 -0.746 . . . . 61.01 109.245 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.637 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -83.97 135.68 34.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.276 -0.42 . . . . 54.34 111.311 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 63.9 p -107.27 2.66 24.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.796 -0.638 . . . . 74.23 109.571 176.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 171.09 -115.99 0.61 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.214 -0.903 . . . . 52.42 111.62 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -98.19 94.21 6.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.702 0.251 . . . . 61.34 110.636 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.11 111.57 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.398 0.436 . . . . 72.12 111.865 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.2 p -104.58 140.84 21.47 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 116.122 -0.49 . . . . 63.14 110.188 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.96 179.96 3.93 Favored 'Trans proline' 0 N--CA 1.472 0.248 0 C-N-CA 123.717 2.945 . . . . 63.44 113.351 -172.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.83 -172.01 16.97 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.631 -0.795 . . . . 74.33 111.811 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.21 102.01 2.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.986 0.422 . . . . 50.34 110.947 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.22 76.85 1.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.179 0.514 . . . . 71.24 110.765 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -121.81 142.92 49.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.964 -0.562 . . . . 73.42 109.492 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.573 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -141.46 165.66 26.89 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 123.051 0.219 . . . . 72.32 111.027 -176.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -141.85 146.31 35.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.087 -0.338 . . . . 63.3 110.087 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.498 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -155.39 147.63 23.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.288 -0.415 . . . . 63.43 111.064 -178.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 13' ' ' LYS . 16.6 p -104.29 127.2 51.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.954 -0.566 . . . . 64.22 110.064 175.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.405 ' CD1' HD13 ' A' ' 56' ' ' ILE . 36.5 p90 -97.09 127.77 43.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.261 0.553 . . . . 74.13 110.947 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.573 ' HA ' HG21 ' A' ' 16' ' ' VAL . 8.5 ttmm -103.18 98.77 8.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.692 -0.686 . . . . 62.45 110.157 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 71' ' ' VAL . 1.2 m -74.57 133.4 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.304 0.573 . . . . 74.14 109.631 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -117.17 110.47 18.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.087 -0.506 . . . . 72.33 110.05 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.726 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -123.02 -12.63 7.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.619 0.723 . . . . 74.33 110.377 172.058 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.637 ' HG3' ' HD1' ' A' ' 158' ' ' TYR . 51.3 mt-30 . . . . . 0 C--O 1.249 1.072 0 CA-C-N 114.966 -1.015 . . . . 44.04 109.437 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.687 0.279 . . . . 71.32 110.285 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.86 161.46 30.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.297 -0.411 . . . . 61.32 110.319 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 t -87.83 -6.86 57.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.178 0.513 . . . . 53.14 110.719 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.3 p -113.85 176.33 5.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.3 -0.409 . . . . 70.42 110.584 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.453 HG22 HG12 ' A' ' 37' ' ' VAL . 36.0 m -89.18 13.95 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.264 -0.426 . . . . 70.13 110.691 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.441 ' C ' ' HG2' ' A' ' 36' ' ' GLN . 54.8 m-80 64.41 4.87 2.36 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.437 -0.801 . . . . 65.32 112.655 175.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.52 110.78 3.51 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.497 -0.859 . . . . 55.52 111.855 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.437 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -92.46 155.25 22.65 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.368 -0.92 . . . . 61.1 112.383 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.468 ' HB ' ' CG2' ' A' ' 31' ' ' THR . 1.6 p -145.9 125.1 12.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.568 0.223 . . . . 62.34 110.573 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.473 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -104.02 126.17 58.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.849 -0.426 . . . . 63.22 109.849 177.023 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -93.21 109.06 20.57 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.11 0.481 . . . . 71.42 110.174 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.473 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 87.6 m-85 -101.86 121.54 42.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.052 -0.522 . . . . 70.11 110.207 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -114.72 138.79 50.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.923 0.392 . . . . 72.34 110.431 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.49 -123.15 5.06 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.535 -0.626 . . . . 73.53 111.535 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.457 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 35.0 mt-10 63.57 25.64 14.44 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.395 0.617 . . . . 54.51 110.31 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.723 HG23 HG22 ' A' ' 17' ' ' VAL . 20.0 m -85.87 -32.33 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.615 -0.721 . . . . 72.4 111.59 -176.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.723 HG22 HG23 ' A' ' 16' ' ' VAL . 6.9 m -141.35 154.96 20.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.375 -0.375 . . . . 72.0 111.164 -174.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -168.74 90.24 0.24 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.434 -0.95 . . . . 65.33 108.434 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.26 -75.1 0.13 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.346 -0.843 . . . . 73.2 109.811 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.77 -37.82 62.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.761 -0.654 . . . . 64.11 109.689 174.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 1.8 m -147.17 162.02 39.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.382 -0.826 . . . . 74.34 108.832 -177.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.91 134.92 55.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.188 -0.301 . . . . 72.43 110.188 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.546 ' HA ' HD23 ' A' ' 58' ' ' LEU . 15.6 t -69.01 137.34 24.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.519 -0.31 . . . . 71.33 110.371 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.53 ' O ' HG13 ' A' ' 28' ' ' VAL . 20.5 t70 -57.22 141.55 46.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 72.22 111.69 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.48 -27.0 67.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 72.33 112.093 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.48 -14.06 60.56 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.436 -0.887 . . . . 71.55 111.722 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 t -97.94 -18.83 18.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.413 0.149 . . . . 64.34 110.913 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 24' ' ' ASP . 35.9 m -78.35 -5.74 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.556 0.217 . . . . 74.23 111.177 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -165.07 94.12 0.64 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.417 -0.586 . . . . 73.44 109.417 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -147.52 150.04 33.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.99 -0.55 . . . . 63.22 110.878 -176.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.468 ' CG2' ' HB ' ' A' ' 9' ' ' THR . 5.4 m -121.74 114.15 20.7 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.644 -0.707 . . . . 73.23 109.673 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.75 139.03 18.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.14 -0.482 . . . . 63.54 110.823 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -92.68 121.91 34.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.826 -0.625 . . . . 70.23 110.46 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.409 HD21 HG23 ' A' ' 10' ' ' VAL . 2.2 mm? -97.32 -27.2 14.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.235 0.541 . . . . 74.04 109.842 176.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.38 178.43 44.18 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.582 -0.736 . . . . 65.31 112.225 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.441 ' HG2' ' C ' ' A' ' 6' ' ' ASN . 82.6 mt-30 -80.56 94.2 6.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.154 -0.313 . . . . 73.42 110.154 177.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.453 HG12 HG22 ' A' ' 5' ' ' VAL . 9.0 p -70.25 149.82 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 73.42 110.618 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.01 134.46 35.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.931 -0.577 . . . . 71.44 110.094 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 p -77.5 -19.16 56.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.108 0.48 . . . . 75.45 110.775 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.91 -16.69 60.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 55.5 111.258 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.4 m -90.85 3.68 53.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.103 0.478 . . . . 61.04 110.907 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.735 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.1 mt -142.46 54.67 1.43 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.866 -0.606 . . . . 55.11 110.008 -175.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.25 10.53 41.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.114 0.413 . . . . 74.52 112.114 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -145.65 141.44 28.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.699 0.285 . . . . 75.3 111.171 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 8.9 tm-20 -55.43 116.42 2.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.903 -0.59 . . . . 74.13 109.559 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.14 -7.43 27.07 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.665 -0.779 . . . . 72.42 112.375 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.574 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -67.78 132.96 48.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.681 0.277 . . . . 71.33 110.61 177.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 p -122.78 138.83 54.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.291 -0.413 . . . . 70.23 110.715 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 t -96.36 179.0 5.18 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.356 -0.384 . . . . 74.43 110.519 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 m -68.62 126.05 28.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.936 -0.575 . . . . 65.21 110.265 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.598 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -82.49 164.66 20.78 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.668 0.747 . . . . 74.33 112.157 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.0 m -106.33 155.92 7.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.45 -1.25 . . . . 73.21 109.208 171.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.3 93.01 0.67 Allowed Glycine 0 C--N 1.311 -0.847 0 C-N-CA 120.818 -0.706 . . . . 54.43 112.104 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -105.54 171.52 7.28 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.556 -0.535 . . . . 73.41 109.556 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -139.69 142.84 36.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.044 0.449 . . . . 63.31 111.38 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.7 mt -102.27 117.8 48.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.534 -0.757 . . . . 73.14 109.318 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -99.37 137.6 37.65 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.785 -0.643 . . . . 72.24 110.676 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 23' ' ' VAL . 44.8 mt -117.34 134.72 54.49 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.454 -0.573 . . . . 73.23 109.454 176.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -110.26 143.97 39.65 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.902 -0.407 . . . . 63.43 109.902 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 33.8 t70 50.39 73.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 124.071 0.857 . . . . 72.11 110.715 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 32.7 t -112.78 119.66 38.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.115 -0.948 . . . . 73.21 110.212 -174.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.73 138.03 36.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.948 0.404 . . . . 72.45 111.734 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.3 p -107.43 5.21 27.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 70.41 112.258 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -78.3 -21.96 48.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.656 -0.498 . . . . 61.24 109.656 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.8 p -112.53 -30.71 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.768 -0.651 . . . . 73.34 111.353 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -116.95 166.57 12.03 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.194 -0.316 . . . . 63.54 111.126 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.51 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 32.7 m -124.64 -56.27 1.6 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.772 0.32 . . . . 73.43 111.569 -177.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.51 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -133.01 157.08 46.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.721 -0.474 . . . . 74.43 109.721 -178.238 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -114.14 132.63 56.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.977 0.418 . . . . 63.43 110.353 175.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.58 120.58 12.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.753 -0.658 . . . . 60.31 109.492 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.715 HG12 HG12 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -92.41 147.3 5.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.097 0.475 . . . . 75.23 111.158 -173.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.51 117.53 28.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.607 -0.724 . . . . 73.15 109.234 174.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 86.8 m-85 -82.81 135.99 34.79 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.951 0.405 . . . . 71.44 111.065 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.1 tp -131.32 115.42 16.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.878 -0.601 . . . . 74.22 109.616 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.439 ' H ' ' HB3' ' A' ' 113' ' ' LEU . . . -153.31 -174.22 23.39 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.576 -0.738 . . . . 74.53 111.326 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.464 ' O ' HD13 ' A' ' 86' ' ' LEU . 8.1 m -79.3 114.78 18.51 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.242 -0.281 . . . . 72.13 110.242 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -75.89 149.53 37.75 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.945 -0.391 . . . . 61.22 109.945 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.578 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 14.5 tt -62.48 -35.79 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.409 . . . . 71.23 110.209 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -162.43 -174.5 4.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.986 -0.552 . . . . 73.44 109.53 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.85 -12.15 59.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.141 0.423 . . . . 72.33 112.141 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.21 -43.71 3.98 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.769 -0.729 . . . . 73.33 111.8 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -103.06 82.2 2.06 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.076 -0.713 . . . . 74.42 109.076 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.416 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.7 p -95.59 7.34 46.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.251 -0.886 . . . . 72.01 112.503 -172.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -107.17 -1.64 21.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.121 0.486 . . . . 75.23 110.541 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.52 121.68 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.739 -0.664 . . . . 75.34 110.292 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.607 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -68.21 132.37 47.03 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.841 -0.429 . . . . 74.13 109.841 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.578 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -76.46 149.54 36.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.175 -0.466 . . . . 75.21 110.294 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.412 HD22 ' H ' ' A' ' 88' ' ' LEU . 2.1 mm? -77.84 132.93 38.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.157 -0.474 . . . . 52.11 109.839 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.556 ' HG3' ' HA ' ' A' ' 150' ' ' ALA . 90.8 mt-30 -64.21 128.04 34.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 74.35 110.541 -177.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.76 101.6 0.83 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.919 -0.582 . . . . 74.2 110.977 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.4 m -85.88 -10.77 54.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.072 -0.513 . . . . 75.3 110.296 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.09 5.42 5.28 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.368 -0.833 . . . . 65.45 111.633 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -109.6 -21.29 12.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.035 -0.529 . . . . 71.02 110.701 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 138.74 84.51 0.11 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.863 -0.684 . . . . 61.1 111.986 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.472 ' HA ' ' H ' ' A' ' 147' ' ' ALA . 2.7 p -88.47 164.15 15.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.762 0.315 . . . . 60.24 110.344 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.23 148.22 35.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.579 -0.526 . . . . 42.23 109.579 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.34 163.51 29.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.03 -0.359 . . . . 74.32 110.03 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.405 HD22 HG23 ' A' ' 144' ' ' THR . 57.5 m-20 69.8 10.99 7.73 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.575 0.547 . . . . 63.13 110.319 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.06 -177.29 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.478 -0.783 . . . . 70.13 110.212 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 175.94 -172.64 45.63 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.574 -1.01 . . . . 74.12 110.574 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.406 HG21 HG21 ' A' ' 10' ' ' VAL . 2.7 p -118.42 115.31 47.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.337 0.589 . . . . 64.24 110.62 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -105.34 140.66 38.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.24 -0.652 . . . . 63.21 109.24 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.429 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -102.56 122.59 55.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.147 0.499 . . . . 64.54 110.672 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.522 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 15.5 mt -89.58 143.55 26.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.503 -0.771 . . . . 54.42 109.378 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.544 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.9 -170.49 0.91 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.713 -0.477 . . . . 73.34 109.713 175.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -60.0 -29.83 68.73 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.467 0.173 . . . . 45.03 111.467 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.4 p -92.4 3.54 55.24 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.808 0.337 . . . . 60.34 111.573 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 82.08 30.67 33.93 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.858 -0.687 . . . . 72.33 113.1 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.01 126.4 48.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.713 0.256 . . . . 64.25 110.524 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.98 109.02 2.8 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.049 0.452 . . . . 63.14 110.919 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.9 mt -79.07 130.6 35.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 74.01 110.76 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 m -70.56 135.99 48.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 74.23 110.599 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.607 HD13 HD22 ' A' ' 86' ' ' LEU . 34.4 mt -78.05 41.52 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 73.53 110.844 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -98.9 -9.82 23.67 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.021 -0.536 . . . . 64.03 110.472 -175.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.53 1.15 75.56 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.025 -0.607 . . . . 60.32 112.663 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.27 -3.4 11.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.947 0.403 . . . . 74.02 111.228 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.4 m -101.0 109.5 21.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.807 0.337 . . . . 70.43 110.238 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -99.18 156.68 16.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 74.04 111.338 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 1.7 m -68.45 177.02 2.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.561 -0.745 . . . . 63.44 111.291 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.3 t -63.58 148.08 49.79 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.551 -0.537 . . . . 61.33 109.551 170.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.402 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 85.6 mt-10 -63.8 103.63 0.59 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 71.12 111.409 -176.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -87.22 110.86 20.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.962 -0.563 . . . . 63.51 109.743 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 m -59.96 122.4 14.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 75.5 111.28 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 69' ' ' ALA . 85.4 mt -84.38 146.39 27.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.514 . . . . 75.42 111.455 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -122.97 152.83 40.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.412 -0.813 . . . . 70.13 109.244 174.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 19.7 m120 -62.82 111.93 2.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.85 0.357 . . . . 61.35 110.569 176.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.17 -128.61 6.68 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.689 -0.767 . . . . 52.41 112.69 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.7 m -96.56 135.71 38.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.744 0.307 . . . . 74.55 110.849 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -132.58 148.56 52.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 64.54 110.482 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.47 120.73 31.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.372 -0.376 . . . . 74.2 111.301 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.2 mt -99.29 113.03 64.47 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.035 -0.728 . . . . 70.13 109.035 174.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.63 140.29 11.7 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.423 2.082 . . . . 73.52 112.704 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 87.4 m-85 -136.65 162.97 31.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 73.53 110.704 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.634 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.0 mt-30 -132.55 110.47 10.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.175 -0.466 . . . . 52.42 110.783 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -97.15 123.6 40.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.424 -0.353 . . . . 74.52 110.28 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.598 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 11.2 ptp180 -135.47 160.65 37.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.9 0.381 . . . . 63.13 110.65 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.437 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 81.3 m-85 -81.28 144.32 31.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.039 -0.528 . . . . 71.23 110.657 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -129.31 126.06 38.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.755 -0.657 . . . . 75.24 109.428 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.735 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -89.24 133.47 34.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.294 -0.412 . . . . 73.24 111.356 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.421 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 71.1 p -105.37 7.66 33.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.856 0.836 . . . . 74.05 109.022 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.08 -128.33 1.63 Allowed Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.524 -1.217 . . . . 72.15 110.838 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 96.18 10.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.827 0.314 . . . . 62.41 110.233 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -46.45 113.84 0.71 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.564 0.54 . . . . 33.22 111.539 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.405 HG23 HD22 ' A' ' 98' ' ' ASN . 31.9 p -103.14 141.45 22.52 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-O 121.122 0.487 . . . . 61.12 110.669 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.58 170.48 15.0 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 123.642 2.895 . . . . 43.54 113.273 -175.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.58 -122.47 1.77 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.627 -0.715 . . . . 72.23 111.795 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.472 ' H ' ' HA ' ' A' ' 95' ' ' SER . . . -122.17 133.87 54.73 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.686 -0.487 . . . . 65.35 109.686 177.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -122.05 51.49 1.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.589 0.709 . . . . 63.13 111.07 -173.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -102.56 144.45 30.96 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.255 -0.884 . . . . 65.02 110.197 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.556 ' HA ' ' HG3' ' A' ' 89' ' ' GLN . . . -152.86 177.26 10.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.113 -0.494 . . . . 71.14 109.979 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -154.1 152.05 30.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.963 -0.295 . . . . 73.43 110.622 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -156.29 153.0 28.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.177 -0.465 . . . . 63.1 110.829 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.3 p -105.31 136.71 44.33 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.454 -0.573 . . . . 75.32 109.454 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -109.59 122.82 48.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.088 0.47 . . . . 71.23 110.55 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.603 ' HA ' HG21 ' A' ' 16' ' ' VAL . 2.9 ttmm -102.48 104.85 15.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.081 -0.509 . . . . 74.34 110.224 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.715 HG12 HG12 ' A' ' 71' ' ' VAL . 1.5 m -81.45 139.2 18.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.207 0.527 . . . . 61.42 110.216 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -110.66 110.7 21.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.97 -0.559 . . . . 63.21 111.01 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.609 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -145.46 -32.49 0.37 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.088 -0.506 . . . . 73.23 110.401 170.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.473 ' N ' ' HD1' ' A' ' 158' ' ' TYR . 8.9 tm0? . . . . . 0 C--O 1.248 1.02 0 N-CA-C 108.346 -0.983 . . . . 64.52 108.346 174.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.651 0.262 . . . . 44.33 110.326 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.08 162.44 13.37 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.48 -0.563 . . . . 73.34 109.48 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 4' ' ' THR . 11.5 t -94.27 -2.03 53.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.856 0.36 . . . . 74.31 110.942 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 3' ' ' THR . 63.1 p -130.98 -173.23 3.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.971 0.415 . . . . 63.35 110.363 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 37' ' ' VAL . 31.6 m -89.8 14.36 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.756 0.312 . . . . 54.22 111.216 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 66.59 8.87 6.16 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.82 -0.627 . . . . 61.11 112.107 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 36' ' ' GLN . . . 95.78 97.8 1.78 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.112 -0.795 . . . . 62.34 111.112 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.56 154.24 25.81 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.206 -0.997 . . . . 43.12 112.206 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.48 ' HB ' HG22 ' A' ' 31' ' ' THR . 24.4 p -141.85 132.31 25.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.801 0.334 . . . . 71.35 111.128 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -106.95 120.46 58.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.178 -0.675 . . . . 73.52 109.178 171.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -94.33 106.1 18.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.689 -0.486 . . . . 73.24 109.689 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.415 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 81.8 m-85 -96.91 129.77 44.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.842 -0.617 . . . . 73.54 110.149 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -117.3 133.0 56.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.211 -0.45 . . . . 74.53 110.25 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.97 -123.24 4.24 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.982 -0.627 . . . . 40.53 111.951 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.772 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 31.7 mt-10 63.35 15.94 9.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.135 0.493 . . . . 51.43 110.891 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' A' ' 155' ' ' LYS . 24.2 m -76.91 -27.61 16.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.529 -0.76 . . . . 74.23 111.932 -174.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.6 HG21 ' CG2' ' A' ' 156' ' ' VAL . 18.8 m -135.81 144.6 33.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.214 0.531 . . . . 73.4 112.205 -174.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -148.41 21.38 1.06 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.487 -0.931 . . . . 65.2 108.487 170.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.96 -74.54 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.248 -0.887 . . . . 73.34 110.974 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HB2' HG13 ' A' ' 65' ' ' VAL . . . -88.72 -38.71 14.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.067 0.46 . . . . 62.32 110.513 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.8 OUTLIER -144.0 134.99 25.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.555 -0.748 . . . . 73.15 109.847 -176.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.61 151.51 20.09 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.8 -0.445 . . . . 72.11 109.8 177.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.425 ' HB ' HG12 ' A' ' 28' ' ' VAL . 14.9 t -86.52 136.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 110.122 -0.325 . . . . 54.4 110.122 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.467 ' O ' HG13 ' A' ' 28' ' ' VAL . 22.3 t70 -62.86 145.15 55.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.435 -0.348 . . . . 75.02 110.937 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -60.25 -26.04 66.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.253 0.464 . . . . 74.34 112.253 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.1 -14.79 81.9 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.529 -0.844 . . . . 65.22 112.014 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.9 p -119.94 13.55 12.25 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.83 0.307 . . . . 75.23 111.83 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.772 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 27.2 m -100.56 -11.77 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.161 0.505 . . . . 61.4 110.325 173.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -156.52 81.3 0.96 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.289 -0.869 . . . . 62.01 109.426 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -126.18 133.87 51.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.453 0.644 . . . . 74.43 110.369 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.48 HG22 ' HB ' ' A' ' 9' ' ' THR . 2.9 m -118.24 101.31 8.11 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.764 -0.828 . . . . 74.24 108.764 176.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.48 131.86 32.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.993 -0.549 . . . . 64.03 111.034 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -88.13 110.42 20.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.65 -0.704 . . . . 73.12 109.771 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.4 ' HB2' ' OH ' ' A' ' 137' ' ' TYR . 1.8 mm? -81.22 -29.05 34.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.406 0.622 . . . . 54.54 109.495 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 96.18 172.72 35.58 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.242 -0.89 . . . . 44.33 112.131 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 7' ' ' GLY . 69.4 mt-30 -72.83 95.8 1.98 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.448 -0.204 . . . . 73.12 110.448 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.515 HG12 HG22 ' A' ' 5' ' ' VAL . 11.0 p -70.33 142.67 15.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.855 0.36 . . . . 74.2 110.134 177.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -78.22 105.12 9.24 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.201 -0.666 . . . . 63.31 109.201 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 19.5 p -63.05 -25.19 68.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.955 0.407 . . . . 72.42 111.237 -177.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.43 -5.6 37.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.061 -0.518 . . . . 74.43 111.419 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.5 m -95.8 -2.69 47.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.073 0.463 . . . . 65.22 110.411 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.1 mp -131.69 97.3 4.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.888 -0.597 . . . . 61.23 109.504 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.96 17.35 9.32 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.32 -0.552 . . . . 73.15 112.436 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -153.62 150.99 29.21 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.749 -0.381 . . . . 72.14 111.483 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -60.9 119.21 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 72.54 109.827 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.72 -6.19 31.26 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.641 -0.79 . . . . 61.21 111.847 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -72.01 119.39 16.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.014 0.435 . . . . 75.04 110.532 178.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.548 HG22 ' HD1' ' A' ' 138' ' ' PHE . 41.1 p -105.51 148.34 27.33 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.015 -0.539 . . . . 61.04 110.173 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.4 t -100.32 177.54 5.02 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.136 -0.69 . . . . 54.23 109.136 174.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.6 m -70.11 133.51 47.23 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.876 -0.416 . . . . 73.15 109.876 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -87.34 160.41 18.39 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.644 0.735 . . . . 70.15 111.956 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 31.1 m -103.94 152.9 6.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.433 -1.258 . . . . 72.25 109.083 171.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.45 98.48 1.28 Allowed Glycine 0 C--N 1.312 -0.754 0 C-N-CA 120.729 -0.748 . . . . 45.03 112.147 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -108.96 173.19 6.43 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.6 -0.519 . . . . 63.35 109.6 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.594 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.0 p-10 -139.75 137.19 34.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.476 0.655 . . . . 73.44 111.917 -173.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.4 mt -105.5 115.09 46.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.722 -0.844 . . . . 75.25 108.722 171.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -101.57 144.62 30.09 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.977 0.417 . . . . 75.54 110.823 -173.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.2 mt -117.91 130.01 55.97 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.955 -0.566 . . . . 73.25 109.676 176.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -106.41 131.98 52.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.67 -0.695 . . . . 52.12 109.519 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 27.1 t70 58.15 86.44 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.69 0.757 . . . . 63.42 110.217 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 51.7 t -124.38 124.49 42.46 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.335 -0.848 . . . . 55.04 110.421 -174.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -103.92 140.07 38.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.045 -0.525 . . . . 72.31 111.152 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.8 p -107.96 15.61 24.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.071 0.397 . . . . 65.32 112.071 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -90.34 -39.16 12.87 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.912 -0.773 . . . . 74.33 108.912 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 20' ' ' ALA . 12.7 p -96.12 -3.53 10.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.104 -0.953 . . . . 72.41 110.472 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.616 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -144.75 -173.45 4.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 64.13 110.781 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.7 m -151.0 -57.98 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.023 0.379 . . . . 62.31 112.023 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.799 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -138.21 130.4 28.76 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.973 -0.291 . . . . 72.53 110.262 -175.888 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.43 127.49 41.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.108 0.48 . . . . 53.11 111.0 -175.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.33 119.64 16.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.637 -0.711 . . . . 72.1 109.637 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 156' ' ' VAL . 2.5 m -90.19 147.62 5.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.977 0.418 . . . . 70.21 110.756 -175.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.437 ' HB2' ' CD2' ' A' ' 118' ' ' PHE . . . -117.48 118.16 31.42 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.741 -0.663 . . . . 73.24 109.752 174.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 82.3 m-85 -85.62 128.49 34.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.979 0.419 . . . . 70.44 110.205 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.1 tp -126.13 126.76 44.68 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.836 -0.62 . . . . 61.15 109.913 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.52 -166.47 21.36 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.446 -0.662 . . . . 62.53 111.446 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.7 m -87.1 119.71 27.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.853 -0.425 . . . . 75.23 109.853 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -76.98 149.52 35.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.446 -0.343 . . . . 72.42 110.436 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.573 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 12.8 tt -61.77 -37.61 78.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.081 0.467 . . . . 52.43 110.7 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -152.02 -171.51 3.95 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.782 -0.821 . . . . 53.25 108.782 174.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.04 -14.89 43.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.056 0.391 . . . . 74.21 112.056 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.31 -49.83 3.6 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.632 -0.794 . . . . 73.52 112.016 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -96.43 76.64 2.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.383 0.611 . . . . 73.34 109.617 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.478 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 14.6 p -86.97 8.45 23.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.649 -0.705 . . . . 54.43 111.755 -175.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 24.4 p-10 -107.05 7.32 29.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.976 0.417 . . . . 63.11 110.849 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 138' ' ' PHE . 57.6 t -120.11 124.91 73.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.542 . . . . 71.54 109.837 177.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.523 HD22 ' CD1' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -66.94 129.85 41.23 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 110.079 -0.341 . . . . 64.14 110.079 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.46 150.77 34.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.297 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.548 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -88.03 130.3 35.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.561 -0.533 . . . . 62.14 109.561 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -58.24 142.09 48.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 60.2 112.127 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 p -66.91 106.59 1.95 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.311 -0.859 . . . . 52.21 110.785 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.2 m -101.29 -12.25 18.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.913 -0.585 . . . . 64.23 110.773 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.37 4.5 2.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.065 0.546 . . . . 72.22 112.178 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.9 15.16 14.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.101 0.476 . . . . 64.41 110.628 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.27 76.83 1.22 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.565 -0.826 . . . . 62.31 111.829 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.2 m -82.28 154.83 25.14 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.899 -0.408 . . . . 54.42 109.899 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.428 ' O ' HD23 ' A' ' 88' ' ' LEU . . . -71.46 136.64 47.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.71 0.291 . . . . 71.51 110.223 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.36 160.71 35.51 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.848 -0.341 . . . . 72.54 110.546 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 68.55 7.36 5.99 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.337 0.589 . . . . 74.23 110.303 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.405 ' O ' HD12 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -143.25 -179.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.269 -0.878 . . . . 72.01 109.687 175.124 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.3 -169.82 42.86 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.951 -1.26 . . . . 73.45 109.951 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.85 119.46 58.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.278 0.561 . . . . 75.14 110.465 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -109.42 146.15 34.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.648 -0.705 . . . . 74.13 109.755 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.1 mp -103.99 124.24 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.425 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.426 HD11 ' NE ' ' A' ' 136' ' ' ARG . 27.5 mt -87.38 140.03 29.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.651 -0.704 . . . . 43.44 109.177 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.542 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.05 -173.13 1.19 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.913 -0.402 . . . . 64.3 109.913 177.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.1 ptt85 -61.04 -20.3 62.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.096 0.406 . . . . 74.33 112.096 -176.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.7 p -101.47 3.56 40.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.935 -0.306 . . . . 61.54 111.548 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.42 31.52 24.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.778 -0.725 . . . . 53.24 112.866 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -112.02 128.51 56.2 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.959 -0.386 . . . . 60.12 109.959 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.85 130.16 42.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.726 0.298 . . . . 72.22 110.884 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.0 mt -92.77 132.83 36.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.225 -0.443 . . . . 73.1 110.979 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 89.9 m -74.31 139.2 44.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.891 -0.595 . . . . 74.13 110.449 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 34.8 mt -81.46 45.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 71.13 110.682 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -90.7 -17.94 25.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.09 0.472 . . . . 71.31 110.369 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.19 -22.97 26.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.996 -0.621 . . . . 70.31 112.329 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.45 3.87 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.164 0.507 . . . . 41.42 110.915 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.461 HG21 ' H ' ' A' ' 112' ' ' THR . 3.8 m -95.34 99.36 11.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 75.24 110.064 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.493 ' HE2' ' HD2' ' A' ' 155' ' ' LYS . 96.3 m-85 -95.41 162.31 13.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.969 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 4.6 m -71.46 -178.83 2.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.666 -0.697 . . . . 72.45 111.003 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.5 t -73.05 165.55 24.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.596 -0.52 . . . . 71.43 109.596 173.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -65.32 106.98 1.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.366 -0.379 . . . . 75.13 111.33 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.8 m -90.66 102.76 15.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.084 -0.71 . . . . 71.13 109.084 172.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.6 m -58.17 119.21 6.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.753 -0.658 . . . . 60.05 111.247 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.421 HD13 ' SG ' ' A' ' 61' ' ' CYS . 95.9 mt -87.27 150.91 23.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.792 -0.64 . . . . 75.12 111.166 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -125.89 158.68 34.51 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.743 -0.836 . . . . 73.4 108.743 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.4 m120 -65.08 114.49 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.868 0.366 . . . . 50.34 111.058 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.43 -133.27 8.07 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.03 -0.605 . . . . 64.13 112.31 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.5 m -92.83 130.88 38.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.795 0.331 . . . . 65.45 110.706 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -128.34 139.25 52.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.73 -0.47 . . . . 70.34 109.73 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.594 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.2 m -122.51 117.83 26.84 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.755 -0.378 . . . . 73.11 110.78 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.7 mt -95.0 115.26 65.22 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 63.1 109.913 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.19 135.95 7.6 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.469 2.113 . . . . 71.04 112.689 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 68.3 m-85 -134.7 160.76 37.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 64.42 110.258 177.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.61 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 44.9 mt-30 -130.37 114.52 15.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.91 0.386 . . . . 73.32 110.832 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.07 130.63 46.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.547 -0.297 . . . . 65.42 110.407 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 13.8 ptp180 -141.27 158.12 44.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.582 -0.281 . . . . 74.44 110.825 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 94.4 m-85 -75.93 142.03 42.14 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.148 -0.478 . . . . 74.12 110.257 175.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.548 ' HD1' HG22 ' A' ' 48' ' ' THR . 75.7 t80 -128.81 125.78 38.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.934 -0.575 . . . . 73.52 109.988 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -94.02 131.43 39.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.097 0.475 . . . . 72.13 110.736 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.5 p -101.13 7.31 43.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.502 -0.772 . . . . 72.34 109.572 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.83 -129.66 1.75 Allowed Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.246 -1.141 . . . . 73.21 110.246 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 144' ' ' THR . . . -83.82 95.37 8.44 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.452 -0.573 . . . . 73.11 109.452 175.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.48 111.35 0.48 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.824 -0.625 . . . . 70.23 111.363 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 142' ' ' ALA . 36.6 p -103.62 142.98 25.72 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-O 121.328 0.585 . . . . 73.12 110.845 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.75 166.94 22.58 Favored 'Trans proline' 0 C--N 1.331 -0.35 0 C-N-CA 123.816 3.011 . . . . 75.14 112.734 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.02 179.79 19.98 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.799 -0.715 . . . . 64.1 111.513 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.06 112.71 5.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 117.003 0.401 . . . . 72.45 110.915 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.548 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -101.2 74.1 1.55 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.451 0.643 . . . . 62.22 111.031 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -113.0 123.44 50.34 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.323 -0.621 . . . . 72.42 109.323 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.403 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -129.34 156.45 44.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.95 0.405 . . . . 53.21 111.598 -176.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -125.65 130.18 51.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.69 -0.687 . . . . 71.42 109.826 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.09 137.11 32.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.103 0.478 . . . . 44.44 111.663 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.4 p -112.63 125.0 53.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.679 -0.691 . . . . 72.21 109.902 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -105.52 134.84 47.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.144 0.497 . . . . 74.32 110.682 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.592 ' HA ' HG21 ' A' ' 16' ' ' VAL . 1.9 ttmm -117.9 107.42 14.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.684 -0.689 . . . . 74.14 110.158 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -74.45 140.86 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.142 0.496 . . . . 72.14 110.206 179.212 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -128.39 110.12 12.05 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.117 -0.698 . . . . 71.53 109.117 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.799 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -113.49 -7.16 13.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.942 0.401 . . . . 75.42 111.666 177.2 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 . . . . . 0 C--O 1.243 0.75 0 CA-C-O 118.5 -0.762 . . . . 62.21 109.513 168.963 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.883 0.373 . . . . 75.34 110.712 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.09 160.64 37.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 74.13 110.11 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.4 t -89.87 -13.35 36.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.707 0.289 . . . . 61.02 110.934 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.0 p -98.58 -179.56 4.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.823 0.344 . . . . 75.13 110.647 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.488 ' CG2' HG12 ' A' ' 37' ' ' VAL . 32.7 m -93.53 15.88 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.975 0.417 . . . . 72.4 110.955 177.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 61.11 20.58 11.06 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.452 -0.795 . . . . 71.3 112.092 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.558 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 84.79 102.85 0.63 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.591 -0.814 . . . . 45.44 111.978 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.465 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -93.64 155.36 22.09 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.242 -0.98 . . . . 22.35 112.048 -177.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 33' ' ' GLN . 53.8 p -140.99 151.5 44.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.899 -0.408 . . . . 74.2 109.899 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -121.0 124.1 71.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.042 -0.725 . . . . 50.44 109.042 172.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -92.2 116.99 29.43 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.118 -0.633 . . . . 72.15 109.688 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.453 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 93.1 m-85 -104.15 114.5 28.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.626 -0.715 . . . . 73.33 110.157 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -102.32 134.81 45.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 75.4 110.274 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.93 -120.68 3.43 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.944 -0.646 . . . . 53.14 111.899 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.639 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 38.3 mt-10 62.88 19.72 11.73 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.153 0.501 . . . . 54.22 111.085 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.785 HG23 HG22 ' A' ' 17' ' ' VAL . 17.2 m -76.17 -30.49 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.053 -0.521 . . . . 64.01 111.719 -176.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.785 HG22 HG23 ' A' ' 16' ' ' VAL . 4.2 m -149.17 143.87 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.146 0.498 . . . . 64.23 111.145 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -140.7 22.45 2.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.213 -0.903 . . . . 74.01 108.916 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.75 -77.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.089 -0.959 . . . . 72.43 111.131 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.569 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -78.19 -39.15 41.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.024 -0.535 . . . . 65.02 110.492 178.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.8 OUTLIER -143.65 128.39 18.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.055 -0.521 . . . . 74.1 109.778 -176.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.44 119.25 27.53 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.366 -0.379 . . . . 70.53 110.138 -178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.452 ' HA ' HD23 ' A' ' 58' ' ' LEU . 9.6 t -62.45 128.65 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.709 -0.478 . . . . 74.11 109.709 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 28' ' ' VAL . 18.6 t70 -59.57 142.88 51.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.781 -0.645 . . . . 63.44 111.397 -176.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -62.12 -24.37 67.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.774 -0.648 . . . . 74.32 112.221 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.4 -17.91 70.12 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.618 -0.801 . . . . 33.11 111.932 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 p -105.48 -14.23 15.37 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.821 0.304 . . . . 52.4 111.821 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.639 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 33.8 m -79.73 -8.02 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.09 0.471 . . . . 73.42 110.353 175.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -157.78 90.24 1.06 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.559 -0.904 . . . . 62.52 108.559 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.429 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 17.1 pt20 -137.06 112.86 9.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.726 -0.67 . . . . 74.22 110.52 -176.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.55 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.4 m -97.22 95.37 7.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.532 -0.758 . . . . 74.44 109.094 174.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 p -79.26 134.42 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.193 -0.458 . . . . 64.0 110.541 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.567 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.6 mp0 -91.33 120.96 32.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.121 -0.491 . . . . 74.01 110.281 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.429 HD21 HG23 ' A' ' 10' ' ' VAL . 2.8 mm? -86.55 -30.04 22.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.777 -0.647 . . . . 74.41 109.356 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.558 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 92.33 177.35 41.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.329 -0.851 . . . . 51.12 111.951 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -72.31 95.34 1.71 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.707 -0.479 . . . . 72.42 109.707 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.488 HG12 ' CG2' ' A' ' 5' ' ' VAL . 9.8 p -66.49 138.49 22.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.209 0.528 . . . . 74.02 110.379 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.6 mtm-85 -75.25 106.55 6.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.623 -0.717 . . . . 74.01 109.967 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 p -62.49 -26.08 68.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 75.21 111.09 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.19 -8.07 52.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 63.25 111.428 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.1 m -97.07 -15.51 20.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.813 0.339 . . . . 61.15 110.749 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -124.28 95.94 4.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.699 0.285 . . . . 72.31 110.241 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.01 11.34 7.07 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.667 -0.413 . . . . 74.14 112.061 -176.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -152.8 143.42 22.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.417 0.151 . . . . 74.01 110.829 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 41.2 tt0 -58.35 118.46 5.56 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.021 0.438 . . . . 74.34 110.638 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.79 -17.59 8.18 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.22 -0.752 . . . . 64.03 111.22 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.3 124.67 24.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.847 0.356 . . . . 43.31 110.222 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.508 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 4.6 p -121.88 114.23 20.74 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.937 -0.574 . . . . 74.01 110.139 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.8 t -72.22 174.46 7.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.069 -0.514 . . . . 33.21 110.838 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -60.54 120.88 10.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 51.3 110.29 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -80.46 142.48 34.23 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.411 0.624 . . . . 44.03 111.276 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.9 m -83.66 147.88 5.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.825 -1.08 . . . . 72.42 109.306 170.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.99 92.02 0.72 Allowed Glycine 0 C--N 1.307 -1.05 0 C-N-CA 120.837 -0.696 . . . . 72.45 112.257 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -102.19 -175.71 2.91 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.407 -0.59 . . . . 75.31 109.407 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.548 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.0 p-10 -147.31 147.48 30.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.39 0.614 . . . . 71.24 111.821 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.45 115.87 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.342 -0.985 . . . . 73.43 108.342 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . 48.7 tt0 -103.71 138.45 40.34 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.078 -0.51 . . . . 75.21 111.129 -171.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 23' ' ' VAL . 64.4 mt -119.11 115.23 23.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.711 -0.677 . . . . 73.14 109.744 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -92.63 136.26 33.38 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.977 -0.556 . . . . 74.12 110.239 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 51.02 68.91 0.71 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.944 0.777 . . . . 53.3 110.938 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.519 ' SG ' HD13 ' A' ' 124' ' ' LEU . 53.0 t -98.62 129.39 45.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.954 . . . . 62.05 110.435 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -104.06 138.27 40.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.935 -0.575 . . . . 70.15 111.169 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.5 p -104.95 10.5 34.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.094 0.405 . . . . 65.52 112.094 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -85.13 -37.15 20.57 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.459 -0.571 . . . . 72.23 109.459 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 20' ' ' ALA . 10.3 p -100.58 -13.7 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.773 -0.649 . . . . 51.05 110.852 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.679 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -123.92 179.48 4.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.64 0.257 . . . . 74.44 111.066 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 20.3 m -143.24 -60.95 0.42 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.486 . . . . 74.21 110.736 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -136.68 140.72 42.9 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.374 -0.602 . . . . 75.32 109.374 -178.254 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -98.16 119.8 37.44 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.185 0.517 . . . . 54.24 109.977 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -131.25 110.84 11.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.538 -0.756 . . . . 73.43 109.754 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -89.03 145.45 7.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.915 0.388 . . . . 72.15 110.298 -175.715 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -123.37 123.87 41.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.965 -0.561 . . . . 35.04 109.62 174.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 91.1 m-85 -88.95 130.43 35.45 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.021 0.439 . . . . 65.32 110.696 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.7 tp -130.59 125.56 34.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.771 -0.65 . . . . 75.41 110.154 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.37 -164.2 21.48 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.132 -0.787 . . . . 51.4 111.132 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.456 ' O ' HD13 ' A' ' 86' ' ' LEU . 42.3 m -80.79 122.65 27.44 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.27 -0.271 . . . . 70.0 110.27 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.518 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -85.37 140.65 30.6 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.91 -0.404 . . . . 73.43 109.91 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 tt -65.05 -28.98 46.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.886 0.374 . . . . 64.34 110.867 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 22.0 t70 -153.99 174.95 13.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.482 -0.562 . . . . 60.3 109.482 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.36 -37.83 31.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.093 0.473 . . . . 73.14 110.339 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.63 -19.18 62.33 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.161 -0.776 . . . . 65.44 111.161 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 42.4 m80 -107.08 43.5 1.16 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.167 -0.679 . . . . 64.14 109.167 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.518 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -72.62 11.45 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.141 -0.936 . . . . 42.2 112.927 -176.028 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 85' ' ' VAL . 16.4 p30 -110.81 -8.96 14.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.058 0.456 . . . . 73.04 110.554 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.455 HG23 ' OD1' ' A' ' 84' ' ' ASN . 48.3 t -101.84 120.92 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.101 -0.499 . . . . 62.24 110.561 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.555 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -67.03 132.8 48.62 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.16 -0.473 . . . . 70.23 109.746 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.71 148.52 36.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.032 -0.531 . . . . 45.01 110.304 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.447 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 2.0 mm? -82.98 140.77 32.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.14 -0.482 . . . . 61.21 110.557 -177.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -62.26 143.0 57.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.486 -0.779 . . . . 53.01 110.095 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 m -111.54 114.63 27.84 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.672 -0.694 . . . . 65.12 110.984 -172.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -90.83 9.72 29.1 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.667 -0.697 . . . . 73.5 110.234 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 66.49 7.28 4.92 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.258 -0.883 . . . . 75.11 111.98 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.04 -45.96 4.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.104 0.478 . . . . 72.44 110.381 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.94 91.2 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.809 -0.71 . . . . 74.33 112.301 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.459 ' HA ' ' H ' ' A' ' 147' ' ' ALA . 1.5 p -84.14 156.36 22.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.63 0.252 . . . . 75.22 110.404 174.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.92 138.7 50.31 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.061 -0.348 . . . . 74.05 110.061 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.18 159.3 33.32 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.842 -0.343 . . . . 63.52 110.932 -176.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 68.67 10.46 7.9 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.719 -0.673 . . . . 71.0 111.238 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.48 178.28 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.153 -0.476 . . . . 72.44 110.306 174.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 176.28 -175.9 47.59 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 109.831 -1.308 . . . . 53.32 109.831 177.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -118.9 114.21 44.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.334 0.588 . . . . 75.31 111.162 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.41 ' HG2' ' HB2' ' A' ' 138' ' ' PHE . 2.9 pt20 -104.15 140.16 38.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.698 -0.683 . . . . 65.45 109.498 173.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.4 mp -98.11 126.35 51.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.997 -0.547 . . . . 73.34 110.296 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.408 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 15.5 mt -89.92 147.5 23.69 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.262 -0.881 . . . . 72.12 109.141 176.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.406 ' HA ' ' CD1' ' A' ' 133' ' ' PHE . 1.5 p-10 -70.87 -169.94 0.39 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.773 -0.454 . . . . 73.33 109.773 175.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 106' ' ' ARG . 16.9 ptt180 -61.98 -30.86 71.22 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.108 -0.237 . . . . 73.43 111.527 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.4 p -81.92 -34.55 29.83 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.748 -0.381 . . . . 65.55 110.76 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 119.77 31.54 1.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.582 -0.818 . . . . 64.13 112.931 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.48 139.02 42.64 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.128 -0.323 . . . . 63.01 110.128 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.05 130.71 43.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.396 -0.366 . . . . 52.11 111.1 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt -97.37 131.98 43.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.144 -0.48 . . . . 71.03 110.506 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.411 ' H ' HG21 ' A' ' 117' ' ' THR . 14.7 m -72.23 137.01 46.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.257 -0.428 . . . . 74.44 110.72 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.555 HD13 HD22 ' A' ' 86' ' ' LEU . 49.2 mt -79.64 49.09 0.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 75.24 110.876 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -107.45 -8.43 16.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.441 0.639 . . . . 62.34 110.324 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.23 -12.51 12.78 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.0 -0.619 . . . . 63.43 112.811 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.19 -10.85 23.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.932 0.396 . . . . 43.4 111.153 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.411 HG21 ' H ' ' A' ' 112' ' ' THR . 24.5 m -92.57 95.12 9.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.079 0.466 . . . . 61.34 110.21 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.569 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 72.6 m-85 -91.03 153.01 20.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.784 -0.644 . . . . 73.11 110.241 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.4 m -65.23 171.37 3.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.083 -0.508 . . . . 71.52 111.251 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.3 p -61.3 146.17 48.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.104 -0.498 . . . . 72.12 110.301 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.431 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 41.9 mt-10 -57.57 101.34 0.07 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.96 0.409 . . . . 73.24 111.605 -176.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.6 m -85.85 104.18 15.28 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.947 -0.761 . . . . 70.43 108.947 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 m -63.3 115.08 4.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.262 0.553 . . . . 73.51 110.878 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.562 HD21 ' HB2' ' A' ' 69' ' ' ALA . 92.0 mt -74.59 147.08 42.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.176 -0.92 . . . . 74.12 111.777 -174.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -121.14 151.47 39.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.359 -0.837 . . . . 61.02 108.924 171.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 94.6 m-20 -63.12 107.34 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.902 0.382 . . . . 71.32 110.681 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.84 -149.12 20.08 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.967 -0.635 . . . . 65.41 111.789 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 30.1 m -82.12 123.61 29.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.124 0.487 . . . . 73.03 110.994 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 28.0 m-80 -117.48 135.09 54.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.942 -0.572 . . . . 32.52 109.537 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.548 HG22 ' HB2' ' A' ' 55' ' ' ASN . 2.3 m -122.45 118.87 29.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.804 -0.358 . . . . 75.41 110.488 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.0 mt -98.58 112.38 62.34 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.697 -0.482 . . . . 73.11 109.697 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.85 138.96 17.17 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.599 2.2 . . . . 71.25 112.469 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 78.6 m-85 -136.61 163.69 29.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.692 0.282 . . . . 74.0 110.528 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 96.2 mt-30 -130.71 119.09 21.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.102 -0.499 . . . . 72.13 110.896 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.21 123.23 47.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.099 -0.334 . . . . 73.04 110.099 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.539 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 2.8 ptp180 -135.98 159.17 42.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.39 -0.368 . . . . 74.12 111.234 -176.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 59.8 m-85 -80.5 134.41 35.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.746 -0.661 . . . . 64.53 110.418 174.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.41 ' HB2' ' HG2' ' A' ' 102' ' ' GLN . 84.8 t80 -117.69 119.21 34.26 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.139 -0.689 . . . . 71.11 109.139 176.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 45' ' ' GLU . . . -83.6 130.29 34.98 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.023 -0.535 . . . . 72.35 110.661 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 69.3 p -101.32 -0.54 35.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.88 0.848 . . . . 71.33 108.763 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.21 -131.54 1.77 Allowed Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.28 -1.327 . . . . 73.22 110.594 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 144' ' ' THR . . . -88.66 98.72 11.84 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.749 -0.463 . . . . 72.04 109.749 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -47.47 113.01 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.896 0.747 . . . . 71.33 111.395 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 142' ' ' ALA . 41.3 p -104.06 146.34 32.37 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 116.012 -0.54 . . . . 64.43 110.585 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.27 173.36 5.25 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.6 2.866 . . . . 62.55 113.628 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 138.0 -147.47 19.25 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.675 -0.693 . . . . 74.52 111.857 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.459 ' H ' ' HA ' ' A' ' 95' ' ' SER . . . -98.84 117.08 32.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.22 -0.289 . . . . 70.43 110.22 175.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.447 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -115.48 59.65 0.71 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.95 0.405 . . . . 34.31 111.625 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -112.69 137.03 51.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.035 -0.728 . . . . 73.34 109.035 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.486 ' HB3' HG13 ' A' ' 10' ' ' VAL . . . -128.81 169.92 13.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.016 0.436 . . . . 55.13 111.756 -175.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -137.8 127.26 24.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.581 -0.736 . . . . 75.12 109.618 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.86 140.59 29.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.075 0.464 . . . . 74.02 111.774 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.1 p -110.28 126.11 53.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.595 . . . . 65.52 109.53 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -106.44 143.39 34.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.059 0.457 . . . . 64.42 110.834 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.594 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.9 ttmm -120.04 111.96 18.55 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.812 -0.631 . . . . 74.15 110.435 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 71' ' ' VAL . 1.4 m -81.81 127.17 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.165 -0.68 . . . . 72.5 109.165 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -112.18 121.87 46.14 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.137 -0.483 . . . . 50.13 109.849 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.679 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -137.39 -18.32 1.28 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.841 0.311 . . . . 72.04 111.841 177.003 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.495 ' HG2' ' OXT' ' A' ' 159' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.926 0 N-CA-C 109.163 -0.68 . . . . 72.45 109.163 170.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.713 0.292 . . . . 52.32 110.293 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.53 179.42 8.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.361 -0.381 . . . . 65.45 110.279 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.416 HG23 HG23 ' A' ' 4' ' ' THR . 9.0 t -113.23 -7.57 13.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.131 0.491 . . . . 71.5 110.099 176.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.416 HG23 HG23 ' A' ' 3' ' ' THR . 73.1 p -121.02 -179.27 3.97 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.911 -0.586 . . . . 74.44 110.092 177.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.51 HG22 HG12 ' A' ' 37' ' ' VAL . 28.1 m -92.64 15.79 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.004 0.43 . . . . 74.15 110.526 176.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 61.95 13.09 5.32 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.355 -0.839 . . . . 74.02 112.563 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.426 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 91.09 94.96 1.27 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.731 -0.747 . . . . 55.25 111.967 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.02 158.64 31.97 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.532 -0.842 . . . . 70.2 112.171 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.523 ' HB ' HG22 ' A' ' 31' ' ' THR . 11.2 p -140.24 135.32 32.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.361 . . . . 61.21 111.102 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.463 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -108.11 125.47 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.423 -0.584 . . . . 74.33 109.423 173.347 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -96.81 111.03 23.39 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.068 0.461 . . . . 72.04 110.19 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 95.7 m-85 -101.07 122.9 44.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.886 -0.597 . . . . 74.35 110.47 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -108.08 138.43 44.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.449 -0.341 . . . . 70.12 110.535 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -109.3 -133.08 6.65 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.935 -0.65 . . . . 72.04 112.321 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 62.95 34.55 14.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.39 0.614 . . . . 65.2 110.897 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 155' ' ' LYS . 25.3 m -93.76 -22.88 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.592 -0.731 . . . . 73.42 111.663 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.468 HG21 ' CG2' ' A' ' 156' ' ' VAL . 19.0 m -143.01 149.18 18.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.537 -0.301 . . . . 55.41 111.303 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -156.86 32.04 0.3 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.797 0.808 . . . . 65.22 109.346 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.89 -66.73 0.9 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.313 -0.858 . . . . 73.01 111.469 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.414 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -98.92 -41.03 7.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 61.44 110.804 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 1.8 m -135.63 128.88 31.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.153 -0.476 . . . . 71.55 110.075 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.5 127.84 39.33 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.022 -0.536 . . . . 53.33 110.007 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.58 131.26 31.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.338 -0.392 . . . . 51.24 110.217 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 28' ' ' VAL . 25.1 t70 -57.93 145.45 35.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.736 -0.666 . . . . 71.45 111.254 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.32 -30.72 70.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 64.02 111.775 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.66 -12.03 82.17 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.61 -0.805 . . . . 74.13 111.652 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 t -97.82 -24.38 15.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.453 0.168 . . . . 71.12 110.591 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 24' ' ' ASP . 20.7 m -80.44 -7.14 10.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.822 0.344 . . . . 73.4 110.597 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -154.85 88.95 1.21 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.813 -0.631 . . . . 53.33 109.681 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.86 115.57 10.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.638 0.732 . . . . 65.53 110.98 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.523 HG22 ' HB ' ' A' ' 9' ' ' THR . 3.9 m -98.38 97.63 8.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.027 -0.988 . . . . 72.52 109.067 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.69 127.94 39.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.128 0.49 . . . . 74.44 111.092 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -86.61 125.43 33.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.645 . . . . 65.02 109.976 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.406 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.7 mm? -87.54 -22.91 24.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.109 0.481 . . . . 72.52 110.032 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.426 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 93.41 173.32 40.1 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.581 -0.736 . . . . 53.42 112.095 -178.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.74 91.49 5.91 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.761 0.315 . . . . 44.43 110.701 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.51 HG12 HG22 ' A' ' 5' ' ' VAL . 7.2 p -78.06 146.07 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.171 -0.468 . . . . 53.41 109.824 176.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -87.07 132.15 33.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.02 -0.363 . . . . 73.51 110.02 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 53.2 p -68.33 -18.64 64.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.228 0.537 . . . . 72.12 111.129 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.44 -12.92 61.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 63.31 111.197 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.0 m -97.04 9.14 42.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.22 0.533 . . . . 65.01 110.426 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.617 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 6.0 mt -145.61 49.35 1.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.584 -0.734 . . . . 72.11 109.612 -174.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.23 6.06 41.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.529 0.937 . . . . 52.52 113.529 -168.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -161.27 155.34 22.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.488 -0.19 . . . . 63.03 110.488 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 33.1 tt0 -56.95 132.61 53.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 123.347 0.404 . . . . 55.41 110.371 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.84 -17.01 36.15 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.706 -0.759 . . . . 44.24 111.663 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 42' ' ' LEU . . . -69.68 121.61 17.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.333 . . . . 75.2 110.302 176.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.524 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 37.7 p -119.15 135.78 54.5 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.045 -0.525 . . . . 74.42 110.432 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.0 t -89.46 178.26 6.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.673 -0.491 . . . . 64.35 109.673 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -67.51 129.27 39.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.375 -0.375 . . . . 74.33 110.069 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -81.36 158.56 24.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.449 0.642 . . . . 62.35 111.316 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 27.7 m -101.22 147.34 8.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.824 -1.08 . . . . 71.51 109.124 171.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.92 86.39 0.58 Allowed Glycine 0 C--N 1.31 -0.911 0 C-N-CA 120.675 -0.774 . . . . 53.04 111.978 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -96.08 166.46 11.75 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.699 -0.482 . . . . 64.32 109.699 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.469 ' HB2' HG22 ' A' ' 130' ' ' THR . 20.7 p-10 -125.45 139.37 53.7 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.407 0.622 . . . . 70.54 111.998 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.2 mt -109.74 107.05 21.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.562 -0.903 . . . . 74.15 108.562 167.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -100.59 135.51 41.91 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.715 -0.675 . . . . 73.2 111.322 -170.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.4 mt -112.12 132.58 54.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.504 -0.771 . . . . 73.11 109.527 175.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -109.07 145.49 35.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.419 -0.355 . . . . 74.43 110.058 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.11 48.71 20.39 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.616 0.722 . . . . 73.32 110.944 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.51 ' SG ' HD22 ' A' ' 124' ' ' LEU . 48.0 t -85.8 155.97 20.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.066 -0.97 . . . . 74.1 110.323 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' HA ' ' ND2' ' A' ' 126' ' ' ASN . 21.1 t70 -128.3 152.86 47.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.524 -0.307 . . . . 73.34 111.512 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.9 p -119.06 5.81 11.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 72.13 111.677 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -84.34 -34.99 23.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.091 0.472 . . . . 74.4 109.978 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.437 HG22 HE22 ' A' ' 159' ' ' GLN . 10.4 p -103.68 -21.36 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 54.23 111.196 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -124.27 -175.53 3.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.269 -0.271 . . . . 72.23 110.269 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.5 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 20.4 m -146.26 -55.8 0.28 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.731 0.301 . . . . 74.0 111.629 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.5 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -135.97 143.81 45.06 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 109.881 -0.414 . . . . 62.41 109.881 -178.603 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.523 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -106.09 127.48 53.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.135 0.493 . . . . 42.14 110.163 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.2 118.82 15.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.509 -0.769 . . . . 70.0 109.016 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.725 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -90.99 146.76 5.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.999 0.428 . . . . 74.11 110.54 -175.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.434 ' HB2' ' CD2' ' A' ' 118' ' ' PHE . . . -118.79 119.13 33.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.782 -0.645 . . . . 62.03 109.354 174.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 93.8 m-85 -84.67 130.88 34.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.993 0.425 . . . . 45.31 110.527 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.9 tp -125.91 123.59 38.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.664 -0.698 . . . . 74.11 109.935 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.5 -170.99 26.93 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.513 -0.635 . . . . 61.14 111.513 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.7 m -84.06 125.49 32.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.62 0.248 . . . . 74.22 110.631 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 83' ' ' THR . . . -87.72 138.98 30.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.591 -0.277 . . . . 73.1 110.515 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.446 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 10.8 tt -64.06 -31.95 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 73.31 111.224 -177.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -145.81 -178.19 5.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.268 -0.642 . . . . 72.33 109.268 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.57 -42.52 24.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.692 0.282 . . . . 63.1 110.865 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.67 -16.77 74.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.58 -0.819 . . . . 75.34 111.951 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -105.12 51.3 0.76 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.13 0.491 . . . . 52.44 109.979 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.405 ' HA ' ' CB ' ' A' ' 77' ' ' ALA . 1.1 p -74.93 3.6 7.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.806 -0.634 . . . . 55.14 112.138 -178.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -104.79 -5.96 20.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.927 0.394 . . . . 75.31 110.671 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.05 120.12 58.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.175 -0.466 . . . . 75.45 110.628 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.494 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -67.51 129.78 40.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.93 -0.396 . . . . 74.31 109.93 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.49 141.62 39.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.27 -0.423 . . . . 51.21 110.605 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.8 mm? -82.38 140.32 33.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.074 -0.512 . . . . 71.03 110.027 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -62.01 127.61 32.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.37 0.605 . . . . 74.01 110.748 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.45 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 0.7 OUTLIER -83.54 115.08 21.94 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.168 -0.924 . . . . 53.32 110.909 -177.312 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.1 m -87.99 -6.89 57.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.062 -0.517 . . . . 73.24 109.776 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.71 16.34 10.45 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.502 -0.772 . . . . 70.54 111.517 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.25 4.28 2.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 53.21 111.452 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.37 64.62 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.289 -0.958 . . . . 51.41 112.749 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 90' ' ' SER . 71.1 m -95.73 149.97 20.91 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.709 -0.289 . . . . 64.02 110.571 173.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.94 125.45 27.61 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.785 -0.45 . . . . 71.34 109.785 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.07 166.46 16.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.35 -0.386 . . . . 71.1 110.243 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 68.88 9.96 7.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.253 0.549 . . . . 63.1 110.446 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.45 -174.47 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.279 -0.873 . . . . 63.21 109.685 173.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.49 -174.5 46.56 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.637 -0.985 . . . . 41.11 110.637 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 p -119.66 115.65 48.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.446 0.641 . . . . 75.14 110.841 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -107.1 142.22 37.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.489 -0.778 . . . . 73.45 109.642 175.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.1 mp -103.12 123.78 56.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.032 -0.531 . . . . 72.51 110.3 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.493 HD11 ' NE ' ' A' ' 136' ' ' ARG . 12.7 mt -86.27 147.64 25.99 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.647 -0.706 . . . . 60.21 109.11 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.585 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.1 p-10 -74.1 -170.99 1.03 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.59 -0.522 . . . . 73.42 109.59 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -69.04 -25.53 64.52 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.975 -0.29 . . . . 65.43 111.554 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.1 p -84.69 -26.47 27.71 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 120.647 -0.421 . . . . 62.1 111.015 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.81 34.51 1.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 60.54 112.825 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -114.73 135.56 54.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.424 -0.213 . . . . 62.2 110.424 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.43 122.74 17.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 55.53 110.836 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.1 mt -88.88 135.84 33.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.367 -0.379 . . . . 75.04 110.614 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.2 m -83.7 145.44 28.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.025 -0.534 . . . . 51.41 110.556 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 52.7 mt -81.34 40.14 0.55 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 73.1 111.275 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -77.02 -22.64 52.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.432 -0.349 . . . . 65.3 111.092 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.17 -11.27 37.4 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.764 -0.731 . . . . 74.23 112.005 -172.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.41 2.56 9.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.178 0.513 . . . . 64.3 110.562 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.9 m -99.74 102.65 14.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.829 -0.623 . . . . 71.25 109.491 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.434 ' CD2' ' HB2' ' A' ' 72' ' ' ALA . 83.8 m-85 -93.81 167.24 11.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.746 -0.661 . . . . 70.3 111.771 -171.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.585 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.9 m -73.93 179.45 4.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.242 -0.89 . . . . 71.22 110.572 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.7 t -69.08 146.01 52.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.246 -0.649 . . . . 74.23 109.246 173.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -54.14 106.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.475 0.484 . . . . 64.12 111.544 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.5 m -91.16 103.76 16.4 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.076 -0.713 . . . . 72.21 109.076 173.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 m -55.41 124.36 16.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.789 -0.641 . . . . 75.21 111.099 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 69' ' ' ALA . 83.7 mt -83.38 150.69 25.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.79 -0.641 . . . . 73.55 111.275 -176.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -129.34 152.29 49.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.174 -0.921 . . . . 70.13 108.747 171.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.8 m120 -65.53 118.39 9.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.996 0.427 . . . . 71.41 110.43 175.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 124.76 -137.88 10.78 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.817 -0.706 . . . . 64.3 112.167 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 20.5 m -88.61 127.81 35.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.411 . . . . 54.33 111.016 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -124.95 112.72 16.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.219 -0.446 . . . . 74.35 110.078 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.8 m -102.98 106.52 17.07 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.798 0.332 . . . . 74.33 110.527 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.7 mt -87.63 115.39 62.76 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.624 -0.51 . . . . 74.14 109.624 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -84.23 132.94 5.38 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.602 2.201 . . . . 64.33 112.841 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.429 ' HE1' ' HG ' ' A' ' 119' ' ' SER . 76.2 m-85 -131.9 159.55 38.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 54.31 110.462 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.681 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 99.2 mt-30 -127.97 112.88 15.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.246 -0.434 . . . . 73.13 111.487 -176.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.54 127.7 45.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.206 -0.452 . . . . 71.51 110.192 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.524 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 15.8 ptp180 -139.06 163.08 33.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.45 -0.341 . . . . 55.13 110.719 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 71.7 m-85 -81.57 142.5 32.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.97 -0.559 . . . . 63.4 110.715 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -130.43 119.79 23.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.639 -0.709 . . . . 74.42 109.421 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 45' ' ' GLU . . . -81.27 137.62 35.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.397 -0.365 . . . . 61.13 111.009 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.442 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 68.9 p -110.13 2.79 19.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.676 0.75 . . . . 53.31 109.349 176.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.22 -129.45 1.74 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.915 -1.039 . . . . 53.5 110.864 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.15 90.26 8.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.848 0.324 . . . . 74.31 110.283 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.64 114.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.491 0.495 . . . . 62.33 111.557 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 26.6 p -104.71 139.62 20.28 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-O 121.385 0.612 . . . . 75.24 110.613 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.59 162.77 41.32 Favored 'Trans proline' 0 C--N 1.333 -0.272 0 C-N-CA 123.799 3.0 . . . . 73.01 112.868 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.63 -162.88 26.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.732 -0.747 . . . . 54.25 111.817 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.84 113.65 8.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.866 0.365 . . . . 63.24 111.338 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.598 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -111.47 63.61 0.61 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.5 0.667 . . . . 75.33 110.357 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -117.48 128.46 55.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.818 . . . . 63.54 109.782 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.494 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -134.21 169.5 17.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.364 -0.38 . . . . 65.43 111.342 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.8 146.36 50.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 63.23 109.62 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.02 138.86 19.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.146 0.498 . . . . 65.14 111.291 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.6 p -107.2 121.81 45.27 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.794 -0.639 . . . . 64.43 109.771 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -102.61 137.19 41.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.367 -0.378 . . . . 73.34 110.528 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HA ' HG21 ' A' ' 16' ' ' VAL . 3.9 tmmm? -119.78 113.08 20.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.344 -0.389 . . . . 75.44 110.345 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.725 HG12 HG12 ' A' ' 71' ' ' VAL . 1.2 m -77.57 137.28 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.773 -0.454 . . . . 70.52 109.773 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -115.2 123.56 49.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.393 -0.367 . . . . 71.03 110.172 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.647 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 3.1 p90 -142.88 -19.07 0.66 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.688 -0.687 . . . . 75.14 109.875 171.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.485 ' HG2' ' CD1' ' A' ' 158' ' ' TYR . 17.1 mm-40 . . . . . 0 C--O 1.251 1.174 0 CA-C-N 115.184 -0.916 . . . . 65.4 109.363 168.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.62 0.248 . . . . 54.14 111.015 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.83 -174.91 3.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.7 -0.227 . . . . 64.15 110.853 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 t -94.56 -10.87 30.75 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.883 0.373 . . . . 71.41 110.849 177.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.0 p -113.84 -179.87 3.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.16 -0.473 . . . . 63.21 109.914 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.98 12.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.898 0.38 . . . . 72.24 110.922 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 61.86 17.89 9.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.58 -0.736 . . . . 75.44 111.872 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.412 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 83.0 95.53 0.56 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.598 -0.81 . . . . 54.25 111.396 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.78 157.39 45.47 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.174 -1.012 . . . . 34.13 111.895 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.473 ' HB ' HG22 ' A' ' 31' ' ' THR . 4.8 p -140.79 138.9 34.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.679 0.276 . . . . 64.22 111.077 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -115.48 120.44 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 116.441 -0.345 . . . . 54.14 110.071 176.025 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -91.09 107.37 19.16 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.165 -0.471 . . . . 65.51 110.08 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.11 125.11 40.42 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.02 -0.536 . . . . 72.52 110.545 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -112.33 133.81 54.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.994 -0.548 . . . . 54.3 111.165 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.07 -130.07 5.62 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.461 -0.79 . . . . 73.11 111.88 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.47 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 44.3 mt-10 62.91 24.13 14.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.123 0.487 . . . . 65.13 110.993 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' A' ' 155' ' ' LYS . 22.1 m -77.85 -34.44 19.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.823 -0.626 . . . . 51.43 111.273 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.584 HG22 HG23 ' A' ' 16' ' ' VAL . 17.9 m -142.89 150.28 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.014 0.435 . . . . 64.14 111.189 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -144.34 22.42 1.68 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.417 -0.81 . . . . 74.01 108.961 175.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.92 -82.99 0.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.491 -0.777 . . . . 54.15 111.255 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.475 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -81.34 -35.65 30.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.796 0.332 . . . . 73.34 110.278 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 m -142.54 135.4 28.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.887 0.375 . . . . 64.54 110.023 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.04 123.97 40.92 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.102 -0.499 . . . . 64.3 109.861 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.487 ' HA ' HD23 ' A' ' 58' ' ' LEU . 14.2 t -61.03 131.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 109.722 -0.473 . . . . 65.34 109.722 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.431 ' O ' HG13 ' A' ' 28' ' ' VAL . 27.7 t70 -59.86 140.07 56.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.107 -0.497 . . . . 61.0 111.335 -176.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.13 -27.34 65.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.793 -0.64 . . . . 71.42 111.819 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.86 7.47 79.94 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.717 -0.754 . . . . 74.31 112.282 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.3 p -129.54 -10.96 4.52 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 122.712 -0.287 . . . . 72.55 111.387 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.47 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 29.2 m -78.24 -5.81 8.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 121.109 0.48 . . . . 73.1 110.505 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -157.2 96.14 1.54 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.446 -0.797 . . . . 73.25 109.015 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -143.64 121.8 12.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.212 0.53 . . . . 64.05 110.546 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 16.4 m -106.83 103.19 12.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.406 -0.815 . . . . 70.22 109.542 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 9' ' ' THR . 11.0 p -89.34 137.41 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.919 0.39 . . . . 73.32 110.97 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -91.05 128.7 36.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.767 -0.651 . . . . 74.44 109.574 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.16 -19.92 24.88 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.103 0.478 . . . . 72.42 110.265 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.6 165.03 35.9 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.868 -0.682 . . . . 32.5 112.082 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -75.18 96.44 3.29 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.055 -0.35 . . . . 62.13 110.055 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 p -80.05 149.34 5.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.152 -0.476 . . . . 74.43 110.274 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.0 mtt85 -83.29 128.68 34.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.996 -0.547 . . . . 64.42 109.864 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 6.6 p -77.78 -13.52 59.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.929 -0.578 . . . . 62.12 111.944 -172.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.14 50.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 65.11 110.915 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.486 ' HB2' HD12 ' A' ' 42' ' ' LEU . 5.5 m -67.42 -29.34 68.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.325 0.583 . . . . 33.45 110.472 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.5 mp -112.77 86.81 2.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.494 -0.775 . . . . 63.11 109.996 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.0 14.58 12.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.127 0.489 . . . . 72.43 111.122 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HG2' ' HB2' ' A' ' 47' ' ' ALA . 3.2 pm0 -141.5 135.91 30.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.052 -0.522 . . . . 75.15 110.324 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.5 tm-20 -59.32 119.97 8.41 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.563 -0.532 . . . . 73.44 109.563 175.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 109.9 -6.29 30.99 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.738 -0.744 . . . . 71.45 111.752 -175.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -65.8 135.31 54.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 73.43 111.005 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.1 p -120.97 140.82 51.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.055 -0.521 . . . . 45.0 110.355 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -104.34 -175.79 2.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.216 -0.447 . . . . 71.22 109.814 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.7 m -75.05 133.51 41.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.459 -0.337 . . . . 60.14 110.19 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -89.92 154.81 19.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.496 0.665 . . . . 74.33 112.021 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 31.5 m -92.82 156.65 3.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.646 -1.161 . . . . 62.25 109.22 169.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 101.65 1.22 Allowed Glycine 0 C--N 1.315 -0.587 0 C-N-CA 120.859 -0.686 . . . . 73.05 112.267 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -111.04 176.59 4.96 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.752 -0.462 . . . . 75.54 109.752 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.549 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.5 p-10 -136.24 149.51 48.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.403 0.621 . . . . 75.12 111.904 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.435 HD12 ' CE2' ' A' ' 133' ' ' PHE . 72.6 mt -113.93 113.86 45.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.11 -0.95 . . . . 61.03 108.684 169.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . 49.8 tt0 -96.83 140.33 31.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.101 -0.499 . . . . 72.43 110.951 -172.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 23' ' ' VAL . 64.5 mt -120.63 122.35 40.33 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.951 -0.568 . . . . 71.24 109.565 177.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -99.39 143.79 29.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.075 -0.511 . . . . 74.31 110.034 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 56.82 44.02 24.05 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.779 0.674 . . . . 75.35 110.845 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.597 ' SG ' HD22 ' A' ' 124' ' ' LEU . 6.0 t -75.24 142.04 43.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.109 -0.496 . . . . 74.42 110.31 -175.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -117.71 142.36 47.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.944 -0.571 . . . . 63.52 112.044 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.4 p -113.28 4.51 16.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.79 -0.641 . . . . 62.42 111.398 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -76.0 -38.1 57.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.975 0.417 . . . . 74.24 110.085 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.404 HG22 ' HG3' ' A' ' 159' ' ' GLN . 12.6 p -107.86 -18.96 7.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.107 -0.497 . . . . 75.02 111.381 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.704 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -126.47 161.75 27.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.741 0.305 . . . . 75.32 111.52 -176.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.551 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 15.0 m -120.18 -55.74 2.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.203 -0.453 . . . . 72.44 111.462 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.551 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -136.53 148.87 47.83 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.81 -0.441 . . . . 65.24 109.81 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.636 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -103.48 140.6 37.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.039 0.447 . . . . 63.53 110.308 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.57 114.17 6.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.6 -0.727 . . . . 65.32 109.067 176.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.655 HG12 HG12 ' A' ' 156' ' ' VAL . 1.3 m -88.13 145.64 7.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.971 0.415 . . . . 60.52 110.834 -173.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.52 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -119.97 123.28 43.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.807 -0.633 . . . . 71.42 109.74 173.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.454 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 57.4 m-85 -86.34 142.52 28.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.2 0.524 . . . . 74.33 111.096 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.6 tp -134.18 123.15 23.87 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.487 -0.778 . . . . 54.41 109.963 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 113' ' ' LEU . . . -164.64 -177.05 36.95 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.767 -0.933 . . . . 62.23 110.767 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.9 m -77.41 121.73 24.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.954 0.377 . . . . 70.43 110.828 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.28 138.68 39.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 62.44 110.529 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.459 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 9.5 tt -69.14 -30.84 47.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 74.13 111.133 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -146.32 178.67 8.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.995 -0.372 . . . . 71.34 109.995 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.71 -30.77 28.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.074 0.464 . . . . 71.34 110.106 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.5 -25.85 31.91 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.726 -0.749 . . . . 54.32 111.539 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.423 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 67.1 m80 -103.5 72.64 1.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.302 0.572 . . . . 74.21 110.046 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 p -92.1 5.43 50.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.547 -0.751 . . . . 72.42 111.853 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -112.43 2.53 16.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 71.13 110.624 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 102' ' ' GLN . 57.6 t -111.01 122.85 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.861 -0.608 . . . . 70.32 110.095 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -69.88 131.38 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.674 0.274 . . . . 74.15 110.275 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.459 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.43 145.72 36.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 52.55 110.441 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.66 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -85.16 135.42 33.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.126 -0.488 . . . . 61.44 109.943 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -59.33 116.17 3.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 72.44 110.099 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 p -67.56 115.4 7.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.818 -0.628 . . . . 61.21 111.978 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.7 m -90.14 -9.82 46.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.778 -0.646 . . . . 52.42 110.146 177.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 67.6 -3.62 1.08 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.384 -0.826 . . . . 74.41 112.282 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -105.08 -22.92 13.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.056 0.455 . . . . 63.41 110.847 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 159.76 76.39 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.456 -0.658 . . . . 73.32 111.456 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 m -92.42 147.8 22.62 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.684 -0.488 . . . . 64.35 109.684 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.72 106.48 1.51 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.048 0.452 . . . . 62.21 110.319 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.36 159.31 15.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.143 -0.481 . . . . 74.01 110.574 -176.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.46 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 48.1 m-80 67.01 13.05 9.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.333 0.653 . . . . 54.51 111.17 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.48 167.62 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 CA-C-N 116.271 -0.422 . . . . 61.11 110.336 175.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.527 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . -169.08 -173.8 37.07 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.221 -1.152 . . . . 52.03 110.221 176.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.78 115.26 47.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.363 0.601 . . . . 65.41 110.647 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.501 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.2 pt20 -100.49 139.77 35.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.771 -0.65 . . . . 63.35 109.365 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.454 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.2 mp -96.36 129.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.955 0.407 . . . . 62.12 110.295 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.537 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 49.0 mt -96.91 141.6 29.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.705 -0.679 . . . . 63.12 109.925 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.577 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.69 -173.05 1.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.131 -0.486 . . . . 74.15 110.033 177.272 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.438 ' HG3' HG23 ' A' ' 107' ' ' THR . 13.7 ptm180 -57.83 -25.28 60.44 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.276 0.473 . . . . 71.22 112.276 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.438 HG23 ' HG3' ' A' ' 106' ' ' ARG . 74.5 p -100.04 1.7 42.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 73.51 111.762 -177.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 83.32 38.09 11.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.642 -0.79 . . . . 71.14 112.713 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.52 136.13 51.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.228 -0.286 . . . . 74.43 110.228 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.91 120.74 14.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.328 -0.396 . . . . 63.22 111.013 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 105' ' ' ASP . 95.1 mt -88.21 129.94 35.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.064 -0.516 . . . . 74.31 110.617 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.8 m -76.43 137.6 39.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.903 -0.589 . . . . 73.45 110.954 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.472 HD13 HD22 ' A' ' 86' ' ' LEU . 37.5 mt -79.56 47.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 74.05 110.98 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -100.11 -14.34 18.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.878 -0.601 . . . . 74.21 110.367 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.4 -13.48 33.86 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.745 -0.74 . . . . 62.23 112.525 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.61 4.83 15.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.943 0.401 . . . . 62.13 111.12 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.2 m -100.5 99.65 10.28 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.555 -0.535 . . . . 65.33 109.555 176.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.529 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 64.1 m-85 -94.26 164.11 13.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.089 -0.505 . . . . 74.45 111.487 -172.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.577 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 8.3 m -72.94 -178.56 2.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.45 -0.795 . . . . 61.42 111.459 177.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 m -69.05 160.95 30.03 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.915 -0.584 . . . . 72.31 109.521 170.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.66 125.96 25.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 74.44 110.944 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.428 HG21 HG12 ' A' ' 131' ' ' ILE . 20.1 m -109.23 98.72 8.1 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.38 -0.97 . . . . 70.44 108.38 168.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.4 m -57.22 116.58 3.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 73.22 111.078 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.636 HD21 ' HB2' ' A' ' 69' ' ' ALA . 76.3 mt -74.83 150.17 39.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.307 -0.86 . . . . 62.43 111.522 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -128.12 150.42 49.98 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.259 -0.882 . . . . 54.53 108.83 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -65.31 109.96 2.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.802 0.334 . . . . 71.53 110.354 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.4 -139.2 10.86 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.637 -0.792 . . . . 63.24 112.517 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 m -86.31 117.79 25.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.942 0.401 . . . . 63.42 111.061 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.526 HD22 ' N ' ' A' ' 129' ' ' ASN . 0.8 OUTLIER -112.16 148.62 33.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.508 -0.552 . . . . 70.41 109.508 178.198 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.549 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.2 m -138.01 113.65 9.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.265 -0.272 . . . . 72.32 110.265 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 10.2 mt -94.46 119.71 66.03 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.982 -0.377 . . . . 63.23 109.982 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 4.9 Cg_endo -84.14 133.31 5.59 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.971 2.447 . . . . 74.11 112.514 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 70.7 m-85 -135.63 163.44 30.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.296 -0.411 . . . . 73.32 110.691 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 90.0 mt-30 -126.71 148.87 49.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.016 -0.538 . . . . 73.42 110.66 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.24 122.52 26.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.182 -0.463 . . . . 50.21 110.335 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 2.1 ptp180 -134.1 164.96 26.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.458 -0.337 . . . . 64.01 110.633 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -83.98 143.07 30.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.116 -0.493 . . . . 63.5 110.555 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.51 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 57.2 t80 -130.17 125.94 36.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.894 -0.78 . . . . 61.24 108.894 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.648 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -89.73 135.18 33.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.017 0.437 . . . . 72.31 111.435 -177.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.545 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 72.2 p -102.53 9.91 39.18 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.756 -0.831 . . . . 55.04 108.756 175.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.09 -123.75 1.2 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.833 -1.076 . . . . 33.32 111.111 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.27 96.65 10.41 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.784 -0.45 . . . . 61.05 109.784 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.93 112.19 0.44 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.699 0.624 . . . . 62.43 111.164 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.7 p -105.12 139.57 20.25 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 115.947 -0.57 . . . . 72.02 109.944 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.83 157.41 58.38 Favored 'Trans proline' 0 C--N 1.328 -0.503 0 C-N-CA 123.417 2.745 . . . . 75.01 113.153 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.33 -165.2 29.43 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.598 -0.728 . . . . 62.24 112.11 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.18 114.57 11.51 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.796 0.331 . . . . 74.42 111.086 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.66 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -109.08 69.96 0.72 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.213 0.53 . . . . 61.1 110.361 176.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -110.34 123.63 50.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.567 -0.531 . . . . 75.14 109.567 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.455 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -132.38 158.81 40.99 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.841 0.353 . . . . 70.41 111.036 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.41 143.84 39.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.252 -0.431 . . . . 71.22 110.15 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.513 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -153.84 157.94 40.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.976 0.417 . . . . 73.12 111.358 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.3 p -109.49 155.12 21.73 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.723 -0.672 . . . . 64.33 109.412 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -127.6 123.22 35.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.092 0.472 . . . . 70.03 110.679 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.607 ' HA ' HG21 ' A' ' 16' ' ' VAL . 9.2 ttmt -102.6 105.63 16.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.095 -0.502 . . . . 71.03 110.359 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.655 HG12 HG12 ' A' ' 71' ' ' VAL . 1.3 m -76.61 128.85 37.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.507 -0.553 . . . . 54.32 109.507 177.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 57.9 tt0 -107.5 129.9 54.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.227 -0.442 . . . . 55.21 110.087 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.704 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -153.35 -23.66 0.15 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.18 -0.464 . . . . 75.0 110.836 174.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.404 ' HG3' HG22 ' A' ' 65' ' ' VAL . 19.9 tm0? . . . . . 0 C--O 1.242 0.679 0 N-CA-C 108.415 -0.958 . . . . 63.53 108.415 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.72 0.295 . . . . 64.24 110.53 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 145' ' ' PRO . . . -99.1 -171.54 2.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.093 -0.503 . . . . 74.32 109.675 174.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.469 HG23 HG23 ' A' ' 4' ' ' THR . 14.6 t -115.99 -14.53 11.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.441 0.639 . . . . 73.52 110.359 176.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.469 HG23 HG23 ' A' ' 3' ' ' THR . 49.0 p -120.95 175.72 5.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.84 -0.618 . . . . 74.44 110.203 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.488 HG22 HG12 ' A' ' 37' ' ' VAL . 35.2 m -91.65 17.39 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.137 0.494 . . . . 63.34 110.662 176.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 61.97 11.85 4.49 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.202 -0.908 . . . . 73.43 112.515 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 35' ' ' GLY . . . 82.97 95.53 0.56 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.43 -0.89 . . . . 52.34 111.566 -176.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.19 160.91 33.88 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.198 -1.001 . . . . 52.45 111.305 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.601 ' HB ' HG22 ' A' ' 31' ' ' THR . 65.8 p -138.88 140.6 38.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.684 0.278 . . . . 72.1 110.439 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.96 122.27 63.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.194 -0.669 . . . . 72.3 109.194 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -90.47 109.69 20.82 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.322 -0.621 . . . . 74.44 109.322 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -97.52 124.05 41.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.899 -0.591 . . . . 63.32 110.173 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -106.51 135.13 48.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.951 -0.568 . . . . 74.13 110.816 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.26 -137.72 6.61 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 121.098 -0.573 . . . . 74.41 112.534 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.408 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 46.4 mt-10 59.34 27.44 16.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.362 0.601 . . . . 64.41 110.774 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.716 HG23 HG22 ' A' ' 17' ' ' VAL . 22.8 m -80.29 -21.93 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.48 -0.782 . . . . 63.15 110.672 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.765 HG21 HG22 ' A' ' 156' ' ' VAL . 3.5 m -148.46 139.27 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.737 -0.665 . . . . 73.1 110.865 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -139.02 26.3 2.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.02 -0.536 . . . . 75.04 109.637 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.09 -86.97 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.28 0.474 . . . . 72.33 112.28 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.485 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -76.4 -16.79 59.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 72.31 111.08 -178.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 58' ' ' LEU . 59.7 m -150.87 157.16 42.57 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.425 -0.954 . . . . 55.14 108.425 178.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.55 116.22 26.19 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.491 -0.559 . . . . 71.01 109.491 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.65 134.04 23.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.378 -0.373 . . . . 64.34 110.113 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.476 ' O ' HG13 ' A' ' 28' ' ' VAL . 16.8 t70 -63.56 142.94 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.503 -0.317 . . . . 64.22 110.923 -177.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -59.43 -27.52 66.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 52.43 112.261 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.24 -21.38 78.0 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.508 -0.853 . . . . 73.35 112.095 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 p -104.73 -12.41 16.36 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.062 0.393 . . . . 74.31 112.062 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 25' ' ' ALA . 31.4 m -80.58 -5.32 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.894 0.378 . . . . 75.35 110.708 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -163.29 89.78 0.63 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.277 -0.638 . . . . 74.15 109.277 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -141.78 132.33 25.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.039 -0.528 . . . . 74.3 110.591 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.601 HG22 ' HB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -107.72 99.29 8.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.757 -0.656 . . . . 43.34 109.286 178.045 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.6 p -82.32 126.87 40.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.108 0.48 . . . . 62.42 111.252 -175.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.564 ' HA ' HG22 ' A' ' 9' ' ' THR . 25.7 mp0 -84.66 120.7 26.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 74.41 109.706 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.74 -28.83 36.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.058 -0.519 . . . . 73.22 110.183 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.494 ' O ' ' HA2' ' A' ' 7' ' ' GLY . . . 106.38 170.96 22.98 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.765 -0.652 . . . . 62.31 111.911 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -83.93 83.6 7.88 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.893 -0.41 . . . . 62.22 109.893 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.488 HG12 HG22 ' A' ' 5' ' ' VAL . 9.7 p -67.8 143.04 15.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.018 0.437 . . . . 75.12 110.65 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -77.73 115.51 17.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.818 -0.628 . . . . 63.14 109.795 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.7 p -61.45 -32.04 72.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.274 -0.421 . . . . 75.25 111.318 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.22 -24.34 66.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.515 . . . . 74.24 111.791 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.1 m -76.22 -23.46 54.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.814 0.34 . . . . 74.42 110.939 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -114.17 92.03 3.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.094 0.473 . . . . 71.44 110.225 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.36 19.26 8.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.004 0.431 . . . . 73.25 111.245 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -149.73 138.34 20.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.942 -0.572 . . . . 74.23 110.52 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.6 tm-20 -55.79 124.02 16.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 53.41 109.61 175.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.0 -3.93 38.58 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.961 -0.637 . . . . 61.5 111.962 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -67.42 123.1 19.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.772 0.32 . . . . 74.31 110.554 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.82 ' HB ' HH11 ' A' ' 136' ' ' ARG . 22.9 p -112.72 121.42 44.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.914 -0.585 . . . . 71.4 111.024 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.47 ' HB2' ' H ' ' A' ' 137' ' ' TYR . 60.7 m -73.81 157.48 36.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.177 -0.465 . . . . 73.21 110.458 175.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.4 m -60.66 127.93 34.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.751 -0.463 . . . . 65.22 109.751 175.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.11 154.95 28.96 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.479 0.656 . . . . 65.11 111.749 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 33.1 m -95.58 147.86 5.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 114.859 -1.064 . . . . 64.14 109.451 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.88 103.06 2.35 Favored Glycine 0 C--N 1.309 -0.964 0 C-N-CA 120.899 -0.667 . . . . 34.2 111.858 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -113.82 179.92 3.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.627 -0.509 . . . . 74.32 109.627 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.5 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 3.9 p-10 -138.34 149.94 46.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.424 0.631 . . . . 54.41 112.308 -173.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.461 HD12 ' CE2' ' A' ' 133' ' ' PHE . 81.1 mt -121.42 113.7 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.932 -1.031 . . . . 74.11 108.484 168.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 29.8 tt0 -99.07 136.9 38.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 65.43 111.181 -172.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 78.3 mt -112.04 129.94 56.04 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.825 -0.625 . . . . 74.14 109.811 176.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -102.87 136.52 42.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.915 -0.584 . . . . 63.43 110.535 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 54.49 75.88 0.27 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 124.008 0.818 . . . . 74.4 112.055 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.6 m -97.55 138.81 34.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.652 -0.704 . . . . 34.15 111.18 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -112.57 137.63 50.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.727 -0.67 . . . . 61.22 110.638 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 p -102.25 6.2 40.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.099 -0.5 . . . . 75.41 111.94 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -90.27 -31.12 17.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.663 -0.495 . . . . 51.32 109.663 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 p -98.27 -22.18 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.733 -0.667 . . . . 72.55 111.337 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -141.58 168.42 19.82 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.028 -0.42 . . . . 25.51 111.029 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.543 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 36.9 m -125.7 -51.7 1.59 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.216 0.451 . . . . 54.22 112.216 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.549 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -132.99 150.46 52.16 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.086 -0.383 . . . . 53.14 110.518 -177.028 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.69 130.42 55.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.916 0.389 . . . . 65.14 109.984 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.34 114.84 8.89 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.585 -0.524 . . . . 73.43 109.585 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.759 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -84.2 145.84 7.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 42.31 111.028 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -117.63 116.92 28.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.498 -0.774 . . . . 51.41 109.806 174.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.409 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 65.7 m-85 -85.54 130.12 34.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.325 0.583 . . . . 64.53 110.979 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.9 tp -128.9 116.02 18.77 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.33 -0.85 . . . . 74.21 109.951 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.34 -171.54 20.04 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.201 -0.76 . . . . 62.01 111.201 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.7 m -85.58 116.14 23.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.864 0.332 . . . . 72.01 110.177 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.05 147.68 36.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.45 -0.341 . . . . 72.12 110.845 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.436 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 9.3 tt -63.52 -30.22 49.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.998 -0.546 . . . . 74.22 110.643 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.82 -178.56 5.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 71.01 109.584 174.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.74 -10.23 59.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.038 0.385 . . . . 74.23 112.038 -174.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.53 -44.05 3.27 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.978 -0.629 . . . . 63.13 111.607 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.406 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 60.7 m80 -97.1 61.15 1.74 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.576 0.703 . . . . 74.43 109.373 177.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -76.69 5.46 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.106 -0.952 . . . . 73.11 112.266 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -106.07 -4.82 19.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.478 . . . . 61.5 110.349 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.26 127.77 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.613 . . . . 72.23 110.448 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.477 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -72.25 134.54 45.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.755 -0.461 . . . . 73.4 109.755 178.382 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.14 149.72 33.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.175 -0.466 . . . . 74.13 110.061 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.5 mm? -82.04 133.19 35.27 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.222 -0.444 . . . . 64.24 110.374 -176.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -68.25 146.41 53.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.831 -0.622 . . . . 43.5 110.834 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.19 97.38 4.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.897 -0.592 . . . . 74.23 110.831 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.0 m -88.11 3.3 49.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.801 -0.636 . . . . 50.13 110.432 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.82 6.2 3.83 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.496 -0.774 . . . . 63.14 111.985 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -108.18 4.01 24.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.061 0.458 . . . . 41.21 110.738 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.14 89.07 1.86 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.721 -0.952 . . . . 74.21 110.721 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.2 m -73.06 145.36 46.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.749 0.309 . . . . 71.11 110.696 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.33 109.01 2.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 73.01 110.502 -175.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.37 160.68 14.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.154 -0.475 . . . . 71.14 110.974 -174.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 72.02 9.26 6.06 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.8 -0.636 . . . . 35.35 110.743 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.94 -172.37 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.852 -0.613 . . . . 62.34 110.459 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.31 -176.95 46.66 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.552 -1.019 . . . . 71.21 110.552 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.54 113.35 40.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.361 0.6 . . . . 64.34 110.648 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -102.29 137.58 40.36 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.223 -0.658 . . . . 72.15 109.223 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.409 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -100.42 120.35 49.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.054 0.454 . . . . 70.31 110.349 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.458 HD11 ' HE ' ' A' ' 136' ' ' ARG . 24.9 mt -86.1 145.86 26.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.686 -0.688 . . . . 72.41 109.225 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.528 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.2 OUTLIER -74.68 -171.93 1.4 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.242 -0.436 . . . . 72.54 109.914 177.569 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.457 HH11 ' HD2' ' A' ' 106' ' ' ARG . 19.0 ptt85 -58.49 -27.33 64.35 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.727 0.269 . . . . 71.44 111.727 -177.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 106' ' ' ARG . 19.0 p -100.45 7.96 43.87 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.877 0.37 . . . . 64.32 111.838 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 83.71 28.09 36.44 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 33.35 113.099 175.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.23 120.12 39.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.222 -0.288 . . . . 74.23 110.222 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 115.81 4.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.898 0.38 . . . . 74.52 110.518 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.7 mt -83.71 132.56 34.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.328 -0.396 . . . . 73.34 111.129 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.516 ' H ' HG21 ' A' ' 117' ' ' THR . 15.6 m -73.05 140.45 47.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.723 -0.672 . . . . 74.22 110.547 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.414 ' CD1' HD22 ' A' ' 86' ' ' LEU . 74.2 mt -78.74 49.25 0.88 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.329 0.585 . . . . 74.35 110.504 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -85.67 -27.58 25.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.49 -0.777 . . . . 74.21 109.983 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.34 -22.47 32.39 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.627 -0.715 . . . . 12.25 111.539 -172.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.21 14.63 14.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.757 0.313 . . . . 30.04 111.119 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.516 HG21 ' H ' ' A' ' 112' ' ' THR . 21.6 m -95.24 105.25 17.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.47 -0.567 . . . . 64.35 109.47 174.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 72' ' ' ALA . 86.5 m-85 -97.41 156.29 16.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.225 0.536 . . . . 74.41 111.473 -173.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 7.3 m -68.92 -178.83 1.3 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.392 -0.822 . . . . 72.42 111.143 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.3 t -69.36 156.69 38.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.883 -0.784 . . . . 73.24 108.883 170.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.549 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 51.7 mt-10 -66.06 109.14 2.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.729 0.299 . . . . 72.34 111.476 -175.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.429 ' OG1' ' HD3' ' A' ' 106' ' ' ARG . 22.7 m -89.08 96.82 10.88 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.644 -0.873 . . . . 53.33 108.644 171.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.6 m -60.07 122.05 13.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.911 -0.586 . . . . 73.14 110.903 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.8 mt -81.87 150.45 27.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.423 -0.808 . . . . 60.5 111.16 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -130.68 161.46 31.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.227 -0.657 . . . . 72.15 109.227 169.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -60.35 112.74 2.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 72.54 110.973 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.47 -141.45 13.0 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.766 -0.731 . . . . 71.22 112.595 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.0 m -82.1 131.56 35.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.791 0.329 . . . . 74.2 111.233 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -130.82 114.47 15.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.158 -0.474 . . . . 74.43 109.873 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.5 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 4.7 m -107.04 117.81 35.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.827 0.346 . . . . 61.23 110.267 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.4 mt -94.39 116.8 66.82 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.988 -0.551 . . . . 74.41 110.174 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.59 138.13 10.59 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.033 2.489 . . . . 64.41 111.958 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.461 ' CE2' HD12 ' A' ' 56' ' ' ILE . 74.0 m-85 -135.35 161.77 34.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.365 -0.379 . . . . 62.43 110.53 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.678 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 43.0 mt-30 -127.91 114.65 17.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 53.31 110.802 -175.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.43 132.38 49.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.68 -0.237 . . . . 71.32 110.55 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.82 HH11 ' HB ' ' A' ' 48' ' ' THR . 12.4 ptp180 -143.1 160.07 41.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.967 0.413 . . . . 75.34 111.206 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.47 ' H ' ' HB2' ' A' ' 49' ' ' SER . 73.3 m-85 -80.32 145.83 31.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.776 -0.647 . . . . 74.22 110.553 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.406 ' HE2' ' CD2' ' A' ' 82' ' ' HIS . 64.4 t80 -131.88 118.45 19.84 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.845 -0.616 . . . . 71.34 109.661 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -86.97 132.66 33.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.299 -0.41 . . . . 75.51 111.235 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.496 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 66.0 p -99.14 5.08 47.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.679 0.752 . . . . 65.21 109.424 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 173.14 -117.78 0.67 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.647 -1.16 . . . . 45.32 110.744 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -94.72 98.47 10.8 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.927 -0.397 . . . . 74.33 109.927 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -50.54 123.71 9.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.018 -0.537 . . . . 60.43 110.807 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 39.9 p -116.02 147.62 39.65 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.125 0.488 . . . . 73.32 110.686 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.423 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 43.4 Cg_endo -64.31 163.18 27.35 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.668 2.912 . . . . 73.25 112.553 -178.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.59 -164.43 27.39 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.645 -0.788 . . . . 61.22 112.065 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -85.35 115.1 22.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.65 0.262 . . . . 70.3 110.459 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -108.48 55.15 0.64 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.138 0.494 . . . . 64.42 111.323 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -105.13 138.98 40.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.062 -0.517 . . . . 73.33 109.895 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.477 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -140.63 179.69 6.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.932 0.396 . . . . 72.25 111.773 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -143.95 137.1 27.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.621 -0.718 . . . . 75.41 109.71 -178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.36 139.84 21.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.892 0.377 . . . . 72.22 111.271 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 30.5 p -103.71 132.28 50.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.195 -0.457 . . . . 51.41 109.899 176.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -107.39 124.05 49.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.104 0.478 . . . . 63.2 110.391 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.619 ' HA ' HG21 ' A' ' 16' ' ' VAL . 3.0 tmmm? -105.62 99.39 8.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.921 -0.581 . . . . 75.24 109.492 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.765 HG22 HG21 ' A' ' 17' ' ' VAL . 1.4 m -74.84 127.96 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.64 0.733 . . . . 73.42 110.178 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -103.67 108.61 19.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.525 -0.761 . . . . 73.44 111.009 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.571 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 2.5 p90 -126.15 -33.95 2.59 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.017 -0.734 . . . . 73.02 109.017 166.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 C--O 1.245 0.834 0 CA-C-N 115.263 -0.88 . . . . 60.11 109.336 168.617 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.417 ' CB ' ' HB3' ' A' ' 36' ' ' GLN . 80.4 p . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.927 0.394 . . . . 74.22 110.682 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 37' ' ' VAL . 27.7 m -86.86 16.65 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.05 0.452 . . . . 75.53 111.083 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 61.93 13.12 5.32 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.566 -0.743 . . . . 71.11 112.211 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.483 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 91.14 101.26 1.25 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.558 -0.829 . . . . 63.42 111.785 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.65 160.19 25.29 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.431 -0.89 . . . . 71.34 111.777 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 33' ' ' GLN . 66.4 p -143.3 149.17 37.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.883 0.373 . . . . 41.32 110.637 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.518 HG22 HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -123.67 117.86 52.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.997 -0.547 . . . . 72.23 110.503 175.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -95.72 112.51 24.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.399 -0.818 . . . . 61.0 110.118 -177.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 59.4 m-85 -94.39 137.29 33.72 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.812 -0.631 . . . . 65.23 110.562 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.598 ' HZ3' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -114.58 137.62 51.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.973 -0.558 . . . . 62.33 110.301 -179.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.21 -133.41 4.06 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.759 -0.734 . . . . 60.23 112.504 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 49.2 mt-10 60.65 21.27 11.19 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.212 0.53 . . . . 62.1 111.115 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.56 HG21 ' HA ' ' A' ' 155' ' ' LYS . 24.8 m -76.32 -23.81 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.748 -0.66 . . . . 75.11 111.132 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.428 HG21 ' CG2' ' A' ' 156' ' ' VAL . 24.1 m -135.71 148.28 28.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.126 -0.488 . . . . 35.31 111.361 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -151.31 26.73 0.68 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.502 -0.925 . . . . 54.42 108.502 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.36 -79.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.115 -0.948 . . . . 54.21 111.408 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.468 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -84.73 -37.53 20.77 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.859 0.361 . . . . 71.32 110.858 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -140.7 132.46 27.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.141 -0.481 . . . . 74.04 109.873 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.58 123.21 37.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.254 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 t -66.44 133.33 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.862 -0.422 . . . . 71.24 109.862 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 28' ' ' VAL . 19.2 t70 -62.05 147.96 45.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 72.22 111.043 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -62.25 -25.39 67.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 74.55 111.783 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 30' ' ' GLN . . . -86.13 -9.76 76.18 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.589 -0.815 . . . . 71.35 111.627 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.0 m -105.23 -23.25 12.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.465 0.174 . . . . 40.34 111.124 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 25.5 m -77.56 -12.18 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.335 0.588 . . . . 74.25 110.215 176.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -153.58 96.01 1.97 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.964 -1.016 . . . . 71.43 109.217 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 24.9 pt20 -148.34 142.81 26.38 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.01 -0.541 . . . . 74.54 110.421 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.506 HG22 ' HB ' ' A' ' 9' ' ' THR . 6.9 m -124.0 101.3 7.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.628 -0.714 . . . . 72.45 109.649 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.18 129.22 39.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.088 0.47 . . . . 75.45 110.407 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.515 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.2 mp0 -85.63 130.57 34.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.698 -0.683 . . . . 63.41 110.245 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.518 HD21 HG22 ' A' ' 10' ' ' VAL . 2.3 mm? -91.27 -17.08 26.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.152 -0.476 . . . . 64.35 110.109 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.483 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 86.58 174.87 49.47 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.939 -0.648 . . . . 72.14 112.476 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.417 ' HB3' ' CB ' ' A' ' 4' ' ' THR . 81.2 mt-30 -77.36 89.11 3.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.137 -0.32 . . . . 74.25 110.137 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.459 HG12 HG22 ' A' ' 5' ' ' VAL . 9.9 p -68.49 144.67 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.804 -0.443 . . . . 53.4 109.804 176.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 38' ' ' ARG . 44.3 mtp180 -85.31 123.75 31.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.899 -0.408 . . . . 73.02 109.899 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 35.6 p -68.7 -23.22 64.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.169 -0.469 . . . . 65.54 111.456 -176.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.98 -15.71 61.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 63.23 111.066 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -87.92 -12.7 43.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.398 . . . . 70.34 110.731 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -129.02 84.75 2.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.225 -0.443 . . . . 65.43 110.089 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.37 19.58 12.71 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.704 -0.399 . . . . 42.41 111.849 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -150.04 140.21 22.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.702 0.287 . . . . 65.32 110.774 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 3.9 tm-20 -56.12 117.96 4.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.714 -0.676 . . . . 65.02 109.478 174.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.35 -1.09 31.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.756 -0.735 . . . . 52.21 112.345 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -74.15 134.4 42.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 73.02 110.708 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.2 p -119.7 145.83 46.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.21 -0.45 . . . . 74.32 110.934 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 t -110.23 -179.23 3.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.307 -0.406 . . . . 61.54 110.08 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.8 m -70.57 140.74 51.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.346 -0.388 . . . . 60.02 110.255 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -95.58 155.79 16.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.455 0.645 . . . . 73.41 111.936 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.7 m -95.61 152.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.485 -1.234 . . . . 73.33 109.265 170.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.23 79.63 0.26 Allowed Glycine 0 C--N 1.312 -0.793 0 C-N-CA 120.795 -0.717 . . . . 32.34 112.315 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 133' ' ' PHE . 41.8 p90 -87.83 162.48 16.95 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.807 -0.442 . . . . 75.24 109.807 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.522 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.8 p-10 -132.05 142.55 49.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.258 0.551 . . . . 51.51 111.733 -174.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.5 mt -106.62 109.14 27.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.604 -0.725 . . . . 75.23 109.305 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -89.33 136.22 33.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.197 0.523 . . . . 74.24 111.111 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.38 124.66 49.43 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.494 -0.776 . . . . 52.2 109.18 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -100.56 130.64 46.65 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.974 -0.38 . . . . 74.1 109.974 -176.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.8 t70 54.92 74.61 0.35 Allowed 'General case' 0 C--N 1.332 -0.189 0 O-C-N 124.0 0.813 . . . . 73.22 110.619 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 38.3 t -102.28 124.06 47.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.228 -0.896 . . . . 75.02 110.066 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -98.33 137.41 37.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.21 -0.45 . . . . 72.53 111.555 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.442 HG22 ' HB2' ' A' ' 124' ' ' LEU . 64.1 p -110.09 18.97 19.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 44.32 112.071 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -98.96 -26.51 14.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.458 -0.571 . . . . 34.04 109.458 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 20' ' ' ALA . 8.8 p -109.0 -2.3 10.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 72.33 110.251 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.754 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -144.21 179.16 7.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 73.3 110.462 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.7 m -141.2 -56.86 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.709 0.29 . . . . 75.43 111.297 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -136.2 143.09 44.19 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.756 -0.461 . . . . 64.24 109.756 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.495 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -102.65 123.49 46.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.072 0.463 . . . . 51.32 110.445 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.55 115.15 16.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.633 -0.712 . . . . 74.45 109.606 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 156' ' ' VAL . 3.3 m -91.53 149.8 3.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.137 0.494 . . . . 63.34 111.282 -173.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -116.08 118.61 33.36 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.726 -0.67 . . . . 73.11 109.904 174.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.522 ' CE1' HG21 ' A' ' 103' ' ' ILE . 49.2 m-85 -87.96 124.14 33.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.19 0.519 . . . . 74.13 110.993 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 56.4 tp -114.97 125.77 54.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.571 -0.74 . . . . 60.22 109.38 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.433 ' H ' ' HB3' ' A' ' 113' ' ' LEU . . . -158.66 -179.56 33.6 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.037 -0.825 . . . . 74.43 111.037 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -67.5 120.26 13.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.785 0.293 . . . . 75.23 110.778 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.49 132.55 35.71 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.972 -0.381 . . . . 73.55 109.972 175.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.484 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 7.3 tt -73.78 -25.66 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.017 0.437 . . . . 73.22 110.941 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 19.1 t70 -159.54 174.53 14.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.423 -0.584 . . . . 75.45 109.423 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.06 -33.15 44.88 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.167 0.508 . . . . 62.32 109.974 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.98 -0.58 80.87 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.216 -0.753 . . . . 51.31 111.216 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 53.5 m80 -131.37 43.35 3.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.938 -0.631 . . . . 74.24 109.958 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 p -71.65 -2.06 15.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 72.14 110.984 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 33.6 p-10 -104.02 9.6 36.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.97 -0.559 . . . . 61.34 110.334 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 t -120.36 123.22 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.858 -0.61 . . . . 71.32 110.174 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.494 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -68.46 124.58 23.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.158 -0.682 . . . . 73.12 109.158 177.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.0 150.31 33.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.887 -0.597 . . . . 50.51 109.846 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.515 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.5 mm? -78.2 126.23 30.49 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.227 -0.657 . . . . 61.43 109.227 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.592 ' HG2' ' HA ' ' A' ' 150' ' ' ALA . 14.1 mm100 . . . . . 0 CA--C 1.512 -0.497 0 CA-C-O 121.639 0.733 . . . . 64.43 109.752 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 C--O 1.233 0.196 0 N-CA-C 109.862 -0.422 . . . . 72.44 109.862 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.05 152.63 29.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.244 -0.28 . . . . 75.41 110.244 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.57 164.09 30.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.613 -0.435 . . . . 65.4 111.208 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 66.48 16.5 10.43 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.583 -0.735 . . . . 63.23 111.104 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.408 ' O ' HD12 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -147.79 -175.07 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 63.21 110.559 175.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -179.68 -167.15 36.49 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.067 -1.213 . . . . 74.24 110.067 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' A' ' 86' ' ' LEU . 2.3 p -135.8 129.35 48.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.724 0.774 . . . . 74.14 110.847 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -110.54 138.78 46.48 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.132 -0.94 . . . . 64.51 110.322 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.522 HG21 ' CE1' ' A' ' 73' ' ' PHE . 3.9 mp -95.02 114.66 32.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.023 -0.732 . . . . 64.32 109.023 173.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 57.5 mt -85.55 128.0 34.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.724 -0.671 . . . . 63.1 110.331 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.685 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 2.8 t70 -57.42 166.34 1.26 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 64.23 110.406 174.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 106' ' ' ARG . 13.4 ptm180 -58.94 -17.5 25.07 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.386 0.514 . . . . 74.23 112.386 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.1 p -92.08 -7.67 48.01 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.836 0.35 . . . . 64.21 111.512 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.66 48.06 3.29 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.868 -0.682 . . . . 70.43 112.319 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -134.04 134.13 42.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.839 -0.212 . . . . 63.53 110.82 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.01 131.98 48.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.613 0.244 . . . . 73.35 110.911 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.549 HD21 ' HB2' ' A' ' 105' ' ' ASP . 84.9 mt -94.57 134.21 37.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.969 0.414 . . . . 74.14 111.283 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 82.0 m -73.45 134.43 43.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.789 -0.641 . . . . 73.14 110.715 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 43.5 mt -81.08 50.59 1.43 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.478 0.656 . . . . 74.21 110.731 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.428 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 13.9 t70 -90.11 -19.9 23.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.224 -0.898 . . . . 74.11 110.787 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.47 -28.76 6.63 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.776 -0.725 . . . . 43.21 112.349 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.75 4.07 21.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.382 . . . . 74.21 111.006 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 114' ' ' ASP . 26.9 m -90.86 99.83 12.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.382 -0.372 . . . . 70.13 110.1 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.656 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 63.1 m-85 -90.04 157.47 17.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 70.54 111.152 -175.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.685 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . 5.4 m -73.72 -167.24 0.44 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.649 -0.705 . . . . 51.23 111.255 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.9 m -80.98 178.41 8.44 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.875 0.369 . . . . 62.41 111.067 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.542 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 38.1 mt-10 -75.09 105.67 6.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.079 -0.51 . . . . 64.31 111.573 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.537 HG21 HG12 ' A' ' 131' ' ' ILE . 88.4 m -87.32 99.46 12.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.819 -0.808 . . . . 74.21 108.819 168.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.3 m -56.91 114.86 2.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.851 -0.613 . . . . 73.21 110.653 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.524 ' C ' HD22 ' A' ' 125' ' ' ASN . 97.5 mt -79.89 146.43 32.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.664 -0.698 . . . . 63.34 110.965 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.524 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -123.06 149.06 44.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.829 -0.804 . . . . 44.34 108.829 174.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 94.6 m-20 -68.52 95.99 0.67 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.964 0.412 . . . . 73.32 110.694 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 146.99 -141.05 9.05 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.998 -0.62 . . . . 73.41 111.8 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.452 ' C ' HD22 ' A' ' 129' ' ' ASN . 29.1 m -81.58 124.71 29.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.001 0.429 . . . . 62.22 110.257 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.481 HD22 ' N ' ' A' ' 129' ' ' ASN . 0.9 OUTLIER -119.8 160.2 23.08 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.321 -0.622 . . . . 54.14 109.321 177.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -149.06 126.57 11.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.24 -0.281 . . . . 75.34 110.24 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.537 HG12 HG21 ' A' ' 122' ' ' THR . 9.2 mt -104.23 109.41 62.52 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.937 -0.394 . . . . 61.14 109.937 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -88.6 127.31 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.821 2.347 . . . . 72.04 112.904 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . 73.6 m-85 -124.9 167.31 14.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.1 -0.5 . . . . 74.22 110.266 178.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.66 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 99.4 mt-30 -124.27 122.14 36.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.923 0.392 . . . . 74.01 111.1 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.85 123.03 47.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.376 -0.375 . . . . 71.45 110.403 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.514 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 5.7 ptp180 -137.86 161.2 37.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.537 -0.301 . . . . 74.53 110.96 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 63.2 m-85 -80.55 147.15 30.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.987 -0.552 . . . . 74.21 111.204 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -134.38 122.48 22.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.392 -0.822 . . . . 73.51 109.003 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.639 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -86.98 135.36 33.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.91 0.386 . . . . 44.23 111.63 -176.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.573 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 34.8 p -109.45 14.72 23.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.712 0.768 . . . . 62.5 109.228 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.17 -132.05 2.51 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 114.722 -1.126 . . . . 52.01 110.293 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.78 100.59 12.77 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.879 -0.786 . . . . 72.13 108.879 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.593 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.47 114.92 0.83 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.013 0.82 . . . . 64.42 110.848 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.6 p -105.63 143.15 26.25 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 116.281 -0.418 . . . . 63.01 110.198 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.84 158.15 58.6 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.165 2.577 . . . . 71.02 112.821 -174.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.84 -174.38 24.98 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.55 -0.75 . . . . 51.43 111.364 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.93 103.84 2.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.968 0.413 . . . . 61.34 111.144 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.515 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -99.68 66.13 1.39 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.238 0.542 . . . . 74.5 110.535 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -119.88 136.88 54.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.867 -0.606 . . . . 61.43 109.814 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.592 ' HA ' ' HG2' ' A' ' 89' ' ' GLN . . . -136.25 163.63 29.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.083 0.468 . . . . 31.42 111.837 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -123.08 135.24 54.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.541 -0.754 . . . . 74.14 109.559 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 12' ' ' PHE . . . -141.52 129.72 22.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.049 0.452 . . . . 71.33 111.275 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 13' ' ' LYS . 49.1 p -106.6 125.5 51.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.136 -0.484 . . . . 71.11 109.921 175.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -105.46 136.49 44.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.168 0.508 . . . . 72.3 111.343 -176.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.656 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 10.1 ttmm -113.05 106.45 14.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.645 -0.707 . . . . 54.22 110.213 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -74.56 141.53 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.199 -0.6 . . . . 62.53 109.573 178.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' A' ' 157' ' ' GLN . 4.1 tt0 -125.79 115.73 20.48 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.164 -0.471 . . . . 64.23 109.789 175.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.754 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 1.3 p90 . . . . . 0 C--N 1.32 -0.684 0 CA-C-O 121.465 0.65 . . . . 73.21 110.324 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.8 p . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 120.78 0.324 . . . . 72.11 110.277 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.441 HG22 HG12 ' A' ' 37' ' ' VAL . 35.7 m -86.47 14.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.093 0.473 . . . . 64.12 111.053 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 62.81 13.95 6.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.452 -0.794 . . . . 72.51 112.359 175.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.505 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 92.42 89.39 1.51 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.673 -0.775 . . . . 65.34 111.82 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.75 158.13 48.2 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.691 -0.766 . . . . 44.1 112.072 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.577 ' HB ' HG22 ' A' ' 31' ' ' THR . 12.9 p -141.4 139.66 33.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.571 0.224 . . . . 64.33 110.904 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -114.33 120.05 63.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.512 -0.551 . . . . 71.32 109.512 174.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -86.17 102.91 14.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.732 -0.47 . . . . 72.0 109.732 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -92.55 105.43 17.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 75.15 109.776 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 50.3 tttp -106.31 136.43 46.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.012 -0.54 . . . . 75.54 110.149 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.45 -112.81 2.44 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.874 -0.679 . . . . 71.51 112.111 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.585 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 28.0 mt-10 61.09 22.72 12.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.25 0.548 . . . . 71.43 110.685 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.645 HG21 ' HA ' ' A' ' 155' ' ' LYS . 19.1 m -77.72 -27.28 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.311 -0.859 . . . . 71.02 111.798 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.65 145.11 34.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.209 0.528 . . . . 65.24 111.821 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -159.65 84.11 0.75 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.911 -1.04 . . . . 74.23 108.236 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.35 -79.1 0.1 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.571 -0.741 . . . . 73.12 110.947 -172.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.524 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -76.76 -33.12 58.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.293 0.568 . . . . 75.34 109.642 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.6 m -141.73 173.64 11.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.327 -0.851 . . . . 54.34 109.165 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.09 123.81 27.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.683 -0.488 . . . . 71.22 109.683 173.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.7 t -66.14 128.82 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.644 -0.502 . . . . 73.25 109.644 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.468 ' O ' HG13 ' A' ' 28' ' ' VAL . 28.8 t70 -60.7 138.02 58.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.99 -0.55 . . . . 73.1 111.203 -176.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.554 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -59.35 -24.94 63.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.822 -0.627 . . . . 75.41 112.126 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.91 -13.14 83.42 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.581 -0.819 . . . . 71.21 112.229 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.8 p -112.43 -9.83 13.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.714 0.264 . . . . 73.4 111.714 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.3 m -86.35 -1.5 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 122.361 -0.212 . . . . 75.23 111.486 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -156.82 42.27 0.35 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.438 0.637 . . . . 73.53 109.552 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -91.98 123.64 35.49 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.491 -0.777 . . . . 72.12 110.127 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.577 HG22 ' HB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -109.84 95.26 5.48 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.525 -0.761 . . . . 42.54 109.606 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.1 p -81.64 130.06 36.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.984 -0.553 . . . . 63.15 111.28 -174.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -83.94 118.97 24.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.711 -0.677 . . . . 54.13 109.933 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.457 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.6 mm? -79.13 -22.49 45.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.347 0.594 . . . . 71.32 109.468 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.22 175.92 39.12 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.384 -0.826 . . . . 70.05 111.78 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -78.63 83.95 4.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.441 -0.207 . . . . 72.41 110.441 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.441 HG12 HG22 ' A' ' 5' ' ' VAL . 8.8 p -66.52 140.28 19.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.471 -0.566 . . . . 60.44 109.471 176.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -86.19 117.83 25.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.216 0.532 . . . . 74.34 109.838 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.623 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 26.7 p -65.75 -21.98 66.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 70.14 111.5 -174.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.56 -17.28 64.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.913 -0.585 . . . . 50.41 111.118 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.7 m -84.02 -14.15 51.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 74.31 111.138 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -123.63 94.49 4.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.925 0.393 . . . . 73.23 109.977 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.39 10.96 10.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.651 0.612 . . . . 44.04 112.651 -170.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -150.04 146.31 26.9 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.873 -0.331 . . . . 64.1 110.851 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -56.35 122.53 12.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.718 -0.674 . . . . 74.02 109.64 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.42 -7.0 32.07 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.646 -0.788 . . . . 72.42 112.272 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -70.61 119.09 14.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 54.45 110.697 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 p -113.31 130.64 56.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.016 -0.538 . . . . 74.54 110.158 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.5 t -89.98 175.47 7.17 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.977 -0.379 . . . . 74.12 109.977 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.1 m -70.77 136.79 49.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.791 -0.448 . . . . 72.22 109.791 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -89.08 159.69 17.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.526 0.679 . . . . 71.4 112.161 -173.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.1 m -91.31 152.42 3.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.715 -1.13 . . . . 71.34 109.552 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.0 106.13 2.44 Favored Glycine 0 C--N 1.312 -0.759 0 C-N-CA 121.095 -0.574 . . . . 71.52 112.076 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -122.77 170.28 10.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.346 -0.613 . . . . 74.31 109.346 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.466 HD22 ' C ' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -135.89 149.93 49.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.449 0.642 . . . . 70.33 112.454 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.0 mt -103.54 119.79 52.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.369 -0.832 . . . . 64.03 109.129 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -102.85 132.28 49.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.095 0.474 . . . . 71.53 111.187 -172.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.2 mt -115.31 124.7 51.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.902 -0.59 . . . . 75.32 109.757 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -98.95 132.67 44.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.166 -0.47 . . . . 62.0 110.355 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.3 t70 55.65 76.45 0.27 Allowed 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.918 0.762 . . . . 75.31 110.807 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.58 146.96 23.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.286 -0.87 . . . . 74.01 111.282 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -116.92 129.69 56.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.476 -0.784 . . . . 74.55 110.849 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.1 p -105.96 16.71 24.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.283 -0.417 . . . . 65.0 111.791 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -92.24 -32.93 14.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.086 0.469 . . . . 73.44 109.92 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.2 p -105.96 -33.67 2.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.154 -0.476 . . . . 65.12 110.692 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -103.81 178.61 4.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 55.33 110.643 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 18.5 m -140.19 -56.9 0.54 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.868 0.366 . . . . 73.21 111.049 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.487 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -135.89 154.82 51.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.343 -0.614 . . . . 73.22 109.343 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.496 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -111.26 133.64 53.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.084 0.468 . . . . 72.12 110.104 176.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.01 117.62 9.79 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.623 -0.717 . . . . 63.5 109.622 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.681 HG12 HG12 ' A' ' 156' ' ' VAL . 1.2 m -90.88 147.24 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.085 0.469 . . . . 54.34 111.226 -174.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.2 123.58 41.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.542 -0.754 . . . . 43.22 109.207 172.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 80.1 m-85 -85.59 135.11 33.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.024 0.44 . . . . 75.4 110.577 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.1 tp -133.49 118.69 18.63 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.807 -0.633 . . . . 64.12 110.308 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.42 -168.88 29.28 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.131 -0.788 . . . . 64.0 111.131 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -81.48 118.96 23.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.83 0.315 . . . . 73.33 111.006 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -77.16 141.77 39.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.251 -0.431 . . . . 74.33 110.366 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 85' ' ' VAL . 5.1 tt -68.11 -32.47 56.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.282 -0.417 . . . . 73.02 111.18 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.64 175.03 11.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.527 -0.306 . . . . 75.23 110.181 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.59 -33.61 35.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.886 -0.597 . . . . 74.42 110.513 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.58 -14.93 59.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.55 -0.833 . . . . 74.04 111.77 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -114.21 57.71 0.7 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.28 0.562 . . . . 53.13 109.574 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.428 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.4 p -77.15 8.5 3.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.382 -0.826 . . . . 70.3 112.474 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.416 ' OD1' HG23 ' A' ' 85' ' ' VAL . 23.4 p30 -108.55 -8.82 15.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.979 0.418 . . . . 75.41 110.802 177.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.489 ' HB ' HG22 ' A' ' 78' ' ' ILE . 48.5 t -98.76 122.56 50.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.459 . . . . 41.12 110.983 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.472 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -70.39 134.46 47.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 74.42 109.84 177.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.44 152.07 32.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.165 -0.471 . . . . 70.03 110.571 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.466 HD22 ' H ' ' A' ' 88' ' ' LEU . 1.9 mm? -78.02 138.45 38.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.232 -0.44 . . . . 70.33 110.391 -177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 70.31 110.211 177.862 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.919 -0.4 . . . . 71.41 109.919 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.432 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -71.68 153.01 42.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.69 -0.485 . . . . 64.41 109.69 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.44 161.22 38.97 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.612 -0.435 . . . . 72.43 111.025 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 66.45 13.33 9.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.916 -0.584 . . . . 74.04 110.748 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.49 179.76 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.773 -0.649 . . . . 73.11 110.177 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -179.83 -173.43 44.85 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.209 -1.157 . . . . 64.51 110.209 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.9 p -121.9 120.03 60.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.281 0.562 . . . . 73.43 110.935 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.456 ' HG2' ' HB2' ' A' ' 138' ' ' PHE . 1.5 pt20 -108.69 150.19 27.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.819 -0.628 . . . . 72.31 109.823 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.446 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.3 mp -111.45 128.1 68.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.181 0.515 . . . . 64.34 110.502 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 13.4 mt -92.93 143.22 26.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.383 -0.826 . . . . 64.34 109.431 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.545 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.0 OUTLIER -70.46 -176.72 1.3 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.287 -0.634 . . . . 53.22 109.287 174.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -64.45 -20.63 66.3 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.197 -0.314 . . . . 73.41 111.708 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.414 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 40.0 p -98.46 6.5 47.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 72.3 111.457 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.76 28.7 28.46 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.972 -0.632 . . . . 73.1 113.464 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.18 128.02 53.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.894 0.347 . . . . 65.33 110.553 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.09 119.05 11.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.859 0.361 . . . . 54.42 110.704 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.6 mt -85.86 129.72 34.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.037 0.446 . . . . 72.43 111.199 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.457 ' H ' HG21 ' A' ' 117' ' ' THR . 78.7 m -73.18 140.65 47.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.623 -0.717 . . . . 74.04 110.557 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 45.4 mt -80.07 40.29 0.47 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.542 . . . . 61.01 111.301 -176.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -81.14 -23.23 38.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.162 0.506 . . . . 73.24 110.278 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.04 -13.54 66.7 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.789 -0.642 . . . . 33.14 111.973 -173.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.9 1.84 11.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.787 0.327 . . . . 74.42 111.728 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.457 HG21 ' H ' ' A' ' 112' ' ' THR . 4.3 m -86.91 88.06 7.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.086 0.47 . . . . 41.22 110.088 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -83.18 152.63 25.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.864 -0.607 . . . . 73.0 111.199 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.9 m -67.82 -179.1 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.742 -0.663 . . . . 64.35 111.431 175.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.6 p -68.65 152.9 44.73 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.316 -0.402 . . . . 30.21 110.377 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.34 107.13 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 75.4 111.543 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 m -94.1 103.5 15.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.356 -0.609 . . . . 62.41 109.356 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.8 m -57.16 122.38 12.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.723 -0.671 . . . . 73.35 111.21 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 69' ' ' ALA . 61.9 mt -78.38 142.32 37.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.128 -0.487 . . . . 70.04 111.077 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.84 148.68 39.66 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.057 -0.72 . . . . 65.54 109.057 170.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -65.37 111.78 3.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.816 0.341 . . . . 75.22 110.256 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 134.56 -126.82 4.26 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.576 -0.61 . . . . 62.52 111.576 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.2 m -108.77 132.44 53.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.848 0.356 . . . . 74.22 110.879 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -127.46 131.46 50.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.35 -0.386 . . . . 61.35 110.592 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.99 115.71 25.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.817 0.341 . . . . 72.1 111.146 176.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mt -93.26 110.71 48.19 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.128 -0.693 . . . . 73.01 109.128 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.31 130.83 7.32 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.467 2.111 . . . . 74.41 112.673 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 73.0 m-85 -129.39 166.36 19.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.067 0.461 . . . . 75.41 111.267 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.627 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 47.6 mt-30 -130.0 124.45 32.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.654 -0.703 . . . . 73.11 110.766 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.64 126.29 54.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.102 -0.332 . . . . 42.53 110.102 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.545 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 6.9 ptp180 -136.72 161.4 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.901 0.381 . . . . 71.13 111.32 -176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 60.5 m-85 -82.04 146.09 29.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 75.4 111.074 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.456 ' HB2' ' HG2' ' A' ' 102' ' ' GLN . 61.1 t80 -132.08 126.71 34.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.49 -0.777 . . . . 74.03 109.178 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.648 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -92.73 135.98 33.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.81 0.338 . . . . 54.41 111.443 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 51.0 p -103.88 0.36 30.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.486 0.66 . . . . 64.32 109.552 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.05 -122.56 0.91 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.124 -0.943 . . . . 74.11 111.302 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.63 94.5 9.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.945 -0.391 . . . . 72.42 109.945 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.623 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -47.58 118.99 2.48 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.507 0.504 . . . . 73.34 111.197 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.2 p -112.79 143.89 29.93 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.171 -0.468 . . . . 64.22 110.708 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.12 174.19 8.33 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.714 2.943 . . . . 53.01 113.278 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.73 -168.35 19.76 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.715 -0.755 . . . . 71.5 111.709 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.38 109.44 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 63.45 110.889 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.402 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . . . -108.37 52.77 0.7 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.656 0.741 . . . . 62.42 109.766 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -108.65 138.24 45.28 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.968 -1.014 . . . . 73.01 109.669 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -144.12 169.38 17.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.42 -0.355 . . . . 62.41 110.101 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.99 144.86 30.37 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.947 -0.39 . . . . 52.31 109.947 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.416 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -152.32 146.12 25.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.081 -0.509 . . . . 70.41 110.705 -177.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 36.0 p -97.5 128.46 44.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.197 -0.456 . . . . 72.23 109.973 176.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -96.42 127.93 42.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.327 0.584 . . . . 73.32 110.042 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.645 ' HA ' HG21 ' A' ' 16' ' ' VAL . 1.8 tmtm? -111.4 100.26 8.89 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.714 -0.676 . . . . 63.21 109.832 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.681 HG12 HG12 ' A' ' 71' ' ' VAL . 1.5 m -77.45 144.3 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.145 0.498 . . . . 70.24 110.471 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 7.3 tt0 -115.02 120.5 40.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.0 -0.546 . . . . 74.42 110.637 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.579 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 9.8 p90 . . . . . 0 C--N 1.326 -0.436 0 O-C-N 123.734 0.646 . . . . 73.51 109.494 170.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.907 0.384 . . . . 74.42 110.427 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.405 ' HB ' ' CB ' ' A' ' 148' ' ' ALA . 35.0 m -87.95 15.05 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.129 0.49 . . . . 72.33 110.399 175.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 62.41 23.51 13.95 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.314 -0.857 . . . . 74.33 112.358 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.486 ' N ' ' HG2' ' A' ' 36' ' ' GLN . . . 77.69 88.13 0.38 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.389 -0.91 . . . . 75.32 111.625 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.17 156.27 46.92 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.566 -0.826 . . . . 71.05 111.998 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.578 ' HB ' HG22 ' A' ' 31' ' ' THR . 5.2 p -142.7 137.18 29.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.559 0.219 . . . . 70.22 110.845 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -111.69 121.36 64.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.602 -0.518 . . . . 52.23 109.602 175.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -88.11 98.42 11.53 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.041 0.448 . . . . 51.52 109.818 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.463 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 61.8 m-85 -88.44 118.35 28.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.927 -0.579 . . . . 72.12 110.044 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 78.3 tttt -112.65 145.28 40.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.384 -0.371 . . . . 63.13 110.486 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -122.66 -116.25 2.32 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.898 -0.667 . . . . 74.15 112.523 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.546 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 93.0 mt-10 64.05 17.7 10.77 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.841 0.457 . . . . 71.3 111.347 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 155' ' ' LYS . 31.0 m -76.85 -28.51 17.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.088 -0.505 . . . . 71.21 111.712 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.515 HG21 ' CG2' ' A' ' 156' ' ' VAL . 17.1 m -137.38 141.41 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.098 0.475 . . . . 63.12 111.973 -176.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -140.39 21.2 2.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.019 -0.992 . . . . 64.33 108.559 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.18 -76.55 0.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.368 -0.833 . . . . 50.21 111.495 -172.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.531 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -88.84 -33.28 17.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.856 0.36 . . . . 73.1 110.751 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -146.09 128.42 15.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.131 -0.486 . . . . 52.41 109.819 -177.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.29 128.56 36.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.321 -0.399 . . . . 73.43 110.29 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 3.6 t -72.5 128.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.019 -0.363 . . . . 74.52 110.019 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.444 ' O ' HG13 ' A' ' 28' ' ' VAL . 16.0 t70 -58.71 142.55 49.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 64.03 111.09 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -59.69 -27.09 66.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.989 -0.551 . . . . 73.13 112.073 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.08 -19.11 73.17 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.59 -0.814 . . . . 41.42 112.066 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.9 p -102.94 -16.04 15.97 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.15 -0.22 . . . . 54.14 111.458 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 25' ' ' ALA . 27.4 m -81.51 -2.85 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.954 0.407 . . . . 74.3 110.313 175.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -158.34 87.67 0.91 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.402 -0.962 . . . . 71.14 108.402 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.463 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 16.0 pt20 -134.9 98.09 3.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.517 0.675 . . . . 63.25 110.804 -176.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.578 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.5 m -82.07 94.53 7.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.151 -0.931 . . . . 70.15 109.279 174.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.7 p -81.72 130.86 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.9 -0.591 . . . . 64.15 111.187 -174.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.432 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.7 mp0 -85.9 127.31 34.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.895 -0.593 . . . . 72.42 110.15 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.91 -30.44 17.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.303 0.573 . . . . 65.43 109.737 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.437 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 100.23 167.85 29.09 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.485 -0.779 . . . . 65.43 111.706 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.486 ' HG2' ' N ' ' A' ' 7' ' ' GLY . 60.4 mt-30 -79.27 86.77 5.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.071 0.462 . . . . 73.34 110.841 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.34 145.96 12.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 71.4 109.875 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -83.39 126.78 33.09 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.362 -0.607 . . . . 74.33 109.362 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.629 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 24.4 p -68.55 -25.02 64.7 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.048 -0.523 . . . . 73.34 111.315 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.49 -10.47 58.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.075 -0.511 . . . . 55.35 111.409 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.8 m -86.94 -7.75 57.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.041 0.448 . . . . 75.13 110.607 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.621 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 4.7 mp -132.73 90.17 2.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 75.41 110.266 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.44 12.32 11.59 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.311 0.486 . . . . 75.34 112.311 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -144.73 141.55 29.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.767 -0.197 . . . . 75.13 110.695 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.451 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 42.9 tt0 -59.5 122.28 13.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.007 0.432 . . . . 64.11 110.141 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.79 -7.06 33.37 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.786 -0.721 . . . . 73.03 111.888 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -68.23 120.88 15.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.92 0.39 . . . . 44.15 110.302 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 p -112.01 125.43 54.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.953 -0.567 . . . . 72.02 110.454 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.409 ' HB2' HD21 ' A' ' 42' ' ' LEU . 8.0 t -84.88 174.91 9.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.486 -0.561 . . . . 70.41 109.486 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.3 m -62.2 136.4 57.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.776 -0.453 . . . . 63.21 109.776 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' A' ' 136' ' ' ARG . . . -95.91 157.25 15.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.309 0.576 . . . . 72.1 111.018 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.1 m -99.18 148.91 5.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.131 -0.94 . . . . 63.41 109.228 172.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.62 86.81 0.54 Allowed Glycine 0 C--N 1.309 -0.947 0 C-N-CA 120.771 -0.728 . . . . 72.4 112.045 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -88.95 170.21 10.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.382 -0.599 . . . . 65.14 109.382 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.546 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.3 p-10 -138.78 150.85 46.54 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.412 0.625 . . . . 51.23 111.904 -175.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.425 HD12 HG11 ' A' ' 71' ' ' VAL . 61.4 mt -109.29 110.28 31.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.176 -0.92 . . . . 62.2 108.599 171.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -96.71 122.45 39.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.989 -0.55 . . . . 72.4 110.787 -173.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.5 mt -106.54 119.36 39.09 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.3 -0.409 . . . . 63.21 110.049 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -96.35 133.28 40.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.097 -0.501 . . . . 74.22 110.044 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 54.35 79.31 0.14 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.776 0.798 . . . . 72.15 110.469 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 42.9 t -112.2 138.51 48.79 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.996 -1.002 . . . . 74.21 109.485 -177.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -116.37 141.55 48.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.845 0.355 . . . . 63.01 111.75 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.5 p -105.42 4.25 30.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.137 -0.483 . . . . 74.32 112.157 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -76.14 -41.86 48.61 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.453 -0.573 . . . . 73.41 109.453 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 p -93.33 -35.2 6.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.747 -0.661 . . . . 60.01 111.021 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -108.19 -174.93 2.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.615 0.245 . . . . 64.44 110.904 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 34.3 m -148.32 -57.46 0.23 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.834 0.349 . . . . 64.42 110.779 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -138.05 141.65 40.33 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.686 -0.487 . . . . 71.14 109.686 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -100.09 130.89 46.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.946 0.403 . . . . 44.11 110.563 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.02 115.21 11.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.875 -0.602 . . . . 53.21 109.587 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.617 HG12 HG12 ' A' ' 156' ' ' VAL . 1.9 m -92.76 147.18 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.986 0.422 . . . . 64.13 111.136 -173.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.491 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -122.63 131.08 53.65 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.969 -0.559 . . . . 62.21 109.516 173.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.557 ' CE1' HG21 ' A' ' 103' ' ' ILE . 49.5 m-85 -95.46 138.56 32.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.94 0.4 . . . . 72.14 111.047 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.6 tp -133.85 134.94 43.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.838 -0.619 . . . . 71.23 110.021 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.83 -160.8 24.96 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.191 -0.763 . . . . 44.31 111.191 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.0 m -88.4 118.42 28.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.929 0.364 . . . . 75.54 110.209 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.45 147.03 31.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.337 -0.392 . . . . 61.23 110.155 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.589 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 7.6 tt -64.41 -26.19 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 63.4 111.139 -177.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -154.56 -179.8 8.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.4 -0.593 . . . . 74.34 109.4 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.44 -32.63 28.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.923 0.392 . . . . 74.52 110.112 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.67 -34.68 24.45 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.699 -0.762 . . . . 61.23 111.561 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -96.64 73.8 2.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.13 0.49 . . . . 70.01 109.972 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.452 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.4 p -95.32 15.4 19.5 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.762 -0.654 . . . . 63.35 111.512 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -112.38 -4.32 14.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.144 0.497 . . . . 73.34 110.921 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 102' ' ' GLN . 48.8 t -115.24 126.34 72.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.995 -0.548 . . . . 71.54 110.198 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.585 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -68.68 131.16 44.74 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.525 -0.546 . . . . 54.41 109.525 178.171 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.54 143.09 36.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.06 -0.518 . . . . 62.33 110.517 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.67 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.6 mm? -75.98 135.78 40.01 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.965 -0.754 . . . . 73.21 108.965 177.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 . . . . . 0 C--N 1.325 -0.471 0 CA-C-O 121.208 0.528 . . . . 74.34 111.06 -175.796 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 109.824 -0.436 . . . . 74.25 109.824 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.01 133.86 48.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.686 -0.487 . . . . 73.21 109.686 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.95 163.87 22.72 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.545 -0.462 . . . . 52.13 110.989 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 66.24 13.7 9.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.604 -0.726 . . . . 65.21 110.496 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.15 -178.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.549 -0.75 . . . . 70.02 109.902 175.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 176.21 -172.24 45.23 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 110.06 -1.216 . . . . 72.4 110.06 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 10' ' ' VAL . 2.3 p -118.8 111.43 33.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.549 0.69 . . . . 74.12 110.898 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.41 ' HB3' HG22 ' A' ' 85' ' ' VAL . 2.4 pt20 -96.11 141.13 29.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.511 -0.768 . . . . 70.02 109.502 177.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.557 HG21 ' CE1' ' A' ' 73' ' ' PHE . 3.8 mp -98.71 127.79 50.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.037 0.446 . . . . 71.13 110.13 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 44.4 mt -99.35 138.94 35.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.504 -0.771 . . . . 61.51 110.63 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.592 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 3.8 t70 -60.67 165.95 3.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.642 -0.708 . . . . 74.31 110.188 170.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.44 ' HE ' ' HB3' ' A' ' 120' ' ' SER . 26.5 ptt180 -54.84 -24.67 24.09 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.474 0.546 . . . . 73.1 112.474 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.2 p -87.13 -20.52 26.93 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.758 0.313 . . . . 72.24 111.719 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.38 44.36 1.26 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.663 -0.779 . . . . 71.21 112.661 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.72 130.16 45.11 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.065 -0.346 . . . . 74.43 110.065 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.72 140.3 57.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 73.32 111.183 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.49 155.21 17.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.94 -0.573 . . . . 72.24 110.555 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -94.46 141.15 28.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.363 -0.38 . . . . 72.34 110.176 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 60.5 mt -84.94 51.04 2.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.012 0.434 . . . . 73.13 110.988 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -108.94 -4.54 16.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.43 . . . . 75.55 110.261 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.82 0.11 39.74 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.017 -0.611 . . . . 35.14 112.739 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -116.73 -17.48 10.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.371 . . . . 63.32 111.105 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.3 m -86.06 94.96 9.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.023 0.44 . . . . 64.24 109.836 174.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.689 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 69.3 m-85 -85.59 162.26 18.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.05 -0.523 . . . . 70.43 110.189 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.592 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . 6.9 m -77.95 -172.16 2.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.882 -0.599 . . . . 64.12 110.943 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.44 ' HB3' ' HE ' ' A' ' 106' ' ' ARG . 35.6 t -68.84 148.77 49.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.869 -0.605 . . . . 72.13 110.165 178.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -63.81 98.29 0.19 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.793 0.33 . . . . 71.14 111.293 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.2 m -78.7 102.28 7.97 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.43 -0.581 . . . . 65.14 109.43 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.0 m -57.23 112.17 1.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.44 -0.8 . . . . 64.13 110.997 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 69' ' ' ALA . 96.0 mt -75.19 143.79 43.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.766 -0.652 . . . . 73.31 111.402 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -125.11 145.24 50.03 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.192 -0.67 . . . . 72.11 109.192 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -53.9 113.02 1.06 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.872 0.368 . . . . 64.32 111.508 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 129.81 -143.09 14.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.15 -0.548 . . . . 62.25 112.462 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.6 m -82.73 122.1 27.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.763 0.316 . . . . 75.11 110.794 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.431 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 21.9 m-80 -114.86 113.08 23.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.976 0.417 . . . . 74.22 110.337 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.546 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.1 m -102.27 106.37 17.17 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.78 -0.645 . . . . 54.43 110.327 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 6.6 mt -91.66 113.4 58.6 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.847 -0.427 . . . . 64.14 109.847 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 24.7 Cg_endo -88.72 133.07 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.873 2.382 . . . . 74.34 112.706 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -133.1 169.81 16.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.826 -0.624 . . . . 73.3 109.733 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.651 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 97.1 mt-30 -126.1 140.42 52.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.018 0.437 . . . . 51.04 111.122 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.05 125.6 41.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.077 -0.51 . . . . 74.45 109.779 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.519 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 36.7 ptt180 -144.36 166.18 25.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.097 0.475 . . . . 73.22 111.513 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.602 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 82.4 m-85 -81.56 131.91 35.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.323 -0.853 . . . . 73.22 110.456 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -118.13 116.19 26.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.457 -0.792 . . . . 72.13 109.366 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -80.78 130.92 35.33 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.18 -0.463 . . . . 73.41 110.996 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.451 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 41.7 p -102.05 9.27 40.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.055 -0.721 . . . . 74.05 109.055 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.41 -120.95 0.94 Allowed Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.933 -1.03 . . . . 75.05 111.018 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.89 95.4 7.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.752 -0.462 . . . . 74.34 109.752 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.629 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -47.3 114.63 0.91 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.716 0.635 . . . . 25.31 111.206 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 p -107.02 139.58 20.55 Favored Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-N 116.082 -0.508 . . . . 72.23 110.373 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.56 159.76 51.75 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 123.679 2.919 . . . . 63.33 113.086 -172.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.95 -167.48 28.28 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.667 -0.697 . . . . 45.22 111.404 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.76 112.06 5.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.922 0.392 . . . . 64.4 110.901 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.67 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -109.8 58.62 0.61 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.505 0.669 . . . . 33.14 110.361 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -116.42 133.42 56.04 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.446 -0.797 . . . . 72.14 110.045 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.585 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -142.16 175.72 9.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.404 -0.362 . . . . 62.25 110.84 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -148.91 150.78 33.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.697 -0.483 . . . . 72.31 109.697 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -154.06 151.26 29.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.86 0.362 . . . . 52.15 110.874 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.405 HG22 ' HB3' ' A' ' 13' ' ' LYS . 10.6 p -108.77 132.96 53.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.096 -0.502 . . . . 60.35 109.835 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.406 ' CD1' HD13 ' A' ' 56' ' ' ILE . 27.9 p90 -106.53 133.67 50.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.25 0.547 . . . . 63.22 111.082 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.689 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 20.7 ttmt -109.59 103.44 12.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.469 -0.787 . . . . 71.41 110.409 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.617 HG12 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -77.95 130.05 36.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.242 -0.651 . . . . 75.41 109.242 176.141 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -114.67 117.86 32.03 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.862 -0.422 . . . . 74.33 109.862 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.595 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 116.225 -0.443 . . . . 75.41 111.075 175.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 120.986 0.422 . . . . 73.43 110.533 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.0 m -83.9 6.99 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.314 0.578 . . . . 63.11 110.439 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 60.77 18.33 8.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.145 -0.934 . . . . 62.21 112.083 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.93 95.67 0.87 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.772 -0.727 . . . . 75.14 111.915 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.48 159.92 31.19 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.43 -0.89 . . . . 74.34 111.366 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.561 ' HB ' HG22 ' A' ' 31' ' ' THR . 60.8 p -139.03 143.55 38.47 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.724 0.262 . . . . 41.42 110.446 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -111.73 123.68 67.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.855 -0.424 . . . . 64.11 109.855 175.415 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -92.5 113.35 25.6 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.106 -0.497 . . . . 74.21 109.869 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.459 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 95.2 m-85 -104.71 125.96 51.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.167 -0.47 . . . . 64.34 110.389 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -117.67 143.74 45.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.978 -0.379 . . . . 71.32 109.978 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.41 -126.56 2.78 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.74 -0.743 . . . . 63.14 112.849 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.651 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 35.8 mt-10 62.21 27.91 16.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.286 0.565 . . . . 71.31 110.581 -174.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' A' ' 155' ' ' LYS . 31.0 m -74.24 -26.48 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.399 -0.818 . . . . 51.41 111.321 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.463 HG21 ' CG2' ' A' ' 156' ' ' VAL . 27.1 m -136.64 147.19 27.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 63.54 111.493 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -143.94 19.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.121 -0.945 . . . . 54.44 109.188 175.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.69 -83.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.538 -0.755 . . . . 70.32 111.489 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.559 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -80.96 -36.53 30.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.934 -0.307 . . . . 64.31 110.724 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 0.8 OUTLIER -143.01 132.98 24.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.735 0.302 . . . . 51.11 110.19 -176.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.32 126.7 39.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.376 -0.375 . . . . 63.51 110.324 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.455 ' HA ' HD23 ' A' ' 58' ' ' LEU . 8.2 t -65.77 131.97 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.235 -0.283 . . . . 74.43 110.235 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.54 ' O ' HG13 ' A' ' 28' ' ' VAL . 22.9 t70 -58.04 140.83 51.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 65.24 111.717 -176.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.55 -25.3 64.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.835 -0.621 . . . . 53.22 112.15 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.72 -24.84 55.03 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.401 -0.904 . . . . 55.11 112.388 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.2 p -98.11 -12.09 22.17 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.873 0.323 . . . . 41.42 111.873 -175.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.651 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 30.8 m -79.85 -4.62 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.672 0.272 . . . . 74.4 111.609 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -166.72 96.01 0.53 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.404 -0.962 . . . . 73.44 108.404 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -145.9 140.78 27.23 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.548 -0.751 . . . . 64.23 109.91 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.561 HG22 ' HB ' ' A' ' 9' ' ' THR . 25.0 m -117.05 103.9 10.71 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.71 -0.677 . . . . 53.15 109.992 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 p -88.26 133.67 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.039 0.447 . . . . 74.42 111.084 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.518 ' HA ' HG22 ' A' ' 9' ' ' THR . 25.3 mp0 -90.67 128.34 36.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 74.01 109.72 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.74 -31.32 21.02 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.156 0.503 . . . . 74.33 110.055 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.64 172.48 24.71 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.668 -0.696 . . . . 73.31 112.025 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -80.79 97.66 7.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.76 0.314 . . . . 72.12 110.358 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.11 143.1 12.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.024 -0.535 . . . . 73.33 110.212 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.436 ' CD ' ' H ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -82.9 127.7 33.75 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.555 -0.535 . . . . 73.31 109.555 177.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.4 p -74.49 -10.04 59.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.148 -0.478 . . . . 74.55 111.584 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.47 -21.25 58.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.254 -0.43 . . . . 74.04 111.379 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.5 m -81.14 -23.42 38.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 71.23 110.868 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.2 mp -114.34 99.04 7.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.107 -0.497 . . . . 75.44 109.923 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.83 11.49 6.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.364 0.505 . . . . 71.25 112.364 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -151.43 152.13 32.63 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.693 -0.403 . . . . 65.53 111.432 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.37 120.03 8.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.634 -0.712 . . . . 73.44 109.484 175.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.05 6.8 39.23 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.676 -0.773 . . . . 75.4 112.032 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.689 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -81.17 120.27 24.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.837 0.351 . . . . 73.43 110.257 176.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.542 HG22 ' HD1' ' A' ' 138' ' ' PHE . 59.9 p -112.44 128.09 56.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.161 -0.472 . . . . 51.13 110.415 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.9 t -84.73 -177.76 6.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.794 -0.447 . . . . 74.31 109.794 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -67.37 137.2 55.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.272 -0.422 . . . . 64.52 110.074 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -92.01 153.52 19.38 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.664 0.745 . . . . 64.01 111.882 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 27.8 m -93.32 153.74 3.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.363 -1.29 . . . . 63.13 109.536 170.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.22 100.54 1.66 Allowed Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.809 -0.71 . . . . 72.2 111.996 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -116.33 -179.4 3.66 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.416 -0.586 . . . . 71.25 109.416 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.547 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.0 p-10 -146.35 152.72 39.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.502 0.668 . . . . 25.35 111.965 -174.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 74.4 mt -113.84 111.86 37.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.911 -1.04 . . . . 70.12 108.303 167.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -97.75 140.93 31.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.985 0.421 . . . . 73.31 110.801 -172.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 23' ' ' VAL . 65.7 mt -117.66 124.66 49.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.841 -0.618 . . . . 74.43 109.491 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -102.6 135.85 43.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.79 -0.641 . . . . 73.4 109.386 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 27.3 t70 56.19 87.65 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.821 0.701 . . . . 63.22 110.486 -176.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' A' ' 124' ' ' LEU . 42.3 t -124.85 134.85 52.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.704 -0.68 . . . . 61.11 110.373 -174.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.09 138.03 47.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 73.21 111.867 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 p -105.35 10.9 33.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.798 -0.637 . . . . 71.14 112.31 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -88.32 -36.33 16.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.018 0.437 . . . . 64.41 110.027 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 p -102.01 -12.55 8.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.875 -0.602 . . . . 74.24 110.435 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -129.13 -174.11 3.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.866 -0.606 . . . . 73.15 110.423 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -150.59 -56.55 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.78 0.324 . . . . 74.23 111.175 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -137.58 141.3 41.32 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.503 -0.554 . . . . 75.14 109.503 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -99.43 130.34 45.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.091 0.472 . . . . 54.25 110.29 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.95 113.66 9.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.559 -0.746 . . . . 72.21 109.792 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.695 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 2.0 m -90.37 146.42 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.272 0.558 . . . . 65.02 110.864 -175.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.54 119.24 34.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.356 -0.838 . . . . 61.42 109.166 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 83.7 m-85 -79.55 137.46 37.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.855 -0.424 . . . . 61.23 109.855 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.9 tp -137.33 115.55 11.73 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.671 -0.492 . . . . 74.34 109.671 -175.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.6 -158.12 10.07 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.524 -0.762 . . . . 74.24 111.379 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.505 ' O ' HD13 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -81.09 116.69 21.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.73 0.265 . . . . 62.41 110.869 -178.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.564 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -79.69 139.31 37.42 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.936 -0.394 . . . . 71.13 109.936 175.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.558 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 6.6 tt -63.62 -36.12 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.904 0.383 . . . . 70.25 110.781 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -151.92 175.17 12.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.31 -0.626 . . . . 73.33 109.31 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.83 -24.58 28.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.997 0.427 . . . . 65.05 110.503 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.84 -21.54 49.93 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.756 -0.735 . . . . 61.53 111.356 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -118.61 62.46 0.78 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.457 0.646 . . . . 71.55 109.518 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.564 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 2.6 p -80.85 7.64 10.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.421 -0.809 . . . . 72.23 111.407 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -106.25 1.55 26.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.056 0.455 . . . . 73.41 110.947 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.544 HG22 ' HB3' ' A' ' 102' ' ' GLN . 61.9 t -117.34 129.4 73.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.015 -0.539 . . . . 70.32 110.164 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.596 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -69.98 133.61 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.715 0.293 . . . . 65.32 110.378 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.14 148.36 34.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.123 -0.49 . . . . 72.12 110.302 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.443 HD22 ' H ' ' A' ' 88' ' ' LEU . 1.7 mm? -81.61 149.82 28.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.246 -0.434 . . . . 73.05 110.499 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 . . . . . 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.594 . . . . 73.3 110.334 179.044 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.912 -0.403 . . . . 75.11 109.912 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.08 147.77 29.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.467 -0.333 . . . . 74.12 110.457 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.48 165.55 27.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.557 -0.292 . . . . 64.45 110.335 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.422 HD22 HG23 ' A' ' 144' ' ' THR . 26.0 m-20 70.11 7.62 6.3 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.327 0.584 . . . . 73.05 110.417 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.35 -177.42 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.272 -0.877 . . . . 70.32 109.644 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 177.22 -170.6 43.25 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.12 -1.192 . . . . 70.32 110.12 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -121.03 115.18 46.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.476 0.655 . . . . 62.32 110.49 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.544 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.6 pt20 -105.39 145.53 30.66 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.63 -0.713 . . . . 75.41 109.532 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.476 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.4 mp -104.96 123.15 58.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.148 0.499 . . . . 72.41 110.385 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 18.8 mt -91.21 139.51 30.68 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.376 -0.829 . . . . 72.5 109.246 177.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.8 OUTLIER -72.57 -169.12 0.51 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.282 -0.417 . . . . 54.32 110.282 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -56.72 -35.07 68.11 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.733 0.272 . . . . 74.12 111.733 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.7 p -87.43 -6.29 58.49 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.883 0.373 . . . . 53.15 111.768 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.89 30.03 10.93 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.606 -0.807 . . . . 73.4 112.804 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.38 134.74 50.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.177 -0.305 . . . . 74.02 110.177 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.37 117.96 10.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.966 0.412 . . . . 72.11 111.175 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.16 132.7 35.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.891 -0.595 . . . . 64.5 110.573 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.3 m -74.33 137.41 42.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.905 -0.589 . . . . 74.31 110.647 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.571 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 36.5 mt -82.43 47.89 1.22 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.067 -0.515 . . . . 70.45 110.971 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -104.93 -0.75 26.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.959 0.409 . . . . 65.11 110.332 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.12 10.57 59.6 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.871 -0.604 . . . . 75.24 112.672 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.32 -23.97 4.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 60.3 110.798 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -80.3 99.43 7.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.96 0.41 . . . . 74.11 110.264 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -89.03 157.88 18.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.02 -0.536 . . . . 62.51 110.635 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.537 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.3 m -64.96 171.15 3.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.019 -0.537 . . . . 62.55 111.08 177.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 42.9 m -65.37 156.76 31.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.459 -0.571 . . . . 73.33 109.459 171.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.495 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 45.7 mt-10 -55.6 121.15 8.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.101 0.477 . . . . 72.43 111.913 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.0 m -105.57 98.84 8.48 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.269 -1.011 . . . . 74.34 108.269 168.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.1 m -59.24 122.05 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.556 . . . . 74.11 110.915 -175.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.539 HD13 ' SG ' ' A' ' 61' ' ' CYS . 96.2 mt -82.96 153.23 25.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.464 -0.789 . . . . 72.25 111.662 -174.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.484 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -123.87 157.32 34.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.356 -0.838 . . . . 72.13 108.911 171.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 3.8 m120 -68.37 99.64 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.913 0.387 . . . . 73.44 110.34 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.06 -136.41 7.95 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.895 -0.669 . . . . 72.31 112.029 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.3 m -84.96 127.58 34.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.022 0.439 . . . . 54.5 110.976 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 33.5 m-80 -128.61 124.94 37.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.968 -0.56 . . . . 54.0 109.9 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.547 HG22 ' HB2' ' A' ' 55' ' ' ASN . 2.5 m -115.65 114.78 25.34 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.974 -0.291 . . . . 75.11 110.702 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.6 mt -92.25 109.81 40.33 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.282 -0.417 . . . . 63.13 109.95 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.33 138.76 10.06 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.767 2.311 . . . . 72.44 112.806 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 62.3 m-85 -136.55 164.13 28.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 72.51 111.113 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 97.5 mt-30 -125.59 125.12 42.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.795 -0.639 . . . . 71.22 110.412 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.48 124.08 51.55 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.199 -0.297 . . . . 53.32 110.199 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 14.9 ptp180 -138.87 160.22 40.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.934 0.397 . . . . 63.21 110.983 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 66.8 m-85 -77.32 139.7 39.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.7 -0.682 . . . . 74.12 110.516 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.542 ' HD1' HG22 ' A' ' 48' ' ' THR . 80.5 t80 -127.59 122.26 32.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.696 -0.684 . . . . 74.15 109.501 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.689 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -93.26 137.13 32.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.074 0.464 . . . . 72.11 111.333 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 52.0 p -103.81 5.51 36.02 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.439 -0.801 . . . . 65.14 109.224 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.26 -131.6 2.33 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.901 -1.045 . . . . 54.34 110.697 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.39 94.89 4.96 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.4 -0.222 . . . . 34.13 110.4 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.23 120.9 3.88 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.546 0.529 . . . . 63.54 111.105 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.422 HG23 HD22 ' A' ' 98' ' ' ASN . 33.2 p -111.57 145.1 31.92 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 121.248 0.547 . . . . 73.02 111.2 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.17 163.16 37.16 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.867 3.044 . . . . 74.31 113.089 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.36 -174.76 21.09 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.993 -0.622 . . . . 54.34 111.937 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.73 108.04 0.78 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.971 0.415 . . . . 42.04 111.207 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.43 43.88 1.07 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 65.25 110.228 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -101.74 147.11 26.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.58 -0.736 . . . . 75.15 109.805 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.523 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -153.79 170.61 20.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.46 -0.337 . . . . 72.01 111.07 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.42 146.02 36.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.435 -0.348 . . . . 64.2 110.219 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.596 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -151.28 149.63 29.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.303 -0.408 . . . . 74.24 110.993 -177.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.7 p -107.21 128.45 54.43 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.019 -0.537 . . . . 73.4 109.621 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -100.01 132.5 45.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.208 0.528 . . . . 75.43 110.831 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.648 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.8 tmtm? -117.19 105.17 11.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.783 -0.644 . . . . 71.4 110.248 -178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.695 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.2 m -74.87 156.52 6.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.173 0.511 . . . . 74.21 110.614 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 157' ' ' GLN . 1.4 tt0 -140.7 118.48 11.72 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.424 -0.807 . . . . 72.3 108.958 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.563 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.535 0 N-CA-C 112.038 0.384 . . . . 65.51 112.038 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.1 p . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 120.973 0.415 . . . . 72.21 110.025 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.554 HG22 HG12 ' A' ' 37' ' ' VAL . 34.2 m -94.26 20.25 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.22 0.533 . . . . 54.15 110.468 175.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 59.75 25.59 14.61 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.934 -1.03 . . . . 75.1 112.542 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.537 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 76.78 89.95 0.27 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.537 -0.839 . . . . 51.01 112.078 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.86 159.95 46.28 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.354 -0.927 . . . . 34.13 112.157 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.582 ' HB ' HG22 ' A' ' 31' ' ' THR . 74.3 p -140.44 145.67 37.28 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.856 -0.424 . . . . 71.12 109.856 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.65 125.25 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 109.803 -0.443 . . . . 74.13 109.803 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -90.04 111.95 23.22 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.73 -0.668 . . . . 54.31 109.6 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -98.86 124.63 43.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.164 -0.471 . . . . 73.12 109.776 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.511 ' HB3' HG22 ' A' ' 153' ' ' THR . 58.6 tttm -118.42 132.88 56.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.444 -0.344 . . . . 74.42 110.644 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.05 -115.11 2.48 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.921 -0.657 . . . . 74.4 112.846 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.467 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 31.6 mt-10 65.18 21.29 12.11 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.939 0.496 . . . . 70.51 111.176 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 155' ' ' LYS . 13.8 m -79.61 -33.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 113.307 0.855 . . . . 61.33 113.307 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.456 HG22 HG23 ' A' ' 16' ' ' VAL . 21.1 m -140.38 150.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.264 0.554 . . . . 72.0 112.436 -171.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -149.57 34.21 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.627 -1.249 . . . . 74.13 107.627 169.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.45 -74.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.048 -0.978 . . . . 65.41 110.88 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.417 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -94.79 -31.59 13.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.841 0.353 . . . . 63.11 110.629 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -142.36 136.24 29.43 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.923 -0.58 . . . . 61.5 109.976 -176.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.51 130.56 45.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.642 -0.254 . . . . 72.25 110.47 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.61 126.39 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.691 0.282 . . . . 73.41 110.245 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.12 143.99 36.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.935 -0.575 . . . . 73.11 111.516 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.67 -27.64 66.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.784 -0.643 . . . . 74.3 111.99 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 -5.16 87.91 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.51 -0.852 . . . . 63.21 112.216 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.2 p -123.59 12.61 9.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.717 0.265 . . . . 70.42 111.717 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.467 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 26.6 m -98.53 -12.78 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.967 0.413 . . . . 75.51 110.417 174.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -157.9 93.14 1.24 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.43 -0.952 . . . . 75.32 108.43 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pm0 -135.96 142.49 44.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.05 0.452 . . . . 72.11 110.19 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.582 HG22 ' HB ' ' A' ' 9' ' ' THR . 3.6 m -120.29 106.7 12.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.774 -0.648 . . . . 65.53 110.108 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 p -87.0 147.43 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 64.22 111.138 -175.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -99.6 117.46 34.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 73.31 110.466 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.402 ' HB3' ' HE2' ' A' ' 137' ' ' TYR . 2.7 mm? -85.99 -29.25 23.65 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.196 0.522 . . . . 63.15 110.083 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.537 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 92.47 171.28 41.01 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.559 -0.746 . . . . 70.14 111.88 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -78.9 91.42 4.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.713 0.292 . . . . 73.05 110.461 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.554 HG12 HG22 ' A' ' 5' ' ' VAL . 9.8 p -72.46 146.78 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.382 -0.599 . . . . 71.23 109.382 175.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -89.07 139.85 30.04 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.944 0.402 . . . . 75.42 110.803 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.9 p -73.13 -7.24 50.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.858 -0.61 . . . . 70.11 111.371 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.67 -26.99 27.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.019 -0.537 . . . . 52.15 110.606 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.531 ' HB2' HD12 ' A' ' 42' ' ' LEU . 9.1 m -74.24 -21.7 59.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 60.15 110.712 -177.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -127.43 107.71 10.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.624 -0.716 . . . . 52.12 109.828 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.78 10.9 3.4 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.708 -0.397 . . . . 65.41 111.781 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -146.66 143.69 28.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.773 0.321 . . . . 72.42 111.351 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.0 tm-20 -57.93 119.51 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.683 -0.69 . . . . 75.34 109.932 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.48 -6.09 29.93 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.793 -0.718 . . . . 54.04 111.999 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -72.69 131.33 42.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.677 0.275 . . . . 50.44 110.344 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.536 HG22 ' HD1' ' A' ' 138' ' ' PHE . 40.1 p -121.04 145.82 47.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.221 -0.445 . . . . 74.22 110.205 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.6 t -99.3 176.58 5.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.12 -0.696 . . . . 74.43 109.12 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.5 m -71.86 140.34 49.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.956 0.408 . . . . 74.4 110.083 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -92.4 159.36 15.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.573 0.702 . . . . 51.43 111.926 -176.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.3 m -98.33 151.84 4.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.463 -1.244 . . . . 70.25 109.16 170.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.7 73.32 0.27 Allowed Glycine 0 C--N 1.313 -0.733 0 C-N-CA 120.761 -0.733 . . . . 61.25 112.353 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -82.22 153.34 25.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.75 -0.463 . . . . 64.14 109.75 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.603 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.1 p-10 -122.78 145.02 48.79 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.185 0.516 . . . . 64.1 111.808 -174.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.437 HD12 ' CE2' ' A' ' 133' ' ' PHE . 67.3 mt -110.85 118.37 57.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.861 -0.792 . . . . 74.21 108.861 171.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -100.77 130.53 46.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 71.41 110.881 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 128' ' ' THR . 40.9 mt -112.35 118.18 34.5 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.823 -0.436 . . . . 72.21 109.823 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -94.54 140.86 29.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.309 -0.405 . . . . 41.31 110.117 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.4 t70 49.0 76.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.136 0.898 . . . . 73.04 110.721 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 41.7 t -109.68 143.73 39.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.05 -0.977 . . . . 70.02 109.564 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -120.79 153.04 37.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.255 0.465 . . . . 64.13 112.255 -171.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.2 p -115.16 -2.59 12.7 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.934 -0.575 . . . . 63.2 111.835 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -72.15 -38.36 69.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.677 -0.49 . . . . 73.02 109.677 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.86 -32.4 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.864 -0.607 . . . . 65.23 111.383 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -110.06 171.98 7.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.764 0.316 . . . . 75.24 111.474 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.434 ' CB ' ' HD2' ' A' ' 68' ' ' LYS . 20.1 m -133.73 -58.43 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.349 -0.387 . . . . 34.24 111.439 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -139.21 136.4 34.96 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.087 -0.338 . . . . 54.23 110.087 -177.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.466 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -99.4 130.07 45.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.278 0.561 . . . . 71.04 110.676 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.66 125.56 19.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.333 -0.848 . . . . 72.04 109.217 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.782 HG12 HG12 ' A' ' 156' ' ' VAL . 2.1 m -95.39 145.13 8.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.927 0.394 . . . . 74.41 110.993 -175.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.82 126.37 54.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.799 -0.637 . . . . 62.25 109.453 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 61.7 m-85 -93.02 137.19 32.6 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.122 0.487 . . . . 73.34 111.16 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.6 tp -134.73 134.1 40.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.7 -0.682 . . . . 61.33 109.709 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.39 -140.31 3.02 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.45 -0.66 . . . . 62.34 111.45 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.504 ' O ' HD13 ' A' ' 86' ' ' LEU . 39.2 m -103.26 118.59 37.12 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.092 -0.336 . . . . 72.13 110.092 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.41 138.26 36.61 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.176 -0.305 . . . . 73.13 110.176 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.599 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 10.4 tt -65.69 -27.82 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 75.22 110.694 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -158.83 176.8 11.88 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.323 -0.621 . . . . 44.55 109.323 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.1 -39.5 23.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.965 0.412 . . . . 70.12 110.244 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.02 -17.53 78.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.833 -0.699 . . . . 51.32 111.456 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.404 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 66.2 m80 -119.77 54.34 1.02 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.552 0.691 . . . . 64.21 109.685 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.568 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -78.78 14.62 1.28 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.13 -0.941 . . . . 72.33 111.86 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -112.57 2.38 16.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.201 0.524 . . . . 53.22 110.415 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.558 HG22 ' HB3' ' A' ' 102' ' ' GLN . 61.1 t -116.61 125.95 73.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 75.23 110.027 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.546 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -70.2 132.16 45.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.805 0.336 . . . . 75.21 110.307 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -80.02 152.86 29.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.833 -0.622 . . . . 64.41 110.149 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.662 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.6 mm? -85.61 144.86 27.63 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.378 -0.374 . . . . 71.24 110.635 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 115.904 -0.589 . . . . 64.14 110.926 -178.444 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 120.876 0.37 . . . . 73.22 110.968 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.448 ' O ' HD23 ' A' ' 88' ' ' LEU . . . -69.06 148.76 49.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.082 -0.508 . . . . 62.11 109.672 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.56 160.18 40.57 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.761 -0.375 . . . . 73.52 110.478 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 65.95 8.8 5.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 73.45 110.232 -174.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.29 154.46 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 115.356 -0.838 . . . . 62.11 109.8 175.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -159.2 -169.15 22.19 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 110.597 -1.001 . . . . 55.33 110.597 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.41 109.25 27.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.53 0.681 . . . . 52.52 110.376 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.558 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.3 pt20 -96.88 150.42 20.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.757 -0.656 . . . . 73.4 109.676 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.54 122.18 67.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.151 0.501 . . . . 64.22 110.869 -175.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 14.4 mt -92.84 146.71 23.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 64.31 109.811 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.4 p-10 -78.43 -169.19 1.58 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.104 -0.498 . . . . 71.51 109.811 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -61.22 -30.05 70.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.928 0.344 . . . . 70.14 111.928 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.1 p -84.47 -10.95 57.03 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.692 -0.403 . . . . 70.33 111.218 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.53 23.89 17.56 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.659 -0.781 . . . . 74.03 112.58 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.61 134.05 51.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.327 -0.249 . . . . 74.15 110.327 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.14 132.3 50.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.074 0.464 . . . . 73.24 111.078 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.5 mt -94.38 141.08 28.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.754 -0.657 . . . . 53.01 110.323 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.1 m -78.99 139.56 38.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.353 -0.385 . . . . 73.13 110.436 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.546 HD13 HD22 ' A' ' 86' ' ' LEU . 36.5 mt -86.05 47.77 1.51 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.3 -0.409 . . . . 73.42 110.918 -176.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -104.45 -3.89 23.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.359 -0.382 . . . . 74.5 110.654 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.5 -0.76 63.52 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.149 -0.548 . . . . 54.2 113.345 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.04 -15.79 9.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.03 0.415 . . . . 62.4 111.103 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -84.94 104.17 14.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.252 -0.431 . . . . 71.14 110.545 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.444 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 96.0 m-85 -94.33 162.02 14.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.159 -0.473 . . . . 73.41 110.468 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.6 m -67.34 179.86 1.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.995 -0.548 . . . . 72.4 111.088 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.0 m -71.91 167.95 18.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.749 -0.463 . . . . 71.23 109.749 172.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.525 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 39.7 mt-10 -68.98 109.03 3.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.984 0.421 . . . . 75.14 111.785 -173.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.0 m -90.92 96.93 10.88 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.798 -0.816 . . . . 62.51 108.798 168.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.0 m -60.55 126.92 29.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.173 0.511 . . . . 72.52 110.484 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.521 HD13 ' SG ' ' A' ' 61' ' ' CYS . 96.5 mt -85.96 153.73 21.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.585 -0.734 . . . . 61.14 112.387 -170.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -128.85 150.53 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.956 -1.02 . . . . 70.05 108.43 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.6 m120 -64.61 107.77 1.5 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.17 0.51 . . . . 63.23 111.016 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.49 -151.21 21.81 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.514 -0.766 . . . . 74.45 111.497 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 50.7 m -89.48 116.92 28.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.267 0.556 . . . . 64.55 111.097 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.445 HD22 ' HB3' ' A' ' 61' ' ' CYS . 36.6 m-80 -110.06 126.64 54.22 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.744 -0.662 . . . . 64.11 109.974 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.603 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.3 m -106.93 114.95 29.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.247 -0.433 . . . . 44.45 110.148 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.1 mt -91.21 118.74 68.69 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.709 -0.478 . . . . 62.34 109.709 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -84.54 129.57 4.29 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.787 2.325 . . . . 73.41 112.656 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.437 ' CE2' HD12 ' A' ' 56' ' ' ILE . 62.6 m-85 -129.45 168.82 15.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.139 -0.482 . . . . 74.51 110.333 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 22.8 mt-30 -135.85 120.29 18.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.926 0.394 . . . . 71.41 111.621 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.23 125.97 51.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.373 -0.376 . . . . 72.41 110.039 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.528 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 6.2 ptp180 -140.35 165.03 28.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 71.41 110.921 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 67.3 m-85 -83.89 145.05 28.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.111 -0.495 . . . . 75.43 110.974 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.536 ' HD1' HG22 ' A' ' 48' ' ' THR . 78.9 t80 -133.58 128.86 36.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.67 -0.695 . . . . 72.11 109.212 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -94.95 133.92 38.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.269 -0.423 . . . . 75.04 111.496 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.549 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 82.0 p -104.57 6.02 34.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.664 0.745 . . . . 75.44 109.279 175.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.86 -129.57 1.95 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.12 -0.946 . . . . 74.41 111.4 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -85.47 93.03 8.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.244 -0.28 . . . . 72.14 110.244 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -45.75 112.66 0.49 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.755 0.659 . . . . 73.33 111.264 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.2 p -102.48 140.49 21.16 Favored Pre-proline 0 N--CA 1.442 -0.861 0 CA-C-O 121.061 0.457 . . . . 71.43 110.417 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.67 165.76 29.77 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 123.534 2.823 . . . . 63.25 112.666 -175.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.5 -149.76 21.84 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.482 -0.866 . . . . 45.11 111.803 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.86 120.81 35.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.155 -0.313 . . . . 71.24 110.155 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.662 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -111.73 50.35 0.85 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 71.54 111.299 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -101.43 136.21 41.65 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.201 -0.666 . . . . 75.31 109.201 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.508 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -143.31 165.32 27.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.619 0.247 . . . . 72.21 111.045 -177.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -135.06 143.7 46.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.34 -0.391 . . . . 70.41 110.204 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.21 141.31 24.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.049 0.452 . . . . 74.33 110.959 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 13' ' ' LYS . 35.9 p -103.28 131.29 50.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.938 -0.574 . . . . 63.24 109.616 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.432 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 53.1 p90 -111.78 140.94 46.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.919 0.39 . . . . 61.11 110.557 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.577 ' HA ' HG21 ' A' ' 16' ' ' VAL . 2.0 tmmm? -127.25 111.11 13.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.656 -0.702 . . . . 73.14 110.092 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.782 HG12 HG12 ' A' ' 71' ' ' VAL . 1.3 m -78.44 143.59 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.018 0.437 . . . . 75.32 110.372 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -126.82 126.26 43.06 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.446 -0.575 . . . . 74.43 109.446 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.657 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 120.936 0.398 . . . . 72.44 111.781 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.424 ' CB ' ' HB3' ' A' ' 36' ' ' GLN . 61.8 p . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.962 0.41 . . . . 62.13 110.891 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.561 HG22 HG12 ' A' ' 37' ' ' VAL . 33.5 m -90.13 15.48 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.11 0.481 . . . . 72.21 110.601 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 62.19 22.72 13.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.16 -0.927 . . . . 75.31 112.541 172.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.523 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 83.14 90.25 0.7 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.46 -0.876 . . . . 71.42 111.916 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -85.23 161.03 35.42 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.436 -0.888 . . . . 43.34 112.382 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.532 ' HB ' HG22 ' A' ' 31' ' ' THR . 60.2 p -140.34 146.21 38.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.645 0.259 . . . . 73.43 110.781 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.461 HG23 HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -122.05 122.08 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.586 -0.524 . . . . 73.43 109.586 170.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -93.09 121.82 34.83 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.834 -0.432 . . . . 71.4 109.834 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 85.2 m-85 -107.69 123.32 48.33 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.841 -0.618 . . . . 74.34 110.46 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.607 ' HB3' HG22 ' A' ' 153' ' ' THR . 41.2 tptt -104.07 137.7 41.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.092 -0.504 . . . . 73.52 110.045 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -125.56 -136.24 4.47 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.709 -0.757 . . . . 34.42 112.836 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.645 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 48.9 mt-10 64.06 20.55 12.24 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.986 0.514 . . . . 64.45 110.89 -176.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 155' ' ' LYS . 26.8 m -69.62 -24.44 27.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.685 -0.688 . . . . 71.4 111.107 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.483 HG21 ' CG2' ' A' ' 156' ' ' VAL . 16.4 m -138.19 141.17 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.171 0.51 . . . . 75.21 112.004 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -143.75 24.78 1.68 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.961 -1.018 . . . . 63.15 108.483 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.73 -73.5 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.414 -0.812 . . . . 74.01 111.047 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.547 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -90.28 -40.88 11.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.901 0.381 . . . . 74.44 110.502 177.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -139.16 133.14 31.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.098 -0.501 . . . . 53.04 110.038 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.95 124.67 40.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.419 -0.355 . . . . 53.43 110.434 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.489 ' HA ' HD23 ' A' ' 58' ' ' LEU . 7.3 t -63.96 133.4 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.669 -0.493 . . . . 64.22 109.669 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.491 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.7 t70 -59.4 140.42 56.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.239 -0.437 . . . . 71.35 110.671 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -60.75 -26.49 67.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.488 . . . . 74.01 112.115 -174.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.55 -23.66 72.46 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.496 -0.859 . . . . 45.22 112.062 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.2 p -102.86 -7.72 21.34 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.913 0.338 . . . . 70.04 111.913 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.645 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 34.1 m -84.4 -2.87 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.063 0.458 . . . . 65.32 110.82 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -165.08 85.19 0.39 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.124 -1.065 . . . . 53.41 108.124 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -137.19 133.22 34.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.552 -0.749 . . . . 53.32 110.469 -173.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.532 HG22 ' HB ' ' A' ' 9' ' ' THR . 3.5 m -110.45 100.57 9.38 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.567 -0.742 . . . . 53.12 109.098 176.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.461 HG13 HG23 ' A' ' 10' ' ' VAL . 8.2 p -84.77 128.32 39.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.228 0.537 . . . . 73.14 110.488 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HG3' HG22 ' A' ' 9' ' ' THR . 26.4 mp0 -88.43 128.61 35.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.541 -0.754 . . . . 63.22 109.718 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.458 HD21 HG22 ' A' ' 10' ' ' VAL . 2.7 mm? -88.74 -34.56 17.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.336 0.589 . . . . 54.42 109.87 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.523 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 104.37 -179.6 24.72 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.433 -0.803 . . . . 55.02 111.813 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.424 ' HB3' ' CB ' ' A' ' 4' ' ' THR . 44.7 mt-30 -84.44 89.85 7.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.829 0.347 . . . . 72.25 110.576 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.561 HG12 HG22 ' A' ' 5' ' ' VAL . 9.5 p -70.81 141.82 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 73.14 110.267 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.54 137.27 40.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.972 -0.558 . . . . 60.13 109.965 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.3 p -86.88 5.17 38.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.468 0.652 . . . . 63.34 110.346 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.31 -27.87 18.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.433 -0.803 . . . . 53.15 110.737 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.476 ' HB2' HD12 ' A' ' 42' ' ' LEU . 12.3 m -72.23 -41.46 66.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.427 0.632 . . . . 70.24 110.342 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.1 mp -98.88 114.51 27.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.362 -0.835 . . . . 74.33 109.54 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.4 10.78 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.217 0.451 . . . . 65.12 112.217 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -150.57 153.51 35.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.552 0.215 . . . . 74.13 110.854 -177.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -65.58 121.11 14.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.022 -0.732 . . . . 75.32 109.022 176.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.424 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 106.27 2.57 38.46 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.591 -0.814 . . . . 64.12 111.761 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -80.91 140.4 35.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.817 0.341 . . . . 62.51 110.74 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.8 p -126.36 151.6 47.4 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.977 -0.556 . . . . 73.42 110.991 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.493 ' O ' ' HD2' ' A' ' 136' ' ' ARG . 27.3 t -104.07 179.47 4.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.044 -0.725 . . . . 53.24 109.044 174.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.3 m -73.54 129.59 38.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.239 -0.282 . . . . 53.45 110.239 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.665 ' HA ' ' HB3' ' A' ' 136' ' ' ARG . . . -82.29 157.6 23.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.595 0.712 . . . . 70.11 112.019 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.2 m -98.12 152.13 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.61 -1.177 . . . . 64.43 109.622 172.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.54 94.78 1.02 Allowed Glycine 0 C--N 1.313 -0.743 0 C-N-CA 120.785 -0.722 . . . . 60.22 112.276 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -107.93 178.34 4.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.031 -0.729 . . . . 72.11 109.031 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.599 ' HB2' HG22 ' A' ' 130' ' ' THR . 0.3 OUTLIER -148.97 151.51 34.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.964 0.727 . . . . 63.51 112.964 -177.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.4 HD12 ' CE2' ' A' ' 133' ' ' PHE . 83.0 mt -109.53 111.8 37.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.905 -1.043 . . . . 73.41 108.837 173.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 52.8 tt0 -94.55 135.01 36.49 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.198 -0.455 . . . . 71.43 111.074 -172.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 23' ' ' VAL . 75.4 mt -116.12 119.32 35.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.25 -0.432 . . . . 63.45 110.288 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -101.41 146.1 28.06 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.074 -0.512 . . . . 63.44 110.06 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 52.04 65.73 1.41 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.635 0.731 . . . . 73.21 110.224 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.481 ' SG ' HD13 ' A' ' 124' ' ' LEU . 39.1 t -100.24 137.26 38.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.245 -0.889 . . . . 64.12 110.258 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.44 ' OD2' HG12 ' A' ' 65' ' ' VAL . 17.1 t70 -111.64 137.75 49.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.213 -0.448 . . . . 73.12 111.494 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -102.32 0.98 35.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.133 -0.485 . . . . 73.23 112.246 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -79.74 -34.75 39.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.852 0.358 . . . . 64.5 110.371 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.471 HG13 ' HB2' ' A' ' 20' ' ' ALA . 11.7 p -107.5 -12.37 10.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.035 0.445 . . . . 55.13 110.928 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -122.8 179.41 4.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.709 0.29 . . . . 71.21 111.152 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.2 m -143.6 -59.17 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.3 -0.409 . . . . 52.14 110.796 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -137.94 139.58 39.83 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.576 -0.527 . . . . 65.33 109.576 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.403 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -100.27 118.53 36.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.143 0.497 . . . . 62.13 110.471 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.16 119.11 21.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.545 -0.752 . . . . 74.45 109.476 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 156' ' ' VAL . 2.4 m -90.31 146.49 6.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.963 0.411 . . . . 72.01 110.838 -175.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.07 142.3 46.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.599 -0.728 . . . . 43.03 109.149 172.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.471 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 78.3 m-85 -106.68 140.06 40.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.114 0.483 . . . . 71.14 110.93 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.3 tp -131.54 138.03 48.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.554 -0.748 . . . . 75.14 109.746 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.434 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -174.39 -160.06 21.86 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.23 -0.748 . . . . 31.1 111.23 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.4 m -91.82 114.37 26.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.671 0.235 . . . . 64.1 110.538 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.83 134.33 43.33 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.07 -0.344 . . . . 65.33 110.07 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.629 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 7.9 tt -63.54 -28.49 45.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.175 -0.466 . . . . 74.22 111.515 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -154.03 -178.94 7.42 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.79 -0.448 . . . . 71.22 109.79 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.81 -29.68 23.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.306 0.574 . . . . 73.43 109.703 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.44 -33.23 53.45 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.785 -0.721 . . . . 61.45 111.572 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -112.97 86.82 2.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.126 0.489 . . . . 73.31 110.155 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.5 p -93.56 8.74 39.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.821 -0.627 . . . . 70.22 111.411 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -115.14 0.47 13.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.146 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 102' ' ' GLN . 85.3 t -114.55 121.89 67.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.292 -0.413 . . . . 63.34 110.12 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.771 HD22 HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -70.56 130.09 40.92 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 110.039 -0.356 . . . . 64.12 110.039 -178.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.629 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.1 149.38 35.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.864 -0.607 . . . . 75.41 110.417 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.571 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -86.18 138.45 31.89 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.274 -0.421 . . . . 74.5 110.345 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 121.356 0.598 . . . . 64.42 110.584 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.421 ' HA ' ' H ' ' A' ' 147' ' ' ALA . 67.4 m . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 110.115 -0.328 . . . . 61.41 110.115 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.3 129.49 38.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.341 -0.39 . . . . 74.11 110.41 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.63 163.64 20.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.39 -0.368 . . . . 63.15 110.66 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 69.41 9.38 7.26 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.565 0.54 . . . . 52.41 110.409 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.87 174.12 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.423 -0.808 . . . . 71.13 110.133 174.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.528 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . -172.33 -174.05 39.41 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.255 -1.138 . . . . 62.1 110.255 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.15 114.81 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.469 0.652 . . . . 61.2 110.565 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.463 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.4 pt20 -104.54 145.03 30.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.753 -0.658 . . . . 74.22 109.396 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.471 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -104.13 123.63 58.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.142 0.496 . . . . 73.24 110.254 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 16.7 mt -91.46 144.63 25.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.503 -0.771 . . . . 75.43 108.947 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.548 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.1 p-10 -71.63 -171.7 0.69 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.7 -0.481 . . . . 74.43 109.7 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.441 ' CG ' ' HB3' ' A' ' 120' ' ' SER . 12.8 ptm180 -63.28 -25.2 68.21 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.098 0.407 . . . . 75.44 112.098 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.1 p -85.88 -34.33 21.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.709 -0.396 . . . . 71.41 110.759 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.74 29.6 1.38 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.655 -0.783 . . . . 61.54 112.446 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.08 131.32 54.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.034 -0.358 . . . . 71.23 110.034 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.35 120.88 15.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.398 -0.365 . . . . 52.21 110.797 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.7 133.31 33.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.168 -0.469 . . . . 60.34 110.539 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.536 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 16.2 m -69.38 139.34 54.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.164 -0.471 . . . . 74.4 110.445 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.771 HD13 HD22 ' A' ' 86' ' ' LEU . 29.6 mt -84.37 47.44 1.35 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.202 -0.454 . . . . 64.54 111.055 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -107.14 -6.04 17.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.964 0.412 . . . . 74.2 110.487 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.69 1.42 77.48 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.972 -0.632 . . . . 70.42 112.621 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -120.7 -0.85 10.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.008 0.432 . . . . 71.51 110.973 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.536 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 10.7 m -98.5 112.4 24.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.059 -0.518 . . . . 70.55 109.659 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -103.67 162.38 13.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.189 0.518 . . . . 75.31 111.492 -172.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.548 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.7 m -77.63 -175.0 3.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 63.51 111.405 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.441 ' HB3' ' CG ' ' A' ' 106' ' ' ARG . 42.5 t -63.74 153.86 35.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.043 -0.526 . . . . 62.44 110.572 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.564 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 40.4 mt-10 -68.35 97.84 0.78 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.916 -0.584 . . . . 73.34 110.686 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.6 m -79.54 100.5 7.78 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.442 -0.577 . . . . 64.33 109.442 173.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.8 m -57.07 114.95 2.35 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.906 -0.588 . . . . 61.32 110.683 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.481 HD13 ' SG ' ' A' ' 61' ' ' CYS . 91.3 mt -80.47 150.5 29.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.659 -0.7 . . . . 65.32 111.444 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -136.3 157.46 46.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.684 -0.858 . . . . 74.32 108.684 170.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -59.03 115.88 3.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.709 0.29 . . . . 51.2 110.868 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 131.45 -138.44 10.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 64.22 112.383 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 54.9 m -97.43 125.06 41.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.285 0.564 . . . . 75.21 111.378 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -121.97 110.97 16.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.5 -0.773 . . . . 61.44 109.612 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.599 HG22 ' HB2' ' A' ' 55' ' ' ASN . 5.7 m -103.54 116.93 33.29 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.435 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.61 112.9 59.61 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.093 -0.503 . . . . 65.12 110.479 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -80.3 143.37 15.61 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.504 2.136 . . . . 75.53 112.633 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 105' ' ' ASP . 68.2 m-85 -140.64 165.67 26.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 74.44 110.618 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.629 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 96.4 mt-30 -126.7 121.31 31.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.178 -0.465 . . . . 72.03 111.011 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -110.34 130.21 55.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.189 -0.3 . . . . 71.55 110.189 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.665 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 39.8 ptt180 -149.78 170.68 18.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 74.04 111.397 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 92.0 m-85 -86.37 145.33 26.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.593 -0.73 . . . . 71.33 111.084 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.424 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 75.3 t80 -130.33 133.28 46.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.244 -0.889 . . . . 72.25 108.644 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -100.52 138.7 37.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.039 0.447 . . . . 70.32 111.617 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.546 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 57.0 p -102.98 3.36 36.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.506 -0.77 . . . . 70.33 109.575 176.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.57 -132.92 2.73 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.998 -1.001 . . . . 41.32 110.86 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.54 91.47 2.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.063 -0.347 . . . . 62.13 110.063 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.12 112.49 0.58 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 53.54 111.333 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -104.24 141.44 22.53 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 116.052 -0.522 . . . . 55.24 110.593 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -71.1 171.78 15.24 Favored 'Trans proline' 0 C--N 1.334 -0.222 0 C-N-CA 123.877 3.051 . . . . 73.52 113.035 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.6 -161.35 26.61 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.665 -0.779 . . . . 75.12 111.989 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.421 ' H ' ' HA ' ' A' ' 95' ' ' SER . . . -79.31 112.52 16.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.652 0.226 . . . . 64.2 110.397 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.571 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -113.75 71.92 0.76 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.447 . . . . 72.13 111.375 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -120.92 128.09 52.44 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.444 -0.576 . . . . 73.34 109.444 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.488 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -130.5 171.86 12.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 72.33 111.913 -173.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -129.9 127.22 39.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.667 -0.697 . . . . 73.41 110.428 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 12' ' ' PHE . . . -139.13 125.81 20.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.191 0.519 . . . . 43.23 110.784 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.607 HG22 ' HB3' ' A' ' 13' ' ' LYS . 16.9 p -105.86 130.07 53.9 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.937 -0.574 . . . . 74.44 110.143 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -106.44 141.21 38.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.183 0.516 . . . . 75.13 111.072 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.675 ' HA ' HG21 ' A' ' 16' ' ' VAL . 3.9 tmmm? -126.38 109.39 12.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.602 -0.726 . . . . 73.24 109.808 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -75.2 142.86 14.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.029 0.443 . . . . 75.32 110.321 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -122.31 121.6 37.11 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.5 -0.556 . . . . 74.11 109.5 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.579 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 1.1 p90 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.394 . . . . 75.54 111.075 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 p . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.969 0.414 . . . . 62.22 110.723 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.549 HG22 HG12 ' A' ' 37' ' ' VAL . 33.7 m -89.52 13.69 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.824 0.345 . . . . 54.51 110.871 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 60.61 16.29 6.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.356 -0.838 . . . . 65.44 112.648 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.32 107.02 3.05 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.575 -0.821 . . . . 65.52 112.127 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.578 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -98.23 150.35 19.38 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.383 -0.913 . . . . 44.02 111.772 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.523 ' HB ' HG22 ' A' ' 31' ' ' THR . 16.9 p -142.55 145.45 33.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.746 0.308 . . . . 60.21 110.766 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.628 HG22 HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -121.39 119.65 59.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.955 -0.566 . . . . 74.31 110.789 175.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -86.65 123.45 31.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.413 -0.812 . . . . 63.22 110.124 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -107.93 126.89 53.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.289 -0.414 . . . . 74.14 110.374 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HB3' HG22 ' A' ' 153' ' ' THR . 64.7 tttp -111.88 129.14 56.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.133 -0.485 . . . . 55.44 110.087 177.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.4 -123.99 5.34 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.871 -0.681 . . . . 75.02 111.906 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 34.7 mt-10 64.33 16.35 10.07 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.135 0.493 . . . . 73.5 111.522 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 155' ' ' LYS . 27.2 m -81.33 -21.63 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.936 -0.575 . . . . 70.35 111.284 -177.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.539 HG11 HG22 ' A' ' 156' ' ' VAL . 18.5 m -137.74 141.88 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.296 0.569 . . . . 53.22 111.352 -176.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -147.0 23.24 1.2 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.289 -1.004 . . . . 71.24 108.289 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.2 -92.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.306 -0.861 . . . . 73.03 111.107 -176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -73.2 -35.53 66.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.898 0.38 . . . . 55.5 110.776 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 1.4 m -141.59 133.12 26.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.938 -0.574 . . . . 73.2 109.825 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.96 126.3 41.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.25 -0.432 . . . . 23.1 110.276 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 t -67.4 131.62 32.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.773 -0.454 . . . . 70.33 109.773 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.438 ' O ' HG13 ' A' ' 28' ' ' VAL . 19.4 t70 -62.62 151.53 37.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.436 -0.347 . . . . 75.31 110.949 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.421 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -57.85 -36.02 71.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 73.3 111.472 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.24 -2.01 86.68 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.903 -0.665 . . . . 74.32 111.961 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.414 ' OG ' HG23 ' A' ' 56' ' ' ILE . 46.5 t -119.6 -3.45 10.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.502 0.191 . . . . 72.34 110.901 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 32.9 m -94.34 -14.34 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.61 -0.515 . . . . 64.34 109.61 172.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -150.38 91.17 1.72 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.194 -0.912 . . . . 75.32 109.577 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -141.17 141.96 34.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.143 0.496 . . . . 71.14 109.978 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.523 HG22 ' HB ' ' A' ' 9' ' ' THR . 9.1 m -123.41 109.6 14.08 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.83 -0.623 . . . . 65.11 109.664 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.411 HG12 HG23 ' A' ' 10' ' ' VAL . 10.9 p -86.29 136.39 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.949 0.404 . . . . 73.43 110.324 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.516 ' HA ' HG22 ' A' ' 9' ' ' THR . 27.0 mp0 -93.31 115.08 27.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.989 -0.551 . . . . 54.24 110.43 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.628 HD21 HG22 ' A' ' 10' ' ' VAL . 2.7 mm? -76.96 -30.03 55.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.65 -0.705 . . . . 73.32 109.61 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.94 -173.48 30.6 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.511 -0.768 . . . . 64.24 111.75 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -83.54 90.45 7.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.564 0.221 . . . . 60.12 110.541 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.549 HG12 HG22 ' A' ' 5' ' ' VAL . 7.5 p -61.6 141.32 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.183 0.516 . . . . 53.43 110.399 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -86.49 116.01 24.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.794 -0.639 . . . . 73.33 110.098 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 p -70.62 -12.65 61.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.362 -0.835 . . . . 73.13 112.197 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.26 -30.47 48.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.887 0.375 . . . . 63.3 111.006 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.438 ' HB2' HD12 ' A' ' 42' ' ' LEU . 15.2 m -70.28 -40.66 74.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.547 0.689 . . . . 72.13 110.277 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -99.31 87.08 3.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.48 -0.782 . . . . 75.54 110.298 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.13 14.21 9.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.019 0.438 . . . . 72.51 111.257 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -154.64 146.74 23.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.782 -0.645 . . . . 71.1 109.504 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 43.1 tt0 -60.1 136.52 58.05 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.103 -0.332 . . . . 73.45 110.103 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.97 -14.3 60.13 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.606 -0.806 . . . . 63.24 111.813 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.35 125.15 25.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.698 0.285 . . . . 52.23 110.448 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 20.3 p -117.41 140.5 49.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.323 -0.399 . . . . 61.51 110.515 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.1 t -86.39 174.51 8.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.74 -0.466 . . . . 55.51 109.74 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -68.0 134.53 50.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.504 -0.554 . . . . 61.21 109.504 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -87.06 155.67 20.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.429 0.633 . . . . 72.04 111.757 -175.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.5 m -90.96 152.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.688 -1.142 . . . . 72.43 109.024 169.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.05 87.16 0.46 Allowed Glycine 0 C--N 1.31 -0.888 0 C-N-CA 120.784 -0.722 . . . . 41.1 111.776 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -101.68 173.12 6.56 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.769 -0.456 . . . . 73.32 109.769 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -140.82 146.92 38.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.905 0.383 . . . . 61.22 111.244 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.417 HD13 ' CE1' ' A' ' 154' ' ' PHE . 41.1 mt -102.58 122.45 54.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.605 -0.725 . . . . 72.34 109.251 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -100.72 126.86 47.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.099 -0.5 . . . . 74.25 111.305 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 128' ' ' THR . 70.4 mt -111.44 129.5 56.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.664 -0.698 . . . . 74.34 109.835 175.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -102.27 135.09 44.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.157 -0.474 . . . . 63.24 110.098 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.9 t70 49.09 77.51 0.1 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.069 0.855 . . . . 65.31 111.052 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.472 ' SG ' HD13 ' A' ' 124' ' ' LEU . 49.0 t -108.85 129.83 55.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.162 -0.927 . . . . 63.32 110.128 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 64' ' ' ASN . 24.9 t70 -99.12 147.55 24.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.029 0.443 . . . . 70.1 111.772 -176.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -115.84 8.99 14.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.647 -0.706 . . . . 74.43 111.546 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.414 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 55.4 m-80 -91.24 -31.49 16.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.006 0.431 . . . . 60.25 110.006 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.29 -16.17 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.17 0.509 . . . . 63.01 110.571 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.623 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -128.35 -178.33 4.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.269 -0.423 . . . . 74.34 110.792 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.513 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 37.1 m -144.19 -59.2 0.38 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.696 -0.229 . . . . 71.15 111.231 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -135.65 141.17 44.98 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 110.041 -0.355 . . . . 75.41 110.041 -178.331 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.06 124.74 49.1 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.093 0.473 . . . . 64.44 110.618 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.59 117.71 17.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.734 -0.667 . . . . 73.13 109.369 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.626 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -93.4 150.16 4.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.071 0.462 . . . . 61.35 110.768 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.37 124.15 44.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.49 -0.777 . . . . 53.12 109.474 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.451 ' CE1' HG21 ' A' ' 103' ' ' ILE . 62.9 m-85 -86.39 134.73 33.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.213 0.53 . . . . 73.12 110.643 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.6 tp -132.38 122.44 25.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.512 -0.767 . . . . 52.33 109.73 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.15 -166.55 27.4 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.127 -0.789 . . . . 54.22 111.127 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.506 ' O ' HD13 ' A' ' 86' ' ' LEU . 4.1 m -76.8 124.95 28.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.476 0.179 . . . . 72.02 110.823 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.39 140.62 35.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.264 -0.273 . . . . 61.31 110.264 177.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 13.3 tt -62.98 -29.03 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.011 0.434 . . . . 75.04 111.118 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -149.68 178.08 9.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.443 -0.577 . . . . 73.12 109.443 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.95 -27.84 30.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.069 0.462 . . . . 73.3 109.981 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.32 -37.91 9.44 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.817 -0.706 . . . . 55.54 111.505 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -95.5 77.57 3.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.709 -0.478 . . . . 72.41 109.709 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.452 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 15.6 p -91.61 12.89 19.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.807 -0.633 . . . . 70.24 111.316 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -112.79 -5.01 13.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.125 -0.489 . . . . 73.52 110.993 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -112.12 128.83 68.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.384 -0.371 . . . . 72.44 110.249 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.526 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -68.64 137.56 54.3 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.014 -0.365 . . . . 63.21 110.014 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.97 157.57 29.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.181 -0.463 . . . . 65.21 110.34 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.593 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.5 mm? -93.71 139.63 30.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.371 -0.377 . . . . 63.33 110.451 -176.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 149' ' ' ASN . 31.4 mt-30 . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 121.256 0.551 . . . . 71.13 109.642 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 54.7 m . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.878 -0.416 . . . . 62.21 109.878 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -92.94 146.26 23.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.68 -0.236 . . . . 44.1 110.38 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.22 164.81 26.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.728 0.299 . . . . 71.35 110.935 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.407 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 23.6 m-80 68.76 7.56 6.21 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.881 0.873 . . . . 64.11 111.285 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.593 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -147.65 150.21 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-N 115.965 -0.561 . . . . 34.34 109.882 173.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.86 -170.2 15.71 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.712 -0.955 . . . . 52.43 110.712 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.428 HG11 HG13 ' A' ' 10' ' ' VAL . 2.5 p -121.34 122.44 67.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.155 0.502 . . . . 71.15 110.412 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.16 138.88 51.38 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.136 0.494 . . . . 72.33 109.768 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.451 HG21 ' CE1' ' A' ' 73' ' ' PHE . 4.2 mp -94.14 128.42 45.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.841 -0.618 . . . . 62.23 110.071 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 18.4 mt -96.35 154.86 17.03 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.486 -0.779 . . . . 72.43 109.462 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.557 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 2.4 p-10 -72.92 -167.95 0.43 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.401 -0.592 . . . . 72.22 109.401 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -71.29 -19.06 62.38 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.462 -0.495 . . . . 74.31 111.858 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.2 p -90.6 -35.22 15.13 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.913 -0.315 . . . . 73.34 110.952 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.83 26.34 1.41 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.516 -0.85 . . . . 62.54 113.349 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . -100.52 140.45 34.76 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.332 -0.247 . . . . 43.24 110.332 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.03 126.33 30.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.317 -0.401 . . . . 71.32 111.465 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.7 mt -87.28 147.28 25.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.017 -0.538 . . . . 72.23 110.326 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.6 m -93.37 141.04 28.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.109 -0.496 . . . . 73.24 110.55 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.412 ' CD1' HD22 ' A' ' 86' ' ' LEU . 63.7 mt -84.25 60.25 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.074 0.464 . . . . 74.41 110.977 -176.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -119.57 -4.84 10.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.016 -0.538 . . . . 74.41 109.909 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.29 4.97 65.43 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.617 -0.72 . . . . 74.12 112.726 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.48 -16.65 7.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 72.23 110.811 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 m -84.15 97.76 9.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.664 -0.495 . . . . 72.12 109.664 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.496 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 86.6 m-85 -87.49 165.43 15.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.23 -0.441 . . . . 62.3 110.837 -175.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.0 m -74.53 -171.08 1.14 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.948 -0.569 . . . . 74.14 110.888 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.2 p -72.79 164.9 25.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.963 -0.384 . . . . 52.22 109.963 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.418 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 41.7 mt-10 -72.78 103.03 3.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.924 0.392 . . . . 74.05 111.193 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.0 m -84.19 109.65 17.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.317 -0.623 . . . . 75.02 109.317 174.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 m -63.6 113.52 3.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.941 -0.572 . . . . 62.44 111.095 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.472 HD13 ' SG ' ' A' ' 61' ' ' CYS . 94.6 mt -77.66 150.14 34.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.857 -0.61 . . . . 73.22 110.943 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.429 HD22 ' C ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER -135.96 152.47 51.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.949 -0.569 . . . . 63.24 109.642 170.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 2.7 m120 -55.15 113.31 1.32 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.988 0.423 . . . . 72.32 111.587 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.75 -145.93 16.55 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.901 -0.666 . . . . 73.41 112.265 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 28.3 m -82.76 129.27 34.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.782 0.325 . . . . 53.41 110.379 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 26.1 m-80 -122.25 133.13 54.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.214 -0.448 . . . . 63.23 110.884 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.63 113.33 26.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.245 -0.434 . . . . 62.12 110.922 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 16.1 mt -92.87 106.4 18.82 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.042 -0.725 . . . . 63.34 109.042 175.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 6.2 Cg_exo -79.09 135.13 12.07 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.033 2.489 . . . . 55.31 112.31 -176.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -136.41 166.87 22.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.294 -0.412 . . . . 72.25 110.623 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.574 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 27.5 mt-30 -132.89 117.9 18.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.954 -0.566 . . . . 73.42 110.922 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.95 125.26 50.2 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.188 -0.301 . . . . 55.22 110.188 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.55 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 14.8 ptp180 -140.63 164.45 30.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.818 0.342 . . . . 74.23 110.836 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.578 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 58.6 m-85 -81.54 149.02 28.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.931 -0.577 . . . . 72.33 111.206 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -132.03 127.68 36.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.427 -0.806 . . . . 74.45 109.127 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.645 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -91.64 135.0 34.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.978 0.418 . . . . 74.22 111.416 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 55.8 p -101.82 1.03 36.65 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.425 -0.954 . . . . 74.22 108.425 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.82 -123.89 1.1 Allowed Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.34 -1.3 . . . . 60.33 111.189 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.25 98.0 11.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.44 -0.207 . . . . 31.22 110.44 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -47.71 117.3 1.78 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.075 -0.511 . . . . 75.12 111.083 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.6 p -107.29 146.74 33.85 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.169 -0.469 . . . . 73.44 110.79 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.73 167.7 23.65 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.382 2.722 . . . . 54.42 112.726 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.63 -125.04 2.75 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.663 -0.78 . . . . 42.01 111.768 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -129.91 118.47 21.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.738 0.304 . . . . 65.44 110.461 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.429 ' C ' HD22 ' A' ' 149' ' ' ASN . . . -114.53 71.85 0.77 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.12 0.486 . . . . 63.4 110.933 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.488 HD22 ' N ' ' A' ' 149' ' ' ASN . 0.8 OUTLIER -111.98 146.16 38.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.392 -0.596 . . . . 71.24 109.392 178.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.526 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -150.25 163.22 38.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.801 0.334 . . . . 63.01 111.395 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -132.99 144.88 50.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 74.34 109.797 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.96 152.05 33.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.408 0.623 . . . . 74.0 111.68 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.53 HG22 ' HB3' ' A' ' 13' ' ' LYS . 7.9 p -108.1 142.6 38.05 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.299 -0.864 . . . . 74.34 109.259 173.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.417 ' CE1' HD13 ' A' ' 56' ' ' ILE . 53.7 p90 -117.94 130.47 56.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.926 0.393 . . . . 72.41 110.572 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.625 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -110.03 112.45 24.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.098 -0.501 . . . . 75.12 110.36 178.157 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.626 HG12 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -80.47 146.32 7.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.912 -0.403 . . . . 72.44 109.912 178.31 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -127.29 123.53 36.63 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.281 -0.637 . . . . 62.33 109.281 171.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.623 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.323 -0.586 0 CA-C-O 120.927 0.394 . . . . 75.22 111.337 175.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.9 p . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 110.135 -0.32 . . . . 72.54 110.135 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.453 HG22 HG12 ' A' ' 37' ' ' VAL . 27.2 m -87.84 21.49 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.018 0.437 . . . . 41.34 111.27 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 58.83 19.13 6.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.442 -0.799 . . . . 65.53 112.436 173.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.526 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 88.29 99.97 0.94 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.652 -0.785 . . . . 71.45 111.77 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.424 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -92.84 157.74 23.72 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.206 -0.997 . . . . 62.33 112.19 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.578 ' HB ' HG22 ' A' ' 31' ' ' THR . 73.0 p -140.91 148.95 41.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.57 0.224 . . . . 70.54 110.574 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.516 HG23 HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -121.69 119.36 58.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.943 -0.762 . . . . 62.24 108.943 171.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -91.15 109.56 20.82 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.402 -0.519 . . . . 74.13 109.694 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.455 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 97.7 m-85 -96.0 126.49 41.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.703 -0.68 . . . . 75.12 109.901 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -110.38 128.92 55.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.374 -0.376 . . . . 71.45 110.596 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.67 -139.1 10.35 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.056 -0.593 . . . . 62.12 111.85 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 60.83 27.48 17.28 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.356 0.598 . . . . 74.24 111.311 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.626 HG21 ' HA ' ' A' ' 155' ' ' LYS . 31.2 m -83.29 -28.96 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.647 -0.706 . . . . 74.1 111.188 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.648 HG21 HG22 ' A' ' 156' ' ' VAL . 16.4 m -142.36 151.04 18.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.349 -0.387 . . . . 64.04 110.939 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -167.98 84.17 0.2 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.713 -0.847 . . . . 74.12 108.713 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.1 -74.05 0.26 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.349 -0.841 . . . . 34.11 110.025 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.546 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -73.52 -35.27 65.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 75.53 109.997 173.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.41 ' CB ' ' HA ' ' A' ' 61' ' ' CYS . 4.2 m -143.56 -176.63 5.03 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.13 -0.693 . . . . 73.43 109.13 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.64 146.69 41.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.202 -0.666 . . . . 54.13 109.202 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 t -81.32 137.23 21.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.74 -0.467 . . . . 72.22 109.74 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' O ' HG13 ' A' ' 28' ' ' VAL . 12.3 t70 -65.45 141.35 58.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.61 -0.268 . . . . 73.05 110.328 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -57.12 -28.74 62.96 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.405 0.441 . . . . 74.11 111.98 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.28 -11.09 82.19 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.564 -0.827 . . . . 75.44 112.415 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.9 p -124.97 14.96 8.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.833 0.309 . . . . 74.42 111.833 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 24' ' ' ASP . 32.9 m -102.9 -5.74 9.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.087 0.47 . . . . 61.34 110.241 173.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -155.66 90.88 1.26 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.311 -0.859 . . . . 75.11 109.325 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 20.3 pm0 -139.65 124.29 18.33 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.346 0.593 . . . . 70.13 110.672 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.578 HG22 ' HB ' ' A' ' 9' ' ' THR . 2.2 m -100.54 95.09 6.48 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.452 -0.795 . . . . 63.02 109.29 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.99 136.59 24.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.209 0.528 . . . . 75.31 110.718 -174.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -96.58 118.63 33.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.448 -0.796 . . . . 54.31 110.267 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.516 HD21 HG23 ' A' ' 10' ' ' VAL . 2.6 mm? -90.13 -26.2 20.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.116 -0.493 . . . . 61.02 109.855 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.526 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 90.2 179.85 43.98 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.642 -0.708 . . . . 75.02 112.644 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -81.65 90.11 6.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.67 0.271 . . . . 65.51 110.636 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.453 HG12 HG22 ' A' ' 5' ' ' VAL . 7.3 p -79.28 142.36 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 110.249 -0.278 . . . . 53.21 110.249 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -71.89 126.41 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 74.21 110.649 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.601 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 32.5 p -74.43 -20.22 60.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.07 0.462 . . . . 72.02 110.903 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.11 -29.95 65.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 51.11 111.442 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -71.06 -35.12 71.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.253 0.549 . . . . 74.41 110.25 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -98.74 74.08 2.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.713 -0.676 . . . . 73.32 110.256 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.94 17.66 18.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.083 0.468 . . . . 65.22 110.993 -172.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -150.37 138.7 20.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.866 -0.606 . . . . 64.42 110.218 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -55.72 126.59 26.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 74.54 110.358 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.37 -9.54 38.71 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.708 -0.758 . . . . 75.23 111.898 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -62.97 121.04 12.56 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.73 0.3 . . . . 63.23 110.427 177.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.1 p -115.9 119.66 36.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.956 -0.566 . . . . 53.01 110.216 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.5 t -83.04 171.09 14.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.264 -0.425 . . . . 71.13 109.908 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.0 m -64.76 127.94 33.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.985 -0.552 . . . . 45.32 110.368 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 134' ' ' GLN . . . -83.3 147.58 27.87 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.492 0.663 . . . . 51.03 111.638 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.2 m -87.07 151.62 3.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 114.775 -1.102 . . . . 71.12 109.278 171.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.6 97.51 0.99 Allowed Glycine 0 C--N 1.311 -0.84 0 C-N-CA 120.976 -0.631 . . . . 61.32 112.322 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -109.87 172.44 6.85 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.81 -0.441 . . . . 73.24 109.81 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.579 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.3 p-10 -135.25 144.38 46.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.123 0.487 . . . . 74.34 111.648 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 81.7 mt -113.05 124.64 69.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.389 -0.823 . . . . 72.25 108.803 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -109.47 144.1 38.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.847 0.356 . . . . 74.04 111.089 -172.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 128' ' ' THR . 23.7 mt -120.52 133.4 55.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.227 -0.442 . . . . 75.02 109.823 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -112.15 155.29 24.17 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.928 -0.578 . . . . 61.14 109.839 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 51.58 45.77 27.55 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 123.849 0.718 . . . . 71.22 110.638 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 5.8 t -89.18 143.4 26.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.355 -0.838 . . . . 63.32 110.602 -174.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 64' ' ' ASN . 20.9 t70 -117.87 154.43 31.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 64.42 111.612 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.6 p -124.12 9.64 8.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.354 -0.384 . . . . 72.52 111.263 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.453 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 52.7 m-80 -84.37 -34.12 23.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 73.21 110.159 177.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.5 p -110.7 -17.09 8.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.044 -0.526 . . . . 52.22 110.985 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -122.68 167.38 13.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.631 -0.259 . . . . 71.32 110.983 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.546 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 13.8 m -130.22 -55.4 1.11 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.404 -0.362 . . . . 44.24 111.117 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.546 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -138.67 153.23 48.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.177 -0.305 . . . . 73.3 110.177 -178.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.479 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -105.1 127.11 52.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.061 0.458 . . . . 64.24 110.369 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -135.14 116.0 14.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.746 -0.661 . . . . 53.25 109.56 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.0 OUTLIER -89.81 144.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.158 0.504 . . . . 71.13 111.199 -174.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.85 118.07 29.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.215 -0.902 . . . . 74.42 109.537 173.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 89.5 m-85 -82.71 137.83 34.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.188 0.518 . . . . 73.24 110.874 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.2 tp -128.42 135.78 49.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.554 -0.748 . . . . 72.44 109.521 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.08 -177.54 47.68 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.994 -0.622 . . . . 74.21 111.621 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 m -75.16 120.96 21.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.782 0.325 . . . . 73.45 110.818 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -79.18 144.14 34.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.137 -0.483 . . . . 45.45 110.402 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 tt -77.9 -21.26 13.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.013 0.435 . . . . 74.31 110.784 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -155.12 176.32 12.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.552 -0.536 . . . . 74.43 109.552 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.03 -29.02 32.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.98 0.419 . . . . 61.25 110.433 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.78 -24.63 19.97 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.832 -0.699 . . . . 72.43 111.692 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -99.91 50.71 0.91 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.348 0.594 . . . . 65.23 109.652 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.459 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 5.6 p -78.63 4.99 12.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.549 -0.751 . . . . 65.35 112.098 -176.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -107.7 -1.79 20.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.117 0.484 . . . . 72.43 110.525 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.422 HG22 ' HB3' ' A' ' 102' ' ' GLN . 60.0 t -108.62 123.98 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 72.25 110.285 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.568 HD22 HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -70.04 131.79 44.88 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.982 -0.377 . . . . 74.44 109.982 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.53 149.49 33.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.141 -0.482 . . . . 52.43 110.775 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.3 mm? -81.02 143.75 32.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.896 -0.593 . . . . 72.42 110.567 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.026 -0.534 . . . . 73.42 111.09 178.102 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.541 -0.541 . . . . 70.13 109.541 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.23 121.73 14.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.094 -0.335 . . . . 74.21 110.094 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.4 160.69 18.15 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.788 -0.365 . . . . 63.41 110.755 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 69.26 14.61 8.59 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.669 -0.696 . . . . 63.44 110.476 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.0 -179.99 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.887 -0.597 . . . . 71.31 110.058 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 179.4 -173.57 45.5 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.172 -1.171 . . . . 73.31 110.172 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.431 HG21 HG21 ' A' ' 10' ' ' VAL . 3.2 p -119.95 114.59 44.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.628 0.727 . . . . 72.13 110.674 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.6 pt20 -103.9 141.7 35.7 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.486 -0.779 . . . . 73.24 109.114 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.498 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.3 mp -104.18 127.66 58.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.199 0.523 . . . . 72.23 110.464 -177.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.0 mt -93.44 147.24 23.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.425 -0.807 . . . . 64.11 109.222 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -70.29 -172.71 0.61 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.494 -0.558 . . . . 71.53 109.494 174.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -67.92 -16.62 64.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.398 0.518 . . . . 74.11 112.398 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.403 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 69.0 p -95.53 -32.49 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.718 -0.393 . . . . 64.54 111.053 177.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.71 32.49 0.76 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.735 -0.745 . . . . 73.53 112.82 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.4 125.41 50.96 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.724 -0.28 . . . . 71.34 110.36 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.61 116.59 12.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.953 0.406 . . . . 65.41 110.436 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.6 mt -84.85 132.74 34.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.007 -0.542 . . . . 72.13 111.238 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.449 ' H ' HG21 ' A' ' 117' ' ' THR . 25.0 m -68.72 141.61 55.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.816 -0.629 . . . . 73.35 110.604 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.568 HD13 HD22 ' A' ' 86' ' ' LEU . 49.8 mt -82.7 41.2 0.71 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 74.02 111.207 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.41 -16.36 46.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.86 0.362 . . . . 73.52 110.56 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.67 3.58 89.06 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.735 -0.745 . . . . 71.34 111.603 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -128.1 2.3 5.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.725 0.298 . . . . 51.21 111.316 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 112' ' ' THR . 9.0 m -94.37 102.89 14.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.016 -0.365 . . . . 53.01 110.016 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.515 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 75.6 m-85 -93.99 150.84 19.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.213 -0.449 . . . . 71.55 111.876 -172.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.1 m -68.01 179.82 1.4 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.388 -0.824 . . . . 71.24 111.264 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.2 m -67.36 147.75 52.53 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.019 -0.537 . . . . 74.4 109.766 173.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.469 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 47.0 mt-10 -55.28 110.44 0.69 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 73.14 111.662 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.8 m -96.35 107.25 19.6 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.016 -0.735 . . . . 75.24 109.016 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 m -61.93 132.96 54.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.088 -0.506 . . . . 52.42 111.414 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 69' ' ' ALA . 82.2 mt -94.6 149.14 21.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.241 0.543 . . . . 73.01 111.926 -176.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -128.38 151.55 49.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.219 -0.9 . . . . 73.24 108.835 168.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 17.9 m120 -63.7 121.94 15.18 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.952 0.406 . . . . 74.45 110.68 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.97 -109.94 1.22 Allowed Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.814 -0.63 . . . . 50.3 111.892 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 98.5 m -127.11 133.03 50.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.055 0.455 . . . . 53.12 111.173 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -129.65 145.25 51.52 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.359 -0.608 . . . . 72.32 109.359 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.579 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.6 m -125.82 122.64 36.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.867 0.365 . . . . 74.21 110.73 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.6 mt -102.91 115.74 63.68 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.167 -0.47 . . . . 50.22 110.084 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -80.26 138.27 12.48 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.84 2.36 . . . . 64.24 112.215 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -137.44 163.2 31.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.888 0.375 . . . . 75.12 110.81 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.625 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 19.9 mt-30 -131.82 119.3 21.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.98 -0.555 . . . . 74.5 111.235 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.93 129.9 53.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.442 -0.344 . . . . 63.24 110.259 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.431 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 1.4 ptp180 -140.86 164.97 28.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.892 0.377 . . . . 74.31 111.361 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 70.2 m-85 -86.55 141.75 28.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.865 -0.607 . . . . 75.01 110.33 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -127.97 122.53 32.57 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.238 -0.653 . . . . 70.33 109.238 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.636 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -85.45 130.55 34.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.89 0.376 . . . . 72.32 110.908 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 63.8 p -102.19 11.43 38.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.716 0.77 . . . . 75.24 108.933 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 163.84 -123.57 1.19 Allowed Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.616 -1.175 . . . . 70.2 111.385 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.9 95.35 8.19 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.242 -0.281 . . . . 61.44 110.242 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.601 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.02 115.55 1.33 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.006 0.432 . . . . 74.13 111.136 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.0 p -103.87 141.39 22.41 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.825 -0.435 . . . . 64.43 109.825 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.49 163.43 38.07 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.449 2.766 . . . . 73.05 112.396 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.35 -153.91 25.63 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.628 -0.796 . . . . 63.34 111.796 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.45 108.07 19.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.737 0.303 . . . . 73.4 110.828 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -107.05 75.78 1.05 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.201 0.524 . . . . 74.04 110.71 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -123.77 134.32 53.67 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.331 -0.618 . . . . 75.01 109.331 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -136.91 167.57 21.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.993 0.425 . . . . 41.32 111.434 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -131.16 142.47 50.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.643 -0.708 . . . . 74.42 109.561 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.81 139.05 27.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.224 0.535 . . . . 71.34 111.255 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.6 p -108.86 117.0 33.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.821 -0.627 . . . . 73.22 110.014 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.443 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 47.4 p90 -95.04 123.6 38.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.511 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.626 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.5 tmmm? -106.01 100.91 10.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.702 -0.481 . . . . 73.21 109.702 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.1 m -78.57 133.21 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.314 0.578 . . . . 51.0 110.168 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -111.7 113.38 25.72 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.876 -0.602 . . . . 72.15 110.987 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.546 ' CD1' ' HB3' ' A' ' 20' ' ' ALA . 5.3 p90 . . . . . 0 C--N 1.317 -0.83 0 CA-C-N 115.542 -0.754 . . . . 73.41 109.208 169.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.423 HG22 ' HA ' ' A' ' 38' ' ' ARG . 74.2 p . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 110.156 -0.313 . . . . 61.52 110.156 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.552 HG22 HG12 ' A' ' 37' ' ' VAL . 34.6 m -90.42 17.71 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.901 0.381 . . . . 73.42 111.001 176.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 59.55 31.07 20.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.597 -0.729 . . . . 74.33 112.275 171.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.451 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 79.82 92.53 0.4 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.68 -0.771 . . . . 31.32 112.3 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.31 153.42 25.26 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.208 -0.996 . . . . 65.11 111.678 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.556 ' HB ' HG22 ' A' ' 31' ' ' THR . 45.2 p -138.53 144.97 40.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.71 0.291 . . . . 72.13 110.486 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.485 ' CG2' HD21 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -118.04 120.44 64.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.97 -0.752 . . . . 71.02 108.97 172.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -86.86 111.28 20.62 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.405 -0.518 . . . . 73.2 109.611 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -100.92 118.84 37.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.808 -0.633 . . . . 62.2 110.02 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HB3' HG22 ' A' ' 153' ' ' THR . 48.0 tttp -116.21 138.08 51.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.145 -0.479 . . . . 72.1 110.597 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -116.22 -116.43 2.96 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.786 -0.643 . . . . 73.52 111.86 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.934 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 28.3 mt-10 62.45 22.45 13.26 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.158 0.504 . . . . 73.15 110.915 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.683 HG21 ' HA ' ' A' ' 155' ' ' LYS . 29.7 m -83.13 -26.46 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.574 -0.739 . . . . 73.02 111.659 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.705 HG21 HG22 ' A' ' 156' ' ' VAL . 3.8 m -140.28 134.63 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.099 0.476 . . . . 54.03 112.204 -173.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -139.22 23.4 2.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 75.55 109.33 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.71 -83.1 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 50.23 111.886 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.3 -34.05 70.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.467 0.651 . . . . 53.41 110.637 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 2.8 m -146.44 162.72 37.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.262 -0.881 . . . . 73.32 108.628 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.05 127.22 53.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.482 0.182 . . . . 62.42 110.601 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 t -70.04 130.09 34.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.904 -0.406 . . . . 71.21 109.904 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.9 t70 -57.84 140.87 50.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 64.43 111.067 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.431 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -63.84 -17.08 62.78 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 112.443 0.534 . . . . 53.23 112.443 -174.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.51 -23.12 48.49 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.596 -0.811 . . . . 61.04 111.949 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.0 p -101.63 -8.43 21.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.787 0.292 . . . . 61.41 111.787 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.934 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 30.5 m -82.4 -4.14 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.705 0.288 . . . . 64.24 111.471 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -164.44 85.07 0.43 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.048 -0.723 . . . . 40.25 109.048 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -136.33 130.6 33.11 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.872 -0.604 . . . . 64.04 110.716 -172.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.556 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.1 m -106.43 104.64 14.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.761 -0.654 . . . . 74.51 109.818 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' THR . 12.1 p -88.53 132.55 33.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.13 0.491 . . . . 54.55 110.928 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.435 ' HA ' HG22 ' A' ' 9' ' ' THR . 25.0 mp0 -89.2 123.39 33.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.811 -0.631 . . . . 73.24 110.129 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.485 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.5 mm? -83.6 -23.86 31.73 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.926 -0.768 . . . . 71.5 108.926 175.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.451 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 93.19 179.63 39.73 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.077 -0.965 . . . . 75.12 112.058 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -80.82 87.1 5.92 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.219 -0.289 . . . . 63.23 110.219 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.552 HG12 HG22 ' A' ' 5' ' ' VAL . 7.9 p -71.95 136.0 26.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.51 -0.552 . . . . 74.22 109.51 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.423 ' HA ' HG22 ' A' ' 4' ' ' THR . 76.3 mtp180 -78.82 130.29 35.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.245 -0.434 . . . . 73.44 110.411 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.0 p -82.03 13.09 3.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.065 -0.516 . . . . 72.13 111.224 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.4 -22.47 17.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.177 0.513 . . . . 63.02 109.785 174.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -81.88 -15.72 53.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.462 -0.79 . . . . 32.01 110.541 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 5.0 mp -125.87 117.19 22.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.06 -0.719 . . . . 74.54 109.06 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.96 10.35 2.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.763 0.653 . . . . 50.3 112.763 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -153.98 156.21 37.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.358 -0.238 . . . . 74.24 110.358 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 42.2 tt0 -61.04 131.04 49.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.396 -0.366 . . . . 73.12 110.047 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.45 -1.96 57.36 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.686 -0.769 . . . . 54.15 111.939 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -78.09 115.57 17.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.008 0.432 . . . . 63.42 110.012 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.568 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 4.7 p -111.46 135.43 52.02 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.766 -0.652 . . . . 64.32 110.431 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 t -88.07 179.47 6.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 62.02 109.649 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 m -71.55 139.57 49.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.725 -0.472 . . . . 63.3 109.725 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.514 ' HB2' ' HE ' ' A' ' 136' ' ' ARG . . . -90.96 152.61 20.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.311 0.576 . . . . 75.54 112.03 -175.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 24.7 m -83.53 158.56 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.77 -1.105 . . . . 54.33 109.199 168.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.79 89.92 0.51 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.896 -0.669 . . . . 65.21 112.054 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -103.25 175.56 5.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.575 -0.528 . . . . 73.21 109.575 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.58 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.3 p-10 -143.68 155.06 44.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.367 0.603 . . . . 54.25 111.869 -174.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.422 HD12 ' CE2' ' A' ' 133' ' ' PHE . 80.0 mt -115.05 112.62 40.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.052 -0.976 . . . . 74.22 108.903 171.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -96.52 128.25 43.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.036 0.445 . . . . 74.34 110.703 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.3 mt -110.33 126.01 53.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.88 -0.6 . . . . 60.54 110.046 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -105.36 145.09 31.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.019 -0.537 . . . . 72.24 109.555 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 30.2 t70 49.69 69.14 0.63 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.926 0.869 . . . . 71.34 110.563 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.415 ' SG ' HD22 ' A' ' 124' ' ' LEU . 10.2 t -106.28 114.84 29.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.048 -0.978 . . . . 63.05 109.734 -176.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -96.68 131.59 43.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.08 -0.509 . . . . 75.43 111.515 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.0 p -102.24 12.8 36.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 71.12 111.879 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -87.87 -26.36 22.81 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.539 -0.541 . . . . 65.42 109.539 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.73 -32.97 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.674 -0.694 . . . . 63.44 110.841 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -113.57 -179.19 3.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.725 0.298 . . . . 71.34 111.326 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 29.4 m -139.32 -55.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.503 -0.317 . . . . 74.4 111.596 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -136.31 144.7 44.84 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 110.408 -0.219 . . . . 72.43 110.408 -177.031 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.512 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -103.23 137.29 41.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.967 0.413 . . . . 65.24 110.72 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.39 113.74 6.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 74.31 109.417 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.709 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -87.01 145.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.98 0.419 . . . . 54.24 110.977 -173.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.563 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -118.18 122.06 42.07 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.738 -0.665 . . . . 53.45 109.919 174.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.466 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 88.6 m-85 -87.58 130.62 34.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.297 0.57 . . . . 75.34 110.812 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.5 tp -125.41 122.66 37.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.605 -0.725 . . . . 75.04 109.763 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.05 -171.43 29.28 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.768 -0.651 . . . . 63.42 111.586 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.419 ' O ' HD13 ' A' ' 86' ' ' LEU . 8.8 m -84.59 119.9 25.73 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.374 -0.232 . . . . 71.23 110.374 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -78.65 144.67 35.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.522 -0.308 . . . . 65.43 110.987 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.409 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 6.7 tt -69.79 -37.29 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.417 . . . . 73.11 110.835 178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.33 175.45 10.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.316 -0.624 . . . . 73.42 109.316 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.34 -37.15 38.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.083 0.468 . . . . 70.25 110.323 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.5 -19.01 67.2 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.591 -0.814 . . . . 74.54 111.276 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -111.17 47.57 0.99 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.16 0.505 . . . . 74.42 109.728 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.511 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -74.14 4.1 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.602 -0.727 . . . . 53.01 112.373 -176.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 30.3 p-10 -108.09 -0.6 21.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.158 0.504 . . . . 71.34 110.288 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 102' ' ' GLN . 46.2 t -108.01 125.82 64.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.875 -0.602 . . . . 62.42 110.153 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.504 HD22 ' CD1' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -69.0 134.42 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.382 -0.372 . . . . 72.12 110.588 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.409 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.36 150.27 35.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.06 -0.518 . . . . 43.32 110.483 177.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.428 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.5 mm? -91.77 134.47 34.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.313 -0.403 . . . . 74.0 110.451 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 . . . . . 0 C--N 1.324 -0.516 0 CA-C-O 121.364 0.602 . . . . 52.11 110.611 -179.5 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 110.18 -0.304 . . . . 72.44 110.18 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.95 149.89 21.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.784 -0.45 . . . . 75.43 109.784 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.45 167.54 21.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.918 -0.401 . . . . 64.25 109.918 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 68.62 10.18 7.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.17 0.51 . . . . 71.04 110.498 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.07 -177.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.634 -0.712 . . . . 73.04 110.444 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.84 -174.78 46.86 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.171 -1.172 . . . . 75.01 110.171 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.65 115.27 46.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.364 0.602 . . . . 71.01 110.62 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.412 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.9 pt20 -107.28 135.42 48.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.206 -0.664 . . . . 72.44 109.206 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.466 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -95.83 123.61 48.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.968 0.413 . . . . 73.32 110.813 -175.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.52 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 15.5 mt -88.65 136.19 33.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.485 -0.779 . . . . 72.12 109.336 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.2 OUTLIER -71.78 -173.64 1.02 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.776 -0.453 . . . . 72.34 109.776 175.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.47 ' HG3' HG23 ' A' ' 107' ' ' THR . 15.4 ptm180 -57.96 -23.77 55.15 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.973 0.36 . . . . 73.3 111.973 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.47 HG23 ' HG3' ' A' ' 106' ' ' ARG . 71.0 p -102.02 11.41 38.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.792 0.33 . . . . 52.31 111.647 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.52 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 76.52 35.57 41.13 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.836 -0.697 . . . . 61.54 112.985 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.63 120.71 42.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.352 -0.24 . . . . 75.35 110.352 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 103' ' ' ILE . . . -65.83 111.42 3.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.984 0.421 . . . . 74.13 110.534 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.5 mt -78.26 132.93 37.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.849 -0.614 . . . . 72.4 111.3 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.515 ' H ' HG21 ' A' ' 117' ' ' THR . 15.3 m -67.55 142.06 56.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.492 -0.776 . . . . 54.44 110.598 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.504 ' CD1' HD22 ' A' ' 86' ' ' LEU . 59.5 mt -81.79 44.15 0.81 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.057 0.456 . . . . 74.25 110.808 -177.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -92.97 -18.03 23.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.836 -0.62 . . . . 75.32 110.516 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.58 -16.29 46.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.613 -0.803 . . . . 53.24 112.325 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.82 8.11 20.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.476 . . . . 54.15 110.717 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.515 HG21 ' H ' ' A' ' 112' ' ' THR . 2.1 m -97.03 95.88 8.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.011 -0.541 . . . . 71.23 110.059 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.715 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 65.3 m-85 -93.61 158.0 15.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.178 -0.465 . . . . 73.44 111.405 -173.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 5.7 m -69.58 -175.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.639 -0.71 . . . . 71.52 111.586 178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.9 t -69.37 163.52 24.98 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.765 -0.457 . . . . 62.42 109.765 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.418 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 48.9 mt-10 -68.03 104.58 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 54.24 111.245 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.513 HG21 HG12 ' A' ' 131' ' ' ILE . 75.1 m -85.14 99.11 10.85 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.649 -0.501 . . . . 64.1 109.649 173.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.4 m -56.16 112.92 1.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.719 -0.673 . . . . 75.33 110.585 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 69' ' ' ALA . 85.1 mt -74.33 144.39 44.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 52.42 111.712 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -117.41 141.93 47.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.188 -0.915 . . . . 75.01 109.215 173.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -55.59 116.69 3.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.36 0.413 . . . . 63.42 110.868 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 119.67 -111.51 2.05 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.592 -0.813 . . . . 73.21 112.57 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.6 m -112.05 134.77 53.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.943 0.401 . . . . 50.04 111.198 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -131.17 124.11 29.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.948 -0.569 . . . . 73.43 110.122 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.58 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.7 m -110.75 107.06 16.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.738 0.304 . . . . 72.22 110.331 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 122' ' ' THR . 13.7 mt -88.14 118.04 69.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.365 -0.38 . . . . 72.4 110.119 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.18 137.98 9.83 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.812 2.341 . . . . 74.31 112.956 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 74.2 m-85 -136.43 161.84 34.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 73.1 111.135 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 26.3 mt-30 -130.17 118.1 20.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 72.31 110.934 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -107.05 125.62 51.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.134 -0.321 . . . . 63.14 110.134 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.568 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 10.1 ptp180 -138.64 163.53 31.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.011 0.434 . . . . 54.3 111.092 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 64.4 m-85 -81.52 142.3 32.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 73.14 111.053 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -126.4 116.84 21.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.435 -0.802 . . . . 74.1 109.376 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -82.19 131.28 35.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.479 -0.328 . . . . 53.14 110.566 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 68.9 p -101.3 2.84 40.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.645 0.736 . . . . 75.15 109.471 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 173.81 -134.75 2.97 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.742 -1.117 . . . . 71.13 110.635 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 144' ' ' THR . . . -78.08 85.91 4.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.712 0.256 . . . . 75.03 110.338 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -46.48 111.67 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.614 0.571 . . . . 42.32 111.781 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 142' ' ' ALA . 20.4 p -102.49 144.49 28.71 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-O 121.075 0.464 . . . . 72.43 111.232 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.41 167.38 26.49 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.413 2.742 . . . . 72.41 112.648 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.39 -128.78 3.14 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.867 -0.682 . . . . 70.52 111.783 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -120.68 117.24 27.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.719 0.295 . . . . 51.15 110.468 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.428 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -118.09 74.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.164 0.507 . . . . 42.03 111.309 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -117.31 138.67 51.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.963 -0.562 . . . . 70.24 109.897 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.473 ' HB3' HG13 ' A' ' 10' ' ' VAL . . . -135.63 171.58 14.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.586 0.587 . . . . 64.12 112.586 -172.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -134.01 128.67 34.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.247 -0.888 . . . . 73.55 109.739 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.415 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -150.67 144.31 25.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.281 0.562 . . . . 74.13 111.867 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.438 HG22 ' HB3' ' A' ' 13' ' ' LYS . 21.7 p -112.4 150.67 30.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.694 -0.684 . . . . 51.24 109.529 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -121.92 134.25 54.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.257 0.551 . . . . 64.34 111.219 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.715 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 20.2 ttmt -111.22 101.57 10.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.608 -0.724 . . . . 70.23 110.499 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.709 HG12 HG12 ' A' ' 71' ' ' VAL . 1.3 m -75.13 126.82 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 119.983 -0.687 . . . . 74.15 109.539 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -108.48 111.82 23.9 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.874 -0.603 . . . . 70.13 110.434 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 120.882 0.372 . . . . 73.13 110.839 171.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.857 0.36 . . . . 72.33 110.259 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.489 ' CG2' HG12 ' A' ' 37' ' ' VAL . 35.5 m -88.42 13.19 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.189 0.519 . . . . 75.24 110.715 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 63.67 14.31 8.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.233 -0.894 . . . . 71.14 112.502 172.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.43 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 88.59 94.45 1.04 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.674 -0.774 . . . . 71.34 111.677 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.412 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -84.66 152.22 27.29 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.425 -0.893 . . . . 53.55 112.084 -176.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.531 ' HB ' HG22 ' A' ' 31' ' ' THR . 21.0 p -143.06 139.97 30.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.342 -0.244 . . . . 74.41 110.342 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.29 126.28 68.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.835 -0.432 . . . . 72.12 109.835 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -93.91 112.7 24.58 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.574 -0.528 . . . . 64.13 109.574 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -100.08 122.64 43.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.962 -0.563 . . . . 53.11 110.657 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HB3' HG22 ' A' ' 153' ' ' THR . 59.3 tttm -112.09 136.09 51.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 61.5 110.092 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.08 -120.72 3.41 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.715 -0.755 . . . . 64.0 112.349 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.573 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 34.8 mt-10 63.28 20.01 12.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.06 0.457 . . . . 75.54 110.943 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.634 HG21 ' HA ' ' A' ' 155' ' ' LYS . 18.9 m -80.39 -21.95 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.661 . . . . 72.34 112.207 -175.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.411 HG13 HG23 ' A' ' 16' ' ' VAL . 17.3 m -133.49 157.3 42.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.237 0.542 . . . . 61.03 112.032 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -157.54 24.74 0.29 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.696 -1.138 . . . . 63.41 108.49 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.1 -81.07 0.32 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 64.43 111.664 -174.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.407 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -93.77 -38.78 11.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.951 0.405 . . . . 63.54 110.917 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 2.0 m -137.36 128.58 27.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.126 -0.488 . . . . 75.01 110.148 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.08 125.54 35.9 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.645 -0.707 . . . . 71.14 110.361 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.473 ' HA ' HD23 ' A' ' 58' ' ' LEU . 15.8 t -66.23 128.66 29.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.72 -0.474 . . . . 70.41 109.72 177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.27 145.49 42.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.154 -0.475 . . . . 64.35 111.235 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.553 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -63.11 -22.13 66.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 75.11 111.71 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.66 -10.24 79.72 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.732 -0.747 . . . . 60.41 111.876 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.0 t -104.3 -27.5 11.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.088 . . . . 54.22 110.827 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.573 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 27.7 m -74.66 -6.84 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.095 0.474 . . . . 74.41 110.923 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -153.54 95.14 1.87 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.36 -0.836 . . . . 73.41 109.356 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -151.57 137.73 18.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.888 -0.596 . . . . 63.25 110.681 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.531 HG22 ' HB ' ' A' ' 9' ' ' THR . 6.9 m -115.66 111.96 21.4 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.591 -0.731 . . . . 73.34 109.698 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 p -92.87 139.54 17.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.846 0.355 . . . . 74.53 110.691 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.439 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.4 mp0 -95.86 126.75 41.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.239 -0.437 . . . . 53.52 110.362 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -91.32 -27.59 18.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.39 0.614 . . . . 70.55 109.482 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.43 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.58 171.71 37.76 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.263 -0.881 . . . . 71.21 112.127 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -73.02 88.17 1.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.778 0.323 . . . . 72.34 110.717 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.489 HG12 ' CG2' ' A' ' 5' ' ' VAL . 9.8 p -67.44 151.93 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.478 -0.328 . . . . 71.01 110.171 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -91.31 125.02 35.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.095 -0.502 . . . . 60.53 110.725 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.3 p -74.71 -15.04 60.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.947 -0.569 . . . . 71.03 111.047 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.98 -22.51 60.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.475 . . . . 53.35 111.204 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 m -85.66 -33.93 21.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.136 0.494 . . . . 51.04 110.638 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.5 mp -108.61 97.74 7.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.986 -0.552 . . . . 71.02 109.956 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.25 14.87 4.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.025 0.441 . . . . 74.01 111.119 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -152.49 146.98 25.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.858 -0.61 . . . . 64.15 110.086 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 44.2 tt0 -62.65 130.76 46.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 63.34 110.303 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.98 -5.93 42.95 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.678 -0.772 . . . . 73.12 111.617 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -74.88 119.93 19.73 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.99 -0.374 . . . . 70.41 109.99 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.582 ' HB ' HH11 ' A' ' 136' ' ' ARG . 37.9 p -115.15 126.07 54.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.115 -0.493 . . . . 72.2 110.476 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.2 t -80.0 172.4 13.83 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.836 -0.431 . . . . 55.12 109.836 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.7 m -69.58 134.99 49.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.302 -0.408 . . . . 71.42 110.054 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -86.98 162.12 17.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.625 0.726 . . . . 62.34 111.93 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.5 m -104.66 152.22 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.575 -1.193 . . . . 61.41 109.349 172.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.82 105.23 2.19 Favored Glycine 0 C--N 1.312 -0.779 0 C-N-CA 120.802 -0.714 . . . . 75.11 112.188 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -117.93 171.89 7.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.12 -0.696 . . . . 65.43 109.12 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.82 139.6 32.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.526 0.679 . . . . 74.24 112.507 -175.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.443 HD13 ' CD1' ' A' ' 154' ' ' PHE . 45.9 mt -95.22 116.48 36.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.268 -0.878 . . . . 71.04 109.585 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -93.32 133.39 36.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.771 -0.65 . . . . 75.24 111.249 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 23' ' ' VAL . 69.3 mt -117.76 129.68 55.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.59 -0.732 . . . . 63.24 109.587 176.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -103.89 146.24 28.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.297 -0.41 . . . . 75.43 110.493 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 49.95 41.84 23.56 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.873 0.733 . . . . 50.53 111.235 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.423 ' SG ' HD22 ' A' ' 124' ' ' LEU . 53.6 t -76.76 124.55 27.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.83 -0.623 . . . . 72.52 110.492 -175.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.52 132.48 45.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.054 -0.521 . . . . 71.31 111.292 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.8 p -107.62 18.21 21.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.093 0.473 . . . . 72.31 111.661 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -90.85 -33.66 15.57 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.975 -0.75 . . . . 62.42 108.975 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 p -101.71 -12.88 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.548 -0.751 . . . . 52.11 111.086 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -135.45 169.47 17.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.692 0.282 . . . . 72.41 110.997 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.506 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 44.8 m -129.01 -57.13 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 35.33 111.97 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -135.91 141.73 44.59 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 122.164 -0.335 . . . . 75.22 110.172 -176.26 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.461 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -104.32 134.7 47.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.218 0.533 . . . . 72.24 110.495 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.86 120.43 12.5 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.351 -0.841 . . . . 71.15 109.201 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 156' ' ' VAL . 1.6 m -93.78 149.44 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.067 0.461 . . . . 64.01 110.965 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.22 119.32 32.87 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.461 -0.791 . . . . 75.52 109.396 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 62.7 m-85 -83.09 126.28 32.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.955 0.407 . . . . 62.2 110.547 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.8 tp -122.42 127.65 49.92 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.897 -0.592 . . . . 65.13 109.857 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.75 -164.44 26.47 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.343 -0.703 . . . . 71.33 111.343 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.418 ' O ' HD13 ' A' ' 86' ' ' LEU . 8.7 m -82.35 128.33 34.11 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.614 0.207 . . . . 74.23 110.476 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -87.67 148.48 24.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.176 -0.305 . . . . 63.43 110.176 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.3 tt -74.33 -25.64 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.988 0.423 . . . . 64.2 110.731 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -155.66 -174.2 4.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.522 -0.547 . . . . 73.43 109.522 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.88 -44.11 13.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.078 0.466 . . . . 72.01 110.067 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.3 -18.56 71.23 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.723 -0.751 . . . . 65.21 111.333 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -104.98 46.22 0.93 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.352 0.596 . . . . 73.03 109.89 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.409 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -78.9 12.42 2.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.53 -0.759 . . . . 72.14 111.803 -178.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -107.6 -12.35 15.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.061 -0.518 . . . . 65.21 110.491 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 65.0 t -106.92 125.83 62.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.916 -0.584 . . . . 62.04 110.778 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.55 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -66.08 133.19 50.24 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.795 -0.446 . . . . 72.33 109.795 178.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.15 147.8 36.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.449 . . . . 51.35 110.114 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 2.0 mm? -78.77 145.56 34.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.133 -0.485 . . . . 73.32 110.111 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 8.8 mm-40 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.923 -0.581 . . . . 70.24 110.647 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.736 -0.468 . . . . 75.0 109.736 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.4 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -74.62 142.0 44.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.073 -0.343 . . . . 71.35 110.073 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.0 163.44 30.28 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.02 -0.363 . . . . 60.51 110.02 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.418 HD22 HG23 ' A' ' 144' ' ' THR . 77.1 m-20 70.32 10.68 7.33 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.512 0.508 . . . . 71.54 110.824 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 143' ' ' ALA . 0.0 OUTLIER -146.63 -177.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.658 -0.701 . . . . 60.32 109.677 174.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 172.71 -175.89 45.68 Favored Glycine 0 N--CA 1.437 -1.259 0 N-CA-C 110.602 -0.999 . . . . 75.35 110.602 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.52 114.58 46.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.399 0.619 . . . . 72.14 110.83 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.408 ' HG2' ' HB2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -106.37 140.14 39.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.52 -0.764 . . . . 53.31 109.596 176.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 103' ' ' ILE . 3.9 mp -101.58 123.85 54.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.233 -0.44 . . . . 74.52 110.256 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 16.4 mt -87.74 148.61 24.66 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.537 -0.756 . . . . 62.34 109.411 176.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.567 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 2.1 p-10 -72.39 -170.74 0.68 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.715 -0.476 . . . . 64.22 109.715 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -72.09 -17.09 62.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.135 0.42 . . . . 75.34 112.135 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.6 p -89.23 -36.99 15.32 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.553 -0.459 . . . . 74.51 110.683 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.87 31.04 0.72 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.658 -0.782 . . . . 52.13 113.363 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -117.76 133.04 56.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.783 0.292 . . . . 62.04 110.517 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.03 141.61 57.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.962 0.41 . . . . 65.14 110.973 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.433 HD12 ' HD1' ' A' ' 73' ' ' PHE . 80.6 mt -91.09 -176.53 4.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.039 -0.528 . . . . 61.1 110.214 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.3 m -125.29 142.01 51.75 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.003 -0.369 . . . . 53.21 110.003 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 53.9 mt -84.46 39.48 0.73 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.384 -0.371 . . . . 75.41 111.548 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -102.19 -0.59 32.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.99 0.424 . . . . 62.3 110.26 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.3 3.22 45.5 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.747 -0.66 . . . . 53.44 113.141 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -120.88 -11.6 8.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.932 0.366 . . . . 72.45 111.051 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.2 m -91.16 108.6 19.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.015 -0.365 . . . . 71.41 110.015 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.53 ' CE1' ' HE3' ' A' ' 155' ' ' LYS . 93.7 m-85 -98.27 163.96 12.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.107 0.479 . . . . 72.13 111.228 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 4.0 m -70.23 175.33 4.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 62.12 110.499 175.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.0 t -68.08 146.09 53.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.229 -0.656 . . . . 75.43 109.229 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -53.76 112.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 62.01 111.444 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.6 m -97.19 106.6 18.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.744 -0.662 . . . . 74.2 109.542 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.5 m -58.49 116.34 3.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.228 0.537 . . . . 64.13 111.277 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.493 ' C ' HD22 ' A' ' 125' ' ' ASN . 87.8 mt -77.31 152.44 34.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.362 -0.836 . . . . 72.42 111.544 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.493 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -122.5 153.34 39.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.514 -0.767 . . . . 72.34 109.583 173.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 82.8 m-20 -68.58 106.63 2.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.838 0.352 . . . . 61.41 110.793 176.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 131.88 -128.72 5.39 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.747 -0.739 . . . . 64.11 112.497 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.3 m -94.09 127.46 39.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.841 0.353 . . . . 64.51 110.709 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -123.58 150.05 44.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.283 -0.417 . . . . 74.13 110.216 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.59 111.43 10.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.355 -0.384 . . . . 70.21 111.068 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 mt -90.99 110.17 40.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.233 -0.654 . . . . 74.23 109.233 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.6 133.9 9.61 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.914 2.409 . . . . 72.33 112.127 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.482 ' HE1' ' HG ' ' A' ' 119' ' ' SER . 74.3 m-85 -131.27 158.85 39.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.426 -0.352 . . . . 74.13 110.501 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 92.4 mt-30 -123.04 113.53 19.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.864 -0.607 . . . . 75.12 110.804 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.75 126.89 44.5 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 121.008 -0.277 . . . . 61.1 110.329 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.582 HH11 ' HB ' ' A' ' 48' ' ' THR . 13.1 ptp180 -140.8 162.85 34.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.859 0.361 . . . . 71.42 110.809 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 62.3 m-85 -82.28 137.44 34.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.016 -0.538 . . . . 74.21 110.853 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.421 ' HD1' HG22 ' A' ' 48' ' ' THR . 80.2 t80 -121.62 119.52 32.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.771 -0.65 . . . . 63.23 109.4 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -84.0 130.32 34.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.305 -0.407 . . . . 72.45 110.746 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.502 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 73.6 p -102.01 5.34 40.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.876 0.846 . . . . 71.52 109.258 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.05 -136.89 4.01 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.455 -1.248 . . . . 42.21 110.274 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.15 92.19 6.25 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.663 -0.495 . . . . 72.22 109.663 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.403 ' HB2' HG13 ' A' ' 99' ' ' VAL . . . -48.43 114.1 0.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 123.768 0.668 . . . . 34.14 111.334 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.418 HG23 HD22 ' A' ' 98' ' ' ASN . 39.9 p -101.89 140.21 20.99 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 121.209 0.528 . . . . 74.51 110.407 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.63 162.52 40.68 Favored 'Trans proline' 0 C--N 1.331 -0.364 0 C-N-CA 123.713 2.942 . . . . 52.35 113.342 -174.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 142.08 -167.05 26.16 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.797 -0.638 . . . . 45.35 111.731 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.88 114.03 4.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 72.43 110.894 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.484 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . . . -112.77 49.85 0.91 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.441 0.639 . . . . 71.44 110.806 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.52 ' O ' ' HG2' ' A' ' 89' ' ' GLN . 89.1 m-20 -105.79 147.53 28.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.368 -0.833 . . . . 54.3 109.411 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.55 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -148.82 169.24 20.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.717 0.294 . . . . 71.13 111.083 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -140.16 147.73 40.57 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.528 -0.545 . . . . 42.54 109.528 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.19 144.46 21.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.992 0.425 . . . . 73.12 111.346 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 13' ' ' LYS . 22.7 p -103.11 123.98 47.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.83 -0.623 . . . . 64.32 109.756 175.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.443 ' CD1' HD13 ' A' ' 56' ' ' ILE . 39.5 p90 -97.21 124.11 41.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.255 0.55 . . . . 62.24 110.654 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.634 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.1 tmmm? -107.31 104.23 13.79 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.782 -0.645 . . . . 65.44 109.87 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 71' ' ' VAL . 1.3 m -75.55 147.95 7.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.026 0.441 . . . . 63.31 110.046 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -133.51 129.39 37.07 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.232 -0.655 . . . . 73.43 109.232 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.617 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 121.042 0.449 . . . . 73.4 110.989 175.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.905 0.383 . . . . 64.42 110.563 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.35 15.64 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.104 0.478 . . . . 75.22 110.526 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.512 HD22 ' N ' ' A' ' 6' ' ' ASN . 0.8 OUTLIER 65.09 11.97 7.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.186 -0.915 . . . . 34.35 112.348 171.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.484 ' N ' ' HG2' ' A' ' 36' ' ' GLN . . . 87.8 98.25 0.91 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.441 -0.885 . . . . 53.43 111.537 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.68 153.06 22.91 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.191 -1.004 . . . . 52.42 112.046 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.658 ' HB ' HG22 ' A' ' 31' ' ' THR . 75.0 p -137.05 140.47 42.07 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.857 -0.423 . . . . 74.21 109.857 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -110.85 118.82 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 109.7 -0.481 . . . . 71.4 109.7 176.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 13.1 t-80 -85.88 106.52 17.15 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.987 0.422 . . . . 52.01 110.005 177.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 77.8 m-85 -94.64 114.43 26.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.968 -0.56 . . . . 72.35 110.313 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 62.9 tttp -109.54 132.73 53.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.678 -0.692 . . . . 54.13 110.179 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.94 -114.64 3.01 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.89 -0.672 . . . . 41.3 112.073 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.672 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 37.4 mt-10 63.94 17.14 10.38 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.006 0.432 . . . . 75.12 111.236 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 155' ' ' LYS . 18.4 m -75.19 -30.88 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.905 -0.589 . . . . 72.33 111.92 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.453 HG21 ' CG2' ' A' ' 156' ' ' VAL . 29.6 m -140.16 154.7 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.246 0.546 . . . . 71.24 111.921 -174.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -155.29 28.61 0.4 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.026 -1.101 . . . . 70.12 108.026 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.43 -78.04 0.32 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.252 -0.886 . . . . 64.3 111.523 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.508 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -83.9 -37.63 22.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.124 0.487 . . . . 71.34 110.585 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.8 m -142.87 131.53 22.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.759 -0.655 . . . . 74.44 109.567 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.63 124.45 35.07 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.177 -0.465 . . . . 73.1 110.307 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.471 ' HA ' HD23 ' A' ' 58' ' ' LEU . 6.0 t -66.13 124.69 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.244 -0.651 . . . . 63.33 109.244 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' HG13 ' A' ' 28' ' ' VAL . 16.5 t70 -56.89 139.84 50.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 71.35 111.206 -175.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -59.72 -24.44 63.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 74.12 112.146 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.68 -17.55 70.35 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.555 -0.831 . . . . 60.04 111.915 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 p -104.98 -13.28 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.723 0.268 . . . . 65.03 111.723 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.672 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 34.7 m -78.68 -10.59 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.039 0.447 . . . . 63.03 110.623 177.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -152.68 90.43 1.48 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.415 -0.811 . . . . 73.02 108.882 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -142.99 115.96 8.83 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.517 0.675 . . . . 62.53 110.726 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.658 HG22 ' HB ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -97.1 97.02 8.86 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.277 -0.874 . . . . 54.22 108.96 176.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 9' ' ' THR . 8.8 p -75.63 132.3 33.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.938 0.399 . . . . 74.14 110.987 -175.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.56 ' HA ' HG22 ' A' ' 9' ' ' THR . 27.3 mp0 -87.82 125.76 34.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.103 -0.499 . . . . 73.34 110.107 177.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.409 HD21 HG23 ' A' ' 10' ' ' VAL . 2.9 mm? -90.59 -32.63 16.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.963 -0.562 . . . . 65.21 109.886 177.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.447 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 99.5 168.58 30.08 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.363 -0.835 . . . . 74.24 111.599 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.484 ' HG2' ' N ' ' A' ' 7' ' ' GLY . 77.4 mt-30 -74.35 86.37 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.159 0.479 . . . . 74.25 110.598 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.24 149.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 110.043 -0.355 . . . . 61.23 110.043 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -84.53 128.71 34.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.301 -0.409 . . . . 64.01 110.345 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p -68.32 -23.32 64.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.874 -0.603 . . . . 65.34 111.526 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.48 -18.35 62.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.027 -0.533 . . . . 74.12 111.496 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 m -90.3 -0.68 57.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.381 . . . . 73.53 111.276 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 3.6 mt -134.09 43.57 2.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.319 0.58 . . . . 73.3 110.285 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.36 8.41 33.63 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.667 0.617 . . . . 54.51 112.667 -168.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -150.51 144.76 25.56 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.347 -0.242 . . . . 74.32 110.347 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 86.0 tt0 -59.4 123.17 15.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.101 0.477 . . . . 62.44 110.018 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.5 -9.77 30.58 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.823 -0.703 . . . . 30.43 111.503 -175.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 42' ' ' LEU . . . -71.2 121.86 19.13 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.641 -0.503 . . . . 71.45 109.641 173.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.424 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 25.4 p -117.0 137.0 52.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.159 0.504 . . . . 72.51 111.182 -178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.462 ' HB2' ' H ' ' A' ' 137' ' ' TYR . 64.0 m -85.63 164.45 17.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.775 -0.648 . . . . 75.22 110.689 176.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.7 m -63.99 124.46 21.64 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.66 -0.496 . . . . 51.34 109.66 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.509 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -80.59 138.91 36.5 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.217 0.532 . . . . 72.11 111.489 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.2 m -78.49 148.07 6.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.107 -0.951 . . . . 62.33 109.358 170.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.42 90.46 0.69 Allowed Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.976 -0.631 . . . . 54.31 111.579 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -99.63 174.44 6.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.811 -0.44 . . . . 74.21 109.811 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.504 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 3.7 p-10 -138.06 142.78 40.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.325 0.583 . . . . 74.32 112.21 -170.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.495 HD12 ' CE2' ' A' ' 133' ' ' PHE . 73.5 mt -111.77 119.26 59.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.693 -0.855 . . . . 74.3 108.693 169.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -104.48 140.93 37.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.115 0.484 . . . . 74.32 111.238 -171.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 23' ' ' VAL . 55.1 mt -120.36 122.62 41.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.553 -0.748 . . . . 63.24 109.753 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -100.82 152.02 21.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.761 -0.654 . . . . 73.14 110.378 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 54.38 38.69 30.01 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.968 0.793 . . . . 74.41 110.827 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.28 129.41 34.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.946 -0.57 . . . . 73.34 110.266 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.413 ' OD1' ' HB2' ' A' ' 64' ' ' ASN . 15.7 t70 -111.29 133.95 53.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.565 . . . . 74.15 110.833 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -102.58 16.23 26.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.189 0.44 . . . . 62.4 112.189 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.413 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 93.7 m-20 -90.45 -35.46 15.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.298 0.571 . . . . 73.22 109.478 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.73 -31.5 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.521 -0.763 . . . . 72.41 111.153 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.6 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -118.85 173.11 7.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.646 0.26 . . . . 75.23 110.89 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 m -133.84 -58.94 0.86 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.223 -0.444 . . . . 74.42 111.614 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -134.71 136.62 42.86 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.258 -0.275 . . . . 74.43 110.258 -177.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.71 139.69 36.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.994 0.426 . . . . 75.44 110.594 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.4 122.75 10.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.711 -0.677 . . . . 62.24 109.418 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.661 HG12 HG12 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -96.53 147.07 6.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.068 0.461 . . . . 70.35 110.973 -175.298 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.49 127.09 53.67 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.733 -0.667 . . . . 71.54 109.466 173.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 83.8 m-85 -88.99 131.7 35.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.899 0.38 . . . . 74.3 110.294 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.4 tp -130.52 125.06 33.34 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.976 -0.556 . . . . 71.52 110.355 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.48 -131.95 1.3 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.647 -0.706 . . . . 70.53 111.545 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.1 m -121.34 131.06 53.97 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.177 -0.305 . . . . 74.4 110.177 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -82.46 142.09 32.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.592 -0.276 . . . . 74.51 110.847 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 tt -69.18 -26.53 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.012 0.434 . . . . 73.53 111.09 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -144.6 179.74 7.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.599 -0.519 . . . . 52.33 109.599 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.67 27.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.181 0.515 . . . . 75.43 109.745 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.37 -37.77 7.46 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.812 -0.709 . . . . 73.1 111.594 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -91.17 77.66 5.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.359 0.6 . . . . 70.44 110.163 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.446 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 9.2 p -94.53 6.17 49.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.28 -0.873 . . . . 52.44 111.586 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -111.8 2.34 17.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.207 0.527 . . . . 64.43 110.653 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 102' ' ' GLN . 47.9 t -113.65 125.98 71.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.775 -0.648 . . . . 53.11 109.73 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -68.64 135.92 52.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.648 0.261 . . . . 72.12 110.506 -178.338 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.47 149.89 34.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.086 -0.506 . . . . 74.01 110.376 177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.474 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.9 mm? -84.3 139.11 32.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.342 -0.39 . . . . 52.33 110.176 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.425 ' HG3' ' HA ' ' A' ' 150' ' ' ALA . 89.9 mt-30 . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.878 -0.601 . . . . 72.4 110.491 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 109.556 -0.535 . . . . 71.34 109.556 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.45 148.64 51.37 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.091 -0.337 . . . . 53.33 110.091 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.61 159.82 41.43 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.865 -0.334 . . . . 73.4 110.343 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 69.31 4.49 4.64 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.626 0.579 . . . . 73.51 110.586 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.474 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -146.8 151.62 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 115.279 -0.873 . . . . 74.52 109.035 173.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -153.67 -171.64 21.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.888 -0.885 . . . . 52.21 110.888 177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 10' ' ' VAL . 3.0 p -117.37 112.41 38.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.521 0.676 . . . . 74.11 110.516 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.507 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.5 pt20 -102.27 139.04 38.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.603 -0.726 . . . . 71.35 109.447 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.487 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.8 mp -101.35 117.29 46.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.899 0.38 . . . . 63.54 110.175 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 13.4 mt -86.44 144.81 27.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.622 -0.717 . . . . 54.23 109.37 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.4 p-10 -72.95 -168.24 0.46 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.759 -0.46 . . . . 54.44 109.759 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -64.03 -31.21 72.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.561 -0.29 . . . . 70.34 111.531 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.1 p -84.85 -29.96 24.88 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.829 -0.349 . . . . 70.43 111.218 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.32 34.68 1.0 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.324 -0.941 . . . . 71.52 113.246 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.39 130.61 56.25 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.96 -0.385 . . . . 51.25 109.96 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.56 119.1 14.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 62.31 110.417 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.1 mt -79.76 132.99 36.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.002 -0.544 . . . . 61.41 111.148 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.443 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 7.9 m -68.36 140.25 55.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.688 -0.687 . . . . 74.14 110.564 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 33.2 mt -85.01 42.95 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.09 -0.504 . . . . 40.34 111.203 -176.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -100.65 -3.03 31.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.006 0.432 . . . . 74.21 110.539 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.03 12.58 68.59 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.879 -0.6 . . . . 54.23 112.795 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.68 -14.45 5.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.749 0.309 . . . . 43.12 111.071 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.443 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 18.3 m -86.25 96.52 9.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.326 -0.397 . . . . 73.43 110.079 175.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -86.51 163.46 17.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.981 -0.554 . . . . 74.5 110.506 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.518 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 1.6 m -72.82 176.26 5.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.079 -0.51 . . . . 55.23 110.805 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.0 t -66.15 139.27 58.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.509 -0.552 . . . . 74.54 109.509 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -51.58 107.42 0.19 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.638 0.586 . . . . 75.43 111.387 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.5 m -93.01 106.24 18.22 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.316 -0.624 . . . . 51.05 109.316 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.55 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 26.5 m -57.36 128.58 37.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 53.33 111.163 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.33 149.86 23.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.723 -0.671 . . . . 72.21 110.918 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -126.61 158.64 35.78 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.871 -0.788 . . . . 62.4 108.871 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -62.33 117.73 6.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.855 0.36 . . . . 72.24 110.564 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 116.7 -134.77 11.53 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.47 -0.872 . . . . 62.13 112.733 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.8 m -86.76 128.61 35.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.94 0.4 . . . . 64.43 110.984 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -124.37 144.4 50.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.568 -0.53 . . . . 72.14 109.568 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 1.5 m -128.38 118.28 22.89 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.888 0.375 . . . . 74.51 110.582 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 11.2 mt -95.04 114.03 62.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.112 -0.699 . . . . 45.14 109.112 176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 2.1 Cg_endo -81.85 136.14 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.989 2.46 . . . . 71.1 112.554 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.495 ' CE2' HD12 ' A' ' 56' ' ' ILE . 76.3 m-85 -134.19 159.74 39.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.119 -0.492 . . . . 73.34 110.588 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.628 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 19.9 mt-30 -129.15 111.8 13.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.856 -0.611 . . . . 72.21 110.864 -175.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -101.64 124.54 47.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.473 -0.33 . . . . 75.11 110.358 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 4.7 ptp180 -138.13 160.09 40.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.37 -0.377 . . . . 75.35 110.536 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 69.0 m-85 -79.25 139.58 37.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.93 -0.577 . . . . 73.51 110.23 173.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -127.0 122.63 35.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.652 -0.704 . . . . 73.42 109.328 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -85.35 132.39 34.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.381 -0.372 . . . . 43.32 111.318 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.474 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 74.3 p -105.24 3.61 30.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.635 0.731 . . . . 64.32 109.19 176.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.73 -128.48 1.54 Allowed Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.798 -1.092 . . . . 54.2 110.838 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.24 96.16 10.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.098 -0.334 . . . . 75.41 110.098 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -43.75 109.56 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.721 0.638 . . . . 64.51 111.917 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 26.9 p -102.48 139.35 20.13 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 121.271 0.558 . . . . 64.32 110.407 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.24 -179.84 2.49 Favored 'Trans proline' 0 C--N 1.332 -0.299 0 C-N-CA 124.021 3.147 . . . . 71.33 113.421 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.46 -139.34 10.7 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.408 -0.814 . . . . 55.12 111.83 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.85 117.46 33.88 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.16 -0.311 . . . . 64.41 110.16 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -111.77 60.38 0.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.033 0.444 . . . . 51.5 111.565 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -106.98 145.82 31.82 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.412 -0.588 . . . . 63.14 109.412 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -148.61 168.01 23.94 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.347 -0.242 . . . . 74.35 110.347 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -147.7 146.19 29.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.119 -0.326 . . . . 64.34 110.119 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -153.2 149.3 27.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.076 -0.511 . . . . 71.42 110.911 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.0 p -101.15 127.24 47.79 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.99 -0.55 . . . . 72.4 109.757 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -99.57 129.29 45.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.311 0.577 . . . . 74.54 110.359 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.581 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -112.52 107.34 16.04 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.636 -0.711 . . . . 74.54 110.145 -178.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.661 HG12 HG12 ' A' ' 71' ' ' VAL . 1.5 m -79.71 147.6 6.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.984 0.421 . . . . 70.2 110.315 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -130.16 124.97 33.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.417 -0.586 . . . . 62.14 109.417 173.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.6 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 121.056 0.455 . . . . 75.13 111.045 176.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.3 p . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 121.019 0.438 . . . . 73.11 110.445 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.459 HG23 ' H ' ' A' ' 7' ' ' GLY . 35.6 m -83.83 6.61 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.006 0.431 . . . . 71.41 110.791 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 67.42 -3.46 1.06 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.352 -0.84 . . . . 64.35 112.648 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.459 ' H ' HG23 ' A' ' 5' ' ' VAL . . . 116.17 95.56 1.94 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.938 -0.649 . . . . 74.43 111.738 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.477 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -77.1 154.86 43.52 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.48 -0.867 . . . . 50.25 111.831 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.6 p -146.07 125.89 13.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.714 0.292 . . . . 73.44 110.862 -177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -105.19 122.35 58.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.369 -0.604 . . . . 60.11 109.369 176.035 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -90.23 99.28 12.33 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.379 -0.529 . . . . 73.41 110.049 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -90.86 117.14 29.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.605 -0.725 . . . . 71.2 110.023 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -110.76 136.91 49.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.04 0.448 . . . . 62.14 110.255 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.75 -126.25 5.58 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.768 -0.651 . . . . 44.44 111.82 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 29.3 mt-10 66.52 14.73 9.86 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.462 0.648 . . . . 73.42 110.526 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' A' ' 155' ' ' LYS . 29.7 m -76.29 -24.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.366 -0.834 . . . . 75.01 111.856 -175.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.517 HG21 HG22 ' A' ' 156' ' ' VAL . 19.1 m -139.08 142.27 34.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.271 0.558 . . . . 74.15 111.884 -175.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -142.62 18.72 2.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.804 -1.089 . . . . 73.44 108.239 173.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.51 -77.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.171 -0.922 . . . . 60.43 111.426 -172.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.522 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -92.47 -37.07 12.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.941 0.401 . . . . 64.12 110.258 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.34 132.09 25.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.245 -0.434 . . . . 72.24 110.303 -175.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.86 127.41 39.6 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.986 -0.552 . . . . 71.31 109.738 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.433 ' HB ' HG12 ' A' ' 28' ' ' VAL . 13.0 t -64.12 132.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.406 -0.361 . . . . 73.31 110.316 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.457 ' O ' HG13 ' A' ' 28' ' ' VAL . 19.2 t70 -57.27 139.34 53.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.938 -0.574 . . . . 73.11 110.682 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -64.02 -19.67 65.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.175 0.435 . . . . 72.32 112.175 -173.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.07 -18.53 74.47 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.394 -0.908 . . . . 74.52 111.937 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 p -110.63 -6.07 14.92 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.235 0.458 . . . . 65.54 112.235 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 25' ' ' ALA . 35.5 m -81.97 -7.29 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.912 0.387 . . . . 73.35 110.893 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -157.94 95.83 1.43 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.909 -0.774 . . . . 74.41 108.909 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -142.24 112.12 6.85 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.862 -0.608 . . . . 73.33 110.567 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.49 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.1 m -92.91 93.7 8.53 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.861 -0.792 . . . . 75.44 108.861 175.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' THR . 8.3 p -80.66 128.93 38.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.968 -0.56 . . . . 64.45 111.07 -172.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -86.62 120.99 28.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.886 -0.597 . . . . 74.12 109.685 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.44 -20.34 40.54 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.453 -0.573 . . . . 72.42 109.453 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.13 -178.72 42.07 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.203 -0.908 . . . . 73.51 111.669 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.92 90.37 6.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.615 -0.513 . . . . 61.23 109.615 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.446 HG12 HG22 ' A' ' 5' ' ' VAL . 11.8 p -64.64 136.24 26.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 61.13 110.688 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 38' ' ' ARG . 67.2 mtt180 -66.91 108.25 2.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.485 -0.779 . . . . 73.31 109.741 175.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 22.9 p -67.29 -23.63 65.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.197 0.522 . . . . 64.51 110.281 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.01 -5.77 47.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.758 -0.655 . . . . 73.15 111.389 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.9 m -97.79 -4.49 36.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 73.14 110.841 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -131.07 101.54 5.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.516 . . . . 63.23 109.755 177.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.18 15.97 5.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.244 0.461 . . . . 73.24 112.244 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.92 147.39 26.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.801 0.334 . . . . 62.43 110.983 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -58.6 123.03 14.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.664 -0.698 . . . . 75.11 109.472 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.464 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 101.97 8.48 44.91 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.512 -0.852 . . . . 73.12 111.965 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.697 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -79.9 128.28 33.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.065 -0.346 . . . . 75.14 110.065 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 p -115.79 118.92 34.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.917 -0.583 . . . . 63.22 110.378 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.1 t -83.68 173.59 11.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.86 0.362 . . . . 41.13 110.256 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.2 m -69.21 129.29 39.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.853 -0.612 . . . . 53.43 110.093 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -82.22 165.19 20.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.745 0.783 . . . . 74.43 112.071 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.9 m -101.39 157.62 4.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.458 -1.246 . . . . 64.24 109.22 169.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.5 107.49 2.27 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.829 -0.701 . . . . 65.55 112.059 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -125.07 178.61 5.45 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.749 -0.463 . . . . 64.3 109.749 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.494 ' HB2' HG22 ' A' ' 130' ' ' THR . 30.2 p30 -137.26 156.99 47.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.46 0.648 . . . . 72.21 111.99 -174.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.487 HD13 ' CD1' ' A' ' 154' ' ' PHE . 65.3 mt -123.51 105.37 15.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 107.956 -1.127 . . . . 72.43 107.956 167.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 26.1 tt0 -99.05 143.29 29.49 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.939 -0.573 . . . . 64.13 110.72 -171.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 23' ' ' VAL . 41.5 mt -117.96 125.46 50.46 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.056 -0.52 . . . . 73.34 109.847 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -100.51 143.1 31.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.045 -0.525 . . . . 73.31 110.107 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 52.9 46.96 25.72 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.834 0.708 . . . . 63.1 110.926 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 44.5 t -79.26 139.92 37.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.114 -0.948 . . . . 64.11 110.812 -175.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 64' ' ' ASN . 26.6 t70 -108.89 151.47 26.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.045 -0.525 . . . . 61.44 111.592 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 75.6 p -122.92 11.88 9.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.464 -0.334 . . . . 73.44 111.66 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.408 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 56.3 m-80 -81.44 -35.32 30.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.449 -0.574 . . . . 71.0 109.449 177.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.39 -27.9 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.531 -0.759 . . . . 75.35 110.805 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -112.05 166.41 11.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.045 0.45 . . . . 73.1 111.675 -176.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 m -132.7 -56.37 0.94 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.101 -0.5 . . . . 65.25 110.994 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.835 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -136.59 131.06 33.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.458 -0.337 . . . . 73.14 110.194 -177.048 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 158' ' ' TYR . . . -88.38 139.67 30.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.848 0.356 . . . . 32.23 110.707 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -143.88 114.36 7.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.645 -0.707 . . . . 52.32 109.672 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.612 HG12 HG12 ' A' ' 156' ' ' VAL . 0.8 OUTLIER -93.48 143.28 11.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.967 0.413 . . . . 63.22 110.563 -175.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.511 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -118.6 125.73 50.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.01 -0.541 . . . . 61.12 110.26 175.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 86.4 m-85 -91.73 122.67 34.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 72.13 110.319 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.3 tp -118.9 133.25 55.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.009 -0.542 . . . . 75.23 110.066 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.91 -174.48 41.6 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.237 -0.745 . . . . 53.23 111.237 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.8 m -75.99 128.0 34.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.803 0.302 . . . . 70.15 111.103 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -82.49 140.67 33.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.773 0.321 . . . . 53.34 110.648 177.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.503 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 11.6 tt -70.58 -27.02 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.382 -0.372 . . . . 75.11 111.458 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.56 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 20.1 t70 -141.26 179.29 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.717 -0.475 . . . . 72.55 109.717 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.94 -33.7 26.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.078 0.466 . . . . 71.11 109.774 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.58 -28.26 13.07 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.8 -0.714 . . . . 72.3 111.651 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 77.0 m80 -92.65 69.25 4.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.421 0.629 . . . . 62.42 109.554 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.471 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 4.1 p -91.26 7.99 38.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.277 -0.874 . . . . 74.21 111.201 -178.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -110.0 4.1 21.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.947 -0.569 . . . . 74.14 110.22 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 102' ' ' GLN . 58.7 t -120.04 126.38 75.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 72.4 110.141 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.539 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -70.72 133.63 46.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.656 0.265 . . . . 73.51 110.361 -178.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -79.56 155.71 28.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.004 -0.543 . . . . 72.32 110.394 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.514 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.6 mm? -81.84 148.37 28.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.293 -0.412 . . . . 75.3 110.106 -175.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 116.272 -0.422 . . . . 70.55 110.294 178.94 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 120.633 0.254 . . . . 75.43 110.48 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.26 49.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 60.22 110.816 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.14 152.92 47.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.481 -0.327 . . . . 42.22 110.702 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.413 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 42.5 m-80 68.26 7.47 5.94 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.803 -0.635 . . . . 75.14 111.919 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.514 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -147.6 151.98 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 CA-C-O 120.978 0.418 . . . . 73.3 110.758 176.082 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -151.22 -171.29 19.1 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 110.277 -1.129 . . . . 65.51 110.277 174.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 10' ' ' VAL . 2.7 p -117.1 118.81 59.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.378 0.609 . . . . 75.53 110.965 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.456 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.0 pt20 -110.46 147.09 34.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.66 -0.7 . . . . 75.01 109.793 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.3 mp -107.44 127.87 62.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.987 0.422 . . . . 73.13 110.804 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.2 mt -91.47 142.8 27.26 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.559 -0.746 . . . . 73.45 109.116 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.557 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.9 OUTLIER -75.14 -170.42 1.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.508 -0.314 . . . . 72.32 110.167 178.282 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.5 ptt85 -62.96 -24.8 68.06 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.604 0.224 . . . . 72.04 111.604 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.423 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 69.9 p -93.49 1.06 56.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 74.1 111.391 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.68 29.47 29.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.879 -0.676 . . . . 74.11 112.996 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.8 130.23 55.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.237 -0.283 . . . . 74.33 110.237 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.73 128.55 36.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.897 0.38 . . . . 63.02 111.034 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.45 148.95 23.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.956 -0.565 . . . . 65.24 110.785 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.5 m -85.66 141.9 29.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 74.45 110.251 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 63.4 mt -79.23 42.16 0.48 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.168 0.509 . . . . 73.21 110.683 -178.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.449 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 16.6 t70 -85.37 -18.72 32.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.817 -0.628 . . . . 74.52 110.936 -176.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.74 -24.77 7.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.584 -0.817 . . . . 71.25 112.454 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.2 7.5 19.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.006 0.431 . . . . 73.13 110.563 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 114' ' ' ASP . 15.8 m -93.7 97.29 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 72.42 109.853 175.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.57 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 58.3 m-85 -92.79 162.7 14.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.122 -0.49 . . . . 75.35 111.005 -174.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 5.6 m -72.97 176.35 5.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 64.35 111.314 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.9 m -65.05 131.47 46.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.231 -0.441 . . . . 62.44 110.191 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -44.25 115.48 0.85 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.027 0.829 . . . . 52.41 111.944 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.6 m -102.25 105.27 15.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.137 -0.483 . . . . 71.33 109.965 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.835 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 59.9 m -60.58 115.83 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.48 0.657 . . . . 72.4 111.361 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.539 HD13 ' SG ' ' A' ' 61' ' ' CYS . 96.0 mt -83.22 155.63 23.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.19 -0.913 . . . . 64.22 112.097 -173.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.38 153.3 50.92 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.668 -0.864 . . . . 73.43 108.668 170.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.9 m120 -63.82 112.35 2.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.956 0.408 . . . . 72.33 110.762 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.1 -137.66 9.29 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.934 -0.651 . . . . 62.53 112.046 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.7 m -93.61 126.96 39.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.71 0.291 . . . . 62.12 110.889 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -129.8 120.79 25.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.721 -0.474 . . . . 74.13 109.721 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.494 HG22 ' HB2' ' A' ' 55' ' ' ASN . 2.3 m -110.44 117.52 33.79 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.626 0.251 . . . . 74.33 110.468 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.5 mt -95.48 113.9 62.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.597 -0.52 . . . . 72.04 109.597 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.78 138.55 13.39 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.09 2.527 . . . . 72.22 112.667 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 86.5 m-85 -135.9 161.09 36.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 74.44 110.887 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.572 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 52.2 mt-30 -133.04 118.24 18.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.655 . . . . 73.01 110.751 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.37 126.7 50.67 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.318 -0.239 . . . . 55.02 110.44 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.525 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -134.44 164.99 26.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.802 0.334 . . . . 45.4 111.048 -178.021 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.477 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 63.1 m-85 -85.46 142.2 29.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.997 -0.547 . . . . 73.1 110.466 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.464 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 61.1 t80 -126.83 124.11 38.88 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.895 -0.78 . . . . 74.21 108.895 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.697 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -91.19 135.99 33.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.12 0.486 . . . . 71.31 111.572 -176.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.413 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 78.7 p -100.36 1.27 41.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.296 -0.865 . . . . 71.32 108.909 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.11 -128.77 1.7 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.553 -1.203 . . . . 71.15 111.059 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -87.55 95.71 10.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.184 -0.302 . . . . 72.01 110.184 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -46.52 112.05 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.847 -0.615 . . . . 71.14 111.587 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.2 p -107.61 149.51 38.98 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-O 121.003 0.43 . . . . 73.33 110.736 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.5 163.99 25.08 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.85 3.034 . . . . 72.0 113.239 -176.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.91 179.99 18.34 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.672 -0.694 . . . . 64.52 111.975 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.07 119.85 10.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.789 0.328 . . . . 64.14 110.707 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.01 42.64 2.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.649 0.738 . . . . 75.14 110.411 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -98.72 145.13 27.22 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.036 -0.984 . . . . 72.32 110.078 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.539 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -147.45 164.89 31.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.917 0.389 . . . . 63.24 111.322 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -123.05 133.31 54.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.321 -0.622 . . . . 72.41 109.321 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.22 128.94 14.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.932 0.396 . . . . 70.14 111.108 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.0 p -102.53 129.71 49.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.132 -0.485 . . . . 74.03 110.265 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.487 ' CD1' HD13 ' A' ' 56' ' ' ILE . 47.3 p90 -103.45 127.26 50.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.958 0.409 . . . . 73.13 110.706 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.62 ' HA ' HG21 ' A' ' 16' ' ' VAL . 6.9 ttmm -110.14 108.7 18.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.259 -0.428 . . . . 71.41 110.331 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.612 HG12 HG12 ' A' ' 71' ' ' VAL . 1.5 m -80.62 129.7 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.447 -0.575 . . . . 73.33 109.447 174.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -123.02 115.19 21.45 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.143 -0.688 . . . . 60.45 109.143 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.644 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 112.392 0.515 . . . . 75.22 112.392 -177.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 62.4 p . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.891 0.377 . . . . 65.22 110.422 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.523 HG22 HG12 ' A' ' 37' ' ' VAL . 34.8 m -91.31 17.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.013 0.435 . . . . 64.55 110.563 175.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 59.96 20.15 9.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.325 -0.852 . . . . 64.1 111.999 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.12 101.57 1.02 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.718 -0.753 . . . . 34.11 111.712 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.46 151.69 31.39 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.035 -1.078 . . . . 71.44 111.348 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.525 ' HB ' HG22 ' A' ' 31' ' ' THR . 17.4 p -141.47 135.64 30.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.55 0.214 . . . . 54.01 110.913 -176.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.45 ' CG2' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -117.49 115.89 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.566 -0.531 . . . . 65.14 109.566 174.21 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 18.1 t-80 -83.04 108.76 16.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.286 -0.415 . . . . 70.23 109.928 177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -100.03 113.78 26.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.125 -0.489 . . . . 73.14 110.302 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -106.12 135.02 48.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.867 -0.42 . . . . 42.35 109.867 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.01 -125.91 5.7 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.962 -0.637 . . . . 31.33 111.888 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 67.6 12.95 9.12 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.886 0.474 . . . . 71.11 110.93 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.569 HG23 HG13 ' A' ' 17' ' ' VAL . 34.2 m -76.38 -30.66 19.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.063 -0.517 . . . . 65.13 111.859 -173.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.569 HG13 HG23 ' A' ' 16' ' ' VAL . 24.9 m -133.75 145.46 33.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.299 0.571 . . . . 70.02 111.468 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -151.68 30.41 0.59 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.933 -1.136 . . . . 61.43 107.933 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.66 -79.26 0.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.227 -0.897 . . . . 75.53 111.214 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -90.68 -34.87 15.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.969 0.414 . . . . 53.31 110.602 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.2 m -140.78 136.31 32.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.485 . . . . 51.45 109.75 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.31 130.45 47.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.357 -0.383 . . . . 60.11 110.304 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 58' ' ' LEU . 20.7 t -67.69 130.93 33.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.964 -0.384 . . . . 60.4 109.964 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 28' ' ' VAL . 15.3 t70 -61.66 141.11 58.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.36 -0.382 . . . . 71.54 110.72 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.81 -26.99 64.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 34.12 111.798 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.84 2.67 79.02 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.792 -0.718 . . . . 75.24 112.302 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.3 p -131.89 3.05 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.593 0.235 . . . . 64.43 111.521 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 24' ' ' ASP . 35.2 m -89.4 -1.32 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.873 0.368 . . . . 62.21 110.687 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -158.72 97.58 1.45 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.085 -0.709 . . . . 73.41 109.085 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -144.6 104.01 4.0 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.483 0.658 . . . . 74.13 111.041 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.525 HG22 ' HB ' ' A' ' 9' ' ' THR . 5.8 m -81.59 94.48 6.92 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.389 -0.823 . . . . 72.24 109.096 173.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.42 140.33 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.122 -0.49 . . . . 75.14 111.043 -172.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -96.58 117.82 31.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 71.44 110.095 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.45 HD21 ' CG2' ' A' ' 10' ' ' VAL . 1.7 mm? -87.98 -23.85 23.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.444 -0.576 . . . . 74.41 109.444 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.29 166.96 32.67 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.317 -0.856 . . . . 55.22 112.618 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -73.21 94.46 1.98 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.907 -0.405 . . . . 75.21 109.907 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.523 HG12 HG22 ' A' ' 5' ' ' VAL . 9.5 p -75.54 145.24 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.19 -0.459 . . . . 54.4 110.858 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -76.47 117.56 18.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.788 -0.642 . . . . 71.34 110.562 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 29.9 p -72.67 -16.28 61.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 65.41 110.99 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.0 -16.52 54.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 71.5 110.909 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.4 m -83.23 -44.34 15.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.167 -0.47 . . . . 72.23 110.263 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 6.2 mp -93.83 95.85 9.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.18 0.514 . . . . 62.21 110.306 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.47 22.26 5.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.326 0.584 . . . . 71.3 110.379 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.431 ' HG2' ' HB2' ' A' ' 47' ' ' ALA . 3.6 pm0 -151.66 137.96 18.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.311 -0.859 . . . . 54.12 110.233 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 40.8 tt0 -62.26 123.62 18.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.978 0.418 . . . . 60.33 110.117 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.67 -13.35 27.46 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.27 -0.732 . . . . 55.32 111.27 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -63.95 121.89 15.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.67 0.272 . . . . 72.35 110.281 176.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 25.4 p -123.75 118.62 27.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.34 -0.391 . . . . 73.42 110.724 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 t -75.8 173.72 10.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.1 -0.5 . . . . 64.43 110.172 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.8 m -64.41 135.79 56.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.107 0.48 . . . . 74.2 110.446 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -85.6 159.37 19.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.733 -0.667 . . . . 44.32 111.771 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.6 m -90.48 158.41 2.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.898 -1.047 . . . . 71.1 108.991 168.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.55 81.13 0.31 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.446 -0.883 . . . . 71.34 112.237 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -95.95 165.33 12.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.989 -0.374 . . . . 75.43 109.989 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.587 ' HB2' HG22 ' A' ' 130' ' ' THR . 2.4 p-10 -138.12 144.66 40.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.38 0.609 . . . . 75.54 111.517 -175.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.409 HD13 ' CD2' ' A' ' 154' ' ' PHE . 79.7 mt -105.53 120.25 55.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.34 -0.846 . . . . 72.32 109.383 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -98.15 136.98 37.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.98 0.419 . . . . 75.41 110.643 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 23' ' ' VAL . 50.8 mt -119.04 130.75 55.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 74.54 109.597 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -108.15 144.84 35.02 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.243 -0.435 . . . . 72.34 110.395 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 53.39 46.38 26.41 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.868 0.73 . . . . 52.21 111.225 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.487 ' SG ' HD13 ' A' ' 124' ' ' LEU . 27.5 t -81.34 131.89 35.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.461 -0.791 . . . . 64.54 110.074 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.431 ' OD2' HG12 ' A' ' 65' ' ' VAL . 16.3 t70 -107.68 134.01 51.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.243 -0.435 . . . . 74.32 111.646 -175.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.1 p -104.67 13.77 30.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 73.15 112.064 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -89.07 -35.39 16.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.905 -0.406 . . . . 71.33 109.905 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.431 HG12 ' OD2' ' A' ' 62' ' ' ASP . 14.0 p -97.26 -28.31 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.975 -0.557 . . . . 74.14 111.044 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -121.1 -177.59 3.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.493 -0.322 . . . . 52.22 110.953 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.2 m -140.75 -54.89 0.5 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.644 0.259 . . . . 73.23 111.454 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.81 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -134.56 140.95 46.5 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.318 -0.239 . . . . 72.15 110.843 -178.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.52 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -102.59 135.4 44.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.101 0.477 . . . . 62.03 110.557 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.9 114.92 7.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.759 -0.655 . . . . 31.52 109.576 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.666 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -85.32 149.33 4.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.142 0.496 . . . . 75.31 110.895 -174.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.74 118.33 29.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.54 -0.755 . . . . 74.41 109.211 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 75.2 m-85 -83.16 128.98 34.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.027 0.441 . . . . 55.04 110.498 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.7 tp -128.22 127.44 42.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.008 -0.542 . . . . 55.23 109.804 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.47 -167.94 25.79 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.965 -0.854 . . . . 70.35 110.965 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.437 ' O ' HD13 ' A' ' 86' ' ' LEU . 9.5 m -74.29 120.85 20.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.102 0.451 . . . . 64.11 110.622 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.59 136.17 36.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.592 0.234 . . . . 72.22 110.817 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.496 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 10.9 tt -65.16 -30.6 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.29 -0.414 . . . . 72.23 111.213 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 19.9 t70 -151.3 173.21 14.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.478 -0.564 . . . . 71.2 109.478 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.59 -30.78 52.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.059 -0.519 . . . . 73.4 110.301 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.12 -20.26 28.47 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.842 -0.694 . . . . 54.1 111.711 177.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 65.1 m80 -103.5 47.85 0.87 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.382 -0.599 . . . . 55.54 109.382 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.495 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.4 p -72.81 9.63 1.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.572 -0.74 . . . . 51.32 112.331 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 16.7 p-10 -99.75 -18.6 17.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.784 0.326 . . . . 62.3 110.895 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.7 t -105.03 132.57 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.388 -0.369 . . . . 61.03 110.87 -176.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -67.29 135.18 52.94 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.21 -0.45 . . . . 72.41 110.519 179.18 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.83 146.78 33.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.964 -0.562 . . . . 60.32 109.684 175.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.2 mm? -85.7 129.87 34.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.333 -0.394 . . . . 65.15 110.77 -175.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.646 . . . . 71.04 109.493 176.907 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.412 ' HA ' ' H ' ' A' ' 147' ' ' ALA . 4.3 p . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.608 -0.516 . . . . 63.32 109.608 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.19 144.77 38.08 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.805 -0.443 . . . . 55.43 109.805 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.09 164.7 29.4 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.964 -0.384 . . . . 75.04 109.964 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.503 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 67.0 m-20 69.03 8.11 6.64 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.347 0.594 . . . . 53.12 110.12 -177.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -178.23 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.023 -0.99 . . . . 73.34 109.628 173.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 175.25 -172.07 45.14 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 110.268 -1.133 . . . . 73.45 110.268 177.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 2.5 p -126.13 120.06 55.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.096 0.474 . . . . 54.32 110.409 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.441 ' OE1' ' HB1' ' A' ' 110' ' ' ALA . 25.9 pt20 -117.14 149.51 40.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.52 -0.548 . . . . 71.35 109.52 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.3 mp -101.02 128.2 53.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.089 -0.505 . . . . 71.41 110.598 -174.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 16.3 mt -94.1 146.0 24.28 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.367 -0.833 . . . . 74.21 108.917 175.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.572 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.4 OUTLIER -72.39 -173.21 1.07 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.825 -0.435 . . . . 63.1 109.825 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.427 ' HE ' ' CB ' ' A' ' 120' ' ' SER . 24.1 ptt180 -58.31 -32.49 68.52 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.556 0.206 . . . . 71.52 111.556 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.408 HG23 ' HG3' ' A' ' 106' ' ' ARG . 40.3 p -89.28 0.32 56.88 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.817 0.341 . . . . 72.14 111.793 -177.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.04 29.95 24.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 62.22 113.07 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . -102.78 134.35 46.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.364 -0.236 . . . . 72.34 110.364 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.51 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -67.05 122.76 18.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.998 0.428 . . . . 72.32 111.323 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.6 mt -90.56 148.4 22.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.026 -0.534 . . . . 74.04 110.523 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.485 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 25.8 m -96.91 142.22 29.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.258 -0.428 . . . . 51.3 110.439 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 50.0 mt -83.95 51.55 2.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 74.24 110.857 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -109.72 -5.43 15.61 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.018 0.437 . . . . 73.12 110.046 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.26 2.29 62.46 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.745 -0.661 . . . . 71.14 112.95 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.66 -13.09 9.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 63.33 111.066 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.485 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 12.1 m -85.51 100.29 11.8 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.968 -0.382 . . . . 75.21 109.968 175.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.418 ' HE1' ' HE3' ' A' ' 155' ' ' LYS . 83.3 m-85 -90.17 154.7 19.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.945 -0.571 . . . . 65.23 111.185 -176.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.572 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 11.5 m -69.64 179.73 2.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.66 -0.7 . . . . 63.32 110.843 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.427 ' CB ' ' HE ' ' A' ' 106' ' ' ARG . 40.8 t -64.14 150.19 46.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.936 -0.394 . . . . 72.22 109.936 174.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -61.83 102.73 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 73.34 111.075 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -84.5 97.81 9.76 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.864 -0.791 . . . . 70.21 108.864 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.81 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 49.8 m -60.69 122.91 15.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.073 -0.512 . . . . 61.31 110.391 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 69' ' ' ALA . 97.0 mt -80.97 151.98 28.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.383 -0.826 . . . . 61.24 112.066 -170.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -116.78 159.51 22.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.142 -0.936 . . . . 73.2 109.37 170.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.35 108.0 6.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.129 0.49 . . . . 73.11 110.356 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.27 -135.91 9.55 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.739 -0.743 . . . . 72.44 112.339 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.1 m -83.84 126.09 32.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.165 0.507 . . . . 75.21 111.335 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -124.56 160.4 28.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.716 -0.675 . . . . 74.42 109.646 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.587 HG22 ' HB2' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -144.18 122.28 12.16 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.848 -0.341 . . . . 64.04 110.576 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 7.0 mt -102.98 113.43 65.91 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.984 -0.376 . . . . 63.34 109.984 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 1.8 Cg_endo -82.9 137.31 8.62 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 123.131 2.554 . . . . 62.1 112.399 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -134.66 163.17 30.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.028 0.442 . . . . 54.22 111.211 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 104' ' ' LEU . 99.3 mt-30 -127.89 112.91 15.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.871 -0.604 . . . . 74.51 111.217 -177.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.17 121.59 42.53 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.944 -0.303 . . . . 64.32 110.236 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.55 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 10.6 ptp180 -137.45 164.05 29.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.848 0.356 . . . . 75.12 110.857 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.425 ' CE2' ' HB ' ' A' ' 37' ' ' VAL . 87.4 m-85 -78.95 147.47 32.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.607 . . . . 72.53 111.007 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -131.81 122.14 25.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.673 -0.694 . . . . 74.1 109.529 176.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -91.32 139.36 30.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.902 0.382 . . . . 61.35 111.528 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 48.0 p -103.89 -0.73 28.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.536 0.684 . . . . 74.32 109.316 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.8 -127.57 1.48 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.05 -0.977 . . . . 72.31 111.111 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.83 93.92 6.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.359 -0.237 . . . . 74.23 110.359 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.412 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.32 116.75 1.84 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.384 0.428 . . . . 74.24 111.094 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.472 HG23 HD22 ' A' ' 98' ' ' ASN . 36.0 p -104.12 142.67 25.09 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-O 121.256 0.551 . . . . 75.0 110.898 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.25 165.53 28.35 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.581 2.854 . . . . 72.35 113.018 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 145.99 -140.2 8.72 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.605 -0.725 . . . . 65.32 111.869 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.412 ' H ' ' HA ' ' A' ' 95' ' ' SER . . . -107.3 117.01 32.95 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.412 0.149 . . . . 64.4 110.745 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -105.97 58.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.341 0.591 . . . . 70.41 111.141 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.412 HD22 ' N ' ' A' ' 149' ' ' ASN . 0.9 OUTLIER -99.1 140.5 33.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.971 -0.558 . . . . 63.24 109.592 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.484 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -153.01 165.08 36.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.583 0.23 . . . . 74.31 110.634 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -138.91 148.0 43.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.923 -0.399 . . . . 73.22 109.923 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.518 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -154.72 146.37 23.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.097 0.475 . . . . 73.35 110.951 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.1 p -108.87 127.93 54.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.043 -0.526 . . . . 62.54 110.034 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.409 ' CD2' HD13 ' A' ' 56' ' ' ILE . 46.6 p90 -96.64 123.5 40.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.006 0.432 . . . . 72.34 110.425 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.549 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.5 tmmm? -107.49 109.12 20.72 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.201 -0.454 . . . . 71.43 109.802 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.666 HG12 HG12 ' A' ' 71' ' ' VAL . 1.4 m -78.8 136.16 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.28 0.562 . . . . 75.53 110.619 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -114.45 118.14 32.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.871 -0.604 . . . . 61.34 110.067 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.571 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 1.5 p90 . . . . . 0 C--N 1.319 -0.752 0 CA-C-O 120.997 0.427 . . . . 75.23 110.15 171.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.3 p . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.846 0.355 . . . . 54.22 110.573 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.529 HG22 HG12 ' A' ' 37' ' ' VAL . 34.4 m -91.25 16.02 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.983 0.421 . . . . 75.32 111.062 177.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 62.57 13.93 6.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.595 -0.73 . . . . 72.25 112.64 173.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.504 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 86.24 95.55 0.82 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.37 -0.919 . . . . 71.31 111.278 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.92 164.06 27.29 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.491 -0.862 . . . . 44.44 112.181 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.563 ' HB ' HG22 ' A' ' 31' ' ' THR . 63.2 p -140.85 147.74 39.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.683 0.278 . . . . 73.12 110.887 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.526 HG23 HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -112.81 123.46 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 N-CA-C 109.044 -0.725 . . . . 72.51 109.044 171.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -90.86 99.41 12.45 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.645 -0.502 . . . . 62.23 109.645 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 74.6 m-85 -88.89 117.57 27.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.781 -0.645 . . . . 65.42 110.213 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HB3' HG22 ' A' ' 153' ' ' THR . 80.1 tttt -110.12 139.35 45.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 74.03 110.736 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.88 -123.34 3.72 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.882 -0.599 . . . . 61.22 112.176 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.429 ' HG2' ' HB ' ' A' ' 28' ' ' VAL . 24.9 mm-40 60.44 19.71 9.4 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.695 0.398 . . . . 61.4 111.783 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.689 HG23 HG22 ' A' ' 17' ' ' VAL . 29.1 m -77.78 -28.79 15.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.35 -0.386 . . . . 52.33 111.581 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.689 HG22 HG23 ' A' ' 16' ' ' VAL . 7.7 m -148.04 153.05 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 53.15 110.84 -176.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -162.29 53.99 0.22 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.288 -1.005 . . . . 54.25 108.288 176.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -110.25 -72.88 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.709 -1.132 . . . . 65.13 110.274 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -76.87 -41.56 43.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.959 -0.564 . . . . 62.31 110.147 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -136.36 156.72 48.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.526 -0.546 . . . . 74.34 109.526 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.91 127.67 54.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.862 -0.421 . . . . 72.24 109.862 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.426 ' HA ' HD23 ' A' ' 58' ' ' LEU . 16.4 t -68.23 132.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.974 -0.38 . . . . 71.11 109.974 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' HG13 ' A' ' 28' ' ' VAL . 24.2 t70 -56.3 143.17 35.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 63.13 111.461 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.49 -25.09 67.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 51.34 112.143 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.73 -15.37 61.63 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.57 -0.824 . . . . 72.22 111.701 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 t -93.89 -24.94 17.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.755 -0.223 . . . . 71.34 110.804 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 24' ' ' ASP . 33.6 m -74.28 -6.92 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.829 0.347 . . . . 51.33 111.083 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -161.13 94.36 1.0 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.944 -0.761 . . . . 63.22 108.944 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.439 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 16.4 pt20 -137.95 114.9 10.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.396 0.617 . . . . 65.15 110.699 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.563 HG22 ' HB ' ' A' ' 9' ' ' THR . 5.2 m -95.91 93.8 7.24 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.205 -0.907 . . . . 63.41 109.752 177.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.23 140.08 17.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.748 -0.66 . . . . 63.1 111.164 -173.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -92.59 118.91 31.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 73.35 110.458 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.526 HD21 HG23 ' A' ' 10' ' ' VAL . 2.9 mm? -87.81 -30.26 20.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.223 0.535 . . . . 70.41 109.717 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.504 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.79 174.7 38.2 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.517 -0.765 . . . . 51.41 112.408 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.8 90.67 2.91 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.81 -0.23 . . . . 73.31 110.516 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.529 HG12 HG22 ' A' ' 5' ' ' VAL . 5.0 p -73.87 145.88 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.422 -0.584 . . . . 70.04 109.422 175.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -92.05 128.38 37.87 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.35 -0.386 . . . . 73.44 110.041 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.9 p -66.6 -24.34 66.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.02 -0.536 . . . . 74.44 111.721 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.78 -19.85 65.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.062 -0.517 . . . . 72.54 111.305 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -89.42 -0.58 57.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.126 -0.488 . . . . 72.15 111.21 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.637 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 6.8 mt -137.08 48.61 2.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.224 0.535 . . . . 64.43 110.487 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.84 16.93 16.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.136 -0.484 . . . . 63.4 112.136 -171.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 47' ' ' ALA . 4.0 pm0 -157.79 142.99 16.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.218 -0.447 . . . . 74.55 110.312 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 33.6 tt0 -59.28 123.56 17.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.942 0.401 . . . . 74.42 110.045 175.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.0 -15.58 21.02 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.206 -0.758 . . . . 64.52 111.206 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 42' ' ' LEU . . . -67.76 123.53 20.77 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.451 -0.574 . . . . 53.21 109.451 174.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.469 HG22 ' HD1' ' A' ' 138' ' ' PHE . 37.3 p -123.27 134.26 54.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.969 0.414 . . . . 73.43 110.94 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.1 t -84.43 176.37 8.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.924 -0.58 . . . . 75.55 109.611 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -68.77 133.43 48.34 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.853 -0.425 . . . . 64.52 109.853 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -88.77 152.69 21.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.599 0.714 . . . . 54.23 111.944 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 23.8 m -94.1 149.92 4.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.354 -1.294 . . . . 61.22 108.922 169.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.76 77.14 0.23 Allowed Glycine 0 C--N 1.311 -0.842 0 C-N-CA 120.988 -0.625 . . . . 61.1 112.255 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -81.77 167.98 18.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.984 -0.376 . . . . 61.05 109.984 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.558 ' HB2' HG22 ' A' ' 130' ' ' THR . 2.2 p-10 -138.05 138.44 38.8 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.998 0.427 . . . . 72.22 111.251 -175.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.405 HD13 ' CD1' ' A' ' 154' ' ' PHE . 59.5 mt -100.38 114.14 38.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.547 -0.751 . . . . 62.34 109.335 174.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -98.83 135.67 39.94 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.704 -0.68 . . . . 71.11 110.812 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 23' ' ' VAL . 70.0 mt -114.5 117.8 31.97 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.35 -0.611 . . . . 74.34 109.35 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -96.63 124.18 40.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.775 -0.648 . . . . 51.35 110.649 -175.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.7 t70 61.8 92.37 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.001 0.813 . . . . 50.52 111.122 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 48.4 t -128.6 152.83 47.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.794 -0.639 . . . . 64.21 110.627 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.414 ' HA ' ' ND2' ' A' ' 126' ' ' ASN . 18.3 t70 -116.85 142.13 47.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.873 -0.603 . . . . 74.3 110.978 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.0 p -106.08 14.08 28.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.04 0.385 . . . . 64.4 112.04 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -91.28 -31.17 16.22 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.382 -0.599 . . . . 75.24 109.382 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 20' ' ' ALA . 8.0 p -104.2 -3.79 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.549 -0.75 . . . . 65.51 111.369 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.578 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -146.57 178.83 7.99 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.319 -0.238 . . . . 63.42 110.89 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.42 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 49.4 m -143.56 -53.78 0.37 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.053 0.39 . . . . 54.34 112.053 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.726 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -137.82 141.81 40.81 Favored 'General case' 0 C--O 1.221 -0.406 0 O-C-N 122.216 -0.302 . . . . 71.35 110.437 -179.014 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.92 127.66 48.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.028 0.442 . . . . 74.55 110.594 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.72 116.18 11.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.821 -0.627 . . . . 74.04 109.729 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -90.65 146.4 6.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.963 0.411 . . . . 73.11 111.356 -173.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -119.57 123.06 43.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.736 -0.666 . . . . 62.31 109.513 171.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.56 ' CE1' HG21 ' A' ' 103' ' ' ILE . 55.3 m-85 -86.52 134.59 33.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.107 0.48 . . . . 74.34 110.959 -178.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.0 tp -131.18 129.1 41.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 74.11 110.3 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.23 -160.17 19.13 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.94 -0.864 . . . . 60.02 110.94 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.484 ' O ' HD13 ' A' ' 86' ' ' LEU . 26.3 m -88.05 130.48 34.98 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.258 -0.275 . . . . 62.01 110.258 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.421 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -85.61 144.55 27.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.268 -0.271 . . . . 62.44 110.268 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.512 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 15.3 tt -62.34 -28.18 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 74.42 111.382 -176.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -152.6 177.18 10.93 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.714 -0.476 . . . . 63.42 109.714 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.63 -27.72 34.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.191 -0.459 . . . . 65.03 110.215 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.51 -7.85 61.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.759 -0.734 . . . . 74.2 111.902 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -122.82 75.51 1.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.264 0.554 . . . . 70.43 109.945 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.421 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.9 p -90.02 16.24 8.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.691 -0.686 . . . . 63.43 111.795 -176.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -118.94 -0.29 11.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.342 -0.39 . . . . 74.33 111.163 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.422 HG22 ' HB3' ' A' ' 102' ' ' GLN . 47.3 t -117.43 127.32 74.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.35 -0.386 . . . . 54.24 110.096 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.573 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -66.77 135.22 53.63 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.658 0.266 . . . . 74.13 110.385 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.57 160.49 27.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.124 -0.489 . . . . 64.51 110.583 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.58 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.9 mm? -91.1 137.66 32.19 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.898 -0.408 . . . . 73.45 109.898 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 116.019 -0.537 . . . . 61.32 110.456 178.817 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 110.265 -0.272 . . . . 60.24 110.265 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.48 156.14 21.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.063 -0.347 . . . . 74.43 110.063 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.97 164.65 31.37 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.877 -0.329 . . . . 72.4 110.794 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 68.89 -1.73 1.96 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.619 0.768 . . . . 73.11 111.247 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.58 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -138.76 145.59 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 109.223 -0.658 . . . . 62.13 109.223 170.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -148.81 -167.66 13.97 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 110.753 -0.939 . . . . 75.41 110.753 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.38 110.87 28.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 121.359 0.599 . . . . 54.41 110.326 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.7 pt20 -100.6 132.03 46.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.748 -0.66 . . . . 64.14 109.416 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.56 HG21 ' CE1' ' A' ' 73' ' ' PHE . 4.0 mp -89.03 123.83 41.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.229 0.538 . . . . 75.44 110.219 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 134' ' ' GLN . 14.8 mt -92.73 140.88 29.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.362 -0.835 . . . . 72.25 109.237 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.514 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.6 OUTLIER -71.57 -173.63 0.97 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.74 -0.467 . . . . 64.22 109.74 176.512 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -59.88 -23.36 63.39 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.448 0.536 . . . . 74.43 112.448 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.0 p -91.5 -16.66 26.89 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.502 -0.479 . . . . 62.11 111.236 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.33 29.1 6.13 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.912 -0.661 . . . . 63.24 112.532 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.29 124.7 50.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.515 0.198 . . . . 63.43 110.683 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.04 120.62 11.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 72.15 110.573 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.7 mt -83.78 144.14 29.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.103 -0.499 . . . . 74.12 111.031 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.459 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 3.1 m -73.83 140.29 45.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.2 -0.454 . . . . 73.2 109.951 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.496 HD13 HD22 ' A' ' 86' ' ' LEU . 52.4 mt -85.0 43.24 0.99 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.886 0.374 . . . . 74.03 110.571 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -105.33 -1.55 25.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.524 . . . . 75.43 110.516 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.4 -1.76 41.4 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.073 -0.584 . . . . 35.23 113.353 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.03 -22.12 11.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 117.012 0.406 . . . . 71.11 110.91 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.459 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 8.8 m -81.06 96.17 7.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.273 -0.421 . . . . 55.2 110.26 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.524 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 89.2 m-85 -86.51 162.86 17.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.455 . . . . 75.42 110.327 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.514 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 13.4 m -73.55 -178.01 2.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.984 -0.553 . . . . 75.41 110.593 176.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.7 m -69.15 152.98 44.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.387 -0.37 . . . . 74.13 110.288 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.19 111.77 2.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.131 0.491 . . . . 72.1 111.623 -178.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.8 m -95.67 104.52 16.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.876 -0.602 . . . . 64.12 109.426 174.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -57.25 125.55 23.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 72.41 110.888 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.3 mt -91.62 163.4 14.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.203 0.525 . . . . 72.42 111.661 -176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -141.95 157.11 45.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.254 -0.885 . . . . 73.05 108.994 169.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 16.4 m120 -60.14 111.39 1.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.833 0.349 . . . . 72.42 110.267 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 137.86 -140.15 10.99 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.898 -0.668 . . . . 64.3 111.927 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.1 m -96.55 120.63 37.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.121 0.486 . . . . 65.53 110.939 -177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -114.22 137.14 52.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.974 -0.557 . . . . 45.12 109.79 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.558 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.4 m -125.45 121.42 33.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.688 0.28 . . . . 64.05 110.449 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 mt -106.31 112.71 63.86 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.801 -0.444 . . . . 54.41 109.801 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.8 139.39 9.81 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.991 2.461 . . . . 74.43 112.611 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.43 ' HD1' ' HA ' ' A' ' 105' ' ' ASP . 71.6 m-85 -138.71 164.02 30.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 71.13 110.309 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 87.0 mt-30 -124.37 134.18 53.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.961 0.41 . . . . 71.24 111.109 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -121.9 124.73 44.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.07 -0.514 . . . . 64.24 109.952 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.536 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 18.1 ptp180 -142.85 161.96 36.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.588 -0.278 . . . . 72.53 110.322 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 64.7 m-85 -77.9 135.63 37.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.098 -0.501 . . . . 72.25 110.525 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.469 ' HD1' HG22 ' A' ' 48' ' ' THR . 89.7 t80 -125.88 122.0 34.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.558 -0.746 . . . . 61.01 109.245 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.637 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -83.97 135.68 34.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.276 -0.42 . . . . 54.34 111.311 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 63.9 p -107.27 2.66 24.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.796 -0.638 . . . . 74.23 109.571 176.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 171.09 -115.99 0.61 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.214 -0.903 . . . . 52.42 111.62 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -98.19 94.21 6.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.702 0.251 . . . . 61.34 110.636 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.11 111.57 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.398 0.436 . . . . 72.12 111.865 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.2 p -104.58 140.84 21.47 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 116.122 -0.49 . . . . 63.14 110.188 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.96 179.96 3.93 Favored 'Trans proline' 0 N--CA 1.472 0.248 0 C-N-CA 123.717 2.945 . . . . 63.44 113.351 -172.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.83 -172.01 16.97 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.631 -0.795 . . . . 74.33 111.811 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.21 102.01 2.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.986 0.422 . . . . 50.34 110.947 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.22 76.85 1.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.179 0.514 . . . . 71.24 110.765 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -121.81 142.92 49.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.964 -0.562 . . . . 73.42 109.492 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.573 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -141.46 165.66 26.89 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 123.051 0.219 . . . . 72.32 111.027 -176.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -141.85 146.31 35.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.087 -0.338 . . . . 63.3 110.087 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.498 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -155.39 147.63 23.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.288 -0.415 . . . . 63.43 111.064 -178.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 13' ' ' LYS . 16.6 p -104.29 127.2 51.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.954 -0.566 . . . . 64.22 110.064 175.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.405 ' CD1' HD13 ' A' ' 56' ' ' ILE . 36.5 p90 -97.09 127.77 43.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.261 0.553 . . . . 74.13 110.947 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.573 ' HA ' HG21 ' A' ' 16' ' ' VAL . 8.5 ttmm -103.18 98.77 8.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.692 -0.686 . . . . 62.45 110.157 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 71' ' ' VAL . 1.2 m -74.57 133.4 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.304 0.573 . . . . 74.14 109.631 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -117.17 110.47 18.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.087 -0.506 . . . . 72.33 110.05 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.726 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.619 0.723 . . . . 74.33 110.377 172.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.3 p . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.912 0.387 . . . . 70.42 110.584 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.453 HG22 HG12 ' A' ' 37' ' ' VAL . 36.0 m -89.18 13.95 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.264 -0.426 . . . . 70.13 110.691 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.441 ' C ' ' HG2' ' A' ' 36' ' ' GLN . 54.8 m-80 64.41 4.87 2.36 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.437 -0.801 . . . . 65.32 112.655 175.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.52 110.78 3.51 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.497 -0.859 . . . . 55.52 111.855 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.437 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -92.46 155.25 22.65 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.368 -0.92 . . . . 61.1 112.383 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.468 ' HB ' ' CG2' ' A' ' 31' ' ' THR . 1.6 p -145.9 125.1 12.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.568 0.223 . . . . 62.34 110.573 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.473 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -104.02 126.17 58.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.849 -0.426 . . . . 63.22 109.849 177.023 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -93.21 109.06 20.57 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.11 0.481 . . . . 71.42 110.174 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.473 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 87.6 m-85 -101.86 121.54 42.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.052 -0.522 . . . . 70.11 110.207 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -114.72 138.79 50.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.923 0.392 . . . . 72.34 110.431 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.49 -123.15 5.06 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.535 -0.626 . . . . 73.53 111.535 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.457 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 35.0 mt-10 63.57 25.64 14.44 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.395 0.617 . . . . 54.51 110.31 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.723 HG23 HG22 ' A' ' 17' ' ' VAL . 20.0 m -85.87 -32.33 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.615 -0.721 . . . . 72.4 111.59 -176.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.723 HG22 HG23 ' A' ' 16' ' ' VAL . 6.9 m -141.35 154.96 20.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.375 -0.375 . . . . 72.0 111.164 -174.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -168.74 90.24 0.24 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.434 -0.95 . . . . 65.33 108.434 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.26 -75.1 0.13 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.346 -0.843 . . . . 73.2 109.811 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.77 -37.82 62.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.761 -0.654 . . . . 64.11 109.689 174.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 1.8 m -147.17 162.02 39.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.382 -0.826 . . . . 74.34 108.832 -177.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.91 134.92 55.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.188 -0.301 . . . . 72.43 110.188 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.546 ' HA ' HD23 ' A' ' 58' ' ' LEU . 15.6 t -69.01 137.34 24.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.519 -0.31 . . . . 71.33 110.371 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.53 ' O ' HG13 ' A' ' 28' ' ' VAL . 20.5 t70 -57.22 141.55 46.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 72.22 111.69 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.48 -27.0 67.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 72.33 112.093 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.48 -14.06 60.56 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.436 -0.887 . . . . 71.55 111.722 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 t -97.94 -18.83 18.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.413 0.149 . . . . 64.34 110.913 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 24' ' ' ASP . 35.9 m -78.35 -5.74 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.556 0.217 . . . . 74.23 111.177 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -165.07 94.12 0.64 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.417 -0.586 . . . . 73.44 109.417 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -147.52 150.04 33.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.99 -0.55 . . . . 63.22 110.878 -176.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.468 ' CG2' ' HB ' ' A' ' 9' ' ' THR . 5.4 m -121.74 114.15 20.7 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.644 -0.707 . . . . 73.23 109.673 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.75 139.03 18.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.14 -0.482 . . . . 63.54 110.823 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -92.68 121.91 34.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.826 -0.625 . . . . 70.23 110.46 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.409 HD21 HG23 ' A' ' 10' ' ' VAL . 2.2 mm? -97.32 -27.2 14.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.235 0.541 . . . . 74.04 109.842 176.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.38 178.43 44.18 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.582 -0.736 . . . . 65.31 112.225 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.441 ' HG2' ' C ' ' A' ' 6' ' ' ASN . 82.6 mt-30 -80.56 94.2 6.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.154 -0.313 . . . . 73.42 110.154 177.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.453 HG12 HG22 ' A' ' 5' ' ' VAL . 9.0 p -70.25 149.82 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 73.42 110.618 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.01 134.46 35.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.931 -0.577 . . . . 71.44 110.094 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 p -77.5 -19.16 56.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.108 0.48 . . . . 75.45 110.775 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.91 -16.69 60.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 55.5 111.258 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.4 m -90.85 3.68 53.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.103 0.478 . . . . 61.04 110.907 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.735 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.1 mt -142.46 54.67 1.43 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.866 -0.606 . . . . 55.11 110.008 -175.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.25 10.53 41.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.114 0.413 . . . . 74.52 112.114 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -145.65 141.44 28.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.699 0.285 . . . . 75.3 111.171 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 8.9 tm-20 -55.43 116.42 2.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.903 -0.59 . . . . 74.13 109.559 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.14 -7.43 27.07 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.665 -0.779 . . . . 72.42 112.375 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.574 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -67.78 132.96 48.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.681 0.277 . . . . 71.33 110.61 177.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 p -122.78 138.83 54.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.291 -0.413 . . . . 70.23 110.715 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 t -96.36 179.0 5.18 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.356 -0.384 . . . . 74.43 110.519 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 m -68.62 126.05 28.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.936 -0.575 . . . . 65.21 110.265 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.598 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -82.49 164.66 20.78 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.668 0.747 . . . . 74.33 112.157 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.0 m -106.33 155.92 7.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.45 -1.25 . . . . 73.21 109.208 171.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.3 93.01 0.67 Allowed Glycine 0 C--N 1.311 -0.847 0 C-N-CA 120.818 -0.706 . . . . 54.43 112.104 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -105.54 171.52 7.28 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.556 -0.535 . . . . 73.41 109.556 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -139.69 142.84 36.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.044 0.449 . . . . 63.31 111.38 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.7 mt -102.27 117.8 48.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.534 -0.757 . . . . 73.14 109.318 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -99.37 137.6 37.65 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.785 -0.643 . . . . 72.24 110.676 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 23' ' ' VAL . 44.8 mt -117.34 134.72 54.49 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.454 -0.573 . . . . 73.23 109.454 176.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -110.26 143.97 39.65 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.902 -0.407 . . . . 63.43 109.902 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 33.8 t70 50.39 73.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 124.071 0.857 . . . . 72.11 110.715 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 32.7 t -112.78 119.66 38.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.115 -0.948 . . . . 73.21 110.212 -174.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.73 138.03 36.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.948 0.404 . . . . 72.45 111.734 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.3 p -107.43 5.21 27.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 70.41 112.258 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -78.3 -21.96 48.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.656 -0.498 . . . . 61.24 109.656 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.8 p -112.53 -30.71 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.768 -0.651 . . . . 73.34 111.353 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -116.95 166.57 12.03 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.194 -0.316 . . . . 63.54 111.126 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.51 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 32.7 m -124.64 -56.27 1.6 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.772 0.32 . . . . 73.43 111.569 -177.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.51 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -133.01 157.08 46.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.721 -0.474 . . . . 74.43 109.721 -178.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -114.14 132.63 56.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.977 0.418 . . . . 63.43 110.353 175.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.58 120.58 12.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.753 -0.658 . . . . 60.31 109.492 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.715 HG12 HG12 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -92.41 147.3 5.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.097 0.475 . . . . 75.23 111.158 -173.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.51 117.53 28.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.607 -0.724 . . . . 73.15 109.234 174.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 86.8 m-85 -82.81 135.99 34.79 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.951 0.405 . . . . 71.44 111.065 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.1 tp -131.32 115.42 16.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.878 -0.601 . . . . 74.22 109.616 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.439 ' H ' ' HB3' ' A' ' 113' ' ' LEU . . . -153.31 -174.22 23.39 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.576 -0.738 . . . . 74.53 111.326 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.464 ' O ' HD13 ' A' ' 86' ' ' LEU . 8.1 m -79.3 114.78 18.51 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.242 -0.281 . . . . 72.13 110.242 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -75.89 149.53 37.75 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.945 -0.391 . . . . 61.22 109.945 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.578 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 14.5 tt -62.48 -35.79 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.409 . . . . 71.23 110.209 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -162.43 -174.5 4.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.986 -0.552 . . . . 73.44 109.53 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.85 -12.15 59.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.141 0.423 . . . . 72.33 112.141 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.21 -43.71 3.98 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.769 -0.729 . . . . 73.33 111.8 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -103.06 82.2 2.06 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.076 -0.713 . . . . 74.42 109.076 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.416 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.7 p -95.59 7.34 46.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.251 -0.886 . . . . 72.01 112.503 -172.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -107.17 -1.64 21.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.121 0.486 . . . . 75.23 110.541 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.52 121.68 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.739 -0.664 . . . . 75.34 110.292 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.607 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -68.21 132.37 47.03 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.841 -0.429 . . . . 74.13 109.841 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.578 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -76.46 149.54 36.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.175 -0.466 . . . . 75.21 110.294 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.412 HD22 ' H ' ' A' ' 88' ' ' LEU . 2.1 mm? -77.84 132.93 38.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.157 -0.474 . . . . 52.11 109.839 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.556 ' HG3' ' HA ' ' A' ' 150' ' ' ALA . 90.8 mt-30 . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 74.35 110.541 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.472 ' HA ' ' H ' ' A' ' 147' ' ' ALA . 2.7 p . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 120.762 0.315 . . . . 60.24 110.344 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.23 148.22 35.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.579 -0.526 . . . . 42.23 109.579 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.34 163.51 29.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.03 -0.359 . . . . 74.32 110.03 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.405 HD22 HG23 ' A' ' 144' ' ' THR . 57.5 m-20 69.8 10.99 7.73 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.575 0.547 . . . . 63.13 110.319 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.06 -177.29 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.478 -0.783 . . . . 70.13 110.212 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 175.94 -172.64 45.63 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.574 -1.01 . . . . 74.12 110.574 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.406 HG21 HG21 ' A' ' 10' ' ' VAL . 2.7 p -118.42 115.31 47.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.337 0.589 . . . . 64.24 110.62 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -105.34 140.66 38.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.24 -0.652 . . . . 63.21 109.24 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.429 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -102.56 122.59 55.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.147 0.499 . . . . 64.54 110.672 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.522 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 15.5 mt -89.58 143.55 26.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.503 -0.771 . . . . 54.42 109.378 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.544 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.9 -170.49 0.91 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.713 -0.477 . . . . 73.34 109.713 175.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -60.0 -29.83 68.73 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.467 0.173 . . . . 45.03 111.467 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.4 p -92.4 3.54 55.24 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.808 0.337 . . . . 60.34 111.573 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 82.08 30.67 33.93 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.858 -0.687 . . . . 72.33 113.1 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.01 126.4 48.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.713 0.256 . . . . 64.25 110.524 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.98 109.02 2.8 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.049 0.452 . . . . 63.14 110.919 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.9 mt -79.07 130.6 35.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 74.01 110.76 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 m -70.56 135.99 48.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 74.23 110.599 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.607 HD13 HD22 ' A' ' 86' ' ' LEU . 34.4 mt -78.05 41.52 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 73.53 110.844 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -98.9 -9.82 23.67 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.021 -0.536 . . . . 64.03 110.472 -175.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.53 1.15 75.56 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.025 -0.607 . . . . 60.32 112.663 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.27 -3.4 11.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.947 0.403 . . . . 74.02 111.228 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.4 m -101.0 109.5 21.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.807 0.337 . . . . 70.43 110.238 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -99.18 156.68 16.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 74.04 111.338 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 1.7 m -68.45 177.02 2.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.561 -0.745 . . . . 63.44 111.291 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.3 t -63.58 148.08 49.79 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.551 -0.537 . . . . 61.33 109.551 170.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.402 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 85.6 mt-10 -63.8 103.63 0.59 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 71.12 111.409 -176.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -87.22 110.86 20.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.962 -0.563 . . . . 63.51 109.743 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 m -59.96 122.4 14.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 75.5 111.28 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.482 ' C ' HD22 ' A' ' 125' ' ' ASN . 85.4 mt -84.38 146.39 27.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.514 . . . . 75.42 111.455 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.482 HD22 ' C ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -122.97 152.83 40.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.412 -0.813 . . . . 70.13 109.244 174.184 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 19.7 m120 -62.82 111.93 2.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.85 0.357 . . . . 61.35 110.569 176.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.17 -128.61 6.68 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.689 -0.767 . . . . 52.41 112.69 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.7 m -96.56 135.71 38.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.744 0.307 . . . . 74.55 110.849 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -132.58 148.56 52.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 64.54 110.482 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.47 120.73 31.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.372 -0.376 . . . . 74.2 111.301 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.2 mt -99.29 113.03 64.47 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.035 -0.728 . . . . 70.13 109.035 174.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.63 140.29 11.7 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.423 2.082 . . . . 73.52 112.704 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 87.4 m-85 -136.65 162.97 31.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 73.53 110.704 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.634 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.0 mt-30 -132.55 110.47 10.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.175 -0.466 . . . . 52.42 110.783 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -97.15 123.6 40.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.424 -0.353 . . . . 74.52 110.28 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.598 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 11.2 ptp180 -135.47 160.65 37.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.9 0.381 . . . . 63.13 110.65 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.437 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 81.3 m-85 -81.28 144.32 31.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.039 -0.528 . . . . 71.23 110.657 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -129.31 126.06 38.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.755 -0.657 . . . . 75.24 109.428 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.735 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -89.24 133.47 34.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.294 -0.412 . . . . 73.24 111.356 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.421 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 71.1 p -105.37 7.66 33.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.856 0.836 . . . . 74.05 109.022 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.08 -128.33 1.63 Allowed Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.524 -1.217 . . . . 72.15 110.838 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 96.18 10.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.827 0.314 . . . . 62.41 110.233 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -46.45 113.84 0.71 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.564 0.54 . . . . 33.22 111.539 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.405 HG23 HD22 ' A' ' 98' ' ' ASN . 31.9 p -103.14 141.45 22.52 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-O 121.122 0.487 . . . . 61.12 110.669 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.58 170.48 15.0 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 123.642 2.895 . . . . 43.54 113.273 -175.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.58 -122.47 1.77 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.627 -0.715 . . . . 72.23 111.795 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.472 ' H ' ' HA ' ' A' ' 95' ' ' SER . . . -122.17 133.87 54.73 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.686 -0.487 . . . . 65.35 109.686 177.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -122.05 51.49 1.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.589 0.709 . . . . 63.13 111.07 -173.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -102.56 144.45 30.96 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.255 -0.884 . . . . 65.02 110.197 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.556 ' HA ' ' HG3' ' A' ' 89' ' ' GLN . . . -152.86 177.26 10.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.113 -0.494 . . . . 71.14 109.979 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -154.1 152.05 30.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.963 -0.295 . . . . 73.43 110.622 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -156.29 153.0 28.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.177 -0.465 . . . . 63.1 110.829 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.3 p -105.31 136.71 44.33 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.454 -0.573 . . . . 75.32 109.454 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -109.59 122.82 48.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.088 0.47 . . . . 71.23 110.55 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.603 ' HA ' HG21 ' A' ' 16' ' ' VAL . 2.9 ttmm -102.48 104.85 15.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.081 -0.509 . . . . 74.34 110.224 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.715 HG12 HG12 ' A' ' 71' ' ' VAL . 1.5 m -81.45 139.2 18.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.207 0.527 . . . . 61.42 110.216 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -110.66 110.7 21.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.97 -0.559 . . . . 63.21 111.01 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.609 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 116.088 -0.506 . . . . 73.23 110.401 170.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.415 ' CB ' ' HB3' ' A' ' 36' ' ' GLN . 63.1 p . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.971 0.415 . . . . 63.35 110.363 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 37' ' ' VAL . 31.6 m -89.8 14.36 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.756 0.312 . . . . 54.22 111.216 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 66.59 8.87 6.16 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.82 -0.627 . . . . 61.11 112.107 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 36' ' ' GLN . . . 95.78 97.8 1.78 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.112 -0.795 . . . . 62.34 111.112 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.56 154.24 25.81 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.206 -0.997 . . . . 43.12 112.206 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.48 ' HB ' HG22 ' A' ' 31' ' ' THR . 24.4 p -141.85 132.31 25.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.801 0.334 . . . . 71.35 111.128 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -106.95 120.46 58.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.178 -0.675 . . . . 73.52 109.178 171.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -94.33 106.1 18.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.689 -0.486 . . . . 73.24 109.689 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.415 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 81.8 m-85 -96.91 129.77 44.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.842 -0.617 . . . . 73.54 110.149 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -117.3 133.0 56.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.211 -0.45 . . . . 74.53 110.25 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.97 -123.24 4.24 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.982 -0.627 . . . . 40.53 111.951 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.772 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 31.7 mt-10 63.35 15.94 9.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.135 0.493 . . . . 51.43 110.891 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' A' ' 155' ' ' LYS . 24.2 m -76.91 -27.61 16.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.529 -0.76 . . . . 74.23 111.932 -174.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.6 HG21 ' CG2' ' A' ' 156' ' ' VAL . 18.8 m -135.81 144.6 33.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.214 0.531 . . . . 73.4 112.205 -174.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.413 ' ND2' ' HB2' ' A' ' 22' ' ' ALA . 0.2 OUTLIER -148.41 21.38 1.06 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.487 -0.931 . . . . 65.2 108.487 170.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.96 -74.54 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.248 -0.887 . . . . 73.34 110.974 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HB2' HG13 ' A' ' 65' ' ' VAL . . . -88.72 -38.71 14.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.067 0.46 . . . . 62.32 110.513 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.8 OUTLIER -144.0 134.99 25.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.555 -0.748 . . . . 73.15 109.847 -176.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HB2' ' ND2' ' A' ' 18' ' ' ASN . . . -92.61 151.51 20.09 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.8 -0.445 . . . . 72.11 109.8 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.425 ' HB ' HG12 ' A' ' 28' ' ' VAL . 14.9 t -86.52 136.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 110.122 -0.325 . . . . 54.4 110.122 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.467 ' O ' HG13 ' A' ' 28' ' ' VAL . 22.3 t70 -62.86 145.15 55.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.435 -0.348 . . . . 75.02 110.937 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -60.25 -26.04 66.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.253 0.464 . . . . 74.34 112.253 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.1 -14.79 81.9 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.529 -0.844 . . . . 65.22 112.014 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.9 p -119.94 13.55 12.25 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.83 0.307 . . . . 75.23 111.83 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.772 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 27.2 m -100.56 -11.77 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.161 0.505 . . . . 61.4 110.325 173.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -156.52 81.3 0.96 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.289 -0.869 . . . . 62.01 109.426 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -126.18 133.87 51.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.453 0.644 . . . . 74.43 110.369 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.48 HG22 ' HB ' ' A' ' 9' ' ' THR . 2.9 m -118.24 101.31 8.11 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.764 -0.828 . . . . 74.24 108.764 176.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.48 131.86 32.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.993 -0.549 . . . . 64.03 111.034 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -88.13 110.42 20.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.65 -0.704 . . . . 73.12 109.771 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.4 ' HB2' ' OH ' ' A' ' 137' ' ' TYR . 1.8 mm? -81.22 -29.05 34.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.406 0.622 . . . . 54.54 109.495 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.418 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 96.18 172.72 35.58 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.242 -0.89 . . . . 44.33 112.131 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 7' ' ' GLY . 69.4 mt-30 -72.83 95.8 1.98 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.448 -0.204 . . . . 73.12 110.448 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.515 HG12 HG22 ' A' ' 5' ' ' VAL . 11.0 p -70.33 142.67 15.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.855 0.36 . . . . 74.2 110.134 177.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -78.22 105.12 9.24 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.201 -0.666 . . . . 63.31 109.201 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 19.5 p -63.05 -25.19 68.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.955 0.407 . . . . 72.42 111.237 -177.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.43 -5.6 37.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.061 -0.518 . . . . 74.43 111.419 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.5 m -95.8 -2.69 47.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.073 0.463 . . . . 65.22 110.411 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.1 mp -131.69 97.3 4.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.888 -0.597 . . . . 61.23 109.504 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.96 17.35 9.32 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.32 -0.552 . . . . 73.15 112.436 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -153.62 150.99 29.21 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.749 -0.381 . . . . 72.14 111.483 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -60.9 119.21 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 72.54 109.827 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.72 -6.19 31.26 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.641 -0.79 . . . . 61.21 111.847 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -72.01 119.39 16.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.014 0.435 . . . . 75.04 110.532 178.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.548 HG22 ' HD1' ' A' ' 138' ' ' PHE . 41.1 p -105.51 148.34 27.33 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.015 -0.539 . . . . 61.04 110.173 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.4 t -100.32 177.54 5.02 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.136 -0.69 . . . . 54.23 109.136 174.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.6 m -70.11 133.51 47.23 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.876 -0.416 . . . . 73.15 109.876 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -87.34 160.41 18.39 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.644 0.735 . . . . 70.15 111.956 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 31.1 m -103.94 152.9 6.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.433 -1.258 . . . . 72.25 109.083 171.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.45 98.48 1.28 Allowed Glycine 0 C--N 1.312 -0.754 0 C-N-CA 120.729 -0.748 . . . . 45.03 112.147 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -108.96 173.19 6.43 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.6 -0.519 . . . . 63.35 109.6 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.594 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.0 p-10 -139.75 137.19 34.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.476 0.655 . . . . 73.44 111.917 -173.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.4 mt -105.5 115.09 46.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.722 -0.844 . . . . 75.25 108.722 171.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -101.57 144.62 30.09 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.977 0.417 . . . . 75.54 110.823 -173.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.2 mt -117.91 130.01 55.97 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.955 -0.566 . . . . 73.25 109.676 176.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -106.41 131.98 52.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.67 -0.695 . . . . 52.12 109.519 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 27.1 t70 58.15 86.44 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.69 0.757 . . . . 63.42 110.217 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 51.7 t -124.38 124.49 42.46 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.335 -0.848 . . . . 55.04 110.421 -174.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -103.92 140.07 38.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.045 -0.525 . . . . 72.31 111.152 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.8 p -107.96 15.61 24.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.071 0.397 . . . . 65.32 112.071 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -90.34 -39.16 12.87 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.912 -0.773 . . . . 74.33 108.912 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 20' ' ' ALA . 12.7 p -96.12 -3.53 10.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.104 -0.953 . . . . 72.41 110.472 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.616 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -144.75 -173.45 4.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 64.13 110.781 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.7 m -151.0 -57.98 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.023 0.379 . . . . 62.31 112.023 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.799 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -138.21 130.4 28.76 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.973 -0.291 . . . . 72.53 110.262 -175.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.43 127.49 41.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.108 0.48 . . . . 53.11 111.0 -175.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.33 119.64 16.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.637 -0.711 . . . . 72.1 109.637 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 156' ' ' VAL . 2.5 m -90.19 147.62 5.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.977 0.418 . . . . 70.21 110.756 -175.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.437 ' HB2' ' CD2' ' A' ' 118' ' ' PHE . . . -117.48 118.16 31.42 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.741 -0.663 . . . . 73.24 109.752 174.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 82.3 m-85 -85.62 128.49 34.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.979 0.419 . . . . 70.44 110.205 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.1 tp -126.13 126.76 44.68 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.836 -0.62 . . . . 61.15 109.913 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.52 -166.47 21.36 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.446 -0.662 . . . . 62.53 111.446 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.7 m -87.1 119.71 27.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.853 -0.425 . . . . 75.23 109.853 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -76.98 149.52 35.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.446 -0.343 . . . . 72.42 110.436 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.573 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 12.8 tt -61.77 -37.61 78.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.081 0.467 . . . . 52.43 110.7 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -152.02 -171.51 3.95 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.782 -0.821 . . . . 53.25 108.782 174.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.04 -14.89 43.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.056 0.391 . . . . 74.21 112.056 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.31 -49.83 3.6 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.632 -0.794 . . . . 73.52 112.016 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -96.43 76.64 2.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.383 0.611 . . . . 73.34 109.617 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.478 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 14.6 p -86.97 8.45 23.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.649 -0.705 . . . . 54.43 111.755 -175.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 24.4 p-10 -107.05 7.32 29.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.976 0.417 . . . . 63.11 110.849 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 138' ' ' PHE . 57.6 t -120.11 124.91 73.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.542 . . . . 71.54 109.837 177.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.523 HD22 ' CD1' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -66.94 129.85 41.23 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 110.079 -0.341 . . . . 64.14 110.079 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.46 150.77 34.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.297 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.548 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -88.03 130.3 35.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.561 -0.533 . . . . 62.14 109.561 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 60.2 112.127 -174.184 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 109.899 -0.408 . . . . 54.42 109.899 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.428 ' O ' HD23 ' A' ' 88' ' ' LEU . . . -71.46 136.64 47.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.71 0.291 . . . . 71.51 110.223 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.36 160.71 35.51 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.848 -0.341 . . . . 72.54 110.546 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 68.55 7.36 5.99 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.337 0.589 . . . . 74.23 110.303 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.405 ' O ' HD12 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -143.25 -179.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.269 -0.878 . . . . 72.01 109.687 175.124 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.3 -169.82 42.86 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.951 -1.26 . . . . 73.45 109.951 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.85 119.46 58.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.278 0.561 . . . . 75.14 110.465 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -109.42 146.15 34.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.648 -0.705 . . . . 74.13 109.755 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.1 mp -103.99 124.24 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.425 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.426 HD11 ' NE ' ' A' ' 136' ' ' ARG . 27.5 mt -87.38 140.03 29.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.651 -0.704 . . . . 43.44 109.177 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.542 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.05 -173.13 1.19 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.913 -0.402 . . . . 64.3 109.913 177.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.1 ptt85 -61.04 -20.3 62.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.096 0.406 . . . . 74.33 112.096 -176.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.7 p -101.47 3.56 40.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.935 -0.306 . . . . 61.54 111.548 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.42 31.52 24.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.778 -0.725 . . . . 53.24 112.866 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -112.02 128.51 56.2 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.959 -0.386 . . . . 60.12 109.959 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.85 130.16 42.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.726 0.298 . . . . 72.22 110.884 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.0 mt -92.77 132.83 36.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.225 -0.443 . . . . 73.1 110.979 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 89.9 m -74.31 139.2 44.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.891 -0.595 . . . . 74.13 110.449 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 34.8 mt -81.46 45.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 71.13 110.682 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -90.7 -17.94 25.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.09 0.472 . . . . 71.31 110.369 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.19 -22.97 26.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.996 -0.621 . . . . 70.31 112.329 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.45 3.87 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.164 0.507 . . . . 41.42 110.915 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.461 HG21 ' H ' ' A' ' 112' ' ' THR . 3.8 m -95.34 99.36 11.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 75.24 110.064 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.493 ' HE2' ' HD2' ' A' ' 155' ' ' LYS . 96.3 m-85 -95.41 162.31 13.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.969 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 4.6 m -71.46 -178.83 2.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.666 -0.697 . . . . 72.45 111.003 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.5 t -73.05 165.55 24.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.596 -0.52 . . . . 71.43 109.596 173.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -65.32 106.98 1.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.366 -0.379 . . . . 75.13 111.33 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.8 m -90.66 102.76 15.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.084 -0.71 . . . . 71.13 109.084 172.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.6 m -58.17 119.21 6.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.753 -0.658 . . . . 60.05 111.247 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.421 HD13 ' SG ' ' A' ' 61' ' ' CYS . 95.9 mt -87.27 150.91 23.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.792 -0.64 . . . . 75.12 111.166 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -125.89 158.68 34.51 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.743 -0.836 . . . . 73.4 108.743 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.4 m120 -65.08 114.49 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.868 0.366 . . . . 50.34 111.058 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.43 -133.27 8.07 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.03 -0.605 . . . . 64.13 112.31 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.5 m -92.83 130.88 38.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.795 0.331 . . . . 65.45 110.706 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -128.34 139.25 52.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.73 -0.47 . . . . 70.34 109.73 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.594 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.2 m -122.51 117.83 26.84 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.755 -0.378 . . . . 73.11 110.78 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.7 mt -95.0 115.26 65.22 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 63.1 109.913 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.19 135.95 7.6 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.469 2.113 . . . . 71.04 112.689 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 68.3 m-85 -134.7 160.76 37.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 64.42 110.258 177.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.61 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 44.9 mt-30 -130.37 114.52 15.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.91 0.386 . . . . 73.32 110.832 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.07 130.63 46.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.547 -0.297 . . . . 65.42 110.407 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 13.8 ptp180 -141.27 158.12 44.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.582 -0.281 . . . . 74.44 110.825 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 94.4 m-85 -75.93 142.03 42.14 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.148 -0.478 . . . . 74.12 110.257 175.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.548 ' HD1' HG22 ' A' ' 48' ' ' THR . 75.7 t80 -128.81 125.78 38.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.934 -0.575 . . . . 73.52 109.988 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -94.02 131.43 39.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.097 0.475 . . . . 72.13 110.736 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.5 p -101.13 7.31 43.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.502 -0.772 . . . . 72.34 109.572 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.83 -129.66 1.75 Allowed Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.246 -1.141 . . . . 73.21 110.246 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 144' ' ' THR . . . -83.82 95.37 8.44 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.452 -0.573 . . . . 73.11 109.452 175.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.48 111.35 0.48 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.824 -0.625 . . . . 70.23 111.363 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 142' ' ' ALA . 36.6 p -103.62 142.98 25.72 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-O 121.328 0.585 . . . . 73.12 110.845 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.75 166.94 22.58 Favored 'Trans proline' 0 C--N 1.331 -0.35 0 C-N-CA 123.816 3.011 . . . . 75.14 112.734 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.02 179.79 19.98 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.799 -0.715 . . . . 64.1 111.513 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.06 112.71 5.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 117.003 0.401 . . . . 72.45 110.915 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.548 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -101.2 74.1 1.55 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.451 0.643 . . . . 62.22 111.031 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.432 HD22 ' C ' ' A' ' 148' ' ' ALA . 0.9 OUTLIER -113.0 123.44 50.34 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.323 -0.621 . . . . 72.42 109.323 178.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.403 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -129.34 156.45 44.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.95 0.405 . . . . 53.21 111.598 -176.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -125.65 130.18 51.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.69 -0.687 . . . . 71.42 109.826 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.09 137.11 32.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.103 0.478 . . . . 44.44 111.663 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.4 p -112.63 125.0 53.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.679 -0.691 . . . . 72.21 109.902 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -105.52 134.84 47.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.144 0.497 . . . . 74.32 110.682 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.592 ' HA ' HG21 ' A' ' 16' ' ' VAL . 1.9 ttmm -117.9 107.42 14.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.684 -0.689 . . . . 74.14 110.158 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -74.45 140.86 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.142 0.496 . . . . 72.14 110.206 179.212 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -128.39 110.12 12.05 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.117 -0.698 . . . . 71.53 109.117 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.799 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.587 0 CA-C-O 120.942 0.401 . . . . 75.42 111.666 177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.0 p . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.823 0.344 . . . . 75.13 110.647 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.488 ' CG2' HG12 ' A' ' 37' ' ' VAL . 32.7 m -93.53 15.88 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.975 0.417 . . . . 72.4 110.955 177.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 61.11 20.58 11.06 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.452 -0.795 . . . . 71.3 112.092 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.558 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 84.79 102.85 0.63 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.591 -0.814 . . . . 45.44 111.978 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.465 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -93.64 155.36 22.09 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.242 -0.98 . . . . 22.35 112.048 -177.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 33' ' ' GLN . 53.8 p -140.99 151.5 44.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.899 -0.408 . . . . 74.2 109.899 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -121.0 124.1 71.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.042 -0.725 . . . . 50.44 109.042 172.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -92.2 116.99 29.43 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.118 -0.633 . . . . 72.15 109.688 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.453 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 93.1 m-85 -104.15 114.5 28.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.626 -0.715 . . . . 73.33 110.157 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -102.32 134.81 45.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 75.4 110.274 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.93 -120.68 3.43 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.944 -0.646 . . . . 53.14 111.899 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.639 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 38.3 mt-10 62.88 19.72 11.73 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.153 0.501 . . . . 54.22 111.085 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.785 HG23 HG22 ' A' ' 17' ' ' VAL . 17.2 m -76.17 -30.49 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.053 -0.521 . . . . 64.01 111.719 -176.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.785 HG22 HG23 ' A' ' 16' ' ' VAL . 4.2 m -149.17 143.87 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.146 0.498 . . . . 64.23 111.145 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -140.7 22.45 2.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.213 -0.903 . . . . 74.01 108.916 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.75 -77.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.089 -0.959 . . . . 72.43 111.131 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.569 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -78.19 -39.15 41.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.024 -0.535 . . . . 65.02 110.492 178.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.8 OUTLIER -143.65 128.39 18.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.055 -0.521 . . . . 74.1 109.778 -176.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.44 119.25 27.53 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.366 -0.379 . . . . 70.53 110.138 -178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.452 ' HA ' HD23 ' A' ' 58' ' ' LEU . 9.6 t -62.45 128.65 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.709 -0.478 . . . . 74.11 109.709 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 28' ' ' VAL . 18.6 t70 -59.57 142.88 51.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.781 -0.645 . . . . 63.44 111.397 -176.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -62.12 -24.37 67.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.774 -0.648 . . . . 74.32 112.221 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.4 -17.91 70.12 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.618 -0.801 . . . . 33.11 111.932 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 p -105.48 -14.23 15.37 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.821 0.304 . . . . 52.4 111.821 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.639 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 33.8 m -79.73 -8.02 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.09 0.471 . . . . 73.42 110.353 175.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -157.78 90.24 1.06 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.559 -0.904 . . . . 62.52 108.559 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.429 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 17.1 pt20 -137.06 112.86 9.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.726 -0.67 . . . . 74.22 110.52 -176.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.55 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.4 m -97.22 95.37 7.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.532 -0.758 . . . . 74.44 109.094 174.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 p -79.26 134.42 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.193 -0.458 . . . . 64.0 110.541 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.567 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.6 mp0 -91.33 120.96 32.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.121 -0.491 . . . . 74.01 110.281 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.429 HD21 HG23 ' A' ' 10' ' ' VAL . 2.8 mm? -86.55 -30.04 22.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.777 -0.647 . . . . 74.41 109.356 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.558 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 92.33 177.35 41.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.329 -0.851 . . . . 51.12 111.951 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -72.31 95.34 1.71 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.707 -0.479 . . . . 72.42 109.707 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.488 HG12 ' CG2' ' A' ' 5' ' ' VAL . 9.8 p -66.49 138.49 22.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.209 0.528 . . . . 74.02 110.379 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.6 mtm-85 -75.25 106.55 6.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.623 -0.717 . . . . 74.01 109.967 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 p -62.49 -26.08 68.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 75.21 111.09 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.19 -8.07 52.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 63.25 111.428 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.1 m -97.07 -15.51 20.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.813 0.339 . . . . 61.15 110.749 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -124.28 95.94 4.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.699 0.285 . . . . 72.31 110.241 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.01 11.34 7.07 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.667 -0.413 . . . . 74.14 112.061 -176.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -152.8 143.42 22.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.417 0.151 . . . . 74.01 110.829 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 41.2 tt0 -58.35 118.46 5.56 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.021 0.438 . . . . 74.34 110.638 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.79 -17.59 8.18 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.22 -0.752 . . . . 64.03 111.22 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.3 124.67 24.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.847 0.356 . . . . 43.31 110.222 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.508 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 4.6 p -121.88 114.23 20.74 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.937 -0.574 . . . . 74.01 110.139 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.8 t -72.22 174.46 7.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.069 -0.514 . . . . 33.21 110.838 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -60.54 120.88 10.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 51.3 110.29 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -80.46 142.48 34.23 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.411 0.624 . . . . 44.03 111.276 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.9 m -83.66 147.88 5.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.825 -1.08 . . . . 72.42 109.306 170.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.99 92.02 0.72 Allowed Glycine 0 C--N 1.307 -1.05 0 C-N-CA 120.837 -0.696 . . . . 72.45 112.257 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -102.19 -175.71 2.91 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.407 -0.59 . . . . 75.31 109.407 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.548 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.0 p-10 -147.31 147.48 30.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.39 0.614 . . . . 71.24 111.821 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.45 115.87 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.342 -0.985 . . . . 73.43 108.342 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . 48.7 tt0 -103.71 138.45 40.34 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.078 -0.51 . . . . 75.21 111.129 -171.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 23' ' ' VAL . 64.4 mt -119.11 115.23 23.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.711 -0.677 . . . . 73.14 109.744 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -92.63 136.26 33.38 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.977 -0.556 . . . . 74.12 110.239 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 51.02 68.91 0.71 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.944 0.777 . . . . 53.3 110.938 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.519 ' SG ' HD13 ' A' ' 124' ' ' LEU . 53.0 t -98.62 129.39 45.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.954 . . . . 62.05 110.435 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -104.06 138.27 40.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.935 -0.575 . . . . 70.15 111.169 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.5 p -104.95 10.5 34.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.094 0.405 . . . . 65.52 112.094 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -85.13 -37.15 20.57 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.459 -0.571 . . . . 72.23 109.459 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 20' ' ' ALA . 10.3 p -100.58 -13.7 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.773 -0.649 . . . . 51.05 110.852 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.679 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -123.92 179.48 4.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.64 0.257 . . . . 74.44 111.066 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 20.3 m -143.24 -60.95 0.42 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.486 . . . . 74.21 110.736 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -136.68 140.72 42.9 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.374 -0.602 . . . . 75.32 109.374 -178.254 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -98.16 119.8 37.44 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.185 0.517 . . . . 54.24 109.977 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -131.25 110.84 11.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.538 -0.756 . . . . 73.43 109.754 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -89.03 145.45 7.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.915 0.388 . . . . 72.15 110.298 -175.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -123.37 123.87 41.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.965 -0.561 . . . . 35.04 109.62 174.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 91.1 m-85 -88.95 130.43 35.45 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.021 0.439 . . . . 65.32 110.696 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.7 tp -130.59 125.56 34.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.771 -0.65 . . . . 75.41 110.154 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.37 -164.2 21.48 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.132 -0.787 . . . . 51.4 111.132 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.456 ' O ' HD13 ' A' ' 86' ' ' LEU . 42.3 m -80.79 122.65 27.44 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.27 -0.271 . . . . 70.0 110.27 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.518 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -85.37 140.65 30.6 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.91 -0.404 . . . . 73.43 109.91 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 tt -65.05 -28.98 46.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.886 0.374 . . . . 64.34 110.867 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 22.0 t70 -153.99 174.95 13.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.482 -0.562 . . . . 60.3 109.482 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.36 -37.83 31.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.093 0.473 . . . . 73.14 110.339 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.63 -19.18 62.33 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.161 -0.776 . . . . 65.44 111.161 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 42.4 m80 -107.08 43.5 1.16 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.167 -0.679 . . . . 64.14 109.167 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.518 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -72.62 11.45 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.141 -0.936 . . . . 42.2 112.927 -176.028 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 85' ' ' VAL . 16.4 p30 -110.81 -8.96 14.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.058 0.456 . . . . 73.04 110.554 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.455 HG23 ' OD1' ' A' ' 84' ' ' ASN . 48.3 t -101.84 120.92 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.101 -0.499 . . . . 62.24 110.561 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.555 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -67.03 132.8 48.62 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.16 -0.473 . . . . 70.23 109.746 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.71 148.52 36.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.032 -0.531 . . . . 45.01 110.304 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.447 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 2.0 mm? -82.98 140.77 32.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.14 -0.482 . . . . 61.21 110.557 -177.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.486 -0.779 . . . . 53.01 110.095 177.301 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.459 ' HA ' ' H ' ' A' ' 147' ' ' ALA . 1.5 p . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 120.63 0.252 . . . . 75.22 110.404 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.92 138.7 50.31 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.061 -0.348 . . . . 74.05 110.061 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.18 159.3 33.32 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.842 -0.343 . . . . 63.52 110.932 -176.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 68.67 10.46 7.9 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.719 -0.673 . . . . 71.0 111.238 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.48 178.28 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.153 -0.476 . . . . 72.44 110.306 174.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 176.28 -175.9 47.59 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 109.831 -1.308 . . . . 53.32 109.831 177.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -118.9 114.21 44.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.334 0.588 . . . . 75.31 111.162 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.41 ' HG2' ' HB2' ' A' ' 138' ' ' PHE . 2.9 pt20 -104.15 140.16 38.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.698 -0.683 . . . . 65.45 109.498 173.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.4 mp -98.11 126.35 51.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.997 -0.547 . . . . 73.34 110.296 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.408 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 15.5 mt -89.92 147.5 23.69 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.262 -0.881 . . . . 72.12 109.141 176.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.406 ' HA ' ' CD1' ' A' ' 133' ' ' PHE . 1.5 p-10 -70.87 -169.94 0.39 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.773 -0.454 . . . . 73.33 109.773 175.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 106' ' ' ARG . 16.9 ptt180 -61.98 -30.86 71.22 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.108 -0.237 . . . . 73.43 111.527 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.4 p -81.92 -34.55 29.83 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.748 -0.381 . . . . 65.55 110.76 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 119.77 31.54 1.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.582 -0.818 . . . . 64.13 112.931 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.48 139.02 42.64 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.128 -0.323 . . . . 63.01 110.128 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.05 130.71 43.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.396 -0.366 . . . . 52.11 111.1 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt -97.37 131.98 43.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.144 -0.48 . . . . 71.03 110.506 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.411 ' H ' HG21 ' A' ' 117' ' ' THR . 14.7 m -72.23 137.01 46.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.257 -0.428 . . . . 74.44 110.72 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.555 HD13 HD22 ' A' ' 86' ' ' LEU . 49.2 mt -79.64 49.09 0.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 75.24 110.876 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -107.45 -8.43 16.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.441 0.639 . . . . 62.34 110.324 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.23 -12.51 12.78 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.0 -0.619 . . . . 63.43 112.811 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.19 -10.85 23.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.932 0.396 . . . . 43.4 111.153 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.411 HG21 ' H ' ' A' ' 112' ' ' THR . 24.5 m -92.57 95.12 9.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.079 0.466 . . . . 61.34 110.21 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.569 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 72.6 m-85 -91.03 153.01 20.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.784 -0.644 . . . . 73.11 110.241 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.4 m -65.23 171.37 3.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.083 -0.508 . . . . 71.52 111.251 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.3 p -61.3 146.17 48.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.104 -0.498 . . . . 72.12 110.301 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.431 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 41.9 mt-10 -57.57 101.34 0.07 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.96 0.409 . . . . 73.24 111.605 -176.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.6 m -85.85 104.18 15.28 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.947 -0.761 . . . . 70.43 108.947 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 m -63.3 115.08 4.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.262 0.553 . . . . 73.51 110.878 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.562 HD21 ' HB2' ' A' ' 69' ' ' ALA . 92.0 mt -74.59 147.08 42.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.176 -0.92 . . . . 74.12 111.777 -174.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.464 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -121.14 151.47 39.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.359 -0.837 . . . . 61.02 108.924 171.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 94.6 m-20 -63.12 107.34 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.902 0.382 . . . . 71.32 110.681 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.84 -149.12 20.08 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.967 -0.635 . . . . 65.41 111.789 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 30.1 m -82.12 123.61 29.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.124 0.487 . . . . 73.03 110.994 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 28.0 m-80 -117.48 135.09 54.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.942 -0.572 . . . . 32.52 109.537 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.548 HG22 ' HB2' ' A' ' 55' ' ' ASN . 2.3 m -122.45 118.87 29.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.804 -0.358 . . . . 75.41 110.488 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.0 mt -98.58 112.38 62.34 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.697 -0.482 . . . . 73.11 109.697 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.85 138.96 17.17 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.599 2.2 . . . . 71.25 112.469 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 78.6 m-85 -136.61 163.69 29.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.692 0.282 . . . . 74.0 110.528 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 96.2 mt-30 -130.71 119.09 21.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.102 -0.499 . . . . 72.13 110.896 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.21 123.23 47.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.099 -0.334 . . . . 73.04 110.099 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.539 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 2.8 ptp180 -135.98 159.17 42.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.39 -0.368 . . . . 74.12 111.234 -176.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 59.8 m-85 -80.5 134.41 35.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.746 -0.661 . . . . 64.53 110.418 174.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.41 ' HB2' ' HG2' ' A' ' 102' ' ' GLN . 84.8 t80 -117.69 119.21 34.26 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.139 -0.689 . . . . 71.11 109.139 176.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 45' ' ' GLU . . . -83.6 130.29 34.98 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.023 -0.535 . . . . 72.35 110.661 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 69.3 p -101.32 -0.54 35.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.88 0.848 . . . . 71.33 108.763 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.21 -131.54 1.77 Allowed Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.28 -1.327 . . . . 73.22 110.594 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 144' ' ' THR . . . -88.66 98.72 11.84 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.749 -0.463 . . . . 72.04 109.749 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -47.47 113.01 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.896 0.747 . . . . 71.33 111.395 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 142' ' ' ALA . 41.3 p -104.06 146.34 32.37 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 116.012 -0.54 . . . . 64.43 110.585 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.27 173.36 5.25 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.6 2.866 . . . . 62.55 113.628 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 138.0 -147.47 19.25 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.675 -0.693 . . . . 74.52 111.857 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.459 ' H ' ' HA ' ' A' ' 95' ' ' SER . . . -98.84 117.08 32.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.22 -0.289 . . . . 70.43 110.22 175.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.447 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -115.48 59.65 0.71 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.95 0.405 . . . . 34.31 111.625 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -112.69 137.03 51.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.035 -0.728 . . . . 73.34 109.035 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.486 ' HB3' HG13 ' A' ' 10' ' ' VAL . . . -128.81 169.92 13.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.016 0.436 . . . . 55.13 111.756 -175.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -137.8 127.26 24.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.581 -0.736 . . . . 75.12 109.618 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.86 140.59 29.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.075 0.464 . . . . 74.02 111.774 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.1 p -110.28 126.11 53.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.595 . . . . 65.52 109.53 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -106.44 143.39 34.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.059 0.457 . . . . 64.42 110.834 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.594 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.9 ttmm -120.04 111.96 18.55 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.812 -0.631 . . . . 74.15 110.435 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 71' ' ' VAL . 1.4 m -81.81 127.17 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.165 -0.68 . . . . 72.5 109.165 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -112.18 121.87 46.14 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.137 -0.483 . . . . 50.13 109.849 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.679 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.585 0 N-CA-C 111.841 0.311 . . . . 72.04 111.841 177.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.906 0.384 . . . . 74.44 110.092 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.51 HG22 HG12 ' A' ' 37' ' ' VAL . 28.1 m -92.64 15.79 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.004 0.43 . . . . 74.15 110.526 176.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 61.95 13.09 5.32 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.355 -0.839 . . . . 74.02 112.563 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.426 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 91.09 94.96 1.27 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.731 -0.747 . . . . 55.25 111.967 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.02 158.64 31.97 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.532 -0.842 . . . . 70.2 112.171 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.523 ' HB ' HG22 ' A' ' 31' ' ' THR . 11.2 p -140.24 135.32 32.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.361 . . . . 61.21 111.102 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.463 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -108.11 125.47 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.423 -0.584 . . . . 74.33 109.423 173.347 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -96.81 111.03 23.39 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.068 0.461 . . . . 72.04 110.19 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 95.7 m-85 -101.07 122.9 44.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.886 -0.597 . . . . 74.35 110.47 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -108.08 138.43 44.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.449 -0.341 . . . . 70.12 110.535 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -109.3 -133.08 6.65 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.935 -0.65 . . . . 72.04 112.321 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 62.95 34.55 14.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.39 0.614 . . . . 65.2 110.897 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 155' ' ' LYS . 25.3 m -93.76 -22.88 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.592 -0.731 . . . . 73.42 111.663 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.468 HG21 ' CG2' ' A' ' 156' ' ' VAL . 19.0 m -143.01 149.18 18.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.537 -0.301 . . . . 55.41 111.303 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -156.86 32.04 0.3 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.797 0.808 . . . . 65.22 109.346 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.89 -66.73 0.9 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.313 -0.858 . . . . 73.01 111.469 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.414 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -98.92 -41.03 7.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 61.44 110.804 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 1.8 m -135.63 128.88 31.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.153 -0.476 . . . . 71.55 110.075 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.5 127.84 39.33 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.022 -0.536 . . . . 53.33 110.007 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.58 131.26 31.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.338 -0.392 . . . . 51.24 110.217 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 28' ' ' VAL . 25.1 t70 -57.93 145.45 35.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.736 -0.666 . . . . 71.45 111.254 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.32 -30.72 70.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 64.02 111.775 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.66 -12.03 82.17 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.61 -0.805 . . . . 74.13 111.652 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 t -97.82 -24.38 15.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.453 0.168 . . . . 71.12 110.591 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 24' ' ' ASP . 20.7 m -80.44 -7.14 10.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.822 0.344 . . . . 73.4 110.597 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -154.85 88.95 1.21 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.813 -0.631 . . . . 53.33 109.681 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.86 115.57 10.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.638 0.732 . . . . 65.53 110.98 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.523 HG22 ' HB ' ' A' ' 9' ' ' THR . 3.9 m -98.38 97.63 8.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.027 -0.988 . . . . 72.52 109.067 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.69 127.94 39.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.128 0.49 . . . . 74.44 111.092 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -86.61 125.43 33.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.645 . . . . 65.02 109.976 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.406 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.7 mm? -87.54 -22.91 24.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.109 0.481 . . . . 72.52 110.032 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.426 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 93.41 173.32 40.1 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.581 -0.736 . . . . 53.42 112.095 -178.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.74 91.49 5.91 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.761 0.315 . . . . 44.43 110.701 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.51 HG12 HG22 ' A' ' 5' ' ' VAL . 7.2 p -78.06 146.07 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.171 -0.468 . . . . 53.41 109.824 176.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -87.07 132.15 33.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.02 -0.363 . . . . 73.51 110.02 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 53.2 p -68.33 -18.64 64.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.228 0.537 . . . . 72.12 111.129 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.44 -12.92 61.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 63.31 111.197 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.0 m -97.04 9.14 42.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.22 0.533 . . . . 65.01 110.426 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.617 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 6.0 mt -145.61 49.35 1.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.584 -0.734 . . . . 72.11 109.612 -174.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.23 6.06 41.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.529 0.937 . . . . 52.52 113.529 -168.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.452 HE21 ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -161.27 155.34 22.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.488 -0.19 . . . . 63.03 110.488 177.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 33.1 tt0 -56.95 132.61 53.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 123.347 0.404 . . . . 55.41 110.371 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.84 -17.01 36.15 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.706 -0.759 . . . . 44.24 111.663 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -69.68 121.61 17.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.333 . . . . 75.2 110.302 176.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.524 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 37.7 p -119.15 135.78 54.5 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.045 -0.525 . . . . 74.42 110.432 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.0 t -89.46 178.26 6.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.673 -0.491 . . . . 64.35 109.673 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -67.51 129.27 39.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.375 -0.375 . . . . 74.33 110.069 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -81.36 158.56 24.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.449 0.642 . . . . 62.35 111.316 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 27.7 m -101.22 147.34 8.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.824 -1.08 . . . . 71.51 109.124 171.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.92 86.39 0.58 Allowed Glycine 0 C--N 1.31 -0.911 0 C-N-CA 120.675 -0.774 . . . . 53.04 111.978 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -96.08 166.46 11.75 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.699 -0.482 . . . . 64.32 109.699 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.469 ' HB2' HG22 ' A' ' 130' ' ' THR . 20.7 p-10 -125.45 139.37 53.7 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.407 0.622 . . . . 70.54 111.998 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.2 mt -109.74 107.05 21.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.562 -0.903 . . . . 74.15 108.562 167.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -100.59 135.51 41.91 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.715 -0.675 . . . . 73.2 111.322 -170.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.4 mt -112.12 132.58 54.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.504 -0.771 . . . . 73.11 109.527 175.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -109.07 145.49 35.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.419 -0.355 . . . . 74.43 110.058 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.11 48.71 20.39 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.616 0.722 . . . . 73.32 110.944 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.51 ' SG ' HD22 ' A' ' 124' ' ' LEU . 48.0 t -85.8 155.97 20.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.066 -0.97 . . . . 74.1 110.323 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' HA ' ' ND2' ' A' ' 126' ' ' ASN . 21.1 t70 -128.3 152.86 47.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.524 -0.307 . . . . 73.34 111.512 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.9 p -119.06 5.81 11.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 72.13 111.677 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -84.34 -34.99 23.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.091 0.472 . . . . 74.4 109.978 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 p -103.68 -21.36 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 54.23 111.196 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -124.27 -175.53 3.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.269 -0.271 . . . . 72.23 110.269 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.5 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 20.4 m -146.26 -55.8 0.28 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.731 0.301 . . . . 74.0 111.629 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.5 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -135.97 143.81 45.06 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 109.881 -0.414 . . . . 62.41 109.881 -178.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.523 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -106.09 127.48 53.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.135 0.493 . . . . 42.14 110.163 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.2 118.82 15.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.509 -0.769 . . . . 70.0 109.016 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.725 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -90.99 146.76 5.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.999 0.428 . . . . 74.11 110.54 -175.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.434 ' HB2' ' CD2' ' A' ' 118' ' ' PHE . . . -118.79 119.13 33.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.782 -0.645 . . . . 62.03 109.354 174.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 93.8 m-85 -84.67 130.88 34.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.993 0.425 . . . . 45.31 110.527 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.9 tp -125.91 123.59 38.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.664 -0.698 . . . . 74.11 109.935 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.5 -170.99 26.93 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.513 -0.635 . . . . 61.14 111.513 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.7 m -84.06 125.49 32.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.62 0.248 . . . . 74.22 110.631 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 83' ' ' THR . . . -87.72 138.98 30.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.591 -0.277 . . . . 73.1 110.515 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.446 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 10.8 tt -64.06 -31.95 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 73.31 111.224 -177.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -145.81 -178.19 5.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.268 -0.642 . . . . 72.33 109.268 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.57 -42.52 24.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.692 0.282 . . . . 63.1 110.865 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.67 -16.77 74.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.58 -0.819 . . . . 75.34 111.951 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -105.12 51.3 0.76 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.13 0.491 . . . . 52.44 109.979 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.405 ' HA ' ' CB ' ' A' ' 77' ' ' ALA . 1.1 p -74.93 3.6 7.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.806 -0.634 . . . . 55.14 112.138 -178.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -104.79 -5.96 20.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.927 0.394 . . . . 75.31 110.671 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.05 120.12 58.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.175 -0.466 . . . . 75.45 110.628 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.494 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -67.51 129.78 40.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.93 -0.396 . . . . 74.31 109.93 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.49 141.62 39.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.27 -0.423 . . . . 51.21 110.605 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.8 mm? -82.38 140.32 33.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.074 -0.512 . . . . 71.03 110.027 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.37 0.605 . . . . 74.01 110.748 179.179 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.69 0.281 . . . . 64.02 110.571 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.94 125.45 27.61 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.785 -0.45 . . . . 71.34 109.785 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.07 166.46 16.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.35 -0.386 . . . . 71.1 110.243 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 68.88 9.96 7.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.253 0.549 . . . . 63.1 110.446 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.45 -174.47 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.279 -0.873 . . . . 63.21 109.685 173.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.49 -174.5 46.56 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.637 -0.985 . . . . 41.11 110.637 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 p -119.66 115.65 48.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.446 0.641 . . . . 75.14 110.841 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -107.1 142.22 37.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.489 -0.778 . . . . 73.45 109.642 175.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.1 mp -103.12 123.78 56.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.032 -0.531 . . . . 72.51 110.3 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.493 HD11 ' NE ' ' A' ' 136' ' ' ARG . 12.7 mt -86.27 147.64 25.99 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.647 -0.706 . . . . 60.21 109.11 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.585 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.1 p-10 -74.1 -170.99 1.03 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.59 -0.522 . . . . 73.42 109.59 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -69.04 -25.53 64.52 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.975 -0.29 . . . . 65.43 111.554 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.1 p -84.69 -26.47 27.71 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 120.647 -0.421 . . . . 62.1 111.015 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.81 34.51 1.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 60.54 112.825 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -114.73 135.56 54.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.424 -0.213 . . . . 62.2 110.424 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.43 122.74 17.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 55.53 110.836 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.1 mt -88.88 135.84 33.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.367 -0.379 . . . . 75.04 110.614 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.2 m -83.7 145.44 28.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.025 -0.534 . . . . 51.41 110.556 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 52.7 mt -81.34 40.14 0.55 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 73.1 111.275 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -77.02 -22.64 52.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.432 -0.349 . . . . 65.3 111.092 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.17 -11.27 37.4 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.764 -0.731 . . . . 74.23 112.005 -172.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.41 2.56 9.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.178 0.513 . . . . 64.3 110.562 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.9 m -99.74 102.65 14.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.829 -0.623 . . . . 71.25 109.491 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.434 ' CD2' ' HB2' ' A' ' 72' ' ' ALA . 83.8 m-85 -93.81 167.24 11.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.746 -0.661 . . . . 70.3 111.771 -171.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.585 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.9 m -73.93 179.45 4.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.242 -0.89 . . . . 71.22 110.572 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.7 t -69.08 146.01 52.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.246 -0.649 . . . . 74.23 109.246 173.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -54.14 106.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.475 0.484 . . . . 64.12 111.544 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.5 m -91.16 103.76 16.4 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.076 -0.713 . . . . 72.21 109.076 173.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 m -55.41 124.36 16.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.789 -0.641 . . . . 75.21 111.099 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 69' ' ' ALA . 83.7 mt -83.38 150.69 25.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.79 -0.641 . . . . 73.55 111.275 -176.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.475 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -129.34 152.29 49.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.174 -0.921 . . . . 70.13 108.747 171.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.8 m120 -65.53 118.39 9.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.996 0.427 . . . . 71.41 110.43 175.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 124.76 -137.88 10.78 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.817 -0.706 . . . . 64.3 112.167 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 20.5 m -88.61 127.81 35.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.411 . . . . 54.33 111.016 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -124.95 112.72 16.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.219 -0.446 . . . . 74.35 110.078 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.8 m -102.98 106.52 17.07 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.798 0.332 . . . . 74.33 110.527 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.7 mt -87.63 115.39 62.76 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.624 -0.51 . . . . 74.14 109.624 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -84.23 132.94 5.38 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.602 2.201 . . . . 64.33 112.841 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.429 ' HE1' ' HG ' ' A' ' 119' ' ' SER . 76.2 m-85 -131.9 159.55 38.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 54.31 110.462 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.681 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 99.2 mt-30 -127.97 112.88 15.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.246 -0.434 . . . . 73.13 111.487 -176.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.54 127.7 45.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.206 -0.452 . . . . 71.51 110.192 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.524 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 15.8 ptp180 -139.06 163.08 33.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.45 -0.341 . . . . 55.13 110.719 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 71.7 m-85 -81.57 142.5 32.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.97 -0.559 . . . . 63.4 110.715 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -130.43 119.79 23.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.639 -0.709 . . . . 74.42 109.421 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 45' ' ' GLU . . . -81.27 137.62 35.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.397 -0.365 . . . . 61.13 111.009 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.442 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 68.9 p -110.13 2.79 19.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.676 0.75 . . . . 53.31 109.349 176.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.22 -129.45 1.74 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.915 -1.039 . . . . 53.5 110.864 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.15 90.26 8.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.848 0.324 . . . . 74.31 110.283 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.64 114.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.491 0.495 . . . . 62.33 111.557 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 26.6 p -104.71 139.62 20.28 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-O 121.385 0.612 . . . . 75.24 110.613 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.59 162.77 41.32 Favored 'Trans proline' 0 C--N 1.333 -0.272 0 C-N-CA 123.799 3.0 . . . . 73.01 112.868 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.63 -162.88 26.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.732 -0.747 . . . . 54.25 111.817 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.84 113.65 8.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.866 0.365 . . . . 63.24 111.338 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.598 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -111.47 63.61 0.61 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.5 0.667 . . . . 75.33 110.357 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -117.48 128.46 55.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.818 . . . . 63.54 109.782 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.494 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -134.21 169.5 17.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.364 -0.38 . . . . 65.43 111.342 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.8 146.36 50.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 63.23 109.62 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.02 138.86 19.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.146 0.498 . . . . 65.14 111.291 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.6 p -107.2 121.81 45.27 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.794 -0.639 . . . . 64.43 109.771 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -102.61 137.19 41.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.367 -0.378 . . . . 73.34 110.528 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HA ' HG21 ' A' ' 16' ' ' VAL . 3.9 tmmm? -119.78 113.08 20.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.344 -0.389 . . . . 75.44 110.345 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.725 HG12 HG12 ' A' ' 71' ' ' VAL . 1.2 m -77.57 137.28 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.773 -0.454 . . . . 70.52 109.773 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -115.2 123.56 49.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.393 -0.367 . . . . 71.03 110.172 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.647 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 3.1 p90 . . . . . 0 C--N 1.321 -0.672 0 CA-C-N 115.688 -0.687 . . . . 75.14 109.875 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.914 -0.402 . . . . 63.21 109.914 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.98 12.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.898 0.38 . . . . 72.24 110.922 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 61.86 17.89 9.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.58 -0.736 . . . . 75.44 111.872 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.412 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 83.0 95.53 0.56 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.598 -0.81 . . . . 54.25 111.396 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.78 157.39 45.47 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.174 -1.012 . . . . 34.13 111.895 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.473 ' HB ' HG22 ' A' ' 31' ' ' THR . 4.8 p -140.79 138.9 34.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.679 0.276 . . . . 64.22 111.077 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -115.48 120.44 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 116.441 -0.345 . . . . 54.14 110.071 176.025 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -91.09 107.37 19.16 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.165 -0.471 . . . . 65.51 110.08 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.11 125.11 40.42 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.02 -0.536 . . . . 72.52 110.545 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -112.33 133.81 54.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.994 -0.548 . . . . 54.3 111.165 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.07 -130.07 5.62 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.461 -0.79 . . . . 73.11 111.88 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.47 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 44.3 mt-10 62.91 24.13 14.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.123 0.487 . . . . 65.13 110.993 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' A' ' 155' ' ' LYS . 22.1 m -77.85 -34.44 19.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.823 -0.626 . . . . 51.43 111.273 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.584 HG22 HG23 ' A' ' 16' ' ' VAL . 17.9 m -142.89 150.28 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.014 0.435 . . . . 64.14 111.189 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -144.34 22.42 1.68 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.417 -0.81 . . . . 74.01 108.961 175.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.92 -82.99 0.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.491 -0.777 . . . . 54.15 111.255 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.475 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -81.34 -35.65 30.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.796 0.332 . . . . 73.34 110.278 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 m -142.54 135.4 28.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.887 0.375 . . . . 64.54 110.023 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.04 123.97 40.92 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.102 -0.499 . . . . 64.3 109.861 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.487 ' HA ' HD23 ' A' ' 58' ' ' LEU . 14.2 t -61.03 131.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 109.722 -0.473 . . . . 65.34 109.722 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.431 ' O ' HG13 ' A' ' 28' ' ' VAL . 27.7 t70 -59.86 140.07 56.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.107 -0.497 . . . . 61.0 111.335 -176.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.13 -27.34 65.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.793 -0.64 . . . . 71.42 111.819 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.86 7.47 79.94 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.717 -0.754 . . . . 74.31 112.282 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.3 p -129.54 -10.96 4.52 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 122.712 -0.287 . . . . 72.55 111.387 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.47 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 29.2 m -78.24 -5.81 8.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 121.109 0.48 . . . . 73.1 110.505 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -157.2 96.14 1.54 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.446 -0.797 . . . . 73.25 109.015 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -143.64 121.8 12.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.212 0.53 . . . . 64.05 110.546 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 16.4 m -106.83 103.19 12.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.406 -0.815 . . . . 70.22 109.542 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 9' ' ' THR . 11.0 p -89.34 137.41 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.919 0.39 . . . . 73.32 110.97 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -91.05 128.7 36.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.767 -0.651 . . . . 74.44 109.574 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.16 -19.92 24.88 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.103 0.478 . . . . 72.42 110.265 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.6 165.03 35.9 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.868 -0.682 . . . . 32.5 112.082 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -75.18 96.44 3.29 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.055 -0.35 . . . . 62.13 110.055 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 p -80.05 149.34 5.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.152 -0.476 . . . . 74.43 110.274 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.0 mtt85 -83.29 128.68 34.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.996 -0.547 . . . . 64.42 109.864 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 6.6 p -77.78 -13.52 59.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.929 -0.578 . . . . 62.12 111.944 -172.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.14 50.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 65.11 110.915 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.486 ' HB2' HD12 ' A' ' 42' ' ' LEU . 5.5 m -67.42 -29.34 68.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.325 0.583 . . . . 33.45 110.472 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.5 mp -112.77 86.81 2.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.494 -0.775 . . . . 63.11 109.996 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.0 14.58 12.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.127 0.489 . . . . 72.43 111.122 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HG2' ' HB2' ' A' ' 47' ' ' ALA . 3.2 pm0 -141.5 135.91 30.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.052 -0.522 . . . . 75.15 110.324 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.545 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.5 tm-20 -59.32 119.97 8.41 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.563 -0.532 . . . . 73.44 109.563 175.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 109.9 -6.29 30.99 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.738 -0.744 . . . . 71.45 111.752 -175.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -65.8 135.31 54.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 73.43 111.005 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.1 p -120.97 140.82 51.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.055 -0.521 . . . . 45.0 110.355 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -104.34 -175.79 2.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.216 -0.447 . . . . 71.22 109.814 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.7 m -75.05 133.51 41.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.459 -0.337 . . . . 60.14 110.19 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -89.92 154.81 19.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.496 0.665 . . . . 74.33 112.021 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 31.5 m -92.82 156.65 3.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.646 -1.161 . . . . 62.25 109.22 169.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 101.65 1.22 Allowed Glycine 0 C--N 1.315 -0.587 0 C-N-CA 120.859 -0.686 . . . . 73.05 112.267 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -111.04 176.59 4.96 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.752 -0.462 . . . . 75.54 109.752 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.549 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.5 p-10 -136.24 149.51 48.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.403 0.621 . . . . 75.12 111.904 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.435 HD12 ' CE2' ' A' ' 133' ' ' PHE . 72.6 mt -113.93 113.86 45.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.11 -0.95 . . . . 61.03 108.684 169.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . 49.8 tt0 -96.83 140.33 31.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.101 -0.499 . . . . 72.43 110.951 -172.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 23' ' ' VAL . 64.5 mt -120.63 122.35 40.33 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.951 -0.568 . . . . 71.24 109.565 177.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -99.39 143.79 29.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.075 -0.511 . . . . 74.31 110.034 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 56.82 44.02 24.05 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.779 0.674 . . . . 75.35 110.845 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.597 ' SG ' HD22 ' A' ' 124' ' ' LEU . 6.0 t -75.24 142.04 43.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.109 -0.496 . . . . 74.42 110.31 -175.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -117.71 142.36 47.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.944 -0.571 . . . . 63.52 112.044 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.4 p -113.28 4.51 16.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.79 -0.641 . . . . 62.42 111.398 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -76.0 -38.1 57.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.975 0.417 . . . . 74.24 110.085 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 p -107.86 -18.96 7.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.107 -0.497 . . . . 75.02 111.381 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.704 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -126.47 161.75 27.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.741 0.305 . . . . 75.32 111.52 -176.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.551 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 15.0 m -120.18 -55.74 2.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.203 -0.453 . . . . 72.44 111.462 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.551 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -136.53 148.87 47.83 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.81 -0.441 . . . . 65.24 109.81 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.636 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -103.48 140.6 37.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.039 0.447 . . . . 63.53 110.308 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.57 114.17 6.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.6 -0.727 . . . . 65.32 109.067 176.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.655 HG12 HG12 ' A' ' 156' ' ' VAL . 1.3 m -88.13 145.64 7.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.971 0.415 . . . . 60.52 110.834 -173.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.52 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -119.97 123.28 43.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.807 -0.633 . . . . 71.42 109.74 173.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.454 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 57.4 m-85 -86.34 142.52 28.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.2 0.524 . . . . 74.33 111.096 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.6 tp -134.18 123.15 23.87 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.487 -0.778 . . . . 54.41 109.963 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 113' ' ' LEU . . . -164.64 -177.05 36.95 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.767 -0.933 . . . . 62.23 110.767 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.9 m -77.41 121.73 24.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.954 0.377 . . . . 70.43 110.828 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.28 138.68 39.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 62.44 110.529 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.459 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 9.5 tt -69.14 -30.84 47.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 74.13 111.133 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -146.32 178.67 8.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.995 -0.372 . . . . 71.34 109.995 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.71 -30.77 28.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.074 0.464 . . . . 71.34 110.106 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.5 -25.85 31.91 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.726 -0.749 . . . . 54.32 111.539 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.423 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 67.1 m80 -103.5 72.64 1.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.302 0.572 . . . . 74.21 110.046 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 p -92.1 5.43 50.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.547 -0.751 . . . . 72.42 111.853 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -112.43 2.53 16.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 71.13 110.624 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 102' ' ' GLN . 57.6 t -111.01 122.85 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.861 -0.608 . . . . 70.32 110.095 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -69.88 131.38 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.674 0.274 . . . . 74.15 110.275 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.459 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.43 145.72 36.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 52.55 110.441 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.66 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -85.16 135.42 33.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.126 -0.488 . . . . 61.44 109.943 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 72.44 110.099 -179.669 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.684 -0.488 . . . . 64.35 109.684 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.72 106.48 1.51 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.048 0.452 . . . . 62.21 110.319 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.36 159.31 15.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.143 -0.481 . . . . 74.01 110.574 -176.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.46 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 48.1 m-80 67.01 13.05 9.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.333 0.653 . . . . 54.51 111.17 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.48 167.62 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 CA-C-N 116.271 -0.422 . . . . 61.11 110.336 175.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.527 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . -169.08 -173.8 37.07 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.221 -1.152 . . . . 52.03 110.221 176.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.78 115.26 47.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.363 0.601 . . . . 65.41 110.647 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.501 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.2 pt20 -100.49 139.77 35.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.771 -0.65 . . . . 63.35 109.365 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.454 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.2 mp -96.36 129.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.955 0.407 . . . . 62.12 110.295 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.537 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 49.0 mt -96.91 141.6 29.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.705 -0.679 . . . . 63.12 109.925 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.577 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.69 -173.05 1.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.131 -0.486 . . . . 74.15 110.033 177.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.438 ' HG3' HG23 ' A' ' 107' ' ' THR . 13.7 ptm180 -57.83 -25.28 60.44 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.276 0.473 . . . . 71.22 112.276 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.438 HG23 ' HG3' ' A' ' 106' ' ' ARG . 74.5 p -100.04 1.7 42.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 73.51 111.762 -177.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 83.32 38.09 11.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.642 -0.79 . . . . 71.14 112.713 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.52 136.13 51.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.228 -0.286 . . . . 74.43 110.228 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.91 120.74 14.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.328 -0.396 . . . . 63.22 111.013 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 105' ' ' ASP . 95.1 mt -88.21 129.94 35.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.064 -0.516 . . . . 74.31 110.617 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.8 m -76.43 137.6 39.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.903 -0.589 . . . . 73.45 110.954 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.472 HD13 HD22 ' A' ' 86' ' ' LEU . 37.5 mt -79.56 47.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 74.05 110.98 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -100.11 -14.34 18.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.878 -0.601 . . . . 74.21 110.367 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.4 -13.48 33.86 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.745 -0.74 . . . . 62.23 112.525 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.61 4.83 15.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.943 0.401 . . . . 62.13 111.12 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.2 m -100.5 99.65 10.28 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.555 -0.535 . . . . 65.33 109.555 176.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.529 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 64.1 m-85 -94.26 164.11 13.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.089 -0.505 . . . . 74.45 111.487 -172.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.577 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 8.3 m -72.94 -178.56 2.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.45 -0.795 . . . . 61.42 111.459 177.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 m -69.05 160.95 30.03 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.915 -0.584 . . . . 72.31 109.521 170.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.66 125.96 25.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 74.44 110.944 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.428 HG21 HG12 ' A' ' 131' ' ' ILE . 20.1 m -109.23 98.72 8.1 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.38 -0.97 . . . . 70.44 108.38 168.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.4 m -57.22 116.58 3.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 73.22 111.078 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.636 HD21 ' HB2' ' A' ' 69' ' ' ALA . 76.3 mt -74.83 150.17 39.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.307 -0.86 . . . . 62.43 111.522 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -128.12 150.42 49.98 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.259 -0.882 . . . . 54.53 108.83 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -65.31 109.96 2.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.802 0.334 . . . . 71.53 110.354 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.4 -139.2 10.86 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.637 -0.792 . . . . 63.24 112.517 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 m -86.31 117.79 25.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.942 0.401 . . . . 63.42 111.061 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.526 HD22 ' N ' ' A' ' 129' ' ' ASN . 0.8 OUTLIER -112.16 148.62 33.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.508 -0.552 . . . . 70.41 109.508 178.198 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.549 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.2 m -138.01 113.65 9.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.265 -0.272 . . . . 72.32 110.265 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 10.2 mt -94.46 119.71 66.03 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.982 -0.377 . . . . 63.23 109.982 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 4.9 Cg_endo -84.14 133.31 5.59 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.971 2.447 . . . . 74.11 112.514 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 70.7 m-85 -135.63 163.44 30.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.296 -0.411 . . . . 73.32 110.691 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 90.0 mt-30 -126.71 148.87 49.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.016 -0.538 . . . . 73.42 110.66 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.24 122.52 26.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.182 -0.463 . . . . 50.21 110.335 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 2.1 ptp180 -134.1 164.96 26.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.458 -0.337 . . . . 64.01 110.633 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -83.98 143.07 30.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.116 -0.493 . . . . 63.5 110.555 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.51 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 57.2 t80 -130.17 125.94 36.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.894 -0.78 . . . . 61.24 108.894 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.648 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -89.73 135.18 33.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.017 0.437 . . . . 72.31 111.435 -177.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.545 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 72.2 p -102.53 9.91 39.18 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.756 -0.831 . . . . 55.04 108.756 175.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.09 -123.75 1.2 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.833 -1.076 . . . . 33.32 111.111 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.27 96.65 10.41 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.784 -0.45 . . . . 61.05 109.784 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.93 112.19 0.44 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.699 0.624 . . . . 62.43 111.164 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.7 p -105.12 139.57 20.25 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 115.947 -0.57 . . . . 72.02 109.944 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.83 157.41 58.38 Favored 'Trans proline' 0 C--N 1.328 -0.503 0 C-N-CA 123.417 2.745 . . . . 75.01 113.153 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.33 -165.2 29.43 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.598 -0.728 . . . . 62.24 112.11 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.18 114.57 11.51 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.796 0.331 . . . . 74.42 111.086 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.66 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -109.08 69.96 0.72 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.213 0.53 . . . . 61.1 110.361 176.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.455 HD22 ' N ' ' A' ' 149' ' ' ASN . 0.9 OUTLIER -110.34 123.63 50.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.567 -0.531 . . . . 75.14 109.567 179.25 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.455 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -132.38 158.81 40.99 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.841 0.353 . . . . 70.41 111.036 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.41 143.84 39.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.252 -0.431 . . . . 71.22 110.15 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.513 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -153.84 157.94 40.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.976 0.417 . . . . 73.12 111.358 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.3 p -109.49 155.12 21.73 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.723 -0.672 . . . . 64.33 109.412 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -127.6 123.22 35.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.092 0.472 . . . . 70.03 110.679 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.607 ' HA ' HG21 ' A' ' 16' ' ' VAL . 9.2 ttmt -102.6 105.63 16.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.095 -0.502 . . . . 71.03 110.359 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.655 HG12 HG12 ' A' ' 71' ' ' VAL . 1.3 m -76.61 128.85 37.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.507 -0.553 . . . . 54.32 109.507 177.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 8.0 tt0 -107.5 129.9 54.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.227 -0.442 . . . . 55.21 110.087 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.704 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.18 -0.464 . . . . 75.0 110.836 174.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.0 p . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 110.203 -0.295 . . . . 74.44 110.203 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.488 HG22 HG12 ' A' ' 37' ' ' VAL . 35.2 m -91.65 17.39 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.137 0.494 . . . . 63.34 110.662 176.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 61.97 11.85 4.49 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.202 -0.908 . . . . 73.43 112.515 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 35' ' ' GLY . . . 82.97 95.53 0.56 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.43 -0.89 . . . . 52.34 111.566 -176.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.19 160.91 33.88 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.198 -1.001 . . . . 52.45 111.305 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.601 ' HB ' HG22 ' A' ' 31' ' ' THR . 65.8 p -138.88 140.6 38.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.684 0.278 . . . . 72.1 110.439 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.96 122.27 63.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.194 -0.669 . . . . 72.3 109.194 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -90.47 109.69 20.82 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.322 -0.621 . . . . 74.44 109.322 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -97.52 124.05 41.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.899 -0.591 . . . . 63.32 110.173 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -106.51 135.13 48.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.951 -0.568 . . . . 74.13 110.816 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.26 -137.72 6.61 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 121.098 -0.573 . . . . 74.41 112.534 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.408 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 46.4 mt-10 59.34 27.44 16.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.362 0.601 . . . . 64.41 110.774 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.716 HG23 HG22 ' A' ' 17' ' ' VAL . 22.8 m -80.29 -21.93 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.48 -0.782 . . . . 63.15 110.672 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.765 HG21 HG22 ' A' ' 156' ' ' VAL . 3.5 m -148.46 139.27 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.737 -0.665 . . . . 73.1 110.865 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -139.02 26.3 2.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.02 -0.536 . . . . 75.04 109.637 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.09 -86.97 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.28 0.474 . . . . 72.33 112.28 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.485 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -76.4 -16.79 59.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 72.31 111.08 -178.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 58' ' ' LEU . 59.7 m -150.87 157.16 42.57 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.425 -0.954 . . . . 55.14 108.425 178.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.55 116.22 26.19 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.491 -0.559 . . . . 71.01 109.491 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.65 134.04 23.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.378 -0.373 . . . . 64.34 110.113 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.476 ' O ' HG13 ' A' ' 28' ' ' VAL . 16.8 t70 -63.56 142.94 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.503 -0.317 . . . . 64.22 110.923 -177.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -59.43 -27.52 66.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 52.43 112.261 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.24 -21.38 78.0 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.508 -0.853 . . . . 73.35 112.095 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 p -104.73 -12.41 16.36 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.062 0.393 . . . . 74.31 112.062 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 25' ' ' ALA . 31.4 m -80.58 -5.32 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.894 0.378 . . . . 75.35 110.708 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -163.29 89.78 0.63 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.277 -0.638 . . . . 74.15 109.277 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -141.78 132.33 25.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.039 -0.528 . . . . 74.3 110.591 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.601 HG22 ' HB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -107.72 99.29 8.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.757 -0.656 . . . . 43.34 109.286 178.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.6 p -82.32 126.87 40.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.108 0.48 . . . . 62.42 111.252 -175.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.564 ' HA ' HG22 ' A' ' 9' ' ' THR . 25.7 mp0 -84.66 120.7 26.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 74.41 109.706 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.74 -28.83 36.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.058 -0.519 . . . . 73.22 110.183 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.494 ' O ' ' HA2' ' A' ' 7' ' ' GLY . . . 106.38 170.96 22.98 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.765 -0.652 . . . . 62.31 111.911 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -83.93 83.6 7.88 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.893 -0.41 . . . . 62.22 109.893 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.488 HG12 HG22 ' A' ' 5' ' ' VAL . 9.7 p -67.8 143.04 15.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.018 0.437 . . . . 75.12 110.65 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -77.73 115.51 17.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.818 -0.628 . . . . 63.14 109.795 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.7 p -61.45 -32.04 72.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.274 -0.421 . . . . 75.25 111.318 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.22 -24.34 66.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.515 . . . . 74.24 111.791 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.1 m -76.22 -23.46 54.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.814 0.34 . . . . 74.42 110.939 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -114.17 92.03 3.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.094 0.473 . . . . 71.44 110.225 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.36 19.26 8.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.004 0.431 . . . . 73.25 111.245 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -149.73 138.34 20.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.942 -0.572 . . . . 74.23 110.52 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.6 tm-20 -55.79 124.02 16.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 53.41 109.61 175.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.0 -3.93 38.58 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.961 -0.637 . . . . 61.5 111.962 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -67.42 123.1 19.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.772 0.32 . . . . 74.31 110.554 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.82 ' HB ' HH11 ' A' ' 136' ' ' ARG . 22.9 p -112.72 121.42 44.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.914 -0.585 . . . . 71.4 111.024 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.47 ' HB2' ' H ' ' A' ' 137' ' ' TYR . 60.7 m -73.81 157.48 36.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.177 -0.465 . . . . 73.21 110.458 175.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.4 m -60.66 127.93 34.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.751 -0.463 . . . . 65.22 109.751 175.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.11 154.95 28.96 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.479 0.656 . . . . 65.11 111.749 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 33.1 m -95.58 147.86 5.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 114.859 -1.064 . . . . 64.14 109.451 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.88 103.06 2.35 Favored Glycine 0 C--N 1.309 -0.964 0 C-N-CA 120.899 -0.667 . . . . 34.2 111.858 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -113.82 179.92 3.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.627 -0.509 . . . . 74.32 109.627 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.5 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 3.9 p-10 -138.34 149.94 46.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.424 0.631 . . . . 54.41 112.308 -173.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.461 HD12 ' CE2' ' A' ' 133' ' ' PHE . 81.1 mt -121.42 113.7 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.932 -1.031 . . . . 74.11 108.484 168.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 29.8 tt0 -99.07 136.9 38.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 65.43 111.181 -172.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 78.3 mt -112.04 129.94 56.04 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.825 -0.625 . . . . 74.14 109.811 176.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -102.87 136.52 42.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.915 -0.584 . . . . 63.43 110.535 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 54.49 75.88 0.27 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 124.008 0.818 . . . . 74.4 112.055 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.6 m -97.55 138.81 34.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.652 -0.704 . . . . 34.15 111.18 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -112.57 137.63 50.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.727 -0.67 . . . . 61.22 110.638 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 p -102.25 6.2 40.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.099 -0.5 . . . . 75.41 111.94 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -90.27 -31.12 17.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.663 -0.495 . . . . 51.32 109.663 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 p -98.27 -22.18 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.733 -0.667 . . . . 72.55 111.337 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -141.58 168.42 19.82 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.028 -0.42 . . . . 25.51 111.029 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.543 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 36.9 m -125.7 -51.7 1.59 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.216 0.451 . . . . 54.22 112.216 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.549 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -132.99 150.46 52.16 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.086 -0.383 . . . . 53.14 110.518 -177.028 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.69 130.42 55.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.916 0.389 . . . . 65.14 109.984 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.34 114.84 8.89 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.585 -0.524 . . . . 73.43 109.585 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.759 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -84.2 145.84 7.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 42.31 111.028 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -117.63 116.92 28.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.498 -0.774 . . . . 51.41 109.806 174.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.409 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 65.7 m-85 -85.54 130.12 34.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.325 0.583 . . . . 64.53 110.979 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.9 tp -128.9 116.02 18.77 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.33 -0.85 . . . . 74.21 109.951 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.34 -171.54 20.04 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.201 -0.76 . . . . 62.01 111.201 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.7 m -85.58 116.14 23.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.864 0.332 . . . . 72.01 110.177 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.05 147.68 36.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.45 -0.341 . . . . 72.12 110.845 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.436 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 9.3 tt -63.52 -30.22 49.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.998 -0.546 . . . . 74.22 110.643 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.82 -178.56 5.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 71.01 109.584 174.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.74 -10.23 59.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.038 0.385 . . . . 74.23 112.038 -174.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.53 -44.05 3.27 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.978 -0.629 . . . . 63.13 111.607 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.406 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 60.7 m80 -97.1 61.15 1.74 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.576 0.703 . . . . 74.43 109.373 177.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -76.69 5.46 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.106 -0.952 . . . . 73.11 112.266 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -106.07 -4.82 19.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.478 . . . . 61.5 110.349 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.26 127.77 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.613 . . . . 72.23 110.448 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.477 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -72.25 134.54 45.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.755 -0.461 . . . . 73.4 109.755 178.382 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.14 149.72 33.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.175 -0.466 . . . . 74.13 110.061 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.5 mm? -82.04 133.19 35.27 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.222 -0.444 . . . . 64.24 110.374 -176.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.831 -0.622 . . . . 43.5 110.834 -179.288 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 120.749 0.309 . . . . 71.11 110.696 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.33 109.01 2.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 73.01 110.502 -175.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.37 160.68 14.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.154 -0.475 . . . . 71.14 110.974 -174.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 72.02 9.26 6.06 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.8 -0.636 . . . . 35.35 110.743 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.94 -172.37 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.852 -0.613 . . . . 62.34 110.459 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.31 -176.95 46.66 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.552 -1.019 . . . . 71.21 110.552 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.54 113.35 40.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.361 0.6 . . . . 64.34 110.648 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -102.29 137.58 40.36 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.223 -0.658 . . . . 72.15 109.223 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.409 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -100.42 120.35 49.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.054 0.454 . . . . 70.31 110.349 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.458 HD11 ' HE ' ' A' ' 136' ' ' ARG . 24.9 mt -86.1 145.86 26.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.686 -0.688 . . . . 72.41 109.225 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.528 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.2 OUTLIER -74.68 -171.93 1.4 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.242 -0.436 . . . . 72.54 109.914 177.569 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.457 HH11 ' HD2' ' A' ' 106' ' ' ARG . 19.0 ptt85 -58.49 -27.33 64.35 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.727 0.269 . . . . 71.44 111.727 -177.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 106' ' ' ARG . 19.0 p -100.45 7.96 43.87 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.877 0.37 . . . . 64.32 111.838 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 83.71 28.09 36.44 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 33.35 113.099 175.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.23 120.12 39.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.222 -0.288 . . . . 74.23 110.222 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 115.81 4.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.898 0.38 . . . . 74.52 110.518 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.7 mt -83.71 132.56 34.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.328 -0.396 . . . . 73.34 111.129 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.516 ' H ' HG21 ' A' ' 117' ' ' THR . 15.6 m -73.05 140.45 47.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.723 -0.672 . . . . 74.22 110.547 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.414 ' CD1' HD22 ' A' ' 86' ' ' LEU . 74.2 mt -78.74 49.25 0.88 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.329 0.585 . . . . 74.35 110.504 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -85.67 -27.58 25.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.49 -0.777 . . . . 74.21 109.983 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.34 -22.47 32.39 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.627 -0.715 . . . . 12.25 111.539 -172.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.21 14.63 14.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.757 0.313 . . . . 30.04 111.119 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.516 HG21 ' H ' ' A' ' 112' ' ' THR . 21.6 m -95.24 105.25 17.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.47 -0.567 . . . . 64.35 109.47 174.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 72' ' ' ALA . 86.5 m-85 -97.41 156.29 16.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.225 0.536 . . . . 74.41 111.473 -173.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 7.3 m -68.92 -178.83 1.3 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.392 -0.822 . . . . 72.42 111.143 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.3 t -69.36 156.69 38.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.883 -0.784 . . . . 73.24 108.883 170.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.549 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 51.7 mt-10 -66.06 109.14 2.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.729 0.299 . . . . 72.34 111.476 -175.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.429 ' OG1' ' HD3' ' A' ' 106' ' ' ARG . 22.7 m -89.08 96.82 10.88 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.644 -0.873 . . . . 53.33 108.644 171.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.6 m -60.07 122.05 13.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.911 -0.586 . . . . 73.14 110.903 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.8 mt -81.87 150.45 27.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.423 -0.808 . . . . 60.5 111.16 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -130.68 161.46 31.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.227 -0.657 . . . . 72.15 109.227 169.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -60.35 112.74 2.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 72.54 110.973 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.47 -141.45 13.0 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.766 -0.731 . . . . 71.22 112.595 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.0 m -82.1 131.56 35.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.791 0.329 . . . . 74.2 111.233 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -130.82 114.47 15.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.158 -0.474 . . . . 74.43 109.873 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.5 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 4.7 m -107.04 117.81 35.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.827 0.346 . . . . 61.23 110.267 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.4 mt -94.39 116.8 66.82 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.988 -0.551 . . . . 74.41 110.174 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.59 138.13 10.59 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.033 2.489 . . . . 64.41 111.958 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.461 ' CE2' HD12 ' A' ' 56' ' ' ILE . 74.0 m-85 -135.35 161.77 34.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.365 -0.379 . . . . 62.43 110.53 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.678 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 43.0 mt-30 -127.91 114.65 17.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 53.31 110.802 -175.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.43 132.38 49.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.68 -0.237 . . . . 71.32 110.55 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.82 HH11 ' HB ' ' A' ' 48' ' ' THR . 12.4 ptp180 -143.1 160.07 41.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.967 0.413 . . . . 75.34 111.206 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.47 ' H ' ' HB2' ' A' ' 49' ' ' SER . 73.3 m-85 -80.32 145.83 31.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.776 -0.647 . . . . 74.22 110.553 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.406 ' HE2' ' CD2' ' A' ' 82' ' ' HIS . 64.4 t80 -131.88 118.45 19.84 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.845 -0.616 . . . . 71.34 109.661 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -86.97 132.66 33.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.299 -0.41 . . . . 75.51 111.235 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.496 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 66.0 p -99.14 5.08 47.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.679 0.752 . . . . 65.21 109.424 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 173.14 -117.78 0.67 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.647 -1.16 . . . . 45.32 110.744 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -94.72 98.47 10.8 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.927 -0.397 . . . . 74.33 109.927 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -50.54 123.71 9.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.018 -0.537 . . . . 60.43 110.807 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 39.9 p -116.02 147.62 39.65 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.125 0.488 . . . . 73.32 110.686 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -64.31 163.18 27.35 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.668 2.912 . . . . 73.25 112.553 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.59 -164.43 27.39 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.645 -0.788 . . . . 61.22 112.065 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -85.35 115.1 22.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.65 0.262 . . . . 70.3 110.459 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -108.48 55.15 0.64 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.138 0.494 . . . . 64.42 111.323 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -105.13 138.98 40.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.062 -0.517 . . . . 73.33 109.895 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.477 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -140.63 179.69 6.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.932 0.396 . . . . 72.25 111.773 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -143.95 137.1 27.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.621 -0.718 . . . . 75.41 109.71 -178.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.36 139.84 21.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.892 0.377 . . . . 72.22 111.271 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 30.5 p -103.71 132.28 50.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.195 -0.457 . . . . 51.41 109.899 176.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -107.39 124.05 49.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.104 0.478 . . . . 63.2 110.391 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.619 ' HA ' HG21 ' A' ' 16' ' ' VAL . 3.0 tmmm? -105.62 99.39 8.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.921 -0.581 . . . . 75.24 109.492 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.765 HG22 HG21 ' A' ' 17' ' ' VAL . 1.4 m -74.84 127.96 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.64 0.733 . . . . 73.42 110.178 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -103.67 108.61 19.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.525 -0.761 . . . . 73.44 111.009 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.571 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 2.5 p90 . . . . . 0 C--N 1.319 -0.735 0 N-CA-C 109.017 -0.734 . . . . 73.02 109.017 166.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 120.51 0.195 . . . . 73.33 110.513 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.73 174.57 3.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.42 . . . . 44.34 110.921 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.7 t -98.68 -4.76 33.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.935 0.398 . . . . 75.53 111.123 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.417 ' CB ' ' HB3' ' A' ' 36' ' ' GLN . 80.4 p -116.97 173.01 6.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.927 0.394 . . . . 74.22 110.682 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 37' ' ' VAL . 27.7 m -86.86 16.65 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.05 0.452 . . . . 75.53 111.083 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 61.93 13.12 5.32 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.566 -0.743 . . . . 71.11 112.211 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.483 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 91.14 101.26 1.25 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.558 -0.829 . . . . 63.42 111.785 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.65 160.19 25.29 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.431 -0.89 . . . . 71.34 111.777 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 33' ' ' GLN . 66.4 p -143.3 149.17 37.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.883 0.373 . . . . 41.32 110.637 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.518 HG22 HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -123.67 117.86 52.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.997 -0.547 . . . . 72.23 110.503 175.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -95.72 112.51 24.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.399 -0.818 . . . . 61.0 110.118 -177.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 59.4 m-85 -94.39 137.29 33.72 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.812 -0.631 . . . . 65.23 110.562 -177.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.598 ' HZ3' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -114.58 137.62 51.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.973 -0.558 . . . . 62.33 110.301 -179.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.21 -133.41 4.06 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.759 -0.734 . . . . 60.23 112.504 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 49.2 mt-10 60.65 21.27 11.19 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.212 0.53 . . . . 62.1 111.115 -178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.56 HG21 ' HA ' ' A' ' 155' ' ' LYS . 24.8 m -76.32 -23.81 15.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.748 -0.66 . . . . 75.11 111.132 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.428 HG21 ' CG2' ' A' ' 156' ' ' VAL . 24.1 m -135.71 148.28 28.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.126 -0.488 . . . . 35.31 111.361 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -151.31 26.73 0.68 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.502 -0.925 . . . . 54.42 108.502 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.36 -79.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.115 -0.948 . . . . 54.21 111.408 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.468 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -84.73 -37.53 20.77 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.859 0.361 . . . . 71.32 110.858 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -140.7 132.46 27.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.141 -0.481 . . . . 74.04 109.873 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.58 123.21 37.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.254 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 t -66.44 133.33 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.862 -0.422 . . . . 71.24 109.862 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 28' ' ' VAL . 19.2 t70 -62.05 147.96 45.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 72.22 111.043 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -62.25 -25.39 67.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 74.55 111.783 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 30' ' ' GLN . . . -86.13 -9.76 76.18 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.589 -0.815 . . . . 71.35 111.627 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.0 m -105.23 -23.25 12.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.465 0.174 . . . . 40.34 111.124 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 25.5 m -77.56 -12.18 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.335 0.588 . . . . 74.25 110.215 176.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -153.58 96.01 1.97 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.964 -1.016 . . . . 71.43 109.217 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 26' ' ' GLY . 24.9 pt20 -148.34 142.81 26.38 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.01 -0.541 . . . . 74.54 110.421 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.506 HG22 ' HB ' ' A' ' 9' ' ' THR . 6.9 m -124.0 101.3 7.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.628 -0.714 . . . . 72.45 109.649 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.18 129.22 39.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.088 0.47 . . . . 75.45 110.407 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.515 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.2 mp0 -85.63 130.57 34.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.698 -0.683 . . . . 63.41 110.245 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.518 HD21 HG22 ' A' ' 10' ' ' VAL . 2.3 mm? -91.27 -17.08 26.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.152 -0.476 . . . . 64.35 110.109 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.483 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 86.58 174.87 49.47 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.939 -0.648 . . . . 72.14 112.476 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' HB3' ' CB ' ' A' ' 4' ' ' THR . 81.2 mt-30 -77.36 89.11 3.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.137 -0.32 . . . . 74.25 110.137 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.459 HG12 HG22 ' A' ' 5' ' ' VAL . 9.9 p -68.49 144.67 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.804 -0.443 . . . . 53.4 109.804 176.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 38' ' ' ARG . 44.3 mtp180 -85.31 123.75 31.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.899 -0.408 . . . . 73.02 109.899 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 35.6 p -68.7 -23.22 64.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.169 -0.469 . . . . 65.54 111.456 -176.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.98 -15.71 61.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 63.23 111.066 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.8 m -87.92 -12.7 43.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.323 -0.398 . . . . 70.34 110.731 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -129.02 84.75 2.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.225 -0.443 . . . . 65.43 110.089 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.37 19.58 12.71 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.704 -0.399 . . . . 42.41 111.849 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -150.04 140.21 22.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.702 0.287 . . . . 65.32 110.774 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 3.9 tm-20 -56.12 117.96 4.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.714 -0.676 . . . . 65.02 109.478 174.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.35 -1.09 31.03 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.756 -0.735 . . . . 52.21 112.345 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -74.15 134.4 42.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 73.02 110.708 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.2 p -119.7 145.83 46.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.21 -0.45 . . . . 74.32 110.934 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 t -110.23 -179.23 3.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.307 -0.406 . . . . 61.54 110.08 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.8 m -70.57 140.74 51.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.346 -0.388 . . . . 60.02 110.255 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -95.58 155.79 16.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.455 0.645 . . . . 73.41 111.936 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.7 m -95.61 152.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.485 -1.234 . . . . 73.33 109.265 170.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.23 79.63 0.26 Allowed Glycine 0 C--N 1.312 -0.793 0 C-N-CA 120.795 -0.717 . . . . 32.34 112.315 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 133' ' ' PHE . 41.8 p90 -87.83 162.48 16.95 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.807 -0.442 . . . . 75.24 109.807 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.522 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.8 p-10 -132.05 142.55 49.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.258 0.551 . . . . 51.51 111.733 -174.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.5 mt -106.62 109.14 27.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.604 -0.725 . . . . 75.23 109.305 172.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -89.33 136.22 33.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.197 0.523 . . . . 74.24 111.111 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.38 124.66 49.43 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.494 -0.776 . . . . 52.2 109.18 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -100.56 130.64 46.65 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.974 -0.38 . . . . 74.1 109.974 -176.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.8 t70 54.92 74.61 0.35 Allowed 'General case' 0 C--N 1.332 -0.189 0 O-C-N 124.0 0.813 . . . . 73.22 110.619 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 38.3 t -102.28 124.06 47.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.228 -0.896 . . . . 75.02 110.066 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -98.33 137.41 37.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.21 -0.45 . . . . 72.53 111.555 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.442 HG22 ' HB2' ' A' ' 124' ' ' LEU . 64.1 p -110.09 18.97 19.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 44.32 112.071 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -98.96 -26.51 14.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.458 -0.571 . . . . 34.04 109.458 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 20' ' ' ALA . 8.8 p -109.0 -2.3 10.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 72.33 110.251 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.754 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -144.21 179.16 7.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 73.3 110.462 178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.7 m -141.2 -56.86 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.709 0.29 . . . . 75.43 111.297 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -136.2 143.09 44.19 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.756 -0.461 . . . . 64.24 109.756 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.495 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -102.65 123.49 46.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.072 0.463 . . . . 51.32 110.445 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.55 115.15 16.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.633 -0.712 . . . . 74.45 109.606 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 156' ' ' VAL . 3.3 m -91.53 149.8 3.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.137 0.494 . . . . 63.34 111.282 -173.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -116.08 118.61 33.36 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.726 -0.67 . . . . 73.11 109.904 174.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.522 ' CE1' HG21 ' A' ' 103' ' ' ILE . 49.2 m-85 -87.96 124.14 33.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.19 0.519 . . . . 74.13 110.993 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 56.4 tp -114.97 125.77 54.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.571 -0.74 . . . . 60.22 109.38 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.433 ' H ' ' HB3' ' A' ' 113' ' ' LEU . . . -158.66 -179.56 33.6 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.037 -0.825 . . . . 74.43 111.037 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 m -67.5 120.26 13.65 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.785 0.293 . . . . 75.23 110.778 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.49 132.55 35.71 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.972 -0.381 . . . . 73.55 109.972 175.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.484 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 7.3 tt -73.78 -25.66 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.017 0.437 . . . . 73.22 110.941 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 19.1 t70 -159.54 174.53 14.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.423 -0.584 . . . . 75.45 109.423 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.06 -33.15 44.88 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.167 0.508 . . . . 62.32 109.974 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.98 -0.58 80.87 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.216 -0.753 . . . . 51.31 111.216 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 53.5 m80 -131.37 43.35 3.09 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.938 -0.631 . . . . 74.24 109.958 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 p -71.65 -2.06 15.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 72.14 110.984 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 33.6 p-10 -104.02 9.6 36.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.97 -0.559 . . . . 61.34 110.334 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 t -120.36 123.22 70.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.858 -0.61 . . . . 71.32 110.174 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.494 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -68.46 124.58 23.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.158 -0.682 . . . . 73.12 109.158 177.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.0 150.31 33.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.887 -0.597 . . . . 50.51 109.846 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.515 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.5 mm? -78.2 126.23 30.49 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.227 -0.657 . . . . 61.43 109.227 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.592 ' HG2' ' HA ' ' A' ' 150' ' ' ALA . 14.1 mm100 -59.73 120.26 9.18 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.639 0.733 . . . . 64.43 109.752 -178.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.466 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 0.7 OUTLIER -85.45 109.08 18.21 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.793 -1.094 . . . . 65.34 110.682 -173.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.5 m -93.96 2.03 56.18 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.68 -0.691 . . . . 65.01 110.315 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 59.54 19.81 8.3 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.8 -0.636 . . . . 65.11 111.32 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.51 10.38 11.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.067 -0.515 . . . . 74.33 110.322 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 111.58 63.67 0.49 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.693 -0.765 . . . . 72.21 112.255 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 90' ' ' SER . 70.9 m -83.68 160.79 21.26 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.862 -0.422 . . . . 72.44 109.862 175.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.05 152.63 29.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.244 -0.28 . . . . 75.41 110.244 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.57 164.09 30.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.613 -0.435 . . . . 65.4 111.208 -177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 66.48 16.5 10.43 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.583 -0.735 . . . . 63.23 111.104 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.408 ' O ' HD12 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -147.79 -175.07 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 63.21 110.559 175.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -179.68 -167.15 36.49 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.067 -1.213 . . . . 74.24 110.067 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' A' ' 86' ' ' LEU . 2.3 p -135.8 129.35 48.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.724 0.774 . . . . 74.14 110.847 -177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -110.54 138.78 46.48 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.132 -0.94 . . . . 64.51 110.322 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.522 HG21 ' CE1' ' A' ' 73' ' ' PHE . 3.9 mp -95.02 114.66 32.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.023 -0.732 . . . . 64.32 109.023 173.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 57.5 mt -85.55 128.0 34.61 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.724 -0.671 . . . . 63.1 110.331 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.685 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 2.8 t70 -57.42 166.34 1.26 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 64.23 110.406 174.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 106' ' ' ARG . 13.4 ptm180 -58.94 -17.5 25.07 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.386 0.514 . . . . 74.23 112.386 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.1 p -92.08 -7.67 48.01 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.836 0.35 . . . . 64.21 111.512 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.66 48.06 3.29 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.868 -0.682 . . . . 70.43 112.319 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -134.04 134.13 42.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.839 -0.212 . . . . 63.53 110.82 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.01 131.98 48.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.613 0.244 . . . . 73.35 110.911 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.549 HD21 ' HB2' ' A' ' 105' ' ' ASP . 84.9 mt -94.57 134.21 37.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.969 0.414 . . . . 74.14 111.283 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 82.0 m -73.45 134.43 43.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.789 -0.641 . . . . 73.14 110.715 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 43.5 mt -81.08 50.59 1.43 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.478 0.656 . . . . 74.21 110.731 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.428 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 13.9 t70 -90.11 -19.9 23.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.224 -0.898 . . . . 74.11 110.787 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.47 -28.76 6.63 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.776 -0.725 . . . . 43.21 112.349 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.75 4.07 21.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.903 0.382 . . . . 74.21 111.006 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 114' ' ' ASP . 26.9 m -90.86 99.83 12.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.382 -0.372 . . . . 70.13 110.1 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.656 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 63.1 m-85 -90.04 157.47 17.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.173 -0.467 . . . . 70.54 111.152 -175.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.685 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . 5.4 m -73.72 -167.24 0.44 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.649 -0.705 . . . . 51.23 111.255 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.9 m -80.98 178.41 8.44 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.875 0.369 . . . . 62.41 111.067 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.542 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 38.1 mt-10 -75.09 105.67 6.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.079 -0.51 . . . . 64.31 111.573 -176.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.537 HG21 HG12 ' A' ' 131' ' ' ILE . 88.4 m -87.32 99.46 12.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.819 -0.808 . . . . 74.21 108.819 168.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.3 m -56.91 114.86 2.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.851 -0.613 . . . . 73.21 110.653 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.524 ' C ' HD22 ' A' ' 125' ' ' ASN . 97.5 mt -79.89 146.43 32.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.664 -0.698 . . . . 63.34 110.965 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.524 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -123.06 149.06 44.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.829 -0.804 . . . . 44.34 108.829 174.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 94.6 m-20 -68.52 95.99 0.67 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.964 0.412 . . . . 73.32 110.694 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 146.99 -141.05 9.05 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.998 -0.62 . . . . 73.41 111.8 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.452 ' C ' HD22 ' A' ' 129' ' ' ASN . 29.1 m -81.58 124.71 29.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.001 0.429 . . . . 62.22 110.257 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.481 HD22 ' N ' ' A' ' 129' ' ' ASN . 0.9 OUTLIER -119.8 160.2 23.08 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.321 -0.622 . . . . 54.14 109.321 177.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -149.06 126.57 11.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.24 -0.281 . . . . 75.34 110.24 177.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.537 HG12 HG21 ' A' ' 122' ' ' THR . 9.2 mt -104.23 109.41 62.52 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.937 -0.394 . . . . 61.14 109.937 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -88.6 127.31 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.821 2.347 . . . . 72.04 112.904 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 54' ' ' PHE . 73.6 m-85 -124.9 167.31 14.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.1 -0.5 . . . . 74.22 110.266 178.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.66 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 99.4 mt-30 -124.27 122.14 36.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.923 0.392 . . . . 74.01 111.1 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.85 123.03 47.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.376 -0.375 . . . . 71.45 110.403 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.514 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 5.7 ptp180 -137.86 161.2 37.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.537 -0.301 . . . . 74.53 110.96 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 63.2 m-85 -80.55 147.15 30.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.987 -0.552 . . . . 74.21 111.204 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -134.38 122.48 22.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.392 -0.822 . . . . 73.51 109.003 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.639 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -86.98 135.36 33.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.91 0.386 . . . . 44.23 111.63 -176.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.573 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 34.8 p -109.45 14.72 23.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.712 0.768 . . . . 62.5 109.228 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.17 -132.05 2.51 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 114.722 -1.126 . . . . 52.01 110.293 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.78 100.59 12.77 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.879 -0.786 . . . . 72.13 108.879 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.593 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.47 114.92 0.83 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.013 0.82 . . . . 64.42 110.848 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.6 p -105.63 143.15 26.25 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 116.281 -0.418 . . . . 63.01 110.198 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.84 158.15 58.6 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.165 2.577 . . . . 71.02 112.821 -174.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.84 -174.38 24.98 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.55 -0.75 . . . . 51.43 111.364 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.93 103.84 2.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.968 0.413 . . . . 61.34 111.144 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.515 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -99.68 66.13 1.39 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.238 0.542 . . . . 74.5 110.535 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -119.88 136.88 54.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.867 -0.606 . . . . 61.43 109.814 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.592 ' HA ' ' HG2' ' A' ' 89' ' ' GLN . . . -136.25 163.63 29.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.083 0.468 . . . . 31.42 111.837 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -123.08 135.24 54.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.541 -0.754 . . . . 74.14 109.559 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 12' ' ' PHE . . . -141.52 129.72 22.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.049 0.452 . . . . 71.33 111.275 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 13' ' ' LYS . 49.1 p -106.6 125.5 51.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.136 -0.484 . . . . 71.11 109.921 175.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -105.46 136.49 44.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.168 0.508 . . . . 72.3 111.343 -176.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.656 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 10.1 ttmm -113.05 106.45 14.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.645 -0.707 . . . . 54.22 110.213 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -74.56 141.53 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.199 -0.6 . . . . 62.53 109.573 178.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' A' ' 157' ' ' GLN . 4.1 tt0 -125.79 115.73 20.48 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.164 -0.471 . . . . 64.23 109.789 175.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.754 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 1.3 p90 -129.22 -16.77 3.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.465 0.65 . . . . 73.21 110.324 173.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--O 1.248 1.007 0 CA-C-N 115.13 -0.941 . . . . 63.33 109.109 167.646 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 110.09 -0.337 . . . . 73.32 110.09 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.52 148.03 43.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.082 -0.34 . . . . 75.5 110.082 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 t -77.82 -13.11 59.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.984 0.421 . . . . 71.32 111.367 -176.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.8 p -91.2 173.45 7.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.78 0.324 . . . . 72.11 110.277 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.441 HG22 HG12 ' A' ' 37' ' ' VAL . 35.7 m -86.47 14.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.093 0.473 . . . . 64.12 111.053 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 62.81 13.95 6.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.452 -0.794 . . . . 72.51 112.359 175.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.505 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 92.42 89.39 1.51 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.673 -0.775 . . . . 65.34 111.82 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.75 158.13 48.2 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.691 -0.766 . . . . 44.1 112.072 -177.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.577 ' HB ' HG22 ' A' ' 31' ' ' THR . 12.9 p -141.4 139.66 33.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.571 0.224 . . . . 64.33 110.904 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -114.33 120.05 63.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.512 -0.551 . . . . 71.32 109.512 174.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -86.17 102.91 14.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.732 -0.47 . . . . 72.0 109.732 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -92.55 105.43 17.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 75.15 109.776 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 50.3 tttp -106.31 136.43 46.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.012 -0.54 . . . . 75.54 110.149 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.45 -112.81 2.44 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.874 -0.679 . . . . 71.51 112.111 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.585 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 28.0 mt-10 61.09 22.72 12.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.25 0.548 . . . . 71.43 110.685 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.645 HG21 ' HA ' ' A' ' 155' ' ' LYS . 19.1 m -77.72 -27.28 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.311 -0.859 . . . . 71.02 111.798 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.65 145.11 34.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.209 0.528 . . . . 65.24 111.821 -174.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -159.65 84.11 0.75 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.911 -1.04 . . . . 74.23 108.236 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.35 -79.1 0.1 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.571 -0.741 . . . . 73.12 110.947 -172.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.524 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -76.76 -33.12 58.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.293 0.568 . . . . 75.34 109.642 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.6 m -141.73 173.64 11.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.327 -0.851 . . . . 54.34 109.165 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.09 123.81 27.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.683 -0.488 . . . . 71.22 109.683 173.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.7 t -66.14 128.82 29.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.644 -0.502 . . . . 73.25 109.644 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.468 ' O ' HG13 ' A' ' 28' ' ' VAL . 28.8 t70 -60.7 138.02 58.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.99 -0.55 . . . . 73.1 111.203 -176.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.554 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -59.35 -24.94 63.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.822 -0.627 . . . . 75.41 112.126 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.91 -13.14 83.42 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.581 -0.819 . . . . 71.21 112.229 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.8 p -112.43 -9.83 13.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.714 0.264 . . . . 73.4 111.714 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.3 m -86.35 -1.5 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 122.361 -0.212 . . . . 75.23 111.486 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -156.82 42.27 0.35 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.438 0.637 . . . . 73.53 109.552 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -91.98 123.64 35.49 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.491 -0.777 . . . . 72.12 110.127 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.577 HG22 ' HB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -109.84 95.26 5.48 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.525 -0.761 . . . . 42.54 109.606 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.1 p -81.64 130.06 36.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.984 -0.553 . . . . 63.15 111.28 -174.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -83.94 118.97 24.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.711 -0.677 . . . . 54.13 109.933 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.457 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.6 mm? -79.13 -22.49 45.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.347 0.594 . . . . 71.32 109.468 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.22 175.92 39.12 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.384 -0.826 . . . . 70.05 111.78 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -78.63 83.95 4.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.441 -0.207 . . . . 72.41 110.441 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.441 HG12 HG22 ' A' ' 5' ' ' VAL . 8.8 p -66.52 140.28 19.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.471 -0.566 . . . . 60.44 109.471 176.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -86.19 117.83 25.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.216 0.532 . . . . 74.34 109.838 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.623 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 26.7 p -65.75 -21.98 66.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 70.14 111.5 -174.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.56 -17.28 64.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.913 -0.585 . . . . 50.41 111.118 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.7 m -84.02 -14.15 51.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 74.31 111.138 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -123.63 94.49 4.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.925 0.393 . . . . 73.23 109.977 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.39 10.96 10.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.651 0.612 . . . . 44.04 112.651 -170.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -150.04 146.31 26.9 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.873 -0.331 . . . . 64.1 110.851 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -56.35 122.53 12.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.718 -0.674 . . . . 74.02 109.64 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.42 -7.0 32.07 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.646 -0.788 . . . . 72.42 112.272 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -70.61 119.09 14.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 54.45 110.697 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 p -113.31 130.64 56.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.016 -0.538 . . . . 74.54 110.158 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.5 t -89.98 175.47 7.17 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.977 -0.379 . . . . 74.12 109.977 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.1 m -70.77 136.79 49.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.791 -0.448 . . . . 72.22 109.791 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -89.08 159.69 17.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.526 0.679 . . . . 71.4 112.161 -173.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.1 m -91.31 152.42 3.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.715 -1.13 . . . . 71.34 109.552 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.0 106.13 2.44 Favored Glycine 0 C--N 1.312 -0.759 0 C-N-CA 121.095 -0.574 . . . . 71.52 112.076 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -122.77 170.28 10.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.346 -0.613 . . . . 74.31 109.346 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.466 HD22 ' C ' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -135.89 149.93 49.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.449 0.642 . . . . 70.33 112.454 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.0 mt -103.54 119.79 52.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.369 -0.832 . . . . 64.03 109.129 171.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -102.85 132.28 49.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.095 0.474 . . . . 71.53 111.187 -172.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.2 mt -115.31 124.7 51.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.902 -0.59 . . . . 75.32 109.757 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -98.95 132.67 44.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.166 -0.47 . . . . 62.0 110.355 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.3 t70 55.65 76.45 0.27 Allowed 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.918 0.762 . . . . 75.31 110.807 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.58 146.96 23.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.286 -0.87 . . . . 74.01 111.282 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -116.92 129.69 56.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.476 -0.784 . . . . 74.55 110.849 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.1 p -105.96 16.71 24.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.283 -0.417 . . . . 65.0 111.791 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -92.24 -32.93 14.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.086 0.469 . . . . 73.44 109.92 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.413 ' CG2' HE22 ' A' ' 159' ' ' GLN . 14.2 p -105.96 -33.67 2.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.154 -0.476 . . . . 65.12 110.692 176.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -103.81 178.61 4.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 55.33 110.643 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.487 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 18.5 m -140.19 -56.9 0.54 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.868 0.366 . . . . 73.21 111.049 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.487 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -135.89 154.82 51.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.343 -0.614 . . . . 73.22 109.343 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.496 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -111.26 133.64 53.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.084 0.468 . . . . 72.12 110.104 176.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.01 117.62 9.79 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.623 -0.717 . . . . 63.5 109.622 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.681 HG12 HG12 ' A' ' 156' ' ' VAL . 1.2 m -90.88 147.24 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.085 0.469 . . . . 54.34 111.226 -174.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.2 123.58 41.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.542 -0.754 . . . . 43.22 109.207 172.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 80.1 m-85 -85.59 135.11 33.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.024 0.44 . . . . 75.4 110.577 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.1 tp -133.49 118.69 18.63 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.807 -0.633 . . . . 64.12 110.308 -176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.42 -168.88 29.28 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.131 -0.788 . . . . 64.0 111.131 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -81.48 118.96 23.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.83 0.315 . . . . 73.33 111.006 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -77.16 141.77 39.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.251 -0.431 . . . . 74.33 110.366 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 85' ' ' VAL . 5.1 tt -68.11 -32.47 56.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.282 -0.417 . . . . 73.02 111.18 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -148.64 175.03 11.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.527 -0.306 . . . . 75.23 110.181 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.59 -33.61 35.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.886 -0.597 . . . . 74.42 110.513 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.58 -14.93 59.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.55 -0.833 . . . . 74.04 111.77 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -114.21 57.71 0.7 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.28 0.562 . . . . 53.13 109.574 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.428 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.4 p -77.15 8.5 3.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.382 -0.826 . . . . 70.3 112.474 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.416 ' OD1' HG23 ' A' ' 85' ' ' VAL . 23.4 p30 -108.55 -8.82 15.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.979 0.418 . . . . 75.41 110.802 177.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.489 ' HB ' HG22 ' A' ' 78' ' ' ILE . 48.5 t -98.76 122.56 50.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.459 . . . . 41.12 110.983 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.472 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -70.39 134.46 47.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 74.42 109.84 177.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.44 152.07 32.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.165 -0.471 . . . . 70.03 110.571 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.466 HD22 ' H ' ' A' ' 88' ' ' LEU . 1.9 mm? -78.02 138.45 38.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.232 -0.44 . . . . 70.33 110.391 -177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -61.15 129.43 41.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.083 -0.508 . . . . 70.31 110.211 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -74.85 107.21 6.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.857 -0.611 . . . . 74.05 111.614 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.8 m -87.03 -10.23 53.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.101 -0.499 . . . . 64.43 109.89 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 62.6 22.39 13.28 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.13 -0.941 . . . . 64.12 111.89 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.08 -39.24 0.41 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.758 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.48 74.04 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.393 -0.908 . . . . 53.32 112.777 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.3 m -91.22 154.45 19.29 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.919 -0.4 . . . . 71.41 109.919 175.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.432 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -71.68 153.01 42.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.69 -0.485 . . . . 64.41 109.69 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.44 161.22 38.97 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.612 -0.435 . . . . 72.43 111.025 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 66.45 13.33 9.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.916 -0.584 . . . . 74.04 110.748 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.49 179.76 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.773 -0.649 . . . . 73.11 110.177 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -179.83 -173.43 44.85 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.209 -1.157 . . . . 64.51 110.209 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.9 p -121.9 120.03 60.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.281 0.562 . . . . 73.43 110.935 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.456 ' HG2' ' HB2' ' A' ' 138' ' ' PHE . 1.5 pt20 -108.69 150.19 27.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.819 -0.628 . . . . 72.31 109.823 176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.446 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.3 mp -111.45 128.1 68.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.181 0.515 . . . . 64.34 110.502 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 13.4 mt -92.93 143.22 26.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.383 -0.826 . . . . 64.34 109.431 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.545 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.0 OUTLIER -70.46 -176.72 1.3 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.287 -0.634 . . . . 53.22 109.287 174.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -64.45 -20.63 66.3 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.197 -0.314 . . . . 73.41 111.708 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.414 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 40.0 p -98.46 6.5 47.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 72.3 111.457 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.76 28.7 28.46 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.972 -0.632 . . . . 73.1 113.464 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.18 128.02 53.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.894 0.347 . . . . 65.33 110.553 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.09 119.05 11.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.859 0.361 . . . . 54.42 110.704 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.6 mt -85.86 129.72 34.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.037 0.446 . . . . 72.43 111.199 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.457 ' H ' HG21 ' A' ' 117' ' ' THR . 78.7 m -73.18 140.65 47.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.623 -0.717 . . . . 74.04 110.557 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 45.4 mt -80.07 40.29 0.47 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.542 . . . . 61.01 111.301 -176.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -81.14 -23.23 38.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.162 0.506 . . . . 73.24 110.278 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.04 -13.54 66.7 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.789 -0.642 . . . . 33.14 111.973 -173.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.9 1.84 11.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.787 0.327 . . . . 74.42 111.728 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.457 HG21 ' H ' ' A' ' 112' ' ' THR . 4.3 m -86.91 88.06 7.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.086 0.47 . . . . 41.22 110.088 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -83.18 152.63 25.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.864 -0.607 . . . . 73.0 111.199 -175.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.9 m -67.82 -179.1 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.742 -0.663 . . . . 64.35 111.431 175.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.6 p -68.65 152.9 44.73 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.316 -0.402 . . . . 30.21 110.377 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.34 107.13 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 75.4 111.543 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 m -94.1 103.5 15.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.356 -0.609 . . . . 62.41 109.356 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.8 m -57.16 122.38 12.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.723 -0.671 . . . . 73.35 111.21 -175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 69' ' ' ALA . 61.9 mt -78.38 142.32 37.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.128 -0.487 . . . . 70.04 111.077 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.84 148.68 39.66 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.057 -0.72 . . . . 65.54 109.057 170.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -65.37 111.78 3.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.816 0.341 . . . . 75.22 110.256 176.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 134.56 -126.82 4.26 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.576 -0.61 . . . . 62.52 111.576 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.2 m -108.77 132.44 53.97 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.848 0.356 . . . . 74.22 110.879 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -127.46 131.46 50.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.35 -0.386 . . . . 61.35 110.592 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.99 115.71 25.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.817 0.341 . . . . 72.1 111.146 176.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mt -93.26 110.71 48.19 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.128 -0.693 . . . . 73.01 109.128 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.31 130.83 7.32 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.467 2.111 . . . . 74.41 112.673 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 73.0 m-85 -129.39 166.36 19.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.067 0.461 . . . . 75.41 111.267 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.627 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 47.6 mt-30 -130.0 124.45 32.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.654 -0.703 . . . . 73.11 110.766 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.64 126.29 54.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.102 -0.332 . . . . 42.53 110.102 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.545 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 6.9 ptp180 -136.72 161.4 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.901 0.381 . . . . 71.13 111.32 -176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 60.5 m-85 -82.04 146.09 29.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 75.4 111.074 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.456 ' HB2' ' HG2' ' A' ' 102' ' ' GLN . 61.1 t80 -132.08 126.71 34.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.49 -0.777 . . . . 74.03 109.178 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.648 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -92.73 135.98 33.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.81 0.338 . . . . 54.41 111.443 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 51.0 p -103.88 0.36 30.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.486 0.66 . . . . 64.32 109.552 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.05 -122.56 0.91 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.124 -0.943 . . . . 74.11 111.302 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.63 94.5 9.43 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.945 -0.391 . . . . 72.42 109.945 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.623 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -47.58 118.99 2.48 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.507 0.504 . . . . 73.34 111.197 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.2 p -112.79 143.89 29.93 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.171 -0.468 . . . . 64.22 110.708 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.12 174.19 8.33 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.714 2.943 . . . . 53.01 113.278 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.73 -168.35 19.76 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.715 -0.755 . . . . 71.5 111.709 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.38 109.44 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 63.45 110.889 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.402 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . . . -108.37 52.77 0.7 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.656 0.741 . . . . 62.42 109.766 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -108.65 138.24 45.28 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.968 -1.014 . . . . 73.01 109.669 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -144.12 169.38 17.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.42 -0.355 . . . . 62.41 110.101 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.99 144.86 30.37 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.947 -0.39 . . . . 52.31 109.947 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.416 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -152.32 146.12 25.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.081 -0.509 . . . . 70.41 110.705 -177.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 13' ' ' LYS . 36.0 p -97.5 128.46 44.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.197 -0.456 . . . . 72.23 109.973 176.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -96.42 127.93 42.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.327 0.584 . . . . 73.32 110.042 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.645 ' HA ' HG21 ' A' ' 16' ' ' VAL . 1.8 tmtm? -111.4 100.26 8.89 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.714 -0.676 . . . . 63.21 109.832 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.681 HG12 HG12 ' A' ' 71' ' ' VAL . 1.5 m -77.45 144.3 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.145 0.498 . . . . 70.24 110.471 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 7.3 tt0 -115.02 120.5 40.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.0 -0.546 . . . . 74.42 110.637 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.579 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 9.8 p90 -158.09 -30.6 0.08 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.734 0.646 . . . . 73.51 109.494 170.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.413 HE22 ' CG2' ' A' ' 65' ' ' VAL . 24.9 tp60 . . . . . 0 C--O 1.247 0.972 0 CA-C-N 115.212 -0.904 . . . . 71.34 109.974 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 120.849 0.357 . . . . 61.01 110.321 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.28 172.31 6.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.499 -0.319 . . . . 71.54 111.197 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.4 t -87.93 -7.36 57.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.541 0.686 . . . . 65.43 110.595 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.7 p -112.71 -176.09 2.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.979 -0.555 . . . . 74.42 110.427 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.405 ' HB ' ' CB ' ' A' ' 148' ' ' ALA . 35.0 m -87.95 15.05 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.129 0.49 . . . . 72.33 110.399 175.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 62.41 23.51 13.95 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.314 -0.857 . . . . 74.33 112.358 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.486 ' N ' ' HG2' ' A' ' 36' ' ' GLN . . . 77.69 88.13 0.38 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.389 -0.91 . . . . 75.32 111.625 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.17 156.27 46.92 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.566 -0.826 . . . . 71.05 111.998 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.578 ' HB ' HG22 ' A' ' 31' ' ' THR . 5.2 p -142.7 137.18 29.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.559 0.219 . . . . 70.22 110.845 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -111.69 121.36 64.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.602 -0.518 . . . . 52.23 109.602 175.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -88.11 98.42 11.53 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.041 0.448 . . . . 51.52 109.818 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.463 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 61.8 m-85 -88.44 118.35 28.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.927 -0.579 . . . . 72.12 110.044 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 78.3 tttt -112.65 145.28 40.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.384 -0.371 . . . . 63.13 110.486 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -122.66 -116.25 2.32 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.898 -0.667 . . . . 74.15 112.523 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.546 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 93.0 mt-10 64.05 17.7 10.77 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.841 0.457 . . . . 71.3 111.347 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 155' ' ' LYS . 31.0 m -76.85 -28.51 17.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.088 -0.505 . . . . 71.21 111.712 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.515 HG21 ' CG2' ' A' ' 156' ' ' VAL . 17.1 m -137.38 141.41 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.098 0.475 . . . . 63.12 111.973 -176.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -140.39 21.2 2.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.019 -0.992 . . . . 64.33 108.559 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.18 -76.55 0.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.368 -0.833 . . . . 50.21 111.495 -172.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.531 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -88.84 -33.28 17.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.856 0.36 . . . . 73.1 110.751 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -146.09 128.42 15.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.131 -0.486 . . . . 52.41 109.819 -177.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.29 128.56 36.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.321 -0.399 . . . . 73.43 110.29 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 28' ' ' VAL . 3.6 t -72.5 128.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.019 -0.363 . . . . 74.52 110.019 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.444 ' O ' HG13 ' A' ' 28' ' ' VAL . 16.0 t70 -58.71 142.55 49.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 64.03 111.09 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -59.69 -27.09 66.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.989 -0.551 . . . . 73.13 112.073 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.08 -19.11 73.17 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.59 -0.814 . . . . 41.42 112.066 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.9 p -102.94 -16.04 15.97 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.15 -0.22 . . . . 54.14 111.458 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 25' ' ' ALA . 27.4 m -81.51 -2.85 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.954 0.407 . . . . 74.3 110.313 175.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -158.34 87.67 0.91 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.402 -0.962 . . . . 71.14 108.402 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.463 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 16.0 pt20 -134.9 98.09 3.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.517 0.675 . . . . 63.25 110.804 -176.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.578 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.5 m -82.07 94.53 7.22 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.151 -0.931 . . . . 70.15 109.279 174.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.7 p -81.72 130.86 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.9 -0.591 . . . . 64.15 111.187 -174.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.432 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.7 mp0 -85.9 127.31 34.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.895 -0.593 . . . . 72.42 110.15 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.91 -30.44 17.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.303 0.573 . . . . 65.43 109.737 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.437 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 100.23 167.85 29.09 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.485 -0.779 . . . . 65.43 111.706 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.486 ' HG2' ' N ' ' A' ' 7' ' ' GLY . 60.4 mt-30 -79.27 86.77 5.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.071 0.462 . . . . 73.34 110.841 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.34 145.96 12.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 71.4 109.875 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -83.39 126.78 33.09 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.362 -0.607 . . . . 74.33 109.362 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.629 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 24.4 p -68.55 -25.02 64.7 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.048 -0.523 . . . . 73.34 111.315 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.49 -10.47 58.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.075 -0.511 . . . . 55.35 111.409 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.8 m -86.94 -7.75 57.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.041 0.448 . . . . 75.13 110.607 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.621 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 4.7 mp -132.73 90.17 2.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 75.41 110.266 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.44 12.32 11.59 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.311 0.486 . . . . 75.34 112.311 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -144.73 141.55 29.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.767 -0.197 . . . . 75.13 110.695 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.451 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 42.9 tt0 -59.5 122.28 13.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.007 0.432 . . . . 64.11 110.141 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.79 -7.06 33.37 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.786 -0.721 . . . . 73.03 111.888 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -68.23 120.88 15.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.92 0.39 . . . . 44.15 110.302 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 p -112.01 125.43 54.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.953 -0.567 . . . . 72.02 110.454 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.409 ' HB2' HD21 ' A' ' 42' ' ' LEU . 8.0 t -84.88 174.91 9.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.486 -0.561 . . . . 70.41 109.486 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.3 m -62.2 136.4 57.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.776 -0.453 . . . . 63.21 109.776 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' A' ' 136' ' ' ARG . . . -95.91 157.25 15.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.309 0.576 . . . . 72.1 111.018 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.1 m -99.18 148.91 5.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.131 -0.94 . . . . 63.41 109.228 172.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.62 86.81 0.54 Allowed Glycine 0 C--N 1.309 -0.947 0 C-N-CA 120.771 -0.728 . . . . 72.4 112.045 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -88.95 170.21 10.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.382 -0.599 . . . . 65.14 109.382 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.546 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.3 p-10 -138.78 150.85 46.54 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.412 0.625 . . . . 51.23 111.904 -175.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.425 HD12 HG11 ' A' ' 71' ' ' VAL . 61.4 mt -109.29 110.28 31.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.176 -0.92 . . . . 62.2 108.599 171.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -96.71 122.45 39.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.989 -0.55 . . . . 72.4 110.787 -173.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.5 mt -106.54 119.36 39.09 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.3 -0.409 . . . . 63.21 110.049 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -96.35 133.28 40.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.097 -0.501 . . . . 74.22 110.044 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 54.35 79.31 0.14 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.776 0.798 . . . . 72.15 110.469 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 42.9 t -112.2 138.51 48.79 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.996 -1.002 . . . . 74.21 109.485 -177.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -116.37 141.55 48.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.845 0.355 . . . . 63.01 111.75 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.5 p -105.42 4.25 30.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.137 -0.483 . . . . 74.32 112.157 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -76.14 -41.86 48.61 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.453 -0.573 . . . . 73.41 109.453 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 p -93.33 -35.2 6.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.747 -0.661 . . . . 60.01 111.021 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -108.19 -174.93 2.64 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.615 0.245 . . . . 64.44 110.904 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 34.3 m -148.32 -57.46 0.23 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.834 0.349 . . . . 64.42 110.779 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -138.05 141.65 40.33 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.686 -0.487 . . . . 71.14 109.686 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -100.09 130.89 46.29 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.946 0.403 . . . . 44.11 110.563 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.02 115.21 11.64 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.875 -0.602 . . . . 53.21 109.587 177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.617 HG12 HG12 ' A' ' 156' ' ' VAL . 1.9 m -92.76 147.18 5.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.986 0.422 . . . . 64.13 111.136 -173.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.491 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -122.63 131.08 53.65 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.969 -0.559 . . . . 62.21 109.516 173.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.557 ' CE1' HG21 ' A' ' 103' ' ' ILE . 49.5 m-85 -95.46 138.56 32.97 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.94 0.4 . . . . 72.14 111.047 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.6 tp -133.85 134.94 43.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.838 -0.619 . . . . 71.23 110.021 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.83 -160.8 24.96 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.191 -0.763 . . . . 44.31 111.191 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.0 m -88.4 118.42 28.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.929 0.364 . . . . 75.54 110.209 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.45 147.03 31.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.337 -0.392 . . . . 61.23 110.155 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.589 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 7.6 tt -64.41 -26.19 39.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 63.4 111.139 -177.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -154.56 -179.8 8.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.4 -0.593 . . . . 74.34 109.4 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.44 -32.63 28.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.923 0.392 . . . . 74.52 110.112 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.67 -34.68 24.45 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.699 -0.762 . . . . 61.23 111.561 176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -96.64 73.8 2.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.13 0.49 . . . . 70.01 109.972 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.452 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.4 p -95.32 15.4 19.5 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.762 -0.654 . . . . 63.35 111.512 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -112.38 -4.32 14.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.144 0.497 . . . . 73.34 110.921 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' A' ' 102' ' ' GLN . 48.8 t -115.24 126.34 72.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.995 -0.548 . . . . 71.54 110.198 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.585 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -68.68 131.16 44.74 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.525 -0.546 . . . . 54.41 109.525 178.171 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.54 143.09 36.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.06 -0.518 . . . . 62.33 110.517 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.67 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.6 mm? -75.98 135.78 40.01 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.965 -0.754 . . . . 73.21 108.965 177.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -57.84 122.35 12.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.208 0.528 . . . . 74.34 111.06 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.2 p -69.68 110.33 4.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.495 -0.775 . . . . 62.21 110.735 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.1 m -93.46 -7.38 44.61 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.009 -0.542 . . . . 52.5 110.383 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 62.03 28.35 17.17 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.715 -0.675 . . . . 60.44 110.422 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.37 -43.82 0.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.583 -0.735 . . . . 73.15 110.696 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.16 76.78 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.571 -0.823 . . . . 74.31 112.319 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.5 m -92.66 152.44 19.55 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.824 -0.436 . . . . 74.25 109.824 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.01 133.86 48.69 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.686 -0.487 . . . . 73.21 109.686 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.95 163.87 22.72 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.545 -0.462 . . . . 52.13 110.989 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 66.24 13.7 9.3 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.604 -0.726 . . . . 65.21 110.496 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.15 -178.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.549 -0.75 . . . . 70.02 109.902 175.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 176.21 -172.24 45.23 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 110.06 -1.216 . . . . 72.4 110.06 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 10' ' ' VAL . 2.3 p -118.8 111.43 33.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.549 0.69 . . . . 74.12 110.898 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.41 ' HB3' HG22 ' A' ' 85' ' ' VAL . 2.4 pt20 -96.11 141.13 29.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.511 -0.768 . . . . 70.02 109.502 177.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.557 HG21 ' CE1' ' A' ' 73' ' ' PHE . 3.8 mp -98.71 127.79 50.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.037 0.446 . . . . 71.13 110.13 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 44.4 mt -99.35 138.94 35.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.504 -0.771 . . . . 61.51 110.63 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.592 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 3.8 t70 -60.67 165.95 3.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.642 -0.708 . . . . 74.31 110.188 170.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.44 ' HE ' ' HB3' ' A' ' 120' ' ' SER . 26.5 ptt180 -54.84 -24.67 24.09 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.474 0.546 . . . . 73.1 112.474 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.2 p -87.13 -20.52 26.93 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.758 0.313 . . . . 72.24 111.719 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.38 44.36 1.26 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.663 -0.779 . . . . 71.21 112.661 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.72 130.16 45.11 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.065 -0.346 . . . . 74.43 110.065 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.72 140.3 57.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.068 0.461 . . . . 73.32 111.183 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.49 155.21 17.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.94 -0.573 . . . . 72.24 110.555 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 m -94.46 141.15 28.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.363 -0.38 . . . . 72.34 110.176 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 60.5 mt -84.94 51.04 2.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.012 0.434 . . . . 73.13 110.988 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -108.94 -4.54 16.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.43 . . . . 75.55 110.261 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 71.82 0.11 39.74 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.017 -0.611 . . . . 35.14 112.739 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -116.73 -17.48 10.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.371 . . . . 63.32 111.105 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.3 m -86.06 94.96 9.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.023 0.44 . . . . 64.24 109.836 174.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.689 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 69.3 m-85 -85.59 162.26 18.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.05 -0.523 . . . . 70.43 110.189 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.592 ' HB3' ' OD1' ' A' ' 105' ' ' ASP . 6.9 m -77.95 -172.16 2.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.882 -0.599 . . . . 64.12 110.943 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.44 ' HB3' ' HE ' ' A' ' 106' ' ' ARG . 35.6 t -68.84 148.77 49.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.869 -0.605 . . . . 72.13 110.165 178.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -63.81 98.29 0.19 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.793 0.33 . . . . 71.14 111.293 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.2 m -78.7 102.28 7.97 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.43 -0.581 . . . . 65.14 109.43 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.0 m -57.23 112.17 1.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.44 -0.8 . . . . 64.13 110.997 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 69' ' ' ALA . 96.0 mt -75.19 143.79 43.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.766 -0.652 . . . . 73.31 111.402 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -125.11 145.24 50.03 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.192 -0.67 . . . . 72.11 109.192 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -53.9 113.02 1.06 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.872 0.368 . . . . 64.32 111.508 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 129.81 -143.09 14.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.15 -0.548 . . . . 62.25 112.462 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.6 m -82.73 122.1 27.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.763 0.316 . . . . 75.11 110.794 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.431 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 21.9 m-80 -114.86 113.08 23.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.976 0.417 . . . . 74.22 110.337 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.546 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.1 m -102.27 106.37 17.17 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.78 -0.645 . . . . 54.43 110.327 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 6.6 mt -91.66 113.4 58.6 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.847 -0.427 . . . . 64.14 109.847 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 24.7 Cg_endo -88.72 133.07 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.873 2.382 . . . . 74.34 112.706 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -133.1 169.81 16.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.826 -0.624 . . . . 73.3 109.733 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.651 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 97.1 mt-30 -126.1 140.42 52.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.018 0.437 . . . . 51.04 111.122 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -127.05 125.6 41.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.077 -0.51 . . . . 74.45 109.779 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.519 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 36.7 ptt180 -144.36 166.18 25.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.097 0.475 . . . . 73.22 111.513 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.602 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 82.4 m-85 -81.56 131.91 35.29 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.323 -0.853 . . . . 73.22 110.456 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -118.13 116.19 26.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.457 -0.792 . . . . 72.13 109.366 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -80.78 130.92 35.33 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.18 -0.463 . . . . 73.41 110.996 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.451 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 41.7 p -102.05 9.27 40.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.055 -0.721 . . . . 74.05 109.055 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.41 -120.95 0.94 Allowed Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.933 -1.03 . . . . 75.05 111.018 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.89 95.4 7.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.752 -0.462 . . . . 74.34 109.752 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.629 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -47.3 114.63 0.91 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.716 0.635 . . . . 25.31 111.206 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 p -107.02 139.58 20.55 Favored Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-N 116.082 -0.508 . . . . 72.23 110.373 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.56 159.76 51.75 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 123.679 2.919 . . . . 63.33 113.086 -172.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.95 -167.48 28.28 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.667 -0.697 . . . . 45.22 111.404 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.76 112.06 5.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.922 0.392 . . . . 64.4 110.901 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.67 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -109.8 58.62 0.61 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.505 0.669 . . . . 33.14 110.361 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -116.42 133.42 56.04 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.446 -0.797 . . . . 72.14 110.045 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.585 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -142.16 175.72 9.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.404 -0.362 . . . . 62.25 110.84 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -148.91 150.78 33.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.697 -0.483 . . . . 72.31 109.697 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -154.06 151.26 29.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.86 0.362 . . . . 52.15 110.874 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.405 HG22 ' HB3' ' A' ' 13' ' ' LYS . 10.6 p -108.77 132.96 53.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.096 -0.502 . . . . 60.35 109.835 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.406 ' CD1' HD13 ' A' ' 56' ' ' ILE . 27.9 p90 -106.53 133.67 50.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.25 0.547 . . . . 63.22 111.082 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.689 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 20.7 ttmt -109.59 103.44 12.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.469 -0.787 . . . . 71.41 110.409 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.617 HG12 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -77.95 130.05 36.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.242 -0.651 . . . . 75.41 109.242 176.141 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -114.67 117.86 32.03 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.862 -0.422 . . . . 74.33 109.862 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.595 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -136.34 -16.73 1.59 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.225 -0.443 . . . . 75.41 111.075 175.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.537 -0.744 . . . . 73.23 109.299 173.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 120.553 0.216 . . . . 74.34 110.726 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.14 -174.61 5.38 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.389 -0.226 . . . . 52.15 110.389 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.402 HG23 HG23 ' A' ' 4' ' ' THR . 13.4 t -102.61 -15.59 16.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.078 0.466 . . . . 72.11 110.663 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.402 HG23 HG23 ' A' ' 3' ' ' THR . 73.1 p -110.61 174.26 5.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.986 0.422 . . . . 73.43 110.533 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.0 m -83.9 6.99 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.314 0.578 . . . . 63.11 110.439 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 60.77 18.33 8.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.145 -0.934 . . . . 62.21 112.083 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.93 95.67 0.87 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.772 -0.727 . . . . 75.14 111.915 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.48 159.92 31.19 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.43 -0.89 . . . . 74.34 111.366 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.561 ' HB ' HG22 ' A' ' 31' ' ' THR . 60.8 p -139.03 143.55 38.47 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.724 0.262 . . . . 41.42 110.446 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -111.73 123.68 67.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.855 -0.424 . . . . 64.11 109.855 175.415 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -92.5 113.35 25.6 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.106 -0.497 . . . . 74.21 109.869 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.459 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 95.2 m-85 -104.71 125.96 51.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.167 -0.47 . . . . 64.34 110.389 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -117.67 143.74 45.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.978 -0.379 . . . . 71.32 109.978 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.41 -126.56 2.78 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.74 -0.743 . . . . 63.14 112.849 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.651 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 35.8 mt-10 62.21 27.91 16.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.286 0.565 . . . . 71.31 110.581 -174.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' A' ' 155' ' ' LYS . 31.0 m -74.24 -26.48 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.399 -0.818 . . . . 51.41 111.321 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.463 HG21 ' CG2' ' A' ' 156' ' ' VAL . 27.1 m -136.64 147.19 27.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 63.54 111.493 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -143.94 19.42 1.79 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.121 -0.945 . . . . 54.44 109.188 175.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.69 -83.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.538 -0.755 . . . . 70.32 111.489 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.559 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -80.96 -36.53 30.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.934 -0.307 . . . . 64.31 110.724 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 0.8 OUTLIER -143.01 132.98 24.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.735 0.302 . . . . 51.11 110.19 -176.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.32 126.7 39.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.376 -0.375 . . . . 63.51 110.324 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.455 ' HA ' HD23 ' A' ' 58' ' ' LEU . 8.2 t -65.77 131.97 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.235 -0.283 . . . . 74.43 110.235 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.54 ' O ' HG13 ' A' ' 28' ' ' VAL . 22.9 t70 -58.04 140.83 51.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 65.24 111.717 -176.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.55 -25.3 64.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.835 -0.621 . . . . 53.22 112.15 -175.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.72 -24.84 55.03 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.401 -0.904 . . . . 55.11 112.388 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.2 p -98.11 -12.09 22.17 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.873 0.323 . . . . 41.42 111.873 -175.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.651 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 30.8 m -79.85 -4.62 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.672 0.272 . . . . 74.4 111.609 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -166.72 96.01 0.53 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.404 -0.962 . . . . 73.44 108.404 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -145.9 140.78 27.23 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.548 -0.751 . . . . 64.23 109.91 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.561 HG22 ' HB ' ' A' ' 9' ' ' THR . 25.0 m -117.05 103.9 10.71 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.71 -0.677 . . . . 53.15 109.992 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 p -88.26 133.67 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.039 0.447 . . . . 74.42 111.084 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.518 ' HA ' HG22 ' A' ' 9' ' ' THR . 25.3 mp0 -90.67 128.34 36.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 74.01 109.72 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.74 -31.32 21.02 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.156 0.503 . . . . 74.33 110.055 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.64 172.48 24.71 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.668 -0.696 . . . . 73.31 112.025 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -80.79 97.66 7.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.76 0.314 . . . . 72.12 110.358 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.11 143.1 12.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.024 -0.535 . . . . 73.33 110.212 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.436 ' CD ' ' H ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -82.9 127.7 33.75 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.555 -0.535 . . . . 73.31 109.555 177.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.4 p -74.49 -10.04 59.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.148 -0.478 . . . . 74.55 111.584 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.47 -21.25 58.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.254 -0.43 . . . . 74.04 111.379 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.5 m -81.14 -23.42 38.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 71.23 110.868 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.2 mp -114.34 99.04 7.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.107 -0.497 . . . . 75.44 109.923 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.83 11.49 6.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.364 0.505 . . . . 71.25 112.364 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -151.43 152.13 32.63 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.693 -0.403 . . . . 65.53 111.432 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -59.37 120.03 8.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.634 -0.712 . . . . 73.44 109.484 175.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.05 6.8 39.23 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.676 -0.773 . . . . 75.4 112.032 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.689 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -81.17 120.27 24.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.837 0.351 . . . . 73.43 110.257 176.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.542 HG22 ' HD1' ' A' ' 138' ' ' PHE . 59.9 p -112.44 128.09 56.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.161 -0.472 . . . . 51.13 110.415 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.9 t -84.73 -177.76 6.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.794 -0.447 . . . . 74.31 109.794 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -67.37 137.2 55.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.272 -0.422 . . . . 64.52 110.074 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -92.01 153.52 19.38 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.664 0.745 . . . . 64.01 111.882 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 27.8 m -93.32 153.74 3.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.363 -1.29 . . . . 63.13 109.536 170.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.22 100.54 1.66 Allowed Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.809 -0.71 . . . . 72.2 111.996 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -116.33 -179.4 3.66 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.416 -0.586 . . . . 71.25 109.416 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.547 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.0 p-10 -146.35 152.72 39.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.502 0.668 . . . . 25.35 111.965 -174.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 74.4 mt -113.84 111.86 37.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.911 -1.04 . . . . 70.12 108.303 167.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -97.75 140.93 31.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.985 0.421 . . . . 73.31 110.801 -172.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 23' ' ' VAL . 65.7 mt -117.66 124.66 49.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.841 -0.618 . . . . 74.43 109.491 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -102.6 135.85 43.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.79 -0.641 . . . . 73.4 109.386 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 27.3 t70 56.19 87.65 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.821 0.701 . . . . 63.22 110.486 -176.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' A' ' 124' ' ' LEU . 42.3 t -124.85 134.85 52.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.704 -0.68 . . . . 61.11 110.373 -174.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.09 138.03 47.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 73.21 111.867 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 p -105.35 10.9 33.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.798 -0.637 . . . . 71.14 112.31 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -88.32 -36.33 16.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.018 0.437 . . . . 64.41 110.027 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 p -102.01 -12.55 8.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.875 -0.602 . . . . 74.24 110.435 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -129.13 -174.11 3.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.866 -0.606 . . . . 73.15 110.423 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -150.59 -56.55 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.78 0.324 . . . . 74.23 111.175 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -137.58 141.3 41.32 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.503 -0.554 . . . . 75.14 109.503 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.477 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -99.43 130.34 45.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.091 0.472 . . . . 54.25 110.29 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.95 113.66 9.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.559 -0.746 . . . . 72.21 109.792 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.695 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 2.0 m -90.37 146.42 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.272 0.558 . . . . 65.02 110.864 -175.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.54 119.24 34.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.356 -0.838 . . . . 61.42 109.166 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 83.7 m-85 -79.55 137.46 37.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.855 -0.424 . . . . 61.23 109.855 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.9 tp -137.33 115.55 11.73 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.671 -0.492 . . . . 74.34 109.671 -175.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.6 -158.12 10.07 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.524 -0.762 . . . . 74.24 111.379 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.505 ' O ' HD13 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -81.09 116.69 21.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.73 0.265 . . . . 62.41 110.869 -178.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.564 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -79.69 139.31 37.42 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.936 -0.394 . . . . 71.13 109.936 175.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.558 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 6.6 tt -63.62 -36.12 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.904 0.383 . . . . 70.25 110.781 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -151.92 175.17 12.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.31 -0.626 . . . . 73.33 109.31 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.83 -24.58 28.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.997 0.427 . . . . 65.05 110.503 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.84 -21.54 49.93 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.756 -0.735 . . . . 61.53 111.356 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -118.61 62.46 0.78 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.457 0.646 . . . . 71.55 109.518 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.564 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 2.6 p -80.85 7.64 10.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.421 -0.809 . . . . 72.23 111.407 -177.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -106.25 1.55 26.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.056 0.455 . . . . 73.41 110.947 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.544 HG22 ' HB3' ' A' ' 102' ' ' GLN . 61.9 t -117.34 129.4 73.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.015 -0.539 . . . . 70.32 110.164 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.596 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -69.98 133.61 47.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.715 0.293 . . . . 65.32 110.378 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.14 148.36 34.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.123 -0.49 . . . . 72.12 110.302 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.443 HD22 ' H ' ' A' ' 88' ' ' LEU . 1.7 mm? -81.61 149.82 28.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.246 -0.434 . . . . 73.05 110.499 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -74.53 128.44 35.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.594 . . . . 73.3 110.334 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 p -84.96 110.79 19.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.025 -0.534 . . . . 73.25 111.376 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.9 m -99.14 -4.35 32.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.163 -0.471 . . . . 71.04 110.391 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 68.56 4.96 4.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.338 -0.846 . . . . 75.55 113.128 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.16 -44.43 3.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.364 0.602 . . . . 64.51 110.033 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -167.96 85.06 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.621 -0.718 . . . . 45.11 112.046 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 66.9 m -104.74 149.66 25.42 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.912 -0.403 . . . . 75.11 109.912 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.08 147.77 29.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.467 -0.333 . . . . 74.12 110.457 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.48 165.55 27.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.557 -0.292 . . . . 64.45 110.335 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.422 HD22 HG23 ' A' ' 144' ' ' THR . 26.0 m-20 70.11 7.62 6.3 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.327 0.584 . . . . 73.05 110.417 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.35 -177.42 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.272 -0.877 . . . . 70.32 109.644 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 177.22 -170.6 43.25 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.12 -1.192 . . . . 70.32 110.12 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -121.03 115.18 46.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.476 0.655 . . . . 62.32 110.49 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.544 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.6 pt20 -105.39 145.53 30.66 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.63 -0.713 . . . . 75.41 109.532 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.476 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.4 mp -104.96 123.15 58.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.148 0.499 . . . . 72.41 110.385 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 18.8 mt -91.21 139.51 30.68 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.376 -0.829 . . . . 72.5 109.246 177.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.8 OUTLIER -72.57 -169.12 0.51 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.282 -0.417 . . . . 54.32 110.282 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -56.72 -35.07 68.11 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.733 0.272 . . . . 74.12 111.733 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.7 p -87.43 -6.29 58.49 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.883 0.373 . . . . 53.15 111.768 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.89 30.03 10.93 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.606 -0.807 . . . . 73.4 112.804 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.38 134.74 50.77 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.177 -0.305 . . . . 74.02 110.177 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.37 117.96 10.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.966 0.412 . . . . 72.11 111.175 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.16 132.7 35.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.891 -0.595 . . . . 64.5 110.573 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.3 m -74.33 137.41 42.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.905 -0.589 . . . . 74.31 110.647 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.571 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 36.5 mt -82.43 47.89 1.22 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.067 -0.515 . . . . 70.45 110.971 -177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -104.93 -0.75 26.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.959 0.409 . . . . 65.11 110.332 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.12 10.57 59.6 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.871 -0.604 . . . . 75.24 112.672 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -125.32 -23.97 4.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.953 0.406 . . . . 60.3 110.798 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -80.3 99.43 7.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.96 0.41 . . . . 74.11 110.264 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -89.03 157.88 18.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.02 -0.536 . . . . 62.51 110.635 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.537 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.3 m -64.96 171.15 3.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.019 -0.537 . . . . 62.55 111.08 177.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 42.9 m -65.37 156.76 31.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.459 -0.571 . . . . 73.33 109.459 171.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.495 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 45.7 mt-10 -55.6 121.15 8.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.101 0.477 . . . . 72.43 111.913 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.0 m -105.57 98.84 8.48 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.269 -1.011 . . . . 74.34 108.269 168.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.1 m -59.24 122.05 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.976 -0.556 . . . . 74.11 110.915 -175.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.539 HD13 ' SG ' ' A' ' 61' ' ' CYS . 96.2 mt -82.96 153.23 25.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.464 -0.789 . . . . 72.25 111.662 -174.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.484 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -123.87 157.32 34.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.356 -0.838 . . . . 72.13 108.911 171.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 3.8 m120 -68.37 99.64 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.913 0.387 . . . . 73.44 110.34 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.06 -136.41 7.95 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.895 -0.669 . . . . 72.31 112.029 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.3 m -84.96 127.58 34.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.022 0.439 . . . . 54.5 110.976 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 33.5 m-80 -128.61 124.94 37.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.968 -0.56 . . . . 54.0 109.9 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.547 HG22 ' HB2' ' A' ' 55' ' ' ASN . 2.5 m -115.65 114.78 25.34 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.974 -0.291 . . . . 75.11 110.702 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.6 mt -92.25 109.81 40.33 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.282 -0.417 . . . . 63.13 109.95 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.33 138.76 10.06 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.767 2.311 . . . . 72.44 112.806 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 62.3 m-85 -136.55 164.13 28.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.172 -0.467 . . . . 72.51 111.113 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 97.5 mt-30 -125.59 125.12 42.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.795 -0.639 . . . . 71.22 110.412 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.48 124.08 51.55 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.199 -0.297 . . . . 53.32 110.199 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 14.9 ptp180 -138.87 160.22 40.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.934 0.397 . . . . 63.21 110.983 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 66.8 m-85 -77.32 139.7 39.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.7 -0.682 . . . . 74.12 110.516 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.542 ' HD1' HG22 ' A' ' 48' ' ' THR . 80.5 t80 -127.59 122.26 32.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.696 -0.684 . . . . 74.15 109.501 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.689 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -93.26 137.13 32.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.074 0.464 . . . . 72.11 111.333 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 52.0 p -103.81 5.51 36.02 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.439 -0.801 . . . . 65.14 109.224 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.26 -131.6 2.33 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.901 -1.045 . . . . 54.34 110.697 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.39 94.89 4.96 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.4 -0.222 . . . . 34.13 110.4 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.23 120.9 3.88 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.546 0.529 . . . . 63.54 111.105 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.422 HG23 HD22 ' A' ' 98' ' ' ASN . 33.2 p -111.57 145.1 31.92 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 121.248 0.547 . . . . 73.02 111.2 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.17 163.16 37.16 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 123.867 3.044 . . . . 74.31 113.089 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.36 -174.76 21.09 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.993 -0.622 . . . . 54.34 111.937 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.73 108.04 0.78 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.971 0.415 . . . . 42.04 111.207 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.43 43.88 1.07 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.633 -0.712 . . . . 65.25 110.228 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -101.74 147.11 26.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.58 -0.736 . . . . 75.15 109.805 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.523 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -153.79 170.61 20.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.46 -0.337 . . . . 72.01 111.07 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.42 146.02 36.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.435 -0.348 . . . . 64.2 110.219 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.596 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -151.28 149.63 29.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.303 -0.408 . . . . 74.24 110.993 -177.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.7 p -107.21 128.45 54.43 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.019 -0.537 . . . . 73.4 109.621 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -100.01 132.5 45.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.208 0.528 . . . . 75.43 110.831 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.648 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.8 tmtm? -117.19 105.17 11.94 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.783 -0.644 . . . . 71.4 110.248 -178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.695 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.2 m -74.87 156.52 6.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.173 0.511 . . . . 74.21 110.614 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 157' ' ' GLN . 1.4 tt0 -140.7 118.48 11.72 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.424 -0.807 . . . . 72.3 108.958 175.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.563 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -136.73 -15.02 1.61 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.038 0.384 . . . . 65.51 112.038 177.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.482 -0.77 . . . . 75.25 109.884 177.214 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.728 0.299 . . . . 72.21 110.681 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.85 -174.18 1.76 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.43 . . . . 73.33 110.195 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.8 t -107.6 6.52 27.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.415 0.626 . . . . 74.42 110.243 175.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.1 p -124.96 172.86 9.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.275 -0.42 . . . . 72.21 110.025 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.554 HG22 HG12 ' A' ' 37' ' ' VAL . 34.2 m -94.26 20.25 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.22 0.533 . . . . 54.15 110.468 175.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 59.75 25.59 14.61 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.934 -1.03 . . . . 75.1 112.542 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.537 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 76.78 89.95 0.27 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.537 -0.839 . . . . 51.01 112.078 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.86 159.95 46.28 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.354 -0.927 . . . . 34.13 112.157 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.582 ' HB ' HG22 ' A' ' 31' ' ' THR . 74.3 p -140.44 145.67 37.28 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.856 -0.424 . . . . 71.12 109.856 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.65 125.25 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 109.803 -0.443 . . . . 74.13 109.803 175.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -90.04 111.95 23.22 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.73 -0.668 . . . . 54.31 109.6 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -98.86 124.63 43.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.164 -0.471 . . . . 73.12 109.776 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.511 ' HB3' HG22 ' A' ' 153' ' ' THR . 58.6 tttm -118.42 132.88 56.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.444 -0.344 . . . . 74.42 110.644 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.05 -115.11 2.48 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.921 -0.657 . . . . 74.4 112.846 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.467 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 31.6 mt-10 65.18 21.29 12.11 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.939 0.496 . . . . 70.51 111.176 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 155' ' ' LYS . 13.8 m -79.61 -33.23 14.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 113.307 0.855 . . . . 61.33 113.307 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.456 HG22 HG23 ' A' ' 16' ' ' VAL . 21.1 m -140.38 150.4 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.264 0.554 . . . . 72.0 112.436 -171.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -149.57 34.21 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.627 -1.249 . . . . 74.13 107.627 169.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.45 -74.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.048 -0.978 . . . . 65.41 110.88 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.417 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -94.79 -31.59 13.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.841 0.353 . . . . 63.11 110.629 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -142.36 136.24 29.43 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.923 -0.58 . . . . 61.5 109.976 -176.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.51 130.56 45.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.642 -0.254 . . . . 72.25 110.47 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.61 126.39 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.691 0.282 . . . . 73.41 110.245 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.12 143.99 36.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.935 -0.575 . . . . 73.11 111.516 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.67 -27.64 66.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.784 -0.643 . . . . 74.3 111.99 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.04 -5.16 87.91 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.51 -0.852 . . . . 63.21 112.216 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.2 p -123.59 12.61 9.3 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.717 0.265 . . . . 70.42 111.717 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 26.6 m -98.53 -12.78 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.967 0.413 . . . . 75.51 110.417 174.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -157.9 93.14 1.24 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.43 -0.952 . . . . 75.32 108.43 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pm0 -135.96 142.49 44.57 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.05 0.452 . . . . 72.11 110.19 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.582 HG22 ' HB ' ' A' ' 9' ' ' THR . 3.6 m -120.29 106.7 12.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.774 -0.648 . . . . 65.53 110.108 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 p -87.0 147.43 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 64.22 111.138 -175.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -99.6 117.46 34.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 73.31 110.466 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.402 ' HB3' ' HE2' ' A' ' 137' ' ' TYR . 2.7 mm? -85.99 -29.25 23.65 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.196 0.522 . . . . 63.15 110.083 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.537 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 92.47 171.28 41.01 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.559 -0.746 . . . . 70.14 111.88 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -78.9 91.42 4.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.713 0.292 . . . . 73.05 110.461 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.554 HG12 HG22 ' A' ' 5' ' ' VAL . 9.8 p -72.46 146.78 10.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.382 -0.599 . . . . 71.23 109.382 175.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -89.07 139.85 30.04 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.944 0.402 . . . . 75.42 110.803 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.9 p -73.13 -7.24 50.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.858 -0.61 . . . . 70.11 111.371 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.67 -26.99 27.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.019 -0.537 . . . . 52.15 110.606 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.531 ' HB2' HD12 ' A' ' 42' ' ' LEU . 9.1 m -74.24 -21.7 59.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.963 -0.562 . . . . 60.15 110.712 -177.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -127.43 107.71 10.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.624 -0.716 . . . . 52.12 109.828 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.78 10.9 3.4 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.708 -0.397 . . . . 65.41 111.781 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -146.66 143.69 28.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.773 0.321 . . . . 72.42 111.351 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.0 tm-20 -57.93 119.51 6.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.683 -0.69 . . . . 75.34 109.932 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.48 -6.09 29.93 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.793 -0.718 . . . . 54.04 111.999 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -72.69 131.33 42.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.677 0.275 . . . . 50.44 110.344 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.536 HG22 ' HD1' ' A' ' 138' ' ' PHE . 40.1 p -121.04 145.82 47.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.221 -0.445 . . . . 74.22 110.205 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.6 t -99.3 176.58 5.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.12 -0.696 . . . . 74.43 109.12 174.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.5 m -71.86 140.34 49.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.956 0.408 . . . . 74.4 110.083 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -92.4 159.36 15.59 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.573 0.702 . . . . 51.43 111.926 -176.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.3 m -98.33 151.84 4.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.463 -1.244 . . . . 70.25 109.16 170.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.7 73.32 0.27 Allowed Glycine 0 C--N 1.313 -0.733 0 C-N-CA 120.761 -0.733 . . . . 61.25 112.353 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -82.22 153.34 25.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.75 -0.463 . . . . 64.14 109.75 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.603 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.1 p-10 -122.78 145.02 48.79 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.185 0.516 . . . . 64.1 111.808 -174.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.437 HD12 ' CE2' ' A' ' 133' ' ' PHE . 67.3 mt -110.85 118.37 57.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.861 -0.792 . . . . 74.21 108.861 171.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -100.77 130.53 46.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 71.41 110.881 -172.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 128' ' ' THR . 40.9 mt -112.35 118.18 34.5 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.823 -0.436 . . . . 72.21 109.823 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -94.54 140.86 29.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.309 -0.405 . . . . 41.31 110.117 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.4 t70 49.0 76.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.136 0.898 . . . . 73.04 110.721 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 41.7 t -109.68 143.73 39.03 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.05 -0.977 . . . . 70.02 109.564 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -120.79 153.04 37.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.255 0.465 . . . . 64.13 112.255 -171.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.2 p -115.16 -2.59 12.7 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.934 -0.575 . . . . 63.2 111.835 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -72.15 -38.36 69.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.677 -0.49 . . . . 73.02 109.677 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.7 p -102.86 -32.4 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.864 -0.607 . . . . 65.23 111.383 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -110.06 171.98 7.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.764 0.316 . . . . 75.24 111.474 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.434 ' CB ' ' HD2' ' A' ' 68' ' ' LYS . 20.1 m -133.73 -58.43 0.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.349 -0.387 . . . . 34.24 111.439 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -139.21 136.4 34.96 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.087 -0.338 . . . . 54.23 110.087 -177.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.466 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -99.4 130.07 45.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.278 0.561 . . . . 71.04 110.676 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.66 125.56 19.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.333 -0.848 . . . . 72.04 109.217 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.782 HG12 HG12 ' A' ' 156' ' ' VAL . 2.1 m -95.39 145.13 8.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.927 0.394 . . . . 74.41 110.993 -175.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.82 126.37 54.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.799 -0.637 . . . . 62.25 109.453 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 61.7 m-85 -93.02 137.19 32.6 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.122 0.487 . . . . 73.34 111.16 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.6 tp -134.73 134.1 40.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.7 -0.682 . . . . 61.33 109.709 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.39 -140.31 3.02 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.45 -0.66 . . . . 62.34 111.45 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.504 ' O ' HD13 ' A' ' 86' ' ' LEU . 39.2 m -103.26 118.59 37.12 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.092 -0.336 . . . . 72.13 110.092 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.41 138.26 36.61 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.176 -0.305 . . . . 73.13 110.176 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.599 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 10.4 tt -65.69 -27.82 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.381 . . . . 75.22 110.694 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -158.83 176.8 11.88 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.323 -0.621 . . . . 44.55 109.323 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.1 -39.5 23.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.965 0.412 . . . . 70.12 110.244 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.02 -17.53 78.23 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.833 -0.699 . . . . 51.32 111.456 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.404 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 66.2 m80 -119.77 54.34 1.02 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.552 0.691 . . . . 64.21 109.685 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.568 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -78.78 14.62 1.28 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.13 -0.941 . . . . 72.33 111.86 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -112.57 2.38 16.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.201 0.524 . . . . 53.22 110.415 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.558 HG22 ' HB3' ' A' ' 102' ' ' GLN . 61.1 t -116.61 125.95 73.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 75.23 110.027 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.546 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -70.2 132.16 45.34 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.805 0.336 . . . . 75.21 110.307 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -80.02 152.86 29.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.833 -0.622 . . . . 64.41 110.149 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.662 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.6 mm? -85.61 144.86 27.63 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.378 -0.374 . . . . 71.24 110.635 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -71.84 144.52 49.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.904 -0.589 . . . . 64.14 110.926 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.61 102.46 3.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.01 -0.541 . . . . 63.14 109.865 174.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.2 m -101.43 6.09 42.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.067 -0.515 . . . . 33.11 110.573 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.61 13.19 8.77 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.514 -0.766 . . . . 74.31 111.228 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.22 6.17 12.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.773 -0.649 . . . . 64.53 110.483 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.67 95.04 1.03 Allowed Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.778 -0.929 . . . . 73.53 110.778 -176.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.05 154.23 35.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.876 0.37 . . . . 73.22 110.968 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.448 ' O ' HD23 ' A' ' 88' ' ' LEU . . . -69.06 148.76 49.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.082 -0.508 . . . . 62.11 109.672 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.56 160.18 40.57 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.761 -0.375 . . . . 73.52 110.478 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 65.95 8.8 5.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 73.45 110.232 -174.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.29 154.46 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 115.356 -0.838 . . . . 62.11 109.8 175.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -159.2 -169.15 22.19 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 110.597 -1.001 . . . . 55.33 110.597 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.41 109.25 27.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.53 0.681 . . . . 52.52 110.376 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.558 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.3 pt20 -96.88 150.42 20.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.757 -0.656 . . . . 73.4 109.676 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.5 mt -113.54 122.18 67.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.151 0.501 . . . . 64.22 110.869 -175.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 14.4 mt -92.84 146.71 23.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 64.31 109.811 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.4 p-10 -78.43 -169.19 1.58 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.104 -0.498 . . . . 71.51 109.811 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -61.22 -30.05 70.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.928 0.344 . . . . 70.14 111.928 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.1 p -84.47 -10.95 57.03 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.692 -0.403 . . . . 70.33 111.218 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.53 23.89 17.56 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.659 -0.781 . . . . 74.03 112.58 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.61 134.05 51.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.327 -0.249 . . . . 74.15 110.327 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.14 132.3 50.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.074 0.464 . . . . 73.24 111.078 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.5 mt -94.38 141.08 28.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.754 -0.657 . . . . 53.01 110.323 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.1 m -78.99 139.56 38.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.353 -0.385 . . . . 73.13 110.436 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.546 HD13 HD22 ' A' ' 86' ' ' LEU . 36.5 mt -86.05 47.77 1.51 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.3 -0.409 . . . . 73.42 110.918 -176.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -104.45 -3.89 23.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.359 -0.382 . . . . 74.5 110.654 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.5 -0.76 63.52 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.149 -0.548 . . . . 54.2 113.345 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.04 -15.79 9.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.03 0.415 . . . . 62.4 111.103 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.0 m -84.94 104.17 14.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.252 -0.431 . . . . 71.14 110.545 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.444 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 96.0 m-85 -94.33 162.02 14.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.159 -0.473 . . . . 73.41 110.468 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.6 m -67.34 179.86 1.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.995 -0.548 . . . . 72.4 111.088 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.0 m -71.91 167.95 18.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.749 -0.463 . . . . 71.23 109.749 172.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.525 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 39.7 mt-10 -68.98 109.03 3.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.984 0.421 . . . . 75.14 111.785 -173.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.0 m -90.92 96.93 10.88 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.798 -0.816 . . . . 62.51 108.798 168.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.0 m -60.55 126.92 29.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.173 0.511 . . . . 72.52 110.484 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.521 HD13 ' SG ' ' A' ' 61' ' ' CYS . 96.5 mt -85.96 153.73 21.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.585 -0.734 . . . . 61.14 112.387 -170.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -128.85 150.53 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.956 -1.02 . . . . 70.05 108.43 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.6 m120 -64.61 107.77 1.5 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.17 0.51 . . . . 63.23 111.016 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 139.49 -151.21 21.81 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.514 -0.766 . . . . 74.45 111.497 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 50.7 m -89.48 116.92 28.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.267 0.556 . . . . 64.55 111.097 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.445 HD22 ' HB3' ' A' ' 61' ' ' CYS . 36.6 m-80 -110.06 126.64 54.22 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.744 -0.662 . . . . 64.11 109.974 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.603 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.3 m -106.93 114.95 29.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.247 -0.433 . . . . 44.45 110.148 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.1 mt -91.21 118.74 68.69 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.709 -0.478 . . . . 62.34 109.709 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -84.54 129.57 4.29 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.787 2.325 . . . . 73.41 112.656 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.437 ' CE2' HD12 ' A' ' 56' ' ' ILE . 62.6 m-85 -129.45 168.82 15.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.139 -0.482 . . . . 74.51 110.333 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 22.8 mt-30 -135.85 120.29 18.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.926 0.394 . . . . 71.41 111.621 -177.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.23 125.97 51.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.373 -0.376 . . . . 72.41 110.039 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.528 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 6.2 ptp180 -140.35 165.03 28.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 71.41 110.921 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 67.3 m-85 -83.89 145.05 28.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.111 -0.495 . . . . 75.43 110.974 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.536 ' HD1' HG22 ' A' ' 48' ' ' THR . 78.9 t80 -133.58 128.86 36.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.67 -0.695 . . . . 72.11 109.212 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -94.95 133.92 38.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.269 -0.423 . . . . 75.04 111.496 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.549 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 82.0 p -104.57 6.02 34.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.664 0.745 . . . . 75.44 109.279 175.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.86 -129.57 1.95 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.12 -0.946 . . . . 74.41 111.4 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -85.47 93.03 8.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.244 -0.28 . . . . 72.14 110.244 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -45.75 112.66 0.49 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.755 0.659 . . . . 73.33 111.264 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.2 p -102.48 140.49 21.16 Favored Pre-proline 0 N--CA 1.442 -0.861 0 CA-C-O 121.061 0.457 . . . . 71.43 110.417 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.67 165.76 29.77 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 123.534 2.823 . . . . 63.25 112.666 -175.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.5 -149.76 21.84 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.482 -0.866 . . . . 45.11 111.803 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.86 120.81 35.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.155 -0.313 . . . . 71.24 110.155 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.662 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -111.73 50.35 0.85 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 71.54 111.299 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -101.43 136.21 41.65 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.201 -0.666 . . . . 75.31 109.201 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.508 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -143.31 165.32 27.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.619 0.247 . . . . 72.21 111.045 -177.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -135.06 143.7 46.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.34 -0.391 . . . . 70.41 110.204 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.21 141.31 24.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.049 0.452 . . . . 74.33 110.959 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 13' ' ' LYS . 35.9 p -103.28 131.29 50.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.938 -0.574 . . . . 63.24 109.616 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.432 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 53.1 p90 -111.78 140.94 46.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.919 0.39 . . . . 61.11 110.557 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.577 ' HA ' HG21 ' A' ' 16' ' ' VAL . 2.0 tmmm? -127.25 111.11 13.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.656 -0.702 . . . . 73.14 110.092 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.782 HG12 HG12 ' A' ' 71' ' ' VAL . 1.3 m -78.44 143.59 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.018 0.437 . . . . 75.32 110.372 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -126.82 126.26 43.06 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.446 -0.575 . . . . 74.43 109.446 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.657 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -136.21 -11.78 1.92 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.936 0.398 . . . . 72.44 111.781 178.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.36 -0.829 . . . . 72.51 109.172 172.255 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.976 -0.379 . . . . 61.45 109.976 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.72 -172.67 1.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.445 -0.343 . . . . 43.44 110.199 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.475 HG23 HG23 ' A' ' 4' ' ' THR . 15.0 t -85.92 -8.75 57.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.053 0.454 . . . . 65.42 111.037 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.475 HG23 HG23 ' A' ' 3' ' ' THR . 61.8 p -121.13 -178.37 3.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.962 0.41 . . . . 62.13 110.891 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.561 HG22 HG12 ' A' ' 37' ' ' VAL . 33.5 m -90.13 15.48 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.11 0.481 . . . . 72.21 110.601 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 62.19 22.72 13.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.16 -0.927 . . . . 75.31 112.541 172.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.523 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 83.14 90.25 0.7 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.46 -0.876 . . . . 71.42 111.916 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -85.23 161.03 35.42 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.436 -0.888 . . . . 43.34 112.382 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.532 ' HB ' HG22 ' A' ' 31' ' ' THR . 60.2 p -140.34 146.21 38.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.645 0.259 . . . . 73.43 110.781 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.461 HG23 HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -122.05 122.08 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.586 -0.524 . . . . 73.43 109.586 170.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -93.09 121.82 34.83 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.834 -0.432 . . . . 71.4 109.834 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' A' ' 152' ' ' ALA . 85.2 m-85 -107.69 123.32 48.33 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.841 -0.618 . . . . 74.34 110.46 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.607 ' HB3' HG22 ' A' ' 153' ' ' THR . 41.2 tptt -104.07 137.7 41.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.092 -0.504 . . . . 73.52 110.045 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -125.56 -136.24 4.47 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.709 -0.757 . . . . 34.42 112.836 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.645 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 48.9 mt-10 64.06 20.55 12.24 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.986 0.514 . . . . 64.45 110.89 -176.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 155' ' ' LYS . 26.8 m -69.62 -24.44 27.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.685 -0.688 . . . . 71.4 111.107 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.483 HG21 ' CG2' ' A' ' 156' ' ' VAL . 16.4 m -138.19 141.17 38.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.171 0.51 . . . . 75.21 112.004 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -143.75 24.78 1.68 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.961 -1.018 . . . . 63.15 108.483 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.73 -73.5 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.414 -0.812 . . . . 74.01 111.047 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.547 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -90.28 -40.88 11.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.901 0.381 . . . . 74.44 110.502 177.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -139.16 133.14 31.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.098 -0.501 . . . . 53.04 110.038 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.95 124.67 40.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.419 -0.355 . . . . 53.43 110.434 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.489 ' HA ' HD23 ' A' ' 58' ' ' LEU . 7.3 t -63.96 133.4 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.669 -0.493 . . . . 64.22 109.669 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.491 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.7 t70 -59.4 140.42 56.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.239 -0.437 . . . . 71.35 110.671 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -60.75 -26.49 67.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.488 . . . . 74.01 112.115 -174.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.55 -23.66 72.46 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.496 -0.859 . . . . 45.22 112.062 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.2 p -102.86 -7.72 21.34 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.913 0.338 . . . . 70.04 111.913 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.645 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 34.1 m -84.4 -2.87 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.063 0.458 . . . . 65.32 110.82 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -165.08 85.19 0.39 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.124 -1.065 . . . . 53.41 108.124 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -137.19 133.22 34.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.552 -0.749 . . . . 53.32 110.469 -173.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.532 HG22 ' HB ' ' A' ' 9' ' ' THR . 3.5 m -110.45 100.57 9.38 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.567 -0.742 . . . . 53.12 109.098 176.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.461 HG13 HG23 ' A' ' 10' ' ' VAL . 8.2 p -84.77 128.32 39.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.228 0.537 . . . . 73.14 110.488 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HG3' HG22 ' A' ' 9' ' ' THR . 26.4 mp0 -88.43 128.61 35.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.541 -0.754 . . . . 63.22 109.718 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.458 HD21 HG22 ' A' ' 10' ' ' VAL . 2.7 mm? -88.74 -34.56 17.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.336 0.589 . . . . 54.42 109.87 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.523 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 104.37 -179.6 24.72 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.433 -0.803 . . . . 55.02 111.813 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.424 ' HB3' ' CB ' ' A' ' 4' ' ' THR . 44.7 mt-30 -84.44 89.85 7.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.829 0.347 . . . . 72.25 110.576 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.561 HG12 HG22 ' A' ' 5' ' ' VAL . 9.5 p -70.81 141.82 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 73.14 110.267 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -75.54 137.27 40.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.972 -0.558 . . . . 60.13 109.965 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.3 p -86.88 5.17 38.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.468 0.652 . . . . 63.34 110.346 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.31 -27.87 18.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.433 -0.803 . . . . 53.15 110.737 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.476 ' HB2' HD12 ' A' ' 42' ' ' LEU . 12.3 m -72.23 -41.46 66.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.427 0.632 . . . . 70.24 110.342 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.1 mp -98.88 114.51 27.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.362 -0.835 . . . . 74.33 109.54 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.4 10.78 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.217 0.451 . . . . 65.12 112.217 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -150.57 153.51 35.89 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.552 0.215 . . . . 74.13 110.854 -177.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 0.9 OUTLIER -65.58 121.11 14.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.022 -0.732 . . . . 75.32 109.022 176.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.424 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 106.27 2.57 38.46 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.591 -0.814 . . . . 64.12 111.761 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -80.91 140.4 35.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.817 0.341 . . . . 62.51 110.74 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.8 p -126.36 151.6 47.4 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.977 -0.556 . . . . 73.42 110.991 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.493 ' O ' ' HD2' ' A' ' 136' ' ' ARG . 27.3 t -104.07 179.47 4.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.044 -0.725 . . . . 53.24 109.044 174.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.3 m -73.54 129.59 38.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.239 -0.282 . . . . 53.45 110.239 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.665 ' HA ' ' HB3' ' A' ' 136' ' ' ARG . . . -82.29 157.6 23.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.595 0.712 . . . . 70.11 112.019 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.2 m -98.12 152.13 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.61 -1.177 . . . . 64.43 109.622 172.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.54 94.78 1.02 Allowed Glycine 0 C--N 1.313 -0.743 0 C-N-CA 120.785 -0.722 . . . . 60.22 112.276 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -107.93 178.34 4.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.031 -0.729 . . . . 72.11 109.031 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.599 ' HB2' HG22 ' A' ' 130' ' ' THR . 0.3 OUTLIER -148.97 151.51 34.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.964 0.727 . . . . 63.51 112.964 -177.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.4 HD12 ' CE2' ' A' ' 133' ' ' PHE . 83.0 mt -109.53 111.8 37.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 114.905 -1.043 . . . . 73.41 108.837 173.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 52.8 tt0 -94.55 135.01 36.49 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.198 -0.455 . . . . 71.43 111.074 -172.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 23' ' ' VAL . 75.4 mt -116.12 119.32 35.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.25 -0.432 . . . . 63.45 110.288 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -101.41 146.1 28.06 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.074 -0.512 . . . . 63.44 110.06 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 52.04 65.73 1.41 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.635 0.731 . . . . 73.21 110.224 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.481 ' SG ' HD13 ' A' ' 124' ' ' LEU . 39.1 t -100.24 137.26 38.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.245 -0.889 . . . . 64.12 110.258 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.44 ' OD2' HG12 ' A' ' 65' ' ' VAL . 17.1 t70 -111.64 137.75 49.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.213 -0.448 . . . . 73.12 111.494 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 p -102.32 0.98 35.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.133 -0.485 . . . . 73.23 112.246 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -79.74 -34.75 39.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.852 0.358 . . . . 64.5 110.371 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.471 HG13 ' HB2' ' A' ' 20' ' ' ALA . 11.7 p -107.5 -12.37 10.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.035 0.445 . . . . 55.13 110.928 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -122.8 179.41 4.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.709 0.29 . . . . 71.21 111.152 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.2 m -143.6 -59.17 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.3 -0.409 . . . . 52.14 110.796 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -137.94 139.58 39.83 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.576 -0.527 . . . . 65.33 109.576 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.403 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -100.27 118.53 36.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.143 0.497 . . . . 62.13 110.471 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.16 119.11 21.41 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.545 -0.752 . . . . 74.45 109.476 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 156' ' ' VAL . 2.4 m -90.31 146.49 6.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.963 0.411 . . . . 72.01 110.838 -175.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.07 142.3 46.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.599 -0.728 . . . . 43.03 109.149 172.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.471 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 78.3 m-85 -106.68 140.06 40.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.114 0.483 . . . . 71.14 110.93 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.3 tp -131.54 138.03 48.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.554 -0.748 . . . . 75.14 109.746 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.434 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -174.39 -160.06 21.86 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.23 -0.748 . . . . 31.1 111.23 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.4 m -91.82 114.37 26.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.671 0.235 . . . . 64.1 110.538 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.83 134.33 43.33 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.07 -0.344 . . . . 65.33 110.07 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.629 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 7.9 tt -63.54 -28.49 45.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.175 -0.466 . . . . 74.22 111.515 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -154.03 -178.94 7.42 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.79 -0.448 . . . . 71.22 109.79 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.81 -29.68 23.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.306 0.574 . . . . 73.43 109.703 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.44 -33.23 53.45 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.785 -0.721 . . . . 61.45 111.572 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -112.97 86.82 2.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.126 0.489 . . . . 73.31 110.155 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.5 p -93.56 8.74 39.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.821 -0.627 . . . . 70.22 111.411 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -115.14 0.47 13.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.146 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 102' ' ' GLN . 85.3 t -114.55 121.89 67.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.292 -0.413 . . . . 63.34 110.12 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.771 HD22 HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -70.56 130.09 40.92 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 110.039 -0.356 . . . . 64.12 110.039 -178.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.629 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.1 149.38 35.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.864 -0.607 . . . . 75.41 110.417 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.571 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -86.18 138.45 31.89 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.274 -0.421 . . . . 74.5 110.345 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -68.02 141.15 56.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.356 0.598 . . . . 64.42 110.584 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.461 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 0.9 OUTLIER -85.28 116.21 23.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.335 -0.848 . . . . 72.32 111.214 -174.063 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.5 m -92.77 -1.67 56.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.797 -0.638 . . . . 65.04 110.464 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 66.47 5.82 4.01 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.777 -0.647 . . . . 63.12 111.955 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.77 11.24 12.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.149 0.499 . . . . 51.43 110.596 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.78 77.52 0.96 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.641 -0.79 . . . . 71.45 112.135 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' A' ' 90' ' ' SER . 67.4 m -81.46 156.62 25.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.115 -0.328 . . . . 61.41 110.115 173.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.3 129.49 38.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.341 -0.39 . . . . 74.11 110.41 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.63 163.64 20.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.39 -0.368 . . . . 63.15 110.66 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 69.41 9.38 7.26 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.565 0.54 . . . . 52.41 110.409 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.87 174.12 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.423 -0.808 . . . . 71.13 110.133 174.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.528 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . -172.33 -174.05 39.41 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.255 -1.138 . . . . 62.1 110.255 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.15 114.81 45.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.469 0.652 . . . . 61.2 110.565 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.463 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.4 pt20 -104.54 145.03 30.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.753 -0.658 . . . . 74.22 109.396 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.471 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -104.13 123.63 58.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.142 0.496 . . . . 73.24 110.254 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 16.7 mt -91.46 144.63 25.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.503 -0.771 . . . . 75.43 108.947 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.548 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.1 p-10 -71.63 -171.7 0.69 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.7 -0.481 . . . . 74.43 109.7 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.441 ' CG ' ' HB3' ' A' ' 120' ' ' SER . 12.8 ptm180 -63.28 -25.2 68.21 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.098 0.407 . . . . 75.44 112.098 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.1 p -85.88 -34.33 21.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.709 -0.396 . . . . 71.41 110.759 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.74 29.6 1.38 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.655 -0.783 . . . . 61.54 112.446 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.08 131.32 54.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.034 -0.358 . . . . 71.23 110.034 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.35 120.88 15.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.398 -0.365 . . . . 52.21 110.797 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.7 mt -87.7 133.31 33.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.168 -0.469 . . . . 60.34 110.539 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.536 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 16.2 m -69.38 139.34 54.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.164 -0.471 . . . . 74.4 110.445 177.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.771 HD13 HD22 ' A' ' 86' ' ' LEU . 29.6 mt -84.37 47.44 1.35 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.202 -0.454 . . . . 64.54 111.055 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -107.14 -6.04 17.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.964 0.412 . . . . 74.2 110.487 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.69 1.42 77.48 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.972 -0.632 . . . . 70.42 112.621 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -120.7 -0.85 10.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.008 0.432 . . . . 71.51 110.973 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.536 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 10.7 m -98.5 112.4 24.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.059 -0.518 . . . . 70.55 109.659 175.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -103.67 162.38 13.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.189 0.518 . . . . 75.31 111.492 -172.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.548 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.7 m -77.63 -175.0 3.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 63.51 111.405 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.441 ' HB3' ' CG ' ' A' ' 106' ' ' ARG . 42.5 t -63.74 153.86 35.03 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.043 -0.526 . . . . 62.44 110.572 175.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.564 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 40.4 mt-10 -68.35 97.84 0.78 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.916 -0.584 . . . . 73.34 110.686 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.6 m -79.54 100.5 7.78 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.442 -0.577 . . . . 64.33 109.442 173.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.8 m -57.07 114.95 2.35 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.906 -0.588 . . . . 61.32 110.683 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.481 HD13 ' SG ' ' A' ' 61' ' ' CYS . 91.3 mt -80.47 150.5 29.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.659 -0.7 . . . . 65.32 111.444 -175.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -136.3 157.46 46.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.684 -0.858 . . . . 74.32 108.684 170.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -59.03 115.88 3.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.709 0.29 . . . . 51.2 110.868 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 131.45 -138.44 10.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.832 -0.699 . . . . 64.22 112.383 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 54.9 m -97.43 125.06 41.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.285 0.564 . . . . 75.21 111.378 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -121.97 110.97 16.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.5 -0.773 . . . . 61.44 109.612 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.599 HG22 ' HB2' ' A' ' 55' ' ' ASN . 5.7 m -103.54 116.93 33.29 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.435 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.61 112.9 59.61 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.093 -0.503 . . . . 65.12 110.479 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -80.3 143.37 15.61 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.504 2.136 . . . . 75.53 112.633 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 105' ' ' ASP . 68.2 m-85 -140.64 165.67 26.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 74.44 110.618 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.629 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 96.4 mt-30 -126.7 121.31 31.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.178 -0.465 . . . . 72.03 111.011 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -110.34 130.21 55.6 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.189 -0.3 . . . . 71.55 110.189 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.665 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 39.8 ptt180 -149.78 170.68 18.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.036 0.446 . . . . 74.04 111.397 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 92.0 m-85 -86.37 145.33 26.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.593 -0.73 . . . . 71.33 111.084 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.424 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 75.3 t80 -130.33 133.28 46.32 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.244 -0.889 . . . . 72.25 108.644 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -100.52 138.7 37.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.039 0.447 . . . . 70.32 111.617 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.546 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 57.0 p -102.98 3.36 36.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.506 -0.77 . . . . 70.33 109.575 176.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.57 -132.92 2.73 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.998 -1.001 . . . . 41.32 110.86 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.54 91.47 2.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.063 -0.347 . . . . 62.13 110.063 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -48.12 112.49 0.58 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 53.54 111.333 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.0 p -104.24 141.44 22.53 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-N 116.052 -0.522 . . . . 55.24 110.593 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -71.1 171.78 15.24 Favored 'Trans proline' 0 C--N 1.334 -0.222 0 C-N-CA 123.877 3.051 . . . . 73.52 113.035 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.6 -161.35 26.61 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.665 -0.779 . . . . 75.12 111.989 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.421 ' H ' ' HA ' ' A' ' 95' ' ' SER . . . -79.31 112.52 16.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.652 0.226 . . . . 64.2 110.397 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.571 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -113.75 71.92 0.76 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.04 0.447 . . . . 72.13 111.375 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -120.92 128.09 52.44 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.444 -0.576 . . . . 73.34 109.444 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.488 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -130.5 171.86 12.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 72.33 111.913 -173.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -129.9 127.22 39.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.667 -0.697 . . . . 73.41 110.428 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 12' ' ' PHE . . . -139.13 125.81 20.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.191 0.519 . . . . 43.23 110.784 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.607 HG22 ' HB3' ' A' ' 13' ' ' LYS . 16.9 p -105.86 130.07 53.9 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.937 -0.574 . . . . 74.44 110.143 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -106.44 141.21 38.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.183 0.516 . . . . 75.13 111.072 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.675 ' HA ' HG21 ' A' ' 16' ' ' VAL . 3.9 tmmm? -126.38 109.39 12.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.602 -0.726 . . . . 73.24 109.808 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -75.2 142.86 14.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.029 0.443 . . . . 75.32 110.321 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -122.31 121.6 37.11 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.5 -0.556 . . . . 74.11 109.5 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.579 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 1.1 p90 -142.22 -17.59 0.73 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.332 -0.394 . . . . 75.54 111.075 175.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.358 -0.829 . . . . 72.1 108.925 174.855 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.816 0.341 . . . . 65.01 110.724 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.33 -176.96 5.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.088 -0.506 . . . . 62.35 110.134 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 t -81.96 -16.82 49.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.175 0.512 . . . . 61.5 110.375 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.8 p -98.97 -176.42 3.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.949 -0.569 . . . . 62.22 110.723 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.549 HG22 HG12 ' A' ' 37' ' ' VAL . 33.7 m -89.52 13.69 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.824 0.345 . . . . 54.51 110.871 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 60.61 16.29 6.44 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.356 -0.838 . . . . 65.44 112.648 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.32 107.02 3.05 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.575 -0.821 . . . . 65.52 112.127 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.578 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -98.23 150.35 19.38 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.383 -0.913 . . . . 44.02 111.772 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.523 ' HB ' HG22 ' A' ' 31' ' ' THR . 16.9 p -142.55 145.45 33.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.746 0.308 . . . . 60.21 110.766 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.628 HG22 HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -121.39 119.65 59.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.955 -0.566 . . . . 74.31 110.789 175.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -86.65 123.45 31.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.413 -0.812 . . . . 63.22 110.124 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -107.93 126.89 53.23 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.289 -0.414 . . . . 74.14 110.374 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HB3' HG22 ' A' ' 153' ' ' THR . 64.7 tttp -111.88 129.14 56.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.133 -0.485 . . . . 55.44 110.087 177.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.4 -123.99 5.34 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.871 -0.681 . . . . 75.02 111.906 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 34.7 mt-10 64.33 16.35 10.07 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.135 0.493 . . . . 73.5 111.522 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 155' ' ' LYS . 27.2 m -81.33 -21.63 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.936 -0.575 . . . . 70.35 111.284 -177.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.539 HG11 HG22 ' A' ' 156' ' ' VAL . 18.5 m -137.74 141.88 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.296 0.569 . . . . 53.22 111.352 -176.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -147.0 23.24 1.2 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.289 -1.004 . . . . 71.24 108.289 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.2 -92.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.306 -0.861 . . . . 73.03 111.107 -176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -73.2 -35.53 66.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.898 0.38 . . . . 55.5 110.776 -177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 1.4 m -141.59 133.12 26.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.938 -0.574 . . . . 73.2 109.825 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.96 126.3 41.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.25 -0.432 . . . . 23.1 110.276 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 t -67.4 131.62 32.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.773 -0.454 . . . . 70.33 109.773 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.438 ' O ' HG13 ' A' ' 28' ' ' VAL . 19.4 t70 -62.62 151.53 37.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.436 -0.347 . . . . 75.31 110.949 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.421 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -57.85 -36.02 71.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 73.3 111.472 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.24 -2.01 86.68 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.903 -0.665 . . . . 74.32 111.961 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.414 ' OG ' HG23 ' A' ' 56' ' ' ILE . 46.5 t -119.6 -3.45 10.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.502 0.191 . . . . 72.34 110.901 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 32.9 m -94.34 -14.34 8.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.61 -0.515 . . . . 64.34 109.61 172.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -150.38 91.17 1.72 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.194 -0.912 . . . . 75.32 109.577 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -141.17 141.96 34.06 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.143 0.496 . . . . 71.14 109.978 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.523 HG22 ' HB ' ' A' ' 9' ' ' THR . 9.1 m -123.41 109.6 14.08 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.83 -0.623 . . . . 65.11 109.664 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.411 HG12 HG23 ' A' ' 10' ' ' VAL . 10.9 p -86.29 136.39 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.949 0.404 . . . . 73.43 110.324 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.516 ' HA ' HG22 ' A' ' 9' ' ' THR . 27.0 mp0 -93.31 115.08 27.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.989 -0.551 . . . . 54.24 110.43 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.628 HD21 HG22 ' A' ' 10' ' ' VAL . 2.7 mm? -76.96 -30.03 55.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.65 -0.705 . . . . 73.32 109.61 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.94 -173.48 30.6 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.511 -0.768 . . . . 64.24 111.75 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -83.54 90.45 7.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.564 0.221 . . . . 60.12 110.541 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.549 HG12 HG22 ' A' ' 5' ' ' VAL . 7.5 p -61.6 141.32 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.183 0.516 . . . . 53.43 110.399 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -86.49 116.01 24.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.794 -0.639 . . . . 73.33 110.098 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 p -70.62 -12.65 61.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.362 -0.835 . . . . 73.13 112.197 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.26 -30.47 48.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.887 0.375 . . . . 63.3 111.006 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.438 ' HB2' HD12 ' A' ' 42' ' ' LEU . 15.2 m -70.28 -40.66 74.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.547 0.689 . . . . 72.13 110.277 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -99.31 87.08 3.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.48 -0.782 . . . . 75.54 110.298 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.13 14.21 9.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.019 0.438 . . . . 72.51 111.257 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -154.64 146.74 23.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.782 -0.645 . . . . 71.1 109.504 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 43.1 tt0 -60.1 136.52 58.05 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.103 -0.332 . . . . 73.45 110.103 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.97 -14.3 60.13 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.606 -0.806 . . . . 63.24 111.813 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.35 125.15 25.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.698 0.285 . . . . 52.23 110.448 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 20.3 p -117.41 140.5 49.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.323 -0.399 . . . . 61.51 110.515 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.1 t -86.39 174.51 8.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.74 -0.466 . . . . 55.51 109.74 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -68.0 134.53 50.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.504 -0.554 . . . . 61.21 109.504 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -87.06 155.67 20.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.429 0.633 . . . . 72.04 111.757 -175.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.5 m -90.96 152.09 3.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.688 -1.142 . . . . 72.43 109.024 169.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.05 87.16 0.46 Allowed Glycine 0 C--N 1.31 -0.888 0 C-N-CA 120.784 -0.722 . . . . 41.1 111.776 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -101.68 173.12 6.56 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.769 -0.456 . . . . 73.32 109.769 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -140.82 146.92 38.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.905 0.383 . . . . 61.22 111.244 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.417 HD13 ' CE1' ' A' ' 154' ' ' PHE . 41.1 mt -102.58 122.45 54.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.605 -0.725 . . . . 72.34 109.251 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -100.72 126.86 47.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.099 -0.5 . . . . 74.25 111.305 -173.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 128' ' ' THR . 70.4 mt -111.44 129.5 56.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.664 -0.698 . . . . 74.34 109.835 175.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -102.27 135.09 44.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.157 -0.474 . . . . 63.24 110.098 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.9 t70 49.09 77.51 0.1 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.069 0.855 . . . . 65.31 111.052 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.472 ' SG ' HD13 ' A' ' 124' ' ' LEU . 49.0 t -108.85 129.83 55.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.162 -0.927 . . . . 63.32 110.128 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 64' ' ' ASN . 24.9 t70 -99.12 147.55 24.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.029 0.443 . . . . 70.1 111.772 -176.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 p -115.84 8.99 14.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.647 -0.706 . . . . 74.43 111.546 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.414 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 55.4 m-80 -91.24 -31.49 16.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.006 0.431 . . . . 60.25 110.006 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 p -102.29 -16.17 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.17 0.509 . . . . 63.01 110.571 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.623 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -128.35 -178.33 4.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.269 -0.423 . . . . 74.34 110.792 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.513 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 37.1 m -144.19 -59.2 0.38 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.696 -0.229 . . . . 71.15 111.231 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.618 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -135.65 141.17 44.98 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 110.041 -0.355 . . . . 75.41 110.041 -178.331 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.06 124.74 49.1 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.093 0.473 . . . . 64.44 110.618 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.59 117.71 17.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.734 -0.667 . . . . 73.13 109.369 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.626 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -93.4 150.16 4.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.071 0.462 . . . . 61.35 110.768 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.37 124.15 44.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.49 -0.777 . . . . 53.12 109.474 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.451 ' CE1' HG21 ' A' ' 103' ' ' ILE . 62.9 m-85 -86.39 134.73 33.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.213 0.53 . . . . 73.12 110.643 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.6 tp -132.38 122.44 25.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.512 -0.767 . . . . 52.33 109.73 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.15 -166.55 27.4 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.127 -0.789 . . . . 54.22 111.127 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.506 ' O ' HD13 ' A' ' 86' ' ' LEU . 4.1 m -76.8 124.95 28.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.476 0.179 . . . . 72.02 110.823 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.39 140.62 35.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.264 -0.273 . . . . 61.31 110.264 177.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 13.3 tt -62.98 -29.03 46.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.011 0.434 . . . . 75.04 111.118 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -149.68 178.08 9.18 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.443 -0.577 . . . . 73.12 109.443 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.95 -27.84 30.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.069 0.462 . . . . 73.3 109.981 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.32 -37.91 9.44 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.817 -0.706 . . . . 55.54 111.505 175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -95.5 77.57 3.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.709 -0.478 . . . . 72.41 109.709 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.452 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 15.6 p -91.61 12.89 19.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.807 -0.633 . . . . 70.24 111.316 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -112.79 -5.01 13.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.125 -0.489 . . . . 73.52 110.993 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.2 t -112.12 128.83 68.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.384 -0.371 . . . . 72.44 110.249 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.526 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -68.64 137.56 54.3 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.014 -0.365 . . . . 63.21 110.014 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.97 157.57 29.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.181 -0.463 . . . . 65.21 110.34 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.593 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.5 mm? -93.71 139.63 30.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.371 -0.377 . . . . 63.33 110.451 -176.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 149' ' ' ASN . 31.4 mt-30 -65.38 135.62 55.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.256 0.551 . . . . 71.13 109.642 176.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.438 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 1.2 m -96.93 123.52 40.66 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.708 -0.678 . . . . 73.44 110.263 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.4 m -97.78 -3.03 39.78 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.33 -0.396 . . . . 62.34 110.391 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 60.54 26.39 16.05 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.603 -0.726 . . . . 62.54 110.521 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.41 -12.97 1.35 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.701 -0.681 . . . . 61.14 112.134 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.65 74.58 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.137 -1.03 . . . . 51.5 112.679 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.438 ' OG ' ' HA ' ' A' ' 90' ' ' SER . 54.7 m -90.66 168.71 11.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.878 -0.416 . . . . 62.21 109.878 174.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -92.94 146.26 23.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.68 -0.236 . . . . 44.1 110.38 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.22 164.81 26.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.728 0.299 . . . . 71.35 110.935 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.407 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 23.6 m-80 68.76 7.56 6.21 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.881 0.873 . . . . 64.11 111.285 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.593 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -147.65 150.21 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 CA-C-N 115.965 -0.561 . . . . 34.34 109.882 173.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.86 -170.2 15.71 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.712 -0.955 . . . . 52.43 110.712 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.428 HG11 HG13 ' A' ' 10' ' ' VAL . 2.5 p -121.34 122.44 67.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.155 0.502 . . . . 71.15 110.412 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.16 138.88 51.38 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.136 0.494 . . . . 72.33 109.768 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.451 HG21 ' CE1' ' A' ' 73' ' ' PHE . 4.2 mp -94.14 128.42 45.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.841 -0.618 . . . . 62.23 110.071 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 18.4 mt -96.35 154.86 17.03 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.486 -0.779 . . . . 72.43 109.462 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.557 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 2.4 p-10 -72.92 -167.95 0.43 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.401 -0.592 . . . . 72.22 109.401 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -71.29 -19.06 62.38 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.462 -0.495 . . . . 74.31 111.858 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.2 p -90.6 -35.22 15.13 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.913 -0.315 . . . . 73.34 110.952 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.83 26.34 1.41 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.516 -0.85 . . . . 62.54 113.349 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . -100.52 140.45 34.76 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.332 -0.247 . . . . 43.24 110.332 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.03 126.33 30.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.317 -0.401 . . . . 71.32 111.465 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.7 mt -87.28 147.28 25.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.017 -0.538 . . . . 72.23 110.326 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.6 m -93.37 141.04 28.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.109 -0.496 . . . . 73.24 110.55 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.412 ' CD1' HD22 ' A' ' 86' ' ' LEU . 63.7 mt -84.25 60.25 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.074 0.464 . . . . 74.41 110.977 -176.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -119.57 -4.84 10.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.016 -0.538 . . . . 74.41 109.909 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.29 4.97 65.43 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.617 -0.72 . . . . 74.12 112.726 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.48 -16.65 7.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.848 0.356 . . . . 72.23 110.811 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.2 m -84.15 97.76 9.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.664 -0.495 . . . . 72.12 109.664 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.496 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 86.6 m-85 -87.49 165.43 15.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.23 -0.441 . . . . 62.3 110.837 -175.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.0 m -74.53 -171.08 1.14 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.948 -0.569 . . . . 74.14 110.888 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.2 p -72.79 164.9 25.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.963 -0.384 . . . . 52.22 109.963 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.418 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 41.7 mt-10 -72.78 103.03 3.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.924 0.392 . . . . 74.05 111.193 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.0 m -84.19 109.65 17.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.317 -0.623 . . . . 75.02 109.317 174.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.3 m -63.6 113.52 3.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.941 -0.572 . . . . 62.44 111.095 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.472 HD13 ' SG ' ' A' ' 61' ' ' CYS . 94.6 mt -77.66 150.14 34.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.857 -0.61 . . . . 73.22 110.943 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.429 HD22 ' C ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER -135.96 152.47 51.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.949 -0.569 . . . . 63.24 109.642 170.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 2.7 m120 -55.15 113.31 1.32 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.988 0.423 . . . . 72.32 111.587 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.75 -145.93 16.55 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.901 -0.666 . . . . 73.41 112.265 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 28.3 m -82.76 129.27 34.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.782 0.325 . . . . 53.41 110.379 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 26.1 m-80 -122.25 133.13 54.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.214 -0.448 . . . . 63.23 110.884 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.63 113.33 26.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.245 -0.434 . . . . 62.12 110.922 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 16.1 mt -92.87 106.4 18.82 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.042 -0.725 . . . . 63.34 109.042 175.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 6.2 Cg_exo -79.09 135.13 12.07 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.033 2.489 . . . . 55.31 112.31 -176.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -136.41 166.87 22.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.294 -0.412 . . . . 72.25 110.623 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.574 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 27.5 mt-30 -132.89 117.9 18.27 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.954 -0.566 . . . . 73.42 110.922 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.95 125.26 50.2 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.188 -0.301 . . . . 55.22 110.188 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.55 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 14.8 ptp180 -140.63 164.45 30.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.818 0.342 . . . . 74.23 110.836 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.578 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 58.6 m-85 -81.54 149.02 28.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.931 -0.577 . . . . 72.33 111.206 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -132.03 127.68 36.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.427 -0.806 . . . . 74.45 109.127 177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.645 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -91.64 135.0 34.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.978 0.418 . . . . 74.22 111.416 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 55.8 p -101.82 1.03 36.65 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.425 -0.954 . . . . 74.22 108.425 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.82 -123.89 1.1 Allowed Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.34 -1.3 . . . . 60.33 111.189 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.25 98.0 11.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.44 -0.207 . . . . 31.22 110.44 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -47.71 117.3 1.78 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.075 -0.511 . . . . 75.12 111.083 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.6 p -107.29 146.74 33.85 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.169 -0.469 . . . . 73.44 110.79 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.73 167.7 23.65 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.382 2.722 . . . . 54.42 112.726 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.63 -125.04 2.75 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.663 -0.78 . . . . 42.01 111.768 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -129.91 118.47 21.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.738 0.304 . . . . 65.44 110.461 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.429 ' C ' HD22 ' A' ' 149' ' ' ASN . . . -114.53 71.85 0.77 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.12 0.486 . . . . 63.4 110.933 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.488 HD22 ' N ' ' A' ' 149' ' ' ASN . 0.8 OUTLIER -111.98 146.16 38.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.392 -0.596 . . . . 71.24 109.392 178.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.526 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -150.25 163.22 38.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.801 0.334 . . . . 63.01 111.395 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -132.99 144.88 50.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 74.34 109.797 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.96 152.05 33.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.408 0.623 . . . . 74.0 111.68 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.53 HG22 ' HB3' ' A' ' 13' ' ' LYS . 7.9 p -108.1 142.6 38.05 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.299 -0.864 . . . . 74.34 109.259 173.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.417 ' CE1' HD13 ' A' ' 56' ' ' ILE . 53.7 p90 -117.94 130.47 56.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.926 0.393 . . . . 72.41 110.572 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.625 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -110.03 112.45 24.46 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.098 -0.501 . . . . 75.12 110.36 178.157 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.626 HG12 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -80.47 146.32 7.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.912 -0.403 . . . . 72.44 109.912 178.31 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -127.29 123.53 36.63 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.281 -0.637 . . . . 62.33 109.281 171.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.623 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -135.27 -12.89 2.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.927 0.394 . . . . 75.22 111.337 175.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.23 -0.89 . . . . 54.43 109.559 170.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.882 0.373 . . . . 74.24 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.63 165.0 35.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.141 -0.481 . . . . 31.41 110.137 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.4 t -95.45 12.58 28.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.386 0.612 . . . . 73.01 110.566 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.9 p -118.64 171.49 8.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.042 -0.527 . . . . 72.54 110.135 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.453 HG22 HG12 ' A' ' 37' ' ' VAL . 27.2 m -87.84 21.49 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.018 0.437 . . . . 41.34 111.27 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 58.83 19.13 6.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.442 -0.799 . . . . 65.53 112.436 173.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.526 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 88.29 99.97 0.94 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.652 -0.785 . . . . 71.45 111.77 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.424 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -92.84 157.74 23.72 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.206 -0.997 . . . . 62.33 112.19 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.578 ' HB ' HG22 ' A' ' 31' ' ' THR . 73.0 p -140.91 148.95 41.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.57 0.224 . . . . 70.54 110.574 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.516 HG23 HD21 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -121.69 119.36 58.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.943 -0.762 . . . . 62.24 108.943 171.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -91.15 109.56 20.82 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.402 -0.519 . . . . 74.13 109.694 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.455 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 97.7 m-85 -96.0 126.49 41.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.703 -0.68 . . . . 75.12 109.901 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -110.38 128.92 55.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.374 -0.376 . . . . 71.45 110.596 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.67 -139.1 10.35 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.056 -0.593 . . . . 62.12 111.85 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 60.83 27.48 17.28 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.356 0.598 . . . . 74.24 111.311 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.626 HG21 ' HA ' ' A' ' 155' ' ' LYS . 31.2 m -83.29 -28.96 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.647 -0.706 . . . . 74.1 111.188 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.648 HG21 HG22 ' A' ' 156' ' ' VAL . 16.4 m -142.36 151.04 18.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.349 -0.387 . . . . 64.04 110.939 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -167.98 84.17 0.2 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.713 -0.847 . . . . 74.12 108.713 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.1 -74.05 0.26 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.349 -0.841 . . . . 34.11 110.025 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.546 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -73.52 -35.27 65.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.996 0.427 . . . . 75.53 109.997 173.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.41 ' CB ' ' HA ' ' A' ' 61' ' ' CYS . 4.2 m -143.56 -176.63 5.03 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.13 -0.693 . . . . 73.43 109.13 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.64 146.69 41.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.202 -0.666 . . . . 54.13 109.202 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 t -81.32 137.23 21.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.74 -0.467 . . . . 72.22 109.74 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' O ' HG13 ' A' ' 28' ' ' VAL . 12.3 t70 -65.45 141.35 58.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.61 -0.268 . . . . 73.05 110.328 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -57.12 -28.74 62.96 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.405 0.441 . . . . 74.11 111.98 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.28 -11.09 82.19 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.564 -0.827 . . . . 75.44 112.415 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.9 p -124.97 14.96 8.53 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.833 0.309 . . . . 74.42 111.833 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 24' ' ' ASP . 32.9 m -102.9 -5.74 9.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.087 0.47 . . . . 61.34 110.241 173.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -155.66 90.88 1.26 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.311 -0.859 . . . . 75.11 109.325 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 20.3 pm0 -139.65 124.29 18.33 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.346 0.593 . . . . 70.13 110.672 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.578 HG22 ' HB ' ' A' ' 9' ' ' THR . 2.2 m -100.54 95.09 6.48 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.452 -0.795 . . . . 63.02 109.29 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.99 136.59 24.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.209 0.528 . . . . 75.31 110.718 -174.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -96.58 118.63 33.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.448 -0.796 . . . . 54.31 110.267 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.516 HD21 HG23 ' A' ' 10' ' ' VAL . 2.6 mm? -90.13 -26.2 20.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.116 -0.493 . . . . 61.02 109.855 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.526 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 90.2 179.85 43.98 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.642 -0.708 . . . . 75.02 112.644 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -81.65 90.11 6.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.67 0.271 . . . . 65.51 110.636 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.453 HG12 HG22 ' A' ' 5' ' ' VAL . 7.3 p -79.28 142.36 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 110.249 -0.278 . . . . 53.21 110.249 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -71.89 126.41 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 74.21 110.649 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.601 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 32.5 p -74.43 -20.22 60.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.07 0.462 . . . . 72.02 110.903 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.11 -29.95 65.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 51.11 111.442 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.8 m -71.06 -35.12 71.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.253 0.549 . . . . 74.41 110.25 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -98.74 74.08 2.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.713 -0.676 . . . . 73.32 110.256 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.94 17.66 18.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.083 0.468 . . . . 65.22 110.993 -172.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -150.37 138.7 20.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.866 -0.606 . . . . 64.42 110.218 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -55.72 126.59 26.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.955 0.407 . . . . 74.54 110.358 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.37 -9.54 38.71 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.708 -0.758 . . . . 75.23 111.898 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -62.97 121.04 12.56 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.73 0.3 . . . . 63.23 110.427 177.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.1 p -115.9 119.66 36.68 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.956 -0.566 . . . . 53.01 110.216 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.5 t -83.04 171.09 14.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.264 -0.425 . . . . 71.13 109.908 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.0 m -64.76 127.94 33.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.985 -0.552 . . . . 45.32 110.368 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 134' ' ' GLN . . . -83.3 147.58 27.87 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.492 0.663 . . . . 51.03 111.638 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 29.2 m -87.07 151.62 3.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 114.775 -1.102 . . . . 71.12 109.278 171.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.6 97.51 0.99 Allowed Glycine 0 C--N 1.311 -0.84 0 C-N-CA 120.976 -0.631 . . . . 61.32 112.322 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -109.87 172.44 6.85 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.81 -0.441 . . . . 73.24 109.81 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.579 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.3 p-10 -135.25 144.38 46.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.123 0.487 . . . . 74.34 111.648 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 81.7 mt -113.05 124.64 69.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.389 -0.823 . . . . 72.25 108.803 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -109.47 144.1 38.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.847 0.356 . . . . 74.04 111.089 -172.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 128' ' ' THR . 23.7 mt -120.52 133.4 55.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.227 -0.442 . . . . 75.02 109.823 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -112.15 155.29 24.17 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.928 -0.578 . . . . 61.14 109.839 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 51.58 45.77 27.55 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 123.849 0.718 . . . . 71.22 110.638 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 5.8 t -89.18 143.4 26.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.355 -0.838 . . . . 63.32 110.602 -174.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 64' ' ' ASN . 20.9 t70 -117.87 154.43 31.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 64.42 111.612 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.6 p -124.12 9.64 8.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.354 -0.384 . . . . 72.52 111.263 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.453 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 52.7 m-80 -84.37 -34.12 23.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 73.21 110.159 177.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.834 HG22 ' HG3' ' A' ' 159' ' ' GLN . 8.5 p -110.7 -17.09 8.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.044 -0.526 . . . . 52.22 110.985 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -122.68 167.38 13.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.631 -0.259 . . . . 71.32 110.983 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.546 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 13.8 m -130.22 -55.4 1.11 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.404 -0.362 . . . . 44.24 111.117 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.546 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -138.67 153.23 48.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.177 -0.305 . . . . 73.3 110.177 -178.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.479 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -105.1 127.11 52.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.061 0.458 . . . . 64.24 110.369 177.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -135.14 116.0 14.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.746 -0.661 . . . . 53.25 109.56 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 1.0 OUTLIER -89.81 144.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.158 0.504 . . . . 71.13 111.199 -174.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.85 118.07 29.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.215 -0.902 . . . . 74.42 109.537 173.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 89.5 m-85 -82.71 137.83 34.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.188 0.518 . . . . 73.24 110.874 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.2 tp -128.42 135.78 49.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.554 -0.748 . . . . 72.44 109.521 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.08 -177.54 47.68 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.994 -0.622 . . . . 74.21 111.621 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 m -75.16 120.96 21.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.782 0.325 . . . . 73.45 110.818 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -79.18 144.14 34.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.137 -0.483 . . . . 45.45 110.402 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 tt -77.9 -21.26 13.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.013 0.435 . . . . 74.31 110.784 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -155.12 176.32 12.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.552 -0.536 . . . . 74.43 109.552 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.03 -29.02 32.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.98 0.419 . . . . 61.25 110.433 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.78 -24.63 19.97 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.832 -0.699 . . . . 72.43 111.692 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -99.91 50.71 0.91 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.348 0.594 . . . . 65.23 109.652 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.459 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 5.6 p -78.63 4.99 12.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.549 -0.751 . . . . 65.35 112.098 -176.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -107.7 -1.79 20.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.117 0.484 . . . . 72.43 110.525 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.422 HG22 ' HB3' ' A' ' 102' ' ' GLN . 60.0 t -108.62 123.98 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 72.25 110.285 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.568 HD22 HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -70.04 131.79 44.88 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.982 -0.377 . . . . 74.44 109.982 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.53 149.49 33.07 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.141 -0.482 . . . . 52.43 110.775 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.3 mm? -81.02 143.75 32.28 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.896 -0.593 . . . . 72.42 110.567 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -63.19 141.68 58.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.026 -0.534 . . . . 73.42 111.09 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.8 p -77.14 112.33 13.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.765 -0.652 . . . . 75.54 110.678 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.5 m -105.17 -8.14 18.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.23 -0.441 . . . . 62.11 110.814 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 64.94 3.88 2.26 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.451 0.7 . . . . 63.22 112.174 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.13 11.03 20.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.219 0.533 . . . . 72.44 110.254 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.54 85.06 1.84 Allowed Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.429 -0.805 . . . . 64.41 111.673 -175.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.1 m -82.11 146.86 29.39 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.541 -0.541 . . . . 70.13 109.541 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.23 121.73 14.42 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.094 -0.335 . . . . 74.21 110.094 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.4 160.69 18.15 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.788 -0.365 . . . . 63.41 110.755 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 69.26 14.61 8.59 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.669 -0.696 . . . . 63.44 110.476 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.0 -179.99 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.887 -0.597 . . . . 71.31 110.058 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 179.4 -173.57 45.5 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.172 -1.171 . . . . 73.31 110.172 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.431 HG21 HG21 ' A' ' 10' ' ' VAL . 3.2 p -119.95 114.59 44.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.628 0.727 . . . . 72.13 110.674 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.6 pt20 -103.9 141.7 35.7 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.486 -0.779 . . . . 73.24 109.114 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.498 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.3 mp -104.18 127.66 58.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.199 0.523 . . . . 72.23 110.464 -177.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.0 mt -93.44 147.24 23.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.425 -0.807 . . . . 64.11 109.222 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -70.29 -172.71 0.61 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.494 -0.558 . . . . 71.53 109.494 174.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -67.92 -16.62 64.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.398 0.518 . . . . 74.11 112.398 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.403 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 69.0 p -95.53 -32.49 12.83 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.718 -0.393 . . . . 64.54 111.053 177.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.71 32.49 0.76 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.735 -0.745 . . . . 73.53 112.82 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.4 125.41 50.96 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.724 -0.28 . . . . 71.34 110.36 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.61 116.59 12.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.953 0.406 . . . . 65.41 110.436 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.6 mt -84.85 132.74 34.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.007 -0.542 . . . . 72.13 111.238 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.449 ' H ' HG21 ' A' ' 117' ' ' THR . 25.0 m -68.72 141.61 55.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.816 -0.629 . . . . 73.35 110.604 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.568 HD13 HD22 ' A' ' 86' ' ' LEU . 49.8 mt -82.7 41.2 0.71 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 74.02 111.207 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.41 -16.36 46.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.86 0.362 . . . . 73.52 110.56 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.67 3.58 89.06 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.735 -0.745 . . . . 71.34 111.603 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -128.1 2.3 5.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.725 0.298 . . . . 51.21 111.316 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 112' ' ' THR . 9.0 m -94.37 102.89 14.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.016 -0.365 . . . . 53.01 110.016 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.515 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 75.6 m-85 -93.99 150.84 19.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.213 -0.449 . . . . 71.55 111.876 -172.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 6.1 m -68.01 179.82 1.4 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.388 -0.824 . . . . 71.24 111.264 177.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.2 m -67.36 147.75 52.53 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.019 -0.537 . . . . 74.4 109.766 173.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.469 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 47.0 mt-10 -55.28 110.44 0.69 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 73.14 111.662 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.8 m -96.35 107.25 19.6 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.016 -0.735 . . . . 75.24 109.016 173.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 m -61.93 132.96 54.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.088 -0.506 . . . . 52.42 111.414 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 69' ' ' ALA . 82.2 mt -94.6 149.14 21.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.241 0.543 . . . . 73.01 111.926 -176.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -128.38 151.55 49.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.219 -0.9 . . . . 73.24 108.835 168.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 17.9 m120 -63.7 121.94 15.18 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.952 0.406 . . . . 74.45 110.68 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.97 -109.94 1.22 Allowed Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.814 -0.63 . . . . 50.3 111.892 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 98.5 m -127.11 133.03 50.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.055 0.455 . . . . 53.12 111.173 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -129.65 145.25 51.52 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.359 -0.608 . . . . 72.32 109.359 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.579 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.6 m -125.82 122.64 36.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.867 0.365 . . . . 74.21 110.73 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.6 mt -102.91 115.74 63.68 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.167 -0.47 . . . . 50.22 110.084 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -80.26 138.27 12.48 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.84 2.36 . . . . 64.24 112.215 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -137.44 163.2 31.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.888 0.375 . . . . 75.12 110.81 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.625 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 19.9 mt-30 -131.82 119.3 21.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.98 -0.555 . . . . 74.5 111.235 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.93 129.9 53.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.442 -0.344 . . . . 63.24 110.259 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.431 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 1.4 ptp180 -140.86 164.97 28.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.892 0.377 . . . . 74.31 111.361 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 70.2 m-85 -86.55 141.75 28.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.865 -0.607 . . . . 75.01 110.33 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -127.97 122.53 32.57 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.238 -0.653 . . . . 70.33 109.238 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.636 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -85.45 130.55 34.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.89 0.376 . . . . 72.32 110.908 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 63.8 p -102.19 11.43 38.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.716 0.77 . . . . 75.24 108.933 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 163.84 -123.57 1.19 Allowed Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.616 -1.175 . . . . 70.2 111.385 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.9 95.35 8.19 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.242 -0.281 . . . . 61.44 110.242 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.601 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.02 115.55 1.33 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.006 0.432 . . . . 74.13 111.136 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 36.0 p -103.87 141.39 22.41 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.825 -0.435 . . . . 64.43 109.825 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.49 163.43 38.07 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.449 2.766 . . . . 73.05 112.396 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.35 -153.91 25.63 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.628 -0.796 . . . . 63.34 111.796 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.45 108.07 19.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.737 0.303 . . . . 73.4 110.828 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -107.05 75.78 1.05 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.201 0.524 . . . . 74.04 110.71 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -123.77 134.32 53.67 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.331 -0.618 . . . . 75.01 109.331 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -136.91 167.57 21.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.993 0.425 . . . . 41.32 111.434 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -131.16 142.47 50.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.643 -0.708 . . . . 74.42 109.561 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.81 139.05 27.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.224 0.535 . . . . 71.34 111.255 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.6 p -108.86 117.0 33.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.821 -0.627 . . . . 73.22 110.014 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.443 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 47.4 p90 -95.04 123.6 38.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.511 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.626 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.5 tmmm? -106.01 100.91 10.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.702 -0.481 . . . . 73.21 109.702 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 1.1 m -78.57 133.21 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 121.314 0.578 . . . . 51.0 110.168 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -111.7 113.38 25.72 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.876 -0.602 . . . . 72.15 110.987 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.546 ' CD1' ' HB3' ' A' ' 20' ' ' ALA . 5.3 p90 -135.39 -40.37 0.73 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.542 -0.754 . . . . 73.41 109.208 169.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.834 ' HG3' HG22 ' A' ' 65' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.073 0 N-CA-C 108.082 -1.081 . . . . 75.31 108.082 176.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 120.9 0.381 . . . . 75.41 110.826 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.9 -179.08 6.26 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.52 -0.548 . . . . 70.23 109.52 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.0 t -97.22 -10.04 26.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.591 0.71 . . . . 71.32 109.881 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.423 HG22 ' HA ' ' A' ' 38' ' ' ARG . 74.2 p -118.01 -178.03 3.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.528 -0.76 . . . . 61.52 110.156 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.552 HG22 HG12 ' A' ' 37' ' ' VAL . 34.6 m -90.42 17.71 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.901 0.381 . . . . 73.42 111.001 176.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 59.55 31.07 20.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.597 -0.729 . . . . 74.33 112.275 171.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.451 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 79.82 92.53 0.4 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.68 -0.771 . . . . 31.32 112.3 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.31 153.42 25.26 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.208 -0.996 . . . . 65.11 111.678 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.556 ' HB ' HG22 ' A' ' 31' ' ' THR . 45.2 p -138.53 144.97 40.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.71 0.291 . . . . 72.13 110.486 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.485 ' CG2' HD21 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -118.04 120.44 64.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.97 -0.752 . . . . 71.02 108.97 172.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -86.86 111.28 20.62 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.405 -0.518 . . . . 73.2 109.611 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -100.92 118.84 37.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.808 -0.633 . . . . 62.2 110.02 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HB3' HG22 ' A' ' 153' ' ' THR . 48.0 tttp -116.21 138.08 51.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.145 -0.479 . . . . 72.1 110.597 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -116.22 -116.43 2.96 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.786 -0.643 . . . . 73.52 111.86 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.934 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 28.3 mt-10 62.45 22.45 13.26 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.158 0.504 . . . . 73.15 110.915 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.683 HG21 ' HA ' ' A' ' 155' ' ' LYS . 29.7 m -83.13 -26.46 7.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.574 -0.739 . . . . 73.02 111.659 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.705 HG21 HG22 ' A' ' 156' ' ' VAL . 3.8 m -140.28 134.63 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.099 0.476 . . . . 54.03 112.204 -173.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -139.22 23.4 2.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.174 -0.921 . . . . 75.55 109.33 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.71 -83.1 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 50.23 111.886 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.3 -34.05 70.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.467 0.651 . . . . 53.41 110.637 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 2.8 m -146.44 162.72 37.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.262 -0.881 . . . . 73.32 108.628 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.05 127.22 53.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.482 0.182 . . . . 62.42 110.601 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 t -70.04 130.09 34.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.904 -0.406 . . . . 71.21 109.904 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.9 t70 -57.84 140.87 50.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 64.43 111.067 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.431 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -63.84 -17.08 62.78 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 112.443 0.534 . . . . 53.23 112.443 -174.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.51 -23.12 48.49 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.596 -0.811 . . . . 61.04 111.949 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.0 p -101.63 -8.43 21.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.787 0.292 . . . . 61.41 111.787 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.934 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 30.5 m -82.4 -4.14 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.705 0.288 . . . . 64.24 111.471 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -164.44 85.07 0.43 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.048 -0.723 . . . . 40.25 109.048 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -136.33 130.6 33.11 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.872 -0.604 . . . . 64.04 110.716 -172.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.556 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.1 m -106.43 104.64 14.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.761 -0.654 . . . . 74.51 109.818 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' THR . 12.1 p -88.53 132.55 33.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.13 0.491 . . . . 54.55 110.928 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.435 ' HA ' HG22 ' A' ' 9' ' ' THR . 25.0 mp0 -89.2 123.39 33.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.811 -0.631 . . . . 73.24 110.129 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.485 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.5 mm? -83.6 -23.86 31.73 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.926 -0.768 . . . . 71.5 108.926 175.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 93.19 179.63 39.73 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.077 -0.965 . . . . 75.12 112.058 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -80.82 87.1 5.92 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.219 -0.289 . . . . 63.23 110.219 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.552 HG12 HG22 ' A' ' 5' ' ' VAL . 7.9 p -71.95 136.0 26.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.51 -0.552 . . . . 74.22 109.51 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.423 ' HA ' HG22 ' A' ' 4' ' ' THR . 76.3 mtp180 -78.82 130.29 35.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.245 -0.434 . . . . 73.44 110.411 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.0 p -82.03 13.09 3.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.065 -0.516 . . . . 72.13 111.224 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.4 -22.47 17.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.177 0.513 . . . . 63.02 109.785 174.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -81.88 -15.72 53.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.462 -0.79 . . . . 32.01 110.541 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.428 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 5.0 mp -125.87 117.19 22.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.06 -0.719 . . . . 74.54 109.06 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.96 10.35 2.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.763 0.653 . . . . 50.3 112.763 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -153.98 156.21 37.0 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 110.358 -0.238 . . . . 74.24 110.358 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 42.2 tt0 -61.04 131.04 49.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.396 -0.366 . . . . 73.12 110.047 177.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.45 -1.96 57.36 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.686 -0.769 . . . . 54.15 111.939 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -78.09 115.57 17.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.008 0.432 . . . . 63.42 110.012 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.568 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 4.7 p -111.46 135.43 52.02 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.766 -0.652 . . . . 64.32 110.431 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 t -88.07 179.47 6.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 62.02 109.649 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 m -71.55 139.57 49.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.725 -0.472 . . . . 63.3 109.725 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.514 ' HB2' ' HE ' ' A' ' 136' ' ' ARG . . . -90.96 152.61 20.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.311 0.576 . . . . 75.54 112.03 -175.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 24.7 m -83.53 158.56 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.77 -1.105 . . . . 54.33 109.199 168.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.79 89.92 0.51 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.896 -0.669 . . . . 65.21 112.054 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -103.25 175.56 5.44 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.575 -0.528 . . . . 73.21 109.575 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.58 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.3 p-10 -143.68 155.06 44.11 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.367 0.603 . . . . 54.25 111.869 -174.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.422 HD12 ' CE2' ' A' ' 133' ' ' PHE . 80.0 mt -115.05 112.62 40.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.052 -0.976 . . . . 74.22 108.903 171.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -96.52 128.25 43.28 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.036 0.445 . . . . 74.34 110.703 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.3 mt -110.33 126.01 53.78 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.88 -0.6 . . . . 60.54 110.046 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -105.36 145.09 31.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.019 -0.537 . . . . 72.24 109.555 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 30.2 t70 49.69 69.14 0.63 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.926 0.869 . . . . 71.34 110.563 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.415 ' SG ' HD22 ' A' ' 124' ' ' LEU . 10.2 t -106.28 114.84 29.2 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.048 -0.978 . . . . 63.05 109.734 -176.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -96.68 131.59 43.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.08 -0.509 . . . . 75.43 111.515 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.0 p -102.24 12.8 36.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 71.12 111.879 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -87.87 -26.36 22.81 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.539 -0.541 . . . . 65.42 109.539 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.73 -32.97 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.674 -0.694 . . . . 63.44 110.841 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -113.57 -179.19 3.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.725 0.298 . . . . 71.34 111.326 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 29.4 m -139.32 -55.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.503 -0.317 . . . . 74.4 111.596 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -136.31 144.7 44.84 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 110.408 -0.219 . . . . 72.43 110.408 -177.031 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.512 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -103.23 137.29 41.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.967 0.413 . . . . 65.24 110.72 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.39 113.74 6.28 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.865 -0.607 . . . . 74.31 109.417 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.709 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -87.01 145.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.98 0.419 . . . . 54.24 110.977 -173.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.563 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -118.18 122.06 42.07 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.738 -0.665 . . . . 53.45 109.919 174.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.466 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 88.6 m-85 -87.58 130.62 34.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.297 0.57 . . . . 75.34 110.812 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.5 tp -125.41 122.66 37.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.605 -0.725 . . . . 75.04 109.763 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.05 -171.43 29.28 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.768 -0.651 . . . . 63.42 111.586 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.419 ' O ' HD13 ' A' ' 86' ' ' LEU . 8.8 m -84.59 119.9 25.73 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.374 -0.232 . . . . 71.23 110.374 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -78.65 144.67 35.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.522 -0.308 . . . . 65.43 110.987 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.409 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 6.7 tt -69.79 -37.29 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.417 . . . . 73.11 110.835 178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.33 175.45 10.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.316 -0.624 . . . . 73.42 109.316 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.34 -37.15 38.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.083 0.468 . . . . 70.25 110.323 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.5 -19.01 67.2 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.591 -0.814 . . . . 74.54 111.276 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -111.17 47.57 0.99 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.16 0.505 . . . . 74.42 109.728 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.511 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -74.14 4.1 6.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.602 -0.727 . . . . 53.01 112.373 -176.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 30.3 p-10 -108.09 -0.6 21.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.158 0.504 . . . . 71.34 110.288 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 102' ' ' GLN . 46.2 t -108.01 125.82 64.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.875 -0.602 . . . . 62.42 110.153 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.504 HD22 ' CD1' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -69.0 134.42 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.382 -0.372 . . . . 72.12 110.588 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.409 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.36 150.27 35.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.06 -0.518 . . . . 43.32 110.483 177.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.428 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.5 mm? -91.77 134.47 34.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.313 -0.403 . . . . 74.0 110.451 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -82.14 130.88 35.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.364 0.602 . . . . 52.11 110.611 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 m -68.33 134.85 50.95 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.9 -1.045 . . . . 51.1 111.707 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.8 m -109.14 3.24 21.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.925 -0.58 . . . . 74.34 110.098 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 59.79 13.37 3.49 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.438 -0.801 . . . . 71.34 112.068 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.58 11.92 14.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.022 0.439 . . . . 52.42 110.405 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.95 77.89 1.06 Allowed Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.463 -0.875 . . . . 72.2 111.153 -176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.2 m -74.35 160.49 30.98 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.18 -0.304 . . . . 72.44 110.18 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.95 149.89 21.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.784 -0.45 . . . . 75.43 109.784 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.45 167.54 21.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.918 -0.401 . . . . 64.25 109.918 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 68.62 10.18 7.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.17 0.51 . . . . 71.04 110.498 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.07 -177.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.634 -0.712 . . . . 73.04 110.444 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.84 -174.78 46.86 Favored Glycine 0 N--CA 1.439 -1.133 0 N-CA-C 110.171 -1.172 . . . . 75.01 110.171 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.65 115.27 46.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.364 0.602 . . . . 71.01 110.62 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.412 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.9 pt20 -107.28 135.42 48.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.206 -0.664 . . . . 72.44 109.206 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.466 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -95.83 123.61 48.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.968 0.413 . . . . 73.32 110.813 -175.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.52 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 15.5 mt -88.65 136.19 33.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.485 -0.779 . . . . 72.12 109.336 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.2 OUTLIER -71.78 -173.64 1.02 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.776 -0.453 . . . . 72.34 109.776 175.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.47 ' HG3' HG23 ' A' ' 107' ' ' THR . 15.4 ptm180 -57.96 -23.77 55.15 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.973 0.36 . . . . 73.3 111.973 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.47 HG23 ' HG3' ' A' ' 106' ' ' ARG . 71.0 p -102.02 11.41 38.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.792 0.33 . . . . 52.31 111.647 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.52 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 76.52 35.57 41.13 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.836 -0.697 . . . . 61.54 112.985 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.63 120.71 42.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.352 -0.24 . . . . 75.35 110.352 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 103' ' ' ILE . . . -65.83 111.42 3.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.984 0.421 . . . . 74.13 110.534 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.5 mt -78.26 132.93 37.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.849 -0.614 . . . . 72.4 111.3 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.515 ' H ' HG21 ' A' ' 117' ' ' THR . 15.3 m -67.55 142.06 56.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.492 -0.776 . . . . 54.44 110.598 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.504 ' CD1' HD22 ' A' ' 86' ' ' LEU . 59.5 mt -81.79 44.15 0.81 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.057 0.456 . . . . 74.25 110.808 -177.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -92.97 -18.03 23.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.836 -0.62 . . . . 75.32 110.516 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.58 -16.29 46.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.613 -0.803 . . . . 53.24 112.325 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.82 8.11 20.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.101 0.476 . . . . 54.15 110.717 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.515 HG21 ' H ' ' A' ' 112' ' ' THR . 2.1 m -97.03 95.88 8.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.011 -0.541 . . . . 71.23 110.059 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.715 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 65.3 m-85 -93.61 158.0 15.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.178 -0.465 . . . . 73.44 111.405 -173.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 5.7 m -69.58 -175.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.639 -0.71 . . . . 71.52 111.586 178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.9 t -69.37 163.52 24.98 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.765 -0.457 . . . . 62.42 109.765 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.418 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 48.9 mt-10 -68.03 104.58 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.765 0.317 . . . . 54.24 111.245 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.513 HG21 HG12 ' A' ' 131' ' ' ILE . 75.1 m -85.14 99.11 10.85 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.649 -0.501 . . . . 64.1 109.649 173.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.4 m -56.16 112.92 1.35 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.719 -0.673 . . . . 75.33 110.585 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' A' ' 69' ' ' ALA . 85.1 mt -74.33 144.39 44.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 52.42 111.712 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -117.41 141.93 47.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.188 -0.915 . . . . 75.01 109.215 173.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -55.59 116.69 3.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.36 0.413 . . . . 63.42 110.868 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 119.67 -111.51 2.05 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.592 -0.813 . . . . 73.21 112.57 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.6 m -112.05 134.77 53.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.943 0.401 . . . . 50.04 111.198 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -131.17 124.11 29.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.948 -0.569 . . . . 73.43 110.122 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.58 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.7 m -110.75 107.06 16.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.738 0.304 . . . . 72.22 110.331 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 122' ' ' THR . 13.7 mt -88.14 118.04 69.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.365 -0.38 . . . . 72.4 110.119 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.18 137.98 9.83 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.812 2.341 . . . . 74.31 112.956 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 74.2 m-85 -136.43 161.84 34.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 73.1 111.135 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 26.3 mt-30 -130.17 118.1 20.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.807 -0.633 . . . . 72.31 110.934 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -107.05 125.62 51.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.134 -0.321 . . . . 63.14 110.134 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.568 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 10.1 ptp180 -138.64 163.53 31.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.011 0.434 . . . . 54.3 111.092 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 64.4 m-85 -81.52 142.3 32.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 73.14 111.053 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -126.4 116.84 21.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.435 -0.802 . . . . 74.1 109.376 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -82.19 131.28 35.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.479 -0.328 . . . . 53.14 110.566 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 68.9 p -101.3 2.84 40.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.645 0.736 . . . . 75.15 109.471 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 173.81 -134.75 2.97 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.742 -1.117 . . . . 71.13 110.635 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 144' ' ' THR . . . -78.08 85.91 4.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.712 0.256 . . . . 75.03 110.338 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -46.48 111.67 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.614 0.571 . . . . 42.32 111.781 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 142' ' ' ALA . 20.4 p -102.49 144.49 28.71 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-O 121.075 0.464 . . . . 72.43 111.232 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.41 167.38 26.49 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 123.413 2.742 . . . . 72.41 112.648 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.39 -128.78 3.14 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.867 -0.682 . . . . 70.52 111.783 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -120.68 117.24 27.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.719 0.295 . . . . 51.15 110.468 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.428 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -118.09 74.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.164 0.507 . . . . 42.03 111.309 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -117.31 138.67 51.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.963 -0.562 . . . . 70.24 109.897 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.473 ' HB3' HG13 ' A' ' 10' ' ' VAL . . . -135.63 171.58 14.25 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.586 0.587 . . . . 64.12 112.586 -172.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -134.01 128.67 34.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.247 -0.888 . . . . 73.55 109.739 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.415 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -150.67 144.31 25.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.281 0.562 . . . . 74.13 111.867 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.438 HG22 ' HB3' ' A' ' 13' ' ' LYS . 21.7 p -112.4 150.67 30.79 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.694 -0.684 . . . . 51.24 109.529 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -121.92 134.25 54.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.257 0.551 . . . . 64.34 111.219 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.715 ' HD2' ' HE1' ' A' ' 118' ' ' PHE . 20.2 ttmt -111.22 101.57 10.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.608 -0.724 . . . . 70.23 110.499 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.709 HG12 HG12 ' A' ' 71' ' ' VAL . 1.3 m -75.13 126.82 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 119.983 -0.687 . . . . 74.15 109.539 176.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -108.48 111.82 23.9 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.874 -0.603 . . . . 70.13 110.434 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -129.92 -21.02 3.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.882 0.372 . . . . 73.13 110.839 171.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 . . . . . 0 C--O 1.249 1.071 0 N-CA-C 109.051 -0.722 . . . . 71.32 109.051 175.401 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.569 -0.53 . . . . 63.34 109.569 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 145' ' ' PRO . . . -65.16 127.87 33.47 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.019 -0.734 . . . . 70.33 109.019 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.6 t -77.65 -14.24 59.68 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.461 0.541 . . . . 60.35 112.461 -169.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.6 p -97.85 176.96 5.61 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 122.087 -0.383 . . . . 72.33 110.259 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.489 ' CG2' HG12 ' A' ' 37' ' ' VAL . 35.5 m -88.42 13.19 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.189 0.519 . . . . 75.24 110.715 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 63.67 14.31 8.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.233 -0.894 . . . . 71.14 112.502 172.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.43 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 88.59 94.45 1.04 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.674 -0.774 . . . . 71.34 111.677 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.412 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -84.66 152.22 27.29 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.425 -0.893 . . . . 53.55 112.084 -176.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.531 ' HB ' HG22 ' A' ' 31' ' ' THR . 21.0 p -143.06 139.97 30.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.342 -0.244 . . . . 74.41 110.342 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.29 126.28 68.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.835 -0.432 . . . . 72.12 109.835 175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -93.91 112.7 24.58 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.574 -0.528 . . . . 64.13 109.574 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -100.08 122.64 43.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.962 -0.563 . . . . 53.11 110.657 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HB3' HG22 ' A' ' 153' ' ' THR . 59.3 tttm -112.09 136.09 51.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 61.5 110.092 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.08 -120.72 3.41 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.715 -0.755 . . . . 64.0 112.349 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.573 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 34.8 mt-10 63.28 20.01 12.01 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.06 0.457 . . . . 75.54 110.943 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.634 HG21 ' HA ' ' A' ' 155' ' ' LYS . 18.9 m -80.39 -21.95 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.661 . . . . 72.34 112.207 -175.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.411 HG13 HG23 ' A' ' 16' ' ' VAL . 17.3 m -133.49 157.3 42.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.237 0.542 . . . . 61.03 112.032 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -157.54 24.74 0.29 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.696 -1.138 . . . . 63.41 108.49 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.1 -81.07 0.32 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 64.43 111.664 -174.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.407 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -93.77 -38.78 11.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.951 0.405 . . . . 63.54 110.917 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 2.0 m -137.36 128.58 27.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.126 -0.488 . . . . 75.01 110.148 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.08 125.54 35.9 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.645 -0.707 . . . . 71.14 110.361 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.473 ' HA ' HD23 ' A' ' 58' ' ' LEU . 15.8 t -66.23 128.66 29.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.72 -0.474 . . . . 70.41 109.72 177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.27 145.49 42.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.154 -0.475 . . . . 64.35 111.235 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.553 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -63.11 -22.13 66.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 75.11 111.71 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.66 -10.24 79.72 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.732 -0.747 . . . . 60.41 111.876 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.0 t -104.3 -27.5 11.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.025 -0.088 . . . . 54.22 110.827 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.573 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 27.7 m -74.66 -6.84 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.095 0.474 . . . . 74.41 110.923 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -153.54 95.14 1.87 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.36 -0.836 . . . . 73.41 109.356 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -151.57 137.73 18.34 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.888 -0.596 . . . . 63.25 110.681 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.531 HG22 ' HB ' ' A' ' 9' ' ' THR . 6.9 m -115.66 111.96 21.4 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.591 -0.731 . . . . 73.34 109.698 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 p -92.87 139.54 17.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.846 0.355 . . . . 74.53 110.691 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.439 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.4 mp0 -95.86 126.75 41.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.239 -0.437 . . . . 53.52 110.362 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -91.32 -27.59 18.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.39 0.614 . . . . 70.55 109.482 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.43 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.58 171.71 37.76 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.263 -0.881 . . . . 71.21 112.127 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -73.02 88.17 1.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.778 0.323 . . . . 72.34 110.717 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.489 HG12 ' CG2' ' A' ' 5' ' ' VAL . 9.8 p -67.44 151.93 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.478 -0.328 . . . . 71.01 110.171 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -91.31 125.02 35.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.095 -0.502 . . . . 60.53 110.725 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.3 p -74.71 -15.04 60.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.947 -0.569 . . . . 71.03 111.047 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.98 -22.51 60.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.475 . . . . 53.35 111.204 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.8 m -85.66 -33.93 21.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.136 0.494 . . . . 51.04 110.638 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.5 mp -108.61 97.74 7.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.986 -0.552 . . . . 71.02 109.956 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.25 14.87 4.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.025 0.441 . . . . 74.01 111.119 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -152.49 146.98 25.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.858 -0.61 . . . . 64.15 110.086 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 44.2 tt0 -62.65 130.76 46.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 63.34 110.303 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.98 -5.93 42.95 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.678 -0.772 . . . . 73.12 111.617 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -74.88 119.93 19.73 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.99 -0.374 . . . . 70.41 109.99 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.582 ' HB ' HH11 ' A' ' 136' ' ' ARG . 37.9 p -115.15 126.07 54.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.115 -0.493 . . . . 72.2 110.476 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.2 t -80.0 172.4 13.83 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.836 -0.431 . . . . 55.12 109.836 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.7 m -69.58 134.99 49.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.302 -0.408 . . . . 71.42 110.054 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -86.98 162.12 17.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.625 0.726 . . . . 62.34 111.93 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.5 m -104.66 152.22 6.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.575 -1.193 . . . . 61.41 109.349 172.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.82 105.23 2.19 Favored Glycine 0 C--N 1.312 -0.779 0 C-N-CA 120.802 -0.714 . . . . 75.11 112.188 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -117.93 171.89 7.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.12 -0.696 . . . . 65.43 109.12 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.82 139.6 32.76 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.526 0.679 . . . . 74.24 112.507 -175.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.443 HD13 ' CD1' ' A' ' 154' ' ' PHE . 45.9 mt -95.22 116.48 36.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.268 -0.878 . . . . 71.04 109.585 174.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -93.32 133.39 36.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.771 -0.65 . . . . 75.24 111.249 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 23' ' ' VAL . 69.3 mt -117.76 129.68 55.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.59 -0.732 . . . . 63.24 109.587 176.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -103.89 146.24 28.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.297 -0.41 . . . . 75.43 110.493 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 49.95 41.84 23.56 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.873 0.733 . . . . 50.53 111.235 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.423 ' SG ' HD22 ' A' ' 124' ' ' LEU . 53.6 t -76.76 124.55 27.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.83 -0.623 . . . . 72.52 110.492 -175.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.52 132.48 45.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.054 -0.521 . . . . 71.31 111.292 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.8 p -107.62 18.21 21.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.093 0.473 . . . . 72.31 111.661 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -90.85 -33.66 15.57 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.975 -0.75 . . . . 62.42 108.975 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 p -101.71 -12.88 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.548 -0.751 . . . . 52.11 111.086 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -135.45 169.47 17.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.692 0.282 . . . . 72.41 110.997 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.506 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 44.8 m -129.01 -57.13 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 35.33 111.97 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -135.91 141.73 44.59 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 122.164 -0.335 . . . . 75.22 110.172 -176.26 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.461 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -104.32 134.7 47.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.218 0.533 . . . . 72.24 110.495 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.86 120.43 12.5 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.351 -0.841 . . . . 71.15 109.201 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 156' ' ' VAL . 1.6 m -93.78 149.44 4.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.067 0.461 . . . . 64.01 110.965 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.22 119.32 32.87 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.461 -0.791 . . . . 75.52 109.396 172.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 62.7 m-85 -83.09 126.28 32.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.955 0.407 . . . . 62.2 110.547 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.8 tp -122.42 127.65 49.92 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.897 -0.592 . . . . 65.13 109.857 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.75 -164.44 26.47 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 111.343 -0.703 . . . . 71.33 111.343 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.418 ' O ' HD13 ' A' ' 86' ' ' LEU . 8.7 m -82.35 128.33 34.11 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.614 0.207 . . . . 74.23 110.476 -178.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -87.67 148.48 24.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.176 -0.305 . . . . 63.43 110.176 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.3 tt -74.33 -25.64 19.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.988 0.423 . . . . 64.2 110.731 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -155.66 -174.2 4.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.522 -0.547 . . . . 73.43 109.522 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.88 -44.11 13.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.078 0.466 . . . . 72.01 110.067 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.3 -18.56 71.23 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.723 -0.751 . . . . 65.21 111.333 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -104.98 46.22 0.93 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.352 0.596 . . . . 73.03 109.89 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.409 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -78.9 12.42 2.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.53 -0.759 . . . . 72.14 111.803 -178.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -107.6 -12.35 15.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.061 -0.518 . . . . 65.21 110.491 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 65.0 t -106.92 125.83 62.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.916 -0.584 . . . . 62.04 110.778 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.55 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -66.08 133.19 50.24 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.795 -0.446 . . . . 72.33 109.795 178.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.15 147.8 36.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.449 . . . . 51.35 110.114 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 2.0 mm? -78.77 145.56 34.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.133 -0.485 . . . . 73.32 110.111 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 8.8 mm-40 -62.29 123.65 18.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.923 -0.581 . . . . 70.24 110.647 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 p -71.79 99.42 2.16 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.494 -0.775 . . . . 71.41 110.933 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.4 m -93.28 -10.52 35.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.838 -0.619 . . . . 73.42 110.053 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 64.41 6.17 2.96 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.441 -0.8 . . . . 74.31 112.367 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.26 11.65 14.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.439 0.637 . . . . 73.04 110.449 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 124.78 67.93 0.19 Allowed Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.474 -0.785 . . . . 72.34 111.5 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 m -86.06 148.62 25.64 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.736 -0.468 . . . . 75.0 109.736 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.4 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -74.62 142.0 44.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.073 -0.343 . . . . 71.35 110.073 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.0 163.44 30.28 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.02 -0.363 . . . . 60.51 110.02 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.418 HD22 HG23 ' A' ' 144' ' ' THR . 77.1 m-20 70.32 10.68 7.33 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.512 0.508 . . . . 71.54 110.824 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.403 HG13 ' HB2' ' A' ' 143' ' ' ALA . 0.0 OUTLIER -146.63 -177.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.658 -0.701 . . . . 60.32 109.677 174.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 172.71 -175.89 45.68 Favored Glycine 0 N--CA 1.437 -1.259 0 N-CA-C 110.602 -0.999 . . . . 75.35 110.602 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -116.52 114.58 46.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.399 0.619 . . . . 72.14 110.83 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.408 ' HG2' ' HB2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -106.37 140.14 39.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.52 -0.764 . . . . 53.31 109.596 176.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 103' ' ' ILE . 3.9 mp -101.58 123.85 54.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.233 -0.44 . . . . 74.52 110.256 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 16.4 mt -87.74 148.61 24.66 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.537 -0.756 . . . . 62.34 109.411 176.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.567 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 2.1 p-10 -72.39 -170.74 0.68 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.715 -0.476 . . . . 64.22 109.715 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -72.09 -17.09 62.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.135 0.42 . . . . 75.34 112.135 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.6 p -89.23 -36.99 15.32 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.553 -0.459 . . . . 74.51 110.683 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 127.87 31.04 0.72 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.658 -0.782 . . . . 52.13 113.363 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -117.76 133.04 56.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.783 0.292 . . . . 62.04 110.517 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.03 141.61 57.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.962 0.41 . . . . 65.14 110.973 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.433 HD12 ' HD1' ' A' ' 73' ' ' PHE . 80.6 mt -91.09 -176.53 4.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.039 -0.528 . . . . 61.1 110.214 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.3 m -125.29 142.01 51.75 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.003 -0.369 . . . . 53.21 110.003 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 53.9 mt -84.46 39.48 0.73 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.384 -0.371 . . . . 75.41 111.548 -173.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -102.19 -0.59 32.89 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.99 0.424 . . . . 62.3 110.26 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.3 3.22 45.5 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.747 -0.66 . . . . 53.44 113.141 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -120.88 -11.6 8.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.932 0.366 . . . . 72.45 111.051 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.2 m -91.16 108.6 19.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.015 -0.365 . . . . 71.41 110.015 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.53 ' CE1' ' HE3' ' A' ' 155' ' ' LYS . 93.7 m-85 -98.27 163.96 12.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.107 0.479 . . . . 72.13 111.228 -175.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 4.0 m -70.23 175.33 4.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 62.12 110.499 175.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.0 t -68.08 146.09 53.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.229 -0.656 . . . . 75.43 109.229 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -53.76 112.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 62.01 111.444 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.6 m -97.19 106.6 18.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.744 -0.662 . . . . 74.2 109.542 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.5 m -58.49 116.34 3.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.228 0.537 . . . . 64.13 111.277 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.493 ' C ' HD22 ' A' ' 125' ' ' ASN . 87.8 mt -77.31 152.44 34.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.362 -0.836 . . . . 72.42 111.544 -175.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.493 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -122.5 153.34 39.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.514 -0.767 . . . . 72.34 109.583 173.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 82.8 m-20 -68.58 106.63 2.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.838 0.352 . . . . 61.41 110.793 176.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 131.88 -128.72 5.39 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.747 -0.739 . . . . 64.11 112.497 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.3 m -94.09 127.46 39.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.841 0.353 . . . . 64.51 110.709 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -123.58 150.05 44.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.283 -0.417 . . . . 74.13 110.216 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.59 111.43 10.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.355 -0.384 . . . . 70.21 111.068 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 mt -90.99 110.17 40.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.233 -0.654 . . . . 74.23 109.233 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.6 133.9 9.61 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.914 2.409 . . . . 72.33 112.127 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.482 ' HE1' ' HG ' ' A' ' 119' ' ' SER . 74.3 m-85 -131.27 158.85 39.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.426 -0.352 . . . . 74.13 110.501 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 92.4 mt-30 -123.04 113.53 19.15 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.864 -0.607 . . . . 75.12 110.804 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -98.75 126.89 44.5 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 121.008 -0.277 . . . . 61.1 110.329 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.582 HH11 ' HB ' ' A' ' 48' ' ' THR . 13.1 ptp180 -140.8 162.85 34.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.859 0.361 . . . . 71.42 110.809 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 62.3 m-85 -82.28 137.44 34.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.016 -0.538 . . . . 74.21 110.853 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.421 ' HD1' HG22 ' A' ' 48' ' ' THR . 80.2 t80 -121.62 119.52 32.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.771 -0.65 . . . . 63.23 109.4 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -84.0 130.32 34.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.305 -0.407 . . . . 72.45 110.746 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.502 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 73.6 p -102.01 5.34 40.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.876 0.846 . . . . 71.52 109.258 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.05 -136.89 4.01 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 114.455 -1.248 . . . . 42.21 110.274 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.15 92.19 6.25 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.663 -0.495 . . . . 72.22 109.663 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.403 ' HB2' HG13 ' A' ' 99' ' ' VAL . . . -48.43 114.1 0.89 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 123.768 0.668 . . . . 34.14 111.334 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.418 HG23 HD22 ' A' ' 98' ' ' ASN . 39.9 p -101.89 140.21 20.99 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 121.209 0.528 . . . . 74.51 110.407 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.455 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 58.1 Cg_endo -68.63 162.52 40.68 Favored 'Trans proline' 0 C--N 1.331 -0.364 0 C-N-CA 123.713 2.942 . . . . 52.35 113.342 -174.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 142.08 -167.05 26.16 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.797 -0.638 . . . . 45.35 111.731 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.88 114.03 4.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 72.43 110.894 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.484 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . . . -112.77 49.85 0.91 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.441 0.639 . . . . 71.44 110.806 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.52 ' O ' ' HG2' ' A' ' 89' ' ' GLN . 89.1 m-20 -105.79 147.53 28.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.368 -0.833 . . . . 54.3 109.411 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.55 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -148.82 169.24 20.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.717 0.294 . . . . 71.13 111.083 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -140.16 147.73 40.57 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.528 -0.545 . . . . 42.54 109.528 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -155.19 144.46 21.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.992 0.425 . . . . 73.12 111.346 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 13' ' ' LYS . 22.7 p -103.11 123.98 47.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.83 -0.623 . . . . 64.32 109.756 175.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.443 ' CD1' HD13 ' A' ' 56' ' ' ILE . 39.5 p90 -97.21 124.11 41.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.255 0.55 . . . . 62.24 110.654 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.634 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.1 tmmm? -107.31 104.23 13.79 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.782 -0.645 . . . . 65.44 109.87 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 71' ' ' VAL . 1.3 m -75.55 147.95 7.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.026 0.441 . . . . 63.31 110.046 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -133.51 129.39 37.07 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.232 -0.655 . . . . 73.43 109.232 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.617 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -136.47 -18.68 1.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.042 0.449 . . . . 73.4 110.989 175.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--O 1.245 0.847 0 N-CA-C 109.034 -0.728 . . . . 75.33 109.034 169.188 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.64 0.257 . . . . 44.42 110.361 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.58 ' HB3' HD21 ' A' ' 6' ' ' ASN . . . -71.45 -173.69 0.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 35.24 111.023 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.519 HG23 HG23 ' A' ' 4' ' ' THR . 8.9 t -79.87 -32.84 40.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.036 0.446 . . . . 75.32 111.411 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.519 HG23 HG23 ' A' ' 3' ' ' THR . 52.2 p -104.84 -175.62 2.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.905 0.383 . . . . 64.42 110.563 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.35 15.64 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.104 0.478 . . . . 75.22 110.526 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.58 HD21 ' HB3' ' A' ' 2' ' ' ALA . 0.8 OUTLIER 65.09 11.97 7.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.186 -0.915 . . . . 34.35 112.348 171.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.484 ' N ' ' HG2' ' A' ' 36' ' ' GLN . . . 87.8 98.25 0.91 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.441 -0.885 . . . . 53.43 111.537 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.68 153.06 22.91 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.191 -1.004 . . . . 52.42 112.046 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.658 ' HB ' HG22 ' A' ' 31' ' ' THR . 75.0 p -137.05 140.47 42.07 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.857 -0.423 . . . . 74.21 109.857 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -110.85 118.82 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 N-CA-C 109.7 -0.481 . . . . 71.4 109.7 176.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 13.1 t-80 -85.88 106.52 17.15 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.987 0.422 . . . . 52.01 110.005 177.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 77.8 m-85 -94.64 114.43 26.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.968 -0.56 . . . . 72.35 110.313 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 62.9 tttp -109.54 132.73 53.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.678 -0.692 . . . . 54.13 110.179 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.94 -114.64 3.01 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.89 -0.672 . . . . 41.3 112.073 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.672 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 37.4 mt-10 63.94 17.14 10.38 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.006 0.432 . . . . 75.12 111.236 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 155' ' ' LYS . 18.4 m -75.19 -30.88 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.905 -0.589 . . . . 72.33 111.92 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.453 HG21 ' CG2' ' A' ' 156' ' ' VAL . 29.6 m -140.16 154.7 23.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.246 0.546 . . . . 71.24 111.921 -174.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -155.29 28.61 0.4 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.026 -1.101 . . . . 70.12 108.026 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.43 -78.04 0.32 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.252 -0.886 . . . . 64.3 111.523 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.508 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -83.9 -37.63 22.13 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.124 0.487 . . . . 71.34 110.585 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.8 m -142.87 131.53 22.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.759 -0.655 . . . . 74.44 109.567 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.63 124.45 35.07 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.177 -0.465 . . . . 73.1 110.307 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.471 ' HA ' HD23 ' A' ' 58' ' ' LEU . 6.0 t -66.13 124.69 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.244 -0.651 . . . . 63.33 109.244 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' HG13 ' A' ' 28' ' ' VAL . 16.5 t70 -56.89 139.84 50.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 71.35 111.206 -175.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -59.72 -24.44 63.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 74.12 112.146 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.68 -17.55 70.35 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.555 -0.831 . . . . 60.04 111.915 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 p -104.98 -13.28 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.723 0.268 . . . . 65.03 111.723 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.672 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 34.7 m -78.68 -10.59 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.039 0.447 . . . . 63.03 110.623 177.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -152.68 90.43 1.48 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.415 -0.811 . . . . 73.02 108.882 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -142.99 115.96 8.83 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.517 0.675 . . . . 62.53 110.726 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.658 HG22 ' HB ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -97.1 97.02 8.86 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.277 -0.874 . . . . 54.22 108.96 176.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 9' ' ' THR . 8.8 p -75.63 132.3 33.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.938 0.399 . . . . 74.14 110.987 -175.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.56 ' HA ' HG22 ' A' ' 9' ' ' THR . 27.3 mp0 -87.82 125.76 34.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.103 -0.499 . . . . 73.34 110.107 177.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.409 HD21 HG23 ' A' ' 10' ' ' VAL . 2.9 mm? -90.59 -32.63 16.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.963 -0.562 . . . . 65.21 109.886 177.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 99.5 168.58 30.08 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.363 -0.835 . . . . 74.24 111.599 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.484 ' HG2' ' N ' ' A' ' 7' ' ' GLY . 77.4 mt-30 -74.35 86.37 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.159 0.479 . . . . 74.25 110.598 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.24 149.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 110.043 -0.355 . . . . 61.23 110.043 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -84.53 128.71 34.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.301 -0.409 . . . . 64.01 110.345 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p -68.32 -23.32 64.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.874 -0.603 . . . . 65.34 111.526 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.48 -18.35 62.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.027 -0.533 . . . . 74.12 111.496 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 m -90.3 -0.68 57.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.381 . . . . 73.53 111.276 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 3.6 mt -134.09 43.57 2.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.319 0.58 . . . . 73.3 110.285 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.36 8.41 33.63 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.667 0.617 . . . . 54.51 112.667 -168.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -150.51 144.76 25.56 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.347 -0.242 . . . . 74.32 110.347 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 86.0 tt0 -59.4 123.17 15.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.101 0.477 . . . . 62.44 110.018 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.5 -9.77 30.58 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.823 -0.703 . . . . 30.43 111.503 -175.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 42' ' ' LEU . . . -71.2 121.86 19.13 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.641 -0.503 . . . . 71.45 109.641 173.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.424 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 25.4 p -117.0 137.0 52.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.159 0.504 . . . . 72.51 111.182 -178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.462 ' HB2' ' H ' ' A' ' 137' ' ' TYR . 64.0 m -85.63 164.45 17.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.775 -0.648 . . . . 75.22 110.689 176.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.7 m -63.99 124.46 21.64 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.66 -0.496 . . . . 51.34 109.66 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.509 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -80.59 138.91 36.5 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.217 0.532 . . . . 72.11 111.489 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.2 m -78.49 148.07 6.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.107 -0.951 . . . . 62.33 109.358 170.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.42 90.46 0.69 Allowed Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.976 -0.631 . . . . 54.31 111.579 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -99.63 174.44 6.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.811 -0.44 . . . . 74.21 109.811 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.504 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 3.7 p-10 -138.06 142.78 40.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.325 0.583 . . . . 74.32 112.21 -170.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.495 HD12 ' CE2' ' A' ' 133' ' ' PHE . 73.5 mt -111.77 119.26 59.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.693 -0.855 . . . . 74.3 108.693 169.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -104.48 140.93 37.24 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.115 0.484 . . . . 74.32 111.238 -171.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 23' ' ' VAL . 55.1 mt -120.36 122.62 41.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.553 -0.748 . . . . 63.24 109.753 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -100.82 152.02 21.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.761 -0.654 . . . . 73.14 110.378 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 54.38 38.69 30.01 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.968 0.793 . . . . 74.41 110.827 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.28 129.41 34.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.946 -0.57 . . . . 73.34 110.266 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.413 ' OD1' ' HB2' ' A' ' 64' ' ' ASN . 15.7 t70 -111.29 133.95 53.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.565 . . . . 74.15 110.833 -177.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -102.58 16.23 26.97 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.189 0.44 . . . . 62.4 112.189 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.413 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 93.7 m-20 -90.45 -35.46 15.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.298 0.571 . . . . 73.22 109.478 176.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.73 -31.5 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.521 -0.763 . . . . 72.41 111.153 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.6 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -118.85 173.11 7.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.646 0.26 . . . . 75.23 110.89 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 m -133.84 -58.94 0.86 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.223 -0.444 . . . . 74.42 111.614 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -134.71 136.62 42.86 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.258 -0.275 . . . . 74.43 110.258 -177.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.71 139.69 36.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.994 0.426 . . . . 75.44 110.594 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.4 122.75 10.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.711 -0.677 . . . . 62.24 109.418 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.661 HG12 HG12 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -96.53 147.07 6.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.068 0.461 . . . . 70.35 110.973 -175.298 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.49 127.09 53.67 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.733 -0.667 . . . . 71.54 109.466 173.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 83.8 m-85 -88.99 131.7 35.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.899 0.38 . . . . 74.3 110.294 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.4 tp -130.52 125.06 33.34 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.976 -0.556 . . . . 71.52 110.355 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.48 -131.95 1.3 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.647 -0.706 . . . . 70.53 111.545 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.1 m -121.34 131.06 53.97 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.177 -0.305 . . . . 74.4 110.177 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -82.46 142.09 32.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.592 -0.276 . . . . 74.51 110.847 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 tt -69.18 -26.53 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.012 0.434 . . . . 73.53 111.09 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -144.6 179.74 7.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.599 -0.519 . . . . 52.33 109.599 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.05 -30.67 27.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.181 0.515 . . . . 75.43 109.745 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.37 -37.77 7.46 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.812 -0.709 . . . . 73.1 111.594 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -91.17 77.66 5.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.359 0.6 . . . . 70.44 110.163 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.446 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 9.2 p -94.53 6.17 49.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.28 -0.873 . . . . 52.44 111.586 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -111.8 2.34 17.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.207 0.527 . . . . 64.43 110.653 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 102' ' ' GLN . 47.9 t -113.65 125.98 71.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.775 -0.648 . . . . 53.11 109.73 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -68.64 135.92 52.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.648 0.261 . . . . 72.12 110.506 -178.338 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.47 149.89 34.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.086 -0.506 . . . . 74.01 110.376 177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.474 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.9 mm? -84.3 139.11 32.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.342 -0.39 . . . . 52.33 110.176 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.425 ' HG3' ' HA ' ' A' ' 150' ' ' ALA . 89.9 mt-30 -61.92 131.89 51.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.878 -0.601 . . . . 72.4 110.491 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.05 113.46 5.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.013 -0.54 . . . . 61.44 110.95 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.1 m -94.57 -4.27 48.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.957 -0.565 . . . . 53.42 110.994 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 61.33 25.76 15.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.844 -0.616 . . . . 73.41 111.335 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.19 -40.18 0.22 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.711 -0.677 . . . . 73.15 110.246 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.03 86.24 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.628 -0.796 . . . . 50.24 112.116 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.3 m -85.63 149.59 25.22 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.556 -0.535 . . . . 71.34 109.556 174.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.45 148.64 51.37 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.091 -0.337 . . . . 53.33 110.091 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.61 159.82 41.43 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.865 -0.334 . . . . 73.4 110.343 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 69.31 4.49 4.64 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.626 0.579 . . . . 73.51 110.586 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.474 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -146.8 151.62 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 115.279 -0.873 . . . . 74.52 109.035 173.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -153.67 -171.64 21.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.888 -0.885 . . . . 52.21 110.888 177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 10' ' ' VAL . 3.0 p -117.37 112.41 38.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.521 0.676 . . . . 74.11 110.516 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.507 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.5 pt20 -102.27 139.04 38.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.603 -0.726 . . . . 71.35 109.447 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.487 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.8 mp -101.35 117.29 46.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.899 0.38 . . . . 63.54 110.175 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 13.4 mt -86.44 144.81 27.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.622 -0.717 . . . . 54.23 109.37 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.4 p-10 -72.95 -168.24 0.46 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.759 -0.46 . . . . 54.44 109.759 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -64.03 -31.21 72.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.561 -0.29 . . . . 70.34 111.531 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.1 p -84.85 -29.96 24.88 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.829 -0.349 . . . . 70.43 111.218 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.32 34.68 1.0 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.324 -0.941 . . . . 71.52 113.246 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.39 130.61 56.25 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.96 -0.385 . . . . 51.25 109.96 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.56 119.1 14.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 62.31 110.417 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.1 mt -79.76 132.99 36.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.002 -0.544 . . . . 61.41 111.148 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.443 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 7.9 m -68.36 140.25 55.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.688 -0.687 . . . . 74.14 110.564 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 33.2 mt -85.01 42.95 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.09 -0.504 . . . . 40.34 111.203 -176.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -100.65 -3.03 31.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.006 0.432 . . . . 74.21 110.539 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.03 12.58 68.59 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.879 -0.6 . . . . 54.23 112.795 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.68 -14.45 5.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.749 0.309 . . . . 43.12 111.071 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.443 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 18.3 m -86.25 96.52 9.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.326 -0.397 . . . . 73.43 110.079 175.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -86.51 163.46 17.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.981 -0.554 . . . . 74.5 110.506 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.518 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 1.6 m -72.82 176.26 5.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.079 -0.51 . . . . 55.23 110.805 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 48.0 t -66.15 139.27 58.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.509 -0.552 . . . . 74.54 109.509 172.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -51.58 107.42 0.19 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.638 0.586 . . . . 75.43 111.387 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.5 m -93.01 106.24 18.22 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.316 -0.624 . . . . 51.05 109.316 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.55 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 26.5 m -57.36 128.58 37.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 53.33 111.163 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.33 149.86 23.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.723 -0.671 . . . . 72.21 110.918 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -126.61 158.64 35.78 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.871 -0.788 . . . . 62.4 108.871 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -62.33 117.73 6.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.855 0.36 . . . . 72.24 110.564 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 116.7 -134.77 11.53 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.47 -0.872 . . . . 62.13 112.733 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.8 m -86.76 128.61 35.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.94 0.4 . . . . 64.43 110.984 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -124.37 144.4 50.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.568 -0.53 . . . . 72.14 109.568 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 1.5 m -128.38 118.28 22.89 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.888 0.375 . . . . 74.51 110.582 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 11.2 mt -95.04 114.03 62.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.112 -0.699 . . . . 45.14 109.112 176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 2.1 Cg_endo -81.85 136.14 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.989 2.46 . . . . 71.1 112.554 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.495 ' CE2' HD12 ' A' ' 56' ' ' ILE . 76.3 m-85 -134.19 159.74 39.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.119 -0.492 . . . . 73.34 110.588 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.628 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 19.9 mt-30 -129.15 111.8 13.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.856 -0.611 . . . . 72.21 110.864 -175.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -101.64 124.54 47.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.473 -0.33 . . . . 75.11 110.358 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 4.7 ptp180 -138.13 160.09 40.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.37 -0.377 . . . . 75.35 110.536 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 69.0 m-85 -79.25 139.58 37.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.93 -0.577 . . . . 73.51 110.23 173.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -127.0 122.63 35.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.652 -0.704 . . . . 73.42 109.328 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -85.35 132.39 34.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.381 -0.372 . . . . 43.32 111.318 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.474 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 74.3 p -105.24 3.61 30.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.635 0.731 . . . . 64.32 109.19 176.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.73 -128.48 1.54 Allowed Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.798 -1.092 . . . . 54.2 110.838 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.24 96.16 10.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.098 -0.334 . . . . 75.41 110.098 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -43.75 109.56 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.721 0.638 . . . . 64.51 111.917 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 26.9 p -102.48 139.35 20.13 Favored Pre-proline 0 N--CA 1.444 -0.726 0 CA-C-O 121.271 0.558 . . . . 64.32 110.407 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.24 -179.84 2.49 Favored 'Trans proline' 0 C--N 1.332 -0.299 0 C-N-CA 124.021 3.147 . . . . 71.33 113.421 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.46 -139.34 10.7 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.408 -0.814 . . . . 55.12 111.83 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.85 117.46 33.88 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.16 -0.311 . . . . 64.41 110.16 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -111.77 60.38 0.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.033 0.444 . . . . 51.5 111.565 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -106.98 145.82 31.82 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.412 -0.588 . . . . 63.14 109.412 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -148.61 168.01 23.94 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.347 -0.242 . . . . 74.35 110.347 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -147.7 146.19 29.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.119 -0.326 . . . . 64.34 110.119 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -153.2 149.3 27.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.076 -0.511 . . . . 71.42 110.911 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.0 p -101.15 127.24 47.79 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.99 -0.55 . . . . 72.4 109.757 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -99.57 129.29 45.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.311 0.577 . . . . 74.54 110.359 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.581 ' HA ' HG21 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -112.52 107.34 16.04 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.636 -0.711 . . . . 74.54 110.145 -178.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.661 HG12 HG12 ' A' ' 71' ' ' VAL . 1.5 m -79.71 147.6 6.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.984 0.421 . . . . 70.2 110.315 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -130.16 124.97 33.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.417 -0.586 . . . . 62.14 109.417 173.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.6 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.6 OUTLIER -139.5 -11.84 1.19 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.056 0.455 . . . . 75.13 111.045 176.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 . . . . . 0 C--O 1.247 0.968 0 CA-C-N 115.337 -0.847 . . . . 74.43 108.829 171.091 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 110.201 -0.296 . . . . 62.41 110.201 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.8 164.2 26.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.355 -0.384 . . . . 63.14 110.709 177.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.6 t -99.93 -19.92 16.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.135 0.493 . . . . 74.41 110.609 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.3 p -100.06 -179.94 4.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.019 0.438 . . . . 73.11 110.445 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.459 HG23 ' H ' ' A' ' 7' ' ' GLY . 35.6 m -83.83 6.61 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.006 0.431 . . . . 71.41 110.791 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 67.42 -3.46 1.06 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.352 -0.84 . . . . 64.35 112.648 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.459 ' H ' HG23 ' A' ' 5' ' ' VAL . . . 116.17 95.56 1.94 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.938 -0.649 . . . . 74.43 111.738 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.477 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -77.1 154.86 43.52 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.48 -0.867 . . . . 50.25 111.831 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.6 p -146.07 125.89 13.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.714 0.292 . . . . 73.44 110.862 -177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -105.19 122.35 58.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.369 -0.604 . . . . 60.11 109.369 176.035 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -90.23 99.28 12.33 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.379 -0.529 . . . . 73.41 110.049 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -90.86 117.14 29.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.605 -0.725 . . . . 71.2 110.023 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -110.76 136.91 49.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.04 0.448 . . . . 62.14 110.255 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.75 -126.25 5.58 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.768 -0.651 . . . . 44.44 111.82 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.403 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 29.3 mt-10 66.52 14.73 9.86 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.462 0.648 . . . . 73.42 110.526 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' A' ' 155' ' ' LYS . 29.7 m -76.29 -24.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.366 -0.834 . . . . 75.01 111.856 -175.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.517 HG21 HG22 ' A' ' 156' ' ' VAL . 19.1 m -139.08 142.27 34.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.271 0.558 . . . . 74.15 111.884 -175.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -142.62 18.72 2.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.804 -1.089 . . . . 73.44 108.239 173.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.51 -77.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.171 -0.922 . . . . 60.43 111.426 -172.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.522 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -92.47 -37.07 12.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.941 0.401 . . . . 64.12 110.258 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.34 132.09 25.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.245 -0.434 . . . . 72.24 110.303 -175.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.86 127.41 39.6 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.986 -0.552 . . . . 71.31 109.738 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.433 ' HB ' HG12 ' A' ' 28' ' ' VAL . 13.0 t -64.12 132.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.406 -0.361 . . . . 73.31 110.316 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.457 ' O ' HG13 ' A' ' 28' ' ' VAL . 19.2 t70 -57.27 139.34 53.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.938 -0.574 . . . . 73.11 110.682 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -64.02 -19.67 65.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.175 0.435 . . . . 72.32 112.175 -173.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.07 -18.53 74.47 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.394 -0.908 . . . . 74.52 111.937 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.8 p -110.63 -6.07 14.92 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.235 0.458 . . . . 65.54 112.235 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 25' ' ' ALA . 35.5 m -81.97 -7.29 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.912 0.387 . . . . 73.35 110.893 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -157.94 95.83 1.43 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.909 -0.774 . . . . 74.41 108.909 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -142.24 112.12 6.85 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.862 -0.608 . . . . 73.33 110.567 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.49 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.1 m -92.91 93.7 8.53 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.861 -0.792 . . . . 75.44 108.861 175.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' THR . 8.3 p -80.66 128.93 38.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.968 -0.56 . . . . 64.45 111.07 -172.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -86.62 120.99 28.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.886 -0.597 . . . . 74.12 109.685 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.44 -20.34 40.54 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.453 -0.573 . . . . 72.42 109.453 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.13 -178.72 42.07 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.203 -0.908 . . . . 73.51 111.669 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.92 90.37 6.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.615 -0.513 . . . . 61.23 109.615 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.446 HG12 HG22 ' A' ' 5' ' ' VAL . 11.8 p -64.64 136.24 26.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.16 0.505 . . . . 61.13 110.688 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 38' ' ' ARG . 67.2 mtt180 -66.91 108.25 2.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.485 -0.779 . . . . 73.31 109.741 175.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 22.9 p -67.29 -23.63 65.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.197 0.522 . . . . 64.51 110.281 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.01 -5.77 47.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.758 -0.655 . . . . 73.15 111.389 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.9 m -97.79 -4.49 36.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 73.14 110.841 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -131.07 101.54 5.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.516 . . . . 63.23 109.755 177.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.18 15.97 5.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.244 0.461 . . . . 73.24 112.244 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -151.92 147.39 26.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.801 0.334 . . . . 62.43 110.983 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -58.6 123.03 14.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.664 -0.698 . . . . 75.11 109.472 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.464 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 101.97 8.48 44.91 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.512 -0.852 . . . . 73.12 111.965 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.697 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -79.9 128.28 33.27 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.065 -0.346 . . . . 75.14 110.065 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 p -115.79 118.92 34.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.917 -0.583 . . . . 63.22 110.378 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.1 t -83.68 173.59 11.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.86 0.362 . . . . 41.13 110.256 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.2 m -69.21 129.29 39.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.853 -0.612 . . . . 53.43 110.093 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -82.22 165.19 20.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.745 0.783 . . . . 74.43 112.071 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.9 m -101.39 157.62 4.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.458 -1.246 . . . . 64.24 109.22 169.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.5 107.49 2.27 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.829 -0.701 . . . . 65.55 112.059 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -125.07 178.61 5.45 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.749 -0.463 . . . . 64.3 109.749 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.494 ' HB2' HG22 ' A' ' 130' ' ' THR . 30.2 p30 -137.26 156.99 47.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.46 0.648 . . . . 72.21 111.99 -174.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.487 HD13 ' CD1' ' A' ' 154' ' ' PHE . 65.3 mt -123.51 105.37 15.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 107.956 -1.127 . . . . 72.43 107.956 167.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 26.1 tt0 -99.05 143.29 29.49 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.939 -0.573 . . . . 64.13 110.72 -171.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 23' ' ' VAL . 41.5 mt -117.96 125.46 50.46 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.056 -0.52 . . . . 73.34 109.847 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -100.51 143.1 31.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.045 -0.525 . . . . 73.31 110.107 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 52.9 46.96 25.72 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.834 0.708 . . . . 63.1 110.926 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 44.5 t -79.26 139.92 37.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.114 -0.948 . . . . 64.11 110.812 -175.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 64' ' ' ASN . 26.6 t70 -108.89 151.47 26.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.045 -0.525 . . . . 61.44 111.592 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 75.6 p -122.92 11.88 9.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.464 -0.334 . . . . 73.44 111.66 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.408 ' H ' ' CG ' ' A' ' 62' ' ' ASP . 56.3 m-80 -81.44 -35.32 30.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.449 -0.574 . . . . 71.0 109.449 177.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.39 -27.9 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.531 -0.759 . . . . 75.35 110.805 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -112.05 166.41 11.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.045 0.45 . . . . 73.1 111.675 -176.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 m -132.7 -56.37 0.94 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.101 -0.5 . . . . 65.25 110.994 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.835 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -136.59 131.06 33.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.458 -0.337 . . . . 73.14 110.194 -177.048 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 158' ' ' TYR . . . -88.38 139.67 30.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.848 0.356 . . . . 32.23 110.707 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -143.88 114.36 7.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.645 -0.707 . . . . 52.32 109.672 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.612 HG12 HG12 ' A' ' 156' ' ' VAL . 0.8 OUTLIER -93.48 143.28 11.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.967 0.413 . . . . 63.22 110.563 -175.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.511 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -118.6 125.73 50.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.01 -0.541 . . . . 61.12 110.26 175.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 86.4 m-85 -91.73 122.67 34.49 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.925 0.393 . . . . 72.13 110.319 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.3 tp -118.9 133.25 55.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.009 -0.542 . . . . 75.23 110.066 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.91 -174.48 41.6 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.237 -0.745 . . . . 53.23 111.237 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.8 m -75.99 128.0 34.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.803 0.302 . . . . 70.15 111.103 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -82.49 140.67 33.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.773 0.321 . . . . 53.34 110.648 177.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.503 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 11.6 tt -70.58 -27.02 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.382 -0.372 . . . . 75.11 111.458 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.56 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 20.1 t70 -141.26 179.29 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.717 -0.475 . . . . 72.55 109.717 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.94 -33.7 26.69 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.078 0.466 . . . . 71.11 109.774 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.58 -28.26 13.07 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.8 -0.714 . . . . 72.3 111.651 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 77.0 m80 -92.65 69.25 4.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.421 0.629 . . . . 62.42 109.554 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.471 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 4.1 p -91.26 7.99 38.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.277 -0.874 . . . . 74.21 111.201 -178.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -110.0 4.1 21.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.947 -0.569 . . . . 74.14 110.22 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 102' ' ' GLN . 58.7 t -120.04 126.38 75.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.816 -0.629 . . . . 72.4 110.141 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.539 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -70.72 133.63 46.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.656 0.265 . . . . 73.51 110.361 -178.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -79.56 155.71 28.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.004 -0.543 . . . . 72.32 110.394 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.514 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.6 mm? -81.84 148.37 28.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.293 -0.412 . . . . 75.3 110.106 -175.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -74.78 147.38 41.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.272 -0.422 . . . . 70.55 110.294 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.6 p -90.49 105.29 17.72 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.057 0.456 . . . . 65.12 111.027 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.3 m -101.42 2.3 39.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.07 -0.514 . . . . 55.23 110.621 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 63.22 21.74 12.99 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.763 -0.653 . . . . 74.12 110.952 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.76 1.94 11.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.842 -0.617 . . . . 72.15 110.414 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.39 89.32 1.99 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.779 -0.724 . . . . 64.24 111.675 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.0 m -79.96 157.53 26.83 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.633 0.254 . . . . 75.43 110.48 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.73 149.26 49.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.419 . . . . 60.22 110.816 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.14 152.92 47.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.481 -0.327 . . . . 42.22 110.702 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.413 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 42.5 m-80 68.26 7.47 5.94 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.803 -0.635 . . . . 75.14 111.919 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.514 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -147.6 151.98 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.584 0 CA-C-O 120.978 0.418 . . . . 73.3 110.758 176.082 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -151.22 -171.29 19.1 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 110.277 -1.129 . . . . 65.51 110.277 174.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 10' ' ' VAL . 2.7 p -117.1 118.81 59.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.378 0.609 . . . . 75.53 110.965 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.456 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.0 pt20 -110.46 147.09 34.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.66 -0.7 . . . . 75.01 109.793 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.3 mp -107.44 127.87 62.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.987 0.422 . . . . 73.13 110.804 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.2 mt -91.47 142.8 27.26 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.559 -0.746 . . . . 73.45 109.116 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.557 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.9 OUTLIER -75.14 -170.42 1.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.508 -0.314 . . . . 72.32 110.167 178.282 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.5 ptt85 -62.96 -24.8 68.06 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.604 0.224 . . . . 72.04 111.604 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.423 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 69.9 p -93.49 1.06 56.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.814 0.34 . . . . 74.1 111.391 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.68 29.47 29.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.879 -0.676 . . . . 74.11 112.996 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.8 130.23 55.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.237 -0.283 . . . . 74.33 110.237 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.73 128.55 36.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.897 0.38 . . . . 63.02 111.034 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.45 148.95 23.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.956 -0.565 . . . . 65.24 110.785 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.5 m -85.66 141.9 29.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.186 -0.461 . . . . 74.45 110.251 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 63.4 mt -79.23 42.16 0.48 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.168 0.509 . . . . 73.21 110.683 -178.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.449 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 16.6 t70 -85.37 -18.72 32.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.817 -0.628 . . . . 74.52 110.936 -176.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.74 -24.77 7.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.584 -0.817 . . . . 71.25 112.454 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.2 7.5 19.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.006 0.431 . . . . 73.13 110.563 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 114' ' ' ASP . 15.8 m -93.7 97.29 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 72.42 109.853 175.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.57 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 58.3 m-85 -92.79 162.7 14.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.122 -0.49 . . . . 75.35 111.005 -174.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.557 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 5.6 m -72.97 176.35 5.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 64.35 111.314 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.9 m -65.05 131.47 46.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.231 -0.441 . . . . 62.44 110.191 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -44.25 115.48 0.85 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.027 0.829 . . . . 52.41 111.944 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.6 m -102.25 105.27 15.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.137 -0.483 . . . . 71.33 109.965 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.835 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 59.9 m -60.58 115.83 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.48 0.657 . . . . 72.4 111.361 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.539 HD13 ' SG ' ' A' ' 61' ' ' CYS . 96.0 mt -83.22 155.63 23.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.19 -0.913 . . . . 64.22 112.097 -173.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.38 153.3 50.92 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.668 -0.864 . . . . 73.43 108.668 170.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.9 m120 -63.82 112.35 2.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.956 0.408 . . . . 72.33 110.762 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.1 -137.66 9.29 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.934 -0.651 . . . . 62.53 112.046 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.7 m -93.61 126.96 39.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.71 0.291 . . . . 62.12 110.889 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -129.8 120.79 25.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.721 -0.474 . . . . 74.13 109.721 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.494 HG22 ' HB2' ' A' ' 55' ' ' ASN . 2.3 m -110.44 117.52 33.79 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.626 0.251 . . . . 74.33 110.468 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.5 mt -95.48 113.9 62.74 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.597 -0.52 . . . . 72.04 109.597 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.78 138.55 13.39 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.09 2.527 . . . . 72.22 112.667 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 86.5 m-85 -135.9 161.09 36.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 74.44 110.887 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.572 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 52.2 mt-30 -133.04 118.24 18.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.655 . . . . 73.01 110.751 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.37 126.7 50.67 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.318 -0.239 . . . . 55.02 110.44 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.525 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -134.44 164.99 26.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.802 0.334 . . . . 45.4 111.048 -178.021 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.477 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 63.1 m-85 -85.46 142.2 29.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.997 -0.547 . . . . 73.1 110.466 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.464 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 61.1 t80 -126.83 124.11 38.88 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.895 -0.78 . . . . 74.21 108.895 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.697 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -91.19 135.99 33.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.12 0.486 . . . . 71.31 111.572 -176.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.413 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 78.7 p -100.36 1.27 41.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.296 -0.865 . . . . 71.32 108.909 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.11 -128.77 1.7 Allowed Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.553 -1.203 . . . . 71.15 111.059 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -87.55 95.71 10.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.184 -0.302 . . . . 72.01 110.184 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -46.52 112.05 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.847 -0.615 . . . . 71.14 111.587 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.2 p -107.61 149.51 38.98 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-O 121.003 0.43 . . . . 73.33 110.736 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.5 163.99 25.08 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.85 3.034 . . . . 72.0 113.239 -176.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.91 179.99 18.34 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.672 -0.694 . . . . 64.52 111.975 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.07 119.85 10.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.789 0.328 . . . . 64.14 110.707 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.01 42.64 2.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.649 0.738 . . . . 75.14 110.411 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -98.72 145.13 27.22 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.036 -0.984 . . . . 72.32 110.078 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.539 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -147.45 164.89 31.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.917 0.389 . . . . 63.24 111.322 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -123.05 133.31 54.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.321 -0.622 . . . . 72.41 109.321 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -148.22 128.94 14.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.932 0.396 . . . . 70.14 111.108 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.0 p -102.53 129.71 49.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.132 -0.485 . . . . 74.03 110.265 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.487 ' CD1' HD13 ' A' ' 56' ' ' ILE . 47.3 p90 -103.45 127.26 50.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.958 0.409 . . . . 73.13 110.706 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.62 ' HA ' HG21 ' A' ' 16' ' ' VAL . 6.9 ttmm -110.14 108.7 18.96 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.259 -0.428 . . . . 71.41 110.331 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.612 HG12 HG12 ' A' ' 71' ' ' VAL . 1.5 m -80.62 129.7 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.447 -0.575 . . . . 73.33 109.447 174.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -123.02 115.19 21.45 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.143 -0.688 . . . . 60.45 109.143 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.644 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -115.08 -11.16 12.11 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.392 0.515 . . . . 75.22 112.392 -177.534 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.444 HE21 ' HB2' ' A' ' 159' ' ' GLN . 1.3 mp0 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.534 -0.746 . . . . 71.12 109.232 170.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 120.95 0.405 . . . . 71.52 110.748 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.04 143.13 48.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.096 -0.502 . . . . 74.11 109.953 175.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.575 HG23 HG23 ' A' ' 4' ' ' THR . 10.0 t -96.12 -23.12 16.91 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.289 -0.414 . . . . 64.53 110.963 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.575 HG23 HG23 ' A' ' 3' ' ' THR . 62.4 p -111.68 -174.01 2.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.891 0.377 . . . . 65.22 110.422 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.523 HG22 HG12 ' A' ' 37' ' ' VAL . 34.8 m -91.31 17.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.013 0.435 . . . . 64.55 110.563 175.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 59.96 20.15 9.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.325 -0.852 . . . . 64.1 111.999 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.12 101.57 1.02 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.718 -0.753 . . . . 34.11 111.712 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.46 151.69 31.39 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.035 -1.078 . . . . 71.44 111.348 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.525 ' HB ' HG22 ' A' ' 31' ' ' THR . 17.4 p -141.47 135.64 30.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.55 0.214 . . . . 54.01 110.913 -176.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.45 ' CG2' HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -117.49 115.89 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.566 -0.531 . . . . 65.14 109.566 174.21 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 18.1 t-80 -83.04 108.76 16.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.286 -0.415 . . . . 70.23 109.928 177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -100.03 113.78 26.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.125 -0.489 . . . . 73.14 110.302 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -106.12 135.02 48.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.867 -0.42 . . . . 42.35 109.867 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.01 -125.91 5.7 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.962 -0.637 . . . . 31.33 111.888 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 67.6 12.95 9.12 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.886 0.474 . . . . 71.11 110.93 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.569 HG23 HG13 ' A' ' 17' ' ' VAL . 34.2 m -76.38 -30.66 19.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.063 -0.517 . . . . 65.13 111.859 -173.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.569 HG13 HG23 ' A' ' 16' ' ' VAL . 24.9 m -133.75 145.46 33.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.299 0.571 . . . . 70.02 111.468 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -151.68 30.41 0.59 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.933 -1.136 . . . . 61.43 107.933 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.66 -79.26 0.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.227 -0.897 . . . . 75.53 111.214 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -90.68 -34.87 15.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.969 0.414 . . . . 53.31 110.602 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.2 m -140.78 136.31 32.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.132 -0.485 . . . . 51.45 109.75 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.31 130.45 47.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.357 -0.383 . . . . 60.11 110.304 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 58' ' ' LEU . 20.7 t -67.69 130.93 33.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.964 -0.384 . . . . 60.4 109.964 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.506 ' O ' HG13 ' A' ' 28' ' ' VAL . 15.3 t70 -61.66 141.11 58.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.36 -0.382 . . . . 71.54 110.72 -178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.81 -26.99 64.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.052 -0.522 . . . . 34.12 111.798 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.84 2.67 79.02 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.792 -0.718 . . . . 75.24 112.302 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.3 p -131.89 3.05 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.593 0.235 . . . . 64.43 111.521 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 24' ' ' ASP . 35.2 m -89.4 -1.32 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.873 0.368 . . . . 62.21 110.687 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -158.72 97.58 1.45 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.085 -0.709 . . . . 73.41 109.085 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -144.6 104.01 4.0 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.483 0.658 . . . . 74.13 111.041 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.525 HG22 ' HB ' ' A' ' 9' ' ' THR . 5.8 m -81.59 94.48 6.92 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.389 -0.823 . . . . 72.24 109.096 173.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.42 140.33 17.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.122 -0.49 . . . . 75.14 111.043 -172.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -96.58 117.82 31.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 71.44 110.095 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.45 HD21 ' CG2' ' A' ' 10' ' ' VAL . 1.7 mm? -87.98 -23.85 23.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.444 -0.576 . . . . 74.41 109.444 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.29 166.96 32.67 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.317 -0.856 . . . . 55.22 112.618 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -73.21 94.46 1.98 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.907 -0.405 . . . . 75.21 109.907 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.523 HG12 HG22 ' A' ' 5' ' ' VAL . 9.5 p -75.54 145.24 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.19 -0.459 . . . . 54.4 110.858 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.2 mtm-85 -76.47 117.56 18.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.788 -0.642 . . . . 71.34 110.562 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 29.9 p -72.67 -16.28 61.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 65.41 110.99 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.0 -16.52 54.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 71.5 110.909 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.4 m -83.23 -44.34 15.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.167 -0.47 . . . . 72.23 110.263 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 6.2 mp -93.83 95.85 9.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.18 0.514 . . . . 62.21 110.306 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.47 22.26 5.14 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.326 0.584 . . . . 71.3 110.379 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.431 ' HG2' ' HB2' ' A' ' 47' ' ' ALA . 3.6 pm0 -151.66 137.96 18.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.311 -0.859 . . . . 54.12 110.233 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 40.8 tt0 -62.26 123.62 18.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.978 0.418 . . . . 60.33 110.117 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.67 -13.35 27.46 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.27 -0.732 . . . . 55.32 111.27 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -63.95 121.89 15.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.67 0.272 . . . . 72.35 110.281 176.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 25.4 p -123.75 118.62 27.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.34 -0.391 . . . . 73.42 110.724 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.4 t -75.8 173.72 10.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.1 -0.5 . . . . 64.43 110.172 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.8 m -64.41 135.79 56.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.107 0.48 . . . . 74.2 110.446 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -85.6 159.37 19.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.733 -0.667 . . . . 44.32 111.771 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 30.6 m -90.48 158.41 2.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.898 -1.047 . . . . 71.1 108.991 168.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.55 81.13 0.31 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.446 -0.883 . . . . 71.34 112.237 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -95.95 165.33 12.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.989 -0.374 . . . . 75.43 109.989 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.587 ' HB2' HG22 ' A' ' 130' ' ' THR . 2.4 p-10 -138.12 144.66 40.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.38 0.609 . . . . 75.54 111.517 -175.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.409 HD13 ' CD2' ' A' ' 154' ' ' PHE . 79.7 mt -105.53 120.25 55.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.34 -0.846 . . . . 72.32 109.383 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -98.15 136.98 37.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.98 0.419 . . . . 75.41 110.643 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 23' ' ' VAL . 50.8 mt -119.04 130.75 55.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 74.54 109.597 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -108.15 144.84 35.02 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.243 -0.435 . . . . 72.34 110.395 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 53.39 46.38 26.41 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.868 0.73 . . . . 52.21 111.225 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.487 ' SG ' HD13 ' A' ' 124' ' ' LEU . 27.5 t -81.34 131.89 35.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.461 -0.791 . . . . 64.54 110.074 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.431 ' OD2' HG12 ' A' ' 65' ' ' VAL . 16.3 t70 -107.68 134.01 51.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.243 -0.435 . . . . 74.32 111.646 -175.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.1 p -104.67 13.77 30.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 73.15 112.064 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -89.07 -35.39 16.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.905 -0.406 . . . . 71.33 109.905 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.431 HG12 ' OD2' ' A' ' 62' ' ' ASP . 14.0 p -97.26 -28.31 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.975 -0.557 . . . . 74.14 111.044 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -121.1 -177.59 3.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.493 -0.322 . . . . 52.22 110.953 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.2 m -140.75 -54.89 0.5 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.644 0.259 . . . . 73.23 111.454 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.81 ' HG3' ' HA ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -134.56 140.95 46.5 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 122.318 -0.239 . . . . 72.15 110.843 -178.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.52 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -102.59 135.4 44.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.101 0.477 . . . . 62.03 110.557 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.9 114.92 7.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.759 -0.655 . . . . 31.52 109.576 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.666 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -85.32 149.33 4.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.142 0.496 . . . . 75.31 110.895 -174.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -120.74 118.33 29.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.54 -0.755 . . . . 74.41 109.211 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 75.2 m-85 -83.16 128.98 34.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.027 0.441 . . . . 55.04 110.498 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.7 tp -128.22 127.44 42.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.008 -0.542 . . . . 55.23 109.804 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.47 -167.94 25.79 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.965 -0.854 . . . . 70.35 110.965 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.437 ' O ' HD13 ' A' ' 86' ' ' LEU . 9.5 m -74.29 120.85 20.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.102 0.451 . . . . 64.11 110.622 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -80.59 136.17 36.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.592 0.234 . . . . 72.22 110.817 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.496 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 10.9 tt -65.16 -30.6 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.29 -0.414 . . . . 72.23 111.213 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 19.9 t70 -151.3 173.21 14.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.478 -0.564 . . . . 71.2 109.478 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.59 -30.78 52.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.059 -0.519 . . . . 73.4 110.301 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.12 -20.26 28.47 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.842 -0.694 . . . . 54.1 111.711 177.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 65.1 m80 -103.5 47.85 0.87 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.382 -0.599 . . . . 55.54 109.382 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.495 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.4 p -72.81 9.63 1.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.572 -0.74 . . . . 51.32 112.331 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 16.7 p-10 -99.75 -18.6 17.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.784 0.326 . . . . 62.3 110.895 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.7 t -105.03 132.57 51.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.388 -0.369 . . . . 61.03 110.87 -176.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -67.29 135.18 52.94 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.21 -0.45 . . . . 72.41 110.519 179.18 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.83 146.78 33.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.964 -0.562 . . . . 60.32 109.684 175.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.2 mm? -85.7 129.87 34.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.333 -0.394 . . . . 65.15 110.77 -175.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -57.99 131.53 50.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.646 . . . . 71.04 109.493 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 m -85.69 125.0 32.85 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.623 -0.717 . . . . 71.31 111.654 -168.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.2 m -92.01 -10.14 40.3 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.665 -0.698 . . . . 72.51 109.779 175.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.75 -0.0 1.4 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.271 -0.877 . . . . 74.01 111.837 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.67 4.33 10.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.954 0.407 . . . . 63.14 111.169 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 133.61 67.45 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.477 -0.868 . . . . 75.25 112.787 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.412 ' HA ' ' H ' ' A' ' 147' ' ' ALA . 4.3 p -78.17 160.61 27.89 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.608 -0.516 . . . . 63.32 109.608 171.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.19 144.77 38.08 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.805 -0.443 . . . . 55.43 109.805 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.09 164.7 29.4 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.964 -0.384 . . . . 75.04 109.964 -179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.503 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 67.0 m-20 69.03 8.11 6.64 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.347 0.594 . . . . 53.12 110.12 -177.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -178.23 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.023 -0.99 . . . . 73.34 109.628 173.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 175.25 -172.07 45.14 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 110.268 -1.133 . . . . 73.45 110.268 177.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 2.5 p -126.13 120.06 55.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.096 0.474 . . . . 54.32 110.409 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.441 ' OE1' ' HB1' ' A' ' 110' ' ' ALA . 25.9 pt20 -117.14 149.51 40.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.52 -0.548 . . . . 71.35 109.52 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.3 mp -101.02 128.2 53.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.089 -0.505 . . . . 71.41 110.598 -174.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 134' ' ' GLN . 16.3 mt -94.1 146.0 24.28 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.367 -0.833 . . . . 74.21 108.917 175.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.572 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.4 OUTLIER -72.39 -173.21 1.07 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.825 -0.435 . . . . 63.1 109.825 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.427 ' HE ' ' CB ' ' A' ' 120' ' ' SER . 24.1 ptt180 -58.31 -32.49 68.52 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.556 0.206 . . . . 71.52 111.556 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.408 HG23 ' HG3' ' A' ' 106' ' ' ARG . 40.3 p -89.28 0.32 56.88 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.817 0.341 . . . . 72.14 111.793 -177.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.04 29.95 24.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.727 -0.749 . . . . 62.22 113.07 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 104' ' ' LEU . . . -102.78 134.35 46.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.364 -0.236 . . . . 72.34 110.364 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.51 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -67.05 122.76 18.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.998 0.428 . . . . 72.32 111.323 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.6 mt -90.56 148.4 22.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.026 -0.534 . . . . 74.04 110.523 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.485 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 25.8 m -96.91 142.22 29.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.258 -0.428 . . . . 51.3 110.439 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 50.0 mt -83.95 51.55 2.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 74.24 110.857 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -109.72 -5.43 15.61 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.018 0.437 . . . . 73.12 110.046 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.26 2.29 62.46 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.745 -0.661 . . . . 71.14 112.95 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.66 -13.09 9.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.905 0.383 . . . . 63.33 111.066 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.485 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 12.1 m -85.51 100.29 11.8 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.968 -0.382 . . . . 75.21 109.968 175.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.418 ' HE1' ' HE3' ' A' ' 155' ' ' LYS . 83.3 m-85 -90.17 154.7 19.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.945 -0.571 . . . . 65.23 111.185 -176.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.572 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 11.5 m -69.64 179.73 2.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.66 -0.7 . . . . 63.32 110.843 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.427 ' CB ' ' HE ' ' A' ' 106' ' ' ARG . 40.8 t -64.14 150.19 46.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.936 -0.394 . . . . 72.22 109.936 174.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -61.83 102.73 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 73.34 111.075 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -84.5 97.81 9.76 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.864 -0.791 . . . . 70.21 108.864 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.81 ' HA ' ' HG3' ' A' ' 68' ' ' LYS . 49.8 m -60.69 122.91 15.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.073 -0.512 . . . . 61.31 110.391 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.52 HD21 ' HB2' ' A' ' 69' ' ' ALA . 97.0 mt -80.97 151.98 28.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.383 -0.826 . . . . 61.24 112.066 -170.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -116.78 159.51 22.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.142 -0.936 . . . . 73.2 109.37 170.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -74.35 108.0 6.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.129 0.49 . . . . 73.11 110.356 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.27 -135.91 9.55 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.739 -0.743 . . . . 72.44 112.339 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.1 m -83.84 126.09 32.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.165 0.507 . . . . 75.21 111.335 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -124.56 160.4 28.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.716 -0.675 . . . . 74.42 109.646 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.587 HG22 ' HB2' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -144.18 122.28 12.16 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.848 -0.341 . . . . 64.04 110.576 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 7.0 mt -102.98 113.43 65.91 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.984 -0.376 . . . . 63.34 109.984 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 1.8 Cg_endo -82.9 137.31 8.62 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 123.131 2.554 . . . . 62.1 112.399 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -134.66 163.17 30.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.028 0.442 . . . . 54.22 111.211 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 104' ' ' LEU . 99.3 mt-30 -127.89 112.91 15.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.871 -0.604 . . . . 74.51 111.217 -177.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.17 121.59 42.53 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.944 -0.303 . . . . 64.32 110.236 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.55 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 10.6 ptp180 -137.45 164.05 29.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.848 0.356 . . . . 75.12 110.857 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.425 ' CE2' ' HB ' ' A' ' 37' ' ' VAL . 87.4 m-85 -78.95 147.47 32.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.607 . . . . 72.53 111.007 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -131.81 122.14 25.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.673 -0.694 . . . . 74.1 109.529 176.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -91.32 139.36 30.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.902 0.382 . . . . 61.35 111.528 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 48.0 p -103.89 -0.73 28.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.536 0.684 . . . . 74.32 109.316 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.8 -127.57 1.48 Allowed Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.05 -0.977 . . . . 72.31 111.111 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.83 93.92 6.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.359 -0.237 . . . . 74.23 110.359 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.412 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.32 116.75 1.84 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.384 0.428 . . . . 74.24 111.094 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.472 HG23 HD22 ' A' ' 98' ' ' ASN . 36.0 p -104.12 142.67 25.09 Favored Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-O 121.256 0.551 . . . . 75.0 110.898 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.25 165.53 28.35 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.581 2.854 . . . . 72.35 113.018 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 145.99 -140.2 8.72 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.605 -0.725 . . . . 65.32 111.869 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.412 ' H ' ' HA ' ' A' ' 95' ' ' SER . . . -107.3 117.01 32.95 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.412 0.149 . . . . 64.4 110.745 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -105.97 58.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.341 0.591 . . . . 70.41 111.141 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.412 HD22 ' N ' ' A' ' 149' ' ' ASN . 0.9 OUTLIER -99.1 140.5 33.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.971 -0.558 . . . . 63.24 109.592 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.484 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -153.01 165.08 36.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.583 0.23 . . . . 74.31 110.634 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -138.91 148.0 43.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.923 -0.399 . . . . 73.22 109.923 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.518 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -154.72 146.37 23.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.097 0.475 . . . . 73.35 110.951 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.1 p -108.87 127.93 54.47 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.043 -0.526 . . . . 62.54 110.034 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.409 ' CD2' HD13 ' A' ' 56' ' ' ILE . 46.6 p90 -96.64 123.5 40.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.006 0.432 . . . . 72.34 110.425 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.549 ' HA ' HG21 ' A' ' 16' ' ' VAL . 5.5 tmmm? -107.49 109.12 20.72 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.201 -0.454 . . . . 71.43 109.802 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.666 HG12 HG12 ' A' ' 71' ' ' VAL . 1.4 m -78.8 136.16 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.28 0.562 . . . . 75.53 110.619 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -114.45 118.14 32.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.871 -0.604 . . . . 61.34 110.067 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.571 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 1.5 p90 -134.21 -20.41 1.9 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.997 0.427 . . . . 75.23 110.15 171.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 . . . . . 0 C--O 1.25 1.101 0 CA-C-N 115.411 -0.813 . . . . 64.35 109.12 173.805 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.684 0.278 . . . . 71.4 110.319 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.24 -177.04 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.257 -0.428 . . . . 41.03 110.162 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.554 HG23 HG23 ' A' ' 4' ' ' THR . 8.7 t -102.61 -18.23 15.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.182 0.515 . . . . 75.1 110.476 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.554 HG23 HG23 ' A' ' 3' ' ' THR . 71.3 p -118.43 -179.91 3.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.057 -0.52 . . . . 54.22 110.573 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.529 HG22 HG12 ' A' ' 37' ' ' VAL . 34.4 m -91.25 16.02 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.983 0.421 . . . . 75.32 111.062 177.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 62.57 13.93 6.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.595 -0.73 . . . . 72.25 112.64 173.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.504 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 86.24 95.55 0.82 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.37 -0.919 . . . . 71.31 111.278 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.92 164.06 27.29 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.491 -0.862 . . . . 44.44 112.181 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.563 ' HB ' HG22 ' A' ' 31' ' ' THR . 63.2 p -140.85 147.74 39.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.683 0.278 . . . . 73.12 110.887 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.526 HG23 HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -112.81 123.46 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 N-CA-C 109.044 -0.725 . . . . 72.51 109.044 171.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -90.86 99.41 12.45 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.645 -0.502 . . . . 62.23 109.645 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 74.6 m-85 -88.89 117.57 27.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.781 -0.645 . . . . 65.42 110.213 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HB3' HG22 ' A' ' 153' ' ' THR . 80.1 tttt -110.12 139.35 45.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 74.03 110.736 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.88 -123.34 3.72 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.882 -0.599 . . . . 61.22 112.176 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.429 ' HG2' ' HB ' ' A' ' 28' ' ' VAL . 24.9 mm-40 60.44 19.71 9.4 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.695 0.398 . . . . 61.4 111.783 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.689 HG23 HG22 ' A' ' 17' ' ' VAL . 29.1 m -77.78 -28.79 15.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.35 -0.386 . . . . 52.33 111.581 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.689 HG22 HG23 ' A' ' 16' ' ' VAL . 7.7 m -148.04 153.05 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 53.15 110.84 -176.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -162.29 53.99 0.22 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.288 -1.005 . . . . 54.25 108.288 176.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -110.25 -72.88 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.709 -1.132 . . . . 65.13 110.274 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -76.87 -41.56 43.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.959 -0.564 . . . . 62.31 110.147 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -136.36 156.72 48.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.526 -0.546 . . . . 74.34 109.526 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -109.91 127.67 54.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.862 -0.421 . . . . 72.24 109.862 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.426 ' HA ' HD23 ' A' ' 58' ' ' LEU . 16.4 t -68.23 132.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.974 -0.38 . . . . 71.11 109.974 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' HG13 ' A' ' 28' ' ' VAL . 24.2 t70 -56.3 143.17 35.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 63.13 111.461 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.49 -25.09 67.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 51.34 112.143 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.73 -15.37 61.63 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.57 -0.824 . . . . 72.22 111.701 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 t -93.89 -24.94 17.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.755 -0.223 . . . . 71.34 110.804 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 24' ' ' ASP . 33.6 m -74.28 -6.92 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.829 0.347 . . . . 51.33 111.083 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -161.13 94.36 1.0 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.944 -0.761 . . . . 63.22 108.944 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.439 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 16.4 pt20 -137.95 114.9 10.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.396 0.617 . . . . 65.15 110.699 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.563 HG22 ' HB ' ' A' ' 9' ' ' THR . 5.2 m -95.91 93.8 7.24 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.205 -0.907 . . . . 63.41 109.752 177.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.23 140.08 17.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.748 -0.66 . . . . 63.1 111.164 -173.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -92.59 118.91 31.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 73.35 110.458 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.526 HD21 HG23 ' A' ' 10' ' ' VAL . 2.9 mm? -87.81 -30.26 20.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.223 0.535 . . . . 70.41 109.717 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.504 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.79 174.7 38.2 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.517 -0.765 . . . . 51.41 112.408 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.8 90.67 2.91 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.81 -0.23 . . . . 73.31 110.516 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.529 HG12 HG22 ' A' ' 5' ' ' VAL . 5.0 p -73.87 145.88 10.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.422 -0.584 . . . . 70.04 109.422 175.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -92.05 128.38 37.87 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.35 -0.386 . . . . 73.44 110.041 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.9 p -66.6 -24.34 66.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.02 -0.536 . . . . 74.44 111.721 -174.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.78 -19.85 65.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.062 -0.517 . . . . 72.54 111.305 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -89.42 -0.58 57.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.126 -0.488 . . . . 72.15 111.21 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.637 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 6.8 mt -137.08 48.61 2.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.224 0.535 . . . . 64.43 110.487 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.84 16.93 16.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.136 -0.484 . . . . 63.4 112.136 -171.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 47' ' ' ALA . 4.0 pm0 -157.79 142.99 16.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.218 -0.447 . . . . 74.55 110.312 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 33.6 tt0 -59.28 123.56 17.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.942 0.401 . . . . 74.42 110.045 175.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.0 -15.58 21.02 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.206 -0.758 . . . . 64.52 111.206 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 42' ' ' LEU . . . -67.76 123.53 20.77 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.451 -0.574 . . . . 53.21 109.451 174.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.469 HG22 ' HD1' ' A' ' 138' ' ' PHE . 37.3 p -123.27 134.26 54.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.969 0.414 . . . . 73.43 110.94 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.1 t -84.43 176.37 8.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.924 -0.58 . . . . 75.55 109.611 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -68.77 133.43 48.34 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.853 -0.425 . . . . 64.52 109.853 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -88.77 152.69 21.62 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.599 0.714 . . . . 54.23 111.944 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 23.8 m -94.1 149.92 4.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.354 -1.294 . . . . 61.22 108.922 169.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.76 77.14 0.23 Allowed Glycine 0 C--N 1.311 -0.842 0 C-N-CA 120.988 -0.625 . . . . 61.1 112.255 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -81.77 167.98 18.51 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.984 -0.376 . . . . 61.05 109.984 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.558 ' HB2' HG22 ' A' ' 130' ' ' THR . 2.2 p-10 -138.05 138.44 38.8 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.998 0.427 . . . . 72.22 111.251 -175.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.405 HD13 ' CD1' ' A' ' 154' ' ' PHE . 59.5 mt -100.38 114.14 38.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.547 -0.751 . . . . 62.34 109.335 174.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -98.83 135.67 39.94 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.704 -0.68 . . . . 71.11 110.812 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 23' ' ' VAL . 70.0 mt -114.5 117.8 31.97 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.35 -0.611 . . . . 74.34 109.35 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -96.63 124.18 40.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.775 -0.648 . . . . 51.35 110.649 -175.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.7 t70 61.8 92.37 0.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.001 0.813 . . . . 50.52 111.122 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 48.4 t -128.6 152.83 47.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.794 -0.639 . . . . 64.21 110.627 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.414 ' HA ' ' ND2' ' A' ' 126' ' ' ASN . 18.3 t70 -116.85 142.13 47.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.873 -0.603 . . . . 74.3 110.978 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.0 p -106.08 14.08 28.25 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.04 0.385 . . . . 64.4 112.04 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -91.28 -31.17 16.22 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.382 -0.599 . . . . 75.24 109.382 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 20' ' ' ALA . 8.0 p -104.2 -3.79 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.549 -0.75 . . . . 65.51 111.369 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.578 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -146.57 178.83 7.99 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.319 -0.238 . . . . 63.42 110.89 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.42 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 49.4 m -143.56 -53.78 0.37 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.053 0.39 . . . . 54.34 112.053 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.726 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -137.82 141.81 40.81 Favored 'General case' 0 C--O 1.221 -0.406 0 O-C-N 122.216 -0.302 . . . . 71.35 110.437 -179.014 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.92 127.66 48.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.028 0.442 . . . . 74.55 110.594 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.72 116.18 11.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.821 -0.627 . . . . 74.04 109.729 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -90.65 146.4 6.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.963 0.411 . . . . 73.11 111.356 -173.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -119.57 123.06 43.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.736 -0.666 . . . . 62.31 109.513 171.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.56 ' CE1' HG21 ' A' ' 103' ' ' ILE . 55.3 m-85 -86.52 134.59 33.65 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.107 0.48 . . . . 74.34 110.959 -178.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.0 tp -131.18 129.1 41.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 74.11 110.3 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.23 -160.17 19.13 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.94 -0.864 . . . . 60.02 110.94 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.484 ' O ' HD13 ' A' ' 86' ' ' LEU . 26.3 m -88.05 130.48 34.98 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.258 -0.275 . . . . 62.01 110.258 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.421 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -85.61 144.55 27.8 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.268 -0.271 . . . . 62.44 110.268 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.512 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 15.3 tt -62.34 -28.18 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 74.42 111.382 -176.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -152.6 177.18 10.93 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.714 -0.476 . . . . 63.42 109.714 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.63 -27.72 34.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.191 -0.459 . . . . 65.03 110.215 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.51 -7.85 61.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.759 -0.734 . . . . 74.2 111.902 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -122.82 75.51 1.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.264 0.554 . . . . 70.43 109.945 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.421 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.9 p -90.02 16.24 8.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.691 -0.686 . . . . 63.43 111.795 -176.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -118.94 -0.29 11.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.342 -0.39 . . . . 74.33 111.163 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.422 HG22 ' HB3' ' A' ' 102' ' ' GLN . 47.3 t -117.43 127.32 74.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.35 -0.386 . . . . 54.24 110.096 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.573 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -66.77 135.22 53.63 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.658 0.266 . . . . 74.13 110.385 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.57 160.49 27.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.124 -0.489 . . . . 64.51 110.583 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.58 HD21 ' O ' ' A' ' 99' ' ' VAL . 1.9 mm? -91.1 137.66 32.19 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.898 -0.408 . . . . 73.45 109.898 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -65.26 130.29 42.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.019 -0.537 . . . . 61.32 110.456 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.66 109.37 6.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.528 -0.76 . . . . 72.43 109.911 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.8 m -92.83 -1.82 56.44 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.893 -0.594 . . . . 41.33 110.607 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 56.91 25.38 10.44 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.93 -0.577 . . . . 72.22 111.107 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.53 -0.9 2.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.929 -0.578 . . . . 75.03 110.864 -178.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 117.22 71.84 0.44 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.683 -0.77 . . . . 62.21 112.334 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.1 m -76.21 163.23 27.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.265 -0.272 . . . . 60.24 110.265 175.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.48 156.14 21.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.063 -0.347 . . . . 74.43 110.063 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.97 164.65 31.37 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.877 -0.329 . . . . 72.4 110.794 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 68.89 -1.73 1.96 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.619 0.768 . . . . 73.11 111.247 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.58 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -138.76 145.59 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 109.223 -0.658 . . . . 62.13 109.223 170.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . -148.81 -167.66 13.97 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 110.753 -0.939 . . . . 75.41 110.753 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.38 110.87 28.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 121.359 0.599 . . . . 54.41 110.326 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.422 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.7 pt20 -100.6 132.03 46.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.748 -0.66 . . . . 64.14 109.416 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.56 HG21 ' CE1' ' A' ' 73' ' ' PHE . 4.0 mp -89.03 123.83 41.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.229 0.538 . . . . 75.44 110.219 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 134' ' ' GLN . 14.8 mt -92.73 140.88 29.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.362 -0.835 . . . . 72.25 109.237 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.514 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.6 OUTLIER -71.57 -173.63 0.97 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.74 -0.467 . . . . 64.22 109.74 176.512 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -59.88 -23.36 63.39 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.448 0.536 . . . . 74.43 112.448 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.0 p -91.5 -16.66 26.89 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.502 -0.479 . . . . 62.11 111.236 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.33 29.1 6.13 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.912 -0.661 . . . . 63.24 112.532 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.29 124.7 50.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.515 0.198 . . . . 63.43 110.683 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.04 120.62 11.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 72.15 110.573 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.7 mt -83.78 144.14 29.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.103 -0.499 . . . . 74.12 111.031 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.459 ' HB ' ' OG1' ' A' ' 117' ' ' THR . 3.1 m -73.83 140.29 45.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.2 -0.454 . . . . 73.2 109.951 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.496 HD13 HD22 ' A' ' 86' ' ' LEU . 52.4 mt -85.0 43.24 0.99 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.886 0.374 . . . . 74.03 110.571 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -105.33 -1.55 25.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.048 -0.524 . . . . 75.43 110.516 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.4 -1.76 41.4 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.073 -0.584 . . . . 35.23 113.353 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.03 -22.12 11.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 117.012 0.406 . . . . 71.11 110.91 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.459 ' OG1' ' HB ' ' A' ' 112' ' ' THR . 8.8 m -81.06 96.17 7.06 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.273 -0.421 . . . . 55.2 110.26 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.524 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 89.2 m-85 -86.51 162.86 17.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.2 -0.455 . . . . 75.42 110.327 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.514 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 13.4 m -73.55 -178.01 2.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.984 -0.553 . . . . 75.41 110.593 176.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.7 m -69.15 152.98 44.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.387 -0.37 . . . . 74.13 110.288 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.19 111.77 2.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.131 0.491 . . . . 72.1 111.623 -178.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.8 m -95.67 104.52 16.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.876 -0.602 . . . . 64.12 109.426 174.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -57.25 125.55 23.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 72.41 110.888 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.3 mt -91.62 163.4 14.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.203 0.525 . . . . 72.42 111.661 -176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -141.95 157.11 45.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.254 -0.885 . . . . 73.05 108.994 169.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 16.4 m120 -60.14 111.39 1.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.833 0.349 . . . . 72.42 110.267 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 137.86 -140.15 10.99 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.898 -0.668 . . . . 64.3 111.927 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.1 m -96.55 120.63 37.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.121 0.486 . . . . 65.53 110.939 -177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -114.22 137.14 52.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.974 -0.557 . . . . 45.12 109.79 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.558 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.4 m -125.45 121.42 33.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.688 0.28 . . . . 64.05 110.449 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 mt -106.31 112.71 63.86 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.801 -0.444 . . . . 54.41 109.801 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.8 139.39 9.81 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.991 2.461 . . . . 74.43 112.611 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.43 ' HD1' ' HA ' ' A' ' 105' ' ' ASP . 71.6 m-85 -138.71 164.02 30.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 71.13 110.309 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 87.0 mt-30 -124.37 134.18 53.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.961 0.41 . . . . 71.24 111.109 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -121.9 124.73 44.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.07 -0.514 . . . . 64.24 109.952 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.536 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 18.1 ptp180 -142.85 161.96 36.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.588 -0.278 . . . . 72.53 110.322 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 64.7 m-85 -77.9 135.63 37.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.098 -0.501 . . . . 72.25 110.525 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.469 ' HD1' HG22 ' A' ' 48' ' ' THR . 89.7 t80 -125.88 122.0 34.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.558 -0.746 . . . . 61.01 109.245 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.637 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -83.97 135.68 34.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.276 -0.42 . . . . 54.34 111.311 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.431 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 63.9 p -107.27 2.66 24.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.796 -0.638 . . . . 74.23 109.571 176.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 171.09 -115.99 0.61 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.214 -0.903 . . . . 52.42 111.62 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -98.19 94.21 6.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.702 0.251 . . . . 61.34 110.636 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -49.11 111.57 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.398 0.436 . . . . 72.12 111.865 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.2 p -104.58 140.84 21.47 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 116.122 -0.49 . . . . 63.14 110.188 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.96 179.96 3.93 Favored 'Trans proline' 0 N--CA 1.472 0.248 0 C-N-CA 123.717 2.945 . . . . 63.44 113.351 -172.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.83 -172.01 16.97 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.631 -0.795 . . . . 74.33 111.811 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.21 102.01 2.96 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.986 0.422 . . . . 50.34 110.947 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.22 76.85 1.92 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.179 0.514 . . . . 71.24 110.765 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -121.81 142.92 49.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.964 -0.562 . . . . 73.42 109.492 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.573 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -141.46 165.66 26.89 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 123.051 0.219 . . . . 72.32 111.027 -176.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -141.85 146.31 35.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.087 -0.338 . . . . 63.3 110.087 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.498 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -155.39 147.63 23.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.288 -0.415 . . . . 63.43 111.064 -178.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 13' ' ' LYS . 16.6 p -104.29 127.2 51.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.954 -0.566 . . . . 64.22 110.064 175.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.405 ' CD1' HD13 ' A' ' 56' ' ' ILE . 36.5 p90 -97.09 127.77 43.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.261 0.553 . . . . 74.13 110.947 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.573 ' HA ' HG21 ' A' ' 16' ' ' VAL . 8.5 ttmm -103.18 98.77 8.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.692 -0.686 . . . . 62.45 110.157 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.663 HG12 HG12 ' A' ' 71' ' ' VAL . 1.2 m -74.57 133.4 31.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.304 0.573 . . . . 74.14 109.631 177.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -117.17 110.47 18.21 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.087 -0.506 . . . . 72.33 110.05 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.726 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -123.02 -12.63 7.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.619 0.723 . . . . 74.33 110.377 172.058 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.637 ' HG3' ' HD1' ' A' ' 158' ' ' TYR . 51.3 mt-30 . . . . . 0 C--O 1.249 1.072 0 CA-C-N 114.966 -1.015 . . . . 44.04 109.437 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.687 0.279 . . . . 71.32 110.285 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.86 161.46 30.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.297 -0.411 . . . . 61.32 110.319 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 t -87.83 -6.86 57.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.178 0.513 . . . . 53.14 110.719 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.3 p -113.85 176.33 5.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.3 -0.409 . . . . 70.42 110.584 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.453 HG22 HG12 ' A' ' 37' ' ' VAL . 36.0 m -89.18 13.95 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.264 -0.426 . . . . 70.13 110.691 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.441 ' C ' ' HG2' ' A' ' 36' ' ' GLN . 54.8 m-80 64.41 4.87 2.36 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.437 -0.801 . . . . 65.32 112.655 175.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.52 110.78 3.51 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.497 -0.859 . . . . 55.52 111.855 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.437 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -92.46 155.25 22.65 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.368 -0.92 . . . . 61.1 112.383 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.468 ' HB ' ' CG2' ' A' ' 31' ' ' THR . 1.6 p -145.9 125.1 12.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.568 0.223 . . . . 62.34 110.573 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.473 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -104.02 126.17 58.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.849 -0.426 . . . . 63.22 109.849 177.023 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -93.21 109.06 20.57 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.11 0.481 . . . . 71.42 110.174 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.473 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 87.6 m-85 -101.86 121.54 42.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.052 -0.522 . . . . 70.11 110.207 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -114.72 138.79 50.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.923 0.392 . . . . 72.34 110.431 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.49 -123.15 5.06 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.535 -0.626 . . . . 73.53 111.535 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.457 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 35.0 mt-10 63.57 25.64 14.44 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.395 0.617 . . . . 54.51 110.31 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.723 HG23 HG22 ' A' ' 17' ' ' VAL . 20.0 m -85.87 -32.33 6.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.615 -0.721 . . . . 72.4 111.59 -176.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.723 HG22 HG23 ' A' ' 16' ' ' VAL . 6.9 m -141.35 154.96 20.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.375 -0.375 . . . . 72.0 111.164 -174.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -168.74 90.24 0.24 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.434 -0.95 . . . . 65.33 108.434 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.26 -75.1 0.13 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.346 -0.843 . . . . 73.2 109.811 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.77 -37.82 62.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.761 -0.654 . . . . 64.11 109.689 174.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 1.8 m -147.17 162.02 39.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.382 -0.826 . . . . 74.34 108.832 -177.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.91 134.92 55.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.188 -0.301 . . . . 72.43 110.188 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.546 ' HA ' HD23 ' A' ' 58' ' ' LEU . 15.6 t -69.01 137.34 24.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.519 -0.31 . . . . 71.33 110.371 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.53 ' O ' HG13 ' A' ' 28' ' ' VAL . 20.5 t70 -57.22 141.55 46.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 72.22 111.69 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.48 -27.0 67.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 72.33 112.093 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.48 -14.06 60.56 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.436 -0.887 . . . . 71.55 111.722 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 t -97.94 -18.83 18.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.413 0.149 . . . . 64.34 110.913 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 24' ' ' ASP . 35.9 m -78.35 -5.74 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.556 0.217 . . . . 74.23 111.177 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -165.07 94.12 0.64 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.417 -0.586 . . . . 73.44 109.417 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -147.52 150.04 33.77 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.99 -0.55 . . . . 63.22 110.878 -176.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.468 ' CG2' ' HB ' ' A' ' 9' ' ' THR . 5.4 m -121.74 114.15 20.7 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.644 -0.707 . . . . 73.23 109.673 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.75 139.03 18.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.14 -0.482 . . . . 63.54 110.823 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -92.68 121.91 34.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.826 -0.625 . . . . 70.23 110.46 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.409 HD21 HG23 ' A' ' 10' ' ' VAL . 2.2 mm? -97.32 -27.2 14.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.235 0.541 . . . . 74.04 109.842 176.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.38 178.43 44.18 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.582 -0.736 . . . . 65.31 112.225 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.441 ' HG2' ' C ' ' A' ' 6' ' ' ASN . 82.6 mt-30 -80.56 94.2 6.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.154 -0.313 . . . . 73.42 110.154 177.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.453 HG12 HG22 ' A' ' 5' ' ' VAL . 9.0 p -70.25 149.82 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 73.42 110.618 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.01 134.46 35.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.931 -0.577 . . . . 71.44 110.094 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 p -77.5 -19.16 56.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.108 0.48 . . . . 75.45 110.775 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.91 -16.69 60.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.868 -0.605 . . . . 55.5 111.258 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.4 m -90.85 3.68 53.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.103 0.478 . . . . 61.04 110.907 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.735 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.1 mt -142.46 54.67 1.43 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.866 -0.606 . . . . 55.11 110.008 -175.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.25 10.53 41.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.114 0.413 . . . . 74.52 112.114 -172.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -145.65 141.44 28.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.699 0.285 . . . . 75.3 111.171 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 8.9 tm-20 -55.43 116.42 2.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.903 -0.59 . . . . 74.13 109.559 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.14 -7.43 27.07 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.665 -0.779 . . . . 72.42 112.375 -177.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.574 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -67.78 132.96 48.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.681 0.277 . . . . 71.33 110.61 177.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 p -122.78 138.83 54.52 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.291 -0.413 . . . . 70.23 110.715 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 t -96.36 179.0 5.18 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.356 -0.384 . . . . 74.43 110.519 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 m -68.62 126.05 28.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.936 -0.575 . . . . 65.21 110.265 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.598 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -82.49 164.66 20.78 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.668 0.747 . . . . 74.33 112.157 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.0 m -106.33 155.92 7.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.45 -1.25 . . . . 73.21 109.208 171.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.3 93.01 0.67 Allowed Glycine 0 C--N 1.311 -0.847 0 C-N-CA 120.818 -0.706 . . . . 54.43 112.104 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -105.54 171.52 7.28 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.556 -0.535 . . . . 73.41 109.556 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -139.69 142.84 36.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.044 0.449 . . . . 63.31 111.38 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.7 mt -102.27 117.8 48.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.534 -0.757 . . . . 73.14 109.318 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -99.37 137.6 37.65 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.785 -0.643 . . . . 72.24 110.676 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 23' ' ' VAL . 44.8 mt -117.34 134.72 54.49 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.454 -0.573 . . . . 73.23 109.454 176.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -110.26 143.97 39.65 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.902 -0.407 . . . . 63.43 109.902 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 33.8 t70 50.39 73.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 124.071 0.857 . . . . 72.11 110.715 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 126' ' ' ASN . 32.7 t -112.78 119.66 38.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.115 -0.948 . . . . 73.21 110.212 -174.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.73 138.03 36.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.948 0.404 . . . . 72.45 111.734 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.3 p -107.43 5.21 27.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 70.41 112.258 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -78.3 -21.96 48.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.656 -0.498 . . . . 61.24 109.656 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.8 p -112.53 -30.71 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.768 -0.651 . . . . 73.34 111.353 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -116.95 166.57 12.03 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.194 -0.316 . . . . 63.54 111.126 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.51 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 32.7 m -124.64 -56.27 1.6 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.772 0.32 . . . . 73.43 111.569 -177.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.51 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -133.01 157.08 46.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.721 -0.474 . . . . 74.43 109.721 -178.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -114.14 132.63 56.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.977 0.418 . . . . 63.43 110.353 175.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.58 120.58 12.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.753 -0.658 . . . . 60.31 109.492 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.715 HG12 HG12 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -92.41 147.3 5.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.097 0.475 . . . . 75.23 111.158 -173.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.51 117.53 28.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.607 -0.724 . . . . 73.15 109.234 174.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 86.8 m-85 -82.81 135.99 34.79 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.951 0.405 . . . . 71.44 111.065 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.1 tp -131.32 115.42 16.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.878 -0.601 . . . . 74.22 109.616 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.439 ' H ' ' HB3' ' A' ' 113' ' ' LEU . . . -153.31 -174.22 23.39 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.576 -0.738 . . . . 74.53 111.326 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.464 ' O ' HD13 ' A' ' 86' ' ' LEU . 8.1 m -79.3 114.78 18.51 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.242 -0.281 . . . . 72.13 110.242 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -75.89 149.53 37.75 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.945 -0.391 . . . . 61.22 109.945 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.578 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 14.5 tt -62.48 -35.79 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.409 . . . . 71.23 110.209 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -162.43 -174.5 4.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.986 -0.552 . . . . 73.44 109.53 172.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.85 -12.15 59.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.141 0.423 . . . . 72.33 112.141 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.21 -43.71 3.98 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.769 -0.729 . . . . 73.33 111.8 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -103.06 82.2 2.06 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.076 -0.713 . . . . 74.42 109.076 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.416 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.7 p -95.59 7.34 46.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.251 -0.886 . . . . 72.01 112.503 -172.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -107.17 -1.64 21.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.121 0.486 . . . . 75.23 110.541 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.52 121.68 59.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.739 -0.664 . . . . 75.34 110.292 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.607 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -68.21 132.37 47.03 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.841 -0.429 . . . . 74.13 109.841 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.578 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -76.46 149.54 36.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.175 -0.466 . . . . 75.21 110.294 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.412 HD22 ' H ' ' A' ' 88' ' ' LEU . 2.1 mm? -77.84 132.93 38.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.157 -0.474 . . . . 52.11 109.839 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.556 ' HG3' ' HA ' ' A' ' 150' ' ' ALA . 90.8 mt-30 -64.21 128.04 34.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 74.35 110.541 -177.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.76 101.6 0.83 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.919 -0.582 . . . . 74.2 110.977 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.4 m -85.88 -10.77 54.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.072 -0.513 . . . . 75.3 110.296 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.09 5.42 5.28 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.368 -0.833 . . . . 65.45 111.633 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -109.6 -21.29 12.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.035 -0.529 . . . . 71.02 110.701 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 138.74 84.51 0.11 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.863 -0.684 . . . . 61.1 111.986 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.472 ' HA ' ' H ' ' A' ' 147' ' ' ALA . 2.7 p -88.47 164.15 15.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.762 0.315 . . . . 60.24 110.344 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.23 148.22 35.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.579 -0.526 . . . . 42.23 109.579 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.34 163.51 29.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.03 -0.359 . . . . 74.32 110.03 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.405 HD22 HG23 ' A' ' 144' ' ' THR . 57.5 m-20 69.8 10.99 7.73 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.575 0.547 . . . . 63.13 110.319 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.06 -177.29 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.478 -0.783 . . . . 70.13 110.212 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 175.94 -172.64 45.63 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.574 -1.01 . . . . 74.12 110.574 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.406 HG21 HG21 ' A' ' 10' ' ' VAL . 2.7 p -118.42 115.31 47.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.337 0.589 . . . . 64.24 110.62 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -105.34 140.66 38.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.24 -0.652 . . . . 63.21 109.24 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.429 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -102.56 122.59 55.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.147 0.499 . . . . 64.54 110.672 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.522 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 15.5 mt -89.58 143.55 26.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.503 -0.771 . . . . 54.42 109.378 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.544 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.9 -170.49 0.91 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.713 -0.477 . . . . 73.34 109.713 175.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -60.0 -29.83 68.73 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.467 0.173 . . . . 45.03 111.467 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 74.4 p -92.4 3.54 55.24 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.808 0.337 . . . . 60.34 111.573 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 82.08 30.67 33.93 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.858 -0.687 . . . . 72.33 113.1 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.01 126.4 48.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.713 0.256 . . . . 64.25 110.524 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.98 109.02 2.8 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.049 0.452 . . . . 63.14 110.919 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.9 mt -79.07 130.6 35.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 74.01 110.76 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 m -70.56 135.99 48.93 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 74.23 110.599 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.607 HD13 HD22 ' A' ' 86' ' ' LEU . 34.4 mt -78.05 41.52 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 73.53 110.844 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -98.9 -9.82 23.67 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.021 -0.536 . . . . 64.03 110.472 -175.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.53 1.15 75.56 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.025 -0.607 . . . . 60.32 112.663 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.27 -3.4 11.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.947 0.403 . . . . 74.02 111.228 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.4 m -101.0 109.5 21.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.807 0.337 . . . . 70.43 110.238 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -99.18 156.68 16.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.038 -0.528 . . . . 74.04 111.338 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 1.7 m -68.45 177.02 2.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.561 -0.745 . . . . 63.44 111.291 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.3 t -63.58 148.08 49.79 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.551 -0.537 . . . . 61.33 109.551 170.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.402 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 85.6 mt-10 -63.8 103.63 0.59 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 71.12 111.409 -176.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -87.22 110.86 20.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.962 -0.563 . . . . 63.51 109.743 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 m -59.96 122.4 14.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 75.5 111.28 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.482 ' C ' HD22 ' A' ' 125' ' ' ASN . 85.4 mt -84.38 146.39 27.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.514 . . . . 75.42 111.455 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.482 HD22 ' C ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -122.97 152.83 40.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.412 -0.813 . . . . 70.13 109.244 174.184 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 19.7 m120 -62.82 111.93 2.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.85 0.357 . . . . 61.35 110.569 176.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.17 -128.61 6.68 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.689 -0.767 . . . . 52.41 112.69 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.7 m -96.56 135.71 38.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.744 0.307 . . . . 74.55 110.849 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -132.58 148.56 52.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 64.54 110.482 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.47 120.73 31.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.372 -0.376 . . . . 74.2 111.301 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.2 mt -99.29 113.03 64.47 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.035 -0.728 . . . . 70.13 109.035 174.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.63 140.29 11.7 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.423 2.082 . . . . 73.52 112.704 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 87.4 m-85 -136.65 162.97 31.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.333 -0.394 . . . . 73.53 110.704 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.634 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.0 mt-30 -132.55 110.47 10.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.175 -0.466 . . . . 52.42 110.783 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -97.15 123.6 40.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.424 -0.353 . . . . 74.52 110.28 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.598 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 11.2 ptp180 -135.47 160.65 37.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.9 0.381 . . . . 63.13 110.65 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.437 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 81.3 m-85 -81.28 144.32 31.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.039 -0.528 . . . . 71.23 110.657 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -129.31 126.06 38.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.755 -0.657 . . . . 75.24 109.428 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.735 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -89.24 133.47 34.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.294 -0.412 . . . . 73.24 111.356 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.421 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 71.1 p -105.37 7.66 33.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.856 0.836 . . . . 74.05 109.022 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.08 -128.33 1.63 Allowed Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.524 -1.217 . . . . 72.15 110.838 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.36 96.18 10.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.827 0.314 . . . . 62.41 110.233 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -46.45 113.84 0.71 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.564 0.54 . . . . 33.22 111.539 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.405 HG23 HD22 ' A' ' 98' ' ' ASN . 31.9 p -103.14 141.45 22.52 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-O 121.122 0.487 . . . . 61.12 110.669 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.58 170.48 15.0 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 123.642 2.895 . . . . 43.54 113.273 -175.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.58 -122.47 1.77 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.627 -0.715 . . . . 72.23 111.795 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.472 ' H ' ' HA ' ' A' ' 95' ' ' SER . . . -122.17 133.87 54.73 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.686 -0.487 . . . . 65.35 109.686 177.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -122.05 51.49 1.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.589 0.709 . . . . 63.13 111.07 -173.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -102.56 144.45 30.96 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.255 -0.884 . . . . 65.02 110.197 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.556 ' HA ' ' HG3' ' A' ' 89' ' ' GLN . . . -152.86 177.26 10.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.113 -0.494 . . . . 71.14 109.979 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -154.1 152.05 30.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.963 -0.295 . . . . 73.43 110.622 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -156.29 153.0 28.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.177 -0.465 . . . . 63.1 110.829 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 19.3 p -105.31 136.71 44.33 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.454 -0.573 . . . . 75.32 109.454 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -109.59 122.82 48.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.088 0.47 . . . . 71.23 110.55 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.603 ' HA ' HG21 ' A' ' 16' ' ' VAL . 2.9 ttmm -102.48 104.85 15.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.081 -0.509 . . . . 74.34 110.224 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.715 HG12 HG12 ' A' ' 71' ' ' VAL . 1.5 m -81.45 139.2 18.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.207 0.527 . . . . 61.42 110.216 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -110.66 110.7 21.48 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.97 -0.559 . . . . 63.21 111.01 -177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.609 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -145.46 -32.49 0.37 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.088 -0.506 . . . . 73.23 110.401 170.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.473 ' N ' ' HD1' ' A' ' 158' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.02 0 N-CA-C 108.346 -0.983 . . . . 64.52 108.346 174.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.651 0.262 . . . . 44.33 110.326 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.08 162.44 13.37 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.48 -0.563 . . . . 73.34 109.48 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 4' ' ' THR . 11.5 t -94.27 -2.03 53.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.856 0.36 . . . . 74.31 110.942 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 3' ' ' THR . 63.1 p -130.98 -173.23 3.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.971 0.415 . . . . 63.35 110.363 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 37' ' ' VAL . 31.6 m -89.8 14.36 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.756 0.312 . . . . 54.22 111.216 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 66.59 8.87 6.16 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.82 -0.627 . . . . 61.11 112.107 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 36' ' ' GLN . . . 95.78 97.8 1.78 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.112 -0.795 . . . . 62.34 111.112 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.56 154.24 25.81 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.206 -0.997 . . . . 43.12 112.206 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.48 ' HB ' HG22 ' A' ' 31' ' ' THR . 24.4 p -141.85 132.31 25.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.801 0.334 . . . . 71.35 111.128 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -106.95 120.46 58.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.178 -0.675 . . . . 73.52 109.178 171.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -94.33 106.1 18.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.689 -0.486 . . . . 73.24 109.689 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.415 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 81.8 m-85 -96.91 129.77 44.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.842 -0.617 . . . . 73.54 110.149 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -117.3 133.0 56.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.211 -0.45 . . . . 74.53 110.25 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.97 -123.24 4.24 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.982 -0.627 . . . . 40.53 111.951 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.772 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 31.7 mt-10 63.35 15.94 9.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.135 0.493 . . . . 51.43 110.891 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' A' ' 155' ' ' LYS . 24.2 m -76.91 -27.61 16.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.529 -0.76 . . . . 74.23 111.932 -174.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.6 HG21 ' CG2' ' A' ' 156' ' ' VAL . 18.8 m -135.81 144.6 33.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.214 0.531 . . . . 73.4 112.205 -174.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.413 ' ND2' ' HB2' ' A' ' 22' ' ' ALA . 0.2 OUTLIER -148.41 21.38 1.06 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.487 -0.931 . . . . 65.2 108.487 170.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.96 -74.54 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.248 -0.887 . . . . 73.34 110.974 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HB2' HG13 ' A' ' 65' ' ' VAL . . . -88.72 -38.71 14.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.067 0.46 . . . . 62.32 110.513 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.8 OUTLIER -144.0 134.99 25.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.555 -0.748 . . . . 73.15 109.847 -176.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HB2' ' ND2' ' A' ' 18' ' ' ASN . . . -92.61 151.51 20.09 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.8 -0.445 . . . . 72.11 109.8 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.425 ' HB ' HG12 ' A' ' 28' ' ' VAL . 14.9 t -86.52 136.64 22.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 110.122 -0.325 . . . . 54.4 110.122 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.467 ' O ' HG13 ' A' ' 28' ' ' VAL . 22.3 t70 -62.86 145.15 55.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.435 -0.348 . . . . 75.02 110.937 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -60.25 -26.04 66.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.253 0.464 . . . . 74.34 112.253 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.1 -14.79 81.9 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.529 -0.844 . . . . 65.22 112.014 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.9 p -119.94 13.55 12.25 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.83 0.307 . . . . 75.23 111.83 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.772 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 27.2 m -100.56 -11.77 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.161 0.505 . . . . 61.4 110.325 173.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -156.52 81.3 0.96 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.289 -0.869 . . . . 62.01 109.426 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -126.18 133.87 51.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.453 0.644 . . . . 74.43 110.369 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.48 HG22 ' HB ' ' A' ' 9' ' ' THR . 2.9 m -118.24 101.31 8.11 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.764 -0.828 . . . . 74.24 108.764 176.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.48 131.86 32.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.993 -0.549 . . . . 64.03 111.034 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -88.13 110.42 20.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.65 -0.704 . . . . 73.12 109.771 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.4 ' HB2' ' OH ' ' A' ' 137' ' ' TYR . 1.8 mm? -81.22 -29.05 34.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.406 0.622 . . . . 54.54 109.495 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 96.18 172.72 35.58 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.242 -0.89 . . . . 44.33 112.131 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 7' ' ' GLY . 69.4 mt-30 -72.83 95.8 1.98 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.448 -0.204 . . . . 73.12 110.448 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.515 HG12 HG22 ' A' ' 5' ' ' VAL . 11.0 p -70.33 142.67 15.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.855 0.36 . . . . 74.2 110.134 177.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -78.22 105.12 9.24 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.201 -0.666 . . . . 63.31 109.201 176.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 19.5 p -63.05 -25.19 68.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.955 0.407 . . . . 72.42 111.237 -177.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.43 -5.6 37.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.061 -0.518 . . . . 74.43 111.419 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.5 m -95.8 -2.69 47.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.073 0.463 . . . . 65.22 110.411 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.1 mp -131.69 97.3 4.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.888 -0.597 . . . . 61.23 109.504 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.96 17.35 9.32 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.32 -0.552 . . . . 73.15 112.436 -173.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -153.62 150.99 29.21 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.749 -0.381 . . . . 72.14 111.483 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -60.9 119.21 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.818 -0.628 . . . . 72.54 109.827 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.72 -6.19 31.26 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.641 -0.79 . . . . 61.21 111.847 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -72.01 119.39 16.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.014 0.435 . . . . 75.04 110.532 178.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.548 HG22 ' HD1' ' A' ' 138' ' ' PHE . 41.1 p -105.51 148.34 27.33 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.015 -0.539 . . . . 61.04 110.173 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.4 t -100.32 177.54 5.02 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.136 -0.69 . . . . 54.23 109.136 174.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.6 m -70.11 133.51 47.23 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.876 -0.416 . . . . 73.15 109.876 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -87.34 160.41 18.39 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.644 0.735 . . . . 70.15 111.956 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 31.1 m -103.94 152.9 6.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.433 -1.258 . . . . 72.25 109.083 171.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.45 98.48 1.28 Allowed Glycine 0 C--N 1.312 -0.754 0 C-N-CA 120.729 -0.748 . . . . 45.03 112.147 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -108.96 173.19 6.43 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.6 -0.519 . . . . 63.35 109.6 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.594 ' HB2' HG22 ' A' ' 130' ' ' THR . 4.0 p-10 -139.75 137.19 34.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.476 0.655 . . . . 73.44 111.917 -173.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.4 mt -105.5 115.09 46.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.722 -0.844 . . . . 75.25 108.722 171.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -101.57 144.62 30.09 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.977 0.417 . . . . 75.54 110.823 -173.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.2 mt -117.91 130.01 55.97 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.955 -0.566 . . . . 73.25 109.676 176.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -106.41 131.98 52.97 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.67 -0.695 . . . . 52.12 109.519 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 27.1 t70 58.15 86.44 0.08 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.69 0.757 . . . . 63.42 110.217 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 51.7 t -124.38 124.49 42.46 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.335 -0.848 . . . . 55.04 110.421 -174.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -103.92 140.07 38.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.045 -0.525 . . . . 72.31 111.152 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.8 p -107.96 15.61 24.22 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.071 0.397 . . . . 65.32 112.071 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -90.34 -39.16 12.87 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.912 -0.773 . . . . 74.33 108.912 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 20' ' ' ALA . 12.7 p -96.12 -3.53 10.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.104 -0.953 . . . . 72.41 110.472 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.616 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -144.75 -173.45 4.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 64.13 110.781 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.7 m -151.0 -57.98 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.023 0.379 . . . . 62.31 112.023 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.799 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -138.21 130.4 28.76 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.973 -0.291 . . . . 72.53 110.262 -175.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.43 127.49 41.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.108 0.48 . . . . 53.11 111.0 -175.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.33 119.64 16.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.637 -0.711 . . . . 72.1 109.637 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 156' ' ' VAL . 2.5 m -90.19 147.62 5.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.977 0.418 . . . . 70.21 110.756 -175.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.437 ' HB2' ' CD2' ' A' ' 118' ' ' PHE . . . -117.48 118.16 31.42 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.741 -0.663 . . . . 73.24 109.752 174.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 82.3 m-85 -85.62 128.49 34.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.979 0.419 . . . . 70.44 110.205 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.1 tp -126.13 126.76 44.68 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.836 -0.62 . . . . 61.15 109.913 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.52 -166.47 21.36 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.446 -0.662 . . . . 62.53 111.446 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.7 m -87.1 119.71 27.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.853 -0.425 . . . . 75.23 109.853 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -76.98 149.52 35.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.446 -0.343 . . . . 72.42 110.436 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.573 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 12.8 tt -61.77 -37.61 78.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.081 0.467 . . . . 52.43 110.7 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -152.02 -171.51 3.95 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.782 -0.821 . . . . 53.25 108.782 174.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.04 -14.89 43.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.056 0.391 . . . . 74.21 112.056 -175.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.31 -49.83 3.6 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.632 -0.794 . . . . 73.52 112.016 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -96.43 76.64 2.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.383 0.611 . . . . 73.34 109.617 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.478 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 14.6 p -86.97 8.45 23.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.649 -0.705 . . . . 54.43 111.755 -175.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 24.4 p-10 -107.05 7.32 29.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.976 0.417 . . . . 63.11 110.849 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' A' ' 138' ' ' PHE . 57.6 t -120.11 124.91 73.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.009 -0.542 . . . . 71.54 109.837 177.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.523 HD22 ' CD1' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -66.94 129.85 41.23 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 110.079 -0.341 . . . . 64.14 110.079 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.46 150.77 34.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.297 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.548 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -88.03 130.3 35.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.561 -0.533 . . . . 62.14 109.561 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -58.24 142.09 48.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 60.2 112.127 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 p -66.91 106.59 1.95 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.311 -0.859 . . . . 52.21 110.785 178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.2 m -101.29 -12.25 18.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.913 -0.585 . . . . 64.23 110.773 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.37 4.5 2.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.065 0.546 . . . . 72.22 112.178 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.9 15.16 14.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.101 0.476 . . . . 64.41 110.628 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.27 76.83 1.22 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.565 -0.826 . . . . 62.31 111.829 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.2 m -82.28 154.83 25.14 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.899 -0.408 . . . . 54.42 109.899 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.428 ' O ' HD23 ' A' ' 88' ' ' LEU . . . -71.46 136.64 47.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.71 0.291 . . . . 71.51 110.223 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.36 160.71 35.51 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.848 -0.341 . . . . 72.54 110.546 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 68.55 7.36 5.99 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.337 0.589 . . . . 74.23 110.303 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.405 ' O ' HD12 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -143.25 -179.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.269 -0.878 . . . . 72.01 109.687 175.124 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.3 -169.82 42.86 Favored Glycine 0 N--CA 1.436 -1.315 0 N-CA-C 109.951 -1.26 . . . . 73.45 109.951 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.85 119.46 58.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.278 0.561 . . . . 75.14 110.465 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -109.42 146.15 34.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.648 -0.705 . . . . 74.13 109.755 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.1 mp -103.99 124.24 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.425 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.426 HD11 ' NE ' ' A' ' 136' ' ' ARG . 27.5 mt -87.38 140.03 29.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.651 -0.704 . . . . 43.44 109.177 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.542 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.05 -173.13 1.19 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.913 -0.402 . . . . 64.3 109.913 177.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.1 ptt85 -61.04 -20.3 62.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.096 0.406 . . . . 74.33 112.096 -176.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.7 p -101.47 3.56 40.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.935 -0.306 . . . . 61.54 111.548 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.42 31.52 24.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.778 -0.725 . . . . 53.24 112.866 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -112.02 128.51 56.2 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.959 -0.386 . . . . 60.12 109.959 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.85 130.16 42.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.726 0.298 . . . . 72.22 110.884 -176.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.0 mt -92.77 132.83 36.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.225 -0.443 . . . . 73.1 110.979 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 89.9 m -74.31 139.2 44.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.891 -0.595 . . . . 74.13 110.449 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 34.8 mt -81.46 45.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 71.13 110.682 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -90.7 -17.94 25.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.09 0.472 . . . . 71.31 110.369 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.19 -22.97 26.75 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.996 -0.621 . . . . 70.31 112.329 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -108.45 3.87 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.164 0.507 . . . . 41.42 110.915 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.461 HG21 ' H ' ' A' ' 112' ' ' THR . 3.8 m -95.34 99.36 11.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.992 -0.549 . . . . 75.24 110.064 178.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.493 ' HE2' ' HD2' ' A' ' 155' ' ' LYS . 96.3 m-85 -95.41 162.31 13.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.969 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 4.6 m -71.46 -178.83 2.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.666 -0.697 . . . . 72.45 111.003 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.5 t -73.05 165.55 24.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.596 -0.52 . . . . 71.43 109.596 173.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -65.32 106.98 1.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.366 -0.379 . . . . 75.13 111.33 -177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.8 m -90.66 102.76 15.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.084 -0.71 . . . . 71.13 109.084 172.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.6 m -58.17 119.21 6.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.753 -0.658 . . . . 60.05 111.247 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.421 HD13 ' SG ' ' A' ' 61' ' ' CYS . 95.9 mt -87.27 150.91 23.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.792 -0.64 . . . . 75.12 111.166 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -125.89 158.68 34.51 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.743 -0.836 . . . . 73.4 108.743 172.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.4 m120 -65.08 114.49 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.868 0.366 . . . . 50.34 111.058 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 126.43 -133.27 8.07 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.03 -0.605 . . . . 64.13 112.31 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.5 m -92.83 130.88 38.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.795 0.331 . . . . 65.45 110.706 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -128.34 139.25 52.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.73 -0.47 . . . . 70.34 109.73 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.594 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.2 m -122.51 117.83 26.84 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.755 -0.378 . . . . 73.11 110.78 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.7 mt -95.0 115.26 65.22 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 63.1 109.913 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.19 135.95 7.6 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.469 2.113 . . . . 71.04 112.689 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 68.3 m-85 -134.7 160.76 37.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 64.42 110.258 177.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.61 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 44.9 mt-30 -130.37 114.52 15.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.91 0.386 . . . . 73.32 110.832 -176.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.07 130.63 46.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.547 -0.297 . . . . 65.42 110.407 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 13.8 ptp180 -141.27 158.12 44.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.582 -0.281 . . . . 74.44 110.825 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 94.4 m-85 -75.93 142.03 42.14 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.148 -0.478 . . . . 74.12 110.257 175.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.548 ' HD1' HG22 ' A' ' 48' ' ' THR . 75.7 t80 -128.81 125.78 38.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.934 -0.575 . . . . 73.52 109.988 177.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -94.02 131.43 39.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.097 0.475 . . . . 72.13 110.736 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.5 p -101.13 7.31 43.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.502 -0.772 . . . . 72.34 109.572 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.83 -129.66 1.75 Allowed Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.246 -1.141 . . . . 73.21 110.246 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 144' ' ' THR . . . -83.82 95.37 8.44 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.452 -0.573 . . . . 73.11 109.452 175.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -49.48 111.35 0.48 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.824 -0.625 . . . . 70.23 111.363 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 142' ' ' ALA . 36.6 p -103.62 142.98 25.72 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-O 121.328 0.585 . . . . 73.12 110.845 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.75 166.94 22.58 Favored 'Trans proline' 0 C--N 1.331 -0.35 0 C-N-CA 123.816 3.011 . . . . 75.14 112.734 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.02 179.79 19.98 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.799 -0.715 . . . . 64.1 111.513 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.06 112.71 5.19 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 117.003 0.401 . . . . 72.45 110.915 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.548 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -101.2 74.1 1.55 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.451 0.643 . . . . 62.22 111.031 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.432 HD22 ' C ' ' A' ' 148' ' ' ALA . 0.9 OUTLIER -113.0 123.44 50.34 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.323 -0.621 . . . . 72.42 109.323 178.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.403 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -129.34 156.45 44.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.95 0.405 . . . . 53.21 111.598 -176.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -125.65 130.18 51.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.69 -0.687 . . . . 71.42 109.826 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.09 137.11 32.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.103 0.478 . . . . 44.44 111.663 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.4 p -112.63 125.0 53.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.679 -0.691 . . . . 72.21 109.902 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -105.52 134.84 47.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.144 0.497 . . . . 74.32 110.682 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.592 ' HA ' HG21 ' A' ' 16' ' ' VAL . 1.9 ttmm -117.9 107.42 14.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.684 -0.689 . . . . 74.14 110.158 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -74.45 140.86 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.142 0.496 . . . . 72.14 110.206 179.212 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -128.39 110.12 12.05 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.117 -0.698 . . . . 71.53 109.117 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.799 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -113.49 -7.16 13.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.942 0.401 . . . . 75.42 111.666 177.2 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.492 HE21 HG22 ' A' ' 65' ' ' VAL . 92.7 mt-30 . . . . . 0 C--O 1.243 0.75 0 CA-C-O 118.5 -0.762 . . . . 62.21 109.513 168.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.883 0.373 . . . . 75.34 110.712 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.09 160.64 37.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 74.13 110.11 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.4 t -89.87 -13.35 36.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.707 0.289 . . . . 61.02 110.934 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.0 p -98.58 -179.56 4.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.823 0.344 . . . . 75.13 110.647 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.488 ' CG2' HG12 ' A' ' 37' ' ' VAL . 32.7 m -93.53 15.88 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.975 0.417 . . . . 72.4 110.955 177.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 61.11 20.58 11.06 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.452 -0.795 . . . . 71.3 112.092 174.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.558 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 84.79 102.85 0.63 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.591 -0.814 . . . . 45.44 111.978 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.465 ' HA3' ' OH ' ' A' ' 137' ' ' TYR . . . -93.64 155.36 22.09 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.242 -0.98 . . . . 22.35 112.048 -177.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 33' ' ' GLN . 53.8 p -140.99 151.5 44.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.899 -0.408 . . . . 74.2 109.899 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -121.0 124.1 71.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.042 -0.725 . . . . 50.44 109.042 172.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -92.2 116.99 29.43 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.118 -0.633 . . . . 72.15 109.688 175.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.453 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 93.1 m-85 -104.15 114.5 28.78 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.626 -0.715 . . . . 73.33 110.157 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -102.32 134.81 45.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 75.4 110.274 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.93 -120.68 3.43 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.944 -0.646 . . . . 53.14 111.899 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.639 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 38.3 mt-10 62.88 19.72 11.73 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.153 0.501 . . . . 54.22 111.085 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.785 HG23 HG22 ' A' ' 17' ' ' VAL . 17.2 m -76.17 -30.49 20.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.053 -0.521 . . . . 64.01 111.719 -176.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.785 HG22 HG23 ' A' ' 16' ' ' VAL . 4.2 m -149.17 143.87 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.146 0.498 . . . . 64.23 111.145 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -140.7 22.45 2.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.213 -0.903 . . . . 74.01 108.916 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.75 -77.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.089 -0.959 . . . . 72.43 111.131 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.569 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -78.19 -39.15 41.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.024 -0.535 . . . . 65.02 110.492 178.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 0.8 OUTLIER -143.65 128.39 18.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.055 -0.521 . . . . 74.1 109.778 -176.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.44 119.25 27.53 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.366 -0.379 . . . . 70.53 110.138 -178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.452 ' HA ' HD23 ' A' ' 58' ' ' LEU . 9.6 t -62.45 128.65 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.709 -0.478 . . . . 74.11 109.709 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 28' ' ' VAL . 18.6 t70 -59.57 142.88 51.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.781 -0.645 . . . . 63.44 111.397 -176.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -62.12 -24.37 67.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.774 -0.648 . . . . 74.32 112.221 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.4 -17.91 70.12 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.618 -0.801 . . . . 33.11 111.932 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 p -105.48 -14.23 15.37 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.821 0.304 . . . . 52.4 111.821 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.639 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 33.8 m -79.73 -8.02 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.09 0.471 . . . . 73.42 110.353 175.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -157.78 90.24 1.06 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.559 -0.904 . . . . 62.52 108.559 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.429 ' HG3' ' HB2' ' A' ' 12' ' ' PHE . 17.1 pt20 -137.06 112.86 9.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.726 -0.67 . . . . 74.22 110.52 -176.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.55 HG22 ' HB ' ' A' ' 9' ' ' THR . 7.4 m -97.22 95.37 7.68 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.532 -0.758 . . . . 74.44 109.094 174.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 p -79.26 134.42 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.193 -0.458 . . . . 64.0 110.541 -176.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.567 ' HA ' HG22 ' A' ' 9' ' ' THR . 26.6 mp0 -91.33 120.96 32.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.121 -0.491 . . . . 74.01 110.281 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.429 HD21 HG23 ' A' ' 10' ' ' VAL . 2.8 mm? -86.55 -30.04 22.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.777 -0.647 . . . . 74.41 109.356 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.558 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 92.33 177.35 41.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.329 -0.851 . . . . 51.12 111.951 -178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -72.31 95.34 1.71 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.707 -0.479 . . . . 72.42 109.707 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.488 HG12 ' CG2' ' A' ' 5' ' ' VAL . 9.8 p -66.49 138.49 22.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.209 0.528 . . . . 74.02 110.379 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.6 mtm-85 -75.25 106.55 6.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.623 -0.717 . . . . 74.01 109.967 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 p -62.49 -26.08 68.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 75.21 111.09 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.19 -8.07 52.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 63.25 111.428 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.1 m -97.07 -15.51 20.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.813 0.339 . . . . 61.15 110.749 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.8 mp -124.28 95.94 4.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.699 0.285 . . . . 72.31 110.241 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.01 11.34 7.07 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.667 -0.413 . . . . 74.14 112.061 -176.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -152.8 143.42 22.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.417 0.151 . . . . 74.01 110.829 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 41.2 tt0 -58.35 118.46 5.56 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.021 0.438 . . . . 74.34 110.638 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.79 -17.59 8.18 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.22 -0.752 . . . . 64.03 111.22 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.3 124.67 24.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.847 0.356 . . . . 43.31 110.222 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.508 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 4.6 p -121.88 114.23 20.74 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.937 -0.574 . . . . 74.01 110.139 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.8 t -72.22 174.46 7.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.069 -0.514 . . . . 33.21 110.838 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -60.54 120.88 10.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 51.3 110.29 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -80.46 142.48 34.23 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.411 0.624 . . . . 44.03 111.276 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 28.9 m -83.66 147.88 5.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.825 -1.08 . . . . 72.42 109.306 170.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.99 92.02 0.72 Allowed Glycine 0 C--N 1.307 -1.05 0 C-N-CA 120.837 -0.696 . . . . 72.45 112.257 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -102.19 -175.71 2.91 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.407 -0.59 . . . . 75.31 109.407 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.548 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.0 p-10 -147.31 147.48 30.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.39 0.614 . . . . 71.24 111.821 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.9 mt -107.45 115.87 49.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.342 -0.985 . . . . 73.43 108.342 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . 48.7 tt0 -103.71 138.45 40.34 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.078 -0.51 . . . . 75.21 111.129 -171.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 23' ' ' VAL . 64.4 mt -119.11 115.23 23.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.711 -0.677 . . . . 73.14 109.744 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -92.63 136.26 33.38 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.977 -0.556 . . . . 74.12 110.239 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 51.02 68.91 0.71 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.944 0.777 . . . . 53.3 110.938 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.519 ' SG ' HD13 ' A' ' 124' ' ' LEU . 53.0 t -98.62 129.39 45.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.954 . . . . 62.05 110.435 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -104.06 138.27 40.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.935 -0.575 . . . . 70.15 111.169 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.5 p -104.95 10.5 34.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.094 0.405 . . . . 65.52 112.094 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -85.13 -37.15 20.57 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.459 -0.571 . . . . 72.23 109.459 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 20' ' ' ALA . 10.3 p -100.58 -13.7 8.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.773 -0.649 . . . . 51.05 110.852 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.679 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -123.92 179.48 4.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.64 0.257 . . . . 74.44 111.066 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 20.3 m -143.24 -60.95 0.42 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.486 . . . . 74.21 110.736 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -136.68 140.72 42.9 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.374 -0.602 . . . . 75.32 109.374 -178.254 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -98.16 119.8 37.44 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.185 0.517 . . . . 54.24 109.977 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -131.25 110.84 11.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.538 -0.756 . . . . 73.43 109.754 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -89.03 145.45 7.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.915 0.388 . . . . 72.15 110.298 -175.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -123.37 123.87 41.67 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.965 -0.561 . . . . 35.04 109.62 174.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 91.1 m-85 -88.95 130.43 35.45 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.021 0.439 . . . . 65.32 110.696 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.7 tp -130.59 125.56 34.44 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.771 -0.65 . . . . 75.41 110.154 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.37 -164.2 21.48 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 111.132 -0.787 . . . . 51.4 111.132 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.456 ' O ' HD13 ' A' ' 86' ' ' LEU . 42.3 m -80.79 122.65 27.44 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.27 -0.271 . . . . 70.0 110.27 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.518 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -85.37 140.65 30.6 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.91 -0.404 . . . . 73.43 109.91 177.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 tt -65.05 -28.98 46.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.886 0.374 . . . . 64.34 110.867 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 22.0 t70 -153.99 174.95 13.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.482 -0.562 . . . . 60.3 109.482 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.36 -37.83 31.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.093 0.473 . . . . 73.14 110.339 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.63 -19.18 62.33 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.161 -0.776 . . . . 65.44 111.161 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 42.4 m80 -107.08 43.5 1.16 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.167 -0.679 . . . . 64.14 109.167 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.518 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -72.62 11.45 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.141 -0.936 . . . . 42.2 112.927 -176.028 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 85' ' ' VAL . 16.4 p30 -110.81 -8.96 14.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.058 0.456 . . . . 73.04 110.554 175.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.455 HG23 ' OD1' ' A' ' 84' ' ' ASN . 48.3 t -101.84 120.92 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.101 -0.499 . . . . 62.24 110.561 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.555 HD22 HD13 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -67.03 132.8 48.62 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.16 -0.473 . . . . 70.23 109.746 178.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.71 148.52 36.72 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.032 -0.531 . . . . 45.01 110.304 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.447 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 2.0 mm? -82.98 140.77 32.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.14 -0.482 . . . . 61.21 110.557 -177.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -62.26 143.0 57.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.486 -0.779 . . . . 53.01 110.095 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 m -111.54 114.63 27.84 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.672 -0.694 . . . . 65.12 110.984 -172.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -90.83 9.72 29.1 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.667 -0.697 . . . . 73.5 110.234 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 66.49 7.28 4.92 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.258 -0.883 . . . . 75.11 111.98 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.04 -45.96 4.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.104 0.478 . . . . 72.44 110.381 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 172.94 91.2 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.809 -0.71 . . . . 74.33 112.301 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.459 ' HA ' ' H ' ' A' ' 147' ' ' ALA . 1.5 p -84.14 156.36 22.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.63 0.252 . . . . 75.22 110.404 174.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.92 138.7 50.31 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.061 -0.348 . . . . 74.05 110.061 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.18 159.3 33.32 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.842 -0.343 . . . . 63.52 110.932 -176.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 68.67 10.46 7.9 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.719 -0.673 . . . . 71.0 111.238 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.48 178.28 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.153 -0.476 . . . . 72.44 110.306 174.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 176.28 -175.9 47.59 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 109.831 -1.308 . . . . 53.32 109.831 177.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -118.9 114.21 44.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.334 0.588 . . . . 75.31 111.162 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.41 ' HG2' ' HB2' ' A' ' 138' ' ' PHE . 2.9 pt20 -104.15 140.16 38.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.698 -0.683 . . . . 65.45 109.498 173.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.4 mp -98.11 126.35 51.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.997 -0.547 . . . . 73.34 110.296 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.408 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 15.5 mt -89.92 147.5 23.69 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.262 -0.881 . . . . 72.12 109.141 176.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.406 ' HA ' ' CD1' ' A' ' 133' ' ' PHE . 1.5 p-10 -70.87 -169.94 0.39 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.773 -0.454 . . . . 73.33 109.773 175.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 106' ' ' ARG . 16.9 ptt180 -61.98 -30.86 71.22 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.108 -0.237 . . . . 73.43 111.527 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.4 p -81.92 -34.55 29.83 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.748 -0.381 . . . . 65.55 110.76 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 119.77 31.54 1.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.582 -0.818 . . . . 64.13 112.931 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.48 139.02 42.64 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.128 -0.323 . . . . 63.01 110.128 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.05 130.71 43.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.396 -0.366 . . . . 52.11 111.1 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt -97.37 131.98 43.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.144 -0.48 . . . . 71.03 110.506 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.411 ' H ' HG21 ' A' ' 117' ' ' THR . 14.7 m -72.23 137.01 46.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.257 -0.428 . . . . 74.44 110.72 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.555 HD13 HD22 ' A' ' 86' ' ' LEU . 49.2 mt -79.64 49.09 0.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 75.24 110.876 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -107.45 -8.43 16.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.441 0.639 . . . . 62.34 110.324 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.23 -12.51 12.78 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.0 -0.619 . . . . 63.43 112.811 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.19 -10.85 23.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.932 0.396 . . . . 43.4 111.153 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.411 HG21 ' H ' ' A' ' 112' ' ' THR . 24.5 m -92.57 95.12 9.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.079 0.466 . . . . 61.34 110.21 178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.569 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 72.6 m-85 -91.03 153.01 20.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.784 -0.644 . . . . 73.11 110.241 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.4 m -65.23 171.37 3.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.083 -0.508 . . . . 71.52 111.251 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.3 p -61.3 146.17 48.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.104 -0.498 . . . . 72.12 110.301 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.431 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 41.9 mt-10 -57.57 101.34 0.07 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.96 0.409 . . . . 73.24 111.605 -176.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.6 m -85.85 104.18 15.28 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.947 -0.761 . . . . 70.43 108.947 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 m -63.3 115.08 4.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.262 0.553 . . . . 73.51 110.878 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.562 HD21 ' HB2' ' A' ' 69' ' ' ALA . 92.0 mt -74.59 147.08 42.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.176 -0.92 . . . . 74.12 111.777 -174.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.464 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -121.14 151.47 39.86 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.359 -0.837 . . . . 61.02 108.924 171.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 94.6 m-20 -63.12 107.34 1.01 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.902 0.382 . . . . 71.32 110.681 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.84 -149.12 20.08 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.967 -0.635 . . . . 65.41 111.789 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 30.1 m -82.12 123.61 29.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.124 0.487 . . . . 73.03 110.994 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 61' ' ' CYS . 28.0 m-80 -117.48 135.09 54.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.942 -0.572 . . . . 32.52 109.537 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.548 HG22 ' HB2' ' A' ' 55' ' ' ASN . 2.3 m -122.45 118.87 29.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.804 -0.358 . . . . 75.41 110.488 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.0 mt -98.58 112.38 62.34 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.697 -0.482 . . . . 73.11 109.697 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.85 138.96 17.17 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.599 2.2 . . . . 71.25 112.469 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 78.6 m-85 -136.61 163.69 29.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.692 0.282 . . . . 74.0 110.528 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 96.2 mt-30 -130.71 119.09 21.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.102 -0.499 . . . . 72.13 110.896 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -105.21 123.23 47.47 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.099 -0.334 . . . . 73.04 110.099 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.539 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 2.8 ptp180 -135.98 159.17 42.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.39 -0.368 . . . . 74.12 111.234 -176.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 59.8 m-85 -80.5 134.41 35.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.746 -0.661 . . . . 64.53 110.418 174.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.41 ' HB2' ' HG2' ' A' ' 102' ' ' GLN . 84.8 t80 -117.69 119.21 34.26 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.139 -0.689 . . . . 71.11 109.139 176.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 45' ' ' GLU . . . -83.6 130.29 34.98 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.023 -0.535 . . . . 72.35 110.661 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 69.3 p -101.32 -0.54 35.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.88 0.848 . . . . 71.33 108.763 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.21 -131.54 1.77 Allowed Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 114.28 -1.327 . . . . 73.22 110.594 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 144' ' ' THR . . . -88.66 98.72 11.84 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.749 -0.463 . . . . 72.04 109.749 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -47.47 113.01 0.62 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.896 0.747 . . . . 71.33 111.395 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 142' ' ' ALA . 41.3 p -104.06 146.34 32.37 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 116.012 -0.54 . . . . 64.43 110.585 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.27 173.36 5.25 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.6 2.866 . . . . 62.55 113.628 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 138.0 -147.47 19.25 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.675 -0.693 . . . . 74.52 111.857 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.459 ' H ' ' HA ' ' A' ' 95' ' ' SER . . . -98.84 117.08 32.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 110.22 -0.289 . . . . 70.43 110.22 175.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.447 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -115.48 59.65 0.71 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.95 0.405 . . . . 34.31 111.625 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -112.69 137.03 51.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.035 -0.728 . . . . 73.34 109.035 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.486 ' HB3' HG13 ' A' ' 10' ' ' VAL . . . -128.81 169.92 13.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.016 0.436 . . . . 55.13 111.756 -175.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -137.8 127.26 24.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.581 -0.736 . . . . 75.12 109.618 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.86 140.59 29.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.075 0.464 . . . . 74.02 111.774 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.1 p -110.28 126.11 53.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.595 . . . . 65.52 109.53 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -106.44 143.39 34.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.059 0.457 . . . . 64.42 110.834 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.594 ' HA ' HG21 ' A' ' 16' ' ' VAL . 4.9 ttmm -120.04 111.96 18.55 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.812 -0.631 . . . . 74.15 110.435 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.676 HG12 HG12 ' A' ' 71' ' ' VAL . 1.4 m -81.81 127.17 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.165 -0.68 . . . . 72.5 109.165 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -112.18 121.87 46.14 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.137 -0.483 . . . . 50.13 109.849 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.679 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -137.39 -18.32 1.28 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.841 0.311 . . . . 72.04 111.841 177.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.495 ' HG2' ' OXT' ' A' ' 159' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.926 0 N-CA-C 109.163 -0.68 . . . . 72.45 109.163 170.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.713 0.292 . . . . 52.32 110.293 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.53 179.42 8.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.361 -0.381 . . . . 65.45 110.279 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.416 HG23 HG23 ' A' ' 4' ' ' THR . 9.0 t -113.23 -7.57 13.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.131 0.491 . . . . 71.5 110.099 176.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.416 HG23 HG23 ' A' ' 3' ' ' THR . 73.1 p -121.02 -179.27 3.97 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.911 -0.586 . . . . 74.44 110.092 177.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.51 HG22 HG12 ' A' ' 37' ' ' VAL . 28.1 m -92.64 15.79 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.004 0.43 . . . . 74.15 110.526 176.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 61.95 13.09 5.32 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.355 -0.839 . . . . 74.02 112.563 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.426 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 91.09 94.96 1.27 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.731 -0.747 . . . . 55.25 111.967 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.02 158.64 31.97 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.532 -0.842 . . . . 70.2 112.171 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.523 ' HB ' HG22 ' A' ' 31' ' ' THR . 11.2 p -140.24 135.32 32.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.857 0.361 . . . . 61.21 111.102 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.463 ' HB ' ' CE2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -108.11 125.47 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.423 -0.584 . . . . 74.33 109.423 173.347 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -96.81 111.03 23.39 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.068 0.461 . . . . 72.04 110.19 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CE2' ' HB ' ' A' ' 10' ' ' VAL . 95.7 m-85 -101.07 122.9 44.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.886 -0.597 . . . . 74.35 110.47 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -108.08 138.43 44.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.449 -0.341 . . . . 70.12 110.535 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -109.3 -133.08 6.65 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.935 -0.65 . . . . 72.04 112.321 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 62.95 34.55 14.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.39 0.614 . . . . 65.2 110.897 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 155' ' ' LYS . 25.3 m -93.76 -22.88 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.592 -0.731 . . . . 73.42 111.663 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.468 HG21 ' CG2' ' A' ' 156' ' ' VAL . 19.0 m -143.01 149.18 18.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.537 -0.301 . . . . 55.41 111.303 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -156.86 32.04 0.3 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.797 0.808 . . . . 65.22 109.346 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.89 -66.73 0.9 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.313 -0.858 . . . . 73.01 111.469 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.414 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -98.92 -41.03 7.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 61.44 110.804 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 1.8 m -135.63 128.88 31.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.153 -0.476 . . . . 71.55 110.075 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.5 127.84 39.33 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.022 -0.536 . . . . 53.33 110.007 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.58 131.26 31.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.338 -0.392 . . . . 51.24 110.217 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 28' ' ' VAL . 25.1 t70 -57.93 145.45 35.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.736 -0.666 . . . . 71.45 111.254 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.32 -30.72 70.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 64.02 111.775 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.66 -12.03 82.17 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.61 -0.805 . . . . 74.13 111.652 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 t -97.82 -24.38 15.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.453 0.168 . . . . 71.12 110.591 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 24' ' ' ASP . 20.7 m -80.44 -7.14 10.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.822 0.344 . . . . 73.4 110.597 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -154.85 88.95 1.21 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.813 -0.631 . . . . 53.33 109.681 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.86 115.57 10.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.638 0.732 . . . . 65.53 110.98 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.523 HG22 ' HB ' ' A' ' 9' ' ' THR . 3.9 m -98.38 97.63 8.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.027 -0.988 . . . . 72.52 109.067 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.69 127.94 39.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.128 0.49 . . . . 74.44 111.092 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -86.61 125.43 33.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.645 . . . . 65.02 109.976 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.406 HD21 ' CG2' ' A' ' 10' ' ' VAL . 2.7 mm? -87.54 -22.91 24.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.109 0.481 . . . . 72.52 110.032 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.426 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 93.41 173.32 40.1 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.581 -0.736 . . . . 53.42 112.095 -178.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.74 91.49 5.91 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.761 0.315 . . . . 44.43 110.701 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.51 HG12 HG22 ' A' ' 5' ' ' VAL . 7.2 p -78.06 146.07 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.171 -0.468 . . . . 53.41 109.824 176.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -87.07 132.15 33.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.02 -0.363 . . . . 73.51 110.02 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 53.2 p -68.33 -18.64 64.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.228 0.537 . . . . 72.12 111.129 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.44 -12.92 61.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 63.31 111.197 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.0 m -97.04 9.14 42.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.22 0.533 . . . . 65.01 110.426 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.617 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 6.0 mt -145.61 49.35 1.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.584 -0.734 . . . . 72.11 109.612 -174.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.23 6.06 41.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.529 0.937 . . . . 52.52 113.529 -168.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.452 HE21 ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -161.27 155.34 22.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.488 -0.19 . . . . 63.03 110.488 177.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 139' ' ' ALA . 33.1 tt0 -56.95 132.61 53.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 123.347 0.404 . . . . 55.41 110.371 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.84 -17.01 36.15 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.706 -0.759 . . . . 44.24 111.663 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -69.68 121.61 17.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.333 . . . . 75.2 110.302 176.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.524 ' HB ' ' HD3' ' A' ' 136' ' ' ARG . 37.7 p -119.15 135.78 54.5 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.045 -0.525 . . . . 74.42 110.432 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.0 t -89.46 178.26 6.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.673 -0.491 . . . . 64.35 109.673 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -67.51 129.27 39.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.375 -0.375 . . . . 74.33 110.069 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -81.36 158.56 24.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.449 0.642 . . . . 62.35 111.316 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 27.7 m -101.22 147.34 8.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.824 -1.08 . . . . 71.51 109.124 171.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.92 86.39 0.58 Allowed Glycine 0 C--N 1.31 -0.911 0 C-N-CA 120.675 -0.774 . . . . 53.04 111.978 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -96.08 166.46 11.75 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.699 -0.482 . . . . 64.32 109.699 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.469 ' HB2' HG22 ' A' ' 130' ' ' THR . 20.7 p-10 -125.45 139.37 53.7 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.407 0.622 . . . . 70.54 111.998 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.2 mt -109.74 107.05 21.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.562 -0.903 . . . . 74.15 108.562 167.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -100.59 135.51 41.91 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.715 -0.675 . . . . 73.2 111.322 -170.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.4 mt -112.12 132.58 54.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.504 -0.771 . . . . 73.11 109.527 175.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -109.07 145.49 35.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.419 -0.355 . . . . 74.43 110.058 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.11 48.71 20.39 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.616 0.722 . . . . 73.32 110.944 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.51 ' SG ' HD22 ' A' ' 124' ' ' LEU . 48.0 t -85.8 155.97 20.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.066 -0.97 . . . . 74.1 110.323 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' HA ' ' ND2' ' A' ' 126' ' ' ASN . 21.1 t70 -128.3 152.86 47.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.524 -0.307 . . . . 73.34 111.512 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.9 p -119.06 5.81 11.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.25 -0.432 . . . . 72.13 111.677 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -84.34 -34.99 23.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.091 0.472 . . . . 74.4 109.978 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 p -103.68 -21.36 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 54.23 111.196 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -124.27 -175.53 3.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.269 -0.271 . . . . 72.23 110.269 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.5 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 20.4 m -146.26 -55.8 0.28 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.731 0.301 . . . . 74.0 111.629 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.5 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -135.97 143.81 45.06 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 109.881 -0.414 . . . . 62.41 109.881 -178.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.523 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -106.09 127.48 53.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.135 0.493 . . . . 42.14 110.163 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.2 118.82 15.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.509 -0.769 . . . . 70.0 109.016 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.725 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -90.99 146.76 5.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.999 0.428 . . . . 74.11 110.54 -175.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.434 ' HB2' ' CD2' ' A' ' 118' ' ' PHE . . . -118.79 119.13 33.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.782 -0.645 . . . . 62.03 109.354 174.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 93.8 m-85 -84.67 130.88 34.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.993 0.425 . . . . 45.31 110.527 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.9 tp -125.91 123.59 38.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.664 -0.698 . . . . 74.11 109.935 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.5 -170.99 26.93 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.513 -0.635 . . . . 61.14 111.513 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.7 m -84.06 125.49 32.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.62 0.248 . . . . 74.22 110.631 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 83' ' ' THR . . . -87.72 138.98 30.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.591 -0.277 . . . . 73.1 110.515 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.446 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 10.8 tt -64.06 -31.95 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.863 0.363 . . . . 73.31 111.224 -177.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -145.81 -178.19 5.98 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.268 -0.642 . . . . 72.33 109.268 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.57 -42.52 24.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.692 0.282 . . . . 63.1 110.865 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.67 -16.77 74.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.58 -0.819 . . . . 75.34 111.951 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -105.12 51.3 0.76 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.13 0.491 . . . . 52.44 109.979 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.405 ' HA ' ' CB ' ' A' ' 77' ' ' ALA . 1.1 p -74.93 3.6 7.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.806 -0.634 . . . . 55.14 112.138 -178.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -104.79 -5.96 20.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.927 0.394 . . . . 75.31 110.671 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.05 120.12 58.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.175 -0.466 . . . . 75.45 110.628 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.494 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -67.51 129.78 40.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.93 -0.396 . . . . 74.31 109.93 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.49 141.62 39.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.27 -0.423 . . . . 51.21 110.605 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.8 mm? -82.38 140.32 33.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.074 -0.512 . . . . 71.03 110.027 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -62.01 127.61 32.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.37 0.605 . . . . 74.01 110.748 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.45 ' HA ' ' OG ' ' A' ' 95' ' ' SER . 0.7 OUTLIER -83.54 115.08 21.94 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.168 -0.924 . . . . 53.32 110.909 -177.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.1 m -87.99 -6.89 57.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.062 -0.517 . . . . 73.24 109.776 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.71 16.34 10.45 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.502 -0.772 . . . . 70.54 111.517 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.25 4.28 2.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 53.21 111.452 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.37 64.62 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.289 -0.958 . . . . 51.41 112.749 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 90' ' ' SER . 71.1 m -95.73 149.97 20.91 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.709 -0.289 . . . . 64.02 110.571 173.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.94 125.45 27.61 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.785 -0.45 . . . . 71.34 109.785 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.07 166.46 16.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.35 -0.386 . . . . 71.1 110.243 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 68.88 9.96 7.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.253 0.549 . . . . 63.1 110.446 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.45 -174.47 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.279 -0.873 . . . . 63.21 109.685 173.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.49 -174.5 46.56 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.637 -0.985 . . . . 41.11 110.637 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 p -119.66 115.65 48.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.446 0.641 . . . . 75.14 110.841 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -107.1 142.22 37.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.489 -0.778 . . . . 73.45 109.642 175.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.1 mp -103.12 123.78 56.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.032 -0.531 . . . . 72.51 110.3 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.493 HD11 ' NE ' ' A' ' 136' ' ' ARG . 12.7 mt -86.27 147.64 25.99 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.647 -0.706 . . . . 60.21 109.11 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.585 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 1.1 p-10 -74.1 -170.99 1.03 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.59 -0.522 . . . . 73.42 109.59 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -69.04 -25.53 64.52 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.975 -0.29 . . . . 65.43 111.554 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.1 p -84.69 -26.47 27.71 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 120.647 -0.421 . . . . 62.1 111.015 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.81 34.51 1.52 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 60.54 112.825 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -114.73 135.56 54.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.424 -0.213 . . . . 62.2 110.424 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.43 122.74 17.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 55.53 110.836 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.1 mt -88.88 135.84 33.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.367 -0.379 . . . . 75.04 110.614 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.2 m -83.7 145.44 28.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.025 -0.534 . . . . 51.41 110.556 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 73' ' ' PHE . 52.7 mt -81.34 40.14 0.55 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.335 -0.393 . . . . 73.1 111.275 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -77.02 -22.64 52.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.432 -0.349 . . . . 65.3 111.092 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.17 -11.27 37.4 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.764 -0.731 . . . . 74.23 112.005 -172.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.41 2.56 9.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.178 0.513 . . . . 64.3 110.562 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.9 m -99.74 102.65 14.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.829 -0.623 . . . . 71.25 109.491 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.434 ' CD2' ' HB2' ' A' ' 72' ' ' ALA . 83.8 m-85 -93.81 167.24 11.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.746 -0.661 . . . . 70.3 111.771 -171.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.585 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 2.9 m -73.93 179.45 4.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.242 -0.89 . . . . 71.22 110.572 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.7 t -69.08 146.01 52.95 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.246 -0.649 . . . . 74.23 109.246 173.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -54.14 106.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.475 0.484 . . . . 64.12 111.544 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.5 m -91.16 103.76 16.4 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.076 -0.713 . . . . 72.21 109.076 173.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.8 m -55.41 124.36 16.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.789 -0.641 . . . . 75.21 111.099 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 69' ' ' ALA . 83.7 mt -83.38 150.69 25.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.79 -0.641 . . . . 73.55 111.275 -176.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.475 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -129.34 152.29 49.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.174 -0.921 . . . . 70.13 108.747 171.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 18.8 m120 -65.53 118.39 9.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.996 0.427 . . . . 71.41 110.43 175.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 124.76 -137.88 10.78 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.817 -0.706 . . . . 64.3 112.167 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 20.5 m -88.61 127.81 35.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.411 . . . . 54.33 111.016 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -124.95 112.72 16.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.219 -0.446 . . . . 74.35 110.078 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.8 m -102.98 106.52 17.07 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.798 0.332 . . . . 74.33 110.527 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.7 mt -87.63 115.39 62.76 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.624 -0.51 . . . . 74.14 109.624 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -84.23 132.94 5.38 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.602 2.201 . . . . 64.33 112.841 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.429 ' HE1' ' HG ' ' A' ' 119' ' ' SER . 76.2 m-85 -131.9 159.55 38.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 54.31 110.462 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.681 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 99.2 mt-30 -127.97 112.88 15.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.246 -0.434 . . . . 73.13 111.487 -176.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.54 127.7 45.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.206 -0.452 . . . . 71.51 110.192 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.524 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 15.8 ptp180 -139.06 163.08 33.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.45 -0.341 . . . . 55.13 110.719 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 100' ' ' GLY . 71.7 m-85 -81.57 142.5 32.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.97 -0.559 . . . . 63.4 110.715 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -130.43 119.79 23.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.639 -0.709 . . . . 74.42 109.421 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 45' ' ' GLU . . . -81.27 137.62 35.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.397 -0.365 . . . . 61.13 111.009 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.442 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 68.9 p -110.13 2.79 19.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.676 0.75 . . . . 53.31 109.349 176.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 172.22 -129.45 1.74 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.915 -1.039 . . . . 53.5 110.864 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.15 90.26 8.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.848 0.324 . . . . 74.31 110.283 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.64 114.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.491 0.495 . . . . 62.33 111.557 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 26.6 p -104.71 139.62 20.28 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-O 121.385 0.612 . . . . 75.24 110.613 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.59 162.77 41.32 Favored 'Trans proline' 0 C--N 1.333 -0.272 0 C-N-CA 123.799 3.0 . . . . 73.01 112.868 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.63 -162.88 26.21 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.732 -0.747 . . . . 54.25 111.817 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.84 113.65 8.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.866 0.365 . . . . 63.24 111.338 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.598 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -111.47 63.61 0.61 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.5 0.667 . . . . 75.33 110.357 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -117.48 128.46 55.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.401 -0.818 . . . . 63.54 109.782 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.494 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -134.21 169.5 17.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.364 -0.38 . . . . 65.43 111.342 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.8 146.36 50.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 63.23 109.62 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -151.02 138.86 19.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.146 0.498 . . . . 65.14 111.291 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.6 p -107.2 121.81 45.27 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.794 -0.639 . . . . 64.43 109.771 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -102.61 137.19 41.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.367 -0.378 . . . . 73.34 110.528 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HA ' HG21 ' A' ' 16' ' ' VAL . 3.9 tmmm? -119.78 113.08 20.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.344 -0.389 . . . . 75.44 110.345 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.725 HG12 HG12 ' A' ' 71' ' ' VAL . 1.2 m -77.57 137.28 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.773 -0.454 . . . . 70.52 109.773 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -115.2 123.56 49.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.393 -0.367 . . . . 71.03 110.172 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.647 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 3.1 p90 -142.88 -19.07 0.66 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.688 -0.687 . . . . 75.14 109.875 171.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.925 HE21 ' HA ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-N 115.184 -0.916 . . . . 65.4 109.363 168.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.62 0.248 . . . . 54.14 111.015 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.83 -174.91 3.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.7 -0.227 . . . . 64.15 110.853 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 t -94.56 -10.87 30.75 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.883 0.373 . . . . 71.41 110.849 177.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.0 p -113.84 -179.87 3.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.16 -0.473 . . . . 63.21 109.914 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.98 12.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.898 0.38 . . . . 72.24 110.922 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 61.86 17.89 9.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.58 -0.736 . . . . 75.44 111.872 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.412 ' HA2' ' C ' ' A' ' 35' ' ' GLY . . . 83.0 95.53 0.56 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.598 -0.81 . . . . 54.25 111.396 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.78 157.39 45.47 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.174 -1.012 . . . . 34.13 111.895 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.473 ' HB ' HG22 ' A' ' 31' ' ' THR . 4.8 p -140.79 138.9 34.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.679 0.276 . . . . 64.22 111.077 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -115.48 120.44 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 116.441 -0.345 . . . . 54.14 110.071 176.025 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -91.09 107.37 19.16 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.165 -0.471 . . . . 65.51 110.08 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.11 125.11 40.42 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.02 -0.536 . . . . 72.52 110.545 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -112.33 133.81 54.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.994 -0.548 . . . . 54.3 111.165 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.07 -130.07 5.62 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.461 -0.79 . . . . 73.11 111.88 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.47 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 44.3 mt-10 62.91 24.13 14.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.123 0.487 . . . . 65.13 110.993 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' A' ' 155' ' ' LYS . 22.1 m -77.85 -34.44 19.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.823 -0.626 . . . . 51.43 111.273 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.584 HG22 HG23 ' A' ' 16' ' ' VAL . 17.9 m -142.89 150.28 18.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.014 0.435 . . . . 64.14 111.189 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -144.34 22.42 1.68 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.417 -0.81 . . . . 74.01 108.961 175.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.92 -82.99 0.07 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.491 -0.777 . . . . 54.15 111.255 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.475 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -81.34 -35.65 30.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.796 0.332 . . . . 73.34 110.278 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 m -142.54 135.4 28.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.887 0.375 . . . . 64.54 110.023 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.04 123.97 40.92 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.102 -0.499 . . . . 64.3 109.861 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.487 ' HA ' HD23 ' A' ' 58' ' ' LEU . 14.2 t -61.03 131.63 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 109.722 -0.473 . . . . 65.34 109.722 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.431 ' O ' HG13 ' A' ' 28' ' ' VAL . 27.7 t70 -59.86 140.07 56.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.107 -0.497 . . . . 61.0 111.335 -176.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.13 -27.34 65.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.793 -0.64 . . . . 71.42 111.819 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.86 7.47 79.94 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.717 -0.754 . . . . 74.31 112.282 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.3 p -129.54 -10.96 4.52 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 122.712 -0.287 . . . . 72.55 111.387 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.47 ' HB ' ' HG3' ' A' ' 15' ' ' GLU . 29.2 m -78.24 -5.81 8.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 121.109 0.48 . . . . 73.1 110.505 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -157.2 96.14 1.54 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.446 -0.797 . . . . 73.25 109.015 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -143.64 121.8 12.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.212 0.53 . . . . 64.05 110.546 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 16.4 m -106.83 103.19 12.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.406 -0.815 . . . . 70.22 109.542 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 9' ' ' THR . 11.0 p -89.34 137.41 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.919 0.39 . . . . 73.32 110.97 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -91.05 128.7 36.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.767 -0.651 . . . . 74.44 109.574 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.16 -19.92 24.88 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.103 0.478 . . . . 72.42 110.265 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' C ' ' HA2' ' A' ' 7' ' ' GLY . . . 94.6 165.03 35.9 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.868 -0.682 . . . . 32.5 112.082 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -75.18 96.44 3.29 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.055 -0.35 . . . . 62.13 110.055 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 p -80.05 149.34 5.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.152 -0.476 . . . . 74.43 110.274 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.0 mtt85 -83.29 128.68 34.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.996 -0.547 . . . . 64.42 109.864 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 143' ' ' ALA . 6.6 p -77.78 -13.52 59.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.929 -0.578 . . . . 62.12 111.944 -172.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.14 50.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 65.11 110.915 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.486 ' HB2' HD12 ' A' ' 42' ' ' LEU . 5.5 m -67.42 -29.34 68.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.325 0.583 . . . . 33.45 110.472 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.5 mp -112.77 86.81 2.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.494 -0.775 . . . . 63.11 109.996 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.0 14.58 12.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.127 0.489 . . . . 72.43 111.122 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HG2' ' HB2' ' A' ' 47' ' ' ALA . 3.2 pm0 -141.5 135.91 30.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.052 -0.522 . . . . 75.15 110.324 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.5 tm-20 -59.32 119.97 8.41 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.563 -0.532 . . . . 73.44 109.563 175.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 109.9 -6.29 30.99 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.738 -0.744 . . . . 71.45 111.752 -175.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -65.8 135.31 54.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 73.43 111.005 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.1 p -120.97 140.82 51.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.055 -0.521 . . . . 45.0 110.355 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 t -104.34 -175.79 2.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.216 -0.447 . . . . 71.22 109.814 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.7 m -75.05 133.51 41.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.459 -0.337 . . . . 60.14 110.19 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -89.92 154.81 19.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.496 0.665 . . . . 74.33 112.021 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 31.5 m -92.82 156.65 3.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.646 -1.161 . . . . 62.25 109.22 169.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.89 101.65 1.22 Allowed Glycine 0 C--N 1.315 -0.587 0 C-N-CA 120.859 -0.686 . . . . 73.05 112.267 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -111.04 176.59 4.96 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.752 -0.462 . . . . 75.54 109.752 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.549 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.5 p-10 -136.24 149.51 48.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.403 0.621 . . . . 75.12 111.904 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.435 HD12 ' CE2' ' A' ' 133' ' ' PHE . 72.6 mt -113.93 113.86 45.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.11 -0.95 . . . . 61.03 108.684 169.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . 49.8 tt0 -96.83 140.33 31.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.101 -0.499 . . . . 72.43 110.951 -172.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 23' ' ' VAL . 64.5 mt -120.63 122.35 40.33 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.951 -0.568 . . . . 71.24 109.565 177.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -99.39 143.79 29.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.075 -0.511 . . . . 74.31 110.034 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 56.82 44.02 24.05 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.779 0.674 . . . . 75.35 110.845 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.597 ' SG ' HD22 ' A' ' 124' ' ' LEU . 6.0 t -75.24 142.04 43.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.109 -0.496 . . . . 74.42 110.31 -175.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -117.71 142.36 47.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.944 -0.571 . . . . 63.52 112.044 -172.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.4 p -113.28 4.51 16.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.79 -0.641 . . . . 62.42 111.398 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -76.0 -38.1 57.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.975 0.417 . . . . 74.24 110.085 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.404 HG22 ' HG3' ' A' ' 159' ' ' GLN . 12.6 p -107.86 -18.96 7.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.107 -0.497 . . . . 75.02 111.381 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.704 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -126.47 161.75 27.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.741 0.305 . . . . 75.32 111.52 -176.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.551 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 15.0 m -120.18 -55.74 2.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.203 -0.453 . . . . 72.44 111.462 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.551 ' HD2' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -136.53 148.87 47.83 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.81 -0.441 . . . . 65.24 109.81 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.636 ' HB2' HD21 ' A' ' 124' ' ' LEU . . . -103.48 140.6 37.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.039 0.447 . . . . 63.53 110.308 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.57 114.17 6.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.6 -0.727 . . . . 65.32 109.067 176.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.655 HG12 HG12 ' A' ' 156' ' ' VAL . 1.3 m -88.13 145.64 7.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.971 0.415 . . . . 60.52 110.834 -173.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.52 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -119.97 123.28 43.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.807 -0.633 . . . . 71.42 109.74 173.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.454 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 57.4 m-85 -86.34 142.52 28.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.2 0.524 . . . . 74.33 111.096 -179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.6 tp -134.18 123.15 23.87 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.487 -0.778 . . . . 54.41 109.963 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 113' ' ' LEU . . . -164.64 -177.05 36.95 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.767 -0.933 . . . . 62.23 110.767 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.9 m -77.41 121.73 24.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.954 0.377 . . . . 70.43 110.828 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.28 138.68 39.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 62.44 110.529 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.459 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 9.5 tt -69.14 -30.84 47.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 74.13 111.133 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -146.32 178.67 8.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.995 -0.372 . . . . 71.34 109.995 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.71 -30.77 28.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.074 0.464 . . . . 71.34 110.106 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.5 -25.85 31.91 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.726 -0.749 . . . . 54.32 111.539 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.423 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 67.1 m80 -103.5 72.64 1.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.302 0.572 . . . . 74.21 110.046 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 p -92.1 5.43 50.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.547 -0.751 . . . . 72.42 111.853 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -112.43 2.53 16.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 71.13 110.624 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 102' ' ' GLN . 57.6 t -111.01 122.85 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.861 -0.608 . . . . 70.32 110.095 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -69.88 131.38 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.674 0.274 . . . . 74.15 110.275 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.459 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -77.43 145.72 36.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 52.55 110.441 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.66 ' HG ' ' HA ' ' A' ' 148' ' ' ALA . 1.9 mm? -85.16 135.42 33.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.126 -0.488 . . . . 61.44 109.943 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -59.33 116.17 3.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 72.44 110.099 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 p -67.56 115.4 7.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.818 -0.628 . . . . 61.21 111.978 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.7 m -90.14 -9.82 46.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.778 -0.646 . . . . 52.42 110.146 177.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 67.6 -3.62 1.08 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.384 -0.826 . . . . 74.41 112.282 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -105.08 -22.92 13.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.056 0.455 . . . . 63.41 110.847 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 159.76 76.39 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.456 -0.658 . . . . 73.32 111.456 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 m -92.42 147.8 22.62 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.684 -0.488 . . . . 64.35 109.684 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.72 106.48 1.51 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.048 0.452 . . . . 62.21 110.319 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.36 159.31 15.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.143 -0.481 . . . . 74.01 110.574 -176.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.46 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 48.1 m-80 67.01 13.05 9.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.333 0.653 . . . . 54.51 111.17 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.48 167.62 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 CA-C-N 116.271 -0.422 . . . . 61.11 110.336 175.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.527 ' HA2' HD21 ' A' ' 88' ' ' LEU . . . -169.08 -173.8 37.07 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.221 -1.152 . . . . 52.03 110.221 176.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.78 115.26 47.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.363 0.601 . . . . 65.41 110.647 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.501 ' HB3' HG22 ' A' ' 85' ' ' VAL . 3.2 pt20 -100.49 139.77 35.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.771 -0.65 . . . . 63.35 109.365 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.454 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.2 mp -96.36 129.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.955 0.407 . . . . 62.12 110.295 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.537 ' HB3' ' HA2' ' A' ' 108' ' ' GLY . 49.0 mt -96.91 141.6 29.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.705 -0.679 . . . . 63.12 109.925 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.577 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -73.69 -173.05 1.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.131 -0.486 . . . . 74.15 110.033 177.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.438 ' HG3' HG23 ' A' ' 107' ' ' THR . 13.7 ptm180 -57.83 -25.28 60.44 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.276 0.473 . . . . 71.22 112.276 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.438 HG23 ' HG3' ' A' ' 106' ' ' ARG . 74.5 p -100.04 1.7 42.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 73.51 111.762 -177.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 83.32 38.09 11.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.642 -0.79 . . . . 71.14 112.713 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.52 136.13 51.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.228 -0.286 . . . . 74.43 110.228 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.91 120.74 14.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.328 -0.396 . . . . 63.22 111.013 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 105' ' ' ASP . 95.1 mt -88.21 129.94 35.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.064 -0.516 . . . . 74.31 110.617 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.8 m -76.43 137.6 39.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.903 -0.589 . . . . 73.45 110.954 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.472 HD13 HD22 ' A' ' 86' ' ' LEU . 37.5 mt -79.56 47.14 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 74.05 110.98 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -100.11 -14.34 18.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.878 -0.601 . . . . 74.21 110.367 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.4 -13.48 33.86 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.745 -0.74 . . . . 62.23 112.525 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -114.61 4.83 15.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.943 0.401 . . . . 62.13 111.12 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.2 m -100.5 99.65 10.28 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.555 -0.535 . . . . 65.33 109.555 176.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.529 ' HE1' ' HD2' ' A' ' 155' ' ' LYS . 64.1 m-85 -94.26 164.11 13.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.089 -0.505 . . . . 74.45 111.487 -172.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.577 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 8.3 m -72.94 -178.56 2.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.45 -0.795 . . . . 61.42 111.459 177.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 m -69.05 160.95 30.03 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.915 -0.584 . . . . 72.31 109.521 170.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.66 125.96 25.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.963 0.411 . . . . 74.44 110.944 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.428 HG21 HG12 ' A' ' 131' ' ' ILE . 20.1 m -109.23 98.72 8.1 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.38 -0.97 . . . . 70.44 108.38 168.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.4 m -57.22 116.58 3.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 73.22 111.078 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.636 HD21 ' HB2' ' A' ' 69' ' ' ALA . 76.3 mt -74.83 150.17 39.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.307 -0.86 . . . . 62.43 111.522 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -128.12 150.42 49.98 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.259 -0.882 . . . . 54.53 108.83 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -65.31 109.96 2.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.802 0.334 . . . . 71.53 110.354 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.4 -139.2 10.86 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.637 -0.792 . . . . 63.24 112.517 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 m -86.31 117.79 25.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.942 0.401 . . . . 63.42 111.061 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.526 HD22 ' N ' ' A' ' 129' ' ' ASN . 0.8 OUTLIER -112.16 148.62 33.63 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.508 -0.552 . . . . 70.41 109.508 178.198 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.549 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.2 m -138.01 113.65 9.67 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.265 -0.272 . . . . 72.32 110.265 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 10.2 mt -94.46 119.71 66.03 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.982 -0.377 . . . . 63.23 109.982 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 131' ' ' ILE . 4.9 Cg_endo -84.14 133.31 5.59 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.971 2.447 . . . . 74.11 112.514 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 105' ' ' ASP . 70.7 m-85 -135.63 163.44 30.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.296 -0.411 . . . . 73.32 110.691 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 90.0 mt-30 -126.71 148.87 49.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.016 -0.538 . . . . 73.42 110.66 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.24 122.52 26.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.182 -0.463 . . . . 50.21 110.335 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 2.1 ptp180 -134.1 164.96 26.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.458 -0.337 . . . . 64.01 110.633 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -83.98 143.07 30.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.116 -0.493 . . . . 63.5 110.555 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.51 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 57.2 t80 -130.17 125.94 36.24 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.894 -0.78 . . . . 61.24 108.894 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.648 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -89.73 135.18 33.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.017 0.437 . . . . 72.31 111.435 -177.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.545 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 72.2 p -102.53 9.91 39.18 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.756 -0.831 . . . . 55.04 108.756 175.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.09 -123.75 1.2 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.833 -1.076 . . . . 33.32 111.111 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -92.27 96.65 10.41 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.784 -0.45 . . . . 61.05 109.784 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 39' ' ' THR . . . -45.93 112.19 0.44 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.699 0.624 . . . . 62.43 111.164 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.7 p -105.12 139.57 20.25 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 115.947 -0.57 . . . . 72.02 109.944 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.83 157.41 58.38 Favored 'Trans proline' 0 C--N 1.328 -0.503 0 C-N-CA 123.417 2.745 . . . . 75.01 113.153 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.33 -165.2 29.43 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.598 -0.728 . . . . 62.24 112.11 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.18 114.57 11.51 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.796 0.331 . . . . 74.42 111.086 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.66 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -109.08 69.96 0.72 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.213 0.53 . . . . 61.1 110.361 176.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.455 HD22 ' N ' ' A' ' 149' ' ' ASN . 0.9 OUTLIER -110.34 123.63 50.19 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.567 -0.531 . . . . 75.14 109.567 179.25 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.455 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -132.38 158.81 40.99 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.841 0.353 . . . . 70.41 111.036 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -138.41 143.84 39.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.252 -0.431 . . . . 71.22 110.15 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.513 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -153.84 157.94 40.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.976 0.417 . . . . 73.12 111.358 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.3 p -109.49 155.12 21.73 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.723 -0.672 . . . . 64.33 109.412 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -127.6 123.22 35.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.092 0.472 . . . . 70.03 110.679 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.607 ' HA ' HG21 ' A' ' 16' ' ' VAL . 9.2 ttmt -102.6 105.63 16.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.095 -0.502 . . . . 71.03 110.359 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.655 HG12 HG12 ' A' ' 71' ' ' VAL . 1.3 m -76.61 128.85 37.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.507 -0.553 . . . . 54.32 109.507 177.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 8.0 tt0 -107.5 129.9 54.91 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.227 -0.442 . . . . 55.21 110.087 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.704 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -153.35 -23.66 0.15 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.18 -0.464 . . . . 75.0 110.836 174.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.404 ' HG3' HG22 ' A' ' 65' ' ' VAL . 19.9 tm0? . . . . . 0 C--O 1.242 0.679 0 N-CA-C 108.415 -0.958 . . . . 63.53 108.415 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.72 0.295 . . . . 64.24 110.53 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 145' ' ' PRO . . . -99.1 -171.54 2.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.093 -0.503 . . . . 74.32 109.675 174.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.469 HG23 HG23 ' A' ' 4' ' ' THR . 14.6 t -115.99 -14.53 11.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.441 0.639 . . . . 73.52 110.359 176.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.469 HG23 HG23 ' A' ' 3' ' ' THR . 49.0 p -120.95 175.72 5.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.84 -0.618 . . . . 74.44 110.203 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.488 HG22 HG12 ' A' ' 37' ' ' VAL . 35.2 m -91.65 17.39 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.137 0.494 . . . . 63.34 110.662 176.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 61.97 11.85 4.49 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.202 -0.908 . . . . 73.43 112.515 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 35' ' ' GLY . . . 82.97 95.53 0.56 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.43 -0.89 . . . . 52.34 111.566 -176.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.19 160.91 33.88 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.198 -1.001 . . . . 52.45 111.305 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.601 ' HB ' HG22 ' A' ' 31' ' ' THR . 65.8 p -138.88 140.6 38.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.684 0.278 . . . . 72.1 110.439 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.96 122.27 63.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.194 -0.669 . . . . 72.3 109.194 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -90.47 109.69 20.82 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.322 -0.621 . . . . 74.44 109.322 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -97.52 124.05 41.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.899 -0.591 . . . . 63.32 110.173 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -106.51 135.13 48.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.951 -0.568 . . . . 74.13 110.816 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.26 -137.72 6.61 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 121.098 -0.573 . . . . 74.41 112.534 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.408 ' HG3' ' HB ' ' A' ' 28' ' ' VAL . 46.4 mt-10 59.34 27.44 16.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.362 0.601 . . . . 64.41 110.774 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.716 HG23 HG22 ' A' ' 17' ' ' VAL . 22.8 m -80.29 -21.93 11.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.48 -0.782 . . . . 63.15 110.672 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.765 HG21 HG22 ' A' ' 156' ' ' VAL . 3.5 m -148.46 139.27 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.737 -0.665 . . . . 73.1 110.865 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -139.02 26.3 2.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.02 -0.536 . . . . 75.04 109.637 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.09 -86.97 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.28 0.474 . . . . 72.33 112.28 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.485 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -76.4 -16.79 59.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 72.31 111.08 -178.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 58' ' ' LEU . 59.7 m -150.87 157.16 42.57 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.425 -0.954 . . . . 55.14 108.425 178.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.55 116.22 26.19 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.491 -0.559 . . . . 71.01 109.491 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.65 134.04 23.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.378 -0.373 . . . . 64.34 110.113 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.476 ' O ' HG13 ' A' ' 28' ' ' VAL . 16.8 t70 -63.56 142.94 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.503 -0.317 . . . . 64.22 110.923 -177.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' A' ' 28' ' ' VAL . . . -59.43 -27.52 66.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 52.43 112.261 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.24 -21.38 78.0 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.508 -0.853 . . . . 73.35 112.095 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 p -104.73 -12.41 16.36 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.062 0.393 . . . . 74.31 112.062 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 25' ' ' ALA . 31.4 m -80.58 -5.32 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.894 0.378 . . . . 75.35 110.708 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -163.29 89.78 0.63 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.277 -0.638 . . . . 74.15 109.277 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -141.78 132.33 25.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.039 -0.528 . . . . 74.3 110.591 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.601 HG22 ' HB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -107.72 99.29 8.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.757 -0.656 . . . . 43.34 109.286 178.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 9' ' ' THR . 7.6 p -82.32 126.87 40.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.108 0.48 . . . . 62.42 111.252 -175.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.564 ' HA ' HG22 ' A' ' 9' ' ' THR . 25.7 mp0 -84.66 120.7 26.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.743 -0.662 . . . . 74.41 109.706 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.74 -28.83 36.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.058 -0.519 . . . . 73.22 110.183 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.494 ' O ' ' HA2' ' A' ' 7' ' ' GLY . . . 106.38 170.96 22.98 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.765 -0.652 . . . . 62.31 111.911 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -83.93 83.6 7.88 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.893 -0.41 . . . . 62.22 109.893 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.488 HG12 HG22 ' A' ' 5' ' ' VAL . 9.7 p -67.8 143.04 15.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.018 0.437 . . . . 75.12 110.65 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -77.73 115.51 17.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.818 -0.628 . . . . 63.14 109.795 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.7 p -61.45 -32.04 72.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.274 -0.421 . . . . 75.25 111.318 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.22 -24.34 66.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.066 -0.515 . . . . 74.24 111.791 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.1 m -76.22 -23.46 54.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.814 0.34 . . . . 74.42 110.939 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 5.4 mp -114.17 92.03 3.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.094 0.473 . . . . 71.44 110.225 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.36 19.26 8.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.004 0.431 . . . . 73.25 111.245 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -149.73 138.34 20.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.942 -0.572 . . . . 74.23 110.52 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 4.6 tm-20 -55.79 124.02 16.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 53.41 109.61 175.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.0 -3.93 38.58 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.961 -0.637 . . . . 61.5 111.962 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -67.42 123.1 19.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.772 0.32 . . . . 74.31 110.554 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.82 ' HB ' HH11 ' A' ' 136' ' ' ARG . 22.9 p -112.72 121.42 44.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.914 -0.585 . . . . 71.4 111.024 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.47 ' HB2' ' H ' ' A' ' 137' ' ' TYR . 60.7 m -73.81 157.48 36.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.177 -0.465 . . . . 73.21 110.458 175.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.4 m -60.66 127.93 34.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.751 -0.463 . . . . 65.22 109.751 175.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.11 154.95 28.96 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.479 0.656 . . . . 65.11 111.749 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 33.1 m -95.58 147.86 5.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 114.859 -1.064 . . . . 64.14 109.451 172.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.88 103.06 2.35 Favored Glycine 0 C--N 1.309 -0.964 0 C-N-CA 120.899 -0.667 . . . . 34.2 111.858 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -113.82 179.92 3.82 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.627 -0.509 . . . . 74.32 109.627 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.5 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 3.9 p-10 -138.34 149.94 46.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.424 0.631 . . . . 54.41 112.308 -173.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.461 HD12 ' CE2' ' A' ' 133' ' ' PHE . 81.1 mt -121.42 113.7 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.932 -1.031 . . . . 74.11 108.484 168.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 130' ' ' THR . 29.8 tt0 -99.07 136.9 38.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.035 0.445 . . . . 65.43 111.181 -172.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 78.3 mt -112.04 129.94 56.04 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.825 -0.625 . . . . 74.14 109.811 176.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -102.87 136.52 42.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.915 -0.584 . . . . 63.43 110.535 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 54.49 75.88 0.27 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 124.008 0.818 . . . . 74.4 112.055 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.6 m -97.55 138.81 34.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.652 -0.704 . . . . 34.15 111.18 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -112.57 137.63 50.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.727 -0.67 . . . . 61.22 110.638 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 p -102.25 6.2 40.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.099 -0.5 . . . . 75.41 111.94 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -90.27 -31.12 17.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.663 -0.495 . . . . 51.32 109.663 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 p -98.27 -22.18 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.733 -0.667 . . . . 72.55 111.337 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' A' ' 158' ' ' TYR . . . -141.58 168.42 19.82 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.028 -0.42 . . . . 25.51 111.029 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.543 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 36.9 m -125.7 -51.7 1.59 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.216 0.451 . . . . 54.22 112.216 -175.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.549 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -132.99 150.46 52.16 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.086 -0.383 . . . . 53.14 110.518 -177.028 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -108.69 130.42 55.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.916 0.389 . . . . 65.14 109.984 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.34 114.84 8.89 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.585 -0.524 . . . . 73.43 109.585 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.759 HG12 HG12 ' A' ' 156' ' ' VAL . 1.5 m -84.2 145.84 7.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 42.31 111.028 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . . . -117.63 116.92 28.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.498 -0.774 . . . . 51.41 109.806 174.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.409 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 65.7 m-85 -85.54 130.12 34.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.325 0.583 . . . . 64.53 110.979 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.9 tp -128.9 116.02 18.77 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.33 -0.85 . . . . 74.21 109.951 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -152.34 -171.54 20.04 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.201 -0.76 . . . . 62.01 111.201 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.7 m -85.58 116.14 23.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.864 0.332 . . . . 72.01 110.177 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.05 147.68 36.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.45 -0.341 . . . . 72.12 110.845 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.436 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 9.3 tt -63.52 -30.22 49.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.998 -0.546 . . . . 74.22 110.643 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.82 -178.56 5.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 71.01 109.584 174.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.74 -10.23 59.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.038 0.385 . . . . 74.23 112.038 -174.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.53 -44.05 3.27 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.978 -0.629 . . . . 63.13 111.607 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.406 ' CD2' ' HE2' ' A' ' 138' ' ' PHE . 60.7 m80 -97.1 61.15 1.74 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.576 0.703 . . . . 74.43 109.373 177.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -76.69 5.46 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.106 -0.952 . . . . 73.11 112.266 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -106.07 -4.82 19.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.478 . . . . 61.5 110.349 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.26 127.77 59.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.613 . . . . 72.23 110.448 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.477 HD12 ' HB1' ' A' ' 150' ' ' ALA . 0.1 OUTLIER -72.25 134.54 45.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.755 -0.461 . . . . 73.4 109.755 178.382 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -78.14 149.72 33.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.175 -0.466 . . . . 74.13 110.061 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 88' ' ' LEU . 2.5 mm? -82.04 133.19 35.27 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.222 -0.444 . . . . 64.24 110.374 -176.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -68.25 146.41 53.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.831 -0.622 . . . . 43.5 110.834 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.19 97.38 4.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.897 -0.592 . . . . 74.23 110.831 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.0 m -88.11 3.3 49.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.801 -0.636 . . . . 50.13 110.432 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.82 6.2 3.83 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.496 -0.774 . . . . 63.14 111.985 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -108.18 4.01 24.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.061 0.458 . . . . 41.21 110.738 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.14 89.07 1.86 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.721 -0.952 . . . . 74.21 110.721 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.2 m -73.06 145.36 46.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.749 0.309 . . . . 71.11 110.696 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.33 109.01 2.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 73.01 110.502 -175.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.37 160.68 14.29 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.154 -0.475 . . . . 71.14 110.974 -174.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 72.02 9.26 6.06 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.8 -0.636 . . . . 35.35 110.743 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.94 -172.37 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.852 -0.613 . . . . 62.34 110.459 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 137' ' ' TYR . . . 174.31 -176.95 46.66 Favored Glycine 0 N--CA 1.44 -1.093 0 N-CA-C 110.552 -1.019 . . . . 71.21 110.552 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -119.54 113.35 40.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.361 0.6 . . . . 64.34 110.648 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -102.29 137.58 40.36 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.223 -0.658 . . . . 72.15 109.223 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.409 HG21 ' CZ ' ' A' ' 73' ' ' PHE . 4.5 mp -100.42 120.35 49.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.054 0.454 . . . . 70.31 110.349 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.458 HD11 ' HE ' ' A' ' 136' ' ' ARG . 24.9 mt -86.1 145.86 26.86 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.686 -0.688 . . . . 72.41 109.225 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.528 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.2 OUTLIER -74.68 -171.93 1.4 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.242 -0.436 . . . . 72.54 109.914 177.569 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.457 HH11 ' HD2' ' A' ' 106' ' ' ARG . 19.0 ptt85 -58.49 -27.33 64.35 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.727 0.269 . . . . 71.44 111.727 -177.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 106' ' ' ARG . 19.0 p -100.45 7.96 43.87 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.877 0.37 . . . . 64.32 111.838 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 83.71 28.09 36.44 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 33.35 113.099 175.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.23 120.12 39.95 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.222 -0.288 . . . . 74.23 110.222 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 115.81 4.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.898 0.38 . . . . 74.52 110.518 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.7 mt -83.71 132.56 34.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.328 -0.396 . . . . 73.34 111.129 -177.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.516 ' H ' HG21 ' A' ' 117' ' ' THR . 15.6 m -73.05 140.45 47.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.723 -0.672 . . . . 74.22 110.547 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.414 ' CD1' HD22 ' A' ' 86' ' ' LEU . 74.2 mt -78.74 49.25 0.88 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.329 0.585 . . . . 74.35 110.504 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -85.67 -27.58 25.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.49 -0.777 . . . . 74.21 109.983 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.34 -22.47 32.39 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.627 -0.715 . . . . 12.25 111.539 -172.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.21 14.63 14.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.757 0.313 . . . . 30.04 111.119 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.516 HG21 ' H ' ' A' ' 112' ' ' THR . 21.6 m -95.24 105.25 17.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.47 -0.567 . . . . 64.35 109.47 174.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 72' ' ' ALA . 86.5 m-85 -97.41 156.29 16.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.225 0.536 . . . . 74.41 111.473 -173.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 7.3 m -68.92 -178.83 1.3 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.392 -0.822 . . . . 72.42 111.143 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.3 t -69.36 156.69 38.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.883 -0.784 . . . . 73.24 108.883 170.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.549 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 51.7 mt-10 -66.06 109.14 2.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.729 0.299 . . . . 72.34 111.476 -175.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.429 ' OG1' ' HD3' ' A' ' 106' ' ' ARG . 22.7 m -89.08 96.82 10.88 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.644 -0.873 . . . . 53.33 108.644 171.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.6 m -60.07 122.05 13.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.911 -0.586 . . . . 73.14 110.903 -176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.8 mt -81.87 150.45 27.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.423 -0.808 . . . . 60.5 111.16 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -130.68 161.46 31.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.227 -0.657 . . . . 72.15 109.227 169.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -60.35 112.74 2.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 72.54 110.973 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 125.47 -141.45 13.0 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.766 -0.731 . . . . 71.22 112.595 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.0 m -82.1 131.56 35.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.791 0.329 . . . . 74.2 111.233 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -130.82 114.47 15.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.158 -0.474 . . . . 74.43 109.873 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.5 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 4.7 m -107.04 117.81 35.05 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.827 0.346 . . . . 61.23 110.267 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.4 mt -94.39 116.8 66.82 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.988 -0.551 . . . . 74.41 110.174 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -81.59 138.13 10.59 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.033 2.489 . . . . 64.41 111.958 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.461 ' CE2' HD12 ' A' ' 56' ' ' ILE . 74.0 m-85 -135.35 161.77 34.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.365 -0.379 . . . . 62.43 110.53 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.678 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 43.0 mt-30 -127.91 114.65 17.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 53.31 110.802 -175.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.43 132.38 49.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.68 -0.237 . . . . 71.32 110.55 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.82 HH11 ' HB ' ' A' ' 48' ' ' THR . 12.4 ptp180 -143.1 160.07 41.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.967 0.413 . . . . 75.34 111.206 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.47 ' H ' ' HB2' ' A' ' 49' ' ' SER . 73.3 m-85 -80.32 145.83 31.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.776 -0.647 . . . . 74.22 110.553 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.406 ' HE2' ' CD2' ' A' ' 82' ' ' HIS . 64.4 t80 -131.88 118.45 19.84 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.845 -0.616 . . . . 71.34 109.661 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -86.97 132.66 33.73 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.299 -0.41 . . . . 75.51 111.235 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.496 ' HA ' ' HG2' ' A' ' 45' ' ' GLU . 66.0 p -99.14 5.08 47.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.679 0.752 . . . . 65.21 109.424 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 173.14 -117.78 0.67 Allowed Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 114.647 -1.16 . . . . 45.32 110.744 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -94.72 98.47 10.8 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.927 -0.397 . . . . 74.33 109.927 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -50.54 123.71 9.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.018 -0.537 . . . . 60.43 110.807 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 39.9 p -116.02 147.62 39.65 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-O 121.125 0.488 . . . . 73.32 110.686 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.423 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 43.4 Cg_endo -64.31 163.18 27.35 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.668 2.912 . . . . 73.25 112.553 -178.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.59 -164.43 27.39 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.645 -0.788 . . . . 61.22 112.065 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -85.35 115.1 22.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.65 0.262 . . . . 70.3 110.459 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -108.48 55.15 0.64 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.138 0.494 . . . . 64.42 111.323 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -105.13 138.98 40.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.062 -0.517 . . . . 73.33 109.895 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.477 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -140.63 179.69 6.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.932 0.396 . . . . 72.25 111.773 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -143.95 137.1 27.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.621 -0.718 . . . . 75.41 109.71 -178.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -150.36 139.84 21.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.892 0.377 . . . . 72.22 111.271 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 30.5 p -103.71 132.28 50.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.195 -0.457 . . . . 51.41 109.899 176.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -107.39 124.05 49.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.104 0.478 . . . . 63.2 110.391 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.619 ' HA ' HG21 ' A' ' 16' ' ' VAL . 3.0 tmmm? -105.62 99.39 8.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.921 -0.581 . . . . 75.24 109.492 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.765 HG22 HG21 ' A' ' 17' ' ' VAL . 1.4 m -74.84 127.96 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.64 0.733 . . . . 73.42 110.178 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -103.67 108.61 19.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.525 -0.761 . . . . 73.44 111.009 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.571 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 2.5 p90 -126.15 -33.95 2.59 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.017 -0.734 . . . . 73.02 109.017 166.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 C--O 1.245 0.834 0 CA-C-N 115.263 -0.88 . . . . 60.11 109.336 168.617 . . . . . . . . 0 0 . 1 stop_ save_